<SEC-DOCUMENT>0001628280-24-045030.txt : 20241104
<SEC-HEADER>0001628280-24-045030.hdr.sgml : 20241104
<ACCEPTANCE-DATETIME>20241104164252
ACCESSION NUMBER:		0001628280-24-045030
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		111
CONFORMED PERIOD OF REPORT:	20240930
FILED AS OF DATE:		20241104
DATE AS OF CHANGE:		20241104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aquestive Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001398733
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				208623253
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38599
		FILM NUMBER:		241424294

	BUSINESS ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059
		BUSINESS PHONE:		908-941-1900

	MAIL ADDRESS:	
		STREET 1:		30 TECHNOLOGY DRIVE
		CITY:			WARREN
		STATE:			NJ
		ZIP:			07059

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MonoSol Rx, Inc.
		DATE OF NAME CHANGE:	20070507
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>aqst-20240930.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525,d:0121722c2f7d4b94a9a7ec2585983b32-->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:aqst="http://aquestive.com/20240930" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>aqst-20240930</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-25">0001398733</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-26">December 31</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-27">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-28">Q3</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-29">False</ix:nonNumeric><ix:nonNumeric contextRef="c-346" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1058">364</ix:nonNumeric><ix:nonNumeric contextRef="c-343" name="ecd:TrdArrDuration" format="ixt-sec:durday" id="f-1059">382</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="aqst-20240930.xsd"/></ix:references><ix:resources><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="product"><xbrli:measure>aqst:product</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="lease"><xbrli:measure>aqst:lease</xbrli:measure></xbrli:unit><xbrli:unit id="payment"><xbrli:measure>aqst:payment</xbrli:measure></xbrli:unit><xbrli:unit id="noteholder"><xbrli:measure>aqst:noteholder</xbrli:measure></xbrli:unit><xbrli:unit id="transaction"><xbrli:measure>aqst:transaction</xbrli:measure></xbrli:unit><xbrli:unit id="quarterlyinstallment"><xbrli:measure>aqst:quarterlyInstallment</xbrli:measure></xbrli:unit><xbrli:unit id="cause"><xbrli:measure>aqst:cause</xbrli:measure></xbrli:unit><xbrli:unit id="plaintiff"><xbrli:measure>aqst:plaintiff</xbrli:measure></xbrli:unit><xbrli:unit id="lawsuit"><xbrli:measure>aqst:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-03</xbrli:startDate><xbrli:endDate>2024-04-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-23</xbrli:startDate><xbrli:endDate>2024-04-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-04-12</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-12</xbrli:startDate><xbrli:endDate>2022-04-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementCommitmentShareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-22</xbrli:startDate><xbrli:endDate>2024-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-03-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-22</xbrli:startDate><xbrli:endDate>2024-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HasicoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:ZevraMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-02</xbrli:startDate><xbrli:endDate>2023-03-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-09-24</xbrli:startDate><xbrli:endDate>2019-02-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-04-01</xbrli:startDate><xbrli:endDate>2016-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:AtnahsPharmaUKLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-26</xbrli:startDate><xbrli:endDate>2022-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedAmendedAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-03-27</xbrli:startDate><xbrli:endDate>2023-03-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-10-26</xbrli:startDate><xbrli:endDate>2022-10-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-06-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-01</xbrli:startDate><xbrli:endDate>2022-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-15</xbrli:startDate><xbrli:endDate>2019-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-15</xbrli:startDate><xbrli:endDate>2023-05-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-05-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-07-15</xbrli:startDate><xbrli:endDate>2019-07-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">aqst:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-11-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-01</xbrli:startDate><xbrli:endDate>2023-11-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:InitialWarrantOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-07-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:PreFundedWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-14</xbrli:startDate><xbrli:endDate>2023-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-02</xbrli:startDate><xbrli:endDate>2023-08-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants0.96ExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants0.96ExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants4.25ExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants5.38ExercisePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-11-03</xbrli:startDate><xbrli:endDate>2020-11-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-11-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-321"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-322"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-323"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-324"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-325"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFourMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-327"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-332"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSixMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-333"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-334"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-335"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-336"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-337"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-338"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:NeurelisIncVAquestiveTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-339"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:NeurelisIncVAquestiveTherapeuticsIncMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-05-03</xbrli:startDate><xbrli:endDate>2022-05-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-340"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-29</xbrli:startDate><xbrli:endDate>2024-07-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-341"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-342"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA-BC</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-343"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-344"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-345"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-346"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-347"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-348"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001398733</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-09-30</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-Q</ix:nonNumeric></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:34.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:472.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3">September&#160;30, 2024</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:511.50pt"><tr><td style="width:1.0pt"/><td style="width:34.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:472.75pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-4">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from _____</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to _____</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-38599</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-6">Aquestive Therapeutics, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in its Charter)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.993%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.796%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-7">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-8">30 Technology Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Warren</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">NJ</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">07059</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-12">82-3827296</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of Incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(&#160;<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">908</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">941-1900</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification Number)</span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address, Zip Code and Telephone Number of Registrant&#8217;s Principal Executive Offices)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:36.528%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.822%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-15">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-16">AQST</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-17">NASDAQ Global Market</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: &#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">None</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-18">Yes</ix:nonNumeric>&#160; &#9744; No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-19">Yes</ix:nonNumeric>&#160; &#9744; No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Securities Exchange Act of 1934.</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.268%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.779%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-20">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="f-21">&#9746;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-22">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160; &#9744; Yes&#160; &#9746; <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-23">No</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of outstanding shares of the registrant&#8217;s common stock, par value of $0.001 per share (the "Common Stock"), as of the close of business on November&#160;1, 2024 was <ix:nonFraction unitRef="shares" contextRef="c-2" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-24">91,178,193</ix:nonFraction>.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.271%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page No.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART I &#8211; FINANCIAL INFORMATION</span></td><td colspan="3" style="border-top:2pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_16">Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_19">Condensed Balance Sheets as of </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_19">September </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_19">30, 2024 and December 31, 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_22">Condensed Statements of Operations and Comprehensive (Loss) Income for the three and </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_22">nine</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_22"> months ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_22">September</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_22"> 30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_25">Condensed Statements of Changes in Stockholders&#8217; Deficit for the three and </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_25">nine</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_25"> months ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_25">September </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_25">30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_31">Condensed Statements of Cash Flows for the </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_31">nine</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_31"> months ended </a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_31">September</a><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_31"> 30, 2024 and 2023</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_31">9</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_34">Notes to Unaudited Condensed Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_34">10</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_103">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_103">32</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_139">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_139">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_142">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_142">50</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PART II &#8211; OTHER INFORMATION</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_148">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_148">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_151">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_151">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_154">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_154">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_157">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_157">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_160">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_160">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_163">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_163">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_166">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_166">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_169">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i0121722c2f7d4b94a9a7ec2585983b32_169">52</a></span></div></td></tr></table></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GLOSSARY OF TERMS, ABBREVIATIONS AND ACRONYMS</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following terms, abbreviations and acronyms are used to identify frequently used terms and phrases that may be used in this report (dollar amounts in thousands):</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:20.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TERM</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEFINITION</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5% Notes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.5% Senior Secured Notes due 2025</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5% Notes</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.5% Senior Secured Notes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ACAAI</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">American College of Allergy Asthma and Immunology</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ABL facility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asset-based borrowing facility</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ADHD</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Attention deficit hyperactivity disorder </span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adrenaverse&#8482; </span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Epinephrine prodrug platform currently comprised of Anaphylm&#8482; and AQST-108</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ALS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amyotrophic lateral sclerosis</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANVISA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brazilian Health Regulatory Agency</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">API</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Active Pharmaceutical Ingredients</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AQST</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ ticker symbol for Aquestive Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASC</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Codification</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assertio</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assertio Holdings, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assertio Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License Agreement between Aquestive and Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASU</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounting Standards Updates</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ATM facility</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">At-The-Market facility for the purchase of AQST Common Stock, then in effect</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Indenture</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture for the 12.5% Notes</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CMC</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chemistry, Manufacturing, Controls</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CNS</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Central Nervous System</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock, par value $0.001 per share, of the Company </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Warrants</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued with private placement of up to $100,000 aggregate principal of 12.5% Notes originally due 2025</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Company</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract research organization</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ESPP</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee Stock Purchase Plan</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Exchange Act of 1934</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Existing Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Purchase Warrants with the holder of the remaining 5,000,000 warrants</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First Amendment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">First amendment to the Sunovion License Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortovia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fortovia Therapeutics Inc. (previously Midatech Pharma PLC)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Generally Accepted Accounting Principles </span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haisco</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haisco Pharmaceutical Group Co., Ltd.</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Haisco Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">License, Development and Supply Agreement with Haisco, a Chinese limited company listed on the Shenzhen Stock Exchange</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hypera</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hypera Pharma</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indenture Agreement</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement governing the 13.5% Senior Secured Notes</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indivior</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indivior Inc. (formerly, Reckitt Benckiser Pharmaceuticals Inc)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indivior Amendment 11</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 11 to the Indivior License Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indivior License Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial Exploitation Agreement with Reckitt Benckiser Pharmaceuticals, Inc. (with subsequent amendments collectively)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Park</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Park Capital Fund, LLC</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.397%"><tr><td style="width:1.0%"/><td style="width:20.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:77.382%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lincoln Park Purchase Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Agreement with Lincoln Park Capital Fund, LLC</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marathon</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marathon Asset Management</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monetization Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase and Sale Agreement between Aquestive and Sunovion </span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MSSP</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed Security Services Provider </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MTPA or Mitsubishi</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mitsubishi Tanabe Pharma America, Inc. (formerly, Mitsubishi Tanabe Pharma Holdings America, Inc.)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Meaningful, used in percentage changes</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NASDAQ</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The NASDAQ Stock Market</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Drug Application</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Warrants</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase 2,750,000 shares of Common Stock </span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Offering</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$45,000 aggregate principal amount of 13.5% Notes due November 1, 2028.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacodynamics</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Atnahs Pharma UK Limited, a company registered in England and Wales</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia Agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and Supply Agreement with Atnahs Pharma UK Limited,</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmanovia Amendment</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended License and Supply Agreement with Atnahs Pharma UK Limited as of March 27, 2023</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PK</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharmacokinetic</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTO</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States Patent and Trademark Office</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PDUFA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prescription Drug User Fee Act</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-IND</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-Investigational New Drug</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Obligations</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the Royalty Rights Agreements</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Rights Agreements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Rights Agreements, component of 13.5% Senior Secured Notes</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSU</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Unit</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities and Exchange Commission</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Purchase Agreements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities Purchase Agreements with certain purchasers entered into on June 6, 2022</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Separation Agreement, including a Consulting Agreement with Keith J. Kendall</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion Pharmaceuticals Inc</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sunovion License Agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KYNMOBI Commercialization Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Territory</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certain countries of the European Union, the United Kingdom, Switzerland, Norway and the Middle East and North Africa under the Pharmanovia Agreement</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TEVA</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teva Pharmaceuticals USA, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TGA</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Australian Government Department of Health&#8217;s Therapeutics Goods Administration</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Underwritten Public Offering</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital raise of gross proceeds of $77,519, including partial exercise of the underwriters' option for $2,519</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zambon</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zambon S.p.A.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zevra</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Zevra Therapeutics, Inc. (formerly KemPharm, Inc.)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_16"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;FINANCIAL STATEMENTS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_19"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:70.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-30">77,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-31">23,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:TradeAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-32">9,684</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TradeAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-33">8,471</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-34">7,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-35">6,769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-36">1,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-37">1,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-38">96,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-39">40,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-40">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-41">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-42">5,310</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-43">5,557</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-45">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-46">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-47">5,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-48">109,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-49">57,418</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders&#8217; deficit</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-50">7,572</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-51">8,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-52">5,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-53">6,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-54">482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="f-55">390</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-56">1,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-57">1,551</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-58">1,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent" scale="3" id="f-59">922</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loans payable, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LoansPayableCurrent" scale="3" id="f-60">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LoansPayableCurrent" scale="3" id="f-61">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-62">15,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-63">18,308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-64">31,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">27,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-66">18,835</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:UnsecuredLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-67">14,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">62,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">63,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">5,109</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">5,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-72">20,266</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-73">32,345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">2,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-76">155,378</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-77">163,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingencies (Note 19)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-3" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-78"/></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-4" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-79"/></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; deficit:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-3" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-80"><ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="3" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-81">0.001</ix:nonFraction></ix:nonFraction> par value. Authorized <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-82"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-83">250,000,000</ix:nonFraction></ix:nonFraction> shares; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-84"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-85">91,178,193</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-86"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-87">68,533,085</ix:nonFraction></ix:nonFraction> shares issued and outstanding at September&#160;30, 2024 and December 31, 2023, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-88">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="f-89">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-90">300,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="f-91">212,521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-92">346,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-93">319,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; deficit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-94">45,420</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-95">106,487</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; deficit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-96">109,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-97">57,418</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Operations and Comprehensive (Loss) Income</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share and per share data amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:53.405%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.801%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.801%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.526%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.805%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-98">13,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-99">13,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-100">45,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-101">37,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs and expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-102">4,437</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-103">4,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-104">13,352</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-105">16,152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-106">5,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-107">3,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-108">15,363</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-109">10,216</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-110">12,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-111">7,385</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-112">34,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-113">22,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-114">21,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-115">15,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-116">62,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="f-117">48,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-118">8,290</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-119">2,377</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-120">17,192</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-121">11,191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income/(expenses):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-122">2,780</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-123">1,256</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-124">8,343</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestExpenseNonoperating" format="ixt:num-dot-decimal" scale="3" id="f-125">4,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to royalty obligations</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="3" id="f-126">1,359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="3" id="f-127">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:num-dot-decimal" scale="3" id="f-128">4,075</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RoyaltyExpense" format="ixt:fixed-zero" scale="3" id="f-129">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to the sale of future revenue</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-130">59</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-131">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-132">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="aqst:InterestExpenseSaleOfFutureRevenues" scale="3" id="f-133">163</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income and other income, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="aqst:InterestAndOtherIncomeNet" scale="3" id="f-134">979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="aqst:InterestAndOtherIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-135">1,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:InterestAndOtherIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-136">2,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="aqst:InterestAndOtherIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-137">16,156</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-138">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="3" id="f-140">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-141">353</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income before income taxes</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-142">11,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-143">2,175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-144">27,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-145">385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes (benefit) expense</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-146">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-147">140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-149">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-150">11,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-151">2,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-152">27,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-153">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive (loss) income</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-154">11,509</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-155">2,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-156">27,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="f-157">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) earnings per share attributable to common stockholders:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (in dollars per share)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-158">0.13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-159">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-160">0.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-161">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (in dollars per share)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-162">0.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-163">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-164">0.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-165">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic (in shares)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-166">91,082,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-167">64,678,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-168">85,224,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-169">59,252,768</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted (in shares)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-170">91,082,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-171">64,678,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-172">85,224,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-173">61,513,736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three Months Ended March 31, 2024, June 30, 2024 and September&#160;30, 2024</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.358%"/><td style="width:0.1%"/></tr><tr style="height:19pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deficit</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-174">68,533,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-175">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-176">212,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-177">319,077</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-178">106,487</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering-ATM</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-179">4,557,220</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-180">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-181">12,381</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-182">12,385</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering-ATM</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-183">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-184">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-185">16,666,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-186">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-187">74,983</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-188">75,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-189">5,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-190">5,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-191">1,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-192">1,580</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-193">490,359</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-194">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-195">893</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-196">231,400</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-197">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-198">539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-199">12,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-200">12,828</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-21" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-201">90,478,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-202">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-203">295,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-204">331,905</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-205">36,301</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering-ATM</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-206">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-207">158</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-208">559,801</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-209">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-210">2,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-211">2,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-212">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-213">359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-214">17,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-215">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-216">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-217">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-218">1,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-219">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-220">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-221">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-222">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-223">2,745</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-224">91,059,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-225">91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-226">299,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-227">334,650</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-228">35,479</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-229">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-230">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-39" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-231">7,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-232">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-233">202</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-39" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-234">125,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-235">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-236">193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-237">11,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-238">11,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-239">91,178,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-240">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-241">300,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-242">346,159</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-243">45,420</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-top:5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_28"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Changes in Stockholders&#8217; Deficit</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Three Months Ended March 31, 2023, June 30, 2023 and September 30, 2023</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands, except share amounts)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.911%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.358%"/><td style="width:0.1%"/></tr><tr style="height:19pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders&#8217;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Deficit</span></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-44" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-244">54,827,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-245">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-246">192,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-247">311,207</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-248">118,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-48" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-249">1,078,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-250">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-251">992</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-252">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-253">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-254">77</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-255">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-256">344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-53" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-257">16,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-258">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-259">8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-51" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="f-260">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockholdersEquityOther" scale="3" id="f-261">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-54" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-262">8,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-263">8,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-55" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-264">55,922,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-265">56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">193,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-267">303,139</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-268">109,235</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued upon warrant exercises</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-59" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-269">3,689,452</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-270">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-271">3,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-272">3,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-62" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-273">1,981,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-274">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-275">4,407</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-276">4,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-277">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-278">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" format="ixt:num-dot-decimal" scale="0" id="f-279">18,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-280">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="3" id="f-281">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-282">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-283">631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested restricted stock units, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-65" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" format="ixt:num-dot-decimal" scale="0" id="f-284">3,510</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-285">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="f-286">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="f-287">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:StockholdersEquityOther" scale="3" id="f-288">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-289">5,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-290">5,792</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2023</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-69" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-291">61,615,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-292">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-293">202,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-294">308,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-295">106,651</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued upon warrant exercises</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-296">5,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-297">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-298">4,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-75" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-299">4,800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock issued under public equity offering</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-300">124,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-301">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="f-302">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;text-indent:-18pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of common stock issued under public equity offering</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-77" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-303">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-78" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-304">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-305">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="f-306">774</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="f-307">625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-308">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="f-309">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-80" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-310">2,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-311">2,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at September 30, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-81" decimals="0" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-312">66,740,765</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-81" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-313">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-314">207,972</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-83" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-315">310,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-316">102,927</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Condensed Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited)</span></div><div><span><br/></span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:74.706%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.630%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.631%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income </span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-317">27,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-318">241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net (loss) income to net cash used for operating activities:</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation, amortization, and impairment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-319">571</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="f-320">878</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on contract termination</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnContractTermination" scale="3" id="f-321">300</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GainLossOnContractTermination" format="ixt:fixed-zero" scale="3" id="f-322">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-323">4,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-324">1,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of debt issuance costs and discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-325">8,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="f-326">174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-327">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-328">239</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-329">1,228</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables" format="ixt:num-dot-decimal" scale="3" id="f-330">3,177</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="f-331">252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" format="ixt:num-dot-decimal" scale="3" id="f-332">1,299</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-333">1,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-334">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-335">146</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-336">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-337">2,408</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-338">3,469</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-339">12,582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="f-340">2,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for operating activities</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-341">29,270</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-342">1,438</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-343">144</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="f-344">979</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-345">144</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="f-346">979</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under public equity offering, net - ATM</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-347">11,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-348">5,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from common stock issued under public equity offering, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:num-dot-decimal" scale="3" id="f-349">71,974</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" format="ixt:fixed-zero" scale="3" id="f-350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance and exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="aqst:ProceedsFromIssuanceAndExerciseOfWarrants" format="ixt:fixed-zero" scale="3" id="f-351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="aqst:ProceedsFromIssuanceAndExerciseOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-352">8,342</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from shares issued under employee stock purchase plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="f-353">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" scale="3" id="f-354">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options, net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="f-355">732</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:fixed-zero" scale="3" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of debt principal including lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="f-357">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-358">12,548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Premium paid to retire debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:fixed-zero" scale="3" id="f-359">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-360">1,027</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments for taxes on share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-361">1,100</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="f-362">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-363">83,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="f-364">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-365">54,021</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-366">2,356</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-367">23,872</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-368">27,273</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents at end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-369">77,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-370">24,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments for income taxes</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="f-371">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" format="ixt:fixed-zero" scale="3" id="f-372">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payments for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-373">5,566</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="f-374">2,827</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to the condensed financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_34"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:center;text-indent:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AQUESTIVE THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Condensed Financial Statements</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Unaudited, in thousands, except share and per share information)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_40"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" id="f-375" continuedAt="f-375-1" escape="true">Company Overview and Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="f-375-1" continuedAt="f-375-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A) Company Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aquestive Therapeutics, Inc. is a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#8217; lives through innovative science and delivery technologies. The Company is developing pharmaceutical products to deliver complex molecules through alternative administrations to invasive and inconvenient standard of care therapies. The Company has a proprietary commercial product, Libervant&#174; (diazepam) Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, seizure clusters, acute repetitive seizures) that are distinct from a patient&#8217;s usual seizure pattern in patients with epilepsy between two and five years of age, which was launched in April 2024. The Company is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, under the trade name "Anaphylm&#8482;", and its Adrenaverse epinephrine prodrug pipeline platform. The Company has <ix:nonFraction unitRef="product" contextRef="c-1" decimals="INF" name="aqst:RevenueFromContractWithCustomerNumberOfCommercializedProducts" format="ixt-sec:numwordsen" id="f-376">five</ix:nonFraction> licensed commercialized products which are marketed by its licensees in the U.S. and around the world. The Company is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm&#174;, and has proven drug development and commercialization capabilities. The Company&#8217;s production facilities are located in Portage, Indiana, and its corporate headquarters and primary research laboratory facilities are based in Warren, New Jersey.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)&#160;Equity Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Offering of Common Stock</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established its first ATM facility in September 2019, and since inception to September&#160;30, 2024, the Company has sold <ix:nonFraction unitRef="shares" contextRef="c-89" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-377">19,857,518</ix:nonFraction> shares of Common Stock which has generated net cash proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-378">60,558</ix:nonFraction>, net of commissions and other transactions costs of $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-379">3,085</ix:nonFraction>. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3 to register the offer and sale of up to $<ix:nonFraction unitRef="usd" contextRef="c-90" decimals="-6" name="aqst:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="3" id="f-380">250,000</ix:nonFraction> worth of shares of Common Stock ("Registration Statement No. 333-278498" or the "2024 Registration Statement"), that was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement was a $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-6" name="aqst:SaleOfStockAggregateOfferingPrice" format="ixt:num-dot-decimal" scale="3" id="f-381">100,000</ix:nonFraction> ATM facility pursuant to the Amended Equity Distribution Agreement with Piper Sandler &amp; Co. (successor to Piper Jaffray &amp; Co.).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2024, there were <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:fixed-zero" scale="0" id="f-382">no</ix:nonFraction> shares of Common Stock sold under the ATM facility. For the nine months ended September 30, 2024, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-85" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-383">4,557,220</ix:nonFraction> shares of Common Stock under the ATM facility which provided net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-384">11,855</ix:nonFraction> after deducting commissions and other transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-85" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-385">530</ix:nonFraction>. For the nine months ended September 30, 2023, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-93" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-386">3,184,740</ix:nonFraction> shares under the ATM facility which provided net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-93" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-387">5,274</ix:nonFraction> after deducting commissions and other transaction costs of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-388">392</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2022, the Company entered into the Lincoln Park Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth in the Lincoln Park Purchase Agreement, the Company has the right, but not the obligation, to sell to Lincoln Park up to $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-3" name="aqst:RightToSellCommonStockValue" format="ixt:num-dot-decimal" scale="0" id="f-389">40,000</ix:nonFraction> worth of shares of Common Stock from time to time over the <ix:nonNumeric contextRef="c-94" name="aqst:AgreementTerm" format="ixt-sec:durmonth" id="f-390">36</ix:nonNumeric>-month term of the Lincoln Park Purchase Agreement. The Lincoln Park Purchase Agreement contains an ownership limitation such that the Company will not issue, and Lincoln Park will not purchase, shares of Common Stock if it would result in Lincoln Park&#8217;s beneficial ownership exceeding <ix:nonFraction unitRef="number" contextRef="c-95" decimals="4" name="aqst:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" scale="-2" id="f-391">9.99</ix:nonFraction>% of the Company&#8217;s then outstanding Common Stock. Lincoln Park has covenanted under the Lincoln Park Purchase Agreement not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company&#8217;s Common Stock. In 2022, the Company sold <ix:nonFraction unitRef="shares" contextRef="c-96" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-392">1,600,000</ix:nonFraction> shares, in addition to <ix:nonFraction unitRef="shares" contextRef="c-97" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-393">236,491</ix:nonFraction> commitment shares, which provided proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-394">1,987</ix:nonFraction> in connection with the Lincoln Park Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company did <ix:nonFraction unitRef="shares" contextRef="c-98" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:fixed-zero" scale="0" id="f-395">not</ix:nonFraction> sell shares in connection with the Lincoln Park Purchase Agreement in 2023 or for the nine months ended September 30, 2024. The Company has no current intent to use the Lincoln Park facility.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2024, the Company completed the Underwritten Public Offering of <ix:nonFraction unitRef="shares" contextRef="c-99" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-396">16,666,667</ix:nonFraction> shares of its common stock at the public offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-100" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-397">4.50</ix:nonFraction> per share. In addition, pursuant to the partial exercise of the underwriters' option, on April 22, 2024, the Company sold an additional <ix:nonFraction unitRef="shares" contextRef="c-101" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-398">559,801</ix:nonFraction> shares of Common Stock. Net proceeds from the Underwritten Public Offering, including the exercise of underwriters' option were $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="3" id="f-399">72,868</ix:nonFraction>, after deducting underwriting discounts of $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-3" name="aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" format="ixt:num-dot-decimal" scale="3" id="f-400">4,651</ix:nonFraction>. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-401">894</ix:nonFraction> as of September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(C) Basis of Presentation</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-402" continuedAt="f-402-1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-402-1"><ix:continuation id="f-375-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December&#160;31, 2023 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;5, 2024 (the &#8220;2023 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2023 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company dissolved its subsidiaries and no longer prepares its financial statements on a consolidated basis. The dissolution of the subsidiaries did not have a material impact on the Company&#8217;s unaudited condensed financial statements as of September&#160;30, 2024 or the audited consolidated financial statements as of December&#160;31, 2023.</span></div></ix:continuation></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_43"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-403" continuedAt="f-403-1" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="f-403-1" continuedAt="f-403-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-404" continuedAt="f-404-1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company is no longer an &#8220;emerging growth company,&#8221; but remains a &#8220;smaller reporting company&#8221;. The Company complies with new or revised accounting standards by the relevant dates on which adoption of such standards is required for smaller reporting companies. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of September&#160;30, 2024:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to clarify the guidance in Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for such equity securities. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2023-0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources and assess performance. Additionally, the standard requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. The guidance in this update is effective for fiscal years beginning after December 15, 2023, and interim periods after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its related disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Accounting Standards Update was issued to enhance the transparency and decision usefulness of income tax </span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-404-1"><ix:continuation id="f-403-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It further requires disclosure on an annual basis of the following information about income taxes paid: 1. The amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes 2. The amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). Additionally, it requires the following information disclosure: 1. Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign 2. Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU eliminates certain current disclosure requirements. These disclosure requirements will be effective for the Company beginning January 1, 2025, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2023-09 on disclosures to its condensed financial statements.</span></div></ix:continuation></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_46"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="f-405" continuedAt="f-405-1" escape="true">Risks and Uncertainties</ix:nonNumeric></span></div><ix:continuation id="f-405-1" continuedAt="f-405-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#8217;s cash requirements for the remainder of 2024 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September&#160;30, 2024, the Company had $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-406">77,893</ix:nonFraction> of cash and cash equivalents.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a history of net losses. The Company&#8217;s accumulated deficits totaled $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-407">346,159</ix:nonFraction> as of September&#160;30, 2024. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#8217;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the <ix:nonFraction unitRef="number" contextRef="c-103" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-408">13.5</ix:nonFraction>% Senior Secured Notes as further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the ATM facility and other equity offerings, including the Underwritten Public Offering as discussed in Note 1, Part B </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Transactions.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-405-2">While the Company&#8217;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#8217;s on-going business, existing cash and cash equivalents, expense management activities, including, but not limited to the ceasing of R&amp;D activities, as well as access to the equity capital markets through its ATM facility and under the Lincoln Park Purchase Agreement, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.</ix:continuation> </span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_49"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-409" continuedAt="f-409-1" escape="true">Revenues and Trade Receivables, Net</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-410" continuedAt="f-410-1" escape="true"><ix:continuation id="f-409-1" continuedAt="f-409-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-410-1" continuedAt="f-410-2"><ix:continuation id="f-409-2" continuedAt="f-409-3"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s research and development projects may range from several months to approximately <ix:nonNumeric contextRef="c-104" name="aqst:ResearchAndDevelopmentProjectDuration" format="ixt-sec:durwordsen" id="f-411">three years</ix:nonNumeric>. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of September&#160;30, 2024, and December&#160;31, 2023, such contract assets were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" scale="3" id="f-412">654</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:num-dot-decimal" scale="3" id="f-413">1,662</ix:nonFraction>, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September&#160;30, 2024 and December&#160;31, 2023, such contract liabilities were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-414">21,314</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="f-415">33,896</ix:nonFraction>, respectively.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-409-3" continuedAt="f-409-4"><ix:continuation id="f-410-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to obtain contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of September&#160;30, 2024 and December&#160;31, 2023, such costs to obtain contracts were $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CapitalizedContractCostNet" scale="3" id="f-416">488</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CapitalizedContractCostNet" scale="3" id="f-417">715</ix:nonFraction>, respectively.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="f-418" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-419">10,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-420">11,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-421">29,312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-422">32,807</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-423">2,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-424">1,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-425">14,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-426">3,503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-427">492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-428">490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-429">1,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-430">1,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-431">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-432">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-433">217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-435">13,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-436">13,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-437">45,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-438">37,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-439" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.016%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.578%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-440">10,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-441">9,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-442">30,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-443">25,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-444">3,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-445">3,108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-446">15,096</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-447">12,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-448">13,542</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-449">13,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-450">45,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-451">37,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), MTPA (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), Haisco (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), and Hypera (manufacture and supply revenue, license and royalty revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue and license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-developm ent and research fees).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Assertio (manufacture and supply revenue, and license and royalty revenue), and Zevra (license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees) and Hypera (manufacture and supply revenue and license and royalty revenue) for revenue markets outside of the United States. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-409-4" continuedAt="f-409-5"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-452" continuedAt="f-452-1" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-453">7,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="3" id="f-454">5,570</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-455">1,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:ContractWithCustomerAssetNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-456">2,915</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-458">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-459">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-460">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:TradeAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-461">9,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:TradeAndOtherReceivablesNet" format="ixt:num-dot-decimal" scale="3" id="f-462">8,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" id="f-463" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the allowance for doubtful accounts:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:70.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.536%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-464">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-133" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-465">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance expense (reduction)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-466">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-467">26</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-469">14</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_55"></div><ix:continuation id="f-409-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Related Allowances</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.</span></div><ix:continuation id="f-452-1" continuedAt="f-452-2"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:center"><ix:continuation id="f-452-2"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:70.793%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.657%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.391%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.659%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-470">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-471">669</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-472">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" format="ixt:fixed-zero" scale="3" id="f-473">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="3" id="f-474">17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" scale="3" id="f-475">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="aqst:AccountsReceivableAllowanceForCreditLossReclassifications" format="ixt:fixed-zero" scale="3" id="f-476">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-3" sign="-" name="aqst:AccountsReceivableAllowanceForCreditLossReclassifications" scale="3" id="f-477">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-478">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:fixed-zero" scale="3" id="f-479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and other rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $<ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-480">28</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-481">640</ix:nonFraction>, respectively, as of September 30, 2024, and $<ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-482">0</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-483">645</ix:nonFraction>, respectively, as of December 31, 2023. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the nine months ended September 30, 2024, Indivior and Haisco, represented approximately <ix:nonFraction unitRef="number" contextRef="c-143" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-484">59</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-144" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-485">15</ix:nonFraction>%, and of total revenue, including the one-time recognition of deferred revenue for Haisco, respectively. As of September&#160;30, 2024, Indivior exceeded the 10% threshold for outstanding receivable balances and represented approximately <ix:nonFraction unitRef="number" contextRef="c-145" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-486">67</ix:nonFraction>% of total trade and other receivables. For the nine months ended September&#160;30, 2023, Indivior </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represented approximately <ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-487">79</ix:nonFraction>% of total revenue. As of December&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Indivior and Zevra Therapeutics, Inc. represented <ix:nonFraction unitRef="number" contextRef="c-147" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-488">65</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-489">13</ix:nonFraction>% of total trade and other receivables, respectively.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_58"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-490" continuedAt="f-490-1" escape="true">Material Agreements</ix:nonNumeric></span></div><ix:continuation id="f-490-1" continuedAt="f-490-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Exploitation Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. which was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a sublingual film formulation, both inside and outside the United States on an exclusive basis.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-490-2" continuedAt="f-490-3"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was <ix:nonNumeric contextRef="c-149" name="aqst:LicenseAgreementTerm" format="ixt-sec:durwordsen" id="f-491">seven years</ix:nonNumeric> from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive <ix:nonNumeric contextRef="c-149" name="aqst:AutomaticRenewalPeriodOfAgreement" format="ixt-sec:durwordsen" id="f-492">one year</ix:nonNumeric> periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Agreement to the Indivior License Amendment. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive <ix:nonNumeric contextRef="c-150" name="aqst:AutomaticRenewalPeriodOfAgreement" format="ixt-sec:durwordsen" id="f-493">one year</ix:nonNumeric> periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#8217;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement. During the nine months ended September 30, 2023, in consideration of the agreements between the parties, the Company received a payment of $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-494">11,482</ix:nonFraction> from Indivior, of which amount $<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DeferredIncome" format="ixt:num-dot-decimal" scale="3" id="f-495">5,482</ix:nonFraction> represented: (a) payment of the portion of a 2022 price increase that had not been previously paid and (b) an estimated payment in 2023 for certain price increases. During the nine months ended September 30, 2023, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-496">4,396</ix:nonFraction>, of which $<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:DeferredIncomeRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-497">1,682</ix:nonFraction> was related to the 2022 price increases, in Manufacture and supply revenue and $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="aqst:InterestAndOtherIncomeNet" format="ixt:num-dot-decimal" scale="3" id="f-498">6,000</ix:nonFraction> in Interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income. As of December&#160;31, 2023, the $<ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="3" id="f-499">5,482</ix:nonFraction> price increase had been fully recognized in Manufacture and supply revenue; there were no retroactive price adjustments included in Manufacture and supply revenue for the nine months ended September 30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company was entitled to receive certain payments from Indivior commencing on the date of the Indivior Supplemental Agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable. Through February 20, 2019, the at-risk launch date of the competing generic products of Dr. Reddy&#8217;s Labs and Alvogen, the Company received an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-500">40,750</ix:nonFraction> from Indivior under the Indivior Supplemental Agreement. Further payments under the Indivior Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. No further payments are due to the Company under the Indivior Supplemental Agreement. See Note 19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement were in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the Indivior License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with Sunovion Pharmaceuticals, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI&#174;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s obligation to remit a payment of $<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-501">4,000</ix:nonFraction>, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-490-3" continuedAt="f-490-4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 16, 2020, the Company entered into the First Amendment to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company form January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the Amendment to the Sunovion License Agreement. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the Sunovion License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-502">22,000</ix:nonFraction> to date. In addition to the upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-503">5,000</ix:nonFraction>, the Company has also earned an aggregate of $<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-504">17,000</ix:nonFraction> in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with an affiliate of Marathon</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-505">40,000</ix:nonFraction> and an additional payment of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-506">10,000</ix:nonFraction> through the achievement of the first milestone. The Company has received an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-507">50,000</ix:nonFraction> through September&#160;30, 2024 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="aqst:ContingentMonetizationAgreementMilestonePayment" format="ixt:num-dot-decimal" scale="3" id="f-508">75,000</ix:nonFraction> may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-509">125,000</ix:nonFraction>. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on the accounting for the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of Zevra&#8217;s KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Haisco for Exservan&#8482; (Riluzole Oral Film) for ALS Treatment in China</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Haisco Agreement with Haisco, a Chinese limited company listed on the Shenzhen Stock Exchange, effective as of March 3, 2022, pursuant to which Aquestive granted Haisco an exclusive license to develop and commercialize Exservan&#8482; (riluzole oral film) for the treatment of ALS in China. Under the terms of the Haisco Agreement, Aquestive was the exclusive sole manufacturer and supplier for Exservan in China. Under the Haisco Agreement, as amended, the Company received a $<ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-510">7,000</ix:nonFraction> upfront cash payment in September 2022 and was entitled to receive regulatory milestone payments and double-digit royalties on net sales of Exservan in China and earn manufacturing revenue upon the sale of Exservan in China. In June 2024, the Haisco Agreement was terminated, and the Company will not receive any contingent </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-490-4"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments under the Haisco Agreement. The termination agreement released all parties from any existing or ongoing obligations. Commissions of $<ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:SalesCommissionsAndFees" scale="3" id="f-511"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:SalesCommissionsAndFees" scale="3" id="f-512">134</ix:nonFraction></ix:nonFraction> that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income. The Company recognized deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-513"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-514">7,000</ix:nonFraction></ix:nonFraction> for the upfront payment received in September 2022 on the Company's condensed financial statements for the nine months ended September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensatory Arrangements of Certain Officers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2022, the Company announced that Keith J. Kendall, former President and Chief Executive Officer of the Company, was leaving the Company and the Company&#8217;s Board of Directors, effective May 17, 2022. In connection with his departure, Mr. Kendall and the Company entered into a Separation Agreement, including a Consulting Agreement, dated as of May 17, 2022. Under the Separation Agreement, in addition to other severance benefits already received by Mr. Kendall in 2022, Mr. Kendall received a monthly severance payment for <ix:nonNumeric contextRef="c-166" name="aqst:SeveranceCostsMonthlyPaymentDuration" format="ixt-sec:durwordsen" id="f-515">eighteen months</ix:nonNumeric> following the Termination Date, or November 22, 2023. During the first quarter of 2023, net severance payments made to Mr. Kendall totaled approximately $<ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:SeveranceCosts1" scale="3" id="f-516">274</ix:nonFraction>. By the end of December 31, 2023, all payments due to Mr. Kendall were made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Atnahs Pharma UK Limited </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#8217;s intellectual property to develop and commercialize Libervant&#8482; (diazepam) Buccal Film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory (as defined in the Pharmanovia Agreement) during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-517">3,500</ix:nonFraction> upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which includes Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-518">2,000</ix:nonFraction> from Pharmanovia in connection with the execution of the Pharmanovia Amendment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Assertio Holdings, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#8208;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan during the term of the Assertio License Agreement for an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:ProceedsFromCollaborators" format="ixt:num-dot-decimal" scale="3" id="f-519">9,000</ix:nonFraction>. In addition, Aquestive received a $<ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-520">6,000</ix:nonFraction> milestone payment subsequent to Aquestive&#8217;s receipt of a notice of allowance from the PTO of the Company&#8217;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Mitsubishi Tanabe Pharma America, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company announced that Aquestive granted an exclusive license to MTPA for the commercialization in the United States of Exservan. MTPA is a multinational pharmaceutical company with a focus on patients with ALS. The product was launched by MTPA in June 2021. Under the terms of the MTPA license agreement, Aquestive was the exclusive manufacturer and supplier of Exservan for MTPA in the United States. In June 2024, under the Second Amendment to the License and Supply Agreement, MTPA and the Company mutually agreed to terminate the agreement. As of June 30, 2024 and as part of the termination, the parties were released from any existing or ongoing obligations (except for the limited post-termination obligations). Upon termination, deferred revenue of $<ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="f-521">3,317</ix:nonFraction> was recognized for milestone payments that had been received. Commissions of $<ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:SalesCommissionsAndFees" scale="3" id="f-522">57</ix:nonFraction> that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2024.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_61"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-523" continuedAt="f-523-1" escape="true">Financial Instruments &#8211; Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="f-523-1" continuedAt="f-523-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted warrants to certain noteholders in connection with its debt repayment and debt refinancing during 2020 and 2019, respectively. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued as Compensation. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-524">12.5</ix:nonFraction>% Senior Secured Notes contained a repurchase offer or put option which gave holders of the option the right, but not the obligation, to require the Company to redeem the <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-525">12.5</ix:nonFraction>% Notes up to a capped portion of milestone payments resulting from the Monetization Agreement. This put option was valued based on Level 3 inputs and its fair value was based primarily on an independent third-party appraisal consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants Accounting and Valuation Guide. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" format="ixt:num-dot-decimal" scale="0" id="f-526">4,000,000</ix:nonFraction> shares of Common Stock and Common Stock Warrants to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-174" decimals="0" name="aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants" format="ixt:num-dot-decimal" scale="0" id="f-527">8,850,000</ix:nonFraction> shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-528">5,000,000</ix:nonFraction> of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-529">0.96</ix:nonFraction> per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-530">2,750,000</ix:nonFraction> shares of Common Stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-176" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-531">2.60</ix:nonFraction> per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, in connection with the issuance of the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-532">13.5</ix:nonFraction>% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provided the Note Holders:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-533">1.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-534">2.0</ix:nonFraction>% of annual worldwide net sales of Anaphylm&#8482; (epinephrine) Sublingual Film for a period of <ix:nonNumeric contextRef="c-180" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:durwordsen" id="f-535">eight years</ix:nonNumeric> from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-536">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-537">2.0</ix:nonFraction>% of annual worldwide net sales of Libervant&#8482; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) <ix:nonNumeric contextRef="c-180" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:durwordsen" id="f-538">eight years</ix:nonNumeric> from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#8217;s judgements, the then current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-523-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_64"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryDisclosureTextBlock" id="f-539" continuedAt="f-539-1" escape="true">Inventories</ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-540" escape="true"><ix:continuation id="f-539-1"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-541">3,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryRawMaterials" format="ixt:num-dot-decimal" scale="3" id="f-542">2,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:InventoryPackingMaterialGross" format="ixt:num-dot-decimal" scale="3" id="f-543">2,731</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:InventoryPackingMaterialGross" format="ixt:num-dot-decimal" scale="3" id="f-544">3,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-545">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryFinishedGoods" format="ixt:num-dot-decimal" scale="3" id="f-546">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-547">7,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="3" id="f-548">6,769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:nonNumeric><div id="i0121722c2f7d4b94a9a7ec2585983b32_67"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="f-549" continuedAt="f-549-1" escape="true">Property and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="f-549-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-550" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:58.371%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.647%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.558%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-181" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-551">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-182" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-552">15</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-553">20,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-554">20,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-185" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-555">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-186" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-556">15</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-557">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="f-558">769</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-559">21,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-560">21,386</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-191" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-561">3</ix:nonNumeric>-<ix:nonNumeric contextRef="c-192" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-562">7</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-563">2,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-564">2,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-565">2,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-566">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-567">47,206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-568">47,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-569">43,358</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-570">42,884</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-571">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-572">4,179</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation, amortization, and impairment related to property and equipment was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-573">159</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-574">218</ix:nonFraction> for the three months ended September 30, 2024 and 2023, respectively. For the respective nine month periods, these expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-575">493</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Depreciation" scale="3" id="f-576">760</ix:nonFraction>.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_70"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-577" continuedAt="f-577-1" escape="true">Right-of-Use Assets and Lease Obligations</ix:nonNumeric></span></div><ix:continuation id="f-577-1" continuedAt="f-577-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these <ix:nonFraction unitRef="lease" contextRef="c-3" decimals="INF" name="aqst:NumberOfOperatingLeases" format="ixt-sec:numwordsen" scale="0" id="f-578">three</ix:nonFraction> leases include the characteristics specified in ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between <ix:nonNumeric contextRef="c-197" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-579">3.5</ix:nonNumeric> years and <ix:nonNumeric contextRef="c-198" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:duryear" id="f-580">9.0</ix:nonNumeric> years, including renewal options expected to be exercised to extend the lease periods. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the year ended December&#160;31, 2023, the Company recognized a lease supporting its manufacturing facilities as a finance lease. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes payable, net on the Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a right-to use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#8217;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to the Company&#8217;s financial results.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the operating lease liability reflects a range of an estimated discount rate of <ix:nonFraction unitRef="number" contextRef="c-197" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-581">14.8</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-198" decimals="3" name="us-gaap:LesseeOperatingLeaseDiscountRate" scale="-2" id="f-582">15.6</ix:nonFraction>% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s collateralized debt refinancing. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs are recorded in manufacture and supply, research and development and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive (Loss) Income. For the three and nine months ended September&#160;30, 2024, total operating lease expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-583">457</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-584">1,345</ix:nonFraction>, respectively, including variable </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-577-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease expenses such as common area maintenance and operating costs of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-585">123</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-586">349</ix:nonFraction>, respectively. For the three and nine months ended September&#160;30, 2023, total operating lease expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="f-587">438</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-588">1,308</ix:nonFraction>, respectively, including variable lease expenses such as common area maintenance and operating costs of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-589">109</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:VariableLeaseCost" scale="3" id="f-590">338</ix:nonFraction>, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-591" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:85.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.537%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="f-592">317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-593">1,284</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-594">1,318</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-595">1,346</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" format="ixt:num-dot-decimal" scale="3" id="f-596">5,095</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-597">9,360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-598">3,769</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-599">5,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_73"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="f-600" continuedAt="f-600-1" escape="true">Intangible Assets, Net</ix:nonNumeric></span></div><ix:continuation id="f-600-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-601" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of identifiable intangible assets, all of which are finite lived:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-602">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-603">3,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased patent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-604">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="f-605">509</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-606">4,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-607">4,367</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-608">4,367</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="3" id="f-609">3,089</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="3" id="f-610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-611">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="f-612">39</ix:nonFraction> for the three months ended September&#160;30, 2023. There was <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:fixed-zero" scale="0" id="f-613">no</ix:nonFraction> amortization expense incurred during the three months ended September 30, 2024. For the nine months ended September&#160;30, 2024 and 2023, these expenses totaled $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="f-614">78</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AmortizationOfIntangibleAssets" scale="3" id="f-615">117</ix:nonFraction>, respectively. In June 2024, in connection with a termination of an agreement, the Company recorded a gain on termination of the contract in the amount of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnDispositionOfIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="f-616">1,500</ix:nonFraction>, which was partially offset by an adjustment to the remaining balance of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ImpairmentOfIntangibleAssetsFinitelived" format="ixt:num-dot-decimal" scale="3" id="f-617">1,200</ix:nonFraction> of the intangible asset. The net gain of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:GainLossOnContractTermination" scale="3" id="f-618"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GainLossOnContractTermination" scale="3" id="f-619">300</ix:nonFraction></ix:nonFraction> was recorded within Other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_76"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:OtherAssetsDisclosureTextBlock" id="f-620" continuedAt="f-620-1" escape="true">Other Non-current Assets</ix:nonNumeric></span></div><ix:continuation id="f-620-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="f-621" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:CumulativeRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-622">3,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:CumulativeRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-623">4,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-624">1,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-625">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-626">4,230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-627">5,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-628">8,000</ix:nonFraction> of royalty revenue and corresponding royalty receivable, related to the <ix:nonFraction unitRef="payment" contextRef="c-5" decimals="INF" name="aqst:NumberOfGuaranteedRoyaltyPayments" format="ixt-sec:numwordsen" scale="0" id="f-629">eight</ix:nonFraction> $<ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="aqst:MinimumAnnualRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-630">1,000</ix:nonFraction> annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of September&#160;30, 2024 and December&#160;31, 2023, Royalty receivable consists of <ix:nonFraction unitRef="payment" contextRef="c-204" decimals="INF" name="aqst:NumberOfAnnualRoyaltyPaymentsReceivable" format="ixt-sec:numwordsen" scale="0" id="f-631">four</ix:nonFraction> and <ix:nonFraction unitRef="payment" contextRef="c-205" decimals="INF" name="aqst:NumberOfAnnualRoyaltyPaymentsReceivable" format="ixt-sec:numwordsen" scale="0" id="f-632">five</ix:nonFraction>, respectively, annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on how this receivable relates to the Monetization Agreement transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of commissions capitalized under ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is recorded within Other non-current assets on the Condensed Balance Sheets. Commissions of $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:SalesCommissionsAndFees" scale="3" id="f-633">191</ix:nonFraction> were expensed in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024 due to the termination of the underlying contracts.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_79"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="f-634" continuedAt="f-634-1" escape="true">Accrued Expenses</ix:nonNumeric></span></div><ix:continuation id="f-634-1"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-635" escape="true"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-636">3,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-637">4,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-638">473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:TaxesPayableCurrent" scale="3" id="f-639">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-640">640</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-641">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:InterestPayableCurrent" scale="3" id="f-642">17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:InterestPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-643">1,013</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-644">438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="f-645">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-646">5,025</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-647">6,497</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in Accrued compensation is related to payments of accrued bonuses during the nine months ended September 30, 2024, partially offset by the current year accrual of bonuses. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in Interest payable is mostly due to the timing of interest payments on the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-648">13.5</ix:nonFraction>% Senior Notes. The third quarter 2024 interest payment on the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-649">13.5</ix:nonFraction>% Senior Notes was made on September&#160;30, 2024. As of December&#160;31, 2023, interest payable on the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-650">13.5</ix:nonFraction>% Senior Notes was due on January 2, 2024. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for discussion of <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-651">13.5</ix:nonFraction>% Notes and related interest payable.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for wholesaler service fees, co-pay support redemptions and other rebates related to the proprietary product Libervant. and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_82"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-652" continuedAt="f-652-1" escape="true">Long-Term Debt</ix:nonNumeric></span></div><ix:continuation id="f-652-1" continuedAt="f-652-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-653">12.5</ix:nonFraction>% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2019, the Company completed a private placement of up to $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-654">100,000</ix:nonFraction> aggregate principal of its <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-655">12.5</ix:nonFraction>% Notes which were due 2025 and issued Warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-209" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-656">2,000,000</ix:nonFraction> shares of Common Stock at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-209" decimals="3" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-657">0.001</ix:nonFraction> par value per share.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Base Indenture, the Company issued $<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-658">70,000</ix:nonFraction> of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-659">12.5</ix:nonFraction>% Notes (the &#8220;Initial Notes&#8221;) along with the Warrants and rights of first offer (the &#8220;First Offer Rights&#8221;) to the noteholders participating in this transaction. Issuance of the Initial Notes and Warrants provided net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" name="aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" format="ixt:num-dot-decimal" scale="3" id="f-660">66,082</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the First Supplemental Indenture (the &#8220;First Supplemental Indenture&#8221; and, together with all other subsequent supplemental indentures and the Base Indenture, collectively, the &#8220;Indenture&#8221;) by and among the Company and U.S. Bank National Association, as Trustee (the &#8220;Trustee&#8221;) and Collateral Agent thereunder to the Base Indenture, by and between the Company and the Trustee. Under the Second Supplemental Indenture, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-661">22,500</ix:nonFraction> of its $<ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-662">70,000</ix:nonFraction> outstanding <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-663">12.5</ix:nonFraction>% Notes from the upfront proceeds received under the Monetization Agreement. Further, the Company entered into an additional Purchase Agreement with its noteholders whereby the Company issued in aggregate $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-664">4,000</ix:nonFraction> of additional <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-665">12.5</ix:nonFraction>% Notes (the &#8220;Additional Notes&#8221;) in lieu of paying a prepayment premium to <ix:nonFraction unitRef="noteholder" contextRef="c-211" decimals="INF" name="aqst:DebtInstrumentNumberOfNoteholders" format="ixt-sec:numwordsen" id="f-666">two</ix:nonFraction> noteholders on the early repayment of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-667">12.5</ix:nonFraction>% Notes discussed above. The result of these <ix:nonFraction unitRef="transaction" contextRef="c-214" decimals="INF" name="aqst:DebtInstrumentNumberOfTransactions" format="ixt-sec:numwordsen" id="f-668">two</ix:nonFraction> transactions reduced the net balance of the Company&#8217;s <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-669">12.5</ix:nonFraction>% Notes outstanding in the aggregate to $<ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-670">51,500</ix:nonFraction> at December 31, 2020. The $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-671">4,000</ix:nonFraction> principal issuance would be repaid proportionally over the same maturities as the other <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-672">12.5</ix:nonFraction>% Notes. The Company also paid to one of its noteholders a $<ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="aqst:PremiumsPaidEarlyRetirementOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-673">2,250</ix:nonFraction> premium as result of the early retirement of debt. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-674">22,500</ix:nonFraction> debt repayment as a debt modification of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-675">12.5</ix:nonFraction>% Notes. The fees paid to noteholders inclusive of (i) a $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="aqst:PremiumsPaidEarlyRetirementOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-676">2,250</ix:nonFraction> early premium prepayment and (ii) $<ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-677">4,000</ix:nonFraction> issuance of Additional Notes in lieu of paying a prepayment penalty were recorded as additional debt discount, amortized over the remaining life of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-678">12.5</ix:nonFraction>% Notes using the effective interest method. Loan origination costs of $<ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:PaymentsOfLoanCosts" scale="3" id="f-679">220</ix:nonFraction> associated with the Additional Notes were expensed as incurred. Existing deferred discounts and loan origination fees on the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-680">12.5</ix:nonFraction>% Notes are amortized as an adjustment of interest expense over the remaining term of modified debt using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Supplemental Indenture contained a provision whereby, as the Company receives any cash proceeds from the Monetization Agreement, each noteholder had the right to require the Company to redeem all or any part of such noteholder&#8217;s outstanding <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-681">12.5</ix:nonFraction>% Notes at a repurchase price in cash equal to <ix:nonFraction unitRef="number" contextRef="c-211" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-682">112.5</ix:nonFraction>% of the principal amount, plus accrued and unpaid interest. This repurchase offer was capped at <ix:nonFraction unitRef="number" contextRef="c-216" decimals="2" name="aqst:DebtInstrumentCovenantMilestoneCapPercentageThreshold" scale="-2" id="f-683">30</ix:nonFraction>% of the cash proceeds received by the Company as the contingent milestones were attained, if any, up through June 30, 2025. The embedded put option was deemed to be a derivative under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which required the recording of the embedded put option at fair value subject to remeasurement at each reporting period. Accordingly, a valuation study was performed by an independent third party appraiser and updated in June 30, 2023. Based on the valuation study, the put option was valued at $<ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="0" id="f-684">0</ix:nonFraction>. The put option fair value decreased by $<ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" sign="-" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="f-685">45</ix:nonFraction> and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-652-2" continuedAt="f-652-3"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was recorded in interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2023. There was <ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" format="ixt:fixed-zero" scale="0" id="f-686">no</ix:nonFraction> change in fair value during the three months ended September 30, 2023. In addition, as of the closing of this transaction, the Company issued to the holders of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-687">12.5</ix:nonFraction>% Notes warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-220" decimals="-3" name="aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" format="ixt:num-dot-decimal" scale="0" id="f-688">143,000</ix:nonFraction> shares of the Company&#8217;s Common Stock. As of September&#160;30, 2024, the put option is no longer in place due to the refinancing of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-689">12.5</ix:nonFraction>% Notes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2021, the Company entered into the Fourth Supplemental Indenture, pursuant to which the amortization schedule for the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-690">12.5</ix:nonFraction>% Notes was amended to provide for the date of the first principal payment to be extended from September 30, 2021 to March 30, 2023. The Fourth Supplemental Indenture did not change the maturity date of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-691">12.5</ix:nonFraction>% Notes or the interest payment obligation due under the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-692">12.5</ix:nonFraction>% Notes. In connection with the Fourth Supplemental Indenture, the Company entered into a Consent Fee Letter with the holders of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-693">12.5</ix:nonFraction>% Notes (the &#8220;Consent Fee Letter&#8221;), pursuant to which the Company agreed to pay the holders of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-694">12.5</ix:nonFraction>% Notes an additional cash payment ("Consent Fee") of $<ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-695">2,700</ix:nonFraction> in the aggregate, payable in <ix:nonFraction unitRef="quarterlyinstallment" contextRef="c-222" decimals="INF" name="aqst:DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" format="ixt-sec:numwordsen" scale="0" id="f-696">four</ix:nonFraction> quarterly payments beginning May 15, 2022. The last Consent Fee installment of $<ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" scale="3" id="f-697">675</ix:nonFraction> was made in February 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-698">12.5</ix:nonFraction>% Notes provided a stated fixed interest rate of <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-699">12.5</ix:nonFraction>%, payable quarterly in arrears, with the final quarterly principal repayment of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-700">12.5</ix:nonFraction>% Notes due at maturity on June 30, 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company could have elected, at its option, to redeem the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-701">12.5</ix:nonFraction>% Notes at any time at premiums that range from <ix:nonFraction unitRef="number" contextRef="c-224" decimals="4" name="aqst:ElectiveRedemptionPercentageOfDebt" scale="-2" id="f-702">101.56</ix:nonFraction>% of outstanding principal if prepayment occurs on or after the fifth anniversary of the issue date of the Initial Notes to <ix:nonFraction unitRef="number" contextRef="c-225" decimals="4" name="aqst:ElectiveRedemptionPercentageOfDebt" scale="-2" id="f-703">112.50</ix:nonFraction>% if payment occurs during the third year after the issuance of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-704">12.5</ix:nonFraction>% Notes. The Indenture also included change of control provisions under which the Company would have been required to redeem the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-705">12.5</ix:nonFraction>% Notes at <ix:nonFraction unitRef="number" contextRef="c-226" decimals="2" name="aqst:RedemptionPercentageOfDebtUnderChangeOfControlProvisions" scale="-2" id="f-706">101</ix:nonFraction>% of the remaining principal plus accrued interest at the election of the noteholders.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30 2023, the Company redeemed $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" name="us-gaap:RepaymentsOfDebt" format="ixt:num-dot-decimal" scale="3" id="f-707">5,647</ix:nonFraction> of its outstanding <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-708">12.5</ix:nonFraction>% Notes. The Company also paid $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-3" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="3" id="f-709">353</ix:nonFraction> in prepayment premium as result of the early retirement of debt which was reflected as a loss on extinguishment of debt on the Company's Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2023. The prepayments along with the scheduled principal payments of $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-3" name="us-gaap:DebtInstrumentPeriodicPaymentPrincipal" format="ixt:num-dot-decimal" scale="3" id="f-710">6,878</ix:nonFraction> during the nine months ended September 30, 2023 reduced the net balance of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-711">12.5</ix:nonFraction>% Notes outstanding in the aggregate to $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-712">38,975</ix:nonFraction> as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from amortization of deferred debt issuance costs and debt discounts related to the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-713">12.5</ix:nonFraction>% Notes for the three and nine months ended September&#160;30, 2023 was $<ix:nonFraction unitRef="usd" contextRef="c-230" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="f-714">3</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-231" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="f-715">11</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company issued the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-716">13.5</ix:nonFraction>% Notes, as described below, and used most of the proceeds from the issuance to repay the outstanding principal balance under the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-717">12.5</ix:nonFraction>% Notes of $<ix:nonFraction unitRef="usd" contextRef="c-232" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-718">36,014</ix:nonFraction>, including accrued and unpaid interest and a redemption fee.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-719">13.5</ix:nonFraction>% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#8220;Note Holders&#8221;) and issued $<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="3" id="f-720">45,000</ix:nonFraction> aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-721">13.5</ix:nonFraction>% Notes due 2028. The Company received net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-233" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-722">4,326</ix:nonFraction> from this transaction after the repayment of the <ix:nonFraction unitRef="number" contextRef="c-207" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-723">12.5</ix:nonFraction>% Notes and deduction of debt discount, and debt issuance costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-724">13.5</ix:nonFraction>% Notes are senior secured obligations of the Company and mature on November 1, 2028. The <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-725">13.5</ix:nonFraction>% Notes bear interest at a fixed rate of <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-726">13.5</ix:nonFraction>% per year, payable quarterly commencing on December 30, 2023; the first interest payment was due and paid on January 2, 2024. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-727">13.5</ix:nonFraction>% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:DebtInstrumentFeeAmount" format="ixt:num-dot-decimal" scale="3" id="f-728">2,000</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, at its option, redeem the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-729">13.5</ix:nonFraction>% Notes in full or in part:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if such redemption occurs prior to November 1, 2025, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-730">100</ix:nonFraction>% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"><ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" scale="-2" id="f-731">1.0</ix:nonFraction>% of the principal redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus <ix:nonFraction unitRef="number" contextRef="c-235" decimals="2" name="aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" scale="-4" id="f-732">100</ix:nonFraction> basis points, exceeds the amount of principal to be redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">if such redemption occurs after November 1, 2025, the redemption price is equal to <ix:nonFraction unitRef="number" contextRef="c-236" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-733">108.5</ix:nonFraction>% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-652-3" continuedAt="f-652-4"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-734">13.5</ix:nonFraction>% Notes at a change of control repurchase price equal at <ix:nonFraction unitRef="number" contextRef="c-233" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-735">108.5</ix:nonFraction>% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $<ix:nonFraction unitRef="usd" contextRef="c-237" decimals="-3" name="aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" format="ixt:num-dot-decimal" scale="0" id="f-736">100,000</ix:nonFraction> of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $<ix:nonFraction unitRef="usd" contextRef="c-238" decimals="-3" name="aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit" format="ixt:num-dot-decimal" scale="0" id="f-737">10,000</ix:nonFraction>. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-738">13.5</ix:nonFraction>% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-739">1.0</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-740">2.0</ix:nonFraction>% of annual worldwide net sales of Anaphylm&#8482; (epinephrine) Sublingual Film for a period of <ix:nonNumeric contextRef="c-180" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:duryear" id="f-741">8</ix:nonNumeric> years from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between <ix:nonFraction unitRef="number" contextRef="c-178" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-742">1.0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-179" decimals="3" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentage" scale="-2" id="f-743">2.0</ix:nonFraction>% of annual worldwide net sales of Libervant&#8482; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) <ix:nonNumeric contextRef="c-180" name="aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm" format="ixt-sec:durwordsen" id="f-744">eight years</ix:nonNumeric> from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-745">13.5</ix:nonFraction>% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are subsequently measured on an amortized cost basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#8217;s judgements, current market conditions, and forecasts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Royalty Right Agreements&#8217; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, there were no material changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-746" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the initial fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:24.484%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.256%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.700%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.431%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-239" decimals="2" name="us-gaap:LongTermDebtMeasurementInput" scale="-2" id="f-747">15</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-240" decimals="2" name="us-gaap:LongTermDebtMeasurementInput" scale="-2" id="f-748">75</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Royalty Right Agreements were issued in connection with the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-749">13.5</ix:nonFraction>% Notes, the Company allocated the proceeds to the two instruments based on their relative fair values. The Company allocated approximately $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-750">13,856</ix:nonFraction> to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of future estimated royalty payments of $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-751">56,926</ix:nonFraction> over the $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="f-752">13,856</ix:nonFraction> of allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, the allocated amounts of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:LongTermDebtFairValue" format="ixt:num-dot-decimal" scale="3" id="f-753">13,856</ix:nonFraction> when combined with the Exit Fee of $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-3" name="aqst:DebtInstrumentExitFee" format="ixt:num-dot-decimal" scale="3" id="f-754">2,000</ix:nonFraction>, original issue discount of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet" format="ixt:num-dot-decimal" scale="3" id="f-755">1,125</ix:nonFraction> and debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-756">3,517</ix:nonFraction>, resulted in a debt discount of $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="f-757">20,498</ix:nonFraction>. The debt discount is being amortized over the term of <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-758">13.5</ix:nonFraction>% Notes using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-759">13.5</ix:nonFraction>% Notes for the three and nine months ended September&#160;30, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-244" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-760">1,254</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-245" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-761">3,765</ix:nonFraction>, respectively. Amortization expense arising from the discounts related to the Royalty Right Agreements for the three and nine months ended September&#160;30, 2024 was $<ix:nonFraction unitRef="usd" contextRef="c-246" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-762">1,359</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-3" name="us-gaap:AmortizationOfDebtDiscountPremium" format="ixt:num-dot-decimal" scale="3" id="f-763">4,075</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized discounts totaled $<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-764">13,900</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-765">17,665</ix:nonFraction> for the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-766">13.5</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-767">38,091</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-768">42,165</ix:nonFraction> for the Royalty obligations as of September&#160;30, 2024 and December&#160;31, 2023, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-652-4"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="f-769" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-770">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-771">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-772">13,900</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-773">17,665</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-774">31,100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-775">27,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-776">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="f-777">173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-234" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-778">31,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-248" decimals="-3" name="us-gaap:LongTermDebtAndCapitalLeaseObligations" format="ixt:num-dot-decimal" scale="3" id="f-779">27,508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-780">56,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="f-781">56,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-782">38,091</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:DebtInstrumentUnamortizedDiscount" format="ixt:num-dot-decimal" scale="3" id="f-783">42,165</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-249" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-784">18,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-785">14,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current portion of royalty obligations payable is not material as of September 30, 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="f-786" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the <ix:nonFraction unitRef="number" contextRef="c-177" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-787">13.5</ix:nonFraction>% Notes as of September&#160;30, 2024 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" format="ixt:fixed-zero" scale="3" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-790">9,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" format="ixt:num-dot-decimal" scale="3" id="f-791">14,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" format="ixt:num-dot-decimal" scale="3" id="f-792">20,925</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="f-793">45,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_85"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="aqst:WarrantsDisclosureTextBlock" id="f-794" continuedAt="f-794-1" escape="true">Warrants</ix:nonNumeric></span></div><ix:continuation id="f-794-1" continuedAt="f-794-2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-795">12.5</ix:nonFraction>% Senior Secured Noteholders </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants that were issued in conjunction with the Initial Notes (the &#8220;Initial Warrants&#8221;) and Additional Notes (the &#8220;Additional Warrants&#8221;) expire on June 30, 2025 and entitled the noteholders to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-251" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-796">2,143,000</ix:nonFraction> shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-3" name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-797">6,800</ix:nonFraction> and the Additional Warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:WarrantsNotSettleableInCashFairValueDisclosure" scale="3" id="f-798">735</ix:nonFraction>, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-799">12.5</ix:nonFraction>% Notes portion applied to reduce the aggregate principal amount of the <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-800">12.5</ix:nonFraction>% Notes. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#8217;s unaudited Condensed Balance Sheets. There were <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-801"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-802">no</ix:nonFraction></ix:nonFraction> warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the nine months ended September&#160;30, 2024 and 2023, respectively. Warrants to purchase a total of <ix:nonFraction unitRef="shares" contextRef="c-254" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-803">1,714,429</ix:nonFraction> shares of Common Stock with exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-254" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-804">4.25</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-255" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-805">5.38</ix:nonFraction> for <ix:nonFraction unitRef="shares" contextRef="c-254" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-806">1,571,429</ix:nonFraction> warrants and <ix:nonFraction unitRef="shares" contextRef="c-255" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-807">143,000</ix:nonFraction> warrants, respectively, remain outstanding as of September&#160;30, 2024 and December&#160;31, 2023. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued Under Securities Purchase Agreements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-256" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-808">4,000,000</ix:nonFraction> shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to <ix:nonFraction unitRef="shares" contextRef="c-257" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-809">8,850,000</ix:nonFraction> shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-258" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-810">0.96</ix:nonFraction> per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-811">5,874</ix:nonFraction> based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#8217;s unaudited Condensed Balance Sheets. On June 14, 2023, <ix:nonFraction unitRef="shares" contextRef="c-260" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" format="ixt:num-dot-decimal" scale="0" id="f-812">3,689,452</ix:nonFraction> Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-813">3,542</ix:nonFraction>.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of <ix:nonFraction unitRef="shares" contextRef="c-175" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-814">5,000,000</ix:nonFraction> of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-794-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $<ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-815">0.96</ix:nonFraction> per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-816"><ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-817">2,750,000</ix:nonFraction></ix:nonFraction> shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-176" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-818">2.60</ix:nonFraction> per share. Management estimated the fair value of the warrants to be $<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:WarrantsAndRightsOutstanding" format="ixt:num-dot-decimal" scale="3" id="f-819">4,671</ix:nonFraction> based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2023, <ix:nonFraction unitRef="shares" contextRef="c-261" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-820">5,000,000</ix:nonFraction> of the Existing Warrants were exercised pursuant to the Securities Purchase Agreement with the Exercising Holder, with the Company receiving gross proceeds therefrom of $<ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-821">4,800</ix:nonFraction>. In total, <ix:nonFraction unitRef="shares" contextRef="c-262" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" format="ixt:num-dot-decimal" scale="0" id="f-822">8,689,452</ix:nonFraction> Common Stock warrants issued pursuant to the Securities Purchase Agreements with net proceeds of approximately $<ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-823">8,307</ix:nonFraction> were exercised during the year ended December 31, 2023. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" scale="3" id="f-824">35</ix:nonFraction> in relation to this transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-825"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="aqst:ClassOfWarrantOrRightWarrantsExercised" format="ixt:fixed-zero" scale="0" id="f-826">no</ix:nonFraction></ix:nonFraction> warrants issued or exercised as it relates to the Warrants Issued Under Securities Purchase Agreements during the nine months ended September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-176" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-827">2,750,000</ix:nonFraction> shares of Common Stock described above, there remain outstanding warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-264" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-828">160,548</ix:nonFraction> shares of Common Stock at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-265" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-829">0.96</ix:nonFraction> and warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-266" decimals="0" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" format="ixt:num-dot-decimal" scale="0" id="f-830">1,714,429</ix:nonFraction> shares of Common Stock outstanding related to the original issuance of the <ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-831">12.5</ix:nonFraction>% Notes prior to the debt refinancing described above in this Note 14, with exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-267" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-832">4.25</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="c-268" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-833">5.38</ix:nonFraction> for <ix:nonFraction unitRef="shares" contextRef="c-267" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-834">1,571,429</ix:nonFraction> warrants and <ix:nonFraction unitRef="shares" contextRef="c-268" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-835">143,000</ix:nonFraction> warrants, respectively.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_88"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="aqst:SaleOfFutureRevenueTextBlock" id="f-836" continuedAt="f-836-1" escape="true">Sale of Future Revenue</ix:nonNumeric></span></div><ix:continuation id="f-836-1" continuedAt="f-836-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI, an apomorphine film therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-837">40,000</ix:nonFraction> and an additional payment of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-838">10,000</ix:nonFraction> through the achievement of the first milestone. The Company has received an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-839">50,000</ix:nonFraction> through September&#160;30, 2024 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="aqst:ContingentMonetizationAgreementMilestonePayment" format="ixt:num-dot-decimal" scale="3" id="f-840">75,000</ix:nonFraction> may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-841">125,000</ix:nonFraction>. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the upfront proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-842">40,000</ix:nonFraction> and subsequent first milestone of $<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-843">10,000</ix:nonFraction>, reduced by $<ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="f-844">2,909</ix:nonFraction> of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-845">8,000</ix:nonFraction> of royalty revenue and corresponding royalty receivable, related to the $<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-3" name="aqst:MinimumAnnualRoyaltyReceivable" format="ixt:num-dot-decimal" scale="3" id="f-846">1,000</ix:nonFraction> annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $<ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="aqst:ProceedsFromSaleOfFutureRevenuesNet" format="ixt:num-dot-decimal" scale="3" id="f-847">50,000</ix:nonFraction> in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately <ix:nonFraction unitRef="number" contextRef="c-272" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-848">24.9</ix:nonFraction>%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-836-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#8217;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.</span></div><ix:nonNumeric contextRef="c-1" name="aqst:RoyaltyObligationActivityTableTextBlock" id="f-849" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-850">64,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-851">65,259</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-852">935</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-3" sign="-" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="f-853">989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-854">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="f-855">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $<ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-856">1,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent" scale="3" id="f-857">922</ix:nonFraction>, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-858">63,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-3" name="aqst:LiabilitiesSaleOfFutureRoyalties" format="ixt:num-dot-decimal" scale="3" id="f-859">64,490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_91"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-860" continuedAt="f-860-1" escape="true">Net (Loss) Earnings Per Share</ix:nonNumeric></span></div><ix:continuation id="f-860-1" continuedAt="f-860-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) earnings per share is calculated by dividing net (loss) income by the weighted-average number of common shares.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-861" continuedAt="f-861-1" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the basic to diluted weighted average shares outstanding for the three and nine months ended September&#160;30, 2024 and 2023. Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended September&#160;30, 2024 and 2023, and for the nine months ended September&#160;30, 2024. all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended September&#160;30, 2024 and 2023 and the nine months ended September&#160;30, 2024 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.383%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.556%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.563%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-862">11,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-863">2,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-864">27,082</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:NetIncomeLoss" scale="3" id="f-865">241</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-866">91,082,081</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-867">64,678,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-868">85,224,263</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-869">59,252,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock options </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-275" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-870">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-276" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-871">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-277" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-872">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-278" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="f-873">57,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-279" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-874">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-280" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-875">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-281" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-876">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="f-877">654,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of warrants </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-878">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-879">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:fixed-zero" scale="0" id="f-880">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants" format="ixt:num-dot-decimal" scale="0" id="f-881">1,547,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Employee Stock Purchase Plan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-882">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-285" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="0" id="f-884">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="0" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="0" id="f-885">1,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-886">91,082,081</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-887">64,678,761</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-888">85,224,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-889">61,513,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Earnings per share attributable to common stockholders:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; basic</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-890">0.13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-891">0.03</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-892">0.32</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-893">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-894">0.13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-895">0.03</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-896">0.32</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-897">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-861-1"><ix:continuation id="f-860-2"><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase <ix:nonFraction unitRef="shares" contextRef="c-287" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-898">6,301,364</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-288" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-899">5,912,647</ix:nonFraction> shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase <ix:nonFraction unitRef="shares" contextRef="c-289" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-900">6,301,364</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-290" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-901">5,339,130</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of <ix:nonFraction unitRef="shares" contextRef="c-291" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-902">3,910,376</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-292" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-903">3,280,313</ix:nonFraction> shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of <ix:nonFraction unitRef="shares" contextRef="c-293" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-904">3,910,376</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-294" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-905">605,650</ix:nonFraction>. shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-295" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-906">4,624,977</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-296" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-907">4,464,429</ix:nonFraction> shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase <ix:nonFraction unitRef="shares" contextRef="c-297" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-908">4,624,977</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-298" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-909">4,464,429</ix:nonFraction> shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three and nine months ended September&#160;30, 2024 and the three months ended September&#160;30, 2023, the estimated effects of ESPP awards were not material.</span></div></ix:continuation></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_94"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="f-910" continuedAt="f-910-1" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="f-910-1" continuedAt="f-910-2"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="f-911" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its unaudited Condensed Statements of Operations and Comprehensive (Loss) Income during 2024 and 2023 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.163%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.577%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-912">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-913">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-914">271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-915">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-916">310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-917">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-918">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-919">277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-920">1,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-921">610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-922">3,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-923">1,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-924">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-925">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-926">4,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-927">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-928">1,049</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-929">312</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-930">2,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-931">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-932">528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-933">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-934">1,698</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-935">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan (ESPP)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="f-936">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:fixed-zero" scale="3" id="f-937">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-938">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-939">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-940">1,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-941">774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-942">4,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-943">1,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Equity Awards</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="f-944" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine month period ended September&#160;30, 2024:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-311" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-945">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-311" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-946">0.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-281" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="3" id="f-947">1,430</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-948">5.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-949">607</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-950">0.96</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-281" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="f-951">43</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-281" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-952">1.58</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-312" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-953">2,728</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-954">3.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-312" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" format="ixt:num-dot-decimal" scale="3" id="f-955">2,539</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-312" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" scale="0" id="f-956">3.33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="f-957">6,677</ix:nonFraction> of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-281" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-958">1.96</ix:nonNumeric> years. The service-based restricted stock units granted to employees are subject to a <ix:nonNumeric contextRef="c-279" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-959">three-year</ix:nonNumeric> graduated vesting schedule and are not subject to performance-based criteria other than continued employment.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-910-2" continuedAt="f-910-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" id="f-960" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-313" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-961">1,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-313" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-962">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-314" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="f-963">150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-314" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-964">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-314" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:fixed-zero" scale="3" id="f-965">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-314" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" format="ixt:fixed-zero" scale="0" id="f-966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-315" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="f-967">1,182</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-315" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-968">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-315" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" format="ixt:num-dot-decimal" scale="3" id="f-969">1,089</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-315" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" scale="0" id="f-970">2.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="f-971">1,451</ix:nonFraction> of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-314" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-972">1.59</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market conditions vesting-based restricted stock units vest based on a Performance Price measured as the <ix:nonNumeric contextRef="c-312" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" format="ixt-sec:durday" id="f-973">30</ix:nonNumeric>-day average of the closing prices of the Company&#8217;s common stock as reported on the NASDAQ Stock Market immediately prior to and including the last calendar day of the <ix:nonNumeric contextRef="c-316" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-974">three-year</ix:nonNumeric> performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-317" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-975">1.75</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-318" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" format="ixt-sec:numwordsen" id="f-976">zero</ix:nonFraction>. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-319" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-977">1.75</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-320" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-978">50</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-321" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-979">1.76</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-322" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-980">2.50</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-323" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-981">50.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-324" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-982">99.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-325" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-983">2.50</ix:nonFraction>, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-326" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-984">100</ix:nonFraction>%. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-327" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-985">2.51</ix:nonFraction> or greater, but less than $<ix:nonFraction unitRef="usdPerShare" contextRef="c-328" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-986">3.25</ix:nonFraction>, the Vesting Percentage will be a prorated amount between <ix:nonFraction unitRef="number" contextRef="c-329" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-987">100.01</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-330" decimals="4" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-988">149.99</ix:nonFraction>%, based on straight-line interpolation. To the extent the Performance Price is $<ix:nonFraction unitRef="usdPerShare" contextRef="c-331" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" scale="0" id="f-989">3.25</ix:nonFraction> or greater, the Vesting Percentage will be <ix:nonFraction unitRef="number" contextRef="c-332" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-990">150</ix:nonFraction>%. In no event will the Vesting Percentage exceed <ix:nonFraction unitRef="number" contextRef="c-333" decimals="2" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-991">150</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Inducement Equity Incentive Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with NASDAQ Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="aqst:InducementEquityCommonStockOptionsOutstandingShares" format="ixt:fixed-zero" scale="0" id="f-992">no</ix:nonFraction> awards outstanding under this Plan as of September&#160;30, 2024.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-993" escape="true"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-334" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-994">5,733</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-334" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-995">5.58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-277" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" format="ixt:num-dot-decimal" scale="3" id="f-996">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-997">4.83</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-277" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="f-998">357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-999">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-277" decimals="-3" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" scale="3" id="f-1000">99</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1001">3.84</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-335" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1002">6,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-335" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-1003">5.68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-335" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="f-1004">6,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-335" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="f-1005">5.70</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-335" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="3" id="f-1006">4,688</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-335" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="f-1007">6.36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.484%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.112%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1008">&#8212;</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" scale="-2" id="f-1009">104</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" scale="-2" id="f-1010">107</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-336" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1011">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-337" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1012">6.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-336" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1013">4.1</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-337" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1014">4.5</ix:nonFraction>%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during the nine months ended September&#160;30, 2024 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1015">3.98</ix:nonFraction>. During the nine months ended September&#160;30, 2024, stock options were granted with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-277" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="f-1016">4.83</ix:nonFraction> and accordingly, given the Company&#8217;s share price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-4" decimals="2" name="us-gaap:SharePrice" scale="0" id="f-1017">4.98</ix:nonFraction> at September&#160;30, 2024, the intrinsic value provided by certain shares granted during this period was de minimis.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-910-3"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $<ix:nonFraction unitRef="usd" contextRef="c-335" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="f-1018">3,559</ix:nonFraction> of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of <ix:nonNumeric contextRef="c-277" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1019">1.56</ix:nonNumeric> years.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_97"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1020" continuedAt="f-1020-1" escape="true">Income Taxes</ix:nonNumeric></span></div><ix:continuation id="f-1020-1"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three and nine months ended September&#160;30, 2024, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1021"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1022">0</ix:nonFraction></ix:nonFraction>%, and the Company recorded <ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt-sec:numwordsen" scale="0" id="f-1023"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt-sec:numwordsen" scale="0" id="f-1024">no</ix:nonFraction></ix:nonFraction> income tax expense from its pretax losses of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1025">11,509</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1026">27,082</ix:nonFraction>, respectively. For the three and nine months ended September&#160;30, 2023, the effective income tax rate was <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1027">6.4</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1028">37.4</ix:nonFraction>%, respectively, and the Company recorded ($<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1029">140</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="f-1030">144</ix:nonFraction> from its pretax (loss) income of ($<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1031">2,175</ix:nonFraction>) and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-1032">385</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors impacting the effective tax rate for nine months ended September&#160;30, 2024 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.</span></div></ix:continuation><div id="i0121722c2f7d4b94a9a7ec2585983b32_100"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 19.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="f-1033" continuedAt="f-1033-1" escape="true">Contingencies</ix:nonNumeric></span></div><ix:continuation id="f-1033-1" continuedAt="f-1033-2"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kentucky Litigation - Humana</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Humana Inc. v. Indivior Inc, Indivior Solutions Inc., Indivior PLC, Reckitt Benckiser Group plc, Reckitt Benckiser Healthcare (UK) Ltd., and Aquestive Therapeutics, Inc. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 20, 2021, Humana filed a complaint in state court in Kentucky, alleging conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment against the Company relating to Indivior&#8217;s launch of Suboxone Sublingual Film in 2010. The Humana action was stayed pending related litigation, and the stay was lifted on October 30, 2023. On February 23, 2024, the Company filed a motion to dismiss the Complaint. Oral argument on the Company's motion to dismiss is currently set for December 9, 2024. No discovery schedule has been set in the action and there is no trial date set in this case. The Company is not able to determine or predict the ultimate outcome of the state court action in Kentucky by Humana or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California Litigation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Aquestive Therapeutics, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, Neurelis Inc. filed a lawsuit against the Company in the Superior Court of California, County of San Diego alleging the following <ix:nonFraction unitRef="cause" contextRef="c-338" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" id="f-1034">three</ix:nonFraction> causes of action: (1) Unfair Competition under California Business and Professional Code &#167; 17200 (&#8220;UCL&#8221;); (2) Defamation; and (3) Malicious Prosecution. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same <ix:nonFraction unitRef="cause" contextRef="c-338" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" id="f-1035">three</ix:nonFraction> causes of action. The Company filed a Motion to Strike Neurelis&#8217;s Complaint under California&#8217;s anti-SLAPP (&#8220;strategic lawsuit against public participation&#8221;) statute on January 31, 2020, which Neurelis opposed. On August 6, 2020, the Court issued an order granting in part and denying in part the Company&#8217;s anti-SLAPP motion. The parties cross-appealed the ruling to the California Court of Appeal. The appeals court held oral argument on the appeal on October 14, 2021, and issued its ruling on November 17, 2021. Under the ruling, the court struck the entirety of the malicious prosecution claim and struck portions of the UCL and defamation claims. On April 12, 2022, Neurelis filed a Second Amended Complaint in response to the Court of Appeal&#8217;s decision. The Second Amended Complaint also added a cause of action for Trade Libel. On May 3, 2022, the Company filed a "demurrer" challenge to the sufficiency of the allegations of the Second Amended Complaint. Oral argument on the Company&#8217;s motion for attorney fees related to the anti-SLAPP motion and on the Second Amended Complaint and demurer challenge was held on June 17, 2022. The Court entered an order granting the Company&#8217;s motion for attorney fees, awarding $<ix:nonFraction unitRef="usd" contextRef="c-339" decimals="-3" name="us-gaap:LitigationSettlementAmountAwardedFromOtherParty" scale="3" id="f-1036">156</ix:nonFraction> and ordering Neurelis to pay the fees within 60 days of June 17, 2022. The Court denied the Company&#8217;s demurrer and the parties proceeded with discovery on the claims in the Second Amended Complaint. The plaintiff filed a motion to file a third amended complaint, which the Court granted on November 17, 2023. The Third Amended Complaint alleges additional facts but includes the same claims as the Second Amended Complaint. Trial in this matter is scheduled for March 7, 2025. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div></ix:continuation><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><ix:continuation id="f-1033-2"><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neurelis FDA Lawsuit</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis v. Califf, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, U.S. District court for the District of Columbia</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, Neurelis Inc. filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving Aquestive&#8217;s New Drug Application for Libervant&#8482; for epilepsy patients aged between two and five years, and asks the Court to vacate that approval and enjoin the defendants from approving Libervant&#8482; for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the orphan drug market exclusivity granted to the nasal spray product of Neurelis, Inc. by the FDA. Aquestive intervened in the litigation to defend the approval of Libervant&#8482; for this pediatric patient population and on June 25, 2024, the Court entered a scheduling order governing further proceedings in the case. Pursuant to that order, Neurelis filed a motion for summary judgment on August 19, 2024; Aquestive and the federal defendants each filed their own cross-motions for summary judgment and opposed Neurelis&#8217;s motion for summary judgment on September 18, 2024; Neurelis filed its combined reply brief in support of its motion for summary judgment and in opposition to the defendants&#8217; cross-motions on October 9, 2024; and Aquestive and the federal defendants filed their closing briefs on October 30, 2024. No oral argument date has been set in this case. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suboxone Product Liability Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of October 21, 2024, the Company was named as a defendant in over <ix:nonFraction unitRef="plaintiff" contextRef="c-340" decimals="0" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="f-1037">560</ix:nonFraction> product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sublingual Film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a Multidistrict Litigation (&#8220;MDL") consolidated in the United States District Court for the Northern District of Ohio. One case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. No discovery schedule or trial date has been set in the MDL matter. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 15, 2024, the Company was named as a defendant in <ix:nonFraction unitRef="lawsuit" contextRef="c-341" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" id="f-1038">three</ix:nonFraction> proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; products caused them dental injuries. <ix:nonFraction unitRef="lawsuit" contextRef="c-342" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" id="f-1039">Two</ix:nonFraction> of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the <ix:nonFraction unitRef="lawsuit" contextRef="c-342" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" id="f-1040">two</ix:nonFraction> cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec, and is proceeding towards an authorization hearing (date to be set). The authorization and certification hearings are where the Courts will determine if the cases will proceed as class actions. No discovery schedule or trial dates have been set, as all the Canadian cases are pre-certification/pre-authorization. Given the early stages of these proceedings, the Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_103"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read this section in conjunction with our unaudited condensed interim financial statements and related notes included in Part I Item 1 of this Quarterly Report on Form 10-Q and our audited financial statements and related notes thereto and management</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s discussion and analysis of financial condition and results of operations for the years ended December&#160;31, 2023 and 2022 included in our 2023 Annual Report on Form 10-K. All dollar amounts are stated in thousands except for share data. </span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_106"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q and certain other communications made by us include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; or the negative of those terms, and similar expressions are intended to identify forward-looking statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements include, but are not limited to, statements regarding the advancement and related timing of our product candidate Anaphylm&#8482; (epinephrine) Sublingual Film through clinical development and approval by the U.S. Food and Drug Administration (FDA), including the timing of submission of supporting and pediatric clinical studies, holding a pre-New Drug Application (NDA) meeting with the FDA and filing the NDA for Anaphylm with the FDA, and the following launch of Anaphylm, if approved by the FDA; that the results of the Company&#8217;s clinical studies for Anaphylm are sufficient to support submission of the NDA for approval of Anaphylm by the FDA; that Anaphylm will be the first and only oral administration of epinephrine and accepted as an alternative to existing standards of care, if Anaphylm is approved by the FDA; the expected growth of the U.S. epinephrine market including in value and the opportunity such growth presents to the Company should Anaphylm be approved by the FDA; the advancement and related timing of our Adrenaverse pipeline epinephrine prodrug product candidates, including AQST-108, through clinical development and FDA regulatory approval process, including holding a pre-IND meeting with the FDA for AQST-108 and the following launch of AQST-108, if approved by the FDA; the potential sale or outlicensing of Anaphylm, Libervant or other product candidates; the advancement and related timing of our product candidate Libervant&#174; (diazepam) Buccal Film for the indicated epilepsy patient population aged between six and eleven years through clinical development and FDA regulatory approval and the following launch of Libervant for this patient population if approved by the FDA; the approval for U.S. market access of Libervant for this patient population aged six years and older and overcoming the orphan drug market exclusivity of an FDA approved nasal spray product of another company extending to January 2027 for Libervant for these epilepsy patients six years of age and older; the advancement, growth and related timing of our Adrenaverse&#8482; pipeline of epinephrine prodrug product candidates, including AQST-108 (epinephrine) Topical Gel, through clinical development including design and timing of clinical studies including those necessary to support the targeted indication of alopecia areata for AQST-108, and holding a pre-investigational new drug application meeting (IND) with the FDA, and the following launch of AQST-108, if approved by the FDA; the commercial opportunity of Libervant, Anaphylm, AQST-108 and our other product candidates, including potential revenues (including projected peak annual sales) generated from commercialization of these products and product candidates should these product candidates be approved by the FDA; the potential growth of our patent portfolio including the extension of patent protection for Anaphylm should the pending patents be approved by the U.S. Patent and Trademark Office (PTO); the potential benefits our products and product candidates could bring to patients; our cash and financial position, including with respect to our 2024 financial outlook; and business strategies, market opportunities, and other statements that are not historical facts.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> These forward-looking statements are based on our current expectations and beliefs and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such risks and uncertainties include, but are not limited to, risks associated with our development work, including any delays or changes to the timing, cost and success of our product development activities and clinical trials and plans, including those relating to Anaphylm (including for pediatric patients), AQST-108, and the Company's other product candidates; risks associated with the Company&#8217;s distribution work for Libervant, including any delays or changes to the timing, cost and success of Company's distribution activities and expansion of market access to patients aged two to five for Libervant; risk of delays in advancement of the regulatory approval process through the FDA of our product candidates, including the filing of the respective NDAs, including for Anaphylm, AQST-108, Libervant for patients aged between six and eleven and other product candidates, or failure to receive FDA approval at all of any of these product candidates; risk of the Company&#8217;s ability to generate sufficient clinical data for approval of our product candidates, including with respect to our PK/PD comparability submission for FDA approval of Anaphylm; risk of the Company&#8217;s ability to address the FDA&#8217;s comments on the Company&#8217;s future clinical trials and other concerns identified in the FDA Type C meeting minutes for Anaphylm, including the risk that the FDA may require additional clinical studies for approval of Anaphylm; risk of the success of any competing products; risk that we may not overcome the seven year orphan drug market exclusivity granted by the FDA for the approved nasal spray product of another company in the U.S. in order for Libervant to be granted U.S. market access for patients aged six years and older until the expiration of the orphan drug market exclusivity period of the nasal spray product due to expire in January 2027, or for other reasons; risk of loss of U.S. market approval of Libervant for patients aged between two and five resulting from a legal challenge relating to U.S. orphan drug market exclusivity by the owner of the approved nasal spray </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">product with respect to the FDA&#8217;s approval for U.S. market access of Libervant for this pediatric patient population, or for other reasons; risks and uncertainties inherent in commercializing a new product (including technology risks, financial risks, market risks and implementation risks and regulatory limitations); risk of development of a sales and marketing capability for commercialization of our product Libervant and other product candidates, including Anaphylm and AQST-108; the potential impact on the value of the Company of the sale or outlicensing of our product and product candidates, including Libervant and Anaphylm and other product candidates; risk of sufficient capital and cash resources, including sufficient access to available debt and equity financing, including under our ATM facility, and revenues from operations, to satisfy all of our short-term and longer-term liquidity and cash requirements and other cash needs, at the times and in the amounts needed, including to fund commercialization activities relating to Libervant for patients between two and five years of age and to fund future clinical development and commercial activities for our product candidates, including Anaphylm, AQST-108 and Libervant for patients aged between six and eleven, should these product candidates be approved by the FDA, and for Libervant patients of six years and older upon expiration of the orphan drug marketing exclusivity period of the nasal spray product; risk that our manufacturing capabilities will be sufficient to support demand for Libervant for patients between two and five years of age and for older patients, should Libervant receive U.S. market access for these older patients, and for demand for our licensed products in the U.S. and abroad; risk of eroding market share for Suboxone&#174; and risk as a sunsetting product, which accounts for the substantial part of our current operating revenue; risk of default of our debt instruments; risks related to the outsourcing of certain sales, marketing and other operational and staff functions to third parties; risk of the rate and degree of market acceptance in the U.S. and abroad of Libervant for epilepsy patients between two and five years of age, and for older epilepsy patients if approved for U.S. market access and after the expiration of the orphan drug market exclusivity period in January 2027; risk of the rate and degree of market acceptance in the U.S. and abroad of Libervant and Anaphylm, AQST-108 and our other product candidates, should these product candidates be approved by the FDA, and for our licensed products in the U.S. and abroad; risk of the success of any competing products including generics; risk of the size and growth of our product markets; risk of compliance with all FDA and other governmental and customer requirements for our manufacturing facilities; risks associated with intellectual property rights and infringement claims relating to our products; risk that our patent applications for our product candidates, including for Anaphylm, will not be timely issued, or issued at all, by the PTO; risk of unexpected patent developments; risk of legislation and regulatory actions and changes in laws or regulations affecting our business including relating to our products and product candidates and product pricing, reimbursement or access therefor; risk of loss of significant customers; risks related to claims and legal proceedings against Aquestive including patent infringement, securities, business torts, investigative, product safety or efficacy and antitrust litigation matters; risk of product recalls and withdrawals; risks related to any disruptions in our information technology networks and systems, including the impact of cybersecurity attacks; risk of increased cybersecurity attacks and data accessibility disruptions due to remote working arrangements; risk of adverse developments affecting the financial services industry; risks related to inflation and rising interest rates; risks related to the impact of the COVID-19 global pandemic and other pandemic diseases on our business, including with respect to our clinical trials and the site initiation, patient enrollment and timing and adequacy of those clinical trials, regulatory submissions and regulatory reviews and approvals of our product candidates, availability of pharmaceutical ingredients and other raw materials used in our products and product candidates, supply chain, manufacture and distribution of our products and product candidates; risks and uncertainties related to general economic, political (including the Ukraine and Israel wars and other acts of war and terrorism), business, industry, regulatory, financial and market conditions and other unusual items; and other uncertainties affecting us including those described in the "Risk Factors" section and in other sections included in this Quarterly Report on Form 10-Q. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these statements. These factors include the matters discussed and referenced in the risk factors of the Company&#8217;s 2023 Annual Report on Form 10&#8209;K and our other Quarterly Reports on Form 10&#8209;Q and in our Current Reports on Form 8-K and our other filings with the SEC. Given these uncertainties, you should not place undue reliance on these forward-looking statements, which speak only as the date made. All subsequent forward-looking statements attributable to us or any person acting on our behalf are expressly qualified in their entirety by this cautionary statement. We assume no obligation to update forward-looking statements, or outlook or guidance after the date of this Quarterly Report on Form 10-Q, whether as a result of new information, future events or otherwise, except as may be required by applicable law. Readers should not rely on the forward-looking statements included in this Quarterly Report on Form 10-Q as representing our views as of any date after the date of the filing of this Quarterly Report on Form&#160;10&#8209;Q.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to &#8220;Aquestive,&#8221; the "Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; and &#8220;our&#8221; refer to Aquestive Therapeutics, Inc.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_109"></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aquestive is a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#8217; lives through innovative science and delivery technologies. We are developing pharmaceutical products to deliver complex molecules through administrations that are alternatives to invasive and inconvenient standard of care therapies. We have a proprietary commercial product, Libervant&#174; (diazepam) Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, seizure clusters, acute repetitive seizures) that are distinct from a patient&#8217;s usual seizure pattern in patients with epilepsy between two and five years of age, which was launched in April 2024. We are advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, under the trade name </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">"Anaphylm&#8482;", and our Adrenaverse epinephrine prodrug pipeline platform. We have five licensed commercial products that are marketed by our licensees in the U.S. and around the world. We are the exclusive manufacturer of these licensed products. Aquestive also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm&#174;, and has proven drug development and commercialization capabilities. Our production facilities are located in Portage, Indiana, and our corporate headquarters and primary research laboratory facilities are based in Warren, New Jersey. </span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture licensed products at our facilities and anticipate that our current manufacturing capacity is sufficient for commercial quantities of our licensed products, proprietary product and product candidates currently in development. Our facilities have been inspected by the FDA, TGA, and DEA, and are subject to inspection by all applicable health agencies, including ANVISA and EMA. Not all collaborative or licensed products of the Company that may be commercially launched in the future will necessarily be manufactured by us.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complex Molecule Portfolio</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed a proprietary pipeline of complex molecule-based product candidates as alternatives to invasively administered standard of care therapeutics addressing large market opportunities. The active programs in our complex molecule pipeline portfolio are:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Anaphylm&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (epinephrine) Sublingual Film &#8211; the first and only non-device based, orally delivered epinephrine product candidate that has shown clinical results comparable to auto-injectors (such as EpiPen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Auvi-Q</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) for the emergency treatment of allergic reactions, including anaphylaxis. Epinephrine is the standard of care in the treatment of anaphylaxis and is typically administered via intramuscular injection (IM) including auto-injectors, such as EpiPen and Auvi-Q, which require patients or their caregivers to inject epinephrine into the patient&#8217;s thigh during an emergency allergic reaction. As a result of this route of administration, many patients and their caregivers are reluctant to use injectable products. In August 2024, a nasal spray device was approved by the FDA for the treatment of severe allergic reactions including anaphylaxis. However, Anaphylm would, if approved by the FDA, allow a patient to simply place a dissolvable strip, approximately the size and weight of a postage stamp, under the tongue, providing an appropriate medication where it is needed, when it is needed and in a form preferred by patients.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA conditionally accepted the proprietary name Anaphylm&#8482; (pronounced &#8220;ana-film&#8221;) as the proposed brand name for Anaphylm. Final approval of the Anaphylm proprietary name is conditioned on FDA approval of Anaphylm, if any.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2022, following a Phase 1 clinical study conducted by the Company, the FDA cleared our IND for Anaphylm, allowing for clinical investigation of Anaphylm in the U.S. The FDA confirmed that the 505(b)(2) regulatory approval pathway is acceptable for the development of Anaphylm. The FDA granted Fast Track designation of Anaphylm in March 2022.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout 2022 and 2023, we reported positive topline data from several clinical studies evaluating multiple oral film formulations and dosage strengths of Anaphylm in healthy adult subjects, including cross over studies comparing the PK and PD of epinephrine delivered via Anaphylm compared to current standards of care, EpiPen&#174; and manual intramuscular (IM) injectors. These studies demonstrated that treatment with Anaphylm was well tolerated, with no serious adverse events, significant medical events, or treatment-related severe adverse events reported. The data from these clinical studies formed the basis for the End-of-Phase 2 (EoP2) meeting with the FDA in December of 2022, which provided clarity as to the FDA&#8217;s expectations regarding key clinical program areas for design of revised dosing instructions expected for use in our pivotal clinical trial.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, we received comments from the FDA on its protocol for our pivotal clinical study for Anaphylm, which comments indicated that our proposed endpoints, sample size, and statistical analysis for the proposed pivotal clinical study were reasonable and provided clarity on PK sustainability with repeat-dose requirements. We incorporated the FDA&#8217;s feedback into the pivotal clinical study design, which study commenced in Q4 2023.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2024, we successfully completed a Type C meeting with the FDA in which the FDA found that we had adequately addressed the FDA&#8217;s previous concerns noted in the EoP2 meeting, including addressing (1) the impact of any product hold time, (2) the potential for emesis (vomiting), and (3) the impact of potential mouth conditions such as angioedema (swelling), by removing product hold time from the administration instructions and providing additional information on how to characterize emesis in our NDA submission with the FDA. Regarding mouth conditions, the FDA recommended administering Anaphylm after oral exposure to a known allergen and assessing PK performance thereunder. This study replaced our previously planned angioedema study. In those comments, the FDA did not outline any new clinical development requirements for the Anaphylm program. The FDA reserved judgement on the sufficiency of the Anaphylm clinical development program until completion of ongoing and planned studies, the </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results of which are expected to be presented at a pre-NDA meeting with the FDA, which is scheduled for the fourth quarter of 2024.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2024, we released topline data from our pivotal clinical study for Anaphylm. The two-part, Phase 3, single-center, open-label, randomized study was designed to compare the PK and PD of single and repeat doses of Anaphylm versus single and repeat doses of the IM injection and epinephrine autoinjectors (EpiPen&#174; and Auvi-Q&#174;) in healthy adult subjects. The results of this study demonstrated that the primary endpoint of epinephrine PK biocomparability of the single administration of Anaphylm to the single administration of Adrenalin (epinephrine IM injection) and autoinjectors in healthy adult subjects was met, as well as the secondary endpoints which included evaluating the PK sustainability of Anaphylm following repeat administration and the safety and tolerability of Anaphylm following single and repeat administrations versus epinephrine IM injection and epinephrine autoinjectors.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">n June 2024, we reported positive topline  PK data from the temperature / pH study of Anaphylm&#8482;. The single-dose, five-period, randomized crossover study was designed to compare the PK and PD of Anaphylm just after consuming normal water at different temperatures (hot, cold, and room temperature) as well as water of different pHs (acidic- lemon water, and basic- baking soda water). The most consumed beverages, such as soda, milk, coffee, and juice, have acidity between lemon water and normal water. The primary PK parameters were the maximum amount of epinephrine measured in plasma (Cmax) and exposure, or the area under the curve (AUC), at predefined time points after dosing, in 30 healthy adult subjects. Topline PK and PD data from the study showed no statistically significant difference in PK and PD results between the different groups based on temperature and pH variability in the mouth.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, we reported positive topline data from the self-administration PK study of Anaphylm. The single-dose, three-period, randomized crossover study was designed to compare the PK and PD of Anaphylm self-administered, Anaphylm healthcare provider (HCP)-administered, and Adrenalin manual intramuscular (IM) injection HCP- administered. The primary PK parameters were the maximum amount of epinephrine measured in plasma (Cmax) and exposure, or the area under the curve (AUC), at predefined time points after dosing in 36 healthy adult subjects. The median time to maximum concentration (Tmax) was 15 minutes for both the Anaphylm self-administered and HCP-administered arms, while the median Tmax for the Adrenalin IM HCP administered arm was 50 minutes post administration. Also, there was no statistical difference between the Anaphylm self-administered and HCP- administered arms of the study based on a comparison of epinephrine exposures across the first 60 minutes post-administration. Topline PD data from the study showed no difference in the median increase in systolic blood pressure, diastolic blood pressure, and heart rate whether Anaphylm is self-administered or HCP-administered.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2024, we reported positive topline data from the oral allergy syndrome challenge study (now referred to as the "OASIS" study), meeting both primary and secondary endpoints. The two-part study demonstrated that Anaphylm maintained its PK and PD profile during allergen-induced oral physiological changes. In addition, following allergen exposure where 94% of subjects exhibited moderate to severe symptoms per the pre-defined oral severity score, rapid symptom resolution was observed beginning as early as two minutes post-administration. The median time to complete symptom resolution was twelve minutes compared to seventy-four minutes at screening baseline, with 50% of all symptoms across all subjects resolving by five minutes. The mean time of symptom resolution for edema, which affected approximately twenty-five percent of subjects, was five minutes after Anaphylm administration. The PK profile remained consistent, with median time to peak drug concentration (Tmax) maintained at twelve minutes and comparable geometric mean maximum concentration (Cmax) values between allergen-exposed and non-exposed cohorts. The safety profile was favorable, with all adverse events classified as mild to moderate and resolving without medical intervention. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in October 2024, at the ACAAI 2024 Annual Meeting in Boston, we presented results from a subsequent analysis of our pivotal study data demonstrating Anaphylm's consistent PK and PD profile regardless of variable placement or intraoral movement. The analysis showed that 87.5% of subjects maintained consistent film placement during disintegration. In the 12.5% of subjects where movement was noted, there were no significant differences in Cmax and Tmax. These findings further demonstrate that initial placement or subsequent movement of the sublingual film had no impact on epinephrine PK or PD comparability to epinephrine autoinjectors.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recently received positive pre-NDA written response feedback from the FDA to the proposed CMC submission for Anaphylm. In addition, a clinically focused pre-NDA meeting with the FDA is scheduled for the fourth quarter of 2024. We are planning on initiating a full product launch of Anaphylm, if approved by the FDA, in the first quarter of 2026. This is based on commencing the pediatric study in subjects from the ages of 7 to 17 (weight greater than or equal to 30 kgs) in the fourth quarter of 2024 and completing an NDA submission with the FDA in the first quarter of 2025.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">AQST-108 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(epinephrine) topical gel &#8211; Our product candidate, AQST&#8209;108 is composed of the prodrug dipivefrin which is enzymatically cleaved into epinephrine after administration. AQST&#8209;108, is a topically delivered adrenergic agonist prodrug, which we believe has the potential to support the re-establishment of immune privilege in the hair follicle and we are pursuing its development for the treatment of alopecia areata. We completed the first human clinical study for AQST108 The two-part study was designed to assess the safety and local tolerability of AQST-108. Part 1 was designed as a single ascending dose escalation study to assess the safety and pharmacokinetics of five different dose levels. The 1.0% dose of AQST-108 was chosen based on the down selection from the highest dose to move into the Part 2 study of the development program. In Part 2, three formulations based on excipient variations were evaluated in twelve healthy subjects. In Parts 1 and 2, no serious adverse events or topical adverse events were observed. In Part 2, the calculated percentage of AQST-108 observed in the skin remained consistent across all studied formulations and zero post dose AQST-108 concentrations in plasma were observed. We outlined the design of our planned Phase 2a study to assess the safety and efficacy of AQST-108 in mild to moderate alopecia areata patients at our investor day presentation on September 27, 2024. We have scheduled an IND meeting with the FDA in the fourth quarter of 2024 to align on the Phase 2a study design and plan to commence the Phase 2a study in the second quarter of 2025.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary CNS Product</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the application of our proprietary PharmFilm</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology is particularly valuable and relevant to patients suffering from certain CNS disorders to meet patients&#8217; unmet medical needs and to solve patients&#8217; therapeutic problems. Additionally, our know-how and proprietary position have broad application beyond CNS, and we plan to explore the applications of PharmFilm in other disease areas. Our most advanced asset within our proprietary CNS portfolio, focused in epilepsy, is as follows:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Libervant&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a buccally, or inside of the cheek, administered soluble film formulation of diazepam is our most advanced proprietary product. Aquestive developed Libervant as an alternative to device-dependent rescue therapies currently available to patients with refractory epilepsy, which are a rectal gel and nasal sprays. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 26, 2024, the FDA approved Libervant for U.S. market access for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, seizure clusters, acute repetitive seizures) that are distinct from a patient&#8217;s usual seizure pattern in patients with epilepsy between two and five years of age. Libervant is the first and only orally administered rescue product for the treatment of seizure cluster in patients between ages two and five. The only other current FDA approved product for these epilepsy patients between two and five years of age is a diazepam rectal gel. In October 2024, Libervant 5mg, 7.5mg, 10mg, 12.5mg and 15 mg for patients between two to five years of age became available through multiple retail distribution channels. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Market access activities have broadened coverage. Libervant is available nationwide with retail distribution capabilities in place. For Medicaid patients, Libervant is available in all states.  Commercial patient access to Libervant continues to expand based on health plan reviews and Pharmacy Benefit Manager agreements.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the FDA approval of Libervant for patients between two to five years old, the FDA granted tentative approval in August 2022 for Libervant for the same indication in patients with epilepsy 12 years of age and older, finding that Libervant had met all required quality, safety, and efficacy standards for approval. However, due to an existing FDA regulatory grant of orphan drug market exclusivity for a diazepam nasal spray product sold by another company for use in patients 6 years of age and older, the FDA determined that Libervant was not yet eligible for marketing in the United States for this patient population of 12 years of age and older. We expect to file for FDA approval of these epilepsy patients aged between six and twelve years prior to the expiration of the orphan drug marketing exclusivity block of the nasal spray product. As a result of the orphan drug marketing exclusivity granted by the FDA to the nasal spray product, the FDA cannot give final approval for U.S. market access for Libervant for any age group of 6 and above until the expiration or inapplicability of the orphan drug market exclusivity, including, for example, by a reversal of the FDA&#8217;s decision and determination that Libervant is &#8220;clinically superior&#8221; to Valtoco. However, overcoming the orphan drug marketing exclusivity determination is difficult to establish, with limited precedent, and there can be no assurance that the FDA will agree with our position seeking to overcome such market exclusivity and approve Libervant for U.S. market access for this age group of six years and older earlier than January 2027, the scheduled date for expiration of orphan drug market exclusivity. See &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Licensed Commercial Products, Product Candidates and Other Products &#8211; Libervant</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a discussion of the licensing arrangement for Libervant.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensed Commercial Products, Product Candidates and Other Products</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our portfolio also includes other products and product candidates that we have licensed, or will seek to license, or for which we have licensed our intellectual property for commercialization. In the years ended December 31, 2023 and 2022, our licensed product portfolio generated $50.6&#160;million and $47.7 million in revenue to Aquestive, respectively. In the nine months ended September&#160;30, 2024 and 2023, our licensed product portfolio generated $45,694 and $37,377 in revenue to Aquestive, respectively. Those products include:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Suboxone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; a sublingual film formulation of buprenorphine and naloxone, respectively an opioid agonist and antagonist, that is marketed in the United States and internationally for the treatment of opioid dependence. Suboxone was launched by our licensee, Indivior, in 2010. Suboxone is the most prescribed branded product in its category and was the first sublingual film product for the treatment of opioid dependence. We are the sole and exclusive supplier and manufacturer of Suboxone and have produced over 2.7 billion doses of Suboxone since its launch in 2010. As of September&#160;30, 2024, Suboxone branded products retain approximately 28% film market share as generic film-based products have penetrated this market. We have filed patent infringement lawsuits against certain companies relating to generic film-based products for buprenorphine-naloxone. More details regarding these lawsuits are described in the accompanying unaudited condensed financial statements, Note 19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, contained herein. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Exservan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; an oral film formulation of riluzole, has been developed by the Company for the treatment of ALS. We believe that Exservan can bring meaningful assistance to patients who are diagnosed with ALS and face difficulties swallowing traditional forms of medication. Exservan was approved by the FDA on November 22, 2019. During the fourth quarter of 2019, we announced the grant of a license to Zambon for the development and commercialization of Exservan in the European Union (or EU) for the treatment of ALS. Zambon is a multinational pharmaceutical company with a focus on the CNS therapeutic area. Under the terms of the license agreement with Zambon, an upfront payment was paid to Aquestive for the development and commercialization rights of Exservan in the EU, and Aquestive will be paid development and sales milestone payments and low double-digit royalties on net sales of the product in the EU. Zambon is responsible for the regulatory approval and marketing of Exservan in the countries where Zambon seeks to market the product, which it markets as Emylif</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Aquestive is responsible for the development and manufacture of the product. During the second quarter of 2023, Aquestive received a $0.5 million milestone payment in connection with the first commercial sale in the first country in the licensed territory for Exservan pursuant to the terms of the license agreement with Zambon.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, we announced that the Company granted an exclusive license to MTPA for the commercialization in the United States of Exservan. MTPA is a multinational pharmaceutical company with a focus on patients with ALS. The product was launched by MTPA in June 2021. Under the terms of the MTPA license agreement, Aquestive was the exclusive manufacturer and supplier of Exservan for MTPA in the United States. Exservan was developed to potentially fulfill a critical need for ALS patients, given it can be administered safely and easily, twice daily, without water. In June 2024, the Company and MTPA mutually agreed to terminate the MTPA Licensing Agreement. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our accompanying unaudited condensed financial statements for details. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we announced the grant of an exclusive license to Haisco for Haisco to develop and commercialize Exservan for the treatment of ALS in China. Haisco is a China-based public pharmaceutical company. Haisco led the regulatory and commercialization activities for Exservan in China. Aquestive was the exclusive sole manufacturer and supplier for Exservan in China. Under the terms of license agreement with Haisco, as amended, Aquestive received a $7.0 million upfront payment in September 2022, and was to receive regulatory milestone payments, double-digit royalties on net sales of Exservan in China, and earn manufacturing revenue upon the sale of Exservan in China. In June 2024, the Company and Haisco mutually agreed to terminate the Haisco Agreement. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our accompanying unaudited condensed financial statements for details. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">KYNMOBI</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; a sublingual film formulation of apomorphine, which is a dopamine agonist, was developed to treat episodic off-periods in Parkinson&#8217;s disease. We licensed our intellectual property to Cynapsus Therapeutics, Inc., a company that was acquired by Sunovion for the commercialization of KYNMOBI under the Sunovion License Agreement. KYNMOBI was approved by the FDA on May 21, 2020 and commercially launched by Sunovion in September 2020. On November 3, 2020, we entered into the Monetization Agreement. Under the terms of the Monetization Agreement, we sold all of our contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:line-through">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Zuplenz</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; an oral soluble film formulation of ondansetron, a 5-HT antagonist, was developed for the treatment of nausea and vomiting associated with chemotherapy and post-operative recovery. Ondansetron is available as branded and generic products as intravenous injections, intramuscular injections, orally dissolving tablets, oral solution tablets, and film. We licensed commercial rights for Zuplenz to Hypera in Brazil (which Hypera markets as Ondif</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). Hypera received approval to market Zuplenz in Brazil from ANVISA on February 21, 2022. Aquestive manufactures and supplies Ondif to Hypera. We licensed commercial rights for Zuplenz to Fortovia in the United States, Canada, and China. Fortovia launched Zuplenz in the United States in 2015. We had been the sole and exclusive manufacturer of Zuplenz for Fortovia. On August 31, 2020, Fortovia filed a Chapter 11 bankruptcy proceeding in the Bankruptcy Court for the Eastern District of North Carolina. On January 29, 2021, the Bankruptcy Court approved an agreement pursuant to which the license and supply agreement between Aquestive and Fortovia was terminated, and all rights to commercialize Zuplenz returned to us, effective January 30, 2021. The Company submitted a request for voluntary </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">withdrawal of NDA 022524, Zuplenz, as the product is no longer marketed in the U.S. The request is currently being processed by FDA. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Azstarys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> an FDA-approved, once-daily product for the treatment of ADHD in patients age six years or older. AZSTARYS consists of serdexmethylphenidate, a prodrug of d-methylphenidate (d-MPH), co-formulated with immediate release d-MPH. In March 2012, the Company entered into an agreement with Zevra (formerly KemPharm, Inc.) to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys. On March 2, 2021, Zevra announced FDA approval of Azstarys for the treatment of ADHD. Pursuant to the terms of the March 2012 agreement with Zevra, the Company has begun to receive </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">milestone revenues for Azstarys.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Libervant&#174; - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Pharmanovia Agreement with Pharmanovia, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#8217;s intellectual property to develop and commercialize Libervant for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. The Company received $3.5 million upon agreement execution. Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of the licensed territory for Libervant to cover the rest of the world, excluding the U.S., Canada and China. Pharmanovia will be responsible for seeking appropriate regulatory approval in the expanded territories. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $2.0 million from Pharmanovia on execution of the Pharmanovia Amendment.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Sympazan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; an oral soluble film formulation of clobazam used for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut syndrome, or LGS, in patients aged two years of age or older, was approved by the FDA on November 1, 2018. We commercially launched Sympazan in December 2018. On October 26, 2022, the Company entered into the Assertio Agreement with Otter Pharmaceuticals, LLC, a subsidiary of Assertio Holdings, Inc., pursuant to which the Company granted an exclusive, worldwide license of its intellectual property for Sympazan to Assertio during the term of that agreement for an upfront payment of $9.0 million. Additionally, the Company subsequently received from Assertio a $6.0 million milestone payment upon the Company's receipt of a notice of allowance from the United States Patent and Trademark Office of its patent application U.S. Serial No. 16/561,573, and payment of the related allowance fee. The Company is the exclusive sole manufacturer and supplier of Sympazan for Assertio and receives manufacturing fees from Assertio for the product through the expiration of such supply agreement.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_112"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">                                                                                                                                                                                                                                                                                                  Critical Accounting Policies and Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting policies and use of estimates as previously disclosed in our 2023 Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">JOBS Act and Smaller Reporting Company</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we were no longer an &#8220;emerging growth company,&#8221; as defined in the United States JOBS Act. While we were an emerging growth company, we were able to take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not &#8220;emerging growth companies,&#8221; including exemption from compliance with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, and exemptions from the requirements of holding a non-binding advisory vote on executive compensation. Even though we are no longer an emerging growth company, we remain exempt from the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act pursuant to rules of the SEC.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We remain a &#8220;smaller reporting company&#8221;, meaning we are not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a "smaller reporting company" which allows us to take advantage of many of the same exemptions from disclosure requirements including reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and certain reduced financial disclosures in our periodic reports. In addition, we are eligible to remain a smaller reporting company, for so long as we have a public float (based on our Common Stock equity) of less than $250 million measured as of the last business day of our most recently completed second fiscal quarter or a public float (based on our Common Stock equity) of less than $700 million as of such date and annual revenues of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">less than $100 million during the most recently completed fiscal year. We cannot predict if investors will find our Common Stock less attractive because we may rely on these exemptions. If some investors find our Common Stock less attractive as a result of these disclosure exemptions, there may be a less active trading market for our Common Stock and our stock price may be more volatile.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_115"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Operations Overview</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues to date have been earned from our manufactured products made to order for licensees.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> R</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">evenues are also earned from our product development services provided under contracts with customers, and from the licensing of our intellectual property. These activities generate revenues in four primary categories: manufacture and supply revenue, license and royalty revenue, co-development and research fees, and proprietary product revenue, net.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and Supply Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture based on receipt of purchase orders from our licensees, and our licensees have an obligation to accept these orders once quality assurance validates the quality of the manufactured product with agreed upon technical specifications. With the exception of our license of Exservan, our licensees are responsible for all other aspects of commercialization of these products, and we have no role, either direct or indirect, in our customers&#8217; commercialization activities, including those related to marketing, pricing, sales, payor access and regulatory operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect future manufacture and supply revenue from licensed products to be based on volume demand for existing licensed products, and for manufacturing and supply rights under license and supply agreements for existing or new agreements for successful product development collaborations.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We realize revenue from licenses of our intellectual property. For licenses that do not require further development or other ongoing activities by us, our licensee has acquired the right to use the licensed intellectual property for self-development of their product candidate, for manufacturing, commercialization or other specified purposes, upon the effective transfer of those rights, and related revenues are generally recorded at a point in time, subject to contingencies or constraints, if any. For licenses that may provide substantial value only in conjunction with other performance obligations to be provided by us, such as development services or the manufacture of specific products, revenues are generally recorded over the term of the license agreement. We also earn royalties based on our licensees&#8217; sales of products that use our intellectual property that are marketed and sold in the countries where we have patented technology rights.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of our research and development projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Costs and Expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our costs and expenses are primarily the result of the following activities: generation of manufacture and supply revenues; development of our pipeline of proprietary product candidates; and selling, general and administrative expenses, including pre-launch and post-launch commercialization efforts, intellectual property procurement, protection, prosecution and litigation expenses, corporate management functions, medical and clinical affairs administration; public company costs, share-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">based compensation expenses and interest on our corporate borrowings. We primarily record our costs and expenses in the following categories:</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply costs and expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply costs and expenses are primarily incurred from the manufacture of our commercialized licensed pharmaceutical products, including raw materials, direct labor and overhead costs principally in our Portage, Indiana facilities. Our material costs include the costs of raw materials used in the production of our proprietary dissolving film and primary packaging materials. Direct labor costs consist of payroll costs (including taxes and benefits) of employees engaged in production activities. Overhead costs principally consist of indirect payroll, facilities rent, utilities and depreciation for leasehold improvements and production machinery and equipment. These costs can increase, or decrease, based on the costs of materials, purchased at market pricing, and the amount of direct labor required to produce a product, along with the allocation of fixed overhead, which is dependent on production volume.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacture and supply costs and expenses are impacted by our customers&#8217; supply requirements. Costs of production reflect the costs of raw materials that are purchased at market prices and production efficiency (measured by the cost of a salable unit). These costs can increase or decrease based on the amount of direct labor and materials required to produce a product and the allocation of fixed overhead, which is dependent on the levels of production.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to seek to rationalize and manage costs to prepare for a potential decline in Suboxone volumes as the generics in that market continue to take market share, at least partially offset by anticipated manufacturing revenue of our proprietary and licensed products. In addition to our proprietary products coming online, we may add licensee products which may need additional resources to manufacture. If such growth should occur for higher volume product opportunities such as Suboxone and Ondansetron, we would incur increased costs associated with hiring additional personnel to support the increased manufacturing and supply costs arising from higher manufactured volumes from licensed products.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have focused significant resources on our research and development activities. Research and development expenses primarily consist of:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">employee-related expenses, including compensation, benefits, share-based compensation and travel expense;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">external research and development expenses incurred under arrangements with third parties, such as CROs, investigational sites and consultants;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of acquiring, developing and manufacturing clinical study materials; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs associated with preclinical and clinical activities and regulatory operations.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to continue to be significant over the next several years as we continue to develop existing product candidates such as Anaphylm, AQST-108 and others, and as we identify and develop or acquire additional product candidates and technologies. We may hire or engage additional skilled colleagues or third parties to perform these activities, conduct clinical trials and ultimately seek regulatory approvals for any product candidate that successfully completes those clinical trials.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, general and administrative expenses</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses consist primarily of salaries, benefits, share-based compensation, other related costs for executive, finance, and operational personnel. Other costs include facility and related costs not otherwise included in research and development expenses such as: professional fees for patent-related and other legal expenses, regulatory fees, consulting, tax and accounting services; insurance; market research; advisory board and key opinion leaders; depreciation; and general corporate expenses, inclusive of IT systems related costs. In addition, these expenses also include warehousing, distribution, selling and business development, engineering, and other costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative costs include costs related to accounting, audit, legal regulatory, and tax-related services required to maintain compliance with exchange listing and SEC regulations, director and officer insurance costs, and investor and public relations costs. We continue to incur significant costs in seeking to protect our intellectual property rights, including significant litigation costs in connection with seeking to enforce our rights concerning third parties&#8217; at-risk launch of generic products.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to manage business costs to prepare for a potential future decline in Suboxone revenue and other external factors affecting our business, as we continue to focus on our core business:</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continuing the development of Anaphylm and AQST-108; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Commercializing Libervant after approval from the FDA on April 26, 2024 for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient&#8217;s usual seizure pattern in pediatric patients with epilepsy between two and five years of age.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists of interest costs on the outstanding balances of our 12.5% Notes and 13.5% Notes at a fixed rate of 12.5% and 13.5%, respectively, payable quarterly, as well as amortization of loan costs and debt discounts. The redemption of 12.5% Notes and the issuance of 13.5% Notes are discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to our Condensed Financial Statements. See </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further detail on our 12.5% Notes and 13.5% Notes.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense related to royalty obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of the 13.5% Notes, we entered into the Royalty Rights Agreements with each of the Note Holders granting the Note Holders a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm (epinephrine) Sublingual Film for a period of eight years from the first sale of Anaphylm on a global basis. The Note Holders are also entitled to a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. These royalty agreements are classified as debt, and the value of the $45,000 13.5% Notes has been allocated between debt and the Royalty Obligations based on their relative fair market values. The excess of future estimated royalty payments of $56,926 over the $13,856 of the allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method. The 13.5% Notes are discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to our Condensed Financial Statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest expense related to the sale of future revenue</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, we entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, we sold to Marathon all of our contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI, an apomorphine film therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, we received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. We have received an aggregate amount of $50,000 through September&#160;30, 2024 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to us upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it has voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, we likely will not receive any of the additional contingent payments under the Monetization agreement. We discontinued recording interest expense related to the sale of future revenue under the Monetization agreement in the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, we recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due in each of the subsequent eight years. In connection with the Monetization Agreement, we performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements for further detail.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest income and other income, net</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income and other income, net consists of earnings derived from an interest-bearing account, investments in money market Treasury mutual funds and other miscellaneous income and expense items.&#160;The interest-bearing account and money market Treasury mutual funds have no minimum amounts to be maintained in the accounts nor any fixed length of period for which interest and dividends are earned.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three and Nine Months Ended September&#160;30, 2024 and 2023</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenues</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our revenue data for the periods indicated.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:27.743%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.513%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.831%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;<br/>Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except %)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(738)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,495)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,059&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">584&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,317&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2024 Compared to Three Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2024, total revenues increased 4%, or $540 compared to the same period in the prior year primarily due to a certain one-time increase in license and royalty revenue, partially offset by decreases in manufacture and supply revenue.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply revenue decreased approximately 6%, or $738 for the three months ended September&#160;30, 2024 compared to the same period in the prior year. This decrease was primarily due to a 13%, or $1,412 decrease in Suboxone revenues and a $690 decrease in Sympazan revenues, partially offset by a $1,123 increase in Ondif revenue that was attributable to an increase in volume.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License and royalty revenue increased 96%, or $1,059 for the three months ended September&#160;30, 2024 compared to the same period in the prior year. This increase was primarily due to the one-time recognition of deferred revenue of $1,227 due to the termination of a licensing and supply agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Co-development and research fees for the three months ended September 30, 2024 remained relatively consistent compared to the same period in the prior year.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary product revenue, net increased by $217 for the three months ended September 30, 2024 compared to the same period in the prior year due to the launch of Libervant for patients between two to five years of age.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_121"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2024 Compared to Nine Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For the nine months ended September&#160;30, 2024, total revenues increased 22%, or $8,317 compared to the same period in the prior year. The increase was primarily due to certain one-time increases in license and royalty revenue and increases in co-development and research fees, partially offset by decreases in manufacture and supply revenue.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply revenue decreased approximately 11%, or $3,495 for the nine months ended September&#160;30, 2024 compared to the same period in the prior year. This decrease was primarily due to a 39%, or $1,329 decrease in Ondif revenue attributable to a decrease in volume and a 7%, or $1,902 decrease in Suboxone revenue mainly due to retroactive price increases in the prior period that were not present in 2024. These decreases were partially offset by a $684 increase in Exservan revenues from Zambon. As part of the Indivior Amendment 11 to the Commercial Exploitation Agreement, we received retroactive price increases related to 2022 Suboxone purchases in the amount of $1,682 which was recognized in Manufacture and supply revenue in the nine months ended September 30, 2023. There were no retroactive price adjustments included in Manufacture and supply revenue for the nine months ended September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">License and royalty revenue increased 314%, or $11,011 for the nine months ended September&#160;30, 2024 compared to the same period in the prior year. This increase was primarily due to the one-time recognition of deferred revenues of $11,544 due to the terminations of licensing and supply agreements. These increases were partially offset by a $500 decrease in license revenue recognized in the prior period for Azstarys from Zevra.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Co-development and research fees increased 55% or $584 for the nine months ended September&#160;30, 2024 compared to the same period in the prior year. The increase was driven by the timing of the achievement of Co-development and research performance obligations which are expected to fluctuate among reporting periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Proprietary product revenue, net increased by $217 for the nine months ended September 30, 2024 compared to the same period in the prior year due to the launch of Libervant for patients between two to five years of age.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Expenses, Interest Income and Other Income:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our expenses and income for the periods indicated.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:29.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.927%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months<br/>Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months<br/>Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands, except %)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,437&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,798&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(361)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,352&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,800)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,363&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,741&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,171&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,524&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,343&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,279&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to royalty obligations</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,359&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense related to the sale of future revenue</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income and other income, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(979)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,514)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,703)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,156)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,453&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on extinguishment of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(353)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2024 Compared to Three Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply costs and expenses decreased 8% or $361 for the three months ended September&#160;30, 2024 compared to the same period in the prior year. The decrease was largely due to lower volume of strips sold, changes in product mix and lower direct production costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased 65% or $2,073 for the three months ended September&#160;30, 2024 compared to the same period in the prior year. The increase in Research and development expenses is primarily due to clinical trial costs and product research expenses associated with the continued advancement of the Anaphylm program, and an increase in share-based compensation. The tables below provide a breakdown of the major costs included in total Research and development expenses and project costs by type of expense for each of the main clinical development projects in which we are engaged for each period presented:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.110%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.502%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.508%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months<br/>Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(185)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,452&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D personnel costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,574&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,525&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consulting and outside services</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation/amortization</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other R&amp;D</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">299&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,269&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,073&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of the project expenses are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anaphylm</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Libervant</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;inc /</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">dec</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">817&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,601&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,125&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Three Months Ended September&#160;30, 2024 Compared to Three Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total project expenses for Anaphylm increased 131%, or $1,476 over the comparable period in 2023. Anaphylm clinical trial expenses and product research expenses increased $1,290 and $347, respectively, over the comparable period in 2023, partially offset by decreases in development and manufacturing of $161. Clinical trial expenses for Anaphylm of $2,107 were primarily due to clinical trial costs associated with the continued advancement of the Anaphylm program. Product research expenses for Anaphylm increased $347, or 439%, primarily related to expenses incurred for the preparation of the NDA filing. During the three months ended September&#160;30, 2023, clinical trial expenses for Anaphylm of $817 were related to the activities leading up to the Phase 3 PK Study.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D share-based compensation increased by $206, or 198% primarily related to the effect of new grants in 2024 to R&amp;D personnel. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other R&amp;D expenses include rent, utilities, maintenance and other expenses and fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 64% or $4,741 for the three months ended September&#160;30, 2024 as compared to the same period in the prior year. The increase primarily represents higher personnel costs of approximately $900, higher consulting and market access costs of $890, higher share-based compensation expenses of $555, higher regulatory and licensing fees of $520 related to the regulatory fee for Libervant, higher expenses of $1,484 due to a change in the allocation of manufacture and supply costs compared to the prior period and other expenses, partially offset by decreases in other general and administrative costs including insurance expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased 121% or $1,524 for the three months ended September&#160;30, 2024 compared to the same period in the prior year. The increase was mostly driven by the increased amortization of debt issuance costs and discounts on the 13.5% Notes refinancing in November 2023 for the three months ended September&#160;30, 2024 compared to the three months ended September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to royalty obligations represents amortization of the discount on the royalty obligations. For the three months ended September&#160;30, 2024, the amount was $1,359. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This amount is due to the accounting associated with the royalty obligations as part of the 13.5% Notes issuance. There were no expenses related to the royalty obligations in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">same period in 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the sale of future revenue was $59 and $56 for the three months ended September&#160;30, 2024 and September&#160;30, 2023, respectively, and represents amortization of the issuance costs. These amounts are due to the accounting associated with the sale of future revenue related to KYNMOBI royalties sold to Marathon on November 3, 2020 and do not represent or imply a monetary obligation or cash outflow at any time during the life of the transaction. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. As a result, the Company discontinued recording interest expense related to the sale of future revenue in the fourth quarter of 2022. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements for details. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income and other income, net was $979 for the three months ended September&#160;30, 2024 which primarily represents higher investment income due to higher cash balances invested in interest-bearing and dividend-earning money market accounts. Interest income and other income, net was $1,514 for the three months ended September&#160;30, 2023 which primarily represented the receipt of the Employee Retention Tax Credit refund. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2024 Compared to Nine Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacture and supply costs and expenses decreased 17% or $2,800 for the nine months ended September&#160;30, 2024 compared to the same period in the prior year. The decrease was largely due to lower volume of strips sold, changes in product mix, and lower direct production costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses increased 50% or $5,147 for the nine months ended September&#160;30, 2024 compared to the same period in the prior year. The increase in Research and development expenses is primarily due to clinical trial costs associated with the continued advancement of the Anaphylm and AQST-108 programs, increases in personnel costs, and an increase in share-based compensation. The tables below provide a breakdown of the major costs included in total Research and development expenses and project costs by type of expense for each of the main clinical development projects in which we are engaged for each period presented:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:59.488%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.164%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.388%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.168%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">(In thousands)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,797&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(312)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,450&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preclinical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">327&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D personnel costs</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,839&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">507&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consulting and outside services</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">511&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation/amortization</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All other R&amp;D</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">663&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,363&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,216&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The details of the project expenses are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.186%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.747%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nine Months Ended September 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Anaphylm</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AQST-108</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%<br/>&#160;inc /<br/>dec</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Libervant</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;inc /</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">dec</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clinical Trials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,194&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,591&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,381&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Development and Manufacturing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product Research Expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">215&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Project Expenses</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,450&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,448&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,219&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/M</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September&#160;30, 2024 Compared to Nine Months Ended September&#160;30, 2023</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total project expenses for Anaphylm increased 77%, or $3,229 over the comparable period in 2023. Clinical trial expenses and product research expenses for Anaphylm increased $3,210 and $322, respectively, over the comparable period in 2023 offset by decreases in development and manufacturing of $303. Clinical trial expenses for Anaphylm of $6,591 were primarily due to clinical trial costs associated with the continued advancement of the Anaphylm program. Clinical trial expenses for Anaphylm of $3,381 were related to the activities leading up to the Phase 3 PK Study. Total project expenses for AQST-108 increased $784 over the comparable period in 2023 and were related to feasibility work for AQST-108. During the nine months ended September&#160;30, 2023, product research expenses for Libervant of $215 were primarily due to data integration and modeling work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D personnel costs increased by 12%, or $507, for the nine months ended September&#160;30, 2024. as compared to the same period in 2023, due to additional headcount. R&amp;D share-based compensation increased by $511, or 184%, which was </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">primarily related to awards granted to our Chief Medical Officer upon his commencement of employment and the effect of new grants in 2024 to R&amp;D personnel. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other R&amp;D expenses include rent, utilities, maintenance and other expenses and fees.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expenses increased 54% or $11,971 for the nine months ended September&#160;30, 2024 as compared to the same period in the prior year. The increase primarily represents higher personnel costs of approximately $2,500, higher consulting and market access costs of approximately $1,830, higher share-based compensation expenses of $1,800, one-time severance costs of approximately $1,100, higher regulatory and licensing fees of approximately $880 related to the regulatory fee for Libervant, higher expenses of $4,100 due to a year-over-year change in the allocation of manufacture and supply costs, and other expenses, partially offset by lower legal fees of $940 and decreases in other general and administrative costs including insurance expense.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense increased 105% or $4,279 for the nine months ended September&#160;30, 2024 as compared to the same period in the prior year. The increase was mostly driven by the increased amortization of debt issuance costs and discounts on the 13.5% Notes refinancing in November 2023 for the nine months ended September&#160;30, 2024 compared to the nine months ended September&#160;30, 2023. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to royalty obligations represents amortization of the discount on the royalty obligations. For the nine months ended September&#160;30, 2024, the amount was $4,075. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This amount is due to the accounting associated with the royalty obligations as part of the 13.5% Notes issuance. There were no expenses related to the royalty obligations in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">same period in 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense related to the sale of future revenue was $175 and $163 for the nine months ended September&#160;30, 2024 and 2023, respectively, and represents amortization of the issuance costs. These amounts are due to the accounting associated with the sale of future revenue related to KYNMOBI royalties sold to Marathon on November 3, 2020 and do not represent or imply a monetary obligation or cash outflow at any time during the life of the transaction. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. As a result, the Company discontinued recording interest expense related to the sale of future revenue in the fourth quarter of 2022. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements for details. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and other income, net was $2,703 and 16,156 for the nine months ended September&#160;30, 2024 and 2023, respectively. The decrease by $13,453 is due to other income of $6,000 related to the Amendment 11 to the Indivior Commercial Exploitation Agreement, $8,500 related to the patent litigation settlement with BioDelivery Sciences International, Inc. and the receipt of the ERTC, which were recognized in the nine months ended September&#160;30, 2023 and did not occur during the comparable period. During the nine months ended September&#160;30, 2024, we recognized a gain of $1,500 on the termination of a license and supply agreement, which was partially offset by the adjustment of $1,200 to the remaining balance of the intangible asset due to the termination of the agreement; we also recognized higher interest income by $2,100 due to higher cash balances invested in interest-bearing and dividend-earning money market accounts.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_130"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources of Liquidity</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had $77,893 in cash and cash equivalents as of September&#160;30, 2024. While our ability to execute our business objectives and achieve profitability over the longer term cannot be assured, our on-going business, existing cash and cash equivalents, expense management activities, as well as access to the equity capital markets, including through the ATM facility and under the Lincoln Park Purchase Agreement, provide near term liquidity for us to fund our operating needs for at least the next twelve months as we continue to execute our business strategy. As discussed below, on November 1, 2023, we issued $45,000 in aggregate principal amount of 13.5% Notes due November 1, 2028. A portion of the net proceeds from this transaction was used to redeem all of the outstanding 12.5% Notes and to pay expenses relating to that offering, with the balance of the proceeds to be used for general corporate purposes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2021, we entered into the Fourth Supplemental Indenture, pursuant to which the amortization schedule for the 12.5% Notes was amended to provide for the date of the first amortization payment to be extended to March 30, 2023. The Fourth Supplemental Indenture did not change the maturity date of the 12.5% Notes or the interest payment obligation due under the 12.5 Notes. In connection with the Fourth Supplemental Indenture, we entered into a Consent Fee Letter with the holders of the 12.5% Notes, pursuant to which we agreed to pay the holders of the 12.5% Notes an additional cash payment of $2,700 in the aggregate, payable in four quarterly payments beginning May 15, 2022. The last quarterly payment was made during the three months ended March 31, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September&#160;30, 2023, we redeemed $5,647 of our outstanding 12.5% Notes. We also paid $353 in prepayment premium as result of the early retirement of debt which was reflected as a loss on extinguishment of debt in our Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023. The prepayments along with the scheduled principal payments of $6,878 during the nine months ended September 30, 2023 reduced the net balance of the 12.5% Notes outstanding in the aggregate to $38,975 as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We established our first ATM facility in September 2019, and since inception to September&#160;30, 2024, we have sold 19,857,518 shares of Common Stock which has generated net cash proceeds of approximately $60,558, net of commissions and other transactions costs of $3,085. On April 3, 2024, we filed a new shelf registration statement on Form S-3 to register the offer and sale of up to $250,000 worth of shares of Common Stock ("Registration Statement No. 333-278498" or the "2024 Registration Statement"), that was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement was a $100,000 ATM facility pursuant to the Amended Equity Distribution Agreement with Piper Sandler &amp; Co.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2024, there were no shares of Common Stock sold under the ATM facility. For the nine months ended September 30, 2024, we sold 4,557,220 shares of Common Stock under the ATM facility which provided net proceeds of approximately $11,855 after deducting commissions and other transaction costs of $530. For the nine months ended September 30, 2023, we sold 3,184,740 shares under the ATM facility which provided net proceeds of approximately $5,274 after deducting commissions and other transaction costs of $392.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2022, we entered into the Lincoln Park Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations under the Lincoln Park Purchase Agreement, we have the right, but not the obligation, to sell to Lincoln Park up to $40,000 worth of shares of our Common Stock from time to time over the 36-month term of the Lincoln Park Purchase Agreement. The Lincoln Park Purchase Agreement contains an ownership limitation such that we will not issue, and Lincoln Park will not purchase, shares of Common Stock if it would result in their beneficial ownership exceeding 9.99%. Lincoln Park has covenanted under the Lincoln Park Purchase Agreement not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of our Common Stock. In 2022, we sold 1,600,000 shares in addition to 236,491 commitment shares, which provided proceeds of approximately $1,987 in connection with the Lincoln Park Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not sell shares in connection with the Lincoln Park Purchase Agreement in 2023 or in the nine months ended September 30, 2024. We have no current intent to use the Lincoln Park facility.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 6, 2022, we entered into the Securities Purchase Agreements with certain purchasers. The Securities Purchase Agreements provide for the sale and issuance by us of an aggregate of: (i) 4,850,000 shares of Common Stock, (ii) pre-funded warrants to purchase up to 4,000,000 shares of Common Stock and (iii) Common Stock warrants to purchase up to 8,850,000 shares of Common Stock. The pre-funded warrants were fully exercised in 2022. In June 2023, 3,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $3,542. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, we entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and Aquestive agreed that the Exercising Holder would exercise all of its Existing Warrants at the then current exercise price of the Existing Warrants. The Exercising Holder subsequently exercised the Existing Warrants, with Aquestive receiving gross proceeds of $4,800. We also issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants are exercisable after February 2, 2024, expire on February 2, 2029 and are exercisable only for cash, unless the shares of Common Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case the New Warrants may also be exercised by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, we issued $45,000 aggregate principal amount of its 13.5% Notes due November 1, 2028. A portion of the net proceeds from that offering was used to redeem all of the outstanding 12.5% Notes and to pay expenses relating to that offering, with the balance of the proceeds to be used for general corporate purposes. Interest on the 13.5% Notes accrues at a rate of 13.5% per annum and is payable quarterly in arrears on March 30, June 30, September 30 and December 30 of each year commencing on December 30, 2023. The 13.5% Notes are interest-only until June 30, 2026, whereupon on such date and each payment date thereafter we will also pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with a portion of an Exit Fee determined as of the applicable date of prepayment, payment, acceleration, repurchase or redemption, as the case may be.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2024, we completed the Underwritten Public Offering of 16,666,667 shares of our common stock at the public offering price of $4.50 per share. In addition, pursuant to the partial exercise of the underwriters' option, on April 22, 2024, we sold an additional 559,801 shares of Common Stock. Net proceeds from the Underwritten Public Offering, including the exercise of underwriters' option were $72,868, after deducting underwriting discounts of $4,651. In addition to the underwriting discounts related to this offering, we incurred professional fees and other costs totaling $894 as of September&#160;30, 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nine Months Ended September 30, 2024 and 2023</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:71.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.516%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.518%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for operating activities</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,270)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,438)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used for investing activities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(144)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(979)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,435&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,356)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash used for operating activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for operating activities for the nine months ended September&#160;30, 2024 increased by $27,832 compared to the same period in the prior year.&#160;The increase in cash used for operating activities was primarily related to the change in net (loss) income of $27,323 and deferred revenue of $15,021, which was attributed to the recognition of deferred revenues due to the termination of license and supply agreements during the nine months ended September&#160;30, 2024, partially offset by decreases in trade and other receivables of $1,949. Other changes were mainly due to higher amortization of debt issuance costs and discounts of $7,841 on the 13.5% Notes refinancing in November 2023 and an increase in share-based compensation of $2,947 as compared with the nine months ended September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash used for investing activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used for investing activities for the nine months ended September&#160;30, 2024 decreased by $835 compared to the same period in the prior year. The use of cash was related to capital expenditures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net cash provided by financing activities</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities for the nine months ended September&#160;30, 2024 increased by $83,374 compared to the same period in the prior year. The increase was primarily related to the Underwritten Public Offering which provided net proceeds of $71,974, higher ATM proceeds of $6,543 due to higher volumes and Common Stock prices as compared to the nine months ended September&#160;30, 2023. These increases during the nine months ended September&#160;30, 2024 were also due to absence of 12.5% Notes principal payments and premium paid to retire debt partially offset by no proceeds received from the issuance and exercise of the warrants as compared to the same period in the prior year. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Funding Requirements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our on-going business, existing cash and equivalents, expense management activities as well as access to the equity capital markets, including through our ATM facility, potentially provide near term funding opportunities for Aquestive, see &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. On November 1, 2023, we issued $45,000 in aggregate principal amount of the 13.5% Notes due November 1, 2028. A portion of the net proceeds from that offering were used to redeem all of the outstanding 12.5% Notes and to pay expenses relating to that offering, with the balance of the proceeds to be used for general corporate purposes. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2024, we completed the Underwritten Public Offering of 16,666,667 shares of our common stock at the public offering price of $4.50 per share. In addition, pursuant to the partial exercise of the underwriters' option, on April 22, 2024, we sold an additional 559,801 shares of Common Stock. Net proceeds from the Underwritten Public Offering, including the exercise of underwriters' option were $72,868 after deducting underwriting discounts of $4,651. In addition to the underwriting discounts related to this offering, we incurred professional fees and other costs totaling $894 as of September&#160;30, 2024. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to use the net proceeds received from these transactions, together with the Company&#8217;s existing cash and cash equivalents, primarily to advance the development and commercialization of the Company's product pipeline, including Libervant, for the treatment of seizure clusters in epilepsy patients between two and five years of age, and Anaphylm, and for working capital, capital expenditures and general corporate purposes. We can provide no assurance that any of these sources of funding, either individually or in combination, will be available on reasonable terms, if at all, or sufficient to fund our business objectives. In addition, we may be required to utilize available financial resources sooner than expected. We have based our expectation on assumptions that could change or prove to be inaccurate, due to unrelated factors including factors arising in the capital markets, asset monetization markets, regulatory approval process, and regulatory oversight and other factors. Key factors and assumptions inherent in our planned continued operations and anticipated growth include, without limitation, those related to the following:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for our manufactured products, including effects of generics and other competitive pressures as currently envisioned;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued ability of our customers to pay, in a timely manner, for presently contracted and future anticipated orders for provided co-development and feasibility services, as well as regulatory support services for recently licensed products;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">access to debt or equity markets if, and at the time, needed for any necessary future funding, including our ability to access funding through our ATM facility and under the Lincoln Park Purchase Agreement, should we choose to access those facilities;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continuing review and appropriate adjustment of our cost structure consistent with our anticipated revenues and funding;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued growth and market penetration of Sympazan, including anticipated patient and physician acceptance and our licensee&#8217;s ability to obtain adequate reimbursement and payment support from government agencies and other private medical insurers;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">effective commercialization within anticipated cost levels and expected ramp-up timeframes of our product Libervant for pediatric patients between two and five years of age;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">infrastructure and administrative costs at expected levels to support operations as an FDA and highly regulated public company;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a manageable level of costs for ongoing efforts to protect our intellectual property rights and litigation matters in which we are involved;</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued compliance with all covenants under our 13.5% Notes, including our ability to comply with our debt service obligations as required thereunder; and</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">absence of significant unforeseen cash requirements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to manage business costs to appropriately reflect the anticipated general decline in Suboxone revenue, and other external resources or factors affecting our business including, if available, future equity financing, other future access to the capital markets or other potential available sources of liquidity. In doing so, we plan to continue to focus on the core drivers of value for our stockholders, including, more importantly, continued investments in our ongoing product development activities in support of Anaphylm and AQST-108. Until profitability is achieved, if at all, additional capital and/or other financing or funding will be required, which could be material, to further advance the commercialization of Libervant for pediatric patients between two and five years of age and development and commercialization of Anaphylm and AQST-108, if approved by the FDA, and to meet our other cash requirements, including debt service, specifically our 13.5% Notes. We plan to conservatively manage our launch spending as to both timing and level relating to Libervant in light of the approval of Libervant by the FDA for patients between two and five years of age. Even as such, we expect to incur losses and negative cash flows for the foreseeable future and, therefore, we expect to be dependent upon external financing and funding to achieve our operating plan.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sufficiency of our short-term and longer-term liquidity is directly impacted by our level of operating revenues and our ability to achieve our operating plan for revenues, regulatory approval in the time period planned for our product candidates and our ability to monetize other royalty streams or other licensed rights within planned timeframes, and there can be no assurance that we will be successful in any monetization transaction. Our operating revenues have fluctuated in the past and can be expected to fluctuate in the future. We expect to incur significant operating losses and negative operating cash flows for the foreseeable future, and we have a significant level of debt on which we have substantial ongoing interest payments, have principal repayments related to our 13.5% Notes starting in June 2026 through the debt maturity date and royalty obligation payments projected to be made from the fourth quarter of 2024 to 2033, which are further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to our Condensed Financial Statements. A substantial portion of our current and past revenues has been dependent upon our licensing, manufacturing and sales with one customer, Indivior, which is expected to continue, and it could take significantly longer than planned to achieve anticipated levels of cash flows to help fund our operations and cash needs. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we raise additional funds by issuance of equity securities, our stockholders would experience further dilution, and the terms of these securities could include liquidation or other preferences (if and to the extent permitted under the Indenture) that would adversely affect our stockholders&#8217; rights. Our ability to secure additional equity financing could be significantly impacted by numerous factors including our operating performance and prospects, positive or negative developments in the regulatory approval process for our product candidates, our existing level of debt which is secured by substantially all of our assets under the Indenture, and general financial market conditions, and there can be no assurance that </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we will continue to be successful in raising capital or that any such needed financing will be available on favorable or acceptable terms, if at all.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If adequate funds are not available for our short-term or longer-term liquidity needs and cash requirements as and when needed, we would be required to engage in expense management activities such as reducing staff, delaying, significantly scaling back, or even discontinuing some or all of our current or planned launch activities and research and development programs and clinical and other product development activities, and otherwise significantly reducing our other spending and adjusting our operating plan, and we would need to seek to take other steps intended to improve our liquidity. We also may seek outlicensing opportunities for our proprietary products and product candidate programs that we currently plan to self-commercialize, including for Libervant and Anaphylm, or explore other potential liquidity options or strategic opportunities. Such strategic opportunities could include asset sales, outlicensing or other monetization opportunities of our proprietary products and product candidates, including Libervant and Anaphylm, although we cannot assure that any of these actions or opportunities would be available or available on reasonable terms. While an outlicensing of our proprietary products and product candidates, if approved by the FDA, could limit our exposure to the costs of commercialization of the product and provide a potential source of royalty and milestone revenues, the benefit from the potential of additional future value that could result from our independent commercialization of these products and product candidates, assuming a successful launch of our proprietary products and product candidates, if approved by the FDA, would likely be limited. In addition, in the event of any such asset sales or outlicensing transactions, the future growth of the Company would be dependent on continued successful development or our early stage product candidates and/or asset acquisitions or other strategic transactions for the Company.  There is no assurance that any such outlicensing or other strategic opportunities will be available or available on reasonable terms. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_136"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period presented, we did not have any material off-balance sheet arrangements, nor do we have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_139"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;smaller reporting company&#8221; as defined by Item 10 of Regulation S-K promulgated by the SEC under the U.S. Securities Act of 1933, as amended, we are not required to provide the information required by this Item 3.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_142"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Evaluation of our Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and (2) accumulated and communicated to our management, including to our principal executive officer and principal financial officer, to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(b) and 13a-15(e) under the Exchange Act). Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.&#160;Our principal executive officer and principal financial officer have concluded based upon the evaluation described above that, as of September&#160;30, 2024, our disclosure controls and procedures were effective at a reasonable assurance level.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act), identified in connection with the evaluation of such internal control that occurred during our last fiscal quarter, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II - OTHER INFORMATION</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_148"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;Legal Proceedings</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on Legal Proceedings, see Part I Item I. Financial Statements (Unaudited), Note 19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_151"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A.&#160;&#160;&#160;&#160;Risk Factors</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should carefully review and consider the information regarding certain risks and uncertainties facing the Company that could have a material adverse effect on our business prospects, financial condition, results of operations, liquidity and available capital resources set forth in Part I, Item 1A of Aquestive&#8217;s 2023 Annual Report on Form 10-K. </span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_154"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.&#160;&#160;&#160;&#160;Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_157"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Defaults Upon Senior Securities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_160"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Mine Safety Disclosures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_163"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-5" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1041"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-1042"><ix:nonNumeric contextRef="c-5" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-1043">Other Information</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></span></div><ix:nonNumeric contextRef="c-344" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1045" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-343" name="ecd:TrdArrIndTitle" id="f-1044">Chief Executive Officer</ix:nonNumeric> <ix:nonNumeric contextRef="c-343" name="ecd:TrdArrIndName" id="f-1046">Daniel Barber</ix:nonNumeric> <ix:nonNumeric contextRef="c-343" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1047">adopted</ix:nonNumeric> a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Barber Plan") on <ix:nonNumeric contextRef="c-343" name="ecd:TrdArrAdoptionDate" id="f-1048">June 14, 2024</ix:nonNumeric>. The Barber Plan commenced on September 13, 2024 and ends on <ix:nonNumeric contextRef="c-343" name="ecd:TrdArrExpirationDate" id="f-1049">September 30, 2025</ix:nonNumeric>. The maximum number of shares to be sold under the Barber Plan is <ix:nonFraction unitRef="shares" contextRef="c-345" decimals="0" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-1050">650,055</ix:nonFraction> shares and no shares have been sold as of the date of this Report; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Barber Plan.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-347" name="ecd:MtrlTermsOfTrdArrTextBlock" id="f-1052" escape="true"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-346" name="ecd:TrdArrIndTitle" id="f-1051">Senior Vice President</ix:nonNumeric> <ix:nonNumeric contextRef="c-346" name="ecd:TrdArrIndName" id="f-1053">Peter Boyd</ix:nonNumeric> <ix:nonNumeric contextRef="c-346" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-true" id="f-1054">adopted</ix:nonNumeric> a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Boyd Plan") on <ix:nonNumeric contextRef="c-346" name="ecd:TrdArrAdoptionDate" id="f-1055">September 11, 2024</ix:nonNumeric>. The Boyd Plan commences on December 13, 2024 and ends on <ix:nonNumeric contextRef="c-346" name="ecd:TrdArrExpirationDate" id="f-1056">December 12, 2025</ix:nonNumeric>. The maximum number of shares to be sold under the Boyd Plan is <ix:nonFraction unitRef="shares" contextRef="c-348" decimals="0" name="ecd:TrdArrSecuritiesAggAvailAmt" format="ixt:num-dot-decimal" id="f-1057">35,000</ix:nonFraction> shares; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Boyd Plan.</span></div></ix:nonNumeric><div id="i0121722c2f7d4b94a9a7ec2585983b32_166"></div><div style="-sec-extract:summary;margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed below are filed or furnished as part of this report.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:9.295%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:87.773%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1398733/000114036118033895/s002128x30_ex3-1.htm">3.1</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Certificate of Incorporation, dated as of July 27, 2018 (filed as Exhibit 3.1 to the Current Report on Form 8-K of the Company, as filed on July 27, 2018, and incorporated by reference herein).</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="aquestiveamendedandresta.htm">3.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated Bylaws, dated as of October 16, 2024 (filed herewith).</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32024ex311.htm">31.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32024ex312.htm">31.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a), as amended, under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32024ex321.htm">32.1</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="q32024ex322.htm">32.2</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith).</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL document and contained in exhibit 101)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*  Filed herewith.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i0121722c2f7d4b94a9a7ec2585983b32_169"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i0121722c2f7d4b94a9a7ec2585983b32_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the County of Somerset, State of New Jersey.</span></div><div style="margin-bottom:6pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:10.027%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.096%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aquestive Therapeutics, Inc.<br/>(REGISTRANT)</span></td></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Daniel Barber</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 4, 2024</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ A. Ernest Toth, Jr.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A. Ernest Toth, Jr.</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.2
<SEQUENCE>2
<FILENAME>aquestiveamendedandresta.htm
<DESCRIPTION>EX-3.2
<TEXT>
<HTML>
<HEAD><!-- Document generated by Workiva Inc -->
<TITLE>aquestiveamendedandresta</TITLE>
</HEAD>
<BODY bgcolor="white">
<DIV align="center">
<DIV style="margin-left:1em;width:1055;"><!-- aquestiveamendedandresta001.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta001.jpg" title="slide1" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">  120172535.2  AMENDED AND RESTATED  BYLAWS    OF    AQUESTIVE THERAPEUTICS, INC.    (As of October 16, 2024)    ARTICLE I  STOCKHOLDERS    Section 1.  The annual meeting of the stockholders of Aquestive Therapeutics, Inc. (the &#8220;Corporation&#8221;)  for the purpose of electing directors and for the transaction of such other business as may properly be brought before  the meeting shall be held on such date, and at such time and place, if any, within or without the State of Delaware as  may be determined exclusively from time to time by the Board of Directors of the Corporation (the &#8220;Board&#8221;). The  Corporation may postpone, reschedule or cancel any annual meeting of stockholders previously scheduled.     Section 2.  Except as otherwise required by law or the certificate of incorporation of the Corporation,  and subject to the rights of the holders of one or more series of Preferred Stock (as defined in the certificate of  incorporation of the Corporation), special meetings of the stockholders of the Corporation may be called only by or at  the direction of the Board, acting pursuant to a resolution adopted by the affirmative vote of the majority of the  members of the Board then in office or by the Chair of the Board. The Corporation may postpone, reschedule or cancel  any special meeting of stockholders previously scheduled.     Section 3.  Except as otherwise provided by law, the certificate of incorporation of the Corporation or  these Bylaws, notice of the date, time, place (if any), the means of remote communications, if any, by which  stockholders and proxy holders may be deemed to be present in person and vote at such meeting, the record date for  determining the stockholders entitled to vote at the meeting (if such date is different from the record date for  stockholders entitled to notice of the meeting) and, in the case of a special meeting, the purpose or purposes of the  meeting of stockholders, shall be given not more than sixty (60) nor less than ten (10) days before the date of each  meeting of stockholders of the Corporation, to each stockholder entitled to vote at the meeting as of the record date  for determining stockholders entitled to notice of the meeting at such address as appears on the records of the  Corporation.     Section 4.  The holders of a majority in voting power of the stock issued and outstanding and entitled  to vote thereat, present in person or represented by proxy, shall constitute a quorum at all meetings of the stockholders  for the transaction of business, except as otherwise provided in these Bylaws, by law or by the certificate of  incorporation of the Corporation; but, if at any meeting of stockholders there shall be less than a quorum present, the  chair of the meeting or, by a majority in voting power thereof, the stockholders present may, to the extent permitted  by law, adjourn the meeting from time to time without further notice other than announcement at such meeting of the  date, time and place, if any, of the adjourned meeting, until a quorum shall be present or represented by proxy.     At any adjourned meeting at which a quorum shall be present or represented by proxy, any business  may be transacted which might have been transacted at the original meeting. When a meeting is adjourned to another  date, time or place (including an adjournment taken to address a technical failure to convene or continue a meeting  using remote communication), notice need not be given of any adjourned meeting if the date, time, place, if any,  thereof, and the means of remote communication, if any, by which stockholders and proxy holders may be deemed to  be present in person and vote at such adjourned meeting are (A) announced at the meeting at which the adjournment  is taken, (B) displayed, during the time scheduled for the meeting, on the same electronic network used to enable  stockholders and proxy holders to participate in the meetings by means of remote communication, or (C) set forth in  the notice of meeting given in accordance with Article I, Section 3 of these Bylaws; provided, however, that if the  adjournment is for more than thirty (30) days, a notice of the adjourned meeting shall be given to each stockholder of  record entitled to vote at the meeting.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta002.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta002.jpg" title="slide2" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">2  Section 5.  The Chair of the Board, or in the Chair&#8217;s absence or at the Chair&#8217;s direction, the Chief  Executive Officer, or in the Chief Executive Officer&#8217;s absence or at the Chief Executive Officer&#8217;s direction, any officer  of the Corporation, shall call all meetings of the stockholders to order and shall act as chair of any such meetings. The  Secretary of the Corporation or, in such officer&#8217;s absence, an Assistant Secretary, shall act as secretary of the meeting.  If neither the Secretary nor an Assistant Secretary is present, the chair of the meeting shall appoint a secretary of the  meeting. The Board may adopt such rules and regulations for the conduct of the meeting of stockholders as it shall  deem appropriate. Unless otherwise determined by the Board prior to the meeting, the chair of the meeting shall  determine the order of business and agenda and shall have the authority in his or her discretion to regulate the conduct  of any such meeting, including, without limitation, convening the meeting and adjourning the meeting (whether or not  a quorum is present), announcing the date and time of the opening and the closing of the polls for each matter upon  which the stockholders will vote, imposing restrictions on the persons (other than stockholders of record of the  Corporation or their duly appointed proxies) who may attend any such meeting, establishing procedures for the  transaction of business at the meeting (including the dismissal of business not properly presented), maintaining order  at the meeting and safety of those present, restricting entry to the meeting after the time fixed for commencement  thereof, limiting the circumstances in which any person may make a statement or ask questions at any meeting of  stockholders, and limitations on the time allotted to questions or comments by participants at such meeting.     Section 6.  At all meetings of stockholders, any stockholder entitled to vote thereat shall be entitled to  vote in person or by proxy, but no proxy shall be voted after three years from its date, unless such proxy provides for  a longer period. Without limiting the manner in which a stockholder may authorize another person or persons to act  for the stockholder as proxy pursuant to the General Corporation Law of the State of Delaware (the &#8220;DGCL&#8221;), the  following shall constitute a valid means by which a stockholder may grant such authority: (A) a stockholder may  execute a writing authorizing another person or persons to act for the stockholder as proxy, and execution of the  writing may be accomplished by the stockholder or the stockholder&#8217;s authorized officer, director, employee or agent  signing such writing or causing his or her signature to be affixed to such writing by any reasonable means including,  but not limited to, by facsimile or electronic signature; or (B) a stockholder may authorize another person or persons  to act for the stockholder as proxy by transmitting or authorizing by means of electronic transmission to the person  who will be the holder of the proxy or to a proxy solicitation firm, proxy support service organization or like agent  duly authorized by the person who will be the holder of the proxy to receive such transmission; provided that any such  means of electronic transmission must either set forth or be submitted with information from which it can be  determined that the electronic transmission was authorized by the stockholder. If it is determined that such electronic  transmissions are valid, the inspector or inspectors of stockholder votes or, if there are no such inspectors, such other  persons making that determination shall specify the information upon which they relied.     A proxy shall be irrevocable if it states that it is irrevocable and if and only as long as it is coupled with an  interest sufficient in law to support an irrevocable power. A stockholder may revoke any proxy which is not irrevocable  by attending the meeting and voting in person or by delivering to the Secretary of the Corporation a revocation of the  proxy or a new proxy bearing a later date.    Any copy, facsimile telecommunication or other reliable reproduction of the writing or transmission created  pursuant to the first paragraph of this Section 6 may be substituted or used in lieu of the original writing or transmission  for any and all purposes for which the original writing or transmission could be used, provided that such copy,  facsimile telecommunication or other reproduction shall be a complete reproduction of the entire original writing or  transmission.    Proxies shall be filed with the secretary of the meeting prior to or at the commencement of the meeting to  which they relate.    Section 7.  When a quorum is present at any meeting of stockholders, the vote of the holders of a  majority of the votes cast shall decide any question brought before such meeting, unless the question is one upon  which by express provision of the certificate of incorporation of the Corporation, these Bylaws or the DGCL a different  vote is required, in which case such express provision shall govern and control the decision of such question.  Notwithstanding the foregoing in this Section 7, where a separate vote by a class or series or classes or series is  required and a quorum is present, the affirmative vote of a majority of the votes cast by shares of such class or series  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta003.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta003.jpg" title="slide3" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">3  or classes or series shall be the act of such class or series or classes or series, unless the question is one upon which  by express provision of the certificate of incorporation of the Corporation, these Bylaws or the DGCL a different vote  is required, in which case such express provision shall govern and control the decision of such question.     Section 8.   (A)  In order that the Corporation may determine the stockholders entitled to notice of any meeting of  stockholders or any adjournment thereof, the Board may fix a record date, which record date shall not precede the date  upon which the resolution fixing the record date is adopted by the Board, and which record date shall, unless otherwise  required by law, not be more than sixty (60) nor less than ten (10) days before the date of such meeting. If the Board  so fixes a date, such date shall also be the record date for determining the stockholders entitled to vote at such meeting  unless the Board determines, at the time it fixes such record date, that a later date on or before the date of the meeting  shall be the date for making such determination. If no record date is fixed by the Board, the record date for determining  stockholders entitled to notice of or to vote at a meeting of stockholders shall be at the close of business on the day  next preceding the day on which notice is given, or, if notice is waived, at the close of business on the day next  preceding the day on which the meeting is held. A determination of stockholders of record entitled to notice of or to  vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board  may fix a new record date for determination of stockholders entitled to vote at the adjourned meeting, and in such case  shall also fix as the record date for stockholders entitled to notice of such adjourned meeting the same or an earlier  date as that fixed for determination of stockholders entitled to vote in accordance herewith at the adjourned meeting.      (B)   In order that the Corporation may determine the stockholders entitled to receive payment of any  dividend or other distribution or allotment of any rights, or entitled to exercise any rights in respect of any change,  conversion or exchange of stock or for the purpose of any other lawful action, the Board may fix a record date, which  record date shall not precede the date on which the resolution fixing the record date is adopted and which record date  shall not be more than sixty (60) days prior to such other action. If no such record date is fixed, the record date for  determining stockholders for any such purpose shall be at the close of business on the day on which the Board adopts  the resolution relating thereto.    Section 9.  The officer who has charge of the stock ledger of the Corporation shall prepare and make,  no later than the tenth (10th) day before each meeting of stockholders, a complete list of the stockholders entitled to  vote at the meeting (provided, however, if the record date for determining the stockholders entitled to vote is less than  ten (10) days before the date of the meeting, the list shall reflect the stockholders entitled to vote as of the tenth (10th)  day before the meeting date), arranged in alphabetical order, and showing the address of each stockholder and the  number of shares registered in the name of each stockholder, as both appear in the records of the Corporation. Nothing  contained in this Section 9 shall require the Corporation to include electronic mail addresses or other electronic contact  information on such list. Such list shall be open to the examination of any stockholder for any purpose germane to the  meeting for a period of ten (10) days ending on the day before the meeting date: (A) on a reasonably accessible  electronic network, provided that the information required to gain access to such list is provided with the notice of the  meeting; or (B) during ordinary business hours, at the principal place of business of the Corporation. In the event that  the Corporation determines to make the list available on an electronic network, the Corporation may take reasonable  steps to ensure that such information is available only to stockholders of the Corporation.     Section 10.  The Board, in advance of all meetings of the stockholders, may (and, if required by law,  shall) appoint one or more inspectors of stockholder votes to make a written report thereof, who may be employees or  agents of the Corporation or stockholders or their proxies, but who shall not be directors of the Corporation or  candidates for election as directors. In the event that the Board fails to so appoint one or more inspectors of stockholder  votes or, in the event that one or more inspectors of stockholder votes previously designated by the Board fails to  appear or act at the meeting of stockholders, the chair of the meeting may appoint one or more inspectors of  stockholder votes to fill such vacancy or vacancies or such position or positions. Inspectors of stockholder votes  appointed to act at any meeting of the stockholders, before entering upon the discharge of their duties, shall take and  sign an oath to faithfully execute the duties of inspector of stockholder votes with strict impartiality and according to  the best of their ability and the oath so taken shall be subscribed by them. Inspectors of stockholder votes shall take  all actions required under the applicable provisions of the DGCL and any other applicable law, rule or regulation.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta004.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta004.jpg" title="slide4" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">4     Section 11. (A) Annual Meetings of Stockholders.   (1)  Nominations of persons for election to the Board and the proposal of other business to be considered  by the stockholders may be made at an annual meeting of stockholders only (a) pursuant to the Corporation&#8217;s notice  of meeting (or any supplement thereto) delivered pursuant to Article I, Section 3 of these Bylaws, (b) by or at the  direction of the Board or any authorized committee thereof or (c) by any stockholder of the Corporation who is entitled  to vote on such election or such other business at the meeting, who complied with the procedures and information  requirements set forth in this Section 11, including without limitation providing timely updates and supplements to  the information contained therein, and who was a stockholder of record at the time such notice is delivered to the  Secretary of the Corporation.    (2) For nominations or other business to be properly brought before an annual meeting by a stockholder,  the stockholder must have given timely notice thereof in writing to the Secretary of the Corporation, and, in the case  of business other than nominations of persons for election to the Board, such other business must constitute a proper  matter for stockholder action. To be timely, a stockholder&#8217;s notice shall be delivered to the Secretary of the  Corporation at the principal place of business of the Corporation not less than ninety (90) days nor more than one  hundred twenty (120) days prior to the first anniversary of the preceding year&#8217;s annual meeting; provided, however,  that, in the event that the date of the annual meeting is advanced by more than twenty (20) days, or delayed by more  than seventy (70) days, from the anniversary date of the previous year&#8217;s meeting, or if no annual meeting was held in  the preceding year, notice by the stockholder to be timely must be so delivered not earlier than the close of business  on the one hundred and twentieth (120th) day prior to such annual meeting and not later than the close of business on  the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which  public announcement of the date of such meeting is first made. For purposes of the application of Rule 14a-4(c) of the  Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the  &#8220;Exchange Act&#8221;) (or any successor provision), the date for notice specified in this paragraph (A)(2) shall be the earlier  of the date calculated as hereinbefore provided or the date specified in paragraph (c)(1) of Rule 14a-4 of the Exchange  Act. The stockholder of record providing notice (the &#8220;Noticing Stockholder&#8221;) of a proposed nomination for election  to the Board or other business proposed to be brought before a meeting (whether given pursuant to this paragraph  (A)(2) or paragraph (B) of this Section 11 of these Bylaws) shall update and supplement such notice from time to time  to the extent necessary so that the information provided or required to be provided in such notice shall be true and  correct as of the record date for determining stockholders entitled to notice of the meeting and as of the date that is  fifteen (15) days prior to the meeting or any adjournment or postponement thereof, provided that, if the record date  for determining the stockholders entitled to vote at the meeting is less than fifteen (15) days prior to the meeting or  any adjournment or postponement thereof, the information shall be supplemented and updated as of such later date.  Any such update and supplement shall be delivered in writing to the Secretary of the Corporation at the principal place  of business of the Corporation not later than five (5) days after the record date for determining stockholders entitled  to notice of the meeting (in the case of any update or supplement required to be made as of the record date for  determining stockholders entitled to notice of the meeting), not later than ten (10) days prior to the date for the meeting  or any adjournment or postponement thereof (in the case of any update or supplement required to be made as of fifteen  (15) days prior to the meeting or any adjournment or postponement thereof) and not later than five (5) days after the  record date for determining the stockholders entitled to vote at the meeting, but no later than the day prior to the  meeting or any adjournment or postponement thereof (in the case of any update and supplement required to be made  as of a date less than fifteen (15) days prior the date of the meeting or any adjournment or postponement thereof).     (3) To be in proper written form, a stockholder&#8217;s notice to the Secretary of the Corporation pursuant to  this Section 11 shall set forth:   (a)  as to each person whom the Nominating Stockholder proposes to nominate for election or re-election  as a director (i) the name, age, business address and residence address of the nominee; (ii) the principal occupation or  employment of the nominee; (iii) the number of shares of Common Stock (as defined in the certificate of  incorporation) of the Corporation which are owned beneficially or of record by the nominee; (iv) all information  relating to such person that is required to be disclosed in solicitations of proxies for election of directors, or is otherwise  required, in each case pursuant to Section 14(a) of the Exchange Act, including such person&#8217;s written consent to being  named as a nominee in any proxy statement or proxy card relating to the applicable meeting of stockholders and to  serving as a director if elected; (v) a complete and accurate description of all direct and indirect compensation and  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta005.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta005.jpg" title="slide5" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">5  other monetary or non-monetary agreements, arrangements and understandings (whether written or oral) existing  presently, that existed during the past two (2) years or were offered during the past two (2) years (whether accepted  or declined), and any other material relationships, between or among the Nominating Stockholder or any Stockholder  Associated Person, on the one hand, and the proposed nominee, and any member of the immediate family of the  nominee, and the nominee&#8217;s respective affiliates and associates, or others acting in concert therewith, or any other  person or persons, on the other hand (including the names of such persons) and all biographical, related party  transaction and other information that would be required to be disclosed pursuant to the federal and state securities  laws, including Rule 404 promulgated under Regulation S-K under the Securities Act of 1933, as amended (or any  successor provision), if any Nominating Stockholder or any Stockholder Associated Person were the &#8220;registrant&#8221; for  purposes of such rule and such nominee were a director or executive officer of such registrant; (vi) whether such  nominee has notified the board of directors of each publicly listed company at which such nominee serves as an officer  or director with respect to such person&#8217;s proposed nomination for election to the Board of Directors, and, as applicable,  received all necessary consents to serve on the Board of Directors if so nominated and elected or otherwise appointed  (or, if any such consents have not been received, how this is to be addressed); (vii) whether the nominee&#8217;s nomination,  election or appointment, as applicable, would violate a corporate governance policy of any publicly listed company at  which such person serves as an officer or director, and, if so, a description of how such person intends to address such  violation; (viii) the first date of contact between any Nominating Stockholder and/or Stockholder Associated Person,  on the one hand, and the nominee, on the other hand, with respect to the Corporation; (ix) the amount and nature of  any direct or indirect economic or financial interest, if any, of the nominee, or of any immediate family member of  such nominee, in any funds or vehicles managed by, under common management with or affiliated with the  Nominating Stockholder or any Stockholder Associated Person; and (x) a completed and signed questionnaire, written  statement and agreement required by Section 11(A)(5) and any and all other information required by this Section 11;    (b)  as to any other business that the Noticing Stockholder proposes to bring before the meeting, a brief  description of the business desired to be brought before the meeting, the text of the proposal or business (including  the text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend  these Bylaws, the language of the proposed amendment), the reasons for conducting such business at the meeting and  any material interest in such business of the Noticing Stockholder and the Stockholder Associated Person, if any;     (c)  as to the Noticing Stockholder and any Stockholder Associated Person, (i) the name and address of  each such Noticing Stockholder, as they appear on the records of the Corporation, and Stockholder Associated Person;  (ii) the class or series and number of shares of capital stock of the Corporation which are owned directly or indirectly,  beneficially and of record, by such Noticing Stockholder and any Stockholder Associated Person, including any shares  of capital stock of the Corporation of which such Noticing Stockholder or any Stockholder Associated Person has the  right to acquire beneficial ownership; (iii) all information that would be required to be set forth in a Schedule 13D  filed pursuant to Rule 13d-1(a) or an amendment pursuant to Rule 13d-2(a) if such a statement were required to be  filed under the Exchange Act by each Noticing Stockholder and Stockholder Associated Person; (iv) a representation  that the Noticing Stockholder is a holder of record of the stock of the Corporation at the time of the giving of the  notice, will be entitled to vote at such meeting and will appear in person or by proxy at the meeting to propose such  business or nomination; (v) a representation as to whether the Noticing Stockholder or Stockholder Associated Person  intends or is part of a group (whether at, below or above 5% in beneficial ownership) that intends to (x) deliver a proxy  statement and/or form of proxy to holders (including any beneficial owners pursuant to Rule 14b-1 and Rule 14b-2 of  the Exchange Act) of at least the percentage of the voting power of the Corporation&#8217;s outstanding capital stock required  to approve or adopt the proposal or elect the nominee, in a manner consistent with Rule 14a-16 as required by law,  (y) solicit the holders of shares representing at least sixty-seven percent (67%) of the voting power of shares entitled  to vote on the election of directors in support of director nominees other than the Corporation&#8217;s nominees pursuant to  Rule 14a-19 of the Exchange Act, and/or (z) otherwise solicit proxies or votes from stockholders in support of such  proposal or nomination; (vi) a certification by the Noticing Stockholder that each Noticing Stockholder and any  Stockholder Associated Person have complied with all applicable federal, state and other legal requirements in  connection with the Noticing Stockholder&#8217;s and/or Stockholder Associated Person&#8217;s acquisition of shares of capital  stock or other securities of the Corporation and/or the Noticing Stockholder&#8217;s and/or Stockholder Associated Person&#8217;s  acts or omissions as a stockholder of the Corporation; (vii) the statement required by Rule 14a-19(b)(3) of the  Exchange Act (or any successor provision); (viii) any other information relating to the Noticing Stockholder and  Stockholder Associated Person, if any, required to be disclosed in a proxy statement or other filings required to be  made in connection with solicitations of proxies for the proposal and/or, if a nominee is being so proposed, for the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta006.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta006.jpg" title="slide6" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">6  election of directors in an election contest pursuant to and in accordance with Section 14(a) of the Exchange Act; and  (ix) a representation by the Noticing Stockholder as to the accuracy of the information set forth in the notice;     (d)  a description of any agreement, arrangement or understanding with respect to the nomination or  proposal and/or the voting of shares of any class or series of stock of the Corporation between or among the Noticing  Stockholder, the Stockholder Associated Person; and     (e)  a description of any agreement, arrangement or understanding (including without limitation any  contract to purchase or sell, acquisition or grant of any option, right or warrant to purchase or sell, swap or other  instrument) to which the Noticing Stockholder or any Stockholder Associated Person is a party, the intent or effect of  which may be (i) to transfer to or from the Noticing Stockholder or any Stockholder Associated Person, in whole or  in part, any of the economic consequences of ownership of any security of the Corporation, (ii) to increase or decrease  the voting power of the Noticing Stockholder or any Stockholder Associated Person with respect to shares of any class  or series of stock of the Corporation and/or (iii) to provide the Noticing Stockholder or any Stockholder Associated  Person, directly or indirectly, with the opportunity to profit or share in any profit derived from, or to otherwise benefit  economically from, any increase or decrease in the value of any security of the Corporation.      (4) The Corporation may require any proposed nominee to furnish such other information as it may  reasonably require to determine the eligibility of such proposed nominee to serve as a director of the Corporation and  to determine the independence of such director under the Exchange Act and rules and regulations thereunder and  applicable stock exchange rules.     (5)         In addition to the other requirements of this Section 11, each nominee that a Noticing Stockholder  proposes to nominate for election or re-election as a director of the Corporation must deliver in writing (in accordance  with the time periods prescribed for delivery of notice under this Section 11) to the Secretary of the Corporation at the  principal place of business of the Corporation (a) a written questionnaire with respect to the background and  qualification of such proposed nominee, completed and executed by such proposed nominee, in the form to be  provided by the Secretary of the Corporation upon written request of any stockholder of record within ten (10) days  of such request, and (b) a written representation and agreement, in the form to be provided by the Secretary of the  Corporation upon written request of any stockholder of record within ten (10) days of such request, executed by each  such nominee acknowledging that such person: (i) intends to serve as a director for the full term for which he or she  is standing for election, (ii) would be in compliance, if elected as a director of the Corporation, and will comply with  all applicable rules of the exchanges upon which the securities of the Corporation are listed, as well as any applicable  law rule or regulation, and agrees to adhere to the Corporation&#8217;s Code of Business Conduct and Ethics, the  Corporation&#8217;s corporate governance, conflict of interest, confidentiality and stock ownership and trading policies and  guidelines, and any other Corporation policies and guidelines applicable to directors (which will be promptly provided  following a request therefor), (iii) is not and will not become a party to any agreement, arrangement, or understanding  with, and has not given any commitment or assurance to, any person or entity as to how such person, if elected as  director of the Corporation, will act or vote on any nomination or other business proposal, issue, or question (a &#8220;Voting  Commitment&#8221;) that has not been disclosed to the Corporation or any Voting Commitment that could limit or interfere  with such person&#8217;s ability to comply, if elected as a director of the Corporation, with such person&#8217;s fiduciary duties  under applicable law, and (iv) is not and will not become a party to any agreement, arrangement, or understanding  with any person or entity other than the Corporation with respect to direct or indirect compensation, reimbursement,  or indemnification that has not been disclosed to the Corporation in connection with such person&#8217;s nomination for  director or service as a director;     (6) Notwithstanding anything in the second sentence of paragraph (A)(2) of this Section 11 of these  Bylaws to the contrary, in the event that the number of directors to be elected to the Board is increased, effective after  the time period for which nominations would otherwise be due under paragraph (A)(2) of this Section 11 of these  Bylaws, and there is no public announcement naming all of the nominees for director or specifying the size of the  increased Board made by the Corporation at least one hundred (100) days prior to the first anniversary of the preceding  year&#8217;s annual meeting, a stockholder&#8217;s notice required by this Bylaw shall also be considered timely, but only with  respect to nominees for any new positions created by such increase, if it shall be delivered to the Secretary at the  principal executive offices of the Corporation not later than the close of business on the tenth (10th) day following the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta007.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta007.jpg" title="slide7" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">7  day on which a public announcement of such increase is first made by the Corporation; provided that, if no such  announcement is made at least ten (10) days before the meeting, then no such notice shall be required.    Section 11. (B) Special Meetings of Stockholders.  (1) Only such business shall be conducted at a special meeting of stockholders as shall have been  brought before the meeting pursuant to the Corporation&#8217;s notice of meeting pursuant to Article I, Section 3 of these  Bylaws. Nominations of persons for election to the Board may be made at a special meeting of stockholders at which  directors are to be elected (1) pursuant to the Corporation&#8217;s notice of meeting or (2) (a) by or at the direction of the  Board or a committee thereof or (b) provided that the Board has determined that directors shall be elected at such  meeting, by any stockholder of the Corporation who is entitled to vote on such election at the meeting who complies  with the notice procedures and information requirements set forth in this Section 11 of these Bylaws and who is a  stockholder of record at the time such notice is delivered to the Secretary of the Corporation. In the event the  Corporation calls a special meeting of stockholders for the purpose of electing one or more directors to the Board, any  such stockholder entitled to vote in such election of directors may nominate a person or persons (as the case may be)  for election to such position(s) as specified in the Corporation&#8217;s notice of meeting if the stockholder&#8217;s notice,  containing the same information required by, and which notice to be updated and supplemented in the same manner  and at the same time or times as set forth in, paragraph (A)(2) of this Section 11 of these Bylaws, shall be delivered  to the Secretary at the principal place of business of the Corporation not earlier than the close of business on the one  hundred twentieth (120th) day prior to such special meeting and not later than the close of business on the later of the  ninetieth (90th) day prior to such special meeting or the tenth (10th) day following the day on which public  announcement is first made of the date of the special meeting and of the nominees proposed by the Board to be elected  at such meeting. The Corporation may require any proposed nominee to furnish such other information as set forth in  the last sentence of paragraph (A)(3) of this Section 11 of these Bylaws.      Section 11. (C) General.   (1 )(a)  Only persons who are nominated in accordance with the procedures set forth in this Section 11 of  these Bylaws shall be eligible to be elected at an annual or special meeting of stockholders of the Corporation to serve  as directors and only such business shall be conducted at a meeting of stockholders as shall have been brought before  the meeting in accordance with the procedures set forth in this Section 11 of these Bylaws. Except as otherwise  provided by law, the certificate of incorporation of the Corporation or these Bylaws, the chair of the meeting shall, in  addition to making any other determination that may be appropriate for the conduct of the meeting, have the power  and duty to determine whether a nomination or any business proposed to be brought before the meeting was made in  accordance with the procedures set forth in these Bylaws and, if any proposed nomination or business is not in  compliance with these Bylaws, to declare that such defective proposal or nomination shall be disregarded and no vote  shall be taken with respect to such proposal or nomination, notwithstanding that proxies in respect of such vote may  have been received by the Corporation.    (b) In furtherance of the foregoing and notwithstanding anything to the contrary in these Bylaws, unless  otherwise required by law, if any Noticing Stockholder or Stockholder Associated Person, (a) provides notice pursuant  to Rule 14a-19(b) of the Exchange Act with respect to any proposed nominee for election as a director of the  Corporation and (b) subsequently fails to comply with the requirements of Rule 14a-19(a)(2) or Rule 14a-19(a)(3) of  the Exchange Act (or fails to timely provide reasonable evidence of such compliance sufficient to satisfy the  Corporation in accordance with the following sentence), then the nomination of each such proposed nominee shall be  disregarded and no vote taken with respect to such nominee, notwithstanding that proxies in respect of such vote may  have been received by the Corporation. If any Noticing Stockholder or Stockholder Associated Person provides notice  pursuant to Rule 14a-19(b) of the Exchange Act, such Noticing Stockholder or Stockholder Associated Person shall  deliver to the Corporation, no later than five (5) business days prior to the applicable meeting, reasonable evidence  that it has met the requirements of Rule 14a-19(a)(3) of the Exchange Act.    (c) Notwithstanding the foregoing provisions of this Section 11, if the Noticing Stockholder (or a qualified  representative of the Noticing Stockholder) does not appear at the annual or special meeting of stockholders of the  Corporation to present a nomination or business, such nomination shall be disregarded and such proposed business  shall not be transacted, notwithstanding that proxies in respect of such vote may have been received by the  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta008.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta008.jpg" title="slide8" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">8  Corporation. For purposes of this Section 11, to be considered a qualified representative of the Noticing Stockholder,  a person must be a duly authorized officer, manager or partner of the Noticing Stockholder or must be authorized by  a writing executed by the Noticing Stockholder or an electronic transmission delivered by the Noticing Stockholder  to act for the Noticing Stockholder as proxy at the meeting of stockholders and such person must produce such writing  or electronic transmission, or a reliable reproduction of the writing or electronic transmission, at the meeting of  stockholders.    (2)      For purposes of this Section 11, &#8220;public announcement&#8221; shall mean disclosure (a) in a press  release released by the Corporation; provided such press release is released by the Corporation following its customary  procedures, is reported by the Dow Jones News Service, Associated Press or comparable national news service, or is  generally available on internet news sites, (b) in a document publicly filed or furnished by the Corporation with the  Securities and Exchange Commission pursuant to Section 13, 14 or 15(d) of the Exchange Act or (c) otherwise  disseminated in a manner constituting &#8220;public disclosure&#8221; under Regulation FD promulgated by the Securities and  Exchange Commission.    (3)      For purposes of this Section 11, a &#8220;Stockholder Associated Person&#8221; of any Noticing Stockholder  shall mean (a) any beneficial owner of shares of stock of the Corporation on whose behalf any nomination or proposal  is made by such Noticing Stockholder and, if such Noticing Stockholder or beneficial owner is an entity, each director,  executive, managing member or control person of such entity, (b) any affiliates or associates of such Noticing  Stockholder or any beneficial owner described in clause (a), (c) any affiliate who controls such Noticing Stockholder  or any beneficial owner described in clause (a), and (d) any person acting in concert with such Noticing Stockholder  or any beneficial owner described in clause (a).    (4)      No adjournment or postponement or notice of adjournment or postponement of any meeting  shall be deemed to constitute a new notice of such meeting for purposes of this Section 11, and in order for any  notification required to be delivered by a stockholder pursuant to this Section 11 to be timely, such notification must  be delivered within the periods set forth above with respect to the originally scheduled meeting.    (5)      Notwithstanding the foregoing provisions of this Section 11, the Noticing Stockholder or any  Stockholder Associated Person shall also comply with all applicable requirements of the Exchange Act and the rules  and regulations thereunder and all applicable state law requirements with respect to the matters set forth in this Section  11; provided, however, that, to the fullest extent permitted by law, any references in these Bylaws to the Exchange  Act, or any applicable state law requirements, are not intended to and shall not limit any requirements applicable to  nominations or proposals as to any other business to be considered pursuant to this Section 11 (including paragraphs  (A)(1)(c) and (B) hereof), and compliance with paragraphs (A)(1)(c) and (B) of this Section 11 shall be the exclusive  means for a stockholder to make nominations or submit other business at such meeting.    (6)      Nothing in this Section 11 shall be deemed to affect any rights (i) of stockholders to request  inclusion of proposals in the Corporation&#8217;s proxy statement pursuant to Rule 14a-8 under the Exchange Act or (ii) of  the holders of any series of Preferred Stock if and to the extent provided for under law, the certificate of incorporation  of the Corporation or these Bylaws. Nothing in this Section 11 shall apply to the right, if any, of the holders of any  series of Preferred Stock to elect directors pursuant to any applicable provisions of the certificate of incorporation of  the Corporation.     (7) Any Noticing Stockholder or Stockholder Associated Person soliciting proxies from other  stockholders must use a proxy card other than white, which shall be reserved for exclusive use by the Board.     (8) The number of nominees any Noticing Stockholder or Stockholder Associated Person may  nominate for election at an annual or special meeting of stockholders (or in the case of a Noticing Stockholder giving  the notice on behalf of a beneficial owner, the number of nominees a Noticing Stockholder may nominate for election  at an annual or special meeting of stockholders on behalf of such beneficial owner) shall not exceed the number of  directors to be elected at such annual or special meeting of stockholders.   </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta009.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta009.jpg" title="slide9" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">9    (9) With respect to nominations made pursuant to this Section 11, without limiting any remedy  available to the Corporation, the Noticing Stockholder may not present such nominations (and any such nominee shall  be disqualified from standing for election or re-election), notwithstanding that proxies in respect of such vote may  have been received by the Corporation, if the Noticing Stockholder or Stockholder Associated Person, or any nominee  for director acted contrary to any representation, certification or agreement required by this Section 11 (or with any  law, rule or regulation identified in this Section 11), including without limitation failure to provide timely updates and  supplements as required, or provided incomplete, false or misleading information to the Corporation.      ARTICLE II  BOARD OF DIRECTORS    Section 1.  The Board shall consist, subject to the certificate of incorporation of the Corporation, of  such number of directors as shall from time to time be fixed exclusively by resolution adopted by the Board. Directors  shall (except as hereinafter provided for the filling of vacancies and newly created directorships and except as  otherwise expressly provided in the certificate of incorporation of the Corporation) be elected by the holders of a  plurality of the votes cast by the holders of shares present in person or represented by proxy at the meeting and entitled  to vote on the election of such directors. A majority of the total number of directors then in office shall constitute a  quorum for the transaction of business. Except as otherwise provided by law, these Bylaws or by the certificate of  incorporation of the Corporation, the act of a majority of the directors present at any meeting at which there is a  quorum shall be the act of the Board. Directors need not be stockholders. If a quorum shall not be present at any  meeting of the Board or of any committee thereof, a majority of the directors present thereat may adjourn the meeting  from time to time, without notice other than announcement at the meeting, until a quorum shall be present.     Section 2.  Subject to the certificate of incorporation of the Corporation, unless otherwise required by  the DGCL, any newly created directorship on the Board that results from an increase in the number of directors and  any vacancy occurring in the Board (whether by death, resignation, removal, retirement, disqualification or otherwise)  shall be filled only by a majority of the directors then in office, even if less than a quorum, or by a sole remaining  director.     Section 3.  Meetings of the Board shall be held at such place, if any, within or without the State of  Delaware as may from time to time be fixed by resolution of the Board or as may be specified in the notice of any  meeting. Regular meetings of the Board shall be held without notice at such times as may from time to time be fixed  by resolution of the Board and special meetings may be held at any time upon the call of the Chair of the Board, the  Chief Executive Officer of the Corporation or by a majority of the Board, by oral or written notice, including, without  limitation, facsimile, email or other means of electronic transmission, duly served on or sent and delivered to each  director to such director&#8217;s address, e-mail address or telephone or telecopy number as shown on the books of the  Corporation not less than twenty-four (24) hours before the meeting. The notice of any meeting of the Board need not  specify the purposes thereof. A meeting of the Board may be held without notice immediately after the annual meeting  of stockholders at the same place, if any, at which such meeting is held.     Section 4.  If at any meeting for the election of directors, the Corporation has outstanding more than  one class of stock, and one or more such classes or series thereof are entitled to vote separately as a class to elect  directors, and there shall be a quorum of only one such class or series of stock, that class or series of stock shall be  entitled to elect its quota of directors notwithstanding the absence of a quorum of the other class or series of stock.     Section 5.  The Board may from time to time establish one or more committees of the Board to serve  at the pleasure of the Board, which shall be composed of one or more members of the Board and have such duties as  the Board shall from time to time determine; but no such committee shall have the power or authority in reference to  amending the certificate of incorporation of the Corporation, adopting an agreement of merger or consolidation,  recommending to the stockholders the sale, lease or exchange of all or substantially all of the Corporation&#8217;s property  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta010.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta010.jpg" title="slide10" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">10  and-assets, recommending to the stockholders a dissolution of the Corporation or a revocation of a dissolution or  amending these Bylaws; and, unless the resolution expressly so provides, no such committee shall have the power or  authority to declare a dividend or to authorize the issuance of stock or to adopt a certificate of ownership and merger.  Any director may belong to any number of committees of the Board. The Board may designate one or more directors  as alternate members of any committee, who may replace any absent or disqualified member at any meeting of the  committee. In the absence or disqualification of a member of a committee, the member or members present at any  meeting and not disqualified from voting, whether or not such member or members constitute a quorum, may  unanimously appoint another member of the Board to act at the meeting in the place of any such absent or disqualified  member. Each such committee shall keep minutes and make such reports as the Board may from time to time request.  Except as the Board may otherwise determine, any committee may make rules for the conduct of its business, but  unless otherwise provided by the directors or in such rules, its business shall be conducted as nearly as possible in the  same manner as is provided in this Article II of these Bylaws for the Board.    Unless otherwise provided in the certificate of incorporation of the Corporation, these Bylaws or the  resolution of the Board designating the committee, a committee may create one or more subcommittees, each  subcommittee to consist of one or more members of the committee, and may delegate to a subcommittee any or all of  the powers and authority of the committee.     Section 6.  Unless otherwise restricted by the certificate of incorporation of the Corporation or these  Bylaws, any action required or permitted to be taken at any meeting of the Board or of any committee thereof may be  taken without a meeting if all members of the Board or such committee, as the case may be, consent thereto in writing  or by electronic transmission, and the writing or writings or electronic transmission or transmissions are filed with the  minutes of proceedings of the Board or such committee, as the case may be.     Section 7.  The members of the Board or any committee thereof may participate in a meeting of the  Board or such committee, as the case may be, by means of conference telephone or other communications equipment  by means of which all persons participating in the meeting can hear each other, and participation in a meeting pursuant  to this subsection shall constitute presence in person at such a meeting.     Section 8. The Board may establish policies for the compensation of directors and for the  reimbursement of the expenses of directors, in each case, in connection with services provided by directors to the  Corporation.    ARTICLE III  OFFICERS    Section 1. The Board shall elect officers of the Corporation, including a Chief Executive Officer,  President and a Secretary. The Board may also from time to time elect such other officers (including, without  limitation, a Chief Financial Officer, a Chief Operating Officer, a General Counsel, one or more Vice Presidents, a  Treasurer, one or more Assistant Vice Presidents, one or more Assistant Secretaries and one or more Assistant  Treasurers) as it may deem proper and the Chief Executive Officer of the Corporation shall also have the power to  appoint and remove any such other officers (other than the Chief Executive Officer, any President, any Chief Financial  Officer, any Chief Operating Officer, any General Counsel, or any Executive Vice President) (collectively, &#8220;Other  Officers&#8221;) and to prescribe the respective terms of office, authorities and duties of any such Other Officers. Any Vice  President may be designated Executive, Senior or Corporate, or may be given such other designation or combination  of designations as the Board or the Chief Executive Officer may determine. Any two or more offices may be held by  the same person. The Board may also elect or appoint a Chair of the Board, who may or may not also be an officer of  the Corporation. The Board may elect or appoint co-Chairs of the Board, co-Presidents or co-Chief Executive Officers  and, in such case, references in these Bylaws to the Chair of the Board, the President or the Chief Executive Officer  shall refer to either such co-Chair of the Board, co-President or co-Chief Executive Officer, as the case may be.     </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta011.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta011.jpg" title="slide11" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">11  Section 2.  The officers of the Corporation shall hold their offices for such terms and shall exercise  such powers and perform such duties as shall be determined from time to time by the Board. All officers of the  Corporation elected by the Board shall hold office for such terms as may be determined by the Board or, in the case  of any Other Officers, the Chief Executive Officer, or until their respective successors are chosen and qualified or  until his or her earlier resignation or removal. Any officer may be removed from office at any time either with or  without cause by the affirmative vote of a majority of the members of the Board then in office, or, in the case of any  Other Officers, by the Chief Executive Officer.     Section 3.  Each of the officers of the Corporation elected by the Board or appointed by the Chief  Executive Officer in accordance with these Bylaws shall have the powers and duties prescribed by law, by these  Bylaws or by the Board or, in the case of Other Officers, by the Chief Executive Officer, and, unless otherwise  prescribed by these Bylaws or by the Board or, in the case of Other Officers, by the Chief Executive Officer, shall  have such further powers and duties as ordinarily pertain to that office.     Section 4.  Unless otherwise provided in these Bylaws, in the absence or disability of any officer of  the Corporation, the Board or the Chief Executive Officer may, during such period, delegate such officer&#8217;s powers  and duties to any other officer or to any director of the Board and the person to whom such powers and duties are  delegated shall, for the time being, hold such office.    ARTICLE IV  CAPITAL STOCK    Section 1.  Issuance of Stock. Unless otherwise voted by the stockholders and subject to the provisions  of the certificate of incorporation of the Corporation, the whole or any part of any unissued balance of the authorized  capital stock of the Corporation or the whole or any part of any shares of the authorized capital stock of the Corporation  held in the Corporation&#8217;s treasury may be issued, sold, transferred or otherwise disposed of by vote of the Board in  such manner, for such lawful consideration and on such terms as the Board may determine.     Section 2.  Uncertificated Shares; Certificates of Stock. The shares of stock of the Corporation shall  be uncertificated, provided that the Board may provide by resolution or resolutions that some or all of any or all classes  or series of its stock shall be represented by certificates. Notwithstanding the foregoing, nothing contained in this  Section 2 of Article IV shall apply to shares represented by a certificate as of the date of adoption of these Bylaws  until such certificate is surrendered to the Corporation. If shares are represented by certificates, such certificates shall  be in the form, other than bearer form, approved by the Board. Every holder of stock represented by certificates shall  be entitled to have a certificate, certifying the number of shares owned by such holder in the Corporation, signed by,  or in the name of the Corporation by, any two authorized officers of the Corporation in accordance with the DGCL.  Any or all signatures on any such certificate may be a facsimile or other electronic reproduction. In case any officer,  transfer agent or registrar who has signed, whose facsimile or electronic signature has been used on or who has duly  affixed a facsimile or electronic signature or signatures to any such certificate or certificates shall cease to be such  officer, transfer agent or registrar of the Corporation whether because of death, resignation or otherwise before such  certificate or certificates have been issued by the Corporation, such certificate or certificates may nevertheless be  issued as though the person or persons who signed such certificate or certificates, whose facsimile or electronic  signature or signatures have been used thereon or who duly affixed a facsimile or electronic signature or signatures  thereon had not ceased to be such officer, transfer agent or registrar of the Corporation. Every certificate for shares of  stock which are subject to any restriction on transfer and every certificate issued when the Corporation is authorized  to issue more than one class or series of stock shall contain such legend with respect thereto as is required by law. The  rights and obligations of stockholders within the same class and/or series of stock shall be identical whether or not  their shares are represented by certificates.     Section 3.  Transfers. Except as otherwise established by rules and regulations adopted by the Board,  and subject to applicable law, shares of stock may be transferred on the books of the Corporation by the surrender to  the Corporation or its transfer agent of the certificate representing such shares properly endorsed or accompanied by  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta012.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta012.jpg" title="slide12" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">12  a written assignment or power of attorney properly executed, and with such proof of authority or the authenticity of  signature as the Corporation or its transfer agent may reasonably require. Shares of stock that are not represented by  a certificate may be transferred on the books of the Corporation by submitting to the Corporation or its transfer agent  such evidence of transfer and following such other procedures as the Corporation or its transfer agent may require.     Section 4.  Record Holders. Except as may be otherwise required by law, by the certificate of  incorporation of the Corporation or by these Bylaws, the Corporation shall be entitled to treat the record holder of  stock as shown on the Corporation&#8217;s stock ledger as the owner of such stock for all purposes, including the payment  of dividends and the right to vote with respect to such stock, regardless of any transfer, pledge or other disposition of  such stock until the shares have been transferred on the Corporation&#8217;s stock ledger in accordance with the requirements  of these Bylaws.     Section 5.  Lost, Stolen or Destroyed Certificates. The Corporation may issue or direct a new  certificate or certificates to be issued in place of any previously issued certificate or certificates alleged to have been  lost, stolen or destroyed, upon such terms and conditions as the Corporation may prescribe, including the presentation  of reasonable evidence of such loss, theft or destruction and the giving of such indemnity and posting of such bond  sufficient to indemnify the Corporation against any claim that may be made against it on account of such alleged loss,  theft or destruction of any such certificate or the issuance of a new certificate for the protection of the Corporation or  any transfer agent or registrar.    ARTICLE V  EXECUTION OF CORPORATE INSTRUMENTS AND VOTING OF SECURITIES  OWNED BY THE CORPORATION    Section 1.  Execution of Corporate Instruments. The Board may, in its discretion, determine the  method and designate the signatory officer or officers, or other person or persons, to execute on behalf of the  Corporation any corporate instrument or document, or to sign on behalf of the Corporation the corporate name without  limitation, or to enter into contracts on behalf of the Corporation, except where otherwise provided by law or these  Bylaws, and such execution or signature shall be binding upon the Corporation.     Unless authorized or ratified by the Board or within the agency power of an officer, no officer, agent or  employee shall have any power or authority to bind the Corporation by any contract or engagement or to pledge its  credit or to render it liable for any purpose or for any amount.     Section 2.  Voting of Securities Owned By the Corporation. All stock and other securities of other  Corporations owned or held by the Corporation for itself, or for other parties in any capacity, shall be voted, and all  proxies with respect thereto shall be executed, by the person authorized so to do by resolution of the Board, or, in the  absence of such authorization, by the Chair of the Board, the Chief Executive Officer, or any Vice President.     ARTICLE VI  INDEMNIFICATION AND ADVANCEMENT  OF EXPENSES    Section 1.  Each person who was or is made a party or is threatened to be made a party to or is otherwise  involved in any action, suit or proceeding, whether civil, criminal, administrative or investigative (hereinafter a  &#8220;proceeding&#8221;), by reason of the fact that he or she is or was a director or an officer of the Corporation or, while a  director or officer of the Corporation, is or was serving at the request of the Corporation as a director, officer,  employee, agent, fiduciary or trustee of another corporation or of a partnership, joint venture, trust or other enterprise,  including service with respect to an employee benefit plan (hereinafter an &#8220;indemnitee&#8221;), whether the basis of such  proceeding is alleged action in an official capacity as a director, officer, employee, agent, fiduciary or trustee or in  any other capacity while serving as a director, officer, employee, agent, fiduciary or trustee, shall be indemnified and  held harmless by the Corporation to the fullest extent permitted by Delaware law, as the same exists or may hereafter  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta013.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta013.jpg" title="slide13" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">13  be amended (but, in the case of any such amendment, only to the extent that such amendment permits the Corporation  to provide broader indemnification rights than such law permitted the Corporation to provide prior to such  amendment), against all expense, liability and loss (including attorneys&#8217; fees, judgments, fines, ERISA excise taxes  or penalties and amounts paid in settlement) reasonably incurred or suffered by such indemnitee in connection  therewith; provided, however, that, except as provided in Section 3 of this Article VI with respect to proceedings to  enforce rights to indemnification or advancement of expenses or with respect to any compulsory counterclaim brought  by such indemnitee, or as may otherwise be expressly approved by the Board or a committee thereof, the Corporation  shall indemnify any such indemnitee in connection with a proceeding (or part thereof) initiated by such indemnitee  only if such proceeding (or part thereof) was authorized by the Board.     Section 2.  In addition to the right to indemnification conferred in Section 1 of this Article VI, an  indemnitee shall also have the right to be paid by the Corporation the expenses (including attorneys&#8217; fees) incurred in  appearing at, participating in or defending any such proceeding in advance of its final disposition or in connection  with a proceeding brought to establish or enforce a right to indemnification or advancement of expenses under this  Article VI (which shall be governed by Section 3 of this Article VI) (hereinafter an &#8220;advancement of expenses&#8221;);  provided, however, that if (x) the DGCL requires or (y) in the case of an advance made in a proceeding brought to  establish or enforce a right to indemnification or advancement, an advancement of expenses incurred by an indemnitee  in his or her capacity as a director or officer of the Corporation (and not in any other capacity in which service was or  is rendered by such indemnitee, including, without limitation, service to an employee benefit plan) shall be made  solely upon delivery to the Corporation of an undertaking (hereinafter an &#8220;undertaking&#8221;), by or on behalf of such  indemnitee, to repay all amounts so advanced if it shall ultimately be determined by final judicial decision from which  there is no further right to appeal (hereinafter a &#8220;final adjudication&#8221;) that such indemnitee is not entitled to be  indemnified or entitled to advancement of expenses under Section 1 or 2 of this Article VI or otherwise.     Section 3.  If a claim under Section 1 or 2 of this Article VI is not paid in full by the Corporation  within (i) sixty (60) days after a written claim for indemnification has been received by the Corporation or (ii) twenty  (20) days after a claim for an advancement of expenses has been received by the Corporation, the indemnitee may at  any time thereafter bring suit against the Corporation to recover the unpaid amount of the claim or to obtain  advancement of expenses, as applicable. To the fullest extent permitted by law, if the indemnitee is successful in  whole or in part in any such suit or in a suit brought by the Corporation to recover an advancement of expenses, the  indemnitee shall be entitled to be paid also the expense of prosecuting or defending such suit (including, without  limitation, attorneys&#8217; fees). In (i) any suit brought by the indemnitee to enforce a right to indemnification hereunder  (but not in a suit brought by the indemnitee to enforce a right to an advancement of expenses) it shall be a defense  that, and (ii) any suit brought by the Corporation to recover an advancement of expenses, the Corporation shall be  entitled to recover such expenses upon a final adjudication that, the indemnitee has not met any applicable standard  for indemnification set forth in the DGCL. Neither the failure of the Corporation (including by its directors who are  not parties to such action, a committee of such directors, independent legal counsel, or its stockholders) to have made  a determination prior to the commencement of such suit that indemnification of the indemnitee is proper in the  circumstances because the indemnitee has met the applicable standard of conduct set forth in the DGCL, nor an actual  determination by the Corporation (including by its directors who are not parties to such action, a committee of such  directors, independent legal counsel, or its stockholders) that the indemnitee has not met such applicable standard of  conduct, shall create a presumption that the indemnitee has not met the applicable standard of conduct or, in the case  of such a suit brought by the indemnitee, be a defense to such suit. In any suit brought by the indemnitee to enforce a  right to indemnification or to an advancement of expenses hereunder, or brought by the Corporation to recover an  advancement of expenses, the burden of proving that the indemnitee is not entitled to be indemnified, or to such  advancement of expenses, under this Article VI or otherwise shall be on the Corporation.     Section 4.  The provision of indemnification to or the advancement of expenses and costs to any  indemnitee under this Article VI, or the entitlement of any indemnitee to indemnification or advancement of expenses  under this Article VI, shall not limit or restrict in any way the power of the Corporation to indemnify or advance  expenses to such indemnitee in any other way permitted by law or be deemed exclusive of, or invalidate, any right to  which any indemnitee seeking indemnification or advancement of expenses may be entitled under any law, agreement,  vote of stockholders or disinterested directors or otherwise, both as to action in such indemnitee&#8217;s capacity as an  officer, director, employee, agent, fiduciary or trustee of the Corporation and as to action in any other capacity.  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta014.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta014.jpg" title="slide14" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">14     Section 5.  The rights conferred upon indemnitees in this Article VI shall be contract rights and such  rights shall continue as to an indemnitee who has ceased to be an officer, director, employee, agent, fiduciary or trustee  of the Corporation and shall inure to the benefit of the indemnitee&#8217;s heirs, executors and administrators. Any  amendment, alteration or repeal of this Article VI that adversely affects any right of an indemnitee or its heirs,  executors, administrators, and successors, as the case may be, shall be prospective only and shall not limit, eliminate,  or impair any such right with respect to any proceeding involving any occurrence or alleged occurrence of any action  or omission to act that took place prior to such amendment or repeal.     Section 6.  The Corporation may purchase and maintain insurance, at its expense, to protect itself and  any director, officer, employee, agent, fiduciary and trustee of the Corporation or another corporation, partnership,  joint venture, trust or other enterprise against any expense, liability or loss, whether or not the Corporation would have  the power to indemnify such person against such expense, liability or loss under the DGCL.     Section 7.  The Corporation may, to the extent authorized from time to time by the Board, grant rights  to indemnification and to the advancement of expenses to any employee or agent of the Corporation to the fullest  extent of the provisions of this Article VI with respect to the indemnification and advancement of expenses of directors  and officers of the Corporation.    ARTICLE VII  CORPORATE BOOKS    The books of the Corporation may be kept inside or outside of the State of Delaware at such place or places  as the Board may from time to time determine.    ARTICLE VIII  FISCAL YEAR    The fiscal year of the Corporation shall be, unless otherwise determined by resolution of the Board, the  calendar year ending on December 31.    ARTICLE IX  CORPORATE SEAL    The corporate seal shall have inscribed thereon the name of the Corporation. In lieu of the corporate seal,  when so authorized by the Board or a duly empowered committee thereof a facsimile thereof may be impressed or  affixed or reproduced.    ARTICLE X  GENERAL PROVISIONS    Section 1.  Whenever notice is required to be given by law or under any provision of the certificate of  incorporation of the Corporation or these Bylaws, notice of any meeting need not be given to any person who shall  attend such meeting (except when the person attends a meeting for the express purpose of objecting, at the beginning  of the meeting, to the transaction of any business because the meeting is not lawfully called or convened), or who  shall waive notice thereof before or after such meeting, in writing (including by electronic transmission).     Section 2.  Form of Notice. Notices to directors and stockholders other than notices to directors of  special meetings of the Board which may be given by any means stated in Section 3 of Article II, shall be in writing  </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
<!-- aquestiveamendedandresta015.jpg -->
<DIV style="padding-top:2em;">
<IMG src="aquestiveamendedandresta015.jpg" title="slide15" width="1055" height="1365">
<DIV><FONT size="1" style="font-size:1pt;color:white">15  and, in addition to any other method of notice permitted by applicable law, may be delivered personally, mailed to the  directors or stockholders at their addresses appearing on the books of the Corporation or transmitted to any director  via electronic mail to an electronic mail address appearing on the books or as part of the records of the Corporation or  transmitted to any stockholder via electronic mail to an electronic mail address at which the stockholder has consented  to receive notice. Notice by mail shall be deemed to be given at the time when the same shall be mailed. Notice to  directors may also be given by telegram.     Section 3.  Section headings in these Bylaws are for convenience of reference only and shall not be  given any substantive effect in limiting or otherwise construing any provision herein.     Section 4.  In the event that any provision of these Bylaws is or becomes inconsistent with any  provision of the certificate of incorporation of the Corporation or the DGCL, the provision of these Bylaws shall not  be given any effect to the extent of such inconsistency but shall otherwise be given full force and effect.    ARTICLE XI  AMENDMENTS    These Bylaws may be made, amended, altered, changed, added to or repealed as set forth in the certificate of  incorporation of the Corporation and these Bylaws.        [Remainder of Page Intentionally Left Blank]        </FONT></DIV>
<P><HR noshade><P>
<DIV style="page-break-before:always;">&nbsp;</DIV>
</DIV>
</DIV>
</DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>q32024ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="ide2e487611a343d08c19049d24563c33_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer of Aquestive Therapeutics, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel Barber, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2024</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>q32024ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i85110119a6ba41c7bd308620e995e325_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial and Accounting Officer of Aquestive Therapeutics, Inc.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, A. Ernest Toth, Jr, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form 10-Q of Aquestive Therapeutics, Inc.&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the consolidated financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, consolidated results of operations and consolidated cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font><br></font></div><div style="padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2024</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; A. ERNEST TOTH, JR.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.28pt">Ernest Toth, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>q32024ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if4c890bde1694ef3aa74cde572933fad_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Executive Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as Adopted</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), I, Daniel Barber, President and Chief Executive Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company&#8217;s Quarterly Report on Form 10-Q for the period-ended September&#160;30, 2024, to which this Certification is attached as Exhibit 32.1 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of operations of the Company for the period covered by the Quarterly Report.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2024 </font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel Barber</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">President and Chief Executive Officer<br>(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:10pt"><font><br></font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>q32024ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if7a13360f9ce49ef8793f5de3ccbf894_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="margin-top:15pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification of Principal Financial and Accounting Officer</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to 18 U.S.C. Section 1350, as Adopted</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350), I, A. Ernest Toth, Jr., Chief Financial Officer of Aquestive Therapeutics, Inc. (the &#8220;Company&#8221;), hereby certify that, to the best of my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company&#8217;s Quarterly Report on Form 10-Q for the period-ended September&#160;30, 2024, to which this Certification is attached as Exhibit 32.2 (the &#8220;Quarterly Report&#8221;), fully complies with the requirements of Section 13(a) or Section 15(d) of the Exchange Act&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Quarterly Report fairly presents, in all material respects, the financial condition of the Company at the end of the period covered by the Quarterly Report and the results of operations of the Company for the period covered by the Quarterly Report.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; November&#160;4, 2024 </font></div><div><font><br></font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; A. ERNEST TOTH, JR</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">A.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:8.28pt">Ernest Toth, Jr.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer<br>(Principal Financial Officer)</font></td></tr></table></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Aquestive Therapeutics, Inc. under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Quarterly Report), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>aqst-20240930.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:aqst="http://aquestive.com/20240930" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://aquestive.com/20240930">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20240930_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20240930_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20240930_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="aqst-20240930_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://aquestive.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheets" roleURI="http://aquestive.com/role/CondensedBalanceSheets">
        <link:definition>9952151 - Statement - Condensed Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedBalanceSheetsParenthetical" roleURI="http://aquestive.com/role/CondensedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofOperationsandComprehensiveLossIncome" roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome">
        <link:definition>9952153 - Statement - Condensed Statements of Operations and Comprehensive (Loss) Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofChangesinStockholdersDeficit" roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit">
        <link:definition>9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedStatementsofCashFlows" roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows">
        <link:definition>9952155 - Statement - Condensed Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOverviewandBasisofPresentation" roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentation">
        <link:definition>9952156 - Disclosure - Company Overview and Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RisksandUncertainties" roleURI="http://aquestive.com/role/RisksandUncertainties">
        <link:definition>9952158 - Disclosure - Risks and Uncertainties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNet" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNet">
        <link:definition>9952159 - Disclosure - Revenues and Trade Receivables, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialAgreements" roleURI="http://aquestive.com/role/MaterialAgreements">
        <link:definition>9952160 - Disclosure - Material Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueMeasurements" roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements">
        <link:definition>9952161 - Disclosure - Financial Instruments &#8211; Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventories" roleURI="http://aquestive.com/role/Inventories">
        <link:definition>9952162 - Disclosure - Inventories</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNet" roleURI="http://aquestive.com/role/PropertyandEquipmentNet">
        <link:definition>9952163 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligations" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligations">
        <link:definition>9952164 - Disclosure - Right-of-Use Assets and Lease Obligations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNet" roleURI="http://aquestive.com/role/IntangibleAssetsNet">
        <link:definition>9952165 - Disclosure - Intangible Assets, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssets" roleURI="http://aquestive.com/role/OtherNoncurrentAssets">
        <link:definition>9952166 - Disclosure - Other Non-current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpenses" roleURI="http://aquestive.com/role/AccruedExpenses">
        <link:definition>9952167 - Disclosure - Accrued Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebt" roleURI="http://aquestive.com/role/LongTermDebt">
        <link:definition>9952168 - Disclosure - Long-Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://aquestive.com/role/Warrants">
        <link:definition>9952169 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenue" roleURI="http://aquestive.com/role/SaleofFutureRevenue">
        <link:definition>9952170 - Disclosure - Sale of Future Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossEarningsPerShare" roleURI="http://aquestive.com/role/NetLossEarningsPerShare">
        <link:definition>9952171 - Disclosure - Net (Loss) Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensation" roleURI="http://aquestive.com/role/ShareBasedCompensation">
        <link:definition>9952172 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://aquestive.com/role/IncomeTaxes">
        <link:definition>9952173 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://aquestive.com/role/Contingencies">
        <link:definition>9952174 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetTables" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables">
        <link:definition>9954472 - Disclosure - Revenues and Trade Receivables, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesTables" roleURI="http://aquestive.com/role/InventoriesTables">
        <link:definition>9954473 - Disclosure - Inventories (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetTables" roleURI="http://aquestive.com/role/PropertyandEquipmentNetTables">
        <link:definition>9954474 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsTables" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables">
        <link:definition>9954475 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetTables" roleURI="http://aquestive.com/role/IntangibleAssetsNetTables">
        <link:definition>9954476 - Disclosure - Intangible Assets, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsTables" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsTables">
        <link:definition>9954477 - Disclosure - Other Non-current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesTables" roleURI="http://aquestive.com/role/AccruedExpensesTables">
        <link:definition>9954478 - Disclosure - Accrued Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtTables" roleURI="http://aquestive.com/role/LongTermDebtTables">
        <link:definition>9954479 - Disclosure - Long-Term Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueTables" roleURI="http://aquestive.com/role/SaleofFutureRevenueTables">
        <link:definition>9954480 - Disclosure - Sale of Future Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossEarningsPerShareTables" roleURI="http://aquestive.com/role/NetLossEarningsPerShareTables">
        <link:definition>9954481 - Disclosure - Net (Loss) Earnings Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationTables" roleURI="http://aquestive.com/role/ShareBasedCompensationTables">
        <link:definition>9954482 - Disclosure - Share-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CompanyOverviewandBasisofPresentationDetails" roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails">
        <link:definition>9954483 - Disclosure - Company Overview and Basis of Presentation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RisksandUncertaintiesDetails" roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails">
        <link:definition>9954484 - Disclosure - Risks and Uncertainties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetNarrativeDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails">
        <link:definition>9954485 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetRevenueDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails">
        <link:definition>9954486 - Disclosure - Revenues and Trade Receivables, Net - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails">
        <link:definition>9954487 - Disclosure - Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails">
        <link:definition>9954488 - Disclosure - Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails">
        <link:definition>9954489 - Disclosure - Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails" roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails">
        <link:definition>9954490 - Disclosure - Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="MaterialAgreementsDetails" roleURI="http://aquestive.com/role/MaterialAgreementsDetails">
        <link:definition>9954491 - Disclosure - Material Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsFairValueMeasurementsDetails" roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails">
        <link:definition>9954492 - Disclosure - Financial Instruments &#8211; Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoriesDetails" roleURI="http://aquestive.com/role/InventoriesDetails">
        <link:definition>9954493 - Disclosure - Inventories (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" roleURI="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails">
        <link:definition>9954494 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyandEquipmentNetNarrativeDetails" roleURI="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails">
        <link:definition>9954495 - Disclosure - Property and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsNarrativeDetails" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails">
        <link:definition>9954496 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsMaturitiesDetails" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails">
        <link:definition>9954497 - Disclosure - Right-of-Use Assets and Lease Obligations - Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RightofUseAssetsandLeaseObligationsMaturitiesDetails_1" roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1">
        <link:definition>9954497 - Disclosure - Right-of-Use Assets and Lease Obligations - Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" roleURI="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails">
        <link:definition>9954498 - Disclosure - Intangible Assets, Net - Components of Identifiable Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsNetNarrativeDetails" roleURI="http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails">
        <link:definition>9954499 - Disclosure - Intangible Assets, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails">
        <link:definition>9954500 - Disclosure - Other Non-current Assets - Summary of Other Non-current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherNoncurrentAssetsNarrativeDetails" roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails">
        <link:definition>9954501 - Disclosure - Other Non-current Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesScheduleofAccruedExpensesDetails" roleURI="http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails">
        <link:definition>9954502 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedExpensesNarrativeDetails" roleURI="http://aquestive.com/role/AccruedExpensesNarrativeDetails">
        <link:definition>9954503 - Disclosure - Accrued Expenses - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtNarrativeDetails" roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails">
        <link:definition>9954504 - Disclosure - Long-Term Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails">
        <link:definition>9954505 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails">
        <link:definition>9954506 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LongTermDebtDebtMaturitiesDetails" roleURI="http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails">
        <link:definition>9954507 - Disclosure - Long-Term Debt - Debt Maturities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsDetails" roleURI="http://aquestive.com/role/WarrantsDetails">
        <link:definition>9954508 - Disclosure - Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueNarrativeDetails" roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails">
        <link:definition>9954509 - Disclosure - Sale of Future Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SaleofFutureRevenueRoyaltyObligationDetails" roleURI="http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails">
        <link:definition>9954510 - Disclosure - Sale of Future Revenue - Royalty Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" roleURI="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails">
        <link:definition>9954511 - Disclosure - Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossEarningsPerShareNarrativeDetails" roleURI="http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails">
        <link:definition>9954512 - Disclosure - Net (Loss) Earnings Per Share - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationExpenseDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationExpenseDetails">
        <link:definition>9954513 - Disclosure - Share-Based Compensation - Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationRestrictedStockUnitAwardsDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails">
        <link:definition>9954514 - Disclosure - Share-Based Compensation - Restricted Stock Unit Awards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationNarrativeDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails">
        <link:definition>9954515 - Disclosure - Share-Based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationPerformanceBasedDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails">
        <link:definition>9954516 - Disclosure - Share-Based Compensation - Performance Based (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationStockOptionActivityDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails">
        <link:definition>9954517 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails" roleURI="http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails">
        <link:definition>9954518 - Disclosure - Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://aquestive.com/role/IncomeTaxesDetails">
        <link:definition>9954519 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ContingenciesDetails" roleURI="http://aquestive.com/role/ContingenciesDetails">
        <link:definition>9954520 - Disclosure - Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="aqst_TradeAndOtherReceivablesNet" abstract="false" name="TradeAndOtherReceivablesNet" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" abstract="false" name="LiabilitiesSaleOfFutureRoyaltiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" abstract="false" name="SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" abstract="false" name="TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_InterestExpenseSaleOfFutureRevenues" abstract="false" name="InterestExpenseSaleOfFutureRevenues" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_InterestAndOtherIncomeNet" abstract="false" name="InterestAndOtherIncomeNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_WarrantExercisesMember" abstract="true" name="WarrantExercisesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_AtTheMarketOfferingMember" abstract="true" name="AtTheMarketOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_PublicEquityOfferingMember" abstract="true" name="PublicEquityOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ProceedsFromIssuanceAndExerciseOfWarrants" abstract="false" name="ProceedsFromIssuanceAndExerciseOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_WarrantsDisclosureTextBlock" abstract="false" name="WarrantsDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="aqst_SaleOfFutureRevenueTextBlock" abstract="false" name="SaleOfFutureRevenueTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="aqst_RoyaltyObligationActivityTableTextBlock" abstract="false" name="RoyaltyObligationActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="aqst_EquityDistributionAgreementMember" abstract="true" name="EquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_AmendedEquityDistributionAgreementMember" abstract="true" name="AmendedEquityDistributionAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_LincolnParkAgreementMember" abstract="true" name="LincolnParkAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LincolnParkAgreementCommitmentShareMember" abstract="true" name="LincolnParkAgreementCommitmentShareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_UnderwrittenPublicOfferingMember" abstract="true" name="UnderwrittenPublicOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" abstract="false" name="RevenueFromContractWithCustomerNumberOfCommercializedProducts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_SaleOfStockAggregateOfferingPrice" abstract="false" name="SaleOfStockAggregateOfferingPrice" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_RightToSellCommonStockValue" abstract="false" name="RightToSellCommonStockValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_AgreementTerm" abstract="false" name="AgreementTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" abstract="false" name="SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" abstract="false" name="SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SeniorSecuredNotes13.5DueNovember12028Member" abstract="true" name="SeniorSecuredNotes13.5DueNovember12028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_IndiviorMember" abstract="true" name="IndiviorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ZevraMember" abstract="true" name="ZevraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_HasicoMember" abstract="true" name="HasicoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_OtherReceivablesAndAccruedExpensesMember" abstract="true" name="OtherReceivablesAndAccruedExpensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ResearchAndDevelopmentProjectDuration" abstract="false" name="ResearchAndDevelopmentProjectDuration" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ManufactureAndSupplyRevenueMember" abstract="true" name="ManufactureAndSupplyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseAndRoyaltyRevenueMember" abstract="true" name="LicenseAndRoyaltyRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_CoDevelopmentAndResearchFeesMember" abstract="true" name="CoDevelopmentAndResearchFeesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_TradeAccountsReceivableDoubtfulAccountsMember" abstract="true" name="TradeAccountsReceivableDoubtfulAccountsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_TradeAccountsReceivableSalesRelatedMember" abstract="true" name="TradeAccountsReceivableSalesRelatedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_AccountsReceivableAllowanceForCreditLossReclassifications" abstract="false" name="AccountsReceivableAllowanceForCreditLossReclassifications" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CommercialExploitationAgreementWithIndiviorMember" abstract="true" name="CommercialExploitationAgreementWithIndiviorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_SupplementalAgreementWithIndiviorMember" abstract="true" name="SupplementalAgreementWithIndiviorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" abstract="true" name="LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_MarathonPangolinRoyaltyLLCMember" abstract="true" name="MarathonPangolinRoyaltyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" abstract="true" name="HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_AtnahsPharmaUKLimitedMember" abstract="true" name="AtnahsPharmaUKLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseSupplyAgreementMember" abstract="true" name="LicenseSupplyAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" abstract="true" name="AtnahsPharmaUKLimitedAmendedAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_MitsubishiTanabePharmaAmericaIncMember" abstract="true" name="MitsubishiTanabePharmaAmericaIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_MonetizationAgreementMember" abstract="true" name="MonetizationAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_AssertioHoldingsIncMember" abstract="true" name="AssertioHoldingsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_LicenseAgreementTerm" abstract="false" name="LicenseAgreementTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_AutomaticRenewalPeriodOfAgreement" abstract="false" name="AutomaticRenewalPeriodOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ProceedsFromSaleOfFutureRevenuesNet" abstract="false" name="ProceedsFromSaleOfFutureRevenuesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ContingentMonetizationAgreementMilestonePayment" abstract="false" name="ContingentMonetizationAgreementMilestonePayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_SeveranceCostsMonthlyPaymentDuration" abstract="false" name="SeveranceCostsMonthlyPaymentDuration" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" abstract="true" name="TwelvePointFiveSeniorSecuredNotesDueJune302025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_SecuritiesPurchaseAgreementMember" abstract="true" name="SecuritiesPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_ExistingWarrantsMember" abstract="true" name="ExistingWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_NewWarrantsMember" abstract="true" name="NewWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" abstract="false" name="SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" abstract="false" name="SharesOfCommonStockToBePurchasedByCommonStockWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" abstract="false" name="DebtInstrumentCovenantTieredRoyaltyPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" abstract="false" name="DebtInstrumentCovenantTieredRoyaltyPercentageTerm" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_InventoryPackingMaterialGross" abstract="false" name="InventoryPackingMaterialGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ComputerNetworkEquipmentAndSoftwareMember" abstract="true" name="ComputerNetworkEquipmentAndSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_NumberOfOperatingLeases" abstract="false" name="NumberOfOperatingLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" abstract="false" name="LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_CumulativeRoyaltyReceivable" abstract="false" name="CumulativeRoyaltyReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" abstract="true" name="MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_NumberOfGuaranteedRoyaltyPayments" abstract="false" name="NumberOfGuaranteedRoyaltyPayments" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_MinimumAnnualRoyaltyReceivable" abstract="false" name="MinimumAnnualRoyaltyReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_NumberOfAnnualRoyaltyPaymentsReceivable" abstract="false" name="NumberOfAnnualRoyaltyPaymentsReceivable" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_RoyaltyObligationsMember" abstract="true" name="RoyaltyObligationsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ABLFacilityMember" abstract="true" name="ABLFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_DebtCovenantRedemptionScenarioAxis" abstract="true" name="DebtCovenantRedemptionScenarioAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_DebtCovenantRedemptionScenarioDomain" abstract="true" name="DebtCovenantRedemptionScenarioDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RedemptionScenario1Member" abstract="true" name="RedemptionScenario1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_RedemptionScenario2Member" abstract="true" name="RedemptionScenario2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" abstract="false" name="NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_DebtInstrumentNumberOfNoteholders" abstract="false" name="DebtInstrumentNumberOfNoteholders" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_DebtInstrumentNumberOfTransactions" abstract="false" name="DebtInstrumentNumberOfTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_PremiumsPaidEarlyRetirementOfDebt" abstract="false" name="PremiumsPaidEarlyRetirementOfDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" abstract="false" name="DebtInstrumentCovenantMilestoneCapPercentageThreshold" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" abstract="false" name="ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" abstract="false" name="DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="aqst_ElectiveRedemptionPercentageOfDebt" abstract="false" name="ElectiveRedemptionPercentageOfDebt" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" abstract="false" name="RedemptionPercentageOfDebtUnderChangeOfControlProvisions" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" abstract="false" name="DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" abstract="false" name="LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" abstract="false" name="LineOfCreditFacilityAccordionFeatureIncreaseLimit" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_DebtInstrumentExitFee" abstract="false" name="DebtInstrumentExitFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_MeasurementInputProbabilityOfSuccessMember" abstract="true" name="MeasurementInputProbabilityOfSuccessMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_FirstAdditionalWarrantOfferingMember" abstract="true" name="FirstAdditionalWarrantOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_InitialWarrantOfferingMember" abstract="true" name="InitialWarrantOfferingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_PreFundedWarrantsMember" abstract="true" name="PreFundedWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_CommonStockWarrantsMember" abstract="true" name="CommonStockWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_Warrants0.96ExercisePriceMember" abstract="true" name="Warrants0.96ExercisePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_Warrants4.25ExercisePriceMember" abstract="true" name="Warrants4.25ExercisePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_Warrants5.38ExercisePriceMember" abstract="true" name="Warrants5.38ExercisePriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ClassOfWarrantOrRightWarrantsExercised" abstract="false" name="ClassOfWarrantOrRightWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_SaleOfFutureRevenueRollForward" abstract="true" name="SaleOfFutureRevenueRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="aqst_LiabilitiesSaleOfFutureRoyalties" abstract="false" name="LiabilitiesSaleOfFutureRoyalties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="aqst_ManufacturingAndSupplyMember" abstract="true" name="ManufacturingAndSupplyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="aqst_MarketBasedMember" abstract="true" name="MarketBasedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionAxis" abstract="true" name="VestingConditionAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="aqst_VestingConditionDomain" abstract="true" name="VestingConditionDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeOneMember" abstract="true" name="VestingConditionRangeOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeTwoMember" abstract="true" name="VestingConditionRangeTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeThreeMember" abstract="true" name="VestingConditionRangeThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeFourMember" abstract="true" name="VestingConditionRangeFourMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeFiveMember" abstract="true" name="VestingConditionRangeFiveMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_VestingConditionRangeSixMember" abstract="true" name="VestingConditionRangeSixMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="aqst_InducementEquityCommonStockOptionsOutstandingShares" abstract="false" name="InducementEquityCommonStockOptionsOutstandingShares" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:perShareItemType"/>
  <xs:element id="aqst_NeurelisIncVAquestiveTherapeuticsIncMember" abstract="true" name="NeurelisIncVAquestiveTherapeuticsIncMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="aqst_SuboxoneProduceLiabilityLitigationMember" abstract="true" name="SuboxoneProduceLiabilityLitigationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_DanielBarberMember" abstract="true" name="DanielBarberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="aqst_PeterBoydMember" abstract="true" name="PeterBoydMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>aqst-20240930_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedBalanceSheets"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_f35be83f-be5e-4e00-9852-169fc12d3673" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_us-gaap_AccountsPayableCurrent_f35be83f-be5e-4e00-9852-169fc12d3673" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a34819bc-2f96-4e3d-b964-07486a2b3ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a34819bc-2f96-4e3d-b964-07486a2b3ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a8a56398-06ef-4e3f-9b74-c3dac1bbb270" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a8a56398-06ef-4e3f-9b74-c3dac1bbb270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5848ff4-db4f-47f1-9062-54faf488d3b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d5848ff4-db4f-47f1-9062-54faf488d3b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent_7e887304-c333-4dde-948a-e2b91f91db6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_us-gaap_LoansPayableCurrent_7e887304-c333-4dde-948a-e2b91f91db6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_4450cc94-a196-46db-8513-b3a43e1f7893" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ed547022-5c70-4a1f-bb65-fab6f3efeec6" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_4450cc94-a196-46db-8513-b3a43e1f7893" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_17b05ecf-45ab-40fd-9aae-69bdb7d1cad6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_17b05ecf-45ab-40fd-9aae-69bdb7d1cad6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d3478c1-48e4-46b4-9602-01095c4fb0f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_8d3478c1-48e4-46b4-9602-01095c4fb0f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_f78c503f-8660-48b8-94f4-50063514b649" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:to="loc_us-gaap_AssetsCurrent_f78c503f-8660-48b8-94f4-50063514b649" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_0079b48b-98b1-47e2-bcf9-388d92519a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_0079b48b-98b1-47e2-bcf9-388d92519a6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_c4f7e064-5b32-4373-8132-ede5668568e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_4f28ff1b-3923-4050-93b6-d921d2ac1516" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_c4f7e064-5b32-4373-8132-ede5668568e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2cb50eb9-eb25-44c2-9fa6-c7533286895f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_295cb150-cf14-4407-a875-f9ae7ea78d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2cb50eb9-eb25-44c2-9fa6-c7533286895f" xlink:to="loc_us-gaap_CommonStockValue_295cb150-cf14-4407-a875-f9ae7ea78d7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c98d27fe-e1c1-4707-885b-512280581e59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2cb50eb9-eb25-44c2-9fa6-c7533286895f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_c98d27fe-e1c1-4707-885b-512280581e59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_c791ffd9-1163-4a28-bedc-708b02a850a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_2cb50eb9-eb25-44c2-9fa6-c7533286895f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_c791ffd9-1163-4a28-bedc-708b02a850a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fec722ce-dafd-4e40-ab26-2905e3476018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fec722ce-dafd-4e40-ab26-2905e3476018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_3affe598-c56c-42c8-ab7d-4fc1ef3d2e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_3affe598-c56c-42c8-ab7d-4fc1ef3d2e71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_919647e9-9174-4ac0-8cb8-c595eae5fcab" xlink:href="aqst-20240930.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_919647e9-9174-4ac0-8cb8-c595eae5fcab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bc3cc718-3f4d-4f35-add5-c5ea4ceb899d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_bc3cc718-3f4d-4f35-add5-c5ea4ceb899d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5c9b2901-5480-4f90-b56e-61e27b20d265" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_us-gaap_LiabilitiesCurrent_5c9b2901-5480-4f90-b56e-61e27b20d265" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_f3904bd4-1042-4490-bdb9-288c9456cc32" xlink:href="aqst-20240930.xsd#aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_f3904bd4-1042-4490-bdb9-288c9456cc32" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a6c44d0f-d22b-43a7-a232-4814dde41dc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_21b7ae2b-11ff-4120-9536-5b60af6decbc" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a6c44d0f-d22b-43a7-a232-4814dde41dc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ac7e76eb-9e7e-4c66-9a8e-241bb77239d5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b3a28e5d-ba1a-4e54-b973-79ffdd1d3871" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ac7e76eb-9e7e-4c66-9a8e-241bb77239d5" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b3a28e5d-ba1a-4e54-b973-79ffdd1d3871" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_697f98ef-4aa8-47db-94a9-4657a669c3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ac7e76eb-9e7e-4c66-9a8e-241bb77239d5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_697f98ef-4aa8-47db-94a9-4657a669c3fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet_439edefa-b025-4367-8903-cc3d2b381275" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ac7e76eb-9e7e-4c66-9a8e-241bb77239d5" xlink:to="loc_aqst_TradeAndOtherReceivablesNet_439edefa-b025-4367-8903-cc3d2b381275" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_a03661be-8217-42b6-8c88-345f3dc73a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ac7e76eb-9e7e-4c66-9a8e-241bb77239d5" xlink:to="loc_us-gaap_InventoryNet_a03661be-8217-42b6-8c88-345f3dc73a4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ba770b3a-a669-45d6-ae17-9540f0b082ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4db79435-c7f6-4c49-a1a2-6dd9a1f03fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ba770b3a-a669-45d6-ae17-9540f0b082ae" xlink:to="loc_us-gaap_StockholdersEquity_4db79435-c7f6-4c49-a1a2-6dd9a1f03fd6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_080c055f-6524-4aaa-a606-ee2944cba824" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ba770b3a-a669-45d6-ae17-9540f0b082ae" xlink:to="loc_us-gaap_CommitmentsAndContingencies_080c055f-6524-4aaa-a606-ee2944cba824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a9f79461-c9bd-4cb8-b4d6-1936fc2b9bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ba770b3a-a669-45d6-ae17-9540f0b082ae" xlink:to="loc_us-gaap_Liabilities_a9f79461-c9bd-4cb8-b4d6-1936fc2b9bdd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofOperationsandComprehensiveLossIncome"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0392345c-b93f-4706-ad73-a7a5fbed8949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0e93a53-1a6f-4e0c-bfdc-ecd47c645f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0392345c-b93f-4706-ad73-a7a5fbed8949" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0e93a53-1a6f-4e0c-bfdc-ecd47c645f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e157afe8-d808-4394-8f2b-6ce67c769f21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_0392345c-b93f-4706-ad73-a7a5fbed8949" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e157afe8-d808-4394-8f2b-6ce67c769f21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7d02f992-bff4-4c40-925d-001c90d29289" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_7fd7e095-8411-4ec7-a24b-331bc786eb0f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7d02f992-bff4-4c40-925d-001c90d29289" xlink:to="loc_us-gaap_CostsAndExpenses_7fd7e095-8411-4ec7-a24b-331bc786eb0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb93a8a6-7845-475e-8d49-a1bd868e370e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_7d02f992-bff4-4c40-925d-001c90d29289" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_fb93a8a6-7845-475e-8d49-a1bd868e370e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_0f23565a-e976-406a-b9b2-fc8fcf66ffd1" xlink:href="aqst-20240930.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_aqst_InterestAndOtherIncomeNet_0f23565a-e976-406a-b9b2-fc8fcf66ffd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_965afdc2-f433-429e-a4c6-eb476aacd8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_us-gaap_RoyaltyExpense_965afdc2-f433-429e-a4c6-eb476aacd8bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues_a7203d33-221a-4dab-a947-b4f16489b1c7" xlink:href="aqst-20240930.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_aqst_InterestExpenseSaleOfFutureRevenues_a7203d33-221a-4dab-a947-b4f16489b1c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_04d6b1aa-cb64-4332-8863-24b766c26b3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_us-gaap_InterestExpenseNonoperating_04d6b1aa-cb64-4332-8863-24b766c26b3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_03a39b88-e808-412c-a901-d6c22f1988a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_us-gaap_OperatingIncomeLoss_03a39b88-e808-412c-a901-d6c22f1988a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8785a01-48a6-4849-b71b-99a2e0f2462e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6f9f0631-7280-4552-8e93-440eea571b50" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8785a01-48a6-4849-b71b-99a2e0f2462e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_d317761e-9113-4105-9e7f-7eccf4ed388a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c7607b64-3012-4f13-bdff-04ebf7c11c92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d317761e-9113-4105-9e7f-7eccf4ed388a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c7607b64-3012-4f13-bdff-04ebf7c11c92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a6e1c56d-b4d2-4a14-aa0b-1f6dbc56c747" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d317761e-9113-4105-9e7f-7eccf4ed388a" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a6e1c56d-b4d2-4a14-aa0b-1f6dbc56c747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_1e265484-d033-4329-9b51-56bf3c9c4fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_d317761e-9113-4105-9e7f-7eccf4ed388a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_1e265484-d033-4329-9b51-56bf3c9c4fdb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_c5050e9e-011c-42ee-ac7b-3ca4956883bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d79bba6c-7a20-4956-9bf5-aeaf9c06988c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_c5050e9e-011c-42ee-ac7b-3ca4956883bc" xlink:to="loc_us-gaap_NetIncomeLoss_d79bba6c-7a20-4956-9bf5-aeaf9c06988c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06c0877d-8a37-484a-91c9-7e2841920eba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_880bb3ee-bc0c-4f69-9931-5f33afaafd56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06c0877d-8a37-484a-91c9-7e2841920eba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_880bb3ee-bc0c-4f69-9931-5f33afaafd56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3e82e6d3-c8b4-4c49-a649-480f86ab5d6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06c0877d-8a37-484a-91c9-7e2841920eba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_3e82e6d3-c8b4-4c49-a649-480f86ab5d6d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c971ab4-90fb-46f9-837d-3b5426fda809" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_06c0877d-8a37-484a-91c9-7e2841920eba" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6c971ab4-90fb-46f9-837d-3b5426fda809" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_402c6e43-a3bc-4e50-8627-9d0fac1a2344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_154c2d90-18bf-4bf1-8c3b-b14618e8ccfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_402c6e43-a3bc-4e50-8627-9d0fac1a2344" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_154c2d90-18bf-4bf1-8c3b-b14618e8ccfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_4c426b94-9b83-407d-b90b-59cd0761b2b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_DepreciationAndAmortization_4c426b94-9b83-407d-b90b-59cd0761b2b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_d76f686f-a743-48fc-afbc-764b140e60a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_GainLossOnContractTermination_d76f686f-a743-48fc-afbc-764b140e60a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_7c00dfbb-dd73-49fb-b94d-48ff24ee6424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_7c00dfbb-dd73-49fb-b94d-48ff24ee6424" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bdbb7007-1378-4f72-af7f-ebf8a9222a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_bdbb7007-1378-4f72-af7f-ebf8a9222a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2554ebcf-d14a-4e91-8b82-a792c70b8eea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2554ebcf-d14a-4e91-8b82-a792c70b8eea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_0275d79f-0c78-4318-8887-5d2f16f637ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_0275d79f-0c78-4318-8887-5d2f16f637ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_cecf4b67-a0dd-4a8c-affb-6681fa9fa2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_cecf4b67-a0dd-4a8c-affb-6681fa9fa2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d8433a44-0065-4d9c-a219-305ab38cfe1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_ShareBasedCompensation_d8433a44-0065-4d9c-a219-305ab38cfe1f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_72fe8a4e-cc8a-4a75-a6b6-fddd892c2f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_72fe8a4e-cc8a-4a75-a6b6-fddd892c2f3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_68b2e3b8-09bc-4e0c-b62e-58278145d4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_68b2e3b8-09bc-4e0c-b62e-58278145d4b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f10cc4f8-2939-4ddf-96c5-8c1d0c3c3f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_f10cc4f8-2939-4ddf-96c5-8c1d0c3c3f9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_98f4efab-5d87-472d-9011-9329df8fb683" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ca73cd29-4382-4bd0-bfac-ef901b55e037" xlink:to="loc_us-gaap_NetIncomeLoss_98f4efab-5d87-472d-9011-9329df8fb683" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_4087ea3d-40ce-49f9-92cf-f7f6b54c384d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_4087ea3d-40ce-49f9-92cf-f7f6b54c384d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_98cf7ffd-6368-4b41-961a-f84d57925718" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromIssuanceAndExerciseOfWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_98cf7ffd-6368-4b41-961a-f84d57925718" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_51a99b34-6611-4581-b683-e5a3156b09e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_51a99b34-6611-4581-b683-e5a3156b09e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_df3ed256-5bd1-4263-8985-e0d51d38f343" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_df3ed256-5bd1-4263-8985-e0d51d38f343" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01752da6-6ac9-494c-870f-c52d5204d27d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_01752da6-6ac9-494c-870f-c52d5204d27d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_a402181f-e70b-40b7-ac4d-e6e9ea153fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_a402181f-e70b-40b7-ac4d-e6e9ea153fc8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_c67ca4d5-8b78-45fe-93f6-00fe2fecef02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69f76ee7-2af2-45c7-b519-8167ed9b023e" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_c67ca4d5-8b78-45fe-93f6-00fe2fecef02" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet_a984bffa-0c74-4c8e-9e9f-37c6c3a5ea3d" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_075961f8-a7c8-45b3-82bd-801fbe6367bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aqst_TradeAndOtherReceivablesNet_a984bffa-0c74-4c8e-9e9f-37c6c3a5ea3d" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_075961f8-a7c8-45b3-82bd-801fbe6367bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1e9fbd86-e38f-4475-bde9-972954261c83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aqst_TradeAndOtherReceivablesNet_a984bffa-0c74-4c8e-9e9f-37c6c3a5ea3d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_1e9fbd86-e38f-4475-bde9-972954261c83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_a128cdfe-d233-4219-b40b-45f9f91652b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_aqst_TradeAndOtherReceivablesNet_a984bffa-0c74-4c8e-9e9f-37c6c3a5ea3d" xlink:to="loc_us-gaap_AccountsReceivableGross_a128cdfe-d233-4219-b40b-45f9f91652b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#InventoriesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_f8bff6f4-55bf-4831-ab57-d1a45cc771e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_1c9663f8-2d01-42f8-ba76-d6aafff66de2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8bff6f4-55bf-4831-ab57-d1a45cc771e7" xlink:to="loc_us-gaap_InventoryRawMaterials_1c9663f8-2d01-42f8-ba76-d6aafff66de2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross_2b225968-2fdb-46e5-8c58-9de245d3d421" xlink:href="aqst-20240930.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8bff6f4-55bf-4831-ab57-d1a45cc771e7" xlink:to="loc_aqst_InventoryPackingMaterialGross_2b225968-2fdb-46e5-8c58-9de245d3d421" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_9deb2e10-2ff0-45ba-bd7c-db0213df72cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_f8bff6f4-55bf-4831-ab57-d1a45cc771e7" xlink:to="loc_us-gaap_InventoryFinishedGoods_9deb2e10-2ff0-45ba-bd7c-db0213df72cc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_5b98383d-d5c5-47ee-aea2-446ed1facddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_29a78677-884d-4f75-8e9f-8a6d37ccd8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5b98383d-d5c5-47ee-aea2-446ed1facddd" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_29a78677-884d-4f75-8e9f-8a6d37ccd8fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_14255fbb-66ab-4103-8777-a928d5b41978" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_5b98383d-d5c5-47ee-aea2-446ed1facddd" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_14255fbb-66ab-4103-8777-a928d5b41978" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_21edb982-848b-44c0-b9c7-611b467fd5ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ce158d84-c078-4dff-90a9-09de6c787533" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_21edb982-848b-44c0-b9c7-611b467fd5ff" xlink:to="loc_us-gaap_OperatingLeaseLiability_ce158d84-c078-4dff-90a9-09de6c787533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e9dea7eb-391f-472b-bce5-73aeca6d2b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_21edb982-848b-44c0-b9c7-611b467fd5ff" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_e9dea7eb-391f-472b-bce5-73aeca6d2b69" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsMaturitiesDetails_1"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_25ff2c37-2d1b-45af-a521-3431be8dd232" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_25ff2c37-2d1b-45af-a521-3431be8dd232" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2f6db16e-9792-453c-a566-7253a4b0c3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2f6db16e-9792-453c-a566-7253a4b0c3c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_79496726-d002-452d-937f-50d0360b9ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_79496726-d002-452d-937f-50d0360b9ff0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_63fef61d-0849-481f-a5c0-3b63ff55dbca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_63fef61d-0849-481f-a5c0-3b63ff55dbca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_7ddecaff-b68c-4d50-84d9-25c7cd7b7962" xlink:href="aqst-20240930.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_e05fdaa7-8de3-4c95-92fb-8022e58cf77c" xlink:to="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_7ddecaff-b68c-4d50-84d9-25c7cd7b7962" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7330859a-1261-47f0-bade-b5ee4802dea4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8f6a2ae-67ba-4e89-aa48-e5aa08870154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7330859a-1261-47f0-bade-b5ee4802dea4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_e8f6a2ae-67ba-4e89-aa48-e5aa08870154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_35502930-cc82-4501-ba77-84beb7f86fff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7330859a-1261-47f0-bade-b5ee4802dea4" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_35502930-cc82-4501-ba77-84beb7f86fff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8c9d850d-1115-4168-8270-18f76403b5ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_8fed1fca-785a-4f1c-83b8-444f172e442a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_8c9d850d-1115-4168-8270-18f76403b5ef" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_8fed1fca-785a-4f1c-83b8-444f172e442a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable_9cb61e30-c870-46f7-977f-c87838be0fcc" xlink:href="aqst-20240930.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_8c9d850d-1115-4168-8270-18f76403b5ef" xlink:to="loc_aqst_CumulativeRoyaltyReceivable_9cb61e30-c870-46f7-977f-c87838be0fcc" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpensesScheduleofAccruedExpensesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ac648eb4-feed-4a2e-bcdc-1ce550f9f15f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ac648eb4-feed-4a2e-bcdc-1ce550f9f15f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4edf5149-bdbe-4f1f-ae58-60dc4dab378d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_4edf5149-bdbe-4f1f-ae58-60dc4dab378d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_59b36611-e49d-4692-8f15-c63b213576d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:to="loc_us-gaap_TaxesPayableCurrent_59b36611-e49d-4692-8f15-c63b213576d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e5179d87-aaf1-417c-bd7f-709a76d1dbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_e5179d87-aaf1-417c-bd7f-709a76d1dbf3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_60292b79-cace-4073-b2b7-8ddb86cbd9d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_c03c7eb9-7029-4404-8e43-7c0e5d4c80b1" xlink:to="loc_us-gaap_InterestPayableCurrent_60292b79-cace-4073-b2b7-8ddb86cbd9d9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_afc28bf9-c48d-416f-be10-9afd3bbf1181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_a10bd66a-8df4-4533-9e6e-b6c2becab9a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_afc28bf9-c48d-416f-be10-9afd3bbf1181" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_a10bd66a-8df4-4533-9e6e-b6c2becab9a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cfafa6ef-3f6a-4af8-97a5-67190f3813e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_afc28bf9-c48d-416f-be10-9afd3bbf1181" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_cfafa6ef-3f6a-4af8-97a5-67190f3813e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_bfdc1435-da37-4612-944a-dc00506c7995" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c3ac9fac-be17-423f-a145-920cf0326914" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_bfdc1435-da37-4612-944a-dc00506c7995" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_c3ac9fac-be17-423f-a145-920cf0326914" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a65b1348-e826-43bd-9750-619e5c0e83cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebtNoncurrent_bfdc1435-da37-4612-944a-dc00506c7995" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a65b1348-e826-43bd-9750-619e5c0e83cd" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtDebtMaturitiesDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d41c6303-cf97-4c3d-be3a-f8c721ccf47d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d41c6303-cf97-4c3d-be3a-f8c721ccf47d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e70c262-6d96-48c5-9331-73e0e92e29e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0e70c262-6d96-48c5-9331-73e0e92e29e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a092a2dc-f5b4-48ee-bd65-bde7db64c5f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_a092a2dc-f5b4-48ee-bd65-bde7db64c5f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_da2b6daf-e6b9-4c15-b0e2-a38926692c7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_da2b6daf-e6b9-4c15-b0e2-a38926692c7d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_fb2d130b-5959-4102-a68b-c2892690db10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f586baec-a578-4314-bc5a-4130d23d1ab8" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_fb2d130b-5959-4102-a68b-c2892690db10" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31759e45-307e-4cce-b398-2e7a264276c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_03b51fe9-548c-45b5-9595-2c27991f9094" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31759e45-307e-4cce-b398-2e7a264276c3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_03b51fe9-548c-45b5-9595-2c27991f9094" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d8d060e7-2963-47a7-ac92-cb0c0f3f2f45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31759e45-307e-4cce-b398-2e7a264276c3" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_d8d060e7-2963-47a7-ac92-cb0c0f3f2f45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c721b95-3bcd-4513-b0e1-b67ce6c4bc1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_31759e45-307e-4cce-b398-2e7a264276c3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_9c721b95-3bcd-4513-b0e1-b67ce6c4bc1b" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>aqst-20240930_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofChangesinStockholdersDeficit"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:to="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1e650d01-9866-45b1-8a10-c210ac4beb11_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:to="loc_us-gaap_EquityComponentDomain_1e650d01-9866-45b1-8a10-c210ac4beb11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:to="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ed2be2a-5584-4dd4-9ca3-4bb795d4ac87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_CommonStockMember_0ed2be2a-5584-4dd4-9ca3-4bb795d4ac87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7ef48d6b-2534-42f0-9e6e-32a671df6523" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7ef48d6b-2534-42f0-9e6e-32a671df6523" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f20f2eee-c2dc-44ee-a612-722be670c1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_RetainedEarningsMember_f20f2eee-c2dc-44ee-a612-722be670c1a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e033bb3a-c13a-4067-a2b8-48eef95d30f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e033bb3a-c13a-4067-a2b8-48eef95d30f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantExercisesMember_40007907-91d9-46d7-9be7-de1e24a6d70c" xlink:href="aqst-20240930.xsd#aqst_WarrantExercisesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_WarrantExercisesMember_40007907-91d9-46d7-9be7-de1e24a6d70c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_e230ac4d-efdc-4103-b9c0-c8ebd159969b" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_AtTheMarketOfferingMember_e230ac4d-efdc-4103-b9c0-c8ebd159969b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PublicEquityOfferingMember_45b5acf3-d633-4e72-a78a-5d9ae30ac230" xlink:href="aqst-20240930.xsd#aqst_PublicEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_PublicEquityOfferingMember_45b5acf3-d633-4e72-a78a-5d9ae30ac230" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b3847c9c-b72f-4a38-8eb1-57086b55644a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_SharesOutstanding_b3847c9c-b72f-4a38-8eb1-57086b55644a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eeffcf24-3ef8-4658-94a4-1741abc0ca6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockholdersEquity_eeffcf24-3ef8-4658-94a4-1741abc0ca6e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3d7b965a-fe9a-466e-9b48-4b7551439eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3d7b965a-fe9a-466e-9b48-4b7551439eb2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62a23fb6-6e4d-4f71-82b6-18c87e9dc046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62a23fb6-6e4d-4f71-82b6-18c87e9dc046" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_be2d47fd-25dd-4524-8afc-4c85fb6d504e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_be2d47fd-25dd-4524-8afc-4c85fb6d504e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3b3b412-4dd7-4595-833b-97448dd49745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3b3b412-4dd7-4595-833b-97448dd49745" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fc339ffa-161b-4b54-be4e-aacc8efb0f64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fc339ffa-161b-4b54-be4e-aacc8efb0f64" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a8de4c9-5149-4dc0-a686-74b927c0ef91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a8de4c9-5149-4dc0-a686-74b927c0ef91" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8f5fd952-36d4-4990-a0bd-13852173a7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8f5fd952-36d4-4990-a0bd-13852173a7f0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_2c2ebe8c-9d98-40ed-a825-e2dbc728f8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_2c2ebe8c-9d98-40ed-a825-e2dbc728f8f5" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dc12dce-05c5-4e45-8f1a-ed6647323b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dc12dce-05c5-4e45-8f1a-ed6647323b4c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7205177f-8265-4012-90ca-28dcab24df4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7205177f-8265-4012-90ca-28dcab24df4d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_32e2b11f-8f77-47bd-9799-0cc25d0911a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockholdersEquityOther_32e2b11f-8f77-47bd-9799-0cc25d0911a3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7bea9b41-2a6d-4baa-a301-049d00fd0a73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_NetIncomeLoss_7bea9b41-2a6d-4baa-a301-049d00fd0a73" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_36b0dbba-3825-4024-9ab8-8be6fc6019c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a842dcf1-5fef-4d1f-9723-786d6a08d4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_70b56c37-8f99-49f2-bbf0-2719e578369d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_70b56c37-8f99-49f2-bbf0-2719e578369d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_3d6c6423-10a5-41a9-aabe-0fe14ca63f91" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:to="loc_aqst_AtTheMarketOfferingMember_3d6c6423-10a5-41a9-aabe-0fe14ca63f91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PublicEquityOfferingMember_647667f5-cbb6-4fb0-be65-ad9d90d7d820" xlink:href="aqst-20240930.xsd#aqst_PublicEquityOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:to="loc_aqst_PublicEquityOfferingMember_647667f5-cbb6-4fb0-be65-ad9d90d7d820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57618b32-5108-4157-b67f-edc1d6ec4cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_NetIncomeLoss_57618b32-5108-4157-b67f-edc1d6ec4cb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d8d1c800-da51-4349-a32c-a24dce849cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_DepreciationAndAmortization_d8d1c800-da51-4349-a32c-a24dce849cf8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_1f9e1505-2f97-4431-8952-37b3ecf3f781" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_GainLossOnContractTermination_1f9e1505-2f97-4431-8952-37b3ecf3f781" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0ac87419-36ab-4b9b-ac53-ba32c75b0758" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_ShareBasedCompensation_0ac87419-36ab-4b9b-ac53-ba32c75b0758" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_17741b4b-7e7d-4ef7-a7da-9e73e703ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_17741b4b-7e7d-4ef7-a7da-9e73e703ac3e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dc984a14-f69f-43b6-b72a-eaed1676b11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dc984a14-f69f-43b6-b72a-eaed1676b11b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_4b83f7f9-e96f-4943-a195-6a5188f245be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_4b83f7f9-e96f-4943-a195-6a5188f245be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8ec07033-7cb0-46b1-82df-4cc858886c97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8ec07033-7cb0-46b1-82df-4cc858886c97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_34628498-1469-4837-8d2c-03be57f9d24a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_34628498-1469-4837-8d2c-03be57f9d24a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e40470c1-eeba-4614-90b8-a3bb0404304c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e40470c1-eeba-4614-90b8-a3bb0404304c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_d1780cca-95d4-40d1-9288-1f6abc8066d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_d1780cca-95d4-40d1-9288-1f6abc8066d8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b9b0cdb6-b07a-4c6f-ab8c-3459844ff59a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b9b0cdb6-b07a-4c6f-ab8c-3459844ff59a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e91ad47-3616-4f3b-9141-51cd921eb58f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e91ad47-3616-4f3b-9141-51cd921eb58f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13c8f205-48f8-42fa-b2bd-f778283123a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13c8f205-48f8-42fa-b2bd-f778283123a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cbf9dd18-72e4-4187-968f-678e8b9b9b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cbf9dd18-72e4-4187-968f-678e8b9b9b46" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d96a1a1-d8ac-4a50-9708-9710524bf56e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d96a1a1-d8ac-4a50-9708-9710524bf56e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_8a8dc6f7-eb0f-4fe0-a48b-f77553cc280b" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromIssuanceAndExerciseOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_8a8dc6f7-eb0f-4fe0-a48b-f77553cc280b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_26b7ff11-529e-4482-a6ea-00b23ce961ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_26b7ff11-529e-4482-a6ea-00b23ce961ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_67746711-098a-4a16-a24d-eb92f9c57989" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_67746711-098a-4a16-a24d-eb92f9c57989" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_28559c1d-e4e2-4a86-b349-bf3cdaa1d059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_28559c1d-e4e2-4a86-b349-bf3cdaa1d059" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a2dc7236-0d0b-4258-a039-4271db33b017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a2dc7236-0d0b-4258-a039-4271db33b017" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c793295-b2eb-4d72-8aa4-006ce631d7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c793295-b2eb-4d72-8aa4-006ce631d7a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa762bf6-5b22-4c51-8f23-6121ac5e6ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa762bf6-5b22-4c51-8f23-6121ac5e6ee7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2af47a16-e2f1-44b5-bada-66b8f4e7d147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2af47a16-e2f1-44b5-bada-66b8f4e7d147" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f03bbbd4-5a47-4a38-a03b-c3ccba966ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f03bbbd4-5a47-4a38-a03b-c3ccba966ba8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_caa5327a-b0e4-4d0b-9547-8f83ea236c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ae45bd7e-fa3d-47c7-9bb4-4091cfcb2e54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ae45bd7e-fa3d-47c7-9bb4-4091cfcb2e54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_97c38abd-0479-4eec-b526-2d9e6e7bb893" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:to="loc_us-gaap_InterestPaidNet_97c38abd-0479-4eec-b526-2d9e6e7bb893" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#CompanyOverviewandBasisofPresentationDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b274a5-640c-41a7-9a85-76ba58f0e150_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_23b274a5-640c-41a7-9a85-76ba58f0e150_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember_56f5cdf4-18de-43ff-86ce-50f507f4171e" xlink:href="aqst-20240930.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_EquityDistributionAgreementMember_56f5cdf4-18de-43ff-86ce-50f507f4171e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_2e72813e-0488-4558-9b50-d2097e0cbac5" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_AtTheMarketOfferingMember_2e72813e-0488-4558-9b50-d2097e0cbac5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember_887ecc41-0dc3-4c42-a025-71eb99d63e71" xlink:href="aqst-20240930.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_AmendedEquityDistributionAgreementMember_887ecc41-0dc3-4c42-a025-71eb99d63e71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementCommitmentShareMember_9553197a-06fa-40ee-a484-03e0e7e716cd" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementCommitmentShareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:to="loc_aqst_LincolnParkAgreementCommitmentShareMember_9553197a-06fa-40ee-a484-03e0e7e716cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember_25a84cb0-caec-4e60-a799-aae7767a3d8f" xlink:href="aqst-20240930.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_UnderwrittenPublicOfferingMember_25a84cb0-caec-4e60-a799-aae7767a3d8f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_8d075cc2-5607-425f-94bb-24501016142f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_us-gaap_OverAllotmentOptionMember_8d075cc2-5607-425f-94bb-24501016142f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:to="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_16757c49-b59d-4dd1-b151-565d59112eb0_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:to="loc_srt_RangeMember_16757c49-b59d-4dd1-b151-565d59112eb0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:to="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3afdc66f-12ca-4fa9-8451-52ea7df2c4c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:to="loc_srt_MaximumMember_3afdc66f-12ca-4fa9-8451-52ea7df2c4c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_42043910-5d7d-4ba8-9d9c-d17e9ec4ebf2" xlink:href="aqst-20240930.xsd#aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_42043910-5d7d-4ba8-9d9c-d17e9ec4ebf2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_961eac06-bc33-45fd-b133-982cb48b9a97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_961eac06-bc33-45fd-b133-982cb48b9a97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9fab8dca-83a1-4a35-a2ba-3056251550c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9fab8dca-83a1-4a35-a2ba-3056251550c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b46eb705-d334-4fe1-9b91-853fed2a452a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b46eb705-d334-4fe1-9b91-853fed2a452a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice_fc3ca43c-e530-4665-9546-2c0737bdc933" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SaleOfStockAggregateOfferingPrice_fc3ca43c-e530-4665-9546-2c0737bdc933" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RightToSellCommonStockValue_011ad886-1d5b-4e6f-a831-d4bceb21190e" xlink:href="aqst-20240930.xsd#aqst_RightToSellCommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_RightToSellCommonStockValue_011ad886-1d5b-4e6f-a831-d4bceb21190e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AgreementTerm_e5bc05e9-402e-4e21-ba63-03826f17c138" xlink:href="aqst-20240930.xsd#aqst_AgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_AgreementTerm_e5bc05e9-402e-4e21-ba63-03826f17c138" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_538f6fa5-1428-4381-a5f3-7db343e0b767" xlink:href="aqst-20240930.xsd#aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_538f6fa5-1428-4381-a5f3-7db343e0b767" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_dd177ab3-1ed0-42c9-9e4a-4c927fb4c093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_dd177ab3-1ed0-42c9-9e4a-4c927fb4c093" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_d85dbefb-e571-4d85-9e56-78942a892d8e" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_d85dbefb-e571-4d85-9e56-78942a892d8e" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RisksandUncertaintiesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a9bdaaa7-3c1c-4684-9727-3d123427b773_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a9bdaaa7-3c1c-4684-9727-3d123427b773_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_5dae5f1e-e100-4ba4-be2d-14895ae283cc" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_5dae5f1e-e100-4ba4-be2d-14895ae283cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8df6fe3c-cfe8-45fb-a43e-27b056fdb51d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8df6fe3c-cfe8-45fb-a43e-27b056fdb51d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42338d11-e332-45c0-8827-3f9505717357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42338d11-e332-45c0-8827-3f9505717357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_219a79a4-784f-4207-9946-6c47dc94a26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_219a79a4-784f-4207-9946-6c47dc94a26f" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fa2a6c9-3600-4645-9048-781b1abc64fc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fa2a6c9-3600-4645-9048-781b1abc64fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_141e5d06-e1f7-47ef-8445-ffa978752498" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_141e5d06-e1f7-47ef-8445-ffa978752498" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_562d1e85-b6c5-4bd5-97e8-b041bd55b891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:to="loc_us-gaap_AccountsReceivableMember_562d1e85-b6c5-4bd5-97e8-b041bd55b891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_75d8e89a-0821-42cc-b589-c0e939737505_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:to="loc_srt_NameOfMajorCustomerDomain_75d8e89a-0821-42cc-b589-c0e939737505_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:to="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_5ed5e8cc-190e-4507-95f0-3683def99efc" xlink:href="aqst-20240930.xsd#aqst_IndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_IndiviorMember_5ed5e8cc-190e-4507-95f0-3683def99efc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember_109df697-95ba-4aed-90c4-76a6baa36d9a" xlink:href="aqst-20240930.xsd#aqst_ZevraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_ZevraMember_109df697-95ba-4aed-90c4-76a6baa36d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HasicoMember_03eeddb1-78df-4500-8070-8eb05f6e5169" xlink:href="aqst-20240930.xsd#aqst_HasicoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_HasicoMember_03eeddb1-78df-4500-8070-8eb05f6e5169" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_6c72bb84-2da7-40ef-bd64-023d998e880a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_6c72bb84-2da7-40ef-bd64-023d998e880a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8964f098-d5ac-429a-9c3d-a3b94bef0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8964f098-d5ac-429a-9c3d-a3b94bef0f8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:to="loc_srt_RangeMember_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:to="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7ae431a-0450-4c25-996e-899ac30859b3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:to="loc_srt_MaximumMember_a7ae431a-0450-4c25-996e-899ac30859b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_384c5fdc-f235-44f9-985c-7179fb3c2f59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:to="loc_us-gaap_ReceivableTypeDomain_384c5fdc-f235-44f9-985c-7179fb3c2f59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:to="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember_736c2220-510e-451b-92ab-d8c75529a6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:to="loc_us-gaap_TradeAccountsReceivableMember_736c2220-510e-451b-92ab-d8c75529a6c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember_0b8bb444-2581-4d12-9c8f-24763189b578" xlink:href="aqst-20240930.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:to="loc_aqst_OtherReceivablesAndAccruedExpensesMember_0b8bb444-2581-4d12-9c8f-24763189b578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration_7ff29cf7-0639-4542-8b37-18a1d2fc1156" xlink:href="aqst-20240930.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_aqst_ResearchAndDevelopmentProjectDuration_7ff29cf7-0639-4542-8b37-18a1d2fc1156" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_adc9ea04-80ec-491b-bab8-04f37c11f228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_adc9ea04-80ec-491b-bab8-04f37c11f228" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c6b6f6f0-292d-483b-9106-721beade7fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c6b6f6f0-292d-483b-9106-721beade7fb9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_63d9b3dc-e6f9-468e-93f4-3168368868d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_CapitalizedContractCostNet_63d9b3dc-e6f9-468e-93f4-3168368868d8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3aaf2f8c-15f2-4b33-8103-68821026a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3aaf2f8c-15f2-4b33-8103-68821026a1fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b2e7f7d7-4fe5-4e58-8fc3-2f0c31460a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b2e7f7d7-4fe5-4e58-8fc3-2f0c31460a08" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetRevenueDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:to="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_09cfa00d-5012-471c-bdf8-45146a5140b5_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:to="loc_srt_ProductsAndServicesDomain_09cfa00d-5012-471c-bdf8-45146a5140b5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:to="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_f077603e-c9bd-4c83-8cd8-731c41c4ec5a" xlink:href="aqst-20240930.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_f077603e-c9bd-4c83-8cd8-731c41c4ec5a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_ba03639f-4ded-4ba4-9164-0e433bdb60d9" xlink:href="aqst-20240930.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_ba03639f-4ded-4ba4-9164-0e433bdb60d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember_cbd72c85-664f-44f0-81b9-abd05ad8c405" xlink:href="aqst-20240930.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_CoDevelopmentAndResearchFeesMember_cbd72c85-664f-44f0-81b9-abd05ad8c405" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_2e3c3b14-14a8-40a5-9887-5081a478ff1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_2e3c3b14-14a8-40a5-9887-5081a478ff1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82c23ce8-bee1-47f9-9429-435ff7e73916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82c23ce8-bee1-47f9-9429-435ff7e73916" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:to="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_830ece13-5230-463f-bd03-2c59ad2a2eb6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:to="loc_srt_SegmentGeographicalDomain_830ece13-5230-463f-bd03-2c59ad2a2eb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:to="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_facb48a1-ef70-4588-bf87-fb618e50955d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:to="loc_country_US_facb48a1-ef70-4588-bf87-fb618e50955d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_827a2c98-8748-4439-bf23-932c0ff2fe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:to="loc_us-gaap_NonUsMember_827a2c98-8748-4439-bf23-932c0ff2fe7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26167f5d-5327-4442-9b5d-471f6b2c75ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26167f5d-5327-4442-9b5d-471f6b2c75ab" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_7331eb6a-afab-46da-b6b3-4a06e80eba4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:to="loc_us-gaap_ReceivableTypeDomain_7331eb6a-afab-46da-b6b3-4a06e80eba4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:to="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_00bc28de-8788-4361-9a63-2af82c438afa" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_00bc28de-8788-4361-9a63-2af82c438afa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_0ad441d4-9774-4308-b822-461e54391ff0" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_0ad441d4-9774-4308-b822-461e54391ff0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_a14e42d3-8ce7-4ebc-acde-1308b282c044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_AccountsReceivableGross_a14e42d3-8ce7-4ebc-acde-1308b282c044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e0a1a835-4e81-4669-b2bf-d0339418fc78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e0a1a835-4e81-4669-b2bf-d0339418fc78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8cfb7528-d33b-4f61-8c53-235238a03707" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8cfb7528-d33b-4f61-8c53-235238a03707" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet_d766ef3d-077a-4114-9407-f6dbf86fa3b4" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_aqst_TradeAndOtherReceivablesNet_d766ef3d-077a-4114-9407-f6dbf86fa3b4" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_2af70de9-0c35-4f4a-9261-2ea429d58445_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:to="loc_us-gaap_ReceivableTypeDomain_2af70de9-0c35-4f4a-9261-2ea429d58445_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:to="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_d772a316-780b-4d43-bec8-43cebda0c1b8" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_d772a316-780b-4d43-bec8-43cebda0c1b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4e35680d-796e-426d-ad90-a38d09c7e8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4e35680d-796e-426d-ad90-a38d09c7e8f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1dcc002d-d4f6-475f-a23f-f8d86de37bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1dcc002d-d4f6-475f-a23f-f8d86de37bc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_41ae2c57-0eef-4518-8012-6e4c50af7fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:to="loc_us-gaap_ReceivableTypeDomain_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:to="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_d38bc53c-df3d-4323-b77f-8a72866ac648" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_d38bc53c-df3d-4323-b77f-8a72866ac648" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cbbf00-4915-44d3-b4e3-e4bcd260ff7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cbbf00-4915-44d3-b4e3-e4bcd260ff7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9d5016a3-e84f-42d3-bca0-87dc0a6ca9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9d5016a3-e84f-42d3-bca0-87dc0a6ca9a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_092a571e-bef6-4f3d-bb62-fc57bcb1087e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_092a571e-bef6-4f3d-bb62-fc57bcb1087e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_c5dfbf6e-bf73-4105-a026-3f4777e03f40" xlink:href="aqst-20240930.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_c5dfbf6e-bf73-4105-a026-3f4777e03f40" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_35a748e0-8994-45cd-a6b4-5724ea3d256b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#MaterialAgreementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_354a1857-9a72-4ab9-907d-b0bfa8ea659a" xlink:href="aqst-20240930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_354a1857-9a72-4ab9-907d-b0bfa8ea659a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3c1844cf-43aa-4cbb-b8db-ca4e8d573796" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3c1844cf-43aa-4cbb-b8db-ca4e8d573796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SupplementalAgreementWithIndiviorMember_c726df01-7557-4ed6-8829-e4c82989da66" xlink:href="aqst-20240930.xsd#aqst_SupplementalAgreementWithIndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_SupplementalAgreementWithIndiviorMember_c726df01-7557-4ed6-8829-e4c82989da66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_60addb29-1502-4154-b4f3-4d9bf12f5a5b" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_60addb29-1502-4154-b4f3-4d9bf12f5a5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_4c5bcde1-d694-4832-826e-4f4fa0ef0a5e" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_4c5bcde1-d694-4832-826e-4f4fa0ef0a5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_c5200853-47d2-4a29-b695-21a14fdddd37" xlink:href="aqst-20240930.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_c5200853-47d2-4a29-b695-21a14fdddd37" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_f4947876-872f-4cf1-aa3f-72f26ebdf9e8" xlink:href="aqst-20240930.xsd#aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_f4947876-872f-4cf1-aa3f-72f26ebdf9e8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_8c16dac9-e7f1-4c8f-a81f-59cd76257912" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_8c16dac9-e7f1-4c8f-a81f-59cd76257912" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_d81aa6fd-0a64-4ca2-b60a-05dc769503d2" xlink:href="aqst-20240930.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_LicenseSupplyAgreementMember_d81aa6fd-0a64-4ca2-b60a-05dc769503d2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_e8477c6b-6d64-41fd-a3e5-908836e51fa5" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_e8477c6b-6d64-41fd-a3e5-908836e51fa5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncMember_7dcac905-79b7-4c0e-96f5-4abfee57299b" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_MitsubishiTanabePharmaAmericaIncMember_7dcac905-79b7-4c0e-96f5-4abfee57299b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_23f40029-8f0e-47f4-8669-1caa1d8281b7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:to="loc_srt_RangeMember_23f40029-8f0e-47f4-8669-1caa1d8281b7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:to="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f98506e5-1ebc-4e74-be18-5884be439ba2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:to="loc_srt_MaximumMember_f98506e5-1ebc-4e74-be18-5884be439ba2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_800c7c04-fb8b-4d9f-9920-463ca3fd9941_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:to="loc_srt_ProductsAndServicesDomain_800c7c04-fb8b-4d9f-9920-463ca3fd9941_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:to="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_0f680225-65a3-46b0-8428-c31c5512f627" xlink:href="aqst-20240930.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_0f680225-65a3-46b0-8428-c31c5512f627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_914eaad6-9059-4ea0-bd4b-1fda942938c8" xlink:href="aqst-20240930.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_914eaad6-9059-4ea0-bd4b-1fda942938c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:to="loc_us-gaap_CreditFacilityDomain_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:to="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_8ed41557-e13c-4ae6-b8ed-f23c765be616" xlink:href="aqst-20240930.xsd#aqst_MonetizationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_MonetizationAgreementMember_8ed41557-e13c-4ae6-b8ed-f23c765be616" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_7ade3d0c-10a8-444b-b1ca-94d12b63bc9a" xlink:href="aqst-20240930.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_LicenseSupplyAgreementMember_7ade3d0c-10a8-444b-b1ca-94d12b63bc9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_fc5d3531-1401-40f6-b717-6e4c5bab0e7e" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_fc5d3531-1401-40f6-b717-6e4c5bab0e7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c692009-1d39-4028-8f5a-576c041cf4fd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_1c692009-1d39-4028-8f5a-576c041cf4fd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_84ad8a8e-b071-48e9-98c9-de9991ed4072" xlink:href="aqst-20240930.xsd#aqst_IndiviorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:to="loc_aqst_IndiviorMember_84ad8a8e-b071-48e9-98c9-de9991ed4072" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_f064225f-9273-49dc-888b-771952327206" xlink:href="aqst-20240930.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:to="loc_aqst_AssertioHoldingsIncMember_f064225f-9273-49dc-888b-771952327206" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bfd464c5-fedf-4785-8cf0-faafee2901fc_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_bfd464c5-fedf-4785-8cf0-faafee2901fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_4d1c26c2-5216-4c22-a34f-f55b4e39d9b3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:to="loc_srt_ChiefExecutiveOfficerMember_4d1c26c2-5216-4c22-a34f-f55b4e39d9b3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm_669eddbf-3c03-4618-8f97-402eb3c833da" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_LicenseAgreementTerm_669eddbf-3c03-4618-8f97-402eb3c833da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement_f6195ffa-bc3c-4ae7-a9ce-5a08765e007c" xlink:href="aqst-20240930.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_AutomaticRenewalPeriodOfAgreement_f6195ffa-bc3c-4ae7-a9ce-5a08765e007c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_5358ff7d-582d-44ca-84e6-c7b24a57c09a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_DeferredIncome_5358ff7d-582d-44ca-84e6-c7b24a57c09a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_90d9fc59-9ea6-49c0-9b6c-c2743ddb4189" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_90d9fc59-9ea6-49c0-9b6c-c2743ddb4189" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeRevenueRecognized_7657090e-cf66-45ca-bcfc-faf91417ab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_DeferredIncomeRevenueRecognized_7657090e-cf66-45ca-bcfc-faf91417ab9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_b4f9c284-ba3f-4ec0-b5d7-8ddc477948cb" xlink:href="aqst-20240930.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_InterestAndOtherIncomeNet_b4f9c284-ba3f-4ec0-b5d7-8ddc477948cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f660a39b-eedb-4ae7-8e9e-2872853313bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f660a39b-eedb-4ae7-8e9e-2872853313bd" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0aa5f5e4-80da-45e5-b3c0-07bf83083bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_Revenues_0aa5f5e4-80da-45e5-b3c0-07bf83083bc1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_256847d2-4bf0-468b-9e93-d1c290979fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_256847d2-4bf0-468b-9e93-d1c290979fb5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_87c0673b-6411-40a6-b506-172d6d79d222" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_87c0673b-6411-40a6-b506-172d6d79d222" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_ceb8b701-3b38-45a3-a424-fee51957d703" xlink:href="aqst-20240930.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_ceb8b701-3b38-45a3-a424-fee51957d703" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_a1986e90-be15-42b0-bddd-ac4f88da981b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_a1986e90-be15-42b0-bddd-ac4f88da981b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_940d09c2-5217-4b82-be92-4495c4fb9eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_SalesCommissionsAndFees_940d09c2-5217-4b82-be92-4495c4fb9eb5" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a81d3762-580b-4bd2-81b6-d966fdeda6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a81d3762-580b-4bd2-81b6-d966fdeda6ec" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeveranceCostsMonthlyPaymentDuration_f8d84bc9-fc5c-49b8-8f30-273944b4c968" xlink:href="aqst-20240930.xsd#aqst_SeveranceCostsMonthlyPaymentDuration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_SeveranceCostsMonthlyPaymentDuration_f8d84bc9-fc5c-49b8-8f30-273944b4c968" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cd815bec-01fb-42bc-bf2a-74eaf41e5789" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_SeveranceCosts1_cd815bec-01fb-42bc-bf2a-74eaf41e5789" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_e51bf661-4211-4373-ab38-8ae6b8719e97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ProceedsFromCollaborators_e51bf661-4211-4373-ab38-8ae6b8719e97" xlink:type="arc" order="16"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#FinancialInstrumentsFairValueMeasurementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f5d9553a-8b06-456c-91c5-ea9f4bf135bf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f5d9553a-8b06-456c-91c5-ea9f4bf135bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_ee28a4ad-a817-4156-957c-461e38adae1d" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_ee28a4ad-a817-4156-957c-461e38adae1d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_04a205d7-b7d3-4e67-8862-7ede6f7e9248" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_04a205d7-b7d3-4e67-8862-7ede6f7e9248" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e23f97d-34a6-49f8-a074-6b37f2f694af_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2e23f97d-34a6-49f8-a074-6b37f2f694af_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember_6af21b3c-4bb4-4e72-a784-29ea5eaf2197" xlink:href="aqst-20240930.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:to="loc_aqst_SecuritiesPurchaseAgreementMember_6af21b3c-4bb4-4e72-a784-29ea5eaf2197" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_8d0f9111-7855-4469-8f40-21af534f84b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_8d0f9111-7855-4469-8f40-21af534f84b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_20c9c62f-d81b-4fa7-ae78-7eb34d4fd10c" xlink:href="aqst-20240930.xsd#aqst_ExistingWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:to="loc_aqst_ExistingWarrantsMember_20c9c62f-d81b-4fa7-ae78-7eb34d4fd10c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_a669bfc8-ddf3-43c7-a3b0-ee3d82b6d328" xlink:href="aqst-20240930.xsd#aqst_NewWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:to="loc_aqst_NewWarrantsMember_a669bfc8-ddf3-43c7-a3b0-ee3d82b6d328" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3d973cc4-84ca-4b9b-a785-9d61dd942771_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3d973cc4-84ca-4b9b-a785-9d61dd942771_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4d4a0e9f-0e8e-421a-909c-d683d44c8390" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:to="loc_us-gaap_SeniorNotesMember_4d4a0e9f-0e8e-421a-909c-d683d44c8390" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a8727045-1e7d-456a-bc0d-83ac474b4668_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:to="loc_srt_RangeMember_a8727045-1e7d-456a-bc0d-83ac474b4668_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:to="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5fe68e05-855c-4fdd-aa9d-592b631c90e7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:to="loc_srt_MinimumMember_5fe68e05-855c-4fdd-aa9d-592b631c90e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_eaba0ad2-039f-4e05-aa0a-bb3d55ddc7b9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:to="loc_srt_MaximumMember_eaba0ad2-039f-4e05-aa0a-bb3d55ddc7b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3067691-0c28-41ec-8831-74a73af7004a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3067691-0c28-41ec-8831-74a73af7004a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_6f79be3c-c9aa-4a56-bd53-c38e9918b960" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_6f79be3c-c9aa-4a56-bd53-c38e9918b960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_9b19371d-0599-4656-9d8b-10fc1ace2f2c" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_9b19371d-0599-4656-9d8b-10fc1ace2f2c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_f16f9607-e849-4ccf-8fa4-fcf7cb9bc3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_f16f9607-e849-4ccf-8fa4-fcf7cb9bc3ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2903127c-4ff7-499e-8d4d-b0539a71a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2903127c-4ff7-499e-8d4d-b0539a71a6af" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_839a0b7f-ec61-43ad-bb3f-3f959a2e9c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_839a0b7f-ec61-43ad-bb3f-3f959a2e9c0e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_740e649d-56f7-41d0-b37c-233760e3a167" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_740e649d-56f7-41d0-b37c-233760e3a167" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_07f772e4-f504-4e6c-bef2-1d5ad693d155" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_07f772e4-f504-4e6c-bef2-1d5ad693d155" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3e110046-7763-47d4-aca8-a6621f4fa36f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3e110046-7763-47d4-aca8-a6621f4fa36f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a9c8a7d3-db61-4621-9a0f-36d79ec63b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a9c8a7d3-db61-4621-9a0f-36d79ec63b8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_93b4b4bf-c796-4ac7-b03e-aae6054468f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_93b4b4bf-c796-4ac7-b03e-aae6054468f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a2c5616e-b01a-4c20-a90a-c2ff6ccf5489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a2c5616e-b01a-4c20-a90a-c2ff6ccf5489" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_30143444-dedc-4a18-9d66-8e6e3bbcd41d" xlink:href="aqst-20240930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_30143444-dedc-4a18-9d66-8e6e3bbcd41d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_db7915b3-e603-4b1d-b546-65df90979493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_ConstructionInProgressMember_db7915b3-e603-4b1d-b546-65df90979493" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:to="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_94bb459e-2f45-42d8-b2e5-8c84ab3070c7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:to="loc_srt_RangeMember_94bb459e-2f45-42d8-b2e5-8c84ab3070c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:to="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3379ffdf-6f97-438a-a31e-01540fce5046" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:to="loc_srt_MinimumMember_3379ffdf-6f97-438a-a31e-01540fce5046" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_203cd313-aae0-41ec-98e5-209f14010235" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:to="loc_srt_MaximumMember_203cd313-aae0-41ec-98e5-209f14010235" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_68a46f42-4bf2-4f4f-9ad6-dd140a9d0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_68a46f42-4bf2-4f4f-9ad6-dd140a9d0a8b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_356d5323-ddc8-47b7-ae45-f65062254bce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_356d5323-ddc8-47b7-ae45-f65062254bce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5fdd9372-16ba-48f3-80dc-65fed04ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5fdd9372-16ba-48f3-80dc-65fed04ceb97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fd17934a-90c8-4d44-89bf-dabfce1060a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fd17934a-90c8-4d44-89bf-dabfce1060a8" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:to="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c67d5179-1474-4bb2-8cd1-069759cc93ed_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:to="loc_srt_RangeMember_c67d5179-1474-4bb2-8cd1-069759cc93ed_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:to="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_21086671-c25f-4011-b35f-f70e0001e4a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:to="loc_srt_MinimumMember_21086671-c25f-4011-b35f-f70e0001e4a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc7b0ee9-709e-476e-b7e9-d9b8ac1bcb57" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:to="loc_srt_MaximumMember_bc7b0ee9-709e-476e-b7e9-d9b8ac1bcb57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases_6d251383-071a-49e8-834e-c89bf4e302c5" xlink:href="aqst-20240930.xsd#aqst_NumberOfOperatingLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_aqst_NumberOfOperatingLeases_6d251383-071a-49e8-834e-c89bf4e302c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2962f68f-028e-4bde-9a7b-b83e290d311d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2962f68f-028e-4bde-9a7b-b83e290d311d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_43c5d3e9-ad5f-4b45-af6d-b0e504357aab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_43c5d3e9-ad5f-4b45-af6d-b0e504357aab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6953c5ff-3ffb-414e-981c-68641f53bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_OperatingLeaseCost_6953c5ff-3ffb-414e-981c-68641f53bdb0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3c65c99e-e7bb-4254-aa7f-b02c391017c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_VariableLeaseCost_3c65c99e-e7bb-4254-aa7f-b02c391017c7" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b69a928f-c0a0-4f97-9e7d-a694bac5111b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b69a928f-c0a0-4f97-9e7d-a694bac5111b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b5638046-d0c1-40f9-9801-3a43f8b1e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b5638046-d0c1-40f9-9801-3a43f8b1e17a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_77bce388-9e64-4f08-8e9a-737650deb6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:to="loc_us-gaap_PatentsMember_77bce388-9e64-4f08-8e9a-737650deb6e5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_65d891d8-c5a4-4671-a5bd-7315df224b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_65d891d8-c5a4-4671-a5bd-7315df224b2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e0ec8304-d74e-48e8-82d9-7f8943be2b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e0ec8304-d74e-48e8-82d9-7f8943be2b0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ce85daf7-8604-460f-8cbe-b9cf9f3a3e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ce85daf7-8604-460f-8cbe-b9cf9f3a3e71" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:to="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_27e1b406-0a11-45a7-9733-74a7d1c5804b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:to="loc_srt_ProductsAndServicesDomain_27e1b406-0a11-45a7-9733-74a7d1c5804b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:to="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3d6ce104-a4c9-4942-a988-ed1aa48954fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:to="loc_us-gaap_RoyaltyMember_3d6ce104-a4c9-4942-a988-ed1aa48954fd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0088f9fc-23ca-4f38-b926-efd601377c6c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_0088f9fc-23ca-4f38-b926-efd601377c6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_b9f5c6e6-112d-497c-b7ae-9e7c79f9ed9e" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_b9f5c6e6-112d-497c-b7ae-9e7c79f9ed9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_a31c1ff9-a4aa-4689-a327-0de0e099a13b" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:to="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_a31c1ff9-a4aa-4689-a327-0de0e099a13b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_017221cc-b998-43a5-b061-0ffdcb5db2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_017221cc-b998-43a5-b061-0ffdcb5db2d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments_8f6a3ffa-215f-4c60-8739-db6955c4bc3b" xlink:href="aqst-20240930.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_NumberOfGuaranteedRoyaltyPayments_8f6a3ffa-215f-4c60-8739-db6955c4bc3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_47c734b2-16e1-4f63-9345-5b71c32dbba9" xlink:href="aqst-20240930.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_47c734b2-16e1-4f63-9345-5b71c32dbba9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_4e9c38d5-49f7-4f8b-8bb9-2cdb20bef549" xlink:href="aqst-20240930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_4e9c38d5-49f7-4f8b-8bb9-2cdb20bef549" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_bdf7ae68-9188-4734-bdcc-12724f79c146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_us-gaap_SalesCommissionsAndFees_bdf7ae68-9188-4734-bdcc-12724f79c146" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpensesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/AccruedExpensesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_2441b820-51b6-47b1-b6ad-98367f175045" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_2441b820-51b6-47b1-b6ad-98367f175045" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_08e3268d-3f16-4980-8232-7d2d448244a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_08e3268d-3f16-4980-8232-7d2d448244a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_37eff14d-727f-46d9-83f3-2eccb3532477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:to="loc_us-gaap_SeniorNotesMember_37eff14d-727f-46d9-83f3-2eccb3532477" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5cc9e3a-032d-41d5-bdd3-750a6e22d43a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5cc9e3a-032d-41d5-bdd3-750a6e22d43a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b167607d-077c-4b0c-9123-a3587a8b73a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b167607d-077c-4b0c-9123-a3587a8b73a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_5f2e018c-29a3-4648-bc52-b09914cb815c" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_5f2e018c-29a3-4648-bc52-b09914cb815c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_3aca395a-e04d-4a21-a4c8-9725663cf2c6" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:to="loc_aqst_RoyaltyObligationsMember_3aca395a-e04d-4a21-a4c8-9725663cf2c6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember_3d24a59f-bc73-4806-941b-d53890a7183f" xlink:href="aqst-20240930.xsd#aqst_ABLFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_ABLFacilityMember_3d24a59f-bc73-4806-941b-d53890a7183f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6a21a5c6-af4e-46f8-9c48-a53ab6da2912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:to="loc_us-gaap_SeniorNotesMember_6a21a5c6-af4e-46f8-9c48-a53ab6da2912" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_11efa9fd-ffff-4825-a9a4-effd4386ecbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:to="loc_us-gaap_UnsecuredDebtMember_11efa9fd-ffff-4825-a9a4-effd4386ecbc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_981ac7a5-5217-4515-a604-d5700609084b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:to="loc_srt_RangeMember_981ac7a5-5217-4515-a604-d5700609084b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:to="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fc65515-58d6-42df-957b-a1236108ab22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:to="loc_srt_MaximumMember_6fc65515-58d6-42df-957b-a1236108ab22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6d89f4d5-9aa5-419b-bc44-f610de12d3c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:to="loc_srt_MinimumMember_6d89f4d5-9aa5-419b-bc44-f610de12d3c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_6a8a65b4-c360-4ee9-9ede-644693fea9fa_default" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_6a8a65b4-c360-4ee9-9ede-644693fea9fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member_fa8d4995-02f6-48fa-bb86-b974d66060c5" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:to="loc_aqst_RedemptionScenario1Member_fa8d4995-02f6-48fa-bb86-b974d66060c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member_874a1b0d-8bd9-44fd-a8a7-bf99995c4fb4" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:to="loc_aqst_RedemptionScenario2Member_874a1b0d-8bd9-44fd-a8a7-bf99995c4fb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_f5748478-c3bc-42fa-9532-1b0b38c3cec2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_f5748478-c3bc-42fa-9532-1b0b38c3cec2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_0ad9c1d3-e3f3-4d7b-a110-081318a771b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:to="loc_us-gaap_PutOptionMember_0ad9c1d3-e3f3-4d7b-a110-081318a771b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32e486af-6095-4fbb-995c-f6ac6a463c41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32e486af-6095-4fbb-995c-f6ac6a463c41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3b625780-aa9e-4f60-ba6a-d6b07f02d58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3b625780-aa9e-4f60-ba6a-d6b07f02d58e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_543e057a-dcc5-48e6-b527-faee84802f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_543e057a-dcc5-48e6-b527-faee84802f7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cf40b0fe-b2d2-4022-a0dc-77277a7772c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cf40b0fe-b2d2-4022-a0dc-77277a7772c1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_5a49733f-11fd-40e6-b928-34a4a07e98c2" xlink:href="aqst-20240930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_5a49733f-11fd-40e6-b928-34a4a07e98c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_71b5d445-79b4-4e10-8bec-841551fb5114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_RepaymentsOfDebt_71b5d445-79b4-4e10-8bec-841551fb5114" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b33cfa0d-a369-45e6-94df-9aed3f512118" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_LongTermDebt_b33cfa0d-a369-45e6-94df-9aed3f512118" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3cc4970e-22f2-4007-9569-23188d2a7c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3cc4970e-22f2-4007-9569-23188d2a7c47" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfNoteholders_bf254c1e-c5c4-40eb-9a02-716f83217541" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfNoteholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentNumberOfNoteholders_bf254c1e-c5c4-40eb-9a02-716f83217541" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfTransactions_8bb6490b-8bf6-4d96-913d-a54b5aaf6cc1" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentNumberOfTransactions_8bb6490b-8bf6-4d96-913d-a54b5aaf6cc1" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PremiumsPaidEarlyRetirementOfDebt_cf882a01-b41c-44f1-b5e5-c901f1adb072" xlink:href="aqst-20240930.xsd#aqst_PremiumsPaidEarlyRetirementOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_PremiumsPaidEarlyRetirementOfDebt_cf882a01-b41c-44f1-b5e5-c901f1adb072" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts_f749f9be-e2f2-44c5-a996-d31bf7fab285" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_PaymentsOfLoanCosts_f749f9be-e2f2-44c5-a996-d31bf7fab285" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_270265f7-55d9-4469-8f66-e81be1a1f117" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_270265f7-55d9-4469-8f66-e81be1a1f117" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_3c581bb1-c88d-4d17-a98d-fc3eb6a64131" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_3c581bb1-c88d-4d17-a98d-fc3eb6a64131" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e0f0f56d-f2af-44d1-8951-81314297bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e0f0f56d-f2af-44d1-8951-81314297bfce" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aaea27f4-5a5a-46f8-a33b-bd3c629e5b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aaea27f4-5a5a-46f8-a33b-bd3c629e5b99" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_35014fd6-6206-468b-919e-92bcb3f40e09" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_35014fd6-6206-468b-919e-92bcb3f40e09" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_844c3581-81d0-4a9e-bdaa-7deb5ecdcab7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_844c3581-81d0-4a9e-bdaa-7deb5ecdcab7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_eaab40a8-2f6c-4b3d-aea6-f690453dacd8" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_eaab40a8-2f6c-4b3d-aea6-f690453dacd8" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_2c599a7b-e204-4cb5-b4b0-570b9c1cf247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_2c599a7b-e204-4cb5-b4b0-570b9c1cf247" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ElectiveRedemptionPercentageOfDebt_b383adb4-de10-43b8-b48a-12283b228148" xlink:href="aqst-20240930.xsd#aqst_ElectiveRedemptionPercentageOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_ElectiveRedemptionPercentageOfDebt_b383adb4-de10-43b8-b48a-12283b228148" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_d59a7861-21b9-43f9-9841-45b593cb362a" xlink:href="aqst-20240930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_d59a7861-21b9-43f9-9841-45b593cb362a" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_00c9e7fd-3be6-42a8-9d23-5adc71af4d34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_00c9e7fd-3be6-42a8-9d23-5adc71af4d34" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_eec8f4d5-0c56-4eb6-b522-fed9500f47fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_eec8f4d5-0c56-4eb6-b522-fed9500f47fd" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_cbd69109-8688-47f4-b42b-73e68f9bc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_cbd69109-8688-47f4-b42b-73e68f9bc25b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_14d31153-6ec5-42cb-ad9f-548e291d019b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_14d31153-6ec5-42cb-ad9f-548e291d019b" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_227139cd-b6dc-459c-a605-894717e83bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_227139cd-b6dc-459c-a605-894717e83bc3" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_333e2341-e80d-4c6f-b482-bbc17a7b1a06" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_333e2341-e80d-4c6f-b482-bbc17a7b1a06" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_7af09250-a9fc-4b4e-a252-a37dfd9ca95d" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_7af09250-a9fc-4b4e-a252-a37dfd9ca95d" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_f3e867ea-983b-4db4-88ca-51aa51bbe8c8" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_f3e867ea-983b-4db4-88ca-51aa51bbe8c8" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_e9658136-23ae-4abb-af55-c9f01621d97d" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_e9658136-23ae-4abb-af55-c9f01621d97d" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_5bda17c6-6f7c-4083-bd0a-778787f491e5" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_5bda17c6-6f7c-4083-bd0a-778787f491e5" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_06fd3ec1-d0ed-46ea-acf1-6043a88c515e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_LongTermDebtFairValue_06fd3ec1-d0ed-46ea-acf1-6043a88c515e" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_44cd2a91-9fd2-4911-aeef-6b12a7508cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_44cd2a91-9fd2-4911-aeef-6b12a7508cbc" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee_ba75e77a-75bf-4b6c-b1fd-563e7a92cf27" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentExitFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentExitFee_ba75e77a-75bf-4b6c-b1fd-563e7a92cf27" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b1c05aed-b32a-4c23-bfd1-509e59456f01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b1c05aed-b32a-4c23-bfd1-509e59456f01" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c3a35d24-e0ea-4ef5-8dd6-66722df777bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c3a35d24-e0ea-4ef5-8dd6-66722df777bd" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a61ef8d-4e26-4b29-aa80-5ac5e8acdf92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a61ef8d-4e26-4b29-aa80-5ac5e8acdf92" xlink:type="arc" order="37"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_0a700edc-e1bc-42a9-9d5d-bc3c0ec5176a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_0a700edc-e1bc-42a9-9d5d-bc3c0ec5176a" xlink:type="arc" order="38"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_e682fb62-275f-4612-8809-313fd80c6e24_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_e682fb62-275f-4612-8809-313fd80c6e24_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_3a3064b8-34e6-4109-8454-3b961166c677" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_3a3064b8-34e6-4109-8454-3b961166c677" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember_70c62668-481f-4892-9ea6-b1a5c60d1685" xlink:href="aqst-20240930.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:to="loc_aqst_MeasurementInputProbabilityOfSuccessMember_70c62668-481f-4892-9ea6-b1a5c60d1685" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput_5bdec6ba-6da4-48db-8532-32d026e6982a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:to="loc_us-gaap_LongTermDebtMeasurementInput_5bdec6ba-6da4-48db-8532-32d026e6982a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_233d1489-77d7-46a6-8b55-89108aa19990_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_233d1489-77d7-46a6-8b55-89108aa19990_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_3e710268-3f39-4350-acd8-c1ae34181e51" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_3e710268-3f39-4350-acd8-c1ae34181e51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_7e055e86-9fe7-4b07-8bea-829478957b89" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:to="loc_aqst_RoyaltyObligationsMember_7e055e86-9fe7-4b07-8bea-829478957b89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_7e6bb970-5c68-403e-9867-8ed144d5c9ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_7e6bb970-5c68-403e-9867-8ed144d5c9ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_56fb10d9-7e2a-4b77-8467-33b1579dfe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:to="loc_us-gaap_SeniorNotesMember_56fb10d9-7e2a-4b77-8467-33b1579dfe4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_243cfc5f-e68a-4749-8644-d42d18c1895f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:to="loc_us-gaap_UnsecuredDebtMember_243cfc5f-e68a-4749-8644-d42d18c1895f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8f8e6f91-77b6-492e-8b54-bb3b99bf8e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8f8e6f91-77b6-492e-8b54-bb3b99bf8e85" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_320faa61-88f3-4860-928b-73d592a0cde6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_320faa61-88f3-4860-928b-73d592a0cde6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fca964d4-6681-40b8-9a78-25cdf3aad4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fca964d4-6681-40b8-9a78-25cdf3aad4e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_36c250a1-cdc3-45f1-916b-a1641698e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_36c250a1-cdc3-45f1-916b-a1641698e4a7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6b424051-1626-4e12-8e0d-efa469c0ddff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6b424051-1626-4e12-8e0d-efa469c0ddff" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1b544bdd-20bb-4b17-8714-c4518571529e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_10dfa57d-c3a1-4b24-b264-78acde0ba215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8040f311-8bfe-4e77-8a76-4c3e860d00cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebt_8040f311-8bfe-4e77-8a76-4c3e860d00cc" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#WarrantsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5fe94904-c3ab-4a2a-929d-5ec522f799e6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5fe94904-c3ab-4a2a-929d-5ec522f799e6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_a9980c31-415f-4dfe-98e7-eea194bdd78d" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_a9980c31-415f-4dfe-98e7-eea194bdd78d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8aec3a82-c2e9-4622-93c6-018781a057a4_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:to="loc_srt_RangeMember_8aec3a82-c2e9-4622-93c6-018781a057a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:to="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dd0640e3-5cd0-4387-9abd-778866afee84" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:to="loc_srt_MinimumMember_dd0640e3-5cd0-4387-9abd-778866afee84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12ccbe00-70dd-4193-a558-ef8d84bd31ce" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:to="loc_srt_MaximumMember_12ccbe00-70dd-4193-a558-ef8d84bd31ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_6e67baa5-f69b-41f8-8540-effc96379891_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_6e67baa5-f69b-41f8-8540-effc96379891_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember_27aa4984-a7cd-4c6f-84bc-dcb5493e80bb" xlink:href="aqst-20240930.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_FirstAdditionalWarrantOfferingMember_27aa4984-a7cd-4c6f-84bc-dcb5493e80bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InitialWarrantOfferingMember_3e395350-dadf-489c-b94e-a42e9257be18" xlink:href="aqst-20240930.xsd#aqst_InitialWarrantOfferingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_InitialWarrantOfferingMember_3e395350-dadf-489c-b94e-a42e9257be18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember_f20243f2-faac-44b2-acca-4dbcb1672bd1" xlink:href="aqst-20240930.xsd#aqst_PreFundedWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_PreFundedWarrantsMember_f20243f2-faac-44b2-acca-4dbcb1672bd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_5a42a16f-77e6-4113-9673-e7987632a82e" xlink:href="aqst-20240930.xsd#aqst_CommonStockWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_CommonStockWarrantsMember_5a42a16f-77e6-4113-9673-e7987632a82e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_5d501e72-f64e-4877-b5fd-1ff05ee199ad" xlink:href="aqst-20240930.xsd#aqst_ExistingWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_ExistingWarrantsMember_5d501e72-f64e-4877-b5fd-1ff05ee199ad" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_40e20062-d4a3-445e-80a0-bbc0fa57553e" xlink:href="aqst-20240930.xsd#aqst_NewWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_NewWarrantsMember_40e20062-d4a3-445e-80a0-bbc0fa57553e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants0.96ExercisePriceMember_c00b4a28-ed9a-4bb4-a79c-e5847e60ee82" xlink:href="aqst-20240930.xsd#aqst_Warrants0.96ExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants0.96ExercisePriceMember_c00b4a28-ed9a-4bb4-a79c-e5847e60ee82" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants4.25ExercisePriceMember_8916aff3-fcde-4176-9fad-75ed7331b1df" xlink:href="aqst-20240930.xsd#aqst_Warrants4.25ExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants4.25ExercisePriceMember_8916aff3-fcde-4176-9fad-75ed7331b1df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants5.38ExercisePriceMember_4ddb2fad-f509-432a-b124-c0264e8b87cf" xlink:href="aqst-20240930.xsd#aqst_Warrants5.38ExercisePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants5.38ExercisePriceMember_4ddb2fad-f509-432a-b124-c0264e8b87cf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d62e8276-f95c-4542-8df1-bf69ca307c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d62e8276-f95c-4542-8df1-bf69ca307c5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_74e5b166-fcb1-4a9a-8cc2-fb0c25069244" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_74e5b166-fcb1-4a9a-8cc2-fb0c25069244" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_58e238bf-9210-4ee2-948a-bd5ef85ee408" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_58e238bf-9210-4ee2-948a-bd5ef85ee408" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_4b6b0c58-4c18-4875-bda9-a24202a21a0f" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_4b6b0c58-4c18-4875-bda9-a24202a21a0f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_789923ca-1913-4aef-886b-6783f01d1873" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_789923ca-1913-4aef-886b-6783f01d1873" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e89e1ecf-4b16-4f23-98a7-35032deacc14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e89e1ecf-4b16-4f23-98a7-35032deacc14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_978a6bc8-c355-41ec-8677-c1b38c598ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_978a6bc8-c355-41ec-8677-c1b38c598ad4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_8b402443-b6bd-49f6-adc5-6a1e5fdc3c97" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_8b402443-b6bd-49f6-adc5-6a1e5fdc3c97" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6b72a9c5-931a-4d96-bbf3-00b6d283d204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6b72a9c5-931a-4d96-bbf3-00b6d283d204" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ab424a2e-2ca0-4b18-aec4-b86c02ac1eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ab424a2e-2ca0-4b18-aec4-b86c02ac1eb7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2c6e2001-1ab9-4d67-924e-578eb5c170f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2c6e2001-1ab9-4d67-924e-578eb5c170f6" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_ec5eda31-ab77-413c-990d-fc45da34e9f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:to="loc_us-gaap_CreditFacilityDomain_ec5eda31-ab77-413c-990d-fc45da34e9f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:to="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_3db8655a-6933-4f2e-8350-21707fe36231" xlink:href="aqst-20240930.xsd#aqst_MonetizationAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:to="loc_aqst_MonetizationAgreementMember_3db8655a-6933-4f2e-8350-21707fe36231" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f1189f01-d6b9-47a6-bebd-16800737034a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f1189f01-d6b9-47a6-bebd-16800737034a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_e7d991e4-5f03-48bf-8064-e24ce62e7a58" xlink:href="aqst-20240930.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_e7d991e4-5f03-48bf-8064-e24ce62e7a58" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_d7a54300-6da2-449d-8783-790be6e420a6" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_d7a54300-6da2-449d-8783-790be6e420a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8101e2af-e995-4adc-855e-590ffeb9357b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:to="loc_srt_RangeMember_8101e2af-e995-4adc-855e-590ffeb9357b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:to="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82b99347-84bb-4022-bd30-77144245d1c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:to="loc_srt_MaximumMember_82b99347-84bb-4022-bd30-77144245d1c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:to="loc_srt_ProductsAndServicesDomain_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:to="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_11043182-f195-4f2b-a4fd-6578d61af4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:to="loc_us-gaap_RoyaltyMember_11043182-f195-4f2b-a4fd-6578d61af4fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_4ebf15d1-7bb7-4aa1-9310-2858086ab734" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_4ebf15d1-7bb7-4aa1-9310-2858086ab734" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_adbd15cb-3fdc-47a3-9022-a2029cfe0d87" xlink:href="aqst-20240930.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_adbd15cb-3fdc-47a3-9022-a2029cfe0d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_fb168307-f061-4180-a4ca-dd61961d8625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_fb168307-f061-4180-a4ca-dd61961d8625" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aa4c54fd-500d-457f-aea7-01f51464636f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aa4c54fd-500d-457f-aea7-01f51464636f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_3b32976d-195c-4b82-b5d3-2383c323ff5b" xlink:href="aqst-20240930.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_3b32976d-195c-4b82-b5d3-2383c323ff5b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_940c0f44-a4e8-42c6-a39e-4d2ee6ebed31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_940c0f44-a4e8-42c6-a39e-4d2ee6ebed31" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenueRoyaltyObligationDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:to="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8f359f9c-9aa1-4815-8032-147afc7bd3b6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:to="loc_srt_ProductsAndServicesDomain_8f359f9c-9aa1-4815-8032-147afc7bd3b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:to="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_663949b2-fecc-41ac-8147-d19ccebdd9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:to="loc_us-gaap_RoyaltyMember_663949b2-fecc-41ac-8147-d19ccebdd9ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:href="aqst-20240930.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:to="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_b5616262-aa32-4820-9475-07348d72c645" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_b5616262-aa32-4820-9475-07348d72c645" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9c3d594-5942-4351-9991-d9e500922f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9c3d594-5942-4351-9991-d9e500922f3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f3df6762-caa1-4654-9529-ded611a6aec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f3df6762-caa1-4654-9529-ded611a6aec7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_a7495d14-e9ad-4063-9d4d-14dd7798530d" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_af840ef3-bbfe-477e-b6e9-beba0331fee7" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_af840ef3-bbfe-477e-b6e9-beba0331fee7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_23eea036-91d9-448a-8474-01f07bff17ab_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_23eea036-91d9-448a-8474-01f07bff17ab_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_69f76c34-02b5-49b3-a1ed-8637fec54489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_69f76c34-02b5-49b3-a1ed-8637fec54489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a0d8e7bb-ff71-46ec-aeed-9c29ee16cc43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a0d8e7bb-ff71-46ec-aeed-9c29ee16cc43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_17dfe302-fb26-4c03-a842-5e9b3701c815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_WarrantMember_17dfe302-fb26-4c03-a842-5e9b3701c815" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:to="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_939828db-d910-4df5-bd67-5249c2a22025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_939828db-d910-4df5-bd67-5249c2a22025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_61b1921d-9eb6-45b9-90f3-f37c13fc06ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_EmployeeStockOptionMember_61b1921d-9eb6-45b9-90f3-f37c13fc06ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1e314287-c336-4ca3-81b3-dd78556e25c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1e314287-c336-4ca3-81b3-dd78556e25c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7d764792-a678-427d-8ea9-82cffa029a83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_EmployeeStockMember_7d764792-a678-427d-8ea9-82cffa029a83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27a58217-d048-4762-8820-98288715cdea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_NetIncomeLoss_27a58217-d048-4762-8820-98288715cdea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_490c2de0-f725-44d8-8428-78dad796eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_490c2de0-f725-44d8-8428-78dad796eb1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6214805f-8f63-4d7d-b457-cdc81324636c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6214805f-8f63-4d7d-b457-cdc81324636c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ea05778-f24d-43a5-81f1-0a211bbb3174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ea05778-f24d-43a5-81f1-0a211bbb3174" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c5b316a-4d6f-4c40-b4b5-291466c718b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c5b316a-4d6f-4c40-b4b5-291466c718b7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_785c5820-77f3-4ec2-84a3-e2ad0ec17a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_EarningsPerShareBasic_785c5820-77f3-4ec2-84a3-e2ad0ec17a1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be7a4bf2-c658-40ed-8a95-80d2d5f32104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be7a4bf2-c658-40ed-8a95-80d2d5f32104" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_672a29d4-15ef-4660-9109-f71eb0b8a059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_672a29d4-15ef-4660-9109-f71eb0b8a059" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2b7797f1-1536-479d-af4d-e810ecd961dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2b7797f1-1536-479d-af4d-e810ecd961dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0324802d-80e4-48b0-a58a-bd57b5f954db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0324802d-80e4-48b0-a58a-bd57b5f954db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4d597f8a-e9ae-4efa-9b0f-dab372040a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:to="loc_us-gaap_WarrantMember_4d597f8a-e9ae-4efa-9b0f-dab372040a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3408c735-b2fb-438c-97cf-9f9a831e3392" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3408c735-b2fb-438c-97cf-9f9a831e3392" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_d9c751e3-d901-4100-abd1-887c81ba1399_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_d9c751e3-d901-4100-abd1-887c81ba1399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember_fe07833a-fe01-436f-a783-d7e98d13ee92" xlink:href="aqst-20240930.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_aqst_ManufacturingAndSupplyMember_fe07833a-fe01-436f-a783-d7e98d13ee92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_795f85ff-a1c7-48e8-8338-175b652a591c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_795f85ff-a1c7-48e8-8338-175b652a591c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_81296d20-314b-453f-8dff-7e1a4644820b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_81296d20-314b-453f-8dff-7e1a4644820b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:to="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e4c0fd-a118-4da8-9fee-c3757c9762de_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22e4c0fd-a118-4da8-9fee-c3757c9762de_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_83d8d6c4-f4ab-4590-bd9a-bbfd132f5d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_83d8d6c4-f4ab-4590-bd9a-bbfd132f5d7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cff32296-fc26-44fb-b6d9-482173c28fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cff32296-fc26-44fb-b6d9-482173c28fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb9dcd3d-b434-4964-af70-6a757029d7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_EmployeeStockMember_fb9dcd3d-b434-4964-af70-6a757029d7a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e0ca3866-d895-4771-b519-c020b2436641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e0ca3866-d895-4771-b519-c020b2436641" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationRestrictedStockUnitAwardsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:to="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5c676c7a-a2e7-4312-baba-29cdce6cd051" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5c676c7a-a2e7-4312-baba-29cdce6cd051" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfec863f-f7e4-432c-825e-f466fa04d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfec863f-f7e4-432c-825e-f466fa04d2ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f30227e9-0109-4f71-85f0-d27d32586a75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f30227e9-0109-4f71-85f0-d27d32586a75" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7db1b4c4-8ba5-448e-86e5-669364a7a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7db1b4c4-8ba5-448e-86e5-669364a7a5ee" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9d8310d3-f9a3-4f70-bd39-79b94a73d050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9d8310d3-f9a3-4f70-bd39-79b94a73d050" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_56174a08-50ff-4e34-9fe7-c5f84c1acf35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_864c88b5-0a0c-4971-a47b-c3a870a578b4" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_864c88b5-0a0c-4971-a47b-c3a870a578b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8413ff14-9bd8-44f8-a583-e164f9d742fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8413ff14-9bd8-44f8-a583-e164f9d742fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68611bb1-5c09-46e0-b951-555ae25b5f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68611bb1-5c09-46e0-b951-555ae25b5f7f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_114e584f-b14d-47db-a196-4610b7720455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_114e584f-b14d-47db-a196-4610b7720455" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c45396ea-487c-48ff-bc4f-890408c2e9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c45396ea-487c-48ff-bc4f-890408c2e9e5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0467e92f-166f-4563-a5dc-9fd9a8dde895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_d19a6b03-d3fb-43b7-a43a-918482d1729c" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_d19a6b03-d3fb-43b7-a43a-918482d1729c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b9f42f8-c331-4079-a4c2-623ce7a0ef53_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0b9f42f8-c331-4079-a4c2-623ce7a0ef53_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a3b07f03-f547-49fa-94b9-d99bea7fd15e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a3b07f03-f547-49fa-94b9-d99bea7fd15e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_13948778-78db-4a9d-b158-2e50ed700605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_PerformanceSharesMember_13948778-78db-4a9d-b158-2e50ed700605" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_15e42478-cec8-4f16-928e-32cfb3ad9d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_EmployeeStockOptionMember_15e42478-cec8-4f16-928e-32cfb3ad9d01" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_249a9732-130d-4830-a67f-a96fdd8d7028_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:to="loc_us-gaap_PlanNameDomain_249a9732-130d-4830-a67f-a96fdd8d7028_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:to="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_d92abdff-a8bd-4dcb-8db5-d84cd5577129" xlink:href="aqst-20240930.xsd#aqst_MarketBasedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:to="loc_aqst_MarketBasedMember_d92abdff-a8bd-4dcb-8db5-d84cd5577129" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:href="aqst-20240930.xsd#aqst_VestingConditionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_355aaf7a-5928-48af-8038-cd144cef0ee6_default" xlink:href="aqst-20240930.xsd#aqst_VestingConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:to="loc_aqst_VestingConditionDomain_355aaf7a-5928-48af-8038-cd144cef0ee6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:href="aqst-20240930.xsd#aqst_VestingConditionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:to="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeOneMember_632c3c3e-e836-47d2-b702-e2135bb69419" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeOneMember_632c3c3e-e836-47d2-b702-e2135bb69419" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwoMember_013ecf5c-cd6e-404c-8c25-d6b856cdd633" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeTwoMember_013ecf5c-cd6e-404c-8c25-d6b856cdd633" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeThreeMember_b767afb1-7cb7-42c9-bb41-bf44bef827e8" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeThreeMember_b767afb1-7cb7-42c9-bb41-bf44bef827e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFourMember_3e5971b6-6d1a-40f6-9980-f3699d4134fb" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeFourMember_3e5971b6-6d1a-40f6-9980-f3699d4134fb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFiveMember_95a372d5-5e46-4bc6-bba7-55b97abae227" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeFiveMember_95a372d5-5e46-4bc6-bba7-55b97abae227" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSixMember_80a9281a-7ba0-49a8-9233-694d28e36e0c" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeSixMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeSixMember_80a9281a-7ba0-49a8-9233-694d28e36e0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0ad48372-76b7-4311-a178-3bcaf8fa3c74_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:to="loc_srt_RangeMember_0ad48372-76b7-4311-a178-3bcaf8fa3c74_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:to="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7c3c6c31-8592-48d4-9e15-2baea529a200" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:to="loc_srt_MinimumMember_7c3c6c31-8592-48d4-9e15-2baea529a200" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8737f872-7180-44cc-907e-e7fb43f7087f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:to="loc_srt_MaximumMember_8737f872-7180-44cc-907e-e7fb43f7087f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5a2a0e42-8147-48a5-97d6-eb342baf6dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5a2a0e42-8147-48a5-97d6-eb342baf6dfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_29f6ee7c-e7bb-4c0c-9d18-2c276b71c82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_29f6ee7c-e7bb-4c0c-9d18-2c276b71c82b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8b6b8d9d-a510-48dc-957e-ea26b155e940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8b6b8d9d-a510-48dc-957e-ea26b155e940" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_a9d44ca6-3b01-498d-b249-8079e4418c2b" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_a9d44ca6-3b01-498d-b249-8079e4418c2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_89bbbb4b-16d6-4941-bf8f-22c49a9cd15c" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_89bbbb4b-16d6-4941-bf8f-22c49a9cd15c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f94c3fa-72f7-4d6c-82b6-f7fc5067d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f94c3fa-72f7-4d6c-82b6-f7fc5067d4a5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares_83a9da82-c4e0-4012-9e0a-e51396d828de" xlink:href="aqst-20240930.xsd#aqst_InducementEquityCommonStockOptionsOutstandingShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares_83a9da82-c4e0-4012-9e0a-e51396d828de" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_08be074f-cb6a-430c-841a-18fe10f25547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_08be074f-cb6a-430c-841a-18fe10f25547" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ac50782-20af-4ea0-99b3-64f94cecad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ac50782-20af-4ea0-99b3-64f94cecad6d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8939f3c4-bb69-4551-bbd0-432bd7999ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_SharePrice_8939f3c4-bb69-4551-bbd0-432bd7999ee7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_62bfc385-a24c-43c9-a7d6-83a36196e623" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_62bfc385-a24c-43c9-a7d6-83a36196e623" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationPerformanceBasedDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:to="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cda3f2a4-81b4-4583-94a1-8632064e3c2d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cda3f2a4-81b4-4583-94a1-8632064e3c2d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_65a22eda-5b45-49b3-9ead-b50c376b1016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:to="loc_us-gaap_PerformanceSharesMember_65a22eda-5b45-49b3-9ead-b50c376b1016" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_73e24e7b-ee36-4a18-b15f-43e012ac6d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_73e24e7b-ee36-4a18-b15f-43e012ac6d1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_429b42a8-c7cf-4528-9898-689f36faebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_429b42a8-c7cf-4528-9898-689f36faebf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_666e0bf4-4532-4289-9c21-7cc493e5143b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_666e0bf4-4532-4289-9c21-7cc493e5143b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_49f2d41d-70e1-48e6-8fd5-c806556d1042" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_49f2d41d-70e1-48e6-8fd5-c806556d1042" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a7c09e1-7c51-44fe-9b62-03da64f6cb54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a7c09e1-7c51-44fe-9b62-03da64f6cb54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f9606631-f0be-434b-ae64-b0d8496011d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f9606631-f0be-434b-ae64-b0d8496011d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76f60eea-f2f5-424f-b86d-e6a6ac6aa2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76f60eea-f2f5-424f-b86d-e6a6ac6aa2ea" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_de06d327-e7e9-4efc-a5ee-89edc0d1b306" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_de06d327-e7e9-4efc-a5ee-89edc0d1b306" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:to="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50dd904-4892-4ee9-9141-8fe7e20e2225_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a50dd904-4892-4ee9-9141-8fe7e20e2225_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff91d295-051c-4bed-a93b-02b81cbe71a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff91d295-051c-4bed-a93b-02b81cbe71a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db4605fc-2c5a-40e7-9301-4ca7077d320c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db4605fc-2c5a-40e7-9301-4ca7077d320c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1dc2854-16c0-4367-8fe6-7ba6c70672a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1dc2854-16c0-4367-8fe6-7ba6c70672a6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d828b9a-fbaf-4e22-9b6a-d28a64e9e016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d828b9a-fbaf-4e22-9b6a-d28a64e9e016" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_3eb36e84-b393-4f0f-bd1e-dffba3694aeb" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_3eb36e84-b393-4f0f-bd1e-dffba3694aeb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b9bc22a0-e676-4162-8c86-eff7aadb5c11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b9bc22a0-e676-4162-8c86-eff7aadb5c11" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ebca7136-2c7b-4d73-8b07-01ce36e08828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ebca7136-2c7b-4d73-8b07-01ce36e08828" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d0cc085e-52fe-401b-bb27-f85e3a679a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d0cc085e-52fe-401b-bb27-f85e3a679a00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2e62ff42-d389-4481-8545-4b18a0d3fd85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2e62ff42-d389-4481-8545-4b18a0d3fd85" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0898c9bf-7fee-4100-90e5-d0a13f54ba71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0898c9bf-7fee-4100-90e5-d0a13f54ba71" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c167d007-2bee-42dc-935b-b09f66ab03e7" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c167d007-2bee-42dc-935b-b09f66ab03e7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_778e1548-1768-4c79-a000-b9bd14ceee50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_778e1548-1768-4c79-a000-b9bd14ceee50" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c85415af-87cd-4e15-9bd7-0e2596b08b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c85415af-87cd-4e15-9bd7-0e2596b08b2c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:to="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4b356ab-9318-4e91-a871-37f9bbc55b84_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a4b356ab-9318-4e91-a871-37f9bbc55b84_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0c2f056b-3a83-4478-ab1d-7f110f8b33eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0c2f056b-3a83-4478-ab1d-7f110f8b33eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:to="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_567493cd-7c51-4528-b30d-c79badeb2c11_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:to="loc_srt_RangeMember_567493cd-7c51-4528-b30d-c79badeb2c11_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:to="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3cb07101-39f3-4fee-af3e-739a9ef354c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:to="loc_srt_MinimumMember_3cb07101-39f3-4fee-af3e-739a9ef354c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6354451-c22a-4f67-abb2-96e3d99cecce" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:to="loc_srt_MaximumMember_a6354451-c22a-4f67-abb2-96e3d99cecce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c5afbea2-1051-476a-9f8a-3bca29acc3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c5afbea2-1051-476a-9f8a-3bca29acc3e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7a930a92-5ff5-40a5-8512-d9503fd884d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7a930a92-5ff5-40a5-8512-d9503fd884d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_ff75abd8-369c-4cc8-8f64-37d5feaf3370" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_ff75abd8-369c-4cc8-8f64-37d5feaf3370" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e48c9a4-9e3d-4176-8e3d-7683bfdda525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e48c9a4-9e3d-4176-8e3d-7683bfdda525" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f9ca5953-82a5-45e8-b8e6-981c012c85df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f9ca5953-82a5-45e8-b8e6-981c012c85df" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ContingenciesDetails"/>
  <link:definitionLink xlink:role="http://aquestive.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f9b15f19-35b5-4800-bb55-509cd98ac04c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:to="loc_srt_LitigationCaseTypeDomain_f9b15f19-35b5-4800-bb55-509cd98ac04c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:to="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_b46bde5e-3199-42b8-95f2-8ed29b467fef" xlink:href="aqst-20240930.xsd#aqst_NeurelisIncVAquestiveTherapeuticsIncMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:to="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_b46bde5e-3199-42b8-95f2-8ed29b467fef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember_829e33bb-9ca4-4bbb-80a6-00eee19e7243" xlink:href="aqst-20240930.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:to="loc_aqst_SuboxoneProduceLiabilityLitigationMember_829e33bb-9ca4-4bbb-80a6-00eee19e7243" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_30db8d4f-9a15-44f8-af60-9104de5d590b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:to="loc_srt_SegmentGeographicalDomain_30db8d4f-9a15-44f8-af60-9104de5d590b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:to="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC_ed69213a-03b1-4018-afa0-c04ce403272a" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA-BC"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:to="loc_stpr_CA-BC_ed69213a-03b1-4018-afa0-c04ce403272a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_1deee74e-d670-483d-8968-f4816bb8f636_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_1deee74e-d670-483d-8968-f4816bb8f636_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_630d09ce-668f-453d-afdb-02800c798dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:to="loc_us-gaap_SubsequentEventMember_630d09ce-668f-453d-afdb-02800c798dee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_70683f4b-aad8-416a-96b1-b122037945a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_70683f4b-aad8-416a-96b1-b122037945a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_4c989943-d2d2-4eac-8ccd-88e747cdc796" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_4c989943-d2d2-4eac-8ccd-88e747cdc796" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_419eb8b0-c4c2-4a6c-8007-dca8e219e1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_419eb8b0-c4c2-4a6c-8007-dca8e219e1e6" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DanielBarberMember_8fd2c147-e54b-4197-922f-7ebb845f0d32" xlink:href="aqst-20240930.xsd#aqst_DanielBarberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_aqst_DanielBarberMember_8fd2c147-e54b-4197-922f-7ebb845f0d32" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PeterBoydMember_c1c9e467-d6da-48ee-885c-a288f8b10834" xlink:href="aqst-20240930.xsd#aqst_PeterBoydMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_aqst_PeterBoydMember_c1c9e467-d6da-48ee-885c-a288f8b10834" xlink:type="arc" order="3"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>aqst-20240930_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_aqst_DebtInstrumentExitFee_b0056538-d4fe-4edb-b232-4ec2123c275d_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, exit fee</link:label>
    <link:label id="lab_aqst_DebtInstrumentExitFee_label_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Exit Fee</link:label>
    <link:label id="lab_aqst_DebtInstrumentExitFee_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentExitFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Exit Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentExitFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentExitFee" xlink:to="lab_aqst_DebtInstrumentExitFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_b828f711-fa4a-4c8e-ab62-7f2bc6fe77f7_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_af70de40-a45d-44bc-b4fa-4ba2d0546cf5_terseLabel_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock in connection with securities purchase agreements (in shares)</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_label_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock To Be Purchased By Common Stock Warrants</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_documentation_en-US" xlink:label="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares of Common Stock to be Purchased by Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:to="lab_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_0f4fe032-eec4-4dac-a98f-437b4bc2c37e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net (loss) income to net cash used for operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_c808a857-e2bf-4ed3-bdd0-4cb71f2916eb_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_23d82f5e-6fd2-4f68-8c7f-1c0109a30bd9_verboseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LincolnParkAgreementCommitmentShareMember_77562541-7fc2-4ef6-b524-2e91d41f4de6_terseLabel_en-US" xlink:label="lab_aqst_LincolnParkAgreementCommitmentShareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lincoln Park Agreement, Commitment Share</link:label>
    <link:label id="lab_aqst_LincolnParkAgreementCommitmentShareMember_label_en-US" xlink:label="lab_aqst_LincolnParkAgreementCommitmentShareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lincoln Park Agreement, Commitment Share [Member]</link:label>
    <link:label id="lab_aqst_LincolnParkAgreementCommitmentShareMember_documentation_en-US" xlink:label="lab_aqst_LincolnParkAgreementCommitmentShareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lincoln Park Agreement, Commitment Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementCommitmentShareMember" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementCommitmentShareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LincolnParkAgreementCommitmentShareMember" xlink:to="lab_aqst_LincolnParkAgreementCommitmentShareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_6b67b8bd-2475-4db5-95a5-b3e5998950e6_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract and other receivables</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNetCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:to="lab_us-gaap_ContractWithCustomerAssetNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_5d13581a-02f1-4329-a1e5-778fe1f43dd9_terseLabel_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income and other income, net</link:label>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_label_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest And Other Income, Net</link:label>
    <link:label id="lab_aqst_InterestAndOtherIncomeNet_documentation_en-US" xlink:label="lab_aqst_InterestAndOtherIncomeNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest And Other Income, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet" xlink:href="aqst-20240930.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InterestAndOtherIncomeNet" xlink:to="lab_aqst_InterestAndOtherIncomeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_a37faf96-7f15-4b9f-8290-354f2d1ea1de_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_a61c4dea-c54d-4101-95e5-4bb9a0f108ca_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionDomain_d47eddc7-e36f-4bed-8d38-d65ce737bad1_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition [Domain]</link:label>
    <link:label id="lab_aqst_VestingConditionDomain_label_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition [Domain]</link:label>
    <link:label id="lab_aqst_VestingConditionDomain_documentation_en-US" xlink:label="lab_aqst_VestingConditionDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Conditions [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain" xlink:href="aqst-20240930.xsd#aqst_VestingConditionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionDomain" xlink:to="lab_aqst_VestingConditionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_5c669758-451d-4525-a17a-96509528b532_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputDiscountRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Discount Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputDiscountRateMember" xlink:to="lab_us-gaap_MeasurementInputDiscountRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_1a56cacd-c0c5-4d0c-a80b-8663e8bf4fe8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PeterBoydMember_label_en-US" xlink:label="lab_aqst_PeterBoydMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peter Boyd [Member]</link:label>
    <link:label id="lab_aqst_PeterBoydMember_documentation_en-US" xlink:label="lab_aqst_PeterBoydMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Peter Boyd</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PeterBoydMember" xlink:href="aqst-20240930.xsd#aqst_PeterBoydMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PeterBoydMember" xlink:to="lab_aqst_PeterBoydMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_5d83d100-13b9-4df5-b034-2dd7f3cfd501_terseLabel_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_label_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Warrants Exercised</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsExercised_documentation_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of class of warrant or right exercised.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:to="lab_aqst_ClassOfWarrantOrRightWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_ac0692ab-d48b-4213-a09e-868a94a0a08b_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_3ed41a4e-15dd-43c8-9c30-af65be468083_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt and Lease Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:to="lab_us-gaap_LongTermDebtAndCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_6d89bf39-054c-4c40-af37-332b742f5422_terseLabel_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty receivable</link:label>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_label_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cumulative Royalty Receivable</link:label>
    <link:label id="lab_aqst_CumulativeRoyaltyReceivable_documentation_en-US" xlink:label="lab_aqst_CumulativeRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable" xlink:href="aqst-20240930.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CumulativeRoyaltyReceivable" xlink:to="lab_aqst_CumulativeRoyaltyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_42b15e04-8079-4f4e-bdfd-e9e08fe9a0ea_terseLabel_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of guaranteed royalty payments</link:label>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_label_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Guaranteed Royalty Payments</link:label>
    <link:label id="lab_aqst_NumberOfGuaranteedRoyaltyPayments_documentation_en-US" xlink:label="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Guaranteed Royalty Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:href="aqst-20240930.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:to="lab_aqst_NumberOfGuaranteedRoyaltyPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_90a44442-c81e-4c95-b236-063e0601482a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9206761d-853c-4c0e-9754-772c0ff49de7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_ff98439b-2f6c-48dd-8aa8-c994c38603a9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_4bcd8319-084b-4524-85e3-5f70a649f14c_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Obligation Activity</link:label>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_label_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligation Activity [Table Text Block]</link:label>
    <link:label id="lab_aqst_RoyaltyObligationActivityTableTextBlock_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligation Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationActivityTableTextBlock" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationActivityTableTextBlock" xlink:to="lab_aqst_RoyaltyObligationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_9824b38a-9a54-4b7f-9645-d039a5eff549_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4b03c53d-11bb-4ba6-99a4-0d3a9ca8e0f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_52d9f09b-b3e5-441d-9fd8-2813e285872c_verboseLabel_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Public Equity Offering - ATM</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_c35872c5-b016-41cb-8c25-853930d0f8db_terseLabel_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">At-the-market offering</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_label_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">At The Market Offering [Member]</link:label>
    <link:label id="lab_aqst_AtTheMarketOfferingMember_documentation_en-US" xlink:label="lab_aqst_AtTheMarketOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">At The Market Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtTheMarketOfferingMember" xlink:to="lab_aqst_AtTheMarketOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_24152ab5-3cdf-4980-9f3c-f53a9a6083c8_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_19211719-d0f7-4023-a6c2-c1720394fb52_terseLabel_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer, network equipment and software</link:label>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_label_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer, Network Equipment and Software [Member]</link:label>
    <link:label id="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember_documentation_en-US" xlink:label="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assets which are related to computer, network equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:href="aqst-20240930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:to="lab_aqst_ComputerNetworkEquipmentAndSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_24b1d8f7-46e1-4614-b75b-9921874007c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested restricted stock units, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_c1021f1a-48fc-46fc-a3a3-93ee9dc02dc7_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligation, percent of net sales</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_label_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:to="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_05838837-7576-4215-ad38-2b2656559f4a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments &#8211; Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_54d3a0be-6009-4c6e-a767-e4f8ac07ed53_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of stock options, net</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_967d83df-2f6e-448d-927b-d8ba685669b2_terseLabel_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028 and thereafter</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_label_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</link:label>
    <link:label id="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_documentation_en-US" xlink:label="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:href="aqst-20240930.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:to="lab_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9ffa06b5-f08a-459b-80d5-0830bab4f9fd_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-Use Assets and Lease Obligations</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_3f2b93b3-9759-4431-879e-8ac95190485b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ElectiveRedemptionPercentageOfDebt_9da8747c-68b6-4ac2-a44d-cd15d26ec717_terseLabel_en-US" xlink:label="lab_aqst_ElectiveRedemptionPercentageOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elective redemption percentage of debt</link:label>
    <link:label id="lab_aqst_ElectiveRedemptionPercentageOfDebt_label_en-US" xlink:label="lab_aqst_ElectiveRedemptionPercentageOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Elective Redemption Percentage Of Debt</link:label>
    <link:label id="lab_aqst_ElectiveRedemptionPercentageOfDebt_documentation_en-US" xlink:label="lab_aqst_ElectiveRedemptionPercentageOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Elective redemption percentage of debt.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ElectiveRedemptionPercentageOfDebt" xlink:href="aqst-20240930.xsd#aqst_ElectiveRedemptionPercentageOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ElectiveRedemptionPercentageOfDebt" xlink:to="lab_aqst_ElectiveRedemptionPercentageOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_590844cf-ee09-49e9-a63c-2d104f1fa70f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:to="lab_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_8bef18d1-5253-4a91-8be8-efe4ec15653b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PreFundedWarrantsMember_cf0dfacf-857e-4416-a5d1-2a353087dec8_terseLabel_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:label id="lab_aqst_PreFundedWarrantsMember_label_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants [Member]</link:label>
    <link:label id="lab_aqst_PreFundedWarrantsMember_documentation_en-US" xlink:label="lab_aqst_PreFundedWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember" xlink:href="aqst-20240930.xsd#aqst_PreFundedWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PreFundedWarrantsMember" xlink:to="lab_aqst_PreFundedWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_7e4f4d04-4733-4768-a563-53452bb138fd_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on disposition of intangible assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:to="lab_us-gaap_GainLossOnDispositionOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_0182ed8a-455c-4af1-a9a8-680229983a86_terseLabel_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_label_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering [Member]</link:label>
    <link:label id="lab_aqst_UnderwrittenPublicOfferingMember_documentation_en-US" xlink:label="lab_aqst_UnderwrittenPublicOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Underwritten Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember" xlink:href="aqst-20240930.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_UnderwrittenPublicOfferingMember" xlink:to="lab_aqst_UnderwrittenPublicOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_651a300d-2e7f-44e1-8939-3cdf7fe0e4bd_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMeasurementInput_fadc6124-4f36-477c-924f-a1fee90b9119_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement input</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMeasurementInput_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMeasurementInput" xlink:to="lab_us-gaap_LongTermDebtMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_2d1ac14e-9bd3-4a0c-8dea-c11f2d88e3e3_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_e7e22fe8-b8f0-4b8e-bbea-7b85a51d2381_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of cases pending</link:label>
    <link:label id="lab_us-gaap_LossContingencyPendingClaimsNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Pending Claims, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyPendingClaimsNumber" xlink:to="lab_us-gaap_LossContingencyPendingClaimsNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_b41e0cf3-beb2-465b-a8f9-7e048e6276eb_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="lab_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_b1b03b75-08b7-4d9b-863d-5013e8889bac_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, current</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_70d17281-e855-4c74-8db7-4f0e5fa34d98_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_478925d4-2e0d-44c8-b131-e0f5d01b6952_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_acdcbe7d-0c79-42b1-9d97-8e43044b2d65_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_IndiviorMember_cff8da07-e910-44fb-abed-5f05cfda3aa7_terseLabel_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indivior</link:label>
    <link:label id="lab_aqst_IndiviorMember_label_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indivior [Member]</link:label>
    <link:label id="lab_aqst_IndiviorMember_documentation_en-US" xlink:label="lab_aqst_IndiviorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indivior</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember" xlink:href="aqst-20240930.xsd#aqst_IndiviorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_IndiviorMember" xlink:to="lab_aqst_IndiviorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7535d899-6b08-4ebc-9b9a-59d7f0c1a942_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_179e26d3-db72-4d6b-8a07-a499652a74c0_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_c923b2e6-e342-46d6-ad27-b167c25b3d5e_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeFiveMember_97cd7d93-f2e5-44c3-8861-fe7347f32b3c_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Five</link:label>
    <link:label id="lab_aqst_VestingConditionRangeFiveMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Five [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeFiveMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeFiveMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFiveMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeFiveMember" xlink:to="lab_aqst_VestingConditionRangeFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_ff82c6d2-7759-4348-904f-4f9f27b15632_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_2f517176-e3f2-44de-a732-79a140df9c2a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, gross</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_9b3a2037-f058-4222-8431-d961ec18a49a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0ec85d9f-f141-424d-a7b3-34ce79ed18d7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_48e4a005-4b54-40ce-9270-e3a3c8d7e2f3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_361592db-be05-4eac-b62f-3737fd6cdade_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_103d5bb8-7b5d-4b54-adeb-25e2200fa6ee_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PatentsMember_7f099a04-976e-4ba7-bf67-02135a09b503_terseLabel_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchased patent</link:label>
    <link:label id="lab_us-gaap_PatentsMember_label_en-US" xlink:label="lab_us-gaap_PatentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Patents [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PatentsMember" xlink:to="lab_us-gaap_PatentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_c3c1bbfb-2134-49ad-aeea-3ae19de89ba8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consideration received on sale of stock</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_fff3effb-bc46-4452-b79d-28899ce5942c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_ac93ba95-f5eb-4475-9d38-6854cf1cb7b3_periodStartLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net at beginning of the period</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_60c3d52b-f07d-4b83-98b2-e26a7480a010_periodEndLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_label_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyalties_documentation_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:to="lab_aqst_LiabilitiesSaleOfFutureRoyalties" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PremiumsPaidEarlyRetirementOfDebt_2b5d26dd-ea67-45d8-8e9c-409e3ea0469f_terseLabel_en-US" xlink:label="lab_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Premium on early retirement of debt</link:label>
    <link:label id="lab_aqst_PremiumsPaidEarlyRetirementOfDebt_label_en-US" xlink:label="lab_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Premiums Paid, Early Retirement of Debt</link:label>
    <link:label id="lab_aqst_PremiumsPaidEarlyRetirementOfDebt_documentation_en-US" xlink:label="lab_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Premiums Paid, Early Retirement of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:href="aqst-20240930.xsd#aqst_PremiumsPaidEarlyRetirementOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:to="lab_aqst_PremiumsPaidEarlyRetirementOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_a633287e-fa45-48df-8fdf-05e4feb54291_terseLabel_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Axis]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_label_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Axis]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioAxis_documentation_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis" xlink:to="lab_aqst_DebtCovenantRedemptionScenarioAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_16a75d20-5fc8-47b5-b247-5d9a31c2b0be_terseLabel_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Real estate and personal property taxes</link:label>
    <link:label id="lab_us-gaap_TaxesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_TaxesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Taxes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxesPayableCurrent" xlink:to="lab_us-gaap_TaxesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_45bd8b65-e154-4619-ab9d-e82cc02001af_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityOther_f09c2e60-10f8-4de1-abd8-481674f662c5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityOther_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityOther" xlink:to="lab_us-gaap_StockholdersEquityOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_ea3123f3-d82b-4df6-b142-0e100874dc71_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_9ec091cf-6ae0-4ccc-9c24-85f5514bf66e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_7fdd5fee-24d7-4a41-8f3e-b46b13f571da_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_5e9e4ab9-7d6e-4c74-9f33-89369818a7ea_terseLabel_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of annual royalty payments receivable</link:label>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_label_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Annual Royalty Payments Receivable</link:label>
    <link:label id="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_documentation_en-US" xlink:label="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:href="aqst-20240930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:to="lab_aqst_NumberOfAnnualRoyaltyPaymentsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_d6d82565-c96e-4683-bf64-95ef66b6496e_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentNumberOfNoteholders_04608d43-2767-4791-9455-ed3057ad7494_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfNoteholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of noteholders</link:label>
    <link:label id="lab_aqst_DebtInstrumentNumberOfNoteholders_label_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfNoteholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Noteholders</link:label>
    <link:label id="lab_aqst_DebtInstrumentNumberOfNoteholders_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfNoteholders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Noteholders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfNoteholders" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfNoteholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentNumberOfNoteholders" xlink:to="lab_aqst_DebtInstrumentNumberOfNoteholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_d4cc2577-8640-4619-b4fc-1e4b107092db_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total costs and expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_ea40b5c9-2ca6-435d-b29d-d86924524129_terseLabel_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued to purchase common stock (in shares)</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_label_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class Of Warrant Or Right Warrants Issued During Period</link:label>
    <link:label id="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_documentation_en-US" xlink:label="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The number of warrants issued during the period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:to="lab_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_a973173a-fc0a-427a-a77e-ce023e654052_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_bb22b462-1a68-4872-8e76-107c0e46d720_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_07717f64-7525-4904-ae2d-4312ea38a83e_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_c77f6d03-9d05-4ba6-98df-75c0d3cac68b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_6c645027-2093-4980-b485-26e7144c4841_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ABLFacilityMember_7ece307e-de1f-42ec-833c-efb53125eee8_terseLabel_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ABL Facility</link:label>
    <link:label id="lab_aqst_ABLFacilityMember_label_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ABL Facility [Member]</link:label>
    <link:label id="lab_aqst_ABLFacilityMember_documentation_en-US" xlink:label="lab_aqst_ABLFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">ABL Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember" xlink:href="aqst-20240930.xsd#aqst_ABLFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ABLFacilityMember" xlink:to="lab_aqst_ABLFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_bebb5ab3-b496-4704-94a4-b4c8546f41d2_terseLabel_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Automatic renewal period of agreement</link:label>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_label_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Automatic Renewal Period of Agreement</link:label>
    <link:label id="lab_aqst_AutomaticRenewalPeriodOfAgreement_documentation_en-US" xlink:label="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Period for which the agreement is renewed automatically.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement" xlink:href="aqst-20240930.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AutomaticRenewalPeriodOfAgreement" xlink:to="lab_aqst_AutomaticRenewalPeriodOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_010b02d4-6936-47a2-94b8-2158809d9fb5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_63e4e4ab-e88d-4f4e-a70a-dad5c0522161_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_35570c6a-23d4-4995-b1b9-32ba9d716cda_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Other Non-current Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets, Noncurrent [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_aa6d684b-ec28-4265-9c1e-b09cc33a9152_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_42063b37-b0fc-40c6-b67b-7fddd3f27231_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_4fc3607b-b333-4a78-997b-033bb3a4c637_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_6a3cefa6-dc91-4644-b61c-1f2c90d72773_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_47d9d569-69ff-4b62-b66b-799d39a25548_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_deb93145-ef2f-47ab-a12e-6206d46be3f8_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3cbca42e-1193-4d68-8ee7-5b8fde58e288_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_f1a50e66-c8d6-4c6e-879e-0a17e5453bf2_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems" xlink:to="lab_us-gaap_ClassOfWarrantOrRightLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InitialWarrantOfferingMember_bddf7867-aaaa-439f-af18-f7655815b532_terseLabel_en-US" xlink:label="lab_aqst_InitialWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial Warrant Offering</link:label>
    <link:label id="lab_aqst_InitialWarrantOfferingMember_label_en-US" xlink:label="lab_aqst_InitialWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Initial Warrant Offering [Member]</link:label>
    <link:label id="lab_aqst_InitialWarrantOfferingMember_documentation_en-US" xlink:label="lab_aqst_InitialWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Initial Warrant Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InitialWarrantOfferingMember" xlink:href="aqst-20240930.xsd#aqst_InitialWarrantOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InitialWarrantOfferingMember" xlink:to="lab_aqst_InitialWarrantOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_729feee9-1911-4ba7-b3b2-adaac085d05c_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_725ec450-3538-4d84-88db-949549a664ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_666cc6a3-5eba-4630-a431-28631b791feb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_a576a6ec-bb28-49e8-8ae8-4f4262da6f9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts and Financing Receivables [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3b43de5e-7a2f-44b3-b83f-47b4ea043ea0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_0eee28d3-7e9c-454e-a6e9-b6be0da91d07_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued distribution expenses and sales returns provision</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_c7242ede-ce4c-4fab-a6eb-20c985219844_negatedLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_7a7b07eb-ebc0-4462-beb7-637b2d1a64ec_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts at beginning of the period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_04e917b5-0c99-4c03-aa68-f737d8a38f07_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Allowance for doubtful accounts at end of the period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_fd031481-b7ba-4f3f-935b-bf7be0ab1737_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for taxes on share-based compensation</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment, Tax Withholding, Share-Based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_64f98308-0afd-420c-9a96-a4498482272c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_d9ec4834-869c-4dd5-853c-08857d8ebdfe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation expenses [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_088495fb-c6ea-4e78-ac55-3d9139393129_terseLabel_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial exploitation agreement with Indivior</link:label>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_label_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Exploitation Agreement with Indivior [Member]</link:label>
    <link:label id="lab_aqst_CommercialExploitationAgreementWithIndiviorMember_documentation_en-US" xlink:label="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The commercial exploitation agreement with Indivior.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:href="aqst-20240930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:to="lab_aqst_CommercialExploitationAgreementWithIndiviorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_08f22bfc-7de2-4edf-a074-fe7db0dd69e4_terseLabel_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement</link:label>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_label_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement [Member]</link:label>
    <link:label id="lab_aqst_AmendedEquityDistributionAgreementMember_documentation_en-US" xlink:label="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amended Equity Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember" xlink:href="aqst-20240930.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AmendedEquityDistributionAgreementMember" xlink:to="lab_aqst_AmendedEquityDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_a28bf71f-22bd-4fd6-a394-80a8b8d557de_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_813b7e6f-34fd-420e-8269-c30e74233138_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_969b5bfd-90cd-43ce-9199-2bd98ca003dd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_827c0530-b4cf-466f-b66e-00f4651fc749_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_34bb7af7-e8bc-48ca-b087-2e77f7f2f697_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_911bc440-0e40-4591-92c3-66859bd998b6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_f8997e67-537b-43fa-9669-ede42a98a91f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_3cc8378d-877a-4d53-bd7c-d6614852282a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive (loss) income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_fd12f546-3924-4ba6-a5cd-b481020302a3_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants on common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_fdfdde14-99ce-4065-8d9e-2d5e833211fe_terseLabel_en-US" xlink:label="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of commercialized products</link:label>
    <link:label id="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_label_en-US" xlink:label="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue From Contract With Customer, Number Of Commercialized Products</link:label>
    <link:label id="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_documentation_en-US" xlink:label="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue From Contract With Customer, Number Of Commercialized Products</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:href="aqst-20240930.xsd#aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:to="lab_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0a0aca5b-4fc1-41e9-a7cc-e22788658980_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_bcba9788-c762-4aef-910f-85a3a0a23540_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_943ebe4a-4b3e-466f-87ce-3f7539343848_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c29d9f2d-4d26-4385-8cde-5ccfaf27e424_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Units</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_1a779ede-5ad7-41ba-9ea1-50526912afeb_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_ad69d4bb-a47e-4cd0-8b06-aef756208aee_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_5f5a9808-e0e5-4c99-871f-ddb9269a7aa7_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retirement of debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_725147f7-6f15-48ec-89d3-96bdb99051b2_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_692d518c-575e-4b4c-8ddd-703b8c18ca23_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Miscellaneous, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:to="lab_us-gaap_OtherAssetsMiscellaneousNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_7cd65225-e465-44ad-947a-fb65e08da57d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_dbc5b03e-f898-47c9-988d-2df537bdb361_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b5afca4e-6127-4ae0-b6f5-37674498abc5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_bb8df6d0-9080-4036-b29f-a57ad69f9c97_terseLabel_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, accordion feature, net revenue threshold</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_label_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Net Revenue Threshold</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_documentation_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Net Revenue Threshold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:to="lab_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_1797cabf-b50a-42de-b9d8-117e5aaf5d52_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e9ade401-a07d-4798-8d5c-a024b512fa71_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_9e6d59dd-01de-4b9d-8db9-5956a9fbb20a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RedemptionScenario1Member_8c04e5d1-61d3-4be8-9f65-ed9f6714a58d_terseLabel_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1</link:label>
    <link:label id="lab_aqst_RedemptionScenario1Member_label_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1 [Member]</link:label>
    <link:label id="lab_aqst_RedemptionScenario1Member_documentation_en-US" xlink:label="lab_aqst_RedemptionScenario1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption Scenario 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RedemptionScenario1Member" xlink:to="lab_aqst_RedemptionScenario1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_4c9c3f6e-d931-4b96-aec3-c79c3f937aa1_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_be02b944-2f5a-4fc4-94a6-05588b8a7637_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units Awards</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_8fa41d36-b933-42f5-89b1-7c055a2f575f_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligation, term</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_label_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage, Term</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Tiered Royalty Percentage, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:to="lab_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_7c8e1141-3a16-4a52-8051-50c3f6f042f7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentrations of risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_de7e376d-a269-46c3-b298-983424e8792b_terseLabel_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License and royalty revenue</link:label>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_label_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License and Royalty Revenue [Member]</link:label>
    <link:label id="lab_aqst_LicenseAndRoyaltyRevenueMember_documentation_en-US" xlink:label="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from licensing and royalties.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember" xlink:href="aqst-20240930.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAndRoyaltyRevenueMember" xlink:to="lab_aqst_LicenseAndRoyaltyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_1d1fb271-5731-4f68-9c60-29e8beaee984_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in Allowance for Bad Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_e54b37a3-77a4-47d5-93d9-c968d9dedd27_terseLabel_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, net</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_label_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</link:label>
    <link:label id="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_documentation_en-US" xlink:label="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:href="aqst-20240930.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:to="lab_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_257d9827-aaa6-4a4f-916b-bdab8fe02b46_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_eb52b31c-a5e1-4e6e-90bc-8dadebc33ca1_terseLabel_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply revenue</link:label>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_label_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacture and Supply Revenue [Member]</link:label>
    <link:label id="lab_aqst_ManufactureAndSupplyRevenueMember_documentation_en-US" xlink:label="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from manufacture and supply.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember" xlink:href="aqst-20240930.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ManufactureAndSupplyRevenueMember" xlink:to="lab_aqst_ManufactureAndSupplyRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AgreementTerm_8c5efd42-9057-4b2d-8aa2-04d04fe5d099_terseLabel_en-US" xlink:label="lab_aqst_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Agreement term</link:label>
    <link:label id="lab_aqst_AgreementTerm_label_en-US" xlink:label="lab_aqst_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Agreement Term</link:label>
    <link:label id="lab_aqst_AgreementTerm_documentation_en-US" xlink:label="lab_aqst_AgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Agreement Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AgreementTerm" xlink:href="aqst-20240930.xsd#aqst_AgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AgreementTerm" xlink:to="lab_aqst_AgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_126b0301-7c9d-4f62-a127-d43926cf34f1_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_9bd02cb4-a760-48fe-bd21-022980acd37c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercises, net (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_683fce68-9cd3-4bdb-965c-5c2fa41e0f1b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_c620b8b1-f781-4888-bf38-5f5023f2ff41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA-BC_0fc53c70-7d5f-435e-8cee-929829c6845a_terseLabel_en-US" xlink:label="lab_stpr_CA-BC" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BRITISH COLUMBIA</link:label>
    <link:label id="lab_stpr_CA-BC_label_en-US" xlink:label="lab_stpr_CA-BC" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BRITISH COLUMBIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA-BC"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA-BC" xlink:to="lab_stpr_CA-BC" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_89a7a47d-8344-4c46-aebe-a2aa1cf30786_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_29496c87-5d72-43b9-8d36-52415808a2f9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_a1ff7eed-30d3-43cb-9f12-30e5141f314b_terseLabel_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Doubtful Accounts</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_label_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Doubtful Accounts [Member]</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember_documentation_en-US" xlink:label="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Doubtful Accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:to="lab_aqst_TradeAccountsReceivableDoubtfulAccountsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_0af71bbd-83da-4882-b162-45c01ae7a0e6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_135c4302-28f5-4710-a3a0-3caef0d70253_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightTable_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable" xlink:to="lab_us-gaap_ClassOfWarrantOrRightTable" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_d84c92c8-2971-41be-a6b3-ddeec6b17e48_terseLabel_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">13.5% Senior Secured Notes due November 1, 2028</link:label>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_label_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Secured Notes, 13.5% due November 1, 2028 [Member]</link:label>
    <link:label id="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member_documentation_en-US" xlink:label="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Secured Notes, 13.5% due November 1, 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:to="lab_aqst_SeniorSecuredNotes13.5DueNovember12028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5df0fbdd-c90a-40c6-a937-05219518a208_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_15700d5f-0cef-447e-912f-4a1676106542_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_64d10ed1-d0e3-4b8c-856d-2de2de558bf6_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares - diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_33361ec6-44a9-4e60-990a-30c793b29dc0_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_d8fc1618-6501-4d05-99b1-d8007e6b193b_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_08d4492e-63da-4e53-900a-2907e6526cb0_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_552f72d5-d303-4ef9-a1b6-a39578b40008_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_64d5d919-574a-4bfc-8d78-7fbb4192836d_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_24081ddb-c9f7-430d-b73b-c124d6955208_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_a1215d58-616f-4c44-8278-1ecb8bd12157_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_e67c65d1-03af-4ef6-b122-47723870c845_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_e85980c5-531c-4cce-b44b-a70e7adad150_terseLabel_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan</link:label>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_label_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan [Member]</link:label>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_documentation_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:to="lab_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_4a871d9f-8f55-4ebc-bd3a-ba5a56e1f71d_terseLabel_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development, project duration</link:label>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_label_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development, Project Duration</link:label>
    <link:label id="lab_aqst_ResearchAndDevelopmentProjectDuration_documentation_en-US" xlink:label="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research and Development, Project Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration" xlink:href="aqst-20240930.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ResearchAndDevelopmentProjectDuration" xlink:to="lab_aqst_ResearchAndDevelopmentProjectDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_f59baaf9-e119-45e1-9881-c47755987c7d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_7598e088-c60b-48a9-8d58-e44b39f1cad4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_49a1affa-3818-48b9-b571-cdc4a7cb1eb9_negatedTerseLabel_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense related to the sale of future revenue</link:label>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_label_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Sale of Future Revenues</link:label>
    <link:label id="lab_aqst_InterestExpenseSaleOfFutureRevenues_documentation_en-US" xlink:label="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Interest Expense, Sale of Future Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues" xlink:href="aqst-20240930.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InterestExpenseSaleOfFutureRevenues" xlink:to="lab_aqst_InterestExpenseSaleOfFutureRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_c813b71a-6855-4059-8922-0f1f32290b48_terseLabel_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_label_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Reclassifications</link:label>
    <link:label id="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_documentation_en-US" xlink:label="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Reclassifications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:href="aqst-20240930.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:to="lab_aqst_AccountsReceivableAllowanceForCreditLossReclassifications" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_526f0fd3-d5ac-4671-8f26-f91c5e4b8e86_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_41ec2c3b-9628-47be-b475-ad6546f60fc5_terseLabel_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum annual royalty receivable</link:label>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_label_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum Annual Royalty Receivable</link:label>
    <link:label id="lab_aqst_MinimumAnnualRoyaltyReceivable_documentation_en-US" xlink:label="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable" xlink:href="aqst-20240930.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MinimumAnnualRoyaltyReceivable" xlink:to="lab_aqst_MinimumAnnualRoyaltyReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_9383afd8-313d-43af-a178-dbbade9ed1ab_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_1688e11d-f4c9-438b-8bbb-0270bac62a05_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_e2fcd39c-114d-4737-b940-fe63abab3326_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_93982aa2-6aa9-41c9-baf5-fd7879aedd98_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total outstanding notes</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_0c6d6554-fff1-4f5e-97a9-8ddf2361808b_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_c53a3aec-0af2-4fa6-a134-3f55dc32ff53_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_b2935842-214f-4415-ba23-2f9aeb7121e8_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_bae411a1-56f0-4e13-bfa3-d28d3ac3dc72_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of share-based payment arrangements (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_5872b686-fdd3-4a52-a87e-751d532941b3_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_3bb98d52-6ba2-4fbb-a733-daaa3bd2cc75_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from warrant exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_44429121-b677-4e8b-8456-65af204199b5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_cc7aa6f8-4741-4909-83a4-c79ddd0f940a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_60126db7-a75e-415e-81c5-e64a162fb1c8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective annual interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_0a625221-0c7e-471b-b265-f67b17ec476a_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain (loss) on derivative instruments, net, pretax</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_bcebd82a-a591-4b77-b7bd-31c16d68f327_terseLabel_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement</link:label>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_label_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement [Member]</link:label>
    <link:label id="lab_aqst_LicenseSupplyAgreementMember_documentation_en-US" xlink:label="lab_aqst_LicenseSupplyAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License &amp; Supply Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember" xlink:href="aqst-20240930.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseSupplyAgreementMember" xlink:to="lab_aqst_LicenseSupplyAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_de1ddaa7-ff58-4562-9056-cbb338b0c55f_terseLabel_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_label_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Disclosure [Text Block]</link:label>
    <link:label id="lab_aqst_WarrantsDisclosureTextBlock_documentation_en-US" xlink:label="lab_aqst_WarrantsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The entire disclosure for warrants.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantsDisclosureTextBlock" xlink:href="aqst-20240930.xsd#aqst_WarrantsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_WarrantsDisclosureTextBlock" xlink:to="lab_aqst_WarrantsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_97d9a857-ac6e-4f77-84b0-ef4593db4526_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_430e4e57-c230-44c8-b818-3d8ebdb96425_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Periodic payment, principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Periodic Payment, Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPaymentPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_015fd866-47be-40ae-91d1-b89dff881f0a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_6d9cc4a2-d923-4eec-93ad-8b0a77cd8b7f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_9b65bbc6-ac40-48e1-998e-868cac4fb8e1_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_adf1032f-4bf5-4c9d-bd53-4c0caaac9ba8_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract liabilities</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SupplementalAgreementWithIndiviorMember_ea457039-5b67-4adb-85d8-d4cb78b7f339_terseLabel_en-US" xlink:label="lab_aqst_SupplementalAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental agreement with Indivior</link:label>
    <link:label id="lab_aqst_SupplementalAgreementWithIndiviorMember_label_en-US" xlink:label="lab_aqst_SupplementalAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Agreement with Indivior [Member]</link:label>
    <link:label id="lab_aqst_SupplementalAgreementWithIndiviorMember_documentation_en-US" xlink:label="lab_aqst_SupplementalAgreementWithIndiviorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The supplemental commercial exploitation agreement with Indivior.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SupplementalAgreementWithIndiviorMember" xlink:href="aqst-20240930.xsd#aqst_SupplementalAgreementWithIndiviorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SupplementalAgreementWithIndiviorMember" xlink:to="lab_aqst_SupplementalAgreementWithIndiviorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_442de9bb-7958-4682-a48c-20f2365c3231_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Repayment of debt principal including lease liabilities</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_454ce463-afc7-4d46-92f1-d5a10320bbfe_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for loan acquisition costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_49f3f329-cd60-4772-af5b-90d3b02584b7_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_aa7cd0dd-dfdf-4c15-9912-bcd2406538e6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_ec1d7c08-4b31-4672-9f73-d0e02f9e98a7_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1ff1bb30-6e51-4a8d-ba60-d2727285ecf9_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_ce0c98c8-353a-4dd7-887d-44fdbb686778_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ex-United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_2afa5cfe-5509-4fe2-a942-88a3c2d318ea_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense related to royalty obligations</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_bc6ba6b3-56e8-4144-b3c2-eb8de17ac684_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_1ecfcb82-8c37-4a56-9d9d-04f000e45a2a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_3b969b57-4300-4abe-895e-1ab46546c893_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount, including exit fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_ad3a54b8-81b2-4cee-be22-95713829d803_negatedLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount, including Exit Fee</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_f1192b12-74f3-43e0-890c-7aba3e429bed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_219df939-f862-4b70-869a-82c733ba8298_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_a416cc44-ce26-4314-8c36-1771d760ad91_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4ea9b473-ddb8-4023-bea3-0c73cb41d47d_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_8c223c7f-db17-4ab0-9da0-01b7cb464770_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Average closing prices period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_657cc386-a3e0-4e4b-b1df-89c5254d6ee9_terseLabel_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Roll Forward]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_label_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Roll Forward]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueRollForward_documentation_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward" xlink:href="aqst-20240930.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward" xlink:to="lab_aqst_SaleOfFutureRevenueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_d16bf706-6e14-49b9-90b8-88e57b4b8df0_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_2791c5cc-9329-4b38-b02f-4dc591adb155_verboseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_6f13b620-3c59-4c4e-a6be-caa841cad02f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of warrant or right, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_fc3da812-bc9c-4e62-9a44-c4cbea959db2_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_772ea889-a930-430d-b843-293d90d63fd5_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_40c850ed-5822-4c2e-9d48-090d2a5c5454_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss)/income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_547d6866-f7a3-490f-bfe3-7e82d0ebdd1a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RightToSellCommonStockValue_56413e7e-1f18-4d43-9110-80cfe27db98d_terseLabel_en-US" xlink:label="lab_aqst_RightToSellCommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right to sell common stock, value</link:label>
    <link:label id="lab_aqst_RightToSellCommonStockValue_label_en-US" xlink:label="lab_aqst_RightToSellCommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right to Sell Common Stock, Value</link:label>
    <link:label id="lab_aqst_RightToSellCommonStockValue_documentation_en-US" xlink:label="lab_aqst_RightToSellCommonStockValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Right to Sell Common Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RightToSellCommonStockValue" xlink:href="aqst-20240930.xsd#aqst_RightToSellCommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RightToSellCommonStockValue" xlink:to="lab_aqst_RightToSellCommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementTerm_3166252c-1649-4e70-9116-20a7e28162f0_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement term</link:label>
    <link:label id="lab_aqst_LicenseAgreementTerm_label_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement Term</link:label>
    <link:label id="lab_aqst_LicenseAgreementTerm_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">License agreement term period.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementTerm" xlink:to="lab_aqst_LicenseAgreementTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_7b47b336-2b17-4136-b387-38a07b7a2b41_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_cfec6182-4b12-4e2b-846e-bf821ec1daf3_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease expense</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_d37d92df-981e-4e3f-b8d7-f9110201d1a8_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_53068adb-5a21-4947-bd45-3d63455bcea8_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_77e2d98f-1f80-4b76-9ea4-696bbe1f0cd1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease, long-term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_7b202643-a33f-4b3b-bfd0-08e3d84e6d27_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and Other Receivables, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_c44e5ed8-abdd-4d4e-b491-1ce9abcd922a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RoyaltyObligationsMember_7abb7c56-6235-4b23-8642-f77346233f6c_terseLabel_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty Obligations</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsMember_label_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty Obligations [Member]</link:label>
    <link:label id="lab_aqst_RoyaltyObligationsMember_documentation_en-US" xlink:label="lab_aqst_RoyaltyObligationsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Royalty Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RoyaltyObligationsMember" xlink:to="lab_aqst_RoyaltyObligationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_4a3e346e-ea36-45f8-bfc6-f3e6490ad18d_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Note Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:to="lab_us-gaap_WarrantsAndRightsNoteDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_76041d6a-d2ba-4ed0-a015-c3d0e8f8d518_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_88e795a7-c6c8-42c0-907d-6964aaa710cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase price percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_aa0401d3-5a65-47a9-ac77-e294ebf6508b_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShortTermDebtLineItems_label_en-US" xlink:label="lab_us-gaap_ShortTermDebtLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermDebtLineItems" xlink:to="lab_us-gaap_ShortTermDebtLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_23081282-6aab-431a-bff6-c204fe2ba2f7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e4cd2b99-0411-4299-b02d-1a1300d4a04b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_50a84704-2488-41a7-98ca-2a87c6b53bf0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_8d616c7a-4c7e-42e6-8044-315615fa621b_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title and Position [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7fe2f6be-f9fb-4a81-ae4d-9944928e6248_negatedLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeRevenueRecognized_e9bf46dc-06c8-4439-893b-1e7a1990cedc_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income, revenue recognized</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeRevenueRecognized" xlink:to="lab_us-gaap_DeferredIncomeRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_d239486e-90d0-4a14-bb43-0ea6839a0ddc_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4fde3776-9db4-40b2-a59b-17980296c20b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition and Performance Obligations</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_43f7ebd6-8990-40d7-96e3-b1f3b7dc41d8_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_90d40927-1953-4478-b690-fde27c846b91_terseLabel_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MAM Pangolin Royalty , LLC</link:label>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_label_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marathon Pangolin Royalty LLC [Member]</link:label>
    <link:label id="lab_aqst_MarathonPangolinRoyaltyLLCMember_documentation_en-US" xlink:label="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Marathon Pangolin Royalty LLC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember" xlink:href="aqst-20240930.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarathonPangolinRoyaltyLLCMember" xlink:to="lab_aqst_MarathonPangolinRoyaltyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_ea0cdeb2-27b2-47b0-bb16-a826db019662_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting rights, percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_124df915-2eda-4909-a04c-5f4edd8792e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, redemption price, percentage of principal amount redeemed</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_e1bf2cd5-0649-47f4-bb31-ae280b4faf15_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_5197c3a7-65a2-485a-9889-2d344e04c034_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e1bf47da-4492-44a0-97fb-58bdf2c8249e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_bc1b04c1-047c-4426-a0fe-25fc593d8484_terseLabel_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses</link:label>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_label_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses [Member]</link:label>
    <link:label id="lab_aqst_OtherReceivablesAndAccruedExpensesMember_documentation_en-US" xlink:label="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Receivables And Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:href="aqst-20240930.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:to="lab_aqst_OtherReceivablesAndAccruedExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_23a528a8-e6c9-4b79-ad5a-61ac43e69ab9_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period Weighted Average Exercise Price</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Weighted average price of options that were either exercised, forfeited or expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cbc0f8f5-ec44-45be-a2ed-3286edc3555f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d6a4a603-a852-49dc-a7df-0d8dee02f8b3_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income taxes (benefit) expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_5ee2ea9b-4171-4c5d-913a-a64a94b804ac_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income/(expenses):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_39efdb15-bda2-442b-bbc9-2dc5d3a2a194_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc. upfront</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc. advance payments.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_e68a126a-13d8-4aa1-a031-b99d0dab409d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5b576c6c-2617-412c-b2ce-c960c02fd2a5_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_91e5e43e-f52d-46b7-b1a9-7cb2c98319cc_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0e9ded34-a1ba-404d-a334-06bb0c5ca0a0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation cost, recognition period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_9b7743c3-c628-4449-9cab-2ff30cb1c59d_terseLabel_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior secured notes due 2025</link:label>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_label_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]</link:label>
    <link:label id="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_documentation_en-US" xlink:label="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:to="lab_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b2e9b594-ecfd-45cb-abf7-14adf133b8b1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_89f8e324-063d-46a9-8c4d-5936a67c9741_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Royalties related to the sale of future revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_900704f8-870c-4def-a0be-fca9044208b3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NumberOfOperatingLeases_c869883b-c4bd-44af-a8ab-fa31fb15ba41_terseLabel_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of leases</link:label>
    <link:label id="lab_aqst_NumberOfOperatingLeases_label_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Leases</link:label>
    <link:label id="lab_aqst_NumberOfOperatingLeases_documentation_en-US" xlink:label="lab_aqst_NumberOfOperatingLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number of operating leases.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases" xlink:href="aqst-20240930.xsd#aqst_NumberOfOperatingLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NumberOfOperatingLeases" xlink:to="lab_aqst_NumberOfOperatingLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bacd818c-bf9a-484d-9624-c96423b791e3_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective income tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_7660512f-cab0-4d2d-9720-3852b2f10bf4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used for investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_81397a85-8f43-438a-9555-60a581483b34_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_1c4edda5-254f-417b-97a5-0e88cf9fc384_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from common stock issued under public equity offering</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Private Placement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfPrivatePlacement" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MarketBasedMember_239231d7-9610-4dc4-a7f5-eaedd7be5f74_terseLabel_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Based</link:label>
    <link:label id="lab_aqst_MarketBasedMember_label_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Market Based [Member]</link:label>
    <link:label id="lab_aqst_MarketBasedMember_documentation_en-US" xlink:label="lab_aqst_MarketBasedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Market Based</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember" xlink:href="aqst-20240930.xsd#aqst_MarketBasedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MarketBasedMember" xlink:to="lab_aqst_MarketBasedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LincolnParkAgreementMember_0ae66ca3-beff-42c3-9d66-4e5a8f58243a_terseLabel_en-US" xlink:label="lab_aqst_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lincoln Park agreement</link:label>
    <link:label id="lab_aqst_LincolnParkAgreementMember_label_en-US" xlink:label="lab_aqst_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lincoln Park Agreement [Member]</link:label>
    <link:label id="lab_aqst_LincolnParkAgreementMember_documentation_en-US" xlink:label="lab_aqst_LincolnParkAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lincoln Park Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementMember" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LincolnParkAgreementMember" xlink:to="lab_aqst_LincolnParkAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_81004594-fc29-4318-a7e9-eac03e19d5ae_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_6335b2c0-c4c0-4611-a2d4-dbf3efa54a14_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ebbfdc38-aec8-401d-a92c-6d3fc58b0ae9_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_0048e079-2220-47f9-9f3a-74a0336b7ba0_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_d1ec6fa1-6e58-4dbd-9a84-15082909b17c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="lab_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4496e69d-4d9a-4bde-be1a-13a3d54e9709_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionAxis_117dd70f-98a9-49d8-a73a-09797bff22e2_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Condition [Axis]</link:label>
    <link:label id="lab_aqst_VestingConditionAxis_label_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition [Axis]</link:label>
    <link:label id="lab_aqst_VestingConditionAxis_documentation_en-US" xlink:label="lab_aqst_VestingConditionAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis" xlink:href="aqst-20240930.xsd#aqst_VestingConditionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionAxis" xlink:to="lab_aqst_VestingConditionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2bfa15db-8ae2-4c88-809b-abdb2fdf25ea_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_6593aca0-368d-49b9-b639-f357b4dce490_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Maturity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Maturities of Long-Term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_18e123d6-7b24-423e-bb3d-212ad89554c4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_21392bd0-f418-430e-9097-8cb584803cc8_terseLabel_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_label_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related [Member]</link:label>
    <link:label id="lab_aqst_TradeAccountsReceivableSalesRelatedMember_documentation_en-US" xlink:label="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable, Sales Related</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:to="lab_aqst_TradeAccountsReceivableSalesRelatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e9e731fd-f723-478e-a5bd-ee81df8285b9_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_9ddd4f2e-0928-4169-9130-aad8740123f6_terseLabel_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_label_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:label id="lab_aqst_DebtCovenantRedemptionScenarioDomain_documentation_en-US" xlink:label="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Covenant, Redemption Scenario [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain" xlink:to="lab_aqst_DebtCovenantRedemptionScenarioDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_090648aa-9589-4f0b-b254-3736c2ae0eca_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_eccf8430-d656-401b-ba82-f3dba770ff80_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_085973b0-2de0-41d2-a265-e02f51632f76_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_065dd54d-e921-40c5-bc99-f43d77cc522e_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f1992e75-b5f3-4631-a2cf-d4d6320a1e05_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_40bc3c65-d295-4da6-9c9e-ab640d10ecde_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_1773d314-7801-402f-80e8-02e55444a5ed_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_cf6a3d61-1284-4edc-a68c-34c33269c0fa_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_0a4eb2f6-9631-408c-bebe-52e3fe289670_terseLabel_en-US" xlink:label="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notes payable, net</link:label>
    <link:label id="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes, Noncurrent And Finance Lease, Liability, Noncurrent</link:label>
    <link:label id="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_documentation_en-US" xlink:label="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Notes, Noncurrent And Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:href="aqst-20240930.xsd#aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:to="lab_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_638e5693-b30d-41b9-9945-5475804ef56b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Costs and expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_53dac54f-4451-4234-b94d-76efe342b09f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_9f232e14-2457-4102-9480-08d68eb3ad0b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeThreeMember_24c4bd95-7569-4827-9695-c557333c9415_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Three</link:label>
    <link:label id="lab_aqst_VestingConditionRangeThreeMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Three [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeThreeMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeThreeMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeThreeMember" xlink:to="lab_aqst_VestingConditionRangeThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_229caffd-a812-4962-98e0-dbceb133cc55_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested, at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_feaa62c1-3ded-4cc0-a4a2-483e8fd2f849_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested, at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9b4528e6-de23-4569-83f5-28d231644f9b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_16aec577-4f02-4d77-8233-56f0cd6df4a9_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and stockholders&#8217; deficit</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_TradeAndOtherReceivablesNet_80692732-95a7-4caa-a785-c1d6ac9cf7eb_terseLabel_en-US" xlink:label="lab_aqst_TradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_aqst_TradeAndOtherReceivablesNet_e4224abb-16c7-404b-96dd-29a43fc85fd8_totalLabel_en-US" xlink:label="lab_aqst_TradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_aqst_TradeAndOtherReceivablesNet_label_en-US" xlink:label="lab_aqst_TradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade And Other Receivables, Net</link:label>
    <link:label id="lab_aqst_TradeAndOtherReceivablesNet_documentation_en-US" xlink:label="lab_aqst_TradeAndOtherReceivablesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_TradeAndOtherReceivablesNet" xlink:to="lab_aqst_TradeAndOtherReceivablesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_32de676e-617d-487f-9df3-2eb7600a57c3_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Trade and other receivables, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts and Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c47cccc1-23a2-4412-b2ba-1d6350833289_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized deferred debt issuance cost and deferred debt discounts</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_e4659e0b-58bd-4b9d-ac2b-f1d5cb516ab7_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of plaintiffs</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_77290863-141b-4100-9357-151c84392931_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_897b79b5-1adb-4c5c-9390-af70a6c648fb_verboseLabel_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply</link:label>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_label_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufacturing And Supply [Member]</link:label>
    <link:label id="lab_aqst_ManufacturingAndSupplyMember_documentation_en-US" xlink:label="lab_aqst_ManufacturingAndSupplyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Primary financial statement caption encompassing Manufacturing and supply expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember" xlink:href="aqst-20240930.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ManufacturingAndSupplyMember" xlink:to="lab_aqst_ManufacturingAndSupplyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_e8392bcf-37c6-4164-a681-51febb8d9d6f_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_af5dbc48-4a2c-47ec-85b7-793d4687f69f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested or expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyMember_26855ec0-2d9f-4fd8-b5e7-5a261412f6f2_terseLabel_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty</link:label>
    <link:label id="lab_us-gaap_RoyaltyMember_label_en-US" xlink:label="lab_us-gaap_RoyaltyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Royalty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyMember" xlink:to="lab_us-gaap_RoyaltyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_e58708ca-eb5d-4d75-8efa-1c93b86d30fd_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_c1752c0e-02a5-4dbf-b148-379fb064c453_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_011be230-e794-4e82-8a6f-c4070bba3966_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_43a1e591-881d-4126-9d83-af553925a052_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_e4fa282f-a5e4-46ed-982a-70610151643c_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_43df2a99-6b76-49bf-a7c6-f90969cf55d8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_3399bbe1-9d81-484c-8fe9-6835460d8960_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Allowance expense (reduction)</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_806b0ac0-391b-4691-adf3-be843cc1bcef_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Allowance expense (reduction)</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_e39b89c8-e085-4a6e-8ee6-c91228960b3d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents:</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash and Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentNumberOfTransactions_d8b469b4-4400-49ca-b6b3-594843959717_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of transactions</link:label>
    <link:label id="lab_aqst_DebtInstrumentNumberOfTransactions_label_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Transactions</link:label>
    <link:label id="lab_aqst_DebtInstrumentNumberOfTransactions_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentNumberOfTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Number Of Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfTransactions" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentNumberOfTransactions" xlink:to="lab_aqst_DebtInstrumentNumberOfTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_909c4642-58de-4783-9733-d794b7be6a58_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_4d60da36-6760-46b5-93a8-f7395996f6f0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total outstanding notes</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_d62c988e-6596-4def-80db-652fc33be51d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligations</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_fb1f72a6-6998-4253-84ad-f2e5ca03ce49_terseLabel_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success</link:label>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_label_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success [Member]</link:label>
    <link:label id="lab_aqst_MeasurementInputProbabilityOfSuccessMember_documentation_en-US" xlink:label="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Measurement Input, Probability Of Success</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:href="aqst-20240930.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:to="lab_aqst_MeasurementInputProbabilityOfSuccessMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_8d5f9854-af20-4852-8b8b-63d66fd7b3d3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (Loss) Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_174bb6ba-872b-4581-8b7d-e1e98b83587f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_24bd66f3-dfe4-4945-b94a-1f2afcef19e5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAccountsReceivableMember_f83aa11e-543f-483a-b1ec-cc4a69857f7e_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_TradeAccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_TradeAccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trade Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAccountsReceivableMember" xlink:to="lab_us-gaap_TradeAccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_578f71bf-9bc1-498a-94d9-f98fea2296f1_terseLabel_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_label_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue [Text Block]</link:label>
    <link:label id="lab_aqst_SaleOfFutureRevenueTextBlock_documentation_en-US" xlink:label="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Future Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueTextBlock" xlink:href="aqst-20240930.xsd#aqst_SaleOfFutureRevenueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfFutureRevenueTextBlock" xlink:to="lab_aqst_SaleOfFutureRevenueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3a995b29-37bc-4b42-9bab-04ea799e5409_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options exercised, net</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_5c81ff74-6e1f-4810-85f8-d00fc6f8543b_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_7bfdc53f-2ce3-4bd3-bf59-464f357b5d7a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; deficit:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_9770321b-8802-483b-86bd-4d0dcc731a48_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_2039af62-12d7-41ab-83c6-f9ffc7e39c49_terseLabel_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Packaging material</link:label>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_label_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Packing Material Gross</link:label>
    <link:label id="lab_aqst_InventoryPackingMaterialGross_documentation_en-US" xlink:label="lab_aqst_InventoryPackingMaterialGross" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross" xlink:href="aqst-20240930.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InventoryPackingMaterialGross" xlink:to="lab_aqst_InventoryPackingMaterialGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_ee726ffe-15c4-4d6c-8d0c-d8bd1dcb596f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, Other Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_539e4776-3a44-4805-b667-845215102424_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated discount rate</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseDiscountRate_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:to="lab_us-gaap_LesseeOperatingLeaseDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_d320ec0c-777d-4e7e-b3c7-c6376f727f7d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_9a769cb8-64ed-41d6-a099-9085a867c04b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_2cf7f2f6-2cba-4cf5-9f9a-9c223f9ef4ea_terseLabel_en-US" xlink:label="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Haisco Pharmaceutical Group Co., Ltd, upfront payment</link:label>
    <link:label id="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_label_en-US" xlink:label="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Haisco Pharmaceutical Group Co., Ltd, Upfront Payment [Member]</link:label>
    <link:label id="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_documentation_en-US" xlink:label="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Haisco Pharmaceutical Group Co., Ltd, Upfront Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:href="aqst-20240930.xsd#aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:to="lab_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6ec15f72-60e6-4468-ad13-7d0b88e9e92c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NewWarrantsMember_549488e3-9080-41f7-9e25-d78e857cb352_terseLabel_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Warrants</link:label>
    <link:label id="lab_aqst_NewWarrantsMember_label_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Warrants [Member]</link:label>
    <link:label id="lab_aqst_NewWarrantsMember_documentation_en-US" xlink:label="lab_aqst_NewWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">New Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember" xlink:href="aqst-20240930.xsd#aqst_NewWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NewWarrantsMember" xlink:to="lab_aqst_NewWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_fa172b89-ee04-4bcf-8933-9c8affdc792e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_e4be07e2-e29b-4ac0-9d0c-7d0b2cef2452_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs of RSU awards</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0858b373-94a5-4d61-9515-0cac7cef9fb9_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2024</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_0ebaf59d-a795-401e-b9a6-9e9d4db2aff3_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Royalty obligations, net</link:label>
    <link:label id="lab_us-gaap_UnsecuredLongTermDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Long-Term Debt, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredLongTermDebt" xlink:to="lab_us-gaap_UnsecuredLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeSixMember_e68f376d-59c8-41ca-b50e-32888c1f4bde_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Six</link:label>
    <link:label id="lab_aqst_VestingConditionRangeSixMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Six [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeSixMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeSixMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Six</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSixMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeSixMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeSixMember" xlink:to="lab_aqst_VestingConditionRangeSixMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeFourMember_a0defac4-7e51-4b87-a1a5-feee1705c343_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Four</link:label>
    <link:label id="lab_aqst_VestingConditionRangeFourMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Four [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeFourMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeFourMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFourMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeFourMember" xlink:to="lab_aqst_VestingConditionRangeFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_e417dd5a-615f-499f-af81-1ae294f71dc0_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_5713c93b-db3b-415c-a1fa-a5e5c456e54f_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_8e76aa79-f657-4750-97e5-2460ded5285e_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:label id="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_label_en-US" xlink:label="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Areas, Revenues from External Customers [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:to="lab_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ZevraMember_cb427a41-00ba-4445-8b8b-b59d78a1424c_terseLabel_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Zevra</link:label>
    <link:label id="lab_aqst_ZevraMember_label_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Zevra [Member]</link:label>
    <link:label id="lab_aqst_ZevraMember_documentation_en-US" xlink:label="lab_aqst_ZevraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Zevra</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember" xlink:href="aqst-20240930.xsd#aqst_ZevraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ZevraMember" xlink:to="lab_aqst_ZevraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_8ce7fd03-f715-407a-958d-6cdfc1906e4f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_f7d2dbba-ed1e-404d-a806-eed16a739048_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Non-current Assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_OtherAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_e8e57698-235a-4c88-a0ba-1e7f84869112_terseLabel_en-US" xlink:label="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of initial notes, warrants and first offer rights</link:label>
    <link:label id="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_label_en-US" xlink:label="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights</link:label>
    <link:label id="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_documentation_en-US" xlink:label="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:href="aqst-20240930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:to="lab_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_e774737e-dbb7-43f3-88fd-cd90054f65b7_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivable</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9ae0c1cc-8aac-4b0d-aa96-28da11a17467_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_9d719dac-2e90-43e7-bb18-a944cee80e72_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_048a659b-a751-49c9-bf26-7206c7d06432_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPayableCurrent_fa3e62b4-18d7-440d-b66b-d2e86e715477_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest payable</link:label>
    <link:label id="lab_us-gaap_InterestPayableCurrent_label_en-US" xlink:label="lab_us-gaap_InterestPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPayableCurrent" xlink:to="lab_us-gaap_InterestPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4fd31448-33a0-4c49-98c0-d49708f2dc3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested or expected to vest at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_b9e4343b-1e68-49a6-9b6b-fe0131edfa74_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of intangible assets, finite-lived</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets, Finite-Lived</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsFinitelived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_1ea4c447-c972-4bfd-b12a-84fe41eded68_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_4cb9434a-5d66-4a52-819f-c111d9b4b823_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_5c80c6c7-9ac8-45fd-80cf-a96327b9c738_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_3e7c321a-57a6-42c5-891a-e59093f79f87_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RedemptionScenario2Member_accf5af6-6c9f-4028-8bd9-73e980522971_terseLabel_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2</link:label>
    <link:label id="lab_aqst_RedemptionScenario2Member_label_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2 [Member]</link:label>
    <link:label id="lab_aqst_RedemptionScenario2Member_documentation_en-US" xlink:label="lab_aqst_RedemptionScenario2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption Scenario 2</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RedemptionScenario2Member" xlink:to="lab_aqst_RedemptionScenario2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_222d8d56-7cc9-4216-987b-7f8ebd941f0e_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9da61f2b-f01d-4e5c-b6fd-2a7f1981caa6_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Stock issued under public equity offering (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncome_51a9fd67-9fda-4bca-bbf0-c6ea0b496027_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income</link:label>
    <link:label id="lab_us-gaap_DeferredIncome_label_en-US" xlink:label="lab_us-gaap_DeferredIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncome" xlink:to="lab_us-gaap_DeferredIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4f1abffe-7d67-46ff-9ab4-593fec5eb9da_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_0759a6a7-2411-48df-9bff-14926954dba7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Costs of common stock issued under public equity offering</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_c9cba7a4-3657-44b0-baff-7eb1fe2b0564_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to additional paid in capital, stock issued, issuance costs</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_bfed00c9-e9d0-4870-bbe9-186aa16f7ad7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_e24c20c5-cb98-4044-81d2-44f3ac61a6fe_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_7d10c26e-8bf0-491f-93b2-6f70e602d138_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_3357e43b-80b5-4be3-8af8-52048d3aa9b1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_909b367b-7d6a-43b9-ac1e-871eeca63aba_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_cb5254c8-80f1-4d90-adc1-4482c18d6b8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_54c9016a-b6ca-4b8a-9671-3fe17338ab50_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_f1de03e4-0a70-401a-8853-93edc47e0fc5_terseLabel_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proprietary product revenue, net</link:label>
    <link:label id="lab_us-gaap_ManufacturedProductOtherMember_label_en-US" xlink:label="lab_us-gaap_ManufacturedProductOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Manufactured Product, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ManufacturedProductOtherMember" xlink:to="lab_us-gaap_ManufacturedProductOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_4a0dfea8-8e41-4a14-aca0-c1a802d0f634_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc.</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc. [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_baf68547-3f2b-47bb-80d6-bd2cc264f0d7_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2fb57f2b-bf97-4c62-a6e8-a4a023579b69_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_02273722-fbf7-4ecc-b295-72508e29e29e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gain on contract termination</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_1593e07f-e3b5-4550-ba07-a30e12d127ed_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gain on contract termination</link:label>
    <link:label id="lab_us-gaap_GainLossOnContractTermination_label_en-US" xlink:label="lab_us-gaap_GainLossOnContractTermination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Contract Termination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnContractTermination" xlink:to="lab_us-gaap_GainLossOnContractTermination" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_57c9b2f2-6354-4726-837a-70fc525749c7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_639b0c5d-8aea-4b24-95de-9421582f5c26_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized contract cost, net</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNet_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNet" xlink:to="lab_us-gaap_CapitalizedContractCostNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_14a9bc77-d9f9-4b72-8826-bc51c1b0afe4_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_f01ab5db-cc5d-4e15-a9b6-6fabf563aa9a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_2179fd4f-164a-4d1d-9bc8-d64fb58da945_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_aa975328-b14e-47de-a488-768bda7f6a9b_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_15fdb474-6ae9-41b1-9067-a547fdb71712_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a7a37fc6-3a90-4fe4-8fba-788041a24db7_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ExistingWarrantsMember_7b12e261-6c25-4744-b11f-079eca87a149_terseLabel_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Existing Warrants</link:label>
    <link:label id="lab_aqst_ExistingWarrantsMember_label_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Existing Warrants [Member]</link:label>
    <link:label id="lab_aqst_ExistingWarrantsMember_documentation_en-US" xlink:label="lab_aqst_ExistingWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Existing Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember" xlink:href="aqst-20240930.xsd#aqst_ExistingWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ExistingWarrantsMember" xlink:to="lab_aqst_ExistingWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_229cb57e-fdbf-4b46-8722-a95867f41f1a_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash payments for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_ff20428e-c7bb-47c2-8e57-b4ceb0dfc620_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested restricted stock units, net</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_907f4c7e-5935-4169-9774-b396bf4ab287_terseLabel_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain_label_en-US" xlink:label="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Option Indexed to Issuer's Equity, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:to="lab_us-gaap_OptionIndexedToIssuersEquityTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_087a5285-9f74-4f3f-ab5e-a4cb470d1ff1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_885783fe-7b25-4451-9703-d9f1a9537cfe_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, redemption price, basis points above treasury rate</link:label>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_label_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate</link:label>
    <link:label id="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Basis Spread On Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:to="lab_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_03266bde-6748-43b6-b5d3-df168f696718_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_ecc4b365-8dcf-4e77-b330-dcc497bca1c7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trade receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_fa28b6d7-0722-4730-86ce-cf6d313ad709_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_17d86055-9b58-4e7d-9a62-4225d070cb0c_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_89dec869-ba27-4727-9f56-c72a043033ce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercisable at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_9178cc90-aade-4ec7-b8fb-1af67d7f3d1d_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_64b93d25-11e6-430d-b62b-e86f1d9e0d0d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7e50c0e9-904a-4959-a991-63621f87d8e1_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Notes payable, long-term</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_4399b346-26f8-40d7-a95c-ce6a265be6dd_terseLabel_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Co-development and research fees</link:label>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_label_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Co-Development and Research Fees [Member]</link:label>
    <link:label id="lab_aqst_CoDevelopmentAndResearchFeesMember_documentation_en-US" xlink:label="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The aggregate revenue generated from Co-development and research fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember" xlink:href="aqst-20240930.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CoDevelopmentAndResearchFeesMember" xlink:to="lab_aqst_CoDevelopmentAndResearchFeesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_9ad477c9-b16b-40d6-96b3-cd1da81de802_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2e6398d2-f171-4640-bf97-9332d4a8e8c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_bd6db7da-4833-4a67-987a-8e19434191e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_6a9ad0f8-6e89-4598-b5ee-4e96bf35ebac_terseLabel_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc</link:label>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_label_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc [Member]</link:label>
    <link:label id="lab_aqst_AssertioHoldingsIncMember_documentation_en-US" xlink:label="lab_aqst_AssertioHoldingsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Assertio Holdings, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember" xlink:href="aqst-20240930.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AssertioHoldingsIncMember" xlink:to="lab_aqst_AssertioHoldingsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_ef711377-5440-40b5-9e5d-2e955b1dce10_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_c02d1e3a-58f0-43a7-86ba-835437f4a9fe_terseLabel_en-US" xlink:label="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Neurelis, Inc. v. Aquestive Therapeutics, Inc.</link:label>
    <link:label id="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_label_en-US" xlink:label="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Neurelis, Inc. v. Aquestive Therapeutics, Inc. [Member]</link:label>
    <link:label id="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_documentation_en-US" xlink:label="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Neurelis, Inc. v. Aquestive Therapeutics, Inc.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:href="aqst-20240930.xsd#aqst_NeurelisIncVAquestiveTherapeuticsIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:to="lab_aqst_NeurelisIncVAquestiveTherapeuticsIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_6a385eab-1003-4beb-bf03-e35016db97cb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_fda6962f-bd2a-45a4-8971-4eb9a83bf39c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Overview and Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_705bd325-3823-4bdb-884e-1cc7925c3554_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">(Loss) earnings per share attributable to common stockholders:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_e1c05740-bcc5-4108-90d6-83bea3775b5a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_5f38c854-211e-484e-8b26-f14b05486fd3_negatedTerseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited/expired (in shares)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised, Forfeitures And Expirations In Period</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4aeccb26-c99c-49ee-b30e-8fcba19a2773_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e2347abb-ff02-4cf2-9577-0664f8e1aa6c_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansPayableCurrent_76921070-f403-4005-8f19-94eeaf21206d_terseLabel_en-US" xlink:label="lab_us-gaap_LoansPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loans payable, current</link:label>
    <link:label id="lab_us-gaap_LoansPayableCurrent_label_en-US" xlink:label="lab_us-gaap_LoansPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loans Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansPayableCurrent" xlink:to="lab_us-gaap_LoansPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_9afd23ce-fe54-4479-b2a4-5b92832d3fa3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_532f1b44-0370-442c-bdac-c93d6be06f31_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_774ccdde-1471-4f03-a36e-0b16723a8f89_terseLabel_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of credit facility, accordion feature, increase limit</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_label_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:label id="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_documentation_en-US" xlink:label="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Accordion Feature, Increase Limit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:to="lab_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_c1cca43f-ded3-4185-b353-9422db02b2ca_terseLabel_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering</link:label>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_label_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering [Member]</link:label>
    <link:label id="lab_aqst_FirstAdditionalWarrantOfferingMember_documentation_en-US" xlink:label="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">First Additional Warrant Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember" xlink:href="aqst-20240930.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_FirstAdditionalWarrantOfferingMember" xlink:to="lab_aqst_FirstAdditionalWarrantOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_f433e031-b82c-4683-b755-e9c584a0dfb1_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares_08252056-23b9-4d68-a410-87186ae366b7_terseLabel_en-US" xlink:label="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inducement equity, common stock options outstanding (in shares)</link:label>
    <link:label id="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares_label_en-US" xlink:label="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inducement Equity, Common Stock Options Outstanding, Shares</link:label>
    <link:label id="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares_documentation_en-US" xlink:label="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Inducement Equity, Common Stock Options Outstanding, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:href="aqst-20240930.xsd#aqst_InducementEquityCommonStockOptionsOutstandingShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:to="lab_aqst_InducementEquityCommonStockOptionsOutstandingShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_62e06a14-8c8d-4c89-b1fc-6a10cebae391_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_b73bacc9-9132-489e-bc66-c4151c407aec_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_c5ffbc6e-a7a8-4aeb-a51a-79c546725f3c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fee amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFeeAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFeeAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Fee Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFeeAmount" xlink:to="lab_us-gaap_DebtInstrumentFeeAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_12abb56c-b3d0-4458-bee8-4110742f0f9b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeTwoMember_ce4e1455-3840-4434-b0d6-9b8ee9cafc86_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range Two</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTwoMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Two [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeTwoMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwoMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeTwoMember" xlink:to="lab_aqst_VestingConditionRangeTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_e81add7a-cbf7-4687-9cfb-b5f5b69ee8c8_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_3c559d3f-84e1-4ff2-812b-26aa880716d1_terseLabel_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity distribution agreement</link:label>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_label_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Distribution Agreement [Member]</link:label>
    <link:label id="lab_aqst_EquityDistributionAgreementMember_documentation_en-US" xlink:label="lab_aqst_EquityDistributionAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Distribution Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember" xlink:href="aqst-20240930.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_EquityDistributionAgreementMember" xlink:to="lab_aqst_EquityDistributionAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_b9280a25-e446-42c2-b503-fbb5bd76a026_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Premium paid to retire debt</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_19832e5e-7304-43f5-8a47-e37e5b35e3ea_verboseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Consent fee payment</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payment for Debt Extinguishment or Debt Prepayment Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:to="lab_us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_c06e3c01-5587-4f5a-bb90-9dd174e6f6a8_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_Warrants0.96ExercisePriceMember_107d853d-5274-4ee5-9b7a-ab0fe59e1937_terseLabel_en-US" xlink:label="lab_aqst_Warrants0.96ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, $0.96 Exercise Price</link:label>
    <link:label id="lab_aqst_Warrants0.96ExercisePriceMember_label_en-US" xlink:label="lab_aqst_Warrants0.96ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, $0.96 Exercise Price [Member]</link:label>
    <link:label id="lab_aqst_Warrants0.96ExercisePriceMember_documentation_en-US" xlink:label="lab_aqst_Warrants0.96ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, $0.96 Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants0.96ExercisePriceMember" xlink:href="aqst-20240930.xsd#aqst_Warrants0.96ExercisePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_Warrants0.96ExercisePriceMember" xlink:to="lab_aqst_Warrants0.96ExercisePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a4847b65-22ea-4a77-b7a7-52981c2ab503_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_28d39158-ced9-4db4-8aab-380eac1f7f2b_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value</link:label>
    <link:label id="lab_us-gaap_LongTermDebtFairValue_label_en-US" xlink:label="lab_us-gaap_LongTermDebtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtFairValue" xlink:to="lab_us-gaap_LongTermDebtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_6df5b461-b9b5-4e43-ad0a-3f27d8038ee2_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_07b539c6-a86b-400a-8d6b-6df5c7a92a72_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of dilutive stock options and warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_2db5e7e5-45de-4af5-844c-17fa5cd79e28_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_38a1d9ce-11cc-4a0a-a54d-c855114eb3a3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_VestingConditionRangeOneMember_36bee30a-0ddc-4a4b-9098-cbbbae3b2316_terseLabel_en-US" xlink:label="lab_aqst_VestingConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Market Condition Range One</link:label>
    <link:label id="lab_aqst_VestingConditionRangeOneMember_label_en-US" xlink:label="lab_aqst_VestingConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Condition Range One [Member]</link:label>
    <link:label id="lab_aqst_VestingConditionRangeOneMember_documentation_en-US" xlink:label="lab_aqst_VestingConditionRangeOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Vesting Condition Range One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeOneMember" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_VestingConditionRangeOneMember" xlink:to="lab_aqst_VestingConditionRangeOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_c354adf4-3067-48f4-86b0-2c9bf1e27edb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt issuance costs, net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7b498074-e19b-4d0a-8505-b65c92b9787d_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_f9869c60-0e65-41dd-9688-10d2dc1264a5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Term Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_7ddc083a-457e-4632-9e82-abd0469def60_terseLabel_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation</link:label>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_label_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation [Member]</link:label>
    <link:label id="lab_aqst_SuboxoneProduceLiabilityLitigationMember_documentation_en-US" xlink:label="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Suboxone Produce Liability Litigation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:href="aqst-20240930.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:to="lab_aqst_SuboxoneProduceLiabilityLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_60c5499f-fa1f-4f63-aa57-9103b138c230_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_51838975-db15-48ff-b03c-14a83058df80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_eaf85ef2-cf1f-481a-99b6-d35c0f2c7824_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_4a45f401-1978-4a62-9d19-d04e2cb8fdcc_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock issued under public equity offering</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_25cda772-3995-4a96-8595-0b72997cfbf7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative liability, noncurrent</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_52035ad0-9104-4800-aa28-b507ee5d52ba_terseLabel_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchased intangible</link:label>
    <link:label id="lab_us-gaap_TechnologyBasedIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Technology-Based Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:to="lab_us-gaap_TechnologyBasedIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_78be3bf1-3611-4734-9568-fdc28ad3f5b0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_d4232e79-42c4-4621-a3f9-6e76f5fc1383_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_a4d4946f-1a78-4edd-b27e-0bb38081e5bf_terseLabel_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares of common stock (in shares)</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_label_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</link:label>
    <link:label id="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_documentation_en-US" xlink:label="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:to="lab_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_cb91a383-2a94-4a03-8bca-9d4bf21b1c6f_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of quarterly installments</link:label>
    <link:label id="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_label_en-US" xlink:label="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Additional Payment, Number Of Quarterly Installments</link:label>
    <link:label id="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Additional Payment, Number Of Quarterly Installments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:to="lab_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_a4112702-c2bd-47b1-ab71-93bf0790c9e4_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_73aa48fe-a3d5-4ca3-a28b-d83b89d5ca05_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_5995f8db-17ee-446c-a5b5-244ad40e4197_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_884bca3f-344d-456b-9d68-4ffbbb44b118_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value. Authorized $250,000,000 shares; 91,178,193 and 68,533,085 shares issued and outstanding at September&#160;30, 2024 and December 31, 2023, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bac82e61-cf2d-4e35-b21e-13c94d721450_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e87ce2ba-bc44-4621-87c6-74e286a5488c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SeveranceCostsMonthlyPaymentDuration_f8d4f0dd-acc4-4fc8-8f76-8be010d10460_terseLabel_en-US" xlink:label="lab_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance costs monthly payment, duration</link:label>
    <link:label id="lab_aqst_SeveranceCostsMonthlyPaymentDuration_label_en-US" xlink:label="lab_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs Monthly Payment, Duration</link:label>
    <link:label id="lab_aqst_SeveranceCostsMonthlyPaymentDuration_documentation_en-US" xlink:label="lab_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Severance Costs Monthly Payment, Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:href="aqst-20240930.xsd#aqst_SeveranceCostsMonthlyPaymentDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:to="lab_aqst_SeveranceCostsMonthlyPaymentDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_CommonStockWarrantsMember_a1038436-9400-41d0-a1be-9f66f7402c6f_terseLabel_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:label id="lab_aqst_CommonStockWarrantsMember_label_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock Warrants [Member]</link:label>
    <link:label id="lab_aqst_CommonStockWarrantsMember_documentation_en-US" xlink:label="lab_aqst_CommonStockWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember" xlink:href="aqst-20240930.xsd#aqst_CommonStockWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_CommonStockWarrantsMember" xlink:to="lab_aqst_CommonStockWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_9dc12618-fc5a-4781-9499-bdefc1f1f0d8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_1ee22d63-1720-4b57-b4e8-482b39b94d85_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_d038badb-2748-4ef5-89d2-bd96c651ad44_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw material</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_5fe0a533-1ce3-42dc-86e3-3c5a2db20fbb_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss on extinguishment of debt</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_1c560cf3-9e53-4ee7-87ee-3a49c3457dd8_terseLabel_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of future revenue</link:label>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_label_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds From Sale of Future Revenues, Net</link:label>
    <link:label id="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet_documentation_en-US" xlink:label="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds From Sale of Future Revenues, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:to="lab_aqst_ProceedsFromSaleOfFutureRevenuesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1fcd2d87-279c-456f-9174-d8ff2f3903ee_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_3bd4b318-0f9e-44ed-a3f4-f0408dd11240_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_WarrantExercisesMember_45f3ccc8-4acf-42ca-99be-544a2304df36_terseLabel_en-US" xlink:label="lab_aqst_WarrantExercisesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant exercises</link:label>
    <link:label id="lab_aqst_WarrantExercisesMember_label_en-US" xlink:label="lab_aqst_WarrantExercisesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Exercises [Member]</link:label>
    <link:label id="lab_aqst_WarrantExercisesMember_documentation_en-US" xlink:label="lab_aqst_WarrantExercisesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantExercisesMember" xlink:href="aqst-20240930.xsd#aqst_WarrantExercisesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_WarrantExercisesMember" xlink:to="lab_aqst_WarrantExercisesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_422c9cbd-2aae-4acf-a756-e73aff3f3f73_terseLabel_en-US" xlink:label="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption percentage of debt under change of control provisions</link:label>
    <link:label id="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_label_en-US" xlink:label="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Redemption Percentage Of Debt Under Change Of Control Provisions</link:label>
    <link:label id="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_documentation_en-US" xlink:label="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Redemption percentage of debt under change of control provisions.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:href="aqst-20240930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:to="lab_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_3110c8a8-1507-4c80-a81b-1b2987270f57_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Useful Lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_53bbb50c-e4c9-4103-b177-5b27459fd56b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoods_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoods" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoods" xlink:to="lab_us-gaap_InventoryFinishedGoods" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_6ec6e75d-8c0b-4d60-9844-4136eb27b377_terseLabel_en-US" xlink:label="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions</link:label>
    <link:label id="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_label_en-US" xlink:label="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions</link:label>
    <link:label id="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_documentation_en-US" xlink:label="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:href="aqst-20240930.xsd#aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:to="lab_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_e5898544-fe97-4aff-80b2-3382e5f445f5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_1b351d09-178f-41c3-a3a0-ff68a7b2fe86_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee stock purchase plan (ESPP)</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_19315b52-1b83-4ae5-b724-bd2b3d5b58c4_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation, amortization, and impairment</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3c55ab72-f537-4343-bc1f-5a1d0e8e8154_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_18cde973-fae7-47a2-b5f8-fcd44f5714c2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Short-Term Debt [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShortTermDebtTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Debt [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable" xlink:to="lab_us-gaap_ScheduleOfShortTermDebtTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_d41498a9-2cf1-4851-8573-a89f605c5612_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_a97ec0e1-6917-4cc0-b07a-9558814482e3_terseLabel_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales commissions and fees</link:label>
    <link:label id="lab_us-gaap_SalesCommissionsAndFees_label_en-US" xlink:label="lab_us-gaap_SalesCommissionsAndFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Commissions and Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesCommissionsAndFees" xlink:to="lab_us-gaap_SalesCommissionsAndFees" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MonetizationAgreementMember_914d45f8-fd6d-4e10-8f33-fab7d0f16138_terseLabel_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Monetization Agreement</link:label>
    <link:label id="lab_aqst_MonetizationAgreementMember_label_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Monetization Agreement [Member]</link:label>
    <link:label id="lab_aqst_MonetizationAgreementMember_documentation_en-US" xlink:label="lab_aqst_MonetizationAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Monetization Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember" xlink:href="aqst-20240930.xsd#aqst_MonetizationAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MonetizationAgreementMember" xlink:to="lab_aqst_MonetizationAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_0e68f311-d85d-451d-814c-436e0b2c7aca_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_4d8f49e1-766d-4aa1-aeaa-300a4769bbcf_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_9ef50c97-6782-4284-bc48-adce8cfcc2a8_terseLabel_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Securities purchase agreement</link:label>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_label_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement [Member]</link:label>
    <link:label id="lab_aqst_SecuritiesPurchaseAgreementMember_documentation_en-US" xlink:label="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Securities Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember" xlink:href="aqst-20240930.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SecuritiesPurchaseAgreementMember" xlink:to="lab_aqst_SecuritiesPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_ccf6a821-2a56-4337-aa3a-d8143a9d6842_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation expense related to non-vested stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_cc174628-2305-4e77-9eed-3125aef8d9d8_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_ecf62af3-91b0-4303-b573-c20fef52e1ac_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Manufacture and supply</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e1de8131-c89d-41ff-918a-02e10210dedb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_00ee65a9-42f0-41fa-9d59-31cc7f29fa9a_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_b183b187-1884-4758-be2d-29f94245e71a_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_fbee9fce-be65-46c9-9471-71ccd9c3f8de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other non-current liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_94bdeef7-dab6-4c20-a93f-f452a89fd0a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies (Note 19)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_6ae99be9-a518-452f-beeb-cc2f6833f0eb_terseLabel_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">License agreement with Sunovion Pharmaceuticals, Inc milestones</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_label_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member]</link:label>
    <link:label id="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_documentation_en-US" xlink:label="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">The license agreement made with sunovion pharmaceuticals, inc. milestones.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:to="lab_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_2c6e6674-c6fa-4ce9-86e5-e539216bb383_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_13f2f61e-3451-4dc0-befc-d48424f05db5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_502bbd27-fbcf-4834-88e4-9c235e9fa801_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_51b6a28b-ab29-45c2-8300-9b5cfd81cd12_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate payment</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_126ece7b-5afc-454c-8145-2ec37e469c8d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0dc7b69e-f031-42a3-b167-650b36bf2711_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_97376a45-53a2-4ecf-ada9-7c2134b4b3f3_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_62e02890-7dbc-4ab9-a2b8-f003ca9241f4_terseLabel_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of cash proceeds</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_label_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant, Milestone Cap Percentage Threshold</link:label>
    <link:label id="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_documentation_en-US" xlink:label="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Repurchase Offer, Percentage of Cash Proceeds Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:to="lab_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_a278cd68-ffab-4cf1-b6df-a9e047becbe6_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of warrants</link:label>
    <link:label id="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants Not Settleable in Cash, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:to="lab_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_284488d2-3788-411e-a65e-41f415445bd7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_04d8e6b0-7de5-427f-938d-4d34cf5892ce_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of long-term debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_5380ba42-14db-404f-a05e-3a220e3c9bd2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments / credits</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_e9596788-98e4-454f-a260-82663efa6108_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from collaborators</link:label>
    <link:label id="lab_us-gaap_ProceedsFromCollaborators_label_en-US" xlink:label="lab_us-gaap_ProceedsFromCollaborators" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Collaborators</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromCollaborators" xlink:to="lab_us-gaap_ProceedsFromCollaborators" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_5fefee37-2149-490f-ac58-9843894cbf6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_dd7447b9-d487-4479-be71-552c5db5e5cc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_484600e3-2209-474c-a17f-fefc064f5761_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expenses</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_f981a921-3d81-46a0-b7cd-3877a31399c4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from collaborative arrangement, excluding revenue from contract with customer</link:label>
    <link:label id="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_8a2086a7-1586-441c-a61e-577ab51594e5_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e7890a46-3b08-4ab3-897d-d500da8de556_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net (loss) income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3854707f-c8a6-440a-9f44-04d1b5277569_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_d367f75d-9aa1-4849-b7ad-377af0ce74b5_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt discount (premium)</link:label>
    <link:label id="lab_us-gaap_AmortizationOfDebtDiscountPremium_label_en-US" xlink:label="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="lab_us-gaap_AmortizationOfDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_372fd074-69d8-4b4d-a5b1-50d41541bf13_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3f040fcd-d4d5-49b3-901b-df3946d696ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1fdbfeff-ce81-40d6-af3f-98360e6a8aab_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_fbde7f1f-2a5e-4a6e-a874-e0cf94966534_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Components of Identifiable Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_e13c9058-cf00-4dae-93e5-8580ab73dbf6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from shares issued under employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_2c3c609a-588d-44c0-8d6c-ecd2000cf52a_terseLabel_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from debt, contingent on additional milestones</link:label>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_label_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contingent Monetization Agreement, Milestone Payment</link:label>
    <link:label id="lab_aqst_ContingentMonetizationAgreementMilestonePayment_documentation_en-US" xlink:label="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contingent Monetization Agreement, Milestone Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:href="aqst-20240930.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:to="lab_aqst_ContingentMonetizationAgreementMilestonePayment" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_Warrants5.38ExercisePriceMember_0ef6dd93-9397-4736-928c-9145e7da384c_terseLabel_en-US" xlink:label="lab_aqst_Warrants5.38ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, $5.38 Exercise Price</link:label>
    <link:label id="lab_aqst_Warrants5.38ExercisePriceMember_label_en-US" xlink:label="lab_aqst_Warrants5.38ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, $5.38 Exercise Price [Member]</link:label>
    <link:label id="lab_aqst_Warrants5.38ExercisePriceMember_documentation_en-US" xlink:label="lab_aqst_Warrants5.38ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, $5.38 Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants5.38ExercisePriceMember" xlink:href="aqst-20240930.xsd#aqst_Warrants5.38ExercisePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_Warrants5.38ExercisePriceMember" xlink:to="lab_aqst_Warrants5.38ExercisePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_07393af4-860b-4928-85a4-2f16610db6f0_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_77961506-6df4-4725-b5ea-c058a0c97106_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenues and Trade Receivables, Net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_434d0046-7308-4b21-82f0-91ef3557613a_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_5fba9f97-63ee-4176-b57f-865a57e2d7a4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1d16611e-4313-4512-a3c3-b922c1d21a48_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_DanielBarberMember_label_en-US" xlink:label="lab_aqst_DanielBarberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Daniel Barber [Member]</link:label>
    <link:label id="lab_aqst_DanielBarberMember_documentation_en-US" xlink:label="lab_aqst_DanielBarberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Daniel Barber</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DanielBarberMember" xlink:href="aqst-20240930.xsd#aqst_DanielBarberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_DanielBarberMember" xlink:to="lab_aqst_DanielBarberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_5aa70200-32d0-4a84-963b-85ad5083e621_terseLabel_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_label_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited [Member]</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedMember_documentation_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtnahsPharmaUKLimitedMember" xlink:to="lab_aqst_AtnahsPharmaUKLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_19bccc5f-40ff-419a-8d48-f0265cfe3f65_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_b616e964-3d85-4218-b26b-63879f79d090_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_faf3a18c-e023-458f-b5ca-d2e1280f9b02_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_ac660880-edf0-4e0f-9273-be4fe92a6785_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_9af72ab8-7261-4a63-abee-c068be64f84c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remainder of 2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_c3604668-c9c3-4317-86cc-643dbafbaade_terseLabel_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liability related to the sale of future revenue, current</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_label_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties, Current</link:label>
    <link:label id="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_documentation_en-US" xlink:label="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Liabilities, Sale of Future Royalties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:to="lab_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_6447d3ec-1d67-4018-befa-4a6debce98b3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unamortized discount (premium), net</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_392c07f0-d28c-459d-abca-a4391b92dec6_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_fb413526-fe64-4457-b770-b0170303f44a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PutOptionMember_f082edae-f69e-4e06-abcc-7a2a4675fd21_terseLabel_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Put Option</link:label>
    <link:label id="lab_us-gaap_PutOptionMember_label_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Put Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PutOptionMember" xlink:to="lab_us-gaap_PutOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_f2ed67d0-f0cc-4ef5-b18b-97ca6bcf08bf_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underwriting discounts</link:label>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_label_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</link:label>
    <link:label id="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_documentation_en-US" xlink:label="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:to="lab_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_d47561c1-55e5-4479-8e20-763c8427e8e3_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_62461107-c383-4bef-b2b0-31ca53965743_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_86859f07-89c8-49df-ac9c-f721d10729db_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested, at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_2eec4bd6-daf3-456c-bb78-2f7c693fb6a8_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested, at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f28c2fe4-a23e-4f02-bef4-1e169a7231d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_59719d35-5e23-4dd6-85c2-5bcc51b430b1_verboseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_c02a3c39-8e27-4740-8145-a76c88258372_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_e34f80a6-e6c8-4580-b78b-e8445590f7ae_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current and non-current contract assets</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_8f5a1f7c-e4d1-43fe-bc5f-630a27169f8d_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance price threshold (in dollars per share)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_5a10c2df-aa41-408e-b68a-f83b51ecc6e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Performance Share Activity</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:to="lab_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_40b100e9-b38f-4a82-b191-47ebaaeec0dd_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_e1a9e2da-7d50-4771-ac90-741f45752827_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c2153ed9-8b04-4dfa-93bd-740c59cdb199_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_c2b97a10-8932-42ef-b58a-32197239489b_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants and rights outstanding</link:label>
    <link:label id="lab_us-gaap_WarrantsAndRightsOutstanding_label_en-US" xlink:label="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantsAndRightsOutstanding" xlink:to="lab_us-gaap_WarrantsAndRightsOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_36587394-14c4-4b27-84a6-ea21b9a7c030_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_0313fa49-e24a-4bcd-969f-28d5ab8d5cc0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_69fe6e1e-cbf4-4328-8b94-e7bc4478a088_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]</link:label>
    <link:label id="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_label_en-US" xlink:label="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:to="lab_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_15f6d490-d89d-4e4b-8a11-83bdb85fc358_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_92273cbd-667d-4f6c-98b4-b1efe2b1b401_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_Warrants4.25ExercisePriceMember_d8171bef-1d9c-4b26-a398-07d0e7acff88_terseLabel_en-US" xlink:label="lab_aqst_Warrants4.25ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants, $4.25 Exercise Price</link:label>
    <link:label id="lab_aqst_Warrants4.25ExercisePriceMember_label_en-US" xlink:label="lab_aqst_Warrants4.25ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants, $4.25 Exercise Price [Member]</link:label>
    <link:label id="lab_aqst_Warrants4.25ExercisePriceMember_documentation_en-US" xlink:label="lab_aqst_Warrants4.25ExercisePriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants, $4.25 Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants4.25ExercisePriceMember" xlink:href="aqst-20240930.xsd#aqst_Warrants4.25ExercisePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_Warrants4.25ExercisePriceMember" xlink:to="lab_aqst_Warrants4.25ExercisePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_e7f40f41-8fbb-4b2d-bdc4-8a4497a10203_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_54dd5081-f30d-4f25-b1a6-c3702631860d_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d014007c-8226-4069-9fe5-839515e5466c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_5b919d57-02ea-4f22-a7be-782b9fcbc6f3_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_9bfe3244-32e0-4b1e-bd49-4b4a5b91c8fc_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfLoanCosts_67190f86-72b8-4645-9b54-17bcc74b33af_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfLoanCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of loan costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfLoanCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfLoanCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Loan Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfLoanCosts" xlink:to="lab_us-gaap_PaymentsOfLoanCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_07bd3d5b-bdac-4514-9650-d1f88494f2bc_terseLabel_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance and exercise of warrants</link:label>
    <link:label id="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_label_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance and Exercise of Warrants</link:label>
    <link:label id="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_documentation_en-US" xlink:label="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance and Exercise of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromIssuanceAndExerciseOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:to="lab_aqst_ProceedsFromIssuanceAndExerciseOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_993c2a95-1398-4210-8076-d73de6f00cd9_terseLabel_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested and expected to vest at end of period (in shares)</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_label_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares</link:label>
    <link:label id="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_documentation_en-US" xlink:label="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:to="lab_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncMember_9b8eaec6-05e7-426b-a9e7-ba62fc0c288c_terseLabel_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc</link:label>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncMember_label_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc [Member]</link:label>
    <link:label id="lab_aqst_MitsubishiTanabePharmaAmericaIncMember_documentation_en-US" xlink:label="lab_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Mitsubishi Tanabe Pharma America, Inc</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:to="lab_aqst_MitsubishiTanabePharmaAmericaIncMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d1d89bd5-a0e8-493a-ab46-104e97eb9a58_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_e6d07c4c-999d-43dc-b3e0-dabc97d46d76_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average number of common shares &#8211; basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_6a4d8f97-4f89-499f-9c24-55c19994bd7c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsidiary, Sale of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems" xlink:to="lab_us-gaap_SubsidiarySaleOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_85b60dfc-437d-4392-901f-f7e45795edf2_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_083ce974-1a11-4f1f-85a3-f666b22ba368_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs and discounts</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_20b96d46-7940-4ddf-8252-9e53998cc902_terseLabel_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, aggregate offering price</link:label>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_label_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:label id="lab_aqst_SaleOfStockAggregateOfferingPrice_documentation_en-US" xlink:label="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sale of Stock, Aggregate Offering Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_SaleOfStockAggregateOfferingPrice" xlink:to="lab_aqst_SaleOfStockAggregateOfferingPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_96012fb6-8367-483e-88ec-009b08c6c3dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_a6328fa5-562a-4a96-a768-1cc9efca33e0_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_HasicoMember_ad2c3a87-dd5b-407d-b38b-cf6bd7e4eecd_terseLabel_en-US" xlink:label="lab_aqst_HasicoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hasico</link:label>
    <link:label id="lab_aqst_HasicoMember_label_en-US" xlink:label="lab_aqst_HasicoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hasico [Member]</link:label>
    <link:label id="lab_aqst_HasicoMember_documentation_en-US" xlink:label="lab_aqst_HasicoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Hasico</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HasicoMember" xlink:href="aqst-20240930.xsd#aqst_HasicoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_HasicoMember" xlink:to="lab_aqst_HasicoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_a4f9503e-3a05-4a1f-8e4a-9349de0712d1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Litigation settlement, amount awarded from other party</link:label>
    <link:label id="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_label_en-US" xlink:label="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Litigation Settlement, Amount Awarded from Other Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:to="lab_us-gaap_LitigationSettlementAmountAwardedFromOtherParty" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_PublicEquityOfferingMember_69527621-1af5-4939-abbd-f6e1634720d5_terseLabel_en-US" xlink:label="lab_aqst_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Public Equity Offering</link:label>
    <link:label id="lab_aqst_PublicEquityOfferingMember_label_en-US" xlink:label="lab_aqst_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Public Equity Offering [Member]</link:label>
    <link:label id="lab_aqst_PublicEquityOfferingMember_documentation_en-US" xlink:label="lab_aqst_PublicEquityOfferingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Public Equity Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PublicEquityOfferingMember" xlink:href="aqst-20240930.xsd#aqst_PublicEquityOfferingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_PublicEquityOfferingMember" xlink:to="lab_aqst_PublicEquityOfferingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_055402d9-07d2-48fe-ad32-23f60e44bac7_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_029c8594-a3ce-4457-bea2-4bbe6695a46e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_f04b4ecb-1e10-49b2-99d5-8bf235caca3c_terseLabel_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_label_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement [Member]</link:label>
    <link:label id="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_documentation_en-US" xlink:label="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Atnahs Pharma UK Limited, Amended Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:to="lab_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_4cca749c-179f-497b-bfa1-b74393f265bc_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>aqst-20240930_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:b565511c-5b45-4388-b386-b34aecbed8cc,g:2f20f260-f7bd-4e7e-bad2-8545b5aec525-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://aquestive.com/role/Cover" xlink:type="simple" xlink:href="aqst-20240930.xsd#Cover"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_11120961-c30f-459d-ade3-72ed331bed84" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentType_11120961-c30f-459d-ade3-72ed331bed84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_a766cfb0-1f7e-4069-88e8-3d06f96ff169" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentQuarterlyReport_a766cfb0-1f7e-4069-88e8-3d06f96ff169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3aa6e751-e3cf-4571-a4f5-fe003d0f2340" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentPeriodEndDate_3aa6e751-e3cf-4571-a4f5-fe003d0f2340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_e117c8c1-5dfd-461f-b705-c53c1702ef0f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentTransitionReport_e117c8c1-5dfd-461f-b705-c53c1702ef0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_1446392b-c5e3-4776-808c-48e510cdb361" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityFileNumber_1446392b-c5e3-4776-808c-48e510cdb361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_2f6e8faa-9c91-46d5-ad68-939b7f369b06" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityRegistrantName_2f6e8faa-9c91-46d5-ad68-939b7f369b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4423ca74-03fd-40c4-b86a-bf129a56ec38" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4423ca74-03fd-40c4-b86a-bf129a56ec38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_3ac29817-16c8-4582-869b-13adb1eaaa41" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityAddressAddressLine1_3ac29817-16c8-4582-869b-13adb1eaaa41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_efde3c27-5bb0-4f1c-8b12-21ff72832402" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityAddressCityOrTown_efde3c27-5bb0-4f1c-8b12-21ff72832402" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2f32a2be-b05d-451a-b8f1-dcca5131a333" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityAddressStateOrProvince_2f32a2be-b05d-451a-b8f1-dcca5131a333" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_85d22813-a2ed-44c1-aca4-be80c95d1b67" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityAddressPostalZipCode_85d22813-a2ed-44c1-aca4-be80c95d1b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_85d228f6-9d09-42e1-a615-a8d30c967f5e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityTaxIdentificationNumber_85d228f6-9d09-42e1-a615-a8d30c967f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a7c8cc63-41be-4c6c-829a-0649af78bf5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_CityAreaCode_a7c8cc63-41be-4c6c-829a-0649af78bf5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6543e84c-cd96-4f6d-a775-32a52367b67e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_LocalPhoneNumber_6543e84c-cd96-4f6d-a775-32a52367b67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_f90a6229-5083-4344-bade-b8bb9ab05934" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_Security12bTitle_f90a6229-5083-4344-bade-b8bb9ab05934" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_039cf92f-161c-4341-9a9a-f199effe0bc1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_TradingSymbol_039cf92f-161c-4341-9a9a-f199effe0bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_fdfabd4b-a592-4c2f-a089-174052784635" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_SecurityExchangeName_fdfabd4b-a592-4c2f-a089-174052784635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_554d7c8f-b9f8-475c-9f41-8be42c98c596" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityCurrentReportingStatus_554d7c8f-b9f8-475c-9f41-8be42c98c596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_76294b07-cee9-48db-96e9-fde67de98108" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityInteractiveDataCurrent_76294b07-cee9-48db-96e9-fde67de98108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_6e5d2b21-5456-4764-8405-c69615de3268" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityFilerCategory_6e5d2b21-5456-4764-8405-c69615de3268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_51d1ff5a-34e6-4658-a46e-5a454146c30a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntitySmallBusiness_51d1ff5a-34e6-4658-a46e-5a454146c30a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_85a2cb68-354d-4b93-a15c-a93bb9eb9a8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityEmergingGrowthCompany_85a2cb68-354d-4b93-a15c-a93bb9eb9a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_d1bba568-7dba-4ba7-8da4-a0faceb8058f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityShellCompany_d1bba568-7dba-4ba7-8da4-a0faceb8058f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_fb7805a3-a584-4dfc-aba7-c4a42fcfc79c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_fb7805a3-a584-4dfc-aba7-c4a42fcfc79c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d8c3d729-f102-41ea-bab3-00fd2a9cf74f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_EntityCentralIndexKey_d8c3d729-f102-41ea-bab3-00fd2a9cf74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_bf4f433a-0e0c-422e-a908-2ce3f77c6d28" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_CurrentFiscalYearEndDate_bf4f433a-0e0c-422e-a908-2ce3f77c6d28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_700720ff-2c30-4f39-bbc1-962b0a7813e3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentFiscalYearFocus_700720ff-2c30-4f39-bbc1-962b0a7813e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_273e79e6-577f-4001-ab6b-4a1e124d5ae5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_DocumentFiscalPeriodFocus_273e79e6-577f-4001-ab6b-4a1e124d5ae5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_82f9fcfd-76d0-452e-a5c8-dbb96c24d1bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_cdd67c4a-de30-4eca-a4f4-4c04d13d952b" xlink:to="loc_dei_AmendmentFlag_82f9fcfd-76d0-452e-a5c8-dbb96c24d1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedBalanceSheets"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_eb6bec6f-f654-462c-92d2-f1e8ebc45403" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eb6bec6f-f654-462c-92d2-f1e8ebc45403" xlink:to="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_15f77dac-b2c0-4114-8315-5b2c1523e4a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_15f77dac-b2c0-4114-8315-5b2c1523e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet_ce7b618d-522d-46ed-8f8d-540b9589d773" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:to="loc_aqst_TradeAndOtherReceivablesNet_ce7b618d-522d-46ed-8f8d-540b9589d773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_ad673e63-4209-4c6e-a694-82c2194404f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:to="loc_us-gaap_InventoryNet_ad673e63-4209-4c6e-a694-82c2194404f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6e4a4446-cab4-4d14-b63e-69f5da0f99dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6e4a4446-cab4-4d14-b63e-69f5da0f99dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_59e5a631-2fd4-4f5a-b95c-b90b41aaff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_aa3f342b-4439-4aeb-b39d-dbce85bc6d97" xlink:to="loc_us-gaap_AssetsCurrent_59e5a631-2fd4-4f5a-b95c-b90b41aaff0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_1b5d6231-3244-4ad1-a1ab-1b40ea2a54f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_1b5d6231-3244-4ad1-a1ab-1b40ea2a54f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f9d252e-fc16-41b1-b8db-a4114546e85b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9f9d252e-fc16-41b1-b8db-a4114546e85b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1c04ebda-93a6-437d-99e8-f7cd87b4ead1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1c04ebda-93a6-437d-99e8-f7cd87b4ead1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_48130d73-4104-4105-b6a9-ede3acd0d143" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_48130d73-4104-4105-b6a9-ede3acd0d143" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_ec2fd6c3-a96e-47d2-a56c-0a1efc2d0ffa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_b854e552-571e-4129-8cc1-19308b46f218" xlink:to="loc_us-gaap_Assets_ec2fd6c3-a96e-47d2-a56c-0a1efc2d0ffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_eb6bec6f-f654-462c-92d2-f1e8ebc45403" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_4771094a-ced2-45d9-bbf5-c9d3a2d71864" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_AccountsPayableCurrent_4771094a-ced2-45d9-bbf5-c9d3a2d71864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_01423048-6583-4351-ab1f-091487ad1eab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_01423048-6583-4351-ab1f-091487ad1eab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7bcd8b0d-7361-40bb-8150-449ed15113e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7bcd8b0d-7361-40bb-8150-449ed15113e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ee3f43e5-8892-40e5-90a2-abe1c5baa8dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_ee3f43e5-8892-40e5-90a2-abe1c5baa8dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_dbbccce7-343b-4e55-85f4-b38b1c508344" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_dbbccce7-343b-4e55-85f4-b38b1c508344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansPayableCurrent_b400327e-40d5-4bbc-a22e-fb856ca66784" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LoansPayableCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_LoansPayableCurrent_b400327e-40d5-4bbc-a22e-fb856ca66784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5b2d0d77-a5b8-42f7-ae8f-30175a1807db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_9570f50f-43b5-415f-b9d9-83a3dc9156b0" xlink:to="loc_us-gaap_LiabilitiesCurrent_5b2d0d77-a5b8-42f7-ae8f-30175a1807db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_82bcad75-b0ae-4b34-9c50-d4c1efb30efc" xlink:href="aqst-20240930.xsd#aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent_82bcad75-b0ae-4b34-9c50-d4c1efb30efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredLongTermDebt_7f31f2c2-1a7b-4ec6-a52e-0e3f03c68d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredLongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_UnsecuredLongTermDebt_7f31f2c2-1a7b-4ec6-a52e-0e3f03c68d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_3c4cff5b-8fcd-4e67-a1ee-5904636ca3c8" xlink:href="aqst-20240930.xsd#aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent_3c4cff5b-8fcd-4e67-a1ee-5904636ca3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b62669c-3126-4251-ac94-a95b947d6772" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_1b62669c-3126-4251-ac94-a95b947d6772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9ff61993-8d9c-4d33-b142-e412754e2895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_9ff61993-8d9c-4d33-b142-e412754e2895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a8cecf5c-eb29-4e47-ac88-0a675de8888c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a8cecf5c-eb29-4e47-ac88-0a675de8888c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b44297a1-0e4a-4212-b9c1-a1b6bb942ca8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_Liabilities_b44297a1-0e4a-4212-b9c1-a1b6bb942ca8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_7ca367ea-73d9-4807-882c-8e69caeb6a6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_CommitmentsAndContingencies_7ca367ea-73d9-4807-882c-8e69caeb6a6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_c0cee09d-7282-4080-95af-c23b3e58345a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:to="loc_us-gaap_CommonStockValue_c0cee09d-7282-4080-95af-c23b3e58345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_24405916-2e6b-48df-9ca2-dfda01440d03" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_24405916-2e6b-48df-9ca2-dfda01440d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc6aefaa-2389-4061-9979-fafb3de42cff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fc6aefaa-2389-4061-9979-fafb3de42cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_e129dacd-22b2-482d-b1b6-991cf0373685" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_267a9692-a3a0-4d22-998a-61d4d2621ac9" xlink:to="loc_us-gaap_StockholdersEquity_e129dacd-22b2-482d-b1b6-991cf0373685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_e0193a1b-7423-4da3-b4dd-053103f9bc57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_81a04cac-dc1d-491c-95de-18bca757dd14" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_e0193a1b-7423-4da3-b4dd-053103f9bc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_758ed2ef-8a84-4778-afaa-f100cc0c1e55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_758ed2ef-8a84-4778-afaa-f100cc0c1e55" xlink:to="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_805831cb-f5dd-4a81-833e-d1404eac81d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_805831cb-f5dd-4a81-833e-d1404eac81d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_812f4631-e795-46fd-9b6e-0b2125be88bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_812f4631-e795-46fd-9b6e-0b2125be88bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_371d87fe-1eb6-49b8-849f-e202df7aa706" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:to="loc_us-gaap_CommonStockSharesIssued_371d87fe-1eb6-49b8-849f-e202df7aa706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e5f5cffe-acc3-4bb6-9cb8-bf50743124a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_29c174cf-446e-4c28-8a8c-8e5497563993" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e5f5cffe-acc3-4bb6-9cb8-bf50743124a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofOperationsandComprehensiveLossIncome"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a5f629dd-768b-4b30-a94d-35d26af89044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a5f629dd-768b-4b30-a94d-35d26af89044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_8603485a-5fd0-4179-8abe-736cb56985cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_8603485a-5fd0-4179-8abe-736cb56985cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_a1c75e02-c006-46a7-8908-208fba5b005d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_a1c75e02-c006-46a7-8908-208fba5b005d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ee0f5ab-57ea-4091-8d18-7a13769edff0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_0ee0f5ab-57ea-4091-8d18-7a13769edff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_f033e2ea-d414-4714-9650-00ea770dd741" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a34254ed-ad6e-47ff-a201-0ad574c54c62" xlink:to="loc_us-gaap_CostsAndExpenses_f033e2ea-d414-4714-9650-00ea770dd741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_cb574f6e-890f-4b6a-8627-5ccf4c234cba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_OperatingIncomeLoss_cb574f6e-890f-4b6a-8627-5ccf4c234cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_90e123d7-c0b7-435b-b344-5583e2480274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_us-gaap_InterestExpenseNonoperating_90e123d7-c0b7-435b-b344-5583e2480274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_bbd743bb-b006-43c4-95de-6d395c8e8fd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_us-gaap_RoyaltyExpense_bbd743bb-b006-43c4-95de-6d395c8e8fd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestExpenseSaleOfFutureRevenues_1ca4028c-38f6-45da-a6ef-75a44ccb9991" xlink:href="aqst-20240930.xsd#aqst_InterestExpenseSaleOfFutureRevenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_aqst_InterestExpenseSaleOfFutureRevenues_1ca4028c-38f6-45da-a6ef-75a44ccb9991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_704da788-27ec-4f36-b6a4-6d6ba27f8dc6" xlink:href="aqst-20240930.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_aqst_InterestAndOtherIncomeNet_704da788-27ec-4f36-b6a4-6d6ba27f8dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f66b734f-ba84-41b3-b06e-93c0890cdef4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_f66b734f-ba84-41b3-b06e-93c0890cdef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b5c3fd6f-f1a0-43a3-a47f-9d5c5e5c5282" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_d48ffb5f-b81f-4d3f-9da5-bb2b32a99339" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b5c3fd6f-f1a0-43a3-a47f-9d5c5e5c5282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ba9e8aa8-745b-43c9-ba54-005b6b41c8da" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ba9e8aa8-745b-43c9-ba54-005b6b41c8da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_adf38f46-b32f-4d4b-8e47-52c78ebc095e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_NetIncomeLoss_adf38f46-b32f-4d4b-8e47-52c78ebc095e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_d27654ee-4460-4f2f-b011-f8ec895b7610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_d27654ee-4460-4f2f-b011-f8ec895b7610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_db9340d2-656e-455e-b388-eaa486515fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_EarningsPerShareAbstract_db9340d2-656e-455e-b388-eaa486515fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_fd85b268-1b78-476e-9420-a2dd2d5001ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_db9340d2-656e-455e-b388-eaa486515fbe" xlink:to="loc_us-gaap_EarningsPerShareBasic_fd85b268-1b78-476e-9420-a2dd2d5001ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_98095a10-5e97-4b51-a8db-32e06658fcf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_db9340d2-656e-455e-b388-eaa486515fbe" xlink:to="loc_us-gaap_EarningsPerShareDiluted_98095a10-5e97-4b51-a8db-32e06658fcf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_4279dff6-fef0-493a-a884-bdeb6c04a4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_fa145a40-232a-4e2e-9afc-2ca480142caa" xlink:to="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_4279dff6-fef0-493a-a884-bdeb6c04a4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_85c2cf2e-b17d-441c-8bbb-20f70fdea6ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_4279dff6-fef0-493a-a884-bdeb6c04a4bb" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_85c2cf2e-b17d-441c-8bbb-20f70fdea6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16ee2b02-fc6e-4ccd-bc10-0a4735d2cc72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract_4279dff6-fef0-493a-a884-bdeb6c04a4bb" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_16ee2b02-fc6e-4ccd-bc10-0a4735d2cc72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofChangesinStockholdersDeficit"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_ca9dd6f9-d3f0-4192-a2a2-574ab19bc6db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_ca9dd6f9-d3f0-4192-a2a2-574ab19bc6db" xlink:to="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1e650d01-9866-45b1-8a10-c210ac4beb11" xlink:to="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_0ed2be2a-5584-4dd4-9ca3-4bb795d4ac87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_CommonStockMember_0ed2be2a-5584-4dd4-9ca3-4bb795d4ac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_7ef48d6b-2534-42f0-9e6e-32a671df6523" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_7ef48d6b-2534-42f0-9e6e-32a671df6523" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_f20f2eee-c2dc-44ee-a612-722be670c1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5ebe734b-aa6c-4319-b31b-f4c61ef7f9cc" xlink:to="loc_us-gaap_RetainedEarningsMember_f20f2eee-c2dc-44ee-a612-722be670c1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e033bb3a-c13a-4067-a2b8-48eef95d30f4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantExercisesMember_40007907-91d9-46d7-9be7-de1e24a6d70c" xlink:href="aqst-20240930.xsd#aqst_WarrantExercisesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_WarrantExercisesMember_40007907-91d9-46d7-9be7-de1e24a6d70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_e230ac4d-efdc-4103-b9c0-c8ebd159969b" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_AtTheMarketOfferingMember_e230ac4d-efdc-4103-b9c0-c8ebd159969b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PublicEquityOfferingMember_45b5acf3-d633-4e72-a78a-5d9ae30ac230" xlink:href="aqst-20240930.xsd#aqst_PublicEquityOfferingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5b46dbc4-1c2a-4cce-9395-9410190388f8" xlink:to="loc_aqst_PublicEquityOfferingMember_45b5acf3-d633-4e72-a78a-5d9ae30ac230" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e9ec7d62-4cd5-43a5-967e-4d7f0280f5a3" xlink:to="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1491c69b-1938-4ec7-9a24-022285eaedff" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_b3847c9c-b72f-4a38-8eb1-57086b55644a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_SharesOutstanding_b3847c9c-b72f-4a38-8eb1-57086b55644a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_eeffcf24-3ef8-4658-94a4-1741abc0ca6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockholdersEquity_eeffcf24-3ef8-4658-94a4-1741abc0ca6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3d7b965a-fe9a-466e-9b48-4b7551439eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_3d7b965a-fe9a-466e-9b48-4b7551439eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62a23fb6-6e4d-4f71-82b6-18c87e9dc046" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_62a23fb6-6e4d-4f71-82b6-18c87e9dc046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_be2d47fd-25dd-4524-8afc-4c85fb6d504e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_be2d47fd-25dd-4524-8afc-4c85fb6d504e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3b3b412-4dd7-4595-833b-97448dd49745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_c3b3b412-4dd7-4595-833b-97448dd49745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fc339ffa-161b-4b54-be4e-aacc8efb0f64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_fc339ffa-161b-4b54-be4e-aacc8efb0f64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a8de4c9-5149-4dc0-a686-74b927c0ef91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2a8de4c9-5149-4dc0-a686-74b927c0ef91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8f5fd952-36d4-4990-a0bd-13852173a7f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_8f5fd952-36d4-4990-a0bd-13852173a7f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_2c2ebe8c-9d98-40ed-a825-e2dbc728f8f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_2c2ebe8c-9d98-40ed-a825-e2dbc728f8f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dc12dce-05c5-4e45-8f1a-ed6647323b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_5dc12dce-05c5-4e45-8f1a-ed6647323b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7205177f-8265-4012-90ca-28dcab24df4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7205177f-8265-4012-90ca-28dcab24df4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityOther_32e2b11f-8f77-47bd-9799-0cc25d0911a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityOther"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockholdersEquityOther_32e2b11f-8f77-47bd-9799-0cc25d0911a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7bea9b41-2a6d-4baa-a301-049d00fd0a73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_NetIncomeLoss_7bea9b41-2a6d-4baa-a301-049d00fd0a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_36b0dbba-3825-4024-9ab8-8be6fc6019c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_SharesOutstanding_36b0dbba-3825-4024-9ab8-8be6fc6019c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a842dcf1-5fef-4d1f-9723-786d6a08d4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_27f66e49-c0ae-40ce-90d4-8fec903e70bf" xlink:to="loc_us-gaap_StockholdersEquity_a842dcf1-5fef-4d1f-9723-786d6a08d4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="simple" xlink:href="aqst-20240930.xsd#CondensedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CondensedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_4e2eceb9-2a98-42eb-9d9e-ddbb29ff418b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_4e2eceb9-2a98-42eb-9d9e-ddbb29ff418b" xlink:to="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_70b56c37-8f99-49f2-bbf0-2719e578369d" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_3d6c6423-10a5-41a9-aabe-0fe14ca63f91" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:to="loc_aqst_AtTheMarketOfferingMember_3d6c6423-10a5-41a9-aabe-0fe14ca63f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PublicEquityOfferingMember_647667f5-cbb6-4fb0-be65-ad9d90d7d820" xlink:href="aqst-20240930.xsd#aqst_PublicEquityOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_5323b6a4-20fc-4133-a845-3364c2bd11ce" xlink:to="loc_aqst_PublicEquityOfferingMember_647667f5-cbb6-4fb0-be65-ad9d90d7d820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_c791aa94-b672-4db5-bdd7-38ad50bd7c27" xlink:to="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_57618b32-5108-4157-b67f-edc1d6ec4cb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_NetIncomeLoss_57618b32-5108-4157-b67f-edc1d6ec4cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_d8d1c800-da51-4349-a32c-a24dce849cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_DepreciationAndAmortization_d8d1c800-da51-4349-a32c-a24dce849cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_1f9e1505-2f97-4431-8952-37b3ecf3f781" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_GainLossOnContractTermination_1f9e1505-2f97-4431-8952-37b3ecf3f781" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0ac87419-36ab-4b9b-ac53-ba32c75b0758" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_ShareBasedCompensation_0ac87419-36ab-4b9b-ac53-ba32c75b0758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_17741b4b-7e7d-4ef7-a7da-9e73e703ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_17741b4b-7e7d-4ef7-a7da-9e73e703ac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dc984a14-f69f-43b6-b72a-eaed1676b11b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dc984a14-f69f-43b6-b72a-eaed1676b11b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_c555720d-f34b-4c14-b57d-520d0da6d0e0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_4b83f7f9-e96f-4943-a195-6a5188f245be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_4b83f7f9-e96f-4943-a195-6a5188f245be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_8ec07033-7cb0-46b1-82df-4cc858886c97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_8ec07033-7cb0-46b1-82df-4cc858886c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_34628498-1469-4837-8d2c-03be57f9d24a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_34628498-1469-4837-8d2c-03be57f9d24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e40470c1-eeba-4614-90b8-a3bb0404304c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_e40470c1-eeba-4614-90b8-a3bb0404304c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_d1780cca-95d4-40d1-9288-1f6abc8066d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_d1780cca-95d4-40d1-9288-1f6abc8066d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b9b0cdb6-b07a-4c6f-ab8c-3459844ff59a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_15cac6d8-fe91-4464-9be2-ebb24b299249" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_b9b0cdb6-b07a-4c6f-ab8c-3459844ff59a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e91ad47-3616-4f3b-9141-51cd921eb58f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b126edca-ae95-4a28-873b-940258492f2f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8e91ad47-3616-4f3b-9141-51cd921eb58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13c8f205-48f8-42fa-b2bd-f778283123a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_13c8f205-48f8-42fa-b2bd-f778283123a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cbf9dd18-72e4-4187-968f-678e8b9b9b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c9348459-debe-4dc4-ac68-92e17ad10970" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_cbf9dd18-72e4-4187-968f-678e8b9b9b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d96a1a1-d8ac-4a50-9708-9710524bf56e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_6d96a1a1-d8ac-4a50-9708-9710524bf56e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_8a8dc6f7-eb0f-4fe0-a48b-f77553cc280b" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromIssuanceAndExerciseOfWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_aqst_ProceedsFromIssuanceAndExerciseOfWarrants_8a8dc6f7-eb0f-4fe0-a48b-f77553cc280b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_26b7ff11-529e-4482-a6ea-00b23ce961ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_26b7ff11-529e-4482-a6ea-00b23ce961ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_67746711-098a-4a16-a24d-eb92f9c57989" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_67746711-098a-4a16-a24d-eb92f9c57989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_28559c1d-e4e2-4a86-b349-bf3cdaa1d059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_28559c1d-e4e2-4a86-b349-bf3cdaa1d059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a2dc7236-0d0b-4258-a039-4271db33b017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_a2dc7236-0d0b-4258-a039-4271db33b017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c793295-b2eb-4d72-8aa4-006ce631d7a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_9c793295-b2eb-4d72-8aa4-006ce631d7a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa762bf6-5b22-4c51-8f23-6121ac5e6ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a0fa59f0-f85d-4d35-a58b-ce7329ae6363" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_fa762bf6-5b22-4c51-8f23-6121ac5e6ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2af47a16-e2f1-44b5-bada-66b8f4e7d147" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2af47a16-e2f1-44b5-bada-66b8f4e7d147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCashAndCashEquivalentsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f03bbbd4-5a47-4a38-a03b-c3ccba966ba8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f03bbbd4-5a47-4a38-a03b-c3ccba966ba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_caa5327a-b0e4-4d0b-9547-8f83ea236c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsAbstract_3780bb14-94ce-401b-a19b-69b1a2a0748a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_caa5327a-b0e4-4d0b-9547-8f83ea236c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_8d4b7c74-1903-4dcd-87b6-a02eefc46437" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_ae45bd7e-fa3d-47c7-9bb4-4091cfcb2e54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_ae45bd7e-fa3d-47c7-9bb4-4091cfcb2e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_97c38abd-0479-4eec-b526-2d9e6e7bb893" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_42d62716-8a05-42f6-b1d7-546ba7425e07" xlink:to="loc_us-gaap_InterestPaidNet_97c38abd-0479-4eec-b526-2d9e6e7bb893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentation" xlink:type="simple" xlink:href="aqst-20240930.xsd#CompanyOverviewandBasisofPresentation"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_847f3831-def2-428f-a099-49ef1f4fa539" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_425aa6e2-f163-4a51-9fa4-fa97afccbc46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_847f3831-def2-428f-a099-49ef1f4fa539" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_425aa6e2-f163-4a51-9fa4-fa97afccbc46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="aqst-20240930.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_514b55c3-aea2-45a4-8fd4-58deecfc7cfe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6f3ad388-2771-4f5f-b547-9a1b9fe9bde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_514b55c3-aea2-45a4-8fd4-58deecfc7cfe" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_6f3ad388-2771-4f5f-b547-9a1b9fe9bde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertainties" xlink:type="simple" xlink:href="aqst-20240930.xsd#RisksandUncertainties"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RisksandUncertainties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_dfe6dd04-53f2-45bc-995e-15ed074f7605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_2e32d388-bc0d-4a69-a6a4-130f195f4f7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_dfe6dd04-53f2-45bc-995e-15ed074f7605" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_2e32d388-bc0d-4a69-a6a4-130f195f4f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNet" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7993f4e3-5ad0-44c2-8e26-d840f7a54904" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_521fc0f5-498e-457e-9503-4fd48511dd05" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7993f4e3-5ad0-44c2-8e26-d840f7a54904" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_521fc0f5-498e-457e-9503-4fd48511dd05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreements" xlink:type="simple" xlink:href="aqst-20240930.xsd#MaterialAgreements"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/MaterialAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_313b4ad7-2d1a-437f-a843-d7cc2124057a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e333c761-cef9-45f1-b2bc-d9b475be1866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_313b4ad7-2d1a-437f-a843-d7cc2124057a" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_e333c761-cef9-45f1-b2bc-d9b475be1866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="simple" xlink:href="aqst-20240930.xsd#FinancialInstrumentsFairValueMeasurements"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_aac8b81b-e0ad-4d0e-933f-9f83e86732aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_fb28ebee-e4f3-4e07-944f-f02b1462b189" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_aac8b81b-e0ad-4d0e-933f-9f83e86732aa" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_fb28ebee-e4f3-4e07-944f-f02b1462b189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/Inventories" xlink:type="simple" xlink:href="aqst-20240930.xsd#Inventories"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Inventories" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_3a080567-ad7f-4f36-8e7d-00fba6c3ef99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_f1f24ecb-bef0-42a0-afcd-172477c41524" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_3a080567-ad7f-4f36-8e7d-00fba6c3ef99" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_f1f24ecb-bef0-42a0-afcd-172477c41524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNet" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7804f221-9177-4f11-8be6-545105f41188" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9964dbc8-6543-4bde-b386-6b27c05744c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7804f221-9177-4f11-8be6-545105f41188" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_9964dbc8-6543-4bde-b386-6b27c05744c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligations" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligations"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_593d5779-eed7-4c1d-9eee-640ef3eaeb20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_03d8bcc5-5040-4aa0-8e00-f74cb0b55a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_593d5779-eed7-4c1d-9eee-640ef3eaeb20" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_03d8bcc5-5040-4aa0-8e00-f74cb0b55a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNet" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNet"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IntangibleAssetsNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c016f4ad-0f3c-468e-8f95-63b63da45393" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_54fd4e86-ab75-4030-8e61-9042813c718b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c016f4ad-0f3c-468e-8f95-63b63da45393" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_54fd4e86-ab75-4030-8e61-9042813c718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssets" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssets"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0a76337-8305-4d13-853d-6ee711e2100c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsDisclosureTextBlock_cfa3802c-ea53-4374-8c11-88dd08c9da81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e0a76337-8305-4d13-853d-6ee711e2100c" xlink:to="loc_us-gaap_OtherAssetsDisclosureTextBlock_cfa3802c-ea53-4374-8c11-88dd08c9da81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpenses" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpenses"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpenses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ecdf507a-5729-4c7a-b23d-f7b7cdd6cb13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_19fae5aa-29b9-4568-b7d4-25e21cfded2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ecdf507a-5729-4c7a-b23d-f7b7cdd6cb13" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_19fae5aa-29b9-4568-b7d4-25e21cfded2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebt" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebt"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8f307761-b13d-49f1-bfa1-01404da160ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_96acfdc5-358a-4119-85e7-b4e12ca7e041" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8f307761-b13d-49f1-bfa1-01404da160ce" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_96acfdc5-358a-4119-85e7-b4e12ca7e041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/Warrants" xlink:type="simple" xlink:href="aqst-20240930.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1fd804e4-5e3e-4705-b219-5b5157643a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_WarrantsDisclosureTextBlock_3b3fbd03-922f-4b12-8c9e-eeeff3e8aa66" xlink:href="aqst-20240930.xsd#aqst_WarrantsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_1fd804e4-5e3e-4705-b219-5b5157643a14" xlink:to="loc_aqst_WarrantsDisclosureTextBlock_3b3fbd03-922f-4b12-8c9e-eeeff3e8aa66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenue" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenue"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c77c4292-0dfa-4ebd-8083-d8b2bfa24541" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueTextBlock_bde0eac3-4bfb-46a0-87e8-c5d175c81cef" xlink:href="aqst-20240930.xsd#aqst_SaleOfFutureRevenueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c77c4292-0dfa-4ebd-8083-d8b2bfa24541" xlink:to="loc_aqst_SaleOfFutureRevenueTextBlock_bde0eac3-4bfb-46a0-87e8-c5d175c81cef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShare" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShare"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_64db04cb-ffc3-4c01-895e-3dfb5789dbfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_d72477ad-3d67-4b97-9118-d7b301293ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_64db04cb-ffc3-4c01-895e-3dfb5789dbfb" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_d72477ad-3d67-4b97-9118-d7b301293ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensation" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensation"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8197dbd0-6185-4fce-a769-6e95eece270d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4c739a59-76a8-45ed-99f0-4458828502a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8197dbd0-6185-4fce-a769-6e95eece270d" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4c739a59-76a8-45ed-99f0-4458828502a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxes" xlink:type="simple" xlink:href="aqst-20240930.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_fa71d114-85c1-4afb-8a2c-cbf6256037ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_7cbe1d98-404c-48d4-b33e-1852e48c8bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_fa71d114-85c1-4afb-8a2c-cbf6256037ec" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_7cbe1d98-404c-48d4-b33e-1852e48c8bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/Contingencies" xlink:type="simple" xlink:href="aqst-20240930.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_707081f8-de41-420c-8649-09bbad274aee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f4f30a8e-7c03-4908-88e6-381b3836ba5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_707081f8-de41-420c-8649-09bbad274aee" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f4f30a8e-7c03-4908-88e6-381b3836ba5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="aqst-20240930.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b235b5c2-bcd2-43a1-8854-cc8578d30a3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5db59b25-3434-4e43-9d97-3af131e2d2aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b235b5c2-bcd2-43a1-8854-cc8578d30a3a" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5db59b25-3434-4e43-9d97-3af131e2d2aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ed4ae1e5-0425-40c2-9b8f-f0e085c98551" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b235b5c2-bcd2-43a1-8854-cc8578d30a3a" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_ed4ae1e5-0425-40c2-9b8f-f0e085c98551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2c2bf924-25bc-444a-9fdc-b4bafc23bbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b235b5c2-bcd2-43a1-8854-cc8578d30a3a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_2c2bf924-25bc-444a-9fdc-b4bafc23bbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3bf533b-8a5f-4f04-8cae-247edeee563e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_8c29277a-9e5c-43f8-9df6-b584fb2a90c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3bf533b-8a5f-4f04-8cae-247edeee563e" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_8c29277a-9e5c-43f8-9df6-b584fb2a90c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3846256c-e77f-4431-83fd-109bb7512e46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3bf533b-8a5f-4f04-8cae-247edeee563e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_3846256c-e77f-4431-83fd-109bb7512e46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_554e97cd-7f6a-45b2-b707-5b2fde093f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3bf533b-8a5f-4f04-8cae-247edeee563e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_554e97cd-7f6a-45b2-b707-5b2fde093f3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_daa1098a-9d86-481d-a181-60a39b8165c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_d3bf533b-8a5f-4f04-8cae-247edeee563e" xlink:to="loc_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock_daa1098a-9d86-481d-a181-60a39b8165c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#InventoriesTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/InventoriesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4ff13b8c-c381-4129-9790-3aa5014b1430" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_edf346c9-ac4d-47ac-bce5-aa40b0bdd33f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4ff13b8c-c381-4129-9790-3aa5014b1430" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_edf346c9-ac4d-47ac-bce5-aa40b0bdd33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9615b954-079e-452c-8800-e9bcecef737b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cab20669-b29b-42df-866b-574399051078" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_9615b954-079e-452c-8800-e9bcecef737b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_cab20669-b29b-42df-866b-574399051078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b3a496c9-b42a-4d38-b0dd-ddcb42cbcaa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9abdefd9-cf25-4877-be34-f3d2e359359e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b3a496c9-b42a-4d38-b0dd-ddcb42cbcaa9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_9abdefd9-cf25-4877-be34-f3d2e359359e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNetTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IntangibleAssetsNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e62135c3-ffc0-4ebe-a01a-5f54b48d3a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a043933c-73d4-4ffd-b47e-5c779e3d5c89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e62135c3-ffc0-4ebe-a01a-5f54b48d3a47" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_a043933c-73d4-4ffd-b47e-5c779e3d5c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssetsTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9f73b32-5981-4de0-a96d-0b854c54fc73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_37d60ee0-a900-44c4-9724-21f7f6ab7f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f9f73b32-5981-4de0-a96d-0b854c54fc73" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock_37d60ee0-a900-44c4-9724-21f7f6ab7f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpensesTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpensesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_ecaa5977-6b82-42ff-b33b-9486f9c0d9f0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_a925194f-a401-4e1f-882d-569a7eddda97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_ecaa5977-6b82-42ff-b33b-9486f9c0d9f0" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_a925194f-a401-4e1f-882d-569a7eddda97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_77480d6a-43bd-4508-a72a-c81ab3df6177" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_394ea75d-aacc-4dc8-a783-9a247b164aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77480d6a-43bd-4508-a72a-c81ab3df6177" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_394ea75d-aacc-4dc8-a783-9a247b164aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fdf182cd-06b5-4e53-aad8-8f8baaaebf9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77480d6a-43bd-4508-a72a-c81ab3df6177" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_fdf182cd-06b5-4e53-aad8-8f8baaaebf9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_50b6dbc0-c3ef-4860-aceb-5602d1170d2e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_77480d6a-43bd-4508-a72a-c81ab3df6177" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_50b6dbc0-c3ef-4860-aceb-5602d1170d2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenueTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4b04dab-f689-4480-b8bb-6fef74bd9e16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationActivityTableTextBlock_e3f5428b-81bd-4523-9f01-106f77389f7c" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_f4b04dab-f689-4480-b8bb-6fef74bd9e16" xlink:to="loc_aqst_RoyaltyObligationActivityTableTextBlock_e3f5428b-81bd-4523-9f01-106f77389f7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_423eabc6-e3b7-4b91-9fa6-20f631f3394c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_93f5705a-9db0-4e34-b3d1-1e81c41569cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_423eabc6-e3b7-4b91-9fa6-20f631f3394c" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_93f5705a-9db0-4e34-b3d1-1e81c41569cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationTables" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_442a0a98-87a7-4dd4-92a8-9a95d326c7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_29dc8895-87cb-4110-bbc6-659136f69d25" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_442a0a98-87a7-4dd4-92a8-9a95d326c7c9" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_29dc8895-87cb-4110-bbc6-659136f69d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_23d5becc-1c81-43c5-afbe-5280da09a4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_442a0a98-87a7-4dd4-92a8-9a95d326c7c9" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_23d5becc-1c81-43c5-afbe-5280da09a4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_27949f25-3bd4-469d-9f24-d2c0c830c04e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_442a0a98-87a7-4dd4-92a8-9a95d326c7c9" xlink:to="loc_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock_27949f25-3bd4-469d-9f24-d2c0c830c04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6498adc1-e9d5-4144-a76b-43568e3567d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_442a0a98-87a7-4dd4-92a8-9a95d326c7c9" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_6498adc1-e9d5-4144-a76b-43568e3567d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#CompanyOverviewandBasisofPresentationDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ded785b8-de8b-44ce-9a67-7bf9b508e067" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ded785b8-de8b-44ce-9a67-7bf9b508e067" xlink:to="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_23b274a5-640c-41a7-9a85-76ba58f0e150" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_EquityDistributionAgreementMember_56f5cdf4-18de-43ff-86ce-50f507f4171e" xlink:href="aqst-20240930.xsd#aqst_EquityDistributionAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_EquityDistributionAgreementMember_56f5cdf4-18de-43ff-86ce-50f507f4171e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtTheMarketOfferingMember_2e72813e-0488-4558-9b50-d2097e0cbac5" xlink:href="aqst-20240930.xsd#aqst_AtTheMarketOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_AtTheMarketOfferingMember_2e72813e-0488-4558-9b50-d2097e0cbac5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AmendedEquityDistributionAgreementMember_887ecc41-0dc3-4c42-a025-71eb99d63e71" xlink:href="aqst-20240930.xsd#aqst_AmendedEquityDistributionAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_AmendedEquityDistributionAgreementMember_887ecc41-0dc3-4c42-a025-71eb99d63e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LincolnParkAgreementCommitmentShareMember_9553197a-06fa-40ee-a484-03e0e7e716cd" xlink:href="aqst-20240930.xsd#aqst_LincolnParkAgreementCommitmentShareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_LincolnParkAgreementMember_94f3b388-6cfb-4cda-a6be-5f63a71df4b1" xlink:to="loc_aqst_LincolnParkAgreementCommitmentShareMember_9553197a-06fa-40ee-a484-03e0e7e716cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_UnderwrittenPublicOfferingMember_25a84cb0-caec-4e60-a799-aae7767a3d8f" xlink:href="aqst-20240930.xsd#aqst_UnderwrittenPublicOfferingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_aqst_UnderwrittenPublicOfferingMember_25a84cb0-caec-4e60-a799-aae7767a3d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_8d075cc2-5607-425f-94bb-24501016142f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_69fde4f9-df00-428f-b4e4-76acbceff276" xlink:to="loc_us-gaap_OverAllotmentOptionMember_8d075cc2-5607-425f-94bb-24501016142f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:to="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_16757c49-b59d-4dd1-b151-565d59112eb0" xlink:to="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_3afdc66f-12ca-4fa9-8451-52ea7df2c4c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_896420da-ecb1-4744-90f8-3a045b9f2cf2" xlink:to="loc_srt_MaximumMember_3afdc66f-12ca-4fa9-8451-52ea7df2c4c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable_6318dfe1-01fb-4262-b3e6-11ee6c7c8b75" xlink:to="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_42043910-5d7d-4ba8-9d9c-d17e9ec4ebf2" xlink:href="aqst-20240930.xsd#aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts_42043910-5d7d-4ba8-9d9c-d17e9ec4ebf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_961eac06-bc33-45fd-b133-982cb48b9a97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_961eac06-bc33-45fd-b133-982cb48b9a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9fab8dca-83a1-4a35-a2ba-3056251550c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_9fab8dca-83a1-4a35-a2ba-3056251550c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b46eb705-d334-4fe1-9b91-853fed2a452a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b46eb705-d334-4fe1-9b91-853fed2a452a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockAggregateOfferingPrice_fc3ca43c-e530-4665-9546-2c0737bdc933" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockAggregateOfferingPrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SaleOfStockAggregateOfferingPrice_fc3ca43c-e530-4665-9546-2c0737bdc933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RightToSellCommonStockValue_011ad886-1d5b-4e6f-a831-d4bceb21190e" xlink:href="aqst-20240930.xsd#aqst_RightToSellCommonStockValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_RightToSellCommonStockValue_011ad886-1d5b-4e6f-a831-d4bceb21190e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AgreementTerm_e5bc05e9-402e-4e21-ba63-03826f17c138" xlink:href="aqst-20240930.xsd#aqst_AgreementTerm"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_AgreementTerm_e5bc05e9-402e-4e21-ba63-03826f17c138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_538f6fa5-1428-4381-a5f3-7db343e0b767" xlink:href="aqst-20240930.xsd#aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions_538f6fa5-1428-4381-a5f3-7db343e0b767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_dd177ab3-1ed0-42c9-9e4a-4c927fb4c093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_dd177ab3-1ed0-42c9-9e4a-4c927fb4c093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_d85dbefb-e571-4d85-9e56-78942a892d8e" xlink:href="aqst-20240930.xsd#aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockLineItems_e51caf0b-ed47-4638-945a-ee41728d2aa9" xlink:to="loc_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts_d85dbefb-e571-4d85-9e56-78942a892d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RisksandUncertaintiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RisksandUncertaintiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_02d0ac69-24a5-4cd2-ac73-38cf214592f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_02d0ac69-24a5-4cd2-ac73-38cf214592f7" xlink:to="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:to="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a9bdaaa7-3c1c-4684-9727-3d123427b773" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_5dae5f1e-e100-4ba4-be2d-14895ae283cc" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_f5a44818-5b46-473c-8999-ac4fe9517076" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_5dae5f1e-e100-4ba4-be2d-14895ae283cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_6136d94c-7c25-4faf-8ac1-21cc604d1201" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8df6fe3c-cfe8-45fb-a43e-27b056fdb51d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8df6fe3c-cfe8-45fb-a43e-27b056fdb51d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42338d11-e332-45c0-8827-3f9505717357" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_42338d11-e332-45c0-8827-3f9505717357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_219a79a4-784f-4207-9946-6c47dc94a26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_dd814a16-7cce-42d5-8b3e-0794a34fc080" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_219a79a4-784f-4207-9946-6c47dc94a26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4432694f-06f9-4b6b-b6cf-bc01e93f00d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_4432694f-06f9-4b6b-b6cf-bc01e93f00d7" xlink:to="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_6fa2a6c9-3600-4645-9048-781b1abc64fc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_141e5d06-e1f7-47ef-8445-ffa978752498" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_141e5d06-e1f7-47ef-8445-ffa978752498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_562d1e85-b6c5-4bd5-97e8-b041bd55b891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_93b36858-b967-4732-8f5b-c42bb5b80acc" xlink:to="loc_us-gaap_AccountsReceivableMember_562d1e85-b6c5-4bd5-97e8-b041bd55b891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_75d8e89a-0821-42cc-b589-c0e939737505" xlink:to="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_5ed5e8cc-190e-4507-95f0-3683def99efc" xlink:href="aqst-20240930.xsd#aqst_IndiviorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_IndiviorMember_5ed5e8cc-190e-4507-95f0-3683def99efc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ZevraMember_109df697-95ba-4aed-90c4-76a6baa36d9a" xlink:href="aqst-20240930.xsd#aqst_ZevraMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_ZevraMember_109df697-95ba-4aed-90c4-76a6baa36d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HasicoMember_03eeddb1-78df-4500-8070-8eb05f6e5169" xlink:href="aqst-20240930.xsd#aqst_HasicoMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_9d59bbac-c6a1-4206-a333-a5ea00db33e3" xlink:to="loc_aqst_HasicoMember_03eeddb1-78df-4500-8070-8eb05f6e5169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_6c72bb84-2da7-40ef-bd64-023d998e880a" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8964f098-d5ac-429a-9c3d-a3b94bef0f8f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_3291cc47-d69b-419a-9dd2-62ee90b6f274" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8964f098-d5ac-429a-9c3d-a3b94bef0f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_f1af72aa-95fa-4e65-9d55-d5fa29c4ba03" xlink:to="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a7ae431a-0450-4c25-996e-899ac30859b3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_66dccbce-d151-463e-8703-b93726982a3a" xlink:to="loc_srt_MaximumMember_a7ae431a-0450-4c25-996e-899ac30859b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_384c5fdc-f235-44f9-985c-7179fb3c2f59" xlink:to="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAccountsReceivableMember_736c2220-510e-451b-92ab-d8c75529a6c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TradeAccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:to="loc_us-gaap_TradeAccountsReceivableMember_736c2220-510e-451b-92ab-d8c75529a6c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_OtherReceivablesAndAccruedExpensesMember_0b8bb444-2581-4d12-9c8f-24763189b578" xlink:href="aqst-20240930.xsd#aqst_OtherReceivablesAndAccruedExpensesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_16478e0f-a7cb-4c66-90e7-25f05587f344" xlink:to="loc_aqst_OtherReceivablesAndAccruedExpensesMember_0b8bb444-2581-4d12-9c8f-24763189b578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d2941ce5-6792-4509-b20a-1715e579fd78" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ResearchAndDevelopmentProjectDuration_7ff29cf7-0639-4542-8b37-18a1d2fc1156" xlink:href="aqst-20240930.xsd#aqst_ResearchAndDevelopmentProjectDuration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_aqst_ResearchAndDevelopmentProjectDuration_7ff29cf7-0639-4542-8b37-18a1d2fc1156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_adc9ea04-80ec-491b-bab8-04f37c11f228" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_adc9ea04-80ec-491b-bab8-04f37c11f228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_c6b6f6f0-292d-483b-9106-721beade7fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ContractWithCustomerLiability_c6b6f6f0-292d-483b-9106-721beade7fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNet_63d9b3dc-e6f9-468e-93f4-3168368868d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CapitalizedContractCostNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_CapitalizedContractCostNet_63d9b3dc-e6f9-468e-93f4-3168368868d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3aaf2f8c-15f2-4b33-8103-68821026a1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_3aaf2f8c-15f2-4b33-8103-68821026a1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_b2e7f7d7-4fe5-4e58-8fc3-2f0c31460a08" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2bedcbdd-67bb-4bff-854c-bfa250f65c30" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_b2e7f7d7-4fe5-4e58-8fc3-2f0c31460a08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetRevenueDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3e2181e-b80c-4d48-8e10-72a68b480d54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e3e2181e-b80c-4d48-8e10-72a68b480d54" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:to="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_09cfa00d-5012-471c-bdf8-45146a5140b5" xlink:to="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_f077603e-c9bd-4c83-8cd8-731c41c4ec5a" xlink:href="aqst-20240930.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_f077603e-c9bd-4c83-8cd8-731c41c4ec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_ba03639f-4ded-4ba4-9164-0e433bdb60d9" xlink:href="aqst-20240930.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_ba03639f-4ded-4ba4-9164-0e433bdb60d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CoDevelopmentAndResearchFeesMember_cbd72c85-664f-44f0-81b9-abd05ad8c405" xlink:href="aqst-20240930.xsd#aqst_CoDevelopmentAndResearchFeesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_aqst_CoDevelopmentAndResearchFeesMember_cbd72c85-664f-44f0-81b9-abd05ad8c405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ManufacturedProductOtherMember_2e3c3b14-14a8-40a5-9887-5081a478ff1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ManufacturedProductOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_055ee869-beae-40da-893e-9cef43af6008" xlink:to="loc_us-gaap_ManufacturedProductOtherMember_2e3c3b14-14a8-40a5-9887-5081a478ff1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ca9baadb-50ed-47d4-aaf4-b7d3ea8cb504" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82c23ce8-bee1-47f9-9429-435ff7e73916" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_07491e3d-b442-4a6b-b54e-d1a76ecf5ae1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_82c23ce8-bee1-47f9-9429-435ff7e73916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_341787a7-fb6d-4a7a-b357-65a9c589f5c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_341787a7-fb6d-4a7a-b357-65a9c589f5c6" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:to="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_830ece13-5230-463f-bd03-2c59ad2a2eb6" xlink:to="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_facb48a1-ef70-4588-bf87-fb618e50955d" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:to="loc_country_US_facb48a1-ef70-4588-bf87-fb618e50955d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_827a2c98-8748-4439-bf23-932c0ff2fe7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6bd85a97-4bd8-42e6-a0b3-e8e37d55dd4b" xlink:to="loc_us-gaap_NonUsMember_827a2c98-8748-4439-bf23-932c0ff2fe7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_19b6013d-d055-4d03-8f6d-bf66022c1c76" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0cc309df-6b4e-403b-baf4-9d9849142e8e" xlink:to="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26167f5d-5327-4442-9b5d-471f6b2c75ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract_fc3bcfaa-38bf-47ab-90b2-efeee1240711" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_26167f5d-5327-4442-9b5d-471f6b2c75ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f30d278-670e-4bdb-9224-ee63cdccb1ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_3f30d278-670e-4bdb-9224-ee63cdccb1ed" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_7331eb6a-afab-46da-b6b3-4a06e80eba4f" xlink:to="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_00bc28de-8788-4361-9a63-2af82c438afa" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_00bc28de-8788-4361-9a63-2af82c438afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_0ad441d4-9774-4308-b822-461e54391ff0" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_32ba6d9a-976f-4f98-95e9-d24111c6d3d3" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_0ad441d4-9774-4308-b822-461e54391ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_0968fb51-cade-43e7-9bf9-26993df73cca" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_a14e42d3-8ce7-4ebc-acde-1308b282c044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_AccountsReceivableGross_a14e42d3-8ce7-4ebc-acde-1308b282c044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e0a1a835-4e81-4669-b2bf-d0339418fc78" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerAssetNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_ContractWithCustomerAssetNetCurrent_e0a1a835-4e81-4669-b2bf-d0339418fc78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8cfb7528-d33b-4f61-8c53-235238a03707" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_8cfb7528-d33b-4f61-8c53-235238a03707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAndOtherReceivablesNet_d766ef3d-077a-4114-9407-f6dbf86fa3b4" xlink:href="aqst-20240930.xsd#aqst_TradeAndOtherReceivablesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_44c904b7-12b7-415c-95ab-32a2672f92aa" xlink:to="loc_aqst_TradeAndOtherReceivablesNet_d766ef3d-077a-4114-9407-f6dbf86fa3b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0020a070-d0de-4f0a-a388-800d56d479c2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_0020a070-d0de-4f0a-a388-800d56d479c2" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2af70de9-0c35-4f4a-9261-2ea429d58445" xlink:to="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_d772a316-780b-4d43-bec8-43cebda0c1b8" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableDoubtfulAccountsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_163a8d70-9663-4ec1-ad69-fb99abbdf4f2" xlink:to="loc_aqst_TradeAccountsReceivableDoubtfulAccountsMember_d772a316-780b-4d43-bec8-43cebda0c1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_47f5dc0b-324d-4531-a258-e6342576dfba" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_73ac8930-8165-4a79-afe1-2ae40ee5bc27" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4e35680d-796e-426d-ad90-a38d09c7e8f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_4e35680d-796e-426d-ad90-a38d09c7e8f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1dcc002d-d4f6-475f-a23f-f8d86de37bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1dcc002d-d4f6-475f-a23f-f8d86de37bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_41ae2c57-0eef-4518-8012-6e4c50af7fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_756cdf5c-e048-46fb-943d-fd220feec6b0" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_41ae2c57-0eef-4518-8012-6e4c50af7fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb3f852e-6f75-4214-b13e-cd06d3ee2a0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eb3f852e-6f75-4214-b13e-cd06d3ee2a0d" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_f4401cf6-9b5d-4355-baa1-d15c2e8e0ef0" xlink:to="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TradeAccountsReceivableSalesRelatedMember_d38bc53c-df3d-4323-b77f-8a72866ac648" xlink:href="aqst-20240930.xsd#aqst_TradeAccountsReceivableSalesRelatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_c0e8ecae-1861-4753-a509-6db461b5adf5" xlink:to="loc_aqst_TradeAccountsReceivableSalesRelatedMember_d38bc53c-df3d-4323-b77f-8a72866ac648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_d8dfac83-241c-4c21-a000-3717ed6f1810" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c73daa27-5722-4bb1-9164-eb63a8994855" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cbbf00-4915-44d3-b4e3-e4bcd260ff7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_46cbbf00-4915-44d3-b4e3-e4bcd260ff7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_9d5016a3-e84f-42d3-bca0-87dc0a6ca9a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_9d5016a3-e84f-42d3-bca0-87dc0a6ca9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_092a571e-bef6-4f3d-bb62-fc57bcb1087e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_092a571e-bef6-4f3d-bb62-fc57bcb1087e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_c5dfbf6e-bf73-4105-a026-3f4777e03f40" xlink:href="aqst-20240930.xsd#aqst_AccountsReceivableAllowanceForCreditLossReclassifications"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_aqst_AccountsReceivableAllowanceForCreditLossReclassifications_c5dfbf6e-bf73-4105-a026-3f4777e03f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_35a748e0-8994-45cd-a6b4-5724ea3d256b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_89f2c8b0-c8a1-4b48-b43f-7a9721d155bb" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_35a748e0-8994-45cd-a6b4-5724ea3d256b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#MaterialAgreementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/MaterialAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1ed3080-77b2-46bc-bace-80f419732fb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c1ed3080-77b2-46bc-bace-80f419732fb6" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_db639d51-e57d-44d2-8fe5-fc6ac49f9fd7" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_354a1857-9a72-4ab9-907d-b0bfa8ea659a" xlink:href="aqst-20240930.xsd#aqst_CommercialExploitationAgreementWithIndiviorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_CommercialExploitationAgreementWithIndiviorMember_354a1857-9a72-4ab9-907d-b0bfa8ea659a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3c1844cf-43aa-4cbb-b8db-ca4e8d573796" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_3c1844cf-43aa-4cbb-b8db-ca4e8d573796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SupplementalAgreementWithIndiviorMember_c726df01-7557-4ed6-8829-e4c82989da66" xlink:href="aqst-20240930.xsd#aqst_SupplementalAgreementWithIndiviorMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_SupplementalAgreementWithIndiviorMember_c726df01-7557-4ed6-8829-e4c82989da66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_60addb29-1502-4154-b4f3-4d9bf12f5a5b" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember_60addb29-1502-4154-b4f3-4d9bf12f5a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_4c5bcde1-d694-4832-826e-4f4fa0ef0a5e" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_e885ddc5-22fb-4083-b422-89f733c533e6" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember_4c5bcde1-d694-4832-826e-4f4fa0ef0a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_c5200853-47d2-4a29-b695-21a14fdddd37" xlink:href="aqst-20240930.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_c5200853-47d2-4a29-b695-21a14fdddd37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_f4947876-872f-4cf1-aa3f-72f26ebdf9e8" xlink:href="aqst-20240930.xsd#aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember_f4947876-872f-4cf1-aa3f-72f26ebdf9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_8c16dac9-e7f1-4c8f-a81f-59cd76257912" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_8c16dac9-e7f1-4c8f-a81f-59cd76257912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_d81aa6fd-0a64-4ca2-b60a-05dc769503d2" xlink:href="aqst-20240930.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_LicenseSupplyAgreementMember_d81aa6fd-0a64-4ca2-b60a-05dc769503d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_e8477c6b-6d64-41fd-a3e5-908836e51fa5" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedAmendedAgreementMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_AtnahsPharmaUKLimitedAmendedAgreementMember_e8477c6b-6d64-41fd-a3e5-908836e51fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncMember_7dcac905-79b7-4c0e-96f5-4abfee57299b" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_3ef9c332-bfaa-425d-ac64-88c60c663ecf" xlink:to="loc_aqst_MitsubishiTanabePharmaAmericaIncMember_7dcac905-79b7-4c0e-96f5-4abfee57299b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_23f40029-8f0e-47f4-8669-1caa1d8281b7" xlink:to="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f98506e5-1ebc-4e74-be18-5884be439ba2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_030e319d-2e40-4d01-af28-7a6829e18011" xlink:to="loc_srt_MaximumMember_f98506e5-1ebc-4e74-be18-5884be439ba2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_800c7c04-fb8b-4d9f-9920-463ca3fd9941" xlink:to="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufactureAndSupplyRevenueMember_0f680225-65a3-46b0-8428-c31c5512f627" xlink:href="aqst-20240930.xsd#aqst_ManufactureAndSupplyRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:to="loc_aqst_ManufactureAndSupplyRevenueMember_0f680225-65a3-46b0-8428-c31c5512f627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAndRoyaltyRevenueMember_914eaad6-9059-4ea0-bd4b-1fda942938c8" xlink:href="aqst-20240930.xsd#aqst_LicenseAndRoyaltyRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_2022fc56-219f-414d-92f5-29504dad6bc5" xlink:to="loc_aqst_LicenseAndRoyaltyRevenueMember_914eaad6-9059-4ea0-bd4b-1fda942938c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_7b4f90de-9bd0-469d-93d0-950c8f0e2d4b" xlink:to="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_8ed41557-e13c-4ae6-b8ed-f23c765be616" xlink:href="aqst-20240930.xsd#aqst_MonetizationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_MonetizationAgreementMember_8ed41557-e13c-4ae6-b8ed-f23c765be616" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseSupplyAgreementMember_7ade3d0c-10a8-444b-b1ca-94d12b63bc9a" xlink:href="aqst-20240930.xsd#aqst_LicenseSupplyAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_LicenseSupplyAgreementMember_7ade3d0c-10a8-444b-b1ca-94d12b63bc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AtnahsPharmaUKLimitedMember_fc5d3531-1401-40f6-b717-6e4c5bab0e7e" xlink:href="aqst-20240930.xsd#aqst_AtnahsPharmaUKLimitedMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_864cc8a3-59e8-47a1-859e-1dd18016fb87" xlink:to="loc_aqst_AtnahsPharmaUKLimitedMember_fc5d3531-1401-40f6-b717-6e4c5bab0e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_1c692009-1d39-4028-8f5a-576c041cf4fd" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_IndiviorMember_84ad8a8e-b071-48e9-98c9-de9991ed4072" xlink:href="aqst-20240930.xsd#aqst_IndiviorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:to="loc_aqst_IndiviorMember_84ad8a8e-b071-48e9-98c9-de9991ed4072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AssertioHoldingsIncMember_f064225f-9273-49dc-888b-771952327206" xlink:href="aqst-20240930.xsd#aqst_AssertioHoldingsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5a543687-a0ed-48a6-a7fc-0faf74faa2d4" xlink:to="loc_aqst_AssertioHoldingsIncMember_f064225f-9273-49dc-888b-771952327206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_bfd464c5-fedf-4785-8cf0-faafee2901fc" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_4d1c26c2-5216-4c22-a34f-f55b4e39d9b3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_986c1384-d107-4dde-be85-6d50c9456c61" xlink:to="loc_srt_ChiefExecutiveOfficerMember_4d1c26c2-5216-4c22-a34f-f55b4e39d9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_543cfffe-cd2c-484e-9829-bfe2145b683b" xlink:to="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementTerm_669eddbf-3c03-4618-8f97-402eb3c833da" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_LicenseAgreementTerm_669eddbf-3c03-4618-8f97-402eb3c833da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_AutomaticRenewalPeriodOfAgreement_f6195ffa-bc3c-4ae7-a9ce-5a08765e007c" xlink:href="aqst-20240930.xsd#aqst_AutomaticRenewalPeriodOfAgreement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_AutomaticRenewalPeriodOfAgreement_f6195ffa-bc3c-4ae7-a9ce-5a08765e007c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncome_5358ff7d-582d-44ca-84e6-c7b24a57c09a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncome"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_DeferredIncome_5358ff7d-582d-44ca-84e6-c7b24a57c09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_90d9fc59-9ea6-49c0-9b6c-c2743ddb4189" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_90d9fc59-9ea6-49c0-9b6c-c2743ddb4189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeRevenueRecognized_7657090e-cf66-45ca-bcfc-faf91417ab9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_DeferredIncomeRevenueRecognized_7657090e-cf66-45ca-bcfc-faf91417ab9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InterestAndOtherIncomeNet_b4f9c284-ba3f-4ec0-b5d7-8ddc477948cb" xlink:href="aqst-20240930.xsd#aqst_InterestAndOtherIncomeNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_InterestAndOtherIncomeNet_b4f9c284-ba3f-4ec0-b5d7-8ddc477948cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_f660a39b-eedb-4ae7-8e9e-2872853313bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_f660a39b-eedb-4ae7-8e9e-2872853313bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0aa5f5e4-80da-45e5-b3c0-07bf83083bc1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_Revenues_0aa5f5e4-80da-45e5-b3c0-07bf83083bc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_256847d2-4bf0-468b-9e93-d1c290979fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_256847d2-4bf0-468b-9e93-d1c290979fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_87c0673b-6411-40a6-b506-172d6d79d222" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_87c0673b-6411-40a6-b506-172d6d79d222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_ceb8b701-3b38-45a3-a424-fee51957d703" xlink:href="aqst-20240930.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_ceb8b701-3b38-45a3-a424-fee51957d703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_a1986e90-be15-42b0-bddd-ac4f88da981b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss_a1986e90-be15-42b0-bddd-ac4f88da981b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_940d09c2-5217-4b82-be92-4495c4fb9eb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_SalesCommissionsAndFees_940d09c2-5217-4b82-be92-4495c4fb9eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a81d3762-580b-4bd2-81b6-d966fdeda6ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_a81d3762-580b-4bd2-81b6-d966fdeda6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeveranceCostsMonthlyPaymentDuration_f8d84bc9-fc5c-49b8-8f30-273944b4c968" xlink:href="aqst-20240930.xsd#aqst_SeveranceCostsMonthlyPaymentDuration"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_aqst_SeveranceCostsMonthlyPaymentDuration_f8d84bc9-fc5c-49b8-8f30-273944b4c968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_cd815bec-01fb-42bc-bf2a-74eaf41e5789" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_SeveranceCosts1_cd815bec-01fb-42bc-bf2a-74eaf41e5789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_e51bf661-4211-4373-ab38-8ae6b8719e97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_fb6435cb-dc2c-4cad-bfb3-56bbaa9f41d4" xlink:to="loc_us-gaap_ProceedsFromCollaborators_e51bf661-4211-4373-ab38-8ae6b8719e97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#FinancialInstrumentsFairValueMeasurementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_fe3b9961-56a0-4509-a787-d21eb38cfcc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_fe3b9961-56a0-4509-a787-d21eb38cfcc8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f5d9553a-8b06-456c-91c5-ea9f4bf135bf" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_ee28a4ad-a817-4156-957c-461e38adae1d" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_ee28a4ad-a817-4156-957c-461e38adae1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_04a205d7-b7d3-4e67-8862-7ede6f7e9248" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_eea99733-72cd-457b-8003-d2f6762d1e89" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_04a205d7-b7d3-4e67-8862-7ede6f7e9248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2e23f97d-34a6-49f8-a074-6b37f2f694af" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SecuritiesPurchaseAgreementMember_6af21b3c-4bb4-4e72-a784-29ea5eaf2197" xlink:href="aqst-20240930.xsd#aqst_SecuritiesPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ef30f327-20a5-4c79-84f0-23a4f77dff98" xlink:to="loc_aqst_SecuritiesPurchaseAgreementMember_6af21b3c-4bb4-4e72-a784-29ea5eaf2197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_8d0f9111-7855-4469-8f40-21af534f84b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_20c9c62f-d81b-4fa7-ae78-7eb34d4fd10c" xlink:href="aqst-20240930.xsd#aqst_ExistingWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:to="loc_aqst_ExistingWarrantsMember_20c9c62f-d81b-4fa7-ae78-7eb34d4fd10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_a669bfc8-ddf3-43c7-a3b0-ee3d82b6d328" xlink:href="aqst-20240930.xsd#aqst_NewWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_21bb3701-cfcb-48dc-a866-98c30f8f6c5c" xlink:to="loc_aqst_NewWarrantsMember_a669bfc8-ddf3-43c7-a3b0-ee3d82b6d328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_3d973cc4-84ca-4b9b-a785-9d61dd942771" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_4d4a0e9f-0e8e-421a-909c-d683d44c8390" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_a8949042-cc74-44d1-a3aa-5ab252ac7891" xlink:to="loc_us-gaap_SeniorNotesMember_4d4a0e9f-0e8e-421a-909c-d683d44c8390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a8727045-1e7d-456a-bc0d-83ac474b4668" xlink:to="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5fe68e05-855c-4fdd-aa9d-592b631c90e7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:to="loc_srt_MinimumMember_5fe68e05-855c-4fdd-aa9d-592b631c90e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_eaba0ad2-039f-4e05-aa0a-bb3d55ddc7b9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_53dade04-4a1b-4d0d-aeb4-2e87fe4a6ef3" xlink:to="loc_srt_MaximumMember_eaba0ad2-039f-4e05-aa0a-bb3d55ddc7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_fd57a712-371e-4a34-b3d5-bf1fe4d251b0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3067691-0c28-41ec-8831-74a73af7004a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_f3067691-0c28-41ec-8831-74a73af7004a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_6f79be3c-c9aa-4a56-bd53-c38e9918b960" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants_6f79be3c-c9aa-4a56-bd53-c38e9918b960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_9b19371d-0599-4656-9d8b-10fc1ace2f2c" xlink:href="aqst-20240930.xsd#aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants_9b19371d-0599-4656-9d8b-10fc1ace2f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_f16f9607-e849-4ccf-8fa4-fcf7cb9bc3ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_f16f9607-e849-4ccf-8fa4-fcf7cb9bc3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2903127c-4ff7-499e-8d4d-b0539a71a6af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_2903127c-4ff7-499e-8d4d-b0539a71a6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_839a0b7f-ec61-43ad-bb3f-3f959a2e9c0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_839a0b7f-ec61-43ad-bb3f-3f959a2e9c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_740e649d-56f7-41d0-b37c-233760e3a167" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_740e649d-56f7-41d0-b37c-233760e3a167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_07f772e4-f504-4e6c-bef2-1d5ad693d155" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_0f940141-4024-4fbb-847e-b23d00ad236a" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_07f772e4-f504-4e6c-bef2-1d5ad693d155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/InventoriesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#InventoriesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/InventoriesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_8652e034-8b33-477a-a98e-0c23f6c903a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_e4021396-2da5-44f3-add9-91e0fe561a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8652e034-8b33-477a-a98e-0c23f6c903a9" xlink:to="loc_us-gaap_InventoryRawMaterials_e4021396-2da5-44f3-add9-91e0fe561a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InventoryPackingMaterialGross_b273e76f-5fcc-4fc9-ad99-3e8318e46df7" xlink:href="aqst-20240930.xsd#aqst_InventoryPackingMaterialGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8652e034-8b33-477a-a98e-0c23f6c903a9" xlink:to="loc_aqst_InventoryPackingMaterialGross_b273e76f-5fcc-4fc9-ad99-3e8318e46df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoods_d2aa33da-bd85-46c2-8b25-4d11bb9299d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoods"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8652e034-8b33-477a-a98e-0c23f6c903a9" xlink:to="loc_us-gaap_InventoryFinishedGoods_d2aa33da-bd85-46c2-8b25-4d11bb9299d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c5891a30-8759-43c3-9bcb-8aa65296df71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_8652e034-8b33-477a-a98e-0c23f6c903a9" xlink:to="loc_us-gaap_InventoryNet_c5891a30-8759-43c3-9bcb-8aa65296df71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1f162fa9-ecfd-4ea2-a3de-c9609ccd2153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_1f162fa9-ecfd-4ea2-a3de-c9609ccd2153" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3e110046-7763-47d4-aca8-a6621f4fa36f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_a9c8a7d3-db61-4621-9a0f-36d79ec63b8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_a9c8a7d3-db61-4621-9a0f-36d79ec63b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_93b4b4bf-c796-4ac7-b03e-aae6054468f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_93b4b4bf-c796-4ac7-b03e-aae6054468f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_a2c5616e-b01a-4c20-a90a-c2ff6ccf5489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_a2c5616e-b01a-4c20-a90a-c2ff6ccf5489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_30143444-dedc-4a18-9d66-8e6e3bbcd41d" xlink:href="aqst-20240930.xsd#aqst_ComputerNetworkEquipmentAndSoftwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_aqst_ComputerNetworkEquipmentAndSoftwareMember_30143444-dedc-4a18-9d66-8e6e3bbcd41d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_db7915b3-e603-4b1d-b546-65df90979493" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_f3704d3d-6879-424b-9d8d-d926edc64442" xlink:to="loc_us-gaap_ConstructionInProgressMember_db7915b3-e603-4b1d-b546-65df90979493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:to="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_94bb459e-2f45-42d8-b2e5-8c84ab3070c7" xlink:to="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3379ffdf-6f97-438a-a31e-01540fce5046" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:to="loc_srt_MinimumMember_3379ffdf-6f97-438a-a31e-01540fce5046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_203cd313-aae0-41ec-98e5-209f14010235" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_29a72723-a684-4dd1-91da-279baa4ae077" xlink:to="loc_srt_MaximumMember_203cd313-aae0-41ec-98e5-209f14010235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_298171e7-f25b-4cc4-bcf8-1f4faeb7af0a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_68a46f42-4bf2-4f4f-9ad6-dd140a9d0a8b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_68a46f42-4bf2-4f4f-9ad6-dd140a9d0a8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_356d5323-ddc8-47b7-ae45-f65062254bce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_356d5323-ddc8-47b7-ae45-f65062254bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5fdd9372-16ba-48f3-80dc-65fed04ceb97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5fdd9372-16ba-48f3-80dc-65fed04ceb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fd17934a-90c8-4d44-89bf-dabfce1060a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_c5ad46e5-aabd-466c-b76a-13a90d8b2485" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fd17934a-90c8-4d44-89bf-dabfce1060a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#PropertyandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_776aebc7-e87f-4a20-b357-f0e217f4f7bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_6470414e-e4b8-4f71-9586-43d01adfbc5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_776aebc7-e87f-4a20-b357-f0e217f4f7bc" xlink:to="loc_us-gaap_Depreciation_6470414e-e4b8-4f71-9586-43d01adfbc5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_25d20bd2-94ca-46aa-b4f2-81e1cf264ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_25d20bd2-94ca-46aa-b4f2-81e1cf264ecd" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:to="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_c67d5179-1474-4bb2-8cd1-069759cc93ed" xlink:to="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_21086671-c25f-4011-b35f-f70e0001e4a5" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:to="loc_srt_MinimumMember_21086671-c25f-4011-b35f-f70e0001e4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bc7b0ee9-709e-476e-b7e9-d9b8ac1bcb57" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76f9901-2c90-4d0a-9577-97c94437b32e" xlink:to="loc_srt_MaximumMember_bc7b0ee9-709e-476e-b7e9-d9b8ac1bcb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_0c44be9d-dfae-4cb8-aba8-770aaac5aae7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfOperatingLeases_6d251383-071a-49e8-834e-c89bf4e302c5" xlink:href="aqst-20240930.xsd#aqst_NumberOfOperatingLeases"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_aqst_NumberOfOperatingLeases_6d251383-071a-49e8-834e-c89bf4e302c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2962f68f-028e-4bde-9a7b-b83e290d311d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_2962f68f-028e-4bde-9a7b-b83e290d311d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseDiscountRate_43c5d3e9-ad5f-4b45-af6d-b0e504357aab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseDiscountRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_LesseeOperatingLeaseDiscountRate_43c5d3e9-ad5f-4b45-af6d-b0e504357aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6953c5ff-3ffb-414e-981c-68641f53bdb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_OperatingLeaseCost_6953c5ff-3ffb-414e-981c-68641f53bdb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_3c65c99e-e7bb-4254-aa7f-b02c391017c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fa23d8b3-0c84-449a-a906-8479847266e6" xlink:to="loc_us-gaap_VariableLeaseCost_3c65c99e-e7bb-4254-aa7f-b02c391017c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#RightofUseAssetsandLeaseObligationsMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ab3d23ed-82be-4ff7-9957-ef8e850fad34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_ab3d23ed-82be-4ff7-9957-ef8e850fad34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_292c0b00-2dbb-4077-9cb4-b232ecf71bf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_292c0b00-2dbb-4077-9cb4-b232ecf71bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0df0ffa7-97f5-4c94-8c88-525080342050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0df0ffa7-97f5-4c94-8c88-525080342050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_da6831c1-d378-4096-a7da-168a12de055c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_da6831c1-d378-4096-a7da-168a12de055c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_94e9132a-2d0e-448e-ba32-9269dd5be3de" xlink:href="aqst-20240930.xsd#aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter_94e9132a-2d0e-448e-ba32-9269dd5be3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b10b7161-18d7-45d5-b564-74ca6e9e66a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b10b7161-18d7-45d5-b564-74ca6e9e66a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4a93dd53-0bc8-443b-9341-b0361df69b70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_4a93dd53-0bc8-443b-9341-b0361df69b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_fab41c7e-2f05-434d-a628-d3c648a926b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_8fdff130-3023-4376-b755-4fe4a5e6958d" xlink:to="loc_us-gaap_OperatingLeaseLiability_fab41c7e-2f05-434d-a628-d3c648a926b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_892c6cfc-0ff4-4330-9c02-3c1ed019023d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_892c6cfc-0ff4-4330-9c02-3c1ed019023d" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b69a928f-c0a0-4f97-9e7d-a694bac5111b" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b5638046-d0c1-40f9-9801-3a43f8b1e17a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TechnologyBasedIntangibleAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:to="loc_us-gaap_TechnologyBasedIntangibleAssetsMember_b5638046-d0c1-40f9-9801-3a43f8b1e17a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PatentsMember_77bce388-9e64-4f08-8e9a-737650deb6e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PatentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_ef9233f4-6baa-4443-9508-b86f21eb80a2" xlink:to="loc_us-gaap_PatentsMember_77bce388-9e64-4f08-8e9a-737650deb6e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_8b5f7c74-72d8-4562-873f-54ac73dc6df7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_4a00ce00-d0b4-406c-b5e9-6b3dff439582" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_65d891d8-c5a4-4671-a5bd-7315df224b2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_65d891d8-c5a4-4671-a5bd-7315df224b2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e0ec8304-d74e-48e8-82d9-7f8943be2b0a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e0ec8304-d74e-48e8-82d9-7f8943be2b0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ce85daf7-8604-460f-8cbe-b9cf9f3a3e71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e6c22ecf-358f-4949-9ce2-69ab9c8f8386" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ce85daf7-8604-460f-8cbe-b9cf9f3a3e71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#IntangibleAssetsNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12f76fc1-505f-4a11-a7c9-93c9a378fff4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_b8872f55-3a9f-451f-80d4-0d70f149e9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12f76fc1-505f-4a11-a7c9-93c9a378fff4" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_b8872f55-3a9f-451f-80d4-0d70f149e9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_6ab30538-c8c6-48a1-87ef-ff9a27b42fb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDispositionOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12f76fc1-505f-4a11-a7c9-93c9a378fff4" xlink:to="loc_us-gaap_GainLossOnDispositionOfIntangibleAssets_6ab30538-c8c6-48a1-87ef-ff9a27b42fb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_90a08732-a96c-4b65-bd89-c62517a8def7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsFinitelived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12f76fc1-505f-4a11-a7c9-93c9a378fff4" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsFinitelived_90a08732-a96c-4b65-bd89-c62517a8def7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnContractTermination_2c69b756-8803-486f-9da0-2c1568768987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnContractTermination"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_12f76fc1-505f-4a11-a7c9-93c9a378fff4" xlink:to="loc_us-gaap_GainLossOnContractTermination_2c69b756-8803-486f-9da0-2c1568768987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09d3295b-7200-4650-bfa5-369878e479b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CumulativeRoyaltyReceivable_bf7d9e65-f1ef-40d9-b236-5e8665476118" xlink:href="aqst-20240930.xsd#aqst_CumulativeRoyaltyReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09d3295b-7200-4650-bfa5-369878e479b1" xlink:to="loc_aqst_CumulativeRoyaltyReceivable_bf7d9e65-f1ef-40d9-b236-5e8665476118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fdde0eb1-f1a2-4025-9fe5-8aa51a57ad76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsMiscellaneousNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09d3295b-7200-4650-bfa5-369878e479b1" xlink:to="loc_us-gaap_OtherAssetsMiscellaneousNoncurrent_fdde0eb1-f1a2-4025-9fe5-8aa51a57ad76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_76b87abf-5fe3-4835-bf76-c207292eb913" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_09d3295b-7200-4650-bfa5-369878e479b1" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_76b87abf-5fe3-4835-bf76-c207292eb913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#OtherNoncurrentAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_91de6a40-cdd7-4a53-b668-3f28c6e5f75f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_91de6a40-cdd7-4a53-b668-3f28c6e5f75f" xlink:to="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:to="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_27e1b406-0a11-45a7-9733-74a7d1c5804b" xlink:to="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_3d6ce104-a4c9-4942-a988-ed1aa48954fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_a4eb1097-d170-4f85-a3f4-0764f8df3357" xlink:to="loc_us-gaap_RoyaltyMember_3d6ce104-a4c9-4942-a988-ed1aa48954fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0088f9fc-23ca-4f38-b926-efd601377c6c" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_b9f5c6e6-112d-497c-b7ae-9e7c79f9ed9e" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_b9f5c6e6-112d-497c-b7ae-9e7c79f9ed9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_a31c1ff9-a4aa-4689-a327-0de0e099a13b" xlink:href="aqst-20240930.xsd#aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_290badfa-37f9-46de-9529-65bc112f8b41" xlink:to="loc_aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember_a31c1ff9-a4aa-4689-a327-0de0e099a13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable_5a35e378-21ff-4a95-8f02-22afc3c6d11d" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_017221cc-b998-43a5-b061-0ffdcb5db2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_017221cc-b998-43a5-b061-0ffdcb5db2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfGuaranteedRoyaltyPayments_8f6a3ffa-215f-4c60-8739-db6955c4bc3b" xlink:href="aqst-20240930.xsd#aqst_NumberOfGuaranteedRoyaltyPayments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_NumberOfGuaranteedRoyaltyPayments_8f6a3ffa-215f-4c60-8739-db6955c4bc3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_47c734b2-16e1-4f63-9345-5b71c32dbba9" xlink:href="aqst-20240930.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_47c734b2-16e1-4f63-9345-5b71c32dbba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_4e9c38d5-49f7-4f8b-8bb9-2cdb20bef549" xlink:href="aqst-20240930.xsd#aqst_NumberOfAnnualRoyaltyPaymentsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_aqst_NumberOfAnnualRoyaltyPaymentsReceivable_4e9c38d5-49f7-4f8b-8bb9-2cdb20bef549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesCommissionsAndFees_bdf7ae68-9188-4734-bdcc-12724f79c146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesCommissionsAndFees"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems_e8df0df5-fd63-49ae-9d4b-c9a7f1c939a2" xlink:to="loc_us-gaap_SalesCommissionsAndFees_bdf7ae68-9188-4734-bdcc-12724f79c146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpensesScheduleofAccruedExpensesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7fcf4e12-3787-475c-9133-2ab6b6516ffb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_7fcf4e12-3787-475c-9133-2ab6b6516ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxesPayableCurrent_b17f1be6-b4fd-4069-a1c3-82ffde3ce6e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxesPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_TaxesPayableCurrent_b17f1be6-b4fd-4069-a1c3-82ffde3ce6e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d8349672-50cf-4ac6-a8a1-b7d1cd8c87ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d8349672-50cf-4ac6-a8a1-b7d1cd8c87ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_97ffc1e2-6d23-4d20-8c3f-857a6e876144" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_InterestPayableCurrent_97ffc1e2-6d23-4d20-8c3f-857a6e876144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_edff5809-59ec-4f30-aec9-7d03be4d6c32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_edff5809-59ec-4f30-aec9-7d03be4d6c32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_924ceec7-e274-4490-9399-f6496b5420a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_06f4c023-609a-4105-9ce6-1ac56e773f33" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_924ceec7-e274-4490-9399-f6496b5420a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/AccruedExpensesNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#AccruedExpensesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/AccruedExpensesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b9635c25-81db-40d1-9947-cd381a5fa37d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShortTermDebtTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b9635c25-81db-40d1-9947-cd381a5fa37d" xlink:to="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:to="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ff75b6c5-d1ee-4a39-9cb9-c08495a38adb" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_2441b820-51b6-47b1-b6ad-98367f175045" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_c18ca42e-03e3-4eae-bddd-8cdc151b09fe" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_2441b820-51b6-47b1-b6ad-98367f175045" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_08e3268d-3f16-4980-8232-7d2d448244a8" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_37eff14d-727f-46d9-83f3-2eccb3532477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_42b8cb65-9149-4394-8534-a5915259aad2" xlink:to="loc_us-gaap_SeniorNotesMember_37eff14d-727f-46d9-83f3-2eccb3532477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermDebtLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShortTermDebtTable_7eed6ddc-8721-443f-b1d9-16851c2221f8" xlink:to="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5cc9e3a-032d-41d5-bdd3-750a6e22d43a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShortTermDebtLineItems_197641b1-66cc-4203-8e93-4141c91c2639" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d5cc9e3a-032d-41d5-bdd3-750a6e22d43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ce1d825a-6c36-4cd5-b7bf-d0c607707249" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ce1d825a-6c36-4cd5-b7bf-d0c607707249" xlink:to="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b167607d-077c-4b0c-9123-a3587a8b73a1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_5f2e018c-29a3-4648-bc52-b09914cb815c" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_5f2e018c-29a3-4648-bc52-b09914cb815c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_3aca395a-e04d-4a21-a4c8-9725663cf2c6" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_1e0e2ba8-e258-4fb9-9ba6-fe9056b07102" xlink:to="loc_aqst_RoyaltyObligationsMember_3aca395a-e04d-4a21-a4c8-9725663cf2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ABLFacilityMember_3d24a59f-bc73-4806-941b-d53890a7183f" xlink:href="aqst-20240930.xsd#aqst_ABLFacilityMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_49e95b28-5e1a-4a64-9ff5-2ab7655ae478" xlink:to="loc_aqst_ABLFacilityMember_3d24a59f-bc73-4806-941b-d53890a7183f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e92a8c3-b6cf-4747-ab4c-9d840d33b59c" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6a21a5c6-af4e-46f8-9c48-a53ab6da2912" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:to="loc_us-gaap_SeniorNotesMember_6a21a5c6-af4e-46f8-9c48-a53ab6da2912" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_11efa9fd-ffff-4825-a9a4-effd4386ecbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2aab56cd-3ed1-4bdb-880f-9995e663b1d7" xlink:to="loc_us-gaap_UnsecuredDebtMember_11efa9fd-ffff-4825-a9a4-effd4386ecbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_981ac7a5-5217-4515-a604-d5700609084b" xlink:to="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_6fc65515-58d6-42df-957b-a1236108ab22" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:to="loc_srt_MaximumMember_6fc65515-58d6-42df-957b-a1236108ab22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_6d89f4d5-9aa5-419b-bc44-f610de12d3c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c7e26b5e-e4d1-429f-99bf-8226ab71e4d9" xlink:to="loc_srt_MinimumMember_6d89f4d5-9aa5-419b-bc44-f610de12d3c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:href="aqst-20240930.xsd#aqst_DebtCovenantRedemptionScenarioDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioAxis_6a8a65b4-c360-4ee9-9ede-644693fea9fa" xlink:to="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario1Member_fa8d4995-02f6-48fa-bb86-b974d66060c5" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:to="loc_aqst_RedemptionScenario1Member_fa8d4995-02f6-48fa-bb86-b974d66060c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionScenario2Member_874a1b0d-8bd9-44fd-a8a7-bf99995c4fb4" xlink:href="aqst-20240930.xsd#aqst_RedemptionScenario2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_DebtCovenantRedemptionScenarioDomain_fe50418c-1b3a-41c5-b991-9d287d4cd92e" xlink:to="loc_aqst_RedemptionScenario2Member_874a1b0d-8bd9-44fd-a8a7-bf99995c4fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OptionIndexedToIssuersEquityTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeAxis_f5748478-c3bc-42fa-9532-1b0b38c3cec2" xlink:to="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_0ad9c1d3-e3f3-4d7b-a110-081318a771b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PutOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OptionIndexedToIssuersEquityTypeDomain_962fbcb7-9ba7-4e87-b387-ba9a41521fc2" xlink:to="loc_us-gaap_PutOptionMember_0ad9c1d3-e3f3-4d7b-a110-081318a771b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_dffd4e83-e5d4-4be6-b6b9-f3c7ed16c224" xlink:to="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32e486af-6095-4fbb-995c-f6ac6a463c41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_32e486af-6095-4fbb-995c-f6ac6a463c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_3b625780-aa9e-4f60-ba6a-d6b07f02d58e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_3b625780-aa9e-4f60-ba6a-d6b07f02d58e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_543e057a-dcc5-48e6-b527-faee84802f7a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_543e057a-dcc5-48e6-b527-faee84802f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cf40b0fe-b2d2-4022-a0dc-77277a7772c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cf40b0fe-b2d2-4022-a0dc-77277a7772c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_5a49733f-11fd-40e6-b928-34a4a07e98c2" xlink:href="aqst-20240930.xsd#aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights_5a49733f-11fd-40e6-b928-34a4a07e98c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_71b5d445-79b4-4e10-8bec-841551fb5114" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_RepaymentsOfDebt_71b5d445-79b4-4e10-8bec-841551fb5114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_b33cfa0d-a369-45e6-94df-9aed3f512118" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_LongTermDebt_b33cfa0d-a369-45e6-94df-9aed3f512118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_3cc4970e-22f2-4007-9569-23188d2a7c47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_3cc4970e-22f2-4007-9569-23188d2a7c47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfNoteholders_bf254c1e-c5c4-40eb-9a02-716f83217541" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfNoteholders"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentNumberOfNoteholders_bf254c1e-c5c4-40eb-9a02-716f83217541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentNumberOfTransactions_8bb6490b-8bf6-4d96-913d-a54b5aaf6cc1" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentNumberOfTransactions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentNumberOfTransactions_8bb6490b-8bf6-4d96-913d-a54b5aaf6cc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PremiumsPaidEarlyRetirementOfDebt_cf882a01-b41c-44f1-b5e5-c901f1adb072" xlink:href="aqst-20240930.xsd#aqst_PremiumsPaidEarlyRetirementOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_PremiumsPaidEarlyRetirementOfDebt_cf882a01-b41c-44f1-b5e5-c901f1adb072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfLoanCosts_f749f9be-e2f2-44c5-a996-d31bf7fab285" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfLoanCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_PaymentsOfLoanCosts_f749f9be-e2f2-44c5-a996-d31bf7fab285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_270265f7-55d9-4469-8f66-e81be1a1f117" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_270265f7-55d9-4469-8f66-e81be1a1f117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_3c581bb1-c88d-4d17-a98d-fc3eb6a64131" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold_3c581bb1-c88d-4d17-a98d-fc3eb6a64131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e0f0f56d-f2af-44d1-8951-81314297bfce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_e0f0f56d-f2af-44d1-8951-81314297bfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aaea27f4-5a5a-46f8-a33b-bd3c629e5b99" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_aaea27f4-5a5a-46f8-a33b-bd3c629e5b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_35014fd6-6206-468b-919e-92bcb3f40e09" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_35014fd6-6206-468b-919e-92bcb3f40e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_844c3581-81d0-4a9e-bdaa-7deb5ecdcab7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_PaymentsOfDebtExtinguishmentCosts_844c3581-81d0-4a9e-bdaa-7deb5ecdcab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_eaab40a8-2f6c-4b3d-aea6-f690453dacd8" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments_eaab40a8-2f6c-4b3d-aea6-f690453dacd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFeeAmount_2c599a7b-e204-4cb5-b4b0-570b9c1cf247" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFeeAmount"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentFeeAmount_2c599a7b-e204-4cb5-b4b0-570b9c1cf247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ElectiveRedemptionPercentageOfDebt_b383adb4-de10-43b8-b48a-12283b228148" xlink:href="aqst-20240930.xsd#aqst_ElectiveRedemptionPercentageOfDebt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_ElectiveRedemptionPercentageOfDebt_b383adb4-de10-43b8-b48a-12283b228148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_d59a7861-21b9-43f9-9841-45b593cb362a" xlink:href="aqst-20240930.xsd#aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions_d59a7861-21b9-43f9-9841-45b593cb362a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_00c9e7fd-3be6-42a8-9d23-5adc71af4d34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_00c9e7fd-3be6-42a8-9d23-5adc71af4d34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_eec8f4d5-0c56-4eb6-b522-fed9500f47fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentPeriodicPaymentPrincipal"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPaymentPrincipal_eec8f4d5-0c56-4eb6-b522-fed9500f47fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_cbd69109-8688-47f4-b42b-73e68f9bc25b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_cbd69109-8688-47f4-b42b-73e68f9bc25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_14d31153-6ec5-42cb-ad9f-548e291d019b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_14d31153-6ec5-42cb-ad9f-548e291d019b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_227139cd-b6dc-459c-a605-894717e83bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed_227139cd-b6dc-459c-a605-894717e83bc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_333e2341-e80d-4c6f-b482-bbc17a7b1a06" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate_333e2341-e80d-4c6f-b482-bbc17a7b1a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_7af09250-a9fc-4b4e-a252-a37dfd9ca95d" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold_7af09250-a9fc-4b4e-a252-a37dfd9ca95d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_f3e867ea-983b-4db4-88ca-51aa51bbe8c8" xlink:href="aqst-20240930.xsd#aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit_f3e867ea-983b-4db4-88ca-51aa51bbe8c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_e9658136-23ae-4abb-af55-c9f01621d97d" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentage"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage_e9658136-23ae-4abb-af55-c9f01621d97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_5bda17c6-6f7c-4083-bd0a-778787f491e5" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm_5bda17c6-6f7c-4083-bd0a-778787f491e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtFairValue_06fd3ec1-d0ed-46ea-acf1-6043a88c515e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtFairValue"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_LongTermDebtFairValue_06fd3ec1-d0ed-46ea-acf1-6043a88c515e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_44cd2a91-9fd2-4911-aeef-6b12a7508cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet_44cd2a91-9fd2-4911-aeef-6b12a7508cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DebtInstrumentExitFee_ba75e77a-75bf-4b6c-b1fd-563e7a92cf27" xlink:href="aqst-20240930.xsd#aqst_DebtInstrumentExitFee"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_aqst_DebtInstrumentExitFee_ba75e77a-75bf-4b6c-b1fd-563e7a92cf27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_b1c05aed-b32a-4c23-bfd1-509e59456f01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_b1c05aed-b32a-4c23-bfd1-509e59456f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c3a35d24-e0ea-4ef5-8dd6-66722df777bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c3a35d24-e0ea-4ef5-8dd6-66722df777bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a61ef8d-4e26-4b29-aa80-5ac5e8acdf92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfDebtDiscountPremium"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_AmortizationOfDebtDiscountPremium_9a61ef8d-4e26-4b29-aa80-5ac5e8acdf92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_0a700edc-e1bc-42a9-9d5d-bc3c0ec5176a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="39" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_2786a66a-42f8-4ab8-825a-31060d36f2d3" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_0a700edc-e1bc-42a9-9d5d-bc3c0ec5176a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_25efced1-5d27-4b51-914e-609964f3cc67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_25efced1-5d27-4b51-914e-609964f3cc67" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_e682fb62-275f-4612-8809-313fd80c6e24" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputDiscountRateMember_3a3064b8-34e6-4109-8454-3b961166c677" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MeasurementInputDiscountRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:to="loc_us-gaap_MeasurementInputDiscountRateMember_3a3064b8-34e6-4109-8454-3b961166c677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MeasurementInputProbabilityOfSuccessMember_70c62668-481f-4892-9ea6-b1a5c60d1685" xlink:href="aqst-20240930.xsd#aqst_MeasurementInputProbabilityOfSuccessMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_f3405e0c-b669-4c48-8b52-539420dd9477" xlink:to="loc_aqst_MeasurementInputProbabilityOfSuccessMember_70c62668-481f-4892-9ea6-b1a5c60d1685" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_f62e9906-fad1-45d1-b9de-0a84fefad9ae" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMeasurementInput_5bdec6ba-6da4-48db-8532-32d026e6982a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_e654e0cf-58be-4cbe-8693-ef36756d419c" xlink:to="loc_us-gaap_LongTermDebtMeasurementInput_5bdec6ba-6da4-48db-8532-32d026e6982a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_04bc38bd-a11d-49b7-a455-5edc308dacb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_04bc38bd-a11d-49b7-a455-5edc308dacb0" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_233d1489-77d7-46a6-8b55-89108aa19990" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_3e710268-3f39-4350-acd8-c1ae34181e51" xlink:href="aqst-20240930.xsd#aqst_SeniorSecuredNotes13.5DueNovember12028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:to="loc_aqst_SeniorSecuredNotes13.5DueNovember12028Member_3e710268-3f39-4350-acd8-c1ae34181e51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_RoyaltyObligationsMember_7e055e86-9fe7-4b07-8bea-829478957b89" xlink:href="aqst-20240930.xsd#aqst_RoyaltyObligationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_77494eb1-3440-474f-9102-d1110dbfeb81" xlink:to="loc_aqst_RoyaltyObligationsMember_7e055e86-9fe7-4b07-8bea-829478957b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_7e6bb970-5c68-403e-9867-8ed144d5c9ba" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_56fb10d9-7e2a-4b77-8467-33b1579dfe4d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:to="loc_us-gaap_SeniorNotesMember_56fb10d9-7e2a-4b77-8467-33b1579dfe4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_243cfc5f-e68a-4749-8644-d42d18c1895f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3a5e3669-6ec1-48c6-8615-ea2917fdccbe" xlink:to="loc_us-gaap_UnsecuredDebtMember_243cfc5f-e68a-4749-8644-d42d18c1895f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_352c460c-2661-421e-bbf9-ca276ae409e7" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_8f8e6f91-77b6-492e-8b54-bb3b99bf8e85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_8f8e6f91-77b6-492e-8b54-bb3b99bf8e85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_320faa61-88f3-4860-928b-73d592a0cde6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_320faa61-88f3-4860-928b-73d592a0cde6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_fca964d4-6681-40b8-9a78-25cdf3aad4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_fca964d4-6681-40b8-9a78-25cdf3aad4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_36c250a1-cdc3-45f1-916b-a1641698e4a7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_36c250a1-cdc3-45f1-916b-a1641698e4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6b424051-1626-4e12-8e0d-efa469c0ddff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtAndCapitalLeaseObligations"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebtAndCapitalLeaseObligations_6b424051-1626-4e12-8e0d-efa469c0ddff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_1b544bdd-20bb-4b17-8714-c4518571529e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_1b544bdd-20bb-4b17-8714-c4518571529e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_10dfa57d-c3a1-4b24-b264-78acde0ba215" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_10dfa57d-c3a1-4b24-b264-78acde0ba215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8040f311-8bfe-4e77-8a76-4c3e860d00cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_beb54876-f9e5-464b-b350-b8751990fba9" xlink:to="loc_us-gaap_LongTermDebt_8040f311-8bfe-4e77-8a76-4c3e860d00cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#LongTermDebtDebtMaturitiesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6f537d97-16fd-435d-8ffe-d7f74fae6ca5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_6f537d97-16fd-435d-8ffe-d7f74fae6ca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_03607cdb-d86a-449c-9529-2970141e7fd7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_03607cdb-d86a-449c-9529-2970141e7fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a69a92da-f90d-417a-bca7-b00ee2cc6e20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_a69a92da-f90d-417a-bca7-b00ee2cc6e20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d8afcf6d-9631-48d5-b567-700b93cfa853" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_d8afcf6d-9631-48d5-b567-700b93cfa853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_93240aed-0523-48bb-a532-d9d9ada8d0e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_93240aed-0523-48bb-a532-d9d9ada8d0e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_bf63d9c3-da20-4945-94fb-562b2971301a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_09d4fee9-89ec-454b-90a6-d5c837b25655" xlink:to="loc_us-gaap_LongTermDebt_bf63d9c3-da20-4945-94fb-562b2971301a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/WarrantsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#WarrantsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_5fd1eb78-01f3-4d2d-8843-9ea1a6896eda" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsNoteDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WarrantsAndRightsNoteDisclosureAbstract_5fd1eb78-01f3-4d2d-8843-9ea1a6896eda" xlink:to="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5fe94904-c3ab-4a2a-929d-5ec522f799e6" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_a9980c31-415f-4dfe-98e7-eea194bdd78d" xlink:href="aqst-20240930.xsd#aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_331d4535-2dbd-44b9-b564-fb9c187b1f1a" xlink:to="loc_aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member_a9980c31-415f-4dfe-98e7-eea194bdd78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8aec3a82-c2e9-4622-93c6-018781a057a4" xlink:to="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_dd0640e3-5cd0-4387-9abd-778866afee84" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:to="loc_srt_MinimumMember_dd0640e3-5cd0-4387-9abd-778866afee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_12ccbe00-70dd-4193-a558-ef8d84bd31ce" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c45d868f-cc08-4091-af69-bf14c792bf7b" xlink:to="loc_srt_MaximumMember_12ccbe00-70dd-4193-a558-ef8d84bd31ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_6e67baa5-f69b-41f8-8540-effc96379891" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_FirstAdditionalWarrantOfferingMember_27aa4984-a7cd-4c6f-84bc-dcb5493e80bb" xlink:href="aqst-20240930.xsd#aqst_FirstAdditionalWarrantOfferingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_FirstAdditionalWarrantOfferingMember_27aa4984-a7cd-4c6f-84bc-dcb5493e80bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InitialWarrantOfferingMember_3e395350-dadf-489c-b94e-a42e9257be18" xlink:href="aqst-20240930.xsd#aqst_InitialWarrantOfferingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_InitialWarrantOfferingMember_3e395350-dadf-489c-b94e-a42e9257be18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PreFundedWarrantsMember_f20243f2-faac-44b2-acca-4dbcb1672bd1" xlink:href="aqst-20240930.xsd#aqst_PreFundedWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_PreFundedWarrantsMember_f20243f2-faac-44b2-acca-4dbcb1672bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_CommonStockWarrantsMember_5a42a16f-77e6-4113-9673-e7987632a82e" xlink:href="aqst-20240930.xsd#aqst_CommonStockWarrantsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_CommonStockWarrantsMember_5a42a16f-77e6-4113-9673-e7987632a82e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ExistingWarrantsMember_5d501e72-f64e-4877-b5fd-1ff05ee199ad" xlink:href="aqst-20240930.xsd#aqst_ExistingWarrantsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_ExistingWarrantsMember_5d501e72-f64e-4877-b5fd-1ff05ee199ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NewWarrantsMember_40e20062-d4a3-445e-80a0-bbc0fa57553e" xlink:href="aqst-20240930.xsd#aqst_NewWarrantsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_NewWarrantsMember_40e20062-d4a3-445e-80a0-bbc0fa57553e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants0.96ExercisePriceMember_c00b4a28-ed9a-4bb4-a79c-e5847e60ee82" xlink:href="aqst-20240930.xsd#aqst_Warrants0.96ExercisePriceMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants0.96ExercisePriceMember_c00b4a28-ed9a-4bb4-a79c-e5847e60ee82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants4.25ExercisePriceMember_8916aff3-fcde-4176-9fad-75ed7331b1df" xlink:href="aqst-20240930.xsd#aqst_Warrants4.25ExercisePriceMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants4.25ExercisePriceMember_8916aff3-fcde-4176-9fad-75ed7331b1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_Warrants5.38ExercisePriceMember_4ddb2fad-f509-432a-b124-c0264e8b87cf" xlink:href="aqst-20240930.xsd#aqst_Warrants5.38ExercisePriceMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2142818e-7d55-4b49-a456-e6d7c7462e49" xlink:to="loc_aqst_Warrants5.38ExercisePriceMember_4ddb2fad-f509-432a-b124-c0264e8b87cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightTable_1507dde0-660b-4ff5-a643-0a1ed8704c90" xlink:to="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d62e8276-f95c-4542-8df1-bf69ca307c5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_d62e8276-f95c-4542-8df1-bf69ca307c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_74e5b166-fcb1-4a9a-8cc2-fb0c25069244" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_74e5b166-fcb1-4a9a-8cc2-fb0c25069244" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_58e238bf-9210-4ee2-948a-bd5ef85ee408" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsNotSettleableInCashFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure_58e238bf-9210-4ee2-948a-bd5ef85ee408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_4b6b0c58-4c18-4875-bda9-a24202a21a0f" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsExercised_4b6b0c58-4c18-4875-bda9-a24202a21a0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_789923ca-1913-4aef-886b-6783f01d1873" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_789923ca-1913-4aef-886b-6783f01d1873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e89e1ecf-4b16-4f23-98a7-35032deacc14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_e89e1ecf-4b16-4f23-98a7-35032deacc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantsAndRightsOutstanding_978a6bc8-c355-41ec-8677-c1b38c598ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantsAndRightsOutstanding"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_WarrantsAndRightsOutstanding_978a6bc8-c355-41ec-8677-c1b38c598ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_8b402443-b6bd-49f6-adc5-6a1e5fdc3c97" xlink:href="aqst-20240930.xsd#aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod_8b402443-b6bd-49f6-adc5-6a1e5fdc3c97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_6b72a9c5-931a-4d96-bbf3-00b6d283d204" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_6b72a9c5-931a-4d96-bbf3-00b6d283d204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ab424a2e-2ca0-4b18-aec4-b86c02ac1eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_ab424a2e-2ca0-4b18-aec4-b86c02ac1eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2c6e2001-1ab9-4d67-924e-578eb5c170f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightLineItems_30354133-604b-4569-b744-3eb35d0a4951" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2c6e2001-1ab9-4d67-924e-578eb5c170f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_178b1e42-d27e-49cd-b11e-ed7612d3d9cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_178b1e42-d27e-49cd-b11e-ed7612d3d9cd" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_ec5eda31-ab77-413c-990d-fc45da34e9f1" xlink:to="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MonetizationAgreementMember_3db8655a-6933-4f2e-8350-21707fe36231" xlink:href="aqst-20240930.xsd#aqst_MonetizationAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_b0854ed0-c2a4-4112-808a-e2cf70a6fc9a" xlink:to="loc_aqst_MonetizationAgreementMember_3db8655a-6933-4f2e-8350-21707fe36231" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_f1189f01-d6b9-47a6-bebd-16800737034a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarathonPangolinRoyaltyLLCMember_e7d991e4-5f03-48bf-8064-e24ce62e7a58" xlink:href="aqst-20240930.xsd#aqst_MarathonPangolinRoyaltyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:to="loc_aqst_MarathonPangolinRoyaltyLLCMember_e7d991e4-5f03-48bf-8064-e24ce62e7a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_d7a54300-6da2-449d-8783-790be6e420a6" xlink:href="aqst-20240930.xsd#aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_e63fee7b-c53a-4210-844b-5501c29dbc73" xlink:to="loc_aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember_d7a54300-6da2-449d-8783-790be6e420a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_8101e2af-e995-4adc-855e-590ffeb9357b" xlink:to="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_82b99347-84bb-4022-bd30-77144245d1c1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_624d542a-24f7-49b3-88bc-998bb418dd50" xlink:to="loc_srt_MaximumMember_82b99347-84bb-4022-bd30-77144245d1c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_c3b828fa-bdcc-46aa-80c0-e91b8ff16f97" xlink:to="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_11043182-f195-4f2b-a4fd-6578d61af4fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5718eda7-44c7-4542-91c1-3cc0d6a8e298" xlink:to="loc_us-gaap_RoyaltyMember_11043182-f195-4f2b-a4fd-6578d61af4fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_eb9d74a6-e4b0-4e16-809d-5e5e8e7c22fe" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_4ebf15d1-7bb7-4aa1-9310-2858086ab734" xlink:href="aqst-20240930.xsd#aqst_ProceedsFromSaleOfFutureRevenuesNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_ProceedsFromSaleOfFutureRevenuesNet_4ebf15d1-7bb7-4aa1-9310-2858086ab734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ContingentMonetizationAgreementMilestonePayment_adbd15cb-3fdc-47a3-9022-a2029cfe0d87" xlink:href="aqst-20240930.xsd#aqst_ContingentMonetizationAgreementMilestonePayment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_ContingentMonetizationAgreementMilestonePayment_adbd15cb-3fdc-47a3-9022-a2029cfe0d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_fb168307-f061-4180-a4ca-dd61961d8625" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_fb168307-f061-4180-a4ca-dd61961d8625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aa4c54fd-500d-457f-aea7-01f51464636f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_aa4c54fd-500d-457f-aea7-01f51464636f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MinimumAnnualRoyaltyReceivable_3b32976d-195c-4b82-b5d3-2383c323ff5b" xlink:href="aqst-20240930.xsd#aqst_MinimumAnnualRoyaltyReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_aqst_MinimumAnnualRoyaltyReceivable_3b32976d-195c-4b82-b5d3-2383c323ff5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_940c0f44-a4e8-42c6-a39e-4d2ee6ebed31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_b65faf0a-eb1a-40d3-af0a-0f0f48a12d57" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_940c0f44-a4e8-42c6-a39e-4d2ee6ebed31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#SaleofFutureRevenueRoyaltyObligationDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c44d1cc-1a5d-43ae-b3e1-ca92cda19765" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_5c44d1cc-1a5d-43ae-b3e1-ca92cda19765" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:to="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_8f359f9c-9aa1-4815-8032-147afc7bd3b6" xlink:to="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyMember_663949b2-fecc-41ac-8147-d19ccebdd9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RoyaltyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_5304adec-935f-4f44-9508-7240f727c295" xlink:to="loc_us-gaap_RoyaltyMember_663949b2-fecc-41ac-8147-d19ccebdd9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_3065d8ab-4bc0-49f1-aaf1-675010b961bf" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:href="aqst-20240930.xsd#aqst_SaleOfFutureRevenueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:to="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_b5616262-aa32-4820-9475-07348d72c645" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_b5616262-aa32-4820-9475-07348d72c645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9c3d594-5942-4351-9991-d9e500922f3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b9c3d594-5942-4351-9991-d9e500922f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f3df6762-caa1-4654-9529-ded611a6aec7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f3df6762-caa1-4654-9529-ded611a6aec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyalties_a7495d14-e9ad-4063-9d4d-14dd7798530d" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyalties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_SaleOfFutureRevenueRollForward_782d9e01-5c86-472d-8dea-4e46e74120ff" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyalties_a7495d14-e9ad-4063-9d4d-14dd7798530d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_af840ef3-bbfe-477e-b6e9-beba0331fee7" xlink:href="aqst-20240930.xsd#aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0ce801fa-411a-4494-850f-5ff921b2a3db" xlink:to="loc_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent_af840ef3-bbfe-477e-b6e9-beba0331fee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5d7a31fd-4591-43b3-874c-efe8046947e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5d7a31fd-4591-43b3-874c-efe8046947e5" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_23eea036-91d9-448a-8474-01f07bff17ab" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_69f76c34-02b5-49b3-a1ed-8637fec54489" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_69f76c34-02b5-49b3-a1ed-8637fec54489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a0d8e7bb-ff71-46ec-aeed-9c29ee16cc43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a0d8e7bb-ff71-46ec-aeed-9c29ee16cc43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_17dfe302-fb26-4c03-a842-5e9b3701c815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_d19a170e-65d5-4d50-bff7-4a8699f047c5" xlink:to="loc_us-gaap_WarrantMember_17dfe302-fb26-4c03-a842-5e9b3701c815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:to="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_939828db-d910-4df5-bd67-5249c2a22025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_61b1921d-9eb6-45b9-90f3-f37c13fc06ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_EmployeeStockOptionMember_61b1921d-9eb6-45b9-90f3-f37c13fc06ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_1e314287-c336-4ca3-81b3-dd78556e25c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_1e314287-c336-4ca3-81b3-dd78556e25c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_7d764792-a678-427d-8ea9-82cffa029a83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cc104235-06f2-41ed-8ebf-f6f4adc1df31" xlink:to="loc_us-gaap_EmployeeStockMember_7d764792-a678-427d-8ea9-82cffa029a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_e03e232f-a9f0-425f-9a18-d9991756ff0b" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_27a58217-d048-4762-8820-98288715cdea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_NetIncomeLoss_27a58217-d048-4762-8820-98288715cdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_490c2de0-f725-44d8-8428-78dad796eb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_490c2de0-f725-44d8-8428-78dad796eb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6214805f-8f63-4d7d-b457-cdc81324636c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_6214805f-8f63-4d7d-b457-cdc81324636c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ea05778-f24d-43a5-81f1-0a211bbb3174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3ea05778-f24d-43a5-81f1-0a211bbb3174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c5b316a-4d6f-4c40-b4b5-291466c718b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9c5b316a-4d6f-4c40-b4b5-291466c718b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_785c5820-77f3-4ec2-84a3-e2ad0ec17a1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_EarningsPerShareBasic_785c5820-77f3-4ec2-84a3-e2ad0ec17a1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_be7a4bf2-c658-40ed-8a95-80d2d5f32104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_EarningsPerShareDiluted_be7a4bf2-c658-40ed-8a95-80d2d5f32104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_672a29d4-15ef-4660-9109-f71eb0b8a059" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_a0a5210d-1fe5-40ae-817f-0a937b6f9b54" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_672a29d4-15ef-4660-9109-f71eb0b8a059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#NetLossEarningsPerShareNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fcf24531-2526-462a-8043-f9e97b99acac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fcf24531-2526-462a-8043-f9e97b99acac" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2b7797f1-1536-479d-af4d-e810ecd961dd" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0324802d-80e4-48b0-a58a-bd57b5f954db" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0324802d-80e4-48b0-a58a-bd57b5f954db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_4d597f8a-e9ae-4efa-9b0f-dab372040a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_c4fa4680-d387-4bdd-ac48-8a85610b1fe1" xlink:to="loc_us-gaap_WarrantMember_4d597f8a-e9ae-4efa-9b0f-dab372040a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_ec7a7ba9-2404-46c5-b68b-5dcd3ea534d4" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3408c735-b2fb-438c-97cf-9f9a831e3392" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_edfa248f-b5f2-488c-aec6-1e4e73ba0c19" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3408c735-b2fb-438c-97cf-9f9a831e3392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ee78b288-74f2-4f21-9a0c-62681c372432" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ee78b288-74f2-4f21-9a0c-62681c372432" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_d9c751e3-d901-4100-abd1-887c81ba1399" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ManufacturingAndSupplyMember_fe07833a-fe01-436f-a783-d7e98d13ee92" xlink:href="aqst-20240930.xsd#aqst_ManufacturingAndSupplyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_aqst_ManufacturingAndSupplyMember_fe07833a-fe01-436f-a783-d7e98d13ee92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_795f85ff-a1c7-48e8-8338-175b652a591c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_795f85ff-a1c7-48e8-8338-175b652a591c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_81296d20-314b-453f-8dff-7e1a4644820b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_6c0d5318-e3ac-43db-be7e-cd9d683f6517" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_81296d20-314b-453f-8dff-7e1a4644820b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:to="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_22e4c0fd-a118-4da8-9fee-c3757c9762de" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_83d8d6c4-f4ab-4590-bd9a-bbfd132f5d7b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_83d8d6c4-f4ab-4590-bd9a-bbfd132f5d7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cff32296-fc26-44fb-b6d9-482173c28fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cff32296-fc26-44fb-b6d9-482173c28fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_fb9dcd3d-b434-4964-af70-6a757029d7a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_440d43f0-0f33-4314-86b9-edecaf4797de" xlink:to="loc_us-gaap_EmployeeStockMember_fb9dcd3d-b434-4964-af70-6a757029d7a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_760c130c-9816-4478-8a92-9374e6e5855e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_e7d2541b-ca9e-4d27-9fae-3400f5391cfd" xlink:to="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_e0ca3866-d895-4771-b519-c020b2436641" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationAbstract_a6efc237-a3d5-4399-aba8-fb0cb82b53b8" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_e0ca3866-d895-4771-b519-c020b2436641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationRestrictedStockUnitAwardsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dc07e386-b675-4d62-bb8a-8d2c9c42851d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_dc07e386-b675-4d62-bb8a-8d2c9c42851d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:to="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_7dbf2a3b-e189-477d-bcb0-5dbaa5f7452c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_5c676c7a-a2e7-4312-baba-29cdce6cd051" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_329b5e3b-2bb7-4a42-9064-67e8ca132ec8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_5c676c7a-a2e7-4312-baba-29cdce6cd051" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_12f71cfa-1bec-47ad-b95b-2d4d1f55771c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfec863f-f7e4-432c-825e-f466fa04d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bfec863f-f7e4-432c-825e-f466fa04d2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f30227e9-0109-4f71-85f0-d27d32586a75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_f30227e9-0109-4f71-85f0-d27d32586a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7db1b4c4-8ba5-448e-86e5-669364a7a5ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_7db1b4c4-8ba5-448e-86e5-669364a7a5ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9d8310d3-f9a3-4f70-bd39-79b94a73d050" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_9d8310d3-f9a3-4f70-bd39-79b94a73d050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_56174a08-50ff-4e34-9fe7-c5f84c1acf35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f382056e-fc40-4b4e-8f1d-ea03976754c4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_56174a08-50ff-4e34-9fe7-c5f84c1acf35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_864c88b5-0a0c-4971-a47b-c3a870a578b4" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_864c88b5-0a0c-4971-a47b-c3a870a578b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8413ff14-9bd8-44f8-a583-e164f9d742fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8413ff14-9bd8-44f8-a583-e164f9d742fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68611bb1-5c09-46e0-b951-555ae25b5f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_68611bb1-5c09-46e0-b951-555ae25b5f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_114e584f-b14d-47db-a196-4610b7720455" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_114e584f-b14d-47db-a196-4610b7720455" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c45396ea-487c-48ff-bc4f-890408c2e9e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c45396ea-487c-48ff-bc4f-890408c2e9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0467e92f-166f-4563-a5dc-9fd9a8dde895" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1b953f51-6654-4a3e-87ab-8312193410d7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0467e92f-166f-4563-a5dc-9fd9a8dde895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_d19a6b03-d3fb-43b7-a43a-918482d1729c" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_25a5acfa-e48d-46dd-b39c-678cdf0c3156" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_d19a6b03-d3fb-43b7-a43a-918482d1729c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9a489495-6367-41d2-9dd9-8986e59b6c44" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9a489495-6367-41d2-9dd9-8986e59b6c44" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0b9f42f8-c331-4079-a4c2-623ce7a0ef53" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a3b07f03-f547-49fa-94b9-d99bea7fd15e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a3b07f03-f547-49fa-94b9-d99bea7fd15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_13948778-78db-4a9d-b158-2e50ed700605" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_PerformanceSharesMember_13948778-78db-4a9d-b158-2e50ed700605" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_15e42478-cec8-4f16-928e-32cfb3ad9d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e049912f-ab4f-4c72-90a0-088f9adeab84" xlink:to="loc_us-gaap_EmployeeStockOptionMember_15e42478-cec8-4f16-928e-32cfb3ad9d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_249a9732-130d-4830-a67f-a96fdd8d7028" xlink:to="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_MarketBasedMember_d92abdff-a8bd-4dcb-8db5-d84cd5577129" xlink:href="aqst-20240930.xsd#aqst_MarketBasedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_4fc29bf2-f970-4321-ac21-2aed29ba50ef" xlink:to="loc_aqst_MarketBasedMember_d92abdff-a8bd-4dcb-8db5-d84cd5577129" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:href="aqst-20240930.xsd#aqst_VestingConditionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:href="aqst-20240930.xsd#aqst_VestingConditionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionAxis_355aaf7a-5928-48af-8038-cd144cef0ee6" xlink:to="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeOneMember_632c3c3e-e836-47d2-b702-e2135bb69419" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeOneMember_632c3c3e-e836-47d2-b702-e2135bb69419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeTwoMember_013ecf5c-cd6e-404c-8c25-d6b856cdd633" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeTwoMember_013ecf5c-cd6e-404c-8c25-d6b856cdd633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeThreeMember_b767afb1-7cb7-42c9-bb41-bf44bef827e8" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeThreeMember_b767afb1-7cb7-42c9-bb41-bf44bef827e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFourMember_3e5971b6-6d1a-40f6-9980-f3699d4134fb" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeFourMember_3e5971b6-6d1a-40f6-9980-f3699d4134fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeFiveMember_95a372d5-5e46-4bc6-bba7-55b97abae227" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeFiveMember_95a372d5-5e46-4bc6-bba7-55b97abae227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_VestingConditionRangeSixMember_80a9281a-7ba0-49a8-9233-694d28e36e0c" xlink:href="aqst-20240930.xsd#aqst_VestingConditionRangeSixMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_aqst_VestingConditionDomain_92873b44-b1e0-433a-a0b2-93e17c4d6c66" xlink:to="loc_aqst_VestingConditionRangeSixMember_80a9281a-7ba0-49a8-9233-694d28e36e0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0ad48372-76b7-4311-a178-3bcaf8fa3c74" xlink:to="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_7c3c6c31-8592-48d4-9e15-2baea529a200" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:to="loc_srt_MinimumMember_7c3c6c31-8592-48d4-9e15-2baea529a200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8737f872-7180-44cc-907e-e7fb43f7087f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_742b016e-7b1c-4382-8585-aa9ad9fea99e" xlink:to="loc_srt_MaximumMember_8737f872-7180-44cc-907e-e7fb43f7087f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_15c4203b-3450-4a90-9c04-7412a4afa6e2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5a2a0e42-8147-48a5-97d6-eb342baf6dfc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5a2a0e42-8147-48a5-97d6-eb342baf6dfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_29f6ee7c-e7bb-4c0c-9d18-2c276b71c82b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_29f6ee7c-e7bb-4c0c-9d18-2c276b71c82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8b6b8d9d-a510-48dc-957e-ea26b155e940" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_8b6b8d9d-a510-48dc-957e-ea26b155e940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_a9d44ca6-3b01-498d-b249-8079e4418c2b" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod_a9d44ca6-3b01-498d-b249-8079e4418c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_89bbbb4b-16d6-4941-bf8f-22c49a9cd15c" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare_89bbbb4b-16d6-4941-bf8f-22c49a9cd15c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f94c3fa-72f7-4d6c-82b6-f7fc5067d4a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_5f94c3fa-72f7-4d6c-82b6-f7fc5067d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares_83a9da82-c4e0-4012-9e0a-e51396d828de" xlink:href="aqst-20240930.xsd#aqst_InducementEquityCommonStockOptionsOutstandingShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_aqst_InducementEquityCommonStockOptionsOutstandingShares_83a9da82-c4e0-4012-9e0a-e51396d828de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_08be074f-cb6a-430c-841a-18fe10f25547" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_08be074f-cb6a-430c-841a-18fe10f25547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ac50782-20af-4ea0-99b3-64f94cecad6d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_7ac50782-20af-4ea0-99b3-64f94cecad6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_8939f3c4-bb69-4551-bbd0-432bd7999ee7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_SharePrice_8939f3c4-bb69-4551-bbd0-432bd7999ee7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_62bfc385-a24c-43c9-a7d6-83a36196e623" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ab0307a1-90b6-4c93-82ac-412f8122b749" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_62bfc385-a24c-43c9-a7d6-83a36196e623" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationPerformanceBasedDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29680fc9-a3fd-4849-a06d-54e7e80cc01f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_29680fc9-a3fd-4849-a06d-54e7e80cc01f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:to="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cda3f2a4-81b4-4583-94a1-8632064e3c2d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_65a22eda-5b45-49b3-9ead-b50c376b1016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_42fd44f3-6de9-43e2-bb24-7607ad79428e" xlink:to="loc_us-gaap_PerformanceSharesMember_65a22eda-5b45-49b3-9ead-b50c376b1016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2e2c8ca3-39c3-4525-bff6-51f947cf44bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_73e24e7b-ee36-4a18-b15f-43e012ac6d1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_73e24e7b-ee36-4a18-b15f-43e012ac6d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_429b42a8-c7cf-4528-9898-689f36faebf2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_429b42a8-c7cf-4528-9898-689f36faebf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_666e0bf4-4532-4289-9c21-7cc493e5143b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_cc074384-d4e8-418f-b387-f594fd5c8192" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_666e0bf4-4532-4289-9c21-7cc493e5143b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_49f2d41d-70e1-48e6-8fd5-c806556d1042" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares_49f2d41d-70e1-48e6-8fd5-c806556d1042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a7c09e1-7c51-44fe-9b62-03da64f6cb54" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6a7c09e1-7c51-44fe-9b62-03da64f6cb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f9606631-f0be-434b-ae64-b0d8496011d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_f9606631-f0be-434b-ae64-b0d8496011d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76f60eea-f2f5-424f-b86d-e6a6ac6aa2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_77e6f39a-da5a-4903-9844-948838c49816" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_76f60eea-f2f5-424f-b86d-e6a6ac6aa2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_de06d327-e7e9-4efc-a5ee-89edc0d1b306" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ed47d955-bb7e-42d1-9dde-55fecf05f4dd" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue_de06d327-e7e9-4efc-a5ee-89edc0d1b306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12c68a2f-cbd7-44b2-ac15-23c9fd893be0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_12c68a2f-cbd7-44b2-ac15-23c9fd893be0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:to="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a50dd904-4892-4ee9-9141-8fe7e20e2225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ff91d295-051c-4bed-a93b-02b81cbe71a0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a5dd5046-28e8-491f-b51e-65d0fca850e2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ff91d295-051c-4bed-a93b-02b81cbe71a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_d61a6c4c-fffb-4c2e-87e3-4e9b61ceb7be" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db4605fc-2c5a-40e7-9301-4ca7077d320c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_db4605fc-2c5a-40e7-9301-4ca7077d320c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1dc2854-16c0-4367-8fe6-7ba6c70672a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c1dc2854-16c0-4367-8fe6-7ba6c70672a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d828b9a-fbaf-4e22-9b6a-d28a64e9e016" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3d828b9a-fbaf-4e22-9b6a-d28a64e9e016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_3eb36e84-b393-4f0f-bd1e-dffba3694aeb" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod_3eb36e84-b393-4f0f-bd1e-dffba3694aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b9bc22a0-e676-4162-8c86-eff7aadb5c11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_634e95df-db0b-466f-ba37-6634af2a77f4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_b9bc22a0-e676-4162-8c86-eff7aadb5c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ebca7136-2c7b-4d73-8b07-01ce36e08828" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_ebca7136-2c7b-4d73-8b07-01ce36e08828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d0cc085e-52fe-401b-bb27-f85e3a679a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_d0cc085e-52fe-401b-bb27-f85e3a679a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2e62ff42-d389-4481-8545-4b18a0d3fd85" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2e62ff42-d389-4481-8545-4b18a0d3fd85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0898c9bf-7fee-4100-90e5-d0a13f54ba71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0898c9bf-7fee-4100-90e5-d0a13f54ba71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c167d007-2bee-42dc-935b-b09f66ab03e7" xlink:href="aqst-20240930.xsd#aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_c167d007-2bee-42dc-935b-b09f66ab03e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_778e1548-1768-4c79-a000-b9bd14ceee50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_acded351-7162-4651-8773-5a0896b5bfa6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_778e1548-1768-4c79-a000-b9bd14ceee50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c85415af-87cd-4e15-9bd7-0e2596b08b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_39fd8243-2c01-4089-b1d9-ed437753bc3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_c85415af-87cd-4e15-9bd7-0e2596b08b2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48858ebc-a9d3-40e5-a23e-1c41da899f83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_48858ebc-a9d3-40e5-a23e-1c41da899f83" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:to="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a4b356ab-9318-4e91-a871-37f9bbc55b84" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_0c2f056b-3a83-4478-ab1d-7f110f8b33eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4932adbc-823d-4456-869a-511a05ae84f5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_0c2f056b-3a83-4478-ab1d-7f110f8b33eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:to="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_567493cd-7c51-4528-b30d-c79badeb2c11" xlink:to="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3cb07101-39f3-4fee-af3e-739a9ef354c4" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:to="loc_srt_MinimumMember_3cb07101-39f3-4fee-af3e-739a9ef354c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a6354451-c22a-4f67-abb2-96e3d99cecce" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed8e073d-f695-48ac-9daa-851797bfb83f" xlink:to="loc_srt_MaximumMember_a6354451-c22a-4f67-abb2-96e3d99cecce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_269744f6-3b6c-463a-8c53-74200984ea1f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c5afbea2-1051-476a-9f8a-3bca29acc3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c5afbea2-1051-476a-9f8a-3bca29acc3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7a930a92-5ff5-40a5-8512-d9503fd884d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_7a930a92-5ff5-40a5-8512-d9503fd884d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_ff75abd8-369c-4cc8-8f64-37d5feaf3370" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_ff75abd8-369c-4cc8-8f64-37d5feaf3370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e48c9a4-9e3d-4176-8e3d-7683bfdda525" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8e48c9a4-9e3d-4176-8e3d-7683bfdda525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f9ca5953-82a5-45e8-b8e6-981c012c85df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_15cfb96a-8bc9-48e0-89a5-c2ec1481b408" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_f9ca5953-82a5-45e8-b8e6-981c012c85df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_07b08597-d073-47eb-8524-3aa81b42d8af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_945ab443-3eab-424c-815b-7e24c72dedb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07b08597-d073-47eb-8524-3aa81b42d8af" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_945ab443-3eab-424c-815b-7e24c72dedb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ebfc7398-abef-4ded-a6f9-0bf9f555e94a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07b08597-d073-47eb-8524-3aa81b42d8af" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ebfc7398-abef-4ded-a6f9-0bf9f555e94a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4e6b9e1c-8492-4e84-b92b-633bde1325e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_07b08597-d073-47eb-8524-3aa81b42d8af" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4e6b9e1c-8492-4e84-b92b-633bde1325e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://aquestive.com/role/ContingenciesDetails" xlink:type="simple" xlink:href="aqst-20240930.xsd#ContingenciesDetails"/>
  <link:presentationLink xlink:role="http://aquestive.com/role/ContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a97c9cd-2fa7-4667-bd33-1402c2f6d6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_5a97c9cd-2fa7-4667-bd33-1402c2f6d6c5" xlink:to="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f9b15f19-35b5-4800-bb55-509cd98ac04c" xlink:to="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_b46bde5e-3199-42b8-95f2-8ed29b467fef" xlink:href="aqst-20240930.xsd#aqst_NeurelisIncVAquestiveTherapeuticsIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:to="loc_aqst_NeurelisIncVAquestiveTherapeuticsIncMember_b46bde5e-3199-42b8-95f2-8ed29b467fef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_SuboxoneProduceLiabilityLitigationMember_829e33bb-9ca4-4bbb-80a6-00eee19e7243" xlink:href="aqst-20240930.xsd#aqst_SuboxoneProduceLiabilityLitigationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_858d46a4-ef1d-4462-8926-c5c6f7c73f5c" xlink:to="loc_aqst_SuboxoneProduceLiabilityLitigationMember_829e33bb-9ca4-4bbb-80a6-00eee19e7243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_30db8d4f-9a15-44f8-af60-9104de5d590b" xlink:to="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA-BC_ed69213a-03b1-4018-afa0-c04ce403272a" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA-BC"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_8c2773be-f13c-4486-b30d-f5c446a8f162" xlink:to="loc_stpr_CA-BC_ed69213a-03b1-4018-afa0-c04ce403272a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_1deee74e-d670-483d-8968-f4816bb8f636" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_630d09ce-668f-453d-afdb-02800c798dee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_351033de-ac01-4c92-a96b-d90587484441" xlink:to="loc_us-gaap_SubsequentEventMember_630d09ce-668f-453d-afdb-02800c798dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_01d1a3ad-d606-4d8f-8928-b95f4566a74d" xlink:to="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyPendingClaimsNumber_70683f4b-aad8-416a-96b1-b122037945a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyPendingClaimsNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LossContingencyPendingClaimsNumber_70683f4b-aad8-416a-96b1-b122037945a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_4c989943-d2d2-4eac-8ccd-88e747cdc796" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LitigationSettlementAmountAwardedFromOtherParty"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LitigationSettlementAmountAwardedFromOtherParty_4c989943-d2d2-4eac-8ccd-88e747cdc796" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_419eb8b0-c4c2-4a6c-8007-dca8e219e1e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_a2db4963-91c1-4de2-86a9-dfb337c132b5" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_419eb8b0-c4c2-4a6c-8007-dca8e219e1e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_PerformanceSharesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_DanielBarberMember" xlink:href="aqst-20240930.xsd#aqst_DanielBarberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_aqst_DanielBarberMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_aqst_PeterBoydMember" xlink:href="aqst-20240930.xsd#aqst_PeterBoydMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_aqst_PeterBoydMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>aquestiveamendedandresta001.jpg
<TEXT>
begin 644 aquestiveamendedandresta001.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !33&C')12?<4ZB@   & ,"F^6@.0BY]<4ZB@!IC1CDHI/J1
M1Y:8QL7!]J=10 THA !52!T&*7:NW;M&WIC'%+10 A )!(!QR/:D>-)%*NBL
MI&"&&<BG44 -1%C0(BA5 P%48 IU%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%8'BWQ;8>#])2]O5DEDFE$%M;0@%YY#T49_G5'5O&DOAF73&\1Z='9V=_
M*+<7,%SYRP2D9"R91< X/S#/0_6@#K:*XW4/&]U:?$*W\'P:3#+<7%J;J.X>
M[*)M&[@@1D@_(?6M_1M0O-0BN3>V*6DD,WEKY<_G)*FQ6#JVU>#NQT[&@#3H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \S^,.@ZA?P>'];L+:6[&
MBWZW$]O$NYVCRI) [XV]/<U2^*QC\>Z)I'AWP[*E]<W5\DTCP_,MM$%8%Y"/
MN?>'!P3R.M>LT4 >-^(+!+[X^Z5";FYAMAHQMGNK>4QLC_O<#>.C<CCW%>L:
M19'3=&L;!G\PVUO'"7_O;5 S^E7** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% &#J/@_1]2UR'6VBFM]4B3RQ=VLS1.R
M?W6VG##ZYK<1=B*H).T8RQR3]33J* "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"!K.!KU+QDW3HA1&))"@]
M<#H,X'/M4]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[/S>9\I(7T/)KI-*\1:SXE\.:1K>F0VEE;7-I+/<BZB:5E=2 JKADX/SG)[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@KLA_A8$%6'?!!QVQ2Z7X9T[1VOIK02B\OFWW-X[[YI6Z#+'L.P P.PK8HH
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M-;5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=Q=1Q02$"-V.-Y/0*.I)[ =:;::SI][=&U@N5-R$,A@8%)%7(&2A (&2.2*
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MH4B"2-D)8!AC*D@_@165IWAG2]*T%]$LXIH]/977RS<2,0&)+88DL,DGH>]
M'%>&]8U/1+#PA%-=BYL+SP^TWV80JOE&&&)EVMU)(8@Y)YY&.E;?A_4/$.I3
M:+JC30/I>H6IDN(W9!L9D#IY.T9(Z@AB>.>QK7M_"FD6LNER10S!M*A:WL\W
M$A$<9 !7!;#<*HYST%1Z-X.T30+IY]-MY8LEBD37$CQ0[OO>7&253/L!Z=*
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M"H<-NVD<$$XIDO@+P]-I3:<UK-Y)NFO%?[5+YD<S$DNC[MRG)/0]Z ,.6_\
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MQ6TD$=PR;DP,H^QL.N1G!R/UH PM)\3ZQKMEHEG%,8KZ[T1-1EFA$89G8A>
MX(V@Y)&,\KR.Z:IXDU_1[.T?6W-G&;,">_T^)9X(+H,RDR@@LL?"\@#!W G@
M5NS> ?#\UAIMF+>XB73%*6DL-W*DL2D8*B0-NP0.F<5<G\+:5<(T;13)"]L+
M22%)W5)(06.UES@_>;GJ<GF@#F8[G48_$'CJZ@U65OLEM"]LLB(\:CR6<
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M",@\]Z+K0==;5(-1M()[/6%-JMQ-!*ALKQ%">9YD9.05^<*0 >%P3V .XO\
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MZIJ,EPD1$! E,<CC VKM&%7\AFK&A:??67BWQ+=S6#QVMU]G-O(&3$GEQ;"
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MW67H%H+33 !I<&F>;(TIM8MOR$G^(KP6/4D<<]3C)U* "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M1F"C+$ 9 Y/<TM<A\05E:RT-8KJ> -K=FC>4P&X&4=<@YP<'TR* .@L]8LK_
M %*_L+=W-Q8,BW"M&R[2PRN"0,\<Y'%7Z\JUI]0T^_\ B#J5AJEQ:SZ?;6MP
MA14/FLD!.'W*<@XZ#'6MN\U+6]=U;6--TF]BL;FQMX'@+2[0&=-^]E*-O7/R
MXR.A[\T =U16'KMW>0^!M0OH+I8KV+3WG2> !E#K&6RNX$$9'<=*YFTFUF;7
M=!LWU^\\G5M'>YGQ'%F-T\K!C.SY<^80<Y_/F@#T*H;NUAO;26UN%+0RJ4=0
MQ7(/49'->>:-XFU;4K+PWITUV#<7R7WF7#2"%IFMY1&J@A& )4EC@#[OID5:
M@U#7QJ.F^&K[4K:6]>UN97N8)O*,Q21550WED;E5LL HR1Z @@';65I;:990
M6-JOE01*(XHRY.U0. ,G. *+*^BOTE:)9E$4SPMYL3(2RG!(R!D>A'!K@[:+
M5V\9^%(M5U<S7BV%Z+AK0@12/')$,X*]2#AN!R#C%5SK>N-I4176)A-_PE;:
M:TABC):#SB@4C;C@ =,4 >@ZII=EK-A)8ZA#YUK)C?&6*AL<\X(S5I$$<:HI
M8A1@;F)/XD\FO/)M9UW3M/\ %UK!>S7LVF7UND,\J(95AD2%W  4!F =]HQR
M<#!X%;_A\ZK)XAUAYKF\?1T\I;%+B(+EBN9.2H<@'&"3CDCMP =-5"PUBRU*
M\O[6V=VFL)1#<*\;)M8J& Y SP0<CCFN7\7:WJ&C:H\\[7<6BB",&\LMKFSE
MW-N::,C)0C;R,XP>AYKG]9N=0TRX^(&L:?J,UM+875M,L<:H5E(MX<A]P)((
MXP,=?I@ ]7K)D\2:9%=:G;/+*)=,A2>Z @<[4;=@C ^;[C?=STKD_%NO:E8R
MZO<Z=J,KG3Y[-#'&BK%!O= Z/GEV8/GC[H(Y!ZRW?_(W>-_^P%;?RN: .SM+
M^WOM+@U&W+/;3PK/&0AR49=P^7KG!Z=:9I&K6>N:7!J5A(TEK."8W9"I(!(Z
M'D<CO5'P9_R(WA__ +!MM_Z*6O/O#,NKZ1X5\(:E::K-)!<WRV4VG-&GE&.2
M1P64A=P9?O9W'H>,4 >N50U#6++2[BQ@NW=)+Z<6\&(V8,^"<$@8' )YQTKD
M=$U+7M=BT[7(-0MH;8WSQ7=O+-E3'O9/+">7E9 =N#NY.<\$8N^/4>2;PJD<
MIB=M=B D4 E?W,W(SQGZY^AH ["J&JZQ9:+!#-?.Z1S3QVZ%8V;YW8*H.!QD
MD<GBN&B\2:I8P7.G2W[3L/$G]E1W=PRHRQ-")0"P3&23L!V_Q#OS1XBAU:V\
M.R6^JWL%UMURP>VV/ODBB:XBPKG:N2"#@XSCK0!W6L:M9Z%I5QJ=^[I:VZ%Y
M&2-G('KA035:]\-Z+JUXFH75A&]SL"^<I*,R]@Q4C(]CFN%\6ZA<Z_X/\?LU
MY+;IIC2VD=O'MP56)6+-D9.\L1[ #'.378^*=9G\/>!M1U>UB$L]K:&2-2,C
M=C@GV'4^PH W888K>%(8(TCB0;51%P%'H *?7%W5WJ6F^)M)L(-4GN[35;*X
M9Y'5"T,D:JPE7Y<8.[!!!'W<#UR?#.L:U*W@:[N]7GNAK5I)]JA>.,)N6'S
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M$].A%6+G0M8@\4ZE=PZ'IFIV6K>5*6O)%5[.18UC8,-K;TPJG"GKGUS7>44
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M\9)QG/; XZ4 =9<ZW;6NO6.CR1S?:+V.22)POR8C +9.>O(_.M*N*\5V8O\
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M]K#,Y8L\<04DMRW3U[^M8VL^.](T1;AY_-DCM0AN6C* PA@",JS!C@$$A02
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M(BGO-&T[7+FXU(7%Y80F:*XN \4CE0QE503LR21@;>/X>E=70 4444 %%%%
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MMF?<KH#$K,\6'4$^;Y@/!Z '(XKL]+\+QV>OZOJMT;6Y>^N4N(LV^&@*QJF
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M:IID,>H&6TU+P_<,Z27>^6=LQ%&EP<>:0S<#IR,D=/6XXTBC6.-%1%&%51@
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M1P016K533H;R&S4:A<1SW3$M(T2%$!]%!)( ]R3WJW0 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M17'?$0HMCH9>X>'=K=DA*3&/(,H!'!&>/RH [&BO'M;LK"WM/B-%#,Z+IL4=
MS9HMRP%O,8 Q=1GABP'XY]35[6-1LM2US4=-U[6H--6:RMY--GE&&*E?F>!]
MP D#YZ9)^7J.* /4ZCGD:&WDD6-I&520BD M[<\5Y;J-K:W6I>-8[VYGE,&A
MVLR^;.RE)0D_S[0<*V0IXZ$U:TAXH/$WA.>&Y=I]5T.>2\9IRYG<+"58Y/4%
MGQ[9'2@#N?#VL)X@\/6&KQPM"EY"LRQL<E01T)K3KQWPG80Q:-X O='GD.K.
M4BO42X9@UN(V\P.N2 %(4#@88@=35WPG<V6M3:3<7>MK#XBMY)4O[*)=EP[8
M(D67YL^6.H. !A<8X% 'JM%>2:!IUM/\.K34K;4XX=3GN&MQ<7D[RPR[;IF6
M&0;L;6P%XY^;ODY['PE>3W'AS4/+TQ;*^M[F:)K=9?,A,H'6-N/D)(X[<CM0
M!U583^(99-5FM+#3I+R.TNH[6\D20*86=5;<%/WE4,I/.>> <&N(TNX>ZT;P
M7J-A,QU^6]CBU/YOWL@PWVE95]%()&?ND+C&16YX(MM/3Q/XQ:VC@$J:F$!3
M&57R(<CZ;@?QS0!T>L:];Z3INJ72H;F73;8W4UO&P#!,,1R>!D(WY5>LKD7M
MA;W078)HED"DYQD X_6O,-973;75/B8'%O%=R:4LD8. [ VSAF'<C/!/K1&9
M-+U6#^PI&-[=^$YIUC\TOYUPGE^4<$G)^9@/;CI0!ZM6!>>)C;>*(] CTRXG
MN9;5KM'1T"%%8*?O,#G+"N;\%3Z/J>IV6IZ7KB3W#66RZLK=<'L=UP"Q(D#9
M )P3D]1T76Y8?^%PZ<CZK]@(T2?,B/&#S,F!\X(YP3TSQ0!UFB>(+77/MD<4
M4UO=64WD75M. 'B? (Z$@@@@@@D&M:O%K>^N]-T[Q:+*9[W38M7M7N-:C),M
MQ"[+]H!9>#Y:C;E   3P,5M:[<V^DZAXADLIIT\/MHJ27(TZ4*(IVDVJR'D(
M63)) Z ,: /3Z#TKQ;5]0MUTKXA6UOJ%JD:Z;;W%O'83E8U8JX8I@\\A 2,
MG&1FNEOUTS1?$^@V<[B/0M16XN)9+B=GBGN]L80.S$CE0Y Z$\XR* .N\/ZX
MNO6=S.+9[8V]W-:,CL"=T;E2>..HJ#5/$]M81:?+#$UW%=ZBNG^9&X C<N4)
M.>N&!''I6-\-#9MHFKV]I)')!'K-ZH"ONPIE;;S[C%<99)I<7@S2+.-X(9E\
M5B.X2)PCH/MDNT''*_+T]J /::*\DN[_ /L)?%-M9S-'I5IK=H;@*6D%O;O%
M&93@'.W=G< >A;WI=6CTR+0YKC2]?%S9SZUI[*+*7R[>%C*BNL95B.5^9ESP
M3GC- 'K55H9[F2^NH9+-HH(PGE3F12)L@[L*.1C@<]<UROA-8+/QGXLTRTD(
MMH7M94A\PL$9XSO(R3C) )]ZYGQ3.J1_$]5O)%:*QMI$ N&!1O+<\<\<XXZ4
M >LT5PNCI;6'Q,>ULYSY=UHB7$J&8OYD@E(#G)/.#C/I5?4)K>]\1^+K+791
M"(+2*33F=]A2+RR6DB/9A)G+#GA1Z4 ==JNL?V?=6=C!"+B^O?,\B)GV*0B[
MF);!P.@Z'DCW(RE\6WUPLJV/AZYGN;4Q)>6IGC22%Y%#!1D[6P"I)W#@\9Y%
M<S#$;O7_ (=OK\4)U:;3IS<B4 .7$49Y'KG/XYIT%OIJ7WQ*>'RHY(BN'B?8
MR#[(A."#D?,#^.: /2+626:TAEG@,$SHK/"6#&-B.5R.#@\9%2UY5::MII?0
M+'Q+=Q0Z1=>&H6MI;F4+$T^,2_,>/,"["#U&3CK2ZG=:<-5&BZUK'V/3)-'A
M_LZZU,?-(07$CAR5 FQY9R?FZ<#G(!ZI17&>*;F_TWX9>=:7%W/)%%;B>X92
ML[0[D$KD#D-LW$]QR>U8VMB*#4M:_L:X5-'D\.33W MI=L23 _NG4J?E9EW]
M.H49S0!Z6Q*H2%+$#(4=367X;UM?$6A0:HEN]NLK2+Y3L"5V.R<D<?PU1\$:
M=96OAJQO+4N\M[:023RM,TGF,(P,\D@?ABO/M$L(1X?\.WNF3RC7TUIXF1+A
MB3#]I?S49,X"B/+'CK@]3R >R5#<W<%G&DEQ*L:O(D2EN[NP51]22!7 K8RV
M'B>^\*"&1K'59TU&";DB*)2//C)[ ,J #L)N.E7_ (D0V9TS0YKQ(?(@UJS+
MO*!MC0R $DG@#'% &]INNC4=<UC2_LLD+Z:T2L[,")-Z[@0!T&/6M>O'O$<=
MA-_PL:[BF DLK2VFM&BF*^6ZP91@ >N0,?EWJ_K6H6.HZ_JFF:]K4&FK+:6\
MFFSR##%2OS/ ^X 2!\] 2?EZCB@#T;5=4L]%TNXU+4)A#:VZ[I'(S[  #DDG
M  '4FLZ3Q!=V]K%=W.AWD=O+)&GWT:2,.P7=(H/ &<G!..]87Q$L+V[\"6LD
M$<]V]C<VMY<1;/WDT<; N-H[XYQ[5T\'B#2+ZTAGM+^WNH[C B6%PYDSV Z_
M7TYSC!H CT+7!K;:FHM9+=K"]>S8.P)8JJMNXZ#YJUZ\<OQ:Q:9XIU9)]E[:
M>*8O)E68CR\O;JV!G'*E@?4?2K'B+6;%=:N+F"^2"YM/$-E',US,/.5,Q*X0
M#&R#:3UR&+-TXH ]2@GN9+VZBELVB@B*^3.9%(FR,G '*X/'/6K->1>*;A%L
MOB<$O9%\J*V>/%PP*$Q \<\#)Z=/:O0'L%T?PUJ;Z C/=2Q2W,6Z5I?,G*?*
M<L3U('3C\Z -VL*+Q#+=ZF\%CITEU:P7ALKFX20 Q.%#%MIZH,@$@YSV(YKD
M-+ECG'@:^T:<O>77R:F-^6EC\EC*9AW99 HR>0QQWQ6K\/+>PCF\3/:1P!UU
MJXCS'C(4!,#CM0!N>(/$UMH6B:KJ*Q->-IJ;YX(F 9>,X)/3@@^N#6TIW*&]
M1FO'=?73;33OBG$!;Q7C8=4X#E&MXB3CK@MW[FM'5Y)M'UWQ!%X?DD-Q+X;%
MVL:2F1GF#N/, ).7VG\<"@#U*N?G\3M'XIE\/Q:5<SW26@O-Z/&$:,N4&,L.
M<@\5C>#I-%OM:;4]$UR*Z2:R"S6EHFV-3N!5Y1N)67DCG!(!SG%4]0E@/QFG
M5M9.G$>'XU+H\0.?/<X_>*PZ<T =AH6OVGB"UGEMDFBDMKA[:X@F4!X95QE3
M@D=P<@D$'K6K7B^F7]SIV@W\<3F?14\31B[U=20;RW<@R2.V<$!MJ,RX4KD8
M S6OK-S!I%WXG6*:9?#Q@LBPM9A&D5R\I5E5L$(A787P. V<9/(!ZC2,2%)
M+$#H.]>+ZKJ$"Z'XXMHM2@2.&\LI8%LIBD:!Q%N* '[I).>Q.3BNGNTTK1O&
M^GZ3>E(="N;*>YA%U,6BFNRZ[LER02$R0#Q\Q(YH ZWPWK:^(M$CU);=[</+
M-'Y3L&*F.1HSDCCJN?QI=5U>;3I-L6EW-XJPM-(\3(JQ@=CN89)YQCT-<O\
M#74]+M/!>G6GVZ /+?7D$"-+EG83RL%]2=O/_P"NNOUATCT2_=V55%O(2S'
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M.^U$+L%#,V#M49Y.*ICQ'*7LK46<1OKUY/LZ+<9B>- "9?,"_=PR]%)RP]R
M#;-M Q),,9+=25'-2*H50J@ #H .E>?:KJ-[=>)/!E\=*N+>]-Q>Q-9R2X!*
MPN,YZ%>-P;&<=NU:UKXXBGTVWDDM!!?RWD]D;9Y<JDD)8.2X4Y7Y>"%[CCT
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M^>YE,LK$ ;C@#L!V _GU)-3I%'%GRXT3/7:H&:?10!$MK;I"T*01+$QR4"
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M#&K2_P"L(4 O]?6I** &I&D:[8T5!UPHQ3J** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M* "BBB@ HHHH **** "BBB@ KS+Q(_\ 8/B35+_Q)H;:IX?O0GEZC GF2:<
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MJ=O+K6EZ99 1Z?=KXATZ7RP5+G), ]"9%D_!L=Q0!ZB]W;1+(TEQ$BQX#EG
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M:XWW*>6'=@-S(FU=JDCT&3D]\FCXPNGL?$?AB\NXY&T6*:;[4ZH76*4IB%W
MSP#O&>@)!H TO#WB/^U[;59[I+>VCL;^2U#K-N1E4*0VX@==U7[W7--T^*UD
MN+R%5NY5A@.\?O&;T]>,D^PKS.RN;6S@N\:=,MN_BN26*9K:410 QY64HH&\
M$@@#H&8$]!4-O$JZ+8^?:7+Q67B^5Y#+9L"D+/+@[=O0[EX P,B@#UUKJW6=
M(&GB$T@RD9<;F'J!WJ6O+-MI>ZUJ>CZXNK)?MJ@N[%(+; F0%3"R2A"5V@!3
MEAC!SWKT/3M:L=4N;ZVM9'::QF\F=7C9,-[9 R.#R..#0 _4]6L='AAEOKA(
M5FGCMX]Q W.[!5 _//T!/:B.YG.HW"R&U%DL*/&ZRDR$G=N++C 7 &#GGFN=
M^(D"OH^FSO;F6.VU:SEE(C+E(Q,NXX )QCK7.:W!:2:GX\"6RB.Y\/0A%,./
M,D"S8 &.7&Z/CJ,B@#TO[;:8D/VJ'$:AW_>#Y5/0GT%.DNK>*W^T23Q)!@'S
M&<!<'H<]*\VL=,TG_A*_##-96ODOH4HN2T0VLX,)429&"W$A&[G@UE:3=OI6
MB>%;B^%Y%HT'VZVF:&W\W[-(TW[DNA1B%V!E!QP&]#0![$K*ZAE8,I&00<@B
MEKE/#MYHN@6.D:);->QI>F9K%;J)\LH)8Y.T!!SE5..,#':NIDC2:-HY$5XW
M!5E89!![$4 1I=6\DHB2>)I"NX(K@G&<9QZ9K'\/^('U6WU6:]BAM!8W\MH2
M)=RD)CYBQ ZY]*\V\)Z587GASP'<:1!$NLV]VKW,T28D6W <2"0]=I&T#/!R
MN.*TH[N&VL[YYK5Y4;Q;)(LQ1V2 $929E7!=<C _AR0<\4 >H"Y@-O\ :!-&
M8,;O,W#;CUSTQ2?:[86WVG[1%]GQN\W>-N/7/2O)+*ZFTRWBN;BUOI=)LO$U
MW+>J;1P5C</Y4A3:,J'8,0!P2#CI6KJDUEIO]D:KI]K?V_AU[^XFNI(K=G(D
MD7Y9O+=6(3=O'W>^1U&0#TI)$EC62-U=&&593D$>QJCJ6J)8S6EJBB2\O9#'
M!%G&< LS$]E !)_ =2*H>#[.PLM$*Z8+O[%+/)-$;E=A.\Y)5"!M7).!@>HX
M(K/U9)$^*?AR>3)MWL+R&,]A+F-OS*J?^^30!OM?2VUQ?O>M:QV5O$CHZR$R
M=#NWJ1A1P,8)SS6?X<UN_P!=AMM0-M;+IEY:)<PO'-F2-FP?+=<8SM(.0>N1
MCO7/".UC\4>/2\48CELK8\IQ(X20'']X@E0>^2*WO *11> =!C1%C=-/@690
MNTB01J&##^]D<YH WI[F"U0/<3QPH3@-(X49].:62XAA&99HT&TMEF X'4_2
MN.\730_\)'I]M+:2AI;&Z1+L0O,/FV Q*@RN]@,[F!P%(P<\<OX=MK*\N? !
MO[17\K0IH;G[5 1AE$.T/N'JKXSZ'% 'K NK<F,">(F0 H-X^8'H1ZU1U768
M=*M3>R%'LX7"W3JW,() W$>@/7T&3VP?.=/L6MOAQI.OVEOF_P##MU<3I$5P
MQM_-D$D0STS$<K]%KI=<M?L?PM\0R7<06ZO+&YGN%QSYLB'">Y&50?[HH [2
MJVH7]KI6GSW][.D%K;H9))'. H%96@ZI#']C\/W,DG]KVVGQ2SHT; $8"L0V
M,'GK@]Q3/'=J][X!\06\4!GE?3YQ'&J[BS;#C ]<]* &_P#"4*?%%IIVR 6%
MQITE\+HS<C8Z+M(Q@#Y^N3TK>ENK>" 3S3Q1PG&)'<!>>G)KSV%-*U'QCH#2
MVT3V"Z'."L\&V,,9(B,A@!DA6(SUP36!HEV=,TGPM)J_VV+2!I\]H9([7SA!
M-Y@PLB%&*AD  ..V.AH ]E!! (.0>A%1RW,$ )FFCCPI<[V PHZGGMR/SK-\
M+V-MIOAJQL[-;I;6)"L(NR?,"9.W.0".,8! (& >E<[J-EIUQ\5HGO;6WDA.
MB2K(TT8*%O-0@,3QG:&(![9H [1;F!I5B6:,R,F\('&2OKCT]Z!<P-<-;B>,
MSJ-QB#C<!ZXZUY)X<M+:TTOX=W"6RQ7J7<D=Q)Y>)%3R95PYZ@9\L8/'W?:K
MOA@6UY<Z=:ZJNK?\)+I5W++)"+?8NXE@TGFA &C=3GEN<@=<4 >G1W5O+-)#
M'/$\L?WT5P67ZCM2)=6\D@C2XB:0J6"JX)(!P3CTSQ7E/A^XMY==\*3_ &.:
MVM39WT$]L]K)MM]Q1O+E=QEVR&+$G'&<#O%X:LK2RTWX>W$5JD-VE[.EPXCV
MR*ABF&'.,@9*#GC[OM0!ZXEU;R3/#'/$TJ?>17!9?J.U2UYWX3-Q;>)+6")X
MM2TZ2"X:*=XC'=V&75FBF[,&.,$X)VYY'-=-XV@U.Y\$ZS#H^_\ M![5Q"$.
M&)QR%/J1D#WH V([NVF$ABN(G$1Q(5<'8??TK!T7Q%=Z]<I<V-O:OI1FG@D?
MSL31F-V0/MQ@ABAXX(!!YY Q[=;34O%N@:EHL:PV,6G3QZBH38JQD)Y<4@/1
M@VX[3R &]:M_#..&/PH52)8Y?MET779M;:;B0ID=<;2"/8T =>\B1@&1U0$@
M L<9)Z"HC?6BI$[74 28XC8R##GV]:Y+XB6]K<1^'1<PI*%UFW9MR;ML?.\G
MT7&,]O6L/6;72].\0ZEHNK6UW::)?V,4-@MC9"2(CY_,B&V-BC[FW#&,Y!Z@
M4 >E2W5O!N\ZXBCV@$[W P"<#KZFG+/"TS0K*AE4 L@8;@#T)%>8W&E:<=>\
M21W5DKK_ ,(];H/M*AV:51,#D]&D * D<\CUJO:VC0MX-DTJ-(-4FT&YCEF"
MX8S&&+8)3Z^8K?>[@T >JI<V\DLD23Q-)']]%<$K]1VJIIVMZ;JME)>6=W%)
M;QN\;2!QM!1BI.?3*GGO7 Z9 +^T\#+I\#PZK82!-21D*O%$(6$RRY_O.%QG
M[QP1GK6;:O)I7ANR8VEY%;V&OW3:HL%H2Z1M)/Y;X*D.JEHVX!P,'TH ]=BE
MCGB66&1)(V&5=&!!^A%$LT4$32S2)'&O+.[  ?4FN?\ !UMIT&GW<^E-=M:7
M=T]P'N4\L.S ;F1-J[5)]ADY/?)H^,;YM*\0^'=1O(9I-%B>=;IHXFD$,K*H
MBD95!.!\ZYQQNH ZQ[JWCM_M#SQ+!@'S&<!<'H<]*=YT01'\U-KX"MN&&STQ
MZUYZ$M-+USPW<064MMX7"W87SE<+#/(P99'#<HK#S N< ;L<9Q6/)I2Q6^F+
M<6X-@WBQYK&-X^([1E8' _AC+Y/IAE[$4 >K"^M&2-UNH"LC;$(D&&;T'J?:
MEEN[:#=YMQ%'MQG>X&,]/SP:\AUG3+!-#\?_ &>QB$J7\;V(CAY4^7"28@!_
M?5LE>X/I6EJ]CIEYK?CV62TMYEFT> PL8PP>39,"5..6Y3ISR* /33=6X>1#
M/$'B ,B[QE >A/I2B>%F55EC+.-R@,,D>H]J\SLK.V76_"YMK>-9;KP_<173
M*F#)(1"0)#W8L'^]SD-[U4\.W,$K?#J%K><M8V,]K>;[5P(7$"J5<E<#D'/;
MUZB@#U5;JW>18UN(FD8$JH<$G!P<#V/%0VEQ<,UZ;S[*D<4Q6,Q2EOW>U3E\
M@;6R3QSQCFO*=$LK.ST/P9<0VD<-Y'KTPE=8MLB0DW ^8XR$PR=>.5]:F=GT
M]-8N(;22338/%HNKV&"(MNMO(0>8% ^91( QP#]P^E 'JHO+4VOVH7,/V?KY
MN\;/SZ56O=;TW3UM&N+N)1>2B*W^<?O&//'J,9.:XJ_NM%BBL+[3-,G6TO-9
M^T&\DAF,:3&)AYOE<$@X"C@+N.[MSA6D*)H>C&XL[EXK'Q9<&7S+-\I$S3[3
MMV]#N3@# )% 'J]O-<O?WD<PMA;Q[/(,<A:0@KSO7&%YZ8)R*FANK>XC:2&>
M*2-20S(X(!'7)%>6:Q!<F?QZ-)M7<R3V$KPPQX:>)53SU4?Q$J&! [DCJ:MZ
M];VVHW^MZCIBI)I4WAR6&YV)^[EGS^Y7&.9 -PQU&5'<4 >D1W,$SLD4\;NH
M#%5<$@'H?QHANK>Y+"">*4H<-L<-M/OBO,+*VL;+5= DA@,*R^&;B.[:V3;(
MS8A(!/\ ?XDQGG(-7O#FJ-X>.H2:C+#J&G6EC!Y>K6EJPE9 S*L,L:@_O%W$
M\#H>0* /1JI&YN$U26.7[*EDL"NK^:?-WY.<KC 7&,'/7-68)H[F".>%P\4B
MAT8="",@UQT:6D7Q3UB62.-89-&MQ*[*-KNLLI()Z$A2GOC% &EX=\07GB$6
M]_;V]L=(N8G=7$Q\V(AL*&7&#N'/&,=.>M;\]Q#;1&6XFCBC'!>1@H_,URGP
MPCCB^'FD((A%,L.V9"FU@P)X8=<_6G>++F&#7?#ZS6TGSO/LO/*>58#L V[%
MX+L"0I;(&#P>E '4M<0HJLTL85QE26&",9X_#FFB\MBD;BYA*R<QG>,/]/6O
M(O#UI:W$/P^AOK,L;9KV&9;F KM7:X56W#[N< =L\#D5H6.BF]\#Z@VG0QK?
M:/K5W>Z8A7"KMF9U4>B.I(XXPV>U 'J"RQN[(KJ77[R@\CZT^N3L-9LM*T!O
M$VK)):_VK,DS#RF=HT8!8E;:#C" $]@2U=90!@:!XB.JRZG#>)!:S6NHR64:
M+-N\T(J-D9 R?FZ8XK:%S 2X$\9,?WP''R_7TKR;4]$M+ZP\8V;6 /B*;56E
MTQC$1."5C\N2-L9"!@26'  .:W];TN[TWQ4#I\.Z'Q-"+&]= !Y4J GSOQB\
MT?54]: .^1UD0.C!E/((.0:B:[ME+AKB(%/O N/E^OI3X88[>&.&%%CBC4*B
M*,!0. !7!^)]!ED\430V]GYEGXFLC87KJ@(A>/)64Y[^6T@'^TJ4 =1X@UK^
MR/#NHZE;+!<36MI)=+"TNT2*BECR ?0]JMZ=?QW]G#('C\YHDDDC5LE"RYP?
M2O/DAU"X^&FNW&KVI34+;2;C28QLYE,:NA=._P"\;;@=]HJ;2+;3K7QEI1C@
M@CMIO#CI=$( KOOC.'/0MC>>>?O>] '<65Y*-)BNM4>S@EQ^],,VZ)3G'#,!
MG\JH7OB%K/Q5INEM'!]CO+2>Y^U&7[OE[.,8QCYP<YKS[P[>_P!B:-X(N]3M
MISH\-G<V\V(&<6UPS+L9T )'RAU!QQN]ZUAIVCKXI\)VL.G^5I4-C?E(+I&(
M0,\13<'^[G#$*W(QT&,  ]'1UD171@R,,JRG((]:=7)?#0;/ ME"5*&&6X0(
M1@HHF?:,'H-NW'MBNMH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHK#\4Z^OARPM[N7$=O)<"*:Z
M:-I$ME*L=[A>=N0%SD8W D\4 ;E%<0^N:Q<^)/"\,-U8&TOH[J60P$NDHCP%
M8,#T*N"!Z]>E._X3>?\ L2Q\2"WA;1+J\6W*C/FQQM)Y22D]#EL$KC@'J<4
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MH4$,$,&HZG#/-)OR\<*PML<@<%LL0 ,CC)SQ@@'7R310A3+(D89@H+,!EB<
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M8<-T.T<$_P 0YJEHGC75]17PU<7-A916VN>;&@CE9GBD5'<$Y&"I"$8Z]#[
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M 4V.:*8N(Y$?8VQ]K [6]#Z'D5S/B74=5M?$_A:SL)X(X+RZF282(27VV\C
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MIH">69B<DAMNX*2,E0<$^Q(JJG@&**Z6]BU.XBODU&2_2X2-0P,@_>1>AC;
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MACP?"]WITUQ=O-'9:?)I_E,@"RQ.%#;O?Y%Z8[U6LO <4.D3Z-J&LZAJ6E-
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MPJ2"Y<J60@Y"8ZOG&!]: ,.7P8PUN;4;/7=1LQ>*BW\,7EE;DJH4-DK\C%0
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M?5'\6ZEI]M-+8W7A[[/M%NV;BZR^PJN,LRJ0,X[@=CB]:6%D/'>D3-IF+9=
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M0L96:V#2N454VX^=6&&((&".IX3PY#=6=AX!EN-.OU6REO+><&T?=&S(P3(
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M6Y9FNKA[F9R -TC8R<  #H/R[G)K*E\%VS:]=:G;ZEJ-I'>LK7ME!*HAN&
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M-T(SGG-0Z9X2M=.&FHUY=7<.E@BQCN"I$.5*CD*"Q"DJ"2>#W/- "^+]:O=
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M51D36\>W=&<Y(<G&" !@GJ<<IHNOZ[J=YI4[:8ATG4+8S/*J[#:DJ&3)+GS
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M2-H*JA^3E0&(]>>32S^!K2?3M2LFU+4!%J%^NH2D&+(D5D8!?DX7,:<<].M
M%#7_ !EJ.GGQ";.WMRVCM;JMO,K%[KS0IRI!&.6VC@Y*D?2WJUY/I7C+PRYV
M@ZGYME>+'G:Q6,R(W/\ =*L![.:Q;[3M2G\5:A=%_$5G<F55MFM;>VGA=%0
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M\FG7$3QS)L/[M@2<2(0,EE&.174:)I4>AZ)9Z7%/-/%:1+"DDQ!<JHP,X '
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %5[J^M+'ROM=U#!YKB./S9 N]R<!1GJ3Z58KD_'UJ]W8Z.B6<UULUBT
MED6*!I=L:R NQ !X S0!K#Q3X?,"SC7=,\EI?(63[7'M,G]P'/WN1QUYJU>Z
MKIVG,BWU_:VQ?[HFE5-W..,GUXKSO7--FG3XDB+2KIY+ZUC2U*V;GSF$&W"'
M;S\P'3TS4EY$?[;U"WUK1-:U#3=8LH$A:S27'"%7AE"D;.26!; ^8\B@#T"[
MU73K":.&\O[6WED(")+,JEB3@8!/.3Q6<WBG2YK[5=-MM1M$O=/C!D,S@(C$
M$\\@D# SCIG&<UQMSIPAU;6-&UKP_J]]8:DL!M#9R2O$56%$,,CJPV[60G<V
M,[B<U?EM;JWU;QM#)IUXZ7MC";=TA>1)-L!0@-CEMV!CKSG&.: .ICU_3K6P
MMWU+6-,29K5;B1UG5(V7 S(N3G9DC!SW'-76U.P6SANS>VPMIL&*;S5V29&1
MM.<'(YXK@M%LY4UWP;-<:;=A;3P\\$SO9O\ NI<0X4G;PV$?_)YRM/\ M.BZ
M!X,N'T_4A=V$]V&M5LI'(C;>.8P-XX9,, 0,X/6@#U2SO[/4(O-LKN"YC_OP
MR!Q^8J.ZU73K*9(;N_M8)7QM26958Y.!@$]SQ6'X"2Q@\/O;V;W!=;F62X6X
MM'MG221S(1Y;@$+\_'7CO6'>V=Y&?'.F7^G75VVK9DL9(X&D256@6-8]P&$*
MLO\ $1USZF@#=USQ-]F\06GA^QO+""_N;>68271W*A4H$0J&4Y8OQST4\&MQ
M+EK738I]5DMH)0B^>ROB,.< A2V.,\#//2N1M+.^LO&?AA+J.ZN#:Z)+:W-V
ML+M&9B8>KXQSL8UL^+[1;W2H(B^H0N+E'CN;",R26[C)5RH!W+D8(QC!H EN
MO%VA6EQIT+ZE:L=0E>.%EE4J=BL6).<8!7;]2!5]]5TZ.]6R>_M5NV.U8#,H
M<G&<;<YSCFN!A37%N/"]]J6GRS-9ZK=K+-:6C*94>*14F:+JFYFYSP"<\ U7
MFTK5+GP=JWAJ:TNAK3ZJTUO=^2QC;=<"5)Q+C:-JGIG(VXQR 0#T>?5=.MKN
M.TGO[:*XD("1/*JNQ/0 $Y.<'%8NC^)6FN->35I[.VBT_4OL<4F[RPP,<;KD
ML?O$N1Q^58=H)8-7US1=8\/WE^;S4_MMI<" O;R)\A3=)T0QE ,'G"C /2LR
M!-6TOQEJFLG3KZ[TQM8.^T^QR%@K0Q(+F,;?F*E&4]>"2,=P#JK?Q=%!XFUN
MPU>]T^TM+0VPM97D$9D,JLV"6;!/ QBM^\U73M.*B]O[:V+#*B:54R,X[GUK
MSS7+&:\D^(CII=Y(U[ID45HWV.3,K")QM7Y>2&*_Y%7+-+FTU?7#JNG7MS9Z
MKIUL+8K:O)PD15X7 &4.YB?FP#O/H: .DO-9N[?QMI6D*L!L[VTN)F;:=X:,
MQXP<XP=_IVJMK'BI;3Q#H>FV-U8S_;+UK:YBW[I$ C=LC#<8* '(/6N<L-'U
MG3[OP=9S+<->6>AW-M-=")GCBF98M@+@8_@(_P" ^]4]-^UMIW@.RET34XKW
M2+T1WVZS?:A$$J,_F8VLK,0VX$]>: /2O[7TW[=]A_M"U^UX)\CSEW\#)^7.
M>!UJ&+Q%HD[,L6L:?(5C,I"W*'"!MA;KT#?+GUXKA?#ED'>RTO6M!UA]5TN]
MDG6Z9I?LI.YCYRN#M;<K'Y,9))!'4A='T:$_#J6"ZT_4;2Z_M&5O,MK1EN8L
MWADCD4%<L /+8C!X7VH ]$M;VUOHC+:7,-Q&K%"T3A@&'49'>GS3Q6T+S3RI
M%$@RSNP55'N37'Z'K6H:19[->MKBY>XU06L5];V+1^<K*@6:9/\ EG\WR9Z$
M@$<'-;/BRVBO/#D\$JWVUI(2'L5+31L)5*R* "3M(#8P>%- %/7?% LCH\VG
M7-C<6MSJ:65RY;=L!5F."#@$;>_K6Q#K>DW.GG4(-3LY;(-L-PDZM&&SC&X'
M&<\5Y]/;ZU<V^F0ZI:27Y@\1Q2_:X]/=#<0+%CS9(\?*02%S@ [<@8ITJ7=G
M/KLBZ+>2Q2^)(;A'%E(YBC\J,&>- /G(9#TSR<D$=0#J?$GB5K'P['JNCSV=
MTAO(+=FSYBD/,L38*G[PW?I4^GZQ>7/C/6M'F6#[-9VUM-"R*0Y\PR AB3@_
M<&, =:X22SU'_A%-?M3INJ--)XDANH]]JQ:6+SH7+@*,8PC$X&!TZ\5UVE1S
M#XD:_<-;7*6\UC9I%,\#JCLAE+ ,1C(WK^= $^M^)&T7Q3I5I=36<&EW5O<R
MS3SG88S%LQ\Q.T [^X[5L#5M..GIJ O[4V4@!2X$R^6V>F&S@USOB6V(\:^&
M=1FLIKBRMH[M)7BMVF\MW$>S*J"1G:W.*Y=-(U#P_P#8=3_LO4)-)_M6]G:Q
ML0WG6T4V!&XC0@\88E1R!(>."* /4+6ZM[ZVCN;2>*>"0926)PRL/4$<&H+G
M6-,LYO)NM1M()>!LEF53R,C@GN ?RJEX6LK.RTAA8:?<V-O-,\ZPW+,9"7.2
MS!B2N3D[>V>@.0.!U4V_]H^(=+NX=5&G7.KPWLES%IDUQM,:PLP5XP5 S&!S
MRO/![ 'H/]L01:C>M/JNEK8P01R%?- DB+%LM(2V I&W' Z&KR:C92&W"7EN
MQN5+0 2J?- &<KS\PQZ5RME:1WOC[6Y'LY'TV]TFVA$IA8138:7<H;&#\KKW
M[U4T/1-</AK4M,N2\5UI]I/I>FW#G!D4@[)L^Z^2/8HWK0!UZ:YI,CSHFJ63
M-;KOF G4^6O3+<\#/<T6FMZ5J%R;:SU.SN+@1+,8H9U=@C8(; .<'(Y]Q7!:
M;!;:CI/G2>&=:MM6L=+EM9/M2S;$RF#'&"2)06 QM!  SQP#+H=C/;:A\/\
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MT6FO::SI&H*;FZ6 HIB4MYA\S&'61<< DY89'!P ="?&TGV!]=\J'^PTU'[
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M=6-S8OITEVSPON='62-0"0V,$.3T[5KKX@T9X9IEU>P,4"AY7%PFV-3T+'/
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M]JMVQVK 9E#DXSC;G.<<_2N?OO$]S=>)+O0=#NM+6^M;>.;%VQ83.S.#&-K
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M >F6US;SV\T*NC131-&R_.V."!Q@BNIH **** "BBB@ HHHH **** "BBB@
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MM*O9839NG,L43[)"6SD.<,1V' (/6@#L-2UC3M(C$FHWL-LA&=TC8 &0"3Z
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M-C'J6GS6<LL\23+M+V\K1R+_ +K+R#7&7/BS5=%OM<L;Y[>[EMGL1;21P^4
M;F0QX8%^0I&?O#(X)'6I[KQ!XAT;STO[16BN+JVM]/F?RQ(6D;:X=5?;\O4'
M(SD ^M '6V%C!IME':6P81)GEW+LQ)R69CR22223R2:5;^T;47T\7$9O$B$S
M0[OF"$D!L>F01^%<#XCOO%,&BW27,@M(UU.Q2VN-J>9-%),BLKJK$#!)Y&-P
M].:T]0UW5['7=;L4ELW^QZ&E]#(UN<F3=("&PW(^3MC&>] '9T5Q&B^(=;DU
M?0HK^6UG@U?27O!'#"4:*1!$<;BQW ^8>PZ57T3Q7K6KWOAX126I^WI,^I6Q
M@+-8^7_!PP*G/R$MGGD#M0!W]%9'B&_N+"SMVMYX(3+<QQ.\H+-M)Y$:@$L_
M' ^I[5RT7C#5AH$EY/:SNEKJ\]E>36MOOEC@3=B3RP3DYV!L9P,D#T /0**S
M?#^H+JNA6M\E[;WJ3*66XMU*HXW$ @'D''4=CD5R7_"9ZBWA:R\6Q^4^GSWR
MPR6?E_,L+3^2K!LY\P':2.G48'6@#L;[6M,TR1([Z^@MV<J!YCX^\<+GTR>!
MGJ>*O5Q.BV\]Q\1?%:74\<]NJ68,3P@@KM<J.3V)S[^U6?$D^H+XV\*6UM?>
M1;SO<F2/RPP8K$2">?0GC\>>* .CL=1LM3B>6QNH;F))&B9XG#*'7J,CN*M5
MY;IFJ:IHL=[>6TUM]CD\6RVDUNT)+.LMP$+!]W!&X$#!Z>_&]_;^OZE/<7&C
M6B206>I-:2Q2>6J-'&VV0ER^X-U8?+C&!@YS0!VE%<_XWU:^T+P?J&J:<81<
MVR!E$R%E/S 'H1Z]?T-9\^J:[;ZRFA/<1SWDT,UX)K6V5?+C#(JIMDDP<%CE
ML],<#.0 =A17&6.M^(-0N[?1+I;73M8736O+DH!*N_S#&H7DC;E23U(R!UYJ
M:WUC6+_6AH#S6EIJ%MIL=U=30H94,KLRA4#8^0%&)SSR!D8- '6U5U#4;+2K
M*2\U"ZAM;:,9>69PJC\37!VGB_Q!KB^'(K-K&QFU);V*X,D#2B.: E2R_,,J
M2#P?S/2JGB_5=0USX?\ C!EN88XM-+V+H(?]<R*AD8\Y7)8[0.F,G.<  ]1J
MK+J-E#J$%A)=0K>7"LT4!<;W"]2!UP/6HM8U./1- OM5F1GCL[9[AE7JP12V
M!^5<;(^H3^-/!-[>W,,GVBUNY2B1[5C8Q(2%.>5P>_/&>^  >@T5PNC^)=7O
M=<T[3YKBWD74=.GN//AA/E1RHR#]TQQYB8DZD<X!![50\+>(M5;PQX5M7GDN
M;[5[:6Y:943>H3:6 W, 6)<'/H#QZ 'I-%97AZ;5YM)7^W((H;]'9&$1!5U!
M^5L G:2N"1DX-:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %9NL:+;ZW%;1W,DR"VN8[J/RF _>(
M=RDY!S@\XK2K"\7^(!X9\-76I!0\J +$K D%V( SCL,Y_"@!EUX0L+P:T)I[
MHKK*+'> .HW*%V@#CY?EXX_GS45WX(TR[U&'4/M.H6]TD*V\LEK=-";F->BR
M;<9QSR,'GK4EMJZZ:D\FJZO%<029FMB+<K(D0 W&0 ?=#?Q8  (S5F_\5Z!I
M:QM>ZO:1"2$W"9D!W1C'SC'4<CF@"I>>"=)N]8.IH]Y:2R1K%<1VERT4=RBC
M"K(HZ@#CMQQTJQ/X6T^:^U*[#W,4FHP+!<+'*0C *5!V],[21G^O-;*.LD:N
MC!D8 J1T(KE/%/BO^SI=-@TZ[A,TNK6UG.K1%P0[@.@;[H< YQR<=J -"U\*
M65G=:=<0W%V)-.LS96Y+J=L1V\'Y>3\B\G^Z/?/.ZMX6FTV+1[#3;;6)]-LS
M,XET^^2.YBD<\??*AD.Y_4Y([5UT^NZ9;7T=G->1I/)((5#9QYA&0F[H&(Y"
MYR?2J>F>+-+U3^TFCE,<=A<&WD>52H) 7)&1_>; '?'N* '^&;*^LK"5;RXO
MI5>3="E_*DDT:X'#,G!YR>IZ]>P9<^$M-N;N_FW3Q1ZD +ZWC<".YP-OS#&0
M2O!*D9'7-2GQ5H26[3R:I;Q(LXMF$K;&64XPA5L$'D<$=#FH4\:^&I4#1ZS:
M/F-Y0%?+;5;8QQUX;B@"RV@VQ\00ZT)9TN8;<VJ(I C$1(8KMQZJ#GKQ5G4-
M.74/LY^T7%O);R^;&\# '.UEY!!!&&/!%5+7Q3H5]=VMK:ZK;3372>9 J/GS
M!C=P>F<<XZXYJO;>(]-MX+NXO-?L9H/MYMHG7""-CM A)R=S GK[]!B@ 7P?
MI2/I\D?VB.6QFFFCDCE*L[2G,N['4,3DCCVP*6W\(:9;.4C,XL_M7VQ;(N#"
MLV[=N QD?-\VW.W/.*2Z\2Z7=:#J=U8Z[9VXM5:-[N0;EMWQD%E)&>H('?M4
MEUXKT+3=\5[J]JDT,2RRKGD*>C;1D@'!/T% $,/@W2[?6Y]3@DO(OM$PN)K1
M+AA;R3<?O#'TW< ^A(!QFHCX&TLD/Y]X)AJ#:BDRR .DS##$$#A2.J]#CI6O
M<:SIUK%#)+=IMFC,L>S+ET !+@+D[0",GH,CUJ:PU&RU2U6ZT^[@NK=ONRP2
M!U/XB@#%NO!>G7L&L0SSW;)K#*UY\ZC>54*,87Y>%4<>E2W'A.PGN[NY\ZZC
M>^A6&^$4@472J-HW\<'!(RNTXXSTK0OM8L--)%W<",JGF-\I;8G3<V!\HSW.
M!Q5.U\4:;=:WJ>EK(4DTU5,\DBE4&06/)&,  '.>_M0 Z3PUI\FK)J#*^4LV
ML1 ,>5Y#$$IMQTX'Y>E4+#P)I>GSZ9)'<ZBZ:6S&RBDNF*PAEVE1W*X. "3Q
MQTK8L]:TZ_GD@MKI&FC02-&P*ML/1P#@E3V8<>]9VH>);1]*U(Z5?6[7T%D]
MU$KH2&4 X<#C>F1C(./>@!FE>"=,T2Z>6PFOHXMSO#:FY9H+=VSEHXSP#R?4
M#)P*GL_"UII^B6FE6EU>10VDOFP.)!O0Y)QG'(^8\$'KCI2:-K8O]&TQ9+B,
M:K=:=%=%?+) W*/F(';=GN*SO!7C&VUW1-)2]OK8ZS=VWG/"GRY(ZX'L,'&<
MXYH Z'3-+MM)@ECMPQ,TSSS2/C=)(QRS'&!^0 XK.?PAIC3WA!G6VOIA<75F
MKCR9I!CYB,9&=HR 0&QR#S5V/7=+EODLTO8S/(S)&.0)&7[RJW1B,'(!)&#F
MLK0=?FF_X2-]7N;=(=-U-[9) OEJ(Q'$PSDG)RY^M &DNAVZ>(Y-<$UQ]KDM
MUMF4L-GEABP&,>K$YZ\T[6=#M-<BM4NFF0VMPMS#)#(49'4$9!'LQ'XUC:-X
MG:]\4>)+:XNH1I^FQ6SH6B,31;Q(7W[N<_*#SCCM6FWBK0X[>YGEU*"%+5U2
M<3$QM&S?=!5L$9[<<]J *EQX*TVZM-6MI9[PQ:K*LUT/,&690H&#C(X11^'U
MHG\%:9/K<FJ^=?133JHNXX;EHXKO:, RH.&XX[9'!XJTGBO0I;=[B+4HI8D,
M@=HP7"[,;R<#@#(R3QR.>:V%97174Y5AD'U% #)X8KF"2">-9(9%*.CC*LI&
M"".XK&L/"MKIUNMG!?:@=.082R>8-&J_W02-^WMMW8QQC'%7)]=TRUO8[.>\
MCCFDD$*ALX\PC(3=T#$<A2<G/2JP\7^'C<K;KK%HTK7'V4*LF?WO'RYZ Y./
M<\=: &77A/3KF\OK@-<0C48Q'?0POM2Y &T;AC(.WC*D$C@U8BT*TMM=DUF)
MIA<-:K:^6I&SRD)*J%QV+'\_2J,GBW3II]=L8[U;.73(\2W5Q&?+C<KG)S@$
M#*GKSFG0>*+(:KINBM<FXO+JQ^U"X2%A&PR@!QVW%LXSP!SU% &3X.\+RQZ)
M%'K,5U&\.HSW:6<KH8PQF=XW^7). P."<!N<9%;/_"(:9YUT09UM;NX%U<68
M<>3)*"#N(QD9*@D @$CD')JMX7\12W?AQK[5YXO.%]<VP,49&_RYG10JC))P
MO09-:L>OZ5-I\=]%>Q26\LGE1LF6+."04"CDL,'Y<9X/I0! OAFP%UK$\C32
M_P!KH$NXW<;6 38 , 8^7CC^=5+#P1I=A<V]P)K^>2"S:R!GNF8-"<?*1T.,
M<?GR>:3P9KMSKUMJTMQ-%,MMJ<UM"\490>6H7&023GDYS5W6/$ECHE_IEG=&
M3S=0F:*/:A(&U&8DX'^SC'7GV- %6V\&Z=:0:/#%<7I32'WV@>;=M^0H <CH
M$)7']>:DB\(:9#)(J&<6<ET+QK+>/)\[<&W 8R/F ;;G;GG%79M>TNWO!:RW
ML:2F00\YVB0C(0MT#$$84G)R.*T: .<NO!>G7=KJUM+/=F+59UGN@) -S*%
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MU7P-P7VSG%6** /.;72[N/5]1TC5/#U[?Q3:F][:7HN/]%"-)YBEQO&UD/&
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M.\6,1>?:W<MN[("2%8QLI8 D\'/4UHVMK#9VZ06\82->@'/7DDGJ23R2>2:
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MQ[,_,<+T4=A@4[PYX=BLM+TM[V*9KVVLEM@EQ*)/)!50ZK@D<E1SR< #..*
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB7Y1M X'OD^YH Z6BN T_P 1:I)XDT*(WYN[/49[R*1TB18&$89D\KC?\NT
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M2*1A)$&8J5RN<9/0C&..E 'HE%>?:+KVL7.N:=9RZ@\\%_I$UT+@P(J&16C
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MWG6LN=DFTKG!(/! /4&KE<C\,0P^'>EAVW,/.!;&,GSGYKKJ "BBB@ HHHH
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M9^R6\GV8E8D:.+8KLB[5!9R 6QDGK71:AXETK2WG6ZN&5;;:;AUB=T@#=-[
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M9WATY[-R&#;&*E=P*D@]<UU]% '#6FBZM?1^%(]0T\VDFA-YDTBRHRS,L+1
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MR.*U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *X_XH1>;X OSYLB;6A/R-C/[U!@_G7854U+2[+6
M+)K/4+=;BV8@M$Y.UL'(R._.#^% '-+/<ZAXPU'PZU_=VT5EI\,T$B.!)*\C
M.#(3CD+M4 =,DY!XQSVFZMKWB1O"<4^KW5@=3T^]-R;547<\3(JR+E3C=NSW
M&#P!UKT"ZT+3;V6&:XMM\T*&-)?,8/L/52P.2I[@G!IQT333>6EW]D19[-#'
M;,N5\I#@%5 X ( R.^!Z4 744I&JEBY  +-U/N<5Y'J\+KX2^([M=7$A&J;
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MV]F (.[KD<\'%0:AJ>MV^G^)M277+POI6N10V\6(PAC;R,HP"\C$C#MZ]:]
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MAK23;L5X8X2FS !'WR.IS]:OZ3<:W?V.FZU'K<*VE[8.TJK-YIDE*;E>-3&
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MTE[L-PQ9LR%""A//\) QZ=J;<^&=&O=-GT^[T^*YMKAQ)*L^7+N  &+$DE@
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M!-"22/+<<!A@]>3S[GUH \TUR_G\0^"=1U6:[F1X-=CMA:JV$C2.\1 C+ZD
M.2><GKCBMB;4=:UJ[UPZ?J5O8S:3?B(>;.0J1*$8[XMAW!P6YSW&,8YZ.Z\'
M>';VYN+BYTBVDDN65YMR\2,I!#%>A/ YQGM4EQX4T&ZUB'5Y])M7OX0H2<IR
M-OW<]CCMGICB@#@/%%_/X@\$^+KN6[FB:PU)K..W1L(J1R(/F7N6^]D],C&,
M5ZO6)>^$/#VI75Q<WFDV\TMR%$Y8'$NWH6'0D8ZGFME$6.-410J* %51@ >@
MH X+7-5U6VU+QO%!J<\:V6B17=J J?N9,3DXRO.=B]<FI]"O-2A\7:7:W&IW
M-W!J&B-=R1S;<)*KQ %, 8&)#QST'>NEN/#VE74]Y-/9J\E[$(+EBS?O8QT5
MN>1R>/<^IIT.A:;;WEO=Q6P6XMH?(ADWL2D?'R#GIP./8>E $FL*S:+?!9)(
MF\A\/&VUE^4\@]C7FNEVLDME\,(EO;A&ELY&,H8%US:#(4D$#\J]690RE6 (
M(P0>]9%MX5T.S-F;73HH?L99K?RR5\HL,'&#W''TXZ4 <7I_B/4_LVEZ5/>&
M5IM8OK W4TWE/(L+.(T+JIPQ '( )V^IJY<S>)]+LH(YI6UE+>XG-Q!83A;H
M0X4QX)"^8R;L$<;LKUY!Z:;PEH-SIDVFSZ7!+9S3&=XGRP,A.2_)R&)R<CGF
MI4\-Z1%;VL$-DL$=H&6#R&:,QAOO8*D'G'/KWH XVUUN^\2S'2]*U4@KHUO<
MVMU)*8))7?>#,5V'=@JN5X ).<Y&.\TMYY-(LWN9H9[AH$,DL(PDC;1EE]B>
M16?J'A#P[JB6:7NCVDRV2[+<&,#RU_NC'\/MTK:5510J@*H&  , "@#A=22\
M?XR60LIX(9?[ FRTT)D7'GQ\8#+WQSFL31H-7F7QYIMI=-%XGM[Q+EKRW($,
M[-&&C15(.P;5VD$D@G.37H5UX=TJ]U$:A<6@>\$?E"?>P8)G.T$'@9YQ44VF
MS:/I;1>%[#389GF#ND^Z-&R?F8E026QW- '.KK0\3^&-9U>UEF73QI+1"%C_
M ,MC&S29]URJ_4-Z5EW&I7<'A2TBL=0G6>T\+I=K!#A!"P3Y9G<_>'RD!,$'
M!SZCN[+1+:WT'^RYU26.0.;C:NQ96<EI#@= S,QQ[XJ&7PCX?G\CSM*MI/(M
MS:Q[UW;8O[G/51V!Z=L4 <Q?:U?V=UHU]=7UR++6=+,02$@>7>[ Z;..KC>
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M:Y(Q+G._.<EL\[CSDYK3H X'4--N-4^)FJP6^JW>FL-$MCYUMLW9\Z?&=P/
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MV/$W&#][/([=>E9ND:%K]EKVFW^H/'>O;Z*UC-/YOSR3%U?/(&1A<9X)/.*
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M\4V:06_FZKJD=W;DS84(HA!W<<']T>F>HKK/$<&JW?AN\AT:5(-2>,>4TC8
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M]90P/4KE5SZAJH>-+^9+N^M[34+A+BVT::[\B*4P+%R=LS.#ECE2 F".N<4
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ME(&[;U8X+$8[XKH;?QEIEUI-E?Q+,6O&D2*V?8DFZ,D.#N8*-I!!YQG&,Y%
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M$/+[/W;8A)!^;KC!SST'@Z:X^V:G%=6-FES*ZW$]U:7WVH2N1M 8[$VD*JX
M&,>G?J9[>"ZA:&XACFB;[R2*&4_4&DM[:"TA$-M!'#$O1(T"J/P% &%+I.I_
M\)XNMQI:-9KIK6@5IF$A<R!\XV$8XQUK#M_!>K1^!]$TYIK--5T:]6]A*R,T
M,I5F.UCM! *NPZ'!P>:[ZL:?Q'#'J3V4%E>W9AN([>XDMHPRV[N PWC.[&&4
MD@$ ,,]\ '.Z_P"#M3UVU\0W(%I#J&J645C%&TS&.-$9F+,P3))+G@#H!S6I
M)HVJMXPFUD1V7DOI(L@GGMN\S>7S]S&WG&>OM6]=7L5K'*3F22.(R^4F-Y4>
M@)%1:-JD&N:+9:K;+(D%Y D\:R !@K#(S@D9Y]: *7A#2KK0O".E:3>F%KBS
MMD@=H6+(VT8R"0#^E<U;^$-=@\+Z-I!.G,VF:K'=!_/<"2))6?\ N<,0<8Z#
M'4YX] HH X+5?"&M7VE^,K6,V"MK<Z26Y:=\(!'&AW_)U_=YXSUJQKOA#4-?
MUC4YI9+:VMKW1A8!TE9I(Y0[.&V[0"H)'?M7:,<*3@G Z#O6+IOB6+5M+M+^
MTT^^>*XNWM2NQ=T)1W1G?YL!04/0D\CB@"/P[!XA7YM=ATJ%TC\O_0"S><W&
M7.Y1MZ?=&>O7@51USPO=ZMXCN+A7@&GWVD2:9<DNPDC#,3N0 $-PQ')&.O/2
MNMHH XZQ\-ZI<+X;AU<V@70FWB6"1F-PZQF-3@J-HPQ8C)Y&.G-:/B;2+_4K
MK1+O3OLYETZ^^T-'<.R*ZF-XS@A3R-^>G..U=!10!P.K^$-;U"V\811'3P=:
MF@>W+3N-@C2-#O\ D."?+SQGK6K/HFJR^*[_ %94LO)N-)6R1#.VX2!G;)^3
M[OSXSUXZ5U-9FL:W!HIL!<0SR"]NX[1&B (5W. 6R1Q],T <=8^$O$FAIH=S
M8+I-U<6NE1:7>VUS*XC<1DE)$<(2#DMD%>AKO;..:&SB2X='F"_.8UVKGO@=
MAZ5/10!Y]/\ #R[%M<"TU!(9[;4A=:0^W_CTC9]\J_COD7'3 3TK=U/0+F76
M/#$VGI;+9Z1*[.DDC*VPPM$ H"G.-V>2.E=)10!Y_+X0UW^RKK3XSIQ0Z^-4
MB=IW!:/[1YY5AL.&_A[COD=*?JW@O5M2U/6[U)K."2>ZLKRP/F,V)+?M(-HP
MK>Q.,UV\ES&AF1<R311B1H4(+D'../?:0/I19W#75E!<-!+;M+&KF&8 /'D9
MVL 2,CH>: .1U?PC>>(3K5W=F"TN[[1VTN!$D,BH"68LS;1GYB. .@]\!+?P
M_K]UKJZAJ":?!&VC/ISI!.\A5RP(8$H,CCIQC/>NUHH QO"EA?Z3X5TW3=1%
MM]HL[>.WS;R,ZL$4*#DJ#SC.,<9QSUKFY?!^L7'A3Q'IDC6*7&H:B]];,LKL
MHS(KJKY0$?=P2,]:[VB@#@=0\,>(M4D\33RQZ9"^LZ.E@D8N780N!*,EO+^8
M?O,YP.F,=ZU-3T+5;F/PQ/;BS^UZ3.))8Y)6",#"\1VL%R2-^1D#..U=22 "
M20 .I-5&U >?9)#;S3PW2LPN(@#'& N06.<_-T& ?PH XR\\(:W<:)X@LE_L
M\2:EK$=_$3</A45HFPW[OK^Z[9'S=>*MVF@^(=,US4$M?[+ETJ_NC=^=,6\^
MU9\;U5=NUQD$KDC&><]*Z'1-;@UVVN)[>&:(6]U+:NLP 8/&VUNA(QFM.@#G
M_#>D7^EZAK\UX+;R]0U W</DRLQ"F-$PP*C!^3/!/6DO=(U"7QOI^LPBU-K;
M6,]LRO*RN6D:-@0 I&!Y?KW]JZ&B@#S[1O!NM:*GAZ\1K*2^TQ;FWGA$S>7-
M#,^_*L4R&4A>",'GD5/-X-U%+>.ZM6M&U!M>&L3122,L7W2FP,%)X7'.WD@\
M#-=U10!PFJ^#-6U2?Q._VFTMVU$V<MG*C,Q26WPP+J5& 64=">*M:GHWB;Q#
MX>>.^DTVQU*&6&XM$@9YH?-C<-ER5!*MC& .!W-=C10!D:%'JXADEUB"PMIF
MP%@LF+J,9RQ8JI).>F.,=3FL";PKJL,7BC3;1[5]/UYY)1+*[![9Y8Q')\NT
MAQQN'(]#ZUVU% '&GPKJ-EJ][)IWV1[*XT>+3U$\K*Z-%Y@7HI!!#C)SQCH:
MKVO@_5 GA."Y-GY.DZ7+871CG?<Y>-(]R93_ &,\XZ^U=/X@UR#P[HTVJ74,
M\L$14.(0"PW$*#R1QDBM.@#C?#6C^)]+L8=-OUTB2"QA,,%S"S"2Y 7:F\%?
MW?&"2"V2*UO!VDW>@^$-+TF^,!N+.!86:!RR-MXR"0#^E7M8U2+1=&O-4GBE
MEAM(6FD6$ MM49. 2!T![U4B\26LNLV&F""X66^LVO(G*KLV*4!!.<[OG7MC
MWH YO6?"&M7EIXQLK5K PZXRR022S.K(WE1QD, AX&PG()SGH*LZOX>\0WFM
M:CJ.GW-G937&BBQ@E$K,T<P=GW?<^[\V,YR.N*Z&\UN"QUS3=)EAG,VH>9Y4
MB@;!L7<0QSD<>U:= 'G$_@O7)T\1>5;Z3:_VQHR6.Q+B1O+E'F LS&/+Y\S)
M8C/&,'[U;]GH>IQ>+K#59A:"W@TDV,BI,Q?>71L@% "/EQU!YKJ** ./\5>'
MM:UN_G2!K*;39]-DMEANI&7R)V)_>A0I#G! Y(*XXZG+-(\/:W8ZUIU_.FGL
MMMH@TYU2X?)D#*V1E/N_+C/7GI79T4 <%X<\(ZUH\OA8S_V>ZZ/IL]G+LG?+
MLYC(*YCZ?N^_K[5'I/@W6M(CT"\5K*2^TQ[N.6$3-Y<T,\A?ABF0RG;VP<'F
MO0:* .$NO!NHK:M>VIM7U-]=76'@>5EB.%V>6'VD_< ^;;U[5!<>$?$-PNJ%
MO[,#7FM6NIK^_D 58O*W)]PY/[K /?.<#I7?S31V\+RS.J1H,LS'  I] '!Z
MOX-U?4KWQ#<Q7%G;2W<UG<V$F]GV2V^"/,7:/E)'8FK>JZ-XEU_0E:ZDTVRU
M2VN(;FTAC9I8-\9).]BH)# D8 XXZUV-% '%ZAHGB/6--L?M$&DVUS#J5K=M
M!#,_EJD,@<_/Y>69L8Z #CKS4>J>%=8OE\:I']A4:[;)#;%IW^0B(QDO\G'7
M/&:[BB@#AQX?\1Z=KTE_IR:3<0WUO#'=17;O^XEC7;OC(7YU*XRIV\@<BI+O
MPOJ\MWXHD1K)TU72XK&!GE92'19%+. F #YF>,]*[2B@#D=-\/:M8>(-(U _
M8FCATA=.NE$K95E8-N3Y?F!P1SMQUYZ5;\0:5JVH:QI\EL;2?34CE2YM+F1E
M4NVW9)@*0^W#?*<#G.<\CHZ* .!T7PCKFEP^#R[:>\NC6\UI<*)7P4<( ZG9
MR1LSM..N,\9KH/%&B#7K6"TFT^TOK/>6FCGD:-U./E>-@"0P/N.">:WJ8\T<
M<D:.ZJ\A*HI/+$ GC\ : .*L_#/B#3+WP_>I<V^H7%E9SV5RUW.X.R1T=6#!
M27*A O(&[KQ5#3?!_B70[/0+NR?39=2TV.XMIX))G6*>&5P_#["58%5[$>]>
MCUF:MK<&CW&FPSPSO_:%T+6-XP"JN06&[)! PIZ9Z4 9,^C:U<^(_#^JS-9/
M]ACN1< 2,O,H7 0;3D+MQDD$]<5:\'Z/>Z%H365]]G,OVJXG!@D9EVR2M(!D
MJ.1NQT[5<UC6X-$^P_:(9Y!>7<=HC1 $*[G +9(X^F:TZ . /A#7#HC6?_$O
M\T^(1JP/VA]OE_:!-MSY?WN,=,4_5O!NKZE>^(KF*>SMY+R6SN;%R[/MEM\$
M"1=H^4D=B>*[RB@#B=0T#Q'K6A!IQI-AJMM<0W-K%!ND@+QDD^8Q4$A@2, <
M>]/U+0_$&L^'E6>+2[;4([RVNH[:&1O)_<RJY#2;-V6P?X<#CKR:[.B@#C-2
M\-ZS>ZIKUV!8 :CHJ:?&#.XVR#S"2?D^[^\]SQTYX8-&O]+O-'U:^^Q"RTC1
M9K6[VRNY.1&2RKL^88B]CS7;44 >6>#S=6CZ T]II%Y#''Y-H]GJIE>W63&X
MI$4' P,_,2J@X..O8Z_HE[=:[HNMZ<T37.FM*C03,566*50& 8 X8%5(XP<8
MXSFMFVTZQLY'DM;*W@>3[[11*I;ZD#FK- '":EX-U*YT75UMS9C4-5U."^E$
MDS".-8FB(4$(23B+K@<L?2NNU*TDU'1;RR)6.2YMWBSG(4LI'X]:NT4 <3I_
MAS78;SPG/<IIP&CV<MM,([AR6+(B KF,9^YDYQUQSC)SX/!OB'3['2[FT;3)
M-2T^\O9/L\LCF&>&XD+E2VS*L/EP<$<>]>C44 4]+CO([%?MXMUN6)9X[8'R
MT_V5) )QZD#)SP.@N444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5RWC/5)-/?0;8S/;VE_J26UU
M.CE"J%&8+N'*[F55R.Q/K74U!>65KJ-K):WMM#<V\@P\4T8=&^H/!H \R\^V
MTG6/&%NNH7<7FZMI\,9CG+2.SQQ?N_,8Y53RI;.5'3H!5+4;A[WP[K=K>7CN
M+'Q1:1Q*MZ[^5&7MR5WD@E07;&>AZ8P,>G#PYH:VTUL-&TX03!1+$+5-L@7&
MW<,8.,#&>F*D.AZ28+B$Z79>5<A1.GV=-LH4 +N&.<  #/3% '!ZA=R:IJVO
MZ8/$ZZ/+IY@-E(TKEA#Y:-YH_> 2Y?>#N#=,&O0[:\@G9X$N8I;B$+YR*1N0
MD9&Y<Y7/7!J"?1-)NKFVN;C2[*6>U %O+);JS0XZ;21E?PI+;1[2UUB]U2.&
M);J[5$D=(PI8+G&XCECSU/8 ?4 YB.UMV^+FI^9-,C/H]N5 N77),DRG SCH
M!QV//7FL#0[J^U'3OAV+C5=0)OEN5NF6Z<&<"&1AN(.2<CKU'8CBO39M.L;B
MZ6ZFL[>2X6,QK*\2EPAZJ"1G!]*ACT/2(?L_E:58I]F),&VW0>43UV\?+^%
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M=<D\):=JE_-Y=UH;732).T;7-P"BE2RD$E5);&>=V3T%5="FDM?"/A46E]<
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MQ^\ 7&'&",X/#&G67@C38;$6\UEIT:F[2[,5I:".*-U  ,:G.T\<L.2">G8
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MJ8= T9HWC;2; H[*[J;9,,RC"DC')   ]* ."U*TFCOO&]FFK:NL%CIT-[;
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M_&@WDD,6H,+A]MC/G,85MWR+)E0V.@*]-P-7-?O+SPSXK2Z62[N;/6+<VEO
MTSLD5Z.8P!G"AQD$CH4]ZZR71],F@G@ETZTDAN'\R:-X%*R/_>88Y/ Y-4AI
M5_+K:2W-Q:?V3:,'LK6& JZOLV_.V[! RV  .H]* +FGK#86]KI;7IGNHX 2
M9I=TL@& 7.3D\]_>KU0FSMC>B]-O$;I8S$)]@WA"<E=W7&0#BIJ "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LKQ%X@L
M/#&CR:IJ3E+:-D4[1D_,P' ]LY/L#6K7):Q"WB76;C3X8K2ZL[&!H;F.:8J/
M-F0@CA3RL9/_ ']]J .GN+NWM+.6\GF2.WB0R/(3P% R3^535X]<WIO?@KX@
MT/4G2;4O#X:SGPV<B-AY<GT*8.3W!KU.&:RAT8SVCJUFD3,K0'?P,YV]<]Z
M+U%>2>&]3LI?$&CK!J2BTO\ 09RX^UYFD<-$5:9U(!FPSDX (^89(H\*!8U^
M'-U]IF>?4K.:*[,EPS^<H@+8()QPP'Z^M 'K=%>>:-:W%OK<W@V=)G@M+O\
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M9N+80AQ=;UVE\D%-N=V<8.<8YKRCQ/%"B_$F_CFDCNK![66V:*9D\IUMX\$
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M<02<C< N 3U 4YYY74-3M=8U?6K#5=:71KA3;S::94*W"PF)&4P_. 6,F\$
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M[M$)#NC.PG&X8Y'M0!LT5P'A3Q9)9Z5X6T[5--GMK>]TV(6U^\JNLCI"&8,
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MLMU;:$^GZ%<74VLV4EW;Q^>B ; I*$GH?F'/2@#J/[.M_P"U?[2*YN1"85;
M&%)!(SC)R0.N<8XQDYL/#%*Z/)$CM&<HS*"5/J/2N-NO'\MI'JLTF@W @TFY
MC@O&,Z90.J-N4#.[ D''H.O:KFL^-8-+EOEAM#>#3W1+I(Y,2Y8*V(TP=Y"L
MI/(Z\9.: .A%A9C;BT@^4;1^[' ].G2LW4=#GO9888+U+32B"+NSCMES<9(X
MWY^48!!X.03TZURGQ!UU]2\#>)5TV!Y(+$>3+<K.8V$F%)VJ!\P7<,Y([C!Q
M77^)M3N=%\*ZIJEI#'-/:6LDZI(Q53M4GD@'TZ=_;K0!K5"]I;27"7#V\33H
M,)(4!91['J*P+/Q%=RBQT];2*?5I;$7DJ&?:BID*"6V]6.<#;C@\\<Z7A_7+
M;Q%H\6HVR21JS-&\4H >*16*LC8[@@B@"[+:6T\GF2V\4C[2FYT!.T]1GT/I
M2/96LDR3/;0M+']QS&"R_0]JYZS\8FXUBSTZ?39+>:]@FG@B:0><HC(XD0@;
M"P8$<D=>E5M)\>-J;:'))H\]M::O))##,\RL5D0.V"H[$(W/KVQS0!U+6-F[
M.S6D!+\L3&/F^OK3DL[:.021V\*.!@,J $#IUKFV\;0)96VJFT8Z+<7?V1;P
M2?,I+F,.4QPA<8SG/(.*YCQ/K>IZKX.\;+=0I!'IMZ+>!H)VW8"PM@X SG>3
MU[XP<9H ]*2RM(HY(X[6%$D.YU6, ,?4CN:;_9UC]F%M]CM_LX.?*\I=N?IC
M%8!\9QVEUJ\&JV$MDVGVT=V/WBR>;$Y95QC@-N0C&<<CFJ6H?$$:9;:K)/I,
MDIL+5;H-;3!XI$+;2-Y PP/5<'@@C- '9HB11K'&JHBC"JHP /0"G52TR[O+
MR&5[S3GL664K&CRJY=,##?+TSGIVQ5V@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L3Q-HEQKEO81
MV]Q% ;6_@O"9$+;O*<,%X(QG'6MNB@#CM1\'7M^GBU/MUNBZ_"L(_=$F "/R
M\_>^;CGM536/ FJ:K'JL7]L6RQZA90V_[RU9V@,?9#O&$8\D8SFNETK7#J6L
MZSIS6K0MIDT<1<N&\S?&'! '3AA6A>7EO86_GW4JQ1;E3<W]YB%4?4D@?C0!
MQ^KVUCXD\3Z78I<R/J6DRDZ@T4+(GDLF6C;/!5V$?RY/ /H:["]MA>V%Q:LQ
M431-&6';((S^M3T4 <EI_@^46NB6FJW,%Q;Z- 8K=88RGFGRO*#ODG'R%N!W
M.<]!4GACP]KFA1V^GW6MQ7>E62[+11;%)F0#"K(^X@A1Z*"< D]CT3WEO'>P
MV;RJ+F9&DCC[LJX#'Z#<OYTVRFNIXI&N[06SK*ZJHE#[D#$*^1TR,'';.* ,
MS6-#N;[Q!HVK6MW%"^G^<C))$7$B2!0<8(P1L&#R.>E9(\&Z@/!^IZ*NJ1)-
M=WLEVDR0G:-\WFF-EW?,IY4\C(-=E10!P=[X$U.]MO$$3:K9I_; MB0EFRK"
M8@HX&_D84#'O^%:L_A[4W\0ZAJ\%]:Q275E!:JC0%PIC=GR?F&X'>P(XX[UT
M]% '!_\ "OYH%D?3;JTL!)J,5\UBL+/:':A4J4R.I(?C RJ\<9I#X"U.*(W%
MOK4":E!JTNIVDWV4[ 901)&Z[^5(8C@@CBN]HH Y?4/#FJZE;:5+-JMO_:5C
M?K>F3[,?)/[MHRBIOR!AR?O'GZ\1V'AG6=*U>\6RUJ)=%O+IKN2W>V)GC=SN
M=4D# !6;)Y4D9./6M6_UPV/B32=(-JSC45F(GW@!#&NXC'4YR*UZ .!F\!ZH
MNE7FBV>KVJ:7+J"W\ EM6>2$^>LS)D. 5W X[\X]Z[F:".ZM9+>X59(Y4*2*
M1PP(P1CTJ6B@#BK'X>PV:: 7U"66?3'833,/FN8MJA4;V!CA_"/W-7;[PQ>7
M6LZY?)>0*NIZ:E@J-$28]OF?,3GG_6'CCH.:W-1U&'388WD!:2:5888E^])(
MW11^I/H 3VIT<]XVH-#)9JEL(5<7 E!W2$G<FW&>  <]\^U '-0>#K@7.A-<
M7<$D&FZ9)ITL8B(,P=44L#GY>(QQSU/-+H?AG7M*TD:3/K=O<V-K T%G_HQ6
M0KM*KYK;L,%!Q@ 9P#FNNILK,D3LB;V )"YQD^F: .1TWP?>6#>$PU] Z:#:
MO;-B(@SAD"9'/RX"@]ZU=;T2XU35M#O(;B*)=-NFN&1T+&3,;1X!!&.')[]*
MF\-:TOB/PY8ZPL!@6[C\P1,VXKSTS6K0!Q-SX*O[C1=:T_\ M"V4ZEJBZ@'\
MECY>'C;9C=S_ *L<\=3Q2:_I=UID7BO6Y)T=-1L(K811VIE,14.H<KSO7]Z2
M1C@+WK7L/$5UJ=MJC6FE%KBPU$V1A:X5=X&PL^[&!@.3COM]ZZ"@#S/08;N]
MCN+&RO\ 0M0ANK-K1[NSBG+VZ!"$#,\CC:">$R#\Q/8UOV7A*[MKSPY+)>P,
MFCZ?)8LJQ$&8,J+N'/R_ZL<<]376T4 8GA/1;GP[X:L](N+N*Z^R1B&*2.(Q
MY0<+D%CSZG]*PQX)O_[-%K_:%MN&N_VQN\EL?Z[S?+QN]>,_I7;T4 <-+X(U
M62\\W^V;8JFLC5(WDM"TA'S 1LV_D*&PN , "MR3PS$_C*/Q L[)_H_E2P ?
M+*ZD^6Y]U5Y!_P "'I6[10!R</AG6=/UV_DTW6HHM(U&?[3/;R6Y:6*0@!_*
M?< -V,\@X/2M/Q-HDFO:7';0W"V\T-U!=1NZ;UW12*X! (."5QUJ*/Q#<7&J
M:_IUMIADN=+BB>)3.%%R9%8J,X^7[N,G/6MR-F:)&=-CE067.=I],]Z .3U3
MP4^MQZE<WE]Y&IW20)!/;IQ:^2YDC*@GYCO))SC(P.,9HO/#&N:UH30:KKD*
MZG'+%-:7%G;%(X)(VW*Q1F.XD]>0,< #J>NHH Y'4/#>NZSH:VVI:M9M=_:K
M><M#;,L2B&02 !2Y.6(Y.?PXK2TS1+FR\3ZSJTMQ$\>HK HB5"#'Y:D=<\YW
M>@Q6Y10!S=]X<O)?$E[JMK?0QQWFG+92PR0EB"ID*L&## _>'(P>G;-4_P#A
M$=13PWX;TV'4K?S=&:+=YENS0W*I&4&Y-P.1D,.>&4?AV%% '#V?@?4;66P+
M:I;2I::Q/J@'V8J6\WS,I]X_\]3S[#BK4'A2^A@U*&2>PNH+_4WO9K:>W+1R
M1NFTQ')/0A6W8[=*ZZH+2\M[Z)I;:598UD>(LO3<K%6'X$$?A0!Q=IX!O-.&
MGQV>K1"VMH+F#R)X&E6(2ON!B^<;2H^0$Y^7\J2R\$:UHXT:YTS6K1;^RTY-
M,N#/:,T,\*G*':'!#*<G.><GI7:I>6\E]+9)*IN8HTEDC'558L%)^NUORJMK
MFIG1=!O]4$!N!9V[SF)6"E@JEB,GV% &5/X7N)M?M-2.H+(JZ?)87:319:97
M96)4@@*<J1T( /%4])\(ZM;Z.^@:IK<=YHJ6SVL*I;F.=HF0H!(^X@[5..%&
M2 3Z5U-C=?;=/MKO9L\^)9-N<XW '&?QJQ0!Q6G^$=;@N?#C7>L6<\6A%TC*
MVC!YXS&8QN^? ;:>H[CWK8U_1+W4]1TF\L[V&'[#*[O#<0F6.7<N V R_,O4
M'W-;M07-Y;V?D_:)5C,TJPQ@]7<] /U_(T <=8>!M0T^RT*./5X&GTB]N)XW
M:U.UXY1("I&_[P\PG.<<=*WO$^B2Z]I,=M;W*6\\-U!=1221EUW12*X! ()!
MVXZUM44 <=>>$-0O#XH+ZA;9UVP2S)$##RMJ.A;&[G.\G'&,#DT@\*ZW8:K'
MJ&CZS:V[S6L5M?17%J94<Q@A9$ <%6P2,$D=/2NRK(N=<-OXKL-#-JQ%Y;33
MK/O&!Y90%=O_  ,<T )KWA^'Q!X7N=#N9Y0D\03S\Y<,N"K^Y# &LR[\+W^J
MN+K4KRU>^AT^:R@:*)@@,H4/(03G)"C"@\<\G/&IJ6N'3M=T;3#:M(-3DDC$
MP< 1E(V?IU.=N*UZ .4N?"E[/X5T+1Q>P++I<UK(TIB.)/(*D #/&=H[G%<I
M?W#3^+=8>*_T>*5KJ,#3]1LY_-E,2J%8*C@2C<"RMM8]/0 >K44 <E/X=U+4
MM2O=5DF@MI+_ $9;!K<H7,+99BVX$;L%R,8'0<U''X/OT?02-2CC.EZ9+I^^
M.(AF+JB^8IS\I'E@XYZUV-% '%:'X.U72=2TN]DU.RD:RTZ2Q9([1D\T%D8.
M3O/S$IECWR>.];?A/1)O#GABSTB:XCN'M5*"5$*!ADGIDXZ^M:=S>6]F81/*
MJ&>411 ]7<YP!^ )_ U/0!Q*^"K]=(BLO[0MMR:W_:V_R6P?WQF\O&[U.,^G
M:G:CX'N=2NM=N#J:V\M_/;7-K+%%EK66 #8QR<.#CD<=2*[3M61X=US^WK2[
MF-J;9K:\FM&0N&R8V*DY'J10!D7WAC7-9T4)J.MP)JT,\5Q:7%I;%8H7C)P2
MC,2V[<0W(X(P!CE]_P"'-:U?1(XM0U:U.I17EO=QO%;,($,3APNPON.<')W=
M_:NKJLDUTVHS0O:!;58U:.X\T'>Q)W+MZC  .>^?:@#FM0\)7]]>:_<&_MP=
M6TM-._U!_=E1(-_WN<^8W'L.:1]#O-*N[+6WG6==*T>6S:""W9I)ON-E1GK^
M[ "\YSUKKZS/$6KG0/#NH:O]F:Y%G \[1*X4L%&3R?84 <!X)>X@N=,2TOM"
MU01QB%TMH)DGMT;!<_,[+&,@$KM0'   X%>CZ;'?16$::E<0W%V"V^6&(QJ?
MF.,*2<<8'7M4]O+Y]M%-MV^8@;&>F1FL6V\07%]J316.FFXL8KQ[.XN1,%:)
MT7);81RN?ER#G/;'- !JOA>VU3Q-HVMNY673O,!0=)E8 @-[*RJP]Q1H/A>W
MT'5=<OH)"QU2Z%QL/2/Y1D#ZN7;_ (%[5JW\UU;V4DMG:"[N!C;"91'NY /S
M'@8&3^%48=<,OBVZT%K5D,%G'=B<N"'5W9<8[8*&@#GV\$W[:9-:?VA;;I-<
M&K[_ "6P,2B7R\;O48S^E6[/PSK.F:S>FQUJ%-&OKEKN6W>W+31.QRXCDW
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MC+2B2$H 3_$ 6([CFN3CFLGT#34-X-B^,Y8P1<$?N_/DP,@]-NW]*]D(!()
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MSP]>R:S/?VFK^3'<(BR6\]JDRKMR!L)P5ZDXY&23BM;3["'3;%+6#.Q2S9(
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MG )]>?6EN-1U#4O =[XF2QFM[Z.WBM6BCCQ(B1R#[5LQS_ST4?\ 7,$=:]+
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MY14QG;CS.?\ 5+SQU-8.K>=<^,-3?^T+>UG#Q1+:WNBRSB<1J"K(490Z[RQ
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M^4B19-F/,Y&4 SZ9J23P0QM]:TZ/4%72=8G:>YMS"2ZL^/-"/NX#8[@XR?P
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M^UH1]LU9=3W_ &0_(1(C[,>9R,H.?K76W5K%>V4UI<J'AGC:*1>FY6&"/R-
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MMO.7R!EN_H#S4<?@"\M=(TVWLM>\B]TJXDEL+D6H(6-RVZ.1"WSY#8)!7H"
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M =9169X>75$T2!=9N%N+X%P\RPB+>NX[24!.TE<9%:= !1110 4444 %%%%
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M(L4K1@L]ZI8,0V/O#(R?3VJYX'.@ZEJ.G7]A=ZA_:UM:&"]M3"L?ED@;A/A
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M_!D@\\#*GTK9NI/#UI)H-O9P%-/NKJZEMI[H.]L&9<D+&?O;BS!!P.&(SQD
M] N-0M;6[M+6:95GNV9($SRY52Q_  =?IZTEI+=R270NK>.%8YBL)27?YD>
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M8;/[@_[2R*I^F[MQ6'=1Z=_9NKZF/(-_!XN1H)\@NB&>+<5/92N[.." <]*
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M:M?0^(+;2K6VMV-Q;2S+++(1@H5&" .GS?\ ZJ ->W@BM;>*W@0)%$H1%'8
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M-WXX[U;U7Q'-9RZLEO!&W]F6:W<@E8KYP.X[5/;A#SSR<8H WK>"*UMXK>!
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MP;;]T<C<.3S5.Q\9W=V=.O\ ^S9#HU[ ]P\XBD4VJ!-ZLY8;6##^[T)_B'-
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M>Q&>] ':T5@>";Z^U/P5H]_J,B27-S:12LZ9^;<@.3[Y)K?H **** "BBB@
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MJU4U&QD:54O;=C""9 )5.S'7//'XT 9#^%8+N5'U*;[64MY+8,8PKO&XP0[
M_-@=.GKR>:FM- ,#6+3WC7+:?&R6A= "N5V[GQ]YMO&>.IXSS6BE[!<&:.TN
M+>:>(?-&)0=I(XW8R1GZ5D>'/$T>J^$=/UO4GMK(W2%F#2 (IR1@%NO2@!MK
MX5%K:Z/;K?,RZ7,TT9,8RY(88;GT=NGM6AJ^D'5#92)=26TUI.)XW10P)VE2
M"#P>&/TJW]MM!-'#]JA\V0;D3S!N8>H'<4U]0LHX99GN[=8HFVR.9 %0^A.>
M#0!B0>$A \#+J,SB#4)+]1)&IR[[L@XQQ\[?I1-X12:*X_TZ5+A[_P#M&&9$
M ,,N O .05P,8/J:W'OK2.T%V]U ML0")FD 0@]/FZ5E>%==F\06%Y<310QF
M"^GM1Y+EU81N5# GKG&: )]+T9]/U&_OI;Z2XEO?+,@**J@JNT8 &?UJ75-%
MMM6FL99RP>SG\Y"IQG@@J?\ 9.>1WQ6C7-S>*HT\86>D126<EI-:SS2SK."T
M31%!M(Z#[_<]J +]QHI.LG5;.Y-M<O"()@4#K(H.5../F&3@^_(-01^&+>WD
MTE[2XF@_LU)(U "MYBO@MNR.I*@Y'O6JM[:N\2)<PLTJ[HU$@)<>H]156\U.
M/[%<_8+RP:\2%WC6>;" C(R^,D*&X)[4 4M)\-/I$WEPZI=/IJ.7ALF5=L9)
MSC=C<5!/ S^=6]4T@ZA>6%W'>2VTUF[,I158,&7:001C..A[58?4+6VA#7=W
M;0L(P[EI0% Z9R>V3C-23WEK:Q++<7,,4;?=>20*#WX)H PK?PBMK:Z?%%J5
MR'L+J2XAD*H3B3<&7&,='//_ .JMN]MIKA(_(N3 \;A\[=P88(VL.X.:G1UD
M7<C!E]0<US>N>,;2QT[7SITMM=:AH]JUQ+;M+@9"LVWC)SA>1[B@!Z^$H8([
M1K.Z:UN+>ZDNE>.-=N9 0ZA#P%P>/3'>HV\&H+7;%J=U'=)?27T%R%3=$[D[
MAC&"""00>OM6WIVHP7]NA2:%IQ&CRQ(X)C+#.".H_&I8+VTNI)8[>ZAF>([9
M%CD#%#Z$#I0!ERZ!).=/>;4)99K.Y^U&1T'[Q]I3! P ,,1@>WOFUI6E?V6]
M\WGF7[7<M<L"N-K$ $#V^44:KKFG:*;47]U'"UU,(85=@"S'Z]@.2:6.]=+N
M_-U/8I9PA&C99?G4%<L9,\+STYZ4 95SX1%Q-<LNJ7,<<U['?! B';*I4]2,
MD?(..U,N_!PF@U.VAU.X@LM0D\^6%8U8K)D%F4D<9(R1ZUNOJFGQK.SWUJHM
MR!,3,H\HGINYX_&I+B^M+2W%Q<W4$,)QB220*ISTY/% '-0:;'X@U/4Y[F"X
M_L^[TV&T;[1$8I&8-(6^4@$$;EYQC)XZ5JVNAE)[6>]NVNY+2%H8&9 I ; +
M-CJQ  SP.O'-:RL&4,I!!&01WJ$7UHUT;474!N1UA$@WCC/3KTH P+'PB;%]
M*QJMQ(FE[Q;(8T V,NW:W'/'?^52?\(J#X7GT(WK^5-([F7RQN&Z0R$>GWB?
MPK4GU*'RKM+2>VGN[>,LT/FC*D?WL9(_*J7A?Q!'K^@Z9>2/!'>75G'=26R2
M E P!Z=<<]: &WOAF'4KR]GO9RZ7EFMG)&B[<*I9@P.3@Y8G\JA?PJ]YI$UA
MJFL7E[N55BE(5&BVD,K#:.6RH.3GI[G.Y'>VDMU):QW4+W$8R\2R NH]QU%8
M>J>)ULO$VBZ5 UI*M[/+#<'SLR0[8GD'RCI]SO0!:L=#FM]9_M2YU*6YN#:K
M;,/*1%(#%LX Z\^O^ GN-*,VNVVJK<;7MX)(5C*9!#E22>?515I;^S=8F6[@
M(F)6,B0'>1U ]?PK*T779M0U/7[6ZAA@72[I85=7)#*8DDW$G&/O_I0!%#X5
M\FPTVT%\Q2PO#=HQC&68EC@\]/G;I[?C)8>&GTZ^D-OJET-.>8SBQVKM5R=Q
MPV-P7=SMS^F16M#?6ES;-<P74$L"YS*D@91CKR..*Q]$\1G6/$>M:>@MGMK!
M8&AF@EW^9Y@?.3T&-O04 .TOPT^DW!2'5+IM-60R16+*NV,DYQNQN*@G(&?S
MJ(>$PFEIIZ:A+Y$=Z+N(-&IV$2&0+VR-Q[]O2K'B/Q%;Z"EE&\D*SWMTEM%Y
MK *N[)+D9&0 #Z9.!D9S4^GZE*L$,6LS6$%]*["-(9\B9<G:RAN>1@XYQZF@
M"E>>%A>Q:W&]ZRKJVWS=L8RFU0GR\^BCKFLC5H+B;Q%,TLU];M'''%"RZ4+J
M*3'S%E.UMGS'!!(^Z#Z8[&6^M()1%+=01R$J CR $ECA1CWP<>M0:QK%CH.E
M3ZEJ,ZPVT*Y9F/4]@/4GH!0 U+6>_P!!:TU%RLT\#13/%\C#<",CDX.#V)P:
MY^R\"R6<UK,=<N99+?36TQ=T$84Q';C@ <C:._)]N*N?\)2B>+9M-F>SCTY=
M.6\2[,W#$R%,$G@#CU-;MS?6EG")KJZ@@B8@!Y9 JDGW- '-S>"(Y?"VDZ.F
MI7$%QI!C-C?Q*HDC9%*@D'(;*D@CH<UNZ583V%H4NK^:^N7;=)<2JJEC@#A5
M "@ #@?7DDFKH((!!R#T(JN=1LEE6(WEN)'<QJAE7+..2H&>O(XH P--T2YT
MP:YI=O-);Q7]S+=VMU&F[RC+@NOH&#;B,\88=<&K.K>%X-6\&OX;DF$<#0)!
MYB1\J%QM*C/!&!CZ5LP7EM="0V]Q#*(V*.8W#;6'4''0TVWOK.[A>6VNH)HD
M)#/'(&"D=<D=* ,'5-%N=571=,N)GN(K*YBN[JZ=-OF^5DHN.A8OM)QQA3TR
M!5_Q#H?]O6=O"MY+:2VUU'=12QJ&PZ'(RIX(]OIZ4Z^\2Z/I^E/J<VH6YM%<
M1B1)58,Y. HYZY/2IDO9'U/"S6+6!MO-!67,I;=UQTV8QSGK0!SI\!YCN4_M
MFY<3ZK%JI\R)#B5-AQP!P2@S[=,=:DU/P0-3&O"34G0:RT)EVPC]WY0 7;D]
M]HSG/X5TL-_9W$OE07<$LFP2;$D#':>C8'8^M"WUH]PUNEU TR?>C$@+#ZCK
M0!@:CX,MM8OM4GU&X,L6I6"6,T*)M 5&9E93DD-N<GOV]*LV_AK==076J7K7
M]Q;VKVL+F,)A'V[V..KMM4$\#C@#)K>J"YO;2SV?:KJ&#>=J>;(%W'T&>M '
M+:;X&DTZ71)/[<N9O[%BD@M%:&,#RV4* V!DX"C)X)QVYS)8^"!86?A^V34G
M=-$F>:$M$,R%E=2&Y]';ICM72SWMK:Y^T7,,.$+GS) N%'4\]AD<^]2QR)+&
MLD;JZ. RLIR"#T(- ',Z)X..AS&"#6+M]'65Y8--=4V1%B21OQN*@DD*3Q[T
MS1?!7]CQFQ.LWEUHJ!UM].E5-L2L"-I<#<R@$X!/''7 J;6_&%I8V&O?V=+;
M76H:1:M<2V[2X&0K-MXR<X7D8[BMC3=2@U"VC99H6N/*1Y8D<$QEES@CJ/QH
M YJQ\!O9#183KUY):Z+.9+*-HH]RIL9 C-CY@%; /''YUM:]H)UI].FCOI;.
MXL+G[1$Z*K@G:R$%6&#PQ^AK1@O;2ZDECM[J&:2(XD6.0,4/H0.E.N+F"TB\
MVYGCAC!QOD<*,_4T <JG@-([&.W36+S?#JS:K#*4C)21BY9<;<$'S&Z^WI6Y
MK^B1>(/#]WI$\TD:7$>PRIC<I!!!YXZ@59EU*P@BCEFO;:..7_5N\J@/]"3S
M3[B^M+7=]HNH(=J;SYD@7"YQGGMD@9]Z ,3_ (1B8ZQ-J;ZH\D\NG_8&WPKC
M;N+;N,<Y8^V,?6LY/ 3VD.COIFNW5C?:;9BP%S'$C^? ,85T8$$C&01W)KK$
MOK22X6W2Z@:9D\Q8Q("Q3^\!UQ[T+>VCW;6BW4)N5&YH1(-X'J5ZT )!;&VL
M5MXYG=U7 EE^9F;^\W3))Y[?A7-V/@@6%EX=M8]1=DT.1I(2T0S)E&3#<^CM
MTQVKJV944LS!549))P *Y[Q+XF&E>$[O6M+-K?" J.)LIRP4\KG)&>G% %&?
MP$D]K=*-5N(;N34SJMO=0H%>WG(VG .0RXXP>H)_":^\&RZA86AEUV]&L6EQ
M]IAU-40,K[=I&S&W85X*XYZGG-='/>VEK+%%<74,4DIVQI)(%+GT /6B:]M;
M>>*":YACEE.(XWD 9S[ ]: ,*Y\*27<&F--K%VU_8W?VO[9L3+L4:,C;C:!M
M8@ #C /)SFM?^"!?P:_$^I.BZS/%-*5B&8S&$4!>?2-<YSWK9@\1:3<WU_9Q
M7\!EL,"XS( $.,D'GL,9],U;;4;%899FO;<11-LD<RKM1O0G/!Y'% ',^(-%
MO+9=<UNVEN;B\N]-6R\FTC =0I;#IDGYAYC-CG. !S5+P?;7EK?QK9W<\U@5
MVSI<Z%]@*@*=N#M3<<X&,$8STXSVWVNV\J*7[1%Y<I C?>,.3TP>^:IWNHE]
M'FN]*N=/D=>$DGFQ#D'!W,N<=_QH HZQX6_M765U)-2N;5C9264J1JC!XV(/
M&X':<CJ.HJOIW@P:=/H4T6JW)DTJR-CDHG[^$[#M/''^K7D<XS]:Z&>]M+62
M..XN887E.V-9) I<^@!ZU/TH S]=TB#7]#O-+N&9([F,IO3[R'JK#W! (]Q5
M.T\*Z=8Z_'J\ =9H[);()G*E5)*L?5@"PSUP3ZUIQ:A93S+#%>6\DK)O5$D!
M8KG&0,],]Z7[?9_:7MOM<'VB-=[Q>8-RKZD9R!0!S4W@CS],U*Q;4G"7^I+J
M3L(1E75T<*.?NYC7KSUYYXEOO!-MJD^O-?74CQ:S!#%*D:[#$8L[&0Y/()SS
MGD"M/3/$NC:O;)<6>HVSQR2/$G[U<N58KP,\Y(X]015L:E8&.207ML4C(#L)
M5PI/8G/% '.W/@ZZU'PW>Z3JGB"[O7NHQ";AX44I&#G"JH W' RQSFM.#0GC
M\42:[)=[Y9+)+-HA'A=JLS!AR3G+'\/SK2>^M([I+5[J%;AQE(FD =A[#J:;
M-?6\;F$7-N+DD*D3RA26()4>O.#V[&@#/O\ 0/MGB&PUJ&]EM[BTAD@*JJLL
MJ.48@Y''*+R,'&?K67;>"!;:;I%DNI.R:9?O?QL81EW8N2K<]/WC]/;TYO>%
M_$BZYX:TS4KPV]K<WR%A").^XC"YY/:MN>X@M8_,N)HXDSC=(P49^IH YO2_
M![Z1J,IM=;O1I+W#7*Z8538DC-N(#XW!-QSMSU]L@Z&O:"=9ETV>.^FL[C3[
MG[1$Z*K@DHR$%6&#PQY[5IBY@,LD0GC,D8RZ!QE1ZD=JCBU"RN(7FAO+>2*,
M9=TE4JOU(/% '*K\/DAB@>WUF[2]M=0FO[6Y9$)C,I8R(5P RMN.?PQBLS6?
M#TL%CJVBV\VH7M]K%Y;WS2-:X@0B6(/\ZKM7"QYP3G &/?OH[ZTFM#=Q74#V
MP!)F60% !U^;I6/H/B)]9UK7+,+;F#3Y8DAE@DWB57C#Y)Z9YQ@4 ,N?":MJ
M.JW5G?R6J:O&J7T00-N(79O0G[C[>">1P.,U'<^#8O[0@N=.OI;"--/&FO#&
MBL&A4DH 6^Z1D\^A_&M:[UW3;'5;33+B[B2\NPS11%@"0.I^F<#W)JT+VT:[
M-H+J$W(&3")!O ]=O6@#G=+\&C2KG094U*64:/8M8Q+)&O[Q&V9R1CD>6N/I
MSFH[OP0+O3];LVU)U35KU;R5A",QLNSA>>G[M>N>_KQUM58M2L9HYI(KVVD2
M'B5EE4B/_>.>/QH Y^\\&F^C\1I+J+ :]$L4^V$?NP(_+^3G^[ZYY_*I;CPA
M#?:C]IO;GSHGTM]+E@$>U7B<@L<YR&R!_GFMZ&\M;B62*&YAEDBQYBHX8IGI
MD#IFLW5]?BM?#FJZGILMK>RV%O),8Q,"N54M@E<XZ4 9EIX.NX=$NM+N_$=]
M?0R6KVD!GC3,,;#:2=H&]\<!F_+DYL0^$A'?:7<O?,XL-/?3PGE >9&VS))S
MPWR+TXZ\5IZ7JL6I:?%)%+;O=F!)9(%D'R,R@@'J0*H^&O$8U;PE;:WJ/V>R
M\PN'S)A$VR,H^9OI0!:\.:*?#VA6NE"\ENX[6,11/*JJ0B@!1\H'0#K6K38Y
M(YHEEB=7C<95E.01Z@TZ@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N1^(\(F\,0@0--*FH6;H$C+
MLNV="Q& 2,*&R?3-==10!YY<?:[?QB9=/?[;:W.IQ&ZTZZ@(>%MBK]I@D'\(
M4#(.1PPR"<5N_$.TFOOA[KUO;P//.]E)LC1=S,<=AW-=-10!Y5XPN4U*WUN&
MTTR]C:Y\/D03+92LUUS(1& 1MC"GDY 8[Q@C S7UQ]1F\2)J-G:SW-K#H=L;
MRTD@=3>1K)(9(02!\^&#;?XL8(P37KM10W,%R',$T<H1BC%&#;6'4''0^U '
MGVM:G!_PD=K>WD6I+X?O]*%M$]O9-)Y4F\EXWCV,R;E*#H/N8[5%8Z+IEMXS
ML8I-,D^PP^'FB7[9$9"N)%VJ[$8WA,\=0,BO1HKF"=Y4BFCD>)MLBHP)0]<'
MT-2T </X$UB#3_"?A31KY+J*^N;/RT62!P%:->58D84X' /7%6?B3'(WA-)5
MR8;>_M)[@>L2SH6S[ <GZ5TLGV.3484DDC-W&K211F3Y@/NE@N??&<<9QWIU
MR]HVVSNGA/VD-&L,A'[T8)8!3][C.1Z4 <9X[1)?$WA#S$NC##>RR3O;B3,:
MF%U!+)RH+$#K47AFREM?B1JL^E0WAT.YLD:YN+U'+/=!L )))\[*$SQDJ#TQ
M7=6MNMI;) C.R1C:N]MQ [#/4XZ<\^M/EC\V)HP[IN&-R'!'TH Y/P%%(H\2
MSG/D7&O73P'L5&U&(]MZ/67JT[6OBOQ/#JUI/+!?Z9''ISK;O*C*$?S(OE!P
MVYLX/48]*[ZUMH;*UCMK:-8X8E"HB] *EH \PT2$I??#J1K.>.6#1)8+AGMV
M1HV\J(!6)''*OC/7G%9-S#<Q>#]:L7VZEI4?ARX:UNKBV,=S9X4;8)NS-W!P
M&&PYZYKV6LSQ#9V>HZ!>V&H7AM+2ZB:"6575"%88(!8$#.<4 <=I.FV)\5>'
M]5T:V6WAM]+F74I8XB@8,$*(_'+[@S8/(P<]167X>D-KH7@VVN-/NXI!:W49
MNOLLDC0,2,Q>7C 9QR&<$ *<=:]2L[<6=G#;"1Y!$@0/)C<0!CG  _2IJ /*
M-.M;FR^&GA?Q!#9S_P!J>'XQYD$D1222$_)-$ P'\/(]T&*U-;BO- /AV_ND
MNS:++<2:G)90^<T4\H!$FW:Q*@EUR!D!A77WVAQ:AJEM>3W=YY< '^B)+B"1
M@P96=<<D$ CGM6I0!YC#';Z#J_AR\@M-0'AO?>,&EA=C#/*5*2-'MRBG]X%X
M&-_;-7?"&KV6@Z9>I=6UY;17?B&ZBMP;.15 DE8H3\ORK[]!7H-13VT5SL$R
M[PCAU4DXW Y!([X///< ]J ,CQE#J5QX,UF'1]W]H/:2+!L.&+8Z*>Q]/>N4
MLKJQU+QKX8N=.T^YB@32;JVD#64B"$YAVQN2N!C##T_.O0C<P"Y%L9H_M!0N
M(MPW%0<$XZXR1S[U+0!Y%X;D(M_AW:2V-Z)--$]O>A[20"%O(=,,2N,9QSTZ
M9ZBG6VB6)^$7B,KHZ?VBRZC'%FT_?$/*[1JO&[!^0@#C@5ZM-<P6^SSYHXO,
M<(F]@NYCT SU)]*+BY@M(3-<S1PQ+U>1@JC\30!YX;*QNO&IGN;!986\-JC/
M);DJ9-Y^7)'W]O;KBLG3K_\ L6P\&W5ZEPSKH$EG-;W%K,Z(?W6<[$8JV5P0
M5P1GD<9]>K%U#PZM[JPU.WU34=/NC"L#M:NA61 20"KJR\%FY !YZT 5/ -K
MIMAX+TZSTNZ6Z@@C\MIA$8R[C[Q*D9!SV/.,5RVO1/%-\28/L=P9;[3E-J4M
MW82YMBF%8#!._C&<YKT:SLX[&#RHR[$DL[R-N9V/4D^O_P"H8 JQ0!Y;<Z?.
M-6,>AVYM[FX\)SP1R1Q&,?:"5* MC ?[QYYZUK>#WTS5-3M-1@M=6BU&ULOL
MLZ75L8$MUR#Y1^10YW#C&< $\9Y[RB@#D?'<9W>'+HV\LT5MK,4DQBA:0HGE
MR+DA03C+*/QKDO$UDL]G\2HXK"1C<P6YMT6W)\V018)7CYF#=<=#7K=% 'G[
M:=I3?$5I#IT)LFT+!8VW[LOYA.#QC=M)]\$USVBW%QI6E>$YM8BU./3/[&-E
M(T-H96MY]RY61-C, R@#./X<5["2 ,G@5'!/#=0)/;RQS0R#<DD;!E8>H(X-
M &=X9L;?3/#EC96D-S#;0Q[88[EB9%3)VAL\CC'!Y'3M7$+%JL.N2VVDR_;+
M>XN;XI'<P%)]-G82GS%?HT3.<#/]]<$XKTA[B".:*&2:-)9<^6C, SX&3@=\
M"I* /._#-WIMYHVG"31[VWUC2M.>VN#-;R1_9R4 <;B-LA9E!&,D]>.:RO#M
MA]D3X=FWLVM[M=/GBNG^SE2CF%0!(<<?.._<5ZS10!Y3X=B-_I^FV[6^KQ>*
MM(M9HL3P&..&4QE6<R; LBNV"/F8DD'L32:5<13M\/$&G7L=[ILLD-\KV<FZ
M%S;.KEFV_P 3X.<\YS7J]1I<023RP)-&TT6#)&K LF>F1VSCB@#R:!G@TO2=
M+:QO3=6/BMYIT6TD(2-IYF5LA<$%6!XSQ5G4UOQ)XOGM+6[E1-:L[F2*&+YY
M[=(X1)Y8(P^"IXYSM(KU2B@#RO4EMY;!]=T:VU6ZLI]4L[C53+;NAGBCR&*P
ME5)V_NRQ"_-M[X-;_A::&X\?>*+NVMYUM[N&S=)FMGC24JKAB"0 3RM=A!<0
M747FV\T<T>2NZ-@PR#@C(]",5+0!R'CE5:Z\,9A:3R]9BDD*QE]D820%FP.%
MR1R>.:P=0@D>R\=Z5J5I-+>W[M+II6(GST,*K"L; 8RCJ>/X3\W .:]-HH \
M]T?1H9/B#<?VM9175PFCV0:>2WW(]RC2%V#$8+CY#GJ.*V?B-:S7GP_UB&"!
MYY?)#+'&A9CA@3@#DG -=310!YY?1V.I^.;JYEL6ELSX>V1F:U8+N\QS@!EX
M;:<XZX/O6+IUQ-IUCX8?6HM333)?#\=D[PVAF,,XQO21-C,-PVCISLKUQW6-
M&=V"JHR6)P *;#-%<0I-#(DD4BAD=&!5@>001U% &?X=LH=.\/6-G;17$5O#
M$$BCN&+2*@^Z&SWQCCMT[5YC>:7;'POXDV:8?M!\2I+!MM3O\OSHCN3 SMP'
M.1QUKV&B@#RO6K*YCU+QE'HEC)MDL].D2*WAVK<".1S,B<;68QX7'/4"EU%8
M=2TC4==\/VVLW,SM:-?++;F%YHXI0S1I&R*'<)NSP01\N3G%>ID@ DG '>HX
M+B&ZA6:WFCFB;.'C8,IP<'D>] 'E^LVVGZEX5UW5](MM4N6NIK&6>2>V=#(8
MID+;8]BDE4!R0.>F3@XT-2CMKCQIJEPMD_V>X\-E"6MF =M[$*01][;CY3SC
M'%>B44 >7^'+**SO_AZ\-DT$JZ1+%>,L!4JYCBPLAQP=RMPW<&L_PU+I%S=>
M%[74+DH^DW$_D-<V4RO<O(65 Y9-BME@V0S98#%>NS1)/!)#("4D4JV"0<$8
M/(Y%8FF^%H].2"!M6U*[L[?;Y%K<R(4CVXV\J@9L8&-S'H* +VD:U9ZW#<26
M?G8M[AK>598FC977&>& .,$$'T-<Q<%;7QSKHUVW>73K_3X8[-S$TB%5WB6'
M@'YB6!QU;CKBNR@MHK8.(EP78NY))+-ZDGD\ #Z #M4M 'E7A_19;76?",6O
M6GG7%OH4\=S)-%O"-OB,:.V"-P4,.3V-=5\-D>'P#IL$D4D3Q>8ACD0HR 2-
MM&#R/EQCVQ75T4 >9:Y$\-U\1X39W!EO=.0VQ2W=A+_H[(0K 8)W<8SG-13:
M?,-62/1+<VUS<>$YX$DCB,8^T$H4#-C ?[QYYZUZE5=;^S>]:R6[@:[5=S0"
M0%P/4KUQ0!Q7@]M-U34K/4(;75H=1M++[+.EU;&!+=>#Y1^10YW#C&< $\9Y
MU/&4,DITQ[;4I--O89GDM[DP>; &V%2LH[*P8C.1@]#G@]310!Y)>SW5UI0M
MKC09=/O+CP]/&#;6TLJR$LP\E 00@.%?YAG# <8J_HUM:77BK1KF]L"T?_",
MB.5[FU8#S Z<-N'WMH;@\X]J],HH \C\.6*VFE_#J06,D-U#<2K=-]G97C4P
MRKASC(&=@Y]JN^%8XKN?2[#5[?5QXATFZDD96@*1!B6#2^:$ 9'!)P6))/3O
M7I]% ',>/5OO^$8,ME!/<>1=033P6ZAI)(5D5G"@\$X&<=\8KD]<BT^]\%>)
MM2T>'5)Y-1^S^8\]NZ&:16 ^2+8IR% RP&#CJ<&O4Z* /,M9-O/XDU[3->@U
M66QU98&L3:6QD2=!&H\L,%)1@X9N2H&[.1UJ1&@BU?7]#\1:3?7;W]Q#-9%8
MI)%GC6./8@E484HZ$DDJ!N)[FO2:* /*?$MIF#XE6CZ?/)-=Q1RVN+5F$G^C
M(H*MC!.\$8'.16Q=6L&D>(/"^HVUBD6BE)OM+0P8$=P\:+'+( ,_=5DW'INY
MZUWU% 'DEQHVR*U,UDSV$OBW[3:1- 3Y=L5^=L8^6,ON/.!A@>]-UJR3_A'/
M'MI!8.4?5(9;2&.W8ACL@!:, <\J^2/0UZ[10!YU>3V@\3>(M-\0:9>7MIJZ
M0-8-#;R2+/&(P#$&4?(1(&;D@?/G(KT"01FU87"+Y>S]XK?,,8Y!]12_:(/M
M)MO.C^T!/,,6X;MN<;L=<9XS4E 'D7ABPCLM/^'<B6#P7,5Q.MTWV=E=%,,J
M_O.,@$E!S[5>\*10WDNE6&L6VK_\)!I5Q([JT!2(,=P>7S0@#(X)."Q))Z=Z
M]/J-KB!+B.W>:-9I 62,L S 8R0.IQD9^M 'F%CIEP_PRQ;V4R:SH=]->Q1R
M0,A:1+B1]@)'S;HR5XR/G%7])TS5$\47%M/:,NF:RR:Q*"H @D0X,1_VCBW)
M]=LE>B44 >5W]I>7/AOQ9HES;S'7I]3DGL7$9S)EU,$B/CH@"@G/R[#G%;&B
MZ;8'X@^)KJ]L(7>,6DL5Q);<;UC.]T)&-P.,D<]*[RB@#R?X<37FD#2;?6+2
M:2*YM66RG-NP-DRM\\+C'R;N&#'&>AZ+78_$2SGO_A[KEM:PO/,]JQ2-%W,Q
M'. .YXKIZ* /--1N+36O%&LW'D:G_9MUX;6$SPVDBL?WLF=N5^\ > 1S[U3N
MYM?2QN99T.IP6-_9S3:AI]MMDO( &SF,Y!DC.PG'!XZ$<>IM<0+ 9VFC$(&3
M(6&T?C3([VUFB26*YA>-SA660$-SC@]^2!^- 'FE\EM%!:ZYI5MJEQI,VLPW
M>J&6W=3* C+Y@AV@[5;RR2%Y*YYQFM[PB\4OC'Q=<6]O-';W,UM+'(UN\:R?
MN%#$%@ 3G_&NTHH Y#Q"AB^('A:\:VEDA$-Y"TD<+2!781% V <9VMR>.#7,
M6=G?7?A#1])>":/Q18ZPDLSM&0583EI9MV,%&C+<YP=VWKQ7JU% &)XPM[^Z
M\':O!I89KV2U=8E4X+''W0>Q(R/QK@]332=>\+^(=2LK+5I+Y]$ELW2ZLVBV
M/C,<038H=PQ."N<>O(KT^2_LXKR.SDNX$N91F.%I '<>R]35B@#S"X@ALM;>
M6STB2>)_"DR2001M']HDW*PC+ <.1O\ ]KDU15)[VXUA;6VO)5O/"7V>$+8R
M11^8OF8C7<,\!@!N))SUKUVHHKF"=I5AFCD:)MD@1@2C8S@XZ'!'% 'GNBZ7
M9OKOA;4=(LUMOL5A*NIRK 8L@HH$;Y RV_+8/(VDG&1G'TN>ZTGP_P"$KVZA
MU&/3K=[V*\\BV+R6\CR9CD:,J3C;O&0.-_O7KKND4;22,J(H+,S'  '4DTD4
ML<\22Q.LD;J&1T.0P/((/<4 8WA*QLM/T".'3H;J*S:1Y(EN@5?#,6)VD H"
M22%P, ]!TK<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ K"\4Z\?#NGV]XRE;=K@1W%R86E6V0J
MQ\QE7!*Y"KUXW9[5NU2U&QEO?L[0WDMJ\$OF H%(D^5EVL".5^;/8Y YH Y-
MM;U>\\2>%8[?4-/:SOHKN5S;H7281X"L&#]"K9QV/7/9?^$WNO[!L/$RP0-H
MUU>+;F,!O.CC:7REEW9P?FP2N. >IQSHV_@>PLWTE[.ZN;=]-DN)%,6P"3SV
MW2*05P 3TVXQVI;7P596L"V*W-PVE1W?VR*P;;L1]_F  XSL#_,%SU[XXH 2
MSUW5M6(O-+MK66P347LY8Y"5D\M',;RALXX920F#D=P3@<_X.U0IK&MZ%IAM
MH[H:S=7,RRH=J0;@N5 (W$MQQP.<XR >BM/!L-AK%S=VNJ7\5C=7!NYM-#)Y
M+3$Y+9V[P"1DJ& )Z\<567P#:)<+=1ZE?1WB:C)J"7*>6'5I!AX_NX,;<94@
M]!S0!SDNK7_AK4O'6J6%O9M;6FH6\EQ')N#.IMX0P7' /).3GGMWKI[SQ'J$
MUSK\>D16S'157S$G#9N)#'YA12"-GRE1N(;DGCCDO? UM?VNO6\NI7@76Y$D
MN2HC!4JJJ-GR\<(O7-69_"<3ZA?WEO?W5L^I0K#?+&$Q-M7:'&0=K[3C(XQC
MC@&@#G4UNQN_&>C>)%0QVTWABYO&)7Y@F^!L'U(&:9/=WNJ>)_A]J]S':QPW
MDD\T<:(?,B5K21E4MG#<'G '([UTS>$=/.I6ETK2)!:Z>^FI9@+Y1@;;E3QG
M^!>_:J-AX#CL9-'QK>I2P:-(S644GE'8I0IL)V98!6(Y.<8H 9I?BC6-7?2[
MVRTP3:7J 8D[&1K=<$QN7)PX. "  1GOBJ-EXRU^3PJOB*ZL;);%CL86R2RR
M18G,;2%1]Y H+8'/'Y;&C>"X]#G9;35]1.FJ[26^G.R&&!F)/RG;N(!)(4D@
M'G'2I].\+#2= M])M-4O$6WG,T<Y"%^6+%3\N"I+$=.AZ]Z +?A[5!K.E+>K
M=6=W$[MY4]H?D=,\'!)(/J,\&L)O%M_#XBL+&>"U\J[U":R\N/<S1!4=T=I
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M[$7=RLVCE&LKP;?,0HNT9XVD%<@C'(/K4O\ PC$!2Z+W<YFO;A)[R3"YN @
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MRJ' 8;4&" [=./4$U;3PK&=1TJ^N-1N[F73K>6W42K'B59-N[> H_N+TQTH
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MLYT62RFA'V2S9_(N'9#O>-%W#<J[<XXZ'&: -+PSXICU/PRFJZI<65MNNKB
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M58#/IQP03F:?'J&D:5H%Y-I>K?V?9WVHI<P6UO(LT(EF8PRB/ 8J%R.!P'H
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MW':02"1AL^U6;CQGJ6CMKUKJ*V=Q<V,]I%;201M$CFY(50REF(VG.2#R/0T
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MXFC$2X<EL.") > N,8]ZJV'BO6[G1O"K6<&EP2ZO<W-O(IA?RXR@E8,H#?\
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M)TV"-)HX-C"+8I"$DDGGGL/85TM !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %96MZ#!KGV%Y+FYM9
M[*X%Q!-;,H96VE3]X$$%6((([UJU5O=3L=-6)KZ\M[82N(XS-($WL>@&>IH
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M3;FW;5-)LS<%)064MM=MN 03@)S@\;A]* '7O@>QOI]0GDOK])[VY@NS)&Z
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M6VJ  #@ '@>E7*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *Y3QY;2W=CHZ16DUR(]7M)I%CA,F
MV-) 68@ \ 5U=% 'GVMVKV7BV^^VZ'J>HZ/JEC' G]G%\1LIDWQR*K+A6\S.
MX\<FHH;:?0]:U'3[WPU=WVDZG8VL-M';I]H2(1QE&@D9CP,G(9N#N/->C44
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M>E7FGK>3>:XO6?S97V@%V5B2O0#G!..G2N,O8=4GU6V<:'?Q?9/$OVAHK>W
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5KZ^@TZW
M$]RS+&9$CR%+?,[!5Z>Y'- %FBLNY\0Z=97KVUU))"4C>4RR1,(B$7<V'Q@D
M#DC/8^APX:[8>5O9Y%/VE+5D:-MR2/MVAACC(=3D^HH TJ*RI/$%G'?O9M'>
M>:BLP/V23:X7 .UMN&Y(''<TV/Q)ITMO;RQ_:':>5X5B6W<R*R'#[EQE0IZD
M\<CGD4 :]%9K:[8QS7L4K2QM9QB67?"R@H20"O'S<J1Q_49F_M.+^S1?>3=!
M".(S;N)3SC&S&[]/?I0!<HJMI]_;ZG8Q7EJY:&4$J64J1@X((/(((((/0BK-
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGN21R<U<HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
7 "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>aquestiveamendedandresta002.jpg
<TEXT>
begin 644 aquestiveamendedandresta002.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVM9IR?+B0_,SN=QZLH[G+>@)&@GA^]MO%9UFWOHW1].CLY8YXR7<QL[*VX$
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M;7I.)K/[0-NP@G \LYDQG@-QVJ9;'2DUCP98QZI-?:?+-?"-IIBJRQ&-B%4
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M?:89""LBD_>]#CH1S4WC"YL-1U3P@IE4P2ZPPW;]HE7[/*,@@\KD@9[_ (T
M=E?37-O;;[2T^U2[T7RO,"?*6 9LGT!)QWQBK->.W,]I;>"]<MX;I8X+'Q3%
M%;(LV!&AGA)4<_=PS\=.OI5[4[G3]1\0ZYIFM:NVG:G'=Q2::40>>T6U#']G
M8]<L'!5<\DYZT =OJ/B">#4;G3]-TUM0N[2".XGB681G8[,JA<C#-\C'!('
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[G) XZT =8L4:L2L: DDY [GJ:4QH<Y1>3D\=ZRO#NL7.L6<\EYIL]A/!</
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MOQRWJ"^UN 6UQ<+!\J1A"@54W=@S'DGECVP*WK*V>VTZ"UFD65HXQ&75-H;
MQG&3C\ZJ:=J%_/J-U97^GI;&"..1)8I_-24.7&!E5((V<Y'<5HQRQR@F.17
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M7J0#2[@W"H8-_F,5*8)W# PQ_&M&\U:PL8;>:XN8U2XF2"$[@=[N< #U_P
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M!]*BAM"OB;P$FN1PRZFFES+>/(H8^;LAQN/KD-CW!Q7I3,J(7=@JJ,DDX %
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M6ECXJT+3+<2:7.;J5+6-<W$$@VS8QU;;AP?5?>N]K*U#13J6I6UQ+J%VMK"
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M[OC[K_+M4<8(ZXXTO#<VEWMQ%INM6=PWBBRU2:=QY;JQR[[9=XX,7EL!@G&
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MC@C"SZ1;&)/+QOD$<N,#'W@2GN"17K1( ))P!4<,\5Q&)()4EC/1D8,#^(H
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MC3[.6V:RMM06>>X9"T,K,#\H0X8!20.GOVK<UO4;C38;9H(H=LLXCEGGD"I
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MZU/++JNGK8SDP1A0%#C<H &.)&P,_7/2K4'A=H=2T.\-\6.DVCVB+Y6!(KA
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MN&,=2>U '=P7\:6%O+?7-I',T ED*2CR^@W%2<97)Z^XJ>2[MHK87$EQ$D!
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M96#$9R,'H<\'G--^U'7_  K>W.D?89)=)NK<)% [QQ3>9$4[952%+#=C ^E
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M,E ^.<="1GZ4 2T5Y]X<\4ZHVA:.EY/;W.I:OJ%U!"WE,JQB.29F8C<<@*F
MH([#/>NCT'79[_5=8TB^BC6]TN2,-)%D)+'(NY' .2IZ@C)P1U- &]4<-Q#<
MH7@FCE4,5)1@P!'4<=Q7,Z[?:I%XW\.:?:W,,=G=)<O-&\18N45>I##C#]/4
M9YKF?#FKW^@VO[FVM#IEQXHNK%URPD7S+EU5EQP #CCG(]* /4**X\>*M4N[
ME9M+TTW=FFHO92QB)@X1',;RB3.WA@3MQR!USQ74WTTMO87$T*(\L<;,JNQ
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M/0"H[F[MK*'S;NXB@BSC?*X49],FF?VA9"S2\^V6_P!E?&R;S5V-GIALX.:
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M[,3/*84C,Z[FD !* 9Y;!''7D5E^,_$J>&O#FH7L,]E]NM[=IXK>YDQYF >
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M-,)EV1OD#:3G .648]Q6A0!Q?@Q9T\2^*FEAO_+N;F">&>ZMC$)5^SQJ2/E
MSE2,8R,<\USVJFZEU7Y-(U&#[+XGBN)(8+*1UDC&%^T%\'=N&.%(P.".]>JU
M!9WMKJ-JMU97$5Q;N2%DB8,I()!P1Z$$?A0!Y9?:8_\ PCWBTQ:1=?:I?$,,
M]OLL7WO&KP'<F%R5&V0Y'OZT_7_M8TGX@:7>:;?7%YJ6^>PDCM))4FB\E51
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MZU3M4OM*CL[U]-U7^R[76M2,L5M;N)8DED8Q2JF,E0"1P. YKUT$$ @Y!HH
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MRPWC?9'7RW,48Q(=O!+*>O<5OZ_;^?\ $/PQ*]G+-;V]O>>9(+=G2-F$6S+
M$ G:V/I77T4 >4:?97$?AGPE$VF7JR6GB.61D-G(&AA,DY#$;?E7#ISTY'I6
MOI<.H6?B^%+/[1<Z5-?W3S6M[:LKV#GS"98Y< -&[$X!S]_@]<>@4A(4$D@
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M])OXG6\O]]T+*5Y;7<\A7";>-ZM]Y@0!]<CU.F22QPA3)(J!F"C<<9)Z >]
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MC8Y97WA@^6&[)&<\YY--3PEI\4^DRP27$)TMY9(51@0SR AV?()8MN;/N<T
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MPD"M%,@4*\;* 5("K^7N<@%%_$7B'3WCLM1T]%N+S4!;6,PV9DC\II"S)YF
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M#TK2N?!-A=V^J027=[LU.ZCN[C:Z#]XFW;CY>!^[3C_9]SFOXA\-R?8]<OK
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MFDZ9/&=0L-H82@[2Y&2OKC& 2/7OBKNAZO!KNCV^HVZLJ2@AD;K&ZDJRGW#
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M3>(]%U;5;_Q@-.M)@UW96'V<R(42X:%W9X\GIE2%Y]?8T =POB'2&AN91J,
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M6WJ=EJ>H^*;V>WL;N"/4_#YLX9V4 02[Y#\_/R\.I]?Q% '4IXCT5WF4:I:
MPQ>=)NE"@1YQOR>JYXW#BGZ;KNE:RTJZ;J%O=F)4:00R!MH<94G'J*X?2[=[
MW2@]UX6U2TU6QTZ6V>6YD:1 63:4A^=MX8@'@8 'TKJ_!EJUGX,T6WEMFM[B
M&QAAFC=-K*ZH 0?QS0!;EU_2((;N:;4;:..S<)<LT@ A8C(#_P!W@CKZU#?^
M+/#VERS17VM6-O)"5659)U!0MG:",\9P?RKA?%.G:JT?CZPM](O;E]72&2TD
MB0%' A1""V>"&0\=>0>E7S-"_CSQ4D^F7%P;C2+1/)6'>3GSLQL1D+GCDG''
M)H [6\UK3;"-9+J]AC1D,H);^ =7X_A&1\W3FH;OQ)HEBX2ZU:SB<P^>%:9<
MF/(&X#TR1CUS7%^%=&U/P??Q1:K;SWUM-HMI:"6",S"*6'?NB(&2%._(/3CG
M%,\+Z!?Z#J_AB.]M9W6QT:YAEE6,R+"[RHZQ[AG)"AEX]/<4 >BVMW;WUI%=
MVDT<]O,H>.6-@RNIZ$$=:FKF/A[:7%AX'TZTN[:6VGA\Q7BE0J5_>,1^A%=/
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MRVID.YFD7:?FZ'8.>P[=ZS]*\9ZMXGLK2*P@:VOI-)COG\M8V'F.[H!AV'R
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M2QTY[<&+4/(\V%)RQ&V?J47&W!X')R>*R+WQ%?:#JGCC59;LW4.GI:K;V[*
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MF(67*(6P0"/2N?36=<AETBRN;I+BXUB-[B,VMNB- B1H60;WVL=SYR>P/'H
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M2*C2.Y R<*N2<#DXKG/!GBQ=6T2P?4;R)[Z]N+M+<I&5698I9 -O;A%!QG-
M'75EW'AW2[J^OKR:U5Y[ZT%E<,?XXAN^7_QX_D/2L?Q!XF9-,L;S1;N)D;6+
M>QN-T9)PTRQR)SC:PR1TK:CU_3)?[0V70/\ 9V1=_(W[GC//'IS].: (;SPS
MIUYHEIH["6.RM#"8DB?:1Y1!3GV*@_A39?#%C-=:I<O+<^9JENMM=8DX9%!
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MFN)8XI;> _/AV^147).T @D==I-95WXN2U\6Z<K7T/\ 8EWI<UTI$1+,ZO&
M1W/#G@"@#4L?"6EZ>84@6;[+;SM<6]HSYB@D.<LHZ_Q$@$D#/ %13^"M(NK3
M4;:<7#I?W0O)&\TADG&,2(PP5(VKT]/K4TVN65S+HDEGK=M'%?2%HD"!S>)L
M8[5.?EQPV?\ 9QWHC\8^'I;J*WCU:W>66<VR!22#*#C9G& <\#/4],T 5_\
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M9CR35JJVGZC9ZK91WEC<)/;R9VNAXR#@CV((((/0BK- !1110 4444 %%%%
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MJM87]KJ=J+JSE\R$LR!MI7E6*L,$ ]010!Q&I:1J']L>(#!ILIAG\.QV$!B
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M?W2%)E!Z\_ZQ>F?TI)-'U4Z'>0KI5SYS^*5U!5PN3 +A9-_7^ZIXZ^U>FT4
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M(!_%%+"VX'_@2(W_  &MG4?!>B:G=WES-!.CWT'V>[$%S)$LZ8VC>JD!B 2
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M'Y+1R7LS[(LY\M"6RB],A<9P,]!0!LZ5;W\$$IU"_%X\DF]"L(C$:D#Y!CJ
M<\GGGVJ_3(8E@A2)"Q5%"@NQ8X'J3R:?0 4444 %%%% !1110 4444 %%%%
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M:U_Q(]2N_#[ZM]N>2SF@96>(IN.6=6 \R,[E /*D T >H^:@B\TL!'MW%FX
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MG?9%$I=VP3@#KTKB]'FU?PEH$\-QH<TX&K3?-'<1C=%-.[B11G)P&4;>&).
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M&^8C(!'.,GT!KG8O"^L2>#?^$0N+1\QZB)4U(2)L:$7/G[\9W!\97&.O?'-
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M=0&!Y(RTTLP0! 0Q&U=I.21U&.]0Z9HVKV]QX#,NF2JNE:=);WA\R(^6YB1
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M=W)%=/%::EI^FQ-JJ*"MN',Y5R#TW'"@D8!8$^A]2B0QQ*A=I"!C<^,GZXH
M?17FTWB'4KWPO9^(8-2F@EFUJ.U-L@38D7VOR3&003G:,DYSD\8'%&H:_K%O
MX<\67":E*)M.UR.WMG*)E8F^SY0_+@C]X_)YYZT >DT5P=YJ6NZQ>^((]*U"
MVL9M(NTC03RX14$:.6D382RMN<9W#@<8()+Y-;U"U\7QVFIO>6UI=7ACL;NW
MV26THV$>2_&8Y V3D]2,9QQ0!U]YJ$%C;K-()70RK%^YC:0AF8*,A03@$\GM
M5JO*M,N]2TSX=VU[;ZK=^<^O>2YDV/N1K]HV!)7/()R<YS6M>ZWJ=]IWC*^M
MK][.XT*:1+:$*I0B.%9,R C+!R2/88Q@Y- '?T5YM<ZKK>I7VL;-6N]/CCT"
MWU**&../,,K"4E<LAR,H,@\^X'%+J7B;5H-+T[5;LW2:9/I,$\UW8!7:SF8$
MM)+&1EHR,<C.-K>Q !Z115:\N4@TVXNO/CB2.%I/.<95 !G<?4#K7G]EJVK3
M7LEC)J-XT%SX<:]$[A$=I0P'FH ,QA@W"GIQP#0!Z0K!E#*05(R"#P:6N<\
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MLV]JTQ8P+<QLT+*DL3<!T8C##_ZWK6K6!X'A:'P-H8:>27=80,#)CY08UX&
M.!^=;] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %4]3TNRUBS^R:A;K/#O60*21AE.5((Y!!'45<J
MI?ZC!IX@$NYI;B7R8(D&6D?:6P,X'W58\GM0!2D\*Z+*M\KV0*7Z+'=*)' E
M51@*1G& .,>G%1W_ (.\/:I<VMQ?:7%/-:QB**1RQ;9_=8Y^9?9LBJTWC"$:
MUH^GPV-V_P#:(G.]HB/+\H[6!!YSN(^@JT?%>E":!3)((+BY-I#=&,^2\P)&
MP-ZY! /0D8!)H NP:18VVJ7&IQ0E;RX14EDWM\ZKG:",XP,G''&3ZU4TWPEH
M.D:E/J&GZ9!;W4Q8NZ9QD]2%SA<]\ 9I)_%.F6]W' [R[)+L6(G6,F,3GI&3
MZYXST!X)SQ6/X:\02HNI0ZA<7%[/_;5S:6P6,%]B8QPH "@=3TY&>M &]8^'
M=)TR5)+.S6+RRQB0.Q2(M][8I.U,\YV@=352\\(:3<Z3J5@EHOEZB_F7 DD=
ME=\@[R-W)^4=QG %8=IXO72-=\3Q:Q=7<UK:ZA#'&X@++;(\,9^8JN%7<YY/
M/UP371ZCXET_3'NEE\Z06<8ENVAB+BW0Y(+8]@3@9('.,4 :=O MM:Q6ZL[+
M$@0,YRQ &,D^M99\*:*;.2T-F3!)<_:W3SGPTV[=O^]UW<_7FLYM4G?XAZ=!
M#?E]+N='GN1&-OEEEDA"N"!D_*Y[XYJG>^)GO/%WA&/3I[M=/OYKC<3$!%<H
MMO(P8-C/W@I'3(Y&1S0!OS>&=(G_ +0\VT+_ -HJ%O,RO^^ & &YZ8X^G%2+
MX?TU;R.\6!Q<1VYMDD\]]RQ'JN=W3@'Z@'M5?_A*]+^W6MLS3*+LNMK,8B8Y
MV0$LJ$=3@$C^]CC-5;+QWHVH0K-;"]:&3"Q2-:NB2.9/+"*S #=N[9X[XP<
M%Q/"FAI9V%HNGQ^18.7M4+,?*)!! YZ$$C'3VHD\*:++#<Q/9DQW-P+J9?.?
M#RC!#GYNHPOY#T%7[&^COX7DCCEC*2-&Z2IM96'7C^O0]J9J6JVVE);FX+%[
MF8001H,M)(02%'X GG XH QO$'A:.\T[4SIMM;M?7ZQI<_:Y'*7$:L,HQYV_
M+N 8 E<Y%5_#/A=M+U#[:-/32QY;(T$.I37*RYQ@D. HQCC )YZCD&ZWC714
ML[2Y:2X"W5VUDBBV=F$ZE@R, #@@JW'?'&:EMO%NE7.GS7:M.GDW7V-X)(66
M43\838>23N!'L<],T 7]3TC3]8BACU"U2=891-&&S\K@$ C'L2/H35.3PIHL
MMO>6\EF6AO)A/<)YSXDD&,,?FZ_*O_?(]!69X6U:[U#Q3XIM[B6Y,-I/ L,-
MPBJ8=T6YE&!R,GKSD8Y-#ZG<V_Q U.TFO)SI\>CQ72Q+&&\MC)(K%0JY)PHZ
MYH TKKPCH%]K$6K7.F0RW\851,Q.6"_=W<X;';=FMEE#*58 J1@@C@BN7L/%
MFE6VF:'#]KU"^DU"T\ZUD>V9I+A54$D[5 W8(X]_2I+7QUHMV+%HS=B.\G-J
MLCVKJL<V2OEN2/E;*D8^GJ* +6F>$=!T9+A--TV.V6X4J_ELPPIY*KS\HSV7
M J2W\+Z/:OI[P6A0Z<A2TQ*^(5/4*,]",#'H *Q-3\6VNBV?B74(9;^_EL9H
MXY+5XMJP.R+M"Y .PY#$Y/7BM._\8:7IOGFZ^T(+:%)[K]T3]GC=BJL_U*MT
MR<#/2@">7PKH4VNC6I--A.H_*3-S\Q7[I(S@D=B1D=JCO/!WA_4+FZN+O3(I
M9+MD:?+-M=EQM8KG&[Y0,XS@8Z5$/%"-XIU'13:72K9VD=PTZQ%L[]_0#)Q\
MG'')IND>(+ :#H[07EYJ3WL&^V9T'GW"J 2[#  ZC).!R!U(H MR^%M&F74%
MDL]RZ@ MVOFOB8 8 (ST XQZ<=*=+X:TB>9I9K4R2-:M9L7E<YA/5#ST/_UZ
MJ-XVT-;2QN1/.R7MPUK$$MY&83*&W1L ,JPVM\IYXXS4MKXLTR\LA<0^?O-V
MUE]G>(I+YX!)3:V,':-W7&* )I/#6D36=U:SV?GQ72+'-Y\CR,ZJ<J-S$G )
M)'/!)(JO<^"O#EXTS7&DP2&>%89<EL.J_=R,\D=FZ^]:MC>QZA:"XB61%+,A
M65"K JQ4@@^X-9J^*]*:>U3S)!#=S&WMKDQGRII1GY%;U.TXS@-C@F@"1O"^
MC,;S-GC[;"MO< 2N!)&H("D ] "1CW/J:AO/!OA[4#9F[TR*9K./RH&9FRJ?
MW"<Y9?\ 9.15>+QWHDT\<:-=[7O38&5K2142<-M",2."6X&?;U%6_%6OCPUH
M$VI&VDN"KI&J(,_,[!03[9(H -3\):!K-]!>ZAI<$]S NQ)""#LZ[3@C<OL<
MBK#Z!IDM[)=O;%I9)4F<&1MC.@ 1BF=I(VK@XXVCTKF)_%3Z5XUU07LE_+I\
M>DP7:6R6Q=H27E#MA1D#" G)_H*Z&Z\2Z?;6BW*&:Y0VPNS]FC+D0D9#D>AY
MP.IP< X- &E=VL-]:2VMPF^&9"DB[B-RGJ,CFJ$/AO2K>:UFAMF22TMS;0,)
MGS'$<?(.>G _(>@J9M8M#H)UFW+75H;?[1&8!DR)MW#:#ZCUK!LO$]OJUMX5
MNIY;ZPGU+$D=ND7[N8F N59BI^4#)'()*B@#H=,TNST:Q2RT^'R;9"2L88D+
MDY.,D]R34DEC:S7L%Y) CW-NKK#(1R@;&['UVC\JP#X^T( .6O!"+PV+S&TD
M"1S!MNUB1QEN/R]15RU\5Z7=)?DM/ ]@Z)/%<0,C@O\ <PI&3NS@8Y)XZT 6
M9M TJ?1Y=(>RC_L^4L7MU)56W,6;.#T))./>D;P_IC7CW;0.;A[?[*TAG?<8
MO[N=W3O]>:--UVSU.]O+*,2Q7EF5\^WF3:ZAAE6]"#@\@GH:KWWBO2]/O)K>
M=Y<6\L,-Q*L9*0O*0(PQ]]R],XR,XH ;<^#/#UYI]C8SZ9&]O8?\>HWL&A&,
M85@<@8XQG'%6QH&F+>6]VEJ(YK: V\+1NR".,XRJ@$ #@?D/2N9O-2U--9\;
MP)J,ZI9Z9!<6F%3]PY68G;\O.2@ZYK5TKQ B:!HPN#/=ZA<:='<O'"F^1EV+
MN<]NI_$],T :^F:79Z/8I9:?#Y-LA)2,,2%R<G&2>Y)K/NO!WAZ]N;FXN-+A
MDEN9$FE))^:1<;7QG ;@<CDXYJG+XVLGO= CT^*:\M]7,A2>)#A51"2,==V0
M 1CC!SBGZ1XQM]2@U">6UN+9+:^>RC5XSND=2%P .K%L\=AU[T 7)?"FB3P7
MT,EENBOW#W2>:^)2  ,C/8 #Z >E0IIVH7NO12ZC;V:V&G2&2Q9)&DED8ILW
M/N VX#.."<Y![<OB\6Z5+!<L9)8YK:Y6TEMGC(E$S8*H%[Y!!!&1CG. <9_A
M75KO4?$_BF"XFN3#:7$"0PW"*K0AH@S+P.1DG!YR,<F@#JR2%) R<=/6N2\(
M>%/[,T_&J6RF[6^N+I-L[21@O([*P4_*&"MC.,^]78_%<!\2ZOI<\$L$&F6T
M4\MU(,)AA(22>R@)U/4Y]*M6?B.PN]0BL,3P7$\)N+=9XBGG1C&67/ID9!PP
MR,B@!O\ PB>@C7FUL:9"-18AFF&1N8# 8KG!;WQGWJ2/PWI,5E=VB6I$%Y*9
MIT,KG?(3DMDG()(!R/2I[[5;>QFAMV626ZG#-%!"NYV"XW'T &1R2!D@=2*S
M[/QAI-\NG-"\^W4+B6V@+PLN98]VY2#RI&QNOI0!:D\.:3-9SVLUF)HYW624
MRNSNS+C:V\DMD8&#GC'%-F\-:1<6,ME/:F2&6199=\KEI'7&UF8G<Q&U<9)Q
M@>@IL'B;3KB":2-I2T5VUB8O+.]IP,E%'?CG/3 )S@$U%;>+=,NT @,SW/VI
M[,VNS;*LR*692#@<*,YS@C&"<B@"_;Z18VNI3ZC#"PN[A%CEE,C$NJYV@Y..
M,G'U/K2W>DV5]>VEY<PE[BS8M;OO8>62,$C![@D?0XK'_P"$PA?Q!I>F0V5V
MRWUM+<>:T1&P(RK@@\@Y;GCBETOQ!IJZ9)<K?WEVLNH2VT:SQ8E,N\YB5=H.
M%P0,C@*23@9H MMX4T5K6:V:S)AFN!=2(9I,--G.\_-UR ?J >U12>"_#LL\
MDTFE0O))<"Z8L6/[T?QXS@$]\=>^:9/XTT:UT^YN[B6:(6EPEK<Q-"Q>&1B
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M*&S*1Z>Y>T42OB$D$$KSZ$CZ$^M-UZ^D;P7J.H6%Q)!(+"2X@E51N4A"RG#
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MW5W:F'4&N;:,3&!;*0N\1R-ZC'*Y4C/K]1D U]+TFQT6Q2RTZV6WMD^[&I)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 245']HA\SR_.CW\_+N&>,9X_$?G1#<0W";X)HY5]48,/TH DHI&940L[!5
MR23@ 5&ES!)")DFC:(]'5P5/;K0!+140N;<JS">(JK;&.\8#>A]Z<)8RRJ)%
M+,,@9Y(]: 'T5'+<00LJRS1QL^=H=@"WTJM;:M8WFH7=C;W"27%H56=5(.PD
M9P??&#^(H NT5'#/#<!C#+'(%.TE&!P?3BL[6M8&G:#JFH6@ANI;""25H?-V
MC*J6*D@'!X]* -6BLI=79_#L>HHD37+V8N1 TNT$E-V,X)Q[XH\.ZRNN:#IM
M^PCCGN[.*Y>!7R4WJ#]<<]: -6BHUGA>9X5EC:5!ED# LOU':LCP]KLNL+JQ
MN;>.V-A?RVGRR%@P0*=V2!UW>E &W16%H_B%M5U_6M/\J$0Z?Y/ES12[Q*)%
M+9/ QC&,<_6MA+JWEA,T<\3Q X+JX*_G0!+138Y$E7=&ZNN2,J<C(X(IJ7$$
MDDD:31L\?WU5@2OU':@"2BHENK=BP6>([5#G#CA3T/T]ZS8M974["TOM&DM;
MFVFN CR22[1Y>X@LN <GC@<9SUH UZ*YS6_%MO8Z!KU_IWD7L^C*_G0F7:-R
MH'(R >@8?CQQ6VMY$+>"2:6.(S!=H9@,DCH,]: +%%9^MZF-(TBZO (7EBB=
MXXI9?+$A4$[<X/IZ&DTK5%OO#ECJUQLMUGM([F3+?+&&0,>3V&>M &C15*RU
M:QO])@U2"YC^QS1K*DK, -K $9STZBKBLK*&4@J1D$'@B@!:*B%Q 4+B:,J.
MIW# I6N(4E2)IHUD?E$+ %OH.] $E%4HM6L9]6N-+CN$:\MXTDEC!&5#[MN?
M?Y2<>F/6K,4\,Y<12QR%#M;8P.T^A]#0!)16=/K%K'J+Z9#+%)J(MS<"!I-O
MRYP,G!(R?8]#5;PMKZ^(O#FFZDZQPSWELMP;=7W% ?U(]Z -JBHUN(6G:!98
MS*@RT88;@/<4BW$#E@LT;%1N(# X'(S^A_*@"6BH5NK=[<W"SQ& #/F!QM_/
MI5:]UG3M/@MI[B[B6.YF2"$[@?,=S@ >OK] 30!?HIK2(D9D9U5 ,EB< #US
M6'J_B%M/U#0X8(H;BWU*\-LTPEYC_=NX( &#]SU'6@#>HJ+[3;FW^T">+R,9
M\S>-N/KTK'\0Z^^CVFFW-M#%<Q7=_;VC-YN-JRR!-PP#NQGID4 ;M%8NF:W-
M?>)=;TF6VCB73A 4D60L9!(K-DC QC'3GZU';^(6;Q7JFCW44$$-G;V\T<YF
M_P!9YID&""!@Y3ISUH WJ*CFN(;=0TTL<:D[078 $^G-24 %%1)=6\B2.D\3
M+&2'97!"D=<^E-DO;6**:62YA5(%W2L7 $8QG+>G'/- $]%9<.JMJ$.E7FFF
MWEL;SYW>20JX0QEEVK@Y;.,@D8&:S-:\8P6?AV\U72Q!?BUNDMI!YNT F18V
M((!S@M[=#S0!T]%1R7$,4B1R2QH\APBLP!8^P[UC^+?$'_"-^&[[4XT@FGMH
M'F2"6;R_,"C)QP2?R_*@#<HJK<ZA;6.F2:A>S)!;Q1>;+(YP%4#)I8]0M9+*
M*\,\:02J&5W8 <]!]: +-%'6B@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BF
M12QSQ++#(LD;#*NAR"/8BGT %%%% !1110 4444 %>;^*[#1-2U34+]+ZXT#
MQ'I_[N"^ARC7(V*P&W&)ER=NT9/&*](HH \JN[ZY:]T]O&L=W:6^I:)%"QAM
M1*B7!+>=&PV.49@R=,?=QSBI!_9VE:O+I7B*TOY='O='@M=/:XA>9]HWB2(E
M 2LARA[$X'<"O3I)8X8S)+(J(.K,< ?C3Z .!M;6QM/B-,+NP,4,^@VZ1^=$
M7 VO+O#/R,A2H))YR*P?"SR6.F^ Y=0C*Z/%9W$,QD7"6]R2-ADS]WY0Z@GI
MN]Z]<HH \AETJ..#3$N+=6T]O%CRV*.G$=HR,#@=HR^3Z89>Q%=;X%BAM;_Q
M5:VT:16ZZNSPQHNU0IABR5'3&X-TXSFNQHH \GU'1%CA\;Q3QRKK]Q>-=Z3-
M&2)'S&@A\HCT=2K8Z#KQBO2+#44DN&TR:0MJ%M!%)<8C8+\P(R&Q@\J> >*T
M** *]]>PZ=8SWEPQ6&%"[$#)P.P'<^@[UYMXAT[58/"MIXHCN;26^LKM=66*
M*!O,D+</#OWG</+.P?+SM6O4:8\L<;(KR*K.<("<%CC.!Z\ T <1-/977Q(\
M/ZL("]M=Z5/'%+Y!;]Z9(64'CY6 #=<8P:M^*[BWC\1Z%#<6S_O%N EV8GE2
M,E5!0(O!=@3@MG&&X.<5U]% 'DOAN5O[,^&22K*CVTL\<HEC92F+>5!G(Z9*
MJ#TSQ76>!6!E\3?[6MSNN>ZE4PP]0<'GV-==10!X[XATZQDTSXD.EG$UQ]IC
M>T*QY;?Y,66C[YW@Y*]Q[5HZY:-#XAUV+PU"D<]SX:_=BU 7S91(Q&".LFT\
M'KR#7J-% 'D\PL]6T75=6\+C5IM1_LU;>: VP@"HKJQBVB-0TFW>!C.!D=QF
M+6;72-=\'^*-2T(:C>3SZ5Y4JR6OE*&3)5=@1<R %AD9(''<5Z[10!P4C:7/
M\0]%NH(85LY='NT=FAV*5+Q%0P('! <@'J,FN;\+65I96/PZN(K9(;L3SQW,
M@CVR!3#*-KGJ!NV  ^WM7L-% 'CMO+HMU?6>EZI?VJ&Q\07%T9;N&02SY>0!
M&#)MY+ 9W$85> >!NZ69[7QK#';O!J5A-J-VQ62+9=Z=(?,WL2/O0L<@9Q]Y
M,$\5T6G^$OL$"V9UO4[C3%X6RG,17;G.TN$#L/JW/0YKHZ ./U^5K3QWHESJ
M*C^Q/LMQ%YCC]W#<DH59ST&4#J"?4CO7*7>G_9O!RQW$(-F?$\<NG1/'DQVG
MVE#P",A,!SZ;2.U>L1RQS1B2)U=#T93D'\:?0!A^)X+6;PC=V[3R6ML\:()K
M9 WE@L &"]"HX)'<9KS^[-Q-9P2:I965PMIXBM9)M1L8"8;I#&%,FWG! "*V
M"1D5ZO\ :K?9O\^+;O\ +W;QC=G&WZYXQ3I)8X8S)+(L:#JS' 'XT >7WZ"?
M3/&^G:C;O_:US*TNE QD22IY2_9_)[Y1QR!]TY)QDU(\EO'K6L:/XSM+BZ>_
MMK46CQ0R.)PL8#I&R#Y6$H9NH^\#7I]% 'DNL3SVOCC7+V6V%WHT9L?[0LPI
M=I5"L-R_W_+<J63G.?P.EJT&E:KXWU*2>*WN;/\ X1Q5C+H&3=YDAP,\;@&'
MN ?>O2** /+?#EPT-QX7FUT Z9)X:BMTEN1F..Z&WS5?/"LR@#GKM(IMC:W6
MGZ?X*@NQ(J1:Y/) DH.Z*U*3B+=GD#:R#GID"O5** /&[JYC?PR;/4[64^(K
M;Q'%<7(-NS.1]K!612!RGE%5!'&!BM%EL[[7=4TG76U6/4SJ@N[%(+8?OD!4
MPLDOEDJ% VMEAC!SQFO4'ECBV^9(J;F"KN.,D]A[T^@#RS3-%T2?2O&,T]NL
M$@U*Z2.Z@@#2PQ2*J[H^.5.6X'!P>M:N@^(!HD.JSZ^]FT27$,8U;3X&\J[+
M+@%E7.UE  8@X''2N^) &2< 5486>K6A"RQW%LQPWER95L=5..H]1WZ&@#%\
M=7$-OX;WW%HUS";NW#XW%8AYJGS'"\LBXR1WQCC.:\]ODBFT?Q-;RQR2,?$=
ME<PEK5H\JQMRSH,<# D/'. 2?6O9Z* /.K7P]I6JZ_XVT'[-#%IUY;6NU(D"
MH'V.&= .-P.SD="!FM7P5]OU-/[2UFV6.^L8SI@.!AFC8B613_==E7C_ &*Z
M'6;7[9I<D/\ :=QIN2I^U6[JKI@@]6!'/3D=ZGL;.'3[**U@W>7&,98Y9CU)
M)[DDDD]R: .#\;F>WUFYN[&2"ZF%E$EQI%W$2+R,.Y7R''*R@EN!G^'('!K,
MUNVNTN/B##IMC+_:$[6LT2Q0D-+!Y40F"L!@DA9!@')->KT4 >9:Y!<ZGJ-Y
M?^#&V^9X?N(I6MQL#2_+Y">T@_>>Z]\9%.EN_#VK>%-7O])T^>"\709;.7=#
M)$(OE.V$J0 S[B<8!/7GD9]+HH \P\-7PM;*^L]9CC.HMIBR6E\$^66VV$+$
M#_ R'(*]_O<Y-5-"LX[-_ +Z?#%;W\FBSQ7$@3!\SR8]JRGK]]3@'N"!7K5%
M 'E>E0O>:-X+BM8GA\0V%[&-1#+B:-0K"Y,G?:YYR>&)4C-03SS0V6ISB*27
M3T\7>=J"(A8FUVK\^T<LF\*3C.0I]Z];HH \BOY3)>^,[O1;6XEMY)M-N9!:
MVY_TB%2#-LRNUB5SD<Y&>N:37K;0K_PGK6IZ6][=B]N+%GDF@\M3(DJ@F- B
MG<$SN8#IWX./69+JWBGC@DGB2:3.R-G 9\>@[U+0!E/IL5CX>O+?P_;V]J\D
M4CP"!0B>:P)#<<<G!S7G&FQZ+JVB"=EU+^U;+29K:[MKBU$2PY3YDD/E@/\
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M=:%;_998H2#)*J3"0JX& <D#.1R5K8\'-HFIZS_:^EMJ1N!9"VN$FMA D(#
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MO!Z# [5T]%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5G1 &@<QB,%/H%7KGD51N_ =EJ+7]Q>3M]NO! 3<VT8B*/"Q:.0#G+Y;DGJ
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M50%&<=\ 4 >:^(+[4M5\&>+6U(VTRV>M1PVZHA!3;) !C)XX)Y]2?7%=%?\
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M!]L_MHZ/=HTY"I(%+!T.WE2,'GD9Z'%0W7C;7+'3M;NI].L&_L.[6*[V3/\
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MQ;OQ<NEV$QM1J&GW+V\,!47,*!/.5!C#'"X('7&.]:U_"UYKNOZQIR2G3YM
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M,L;2\O\ QO#=6L,\4FN2*Z21A@P\F+@@]>IH [O(QGM5*#6-,NI#';ZC:32
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M@8W>V>EN;JWLH&GNIXX8E(!>1@H!)P!D^I(%-L[ZTU" S6=S%<1!BA:-@P#
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MAE(P0?PI@O+4W8M!<PFY,?FB'>-Y3.-V.N,]Z6YN[>SC$ES-'$A8*"[8RQZ
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MSSBMC5=,CU:Q^RR3SP 21RK) VUU9&##!(/<"K-Q<0VL#37$J11+C+NV ,G
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MWHES9W+VQ RW[Q,[PK*=K#!&?P/45=\3:]#H>C7LPO+2&]BMGFA2X.0Q4<9
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M[SYB/S_W?NL<GT]>*7P99B0Z);:EX<U6WU?18C"US<2R?9T^38S1,6VN'P.
M.,]L"O1:KB^M6U![ 7$9O$B$S0[OG"$D!L>F01^% &+XS:X32;5[?3GO=M]
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MWDZ&T(D=0N&ED0 E>PYYXKT&JT&HV5U>7-I;W4,MQ:[?/B1P6BW9P& Z9P:
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M=8\"6UQ@IMW?ZT,1GMMYQ6G#X+TRWUR?4X)KZ(7$WVB:S2Y86\DW7S#'_>R
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M\DDU9H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M..221?-&S@X5B74!0,>W/,S07.NC58;B#5+/6M0T5M,MI;FR^SPL0KMU#O\
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M;3;IQOGG5%9CF38JC<",#!)X].E<U;>*_$.J'0;2*>UL[FYOKW3KN3[.74O
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MJ6FM>"PNXT:VTR6[2&*,/*77.&DW#:L6 1U#$YQTH Z74-3L]+@\Z\F$:G)
M"EF( R<  DX )/H*S;SQEX=L+6.ZN=6MTMI%5UF!+(0R[E^8# )'('4]LUST
MLMWJ7COPA=F[:(7&DW,YB5%*J3]G) R.^?\ "LR"2_T?2?B)J%K=H\MA=R21
M)-;JR;H[6%E.!C&  !V'I0!Z?'(LL:R(P9' 92.X-.KA/$WB+5]".DWPNX?[
M/OXA!*'10;:9@-DQ./\ 5 GYO3(YYQ6AJ6J:B-;B\/V<TQNAIYNWN(TBW,=^
MP?*Y"[<@D@<\CD=P#J7=(HVDD8*B@EF)P /6H-/U"TU6PBOK&=)[689CE3HP
MSC(_*N5TW6M;U/5X="O)8+#4+?35NKQ[8"0-*SL@"[LC:-C$]^0,C!S+\,0W
M_"MM%!(W>2V2!WWM0!UU%>9Z)KNHV&DP1RW\EQ<ZGXBN-/6:9%_=!99<L,
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MG_"0_P!N9F^V_9_LV?,.SR\[L;>G7G/6J,G@[29;'4+.07#17]T+V8^>P83
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M:WDODP.L+_.V2,8VY'0\D8XJU?ZG::9'$]W+L$T@BB4*69W.<*JJ"2< G@=
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M@0.F0=N?QQ[UPNC>'];M-*\#P3:5*LFE7<LEV/-B/EJT<J@\/SS(.GO7I%%
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M_P"$OL5T]KN#7=TUM-YB 1L\*Q,DN6R NT'*AN/?BG6V@:GHVO#R;22]M/\
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M7]S">A3MDC'3'OS7JE8EYX1T._?4'N;'<=1"B[ E=1+@ #(# =%4''7 STH
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MTR[U+2H/MMKJ$B0R^,+BSDM/+0QR)+=,K$DC=N&<@@@<=#6W;ZGXAUJ6XO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5#5-9LM'-I]M>1!=W"VT16)G!D8X4$@'&3W.!5^L?Q3
MHYU[PU?:=&^R>2/=;R?\\YE(:-OP8*: !?%&ENNI%9)R=.E6&Y7[/)N5VP0
M,9;(9<8SU%<[9^,(]+UWQ)#K-[<R6MK?PQ0O]F++;H\4;?.47"KN<C+?T-.T
M_P *:I#XGMM4N)H_+O8%FU:,'(:ZC;=%M]AO(SZ1)5+6?#>M7NG>.+>"P)?5
MYXGM,RH 0L<:$GYN.4)^A% '7ZCXDTW2WN5N))2+6,2W+10M(($.<,^T'' )
M]<<].:TEGCDMA<1L)(F3>K1_-N7&01CKGVKCFTC5[/5_$LD-B;NVUR)'CS*B
MFWE$0C*29/W>%.5W=^.F>D\/Z5_8?AS3=)\TR_8K6.#S#_%M4#/Z4 4K?QCH
MMU%IDL,\S1ZG*T-JQMI '==VY3E?E(VM]['0TS4M=L3+8H-0N[0MJ:VH*6S%
M9Y!G,1)4@*?[P(^Z<'@US>I>!]4<:S]BFC5(;P:GHJ%L;+DE7<-V +*P'M*]
M:^MZ%?-I_AVWM(3<R66IPW=U(&5=V-QD;DC)+,3CW- &1K&N:Q:Z;\0VAU.5
M9-*"O9/Y<>8@;=9"OW<$9)Z\^]=_%OFLD_>,KO&/G7&02.HR,?I7":MX=UB\
MM/'T,5B2VLJJV9,J -B!8B3SQRI/T]^*[NTWBS@$D9C<( R$@D''3CB@#BO!
M/CFVO=%T2UU:\G?5+Y& GDMF2*:0%OE#A0A; Z ^W6NC/B?2EO[:T:9U:ZE:
M""4Q,(I)5SE ^,9^4_7!QG%<MI'A;5&T#P[H=]:" :1?)=2W/F*R2>6S,HC
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MI"0)#'OC@""*W4(F0N,*#@ >@H Y;P/XQAU30] MK^YFDU6]LA-YCV[*DS
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MVB:/]C=S(A*R>8K8P#G& >?6I=<TO4!XKT77[&$W26D<]M<6P=58I)M.]-Q
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M;09XGM9XS@B*?&Z-^!D[@K+C.,E?6MNRMKQ?#7EWUS-]LDA9I7##=&S G:I
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MBY6SU*.6_@C6-W*F$' Y"GC!/L<8[ 'HE%<YX$U"[U/PA:7%].T]RLL\+2L
M"XCF>,$XXSA1FNCH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MB.&64D$ #:2,$9(!Y%3-XLTM)(2S2BUFN39QWFS]RTP8KLSU^\"N<;2>,YH
MLIX>TJ.^>\2S197E\]@"=AEZ>9LSMW_[6,^]:$T4=Q#)#*@>.12CJPR&!&"#
M7.3>/-&@DN5=;W9:7BV=S+]E<)"[;<%B1PI+J,^_IS734 5(M,L89;:6.UB2
M2UA-O P7F.,[<J/0?(OY56E\.Z3.^H-):!CJ*A+S+M^^4# #<\C''TXZ5G:A
MXYTC3I=3CE2^?^R]AO&CM781*PW;B<?= YR/PS@U/'XNTZ6\N;58[L2P6IO%
M#0%1-"#@O&3C< <?F,9S0!=CT+38KRUNTML3VD1@@?S&)2,XRHYZ<#\AZ4Z^
MT:PU*>"XN8,W$ 813([1R(#U 92#@X&1G!Q52W\4:;<RZ2D;2XU:V-U:.R85
MD"ACGT(#*>?6J=]XTM;;0+K5H;*[FABL6OX2$ $\0&=RG/'4'!P0.U &AJ/A
MC0]6TR#3KW3+>6T@(:&+;M$1'0KC!7\*OVEG;6%I%:6D"0V\2[4C08"BH]+O
M&U#3+:[>%X6EC#%'&""1]3Q5;5-=M=*,BO'//)%";B6.W3<R1#/S$9'H<#J<
M' .#0!%;^$]"M!:BVTZ*$6DC2P",LHC<C!(P?0D?3CI1-X3T*XTZ[L)]-BEM
M;N4SSQR$L'D/5^3PWN.:IQ^(=-O-=LWL[V]N&FTM[R&WA3]S/%N3YP2!E^0
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MHC+$F&$9#%E&<%6.W'J.>00* -R+PMHUO%!%!:-"L!D,7E3.A3S""^"&SAB
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M@8D L<D\GN23]2:MU0T;6;+7M.6^L9&:(NT;*ZE61U)5E8'H0015^@ HHHH
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MV^I6<4,T#2A'AEB+;3GH5(<YQR",@'-=/%(LL22+G:ZAAGT-/H X3P]X0O\
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M2";3C=0(S/YD,_DW%O)@;'B;(P>N>1^/0Z6D:U::VMXUH)0+2Z>UE$J%#O4
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M,TR;"BD)M!1L$;B6/0XZY":=H/B=%\(6UW8V070)2DLZW1Q-&('B5E7;D'#
MX/?\Z]"K.NM:M+36[#2)1+]IOED>$A#LP@RV6Z9Y'% &C7G^K> [V[DU[[-<
MQI#+*NHZ6G_/&^^4ESZ#=&#_ -M7KK]1UJTTN\TZUN!+YFH3_9X2B$KOVEN3
MT'"G\JT: .2UK0+^;1M$M;5$GGM-2M[VY<OL#E7WR$9[LQ) ]^U9>M>%M<NK
M+QK96T%L\>MLLEM*T^TAO*CC(9<< ;"<Y/4<>GH-1SS"WMY)F5V5%W$(N3CV
M'>@#G[?3;_\ X3U]9DMU2T?2DM.9 6$@D9SP.V&QGU%:FNVTU[X?U&TMD#SS
MVTD48+8&YE(&3V'-5;7Q5I=[X?@UN"20V5PR) S1E6E9V"(%4X/+$ 9Q^7-6
M+36$O-/NKL65]$ULSI);RPD2EE&2%'1L]BI(.>M '.:5H6JV6L^'[N6U0QZ?
MHC6$P64$F4F(_+ZK^[//'4<51L_#&MVWACPII[6L1GTO4A=7&)QM*#S/NGN?
MW@X..AKO+>Z2>&!\-$\T8D6*4;9 , D%>Q&1GTIMW>"S-N#;W$WGS"']S&7V
M9!.YO11CD^XH Y"7PWJ\$?BO3K>**>SUYGEBF>3!MWDB$;AQU(&T$;<YZ<=:
MN:!H%YHOB6_F$6^P;3K2T@?S 78P!QR.V=X[]JZRB@#SVS\,:U!X>\.6+VL7
MG:=K+WT^)ACRR\K?*>YQ*...AYZ5)/H?B2&XUN:QBB5;[6(;LQ_:?+:6W6-$
M=-X&48E <CMQFNMT?6K77+>>>T$H2"XDMG$J;"'1MK<'WJ^\B1[=[JNX[5R<
M9/I0!YRGA#7(=,O(H[2P1U\0PZM;PQW!VNBLC,F=GRGY3SCGT%6M:\(:GKUY
MXF67RK6/5--MK>&59-VR6)G;D8SMRX'T!X%=]10!R$^D:IK&JZ?J]]9QVUQI
M]C<0K"DP;S9I0H.#V0!3C/)ST&.:6D>&]7LAX'2:WBQHMK)!=L)0>3$(P5]1
MD9[<5WE5KF\%M<VL)M[B3[0Y0/%&66/"ELN?X1QC/J0* +)X!XS[5YW+X9UR
M3PQJ.GBSB%Q<:[_:,>9QM\K[2LV"?[V%QC&,GK7HE% ',76EZC:^-D\0V<(N
M89]/%E<6QD"NA5RZ.I/!'S,",CL1GI63IOA#4-*O?#+HD4J65Q>7-XRR8"M<
M;CM0'J%+8[<#/7BNLUK6K30;%;N\$IB::.$&-"V&=@BY]!EAR:OR2)%&TDCJ
MB("S,QP !U)- 'GS^&-:;0[BU%K%YTGB/^U%'G#'D_:!+C/][ QCIGO7H8Z>
ME9R:U:/XAET,"47D=L+ILH0FPMM&#W.0>E:- '%:UX&;6=:U;?.J:3JEHIGB
M'WOM2*R)(/8*5/\ O1H>U-U#P[K5UX%M;"7R;G6)+JVN[R3?M5G25';![X"!
M1]!7:F1!(L9=0[ L%SR0,9./Q'YBG4 <+JGAW5[V3QL8K:,#6M/CM;4M*!AA
M&Z$MZ#+@\9X!IT6E>)-&U]=2TVSM+N*]L+>UN[>>Y,1@DBW!7#!6W*0YR,9K
MN** ..N=$U=_$>J7QBCE2YT1+!7#A=TRM(2=O93O]^AK;\+V-QIGA32-/NU5
M;BTLXK>0*VX;D0*2#Z<5*=:M!XC30B)?MC6K78.P[-BLJGYNYRPXK1H YVZT
MN]D\?Z?JR1*;*"PGMG;>-VYWC8$#T_=G\Z/ ^E:AH?A.RTG48X5ELU,2M%(7
M$@!.&Z#&?2NA)VJ2<X SP,U0T36;77],74+,2B%I)(P)4VME'9&X[<J: ,?Q
M/IFL-K>CZ[HL4%S/8":&6TFE\H312A<[7P<,"BGD<\U#J5AXEOKW3GFALYK1
MH9ENK07#(D<C%=A)VYD50&!! !)SCICKJ:TB(R*SJI<[5!.-QP3@>O )_"@#
M@/#WAK7-,D\'F[M8,:/IT]I<>5/NR7$84KD#/^K.?3(ZUT'@K2[W1O#:6-_&
MB3I<7$GR/N!#RO(.?HP'U%=#10!SFO:9?R^)-!UBS@6X33_M"S0^8$<B10 5
MSP<$<@D5SEUX,U:UN(=;L[:PO;XZA<W=SI]P^(G28(NU7*G#*(D.2,$[J]&J
MM87@O[-;D6]Q;ABP\NXC*.,,1R#ZXR/8B@"#1K>>WT]1<6EK:2NQ<V]KRD>>
MV<#<?4X'-:%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %<SXOU:6PFT*S25K>'4M22UFG4X*KL9
MMH/8L5"YZ\G'.#7355U'3;+5K)[/4+6&ZMGQNBE0,IQR#@]Z /,Y]0D\-:MX
MN,-RZQOJ^GP2W$\I)ACDBC!)<Y('.W<>1G/:I_%%C>P:-=Q76KO/;G5=.DMX
M([F1GMU>=%96D)!=206 /3\J[J'PSH4$-U%%I%DL=VH2X7R5_?*!@!N.1@=Z
M2#POH-MHTFCPZ19)ITAW/;"$;&.0<D=SP.?8>E ')7EWJ&JZGXATRSUE=-GT
MDP_9I9+EOW<?E(_FNO20%BZG<3]WL>3:TV'4-6\:Z]#/KFHQP6+VLD,4#JBC
M?$2RD%3E<GH?QS71W7A?0;V\M+NZT>QEN+0!;>1X%)C Z <=!V':K,>D:=#=
MW5W%9PI<78 N)57#2@<#<>^.WI0!YKHEWJUSI?@6\EUW46EU9Y+>[S(-K+Y4
MC@@8P&R@^;KR?;$\VJ:I:^%-4":K=E]/\21V<4KN&=H3/$-C,1D\2,,]>E=Y
M%X<T6&.TCBTRU1+-B]LJQ@"$GJ4'\/4]/6D;PUHCPS0MI=JT4TPN)4,8P\H_
MC([MP.>O% '">(KO54;Q]/%K=_%_9$$-S9I&X54;R2^",<KD=#USSGC&A?:A
MJ.NZSK6E0:FFFW-G:P2VTGGM'LWIN,I4#$BAOE(;CY>V<UULGAW1YC>&73;9
M_MH"W6Z,'SP. '_O8'K4=[X6T'4I;26]T>RN)+0 6[2PAC&!T SV]J .)U34
M)]?TKQQ;7=]*CZ7IP6)+=S&K!K;S#*5_B#,2,-D +ZYKK8$\SX>PJ'D3.EKA
MHW*,/W0Z$<C\*N:AX:T35;K[5?Z7:7$_E&$R21 L4/\ "3W'\JO6]K;VEJEK
M;P10V\:[$BC0*JKZ #C% 'EVE68EL_AA"EU<1^;9R,\BRDNN;09"DYV_ATSQ
MBK^DZK=W&GZ=IL^J7<UP-8OK2.,/MDNXX6D"AY005"@*2PR3M P<UV=OX9T.
MT-J;;2;.$VA9K?RX@OE%NI7'3/0^U-?PKH$D*POH]DT2SFX5&A! E/5_J<G)
M[]Z //;&XN-9M? <^H7MP\W]JWL+NERR[E1+A5)*D9.$ W=>OJ:ZGXDQ"7PS
M;?O)4QJED,QRLF0;B,'.",\'\\'J*V_^$9T+[,MM_8]CY"W!N1'Y"[1*<Y?&
M.O)YJ[?6%GJEG)9W]M%<VTF-\4J!E;!R,@^X!H \RUJ.>VOOB!>66I7EM+I^
MG6T\+0R\LZ0R%2Y.2PXY!.#DYS6I=:EJ.OZOJ>E0ZDNG7-OI]O/;/]H:(J74
MDS;0,2*& !#<<=LYKK3X;T0K<J=+M-MU&L5P/*&)4 P%8=P!P >U,O?"N@:D
MUHU]H]E<&S %N985;RP.PSV]NE %+Q%K%WI'@"YU6.5);J*T5S,B?+DX#2!3
MG@9+8.>E8.K0W<7A_P 2S?VO%<:?=:%-)%:B=K@A@C9E61N0K @;>F1D=Z]
MDC26-HY$5XV!5E89!!Z@BLFS\*>'].L+JQL]&LH+6[_X^(8X0%E'HP[CVZ4
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MYL83+\F6V_>V?<SZ[>V>G:G1:)ID%RUS%90I*SO)N Z.^=S = QR<D<G- '
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MIL-XEY'8P+<I%Y"RA/F$?]S/]WVZ4RST+2M/#"SL(( 5*8C7&U2<E5_N@GG
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M!XQ76MX:T1X9H6TNU,4TPN)4,8P\N<[R.[9 YZ\4L_AK1+G5X=7GTJSDU&$
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MR[7RO/\ M.SRQCS<Y\S'][/.>M*_AO1)=:367TJS;4T&%NC"/,&!@<^N.,T
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M2"."WB4+'%&H55 [ #I4U !1110 4444 %%%% !1110 4444 %%%% !1110
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M6%VL5.[<,<\<YQBLF7PWXEN?#UCI=W<V-U)8:E!<174DSAY8(I0ZA_D_UF%
M)'!ZTS5/!6IZCJ6LWR3VD$LU[9WUB=[,%DMU  D&T<-@]"<9[XH O:YXACNM
M#\2V""[T_5+'3I+@(S!'"E&*2(R,01E2.#P1@U/8:XO]D:98>5=WU_+ID=S*
MD#@.J%0-Q9F').0.<D@^A-5]0\,:AJLNLZC.+2'4+W23I<$23,T:*2Y+,^P$
M\N. O1??B&R\-:YI&M6&J61L)F.EPZ=>V\TSJH,9)62-@AS]YLJ0/K0!6\(^
M+([7P)H#7\TUWJ%U:O-B29!(X5L%BTC*.K*.N>?8XO)\1=-NH-.ET_3]2O\
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MIL-U>^?9M>B&(()!&K%3\K,,L&!&!GI[C.]J>I6ND:;/J%[)Y=O NYR!D^@
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M(D*@L0I8\L0.@]:P-(LM;\-1:1I43P7=H]Q/YRS3222P0DDQJC$?,$'!+8[
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MHH **** "BBN1\?/+';:'Y-[<VGFZQ;0.\$QC)1VP0<<'MUH ZZBO*+^]O\
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M'!P223E>_<&NE\4ZDT'B;PSID\S0:=?S3B>0.4#NL>8XRPQ@,23C/.T#H2"
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M^_O)]#\$:U9WUS-J&H74<.H(TS%90R,9P4SA2A4D8 V[<=* /3:*\CEMYO\
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M+R_L]/C22\NH;='<1HTL@4,Q. HSU)/:K%>7ZYK.HZAX7U73M82W^WZ7K=A
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MM&M([0[6C56&"V""2Q'&23P3ZG./J&BO9^&8?!UK97^IV=W;O;"[N)(V6U3
M WG*L< Y& 3\H'TWE\2:(RW##5;,+;QB65FF4!$/1R3_  GUZ4D'B71+EYT@
MU6TE>WB\^58Y0Q2/^\0.U %^UMH;*SAM;=-D,,:QQJ.R@8 _(5E2^&+:XNHY
M9[N[FCBN_ML4#E"D<O."IV[L DG&<9J?0]?L-?T2+5K.93:R+ORQQM&,_-Z'
M&#56P\1:?%I=G+J&O:7-)<F3RYXG$<<P4L24!8Y"@<G)Z$T 5XO!%C#86-FM
M[?>597[:A%EH\^:69CGY.1EVX]_I4<7@'389;9H[W4A':WSWUO$)QLB=]^]1
MQG:=[=22,\$<UT&GZE9:M9K>:?=0W-NY(66)@RD@X(X]#6%X>\2/<Z?J,^L3
MVT1MM4GL49%*!PC[5 !))8^F30 LW@BQGTO4M/>]OO)U&\%[.0R;O,#*W!V<
M#*+Q[?6MV\L8=0TVXL+H-)!<0M#+S@LK#!Y'3@GI5=-?TATM'74[0K>.8[<^
M:/WK@X*KZD$'(ZC%":]I$D$\Z:E:M#;R^3,XE!$<F<;6/9LD#'7F@"K9^%[.
MV\C[3-<7_P!GMVM8/M6PB.)@ P 50#D  DY.!UY.8?#_ (/L_#K*MM?:E<6\
M0*VUO=7'F1VRGL@QGIP,DD#@=35O6?$>FZ%<:?!?3K')?3>3%DX'"EB2>PP/
MY58FUK3+>\6TFO[>.=G6,(T@!W$95?J>PZF@"'4]#@U6_P!-O)9YXY-.F,\(
MC*@%BI0[L@Y^5F'XU17P=9#0]7T@WEZUOJLDLEP2R;@9?O[3MX!R>W';%;ES
M=V]G$)+B58T+!06/4GH .Y]JK0ZWI=Q)!'#J%L\EPKM"JR F0(<,5'?!Z^E
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MDEEN"63=F4DOM.W@')[<=L4[5O"-GJ]KIR2WE]!=:<<VU];RA)TR,'G&""
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M=6D\MK(B-O!<*2ZJRD @JP#9Y_*M\:E8FYN+?[7#YULH:=-XS$,9RWH,<\T
M8UYX,L;X:ZLMW>!=;18[I59  JKM 7Y>/EX[_G4LVBIIVH/X@B:^O;VWL#:K
M;J8_WR [@ ,#YB>^16E8ZMI^I231V5Y#.\)'F(C99,\C(ZX/8]Z8^M:9'?BQ
M>_MUN2XB$9<9WD;@G^]CG'7'- &=X:TM8+C4]:DT]K&ZU:999('(+HJH%4-M
M)&XX+'!_BJUK'A^WUBZT^Z>XNK:YL)&DAEMG"GYEVLIR"""/;/H12#Q3H#7,
M=NNLV!FDF-NB"=26D'\ YZ\@8]>*LQZUI<IO!'J%LYLLBZVR ^1@9^?^[QZT
M 96G^#K72K>*"PU+484B>=E!E60$3/O92'4@C=R._)Y-:^F:9;:/I-MIEBIB
MMK>(11C.2 ![]Z+C5M.M+:"YN+ZVA@N&589))0HD+?="D]2<\8JG%XL\/3Z?
M<:A%K>GO9V[[)IQ<+L1O0G/7T]: *,/@?3K?3K&UBN;Q9+"YDN;2Z#IYL3N6
M+@';@JVYL@@C!]AB6X\'V%S;+&UQ=+)]O349)U9-\LZ$%6;Y<8&U1@ #  J]
M'XBT:6!YHM3M9(TF:W8QR!OWBC)3CJP'./2G'7]'$=G(=4M-EZP2U;SEQ,WH
MAS\Q]A0!SWB/PW)%8ZS<V"ZA>3ZK- ;N.&:-'6-"H)BR%&X(N,$X/?/0R^%+
M'4;:[:0W6MG3S$08=6\C=YF1@IY8! QNSNZY&*VW\0:/'''(^IVBI).;9&,H
M :4'!0>K9XQUJXEY;27DMHD\;7,2J\D0;YE4YP2.P.#^1H QM7\(V.L:E-?3
M7-["]Q9&QN$@E"K-$2Q ;@G(+-@@CK@Y'%0OX+LI=-.FRWU_+8O:QVLT$CHR
MRHF<9)7()S@E2.,=,"M$^)-$6%ICJUD(EG^S,_G+@2_\\\Y^][=:S?%WB.32
M-+>73KBU:Z@NK6.>*0;BL<LJIG (VG#$@G/2@#:U33HM6TF[TV9Y(X;J%H9&
MB(#;6&#C(/8FL^+PM:0ZAIE\ES=B>PM?LBD2 "6+*G:X YP5!XQ[Y%.G\1:9
M=:-J-UI^MZ<GV961KF20-%!)C@OR..0>HS5F;6M/T^SAEU#4;:/?%YAD+;59
M0!EP,\+R.3P,C)H ;K6AP:XEFL\\\0M+I+J/R2HS(ARN<@\>U0?\(S;/>P7$
M]U=7"V]V]Y!#*4*Q2MNR00H; WM@$D<^PK-N/%T>F^,+NRU._L;?24TZ&[BF
M<[#N=W4@L6PPPF> /TK?U"]B@T:XO%OK:V00ETNIR#$F1\K-R,KT/49]: *W
MB#P[9^([.&"Z>>&2WF6>WN+:39+#(,X93SV)'((YJK+X1LIK6T1[J]-Y:3_:
M8K\R@SB3&TL21M(*_*5QMQQC@5<&M6%I8VTE]J5KN>!9&E!VHP('S@9.%)Z9
M/MFK5]J=AIBQ&^O(+832"*/SI N]ST49ZF@#)N_"&GWFF7-I)-<B:YNDO)+Q
M643><A4HX.-H*[% &,8'2N>\6^#S#X9UYM/;4K_4=5-N)%9PQ8QLGS#  7Y5
M)].PQP*[&TUW2;ZQFO;74K6:U@8K+,DJE(R.H8]!U!_&JUYXIT:RT>_U1[V-
M[>P4M<!#ED.,@%>H)[?6@!O_  CMM<"[GGNKN:YO+7[*UQ($61(CD[5 4!>2
M2>,YQGH,4)O >GR1:5Y&H:G9W.F6XM(;NVF5)6A&/W;_ "X8<#MU&:V7U6WF
MT!]2AO;:"$PEUN)F!CC..K'(X!Z\BJA\4:-I]C;'4]=TY)FM4G=_-6-74[1Y
M@4DD*2PQ]1S0!%+X/L3J=KJ-I=7ME=P0?9FDMY03/%G.V3>&W'))W<-DGFK^
M@:);>'-$M=)LY)I+>V79&9FW-CW( ID/B;0KB]6SAUBQDN69T$23J6+( S#
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M0PA_+*!U:&16(VJ=^<GCDYIFMZ+J-_KVJVUG:M;&X\,&PAE1"(4F+,0@;&,
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MJ[T;5)_"_BGPU/97#WU_J$L]G<B,F-UD<.CF0<*8^X)!^08SQ7IU% '-^+;
M7FFV$+/J,<L=TKQWE@I:6V<(^)"H!W*?ND8/WZYR"/7;>]\*ZIJFGS7#6LM_
M#.]G;89A(?W<K1CE-^W)]"W..WH]% 'D=E%/I]QX174M-N8G77]2E\IXM[%7
M$[JP5<DX# \>G%.U+3#IMY:W\MG(EI?^+XKJ&V\HE@OV=E+[.H+,K-C&<8XS
MQ7?FVT?Q)?VVHP7GVB72;AUC:WF^6.7;M8''!.UL$'UJUJFB6FL264ET9MUE
M.+F#RW*[9 " Q]>">#QS0!P.H^']3;4=4U[3K*;[*^LV-Z;+9LDN(X5Q(P0X
MY+$, <$F,'N*/%>C7NJP>+]2L+*Z,6H:5!9PP&!E>XF5G);80",!E7) Z'L*
M]/HH Y#6K:9?$?A/4K/3IY+:"2<3"&+#1[X=JEE.,#( R>G>I?$AN_\ A(](
M\K3;B6W,,Z/=VL2O+&QV8CR?N*V#EO\ 9'(ZUT5C?VFIV4=Y8W$=Q;2@E)8S
ME6P<<?B#5B@#R[POIU_;'P +S2KR(Z;I]S#<&2 GRG*QA>F<9VM^7N,]1X!@
MGL/"9ANK:>WDCN[M_+DB96V-/(ZD#'.58'CZ5U-5X[^TEOYK&.XC:Z@1))8@
M?F16SM)'OM/Y4 >::)IE[#IW@.*XTN[4V-]<O<JULW[D,LP4GCU=/\BM^RTR
M5_&?BMEM)($N;6UCM+EH"$W(C@[3C^$LO].E=I10!Y[X-LS(=&@U+PWJ5MJF
MCP&![FYF8P)\FQC"2Y#!L#@# 'I@9N>'- U+3[G4-+D'E:;I\LITF7KQ,-PX
M_P"F>YT'LWM7;44 >::=I&I77ASPAHTMC<6NI:+?0O<RM&0@2(,&99.CB0<8
M!)^?D#!JYX42\MX+;0=6\.W$M[I][+,E_+&IMV#.["97)^^5<C &<DYP,D=_
M10!Y?H=OJKZ]X4NY]#OK06WVR*X@6%4@M2X& G/*\9W'.>WH%T?0+N?PWX7T
M=]-GMK_2M36ZN)9(2JQ*CNS;7Z/O!"_*3][GI7I]% 'EUQI^KI::K=V^F7LW
MD>)CJ!MDW127-MY80F,\9(.6 R/N^XKL?"]O:A+V_M=)O-/^V2B23[:S>=*P
M7&YE9B5X '/)QTZ5T%-D*K$[,^Q0"2V<;1ZT >3:1IW]N>#+73;2SE6\C\12
M7(N?)(2(1WCLTF_&"=@*XSG)QTJX^B:K<>#-0\*SVER-4;5&FAO?+/ELK7/G
M"?S.@(4GC.[*XQR*[;PO:Z3:Z*O]AW/VC3Y99)4D$OF*69V+D-WRVZMF@#@O
M$'A2\U+Q#J5E "FDZ]9J;V=3S#-#PI'NP*#Z1FH+G3?$=[X"6]NK-I-=\^UN
M+BT278TJ0.I**W&-VUG'H7Q7HE58-2LKF^N;&"ZBENK4*9XD8%H]V=NX=LX/
MY4 >=ZW81ZKX6U2ZT_PWJL-Q?7%CYJWBN\\XBF5CE"S854!Y.,\CTSZ#]L6+
M4;>SCL;DI<1O*9TB BC((X<YR&.[@8[&I+_4+/2[*6]O[F*VMHAN>65@JJ/J
M:0:C9F_CL1<Q_:I(3.D6?F:,$ MCTR0/QH R-7BGU37['3U:\MK>W!NFN8H0
M5:4<(F65E. 6;IU"XYK)\-6=[X=\:ZWIGE7MQI5^5OHKMX<*EPPQ*A*J!SA6
MR !U'6NWHH X+Q38ZE_;MQ?Z(+U-0\N&-K=X#+9Z@@8_*YQB-ER?FR.#W[9V
MKZ1K4DOBJ*TTZXD9]6M-2B& ([J*-8-T88G[Q,;<>W/6O1K^_M-,L9;V^N([
M>VB&Z260X51TY-6* /-O$VAZGXDO-9U/1X)HA+HBVBQW,;0FYE$OF;"K8. H
M*Y/'[SKP:F\023>)?!FO3VWA>^M-0N=-:U_TBW"SR.<[8UQDE02>3@<C&><>
MAT4 >?6 U2RTCQ!HUY97ETTUO)-:Z@+9MUR)$.(Y,#B1.%[#:%Z8Q56WTG4'
M?PE#;VMS:R0^'[BSEF,#*+>9TB"ACC^\C'\/<5Z710!YSI^F7]_I7@FP;3[B
MROM#GC-X[QE51(X6C8*_1PY*_=)X/.,51CLM7M)HM273+V:VM/$]U>3VJPD/
M)#(KJDJJ?O;2V[ Y]J]*U#4;+2;&2]U"ZBMK:(9>65@JC\:L@@@$=#0!Y9>6
M.L3S>(-0L]&OVB_MJTU!8#F%[J%(8U<)R#N!!8#CE<=>*L:KIT5]I*WMAX=U
M.!KK5[&>X6Z1WFE6*12[LA+8 08YP3@\=,^F53OM5T_3-GVZ]M[8R9V"60+N
MQUQGT[T 9'CBTDN_ &N6=E;/+/<6<L<4,49)9V4XX'N:S8+=D\?V%^;"X%K%
MH30&7[,V%?S$8)TZ[0W'X=ZZ^UNK>]MUN+6>*>!\[9(G#*V#@X(XZ@U-0!Y1
MHEGJUIH7AVPFT2]C*:7<6\DT4 \Y)"RXA);[B,!G=W(&".]F/3]5T_P)X0U:
MTLFAUS288+-K:Y^0RI(%B>,^V[:PS_<]Z].K-ET*PGUR+6)4E>[BC"(#,_EK
MC.#Y>=N[YCSC/- ##8KIWA>2RC\R8QVS*2%+-*Q!RV!U+$DGW-<.NF:C8^ _
M!EQ#I-W++I(A^WV,&8IV @>-BN""65G+8SSSZUZ;10!PESX>34_!^HRZ1I=S
MIM\]T-2M!=LQE>Y3:5=@S$KN*[2,]#SUHU;3]6DTK1-7%G(]S'JD>I:A9Q_,
M^PH5V@?Q-&I3COLXYKNZ* /+_$NC7]]:^,-0LK.[,>J)916\ @822O$V7DV$
M97@@<@9V?3-A[+7I?">O^'/LL\U^A\ZUOV1HUU!"0^';C;)@;&S@=,>@](JA
M=ZUIEC=Q6MU>PPS2NJ(KMC+-]T>Q.#@'KCB@##\,+;7VHRZNF@:GIUTUNL$L
MNI._F-@Y"*&9L@$D[N.HQGG'-:M;ZK<:FY70[Y!;>(X+K9;0J(I805'G%LY=
MR!SS\N.0,9/ILTT5O"\T\B1Q("SN[8"@=R3TJ.SO+?4+.&\M)DFMID#QR(<J
MZGH1[4 >9W>FWK^'?$4::7>?:+CQ+%=Q*+9MSQ":%BXXZ;4?_)%;>N:1=?\
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MRUEW;#O5E1B"!P0>.N#ZULIJ>H?\)?9Z-'+ EM+HKW*-Y67217C49.>1\W3
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MSPVCW+-;P,V=QCC)PO4_3)QC-:&LZ'8:]:QP7T;'RI!-#+&Y22&0='1AR#0
MS7&LK&S?6[J#S)-+AFN(ROWL"-MRCZCM[#TKGH_$6K6S>%[JXD@GMM>Q$Z)%
MC[/(\1D0H<Y9?E(.>>^1TKH[?1HXP?M5S<WYVE ;LJ0%(P1M4!>1QDC."1FJ
MNG>%-/TP6B0R7+Q6(8644LF];7<"/DR,G ) W$X!(& : .._X2?Q8/!3>)#>
MZ8V+DVOV;[(PR?MGD[MV_CY<\8/;K5C5/&.M^%+W6;35FM+_ ,JQBO;.:*$P
MJI>40['&YN Q4YSG&:N>)?"CVWP_GT+18+NZ\R[BF5/-4,O^D++(0Q*XZ,>O
M4\5OOX9TV\@O1J$<EZU_ L%PUR1N,0SA!M "@%B>,')SG- &/J6N:QHNN-I<
MD\%R+G3)[NVG>#'ERP[=RLH(RA##'((Z9-5]/UGQ!)X?T74KW4[ #5DMG\N*
MV82QAH6=Q&,MYCD[3T 4;CT%;\?ABT6.02W-W<3-:FT6>9PTB0GJJG'? R2"
M3@9)P*B?P?IKZ;I%D);M%TDC['+',5DC 4IMW#J-IV\]J .2;7M:U?3O#$K7
M8M9I-?FL+@)$,2"/SPI89/\ SR!(!QG\*T;_ ,87^E7/B9)A;2&SO+.UM"(R
MH!G"8:3GG!?)Y&0.V:UU\#:/'91VL9O52*_;4(F%T^Z.5BV=ISD [V_[Z/>I
MIO!^DW1U@72RSQZML^U1R/P2@ 0KC!4@ 8(/8'KS0!C:QXCUG1-0U;3?-@N'
MCT675+2XDA^ZT9PR.JD @Y4@C'?.:FT37-9D\1Z79ZA/;30:EI#7RK%"4,+J
M8P1G)W B3VY';I6L_A:SGMKR*YN+JXEN[7[')<2N/,\GG* @ #.3DXR>YX&'
M6WAFSM=0T^^2:Y::PM39P[G&/*.W((QS]U>>O'UH H^*=7U"PG,5E<0QXL9K
MA8TC\R9Y%QMRIX$7)RQ(YP 16IHVH3ZOX6T_4L1Q7%W91SXVED5G0-TR"0"?
M6H=4\+Z=JVIIJ$[7*3BW:U?R)VC$L3'.UL=1GFK>FZ3!I.B0:5:23K!;Q"&-
MGDWNJ@8')ST_*@#B=)\5>()/#6AZM>SVLKZV\-O#!!;[3"Y#LS;F?#95, '&
M"1U[V=2UKQ5HVD7.H7R0I;65]&TCE%:22Q8@.Y56(5T^8YZ$#I6T?!6COX4A
M\-R+.]A 5,!,I$D)4Y5E<8((/0U=LO#]G9Z5/I[O<7D=PI6>2\F:624$;2&8
M]L<8'% &-JOB6ZLE66&2)XK[5(=,LF9,JI/#N<'G!#@#CE1SS5'5/&.H>'M2
MU72[ORKF2*.TEL[EDVC;/-Y/[T#CY6YXQD<<'FNCF\+Z5/X<M]">!OL5NL8A
MVN0\93!1PPY# @'/K3)_"FEWME?VVHI)??VA&L5S+.PWNJYV#*@!=I)(P!R2
M>O- %/4+K7M(MK]YM0TUH3);BTFF5A( S!904489N?D Y)(!]^8U?Q#K-WX;
MUJ,73V\MAK=K9K*80KR0R/ <..@.)3G&,@=!S75'P1ICZ2;">YU*X;S(Y5NI
M[MGG1HVW(5<]-IS^9SG-#^!M'DMM3@=KUEU&6.>=FNG+"2/;M=23PV44Y]O3
MB@#-U?Q7>^'M9UE;KR;FUT_0EU!0D6QW?>ZD$Y/!V^@QGO4TNMZQI^L:':37
M%O<QZS!+M<0X%O.D?F @ _-&0&&"<\#GFM<^%]/?49KV8S3M/9"PECF?>CPY
M)VD$9/+,<YSS3;+PM96*P*D]U+]EA:WM#-('-LC  A3CDX &6R<#&>M ',^'
M/%.O7C^#[F_GM)(-=MY/,AB@*F)UB,@8-N.<X(QCN/3)Z37-9FM-;T31K=A'
M-JDDH,S+N\M(X]S8'3<> ,\=3@XIEGX.TZQ314@EN@FC!A9J9 =H92I!X^;Y
M21S_ #J_JVB6FLBV:X\R.>TE$UM<0MMDB?!&0>G()!!!!!Y% ' >*=8U.^\)
M>*-,N9D2YTJ^MX&FCCP)XI&B="1GAL/@XXX[9P.]U".>TT&_EAG1+WR'<W*Q
M $L%X8CH<8'7-5;SPEIU]I%UITSW'EW<PN+J57 DFD!4@LV.VQ>!@84#IQ6R
MT"R6S03$RHZ%'+8RP(P<XQ0!YC9?VC<+\-'^VHUW-8RN)Y8MVW-JIY&1N/OF
MM33/%^J7D&G:=( ^HSW5];R3V\:#<+:39N578 $Y4]3T;CTW;/P9IU@=(,$]
M[_Q*59;3?-OVJRA"#D'(V@ #MCUYJ";P#H\]@ML9+U'CNY+V&YBG*30S2$ER
MKKC 8DY'3F@#4\/3:O-I0_MR&**^21T;RB,.H/RM@$[25P2,G!K5JKI]A#IE
MFEM TKJN27FD+N['JS,>235J@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J6HZQIVD)$^HWL%JLT@
MCC,KA=S'L*NUQWQ#8)9Z YB:4+KEF=B@$M\QZ T :L7C'P[-ILNHIK%J;2&4
M022%\;)#T4@\Y.1Q4L7B?1I[87$%^DZ-(\:B%6=F9/OX502<=R!CD5Q/B/P]
M?7\'BS4+/3IW_M5K&.&WV!7E\EPSR%3C'!P-V#\GN*Z&_M[ZT\>6.O):SW&G
M2:<]G(L2Y>W<NKA]O4AL;3CD$#- &P?$>CA+!_[0A:/4&"6CJ=RS,>@4C@GV
MI#XDTA1;%KQ0+J<V\!*-^\D!P5'')X/Y'T-<A'X2N;CPN^@7$$UN=1U&XOEF
M3!_LY3*9(]I!X?IC' );DXP;3V5]K/PV>UU&U&DZIIR!X92H6-)8>8Y4]$.T
M$CJ 2* .SBO;>>ZGMHY-TUOM\U<'Y<C(_2JM[KVEZ=,T5W>1Q%"HD)!VQ[N%
MWMT3/;<1FH/#,5T-&2\OXA%?WQ^U7,8_@9@,)_P%0J_\!KEKK2=3AM_&ND2Z
M?+>#6WDELIUP4;S(5CV.<_)L*CD]NF3Q0!U5WXIT*QU#[!<ZI;1W8:-#"7^8
M&0X0$=LFKM[J-IIXB^TR[&E?9$BJ6>1L$X50"2< G@= 37+:#I-YIWC:5IX)
MI($T6TLEO&7B22-I"WO_ !*:O>*!?_VCHK6NFR75NL\GVB:W5#/""A"["Y&T
M,20S#D#TSF@#=LK^TU&QCO;.XCFM9%W)*ARI'?\ K6;;^+O#]W<V]O;ZM;2R
MW$C11!&R'=205!Z9^4\=\'%4/A]97NF>$(K*_LIK6>">XRDC!BP:9V!!!.1A
MAUYKFK?2-3CT#3(3I=R)HO$[W\B[!E8#/(^_K_=8<=>V* .]EU[2X+^.REO$
M2>23R4!!VF3&=F[&W?CG;G/M4(\4Z*T$<XOT,<MR;1&VM\TP./+Z?>SQCU!]
M*Y'2]*O(=1FT?5?#MW>;-4DO;74#<9M=C3&579=^5D7<1@+R0.Q)HUKP?JMY
M?:_9V3>387!35;.56P5OP,!<?W=R+(?<^YH [Z&\@N+BX@BDW2V[!95VD;21
MD#\B#^(K)N?&GAJTN&@GUNS219_L[ R?=DX^4GH/O#KZU9T"&YCTF.>_C$=_
M='[1<H#G8[?P9[[1A<^BUP4UJ^JK\1]&@L))[B_NQ#$VS]V&:VB +-_#M)#<
M_AD\4 =U)XIT*+5/[-?5+87OFI#Y(;+!V!*K]3C^7J*E@U_2[F\2TBO$::0,
M8A@@2[?O;#C#X[[2<5S6D:+>Q:_XGB9)XDNK*UM[>^9?OM'$R,PYSD$@\]>U
M4=/T;4[S1/!VE7&GRV=WH-S"]S,0-FR&)D^1A][S,C@= 3G&,4 =A;>)-(O"
MHM[U)"URUH JMGSE&63IP0 21VP:=%XBTF>RNKR*\5K>TD,4[A6Q&XX*GCJ,
MC([5R<-CJ.G^,X_$MOI4QM]3=[>\M%0;[<# 2XZXW-L 8#D@KU*G-F;1KF+X
M@/!;,G]DZBJ:A>Q9Y2:$A5(';>?+)]?*;UH U/&VKWNB^$KG4]/DCCFB:+F6
M/<-K2*IXR,'#=_RJ[I_B;1-4^U_8M4MIOL?-QA\>6,9W'/\ #@'GIQUJCX[T
MV[U;P9J%E8P&>X?RV6($ OMD5B!D@9P#7/\ B/P[J7B6\U35-.MWM9&T?['"
MMP/+:XD\T28(ZA1MVY/]\XX&2 =<GB31W2[8W\<?V1 \XE!C,:G[K$, <'L>
MA[4U_$^BPV=S=3:A%#%:R".?S@8VC8@$*RL 02""..<UR%S%>W^BW^I6G@VY
MAU3[/' Z:E(DTD@$JLRQAG8,%&YANP"V,#K6;JNBZQ<Z?XTBCT;49/[46T:V
M,[HS2E0H8'#8!X)QP ...!0!W"^)--U#4M/CT_7K/:T\T3VX7<UP40DJIR-N
MWALX(('O4T'B_P /7-S!;P:O:R2SRM#$%;(9U)!7/3/!QZX.*S]>MKFY\4^$
M[RWLYWM[6>:2=PG^J5X'1<CK]YATKFX](U-=#MXO[+NA*OBMM09=@R(#<M)O
MZ_W2..O;% '<W?B31K"5DN]1@@V2B%GD.$60C(0O]T-C!VDYYJ[=WUK8VANK
MF=(H!@;R>"20 !ZDD@ #J2*\PF*Q7>J13Z7K,FBKK9U(S6UNDREHV4L1()-P
M7>A)&PD8(SZ=OXO^VOH*-IUB+UQ<P.Z!$=TC$BEGC5_E+J!E<]QGM0!JV&I6
M>IQR26<PD$4ABD&"K1N.JLIP0>1P1W%8EMK\T7BWQ%:ZC=6\>FZ?:VUPCE=G
MEA_-W%F)Y^X/2J_@JROK'4?$GVJPN[>*ZOQ<P27$BN74PQKU#$YRISV':LS6
M;'5QK'C"YL]'^V?:M/M8K9)XU:.9D,F\88X) <$ \$T =#J?C'2--T34]3:5
MY%TY-T\(C82*2,J"I&1GL2,=^E7+GQ%I=G:+<W-UY410R$E&RJ X+,,951_>
M.!7G]_H6M:A;>-TATO4,ZKID MGNY(]TCHK@J<-A6)(X  'MTK2U"+45\22:
MC<^'-4O],U2PBMV@MYU62W=&D^61?,52C"3.<G'.: .INO%OA^SNEMI]7M%F
M81D)YF3B0X0\=B>E:5Y>VUA!YUS*(T+!!GDLQ. H Y)/8#FN3TC2I[+QXLHT
MPV]E'H4%DC(,QQNDCL8U)YP R\XP<59\7VVHKJ?A[5[*TEO8--O'DN;6(C>R
MO$T>]02 2N[..O)H C\/>+!=OX@EU"\A^S6>J"TMV6(H2#'&0FTY8ON<C'7/
M&.U7M0\9:186%M>"9IDGO4L0(T8E9"X5@PQE2O)(.#QCJ17)FVUR*36KF+P_
M<F.ZUZ"Z4ND32I#Y4:M)&I8C>&3OTR3U%0IHNLQ:7>@:->YB\40ZDD;RH\DL
M ="2#O.2 #G)^A- '?W7B#2K*1$N;Q(MY1=S A5+_=#-C"D]@V,UIUYQ+IE]
M_;6M:?J?AJ\U.SU:X6YMY5N1Y"91 4G7> -A0'(#9&,<@5WEK=RSW=Y ]E/
MENZJDTFW;."H.5P2< G'..10!;HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L_5-%L=9%L+Z.1Q;3K<1;)G
MCVR+]UOE(SCWK0HH **** "L[5-"TW69+5]0MO/-JYDB!=@H)&#D X8>QR*T
M:* "BBB@ HHHH **** "BBB@ K/T_1;'2[J]N;2.1);V3S;@M,[[WP%SAB0.
M !QCH*T** "BBB@ K.TK0M-T3[0=/MO*:XD,DK%V=F))/5B3C).!T&3CK6C1
M0 4444 %%%% !1110!AP^$-$M[J2>&UE02.9'@6YE$#,3DDP[O+Y//W:W***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"X6YN"3O:95=A]X#=R,#@9R/2M"Y\16VEZKXFNVTBX-YINFPW-P5G!$T>)2
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MSBM+6M!FO=;TK6K&X2&^T_S$VRJ2DT4@ 9#CD'*J0><$=#FLN?P5<,L$L-Y
MMT=975[EVB.UV VA%&>!M &3GIG'- &W=:I?VWA2XU2331#?0VSS&SEG!"LH
M)P77([=16!;^,]3CT_P]#)HKWFHZK8-<1B&=%1V2-6();&W.[Z#U-=;J%H-0
MTRZLF<H+B%XBP&<;@1G]:YG3_"FIVMWX8FGU"TE&BVTELP2!E\U61$R/F."
M@/?))Z4 37'C$V5_:P7>F2V\=Q?)8+YL@$C.R@[U3&&C#';N!Z@\55G\>M N
MH3MHEP+33M26PNIC,F5W>6 X4$YYE7(]._:H;SP1JMQ>W$JZQ:[6U>+4XFEM
M6>0;""(F;>,HH!   I]WX*O[G2-?L1J%LIU74DOPYA8^5M,7RXSS_JASQU-
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MJNY>>>4& .:I6/@:\L++17BU" ZEI%U<S12&(B.6.=F:2-AG(^]P0>-H..U
M%F;Q[%!;-NTNX:\AU2+3+FV1US')(5"L"2-RD,"#QG/.*U="UY]6N]3LKBQ>
MSO-.F6.6,R"0$,@=6##U!Z=B*Q[SP5<7*R7"W<"WUSJUOJ=PYC)4^3L"1J,Y
MQA ,GN2<<X&MI.BW.G^(M<U.6>)TU)XG6-$(,>R,)R<\YQGM0!'?^)9()M03
M3],FU'^S6C6Z6%OWFY@&VQK@[V"L&(R.HP2<@5SXOE.O:CIR:/.8=->/[7=-
M,BK'&Z%_,QG)  Z#G^K)/#.KVOB;4-1TC5X+:TU38UY#-;F1T=5";XB& !*@
M#Y@1D9P>E6+7PU(NL^(;FZGCEM-8CCB,2J0R*B%.6)YR#Z#'O0!7M?&\=S>0
M1?V?,\5S:O=0/;-YS?* VQU ^1R#P,D$@C.:B;QM+MU.W&G(FH6FF#45A:XR
M-IS\DAVY1QCD8/7K2:;X8\16VAS:-=^)$>UCM7MK.X@MC'.N4*HTC;B"5!XP
M!D@$FH;+P1?QW/F76HV8C?1SI<D=M:%!C)(=<N><L2?6@"Q9>+YAHVDBYBMF
MU2[L%NRCW(C0KM7G=MX+%N!CL>>*GLO%R:W#9PZ?83&[N[-KM[>Y<P-!&&V8
M8X)#%L@8'.TG(K/3P?KMDFBW>GZU9QZII]G]@D,EHQ@N(/EP"N_<&!7.0>Y'
M2KLOAC5(?$-IKMEJL+7OV0V=Z+F F.9-Y<,H5@5*LS8&3P<9XS0 WX9222_#
MW2WE,A<^=GS&W-_K7ZGN:ZVL3PEH<_ASPY;Z7<74=R\+.1)'&4&&<MC!)Z;N
MM;= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%<7\1Q"+'0GGG>&+^VK5)'64Q@(6(.2"/S[4 =I
M17CNL6$>E:=XR&F,PT2WGL)X-KED@F$BFXV'L-NTMCID^]2^(]3TZZE^(36M
M_$T3Z%#+"T,V%=P)_F4@X8YV@D=\"@#UVBO-=3TRULK32)M$FTUI[B*2Z>RU
M*4M#?_)&&;>2=L@&,'!ZMGN:KV.IZ<FN64URGV"UU#PM&(;>Z;YI'#XV<_?<
M*5]R,4 >I45XO;ZGIUWX2\/VES<1O=-X9=D:[DWQ,V%!")U:?*XR""H['-:&
MC/IFO:]X7&H727<=QX59KA9+@E9'#09W#."?OY]P3VH ]1FO+>WN+:WEE59K
MEBL*'JY"ECCZ &B:\M[>XMK>655EN7*0H>KD*6./H 37D>A2Z?<V_P -K[46
MMY@([NW,\^'R0I$:;CU/' ZYZ5U?C"+3D\<>#KK4(K;R_-N8C),@(R8B47)[
MDC@>O2@#N*@N;RWLQ$;B58_-E6&//5G8X 'O_@:\K,\UWX4EG#A/&UOK.S&<
M3;C<\)CJ8O)(X^[M&>V:Z7XC0V!_X1FYU".W,$6M1"22=5VHC(X.2> "=OZ4
M ;^D:Y_:NIZS9&U:!M,N5@)9PWF;HU<-QTX85KUXQXB_LXVOQ!U%)8Q=6=[;
M2VD@EP8G$,."HSP<@CUX(K4UR[TS4?$FN:7KVK_V?,S02:5*J#S6B\M"#;-_
M?\P/D+R<CJ* /1-:U:WT/1[K4[H,8;=-Q5!RQZ #W)('XU6L=1UF;5I;2\T,
M6UL@)%XEVLB.?EVA5P&YRV<@8V]\U@_%%;7_ (5O?->B(E?**M.%R&WJ..V<
M9Z>]1W7]FV_Q,TB"*6&&V?1KL&..3:F/,B(P <#C=R/>@#NJ@GO+>VGMH)I5
M26Y<QPJ>KL%+$#_@*D_A7D_A[3;*7X9Z+J%IJ%M;ZI=-'$9[UVEAG9'=EAE&
M[[IY'KG'6I$ETZXOO!UUJ6E6EBD.IW]M*'*R0[]DAQ&Y'*%_NCUX'(H ];HK
MAO&L-G-XN\(17TI2VFGN8I5,Q1''D-A3@@<GCWSCO7.6CV>D6ZV%Q,1HS^(9
M4TM[J;_15C$))5R?OQA]X5<C+ <C&: /7**\7LI[*\T;PM9W-ZK"/Q+=6KH)
M60"+-QA"N>%QL !Z J.]2^+Y])TM=;LK"1+2XTH6 B%Q*6E1 R$&#)RB $[F
MR<G<"!UH ]CHKR7Q;?V%QK7B+3KG6M/AGO;6U.G7%U=K";(X.2NX@XZ/E,YS
M@]*U$TS1M0^)[6,DHN($T6VGBC%RQ!=9G(< -UP%/T^M 'HU!Z>M>0:+JNFW
M/B;PQ/:W21QWDU_!.CR9N6+!B%G<8^;</E4C*XX)JOX;LK>30O!.IZ9<N^N&
M_$5PRW#.S6^Y_-5P3]T*,\C@X[GD ]0\.ZY_;UG=3FU:V:WO)[1D9PWS1.4)
MR/4BM>O&8FT^&S358YXUO$\:21K,)N1&]T0RCGA2I.>QZUV_BVZ\CQ)X9BOM
MHT.>6=+HR?ZHR[/W(?/&"=^ >-VWOB@#H-:U:WT/1[G4KH,8H%R57JQ)  'N
M20/QJ"+5I[>UU"XUJS33H+,EC-YXDCDC"Y+@X!&.000.1QFO-=>BAB\!^*TG
M:%](AU:,:6TI!55+1;Q&3_"&,@&.F".@KK?B-9VC_"S6HH+:%H([1GB1$!5<
M<Y4#@8ZY% &VNNY\7G0#:L/]!^V"XWC##>$V[>O?K5^>:ZCO+6*&T\V"0L)I
MO,"^2 N0=O5LGCCIUKSVY@\.ZKX\2VW6<FFGPZ[+''(%B(\[.< X(ZG]?>J?
MA_4%N5^%L\][YEQ+;3(Y:;)<BW(Y&>3GCUS0!ZO6)/K[MK-UI>GV)O+BSBCE
MN?WJQ[0^[:JYZL0I/.!TYKD_!T[P>)+6!_L>HQ7-I/):ZK:-B5DWH66Y3^_G
M #9Z@C )-6/$VFZ/JOB&XN+776\/^)=/B4+>+*JB2(C< Z-\LB DY';\J .T
MTN^&IZ7;7P@E@$\8?RI0 Z9[-CN.]6Z\F/B.6\@\-3^,&MK"POK&=7DFAS;-
M<!P%+!N%W1@LI/\ >.*ECN=(TJ_TG2]?U&2?P[+I4B65YJ9 267S3G+'C=Y>
MS83SMSCKR >FM>6ZW\=B95%S)$TRQ]RBE03],LOYTVQFNI[8O=VGV67S'7R_
M,$GRAB%;(]0 <=LXK@+>UT>S^(>@&49C?0I(K:>^_P!=*RRQ;3N/)?;D^H!/
M3FLG1=06/2/#:3S*^A-K>H17SL^Y ?,F\@2'^Z6*]>,[: /7J*\?UA5M[358
MDN2FBIXCL!IY68JJ[FB,ZH0?N!BW3@'=C&*ZOPB+2S\:>+=-L71;:)[:58$?
M(1FB^<@9XR0,^] '03:VAUAM)LH3=7L:"2<!MJ0*?N[V[$X.  3QG '-:M>1
M75G/:6/C::.]N[;Q*NJM<60BN'4S A/LX"9VNK ;.0>C#M74_$9E7PQ8/<S>
M3)_:=CDK*4ZSINP01VS0!VE%>0ZO8:.DGQ$MD,:Q6>GQW5O$)B%BG,,F9%&<
M!\JG/7/UYK^+M8M+S1M587:C4XM M[B.6>3<S-AVW6RC!#9&7<$XPO'&: /9
MJR?$VM?\(YX;O]8^RM<BSA:5HE<*6 Z\FN5UMY=)\067B#285NXM;M_[/?8-
MR"<C=!+_ +IY5CTQM/:K_C334T_X2ZSIUHC,D.F21H ,LV%ZGU)ZF@#KT;?&
MK8QD TZO*]0M'L]3NKWP3*\LDV@W,ET8)S*KS87R&ZD&0G?@]2!6MX+DT'4=
M8CU30]7,\CV7EW-I @15Y!#3#J)0<@$\D;NH% '?45YQK$[6GC:6?%GJEJ^H
MVD,L&=MY82%8]ICZ[XCD,5X^\Y]:PY=2LK33)+.2[BBNK7QDI\HOAX83=@@X
MZJA0CGI@XH ],T/7/[9N-6A-JUNVG7IM#N<-OPB/NXZ<../:M>O'M6T_3[N'
MQV[2.NNQ:B9=,$4S+,)3;P^48U!_B<8R!R ?2M6^GN+/Q6)Y_L6JQO?6<-S"
MIV7=C,5C ,?]^(Y#%>/O.?6@#O)]2:2SNI-+A6_N+>7R3"LH0%P1N&X\ @']
M,=:LI>6\E]-9)*K7,,:221CJJN6"D_78WY5X]=KI5EX!\910_9K:Z@UN7*QD
M1LB&X78#C'RE2< \$9Q70RVNFOX_\71F"U:\N])MI+4;%+RG;.&9.Y_A!(]O
M:@#T>H+.\M[^V%Q:RK+"690Z]"58J<?B#7E^@:KIVH:A\/(EO(+AGT::WNAO
M#;G$,/[M_5@=WRGGD^M9NC7^G:7X/\,)*]M;:6+NXAU600ADBERXB$X],_WN
MAVGTH ]IK(\/ZY_;L=^QM6MFL[V6S96<-N*8^;CUSTK@DGTW2;OP[;/J377A
M2YN[MOM%P1]F\PJ#%&#T\H$R;0>,@>@K=^&[V8LO$,6GO$T2:U<E%C;*A3@K
MCV]/;I0!V]%>26$TMYX:T"[A?;XO35DCO5SB8GS2)TD'7RQ'DX/  7'05N>!
M=/TRZUGQ!?AO/N[/6KE(7\]F\M&1 1C.,'GKZ>U '?T5Y5XGO+2PN_B-:W$\
M<,MQI$<]I$S8:1A#+ET'<A@"2.F,FC5[WRW@U.%[+5[9+*S%Q8.^VYB&?EEM
MVYR26Y7')7&>U 'JM9'B77/^$=TC^T#:M<J)XHF57"X\R14!Y]"PK@A<6&I^
M(-0LM7U5['7[75R]I$D8%S)$&!B$1/6-DP& X^\3CDUEZUJ.G7?AC63K$L">
M(;;74#I,P$L<0ND\O:#SY?E8/'!Y/7- 'K]]-=06X>TM/M4OF(IC\P)A2P#-
MD^@R<=\8JS7&_$B:&/PO:SM.$QJ5D4;S-H(-Q'GOR-N?PKC_ !/%I\K?$F=I
MPT]G#!/;'[0<PRB'(91GAMWIZX[T >F>)];_ .$;\-WVL?96N1:1F1HE<*2!
M[FK@GNCJ*P_9/]$,&\W/FCA\XV;>O3G-<O\ $.YCD^%&LSF5"LE@2'W##$@8
MQ]:R]:NYE\<7S:1.)-0?PM,]LBR;MTN\;,#.,\#ZT >C45Y/IXT/6]*N[[1M
M3:YO7T::*YL8(P#NVY!G'7S0XP"?F))ZC)JUX?UBPO/$W@DVU]#,SZ'-',R2
M [I (,*Q[L/FX/(R?6@#TZLW5]732S91",27-]<"VMXRVT,^UFY.#@!48YP:
MYG49;6;X@W=AXB$(TU]+1K$7! B+!V\X@GC>!Y?N!R.]<VL:RZ3\._\ A(O)
MFNVU!T+W@!D>#RI_+W;N3D>63GN1WH ])M=68:=;3ZK;?V;<33>0+=Y0_P Y
M8JH4K]X'&1TXZ@<U'I&N?VIJFLV)M6@;3+A("Q<-YFZ-7!XZ<,*Y_P"(L%@$
M\-7%_%;?9X=9A#R3JNU$*N#DG@ G;[=*X_Q'_9S6WQ#U!)8Q<V=U:RVCK+M,
M3B"'!49X.01Z\$4 >ST5Y9KEWIFH^)=<TO7M7_L^1S!)I4JH/,:+RT(-NW]_
MS _"\G(ZBND\;74]G8:&\Q<::VHPIJ;MQB$AOOXX"[]F[MC@\9H Z^JT\UU'
M>6D<-IYL$C,)YO,"^2 I(.WJV3@<=,YKRCQ2J6ND^-%M+@1:(ILFMO*EVQQW
M!8>:L>#C&-A('&2?>NAU&QTO1O&W@V*P988[BZNY"OGLPD+0,=W).<G'YT =
M_5:UFNI9KI;BT\A(Y=L+^8&\Y-H.[ ^[R2,'TSWKRK2)]-U/4]*LIM;T[^T[
M/5[E[F=KQ4FO$+R!8]F0^<E/E(P @QGBH]9GM5T'QNOVS;Y?B*UV$7!!&?LP
M;G.<??\ R/I0![%67XCUC_A'_#E_J_V9KD6<+3-$KA2P49/)KSS4KK2]#U#Q
MQ;))*MA]DL96AMKC:=[LZN^[G:#\F]L'CGFJ5[?VJZ%\2[2*\LF@-@DL,=K\
ML/S0$$H,D<G R.IH ]AAD\Z".7&-ZAL>F13ZY[6M(3Q+X(EL(I5#SVH-O,I^
MY(%RC _7'X9KAK2^O[[5++5X].:"+Q)9_P!EM'Y7,%P@RTA!Z#_7#W$*GG(H
M ]:K/74F@A:34X5L@;O[/"#*'\W<X6-ACH6R..U<9%H^CW/Q2O-/D :*VTNS
MEAMQ.P"2)+)A@ >H 3\#[USDHTV7P]YMRUO-:VGC5MTDS!UBB,^.6;.%Q@<\
M8H ]=BFNFU"XADM-ELB(8KCS ?,8YW#;U&,#D]<^U6:\GU^>R6;XCI#<JB#0
M;>2)5F*[6$<^-HSQSLX'J*NZ<+.R\901:?>+;M>^&GEED60N6D5TVR$9.Y@"
MWX4 >ET5Y1X)N-*U?5O#<T&JZ<+JTTUH[N&*^5Y;R8A"'* [CC#L2XW9<C'6
MNBU::WD^(B6.NB'^R9=*+6@N<>4TPD/F]>-X39CN!NQWH [6H+J\M[*-'N95
MC625(4+?Q.[!5 ]R2*\ELK87TW@BQUVXDE2=]0B59IV5I[;#"'=R"<KMYZGB
MNH^(5GIUOHOA_P"TPP"SL]7LU+3@%8H]X4Y9N@Q@$G\: .YHKS2PMM&N/&'B
M^[?S)AIPM[FW2WF;=%BW.2B@]>2,=,\5CZ)J.FG581;WMLEG=^&)"5BFR6=6
M0CS9 1OE"EBQP",G- 'L=%>1^&FLK*X^'MS!<!+B^T61+MQ-N:7;#&0#D\[6
M!P.W(JH\_P!G\+:Y9W#65T!X=FGM=9L9"GVA  %\Y<\2EL'.3N^;T- 'L]5K
MF:ZBGM4@M//CDD*S/Y@7R5VD[L'[W( P/7/:O.+33]$E\::1;.8GMK[P^\MU
M&TY*W#*\6UG&?F(#/C/;Z<4=$OHI-%^&\CWN^0:C-!EI\Y01SJ >><80<^U
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M5>2Z)%&/"GPSDV+O74R@;'(4Q7!(SZ<#\J]9E+K$YB17D .U6;:"?0G!Q^5
M"F.-D*,BE3U!'% 1 JJ%4*O08X%<+IGQ O[N'P_?W6A);:9K;"&&9;O>\<S
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M3FUX?\.P: VH/"8@U]<?:)(X(O*B1MJK\J9.,[<GGDDUKR311%!)*B%SA0S
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M-EH-FNKB2'1;HSP!K899=KH%)#>DC<]R!P.Z3^ Y)K:[V:P\%\^JG5;6ZA@
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MHF59)$1FSM#, 3CTK&TGQ U_K.MZ?<P16YTZZCMT82[O-WQ+(#R!@X;ISTH
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M$F;;!F!C\OGY^#M_7\JZH21F0QAU+@9*YY ^E()HFD\M9$+XSM##.,XSCZT
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MU CDE'G<X'!;!3WY%5K2_LK*70%\0PN^BW7AR&U@=H6DC2XZ2H0H)5F78/\
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M%<Y7<&&."R# /U ZFO8:* /.8;#2].\;>&"FGR0V/]DSV]M]HB9V#"2$H&+
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M"RNX[^Q@NXEE6.:,2*LL91P",\J>0?8U/0 444BLKJ&4AE(R"#D$4 +1110
M4444 %%(S*HRQ &0,D]SP*6@ HK/EUNQAU>RTMI&^U7L;RP 1L5=4 +'=C;W
M'&<\UH4 %%%% !1110 4444 %%%% !1110 4444 %%%% !12;E+%<C< "1GD
M#_(-+0 457OKZWTZV\^ZDV)O6,<9+,S!54 =220 />HM,U2WU:WDFMQ,OERM
M#(DT31LCKU!!'ZC@T 7:*S[C6[&VU33].DD;[3?[_LX6-BK;%+-\P&T<#UK0
MH **** "BBB@ HI&8*I9B  ,DGM5=[Z*/4(+(I,9)HWD5EB8H N,Y;& ?F&
M3SS0!9HHHH **0D*I)( '))[4H((R#D4 %%%% !1110 4444 %%%% !1110
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M4'\R[25F<2MQACD]>!R.>!Z"K6DZ/I^AV0L]-M4MX =Q5222?4DY)/ Y/H*
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M=%FM[R"2SW17DPGN$,KXED&,,>>O"_D/04 8^@12GXC>+&>\N72/[(%C=@5
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MBX55'0 =A4E !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFW*Z,0PR"2".XJ271-4'B'P]>0VMK%'8VEU'*(2!'&\NPJ%7@E04.3@9ZX[
M T;'Q?IFHRPQVPN'-S;/=VI\KBYB4@$I^++P<'D'I5?0O&$&L>'K#4S:7"2W
MVXP6P7+N!D\<XP!C)) S]16)H?A_Q'%X@T#5-2M+;S[:TN+:^G^UEVD=S&0Z
MC;POR'"C &>U4K7PCXAT_0?#1&G:=>76AK+;26<T^4NHGQEU8KA6!52 1TS0
M!W^CZQ9:[IRWUA(7B+,A#*59'4E65@>0001BK]8FG)J=G'8Q#2;&"*>1VNDM
MY0JVPVY7;\H\PD@ GCK6W0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %6QTVQT
MR)XK"SM[6-W,C)!$$#,>I( ZGUJU110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%,:6-'5&D17?[JE@"WTH ?10"" 0<
M@]#10 444R*:.>)989$DC895T8$$>Q% #Z*** "BD9U3[S ?4T!@PRI!'J*
M%HHIK.JG#, 3ZF@!U%-#H6P&4D=LTTW$*LBF:,%SM0%A\QQG ]3B@"2BBB@
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M;W^R8=;LK>V?39=22Q1)"WF,IG\DR9' ^;)"XZ8.1TKI](T_^R='L].^T27
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MWP*VFS:;,FN7DCZ?8O80AXHMIB;9@$!1R-B\YR:?:>#DTJW\/[+Z>5/#\;K
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MK%26//7*+TXZ^M9:?#Y;?3M+BL=:O+2^TQYC;7L:(6*2MN='4@JRD^W&!^(
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M10J@*!N&3QDY//3%K7O#7]OPW5K=7A-E=VPMY[=H58#!8[T)^Z_S=><8''%
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M4V1O*%#;>PX Z5K4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ"D^@:#9P::\&OV>M>?-*UL8WAC$[LY9R!E6CX')#9&.G$BZ#+=>#_&@TK3
MFK/J%V;5FM_+D>)BN5C8@'#*& QQS0!Z;%JFGSQRR17UK(D/^M9)E(3_ 'CG
MC\:D2]M'DBC2ZA9Y4\R-1("77^\!W'O7$SVYUWQ-IVHZ/;RPP+I%S!>!X6BS
MN">5"P('S*=YQ_#STR,Y'AR9Y;GX=Q?8;]6L+":UNF>SD40R"&-2K$KZJ1GI
M[T >EC4;)YVMTO+=IUX,0E&X'I@CKUK%\,^)AK%M(+Y[2WO1>W-LD"2\N(I&
M3*@\G[N3Q7!^&)M)GN/"MMJ$\L;:3),+9KFPG5KAI"53>[)L!Y!X9MS8P:=#
M9A-)M+@:=.MT/%[W#/\ 97\P0FY<[S\N=FQNO3!H ]+TO7],UF:\BT^[BG:T
MF,,NQP?F !.,=AG&?4&J.J>(7TOQ7INFSBVBL+JUN)Y+B23:4,6SUX ^?K[5
M1\%H]KJ/B:UFMIXI&U>:=6>%E1HV5-I5B,-GGH>U1>*;6!O&_AN\O[/SM/B@
MO(Y)&@,D:.WE;-W! SM;!/I0!U;W]G'9B\>[@6U(#"=I $(/0[LXK(U_Q39:
M/:6$B7-LS:A<1P0.T@V88\R'GE0,G@\\#(SFN$@LKWPS'IE\]IJ$6@KJ=_(L
M%K 7DLXI2/);R\$A>'X RHDQZBM"^L+.ST?PTFFV-^MI_;Z706:%RZQG>6=E
MQF-=S9P0,9' Z4 =I8:G)'!%%K5SIT-[*["(03?+,F?E90W.2,<<_4U=FU"R
MMY1%/>6\4A*@(\JJ<L<+P3W/ ]:\^OX)3%XZTO4K.>>?4LR:<RPLPGC,*K&B
M$# *.IXXP3NZ'-3Z/HJMX^*ZM9)=3QZ%9QR7,MN61[E'<N0Q&"P^0^O2@#NT
MO[.2\:S2[@:Z0;F@$@+J/4KG-2S316\32S2)'&HRSNP 'U)KS3PC#'=2:/8Z
MM9:P/$&D2N7,D+)"K'<'E$H4*RN"3C<22>G<=?XPMTN=#6)KF[M6^T1-'<VL
M7F-"ZL&5RN#E00,YXQZ=: -6+4K"=HEAO;:0RY\L)*IWXZXP><4Y;^S>V>Y6
M[@:",D/*) 57'7)Z"O-_-U*/_A'M3U6R!6QUR<3W5C;2%9T:"1%G\L L S,
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445@^+-9N]
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M]E T]U/%!"OWI)7"J/J3Q2PSQ7,"3P2I+%( R21L&5@>X(ZBO/)=<NO$VI^
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M"@%2=Q.>O &.:RD\;ZQ=II4%K964=[/JEQI5T)6<HDL2.VY<8)4[ >>><>]
M'?T5Y_/XG\8(=>AAM-%>XT6&&689EVS[HM[*GIT.">G&0<Y&A8>++SQ(UPFA
M1V\;6]A;79%VC-O:="Z1_*1MPH&6Y^]TXY .PHK@+7QKK&OS:,FAVMA$-4TN
M6]4WI<^4\;HI4[<9&7(_7V-R;Q9J-KK]E:3Q6ABN=4:P,409VC78S(YD!VAC
MLSY9 (##TH ZZYN8+.W:>ZGC@A3[TDKA57G')/%+/"EQ;R02@F.12C $C((P
M>1R*\X?7]9M_"'BC4KTV&I?9=5EMU@FMV";5D5!QN/&,$#UR<FNBN_$.HW-]
MKUMHZ6I?1D3>MPK'SY&3S-@((V#;M&[#<D\<<@%O3?"T6G)#"=3U*[M;?;Y-
MM<RJR1[?N\A0S8P,;B>@[UO5P4'C35]:N471H+"*"?1(]5B>[#LREF(V,%(S
MTQD'WYZ5JR>,4@^'$/BR:V_UEE%<" -_'(%PN?3<P&: .HJLNHV3WS6*7ENU
MVJ[F@$JF0#U*YSBL(ZUJ=GXHM="OOLC-J%I+-:7,,3!4DCV[T="QR,.""".X
M]ZSOAS:O=^%;+4+[[+<7237303&#]Y&6FDWG<6.=Q],<<<T =E/=6]KY?VB>
M*'S'$:>8X7<Q. HSU)/:I:\EFN]5U'PIIEYJ$]O=W*^*XXX3Y1CV[+QDQG+8
M7  &!P/7K72+XQO[-M6LM0AMI;^TU&WLH7MT94D\]4925))R QR,\X[9H [:
MJ]S?6=EL^UW4$&\X7S9 NX^V>M9F@WVLW5SJ$&JV ACA=?LURJ[!<(PR?D+,
M5*G(.3SP16!\.'_MBSU?7+Y1)J%SJ-Q"Y<9,4<;;4B'HH SCU)/>@#N5=7&4
M8,.F0<TM<LTL.@:M8>&]&BA@?4#<7@WH6CA52"^%!&<LXP,C&3Z 5E2>-]6\
MB*".SL_M\>N#1[K>6$9)7<LB=P"I!P<XY'- '?45P[:WXQ?6;K1(8-$-_;Z?
M%=F0^;Y;LSR+M SD9V=<\9[T[0O&MQXJ^P0:;%#:7,^F"_F-RC2+&2YC"  J
M3\ROSGH!QSP =M17GUOXWUO5FT6#3K*PANK_ .V0S"Y9V6&>W.TXVXRI/XXJ
MW?>+=4TW4[>"YBLB'U.WL'BA#.VV0*/,+@X0[F.$89(&>] '93W$-K;R7%Q-
M'##&I9Y)&"JH'4DG@"G@AE#*001D$=Z\YFUS6;?1?'M]=/8W\6FW,J16LT#!
M"BP1MM/S'(P3D8Y))R.E= NNW^H:K>Z5I"VD<]A9PSR&X1F5GE#%4 ##:,)R
MW/WAQQ0!T]%<'8>-=4UZ?04TNUL[=-6T^>Y)NMSF&2)D5AA2-PRQ';.,Y'2N
MB\):U-X@\,66IW$213RAUD2,DJ&1V0XSS@E210!M5%;W5O=QF2VGBF0,4+1N
M& 8=1D=Q7-:]>:I'XX\-V%K=PQ6=RMR\L;PEBY1!U(8<88X'8\\\ <SX?U?4
M="MBT,-F=-N/%-S921D-Y@\RY=0RD'  ..,'([B@#LY/#$9U2YOK;5-3M#=N
M)+B&"9?+D8*%SAE)4[54?*1TK4@T^UMFC:*+:8H_*0EB=J\9 SZX&3U.!GI7
M+CQ/K-[<>?I.F"ZLH]1>SFCV8?8DAC>0.6 X8$[=O('7)J*W\<_\3#48;MX+
M>33Q<27%A)$R7 ACW%9$);$BL%!RHXW"@#MJK2:A90R&.6\MTD'56E4$?AFL
M#1]:UZ]U.S^T::ATV[M3,9T38;=^"%)+'S 03\P Y'3GC(U8%?C'9,FG_;6.
M@3 Q@H#CSX^?F('M^- '?*RNH92&4C((.0:;++'!$TLTB1QH,L[G 4>I)KRS
MP]J6I:3I/C.33+6*'4;*_-RVAR*6%M$5!PI4@$N SC;QGCOFNGU75AK6@ZQ]
ME>WN-+_L<S&0(<N\D;,H!SCA=K8QGYEH ZR*6.>))8I%DC=0R.AR&!Y!![BG
MUY\/$.H:)X,TMK5;0)#H"72^:K2O*Z1J=@1""JXZN<@9%7I_%NH1WB*R6D%O
M>:,VH63R(Q_>*%+QL0W. RG@ X)].0#LZ*X[3/%FH:KH-MJ-G:Q7$XTV6ZN;
M5$8.)URJPK\W!+K(O.?N>]7O"GB-?$<=S+%>VES%$$!6*)H989#NW))&S$J1
M@8]>?2@#HZ*X>]\;7D/A_4?$EM#;R:7IUX\$L!5O-DCCD\MW5LX!SDA2IR!U
M&>+MEK>NZAXNU338(M.2QTZ>$2.^\R21R1[^.P8''7B@#7\0:-;:]I#V-W<3
M06Y=)6>)E!^1@XY8$8RH/X5?MIX;FVCFMYTN(F'RRHP8-[Y''Y5S,MWJ4OQ-
M&F&Z@_LT:49S;M 3N)E"G)W8)XX..!D8YS7-^ -9U+3=!\$V$L=HVG:E!)"F
MT-YL;(CR!B<X((4C&...30!Z?5>:^M+=]D]U!$^,[7D"G]:Y?2/$^LZQ+I-]
M:Z8)='O]Q=@FU[=""4<L6P^< $!01GOCF#Q7!#/\2/ RS1)(-]]PZ@_\L,T
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M:RE2'9YA296V%QE0<'J1T]: ,^^\'6>H:/JUA/=W0?5B#>7*;!(X"A0!E2H
M4   ?J2:UKK3A>:-/ILMS-MFA:%Y@%#X(P3TVYP?2FKKFE/917B:A;-;2DK'
M*L@*L1G(&.XP<^F#22:[I,,,4TFHVJQ31K+&YE&UD/1@?0]CWH S;/PA!8WN
MEW46HWIDTVP:PA#>7@QG;RWR<M\B\\=.E45^'EG!I^EP6>K:E;76EM*;:]C:
M/S0LARZ,"FUE)[%>PKL*R)/%7A^&X2WDUO3EF>8VZH;E,F08)3&?O?,O'N/6
M@"O)X4MC=:?>V]Y=0:A9(\8N@RL\R.<NL@((8%@&Z#!Z8'%1GP;9!],>*[NX
MGL+R2^#*4)FFD#!VDRISG>W3&,\8P*T9/$6BQ7XL9-6LENS*L/D&==^]L[5Q
MG.3@\5)#K6F7%TUM#J%M).%9O+64$X4X8@=P#P?2@#D[;1;G4?&'B]9I+^TL
M;Y+>+<L.U9E$6U]K,O!Y(R#WX[$;;>$[6'4S?Z;<W&FRO:I:2K;A-KQIG9PR
MG#*"0".QP<UH1:YI-Q9"]AU*TDM3((A,DRE-^<;<YQG/&/6J]IJT)?4Y9]5T
M^:W@N!&ODG!@^5?DD.XY?<?;J!B@"O:^$;&PU33+VSFN($TVS:R@MU*F/RV*
MDYRI8G**<Y[>]41X!M%EC9=5U-8H=2;4X80\>V.5MQ< [,E3O;J21G@BM2ZU
MJVE_L\V6KZ=&)KL1$2L&,P&0T:88?/G'KC!R*N2ZQIL%ZMG+?VR7+.$$32 ,
M6(R%^I'('4T 8=UX%L[K3=8T\ZCJ$=KJER;F1$:/]VY8,VPE#P2 ><X[8JS/
MX4ADU.\O[>_N[66_@6"]\K9B<*"%;E3M< D9&..W Q;N?$^@V<SQ7.LV$4D<
M@B=7N%!5ST4\\'VK5H YZ/PA96^H_:[2YN;8#3ETV."/9Y<<*DD8RI.1GJ2?
MI4L7A33E\&IX6N#+=:<ML+7]\1O* 8'*@<C YQVK0FU73[>Z6UFO8(YV94$;
M. 2S?='U/8=ZY_P]XNBNYKNSUB_L(;Y=3GLK:)6\LRJAP,*S$DGF@#2L_#RV
M]U#>7-_=7MW;V[6T$\X3=&C$%CPH!8[5R2/X>W.9?#NA1>&](CTRWNKBXAC9
MV5KC;N&YBQ^ZH'5CVJ?^V=,^WBQ^WVWVHN8Q%Y@W%@-Q7']['..N.:X_4O%V
MLV?A_P 87B?8C<:->^3!F%MK1^7$WS#?][]X><XXZ4 :?_""6@MA;)J>HI F
MIC4XHP8R(Y/,,NT93.W>2><GMFGWO@73]1.LFYN[UCJLL4SLKJA@DB "/&0H
M*D;1USTKJ*I7NL:;ISE+V_MK<@!F\V0+M!. 3GH"> 3U- $.C:0^E0.)]2O-
M1N'P&N+LKN(&< !5  &3VR<\DU33PLEGJEW?:5J-UI_VV3S;J"((T4DF,&0*
MRG:Q &2.#W!J_/KNDVUO'<3:E:)#(AD20S+M9!U8'/W1D<]*D.JZ<+Z*Q^W6
MWVN9/,B@\T;W3^\!G)'O0!GWOA>VNY]/O%NKF'4+%W>*[4J7;>,.&!&"K #C
M Q@8Q@57G\&6<T-LHO+N.2'4?[3>5-FZ:?U?*D8QQ@ < >E:SZSID=LUPU_;
MB%9&B+^8"-XSE?J,'(]C5>?Q/H-M;Q3SZUI\<,T1FC=KA 'C'5ASR/>@#!?3
MKVY^)FHW$4M]9V[Z3#;BXC@&QG$DI8!F4C(#*0??O6DG@VPL[C3KG2Y9M/FL
M;7[$C0[6WP9!V.&!S@C<#UR3ZFK0\5^'2T:C7-.)DE$* 7*'<Y (4<]?F7CW
M'K6Q0!SL'@ZQM;W2+FWN;J(Z7YQC0%")6E.9&?*Y)8\\$<U4N/ 5I<3W#C5=
M2BCEU%-36%&CVQSJ0=PRA)!V]"2/05OR:SID-\ME+?VR7+.(Q$T@#;B,A?J1
MR!U-02>)]!BG$$FLV"RF;[/L-PN?-X^3K][D<>X]: ,ZZ\$V=U!K]O\ VA?Q
MV^MY-S$C)A6**C,I*DY*J.I/?&*G;PM$FIKJ5IJ%W:WAM5M)Y8PA\]%^Z6!4
MC<,G! '4]147C3Q,GAWPWJ=U;W=FFH6UJT\45Q\P; . 0"#R1@<]?6M^VD::
MTAE;&YT5CCU(H P[?PA8V5_I=U9SW-NNF6CVEO"A0IL?:6+94DME%.<_S-5[
M/PK<:-#HUGIFK:@+:RN)991(T>V5')9E<!1GDG;C&,DD\ 5N7FL:;ITBQWM_
M;V[MC ED"]3@=>F3P/>B[UC3;"80W=_;02';\LD@4_,<+G/3)X'J: *VJ:##
MJFIZ;J!NKFWN-/:0QM"5^=7 #*VX'@X'3!'8UECP+:"Q6T_M/4-BZI_:H;]U
MGSO,\S'W,;=QZ?K6K>^)="TZ2:.]UBPMW@V^:LMPJE-V=N03QG!_(U'/XHTF
MWU^/1I;R)+I[9KGYG 4("H')[G<3] ?:@"E!X+M[76[F^MM3U&&TNI_M-QIR
M2+Y$DIY+<KN&2,D!@#WXXJ4^$;2>[MYK^YGOEMC.8$G"?()059<A02NUB #V
MZY(!%RW\2Z%=^;]FUBPE\J(32%+A2%0G 8\\#/>JVL^($C\*:SJ>CW5I/<:?
M;2RX;YU5T0MM8 @C('MUS0!'X>\))X>V1IJVI7EK NRTM[J162W7IA2%!.!P
M"Q.!P.]27?A=;KQ.FOQZI?6]VEJUHJQ"(H(RP8\,A.<J.<]JU-,N'N]*L[F3
M'F30)(V!QDJ":SKKQ+8KK<V@P74*ZHMJ9PL@RHSPH(R,DX)P#T'O0!4CTVV\
M(17^IP6FIZO?:A.ANI$"23R8&U>/E4*H[#&!2Z+X5M['P;-HH5K07BRM,(6#
M&+S,Y5200=JD(..BBF^#O%MKX@T32S<7ME_;%S9)<S6D4@#+D DA<D@<C\Q6
MU%K&FS7YL(K^W>[PQ\E9 6.TX; [X/7T[T <_)X LW2-%U34D4:6-*E"M'^^
M@&=N[Y.&&X\KC/>K[>$K"6RT.WN))[@Z/(LEO+(P#L54J V  1R. !T%;U<K
M<>*E?QIHNDV%W97%K>1W#3A/F=3&H*D,&Q@DD=.J]: -"V\,6-E:ZS!:/-;G
M599)99(V&^-G7!*$CCG+#W)/>I-.T&&PU2[U-YI+B^NHHX99G55W+'NV\* ,
M_,<GZ=  *LV^L:;=WK6=O?V\MRJES$D@+;0<$X[@'C/K4::[I4YGC@U.S,D4
M9E?]ZI"KTW'G[N>,]* ,L^"K _;X!<7*Z=?W/VJYL?E,;2$@M@XW!6(!(!YY
MZ9.;^GZ#%I^N:IJJ7=Q))J)C,L4FS8FQ=J[<*#T]2:;::U:0:+97.HZM82-+
M#YAN86V12  ;G7)/R\CG.!D<U+%J"SZ^UM%J5C)$+42&T7F=26X<G=PA! ''
M7O0!%=>'XKCQ#%K<=Y=6]RELUJRQ%-LB%MPR&4G(;G@CT.1Q6?8>![/3X- A
MBU"_9-#9VMMYC^;<K(0_R<_*Q'&*V;?6]*NI)(X-1M9'CC\U@LH.$_O?[OOT
MJ*U\2:'?7<-K::O8SW$R%XHXIU9G4=2 #R* ,W1?!=OH5V3:ZGJ+:<LC2PZ;
M)(I@A8DGY?EW8!)(4L0#SC.,6M7\,QZMK6F:J=1O+:XT[S/($ CVY==K9#(V
M>*W*I)K&FR7PL4O[9KHEE$0D&XE?O #N1W':@"I8>'+2SU>75YIKB]U*2/R?
MM-RRDI'G.Q H"J,\G R>^:K6/A5-'6>'1]1NK&SF=I/LJJCQQ,QRQCW*2N3S
MCE?0"J2>);K6/$E_IFC7FG*VG30I)'/ES.K*&DVE3\NT$ <'Y@<^W53SQ6T#
MS3R)%$@RSN<!1[F@#G1X%TB/P[IFCP-<PKI;![*ZCD'GPN,_,&(P<Y.0000>
ME:EMIEQ&0]UJES=2J"(V=(U"$C&X!5 )QZY]@*<FNZ2YC"ZE:YDF^SH#* 3+
M@'9C^]@@XZ\U(NK:<\=S(M];%+5MEPPE7$+8SAN?E.".OK0!@:=X);2=(?3+
M+Q)K$-LSR/@?9]P+L6;#>5D<L?IGBM/6O#T&LV=E +FXLVL;A+FWEMBNY'0$
M#A@01AB,$5G>(?%(M=+MKW1[JSG3^T[:SN-WS[1)*J,."-K -GG/TK=T[5M.
MU>*273;ZWNXXW,;M!('"L.QQWY% %30O#T.@?;_)N[J<7MRUTXN&4[7;&[&
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M+)>1V8"L,K(Q7AO[N P8Y[?459M-22XU>^C34[":WAAB?R8CF2'.XEG.[&"
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MZ99>8+6W79$LC;BJ^F>] 'GFEZ?J,?AOP9#-I=['-9ZW)/.C0$F.,^?\QQG
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MS()(Y$.5=3R"#4U 'F*Z/K3/=V.D/>+8WUM>J8-0@*G3YG5L-%-@;D9S]WG
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MY"2V".,]<5#=Z/JEQX4\2>&9[.Y;4KO4I)K2Z$3&-UDE#I+Y@^52@Z@D$;.
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M]2T*]U]-1^R7/]FZ7:W"M#$8M\DC2*=V6/R[E!]@3]:M7.I^+K%=2D_LW[7
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M,'RLK!F4AP1C(&.,CGU-!\%Z6+'^ST:X333%%"]D'!B=(\!0<@D< 9(()[T
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M4"S:/=HR^+GU J55L0&1VW\$\#(]SVS0!VG_  FGAOR1+_;-H$\[R"2^-KY
MPW]WJ.3@<CUK4U"X2UTZYGDNHK58XV8SS8V1\?>.2.!]:\[US2-1NM.^(D4&
MFW#R:F\7V,"/'G8@C0X/;#*W7'K7=:P'N/#-\L44CR2VCJD80[BQ0@#'KDT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8FNZ]<Z9(EOIVBW>K7C)YC0P.B"-.F6=R ,G.!R3@^E;=5-0OH=
M.MC/(K.[$)'$@R\KGHBCU/Y#DG !- %#POXFM/%>D&_M8IX&CE>WN+>X7;)!
M*OWD8>HX_.MJL/POHC:)ITXG*&]O;J2^N]A^7S9#D@>P "@]]N:W* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG]=\(6/B&^@N[N\U.&6!"D?
MV2]> *#U/RD<GU]JZ"B@#)T+P]9^'X9H[66[F:9P[RW=P\\AP, ;F).!Z>Y]
M:UJ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
5BB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>aquestiveamendedandresta003.jpg
<TEXT>
begin 644 aquestiveamendedandresta003.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5U931)8Z18O8I ZDNR-Y8SNZ @1CMSDT 6]1U.S\):1I\4DG[MI([.*2ZG(
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M)"RNT\!4Q3$DB6+!)7;G 7.< ?-U) .DNKZ"QTR;4+MO)@@A::4M_ JC)S]
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M9?M$:D&- < ;LG=G&0>./P?8^&M:TK6+U;'6(%T2\NGO'@DMR9XG<[G6-PP
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MX2:$NP 9RK(0P&?WA'(/8\]*YZQM;K1?'?A[2(KRRGNK/PY);,7!C$@62$#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !61KNN?V(VF@VK3K?7L5GN#A?++G 8^OTK7KC?B,L3:=HIN'V6
MXUJU,LF\H$7<026!&WKUR* .RHKS*#PI%J9\7:1I4ICTEQ ^GN)"T<%X%8N4
M//RY\O<!QRP]171>#KJ37U;Q!=61M)S$MDL++@HT9/FX]O,++](P>] '5T5Y
MAXCN=.N_%6MZ/XBU4:;OCA;2Y63YRFT9,#=I!)NX7D_+UQ4?B@6EAK0U=7>7
M3H8X;?Q&F5R%+*R,0.C@X+@=5/TH ]3HKS74[30-5^(=[;:E<H=-ET&&=%^U
M%(S^]D&]<-C@ =.G!K)T>P&J7_@W3O$DLTTMQHETL\4T[(TH#Q>5N (.[;SZ
MY![B@#V"BO*K2?3]2URXL]3U9[+Q#9:RY@@1 +F2(2'RE0GEHFCV@CIC)..M
M26UT;/7)%FFMKNTN3?O#JUF<75J0'9TG3G<%^ZK \%5&!F@#U&BN#\"2RP:K
M=Z=<06$LJV4$B:EIK?N;J++A69?X).I/)SZ\5BZS8:1?>(?'<6IW+JT%K;S6
MP-RRM&_E,0Z#/W@V,8]<=^0#U:BO+M)T^/5?&MA9^(&:6^'ARTGN(&N&4_:%
MD)+8!'((%58)Y[OPK972.$\:0ZR(YESB;<;C#HPZF+R23C[H4 ]J /6ZK1S7
M3:C/"]ILM4C1H[CS ?,8YW+MZC&!SWS[5P\NGO8>,=2T!+<M8>(%2[1PN5BV
M$+<)GL"-A7T:0XJMJ+VR^*O&EH-4&GHVE6:^=NW" EI5+;<\*,KD#'!H ]!O
MYKJWM&DL[3[7.&4"'S!'D%@"<GC@$GWQBK->0:K>,G@W78;VUM+&\M=0L=\V
MGSD6LY:2/YD'&WY/O(<XZ\YK4U.>VO+WQK;ZU*([N")9-+<MM9(?)&QX#UW>
M;NR5YS@>@H ]+HKRC[-'J'B"2W\1.&NSX4@EO(7F(43[FW$KG (X/MP:Z?0[
M[4;KX/V5Y82&XU4Z(K1,3N+SB'C/J=WZT =A6%;^(9[W4FBL=-:XLH;Q[*XN
M!,%:)U7);81RH/RY!SGMCFN1TM[:XNO!5WH<JM//&RZHH;+21>2=YG'4L)0H
MRW.XD=S6E\.(=-5?$3V4=J'76KI,PA<A PP..WI0!T&N>(K?1])U:\C3[7+I
M=N;B>W1P"%VEN2>API/Y>M:EM-]IM(9]NWS$5\9SC(S7E&O+IEG/\4D9;6&\
MDL \8(5796M<,1WP6X)]?>I96;3=:N4\.R?Z==>$Y9T1)=[37"E?+;!)RW)Q
M0!ZO17G_ (+ET'4M7@U31=8,TKV6RYM($"JO((:<=1(#D GD_-U&:CUV_P!(
M?QEJVD^*[E;:TGL(O[,DE;8.KB4Q-VE#%.GS<+B@#T2BO*M8N=.NM=U/1_$.
MJR::'M;=M+EN4_?%-@R8F/2829SCYB<=<5?TK2=+U?XA:_;ZB6NVM[>PF6*>
M8Y#[9-Q9 <9Z9'3G'>@#MO[2:YMK6YTR%;Z":<(\BRA0B9(9QG[P!'0=<\50
MO_$5Q'J-W8Z7IC:C/9+"US&LXC8"0G&S<,,0%)()7C&"3Q7G&BRZ;;^ _ ?D
M3013IK$$=P(W"_/\^Y7 ZD87@\CBNBT^#1_^$Z\<';:I(D%N2RD*R9B?><CD
M9[T =Y8RW$]C!+=VOV6X= TD'F!_+;'*[AP<>HJQ7D.AZS80Z9X,C\1W$(T.
MXT+:LMRP\@W0V9#D\;MF[&?]KO4OB";2(+1=*BN9G,>@3/:2:G(7WKN(4Q*<
M%I3M&&R"%V\'- 'J37ENM\ED95^TR1-*L?<HI4$_3++^=3UY387%I<>*-!U+
M-K-?W7A<_9II=I,URK1XP3U8<_09JSX'GTG5KW1;^#6'.M0VSQ:A91QA9&;;
M\_VD?>.UQPQ[GCK0!Z;6=K&KQ:1!;LZ[Y;FXCM8$S@-(YP,GL.I)YX!X/2N<
MUB>%_B):V.M"+^QYM+<VPN,>4]P)/G!SP6";2.^-V.]<I-'&_A?PF-9:*8#Q
M%Y5I+=D,\EIYD@CR6Y(*A?J-M 'I46H:J^BW%RVBLFH1%U2S^TKB4@X!63I@
M]02 ?45J#) R,'TKD/B9Y4/PQUO:_E*EH?+*/LP1]T#'\JP-;@TK4?&7B".Z
MF26'_A'8I@AN#M#[I?F SC( 4^W!H ]/HKR:RUO3KC^Q(/%EY&-,O?#<#6\]
MS(!&UP<B;YCQYN-F#U'..IK5A:Q?Q.^EZZ[MI7]BP'36U%\%P"PE<EL?O<>6
M2>& YXYH ]$HKR#3K0ZK>>"+#Q)-+-+=:;?)-'+.R-,@9/*+@$'<4Y]<YJ'4
MM-T^;3O'02XF&JV&H[M+"W3F6.7R(?+"#=G+/\OOTH ]EHKS&[F2ZN/%]KXD
MD6+4(+:.2P8MM9$\D8> ]=WF[\E><X'I3=-L4U?QO86GB%C)?GP[:SW-N9V7
M%PLF2=H(P00* /4*SWU)I[(7&EPK?_Z1Y+!90@&V39(<GKMPW'?&*\QTC5M.
MG\4>&;BUNHTCNKR_@N$FDW7+Y#D+.W')8#:A'  P356U.EV7PYMD@>WM[JW\
M1HDZQL$9?]/;"N!CHF>#T% 'M%%>7:I/'=VWCF/4Y/+UJUE:32V#8E2/RE-N
M8._,@;[O5B0?2J&HV\%W-XU_M>56O8- M9V0SD".X$<Q+*,X!#;<>F>.M 'L
M%%<CJM]JDOPHFOM)D>;4FTH21/&=S%R@R5]6ZD>]9EK_ &?/XJ\/S^'GA?3;
MO3YSJ21L"CQ;5\MI!TW[B1D\D;O0T =)I_B&?5+R,V>FM+ICS3VYO!, 4>)B
MI+(1]TLK $$GID#-)X@\46^B:'J>I0Q?;3ISK'/#&X4JQ"G!)]G4_C6-\+8K
M!?"LLEFEN':_NP[1 9(%S+LSCMM(Q[5Q^M+I=EX=^), %K!>G4=VT!5?RV2W
M(/K@MD^YS0![/17E6LRMH^N>+(/#SOO?0X+LQ02%W9_,E#NO.2_EXYZGBM_P
M<VA7FL7&IZ#K"W<4]JBS6]J@2!&!RK.H^[*02.>2!R.* -Z\U](]:71K*W:\
MU'RO/D0,$2&,G 9V/3)S@ $G!XQS4VGZI+=W]W97%A-:S6R1N2S!DD#[L%".
MH^0]0#[5R5A-'X=^*GB.35I5MX-;BM9+&XE;:CF)"CQ[CQN!.<=2#FKGC761
M_8<4]E*9+"._MEU*>$Y46WF?O!N'8#&['12<T =G17DGBU8[:T\:C2YE31/[
M$27$$FV)+PE\!,' )0*2!URI/6K^K:/HEKXA\(HLA2SU&:Y>X)NWV3L;?J3N
MP<X'U_$Y /3**\BLC-I)M+621V\(_P#"1S0J\CED$!BQ&I8]8O/R.>.!3-?
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MGK&0?NC.<#@$MTP:](?1=/L_#5YI]G:J;22*5O*),@8ODG[Q.<D]* (KCQ/
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MN C,!SN) 8$CKBM+X\NH4O;A]#Q9V&JKIUS*;L;AN:-0ZKM^;F09!(XZ$]
M=F8HV0H8U*-U4C@TOEIM"[%VC@#' KB;CQ=JMA?>,)I["WFL]#B21(X[@JS+
MY7F$\IU(/KQ@ 9ZUHP^*;U[BRM)M(2"\U!F:SB:[!#PJBNTCD*=N"P7&#R1V
MY !O7EC!?6DMM*,1RC:^T %AW&?Z]?3%6 BJ@0* H& ,<8KSKQ-K<>N^',/;
MM;7VFZ_9VUQ#OW!'^T1<JW&Y65@0<#@]!72^.=7OM"\&:GJ>G)$US!%E3*Q
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M=KX],@47GA'5=9T)K76/$ EOTEBFM;JWM1$D$D;;E?R]QW$GKSC' QUKKZ*
M.0/A[7+>_P!4UDZU;C4+JPCM5,&G$K&R,Y#!3(<_?/!KI+,7S:1;B[:);\P+
MYQ5<H)-OS8&>F<\9_&K=% '&Z5X(N=+C\+QC58I%T))4'^B$&<.NW^_\N ?>
MMCPUH<N@V=W!+=I<FXO9[O<L)CVF5RY7&XYP2>:VJ* .8U'P38:IJ^J7ES(Y
MBU&R%K+;X^7?AE\W_?V-M!]!27?A&6X\-Z3I4>HA9+&Y@NI+B6$R&>2-Q(21
MN&-S D]>M=110!QVI^";G48O%49U2*-=?C2,XM2?("IL_O\ S9 ]N:EF\*ZI
M%X@?5M*UQ+.2[@CAOXVM/,64ID+(F6^1@"1SN'3(.*ZRB@#E;GPC<37VN7":
MFBKJFG1V 5[<NT80. Q;>-Q/F-Z=JU(M"C;PFN@7L@GA-E]CE=%V;UV;"0,G
M''N:UJ* ./M_".LMX;N=%O\ Q/)-$;1K2VFAMO*D0%=H=SN.]@..-HZ]\$%K
MX0U6VU&74$UNVCN)-/AL]L6G[8U\IV92%\S[I#$%<_B!Q7844 <-+\.D\JZF
ML;Y--OY+V*_MWM+?$,$R(4)\LG!W!FW<C.1Z9/4Z3:7]K:G^T[];V[<Y9XXO
M*C4=@J9.!]222?3 &A10!S#^$GN?$5EJ]Y<V[SV5S++#-%;^7,8W# 0N^X[D
M&[TYVCISG.L/ E_8KHD']M1-:Z->R7%LGV/#,C+(NUVW\D"0X8 #CD'MW%%
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MW-% &)X7T*;P_I]S;37BW1FO)[H.L/E[?,<N1C<<X+50T?PIJ&BWT\-MK?\
MQ(Y+I[I+(V_[R-F;>R"7=]S<2<;<\XS7544 <?9>!C:Z5;Z&]^LNB6MXMU!
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M'/F$;L#J /I79T4 <CHG@_4-,LO['N]=-[H44;0V]L;<)*(R"H1Y WS!0<#
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M=,@T6>W1)HFF6$M+&RHSG(SM#<9..F>F0#K];U_3O#\%O-J%PD2W%Q';Q[F
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M9>!X4T^[L;W177[:9(&41QK T;HK8PX=MF-I.1SVH [ >*/#Y) US3>$+_\
M'TGW0VPGKTW?+]>*LV6L:9J3W"V.HVETULVR<0S*YB;T;!X/!Z^E>77FGI:?
M!;5_M&FO!=+=3,1+;%'*O>;EQN )!7;^GI5_Q-X;O-;O=:N_#MJ]J)=!-E\T
M+6_VB0R!E0!@.B*RYZ#>!G@X /0(=;TJX29X=3LY%@4/*5G4A%/0GG@>]1Q^
M(]$FCD>+6+"1(]F\I<(=N\93.#_$.1Z]JY+4H9=<U?3]7L]/O;:*UTJ[BNXY
M;5T9O,5 D.TC+D,&/&0,>XJO:6TNF>#/!:KH<ZS1>1'=S1V3//:,L+*7\O&2
M=Q*Y((&\G!H ZZ_\6:)I\.GS2ZC;-%J$PAMW252KGG)W9Q@8.3^'6I[341+?
M:F'U#3Y;:W*82%OG@&W+>:<D=02.!Q7G=E9:C;:/I9ETK4O]!\53W,JFW+/Y
M3M/AP%^\/WBY*\<^QJ?6]+U:]G\;&PL+DO-/83QQM$4%TD00R(K'@DA2O7GZ
M&@#T&/6]*EMY[B/4[-H;?'G2"==L>>1N.>/QI;/6M+U"ZDMK+4K2YN(T$CQ0
MS*[*IZ$@'(!KB==LY]8U+5M8L;.\%N_AV>S='M9$>>5SF-0C ,2OS<XXWX]<
M2:-9S0>)?"4BZ?<PQ0Z%+;SM]E=%C<F$A6., Y1^O]: .TO-7TW3Y!'>ZA:V
MSE#)MFF5#M'5L$]!ZU##XAT6XFM88=7L));M-]LB7"%IEYY49^8<'IZ&L77+
M9Y/B%X8N?L<TL-O#>>9,L#.L981[<L!@$[37*VNFW,'AG2HUTJ\26+Q4UTZ"
MSD#+#]H=@Y&WIL8<^G% 'I0U?33?_81J%K]KR5\CS5WY R1C.<@<X]*;'K>D
MRV<MY'J=D]K$VR29;A"B-TP6S@'VKSJ=-0FU;3I!HNH0?9/$TDTL$-H?*$;+
M*HFWD?.7W D@[1G! ZG:72+JU\=7&F0(IT74'35IAG_5S(0&7'H[B)_?;)ZT
M =K+/#;P//-*D<*+N:1V 51ZDGH*YW1O$_\ :?B?7[+[1926&GPV\D<T)Z;Q
M)N#G)'&P>E,\>P7\FC64]C;2W:6FHV]U=6T(W/-"CY8*O\1!PV.^VN5U6WU+
M5;_Q==Z5I=^1=6^G2PB6![<W(AD9I(P6 (8K\O.#SZ4 =OJ'B[0M.T:[U1]2
MMI;>U(63R958[S]U.#U/'\^E79]<TFUABFN-3LXHI1F-WG4*XSC(.>1D@5Y_
MK%A%K7A/Q!J&DZ!K,5[<V\*2_;ED$TWEN&"+&Y).T;N1US@9[6-5S)XEU(ZK
MHFMWND:S911P&T23Y0 ZM%*JD%,[MP+8 W'.#F@#MIO$&C6UR;:?5K&*<.L9
MB>X0,&;.U<$YR<' [X-,C\2Z%++'%'K6GO)(C2(JW*$LBYW,.>0,')]CZ5S7
MA[2X[7QKK3SZ5+' MC8);O)"\B@Q+)N"R$?,1E.>IK!TW2IX_"W@N"32+I9;
M76WGN$:R?,:?OOF8;>!\R<_3TX .]O->LY]":_TK6=*"-(L<=U-*'@W;@&7*
ML,G&0!GKBI[OQ%HEB\J7>L6%N\3*DBRW**49L[0<G@G!Q]#7GVJV%Y)X>\:P
M1Z9>L]UK<,]NBVDA,B#[/EE&.1F-^?;W%7-8L);G4/'\BZ9=2&]T:*"U?[(Y
M\U_+E!53MY.63_(H [R^U;3M,"F_O[:U#_=,TJIGMW/N/SHU35+/1M*N-2OI
MEBM+>,R2.?0>GJ?:O.Y(9H-1*:SHVM7NFZII-M;*;-)<HR*RR12JI!7._.3Q
MR>:ZW7-,E?X;ZCI5E:LLITF2WAM@Y<AO**JFX_>/09[T 4Y/&D,?B#35>[L(
M]%N]-FNWN)' ,;(T:X+[MN/WF,8ZBNCDU;3HK&.^DO[9;24!HYS*NQP1D$-G
M!XYXKC+-9+GQ9X7O9-,OE@M]'GC=YK-QY<A,6 >."0C^_P"8SA:3!J6C:5X6
MO+K2=8DLK:*\M;F"TBD6>W9Y0T;[%PS+M7''3- 'K%O<0W5O'<6\T<T,BADD
MC8,K ]""."*R[WQ5H=AIUY?2ZG:M#:1&:7RY59@O;@'N>!ZFH] L+33?"ZVU
MEIL]I:XD>.TE=FD 9BW.22"<YQGC.*X3^RM:/AG7-(M$O+_3GT&6.R-[:&*Z
MMW(PML6('F#'0XR-O7D9 /1AKVE#3X+Z74;2*WF7<CO,H4XZ\YQQW]*GGU*Q
MM;5+F>\MXH),;)7D 5LC(P>_'-<;9S7=OXML]7N;"_.F7.C+:Q_Z*[/!*KEF
M#Q@%E# CDC^  ]JQ]'L=6\'R^'[V[TV^NM.2"]@,%K$9I++S9A)%E%R2-BA#
MCITZ4 =C<>()5\6:)8VTEI-INI6EQ/YR_,?W?EX*L#@J1)Z=NM0ZGXLCMM:T
M!;:]T^32+]K@3W.\$((XF<$.&V@<<YKEO$6B7]S>>'8= TZ;2TM[.\*QBW8Q
M)N:)EBD*CY1($8'!R,G\=.2X?6=8\$7O]AW]I';R3M<6\MFX%J3 54'Y<8W8
M (]CQ0!V4>KZ;+IR:C'J%J]E)]RX693&W..&S@\\5D>)O$CZ?X6_MG1YK.Z3
M[1!%N)\Q&5YEC;!4CD;OTKC]-L]3L;_3]1;3[W^SK37]2EF@%L^]8YBXBF5,
M991N/0$@.?>I-8TB^_L/Q3<6UG=F#4M9L[BTM4@<OM1X#+(4QE<E';D#IGO0
M!U_C#Q)'X=\.ZE=Q7=DE_;VCW$,-RW^L*@D#:"#R1@>]7O[<L+6PM)]2OK6U
M>>)7Q+*$!) Z9/3)Q7!:VE_%;^/]/N=+O[J75K=Y-.FAM7E21/LX18\@'8RL
M#PV/O9&2:6>&2+5;F'6=#UJ]TS5M-MX8_L:R$*51E>&55(VY+$@GCYCR* ._
MFUW2+>[^R3:K91W.](_*>X4/O?.Q<9SDX.!WQ4MOJFGW=PUO;7UM-,H+-''*
M&8 '&< ],\5R6B:4D/CS4&ETJ1(%TNRA@>2)G0/&9"RB1A\Q&4YSDX'I4/@N
MVU*PU2VMHQ=S:*+!C"-0M6BN-/;<F(-Y \Q2,]B1L'.,9 .SOM5T[3%5K^^M
MK4-]TSRJF?S/N/SJ"\\0Z+I[2+>ZO86YB"F037")LW?=SD\9P<>M<CX@B>W\
M87XU32=6U#2=4L8K>-]/$C!"ID#QR*A& P?()XZ\U VDFWUW5E72+E(!X9AL
MH1Y+S#>OFYB#X.\@,@ZG- '83>)=)@U^WT62\A%Y/;M<(I< ;0RJ/Q.[@=\&
MJ7_"66&G6-K-J>K:=,UY>O;6\EJ^(S\Y !)8\JH^8YQD>X%<]H%O>V6L>#[F
MXT^]\M?#AL93]G;,4VZ E7X^7A&Y/7'&>*HVUE?0>'-(<Z9??Z)XIFNY8A:O
MO6%I)RKA<9(Q(IX'?VH [+2M=N+KQ'XAL;IK9;33O(:*5 5^5T+DL22./48K
M4M]7TV[AGFMM0M98K?(F=)E(CXS\QSQQSSVK@-9L-6N[OQH]CI]VTDK:?-"C
M(T8N5B*M)&K]"2 5X/>HM5LSJFCW>LZ)H&LI<&>SDO8K[S%FNXH90[1+&Y.<
M#//0YP,T =9I7B5M3\9ZGI4,]G<65M9P7$<D!RP9V<%6.2/X >@ZUH'Q%I@\
M2?V#]JC^WB#SC&6 (!. /<GDX]!GTK T69KWXC:EJ46GWT-I<Z5;(DUQ:/"&
M=9)2P.X Y 9>O\JCUNRU&3QM?FTAN$-]X?-I;7:1DI'.'D/S,.%QN!YZ]LF@
M#K+?5M.N[IK6VO[::X4%FBCE5F !P3@'/7CZTZ[U.PL'C2\OK:V:0,46:54+
M!02V,GG !)] *X73[&[U*'P/'%I]U8WFC,/MIE@9!$BP-&Z!B,.&;9C:3D#/
M:MCQ7:O<^)O"4@LY9XK>_DEF=(&=8U\B106(! ^9E_GVH WX=8TRXTT:C#J%
MK)8GI<I,IC/./O9QUX^M4]2\5:-IFBOJTM_ ]HL@B#QR!@TA. @([YZ^G.>E
M<+#8ZG;R"^33[PVEIXJGO)K?[.X9X'5E655QEPK-NP 3WZBI-=T:_N;/QAJ-
ME9W36U]<:?+!;B%A)(870RR",C=R !TR=GTR =Y!J2W.M^3!J.GRVWV42^1&
MVZ?);[^0<;,$=NO>I[75M.O9I(;6_M9Y(UW.D4JL5'J0#TX//M7$:]8ZCJ_B
M75FTZVNX)+SPS);07#PLBB8NQ52V,*<$'GD?7BF3K/XF\)WD=AX;N]/UE-)>
MS+W<!@VGC,",?O*Q'4<#CGF@#N[/5=.U%Y4LKZVN7BQYBPRJY7/3.#QFB]U7
M3]-V_;KZVMMP)'G2JF0.IY/3D5S7A;[%J6K'6(]#UBQO5M/LTTNI&12HW!O+
M4.2& .3N' ]>:9(D^G^-]=FU*RN;K3M2L8$MWAMVF \L.'A8*#MR7W#/!R>:
M +_B#Q/#INJZ7I,-Y9P76H&0B6X8,L2JA()7<I.3@#D=_2M2"\ELM)@FUV>R
M@N<!9GC<K$7/&%+<\]AU^M<+I&DZGI$WP^M+V"ZEEL+:X2ZD2)I%AW1@*K,
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M.8M]I(P&[/S8!P3@9(R,=* /1J*XO1_$/B+6AI.I6FGQG2;\,TA<(# A!,;
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M17,^FK>!'4LBL8]^,9!([=:P;'Q-K[:;H,UU]CFGUZ.)[>.VAP81Y!EDSOD
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MCRBT(. Q)W#!QG Z9[X !Z%17#:5XHU:\US3=/FDLV_M"QN)O,@A8QPRQL@
M1R<2KA^2.I'!["CX8\2ZNWACPS!))]KU#5XII_-$2[E5.6X9P"V7'< #/'%
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M7$\CXS)(V,L< #H . .E9UCX.TW3UMX(I+AK&UN#<VUD[*8H)"205XW8!8D
MD@$\#@8R-=\=(/#^M7>ASPM<Z7=I;N)HRP;+1AB!D?\ /3 /(RO<5T]GKNDZ
M@+HVFHVLPM#BX*2@B+C.6]!@'GIP: &:-H<&B"]$$\\HN[E[J3SBIQ(_WB,
M8!]*R]4\"Z9JUQJ<LUS?Q+J?EFYBAGVH7CP$<#'4!0/0XZ5M6.K:?J4DT=G=
MQ320$>:BGYDSR"1UP>Q[U ?$NAC41IW]K6?VPR^2(!,I?S,9VX]<=J ,^Y\%
M6%U#K44MW?,FL1I'= R*255=@P2N1\HQG^M0W^G/K>L6&FW>DSM9Z5<1W::A
M.R;965#M"!3G.X\Y4# /J*V8->TFYGEABU&V:2*,S,OF ?NQU<>J^XXIT6M:
M9+%<2+>PA+=0\Q=MOEJ<X)ST!P<'O0 [6-*M=<T>[TN]5FMKJ,QR!&VG!]#V
M-8C^ M)N&O6OI[Z^-]9K9W/VB?(D52Q5C@###<<$8'?&>:N:GK\1\.ZQ>:1=
M6\EU86\DA5U+;'5"P#KD$9 ]NN:?I&OVMWIMF;F[@6^>PCO)H@V"JLH);;UV
MY/6@#+_X1]-!U&RU97US6+N.(V()EC8I$QW98?)N *KSR>><]:9H/@I;/P_X
M=2YFEMM6TJV\H7%JRY&X?.AW JRYQU'8$8K3E\7:,FHZ59)>1RMJ:-+;O&V4
M9 /O;AP<D@#ZU+I^KV[6=[=SZQ8W-O'=/&LL.%6(9 $;'<=S@G'&,DXQ0!7N
M?!^G3V%I;QRW5M+:W;7L=U"X$OG-NWN200=V]L@C'/&,"JX\"::MO)"EWJ 5
M]174R3,&/GJ00<L#QD#COCG-:K>(M&2PDO7U.U2VBD\J21Y NQ_[ASR&Y'!Y
MYJ73]9TS59;B/3[^WN7MF"S+%(&*$],X]<'\J *L_ARWGUFXU4W5TMQ/9_8F
M"E-HCR3P"O7+$Y]ZK6'@^RTZ;2I8+N\SI=HUG;!F0@1-MR#\O)^1>?;ZYJ:Q
MXDF;Q*WAW3;ZTM;P637/FW";U\S<%1",CCJ3WQC%7-+\06B:3:3:GKNF7$EU
M</#%/;G9%*^\@1IECDC[O7DB@"*'P380:?IUBEW>^3I]Z;Z#+)GS268Y.WD9
M=N/?Z86T\%:=8:O/?6MUJ$44TYN6L5N/]&\XG)<)CKGG&<9YQ5K5-:M5TF:>
MUUFQM&2<0?:+C#HL@<!D(R,MU7&<@TZ[\5>'[&:6&ZUFQBDA=8Y5>=048] W
M/'XT 4H_!-A%86=FMY>^5:7YU"++)GSBS,<_+R-S,<>_TK1TS0K72;_4+JVE
MN/\ 3IC/)$TF8UD( 8J.V=HZY]L9-3WVL:=IIQ>WD,&$,C;VQM0'!9O1<]SQ
M3+G7--M=#FUEKN*33XHVE:>%O,4J.N"N<],<4 9>H>"M-U$ZT)+B]CCUA5%W
M%'* I(4)D @X)55'X<8J>?PI87FH3WEY)/<FXL/[/FBD*['AR200%!SDDY![
MUDR^-476M"D-U:Q:/J%A/<R-(,-&Z>7@;LX_Y:8QCJ*Z0:UIC:=#J"WT+VDX
MS#*C;A)QGY<=> >GH: ,6W\"V,&C7>E2:EJMS;W%NUH#<W/F-%"PP43(X!&!
MD@G@<\59U3PA8ZM8:=;RW5[#/IQ!M;VWE$<\9QM.& QR."",&M:'4K&XTY=1
MAO('LF3S!<+(/+V]SNZ8JG:^*-"O4E>UU>SF6)(W<QRAMJO]P\?WNWK0!7D\
M)6+C3Y%N+R.]L&=XKX2AIB7&'W%@0P;C((QP,8P,)=>$-/N](_LTS7,<;70O
M)9$9=\LP<2;F)4_Q '  ' '3BK\6N:7-8F]BOX'MQ(8BX;H^<;,==V>-O6E3
M6]+DL5O8[Z![=G,:NK9RX)!0#KNR"-O7B@"O#I=U'XFDU'[?=M;-:B%K:27,
M9<$$.J 84XR">^>@QS'?^&+/4-6EU)KB[AN)K/['+Y,@"O'EB,@@\@LV/KWJ
MPWB+14LX;M]5LUMYI?)CD:90&DSC8/\ :SP1U%5;KQ3I1T5KZRU6S820R202
MY\Q#L)!8@$?*#P3D >M #+;PA8VTFC,+BZ<:1;-:VR.4*F-E52&^7GA5'X?6
MFZ#X-L/#TP-I=ZA);1EOLUI/<EX;;.<^6O;@D#). 3C&:M>%-4GUCPAI&J7>
MP3W=G%/+L&%#,H)P.PYK,/BH7'CC2]*L;NUGL;FSN)Y-JG>"A3:P;."IW-R!
M_">: -'5/#<.J:S8:JU[>075@)!;F$IA=X ;AE.<@#K^%0#P7H\@U1KV.6^F
MU2(0W<UR^YGC'11C 4#.?E YYZU=C\2:-+',\>HP.L,/VA]K9_=?WQ_>7CJ,
MBH=.\4Z5J.@6FL+<K';W2*Z!C\V2N[;@<D@<D"@"$^$+">VE@OY[N_WV3V(>
MY==R0N '4%5')PN6.2=HYJLG@2P5WD?4-4EE>P.G/))."6AYZC;C(R1T[YZ\
MUT$-_9W.GK?P74$EFR>8LZN"A7UW=,5G:?K=K'H=E<WVKV=TTT9?[3;KMCE
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MN"IYRJG\*QO"OC"'4;=;;5K^R359+VZMXX4.PN(Y7084DGHF>O8UO+K>EMJ
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MY>X-CLV?YBNXHH \UTRQ34='*ZEX0U5+^RTV:UG%Q<,5<-'M:. [SNWX&"
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M/U'!KO(Y$FB26,[D=0RGU!IU 'G.G&_O-8\%2'0-0M?[-@GM[L21!5A8Q*N
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MA))+<Q3R,X=GY<\GC)YX_"JMOX&T*'1KK29(;BZM+E!'(+NZDF8(.5568DJ
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M8O8MI[AYF(: ]5(S^.>OO4 \"Z(/-++>N\UE]AE>2]E9GAY^4DM_M$9[9XH
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M$DPM;F_TR6]N;B)%R2CJFU P(&2Q8Y!P!COFNMFT.SGUM-78S+>I;M;*ZRL
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MC6X7;M&]5(!(!QGTXH YKQ#XDU31M%O+FPNT;^SM-MITMXHP^"<[O/+#A2
MH4AOO'%:FI:_?Z'XGOK.]G,EM=V7G:2JHJDS*=KPYQRQ+1E<]B<YQ5R[\ ^'
M[T7*S07.RZMDM9T%Y*%E1!A"PW?,P!X)R:&TRYU+7;.*\TI(M.TB83VEU+<>
M=)._EE0<'E<;F)+')*KUH R]9\0:GH-_;V^J7<]O:-#"JZG';J]NTY8B19L
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M/]GW"55C=UD49X. N1ZY[<5UG_")Z6MKID,:SQMI:[+*9)F\R%=H4J&ZE2
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M:>)+JPEFCU#S-&.H00K$(]LH;;L!'4'(ZY.:UKGP?I%V=4\Y)R-4A2"[ N'
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M(+CS=Q P"?->NNK/T71;+P_I<>G:>DB6T98JKRLY!)R>6)[DG'2M"@ HHHH
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M;Q%K5II_C]X;U!)HZJ]FWDJ=@,"R8([\D\G-=K)?P66D_;[Z=(8(XA)+*YP
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M.O-=\!:O86D!^V75FZ1PNR@[R.%)SC/;KCWK/@AU:T\92ZZ^E7,EIJ.GQ0-
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M%O&ZJS 9 #/G(YZYSQBQY-TOQ"\)3W.I/>F;3;ULE$50W[@DKM X.1P<].M
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MPDO;V-;/1X[NWDE2))E+++N'R# !\L=0&&3TXQWD3OI_A;S7O5W0VAD^T70
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MM9[&>&"5)+&W-K;-]IE/EQ'&5^]S]U>OH/2JFB^,;'5],EOC%<VZ+=R6J))
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M[28I;>1':+^^JE<L/7&2.,]:ATSQCHFKW5I;V=S([WD!N+9GMY$29  3M9E
M)&X9 .1W[T :=IIUI8V1L[:+9 2[,-Q)8L26))Y)))))YR:HP^%M'B@> VK2
MQO:FS(GF>7$!ZQ@L20#@9^@]!6NP+*0&*DC&X=1^=>=6OC#4['X<^(-?O)VO
M+NSN+N&W'D#:/*=E3<$4<< DGCZ4 =39>#M#T^YCN(;61YDMS:AY[B24F$]4
M;>QW+TX.<8XIEAX(\/Z;8W5E:V3I;W,;0NAN96VQGJB$ME%/HN!2VMRVDZ=?
MZOJ.K7=QIP02A;BSV26X4'><*H8@XSRO'/;I+IWBO1]5O?LEK<2><;872>9
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MLT<LEQ)(PCSD*=S'(';/3MBK5WH>G7VIV^HW,#275O&\4;&5PH1\;AM!VD'
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M1ACD#L-L9QE<9Q@X'&.P]*SK7P5X=LI[>:WTN-&MI6F@&]BL+-G)12<+G)X
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M@N,D<=Q3[37[[Q%/#I>DZL23H\=W%=2,())I&=T+E?+;[I097 &6.<\8[)M
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M[F$TL";1N4ODY7=G R<#O2^*M"O=5?2[S2YUM]0LKGB5NT,BE)1]=IW#W04
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MS*BEA@G/7/-:.I)J^GQZ=:?\))/(LOB".#]PY+10R(6\EG;)8C&03S@C.>*
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MH&2[?/EJTP4%@06QM #'GCW-7]:\0ZEHTGC66"]F>.U:P6%G(<6R2X$CJ.G
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M/POHEGMEL-&TV"YB9Y8'%LHV2,.6X&1[XK%TKQ?IEOH^@1VT6L7BZHL@M&F
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M2>)WA\976C363QVEK8+>27;.FT*S,-Q^;(4;&'3.>P') +B^%/#Z6]Q NBV
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M&)9AR=K$ 9/!XZ5D^&]7CFL_!$=]<ZD]_>:3YRN)"8ICY2%S+D_,PR".O)-
M'52Z-IDUW+=RV%L]S-%Y,DK1@LZ?W2>I'MTJ./P_H\1M#'I=FALP1;%85'D
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M:Z9J:WKK(WV4HB2B-3M\S)< *21MYR?3@X -R&&*WA2&&-(XHU"HB* J@=
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQY,FR<DIS\N2JYQUQ6EHAGL_'EK:B^O)H;S0_M4R7%PT@,JR(H=03A>'((4
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M% 7)Y..@J"R\(:[9VFEV_P!HT^6&VO+N>XMI"[12B:1G1L8&60L< \'KD'&
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M/(1U8*<C#$%2!T!S5/1_!D^A:IX?:UEADLM+TZ:S<NQ$DC2,C%P "!RG3/\
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M"S2-^Z"QHGS?+S]S/'KCWJVVA^)+'Q)?7^D7FG)::IY<EW%<J[-!*J!"\1&
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M7Q=;:;=7$>FKX=:\_=3L!;W(W["A!RNY5R0.#MSWY /3ZRM#UR/7([YH[::
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M<(LEQY4<>20LD8'+2Y7 Y&!]<$ ]!FD,4#R"-I"JDA$QEO89('YFL?2/$/\
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MT]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %1SV\-U \%Q#'-"XPT<BAE8>X/6I** *@TK3EMY
M+<6%J(9  \8A7:P  &1C!P ,?2GFPLC'+&;2 I-@2J8QA\# W#'.  .:L44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;>#V'6M^_P!<U^_O-:AT"$&?2[E(%CD\ORI3L21O,)8,H(? *CC&>>@ .T)
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MC+*]VFD1WGGI'$22Q*H"'8#:-ISCDY'([M35?%M[X@LM':YT[3[B32?M<^V
MSA)EE5& .\9!R?IGN>: .[J&[NH+&SFN[J58K>"-I))&Z*H&23^ KSRX\3^)
M8M+U#4Q>616PUX:>8/LI EC:9(^3N)!&_/'<?@+MUX@UW3XO&=M)=6MQ<:18
M)>VTQMMH^9)&*%0W(!CX.>_.<4 =S%+'/"DT3AXY%#(PZ$'D&GUQ']KZ_?\
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M2)B2@(_O;=N??-:5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQ,\84,JKR!@@[\]>,<XR* -RBN.\&>,H-5TG38-3U"!M8NC,/+5-H<H[C [
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MJ+5/%%G_ &;JD>G7T2:I;6CW"0S1L' "%@Q1L$@XZ]/RH C;3KC5O$=H]]I
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MBDX;N6'3D=\5/IFA:M;W4L-A'>6^FW5G<BXL+XJZ6LS8V^1)UVL23MR0!Z'
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M,CIZUF:=H&H?\(AX>T^\L=6TS4--BDC2_LW1GAD&!]T$AXW]"/X1P.M>GT4
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M(_[5B;3M1C8X8VX!DWCT90'4'_IJ*WY/%&BPW=S:R:A$D]J 9T8$&('D%N.
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MG*LK @@CU% '"ZQXGU_3;?Q'917:-<:5=V(@NY(%)EBN'5=K 8&Y<MR ,C'
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MR +/N+;A\W'))QT]J +'B2^FL=/@:WNX[9Y;J*+<R;W8%N5C7!RY&<9&!U/
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MS;>,;L8XKL=%N9[X7EX\YDM9+AEM%VKA8U^7.0.=S!B#SP5K(O- ?3-+?0]
MTF)['43.+J6>[)6V\SDD(P;<"68[1@9^I-=-:6L-C906EM&(X((UBC0=%51@
M#\A0!Q>FV]U_PL#Q@RZA+E;>T*J\:,O*2D C:#A>W(]\U1E\4Z[;_#_PYXL^
MT?:-T,<FH6:1*&G5E)9H\*2"OWB!_"IZ8KLX_#VGQ:E?ZA&LZW-^JI<.+A_F
M"@A<#.%P"<8QUING^&=+TN*RBM(IDCLH&M[=&G=E1&QD8).3P!D\@<4 6=&:
M1]'M));Y;YY(E<W**H63(SE0!C;SQ[5R%EXDU1O$NAPF\6ZM-1NKR"1HXE$
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MOV86JL[H\;N\9)Y!^7KUS^.:#75]JUS\.]:NKW>+^Z-P;=44)$7M96 4@;N
M2#DG/7BNZMM#L+75KW4XHY/M5ZJ+<%I697"@A1M)P, GH.]9=KX#T"RDM&@@
MN42SG-Q:Q"\E\N!R"#L7=@#YCQTYH EU_6)[76]"T:WD\B35)I0T^T$HD<9<
MA0<C<3@<@\9XKE-&N;O3!XBC74E6:7Q,(3*T0,LJF&([8U VF0@>F."3@#CN
M=9T'3]>@ACOHG+6\HF@EBD:.2)QT964@@\FLT^!=!:*1##=;I+M;XR?;9MXG
M5=H<-NR#MX)'4=: .1NM7U?5-(L4GO[FWD@\5+8,RK&'DC63*[\ KN&!TX)'
M0ULRZOXAU.35&T::)6TN^%L4N&C6*14"%S(=NX$AF(*X ^7CK6Q_PA.@BTGM
MEMIECFNUO6*W4H83 Y#JV[*G//!&>:67P5H4VM?VL;65+I@@E$=Q(D<^P87S
M$#;7Q_M T =!7 >(-;U[3M2U[3+:]8WLEK%=:*HA0[R6*/&1CG#;<GLK ]CG
MJ=+T9=-U35+U9),7TBR&)IF=0P!!8;ONDY P./E%6Y]+LKG4K349H%>[LU=8
M)#UC#@!L?4 4 <!XDUD^(OAIX@U*UN7?3CHP"HRKDS,F]LD#.0&0>F2W'%:]
MOJ.L6OB>^TB74$GC;2%OH&-NJ^0^]D*@#JO /S$GWK;D\+Z/)X?GT+[)LTVX
M,ADAC=DW;V+-R"#@DGO[4I\-Z:=0:_*W!NFM/L9D^TR?ZK.=O7'7G/7WH YG
MP_XEU+7H?#VGR7IMKJ]T0:E/<QQIN=R47"A@5 RQ)X].G-0FWU>Y\>:3!-JD
M$6I?V!<)/=VL(9=PGA!*JV0#D=P>XQZ;\_@709K#3;/[/<1+IB[;.6&[ECEA
M4C!42*P;!  QFKJ>&M+BU""^BAEBN(+8VD3).X"Q$@D8SCD@'/7(ZT 0>"]6
MN==\&Z5J=YL^TSP RE!@%@2"0.V<9K>JCH^D6>A:7#INGQM':0@B-&D9]H)S
MC+$FKU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %9^K:WIVAQ0RZE<B!)Y5AC8JQ!=C@#@''XUH5S
M/C2POM0M=)6QLGNFM]5M;J55=%VQQR!F/S,,\#I0!:;Q?HBZ<+\W,OV?RS*S
M"UE)C0,5+.NW*#*MRP'W3Z&I;[Q/HVG0F:XO1Y2PK.\D:-(J1M]UV*@A5.#@
MG X/H:YS6M+U*#QA<WZ^'DUW3=1M(H'0RQJUNZ%^H<@%&#\XR>#QZL@TW6]
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M8RR?V-#I+7$QF:V3:6R0!ND*94N<=B>,<T 0V6N60?597U9KI(;T6_E_9R#
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M K*9XT-M(BE2L@8\H0<Y7=WX.:COM&UB34O%LBZ:TB7^C0V=N\;QJLDJK*"
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MA03W2PR.@89&Q ,*S' [ =<$ [.]U>RT^]L;2YE9)KZ0Q6X\MB'8*6(R!@<
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MT_[Z0#SEQB0#=@-P,D8SWS4VH>*=,TTW33M*8+-E2[GCC+);E@"-Y'L03C.
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MJ0#AAD \@X/(J'3_  UI.E/$UG:F,0[O)0RNR0[NOEJQ(3/^R!QQ2IKUI+J
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MJ?#W4=13R[J[TR]>79E<DK%\PQTSU'UI-*UO4I=#\$W$NHS-/>:M-;7!9_\
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M@CQ4?M-P[_\ "2I&#+*7P!=P '![]/TKTCPWHB:#ISVT:1PK)*91!"[-'#D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M12W5O!)''-/%&\IVQJ[@%SZ 'K4M !13(I8YHQ)%(LB'HRG(/;K3Z "BBB@
MHHHH **9'+',F^*177)&5.1D'!'YT2RQPQF2618T'5F.!0 ^BBF2RQPQ-+*Z
MQQJ,L[G  ]2: 'T444 %%%% !1145O=6]VC/;3Q3*K%6,;A@#Z''>@"6BF-+
M&DB(\BJ\A(12<%B!DX]>*?0 444R2:*';YLB)N.!N8#)H ?10"#T.:* "BBB
M@ HHHH **;)(D,32RNJ1H"S,QP% ZDFE!# $$$'D$=Z %HHHH **1F"J68@
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M*3LJA=P+ F,E0 2IS@#H>:K:EX BO%URWMM6NK.QUH%KNU1$9?,*A2Z$C*Y
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M<VU[HBS6K12$R;HHXLAL@#D.",=,=^M:K^#%N)4GN[]IKJ&RELHKGR5$GER
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M"^HW$<]UJ*:G#/&JAK:X1552N<@C:H!!SG)]: *_A2*>+X@^,1<+;B0BR8M
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ME&3A2<#CK@4 =1165X=M=2L]'C@U6\DO+E7?]]*JARNX[=VSY<XQT_7K6K0
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M%I^I3RQKI>J7,T,ES83!IVD>155W*>6,EP2VXY('3/ !Z\[K&C.[!549+$X
M%4VU?3AI\U^M[;O:P@[Y4E5E&.V0<9K$\>PWTOAZ%[."2X2"^MI[JWB7<\T"
M2*SJ!_%P,X[@$5F20_:/$VO:S9I)_9<^C)#*1$P$]P&?!"XRQ5" 2!W Z@@
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M50 2.Q'>L_1WNM&T7PQ=3V6J0:7;2ZA#<"WLV+V[23;HI/+*DE=NX9 XW^]
M'J\FI6$,*32WMLD4BET=I5"LH&20<\C'.:4:C8FX2W%[;F=P"L?FKN8$9! S
MD\5YRF@Z4FN>#X8-(N6TW=>DK>6[/M61<KO!7Y S$D*V,9Z \"VL%UI_BZ,:
M6#<6$NI 3Z;<6I5K4A-GGP2  ;-H'!R.2 0>* /1*KM?V:7BV;7<"W3<K"9
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MENBXP>E9]Y)/_P (K>:5J&G7LFMP^(([J0K9R2>:ANU99495((\K"CG("XH
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MM%MDO1(4DVRQLCMY>W=PW[MANSCI\OH =N;F!;I;9IXQ<.A=8BXWLH(!('7
M)'/N*EKDHM=GN_%6E0Q6-H!>:-+>13."94.Z+Y-W93O&<=<"L_0/&6M:@?"U
MQ>VU@EKKJR+LAW[XG6-G!R3@@A",8XX.3TH [.Q^Q>7*ME)'(JRLLI23>1(#
M\P8Y)W#OGFK5>?)XLU*VTQYK;3M-29O$ATR1%W(K RA"^1_$>I/Z&K,WC+4=
M-T[Q(;^VM9;K1[F&$/ &6-DE$9#L"20%WDMST7M0!W%-DD2*-I)'5$499F.
M!ZDUS^C:QJ5YXGUC2KE+5[>P6$K<0JR[S(N[;@D@$ <\_P 2GO61?W6I7/BW
MQ)ITUS ^FP:/'*MN83GY_.!YW8SE!SCI@8'4@';0S17$$<\$B2Q2*'21&#*R
MD9!!'4&GUYSX3\07^DZ3X2LKZ.U.G7>A":-H@WFQF&*,G<2<,"K= !@C&3UK
M:T7Q#KFIWFE3G2U;2M0MS,TJIL-J2H9,L6/F @XR%&#ST- &Q>:%#>:_I^L/
M<W"3V*2)%&A781)C=G*DG[H[]JU*Y/Q5XKET#4(;4R6UG'/ S07=Y$S0/-G
MB9P0(R>N6ZY]JS;OQ1?:+KOC"^OKB.;3=)L[:6*V2(@G<LA #;L EL G'/'3
M% '?4V21(HVDD=411EF8X 'J37):AXKO/#NIVT&MQV\MM=65Q<I+:(RF-H4W
MNA!8[@5R0W'3IS3Y+O6K_2'EN[:Q?3+S2Y)V,>0T#E050Y)\P$$_, O*].:
M.HBGAFMTN(I8Y('0.LB,"K*1D$'H1CO26]S!=P+/;31S0MG;)&P93@XX(]ZX
MKX<:L^L>%M)M[1[<V-CIUO;7(D0F1IO*4D 9&%P1R1SVXYK)\#:SJ.DZ#X1M
M7BM#IFH2SVH"AO-1AYL@;.<8^0C&/0Y[4 >H5%#=6]P\J03Q2M"VR0(X8HV,
MX..AP1Q7&)XVNVT/2?$GD6[:/J%VD'E!6$T22.8TD+9P>=I*[1C=U..:5GK"
M^']3\6O#"C3W.OVUI;QGA3++# H)QV&2Q^E 'H"75O)<R6R3Q-/$ TD2N"R
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MKX0L=3T?3[!+BZLWTYD>SNK=P)865=N<D$'()!!!!S6F-8TTZ=%J"W]NUG,
M8IUD!1_]T]^AZ>E2V]]:7EDE[;7,,UJZ[UFC<,A7UR.,4 9S>'+>?P[=Z/?7
M-Q?)>1NES/.5\R0LNW/ "C  Q@ # J'5/"5CJ>@6FDF:YMQ9-'):W,$F)H9$
M& X8@Y/)SD'.35B/Q3X?EDBCCUO3F>5&DC N4.Y5SN(YY P>?8U8MM;TJ\T]
MM0MM1M9K-6*M.DJE 0<$$YQG/:@#*E\'I<VMBEUK&HSW%K>)>FY<Q[Y9$&%!
M&S:% )X4#\R35Y;&^'BI[\7UQ]@-IY36KLOE^9N!#J ,@XW Y/<?A8BUG3)[
M)[V*_MGMD<QM*)!M5P<;3Z'/&.M4+WQCH5E;V,[:C;R1WMS]FA=) 5+?Q9/0
M;<'.?IUH GGT**?Q+;:Y]JN$GM[:2V2-=NPJY4DG*YSE%[]J- T&+P_9S6T-
MU<7"2W$EP3/MR'D8NV-JCC)-1KKMG;W.J37FM:8+*U,8P) K6^1R)6+8R3R!
M@<>M7;/6-,U">Y@L]0M;B6U($Z12JQB)_O 'CH?R- &)J/@:SU%==C;4+^*#
M6MIN88VCVJP54++E"02J*.21UQBI[SP?8ZCJ%W=W\]Q<"[T_^SIH6V!&BR3G
MA00V6)R#6A!KVD75REM!J=G)/(-T<2S+N=>2"HSDC@\CC@U?DD2*-I)&"(@+
M,S'  '4F@#%T#PXVAKB76-1U(HGE0F]=28DXX&U1D\#);)XJ:'0HH?$UUKHN
MKAIKFW2V>$[?+"(6*X^7.<NW?O6!<^.X+BVT'4-*N;5M/O=2-I<-,/F1 LC;
MLY&W_5Y^8=#VKIK?6]+N]..H6VHVLMD&*F=)5* @XQGIG/&* ,?1O!-KHLK1
MP:EJ$NEJS-#IDSJT$);.0/EW%1DX4D@>F<$-TCP-9Z5:O8-J%_>:4$>*"PN7
M5HH$<$%00H9A@E1N)P#7066H6>I6YGL;J*XB#%"\3A@&'4''0CTKF(?$E[):
M>)_M5_IE@^G:A]EM[FX0K$%\N-QO!?D_.1P1VH OZ=X3@L!IRO?75TFF(R6*
MS[#Y.5V Y"C<0I*@GL3U/-0#P+I__"(CPY)=WDENDQGAN"RK-#)YAD#*RJ!D
M,21Q[5N3ZKI]K<I;7%[!%,Y551W )+'"CZD\#UJKH_B/3-<N;^"PN4E>RG,$
M@#<D@*20/3+8SZ@T 0:7X:_L[6[C5Y=5O;R[N+:.WE,PC56"%BIPJ#!^<U7U
M'P;!>ZK?ZA;ZC>V+ZC;BWO8X-A2< %5)#*<, <9&.*V9=5L(KL6CWL"7+,$6
M-G&2Q&0N/4CG'7%8'AGQ=#?B6UU:^L(M2_M"ZM88$;895BD9 54L3R%)_.@"
M%_AY9-;M;KJNII%)I:Z5.H:/]]"H8+D[." YY7&>^:OIX.M%OK:Z>\O)3'8?
MV?,CE"MS%DD!_E]2?N[>N.E:G]LZ9]O%C]OMOM98H(?,&XL!N*X]<<XZXYKC
M]1\7:S:>'O%UZGV(W&C7WD09A;:T>R)N1N^]^\/.<<=* -SP]X23P]LC35]2
MO+6!=EI;W4BLENO3 (4%L#@;B<#@5<U#08]0UW3-6:[N(I=/$GE1Q[-C;QM;
M=E2>@[$5?O+RUT^UDNKVYBM[>,9>69PBJ/<G@53C\1:-+#--%JEG)'#)Y4C)
M,IVOC.TX/7'..M &;#X*L88Y;1;BX.ER7?VPV!V^6)-XDP#C=LWC=MSC/MQ6
MAI6A1:3J&J7D=U<2MJ4XGE27;M5@JI\N%!QM51R3TK.U[QA8:=9:7+:WUFXU
M.Z2"&<R!D"G):3@\@!2.O4BH/#FN:O+K^NZ=KD^G/%I\-O-%<6J-&K1R>:=S
M[F(!PB].!SUH O7_ (6BNM?_ +:M=0N["[D@%M<?9]A6>,$E0P93R"3AA@\D
M5FI\/+6VL](CL-8U.SN]+@-M#>0M'YCPG&8W!0JPR 1D<&NCM]:TR[BN)8-0
MMI([;_7L)1B+C/S>G'//:J&H^,-#TW2IM0?4()(HI5@81N"1(Q 52.Q.0>>W
M/2@ ;PK:_P!J:=J"7=VDUG!);M\ZM]H1V5F$FX$G+*#D8[]JJZ)X+BT%O*M=
M7U-[&+<;2SED1H[4MD?+\NX@ D ,2!Z5KZEK>GZ5H<^LW-P@L88C,9%.X%<9
MXQUSVKGY/&<47B2Q26]L8]%N=+EO&G=L%'22-<%]VW'SD8QG(H L+X(M$\(V
M?AL:A??9+62.2.3,?F'RW$B@G9C&X#M4]SX1@N;G6YWO[P-K%JEK<!?+PJ*&
M4;?EX.';KGK6I)K&FQ6$5\]_;BUF4-%-Y@*R C.5/?CGCM5BWN8+NVCN;::.
M:"10Z2QL&5@>A!'!% &);^%(;;4-/O4U"\\VPL&L(L^7@QG;DGY?O?(OMQTJ
MO8^"+33X- ABU"]*:&SM;;O+^;<K(0_R<\,1QBKNH>+=#T[2[S4)-1@>&TA\
M^01N&;;V( ZY(P#WJTVO:5'90W<NH6T<,RET=I1@@?>.?0=SVH Q_P#A!K7[
M,8/[2O\ !U7^UL_N\^=NWX^Y]W/;K[U3\1^'I;6QUJZLFU.ZEU>> W:VQCWQ
M(FU2T:D#=\BX*G.<G@]#U5QJEA:VL=S/>0)!*,QR&08<8S\OKQSQVK&F\0R_
M\)=H]E;36DVEZA8W%SYJ#<28S'@AP<%2)/3MUH J>$+34+:X?%YJ4VF&,_)J
M%E#;LLF1C:$13C&[.X?W<=ZTKWPO!=ZU=:HM]=V\MU9BSFCB*;'4%BI^92<C
M>W?'3(-4=2\6QVVN:!]GOM/?1K\7!FN-V0/+CW A]VW'3M^-;L>LZ9-IL>I1
MW]L]E+_JYUE!1N<8![G/&/6@#)MO!EI;-H1^VW<B:-:O:0))Y9$D;*JD/\O/
M"KTQTH\/^#HO#SHD&JZE<6,&?LEE<2*T=L#D84A0Q !( 8G IOB?Q*UCX2EU
MG1;BTN=D\4>X_O$(:58V'RD88;C^(Y%3>+O$<7A_P_J-S%>6<=_;VCW$,5P<
MAB < @$'!(P.>OKTH GUGP\FM"YCFO;A+:ZMOLL]N%1D9<GD;E.&^8\_3C@5
M4E\$Z7-=7[N]P;6_LTL[FSW#RW1%95.<;@0&/1O0]15Y-?L;;2K*ZU.^MK5Y
MX$D/F2!!R!D\G@9/6GS^(M%M;L6D^K6,5P71/*>=0VY_N#&<Y.#CUQ0!3M_"
MEL/(_M"ZN-2^SVSVD/VK;\L;@!\[0,L0H!)[>F3FMI?@N/2]/>P&M:I<6JPM
M!:QSNC?94(QA?E^8@< MNP.!WSN6^JZ?=W)MK>]@EG"EC&C@G:#@G'IDXSZT
ME_J^G:6 ;^^M[4$9!FD"\9QGGMDCF@#%TKP1::+=V=S8:A?126]BEBX'EXN(
MT&$,@V<LHX##!QQ26?@>TLK/1+:/4+YH]'N'N+?=Y>69@P(;Y.1AVZ8ZUIWG
MB70M/>5+S6+"W:$*9%DN%4INSMSD\9P?R-,E\3Z5#XA@T5[N(7<ULUR,L -H
M90!GU.[('H#0!2L_!5C90PV:7%PVF6]U]K@L7V^7&^XN #C=M#'< 3P<=N*C
MN_ FGWT6KI/=WI.I74=X75E5K>9 H1XR%X("+UST]Z>/%VGZ?86,NHZM87+7
MUX]O!-:G$;89N^X_=48)SU'O4FE:[<7'B'Q)9WLELEIIC0F*504PCQ[R7))'
M&>O XH K/X$M+Q]2?5-1OK\ZE:1VEP)/+0%4+%6&Q!A@6)!%$G@=;OP_=Z1J
M.NZM?+<QB$W$SQF1(P<[5PF.<#+$$G'7@5NP:SIEU!<3P:A;/%;'$[B48BXS
M\W]WCGGM6/H_B1]4\9:QI<<]K-96EK;S1M"#O#.9 RN<G^X".!P: +^HZ&VH
MJ%?4;A5-N]O,FR-DF5L9+*5QNXXQQR>#27?AG3+WPH/#<L<G]GK;I;H%<AT"
M8V$-_>!4$'U%.'B/3#XE;0!<I]O2 3,A;& 3@#W/!./0>]6;;6--O;DVUM?V
MTTX4OY:2 MM!P2!W&>,^M &%+X)6\T"YTK4-=U6]-P$5KF9H_,5%8,%&$V]0
M,G!)[G@8LW?A&TO[W5+FYN[J3^T]/&GSIE OEC=R,+D-\[<Y[]*UY]2L;:]@
MLI[RWBNKC/DPO( \F.NU3R<>U-;5=/2.:1KVW"PR>5*?,'R/_=/^UR..O- &
M7#X4CBO=&O)-3OIIM*BDBB,GEXD#@ [\(.RC&,=*JCP):)I,>F)J6H+:Q7XO
MX5S&?+82F4*/DY7>2><GMFK^H^+=%TW2HM2DOH9+:6X2V1XW# R,X7&>V">?
M3!JY/KFE6IA$^I6L7G!3'OE4;@W"D?4\#UH R#X+@37+K4;;5-1MH+UQ)>6,
M4BB&=P -Q!4LN0!G:1G%5;WX?6EW'JMM%JNH6MCJ<XN9[2$QE!+N#%U+(67)
M4$C.,UU=S=6]E;M<74T<,*XW/(P4#)P.3[D"JR:SILMFUW'?6[6ZR>4SB0$!
M\XVG_:SQCK0!'K>BP:]H-QI-W-,(IT"M+&0'!!!##C&<@'ICVJB?"J)J;:G;
MZG>P7LUNMM=3+Y9-PJDE68%<!ADX( X.,8QC:M;NVOK=;BTGCGA8D"2-@RD@
MD'D>A!'X5 FL:;+?"R2_MFNB6 B$@W$K]X =R.X[4 /TW3K72=-MM/LHA%;6
MT8BB0'.% P.>_P!:J:=X>L-,U#5;RWC/F:G*)9U8Y7(4+@#L#R3ZEC6/%XEN
MM8\1W^FZ->:<O]G7$*2QS9<SHRAI"I4_*0& '!^8'/7B_>^*+)-5O-%MKJ$:
MI!:?: DG*C.=HQD$GY22 >!0!#I_@RRT^&QM!=7,VGZ?.9[.TE*E86YVC.-S
M!=QV@GCCK@8@N/ .GW-E?VK7U^B7-\=0A9)%5K2<MN+Q$+GJ3][/7%6/"7BJ
MTU_1M+,U[9G5[BPBNI[6*0;EW*"3MR2!DC\Q6M#K&FW%\;&&_MI+H L85D!;
M ."<=\'@^E #-(TM],MF2:_NK^X<YDN;DKO;'084!0!Z =R>I)K/B\*K;W.H
M7-OJE]%-?7B7CLOE_*ZJ$P!M^Z54 @Y^H-6KWQ'IFGZ[8Z-<7*)>7BL\:,<?
M*N!^9)  [_A4XUK2S>FR_M&U^T@,3%YHW87[W'MW].] #-&T6VT2"Y2W)+75
MP]S,Q &Z1L9(   Z#_ZYR:Q9O -C-ID]H=0OUE?47U.&Z1T66WG8DDH0N,<D
M8(/!K8MO$FAWMU#:VNL6,\\ZL\4<=PK,ZKG) !Y P?R-<]JGCN&31Y+W0KFU
MF^SZI!8SB4%LJTRQL1@C'+'!.0<4 ;,/AV6&&#&LW\ERC,TL\OEL9]P PZ[=
MNT # 4#I[G-1?!-G%H_]DV]Y<Q:>UJUK+;[8V5U9F8M@KPV7;I@<].!C;T_5
MM.U9)7TZ^MKM(G\N1H)0X5O0XZ&JZ:M]J\0SZ5:[2+.-)+N0\X+YV(/? +$]
MACUX $U/P_9:KX9FT"7S([.6W%OF-OF10  03GD8'7-55\+J-7.J/JM])=-8
M_869Q%@KN+;L!/O9/T]J72]:N[SQ9KNDW$$$<-A';/"\;$LXD#YW9_W!P/S-
M9%MXVFFT_3M<:* :-J&H?8H@%/FHK.T:2ELX(9@/EP,!AR<<@$L'P]LK:&SB
M@U34HTM]..F, T?[Z#.0K?)P1ZK@U<TWP=!I=WIUS%J=\\MAIYTZ+S/+(,9*
MG)PG7Y%_+ZUG:WX[A&@ZM>:%<6LMQIMY';2+*"P8%XU8@ @\>9@'IE3UKH4U
MBWU.VNCH=]97ES;-M=%E# -UV,0?ESZ]NN#C% "^'M$A\.:';:3;SS306X*H
M\VW=@DGG: ._I6G5'1M5MM<T>UU.T+>3<)O 8893T*GW!!!]Q5Z@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "N7\<VUS/INF36UM-<?9=6M+F5(4+OY:2 L0HY.!S@5U%% 'FEQ92
M2ZOKFE:UX=U:_@U2Y2ZM9(97$#+LC 24JX"%&3J>P&,\9KZ[I=Y/IGQ"2'2[
MMYKZX@-KMMGS,%BB7*G'(#*W\^]>E6VHV5[/<P6MU#-+;.$G6-PQC8C.&QT.
M.U6: .2^(]M/J/PYU5;2-W<1)/LVD,RHZR,,'G)52,58\;J^I?#W68K&.2ZD
MN["1(%@0N9"Z';C'KGK72UGP3Z9IUU#I$-Q#%.Z-)%:>9\P0==J]0HS]!T%
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M]J DM4%N^9E\N%<KQR,HWY?2O4:K3ZC96UY;6<]U#'=71(@A9P'DP"3M'4X
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M/CNRFTN_NSK%H7T^:&W:177[/L\HX'R%6!.&QG=QR:],HH \P:VN;;4635]
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M,CK$/X%)'RCITY.!D\"IW\'V+SZI,+F\0ZI (;Q4=0LHV[=V-N Q'&X<_D*
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MQA23CC'>L4^"[)[&"VFO]2G>&YCNA<37'F2L\9RF68'@'G  '7/4UT@Z=<T
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M%+);:E!.(G$;B(EFWE=P4 <DXYP/0^AJ5/$&DR64-W%?1RP3!C&T67W!?O'
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MDDC!R .,'/2J-QXCTR\MK*73?$.G(LUY'"&#++YI)&8@ PPY!Q[>E<KJ%O\
MV3<>';S3-"O;>>*:ZG%I"JSR+'(H#F1#(,DL5.0WRDX.<U&EH)/"^CV>FV.I
MM)9:_#<W<=Q;&.1,R^=(VWD!?GR ">..2#0!WSZUIR7?V5KI1,69 ,'!95+%
M0<8W!021G.!5'2/%NE:QHXU2&5DMS*\2AT(9B'91A<9).W( &:P+?3=2M?&"
M76EK>Q6\^H2M?V-U'OM]NUA]HA<_<9N/E!YW'@#FL:VTS7=.\/:&QT:_F.CZ
MC<FZM891')-'(TH$D1##=@.#C(R"10!WC^+/#\=K!<OJ]FL4[.D1:0 LRYW#
M'7(P<CMBG/XHT-+6"Y;4X!;SHDB2Y^3:_",QZ*"> 3C-<G/I1-QX=N;+0+NT
MA_MMK^XCD&^10870RR?,V&+,IP"3C!ZYPFHZ==0^)M<M+[P]?ZMIFKF)[=K:
MXVQ*1$L;1S+O4*N4#9P>"?I0!N^-O$ZZ!X;U6>TNX$U&UM&G19(S(JG!V[L$
M;=Q&!D\GUZ5J7E\(/#<M[-?06)^S;_M4X!CB8KPQ!(R >V1FN"U33=9M--\<
MZ.=(NKQM6B>6QN+<!D8&W6,1DDY4J4XSU!XYKKM<@N;KX=ZA:I:3&[FTR2%;
M? +[VC*A>"1U/KB@":3Q5HEA"B7VM6?GK;)/)@X)4C[^WD@'J!Z?2M"?5+*W
MTA]5:=6L5A\_SH_G#)C.1CKD=,5QFGV5W%XEMKJ73KH0IX;2T9S"3B4-DI]<
M?A[UI>&]-O8_A79:5/;O%?)I?V9HI.")!'MQ^?>@"K)XW634/#%U'<0P:1J=
MM--.)4.]&6-64;L^K 8 Y/>NGBUW2Y],AU*&]BEM)^(9(\MYAYX4#DG@\ 9X
M/I7%:59ZA]I\ M/I-Y"-,LI8+HR1@^4WDH@/!/5E8?KP#6=;:9K6G6.F7_\
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M[M7"1+D[4GC=C^"J:YG7M)U"\M?B(D&FW+OJD4*V?[HCSBL*H<9Z88'KCUH
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MI\4C21#(8.J%MC C*D\=1WS57QI8ZA=6FDW5A"UPVGZE#>36R$;I8UW!@N<
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MH?M #2CF/(&[Z<CFN6T'2-1\*:M+'?6T^I6EQI%G:K- GF;9($96C(Z@-NW
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MX+[;=W$CV[JDEK>6XAN+9B.5D4  YZ@C@_A0!HW7B/1K&>2&ZU.UA>(@2;Y
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M;6^]Y@RI.3@\C IPUCQ-/#XJO8]4LXXM%NKB..$V6[S56W1U!._(PS9]^?;
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MF.,!D(W G((XY!H CUCPEI>MZE!J-Q]J@O84,0GM+J2!VC)R48H02N><5/\
M\(WIO]J)J'E-YB6ALA'N_=^02"4V=,9 _*I=.U[3-6N;FVL;M99K7;YJ;2I
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M8)>B^_T=KG[)N,3@B;.-C+MRK9(X('44 )=>$M,O'UAIOM!_M>(17@$Q D0
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MZ=-820)=DZ>CQ6PDNY'5(WQE,%L%?E''3BI=%\':/H+/]A2Y\K#+%!+<O)%
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M5P0"#@]/6N@) !). .I-4+C7-+M+&*]N;Z&&VF8)%)(VT2$G VY^]GMCKUH
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MTM% 'F^L>&=7N;G5M?L;',\U]9W,>GO*(VN(X%*ME@<*S;SC)_@7..@ZKPU
MNVZOO[";27NF4ND[*T\A48W.59ATP!SG [=*WJ* /.;KP_J[:'XN\./8O/\
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ME&4,ZQS([ ;B!G /4BNDHH X0Z=JUM?^*EDTN:Z@UR))+<JZ'RW\D1-%)EN
M, Y&1@GOUVX=#N+3X?)H*RB>YBTO[&')P'<1;,\]LUT%9M[K^F:<UX+NX,7V
M*W%S<$Q.0D9) ;(&#]UN!R,4 <CINGZN-0\$S3Z-<PIIEA-;W6YXCY;&.-1T
M<YR4;IGC&<5EVNB:]ING:->G1)[G[#>ZA]IL$G1)&BGF+I(A#;21A>"1U->G
MQW,4MHETC;H702*V#RI&<XZ]*ATS4[/6=.BU#3YQ/:S9\N0*1NP2#P0#U!H
MJ^'K1+32\)I::8)9&E-J""RECDER"06/4X)Z]3UK5HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=I95BF>R#:(M[9F*$2>?<G.4P0<X^0!1@G<>?3KM%-\VBV3:F?\ 3FA5IQM
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M,0[79(E&,'D9B/YCWP ;VL^*=+T*[AM;UKC[1/$\L44-M)*TBIC=MVJ<D9'
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MMPK<J".JD_C0!TL'BO2;JS2X@G=R]RUHL B;S?.7.Z,H1D$ $G/  STYK/\
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M"3(<2EU8#DCC QGU]N:J:-X>U>R7P)'-8D?V-:R0WC"5"%)B" CGD9&?I^5
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MV[7-NR6[DM& "6QC(^\O7KD5G^)O#]YJ6JZ3?Z=*L,T326MVY.";65?G /\
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M>IFTO58IY&2="'B21F+#..H(P.O7.*T]&L/$6BZIJ.FBPM[C3;K4);V'4&G
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MQWQ6_P"2<:C_ -=K7_THBJ/6)-3NO&]_ID6M7EI:#11=(D C!23S&7()4G'
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M&.:XA0QI*20VP]5)!^93Z'(K+M_%NF6MMI-HC:E>SW>GK=VY^SL\D\8"\D@
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MM[-(IK>#[/$R$C9'G)4#.,9 /N1FN?M]?&H>.-*FLM2:71KS1)[M4X$>5DB
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MV,^O:J/B+1-5_P"$JM]<T[3=/U6)[3['<6=Y)Y>W#EED1BK#^)@1CIBNRHH
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MQ7822)%&TDCJB("S,QP !U)-0&\ U-;'[/<9,)F\_P O]T,$#;N_O<YQZ T
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MW!D2!XLC(')+9QZ#KFN_HH \^'@[4V\+WOA&58VL)KXS1WWF<B!I_.*E>OF
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M#<?4X'-7Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5G";0,+<QQ!?*#?>VXZ9[XZT <7HVK7=[I.AV-SJ=W-=/>W\ B$AC>Z2&21
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M^5%$-,MECAB\E%5,!8^Z8'\/^ST]JO75E:WUE)97=O%/:RIL>&1 R,OH1Z4
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M]\YZM[]: .$OM;U*Y\+>*=<M[V>'4M'U":*WA5SY82(KM1DZ-YB\Y()^?@C
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M.FZ:Z.B6!F:;SRY@4YD_O].OO4H\-Z(-;.LC2K,:F1@W0A7S.F/O=<XXSZ4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M39LQ)MW$Y4G/RKW[5F6G@>TL[/1+6/4;YH]'N&N+<MY>69@P(;Y.1AVZ8ZT
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MUNE7RQ.K#D;"S%2I&.N#D$53D\%6]YH=QIFJZIJ6HM,$ NIY%66+8=R%"B@
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MI?B'Q!J[Z7<V^G1C3=2MFE\XQ'-H2FZ,L=_[T'.#@+S[5D:+X@U1_!W@Z_U
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M.K(VX$H3R4'!)'4XZ8 ,_6_%5_H\WC2>WL=/,VDV=O<1R,K;I@PD.)".N-O
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M:&[M-/$=Q?VES'=B2"\LH3,;=_+<;G3!W(02I!&/F'2@"/4?%:6?B'1HEN[
MZ/?07,LETS\)Y07D/NVX^;GZ5MG6-,6QAO3J-H+2;_53^<NR3C/RMG!X!Z>E
M<)8Q:G<:]X0N=6TMA+;KJ'GR06;B(%F 20C!V%PI;!Y&>U5-$6\T_3] A?1[
M^()J&HYN4L7:6U5Y7,85"N '5@-Q!  QQG( .QU?Q!-:ZAX;%@]K/9:K=F!Y
M!ELKY3R!D8''\'OUJM8>(M3GMO$<TEO;RG2-0>$1Q*0985B1SC)/S_.<=C@#
MC.1RNBVE_#H'@6WFTS4(Y+'596N%>U?,:;)U#' X&749Z<\<5T?AQS8/XRN;
MVWG@@.I27*O-"R*\0@C!8$@ C*-^5 '5V=[;W]A!?6TJR6T\2RQR#HR,,@_D
M:KQ:YI,\4TL.J64D<"AY66=2(U/0L<\ ^M<QX7L;W3?@W96LUB;N\326_P!#
M8X,A*$B(^F<A:YB2.YD.J74MCJ"VTOA)X-T]D88XG3>3& 0"H&< -DGU(YH
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MTGQQ"FE7LAN]6M98$%G(?-11 &9?EY V/S[>XH [ZZ\5:'::5J&I-JEK);6
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M;2 @1G 7&>N>^,4 =/;7]G>23QVMU#.]N_ES+&X8QMC.UL=#[58KRZ\U;5-
MU+QYJ^GFT\JSOK:2:*:)F,R_9X05!##8<'KAN>WKM^)_%>I:)<7LD/V1X;6:
MU40"-I'9)'57,C @1GYOE!ZXSSG@ ZEM7TU)+N-]0M5>S4/<@S*/)4YP7Y^7
M.#U]*LP3Q75O'<02++#*@>.1#D,I&00>X(KA+P#_ (2GQYP.=#ML_P#?-S72
M^#O^1(T#_L&V_P#Z+6@#4N[<7=I-;L[HLJ%"R8R >#C(-0:1ID.BZ1:Z9;/(
MUO:Q+#%YA!8(HP!D 9P!7+:SK_B"'6]?L;"33HX].TR._B>:W=RQ)ERAPXZ^
M7U[9Z'M/8>)[W7[Z"QT\V]I,=)@U&1YHS( TN=J !EX&TY/N,8H Z^HYIXK:
M!YIY4BB0;G=V"JH]23TKSVQ\3ZMX@U;P?/%+'91W0O1=6WEEU,L/R-@[@2,[
ML>G4Y[=WJH!TB]!Z>0__ *": )K:Y@O+:*YMI4F@F0/')&V5=2,@@CJ"*EKS
M+POKFLZ%H7@D7GV*;1M1LHK95BC830.+<NK%BQ#@A&SP,<=>^[H>O>(=7ET;
M4%TV,Z/J,)EE8E%:W#+NC(/F$O\ W2-HYYXZ4 =A5<W]F-0%@;J'[88S*+?>
M/,V @%MO7&2.?>J7B76X_#?AO4-8EC,BVD)D$8.-YZ 9[9) S7->5J:_%+2C
M>7-K)*VB76UHH"H5O-@SD%CE>F.0>M '9V=[:ZA:I=65Q%<6\F=DL3AE;!P<
M$>X-3UYUI_BK7KS2?"7V1-,@FUF2YBE!@?9&425@5 <<?(,COZBKLGB#Q1<)
M?QZ58V]Y=Z7-';3H%5$N)-D;R89I08QASMX;IR3G  .XJ.""*VC\N% JY+'W
M).22>Y/K7,PZUK.KR:A+HXLA'8:B+-X+D-F15V^:V\'Y2-QVC!^[SUXQ+3Q-
MJFF1^()[JYANI'\0IIMHC1%5C9Q"JDG=]Q0Q..I(//- 'HM%<+K?BO6-#FUZ
MQ<6DUS9Z.VK6D_DL$95)#1NN[KD#!!Z'IQRZ_P#$NMZ)86=]J[VRV%T=[W=K
M922+9J44J) &R06+9<8' X&> #N**J:5<M>:197+S03/+ CM+;G,;DJ"2G7Y
M<]/:N:O/$FIW \2RZ2+51H;;/*GC9C<.L8D89##:,,%!P>03R.* .GOM1LM,
MMS/?74-M"/XY7"CIGO[ G\*FAFCN(4FAD22*10R.C JP/(((ZBN":_N=;\;^
M$KZWEBCL[W1[BZ2&6$L0K?9R0?F )PV,XXYX.:[=X!;:<T%B(K81Q;(0L?R1
MX'&%&.!Z<4 0:I)83QC2;J^^S37ZM%$L=QY4S?*23&0<Y !.1TQ4NFZ=;Z58
MI:6WF%%R2\LAD=V)R69F)+$GN:\RT^YU74-)^&UY/=0S7]S<22":2(X!:UE)
M+ -\QZGC;GIQUK>LO&.IR6\-C-%#+JCZO<:;YD,>U&$2LY<(SCDJH&-W4YYQ
MB@#NJCN+B"T@>>YFCAA09:21@JJ/<GI69X>N=:N+.X&N6<=O<17#I$R%<31<
M%7VAFVDYP1D\CWKG=4D:^^,.CZ7=\V-MI<M_!&WW7N/,"9([E5)(],YH Z^U
MU.POCBTO;:X."<12J_3&>A]Q^8JU7/\ BBYL?#MA>>+);7S+JPLI$&W@R*2I
MV$^FY5^G-5)];UC3?$.FZ5=O9SC5+:9H)HH640S1J&(8;CN0@\<@\>_ !U=9
MFLZ);ZVMHMQ-/&+6Y2ZC\H@?O$.5)R#G![5Q-MXM\5OX3T37W.D,NJ36<2VX
MAD!0ROM;+;SZ@CCCGKU-B?QKK&AWNK:5J\=E<7L+V@LKBWC:..1;B0QC>I9B
M-K D\\@=J /0:*X/7_%FLZ!-K=DWV.>XM='DU6TG\E@I$9VO&Z[NN=I!!'!Z
M<<WFU/Q#;K8B[NM,7[:[,AAMY&D5?+!"+'NS(=V<MP HS@9X -N?0[6YUN+5
M9I+IY8D"I";A_(!!.'\O.TMR>2/Y5<M[VUO&G6VN(IC!(891&X;RW !*G'0X
M(X]Z\_LO$>LZ[=>!;M;B"U744N)+F!8BRLZ1D?W@<<G ['DYP*MQ>+[RW2^A
MDALQ=2>(AI%NZ1%4Y1&WN-V20N[N,D <4 =Y17GVO^,=9T*#Q+:E;.6]TRSB
MOK:8Q,$EB<E2K*&X8,IY!P>.*W=,U;5!XROM#U%K25!917L#V\;(4#.Z%&RQ
MW8V@[N.IXH Z2BL7Q/KAT'3(9HT5Y[F[ALX=_P!T/*X0,V.PR3[XQQ7-^(O%
M^L^'VUZS86<US9Z4=4M)S"P1E#%61UW=0<$$'H>G'(!WU%9^D?VH;>1]4EM)
M'=]T0MHV0(A ^5LDY(.>>,\<"M"@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LK6]!M]<^Q-+/<V\
MUE<"X@FMG"LC;2IZ@@@AB"".]:M17-U!9P&:YF2*($ LYP,DX ^I/&* .%UO
MPJ=,L8;;38]:N+.;49+VZ>TNE,\+,&/RA\!E+-DYR?KQBU9^%7UC1KFPU>YU
M=[)GBEM#>21+=6\J$G>C1 ;?X<9R>&SP<5TBZ]I3VBW2ZA T+2F%65\DR#.4
MQUW#!^7KP::WB/1$@MIWU>R6*Z#&!S.H$@4$MCGG !SZ8H SG\&VLUC;6\^I
M:E/)!=1W?VF:57E>2,Y3<2N-H]  .OJ:6[\%Z??)K27%Q>,-8:-[C#J-C1A0
MA3"\$;5ZYZ5IP:YI5UIG]IP:A;26.=OGK("N[.W&?7/&.N:YB'Q=+<_\)6&U
M;3+2#39HXK6\FC(C3=&K$2 N,L"2N,CD=.U &Q<^%+:]26&ZOKZ>VF:)YH)'
M1DD9-I!/RY&2HSM(Z=JWZQ_$&N0:/I=U(;RVANTMWEB$PR/E'4J"#MS@9R.O
M6JVE^*+/_A&-(U#5[VVM[B[L(KN4%MH 9%+-CLH+=3P,CF@ LO!NG6"P012W
M+6%M<FZM[%V4Q0R9)!7Y=V 22 6(!Z#@8N:=H,.FZOJ6I1W-S)+J+H\ZR%=N
M54(N,*",* .M-/B73!XE30?M"F\:W^T8SQC("CW)R3]![BIX-<TJYN9+:'4+
M9YHXS*R"09V X+#U /!(X% !K>CVVOZ//IEX9%AFVDM$VUE*L&4@^H(!_"L]
M_"5L]Y>W;W]\TUY9+8RLSH<QC<1C*]<NQS[^PQJV>J6.H/(EI=1S/&%9U4\J
M&SM)'H<'![XKG+KQ)=:AXFO]"T:]L(+JQBAD_P!)4N)G9GW)P00 J=1SEO;D
M DE\!:>W]F26^H:G9W.GVJV:7-K.$DD@'2-_EPP'TSWS72V]O':VT=O"I6.-
M0J@DDX'J3R?J:J6^N:5=2O%!J%M(ZQF4@2#[@ZN/5?<<4W3_ !#HVK7!@T[5
M+2[E$?FE()E<[,XW<=LCK0!6NO#%M-K3ZO9W=WIU_*BQSRVC)B=5^Z'5U921
MS@XR!QFEO_#%EJ5G%%<RW#7$4ZW,=X' F25>C@XVCC(QC;@D8YJX^M:9'J"6
M#WT"W3ML6(N 6;&=H_VL<XZXYK)\/:_/=1Z\^JS6T::?JDEHDB*8UV!4*YR3
MSE_7F@!U]X.L=0T^]M;BYNR]]+%+<W(9!)(8R"@^[@ ;1P ._J<T=6TV]N?B
M%HMS$U[%!;V%S%)=Q1J0'=HBH.5(Y",>F!@=*Z&+6]+GLGO(K^W:WCD\IW#C
M"OG&P^C9(&.O(K/OO&6AV,%G,U]%(EW=?9(RC9 <'Y@W]W;@YS]* $;P=IHA
MT\0/<6US82R307<3#S=\F3*6+ AMY))!&/I@4DO@^PE6TQ<7226]^=1,BLFZ
M6?!&Y\KSP2,# Q@8X&+=IJD4FH:KNU:QFM[4(3'&0&M?E);S6W$<XR.!@5*F
MOZ1)#<S#4K41VJAIV:4*(E/1FST![$\&@#)U;P+INL7&J2S75_$NII&MU%#,
M%1F081^A((  ZX..0:MGPM:C4[J_CN[V.:[M4MI]LH(<*&"L00<L [>W/3(%
M6K'Q!H^IW;6ECJ=K<7"Q"8Q12AF"'HV/3D?F*DO]:TS2R!?7T%N=AD/F.!A
M<%CZ+DCD\4 94'@NPM(=(%K=7D%QI4!MK:Y1D\SR2 /+;*E67A>HSD9SFI/^
M$1T]9-,>*6YB;3[B2ZC*LI\R60,'=\J<D[V].OTQI76KZ=92+'<WD,3L%(#-
MV8X7/ID\#U/ J>ZN[>R@,]U,D,0(!9VP,DX ^I)  [T 4M&T.#1/MOD3SR_;
M+E[J3SBIQ(WWL8 XX'%-U/0+;4[^RU#SI[6^L]PAN;<J&"L,,A# @J<#@CJ
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M*KDX4$9&2>3@'H/>L_P9XOM?$&B:5]KOK/\ MBZM%N)+6)P",\G"Y)QR/S%
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MB2WNQXL\+ZA#9SW,%M+<),85!*;XMJD\\#/&>@KEFTV^_L6Y5=,O/.;Q:M^
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MPJQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1\H .TC(ZYJM>Z?-K7B"SM[O15BT_2;E;JWNWD0B5Q&0H10<K@MSG'W1USP
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M;:<J, =Z] U7PY:ZOJ=AJ$UQ=1W%@7:V:&0*$++M8].<CCFHXO"6D+)J$UQ
M]Y/J$/V>ZENI#(SQ<_)SPJ\GA0/6@#-NM;U71O$.G:?=3VUW#J5I/(DK+Y2P
MS1*'.2,_NR">N2,=3FLZQ\4ZP][-:M/!,6T,ZBD[6Y$?G*P#!!E2T1SP3SQG
M)S710^$M-2W$%PUQ>1K:O91_:9-QCA< ,@(P>0 "QRW YJK;^!=*MGBD2XU%
MI8[)K$227;,?)./E(/'&../?KS0!CZ=XCUUM-\-/>7EH\_B-8/)\NV*BV'D&
M64Y+'>3@ <  GN!BKO@R.:+Q-XS2XF$T@U&+]X$"Y'V:+&0.,XQG'?L.E:4_
M@[2[C0-/T=S<B'3C&UG,LNV6 H,*58>@XYSD=<U:TCP]9Z-=WUW;R74D]\ZR
M7#SS%]S*H4''0<*.@_3 H PO$Z7;^/?"*PW?E(SW1"^6&PPA//OP<>U5U\17
M]GKNF6L;VLEG=:M-8-';1?NHD"2,F'XS)E/F R 21P1747^AV^H:OI^IRS3I
M<6!<P;& 4%QM;(QSD<<_A66G@/1HYHG1[Y5AOFOX8UNW"12MNW;0#P#O;(]S
M0!S/B'5;W4_ ?BU+TPLUEK"6L9BCV HLD!&02>?F/.:W-1\37-CXN&F7DK:?
M#+<0I92R0;K>[4A=Z&0?=ESN !P.!US5^;P7IL^G:E8R2W9@U*Z%W<CS "TF
M5.0<<#Y%X']WZYLS^&K2ZN))+F>YFBEGBN)('<&-I(PNQL8R.44X! )'(H B
M\;7%U:>!M=NK*X:WN8+&:6.50"5*H3QGZ=:R]/U2_GU.R\.17@BFCTA+Z2Y\
MD%FW-L10IXP-ISW/'2NJO[&WU/3KFPNTWVUS$T,JYQN1@01GZ&LE?"5A$]C/
M!<7D5Y90F".[$VZ5HSC*,6!##(!P1P1QB@!?"&N7&O\ A]+N\A2*[CFEMIQ'
MG87C=D8KGG!*Y]LXK=JMI^GVVEV,5G9Q^7!'G:N2223DDD\DDDDD]2:LT %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 56O;^UTZ))+J81J[B-!@EG<]%4#DGV%6:YSQ<+_ ,O2VLM/
M:[1+Y6G:)$::%-C#?'OX!R0">H5FQZ@ MOXJT&.T@NI-5MHX9W:.-G?;N=<[
MEP>01M.0>F.:9#XP\.SZ<M_'K%I]E:<6PD+[?WI(&P@\@\C@_6O/FM;S2;71
MH[[3+J+'C"6>-'99&='$[*PPQ)(!!YY)'&:F\2Z9+:QZOK+6CI!J6NZ6T-L5
M >01R1J6*GH6.>#@X SC- 'H&G^)M$U2VNKBRU.WEBM&VW#!L>4>OS9Z>Q[]
MJ5/$FD/#<R_;446KK'.DBLCQLV-H*$!LMD8XYSQFN,\0>'-4U;4-<UO2K5XW
M>*Q$-O(QA:[>WF,K9Z%<C" G!R#T&#4MS#>7&F3ZII_A*[@NI9[43B^*373(
MDF2Z!G9<H.4+'KDXX&0#K'\4:)'9M=RZE!%"MQ]E8RDH5ER!L*G!#<C@COFK
MFFZG9:O9+>:?<)<6[,R"1.F5)4C\""*\TN-%U<Z7K]L-%OV^TZ_:7T0D=)"\
M2F N2=QY C;(^@%>JJ05! (SSR,4 4K_ %BPTPXN[@(VPR%0I8J@ZN0H)"CN
MQXJG?^+O#VF!#>:O:1AX/M*_O-VZ+CYQCJ.1S68]O?Z5X]U#4WLY[S3]0L(8
M4:%0[0R1,YV%<]&\S.>F0<XK$\,>&M1T+5_"T-S:221V6EW4,TJX9(9)94=4
MSW  9<CC@>M 'HX(8 @Y!Y!K.BU_2IM06QCO$:X=WC08.'=/OJK8PS+@Y .1
M@YZ5I5YE!8:Y+K>A74^@W4+66L7+SI 8D@2-TF5710PW9WJS,1NR3]* .Z/B
M#2A?+9F]3SW9U08.'9.756QAF&#E0<C!XJ/P[XBL_$VFF^LA((O-DC D1E)V
MNR9Y Z[<X[9P:YOP?!JEC9V6@:IX?=KC3)G*ZG)Y;0LN6Q(ASNWL&P1@8R<G
ML=/P%:7NF^'3IU_92VTMO=7'S.5*R!IG<,N">,,.N* -Z]U*TTX1?:9=K3-L
MB15+/(V"2%4 D\ G@= :R;GQEI$$VC)',;A-6=U@DA1G7"HS$D@?[.,=>?8U
M%XH6_P#[3T5K739+JV6:3[1-;!//ARA"["Y&T-DAF!R!W&:Y31='UK3]-\(-
M+HUUOTO4KSSXA(A;9()@K@EN5RZ\DY[XH ]0/ S7":KX[$^BM?Z/*(DM]7AL
M9S<0,-R&=8W(W8V]6]>G:N[KS"XTC5QH.HZ<=(N6<^)OMR,-A62$W8FW#YNR
M=<XYXYH [RT\0Z1?VUU<6U_"\5HVR=LX\LXSSGU!!'KGBIK#5K'4VG2TG#R6
M[!)HV4H\9(R-RL 1D<C(YK@]:T76KS4?%5Q864I:2;3KJU5W\I;K[.0SH&SE
M2<8!..<?6NF\,1)-/=ZG_85YI<MPL:2-?2;YY2N>OSM\HS@9.>3P!C(!KZCJ
MMAI$*3:A=Q6T<DBQ(TC8W.QP /?-9C^-O#4<,\KZO;JD#[)<YRAP#DC&0N"#
MNZ<]:K^.[.ZO]!MX+2UDN9!J%I*4C .$29'8\_[*FL75-,OY[SQZT6G7#+J6
MEQ6]HVP?OG$4BD#TY=>N/TH [#4-=TS2X_,O+M(T">8S8+!$_OL0#M7_ &C@
M>])?>(-*TU0]W>QQIM5R_)5%8X5F8<*I/0G XKAO[/U*QU)7O- U+5-.U'2[
M:V>.UG"-#)&K*T<B%U!1MW7)'7UITVCWFFZU>VESX;NM2TG4K6".*.QNL10%
M(Q&T4BLZ_)P"&P>">* .J_X2O3I-8U72A.8);"!)9;B1"(UWASU( P H.<X.
M<=C26WBC2;33=-%]KEK/<7%H)TE5=GVA<#,BH,D Y&![XK(@TZ_T[Q)X@/\
M9DK6MYIEM'#) 5*!HTE4I@G=G++CCH:H:%I>HVMQX!-QIUP@TO29K>[8H#Y,
MC)$H''7)C;D9[>M ':1Z_I4UA:7T-['+;W9Q;M&"YE."2%4#)( .1CC!STJ7
M3=7T[6+<SZ;>P742G:S1.&VGT/H?8UYI:VVH:1I_AMO[*OVU2SO]0F$$*(["
M&1Y"24+KN4B2/D,-I(]<'LO! MHM&FMH;>^MYDN9)+B.]B$;^9(QD) !(VG?
MQ@GCWH W;R_MK!$:YEV^8VR-0I9G;!.%49+' )P!T!K!\0^,+33?"4NLV$L=
MR"ZPQ%5+*'+A#N Y&TGD'!XQUIOB*SOX_%7A_6[>"2YL[/[1#=0Q<NHE5=L@
M7^+!7! YPW -<]JGA_4AX5\1_9[&=YM6UB*\@M$ W(BR0DD\X!(C9L9[@=>*
M .XT=;X13O=7RWD,DFZV<P>4ZI@<.. 3G/.!QBI+C6;"UNA;37&V4NB'",0K
M.<(&(&%))& 2,YJXC!T5@" 1G##!_*N&UO2]2_X2>74-%2]M[PW%NLD;J)+.
M^B&W<S _<=!NPPP?E&,]@#>TWQ;I>I?VHRRM#%IUPT$LDR%%)4+DY('=L8[X
MSW%7;?6]-N8[ITNT46G-R)<QM",9RX;!48YR>U<'=Z%KIMM;BM].E:2+Q#'J
M\(+H$O(E:-MBG=][Y3U &0.:E\2>'=5\17>LZKIEN]N\FF06\,-R/+-Q)'/Y
MQ##L,#9D]=Q[<D V/%?BU;;PCK=[HEY$-0T^$2LDT)W(#T)1L'!&<'IQWK2U
M_7/LFCZU_9\Z#4;"S>?#Q,ZH0A9=W0<X]:YOQ&-0\3>"=;-OX7N;._NK1;<)
M.L?GS-G.W*L?D7)P6(SDX [D5MK-KX>\2Z!-8W5VLUO.]C?;!ON/-0X23_IH
MI.W<>" .F* .C\.^)K#6+6VMQ?PRZC]CCN)XUX(R!N8=B QP<=#Q5RUUW3+^
MY%M:WD;SO&98@00)$Z;TSC>O(Y4D<CUKAKOP_JFH'2[6"VGM3_PC%SIKSLN!
M!,ZQ!0<<]4;D9'YUH6FG:AJEQX0DGTZ>PFT4.UV7 P#Y)C\M"#\P8D'(XPO.
M#@4 :?ACQ%)<^&WO]9N(A*+^YM0R1[=^R=XT"J,DDA1P,DU'X9\3MJ'_  D,
MU]=1&WL=3-K RQ&/"^7&0I4\EMSD8ZYXQVKFK+2M<T^VT34?[*N95T[6KZXN
M+)=OF-%.TH2103@E1(#C.>327&DZ_(-7U"VT:[!3Q!'J4=L9EB>YA\A8V52K
M<,.6&<<@?2@#N3XLT%+9;B35+>.,W'V7]X=C"7^X5."&Y'!'3FEB\5:)/;1W
M,-^DD$BAA(B,P +% 6('RY96 SC)!]*Y'4=,EO+&RO++PW>VK2ZU:7=Q'.P>
M=TB8;I)/G8<   9)X_"K?BK2]2EUJ:_T-+VWU,0Q1H=H>TODW',<RGA=N6^;
M@X;@GI0!W=9/B'Q!:>&]-6]O!(RO-' BHA8EG8*,X!P.>O\ 7%/T_5VO=5U*
MP>QN;9K(IB27;MG1LX9<$\95AS@UF^.[&[U#PNT=C;/<SQW=K/Y*$!F6.=';
M&2!G:I[T 45\9PV'BK6H-7U""'3+>UM)[8M$59?,\W<6ZD_<7)P /:NCU#7-
M,TN+S;R[2--GFE@"P5/[[8!PO^T>/>N.U"PU&ZU+QG.-+N0-1T6&VM@54EY
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MIK>Z;9_J9&2)0I]>4;IG]: .MCU[2YM,M]1AO$FM;C_4O$"YD/.0J@$DC!R
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M",,]KX.T:TN8)(+BWLH898W&"KJ@!'H>1U%;- !1110 4444 %%%% !1110
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M+=$5669E#Y SG QCI_4 Z^BN9\5ZC?:+=Z/J27;)I0NUM]0BV(0$D^5'W$9
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M.[J%EC93A790<D8/ R<9P>* &KX1T:.&PCC@FC-@"MM*MS+YL:D8*^9NW%<
M#!)' ]!6I965OI]I':VD0BA3.U1SR3DDD\DDDDD\DDFL[_A*-(_M!;+[4?-:
MY-FK>4_EF<+N,>_&W=@'C/;'7BJP\<>'VN!"+N7=]K^Q,QM90L<V0 CMMPI)
M( R1D]* -"?1+"XUJWU>2.0WUO&T<4@G<!58@D;0=I!P,\=A5-_!^AR6%U9/
M:S&WNKK[9,GVJ7YYMP;=G=D<@' XR!4T?B?29(M4D6XDVZ42M[NMY 8B%W'@
MKEOEYXSP:N7VIVFG:5-J=V[Q6D,1FD<Q,2B 9)*@;N!UXXH B@T6PMM7GU6*
M.07L\20R2&9V#(N=HVDXXR>W<^M2W^FVVI"#[1YH:WE\V)HIFC96VE<Y4C/#
M$8/'-9*^-M"><P)/<M,8!<1QK9S%IHS_ !1@+^\QD9VYQWJW%XDTNXTVTO[:
M=[B&[0O (87=Y .N$ W<=#D<'@\T 13>$M%GBLT-M(ALY9)89(KB2.0-(29"
M75@S;B3NR3GO5>3P+X<ETF/3#8,MM%<-<Q;)Y%:*4DDLC!MR<D\ @<U;C\4:
M1/IUO?6UP]S#<HTD0MX7D=E4X8[%!88/!R."0.O%4H_&NF7.LZ58V?G7,6I6
MKW45S%"[)M4JO4#U;G/W<<XS0!>7PQI"R:=(MM(KZ<6:U(N) 49@0Q/S?,3D
MY+9)R:L:7H]CHT<\=C$\:W$SW$H:5WW2,<LWS$XR>>*Q[3Q7I%IIXN;K69KF
M*XU&6UBEDM63;)O(\G 48VX*Y/7'4U=M_%>C7.GW%ZMRZ16TXMI5E@DCD64D
M )Y;*&W'<N!CG(Q0!?U#3;/58(X;ZW2>..:.=5;LZ,&4_@0*J:CX;TK5K^*^
MO+9GN(XF@#I,Z;HVY*,%(#KD=&R*DT_7M/U2\NK.UDD-S:';/&\+H8S@$ [@
M!R""/4'/2C4-?T[3))([F60O%%Y\JPPO*8X^1N8*#@<'KUP?0T 9LO@/PY+:
MZ=;_ &*5%TY/+MGBNI4D1.Z;PP8KP."2*EO?!?A_4)9'N+#_ %EH+*1(YI(T
M>$ @*RJP4XR<$C([8JCK_BA(M1\/V-E//Y&JL[&ZM(&F/E")G!0A64DD+V.!
MDX&<U;U76)?!_A1+O5)IM3GC9(3-';[3(SN%4LJY"]1G'7L,D"@"Q'X4T>*=
MYD@F$KV@LF;[5+DPC)"_>]23GKDDYYJO<>!O#US;Z="UG*@TZ/RK5XKJ5)(X
M^FS>K!BN ."2*RI?%ZZ7XPU9-1N[DZ7%IMO=QQ"S9GBW-*'8JJ;PH"*26Z>U
M=%>^(M,L;87$L[R1&#[23!"\N(O[Y" X7W[X/H: *.HZ7<ZE>6VCMI5HF@V[
M0SB8RY8M&VY8UCV\8*ISGID5T=5?[2LO[+_M/[3']A\G[1]H#?)Y>-V[/ICF
ML76O&=CI&DW=[Y%Y(]N8E,1M9%.9&VH3E?NYSS[8Z\4 7;SPSI5]?3WDUNXF
MN(A#<&.9XQ.@SA9 I 8#)'/8D=.*FBT/3X-9;5HH66]:!;<N)7V^6I)"[,[0
M 2>W<U%=^)=+LE=IY)QY<(GE5;:1FBC.<,ZA<H.#UQT/H:6\\1Z596ZSR7)D
MC:W-T#;QM-^Y'/F?(#\OOW[4 :M9\>B:;%!J$"6<8BU%WDNTQQ*SJ%8GZ@"N
M?'B79XRD8ZD'T(Z&NH)A 5&9,;P0-Q!7''/7BDU3Q+)8^,-$ N+H:;>6-U*]
MK]D8R,Z&+:0FSS,X=N/;IQ0!I6?@K0+&:*:&R=GBMFM%,UQ++F$]4.]CN7T!
MSCMBH[7P)X<L],NM-CL&:SN8S"\4MQ)(%C/.Q-S$HN><+CD#T%78?$NDW&G6
M5_;W)FAOL_9A'&S/(0"2 @&[C!SD<8YQ6+XA\2F71-.U'0]0*JVKVUI,/+&<
M-.L<D;*XRIY([$4 7F\#>'W6Z62TFD^UVRVMPSWDS-+&,X#$ODGYB,GG!QG'
M%7!X:TK[<+UK=Y)Q:FSS)/(ZF$]4*EB"#[BL+X@>*?[(\*:V^FWDT6HV4.[S
M(K<RK$Y *JY*E02".#V(/&16[J?B32]'61KZX=$A56F=87=80QP"Y4$*/KVY
MZ4 5],\&Z'I%G/:65K*D,T9B*M<ROLC/5$+,2B^RXJ.Z\#>'KRRTZUELY FF
MIY=F\=S*DD*8QM$BL&VX &,]JD;QEH2:I+IQNW^TQ2+'*!;R%8RRE@6;;@*5
M&0Q./>K^GZS9ZG*T=L9MRQI-^\@>,%'SM8%@,YVGI^- %:?PMI%PI1[=UB:V
M6T>))W2-X5SA&4'!'S-U&>2.E:X 4    < "L[Q!-/;>'-3N+68PW$-K))'(
M%#;6521P00>E8_A;QEIVJVNEV$UZS:K-81SL)('C$QV N48J%?!/.TG% &E:
M^%](LIUEM[5D59VN$A\US%'(V<LL9.U3R3P.I)[U9TS1;'1S=&QCDC^U3-<3
M;IG?=(>K?,3C/M5:+Q1I,]Y':I<2&6:%IX 8) )T7[QC.W#XR#\N2001P:YW
M0/$DVJP1:[<ZI<6UM]KN+9K!K([9?WKQQ",[0Q<! 3@MW! [ '7W^FVVI"#[
M1YH:WD\V)HIFC96VE<Y4C/#$8/'-9\WA+19H[-#;2(;.226&2*XDC<-(29"7
M5@S;B26R3GO39O&&AV^G7-]/>-%!:S"WN-\+AH9"0 '7&5SN&"1@Y'/-/7Q7
MI+6IN$>Z8#S,QBSE\P!#ACLV[L XYQ@YXH K2>!/#DFDQZ8;!EMH;AKF'RYY
M%>&1B261PVY,DG@$#FK:>%](CGT^9+:19-/#BV87$@V;_OD_-\Q/<MDFM"RO
MK74;"&^LYTFM9T$D<J'AE(R#66?%VB"7RVNI%+0-<QEK>0":)<;FC.WYP 0?
MESP0>G- %[2M'L=%MI+>PB>.*25YF5I7?+L=S'+$GDDG\:P;O0;F]^(G]IRP
M7"6(TO[()X;GRSO\PL>%8-C!Q]?SJ_8>,=$U.>&&TN9I'GM?M<&;:51-& "2
MA*X<C<,J,D9QBHM%\86.L:%;ZIY=Q"MS(Z0PM Y=\%L;0!\QVKDXR!SSQ0!<
MF\,Z3*E@JVODG3U*VKV\C1-$I&"H92#@@#(Z'%+_ ,(YIH2U6**6#[*)!$T%
MQ)&1O(+Y(8;BQ )+9YYZ\U3;QQX>2WM9C>N5NGDBB5;:4L9(P2Z%0N0XVGY2
M,YZ"HHO%&E_;;^];5K@VMOI\-U):O9NHAC;<1+]S<<CJ.<;>@YH T+?PUI-K
M>V5W;VIBFL;<VUOLE<*D9QE=N<'.!U'856C\&:##9VMI':2K!:W(NH$%U+B.
M0$D$?-P!DX7H,GCFIM-\5:/JU\+.TN7:9K<72"2!XUDBX&Y&8 , 2 <$XS38
M/%NC7-U9V\5S(SWRE[4BWDVSJ#@LK;<$#(YSC!!Z$&@![^%](DO+BY-JP:YD
M66>-97$4KKC#-&#M)X')'.!G.!27/A31[M]4:>VE8ZJ@CO?])E E4# & W P
M2.,<5<OM6LM-N+."[E:.2]F\B#]VQ#R8)VY P#@'KCI6?-XRT&VCEDFO3&D5
MZ+"0O!(-LY"D*<KQPRG/3GK0!LV\$=M;QP1!A'&H50S%C@=.3R?QK+/A?2/M
MD]S]E8&>9;B:(2N(I)1C#M'G:6R <XY(!/(%1V7B_0[^TO;F&\*I8N([E)H7
MBDB8_=!1@&YR,<<]J=)XLT>&WU"::XDB_LZ,2W226\BO&A!(?9MW%>#R 1P?
M0T 6[/1;&PU*]U&WCD6ZOBK7#M,[!RHP/E)(&!QP!63X\TJ[UOPK+IUE;F>6
M6XMW*B0)A4F1VY)&.%.,=\5>TWQ-I6K:@]C:3R-<+"+@*\#QAXR<!T+ !USQ
ME<BHM2\206'B/3=$:&Y,U]')(LJ0LRJ$P.H!YRP]@.N.* )U\/Z8]O=QSVAG
M%]&(KG[2YE:1 " A+$\#)X'&23U)-,C\,:5':SVYAFE2:V-H[37$DC^2?X S
M,64<]B.WI6!X3\8Q2VD5IK%]++?S:E=6D4K6Y",4ED"(750@;:O )!/XUT,W
MB72K>]AM9;AE::X^RI(8G\HS?\\_,QMW<$8SU&.O% $5SX3T:\L[NUNK>6>.
M\1([AI+F0O(B$E5+[MV 23C/<^IJ=_#VFOJBZF8I?MBVXMO-%Q("T8R0#AL,
M1N."<D9.#5N^O[;3;;[1=R^7'N5!P6+,QPJ@#DDD@ #FN)3Q0[3^-3=ZO=6=
MCIXA$,YL_P!Y:;H]S'9LRV#SR#QCMS0!T<?A#1(;#3[.&UDBCTXDV;)<2"2#
M(P0K[MV".",X-2R>&-(EBLXVMGVV=P;J';/(I$QSER0V68[FR6SU-/FU[3[2
M002S2O(JQERD#OMWG"EBHPN3Z_7@4RY\3:3:7:VT]T59KA;7?Y;&,3-]U"X&
MT,<C@GN/44 ,7PII"/-)'%<1R377VQW2[E!,VW9NSNX^7C'0CM4T/AW3+>:T
MEB@=9+226:-A,_+R9WLW/SDY/WLUSFA>,(K>ZU6TUJ_ED=-:>RMY#;':BD((
MU=D7:N2Q +8R:WY?%&D0W_V-[H^8+E;0L(G*+,P!6,N!M#$$<9[@=30!IW$$
M=U;R02[O+D4JVQRIQ]001^%8\'@_0[:TTVTAM95@TR3S;-/M4N(FP1D?-SP2
M,'(Y-(GC+0GU&:Q%W()X97BFW6\@6)E3S#O8KM4;>020#@XSBI;;Q3I%W?06
M44\OVB>#[1$KV\B[XO[^2N-ON?4>HH 1/"FD1M(T45Q&\EV;UG2[E#><5*%\
M[NZD@CH1VK&U#PL3XI\/265G,FGV(NVGECN-C^9-M.[.[<Q)#%L^O>MVT\2:
M7>ZA%8PW#_:)HC/ )(G031C&61F # 9'0G@@]#5J^U2TT^2**=W,TVXQQ11M
M([A?O$*H)P,C)Z<CU% &??>#]"U'28M,N;'=;PRF>,K*ZR)*227$@.[<222<
MY.3FF7?@K0;VQL[2:S<+9.7MY8[B1)HV/WCYH8/D]\GGO5'Q!XRMK?P[9:AI
M4SS+?7D-JDT<#OY8:94?(VG#@%L*PSN&,'I5V2_E\-^&-0U74;RZU*"!7NDS
M:A)EBVY"%0!R.>2!@=>A- %J3PUI$CZ<YM-K:=N^RE)778&QN!P?F!P,AL@X
MYIMOX7TBUN?.AM64>>;D1>:YB64]7$>=H.23P.O/7FN?E\6RQ^)]%D>:Z73K
MW2Y[A[1;1F<RHT6-JA/,/#MTXQS[UT47B32[C3;2_MIWN(;Q#);B&)W>11U(
M0#=QWR.#@'F@!(O#.DPVVHVZ02B+4I&EN@;F0[W( + ELJ< ?=QT%6K'2K33
MY9YH$<S3[1+++(TCL%&%!9B3@9/'N?4UE#Q'IFH7F@R66LN(KYI6ABC@)6Z"
MHVY68KE"N"<9!R,'TJQI?BS1]9O3:6%Q++*/,!S;2*JF-MKJ6*@!@2."<]^E
M %K4M%L=5EM9KJ)O/M6+P31R-')&2,'#*0<$<$=#WJO<^%](N].AT^6V?[-%
M.+A52>1"90V_>6# LV[YLDGGFEUK6;6PAGMS<2I=?9VF @A:5HU'&\@*<#/J
M.<'K@UE^$?%$=_X?T"/4;IY-6OM,6\8>0P\T!5WL"J[>K#@<\]* .J50JA1G
M &.3D_G67;>'-,M)XYHX9&:(N8A+.\BQE_O;0Q(&<D<= 2!@&LV7QQI?G:&+
M1;FYAU::6..6.VD(41HY;(VYSN3&,>IZ"K-CK=EYFL3/JLMQ';7@A>-X"AMW
M*IB)0%!?)8$=22^!0 1>#="M["SLX+22.*RD\RU9;B3? <8^1]VX#'&W.,<8
MQ4E[X2T34-)&F7-EOMQ-]H!$CB02YSY@D!W;\D_-G-+#XITF=9MEQ)YL,XMI
M(&A=95D(W*NPC=R.0<8QD] :T;&^@U&U%S;ES&69/GC9&!5BK JP!&"".E &
M</"NC^581_9Y<6$WGVY^TR;A)@@NQW9=L$C+9ZFH5\%:"EM]F2TF6#[6+T1K
M=S!5F#;MP ;CYN<#C/:M6]U&VL/)$[-OF?RXD1"[.V"Q  !/12?PKE=0\5&W
M\6:&T5W<-I5[97<C6ZVK,[/&T8&$"^9GYFROMTXH VY?"FBSG4_/LS*-4V_;
M!),["3: %."<*1@8(QC J1?#NFBVNH&CFD%W$()Y);B1Y'C ("[RVX#YCP#W
M)ZDU&GBO1YK*PNX+EIX[]6:V6*%W>0*,M\@&X8[Y'!XZUEWWB![G6?!\^DW^
M_3-5FE#A4&V5! [J<D;A@J/3WH OMX.T1GL)%MIHI;"'[/!)%=2HXB_YYLP8
M%EXZ,2*@E\ ^&Y=+L-.-C(L&GDFT:.YE22'/7;(&W 'N,XI?".H7M^=>2]N6
MN#::M-;0LR*I6-50@?*!GJ>:4>,M.35]:L[D36T.DQ))/<2PN$Y#,><8P !C
MUR<9H O1^&]*BOK&]CMF2>QB:&W*S. B-C<-N[!S@$D@DXK5KC_%'BA?^$/\
M1SZ/>2VVI:9:&8A[<J\9*ED)61>0<'G'8]Q6]#K5D9)8))R);:%9;AVC81Q@
MKN^9\;0<<XSG% $\&FV=MJ%W?PVZ)=7803RCK)L!"Y^@)JE;^%](M+CSH;5E
M G-RL/FN8EE.<N(\[0<DG@=3GKS4MEX@TZ_U%]/AED6[2(3^3-"\3-&3@.H8
M#(SQD=.]-U3Q)I>C221WL[J\<!N9%CB>0QP@X+MM!PON?0^AH AG\(:%=)J<
M<]@)8]3;==QO(Y1VX^8+G"M\J\K@Y4'M26OA'1[.QCM((KA5CE$RR&[E,N\
M@'S"VX@ D8)Q@]*2]\8:+8736LUQ*\ZVPN_+AMI92T1.-Z[5.X?3.,<U8?Q!
MIK6MG-#<M*+Z'SK;[/$TCR)@'>% )P R\D8R0.I H N6&GVVFVYAM8]B,[2,
M2Q8L['+,2>223WJS7-> -5NM;\&VFH7MP;B>66X!E*!"RK.ZKP  /E [5TM
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %<_XJBU66+33IEJ;F-+Q6NXXY%CE\K:PS&S$!3DKD@@XS
M@BN@HH \FDT_4]#M]%AN].*N?%TEQ#''.KF1)%G8$$D=C_$021VJQXHTJYLX
M=2UN2U:.34M<TMHK7<N[$4D:@L0=H9CGOTQD]<=WJUOIEU?Z9#?V\LLWG%[5
ME5RL<BJ3N)7A3C(!..N!UJUJ.E66K0QPWT FCCD655+$ .IRK<'J#R/2@#B/
M$/A'5-?NM9U6VB%G<R0V:6MO,Z_OF@F,Q+E20 Q(4<\8R:TKC2K_ %/7I]>;
M3YK5DT>2QCMI)(S)*[L&.2K%<#: ,GJQ].>P P /3UI: . T70]8LKKP2T^F
MR*NDZ1+:79$L9VR%8@,?-R/W9Y]Q[XK:9X>UVQTWPNYTPM/IFJ7<T\'GQ@^7
M-Y^U@<XP/-7(Z]< UZ110!Y_HV@ZE8:E+IM[X:L+RW74)+NWU>1HVPCRF7YD
M/S^8NX@$<=#D5GQZ#XEM?#EIX?.D-<&PUF.[2]6XC"3PBY\XG!;<'P2"",<=
M37J%% '/>-],O-8\(W=G80B6Z+PRI$7"[MDJ.1D\ D*>M9L5AK%AXDUS4/[+
M>[MM9MX6$:S1YMY40H4?<P!4@@Y7.#N]B>Q>14!+'H"V ,D@>@')JII&K6>N
M:9%J.GR-):RE@CLA0G:Q4\$ CD'K0!G:#HMUX?\  ]EHT,L<UW:60A5Y,[&D
M"]^^W/Z5Q</A;Q!J,T7VRPDM&N?#]SI=U/)=(_E3/L^954D!/E.T+CW KU$L
M%&6( SCFEH XW38O$6I>'9=-U318+"XCL'M3.9TD$SE-H*;>50XR=V#T&#UK
M9\*0WMKX4TRTO[0VMS;6L<#QF17Y1 I.5)&"0<<],=.@V:RK/Q'IM_J"V5M+
M(\CQM+$_DL(Y55MK%7QM."1T/<'I0!QFD:-XE_MWPWJ&HZ5LFLS=1WKBZ3RQ
MY@&UHD!P$XZ !O4=ZZ/P+I^H:1X:CTS4;7R)+:64*PD5A*&D9@PQT&&'7!Z\
M>NY=WT-D]LDHE)N9A"GEQ,^&()^; .T<'D\5#JVM6.AV#WM_*R0(ZQLR1L^&
M8@*"%!QDD<GCD4 <-?:-XEO-4@FETKS&M-?%VDBW2)$UM\P4JF?O $%BPW$Y
MP2. 7/A_6Y= UJU72Y#-=>(4OXE\Z+F$31.3G=P<1GCW%>D=*RM/\1:;JE[]
MEM))&=H!<1L865)8B<;T8C##..A[@]#0!S^IZ/)<>/;62TF1;:_M\ZK!U+"!
MU,;<<9);8<]5^E;WBJTN-0\):Q8VD)FN;FRF@B0,%RSH5')( &34,H\/^$FD
MO!:Q6;ZG>(DLL,!)FFD;"[BH[LW4\<GUJ]:ZQ97NJ7VFP2.;JQ$9N$:-EV[\
ME<$C!SM/3- '-VFF:I%XF\/WSZ=*(+/1Y;2<^9'E9&,1 QNY_P!6>?<5S]CX
M:U_2].\/W9T&/4);$7EO=:=+-$&*32B19(V)*Y&T9!(ZFO4Z* //;S0=3L=2
MTO5K+PO87-N+>6WN-)A>./R-[AU="V$+=0W3.>,U>CT2_LO$GAZ^M='MH;6"
MTNK>>WM'1$MC*\;C XW#Y2#M')YQS7:44 >;Q^'];73[:,Z7)O3Q3)J;+YT7
M$#2NX/WNN&'%1:YI=]$?$#R:>_G:CK5G/I@%Q&CR/&D0RO)&X>4[8;@@<UZ;
M5/4M*L-8M/LNI6<-U!N#!)4# ,.A'H1ZB@#GO"CRIK&J&_TB^L=3O=ES*]Q)
M"ZR*JB-0OEL=H  X/)R3D\X7^S]4TKQGK&IPV+ZA9:K;0KMCD16ADB#+M(<C
MY6#9R,X.>*W]/TO3](B\FQMHK=7/.T<N?<]3Q5V@#S_3_"VI:(/ UI';M=Q:
M.LOVN9)$ 4O$RX4,02-S>G0?A6_XXTR\U?PE=6>GQ":Z,D$J1EPN_P N9'(R
M> 2%/6N@+!<9(&3@9[U1TS6++5_MGV*1W^QW#6LP>-D*R *2,, >C#GI0!RU
MWI>L76N>(;W^RY%COM%CM(1YT9S*#*2I^;C_ %@YZ<'VSF0:!K6F7&F73^&X
M-7AET>VT^ZM9)H@]M)#N^8%CM9#O.<'/ /M7I=% &1/8LGA.:P33;25OL;1"
MQBPD+'81Y8Z84].W'I7%7'A/71X;UK3;(7DEB_V233[/4+A'FC:.4/)&) Q^
M3"J%W-P<]!R>]@UBRN=8N]*BD<WEI&DLR-&R@*^[:02,'.T],]*OT <9#8ZQ
M8>)=:U'^RWN[;6;:$B)9H]UO+&A0H^Y@"I!!RN<'=UX)R](\.:_X+N]--E8K
MK5LVD0Z?=*LZQM%)&SL'&_ *'S&&.O XKO9]0@MYK2)O,8W;E(FCC9USM+9)
M PHP#R>*M4 >;^(?#&OZAXEAU2R@$,]EID?V=XW3R'N4D+^6R%@3&0=N2!@X
M/&*V7M]7OO%WA_6)M'F@CMK&YCN4\Z)O+DD\H@##?,/D//N/?'7T4 >:Z)X<
MUW24\-W[6#O)ITE]%<V8ECW&.>0NKH=VTD87()'!/IS->>%M4&G7<L%FSSWW
MB*#5&MQ(@\F*-XR<DM@L1'G@GEL=LUW=[?6^GP":YDVJSK&@ )+NQP% '))-
M58-?L;G19]5B^T&W@$GFK]G<2*4R&79C<2"#QCGM0!PNL:!XB&C>,]$M]+:\
MCUF62ZM+M9XU"EU4&.0,P(*[>" 01CI5VZT?58O$VI3R>%[/6+'5UB?,\L8-
MI(L:QLCAL[D(4'Y<]^#7?1R"6))%SM90PW @X/J#R*=0!Q^F:3J-IK7BJ9]-
M0P7D4(M0601S&.'85VAB5!/KVJAI5CK'A.#4;FPL;R32X[1&@TN^O8R8I0QW
M+'+EML87G#'MQ7?TC(KKM=0PR#@C/(Y% &;?1RZQX8N8HHS%+>6;*J2\%&=#
M@-Z8)YKE8/#6HZM:^&K>\M)-/_L>SDBDE=T9GD: PX38Q^7DMDXZ+QUQWM)N
M&XKD9 SB@#AO".EZG9I86^J>%;"VN=,B,7]HQO&YGPNW,6/F4MP3NQW'.>*%
MCX;UVV\/Z%)]@9;W2-7GO7M&FC_?Q2O-G:0V-P67(R0,@C/>O2:* /.=>\,:
MKJ%OXEOK:P?[3JTUB(K0RQAE2W=6+,=VT$_,, G@+ZG&CXBTS5%\56NMVNAQ
M:S:R6?V2XLY)(TDA(<LKJ7.T_>((SZ=:[6L_4]:L](4?:6D:1D>18H8FD<HF
M-S!5!.!D9^H'4B@"*'2\^&6TP06]AYEN\7E6BXC@W \+C&<9ZX&>N!7(:-H^
MKKHRV=]X2L(+ZQLY+=;Z*2)C<$QE 8NA3=P3NQZ<YX[^UN8;RTANK=]\,R+)
M&V"-RD9!Y]C4FX!@N1D\@4 <)I.B:M;77@4S:>Z+I.F26MXWFQD(YCC48PV2
M,QGIZBLJV\-^(;#0/#Q_L2&\GT::>.:QDGCQ=12$_.A/R@CY2 V#]X<=_4:0
MG ).>/09H X=]&OSJ?AJ\M_#\%E%;W\UU<P6S1#R@\+QY8@@,Y+ G&?J<9*Z
MUHVJW6M^*)X-/>2&^T-+&W<2QC?*/-XP6R!^\')]#^/5:3J]EK=C]ML)&D@\
MQXLM&R'<C%6&& (P012:9K%EK NC92.XM;AK:;?&R%9% )&& /\ $.: .3CT
MV]M-4T._O[+RK#3]!FM;V22:,+&Q\HG.&SMQ&V2/45E^%8;VQ;PVVK:#J,<-
ME#]EL9_M$$D4/FA0,A6\QA@!02.!R1U->FR1I-$\4J*\;J59&&0P/4$=Q7.Z
M58^%]*\12:7IMA#;ZC%;BXVK P"1L=N4)& "<C"^E ">,=/O[N/1KK3[1KN3
M3]3CNW@1U1G0(Z':6(7(WYY(Z5QNJV>JZ=#/<7NG&,WGBZSO+>-9D8NI\I<=
M< Y0]<#W[UZ1/K%E;:S::3+(ZWEVCR0IY;894QN^;&.,CC.>:?J.E66JI"M]
M!YRPRK-&"Q&UUY##!ZCL>U '#ZWX2U75KW5]:M81;7<DMA);6LSJ/.^S.9/G
M*D@;MV!R<;03UXFU_P /ZGKDFNZI%I\L$]SH#Z7!:R21[W=RS%F(8J ,@#G/
M+<=,]]THH Y"PTS4D\9:5J$MA)':PZ(UG*YDC.V4O&V,!LD80\CVJUK>GZ@_
MC+P_JMI:?:(+6*ZAGQ(JE/,\O:W)Y'R'.,GD<5TM)N&X+D;B,@4 ><0>'];3
M0],MFTN030>)'U&1?.BXA,TDF<[NN'''KFK&D:#J5CJ<^FWGAJPO;8:A)>6^
MKR-&VU'E,OS(?G\Q2Q (XZ<BO0** .9\9Z9J5]!I-YI42W%QIFHQWAM2X3ST
M"LK*"> V'R,\9%<[J>B:]J=GXZ*Z/)$VM6L4=I')/%N+"+80V&(&"?4UZ14<
M\RV]O+.X8I&A=@BEC@#/ ')/L* .%UK0=5O-134-+M+O3]6CC@2.ZCN(_)F0
M'YH[B/<=P7+<@$\\'BK.C67B#1]3U'2WTJ&ZL+G49+V#46G7;&LC[RK(?F+J
M2<8&#QR*ZZ"[BN+.&Y3>$EC$JJR%7VD9^Z1D'GIC-0:1JUGKFFQZA82-);2,
MZJS(4)*L5/# $<J>M '"W?A[6Y= UZU32Y#-=^(([^$>=%\T*RQ.3G=P<1GC
MW'X&LZ-XEU"_F=M*,OD:W;7ENR721QM;HR$C;GF3@Y+#Z'&!7I%(6 (!(!)P
M,]Z .'2SFT_3_',^L62Q65]+).GF3*%EC-ND94E22N2A[9Y'?BLS2]/OY'M;
M/6M(U.UNYM+?2+:]>:WDCC!3<<B-MV3L')'\(Z9.?0=3^R#2KLWT GM!"QFB
M,7F[T R1LP=W';'-5-&T+1=-C2XTO3HK;S(QM/ED,%/..>5'3CB@#G_"&FZC
M";*/5?"VGV-UI\7E'4(WC<S?+MS%M^90V,G=CTP<Y%_5M.U&#QKIOB"SMVO+
M=+.6RN+='570.RN)%W$ \I@C(.,8S73;AN"Y&2,@57N+Z&VNK2WD64O=.R1E
M(F900I8[B!A1@'DXH X2X\+:K!H02"S::XNO$::O+ DJ 0QB=9"N20"=J]LC
M<3VYKKO$MC/J_A'5]/MU N+RPF@C5S@!GC*@$_4UK44 <396&L'Q)X>U&?29
M88K/2IK:8>=$Q61C$0.&Y_U9Z<<CWQA6/AK7]*TWP[=G08M0EL4N[:ZTZ6:(
M,4EE$BR1L25R-HR"1P:]3HH XI]%ODU7PI<6VB06MO97%S-<06K1JD DC=0,
M9&YLL"2!Z]:T?!6GWVFZ9?0W]HUO))J5U<H&=&W))*SJ?E)YPPS71E@N,D#)
MP,]ZKV]]#=7-U;QB4/:N$D+Q,JDE0WRDC##!'(S0!RUU8:SIWC74]1MM/;4+
M'5;**#,<R(UM)'OQD.1E#O)R,D'M65HNAZ]H\?@NX;26FDT[3)=/NX4N(P8V
M81;7R3@KF,YQD\]#7<:QK%EH.FR:AJ$CQVT9 9UC9\$G X4'N1STJ87T)U-M
M/ E\Y81,3Y3;-I)'W\;<Y'3.: //])\.Z_I^F^$GDTP-<:7?W<EQ"MPGW)5F
M"L&S@@>8N1UZ\&G:AX9URX3Q#-!81F9]:@U*TAN)$\NZ2..-"C$$[<[&QD>G
MX>C*P90RD%2,@CO2T <)/H;:KI+&Y\'I8_:+B-I(K.XC2ZC**V)A(C ;E)4
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M4,2^TQON0%5&..ISG(QL6WA3S?%^N7E[9@:=>6UO;PK'.5!6,,&5T4@%3N&
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MDTQX6BB"20^>\?S84'<  000..G7/8)X+\.QSI,NEQ"1+EKI#N;"2-G<5&<
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M!&NU$08 %34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMYC$?*ED7.45O7Y3CUP<9KE=)\-:S::5X-MIK("32;V6:ZQ*A 5DE4;>>?\
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M\U*'Q/H,4^J75W%J>B/<S1S;=JRH8<,N ,<2,#Z\9YYKNU974,K!E/((.0:
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M[,02SBX=!$ #(#D-]?\ Z_K6Q10!GKH6EI->3"QA+WJ".YR,B5 ,!6!X( R
M.PXJ.+P[I,-G-:)9)Y$T0AD5F+;HQG"9)SMY/R].3QS6I10!FQZ!I<4]M.EF
M@EMH3!"V2?+C/5!S]W@<>P]*LV&GVFEV$-C8P);VL"[8XD& H]!5FB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "LG6M6O-.15T_1KG5+DJ6,4+I&%4=RSD#)[ 9)K6JKJ,5[/831
M:?=1VMTRD1S20^:$/KMR,_G0!2\,^(;7Q1H-OJUI'-$DI96BF7:\;JQ5E(]0
M0:UZX[X:SWG_  C5QIM_;P176E7LUE(\ (2<J0WF#/=MV3[YKL: "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ K)U'0EU#48;X:EJ5K)$ACV6UR5
MC<$Y^9#E2??&?>M:B@"M8V%MIMHMM:1^7$"6Y)8LQ.2Q)Y)))))Y)-6:** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
0H **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>aquestiveamendedandresta004.jpg
<TEXT>
begin 644 aquestiveamendedandresta004.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MTKJ\D*YD4C<"0.>>] %NBN"^'?BB^O-&N[3Q)=*^HV,:73W#*$$MM*GF))@
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MR2/#<%1Y<@1@K8(.1R1P0,\T :M%9]]K$%E=QV:Q37-Y)&TRV\ !?8I +')
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M A0._4X'2O2** /)M*O;?0[OP]?P:WX?N7MM%CTB]MFU6--I3!$B-SD9!R"
M<$50M1#I^FZ'<KJOA2\O-.DO$FL9M4C,<T,\OF9#D?*ZD+V(QGFO:** /-3J
MNFMK_AN_.K>&X8K+[2US%;ZC$%C\U0JJG3=C')(&>H':F^;I-SXS@U33]9TF
MRO7O0)YK75(RE];X("/%GF3H <=LY[5Z910!4TZ2^EM2VHV\-O/YC@)%*9!L
M#':<X')&#BK=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5CWFK,?$=IH
M=J0)W@:[G?&?+B5@HQ[LQP/96]JV*Y-K:2T^*ZWTG^HOM'^SQ,>GF12EROU*
MOD?[K>E %N35K^/XA6^CEH#83:9+= ",B0.LD:\MG!&'/858CU9K?Q0=%NF!
M-Q;M=6DF,%E5@'0^Z[E(/<-[9-&XL[UOB59:BME*UC'I<UL]P&7:)'DC8#&<
M]$/.*BU&UDO_ (G:'+$#LTRQN99V[#S2B(OX['/_  &@#K**** "BBB@ KA[
M?Q=>Z7XWN=%UO8=-FG6WL+\)L'G&-7,,G.,D.-IXS@BNXKEY-"BUY/$>FZOI
M\HLKVX5XW8K\P$,:AE()*L&0D9 Z"@"Y9ZF]O-K4FI7J?9K.[6&,E N 8HG
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MI(\]I;B>X4(V0G=P,?,ONN14OC#3KG6?!>LZ=9H&NKJREBB5F"Y9E( SVYK
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M"1L!@<X&0,'OA>%M6D;Q/JN@I<R6#2:Q>W(FV*?M(5@#$FX$9'#-WQC&<D@
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MG<.HQ5N/Q/I$MW;VZW1S<R-%!(8G$<KKG*JY&TG@\ \X.,X- $FA:.FBZ>T
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ML=9@EFL9BXAE:"561D>.1>JLK $'D=1W!KF=1U>\B^(Z:,^M&RT]]*:\'RQ
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MR#@@@X(((((/(Q5R@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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ML8I8KB!)89$EAD4,CH0RLI'!![@U4TK1M-T*S^QZ58P6=ON+^7"@4%CU)]Z
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MB6TS3IK&\7SD_=,PBPW7YE_=GID\CBNB\<:9>:OX2NK33XA-=>9!*D9<+O\
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MLEPUM-NC9"LB@$C# 'HPYHM-8LKW4[[3H)'-U8[/M"-&R[=X)7!(P<@'D9H
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MP2 B]O?K3-1N=1TIO'6KV&I36\ECJENXB5$*S?N;<$/E2<$''RX_ECO!X0T
M6/V)=,B6W%T;P(I8;9LD[P0<@\GIQR1TI9?"6B3P7T$ED6BOW62Z3SI,2L
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M')O9U;/RD$K@$=>O;O6Q/X>TF>WLH6LU1;'_ (]3"S1-#QCY64@C(X.#SWH
MX4:]X@N8],LVU26&5?$<^D37*0QYN(ECD8/@J0'^4#CC(/!'%2>(=7UC1;34
M?LNMW%[/I?V-';RHU5"S+O\ -X^9G5LX4?*,="<GM)/#FDRQV2-:86RE,]N%
MD==DASE^#RQW-DG).X^IJ"_\'Z!JEU=W-[IL<LMVJK.2S 2;?ND@'&X8P&Z@
M<9H YV+[8GB[QQ-%J=VC06ENT(^1E3]W(PP"IX!SQ[G.:-"U[4-;N?#^E3WL
MT+7'AZ/4IIX@H>:5MB\$@@ 9)( _B';@]2_AK1WNIKDV2K-- +:1T9EW1@$
M<'L"1GK@D9Q33X8T?[/80+:LBZ>I2T>.9T>%2,%5<,&"X &,XX'I0!Q5CK_B
M#49_#EK+J<D#RZG?Z==2Q0QXN!"DNV0 J<'*#IQG/&.*Z;P7?7M[I>H0WUV]
MS+9:E<V:W#JH=T1R%+8 &<8&0.U:9\/:47L'%H%.GDFUV.RB(D$$@ \D@D$G
MKD^M3:;I-EI*SK90F,3RM/+F1FW2-]YOF)Y/>@#SF]\4:SI,$UO<:E<S7>C:
MJ6U#$<8,NG$JPD(VX&%D3I@Y5OPT/$CW-]:Z#=B\?R[OQ%"UJ=JD11;7"E>.
M=P&\9S]X>E=M-I&GW$MY)+:1.][ +>Y8CF6,;L*?;YV_.F7>AZ=?16<5Q;YC
MLI%DMU5V01LHPI&TCH.E '#+XDU6PGN-(EU"6<GQ)%I:7LJ)YD<3PK+SA0I;
M)*@X_B'I71:'?WZ>+]<T.YG>ZM;6*WN;>:0#>@DW@QL0!G!0D'K@\YJ^_A;1
M98[Z.2R#K?2B:X#R.=\@QA^3PPP,$8(P/2KUEIUKIXD^S1D-*P:21W9W<@8!
M9F))P !R: .0GU/7SJOC"TL+GSY;0V9LH9"D>T.,NBMC&X\A2V>2*UO"&L+J
M]I?$R7PF@N?+EM;^()-:G8IV''##^(-SD-UJ[+X:TF::^FDMF,E\8VN&$S@N
M8R"AX;@J0,8QBKEEIUKIXE^S1E6F?S)79V=W; &69B2> !R>@ H XS0-1\0:
M_:Z/KT6I6T-G<NZW5N\H. 25"(OE_+(C8'+'.#G-9VC:UKIL/"FIW.LSW!O]
M4FL;B!HHUC9,SX;A00P\M>0<>U=G:>$- L=7GU6UTV.&]F9G>1&8#<PPS!<X
M5B,Y8 'D\TL7A/18;:SMX[1EALIS<6Z">3$<ASEA\W7YF_[Z/J: .$6\U32O
M _BO4;75[O[5!K4R(\@C?@3JG=>ZG'M@8Q6]:QSM\1_%):]N6BCTZT*PDJ4&
M[S^,8R ,9X/4\YK=G\):%<17T4FGJ8[^7SKE0[*)'R#DX/'(!..I )J>3P_I
M<NH-?O:YNV@^SM,)&#%!G )!Y/S-SUY//- '!>%=2OI=!\(>'[286_G:"+G>
M)1&SLNQ0%)1^F22,>G8$'6TO4M9N]=LO#6J:G$+N'2VNKFYL, 3R"8Q#&Y>-
MNW+  ?,0.@P=NY\$^';S3++3I],1[:Q.;5?,<-#VPK [@/;.*GN?"VBW?V'S
M+!5:P7;;-"[1-$I&"H9"#M/<=#0!D_#%67X>Z:KOO8/."V,9/GR<UUU4M*TB
MPT.P6QTVV2VME8L(TS@$G)Z^]7: "BBB@ HHHH **** "BBB@ HHHH ****
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MD4*HW.0"?7\:[AW6-&=V"HH)9F. !ZFO/-0\-:U<:'XJM([',NI:O'>6^9D
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M=DR>9N$;$9VD@GM@''-2>)/"^IZ]#XCOXK,PW6H:2FF6]M)(F>&=B[D$J.7
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MAWD/ C31J59\Y<$AF&>GX"E\0:_JGA[5_$K6UQ-=QV/A^*\MX)<,%DWRJ6.
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MZ=9Z591V=A;1V]M&,)'&, 5G6_B2UNM1MM-F@N[*>]@::U,ZJ/.48W;2"<,
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M@ T 61X4T 6B6HTBS$"7!NEC$0P)3G+?7D_@<4[_ (1?0O[=_MO^RK7^T_\
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MMH<UE=6<NFPR6]U+Y\Z/E@\G]_G^+@?-UX%1^([^ULCI*W4E]'Y^H0Q1&T.
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MYV.!NSUP ,>F.*!X<TA9 ZV,:_<!520K;/N;ESAL=1D'!JG_ ,)AIN;60QW
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M (#=,XS[5;U#1?$6K66F/-;Z5;W%OJ4%V]O#,VQ4C)) ?9EF.?0 8'N3VE%
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MD@ 8X ]\#?HH Q/%>BSZYHODV4J0:A;SQW5G,XRJ2HP(S[$94^S&L_1?!_\
M8WB>ZO8KC=82Q1R+ W7[5M*23'W9 O/<LU=710!Y]9>%/$:ZUHNHWQTV>XL+
MRX>>Z,SF2XBD5U4X*?+M# ! <<=15[P[X5O-*U]=3$5OIZ2V[K?VMI.SP7,Y
M*D2JA4!#PV2.3NQ[GLZ* ,#Q)IVK7]QI;:>;:6UAF9KRTN)6C6="I"Y95;.T
MG.TC![TSP5HM[X>\.KIE]]F+17$[QFW)*E'E9QP0,'YL8YZ=:Z*B@#C-5\*W
MFH>*$U:WBM[.[ANH6CU"WG99)+==OF12H%P^<.!DG (/&,&E-X+UAK:[2.:R
M66'7CK-@QD;$A+%C'(-ORC#,N1NZ@]L'T"B@#A=;\%W^OR:IJ3306.IS06L=
MF%8R)&T$IF4N<#.7.#@< =ZFUO2/$_B3PA>V%[%I=O=W'E*D,<[M$H5PS,7*
M9R<8"XX]3V[2B@#@SX5UV#PMX@\,VS6;Z9=6TD6FF:X??;"1"#&WR'**2=IZ
MXP*75?!>H:W=LETUM#:3:#)I<C1RLSI(S*P8#: 5&WU&:[NB@#E+;0]5O=1T
M&^U=+5)M'BEQY$K,)Y701[N5&U<;CCDY(].<73O!_B#2(M O(/L$M]I<MXLM
MNT[B.:&XDWG#[,JRG;_#@X->BT4 >=?\(=XBC@>]@;3!J4.M3ZE!"\CO#+'*
MI5HW.T$'!X8 \@<5JWVB:]J(T*>6'38IK/5%OIH8I6"(@B>/8K;,N?GSDA?3
MWKL** &N@DC9&^ZP(.*X73_!NI1Z!H_AR]>V:QTJ]CGCNDD.^6.)R\:E-ORM
M]T'DC ..O'>44 <]H>DZA8^)?$-_=+;"WU*>*6'RY69E"1+'A@5 YVYX)ZTN
MNZ1?W_B'P[?VHMS#IMS)-,)9"K$/$\>% 4Y/SYY(Z5T%% '&-H/B#3_$NIS:
M:NESZ;JDJSN]V6$MI)L5&*@*1("$! )7GO3[#1?$>C:YJD5A)82:1J-T;OSI
MG83VS, ' 0*5?)&1DC&><]*["B@#A)O!VI_V7XCT".2V?3=9NI9UN&D(D@$Q
M!D79MPQ!W%3GOSC'-Z'PO=-JWB;SS#'IVK6<-K$T<I,J!(V0D@J!_%QR>E=;
M10!P6G>'?$Z3>$TO8],*:"SH\T=P^;A#"T08+L^4X()&3SGD5TOB>SU2_P!"
MEM]'N$AO"\; N[1AT#@NF]02NY01D#(S6Q10!YU<>"=9FL/$\$4>EVPU.>UN
MK:**1]B-$(LHWR# )C/S '.[.!TKT& S&!#<*BS$9=8V+*#Z D#/UP/H*DHH
M \_C\(Z[#H]EIH&GLEGKO]HI)Y[@O%Y[RX(V<-\^,<CC.:=J7@[6;VYUZ[@F
MLH;BXU"VU"P+LSKNAC1-DHVCAMIZ9QGVKOJ* ,K0X]5$#RZM;V-M,^ (+-BZ
M*!GDN54DG/3&!@=>:IWND:@?'%CKEI]F>W2QELYTED964-(CAEPI#?<(P2.N
M>>E=#10!P%KX1UN#2]&M6%@7LM=EU*0BX?!C=Y6"CY/O?O?IQUYI=3\(ZU>Z
M1XOM(Q8A]9NTGMRT[X10D:G=\G!_=YXSUKOJ* .+.A>(K'Q)J-UIZ:5-8ZJZ
M32_:F;S+241JC%0%(D4A%."5Y]*ZVZ29K":.W*&<Q,L9D'R[L<9]L]:GHH \
MYD^'UV^CZ]8V(@TNVU&R$:V$<[RVZ7.XDR*"HV*>!@#GK@8YGU/PCK?B.^U2
M;4?L5E'J&C+88MYVD:&19'<-RB[AEAZ>G/6N_HH XG4M*\7>(/!FIZ5J0TF&
M[N+-K5/(F=DD9A@R,2F5'HH!ZG)K2MM'U)?&T>LRI:K:C2ULV59F9PX??D#:
M!CMUS[5TE% '/^)-(OM4OM!FLQ;[-/U 7<WFR%25$;IA<*<GY\\XZ5@2^#=8
M=[N[22S2[CU\:Q9KYK%'7RQ&8W.WY25W<@'!(KOZ* .&UKP;?ZU:^([HM;0:
MAJEO!!#$9"R(L3%AN;;G+%CG . !UJSJ/AK4M:UY[J]%K#:W.B3Z;.(9F9T:
M5E.5R@!  QDXSUP*["B@#BK70/$FI>%+CPYKTUA%!]A>R%S9NSO/E-BNRLH"
M8') )R>X'!TO#5MXBB"KKL.E1F&/R_,L2S&X;CYSN4;!Q]T9R3U&.>CHH Y_
MQ5I%]JZ:2+(6^;34H;R3SI"N40DD#"G).?:LQ/"MY_PE\.MQ16]A.+J0W4UK
M.V+VWPP19(]H!<93YN<;>IS@=G10!S_C#0[O7-(@73YHHKZSNX;VW\[/EL\;
M;@KXYP>1QTKG]0\):[KESKT]T;&P;4;.T2'RIVF,4T$C2*3E%!4DC/TKT"B@
M#B[S1_$NM>#]8T^^M]'M+R\LWM8TM9',99@079BF0/10#WR3GB[!HFIKXOTO
M59%M1;VVEO92JLS%M[-&V0-N"/DQU'6NGHH YK0_##Z1KVK71G5K&>5IK. #
MF%I=IF_-U!'ID^M4/"NA>(M!@@TBX72I=.L05M[Q"WGS1C.Q&4KA2. 6!/ X
M&3D=I10!P4/@W6%^'UEI FLHM6T^[^UV[[FD@=A*SA7^4'!#%3Q[U-J>@>(M
M7TRSNG32[/5+"^BO;>UA=FA?8&4J\FT'Y@[?P\8'7FNWHH YG0-*U>V\3:WJ
MNHPV<4>HI;[(X)VD9#&I4@DHH(.>O_ZZEUS1[^[\1Z#JEC]F86#3K,DSLN4D
M0+N7 .2,=.,^HKH:* ."LO!>HQ^&K/PM<O;OIME>I-'=+(?,>%)?-5"FWAL@
M*3G&.>O%=AK%DVIZ)?V".$:YMI(0QZ*64C/ZU=HH XNP\/Z[%J/A:ZN8]/ T
MFQFM9ECN'.XNL:@KE!G_ %>3G'WL<XR<VW\'>(M-L-'N;3^S)=1TZXO"UO-*
MYAGAN)?,(W;,JP(7!VD<&O1J* *>F17<5BGVX6ZW#$LZ6X_=IG^%20"<>I R
M>PZ"Y110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !7/\ B_3=,UC3+;3M1N9K1I[I!:7,,FQX;@!F
M1E;L?E(]\X[UT%07=E:7\(AO+:&XB!SLFC#KG&,X/U- 'FEUX@\3^&[3Q#I>
MJ307UY8Z='=0:M;P[7,)D*'S$' =1O88X.#[U+JVH3Z'I6I:OI_B9;RSF@MR
MT,+/-]G0S*KSJ[.Y7]VQXZ97/8UZ%::7I]A')'9V5O;I*<R+%$%#\8YP.>.*
MCLM$TG3;::VL=,L[6"<DRQ0P*BR9X.X 8/XT <1XL,=AX6U^[T?Q'>N6CMI8
MTCNVD%OEPNY7R3AP>A..,BI]2']G>*+3P_+K-S!9WEM/<QRWEU)F6;>H**X=
M2-JG(7./F/' QUD?AS0X=.;3HM'T]+%FWM;+;((RWJ5QC/O4M]HVEZI:1VM_
MIMI=6\9!2*>!712.F 1@4 <#8VZP>-/##W^M2:C)%I%V&OA(\2SE)H0#M#8/
M'7J&Z\\4S0-6EG\0^&A'JEU-9ZKI]V[O-=DO<8:/9(8\[8CEF "\XXXQ@>BR
M:;8326LDME;.]I_Q[LT2DP\8^0X^7CTJO#X=T2W*F'1M/C*,[J4MD&&<88C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN9[EYM1>.2>[!42[HRIC*X&T;2HP,8ZYSDY ,W5?&%]I4_BQ3:17":/:6]Q
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M8R3@/Y>%W8_NT <1X3UK7-(T#P1!<1V#Z5J=G#:1-&K^=!)Y&Y&;)PRG8<@
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MK&AZUJ.FZQ9P)"UF)-HPA5X90&79R206P/F/(H ](EECAB>65UCC12S.QP%
MZDGL*QM1\7Z'IMD+J74;=X_M$=M\D@)$CD  ^G!R<]N:76;&%_!T]A-:W+PF
MU$+PVCLTH7 !V'J6'4'OBN)O;/Q ^@WL5RESJD5IJ=A/!=_8FBN;B))49PT>
M 69 .H S^% 'H5QK>E6OE_:-2M(A*JLA>91N5N 1ST)Z'O3[[5=.TP*;^^MK
M4,"09I0F0.IY[<CGWKB98;M+WQA!?Z9>7,.LP(]D5MV<,I@\LPL0"$(8'[Q
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.>* .TNK/2O%VF6TJ7LLUEYGF(]E=LBR8RI5BA&Y>2"#6PB+&BHBA548"@8
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MYJ]K7C#6](M_$EJHM);W2?LLL,SQ,$FAG;: P#?*X(;GH>#B@#T*D9@JEF(
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MY@CUO5]4U34]+LGL[:\TRT@DE+(94DGE5FV@Y4[!MZ]3GMCD ZB""*VB\N%
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M2//WN&P^<]..E0GQ#J>D:GXRN[BY2ZBM+RUMK:$Q[0AE2(+SNQ@-+D^O/(H
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MU@=AA@YP,#G 3\<X[&K%IXHTZXT2SU21WB2ZA$RQ>6[.!M#-\H&2!D9(&*
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M D8(&3SDD@  #DDD@ #DDT 9>F^&;339+-S<75T;*)H;3[2X;R$. 0" "3@
M9;)P.O)S3M? ^FV4&F0075\(M,N#<6J-*&",0RXY'W0'88]_I4VH>,M*L/L0
M+32-=W?V10L+Y1P-S;AMR" .G4_GB]<:_I5I<>1/>)&P=8V)!VH[8VJS8VJQ
MR, D$Y'J* ,JX\":5=V-[:S37A^U7W]H"990DD-Q@#?&R@;3@#_)-3/X/LY+
M6RBDOM0DDM+M;P3R3!Y))5&%+$CD <8  ]JT+[7M+TR4QWEXD)!7>6!VQ[CA
M=[ 83)X&XC-8]AXCEBU_Q-!JMS$MGI]Q;QP,L1! EC4@'&2268"@#IIH8[B"
M2"5=T<BE&'J",&N?LO!EC8-HYBO+]O[(1H[7S)5;"LH3!RO(V@ ?3/7)JC+X
MOCTOQ?JMKJ]]#!ID%C;7,.Z(JREVD#;NI. @)X&.]=%=ZUIUBB//<KAXS*HC
M4R$QC&7PH)VC(^;IR* ,:/P+IL1M7BN[^.6VNIKJ.5)@K!IB3*O"_=8D_3L1
M3K+P/ING_P!FBWN;X+IUS+<VZM,'"M)N# Y!R,.P_'UYHU+7;A?$?A6*PN8)
M=-U2282%%#>8JP/(I5LXQE1T_.J_B?Q7]@N-*@TV[B\R;5[>RG!A+ AG = _
MW0P'4<D>U &YH^B6^B+>+;S3R?:[E[J3S2#^\<Y8C & ?2LV[\%Z?>V^LP37
M-YY>L2++= .HR5"J-OR\#"J/PK2GU_2[:^CLYKQ$FDE$*[@=ID(R$W8VAB.=
MN<^U167BG0]2U 6-EJ=O/<GS,1QMG.P@-STX)H KW'A*QGN[VX%Q=Q'4(EBO
MTB=56Z &W+?+PVWC*;3CZ"I6\,V?]JRZC%-/#+)9+8[(RH1(@20%&WC!)_.M
M6YN8+.UEN;F9(8(D+R22-A44#))/853M]>TRY2[9+M%%HH:X$H,9B4C(9@P!
M (!(/3@T 9]KX/L;,:&(;F["Z*C1V@+*<*5V$-\O/R\?_7J-/!-@EM! +N]V
MPZBVIH=Z9\\L6)/R],LQQ[T_5/&NCZ9I&HWYF>4V"J98%C82 M]S*D9 ;LQ&
M.OI5J+5(+GQ%#;0ZK%\UF\QL##B0C>H$A)Y4#.,$<[L]J *-SX(TZZDNY7NK
MY9KB^CO_ #4D56CF10JLOR_W0!@Y&*0^!-*\BYB%Q?@SWR:AYGV@EHYUQAE)
MSUQSG/\ *M2W\0:3=726\5[&9)$:2/.5$JK]YD8C#@=RI.*@M?%_A^^N;:WM
M=5MY9+EG2$*<AV4D%0>F?E/'?'% $4OA#2[F?57NO/N8]4MTMKF*5\JR("%Q
MQD$;CSG.3GTI\7ABV56,]Y>7,_V5K-+B=E,D<38W!2% R<#)().!DUN51U)-
M2D$"Z;/;P'S,S//"9/DVG@ ,O.[;SGIF@#,A\'6$']D!;F[*Z3;/:VP+K_JV
M4*0WR\\*HS[?6K6G>'K:PO8KUKBYNKF*V^R12W#*62+()7(49R57DY/'UK"\
M*:MXCUVWDO)KK3_*M]2GM)84M64O'&Y3<&\PX/ /0^E=%#K^EW%[':17B&:7
M<(A@A92OW@C$8<CN 3B@".]\/VUWK$>K13W%G?I";<S6Y7,D1.=K!@00#R#C
M(YP>:@E\):<T.D0PO/;1:3+YULD3# ?:R[FW ECAFSGKDGK6[7%>'O&]H\]U
M8:YJMHE__:MQ9VZ!=@8(Y5!WP3CC)Y[4 7OB%8W6I^!M2L+*WEN+F=45(XL
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MF-+%O=_91<W5N2"RN%("MC))#*!G(Z^U;=_KVEZ7(4O;Q(2NW>6!*QACA2Y
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MU:W\^-VC=%)8JRIO(.!V7FKT6M:?/;V,\5R'BOSBU=5.)?E+#'']T$_09Z4
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MJ]MOL&D:QX=NY+K2YBT>I2W&^V*@G;(@WY#E3C&WC)R>U>BT4 >>VGAZYNO
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MO->2W 76IUVR*F,A4^;A0<XX]/:MO3O"^E:4UO\ 9HI=EKN^RQR3,Z6^[@[
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MMK<QM%+&21N4C!&1R*SH/"VFVU]#>Q_:OM,5J;1)6NI&/EDY(.6.3D Y//%
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MS2K_ $_1VUC3X;$V,MJLR)+'\P99%WD!NA!Y'8T ;;^,_#Z_9]NHK*;FW-U
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M>WS8O^/?SM^[[_7';K1KVEWOE>,&GTZ8#4[ZS;3]L\2M+(@B4%?F/S!DW8;
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M)"D)9LMYS.,G<, !>0.>,@T >A9&<9Y]*6N/TA;EOBAXEWW]RT,5I8E8&V[
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MM"Z"7F2T*M!YOG*K[=RYP2 ?7C&<#% ';6%_;ZE:+=6Q<Q,S*"\;(<JQ4\,
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MT >F5EZGX<TG6+F*YOK))+B)=J3*S(X7KMW*0<>V<5QG]M>))?"VM7T%W/\
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M0JJ,!0, "EK)\.#5DTKR=;N+:XOHI'1I;<Y#+G*[OE #;2,X 'I6M0 4444
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M&Y4@E6 8#*G:?FZ<&K=AXGT^\O+*P)GCOKJV-RD4EM(@*# 8AF4#@D=^X]:
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M<ZQ*B(4ENFC2;;@#)^8!@N?FVY[9Q4^A:8=,LI3+'"EU=SO=7/D_=\QSD@'
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M]>M$MM1M_-CCD66,J[(\;KT964AE(]016<W@?P\\4Z-92,9YTN9)#=2^894
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M/;L8@XP3QGT-;5% 'F4O@W6UTR\MM-$OV&&2UNK#3M5G67$D;EGBW@MB(KM
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MR%ZX(R<9XEU#1-2O]$CN;;PW9Z;=IJ5G=M90R1^9*L,BLVYUPI.,@#/ '7G
M[VB@#S_7M"UK4+KQ:\6G$_VIH<=C 1,F/- ESG)!Q^]'..Q]JEO+*XM=9&K:
MC9"/2X/#LMI<O-,@56RK$'!)QA2,@'K7=UFZ]J>G:1HUQ=ZL";$#9*/),H(8
M[<%0#P<XYXYYH XCPO!J&GWF@'6="OT>VM/L%G<-=021Q[E!(VJ0YR(P,D'
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M\0L#PW][=UW?[6<^]++X3T*;2[;37TV+[+;2>; JDJT;_P!Y6!W!N3SG)R:
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M_?1]31#X4T&WUV36XM+@349"6:90>6(P6QTW8S\V,\GF@"+Q9<:I;:=;2:5
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M.\.ZE=6MS=Z1;2S6J".)BN,(.BG'WE]CD4 <^)9V\<:Y,DXCN/\ A'+5Q-"
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MR:?!Y%N&+",.Q )))(R3C)))]S4$WAW2;B^FO);-3-.5,V&8+,5QM+J#M<C
MP6!Q@4 <B=>U:5_$Y>ZEMS!H-M?PQ87-O,Z3%L9'/*+P<]*AU/Q%JMEINGZC
M>27G]ER:5;R37MCL9[29@2TDL6,M&1CD=-K<=QV6H^&=&U:\-W?6$<TYA-NS
MDD;HSGY2 <$ DD9Z$Y&*:?"VB[%06*K$L"VWE([*C1*251E!PRC<W!!ZGUH
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M)@[?NW4=UX7WQGO6Y4%G96]A;^1:Q"./<SD9)+,QR6)/)))))/)J>@ HHHH
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MR E@W/RG"DXZ\'OQ1<Z3J \>VNM6ZV[VAL&LY@\A5T/F*X8#!W=",9%<_>^
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MB1W+N008A&3A&0C((&<+DY!)H ]&HKB_AS#=77A^VUB]U74+NXF$T3)/-NC
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MRDLP 8%N^!QUZ9C_ .$X6[N/#)TW3KB>VUDRDN=BM&$1B5P6'S!ASVP#C)H
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M#^C6RS+!I-E&L\8AE"P*-Z 8"GCE?;I6'8^.(]7U_2K;3+*:XT^_TU[Y;D%
M<!T7&TL",;CGOG& >:98>+M,LM'LITAUB>.^U*>SC\X"619A(^5/S<+E&"^@
M Z4 ;</A?0+?2SID6BV"6#/YAMA;KY9;^\5Q@G@<^U6X=+L+>]>]ALK>.ZD0
M(\R1@.RCH"W4@>E8\'C33Y-,N+N6WN[>6WOET][655\W[0Q4*@PQ4YWJ0=V,
M'DCFKFE^(8-5U/4-.2UNH+FP95N!,JX!8!EP0QSE2#_]>@"Q>Z'I.HW275[I
MEG<W"1F)99H5=@AZKDCH>>/>F1^'M&A=7BTJR1EA^SJRP*"(O[G3[OMTK+N/
M$&FZ=KVN27,E^CV%A%/.KM^X\LF3#1KG[Q(8$\=!6S8:@;YIE:TN+<QE?];L
M(<$9!4JQ!% $4/A[1K=K=H=*LHVMD,<!2!08E/4+@< ^@IC^&-!DL8[)]&L&
MM(Y?.2 VZ[%?^\!C /)Y]S7,7-W>:YXMU[3)AJ]K;Z=!;O!)8W"1LK'S&+$!
M_FW[5 !!X'(7)JQ8^,].LM$T!+6UUJ_&I6C2V>X"6:0(NXAV+?>Q[_C0!OOX
M9T&6'RI-&T]X_/-SM:V0CS3G+]/O<GFG#PYH@1$&D6(5)S<J!;KA93UD''WO
M?K5:U\3P7MP8;>QO'V3"WE8!/W,FS?M<;LCJ!G&,_G3/"/B"?Q)I,E[/826F
M+F>)0S*00DKIV8\C;ST&>F10!KWMC::E:O:WUK#<V[_>BF0.K?4'@U =$THW
M)N#IUJ9S%Y!D\E=QC_N9QG;[=*PIOB!I\$5S.^G:F+:TOQ87,XA4K#(2H!(W
M9*DN!\H)]0.,V5\96:C5EN;&_MIM,2.66"2)6>1'SL9 K'.2I'."".<4 7;G
MPMX?O-/@T^YT73Y;.W.Z&![="D9_V1C _"GZAX=T75EMEU'2;*Z6V_U F@5Q
M'_NY' X''M5,>+]/C35?M<5Q:RZ8T:SQ2JI8F0 Q[=I(8L2 !G.>*PX_$#V?
MC_6)-1-[9V%OH\,[07$@90QE<%D"LPR0%7CG(H [";2M/N+V.]FL;:2ZBC,4
M<S1*75#U4-C(!]*@B\.Z+ +40Z38QBT8M;A(%'DD]2G'RY]JJZ1XJL-7U>ZT
MJ-)(;VWB68QNR-NC8D!E9&8=001G(]*M>(6=/#FIR122121VLCH\;%65@I((
M(]Q0!C>(/"$5Y:00:98:.(!<FYN;*ZM1Y-TQ4C+%1PP)SG!YJUX7\,P>'Q<R
M16=C9-<A-UM8(5A7;GGGJQW<G X &.*PO!U_!JVF>'I#K.HMJCV$=[<AW<QR
M81!(&#?+R9 1M]/2MV+QCI\KZ<YAN4L]2E\JSO&5?*F?DJ!AMPW ';D#/XC(
M!IWNC:9J,R37MA;7$J*45Y(PQ"GJN?0^G2GMI>GMJ$>H-96YO(T\M+@QCS%7
MT#=0/:LK1_%D&MW\MM;:;J2I#--!+<2Q*(TDB8!E)W9R<\<8J#5/&UKIE_J%
MD-*U6[GL(8[B<6L"L/+;=\P)89QL/'7T!YP =#=6MO?6LMK=P1SV\JE9(I5#
M*X/8@\$537P[HJ%RFDV*EX1 ^(%&Z,=$/'*^W2J=EXMT_4KV"VLHYYS<:>-1
M@D4*%EBR!@9;(;+#@@51_P"$_P!/>TTB>VT[4[DZM;R7%I'#"I9@@R5.6P&P
M1WQ[T :UWX7T"^M+6TN]%L)[>T_X]XI+=66+V4$<#V%:H 50J@  8 ':N.N/
MB1IUK!>7$VEZNMO87 M[V7[.NVV)56W-\V<8<9QDC!R,8SJ7_BRRL?M[);W5
MW%IZ+)>26RJPA!7=SE@6(7#$*"<$>M %F3PSH4NGS:>^C6#6<TAED@-NNQW/
M.XC&,^_6I5T'2$6S5=+LU6R_X]0(%'D?[G'R_A5-O%5D]P8;.*:^VPPW#M;;
M"%CE)V-@L"1@$\ \56O_ !SH^G7@AF,AB%VMF]PK(4CE)Q@C=OQD@$A2 ?H:
M -)O#NB-:36K:18FWFE\Z6(VZE7DSG>1C!;/?K2R>'=%E%T)-)L7%WC[0&@4
M^=CIOX^;'O4-EXAM]0N_*MK:XDA^T2VQN1L*+)&6# _-N'*D#(Y_$9FOM9BL
M[^*PC@FNKV6)IEMX-NX1J0"Q+, !E@.O)/L< %[R(?L_V?RD\G;L\O'R[<8Q
MCTQ5#3M&BLM&&CRA+FQB3RHDE&[]T. C9ZX'&>X SSUYK7O&'VK0-)N]&BNI
M(K_4X;.8H5CDB_>A9(CN8%7.&7(Z<G(X-7=8O9O!7@F^U"!;Z^="9$CNYQ(T
M.\@!2Q.2JD],L>V>X .ABTVQ@T_^SXK.W2RV>7]G6,"/;TV[>F/:D32M/CLI
MK-+*W%M,")8O+&V3(P=P[Y''-<?=Z]=Z;X^NG:UU2>#^Q$N#I\3*Q1A*X9L%
M]@.U1_%SVR:V9_&FEQV-I=0"2Y^U68O8XHV1'\D@$'YV49.< 9SP?0T 7XO#
MNBP,&BTFQC80^0"D"@B/^YT^[[=*BD\/6;MI]O'!#!IUA()X;6% JF09VG X
M 7.0!WP>,<R6WB#3KOPROB""5I-/:V-T'5"6V 9/R]<\'CUK-E\;6-O!J;W5
ME?P2:=9I?2PLB%S"P;#+M8CC8V02#Q0!T5Q;PW=O);W,,<T$BE7CD4,K ]00
M>HK+@\*>'K9'2'1-/17A\AP+9/FCY^0\<CD\5G0>.K"6_:SEL-2MI&M&O+?S
MX0HNHUQN\OYCR,C@X/.:;IGCW3M4O-*M_L6HVL>K0>;8W%Q"%CF.S>4!#$A@
M/4 '!P30!?FT&+3;227PUIVDVFIB)88I);?"",-DJ=F&QRW0]>:O:3IYTZQ\
MJ1UDGD=IIY%7:'D8EF('.!S@#)P !FN)TC5UA\,PG5+K5)=WB.6TBEAF)<$7
M;)&KL3G9P 1Z<8KI[KQ5:6\\BI:WEQ!#=):37$$8=(I6QP1G<0-RY(! S['
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M"@D=LX[9(!L3Z&FFVLDOAG3])L]2V)$DDMOA/+#9*G9@XP3CWJ_I.G_V;8+
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M* @?NP ,'J3[5D:7X0UBPTOP7:.UBS:%(6N&69\2#RGC^3Y.OSYYQTQ7>44
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M_@\W(T[&AV[V\OESN=X,2Q@KE/\ 9R<XZXYQD]K)-%$\222*K2MLC!/+'!;
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M9&#2O;PF=H8R-Y09Y ) ['OVH QK)?%XTRXDNX]%345BVV\4#R&&1_[[L5#
M>B@''/)[:FL6US?:#>VD A^TSV[Q+YCE4!92.2 3CGTJ32=1BUC1K'4X%=(;
MRWCN(U<#<%=0P!QWP:LS310)OFD5%+*N6.!DD #\20/QH QO#NC3:?X0TW1]
M06$S6MBEF[P.6#!4"D@D C.,XQ6%I_@_4DT70M"OY+5[+1KN.>*YC=O,F6(D
MQ IMPI^[D[C]WCKQTMCKD%_K>J:4D$\<^G>49&D"[7$@)4K@GLO?%:E '/\
MA32+[1X-32^^S9NM1GO(_(D9\+(^[!RHY%8JM?GXF>)(]/BMI';2[-3Y\I0*
M=T^#@*<CKGIVKNJ@2RM([I[I+6%;AQAI5C =OJ>IH X^P\'ZAX>O]$?2'M;B
M&STHZ9,;IV1A\RL)5"@[N5/RY7J.:AT'PAK6ECP<LYL&71;>:&X*3/E]Z@ J
M"G.,=R*Z[6M5BT/1+W59X9I8;.%IY$A +;5&3C) Z ]ZM6TZW5K#<("%E17
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M=E-!.S:E.T$4B!=JL$9_FR<]%/0&@"CX6TC4-(?6#?"VQ>ZC+>1^1*S85PH
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MY^M=E<6T%W T%S#'-"XPT<B!E;Z@U2A\/:+;2QRP:/I\4D9RCI;(I4^H('%
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M22JJR,]NA+A2"H)QR 0,>F!0!YIK\UREKX]OX=6U%7TNY@ELME[($B)AB<\
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M265K/]AR;=I(%/DDG/R9'R#T Z  =JL)HNE1K;JFF6:BVY@ @4>5_N\?+^%
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M3^R[+?$H6-OLZ90 Y '' !Y%)KUC+JGA_4=/@9$DN[:2 .^<+O4KGCKC.<4
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MIH)+6[OI;R'8"''F$$AL\<'TZ^U6O$4[PZ!>I ADNIH7BMXAUDD92%'Y]3V
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MX43-_P "*(?8[O6@"CI_BC3+6UNI$BNXGFUF6Q\N\G!_TC!) 8L0J?*< 'V
MR<59NM8MY-9\.QW=AJ-O<W5S<)"/-"HCI')D2!6^8%5)7@CD'BJ,7A.^&G:C
M9W=OI=[;WVJRWDUO.6*/$X/R9V'#!MI! [=J;8^#=0L#X:5+J.6'2+NXG*RR
MNQ6.19$6)6()(17 !/7;VSP :+^-+%(8+UK>?^RI[O[&M\-NP2;R@)&<A"XV
MAL=<=CFJUQX^M[;[>[Z1J'V?3[Y;*[G_ '>V(MLP^-^6'[Q>F2!R0*J6W@B[
MC\/#PO+/;R:+'>K<1RY;SO*$PF$17&/O#&[=T[9I+_P=JMWI/B6S66S5M7U%
M+R-B[8C5?*&#\O)_=?\ CWMR ;%SJ;Z5XUT[3F=FM=7BF**QSY<T0#''LREN
M.@*<=3702,R1.R(9&"DA 0"Q].>*YC4+&75O&VCW:!5BT:&>21\Y7SI5"*F>
M^%WD^F5]:U?#T^J7.BPRZS';I?$N)/LZLL; ,0K*&^8 @ \^M '"R>)M0U?2
M?!NM/;75O)<ZN4-O!-\LR%)B$P& /*KRV.1G@5U%OXVL9-.EN+BWEM+B*^;3
MVMIW0-YP&[&[=MQM^;.>GOQ638^#=8L]*\.V#7%C(FC:B;D,"ZF2/$@ Z'#?
MO/H-O?/!/X,UADOKBUO;2WU#^VO[7LG.YT!\H1&.08!P5W#(_O>W(!TGA_Q'
M:^(8KLP1O'+:3FWF1B&&X $%64D,I!!!'Z&N7\1^('U(>';G3DO$LI-=@@6Z
MCFVI,H<JP*ALE"5."1SC.,$$]CI,>J+:E]8EMFNG.2EJK".,>@+<GN<G'7IQ
M7%VW@C7K/2-+T.*\T]K#2M2CN[6>0/YK1*Y8(R@8R,XR#SCH* .A?Q=;Q:I;
M6DME=11W5\]A#,X"[I45F)VDYV':P#8Y/L0:HZ9XV,EIJ5UJ=F;5(-3>P@7S
M$^=E(4+G.,\%B3@ =SBJ3^#==EU"WN9+W3Y7MM9.H)<2(YEDB(D41MZ;!)@
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M596*$,>,YP,'.,9KE-<\.GPQIMM]F^SVL-UXAT^2VL%F9H+=A(N[:2 0&/)
M&!VKH-5\%W>L2:GJ+7<5GJT[6K6CQ9D2 V[%TSD#=EF;/ X(';) +EMXZTZ=
MKR%HI1=VUQ#;B%&23SFE_P!7L8':0><Y(QM.<5%K?B.W_L.];4M+U:W2UO8+
M>41-Y9)9TV.CAAN3+*#CGJ"*9J7A[Q)KFBQF^U#3[?5[6YBNK/[-&Y@1XR?O
M;CN8,&(/3 QC/.9-8T/7]=\+S65[<:>M[-/!)MBWB&-8Y%DP"068DKC/'4<<
M<@%35YKK5_'<WA^:&^6Q72_.5K6Y$3*[2$>:"&!R-N!GH<\8-3:)XGTJT\-6
M#P?:Q]JN+B*&._N5,I9)'#EW9B  0>YZ@"M%=(U >.)-=_T;[.VG+9^7YC;]
MP<ON^[C'S8Q[9]JP;?P7KMAI6E26%[8QZMIEW=31^8':":.=V9T; ##[PP1G
ME??@ V+#QM8ZI;6GV.WG>\NIIH%M25#*T7^L);.W:./F!.=RXZU7^'MS<7.F
MZPUP;G<FL74:I<RF1XU#X";B3P.G4BB^\/:]/J6CZ['>6+ZM9>:DT#!DMY(I
M0N44C+ C8I#$')SP <#0\*:+?:+#J:WTUO(UWJ$UXOD!@%$AS@YH RX?%NGZ
M99:E>+8:HRC6OL,R/()&69S&N5!<X3++@+^7-;>B^(%U>]U&R>RN+*[L'198
M9RA.UUW*P*,001[\$&N<G\':M+8:C;B6R#76NQZJI,CX55>-MA^7K^[QGW]N
M=W2M'O+/Q3KFJ3M!Y&H" 1JC$LGEJ5YR .<YH YOQ)XAO[S3?'E@MO/:+I-@
MS0W,,^UM_DM(&RI!&>,#VYZXK;T;Q-]HN(])FTZ]CNETY;N(N4_TF,84E?FX
M.2.&P>1TJGJWA/4[N;Q:MM<V@@UZT6$>8&#1/Y1BSQP1CG]/>K5OH.I0^);+
M53]D*6^DM8&,2MDN65MV=O3*8_'VQ0!!HGBG3ET/0H=/@NY3?VLD]K#<S@S,
MB%<@L[?,_P PP,GOR *V-9\0Q:)X6FUZXM+EX88!/)"@7S%&,X() R._-<Q'
MX%NF\'Z5X?U"VTR_AL[9XF+NZ,DF1LEC<*64@9R..HYJ?QU;2:=\&]5L[J[:
MYF@TOR7N).&E8* 6/N3S^- &@GC:W74[RPO=+U&SF@LWOH1)&K&YA7[Q0(Q.
M[I\IPW(XI'\;6\$>K?:=.NTGTRQ2_E@4HS&%@QX^8 ,-C9!Q[9J'4O#FIZY+
M)J)O8+&]33)K.REM79PCR[2TI) (^XH '3DYZ8S6\$ZPXU5@^DP?VCHHTUHH
M5<*CYD^;)Z_ZPG)&3C'^U0!NV_BR6Y2W*Z%J,9NF_P!',NP(Z>7YF\L&.P8X
M^;!S@8ZX+/QG8ZC8Z-/:0S/+JYD6V@;"D&,$ON.2 !M(XSG(Q4%YX?U>>#P\
MD<]D4T]2EW:S;FAF^0*K\ 9*D9 (QSU! -<G>Z?<^&M/\-Z-=:EH\5[;7%U<
MP7-TTEO&5)/RB4'(<^;]T=0#V'(!U"_$"V?3[6[71]3*W.H'353$6X3 L""!
M)P,JPS[9X'-27OCA--L)KR^T;4+:.UBBENQ*$!B$C%0 =V'(QDA3P".YQ618
M:7?ZQI&EQ6D.DQ1:9JRWGFVMS))#<@ LQ5BN2Q9VR3GD'DG.+'BKP;K&OSZT
MD=Y9&VOK1(;<W*,S6K+G<% X 8X);K[' H OZGXW73[_ %6SAT+4[R32XHY[
MCR!'CRW#'<N7&<!#Q]X]A6.?$I'C234]-BOM2L;CP]%>QV\4N%P9&^<!V"J=
MH P.3Z=:=:?VE/X^\66ULUBUQ)I]DDK.[*$8K,-P4 [@,]"1VYJ[8>#;G2-0
M4V3V[6<.AII40D=@Y*DG>V%(YST__50!O'Q#9?\ ")'Q(N\V/V'[<,C#&/9O
MZ>N*CT2Z>/PO#JVJ38EFMA=W+$G;$"NXJ!V51Q^&3R2:IVGAB4?#=/"MY+'O
M_LS[ TL>2I_=[-PR!]<5!;6M_JOA'2],:*W5X?)AU."=B"?+QO08!R&(ZG@J
M?>@"MX1UG53XDU;1]=8BXG1-4LD;JD#@*T7UC88/KNSWJSJ'B-?#/B"^M;QW
M>Q;3)=3BR<E#$?WJ ^A#*0.WS=L )JWA KKVBZOX>MM.L9[&5_/^3RQ/"ZX:
M,[5^A!/0CI5?6_#O_"6>([TLVVSATBXTX2CH9IR-V/78JC/NV.H- &C8Z?=Z
MYX8L9+W4+JWFO$2YNC:RF-OF7(C1ARBKD#C!.WD\G.?X=M=6?P]K%O\ VG<W
M'V:^F72KR=]\C(H&-Y_C ?>O/4#Z&IHDUZ]\&:?8Z<]I:ZA!&EO?+<EP4**
MRKMY^8CAO[IR.H(O6TNKZ1HER^IKI[21H$L[73HV53A?E0;CR2>,= !]: 'Z
M7XHM;_P/!XHD5H[9K(W<J*-Q0*I+@>N""/PK \9ZW-=^!KZZ@2ZM?*-I-#<0
M3Y657F4$*T9^;C((]^_!K:\/Z!=:#\/[30X)8?ML%D8Q)(NZ/SB"22.Z[B?P
MKG[CX?7/]EZQ:Z<MEI\6HM;.+**5VMXGCDWO(HVC:6PJ[0 /ESSTH WU\81*
MVL17&EZA#<Z9'',UN%61YDDW;"@1B,DJPP2,8YK+\3>(1J'A#QC:Q"YLM0TF
MR=G,<V"K&(NC*Z'VY''0]JDU;POK=]J&OWEG>V]G+J-E;V\3*[DH8G9CD@#A
M@Y7(Y YJK)X*U:2U\40K)I<*:W8);)%"CJL#!&0_4 -GH,^U %JVFG'Q"T2/
M[1.8I=!E=XC*Q0L)(0&VYQGD\XSS3-9U&\T[XDVAM;:^O_,T>=OL4$P"LPEB
MPV'8(IP3SU[<UHP:%J">*=*U61K816FFO92(KL6+,R-N'R]!Y?Z^U3:EH]^?
M%EEKU@;:0PV<MG)!.[1Y#NC;@P#<@IC&._6@"M;^/-+O--LKJW5Q-=K*5MKA
MTA>,Q,%D#EC@$,0N.<D\<9(T=+\0P:UX976[""9T:-V6"3"/N4D%3S@'((SG
M'?FN=/@K5=)?3M0T&_M?[4@:Y-T+M&$-R+B022#Y<E<. 5Z\#!S77VL%U_9H
MBOITEN74^8\:;5!.>%![#.!GGB@#SY/$>H:HW@#67MKM)+YYF>T@F&V<&U=A
M\N[;@'&"V",9XKIK?QM83:9%<R0R6UP]Y+8_99W166:/=O!;=MP I.<],8Y(
M%9>E>$-8L+?PC#-/8R+H#.I*%U,J&%HAU!YPVX_E[U&?!FMPQ&[LKVR@U2#6
M+C4K8ON>)DFR&BDX!Z-U'I0!T_A[Q#:^([&:YMTDC,%P]M-&^#M=>N""0P((
M((."#6;:^/-+N]3L+6)7:+4"XMIT='#%03\R@EE# $C(Y[X/%;>F1:@MD?[5
ME@DNI"2ZVZD1H, ;5SR1QG)[D].E<YX=\/>)-$LTT5]5LFTFT5DM)TB;[3LP
M=BOGY?EXY'4*.F: +5KXT@N+J*W;3;V*6XL'O[>-P@=XU(!!4L-C?,IP?7KD
M$5@:]XGFU[P5#JEG9:GIT#SZ?-;W#RA!,LLZ!EPC9( )!##!R",\&IM-\&:]
M9W>F7<USIDD]K87%G.P$FZX:38?-9CR6)3G/3/?M;D\):DWPYTOPV);3[39_
M90TI9MC"%T;(^7.3LQ[9[T 77U_3+#Q#K[W*WD,EA9V\MP\DF8F1C)L\M=Q
M.00> 3Q5:Y^(FGV<.JM+97#R:=:"]=()(I \1)!(8-MR".03GIC-)JO@Z[UC
M4?$,DUS%;P:I8P6T;Q,6>%XF=E?! !^9^F?X??A+_0O%6N>$=3TK5[S2_M-U
M:M;1FV5U3YN#(V<G/HHXZ\G(P =)I>H3:C#+)+IUS9!)-J"XVYD7 (<;2< Y
MZ'!X.15^HK82+;1+,$$H4!@A)&?8D"I: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y/QQ>RV:Z
M'YC%-+FU..+4'S@",JVT,>R%]@/;L>#0!TE_?0:9IUU?W3[+>UB>:5L9PJ@D
MG\A5/2=4N]0ED%QIDEK%Y<<L,QE5UE5P3CCD,,<C&.1@FN UR%8]$^(]JA5M
M$AL=]HI;*0W!@<R*GH,^6=HX!;CK7>:79V;>%K>WBAB:VEM5RBC*L&7GZYH
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MC@88@=35_P )W5KK5SI-S=:W'%XBMYI$OK&--MQ(WS"1)06.8QU!P ,#&.E
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MR3Z ]:YW6+A)/B'I^FZJ%_LB?3I6@67_ %<MR'7(/8L$Y&?5B*Y.XC\[PKH
MU1Q<0IXH6"QFN'W-):^>P0DGD@J!SW !H [F[UW^Q_#NH:]J&A2V\ED9#/'&
MT;,Z+U=&R-P(YYP?:GVOBZWEUFPTJ\L;NQN=0A::T,VQDF"@%E!1CA@"#@XJ
MI\1_*M_AAX@0%4C&GR(HS@?=P *Y_3S'I?C32+SQ!=&[MKFR6/1+Z0JJ6\A0
M>9"=H"[F !5CR0"O:@#TRLBRUQ;SQ+JFC?99(Y+"*"4RLP(D$F_& .F-AZ^M
M>;:MJEM9:!XLM9+Y(;NW\10O#$9=KQQ%[<Y49R$(+<].36EKNH7%KKOCNYTQ
MR]S'I5@X\D[G";IMY7!SD(21CVH ].K*U/78=)U+2K&6VG<ZC.;>.1 NQ&",
M_P V3GHAZ U@>$#I-SK%SJ&BZY;WL%Q;)YMM9+B"-@>'8;CMD()!'!(7D<5+
MXRDC37O!H=U4G6#@$X_Y=YA_,C\Z -OQ#KMIX:T.[U:\#M'!&7\N,9>0@$[5
M'T!/L 2> :OVTRW5K#<*I D0. >HR,_UK@/B(FO?V3XAG73+.XTZ/2YHX97O
M2CQ!HCYC^7Y9!;L/F' QQN-4-:U"*6TLK/4_)M-0.@RRK%-<[[=>0%:,84O-
M\HQC&T$]>X!ZG6-JGB2STK6=*TJ19)+G49C$@0<1C8S;F/8'80/7!]#6/X;U
M/Q!?Z#X>N+./3;RQELK<W-U->.)MVT>9A0A!(YZL.<YQ7-:Q_P )1;:WX:DO
M-%T\W4NLF3S5U)CYC>1, N/*^157..O3U)- 'JU07UY!IUA<WUR^RWMHFFE;
M&<*H))_(5S?CJ]ELH-%+,4TV75(HM0D!P%B(;&X]D+[ >V#@\$US.LP+'I?Q
M%M8RK:'%IWF6R%LQPW!A<NJ=A_RS;:. 6]Z .\TG5;O49'\_3)+6 PQS0SF5
M7617!.#CD,.XY'(P34$_B>V34]"M8(FN(=8:00W2,-@"QL^?4Y"TFF6=H_@J
M"WBAC:WELAE%&5?*<_7-><Z FEW>D?#&VCEB*N)%N%BEVDO]C8,&(.<] 1[X
MH ]CH[5Y!!JXTS2K>WFO$BT*'Q'>V<TL^98H8P7\I)/F'R;B!R<#Y<\5WO@V
M"UM](G6QU0ZC9M=2/#*O,2*<$I$<G**<@<G'([4 -T_Q9+JDFI1V>B7LC:?=
M/:3?O(1F10"=N7Y&&'/%;]M/]IM(9_+>/S45]D@PRY&<$>M>9^'A;74_C:,^
M(VT[?K4XPDL2KCRX_F.Y2<=0<$=.QJ;QE<0SSP:_H\LTJQ6A?5(H6^_8/_&
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MSG<3G/?&.,UN7UHM_8SVCO(B3(49HV*L >N".0?<4 31QI%&L<:*B*,*JC
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M^UFU*4^9<>7Y,1(P(HR02![D@9/?:/2N5F^(3V=CJS7NASQ7^E7$$5Q:+.K
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M:3(MW#J#V%Q%YN8X64$F1I .(]N#G;U(&* .F=%D1D=0RL,%6&013%M;=8!
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M"=WR$JH'S;@,9YK1TG0I].\1:UJ;W<<L6I-$RQ"(AH_+0(,L6.[(&>@K<HH
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MYNX(-V=WR_ZL<<]3S74T4 <58>"+RRLO#]N=4@?^R+Z:\W?9B/-\SS/E^_\
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MQ @L"/0UMT4 <IJ/AK6-9\/BSU#6+9KQKJ"X:2.U(B412*X54WYY*\DL>OT
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MMW!#K' N5(D6+;@;>%+8X!/KFO5M/T^TTJPAL;&%8;6%=L<:DD*/3FK 50
M  .@ Z4$9!&2,]Q0!X_I-QI&HZKI=A<ZUIHU.SUFY>XGDN52>\0O(%BV$ALD
ME.#P @QG@5JVVBV_B.U\?:3!*GGG5-]L^[=Y<H@B*M]-X(/_  (5TEAX2N+:
MVBL;O69+W3X<;(Y;:,2, <@/(!\WN< GN:ZC% 'FUW?WVI^ K_Q3#836][);
MPPF&./$J0QN/M 4=<\R@>H136)KR^'9O!7B74]#U<W,%Q;P[T@58K=) XP0%
M Q(03D=< 9'2O9,8Z4@55&%4 >@% '$:(EA8?%'5+33GB2"XTFWN'CC?(DE\
MR4%SSRQ7;D]3QFD\<Q6,GBCP@NH.%MI+NXBEWR%%8&W?"GD<$X'OG'>NYP/2
ML;5M";5-9T?4!=+&--EDD$1BW"0NC1D$Y&!AC^/Y4 >;_9HM%L1/'((] L_%
M<+6<SO\ )#;D*),,>D7F%AUQQ4.N7NGSZ3XX\JZC6+^V;"2$I)L^5A;Y9<8X
M/SG(Z\GWKV4JI780",?=]J7 ]!0!YAXNTZQT<N-*73);>.QDFGTB[;;YT;L2
MTD$F3MDR#V(Y7IQ537]0LX'\?Q7)6UFOM&AN;6VE&)';R9<LJ]RK 9(Z$9->
MM%5;&5!P<C(Z4%5)R5!.,<CM0!XSXPU.PN=(U98ID6_@T&WF@DG8NS8#L&ME
M&"I!&6<$]%R.,U:UJ/1M4U+QW/+)#.JZ);SP%I<@2;)B'49QN!V8(Z9&.O/K
MA"]\>G-+@>E 'FVD26$OQ!T2]NA;O<7GAV,Q3.H+2RAQD@]V //<#VK7^)T-
ML_A%)KJ*)HH-0LY'>101&OVB,,QST&TG)],UV6!Z4=>M 'F5U+IEUJ7BJTU<
MPQQ"TA?1R<+B#RN&M_1A)G[O.=OM7<>&QJ#>%=*&KY.H&SB^U;NOF;!NS[YS
MFM/"/M;"MCD'KBG4 >+*-)MO"LEFGV:WG3Q>J3I'B-T07Q*@D8( 3D>@Y%6-
M;73[/1?B=IUFT,-K#%%+#!$^U4D: 9*@'J6 S[U[!@>E&!Z4 >9>([I8=9_M
M&![#58%CM%FT^0@7,8W922V;G.2W*XYV]:[GQ.@?PIJZMG'V.8\$@\(3U%:A
M520Q49'0XZ55U2S;4M)N[))1%]IA:+S"N[:&&"<9&>#0!Y?HMK8VUSX.U71'
M>2X?2W;5OLTI=Y(1;C&\9^\)-H4'OP.!Q2T?4-*;4;%X+JV2SO/#5P'5)"6,
MBM$0)I.-\H!8L< C+?6O6=%TW^R-&L]/\Q93;0)#Y@3;O"J%!(R>< 5>V@=A
M0!Y+I\6@:;X&\'W<J1K)J0M$N+F:8^09$@;'GY." <@+Q\P49&.*]KJMO:>$
M+-KB_A6SL?$T\<\$F8XGB\R4K&=W" ##JK''RJ.XKV+ (Q@5DZWHUQJ<EG/:
M:E+8W%H[.A$:R1ON7:=R-UX)P001D^M 'F5W'HP\'SW5MJME-'<^([:5!:78
M86T1G3$>5.!A=S8' W'' S5KQI!H>F+JNCV<,-K)%H,UQ:K,2ZDLTC?Z.F<^
M9N&2X/RC;QCIZ3IFE?8&FGFG^T7<X599O*6,$+G: J] -S=<GGKTQH84GMG%
M 'DR0^'M<\3W0URYCDM+CP]:3YEG(5FW2AI!SRPP,'\J31+47NK>$K+Q1MFG
M_P"$<G^T173<M^\A*B0'J=HR0>X)ZBO08=!:/Q9=:XURCB>UCMO(\G[H1F92
M&SURY[>E;6!Z4 <G\,[C[3\/-(8S>:4C:/<6W$!78 $^P KK*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *YSQAJDUE!I5A;NT<NJZA%9>8IPR(<M(0>QV(P![$@]JZ.L#Q7I$N
MI6VGW5LF^ZTR^BO8XP<&0+D.@]RC-CWQ0 GBBZ@T_0TT^.ZBL#?.+.*4L$$2
MD$NP)X!5 Q'N .]9_P /=5&M^$/L-[+%=76G2/IUVP(=92G ?W#)M;/N:VTL
M9;K7(M6-TCVRVQBAMV@*LA8@LQ8MU.U1@KQCZU2MO#\FF>+M3\01WZ+;7T,:
MW%H+<G+1@A7#!OO8..G(Q0!S)\37:0/X=\^3[4/$"Z0MQN/F"W9?.W;NN[RL
MINZYYZUM>+_#6D7>C75S>).6@M]EFD$K(87_ (/+52/G+$ 'J>!6<WA*Z>TD
MUCRC_:9UQ=96 D!MBCRQ%GIN,6?;<<9QS6UJFD:QJVHV^H:?KT5G;QI^Z@DT
M_P S:QZN=SCYL<<C@9'<Y ,[5[B_\,^%M#UB]F\R_LS:6^HN#_KU<K')GUPS
M;P?4>A.>BUK6DTDV,(C$MU?W(MK>,MM!;!8DG!P JL>AZ8[UDZ[HUUJ^E:=H
M-Q<-=L;B&>^NC&$!2-Q(>!P"S*J@=@2>U:/B+0!KL5D\=R;6\L+I;JUG";PK
M@$$,N1N4J2",CKUH Q-1\>2Z99ZT)M*#7^D2P+- EQ\LD<Q 1T8KSU.00,%3
MST)WUU#4HM%N[R^TZ*&Y@$C+ ESO#JO(.[:,9';'%8VJ>"7U6QU82:A&E_JC
MVYFN%MR55(2&1%3?Z@DDD_>/MC>UAO+\/WQE=<BV<$@8!.T]!]>U '-:7XYO
M+J[\/_;M$^R6.NP![2X6Z$A63R_,V.NT8R,X()SCD#H+&G^,9[S6;;2YM-C@
MN;JSEN4B^T[GB9"H\N4!?D8AU/&<<_4T?".@RZEX5\*3W]X&73[%#!%%$8WC
ME,/EY<EC\RAF&,#GGVJ;2? ]]I=QHLQUQ)6TJUFM(Q]B"B1'V'+?/G=E!N/\
M7H#S0 [2?&6K:IH-MK(\/I%:72Q-$YO0=FYB':3Y?E50,Y&<Y' [/MO'<=QI
M\<HM$-Q)JYTE%2;=$TG)W[]OW2HSTZ\>])'X(N8/"&CZ)#JZB72KB.>*=K;*
M2["2%DCW\CGLPY /:L77M"GT33I()=4F>'4=8^W27/\ 9OG1VQV[L.JG)!=5
MP1MQQSZ@&K<>.[RVTS5;M]%1SINI1Z?(B7?WV=D&Y<H.,2(<'U(XQ5C4_%>K
M:/8S3W^BVT#0V\T[%K[]V^PG;&C;,EV4%L8&/Y9EGH>HZ_X>NM+;4;,69N(+
MF&]ATMX/,=9/,8%&?YN40[\\[B.HK9USPG<ZOJLMXFK?9TN--?3IHC;A\*Q)
M+QDM\A.<'@Y 'H#0!!-XPU&?4X;#2-$2[EGTQ-2B::\$0*L0-K?*<'\^W3J,
M&+7FU_Q5X5US2M.7[5=:9?J8+B7RPCI)$I5V )PK!AD*>O3FK-CI]]IWQ L;
M"WU&%I;7P\MLT\ML2KL)>!M###8 .,GC\ZV;#P6-+U#1[BSO@(]-MIX=DD.X
MRM,RN[DAA@EES@#N?P -+P_X@36_"\&M/ ;8.CF6(MNV,C,K#/&1E3S7$ZM<
M2:K\$-4\07(_TV^LGO%?/,0))C53V"K@<=\GJ37:^&] _L+PZFCS7*W:*TI+
MB+R\AW9R",G^\1UK!MO"MQ<_#N?P5+<FV:*)K07+1;P\&3L9>1SMP#SP0?8D
M R+R[BL?$?@]-.M;C1C/.%N)Y5\JWN4*']R0#M:1C@KGG@\UU%I?-I_Q GT)
M?^/6[L/M\*]HW639(!Z [D./7<>]-O?"5SK#:3'J^IQ36FFW$=TD%M:F+S)4
M'R%V+L<#K@8S4]KIKW?C>XU]U*PPV0L+;<,%\OOD?Z9" >NTGI@D ENM>N&U
M>]TO2K..[NK&W2><2S^4 7W;$!VM\QV,>< <>O',:GXAD\2-X+GTZVAETW5+
MB1Y(+J4IO98)3Y<@",,*PSW^91QWKI9_#L\?B6?7-+ODM9[JW6WNHY8#*DFP
MDHXPRD,-Q'<$'IWJHG@M;0>&XM/O1#!H;.Z+)#O:9F1D8L0PQG>QX'4_A0!%
MKTLWA'2-$L/#]M!';RZG!:[))6^1'?)53AL \CV!X'3&"^M77AC7_'.J0:7%
M<06SVMQ=K]H\O:OD*7V?*=S<D\[0?7-=KXCT-]=L[6.*[%K/:WD5W%(8_,7=
M&V0"N1D'D=16/?\ @B>_@\3Q/JR :]%'&[?9>8@L83(^?!) SVY_*@"2]UJV
ML?%U\S:1YMQ;:(;M;J)]TDL0<_N@N.N03U[BM+P[KP\06[74/V.2T*(T5Q:7
M/FJQ.=RG*@JRX&0?7MTJK-X:O)-;FU5-52&9]*.GKLMN4;)82 E^H8YQ^O>I
MM%\-1Z3K.H:J7@%S?1QI,MK!Y,;%-WSE=S9<[N3GH!]2 <CXDN5T+Q/J5YXI
MTF:\T&\$?V;5(%,ATX! K*0/FC&[+;U[M^6ZWB5--LK73M(C_M::#38KD2 O
MMEC(*H041^7V-UXXK1N-'U9I]3^SZK;BWOFSY-Q9F7R?W:H0I#KD';G!!Y-9
M2^ Y=,ETR;PYK+Z=+962Z?)YT N%N(5)*[ERN&!+$$>IXQ0!:C\6W=_#(-+T
M:62]@L8[R>TNG,$B&0-MBQM/SG8W7 ''//#+;7=9N?'$VF_8X([5-*ANQ%),
M5D5I&<8;"D9!3& <#KD]*6X\(W\>N)JVDZ]+:7$ELEM>F:W6<7(4DJ^,@*XW
M-SR.>E7%\.30>)EUFVU$KG3TL9(I8O,+A&9E;=D<Y<YXY]10!D>&_$UK+H?A
MZSTG2HK:74;>6:&S,V(X(HSAB6"DGEE XY)/I3F\>RFWMO+TC==G5SI%S ;@
M#R9L%@0VWYE(P<\<$<=J73_ DFEV>@FUU11?Z,LL4<[6_P DT4GWD=-^>P((
M;@C\*GE\%%EM7COU2X35_P"UKB0P9$TN"NT#<-JA<#J3P/?(!H^'-=GUG^TH
M;NS2TN]/NS:S)'-YJ$[%<,K%5)!5QU [UF:PI3XF>&&624"6UO=Z>8VP[1%@
M[<XSR><=ZU=%T.32=0UBZ>[68:E="Y*"+9Y9V*F,[CGA!Z<YI+_0YKWQ1I6L
M+>)&NGQS1B$PEBXDVY^;<,8V#''K0!F>(U*^._!CK)*-US<HRB1MC#[-(>5S
MC.>^,UN:[K,&@:-/J5PK.D6U51>KNS!54?5F _&JVK:'-J6NZ-J27B0C3)9)
M1&82WF%XVC/.X8X8]NM3>(M#M_$F@W6DW3O''.!B2,_-&RL&5A[A@#^% %*/
MQ#=KXA;0KNQABOI+0W=JR7!:*958*REM@*D$KV.0<^U8WPYLEU#P]IOB&]M(
M?[5DAD'VM)6+RAW);?P >0,9W8[8K=MM"NO[535K^]AN-1AM&M8'2W,:(&(9
MF*[R2257N.!CO4GA;0W\-^';32'NUNA;*5641>62,D\C)]: ."U/5=2UGPO#
M>ZC:VYFMO%,,,(@DR?DO FT9 QPH&<\YR<5U*^-7MQJT.I:>L-[874%LL4$Q
ME68S!?+(;8#_ !<_*<8.,U"_@:X^Q2V<>L*+<ZP-5B5K7)1O.\XH3O&1N[\<
M=N]2:AX&.I3ZY++J;1/J4EO/"\$.U[66 #RW!+'=R 2,"@!DWCJ2QMK^74M*
MDLTM;B"(7,GF+;NLO ?>R @*<AOEX..<'-7)/%<B)90BTA>]O1-)$L,S2Q&*
M,@>9O1"2#O3'R_Q>U20Z)K?V';>:_'=79==[-9!87C (*&(-WW')W=AQQ62O
MP\:QALY=%U7^S=0M+F>:)X[8- $F(+Q>46X3Y5(&[@C(H Z/0=3DUW1([NZT
MV>QE<LDMK<(05()4]0,J<9!P,@]*\GBF@M?ASX@N$TR^-]#?WJ6]_;*0;<K*
MP1C(#N")QGM@'BO8K&VN+6Q$4]VUS<\EYW3 9CZ*.@'89Z#KGFN7L_!>IV?A
M_4-%CUV 6]]+/)+(MB1(HF8EPI,A ^\0"0: +5AXDN(M1T'3+M;>XBU&P\V/
M4XI_DGE15+*%V]P2P.>@/I67J%VVJ>(/ NI26R0M+?7/E;7W[HC;3;6S@?>
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M<QN)?+P)D+(@ 4Y;:"3T XYYXJ6EI>WWCGQ=;07\4"SVMI"\AMRQ8A'#%/F
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M#-%N9<=!M#<CL#6A=6VF6T'Q*L+>"UCLQ:I)#;HBB/S#;D$JHXW;@O3G..]
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MJ?;01B=?WA\]I._ELF3D\$%<=J /1I=7^TV6H/H_V>\NK.0PE'FV)Y@ )4N
M<8#<\=1BM)I$0J'95+' !/4^U>.:K:Z?#X)\?VGV2)+Q=2E=$\C#;24*8X[\
MD?CCO6YJEWH\WBO7=-\3Q226VH06_P#93I&[^;'L^98F4<.),GC!.5/:@#T=
MI$5E5G4,WW03R?I3J\IU8:==^(=;T?Q+-J5K/<202:8((5=Y(Q&F%BD*,0ZR
M*^<$<G/<FO0M>6)O"^II<S3PQ&RE$DL/,B+L.67'\0ZCWH K^)_$#:!H$NJ6
M\$=V(Y8D9/-VX#R!,Y .<%NG'0\UMJZMG:P.#@X/0UXYJDLP\)^(+*Z73KAE
M.GA-3TT>7'=KYXP"HX615!)VD\$'@8J[JITO2-1\;1V]D'T^33[)WMK,F,.Q
M>17;Y!V!0N0"=O7- 'H'B+6CHOAC4=9MH8[O[';O/Y?F[0P4$D;@#Z>E01>(
M99/%-EH[6B".YTU[X3B7)!5D4KMQ_M]<]NE>>75Q$=,^),,4J.EQIL<D)@MV
MBBD+0,N4'(.2%'4YQWKJ+:>%_B-H3+*C*= F4$'C)DA('U(5C^!H Z#7]<ET
M6;252U29+^_CLV8R;3'N!.X#!W?=/<5KJZNNY6#+Z@Y%<A\1(H9;+0VNDS9Q
MZQ ]RS9V)'AP2Y[+R 2>.:Y.]LCH\>O7>BP2)X6;4+*22*RC#)L /VAXDP05
MSY>0 0=K#L: /6T=)$#HRLIZ%3D&J_\ :-H=4.FB93>"'SVB!Y5,X!/IDYQ]
M#7/>"X-'_P")E?:'=W5U:7LJRL[H$A\P+@^6H11T W$#!/OFLS4K?38OBA=R
M7]M!MN-#4(\D((=EDDW<XZA2N?;':@#O!(C' =2?0&ER#W'%>.6>E:78_"_P
MKK264,=Q!<Z;)?W03+HL<J[BYZ_+D_0<=!4^H7I:Z\9W6FQW$EH;_3KB?[-
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MBTF2**0R-@@.ZD+L^4D\$\[3TXSM^(-:A\/:%=:I.C.D(4!%."[,P55SVRS
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MH^"TU+2M6MY;W;=ZM+%)=7*Q=H]NU57/  4=2>I]:W#K.EB'SCJ5GY6POO\
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MK*75I)0H*@9)&3TQS0!S-GX&^Q66APQ:K*LND7$TT4PA7+K*'#J0<C^,X/;
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MX9;T30:-:26:QM#CSXW0(=WS<':HZ=\_2I-.\'+9V^E65Q?O=6&D2^;8Q/&
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M'Q#]J>/[,_F>5]O\S<%QDC9SP.E>H6E_9ZA&TEE=P7*(Q1FAD#@,.H)'>K%
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M*QQ\I /\6*T?'4;[/#]R+>::*UUF"6;R86D9$VNI.U03C+#MWKK*"0!DG %
M'D6L67GZ/XXG739VNY=6@DM6^R.9&55@Y3C) *OR/0U?U)(;C7/$&CZ[::O/
M#J<\4]B;2!FCG01QA4\Q5/ELKH3R5 SGN37H-MK.EWDX@M=2LYY3NQ'%.K,=
MN-W /;(SZ9%2-J-DM\MBUY;B[8$K;F5?,('.0N<T <%;Z*+K7O';6M@J7[^6
MVGW,EOMQ+]E";XW(QD/G)%9]M;_V]H,C:59ZQ:^)+31YK("YA:W2V8ICRPVU
M5?+ ;<$XZ\=_5J* //[*/^T]9\'WNG6LUI_9]K+'?H\+1^5&8@HA;(&3Y@4@
M?[)(IWAG6+7P]X>U6[O[>\BB;6[MN+23<$DG9E<C&=FTYW=,5WU17%M%=1>5
M.F^/()4DX/L?4>QXH R/&<:2^!M?61%=?[.G.&&1D1L17#V>DV%W/X8U#3+%
M42VTF8:DZVY7S$>)0L;\?,Q?YL<G@GOSZ-JEE!K&F7NER3O&EQ"T4IB9=ZJX
M(/4'&1GM3]+MHK/2K6U@G:>&&)8TE8J2R@8&2H /'M0!YGI^E/I_@+P7>V^E
M.GV6:T;5XTM2)F1$89=<;F"2,&QSTR.E;*>&T\0W_C),-'I&K0P)$Q0J#<*A
MW3*#Z?N^>Y3VKMDO[.7/EW<#X(!VR X). /Q-6* .#@34-4\!:M?ZY8,FHRZ
M>]H;<Q[B3&K*2% _BDW$8ZC96=H<\NFZQI+ZM97;6$_AZWM;9A:O((I5SYL3
M*%)5F^3J.=F.U>D7%U;V<7FW,\4$>0N^5PHR>@R:EH \=T&6YT;1_"5QJ-IJ
MT6F+IDMI*8+-W>WF+J1OCV%MK*,9 /3WK9TZ*+PUXDT;=I^H1Z!_94EM9>9"
M\S02F8L0X )0LFS (XV[?:O2:* .2^&D36_@.QMWMIK9HI)QY4L+1D S.1@$
M#C!'M7*:]!.FA?$2P^P7C7%U>+- $M782HT4 &U@,-RK<#G@UZQ10!YCKL,5
MMKGB5[/0Y;NSG\/1(;:&%XTN&$DF5RH&2$8<#G%4;^"[U"+QVL%O?W)U#0H3
M;N;!XEE95F!" J,=5 !RQ]^M>KS7,%NT2SSQQ-,_EQAW"[VP3M&>IP"<>U2T
M 86G>(K&2XT[31'=QS7-KYT1EM7C4@<$$D##<$X/.!FL[QU#YDWAJ1;=Y7AU
MJ"0M'$7,: -N8D X'(R>E=2;:)KE;EDS*BE58D_*#UP.@^M2T <CH(Q\0_%3
MF&54E6T$4C1,JN51@VUB,'!(SBE\6*\7B;PG?&VGEM[>\F$K0PM(4WP.JY"@
MD L0,].:ZVB@#R.[L@VBZ[<+ITYO3XJBN(7%J_F&,3Q'>IVYV[0YR..M798H
MKG6=9T37;36)9KG4EO+$V\+>5.@V&,B55^0IM .6& /?%>E-=6Z726K3Q+<2
M*62(N [ =2!U(J6@#E/B5;&[^'6N6\=N]Q-):LL421EV9^V  3FLG75@T+6]
M%U.WL;J'1)()TG?3K3<T4S^7MD= I8Y5"N<9'3O7H-% 'F5NMOX5U71ISIFI
M_P#"-M87%O"&MY)WMY'E#Y>, LH=> ,<< @=*NV<*:)XLTZ1].FM= ;1S:VB
M-&SBVD\S<5<<E2Z;.O\ =V]:] HH \DTGP^8-2\'VNIZ:TMNK:CB.:V+K#;N
MV8(Y,@@?+T5NG3M4>OI+%X;\=Z)=Z9=/?W,YEL1%9O(DT&U!$$*J0-FW&.,'
MZUZ_47VF#[4;7SX_M 3S/*WC?LSC=CKC/&: ,[7A?7GA+4ETDNE_-92"U+ H
MPD*';UP0<XZ]*X6RO(;K6/!,UGI-^C65E<P3Q-92(86\I (V8K@?,,9SCOWK
MU"B@#ROPLSMXD\*SKI][;6XTJYMGMS92K':MNA(B+.,G&&RS'!(XQG%5-(FO
M-(\,>"I[FRU6*RTZ*:UU 0VC&2"8JH5]A4EE&'4LH/W^M>OT4 8?A.RLK#0E
MCTZWNH+-Y9)8DN@5?#,6)VD H"22%P, ]!TK<HHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD?B
M:]TG@+43;3)'GRTDW(6W*TBJ0,$8SGWXR*ZZLKQ%H47B319M+N+F>WAE*EW@
MV[OE8,!\P(Z@=J ,B*\NF\1ZII>E1Z;'J4%M%<WMT]LP6>1]RQK@-GA4Y8DX
MR,"LNW\;ZSK8T :/9V,+ZM9W,I%XSMY,L+*K*=N,KN8C]?:NDN/#:2:RNKV]
M_<VM^UO]FFEB"$3(#E=RE2-P)."!W(Y'%16_@^QL[_1KFTGN(4TF"2""!2I1
MEDV[RQ*EB25!SD<_6@"UXAUO_A'?#L^IS1K+)&$18U; >1V"*,]AN8<]A7'W
M^HS^'O'VIZMJ?V><6OAMIS]FC,9?;+]TY9NXX.>_3BNWUS1;/Q#HMUI5^K&V
MN%VML;:RD$$,#V((!'N*QD\$037<ESJFJ7VI--I[:=,MP(U62%CDYV(#GW!S
M0!GZQKOBFUTO6Y!:0Q10:5+=P7WD%1'*@),90N2V1R&X''(J2'7]62"RTJU\
MJXU(:6EX\K6[,I#95%V[P<DJV6SVZ<\7K'P7%;:3=:;>:QJFHVTUJ]F@NI%)
MAA88(4JHR<8^9LGCZYBF\"QN=-N+?7-5M=1L8/LPO8FC\R6'CY'4IL(&!CY>
M#SUH J+XD\4W>L6.EPZ9I]C=W&EF]DCO'9_*D61$9"4/(^8X_ ^QJW'C/7X-
M.U#4OLNFF#3]9&G219?=*C21QA@V<*09 >ASZ#'/2P>&+>VU^VU>.\N_-@M&
MLQ&S*RNC,&)8E=Q8L <YJE+X&M9M+U#3VU*_\J^U :A*P\O<) ZN /D^[N1>
M.O'6@"C=^)-5@@\76=];:=<3:58K=QA4812QNDAV.I)SCRR,]#GH*>GB#6[C
M5[#2=.@TR$7&BB_6257(C8,B[=JD?+\V,9'UXP=*[\(6]Y<ZW/)J%X&UBS6S
MN OEX5%# %?EX.';KGK3K;PI%:ZG:ZA'J-X9K;3_ .ST!$>#'D')^3[V5'MQ
MTH QK'Q7/JP\$7;:?9C^UQ*7+@L\#B!V/EGL#M(SZ&H;;QEKK1VMY<6VG"T?
M7'TB6./?O/[UH@ZDG P0,@@Y]JU['P/::?!H$46H7Q70RYMMWEG=N4J0_P G
M/RL1QBFCP-:BPCM!J=_L35#JH;]WGSO,,F/N8V[B3C]: *%]XRU1?M4EG;6I
M\C6DTK[-*K>8VXJ/,R#T^;=C'W1G-=)XCNKNR\+:G=V<D<5W!:22H[IO4,JD
M],C/2N&73]9DUK4+JWEU^PU62YD:.,VEO-;$9PA\YD)V%0N1N!&2 *]&O+./
M4-.N+*YR8[B)HI-O'##!Q^= 'G:G5)==\!SK-:R:C-I-V3/+&VW!2W.6&XEC
MSZC.>U:NF^-;W4M,T=%MHDU._%UOV1M)&GV>3RW(7<"<L5P-W )Y..=.T\'Q
M6ESHUQ_:M_+)I-O);P&3ROF1PH.["#LBXQCIWR:IGX>V:Z98VUOJFI6]S87$
MUQ:WT;()8S*Q:1?N[2I+'@CTH W/#]YJ=]I$<VKV LKT,R21!LJ<$@,.3@,,
M'!Y&<5A6'BNYU+6KO2EGL[.^@>=6LKF!Q*J*6$<JY8"5&PI.W&-V,]ZZ?3[$
M:?9K!Y\UPXR7FG8%Y&/5F( 'X   8   K,C\+P?VE9WMS=W%V]E)-):^:$S&
M9 0PW!02H#$ 'VSD@8 .;\+>)]4N-"\*VMQ<03:GK5O)<^>\3;8T10S94-\S
M$L ,%1@^V#<M/&MU/=C1I8((]8_M1].+X)APL1F\T#.<%,?+G.3UQS5JU\!V
M5C8:5!;ZA?";278V-RQ0O$C#:8\;<,A'!R,\ YR!4E]X'T^]L#$;F[AO?MO]
MH+J$3*LRW&-N[IMQMPNW&,#'O0!S_C'4;K3[30=1\10P1&QU_=YMLI8/ L,Q
M#A>2I(ZKD].M3^+IKV]\(:??7 LW>75K"6U6+HJ&X3;E\L"2",E>.N,BMV?P
MA%=0Z>MSJ=_-+9W8O3,YC+3RA2GSC9@#:2,* *K+X"M(](&DQ:GJ"6,=ZM[!
M"#&1 5D\Q43*<(& X.?3- %.3QI?Z=/JMAJ$-I)?6]]:6=L\ 9(W-SC9N!)(
MVY;.#R!QC-&N:S=,GB3PWJD5O+(NBR7L$\*%5>,AD*LI+88,!W.0>V*T;WP/
MI^HSZO+=75V[:FT+MAD4P/#_ *MXR%R",9YS5F3PO#<QZ@UW>W$UW?6GV*2Z
M(172+YOE4!=HY9B>#R?8  &1H6KW%Q:Z1X?L/LZS1Z';W<\EQ&9%VL B*%!&
M<E6).> !P<\8W@C6[NW\(:#HUA%&+QK&6Y9C"950"4J!M#*3DD\YXQTYXZ=?
M!4$%UIMY9ZI?VMW96:V)GC\LF> <A7#(5R#R" #R:IQ_#JTM;+2XK'6-4M+O
M35D2"]B>/S#&YW-&P*;67/(R#@]Z (/^$E\5W%]I.FII>GV.H7VGSW$D=V[.
M(9(W1<?(>5._COS[8-W3?%<U[XHDT::2UM;J&>57LIHG25X5#;)8W)Q(&PIX
M' 8YZ<Z$7A>"+6M/U1;V\,ME;R0*KLK"02,&=G)7)8E0>"*!X8A?4K6\NKRX
MN39W4MU;)*$_=/(&! 8*"5 <X!/IG.!0!)KVM/I<NG6D$>^ZU"=H8LH6"[49
MV;:",\+C&1U]JP)O$_B:UCTV.YTJUAN+K5CIX:4LJRQ[&=)54$E<[<%22<BN
M@\1>';;Q'9P0S3W%K/;3"XMKJV<+)#( 1D$@CH2""""#523PC'/'IOVC5=0F
MGLKP7OGN8]TTH4H-PV8 VDC"@?GS0!S>I>)M>FT.=!-:6U[9^(K?3)I88F*2
MHTD1R 6RN1( 1D]" 1G(OZMK>I6FH^)K>&.PBO+'1([R*\6 EG/[WA@3T!0D
M#)QN[UH3>![2:TU*!M0O@;[4(]2,@,>Z&="A4I\F,?NUX8&K,GA.UFU'4+R>
M\NY3?V"Z?,C%,&,;N1A<[OG;G/?I0!S<1N)=:^'5Q>2I-<O!<%I50J2#; \Y
M))/J<\U?T[Q9JVHC3-4ATX2:)>*\DKA"KVT>TE'+%L/G ! 4$9[XK1M_"$4$
MVA2MJE_*^C*RP&3R_P!X&380^$'\/'&/7DU'I'@FUT:X98-2U!],WM)%IDKJ
M8(F8DG'R[BN2<*20.N,XP <Y?ZC>:[)X#UN1+6.TO-466&)4/FQJT$Q0%\X.
M5Y( &#CKUKH_B#?7^F^"[ZZTVX6WN%,:[V0L=K.JG'(P?FZ__KJM:_#^VLX]
M-MXM8U/[%I=W]JLK8F,B'Y679N*;BN'(&22!WK?U[1K?Q!HESI=U)+'%<  O
M$0&4@A@1D$9! ZB@#).M:K=ZKJFE:<;)KO2[>)YGFB;;-+(&944!LH,*.26^
M]TXYTO#FMIXD\,V&L6\9A%W") C\[&[@^N#GZU4;PJBZF^I6^IWL%Y/;K;W4
MJ>63<!<[68%<!QDX( X.,8QC7T[3[72=-MM/LHA%;6T:Q1(.<*!@?6@#FM)\
M2:E?1364ZVD>L0:HUE+$L;;!&!OWXW9P8OF!Z9('O52[\;W<7AVZ\3PPV[Z1
M:WK020E6\YHDE\II V< Y!8+MZ#KDUTL.@6,'B6YUY%87MQ;I;OS\I"DG./4
MY SZ**SAX*L56[MEN+@:9=W7VN:P^4QF3<&.#C<%+ $KG&<]B10!C?\ "2ZG
MI>K>+[B\GBN;:PN+:WMH%B*X,J1[!G<>-TO)QD]>.E=#HM_K<^J7EMJ5BJVJ
M(CV]XD?E!R<[D*%V((P#G."#VQ4%[X*T[4;C6GN9[IH-81!<VP=0@=%"K(IQ
MN# *O?&1G%7=#T*31XV^T:M?ZI-M"+->LI9$'8;5 ^I/)XR>!0!D>+_$^H>'
MX[Z:VCM#%:6#7:K(K2/.RD[EVJ044 #YR",L/2BTU/5+KXC-:_:HAIPTB*Z6
M#RCD%W8'YMW7Y!SCIQCJ38UGP7::U>ZC</J%];KJ-C]ANXH&3;(@W;3\RD@C
M>W0@'OFK-KX7AM=9M=42_O6GALELI Q3;.BL64O\O!!8GY<#MC'% %+QC>ZI
M:7OAN+3KN*!+O5%MY@\1?</+D<=&'&4Y'?CGJ#S":MJ/AN?QEJ5E#9M:VVM1
M&XCD5MTBM%;JP3! 4C=G)SGT[UWFN:%#KB6/F7-Q;2V5TMU#+ 5W*X5E_B!!
M!#L.G>LJZ\"VEW8ZS:/J5^(]7N$N9R#'E64( %)3IB->N>E $.H^)]8>XU1=
M"TU;UM-N4MW@9.9VVH[A7W )A7&,@Y(]ZW/$6I7&D^&-3U.UCC>>TM9+A4ES
MM.Q2V#CZ5F7'@N&37)]4M]5U*T-XJ"^M[>11'=%1M!8%25)  )4J<"MK5],C
MUC1;S2Y99(8;N!H'>+&X*PP<9!'0GM0!R\'B'Q'/K5CIH32E.HZ:U[!)LD/D
M%2@8,-WS@^8,8VXYZ]V:9XUO=6T[1DAMHX]1OK>XFDVQM*D?DR"-L+N4G+,,
M<\#-;4/A:*'5-.U!=0NS-863640(CVLC;<EOEZ_(O3 XZ5F#X>6<6FZ;;VFK
M:E;76FR2O:WT;1^:HD;<Z$;-K*3V*]A0 V#Q1K=P+/3IM,6QUF2UDN)T:,SH
M@5]BD*K@X;[W7@<<DU7T[6/$E]XRT>"]CBT[S='FN+BP=-^V19HE/S!L<@Y4
MXX!.0<\:E_X*@NVL+F#5=2L]2L@ZK?PR*995<Y<2!E*L"0#C& 0,8'%61X6M
MTU73]2BO;V.XLX)+<MO5O/1V5VWY4\EE!RN.XZ<4 <Y:>+-331=(EM=/TV*2
M^UN?3I8U#(BXDE&\8[GR\D]R:LCQGJ-KI&IO>V]JUY8ZO'IC31*RP@.8\2L"
M20 )1D9ZCJ,\7H? UK#:6-LNI7Y2RU%]2C)\O)E8N2#\GW<R-Q[]:S_$/AR6
MPTO4/L;ZM=+JFI1W5X;7RFD@ "Y9$*X<?NT4J=W!)P>00#9T'6-1U#7=;L+N
M.V,.FS)$D\*L/-+(K]"3@@-@C/\ .DU+4Y;;QOHFG_9+:2.ZMKIUF9<RQE-F
M0I[ [AGZ57\(6NHVQE#WFH3:=L_=KJ%I%;R*^?X5C53C'7<.N,=ZU+[08K[7
M]/U=[JX26QBEBCC3;L828W9RN<_*O0CI0!D^$O%<GB*=HY);:.>*'-U8&)XK
MBTER/E8,?F7K\P !Q[TWQ,B_\)QX*?:-WVNY&['./LLG%:6F^&8;'4H-1FN[
MB\O+>T-G'-.$#>62K'<54;CE1R?ZG,^I:%%J>K:5J+W5Q%)ILCRQ)'MVL60H
M=V5)^ZQZ$4 8>F^)]9U:;3;VRTP3Z3>3,DF$VO#'\P63>6PW(&5"@C=U..:V
MG>-[S4+/4)(889=0LK226;2!"\=U#*"-J8)^=3S\R@ X&.N*U-*\%V^CW[O:
MZGJ/]GF9ITTQI%,$<C')*_+NQDDA=V ><4H\&PEX9IM3OI+NWM&LX+O]V)8T
M8J2=P7YFRBX)!'7CDY )O"WB!/$-O<7,%]9WD",%5H(VB=#CYED1B2K ]CVK
M+N[K4I_'VIZ;)<P-IL>CI.+<PDG+O(IYW8SE!SCIQCJ3OZ9H<&FW]]J'F-->
M7WE^?*RJNX("%X4 =SSUY]  (;SPW#=:\^L)>W=O/)9_8Y$B*;'0,S*3N4G(
M+-T/US0!R/@76=2L=)\$Z9/':-8ZCI>(M@;S8VCB5LL2<$$9X &/4UJ:7XMU
M.ZUVPTVXBLB]]:7$P$(8K!)&R#89,E9!\^"5Q@CWJ[:^"+.TCT&-;^]:/187
M@MU8I\Z,FP[R%S]WCC%0Z;X#M]+ETF2+6-3<Z5!);VH<Q86)]OR'"#.-B\]3
MCDD<4 9V@^,M:U#_ (1:YO;:P2TUSS8]D._?$ZQNX;).""$(QCCKGM6C\39+
MF+X<ZV]K,L3"V8.2I)*'@@8(P>>O/TJ6Q\#VEA;:#!%J%\R:)([VV[R\MN5E
M(?Y.1AV'&.M:GB+0X?$FA76D7%Q/!!<KLD>#;OVYZ#<"/TH Q7=M/\=Z9:M8
MZ6UUJ%G</+?1VQ27,6P*.I.W#@=3T[5QT\FJ1^#]=U(W-D]U;>(I4CE:T)>,
MFX$)*,7^7Y6P.X'&>X]'F\/I<:[IVKR7UT;BQAEA1<(%<2;=Q8;>OR+T(Z5G
MGP/9MH.IZ1)J%\\.H737CR$QAXY3(),KA,8W '!!H KZCXCUL7&I6>D6<-[>
M:8L8E0PD"XD90^U3O_=C:1@G=R?;EEYXIUJ=M1_L32?M$NG2QQ26LB_-*Y1)
M&4/N"H0L@&2&!(/:K=SX+CEUC^U+?6M5L[F6)(;PV\B 787H7!7AN2-R[2!T
MQ2S^";9M;EU*RU+4=/6Y1$O+:UD417 0;5SE25.T!<J0<#KWH Q]8\9:]8_\
M)3-!:Z?Y&@B*4K+O+S1M&)"O!PK8/7D<=#G-=CJNHC3=!OM3V;A;6LEQM]=J
MEL?I6->^"+.^C\01R7]ZL>N(J7"IY8"*J; $^3CY1CG-;SV4<^FO87!::*2(
MPR%L NI&#G&!R* ,7PU;+<^ [)KX+<RWUFMQ=&101+)(H9B1Z9. .P ':LOP
MA:7=]\'-(M+"Z6TNIM+2..=D+^62N,X!'/XUMZ!IUS8>&H-$N)'62RA%JEPH
M!\R-1M1QG(SM R".#GJ,$I9^&O[-\*6^@V.JWUNELB)#=+Y9E55(('*[3TP<
MCD&@#"\&6$-I/K'AW4/#VD6-W'%$TTNFP".&]@?>%;'4$%7!!)P>AYK4\!ZG
M<:GX73[7(TMS:7$]E)(QR9/*D9 Q/<D $^^:TX;(Z7#<70,]_?2JH:23:'DV
MYVKP JJ"3V &23R34?AC1?\ A'] @L&<23;GEGD X>5V+N1[;F./;% '$^,=
M6N?$'@O4;NW%JNGV^JPVRJ\9,C^7<HC.&SA?F!P,'@=><#;U3Q;J&FZS' T5
MH8'U6"P\I0SOY<@4"1G4[4.YCA&&2!GO3KOX>VEQ%J5K%JNHVUAJ%RMW+:1&
M,HLP=7+*60L,LH)&<9IT_@"UFEG8:OJ:)+J$>IB-6CPEPI4[AE,X.T<$D>@%
M #3XGU*"\U[3+E+0:E:O%_9Z!&"W$<IVQL?FS]_*MCIMS3F\5S1^+6T*>6UM
M;@2QK#%<0NAO(BJEWB?=M)!+#9R?E]ZD@LTUSQA;ZM-I%W:'2$FMXYKH!3.S
M$ %0&.Y  Q!./OC'>KMYX8AU"\66[O+B:!+R.^CMW";8Y4QMVMMW 94$C/)S
MV)% ">,-:N_#WAY]1LH(9I4GAC*3,0"'D5.W?YJYW4_&7B#0V\0VE_9Z<]W8
MZ8=4M)(2_ER1@D,C@G.X$=1C.>U:OQ&MKB]\&SVMI#<RSR7%L5%O&7<!9T9C
MP#T"D\^E3WOA&UU>TU(7EY=/-J5H+.6<*BND'/R*-N%R68G(SD^P  *%YJ^L
MVLN@-J=GI,J7^J)#%L5V:!6A9@PW?Q@JPR.QZ=:BN_&]W%X>N_$\$-N^DV=Z
M\$D!5O.>))?*>0-G .<L%*\@=036[?\ AN+4(]'6:^N@=+N%N(F79F1U5D&_
MY>F&;ICK54>"K "\MEN+@:;>77VN:P^4QF3<&;!QN"LP!*YQG/0$B@"*PUK7
M=1\6ZKIT<6G)8Z;<Q)([;S))&\0?Y>P8$CKQUH\6WNJ6VL^&+?3[N*".[U!H
MI@\1?<!#(XSAAQE>GKCGC!U-.T*+3=:U74TNKB234G1Y8Y-FQ2BA!MPH/W0.
MI-+K>@PZVUA(]U<6TUC<BYAEMRNX-M9"#N!&"KL.E '.WWC6]BT'5/$5K!;R
M:;IEY)!+ RMYLB1OLD=6S@'.XA2#D+U&>.A\27ES:>%-4OK"5([B&SDFB=TW
M@%5+=,CT_P#U]*H-X*L#_:$"W%RNG:C<?:;JQRIC>0D%L$C< Q W 'GGIDUN
MWUG%J.GW-C.#Y-Q$T,FTX.U@0<?@: //!_:<OB#P-,DUK)J,VD79,\L;;<%;
M<@L-V6//J,Y[5J:;XUO=2TW1HUMHH]3OUNB^R-I(T^SR"-R%W*3EBN!G@$]<
M<Z=IX/BM+K1[G^U;^:72K>2V@,GE89'"@[L(.<(N,8Z=\G-,_#VS33+"VM]5
MU*WNM/N)I[6^C9!+&96+2+]W:RDGH1Z4 ;GA^\U*^T>.;5[#[#?;F62(-E3@
MD!AR< C!P>1G%<E<>,]?@T_4=1^RZ:8-/UD:=)%E]TJ&2- 0V<*07!Z'/H,<
M]OI]D-/LT@$\UPPR7FG8%Y&/5F( 'X  #H  *P)? UK-IFH6#:E?^5?:@-0E
M8>7N$@=7P/D^[E%XY/'6@"G+XPU#2KC7K;5(+66:P%HT#6P95?[0YC16#$]&
M')'4'H*?/XHUK2_M8U'3 T1EMX;&Y2/RQ+)*X0JR%V.5)!SGD<<&KM]X*T_4
M[G6);VXNIEU6WBMYX\JH41DE&0A00P+$YR>?I3&\$6]UH=SIFJZMJ>I^<JJM
MS<2J)8=I#*4*J &# '=@DD#.0,4 8GB/7?%-OX?U5FACL_)N;1+>]$)43QRR
MJCJ$WDHRENN3D'C!Y&I=ZS?6?BF^LS:Z?)/!HGVQ+D(RLY#D;#R2$R"<9/7K
M5F3P;'=Z!=:7J&L:E>R7!C)NY63S4\MPZ;0%"\,,\@Y[YJ:;PI%/JDVH/J5\
M9YM/_L]R?+P4R26^Y][))]/:@#*T+Q7K%Y?>'%U""Q%OKFFM=(+</OB=4C8@
MDG!!#],#&.IZU%IOC+5=3F\./%;6GDZQ).KPE6$EJ(LD[CGD\;3P,,16I#X1
MBT_^Q9[>[O)Y-#M'M[2)FC E4JJX<[>N$49&*YGPOINKV]Q:O;W.O07)D1KV
M"_LH/*P6S(/-"!G_ (L$,QSC/&: .T\1:W_8MM9"-%:XOKR*R@W_ '0[G[QQ
MV #''?&.,YKFM=\:ZKH4'B.VDM[.:_TNRCOX) K+'-$Q*\KDD,&4C[W/!XKJ
MM=T.U\0:>MI=-)&8Y4GAFB(#PRH<JZD@C(/J"*S=0\&6FJZ?JEO>WMT\^IPI
M;W%RH17\I<X11MP!EF/3.6//3 !L:8=3,4QU06@D,I,0M=V!'@8#;NK9SR.#
MQTJ[3(D:.)$:1I&4 %V !;W. !^5/H **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&YN[:RA\ZZN(H
M(L@;Y7"C)X R:FKF?&,LL*:.\>GS7*+J"F2>"W:=[0;''F*B@DGG;G! W9(.
M* -C^VM*^SP7']I6?DW!*PR>>NV0CJ%.>>AZ5&OB'17LX[Q=8T]K623RDF%R
MFQG_ +H;."?:O-K;3[LV&G6]SI&HN8?%TUR_G6;-^Y9I3O.%QCYEY''/'0XV
M[3P\=9M?&VF2P7%H+O4_M%G,\#(%<11;94) SB1">/3WH [H7=LUTUJMQ$;A
M4$AA#C>%/ ;'7'O45YJNG:<RB^O[6U+#*B>94R,XR,GU(_.L;P9)?:CI(UO5
M(5AO[Y$W1J<A$08 ![@L7<?]=*YWQW'>W5UKMG;Z5>%KC07BAN;6U,IN7_>?
MN6;!5 ,YQPS;N#Q@@':ZSJUMI5C+))>6EO-Y;-"+F0*&('ID$CIT]:RM!U^Z
MU?3?#5W+<Z=#)J-D+BXMB2)')C##RANZ YSG/%<Y:S7EGK5])J.EZC+;:EHU
MO#9NMH\GELBN'B< $H26#?-@'N>*@T6WGAD^&D$T$MM=0Z;<0NLT15T98$!!
M!YZB@#T5=5TY[TV27]JUV,Y@$RE^.ORYSQ31K.EM$LHU*S,;2^0KB=<&3.-@
M.?O9[=:\[T_3-2NO"GAK19;.Z@UK2]4BDN)GA8( CL9)1)C:P=2>A.2^#WQ!
M?0WL.GZMIO\ 96I27'_"417X,=H[(T!N(WWJX&&X!R 21@Y '- 'HS^(=%CG
M,#ZO8+,&9#&UR@;<HW,,9Z@$$^@I]MKFD7D[06VJ64TJQ"=HX[A&81D AR ?
MND$<].:XW3]/0S>.9IM)FWS7+26S/9/F1?LR)E,KS\V\<>I]:JZ)92VES\/R
M=,NXA:Z1-#>$64@\MS'%\K_+P2RMUZGZT =RGB+1)94BCUC3WD>-I51;E"61
M<[F SR!@Y/L:F@U?3;K3SJ%OJ%I-9#(^T1S*T?!P?F!QUXKS+2M*EC\->!89
M-'NUEM=6>6Y1K%\Q(5F&YOEX&6CY/MZ4^>UU.W75;R#2]1EM[?Q1]NDMX87C
MDGMS J%XQQN(?YL#J5H ]'77-)>WBN%U2R:&:3RHY!.NUWSC:#GD^U4K[Q?H
M-CHK:N=4M9K,2B%9(9E<-(3@*"#C.3SZ=37&ZCIEE<6FG7>G:%J:PW.OV]W<
M"Y@E>1P!AY&1LE%Q@<XSCIT)BU?3[V2R\;+;Z;>LLFK65U"B6KCS43[/YC(,
M?-S&_3).* /4(I8YXDEAD22-QN5T;(8>H(ZU6AU?3;F:2&#4+266)2\B),K%
M%!P20#P,U7UB.ZU3PMJ$6GL]O=W-G(ENT@*,CLA"D]U.2/<5Q]G:SZBW@N2+
M3KNRFT=&%\LMLZ>7&("C1#(P^7VX"YR%SZ4 =O9ZQI>HS&&RU&TN9502%(9U
M<A2<!L ],@C-,O=>T?3FD6^U:QM6CV[Q/<(A7=]W.3QG!QZXK ^&NG+8^"M/
M673WM+Q%=)1+;F*3_6,<'(!QR#6;>KIH^)^M)?Z>UTDFAVX*I:M-N!DF!7Y0
M<$C ]\4 =O=:G86,*37=];6\3C*O+*JJPQG@D\\4EQJFGVL,<UQ?6T,4@W(\
MDJJK#&<@D\C%>>^%M+U;PKJ&B?VQ;W,]J-!2RW0Q-/\ 9YED+LC! 2 5*C/0
M^6!Z56M]!U32]!TM8)K^PU.WCO7M=MHUS (9)0ZVTR '&5V8Y!&T@=,4 =[_
M ,)7HG]M/I/]HVPN4MQ<MF50 ASCG// )^G/>K5KKFDWUW]EL]4LKBY\L2^3
M#<*[[" 0V <X((Y]ZXE(KY-=FN+_ $F:W6[\+PPLL<1>&&5#*SQE^@QN&,GG
MMFLWP]I0U71OA_/I-H]K=6-H)+B[-LT85&MBI&X@!]SLIXSD F@#TR/5=.EO
M391W]J]T,Y@692XQU^7.>.]0IX@T:2YBMDU>P:>9V2*,7*%G9>H49R2.X%<#
MINFZA=^&O".DO8W=MJ^D:A$]U(\+!56/=YKB0C:PD!/0G._V.*W]G3IHEP8]
M(O5G/B];P8L9 QA%R&\S[N=NS//X4 >FRZKIT%['92W]K'=R'"0/,H=CC. N
M<GBH?^$@T7SXH/[7L/.ED,,<?VE-SN.J@9Y(R..M<+#9B75M2T;6]$UBZFDU
M5KVSGB,HMI%+AXV,BG:A3 !!YPHP#G%4;S2Y9/"OB&$:/=M--XE2XC3[#)N>
M(7$3%P-O*[0_/U]: /3;35]-OXIY;/4+2YC@8K,\,RN(R.2&(/!^M1KKVCM;
M2W*ZK8F"%@DDHN$VHQZ G. ?:N!UW3]2GU3Q@=,TZZ8RV^G21*(GB6Y\F1FE
MC5B ,E,+U[XJ'7K.TUGPEKU_IOA_6UO+R&"&3[9#,992D@(41MDG:-V6QCG
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M2P^&Z'3+R&6S\Y;O-FX,.ZW=/G^7C+E>OUH ](&KZ:UX]FNH6AND!9H1,N\
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MVS81]L15O, PH4Y)Y&.?7F778-2C\/\ CO1+O2]0N[^_F>>SFBM'E2XC*($
M=00&79C:2/;.: /3I]6TZUGCM[F_M8;B3;MBDF568L<# )SR>!ZU6MO$>E7>
MNWNCPWD37EFJ-*F\<%MQP/4@+D^F17G_ (P%]?IXB@MM%U)&D%E+$;>R=OMB
MJ48LS$'!3D!!AN,\YXN:S8ZK=W_C6&RL+L3:GI]L]HS1E4DV(P>,OT5C]W&<
M_-Z9- '>VFJZ=?\ G?8[^UN/)QYOE3*^S(R-V#QQ6+9^*!?^.6T>TN+&YL1I
MQNO,@?>ZOY@7!(.,8.>G>N2U:S/B'P]JVH:+H.LP:L]DEO,-0\R-Y(UE5V@5
M7.&ROF#<..<9Y-;>FW7]I_$F#5(--U"&U?13 9;BRDAVOYP;8=RC! S[>E '
M7WFHV6G1K)?7EO;(Q(#32! <#)ZGTYID^K:;:P1SW&H6L4,J[XY))E577@Y!
M)Y'(Y]ZY_P 323KXDT@)I]TT;07"?;K:W,SQ,=F(^A5 ^.788^7&1G-<;I]A
MJ<7@W03;1ZIIVL66E-!Y<VGO-!<C(W02IMR,E1@Y!Y.,B@#UU6#*&4@J1D$=
MZJ0:MIMU-)#;ZA:S2QKN=(YE9E&<9(!X&:H:C;:EJ'@BZMH%%GJEQIS1HJOQ
M#,T>  WLQZ^U<S8VMQJ=UX*FM["[L9M)C<7HEMVC$2>3L,0) #Y?;C;D87/I
M0!JZ/XENO$6J3'2[C3'L;6]DMIX68F9D48\U64D<MT!7!'>NBN=3L+.9(;J^
MMH)7QM2655)R<# )[GBN=\"I-'!K:S6US 9-8NYD$\#Q[T9\JPW 9!%9GBBW
MU&+7[B^T87;716".:QFM&DM;Y V1AP/W;KN;G.!@$B@#LCK.EK#),VI68BCE
M\EW,Z[5DX^0G/#<CCKS3KG5-/LIXX+J^MH)9" D<LJJS9.!@$\Y/%>9Z_!?1
M:?XVTQ-*U&>XO=3@O+<PVKNDD6+<$AP-I(*,"N<^V*U2TD6N^(M+U?P_?:E;
MZM/%<V<BVS/%(@C11&[=(]C(3\V.N: -JR\61IXBUO3=7N]/M([2YA@M&>3R
MS*9(P^/F;EOFQQ732;S&WEE0^#M+#(S[UY9XDTVYNK;XD>5I=Y+/>1P+:,MF
MY,Q6%5^0[><..WIFO4$F4VJS8?;LW8*'=T_NXSGVQF@#G_#?BF+4/!VF:SK%
MQ9V4EW&68&01ID$\#<?09ZU=NO%&CVFI:=827\'GZ@I> "089 ,[LYQ@\ >I
M/'>N#\/I?66B>#[6?1]0A>.UN8I+E+)VEMW++B/:1A _]]ACY<9&<A?#5KJ%
ME;?#V2XTK44%E:W-K<*;9MT3LJ!=PQE5)4C<<#WQB@#T<:MIIOC8C4+7[6 2
M8/.7> .ORYSQ3;36M*OY_(L]2L[F;89/+AG5VVAMI; /0,",^HQ7 ^&K-7:P
MTS6M#UAM7TJZDE^TOYHMB<MF97!VMN5C\O)))!'4C<^'&GK9^&$\W3WM;P7-
MUN\ZV,4FUIW9?O $@KL/Y>E '1:IJ=MIMLS37MK;2,K&(W,@520/<C(Z=*R?
M#_BJWO?!^D:QK%W964M]:K.P>01IG )V[CT&?6LV\DN=.^(&H3WUA>7-A?Z;
M%!:306SS+&RLY>-@H.W=N4Y. <=>*Y?2X=0B\-:%I\FB:C!-_P (]);&X2R9
MI/,^4>0V1B-3@'+ 9P,$8Y /2)?$NDPZ]:Z*]["+VY@:>--XY4%0/Q);@=\&
MK<6JZ=/>O90W]K)=H"6@292Z@'!)7.>#Q7G^AP:A#?>$)GT^_A_XIQ[!G:V;
M,,^8?]8,?(/D8Y;&<?2G^#+6.;^P[?4M!UB'6M%B:)Y[AI1!&=FQG1R=D@?
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MS-;ZA9V-FP1E&;@)S)\QSMW$\8SC'&: .MO+^ST^)9;VZAMHV<(K32!0S'@
M9ZD^E6*\_P#'/]LKX2U./4/L<L:7]@;.6+<A<&XBR'4YVD-D9!.1VK=T'5M2
MG\1ZWH^I/:RM8B"6*:WB:,%)0WRE2S<@H><\YZ"@#HZ*X75_%VK:?9^-9(EL
MF?0A&]ONB?#JT2R$.-_)YQD8^E2WNL^*+GQ%J^DZ0VE(;2R@NX6N89&+ES(-
MAPXZE/O=O0]@#LY)$BC:21U1%!+,QP /4FH[2[MK^UCNK.>*XMY!E)8G#*P]
M01P:X[0?&5WXL-G#IRP6<KZ5'?SF:,R!6D9E5  5XRC$GTQZ\9'A/5M0T_X?
M>&X;22UC\RPFD.Z-II&=2-JK&I!V\G<W08 XSF@#TZBO/K'Q!JVLZ]X-NEN(
M;>UU'2);V>V\HL-P$).#N'9R!Z>ASQ?T3Q%X@UI]'U*#38VT;4%+RD[%:!",
MQL&\PECT!&T=>V,4 =E17->)]:U#3)A'9R6J#['-.-\;32/(FW: BD83D[GS
M@<#C-95IXFU[6=1TJUL6T^U74-"74PTT#R&*0E!MP'&X?/[?CC! .Y)"@DD
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M&3BM6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M..=6,@7.2,'GH?RH YSP)X9D@\)^'EU;[9]ITV/<EI<!0L,N"N1@9. S 9)
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M@\DD'! < L<^F1[],\;IVDZC=^'O!VDRV%Q::CHEY"]U*T9"*D2LK,K]'$G
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M' 5HR,8P2=HQFK5E83#2/'0?3K@37=Y<R6VZW;=*K0(BE>.<D,/_ *QKOZ*
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M$;JNU%/&27!YS@*?7(Z=_#UD=:75HC/!=+;"U_<R%4* DKE>AVECC([UF-X
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M&/F88R,X&<$!L<YH Q$$]]\5 QN ;630ED\F2$'Y&E.5//?'/Y5K^.9KFQ\
MZY<6$YM9[>PEDCD11E=J$\>G3'M5[^PK<>(SK@FG^UFW%MC<-GEAMVW&/7G/
M7WQ5O4;"WU73+K3[Q-]M=1-#*H.,JPP1D=.#0!PKP:D_CG0XK>^BCNV\/W&;
MAX-P \V#HN1D]!UJ72/&.IZW8:%;QQ[+^^T^6[GDMT0X,;K'\JR,!@ELGDX
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M6,+GAL,IY! W \<=Q;N=(UW5OAC-I5Y)"FM36C(6 "J7SD;@O S@!L<<G'%
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M]T?(W=&ZG!-7#HUY:ZKX7O['0!;V]O+=&>TADC#0><O#.2V"<C+;2>3QNZD
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M_>)!+<EA"C DN5!8@ #T!^O0<U';^)-(NM,CU""\#V\DIA3"-O:0$@H$QNW
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M$%C.<2 N &3Y6^89''6DC\3:7+++"LD_GI;FY$+6TBO)%_>12H+>G&<9&>M
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M+I<%M)+'ODDD.[)(8J%7 [YY;CIGKM5UZPT92;MY"PB:9DAB:5A&I 9RJ@G
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MCUQDXR=.BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M),,T<C1R1Y&" RD$ ]QG!J*;PYH\\-C%)81%+%R]L!D>62"#T/.03D'KGG-
M'+Z1J>OZZEEK5MJ%K#;#4)(;JWEEROE"1H_+"^7D2 [2#NY/L0!TWB>]?3_#
M=[<QWR6,BH EPT7F;&) &%_B))P!ZD5'!X1T&VUV36H=-B34)&+O*I."Y&"V
MW.W=_M8SSUJ_J6FV>L:=-I^H6Z7%K,,21OT/.1TZ<@'/M0!YEXDU/59O#?CJ
MPFN[R&.RCMF@#LGFJLBC<C,HP0>>YZXSCBO5((VBA6-YI)F4<R28W-]< #]*
MQU\'>'U2]7^S(F%]"(+DLS,94'3<2<D^_7WK6M;:&SMH[>W39%&,*,D_F3R3
M[F@#R>]CN3X(\3O)?W$[CQ-'&OG[6 VWD(!X /3 QG&!QBMB^\1ZIX>G\4V\
MNHO=QV;6#03W2HI@%PY1R2J@;5QN&0<>]=7/X1T*X^U^98+B[G6XG"R.H>0$
M$-@'@Y /'4@'J*F?PYI,DU]++9B5K^(0W7FNSB9 " &!)'&3CZGUH JZ)#K5
MMJUZFHWT$]G(B26T7F[Y8SR'R0BY4\$>ASVZ5/$5UJ*>+O#FGVFI36MM??:5
MG6.-"3LCW*064X.?P]JUM$\.Z3X=MF@TJS6WC<C=\[.3CH,L2<#G S@9J:ZT
MBQO=0M+^XB9KJTW>1()&79N&&P <<C@T >?0:QKT.EVM])K=Q,UMXC_LED:*
M(+/";GRLOA<[]I'*D#@<=<Z<.I:_K4UY>Z=J%K:KI^K26TL,TOR>5&^UE9?+
M)RR_,#N[CMQ71?\ "):+]E-M]D?R3=?;"OGR?Z[=NW_>Z[N?KS0_A'07U[^V
MVTV+^T25+398;BOW69<[68=B1D4 <[I^I>(-=V:I9ZA:V\,&K2VUS;S2C;Y*
M2M'Y97R\B0@*P.[J?0XK&CO-4TKP-XFU&UU>[^TPZ[-$KR"-_E%R(R.5[J<>
MV!C%=VGA'08]>?6TTV)=0=M[2@D!FZ;BN=I;_:QGWHF\):%/#>Q26"^7?3>?
M<JLCJ)'SG/!XY /'4C/6@#E==U#6QJ7C1+;7+FVBTK38;VU2.*([7*2L024.
M5)09'7W%6;_6]6GN8$$MQ;PSZ']K@>SA\QFNB>A&&X *X!X.3UQQTLOAK29Y
M+Z22V=GOX1!=$SR?O8P" I^;I@G\SZFN9UGP=)<:U'(NC6E_816L=M;9U&:V
MEMPI8D,5!+J<C'/&.GJ =5X?&HCP]IYU>1GU)H$>YW!1MD(!9?E & 3C\.]8
MGQ,#'P#?A2 WFVV"1G!^T1U/I_A*&VNM'O)G9KG35F$;F>21@LF[]UN8_,J@
M@9;D[5Z=*W=0T^TU6QELKZ!)[:48>-QP<'(_$$ Y[$4 >>Z[J7B'P]<>)+--
M;N+I(]"DU2VN)88O,MI4)&WA I5NH!&?E-:EUJ>I2>(OL U"9+>?P[)=E45
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MJKV5E;:=9Q6EG"L-O$,(B]!_B<\Y[U8H **** "BBB@ HHHH **** "BBB@
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MQAMRR1N01Z@@XX-=#;Z-J%MXLTG4!IL$5K;:;<6\D=HRJB/)(CA5!QD#81G
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M7%S;,D6\X7=C@$]N:Y76K+6II=>UN]TZ*TMI/#4MJ4^TAW5QYC8X&#U]?\
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MGNX)5ER761MP&W'&.AJ&UT:];Q9XEN)X6CLM2MH(8IE=2<HKJW&<C[XQ].U
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MF-US]3@5M7EWJVJ:IX@TO3]42QN-(\D6\TMR1M4QJYE=-I$@)+*<G'R\8/)
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M]^:M-J7B))=;TNT+:@--U.)(@TXBFN8'A$K0K)_?7.<G!(')[T >ALZJ5#,
M6.%!/4XS@?@#^5+7F,-Y'K>O>#9HK[5%7S]022.Y8QR1.BM\CKTW+G;GG('N
M:K37_B&'P]?Z_%K][-<Z=KLMK':LL?ESQ"Z\K8P"@EB#P1C&!@=30!ZO17F]
M_KNIW'AOQ;K=O>RV]]HE]/%;P _N]D.W"LG\7F#)R>?F&",5%K%_K,LOC65-
M8OK3^S=,@O;:&/8!%(8I'*GY>1E1D=^] 'IM5+G3+&[O+:[N+6*6XMB3!*ZY
M:,G@[3VR*XJ75-6\0ZE?:5:7J6-U#IEO<V[B<QD/(K$R[=I\Q00 5/''OD0S
MW&KWNKZQ:OK]RB0Z#;WB-9[543'S<LF5SM)0'!Y]\<4 >C45YQI^LZO!=>%;
M^6_N;PZOH\US<VS!1&9$BCD78 !M.6(]\U)I%WK6J:5I6O0ZY%';WMC(;A%F
M\TR2F,L#&K)MC9"K CD8!!R1F@#T.D5U<91@PR1D'/(."/SKS;P[J&K/+X(F
MN=8N[@:WIDANDD*[0PA1PRX'#9)Y[YK:^&,97P/:2/<33/)+.6,LA<Y\Z09Y
M]>_O0!O:SKECH6FS7]Z[^1"ZH_E(7*LQ  ('3[PZ^HK2KR#4X&7P=X^<W5Q(
MXUH(!+(6  -O@X/IT^F!6OJVNZGX8OO%4:ZA/=16UA:7<3W.TF!I))(W887&
MT!0V,$#!XH ](HKS?Q++KVC^'/$%_;:Z$A.G"XM(XY_/DC=3RZNR#Y&!''8C
M@BK]Y+?6/B.PT!M4N;A=1AN+L27%P(69U\L"*-D3( #,VWK[X&" =S56_P!0
MM]-MUFN&(#R+$B@99W8X50/4D_Y%<9IE]JLNO:7X9U;5/.(T^XGEN[5C&;F1
M)A&%W  Y53\V,9/MQ6+=W%_J^CZ(NHW4[36?BK[ MPA">>D<CJ)" ,;OEQD=
MP: /1-(UVSUH3K )HI[=RDUO<1&.1#DC.#U!(.&&0<'!XK3KC]:>2S^(OA 0
MLQ^TPWEM.2<EHQ&K@GZ,H_[Z/K77JRNH92"#T(- "T444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %4M3TC3]9ACAU&SBN8XI!+&)!G:XZ,/0\G\ZNT4 8\?A70X/\ CWTV
M&W/G-.&@S&PD88+ J002"1QZFM.VMH+.VCM[:)(H8QA$08 %2T4 9MGH&E:?
M/YUI911.&9E"YVH6^\57HN>^ ,U+8Z18:9+<2V=N(7N7,DQ5C^\<]6.3R>!S
MUXJ[10!D7_A70=4NI[F^TJUN)IXA%*\B9+J.@/TSP>HK0:SM7L39-;Q-:F/R
MC"4!0IC&W'3&.,5/10!AVW@WPY:8\G1[0$0-;@LF[]TW5.<_*>F/2GVGA/0+
M&19+;2+2-U@-N&$8)\L]5)/4=OIQ6S10!A7/@SPW=Z;;:=<:-:/:6K;H(RG^
MK/L>H_\ K5LQ6\,%LEM#&L4*($1(QM"J!@ 8Z<5)10!BS>$?#]QHXTB;2K:3
M3UD\U8&7*H^<[E_NG)/3U/K4Q\.:1Y-K"EC'$EK&T4(A)CV(V-RC:1P<#([X
MYK4HH S&\.Z0THD^PQ#Y44JN50A/N J/E(7L"..U6K_3[35+&6ROK>.XMI1A
MXI!D-SD?J :LT4 97_"-Z/OG86$:F> 6\NTD;XAT0X/W>3Q[GUJ&7PAX>G\O
MSM(M9/+MOLJ[TSB'^YSV&3@=NV*VZ* ,J/PUHT,GF16$<;_9Q:Y0E?W0_@X/
MW>IQZDFKEE86NG6,5E9PB&VB79'&A("+Z#T%6:* ,C_A%]$_LZ?3_P"SXS9W
M$GFS0$G8[DY+$9Y)/)]35C^QM/\ [334OLX^VI%Y*SEFW!.NW.>F1G'KS5^B
M@#&E\)>'Y]/N;"71[1K6ZE,TT1C&&?.=WL<DGCU-+-X4T"XT1-%FTFU?3HSN
M2W*?*K==P[@\GGKR:V** ,N/PYH\0L1%80QBPR;4("ODD]2N.A.3D]\G-6+#
M2[+2UF6RMUA$TAFD"D_.YZL<]SW/>KE% &98:2-,U&^EMBHMKV7[1)&>J38
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MW VC[Q]3TP.O:[%XYN=9L5ET*SW7']FPW_E2PO)N:4,5BRN-I^0_,>.1P>:
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MR<#,F2<>I]JNZGXTF\-W^H6>L013&#3CJ%O+; H)0'"-&0Q.U@S)SD@ANV*
M.OEEC@B:6:1(XT&6=V "CU)-*TL:Q&5G41@;BY/ 'KGTKA_&QU>3P7XIM]3M
M+.2S&CRRQ7$)QB7:V4*L23C (;C.>@ISZG_PD'@?6)8/LTFDQZ?+ I929'E1
M&#Y&<* PXR,G!X P2 =M'(DL:R1NKHX#*RG(8'H0:=7G^@>)KO2+31+/4X;9
M=/DT$WL4D+,9$$*1[@V>#D.#QTQCGK6C#XLO8_\ A'+N]MH/L&O,L<8BSOMG
M>,R1AB3AP0""0%P?44 =7%/#.&,,J2!6*,48'##J#CO0D\,LDD<<J.\9 =58
M$J3ZCM7GOAO5ET:TN[&TBC^TZAXFO;6V0C")AW9F('8*IX&,G XSD1Z9JLGA
M_7O%SSQ0O=3ZM:6\8@C8(SR01X;:,GIEB.<G(SSF@#TJFF1%D6,NH=@2JD\G
M'7 KB;_Q;K^F6%U+-I$3&*_MK:&=P\*7$<SJN0ARRLI;!R<=QGI6U%H<FH7N
MEZKK4-D-4T]Y3&]J&(VME0 S8(&TY(QUQS@<@&]17*:'XL;6-=GT\O;0SV\D
MJ3V,BLEQ$JMA'&3AU88.5&!D=:N>*-;OM%;2%LK6WG-]?I9MYTA7;N5B", _
MW?\ ZQH WZ*XF#QI>()K"\M[;^U!K(TF,Q%O*8M&)1(0>>$)XSR1C(SD4?$_
MBW5[32/$VGHT%OJFFI!(ES&C;)89FVAE&<HX(8=3T![\ 'H'GPBX%N94\XJ7
M$>X;BH.,XZXR1S4E<A?:]_9/BJ1-1L[-EMM#FOI+V)#YNU'7<@!Z+WQDY(%2
MR>(]5T_3'UK4;*W;25TU[YV@?YX7 #"(Y/SY!/S  9'3F@#JJ*Y[2M7UBXUL
MVMWI^;)[;SENXXGC$<F<&(A^6X.0PQT/ JOXEO\ 5;;Q1X7L[&XAB@O+F99E
M>,L7VP.P!PPXXSCU ],$ ZFBN)NO&]Q#X?N/$T5O#)HUM>-;R1\^<8UE\II0
M<XX8$[<<@=03BNA\3W=WI_A;5;VQ>-+JVM)9HVD3<H*J3TR,]* -%IX5G2!I
M4$K@E8RPW,!U('>I*\U!U.3Q+X*N4-I+J4^CW1::56"D8@(+<DL1D]QDD]*U
M=.\;7&I:9HX6W2'4;]+EGVQ/,D?D2"-R%7#'+$8Y'!//&" =K43W,$<PA>>-
M92-P0N Q'KBJ'A^_O]1T>*XU/3VL;S<RR0DY'#$!AWP1@C/(SBO/=?5O#]QK
ML?B?1AJ/AS5)WE_M>V022V>X!0LJ]0$QPR],#O0!ZM17(ZEXKO&FOX= M4O9
M;&&.39Y3N+EG7>$5EX3*XPQR,MT &:D;Q%J^H-J2Z+I\+SZ:84EM;EMKRR.B
MR,@;.$VJXY.<G(P,9(!U5%<>WB;6/^$AUFU%I81Z?I!BEN)7D<R-"T;.=H Q
MN&.AX]^>&V_B37;SR)8=.3[)=V3W"SF!PMI(%#(K[B/,!!(RN.1[YH [*BN%
MT/7];;PAX;N)Y;22;4+,2R74BEB&\M65!&&W2,Q+'*] IXID'C;6=5M?##:9
MI]BLVN64TX^TS/MB=%4X.T9*Y;KU^E '>T5QX\4:E:W>MZ?J$%HE_:0Q3621
M;MMR)/E7&3_ST^0^G![UTUS=KIVES7EZPVV\+2S,@XPJY8@?@: +50->VJ7:
M6C7,*W+C<L)D =AZA>I%<M%XLOHAX=N[RVMQ8Z\5CB\O.^VD>,R1ACG#@@$$
M@+@^HJMX,M)-2N=:N-56TNGMM<G:%S"=T<BA4#*23@!>![=Z .YJ.&>*XB$L
M$J2QDD!T8,#@X/(]P17,WU[J;?$BPTI)X!ITFF3SR0O$27(DB4Y.<=&XXXR>
MN>.:\$ZS?Z/H'ABV-M:G3+^^N;,;6;S4;?,ZM_=V_(1CZ'/:@#T^BN0LO%>I
M:E<6%U8::;C3;JZ>!]L3J\,8+*)BY^5AE1E0,C=U.#3/B7J%U9>'K*VM9G@_
MM+4[:PFGC;:T44CX<@]C@8S[T =8EU;R2O&EQ$TB'#J'!*_4=JFK(N/#.D36
MEK;+8P0I:2QS6YBC"F-D8,,$>XY]1FL"Y\;W$7A^;Q-%;PR:-;WC6\D?/G&-
M9?*:4'./O9.W'('4'B@#MJ*XX>(_$%QK6N6UK8Z;]GTB8+(99W#2*T D&,*<
M'+#.>,50LO'6K1Q>'-1U>PLXM)UNW#+);R,TD$GDF7Y@1@J0K8QR.^: /0**
MXV+QA>K:>'=5N+6#^S==ECBC1,^;;F52T18Y(8' !P!@GO45CXH\27NG:EJ*
MZ=I?D64US;;#=%&+Q2[ VY@%"8#$Y(/'% ';U&9X1<"W,J><5+B/<-Q4'!..
MN,D<^]>>:YXQU5O#?BM;.6".ZTLPK'=I"ZB1)54Y52<@C)P<D'@BMF\UTZ5X
ML,>I6EFRP:+/>O>Q(?-"HZ;D /1><XR<D"@#KJ*Y"/Q5?POX>GO+:W^R:[A(
MA&6#6\K1F1%8\AP0""0!@CH:HZ;XUUBX@T2^NK&Q2SU#4I=.=8I',BLK2JK@
MD8Q^[P1[YXZ4 =[16%XOUNY\.^')M3M;:*XDCDB0QR.5&'D5,C Z_-[5SVH^
M,]<T677K34;&P%U8Z8VJVK0.[1RQ*2&1LX(8''(X.<X[4 =]17+7'B6]BUMK
M".VMW4Z.VHH68J0RLJ[2>>.<YQ67%XUU:#PQIFOZK;V5KI^H);N)XEDF%JKQ
M,[/*HQ\NX(H(/&_D\<@'>T5RMKXEO)M9T6Q)L9HM3M;F=;BW8NG[ID"E3G#*
MP<'VQ5>P\6:CJ&A:9>B"TMVNI[F&65B75#&[HH6,$.[,4Z#IS0!V5%<)9>-M
M4U.W\+-:6%HCZU'/O\V5L1/&I/  Y&1]>W'6JT_BG7+_ $_0GA:UM+B77I-,
MO J,ZN8S(,J<@A28\D=><9]0#T2BL3Q=>WNF>#-8O[&2..[M;*69'=-P!5">
MF?;C^M9UCK>HS75EH<,ELVHC3%OIKB6-BFUCM0;=V220V3GC'0YX .LHK&\+
M:]_PD>AQWS6_V>=9)()X=VX)+&Y1@#W&1P?2MF@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLW6
M=>TW0(;>74;J.!;B=+>+>P&YF8#OV&<D]@#0!I45S%AXKC?Q#K-AJ%Q8VUM:
M26Z6LIE"^=YJ%@,DX)] *V3=3?VY]F\^R^SBV,ABWGS]VX#=CILQW]: +U%5
MK74+*^W_ &.\M[C9C?Y,JOMSTS@\=#6)+XAN;GQ3>Z#IWV)+FRMXYV6Z9@T^
M_/" =%&!EN<$XQ0!TE%9EMJZ1Z):W^L&#39)(P94FF 6-R,E=QQG'/Y59N-2
ML+2V2YN;VVA@<9662555N,\$G!XH M5@W>E/;^,+;Q! AD#VAL;I%Y(3>'1P
M.^#N!'H^>U67\1Z3'KL&C-?0?;9H#<+'Y@^[E0._4[N!WP:?8:C_ ,2HW>H7
MNGE1(ZF:WE_<@!R%&XG[V, _[6: *XT&:>8'4=4N+ZWCN1<Q021QH%8-N0$J
MH+!3@CW SFHSI3W_ (RAUB9"L.GVTEO;!A@N\C*9'QZ (JCURW;!.H-2L&MH
MKE;VV,$K!(Y1*NUV)P #G!)/%.M+^SU"-I+*[@N41RC-#(' 8=02._M0!8HK
M#UW7+C2-0T2".UCEAU&]%H\C2$-&2COD+CG[A[BCQ-KEQH-M8SPVL<ZW%_;V
MDA>0J4$LBIN P=V-W3(H W*Q?$'AU?$#::9+R:W%A>1WL8C53ND3.-V0>.3P
M,?6MJL+7/$4-EX?U:]TVXLKJ[L+66X\DR@_<4D@A3D=,4 2ZOH$6J7FG:@MQ
M);:AI[LT$\8!X88=&4\%6&..O ((JQI.D0:3'<>6S2374[7%Q*^,R2' SQP
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M$+34H[O^V9GOY;JR-B\C*(]L1.3M"]"3@D^JC&,5T5% '*_\(9)-X>O=(O\
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MC5ZBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS':#@#U-8U[#,MSXWL-3L;FY&J1A[!D@9UFC\D((P0,*RN"<'&-V[U->BT4
M>=:+HC+XWM(]8L3=S1>';:":ZEMB\;W".2WSD;2W0]<UESVLY\-3Z;+IE\TB
M>*_/D3['(RM";WS-P.W#+LYR,BO6:* ."M%M;+7/'$MYI-Q+IC_9Y/)%BSK<
M 0A7V+MP_( .,UW<>TQJ57:N!@8Q@?3M3J* "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#EF3TD63()'.0OM573+<:EXCT>V\4/ONI?"V^]@FF*@R>8F2ZYQG&2?<9[4
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MUDR<;=N0,\#Y3V%>B>#K>TM/#XCL-0EOK'S9&@GDQMV$YVQGO&"2![#C(Q0
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M0K=Q"41%MQ7/;--\.ZY_;]C<7/V5K8PW<UJT;.&.8W*$Y'J17FOAC5+6+2/
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MC7E]86.FQ75[I]NDUU']J*J"^XJB-L^9B%)Y"CD<\\9B^/9=0ETU-"T9K_\
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MIGMT>H>-6L+7Q/-_9RR?V"J.P$^!,C1B3(.W@X/3GGO0!U@  P  /:@JI!!
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M\*>,YQQTZT 6P !@# IOEH,81>.G%<E:>.XC>S6^IVB67DZ8VIR[;CS6A12
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M\C.??]1>B\:FXO;(6VESW%A=7;6HN(M[-&0642,NS:(R5/S;N 02.N #JMB
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M%Z*!P*#'&75RBEE^ZQ'(^E<G!JLTGBVSAOO#Z6^KMI5Q,LBW8D"JLL:F,':
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M[#)K'NO&L6DWFHV>L6?V>XM+1;V,02^:MQ&6V84D+AM^%P1_$#GT .I"A>@
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M52&#7H%BD1K;>T3"/RMP;>,C:.F.O?'%;>N:W:Z%X?O-8F_>06T)EPA&7P.
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MM([6ZW,KQQ2^8N 2 P; X(P<$9&<4 86I>$&U74K>XNKJ%TM+N&YM9/(/VB
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ML XR >0&!Q_*@"I?>"KB[,UVFIQQZE/J,-]*[6Y>%Q$NQ(C'N!*@<_>SNY]
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M, 5.TB*ZJSJ&?A03R>_% 'E.F1Z5>2?#J!X(6MUL)EN(Y(MJ>9Y,8.X$8/S
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MP* (/B5J]YHW@FYFL)6@N9Y8K99UZPB1PI<>X!.#ZXK1E\'Z(^EK8QV,46P
MI.BCS0P.=Q?J3D<Y//.<YJ_K.D66O:1<Z7J,7FVERFR1<X/J"#V((!!]15*Q
MT?4[>!+6[UR2[MHP &: ),X'9W!P?<A5)]: ,F_\:3P:5JVM6MG'-IFDW3V]
MPI<B601D"5U[#:<X!Z[>HS4L7B36K_Q+J&F:=IM@\%E]G=IIKIE+QRJQR $.
M&X''3W]'R^"H675K..\=-*U:<SW=IL!.]L>9L?/RJ^.1@]3@C-7K/11I>O:M
MK)NBR7L<2O"(N(Q$"%VX.3P3GCTQB@#F],\>ZK<V_AW4KW1[:'2M:E6V5XKD
MO+#*V=A9=H!4E<=<]#[5</CB0:-9>(A:Q-H=U>"VW!SYL:-)Y2RGL06Q\O4
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MOI8HK[3!IACC7!2,%B&#$\G+GKP138O!LZWEY>3:W/-/=Z<MA+F"-5PI?#
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IDDT4(!ED1
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M&DTZV\V!;G4+@01&5L*GR,Q=AD9 "$=LD@9%7;"YNUTI9]96UM9UW>:8I<Q
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MO>EY&0C=)R2I51\I[=:R-1N-9O=!OOM]G9/IMUI$LY>,G,,FW(C().\8.=P
M^[TY%4O"&M:C;+X6T>[@M?LE]HJS6[Q%C(AB2($/G@Y#@\=,8YZT =Y16#J&
ML7C:Z^B:6+<7D=E]L9[A2RX+%44 $=2K9.>,#@YXR->\5ZSHVE/=S6-I;30:
M8;V2!W,S/*N2\2[""%4#_6$%?F'I0!VM%<=?>,F@UNVT_=;6374,,MJ;Q&"W
M1<G>B29"AE&.#DDD4K^*M4N;EY=*TTW=K!J+64T0B8.51]DD@DSM&T@G;@Y
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M4##=D@ GO7'6TVIWDOPVOY'MKC4[FRE?SI$*C#6JGY^26.23QC)]* /4J0D
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MK&PM(K6.YGTB+4;DSH9(U$HPL84$9R0V23P .#G@ Z9+ZS=862[@99V*PD2
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MUW':R6D\,90AD<@LN64]U&&7!Q5-_"6W1-#\,I-//I]A+#+-//MRT<)S''P
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MW\%W#?RZA;WL>P20R2DEP!MP5.XC:0>*Z/3K!K"R\E[R>ZG8EI+F?&]V/<@
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M$-(UG5;FTLGOK5)F#R!$!*Y(&X]J -2SL6LM/%L+J:67!+7,N&=V/5CP!^
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M:/<7D27UTC/'$S@' ('ZD@ =^?2K2ZE8/>FR2]MFNQG, E4N,=?ESF@#"O\
MP18ZK/K,E]<W$J:M;PP31C:H3RBQ1D(&0P+$]^<42>#VN_#M_I.HZYJ%\U[
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MRV#C%  _@:T$,)M;R>TO(M1?4A<0(G^M=2C#805VE21C'ODG.89/A[9R6%Q
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MU*RWB&ZMMI.Q\;D96!5E. >1P1FFR>%(1>V&H6U[<PZC9QO#]I.US.CG<RR
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MM7NIZMI]G=&V;PY<6LRM:NK32L08D"%<EE^?MQNQWKTJB@#&\*V=O:>&]/\
M)LUMI&M8A*IA\MRP0#Y@0#D8QS7 ZC8:??:C\1]/?3/M-W<>4ELJ6Q8F1K5-
MN&QA3OP<Y&.IKU>LO3M#@TW5-2U".>XDEU&19)ED*[0RJ%&, 8^4 ?A0!R&E
M:)(/&EZEY:&6X71+.%+V6U9HVN(S(68.5P6!*'KGIZ52TVPOKSPYX/TS['=6
MVLZ3J$37;R1,-BIN$S>9C#"0$]"=V_V./4*@EO;6&Z@M9;F&.XGR(8F<!Y,
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ML'!P1P>014U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M".R,9<[=YV9*8R WMSTNCZ1:Z'IJ6%F&$2N\F6QDL[%V/  &68G   ["L-/
M-A'+ R:CJ8CM]0?4((1*FV*1]^\#Y<E3O;J21G@B@#3\3:W_ &!HQNUC629Y
MHK>!&.%,DCA%R?0%LGV!KE7;4+/X@Z]-,]G/<)X=BDC*PLB,!+-PR[B3R#WZ
M8KL==T2S\1://IE^KF";!W1MM=&!#*RGL00"/I67%X-C6]N+V?6-3N;JXL!8
M22RF($Q@L0<+&!N^<\XH Q;?Q)K]U'X6M-+BTF!]6T9KS][$^R%U6(X"JP^7
M]YC'4>IQ@W$\2>(+^4SZ5ID=U:PZBUG/'A5)1',<CAS(,$$$A2IR!UYK1L?!
M]I87.BSQ7UZQT>T:SMU<QX:,A00V$R3A$Y&.GUID?@NR@UNYU&WO]1AANIOM
M%QI\<P%O++W<KC(S@$@$ ]P: (]-UO6=;B@U+38[)M/>_EMY(90PD6)'>,R!
MLXW;ESMV]#C.:P])\3ZK:6$QO;F"ZNKSQ%-I5LQA*K&5D==Q&XY4)&<*,<C!
M/.:Z&Q\&66G:M/>6U]J"6T]P;IM.$P^S^<3DN!C<.><;L9[4R3P-ILEM>0&Y
MO=EQ?G48B)%!M;@MO+Q';Q\Q)^;=U(Z'% &/KGC36-$M_$ELT-E+?Z5;PW<$
MOELL<T4A*X*[B0P*L.N#P>*[+31J8AE_M1[1I3*QC^RJRJ(^, [B<L.<G@'T
M%9-_X,LM3T_4K:[O+QY=21([FZ!02,B?=0?+M !)/ [FNAC4I&JL[2$#!=L9
M;W. !^0H X35=6U"?3?B!;QBTMY=.B(CGBB.YU-L),M\P^8 X![8Z=JZ'PM9
M+%H6G7,L=LUVUE#&9HH-C&,*"JDDDD#)[XYZ"HI?"-K-_;^Z^O1_;BA;K!C^
M4>6(_D^3CY0!SG\ZV-/LET[3K>R2:25((UC5Y<;B ,#. !^E '+1>)->U&=+
MK2=,2XT]=1>TF1MJL(TD:-Y YD'(*EMNSD<9K,TO6&T6;Q+Y$(>>[\3_ &6%
M<# 9H(3DC(SP&.,C)P,C-=!;^"K*TUJXO[:_U&*WN9_M,VGI,/LSRYR7VXW#
M)&2 V">HIEQX$TV[L]4MI[F]8:A>"^,@D57@G 4*\;*H*D;%ZYZ>YH JCQ)K
MUI-'8ZGI\,%Q>:BMI8W) "2(8VD+L@=B"H1EQN&3CIVK^(;[Q1:PZ5%-<65M
M)-KL5L)(8F83P'YE)7=E>005R<XZ@'%:=SX(L[[1Q97NHZG<W*S)<1Z@\P%Q
M%(F=C*0H48R>-N.3G))J:?PA;76F06L^HZA)<0W27BWK2(9C*G0_=VXQQC;C
MVSS0!FS>)/$%U+=OHNFQWD=E?"TEB(53*%*B1@YD&PC)(!4\+UYXQ?&>KW>O
M^"->GMS;)86FH+:;'C+22&.=%9MV["_-G P>!UYXZ?\ X0FR36I]1@U#4K>.
MZ97N[.*<""X8 #<X()R0 #@C=CG/-07OP^T^\75(4U'4K:RU.87%S:0.GEF7
M<&+KN0LI)4$@'!]* .BB&H?VG<&9K8V&Q/("*WFA^=^XYQC[N,>]8&OWCR^-
M?#6B$_Z-/]HO)E[/Y*KL4^VYPWU05IVNFWD'B.YO6O[N2TD@2/[/-(K('&/G
M10/EXSGGDGH,#,>MZ2]QJFDZS;+ONM-D?]WG'F12+M=03WX5A[KCC.0 9USX
MDU"P\1:OI=VMM\EFMUI>R-@T^6*%&RW+!R@P,9WCI3?$%W<Z/KWA6\9D,UY=
M?V;=^4I59%>-F!P2?NN@(R3@%O4UMW^AV&J:EIFI7,;&XT]VD@.<?>7!##N,
M[3CU4'M5;4=*?5O$.ESS*5M-+D:X7/\ RTF*%%Q[*K,?J1CH: +.OW]QIVE&
MXM3;+)YL:%[EL(BLX5FQD%B 3A002< =:H^%-=N=;75DND026%^UH'6)HO,4
M(C@E&)*G#XQ[5=U[0X-?L8[:>>XMVAGCN89K=@'CD0Y4C<"#]""*CT7P[;Z'
M<ZC/!=7<S7\PN)A.X8>9M52PP!C(4>P[8'% %*]UG5+O5M7TS0Q9BZTVVBD(
MNE9A-)(&*IPPVC"?>Y^]TXYA;7]6O[[6+'34LXKK28(6E2=6D$DSH7V @KA0
M,#=@\GIQS:U/PC:ZAKJZQ#J&H:?=M$()VLI@@N(P20K@@],G##!&>M/E\)V?
M]HS7ME=75A)<6RVUPMLR[940$)D,IPR@D!A@X/TP 8>G^+]5\0ZAI4.E)96T
M&I:*VHHUS$\C1.'C4J0&7</G([>N>QBTCQCK=Y!X6O[J+3UM=9E:UDAB1]\<
MBI(V\.6QM)C/R[<@'J:Z*#PK96FJVE_9S7%L;.P.GP01[/+2(E3T*DYRB\Y[
M?6JMMX(L;*PT:UCO[\Q:/.US;Y,9)8A@0V$Y&'8<8Z_2@#GSXT\2P:1_;LUO
MI;Z;;:J]A=0QK()2@N#")$); (./E(.>>1TJ1-7_ +"\1^-+B.$232ZEI]M$
MG8O+#$@)Y'3=GJ,XZBI_"?AQ[K3+J+5?MR0_VQ<7BV4T81'_ '[21-RNXC[K
M8SU'/I6Q=^"=,O\ ^VQ=S7<J:P\<DZEU7RWC"A&C*J"I&U<<GI0!S_B76?%M
MMX=U=IH8K)8KBT2VO!&,S1R2JCKL$C%64M][/(/&#R-/4/$'B!KG5++1;*"\
MO-,6)9%:,*L\C('V@F4>6-I&#\W)/IS<;P7;7&@W6EWVJ:I>FX\O==SS*9E\
MM@Z;2%"C##/W>>^:;<^";:?5QJ<6JZK:7,D2PW;6TX07:KT\P;>O)&5VD X&
M.* -]IYAIYG\@+-Y6_R7<##8SM+=.O&:XRS\8:K+=7-JXL99%T7^T8Y(X9%C
M$@.&0$L?,3D89< UV-WI]M>Z7/ILJ8M9X&@=$./D9=I ].#7/6_@.T@DCE.K
M:K+*FGMIV^22/)A/0$! ,C'!Q]<T 9ECXTU2#^Q+O6$LOL.IZ/+J)6VC</"T
M<<;MR6(8$.>,#&,9/6H);O4-3\3?#[5+LVJQ7CSS)%%&=T6ZU=@I<L=W!Y.!
MR*Z&/P58)_8ZO=7<L6E6CV4,4AC*O$ZJK!\)S\JJ.,=/K4%AX#M;"722FK:I
M)%I$C-8PRR1E8E92FS.S<R[20,DD#O0!L:_?W.G:9Y]J;97,T:,]PV%16<!C
MC(+'!X4$$G KF;+QK>3PO;R10B\;7#I,,C1/&A'EB7>R,=P.W(VYY('3/'2Z
M]H4&OV4-O-/<6[07$=S#-;L \<B'*D;@0?H016--\/M+GM+Z"2]U$M=WB7XF
M\\"2"X50OF1D+P?E'7(Z@ #B@"2;6]9L+JSTR^CL1>ZA?O;VD\8;RS"L1D+L
MF<AL*5V[NN#G'%1W.MZ_I=SH\&H16!-[JS63-$K?/#Y;ND@&[Y&^3!4[OK4]
MYX*L]0TJ*TNM0U&2[AN%N8]1\X"X251@,"%V@8R-NW&">,G-277A&WN]-M;=
M]2U 75M=+>)?[T,WG %=QRI3[I*XVXQVH Q+OQCK,-AJ$L4-B\UIX@BTI0R.
MJO&YB&?O'#?O3STXZ5)KWB/Q%X?TZ[>Y?2I+BTT^6\_<P2-YQ5F(78&S&NP+
MER2-S>W-YO 5B;:Z@_M+4@MSJ$>I2-YB$^<A4@@E#QE%./;TXJQJ_@RRUF]O
M+F6]OX?MUC]@NHX)%59H_FQG*D@C>W0CKR".* ,2[\27]IXKN;V6X3^RK7P]
M_:1M1$2WWB6&[=][Y!@D=.,=36SI&I^(KG5H%O=.B_LR>U\W[0@5#%+QA,>8
MQ<$$X( Z=.>'CP;IYNH)Y+F\EV6']G3)(ZE;F').)/E]2?N[>N.G%.\/^$X/
M#P5(]3U.\AB7R[:*\G#K;IZ+@ GCC+9(' /7(!)K&M2VNMZ3HUIY2W6H^:XD
ME4LL<<2@L< C))90!D=2>V#Q_AS5[O2$U"S6.*74+_Q+=0*8X\(-L?F,P4L.
MR=-W4]3BNSUSPY;:Y/871N;FSOK"1I+:ZM64.FX89<,&4JPZ@@]*RY/A]ILN
MGW-J]_J1EFOSJ*72RJLL%QC!="% ''&"".>E %2Z\5:[H^F+<:YIPLHEOGAE
MO4@,R+!M)25HT<L@)PIRQQC/<5:MO$>HZI<1Z=IMQIKW@TQ;YKD*TD$I=F5
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M%VKMPH(X'<FJ6L>$+/6=2N+V6\OH&N;$V%Q'!(JK-%EB <J2""S<@CKSD<4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "HKJZALK26ZN9%C@A0O([=%4#)-2UQOB76I(/$%M9W&B:S=Z=;J
MMP6LK,S)-+D[02.R8W8[DK_=Y -GPMXBA\5:#%JUO;RV\4DDJ+'-]\;'9.1V
MSMSCM6S7GOP=U$7G@QH!9WD/D75PWF3PE$??/(<*>Y'0^AKT*@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** ,_1=&L] TU=/L$9+=9)) &8
ML<NY=N?JQK0HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
<@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>aquestiveamendedandresta005.jpg
<TEXT>
begin 644 aquestiveamendedandresta005.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1%253Y^(RR[L=<D\]ZV;#2KC2->UO7+V[@>"\AA+JD3*8_*4@GJ<YR3CM[T
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MMX?UZ6#3!;ZGI<\4$D4LP90)=A60$ @\../45L/XH8:RVDI:1/?0I#)-!]H
M?;(V-T8*_.J@9)X_.LW4_!5WJ2>*%-]!'_;+P21$1$^2T04#//S [!GIC-2Z
MUX1N]?>,W\UDTD<D4L%Y%"R3VC*06\LY/#8Z$\9YW=* .N8[5)P3@9P!7+V/
MC+[7J<=A+IDL%S/8-?Q0&0>:%4J-DBG'EO\ .IP21UYXKI9XVFMY8DD:)G0J
M)%ZJ2.H]Q7%:1X+U?3;O2KE]3L9'L+":R8+:LIFWE#YC'>?G)3+'OD_6@"UH
MWCH:M-H?F:3/:VVLP/+:S/*K?,J[RI4=!MS@^W2LK7-;EUF7PCJ%I!(FG7&M
M1K#.)R#*FV3EHQQM;;D<D\#(&:OZ=X*O+*W\*6[WMO)'H4<D;_NV!G#1F/CG
MY< Y[U6M/ VL6FG:-I2ZO:-8:-?I<VKO;,96C4. CX<#(#8R.N ?J =O?7#6
MEA<7*QB0Q1L^PMMW8&<9K!M/%\=X_AX)8R;=;LFNX?G&4VHKE2.F<,!G/KTK
MH;B%;FVE@<D+*A0D=<$8KC-)\':S83>&WGU2RD30K>2VC5+9E\U"BHI)+\-A
M1GM[&@";2_'G]H_V-,^CW%M9ZK/);13O*A*RKO."HYP1&W/K[<UF>*=<DU>P
MT:\L8)!I_P#PD%I ERMP5+[;@(QV#JA(8#)]\8YJ]9>"K^TTKP[9&^MG.D:@
M]X7$3#S0WF?+C/R_ZT\\]!59? >K6^EPZ-;:M:#3+34X[^T,MLS2H%F\WRV(
M< C=GG@X- &K=^.+6WN]L5N;FW2]^Q2M%(#*C[MI81XR45N"<YX)P1S5=?'K
M_9M3O9-#NHM/TV6>&YN&FC^1XR!C:#D@YZC(&/RFL?#6M:7K%Z++68%T6]NF
MNY('MR9XG<Y=8WW8"L<GD$C)QZU+IGA[4M-TW6($O;4SWU_)>1N8243>P)1E
M)^88&,Y&<]J *NM>*]3MM*M;JRLK9_/U.UM4F6ZWQ21R.F61@O.=Q7H,')YP
M,V=3\8'2+D+=Z:\< NH+1I&DVEWEVC,0(_>(I< D$=#QQ6:?A\8K&[2PFMM/
M>74;;4(;:*-FMX7B920%R/OE<G&.WIDIJ?@C5]0EU(_VQ:$7=U:W2/+:,SQF
M%HV\O.__ %>4) '=CSW(!9U+QZVG/K9.B7+P:++&MW+YR#",JMN49YX8''UZ
M'BG>+=;:XT?Q)I^GV[S26-@S7,BSF(QLT990I')8* V,@8(YYJ'4O!=_J%IX
MK@-_;*=>\O#^4W[G;&L?3/S9"Y[8SWIU[X0U5K_7)[#4;6*'7+41WD4T+/Y<
MJQ^6'C(8<%< @^F?:@!NC:C;K>>&;62PN);Y]",T-P)L*5 BWIMW8+$E>2./
M7K4VC^._[5DT-WTBXMK76?,2WF>5&Q(BLVTJ.<$(W/J.G>I;+PO?V>IZ'>&]
MMI3I>F/8$>4R^:6V?-U.,>6..>IJIIO@N^T^Q\+6QOK=_P"PYY)681,/.#(Z
M8 S\N!(?7I0!9?QS'LL[F'39I[.\U%]-@D210YE5F7)5L *3&^#G/3CFKVF^
M)DU74IK:T@22*"ZEM9V68>9"Z;N7CQ\JL5X.>00>]<%HM[-)J)N;*ZT2ZN#?
M2W2Z7-!-'=Q,[,.8]Y5'"G!?8!U)/))[%?"4DOBFTURX>U2ZM9IF^TV\926>
M%PP6&3L0NY>>>4& .: -'Q=KC>&_"FHZLD8DEMXOW2-T:1B%0'VW$5!-J3>'
MKG1=,FB>X_M"1H6O7DQ^_"%OF&/XMIQCCC' Q4WC#0W\1^$M2TF)PDT\7[IF
MZ"12&3/MN45#JVG_ /"7>&%A622PO \<T;E<O:SHP8<>H(QZ$'N#0!%IGBW^
MUK4M%9 3KJ<FFO!YX)5TSN;(&. I;W'OQ7.^&/$4NBPS03V5Q-9S^)+JQ%TT
MX8QLT[+&,$EF'0$]L]ZZ72_"-MI'B2YU2UE80RVT42VQY59%&TR9_O%%C7/L
M?6LL>"M0&FK:_;K;<-=.L;O+;'^N\WR\9]3C=^E %VY\<6L-XJ16YN+87OV&
M1XI TJ.&V%O+QDH&R"<YX)P1S7+Z[KNIZKX<U6>YM_(^P>(;>VA%O.<D+/"I
M4C SG)//][':NFT_PUK6E:O>)9:Q NB7=T]V\#VY,\3NVYT1]P 5F)/*DC)Q
MZU4N_!.H36NJ6<.I6PM[S5H]33? VY"LB2%2=W/,>!P.#WH OIXTAA_M=-2L
MI+.?39($:,RJXD\X@188< DG!SP/7'-5+OX@)8V6JS3:7+*VG-#N-M*)(I5E
M;:&1R!G!X(QD<=<T:GX)N=5N]?FDU!;<ZD+5K=X4)>VEMSN1^3AOFP<<=,4_
M4?#?B'7/"]UIVJ:O8M=SF(*\%LR1(J.'SM+$LS$#/( [#KD Z33;J[N[9I+W
M3WL9!(RB)Y5D)4'ALJ2.1V[5@ZGXS.EOX@23369]'MTNROG &>%@WS)D=MC#
M![C'IGJ4W;%WXW8YQTS6%JGAB'4_$>G:LTI06T;Q3PXR+A"RNBM[*ZAA^/K0
M!7U/Q>NGZ3=:FEB;NVMM.74':"8<JV2 ,@9X4G/H.G(JK>:[YUQHAU30+J 7
M&J+'92?:EP&,3,LC!6STWC:0>1]*;'X&-KX!U/PS;7N3>)+"L\JEO*B8%47&
M>=J;1UY(SWK0U30+W4D\/XN8$?2[M+J3Y"1*5C9-HYXSO)SSTH YV[\:Z]#H
M'B*_6PM0UCJ@L8OW^=BEHTS]WDY?/XXZ#G:U;QHFE_:T^R+/<6,:274$=P-_
MS#.V,$?O&V\X^7J,'/%5+SP1>7&E^(=/34H%AU.]%] 3;DM%)NC;#'=\RYCQ
MQC@U/)X;U^V\03ZKI>LV</\ :$<:ZA%/:,Z[T&T218<;3MP,$D<#.: &7WCQ
MK=]8%MHEU<)I=K%>2N94CW1.K-D G.0$/!Y/MWZRVN([NUAN8B3'*BR*3Z$9
M%<K>>$;VXG\3,M[#MUG3X[)2Z$M%M1UWDY^8GS"<<=*Z33+62RTJTM)75Y((
M4B9E& VT 9Q^% &'?^,XK.TU/4([)[C3=+G,%Y.CC<I7&\JF/F";N>0>#@''
M+H_%<]UXCN=(L=&GN!;?9WEN1-&J"*7=^\&3D@;<XZGG\:<W@NX^SZ_ID%[&
MNDZY,\TRLA,L)D $H0YP0V"1G[I)Z]*TM*T";3?$^IZFLL/V6\M[>!(%4AHQ
M"& YSSG>>W84 :.LZM;:'I-QJ5WN\F$#Y4&69B0JJ/<D@#ZUD7'BTZ??75A?
MZ<\=Y%8M?PI#*'6>->& 8[<,I(R#V(()J_XFT*+Q+X>N])EF> 3A2DR#)C=6
M#*V.^&4''>LRY\-7VISR7VH7%J;]=.EL(/*1A&OF8WR')SD[5PO;!Y.> !++
MQ;?7NGV=Z/#]Q##>B)K>629?+V-$9"\A7)C48QDCDLOKQCZKKL?B'2?"NJVP
ME@#Z_' Z"7()5Y$8<'#+E,@^F.E:DGA74O[%\-6<.H6WF:/L$BRP,\-R%C*
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M!R1R.",W4TK7;NP$.JZC9RM-(HNDMH&CC,(SE$!8D%L\L3TX '6LF3P3?_\
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M>CE2/WB@]/8FN8U>*QT'5?$-SILUX=%DT(R7XLKDL1.9,(ZN2=KE-Y)]!DT
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M@7'0[K@=?,#9 )Y.3U&: /0Z*X7QC!97'CCPI!?RE;6X6\CD0S,B2812%."
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M4GD$>A-?0_%VJ'1O",NI65NPUJ)%:[6Y("2F'S%RNS^+##&>#ZT =NJJOW5
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M?:1OX&7//TKKA*CF18W1Y$X*[NA]_2JUG=2_V9;SZD+>WN'4>8L<VZ-6] Q
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M'#GC/7OCBNINY[E#:-:1P2QR3*LS22[=L9!^9< [CG'''7K5@S1A@ID0,3M
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M<#I@8T+#PE<6&HZ3?1ZL6ELM._L^7=;C$R!E8$<_+ROOD>AYKI//APQ\V/"
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MZ/X)GTA_#Q&K+,-%M);2,-;8\Q7"C)PW& B^O?VQTEWJME926B7%PB/>2>5
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M&Z*1@7;(4Y4MQ@-S2QO);>.(I+9[75+6XU.3?!(FV[L)/+93(K#[T6T'KT#
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MZDUQ:7[65RJ>7>6$K MLE[,I? #'!SCKUKUBFF1!((RZ[R"P7/) ZG'XC\Z
M/)(3:ZEH-[J/A:35/^$A@T>6V:W^SB'R6QG8^(US(&!V\DYR1QFM'2[S1+OQ
MQX3N=&A58_[+NH9/+@(,9'DE4?CAA\W!Z9]Z],HH X_XH113> +]9$#MYD)C
M&,G=YJ\KWSC/3MFN4\06SV>I^+K?PW;JHFTRRE:&S7'G8ED\[;MZN8CCCDY'
MJ*];HH \NUZ&QOKS4KW11 ^DR>';B.]\I1Y3R<>0I X\P?/QU P.XIFGZ7HQ
M\0>#MUI:%)]$E%YN0$2L!"4$N?O$$.1N[@^E>J4WS$\WR]Z^9C=MSSCUQZ4
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M7VFK(UWD8F4^:?/=SU,;1Y.?ND%0.U>M44 <3X7@L%^('B]XH;=9/.MS&RH
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MC=L=...0"M=^(6U^VU"PTZUMY%BTR.ZN!=$[3YRL4CP.^%)+=!D<'/%WX?\
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M=G86TRR*Y#7>[S<(QVY&"I Z_>JU=^%)]0TB*WO=:N9K^.[ANUO#$@P\; J
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MP25;&>NTXH ]%DO;6*T%W)<PI;$!A,T@"8/0YZ4/?6D422R74"1NI97:0 ,
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M91+AN,\J3VK3\0?V=<>&7N]'L;E(;S6[.Z=C#(IF831%Y C#(4*O)P <$^Y
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M,_ONA!)SCUST["M[5]:>SUC2M'MA&+S43*R/*"5C2-06. 06.64 9'7.>,$
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M8-+9^+IK?0_#^K1V=LFAZC/%:101J1);(YVQ,3G!'"@J ,;NIQR =S17!?\
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MU2+QMX;T^UN88[.Z6Y>:-XBQ<H@ZD,.,-T]1GF@#I8;B&X5F@FCE56*DHP8
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MK#@94 $9ZG%9FIZG<^(%\$:V8K9+*ZUB-X$V'SD0QR[26S@Y R0 ,' R<9H
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M9_+,+C)E,62XVD;3SW!SB@#M:*SM"U ZIH\-Z9[2X$I<I-:-NC= Q"L.3U4
MD9X.1VK1H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ K+U_0XM?L8;>2XFMG@N8KJ*:';N22-@RG#
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MS:=:/9P^8L84QMLP" HZ;%YZGN>U3>'/%,.H^#M+UO5I[2Q>\A$A#2!$!Y.
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M= MDU"Z>/1'=[?>$)?<K(0_R\C:[#C%=#-J5C;W*6T][;Q3R$!(GE568DX&
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M;6WN;>VFN(HY[DLL$;, TA4;B%'? &:AGU?3;6]ALI[ZWBN9F"QQ/( S,>0
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M2W0G=OQZXJRZ5N\,WD?]C7)D;Q8+@)]@?<8?M0;?C;G;LW<],$BO5;6^M+Z
MSVEU!<0@D&2*0.N1U&1Q1:WMI?(SVEU#<*K%6:*0. 1V..] 'F?B'3+JY7X@
MPV6FW)%Q;VCP*ELRK,47Y]G&&(P!@<]*T7NFU#Q=K6H06.H_99_#T<<4CV4J
M;W$DQ*@%<Y^8<$ GMQBO0J* /*X;J30[3P->26E^9[?17MIK<V4T@3Y(0VY4
M5F5@RCDK@C(R.*DTA;+3;'PM9:9!=W$$"W,4FHQ:?)YL$I"DH8BO[O?G@N"
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M#YD&4)!R#QT(-<C'!X@T_0K.>X_M?5-+TW6V:(E&^V26?E,BN5P&;:[$],D
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M!\IR3D@YYXSQP*T*C@B\BWCB,CR;%"[WQEL=S@ ?I4E !1110 4444 %%%%
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M@X8 8R2>>,$ Z>]\3:'ITCQWFK6<,B1"9D:8;@AZ-CT/;UJ:?6-/ALX;C[=
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MWBG>A'=?O?\  :XJ>R\0+IEO+=QW.IQZ?KUO<QW M?+N;BW"!2S1\$LI.W.
M2%SB@#T!=8TUXKJ1;ZWV6C^7<-Y@_=-@':WH>1Q[BL'Q#XJ%MIMI>:1>6DB?
MVI;6=UO4DHKR*K \C8P#9Y'X5S%U8:Z\NMZC;:-=GR]>M=22V?:K74*0QJRK
MS]X%<@'NH[UI:_%)K&D0W5IX=N;8SZO97$R/; 32K'(I=Y%7/ 5<#/)QTZ9
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M;7"[X9$;<)%QG*XZC'/':L*^\6QV?BG38VO['^P[O39KL3^K(T84A\X((DX
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M((KE=/US7;K5--\/:CY%EJ;6<UW=S0!7RJ2*B! <@%MP8YSC&!UR'_#=)O\
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MIV^HK/<_:K>T-G&^\<1$@D8Q@G*J<^U5K7P9IEG!I,$+W0CTF5I;0&7.QF#
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MT'D)>%+22*%D+1G 5=I)+-N.T$?>/0=,Z5KJ-I>6\D\,N8XF99"ZE"A'4$,
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ML<YXWKUZUUM% 'F_AW3+P:99V&J>$IS?Z3:/!]IFN0\$H\HI^Y.\D%QC(V@
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M:=$T5JA)5&E9\9.3RQ)ZDFKU 'GWB"RN=4N+_P 0&TGLH;?P]=VTBS@*\CN
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M(ZYS\Z\GCK67I-GKOAW_ (1F_?1+N^ACT*/2[NU@:/S;>5=IW ,P4J<$'![
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MWN%\NZD 1W)+8!; !+,=N,9.<9H ET:]&L>%8+NWU/[2)X6*7L484GJ-VTC
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M9P1-&(V=9 .@.-N0.,@]!Q5R]US5M"U>VL=9U"X2V+6\<6II:H;>9RP\Q)@
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M81R(&+DC=DDDC!&!MX/.>QE\$Z%+K/\ :IMIDN2J+*$N9%2?8,+YB!MLF/\
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M_P"Z\SHBA1N7:0,DG@GISUS=TS6-<O\ 6+3P]J%U!::A%IAN[R:R"N'?S3&
MF\$ #:2PQU(&1@YT)_ 6@7%AI]HT%T@T_(M9H[R59H@0 5$@;=C  QG& /2K
M-QX1T>XFL9A!-!/8H8H9K>XDB<(>JLRD%@3R<YYYZT 9OPQ##X>:6'8,X,VX
M@8R?.?M7750T;1K'0-,CT_3HWCMHRS*CRL^"3D\L3W)..G-7Z "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MI9Q-&PBEC0 J5!)(.W[PXY ZFI[JROQ\1K35$L99+*+2IK=I5=/]8TD; 8+
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MHUK;ND7]HWPM6E=]@4>6[@!MK8+% HX/7C!P0 :-]J>GZ##91W!:*.XN([2
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M^_YE(7<&7;N)).>>@XJTU_>Z9X6\57MA=/;3Q^)BNY54[E::%&!R#U#'I@T
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MK9D^T;T:0;"V V%1B>>,>XS;_P"$CLF2W$4=Q+<7".\=LL1\W:AVN2IQM )
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M01QRSO/Y:D[4+8R%R2>V3ZDD\9Q5>#P9X=MKB&>'2H$D@G:XA(S^[=LY*C/
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M(K&[U%-/Q/!=2P_:(8[B(H98^ 67/ID9!P1D9 K4DD2&)Y9&"HBEF8] !U-
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MVQFN1>6OVR&.&,ES#@$N0<8'(Z\DG R:P)/%BGQCIUS:W=W>:/>Z)+=Q6]O
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MGZCK5:/PGK+?#>VTKRK:/5+*]-Y%%.P>&8B=I C$=BK8/'!KT%'62-71@R,
M593D$'N*=0!P-]H.N:AI4%]::-IFE:G9WL-Y%91R@B?RPP97D50!D.P'!Q@'
M//%W6K#Q!KFBVD\EA;07EMJ5M=K9"XW?)&X9@9,8W'GMC@<UV-% '#-X?UFV
M'BFRCMHKBWU[=+')YHQ;RO$(W5\X)0;005!)Z8%6]$\/7>D>+%E6(OIT6C6V
MG1S,XW,T3.<E<YP0P_$&NNHH RM U*\U2TGDOK%+26*X>(+'-YJ.HQA@V!GK
M@^A!%<?:Z!XG;7-#U*_L[::XL+ZY:XG^U_ZR.1)%4QKMPB@,OR\9(Y[FO10
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M RJ5EWN,@[<_P@__ %N*ZF;PUHEPUXTNEVK->J%NCY8_?   !O48 _(>E/\
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M;**ZPIB:<$C9UW#E2,XQD8S6GJ6IVVEVZ2W!;,LJPQ1H,M)(QPJJ/4_D!DG
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MR-&4VX9LL0&W# P<<8KH="O]0OUOO[0M8(3!=O%"T$I=)8P 0V2!SR01V(-
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MF@^#M,TF^$7VFTA$3F)RRG'<$@?RK!_X1#5;KPIK^F2O;6UU>:G)J%I(',B
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MVR2W>,,[0\_.NTD,,@@X/'?%5O$>BZIXG\.W%JS06-QNBFM5W&0"2.19%+D
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M0[(T0NQ;L ,G-<<VOQW'@#_A(M3N+^U@O_+EC^Q?ZR")G'E =@2"NXG^\>V
M.HDB;5-$>&XC:W:ZMBDB9R8RRX(_#-<7'HVI:I\(X/#<*0KJ=I%#93),Y15:
M%ER20"<%4!''(8&@#HK[Q=8:=J\VEW$%T+I(!/&H1?WZEP@$?/S'<P&.OYC*
M:OJTFC:MH\LA?['J5P+*2)R"8I64F-A]2NTCIR#V.<[Q-X?U?6YUU"U^SVVH
M:8R2Z2QD)4N?]9YOR_=9?EP,\9/7&)/$EI<ZW=^&;%HE2XAU"+4;H(^]8DB#
M'K@9RY51P,\^AH T?%>OR>'-(2]BLY+IGN8;<*I4!?,D5,G)'][MWQT&2.>;
MQ3+HWBWQ++?KJ4]E;V-G<BWC0/\ 9E/G&0\' P%&>23CC.*W_&.D7>M^'FM;
M#RC<I<V]PBS,55O*F20J2 <9"D9P:QKSP[K5U>>*YS#9C^V-*BLX0)V^615E
M!W?+]W,O7KQTYH V]2\5Z=IT$DP6:Y2*V%W+]G"DQPG.'()&<[6X&3P>*TX=
M0M9],34HIE>SDA$ZRC.#&1N#?ES7$)X:\0:9J=K?6=CI-^LVGV]I=V]W,5\F
M2($"1'V-E2&.1@'@5V<MO>#1'MK:>*.]%L8XYO+PBR;<!MOIGG% &7:^,=.N
M2P,%Y$?L U&,/%DRP'^)0I)].#@\CBJ]OX\TVY;3Q'9ZD?[1M?M-D?LW^O&U
M6*KSPP##K@=3G'-8NG^%_$,.IQZA/:Z>)GT:2PN&%X\CR3%E(D+%.<D?@/7I
M5O3?#6L6;>"1)':D:'9-;7168_,3$L8*?+R/ESSCK0!M6OB[3;W3K2Z@6X,E
MU.]M%:% LQE0MO0@G *[&))...O2HU\9Z85CW)<I(;]=.EB9!O@G;&U7&>AR
M"&&00>M<]9^$-;LY;#44%J;VQU>]O%@\X[)H+DMN7=MX<!ACC&1UYJ;4?!^I
M3M?:O MO_:5QJUIJ(M6E(39 %4(7Q]XA2<XQDXYQF@#;OO&FEZ=!JLMS'=J-
M,GCM[@+%N(:0*4(P>A#KS[U6U#QS;6NE:_<1:?>FZT>W%Q);31B-G0ABKC)^
MZ=K9[C!XSQ6+J/A3Q%J%KXI4PZ>LFKW5I/"!<MA!$L08$[/^F9 /?T%7M8\+
M:IJU[XJ<"VBBU?1TL8&,I)611+RPV_=S(.03TZ4 =;IUS)>:=!<2P/ \B!C&
M^,C\B1^M9-GXPTZ]N;:*.*[ NX99K21HN+A8R VT EL\@X(!(/%:>EI>)I-N
MEY'##=+&%98G,BJ0,=2!G\A7$Z7X:\30:QH6J7\.GS7EC'<Q7D_VIV>Y,@7#
MC*<#Y>$Z+GCTH W=*\<Z5K$^EQV\-ZD>J1N]I--!M20J"Q7.>NT$],<'G-9?
MB+Q*]Q/X>?2Y+U+2;6HK9KF,*(9U!8,O7=C*GG !P>3Q4.C^$M:L+#P5;S):
M$Z(TGVHI.?F#1/&-GR\_?SSCI5:S\)^);/1-#T+RM/EM]&U..>*[:Y93-"C,
M0"FP[6PV#R1D>_ !V^NZY:>'=*?4KX3&W1D1O*C+D%F"C@=LD50'C/3%35C<
M1WELVEHDLZ30$,R/G8R@9R"5(['(Y I?&FDWNN>%KC3K 0FXEDB8><Y10%D5
MSR >RXZ=ZR-5T'Q'-JWB#4-+DMK::^L+:WMG,Q#*T;NS@X7Y=RN0&&2#S0!:
MUOQQ'INA:[=PZ?<M?:2BF6UDV KO7*,2&(*^N"3P>,UJ+XC@_M&;3Y+.[BO(
MK3[88F"$F/<5X(8C.0>,UR%UX)UF[L_%D"6^G6BZS9PK"J3N^R5 00QV#.<Y
M+=>>AZUL7>DZ^_B:/6(K:Q)N-+-C<1M<MB!MY<,#L^<<D8^7D=J )Y/'NE+!
MILD-MJ-RVI6;7MK';VI=Y$4*2 /[V&'%6+KQEI=G+&)A.MNURMHUSM&R.9L
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M5V9B 48X'3*Y'0TOC>SMX_"6O&#6KJZA<VDR6YNG<0 R*I(?=DJXYVDXXR*
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MR!XG5T.0&4Y'!Q3Z\C\,ZB;3PMX%TS[<T$&IVDCRRRW,B[IE5-D88,"F<N<
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M7P<<'<..* .WJM>WALH4D%M<7&Z5(]L";F7<P&X\CY1G)/8 UYCH4NHW5GX
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M36)AHRB[N$NI$ED2-U+[48O\P4 \$Y[9- '0?V)I6V[7^S+/%Y_Q]#R%_?\
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MHP4D,&VD'CH>16U6/XE\1VOA;2CJ=];W+V4;*LTL"JWE!F"AF!8$C)'0$^U
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MUS@84R97"<=0-V3W &#J>'M;B\1:)#JD,$L$<KR((Y<;E*2,AS@D=5/0UJ4
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M6DH^BRW&GR:$DCF&X7?]J\IF+",KC;QG&[/3MGD=9%96EO.\T-K#'+)]]TC
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M.>U;&M:FFBZ)>ZI)!+/':0/.\<6W<549.,D#H#WJQ9W*WEE;W2J56:-9 #U
M(S_6@#C]'\&7>AZEX;-O);RV>EV-Q;3,SLKR/*R,S*NT@#*'C/?VY[:BB@#@
M-2\(^(;[4GN&ETR<Q:Q#?VT\\DGF"%&!\G&W" 8/()W'J 236YINDZG9>*M?
MU1ULWAOU@$*B9@P,:E?F^3 SGL3CWKHZBN+B&TMI;BXD6.&)2[NQP% ZDT <
M/;^#]:A\$:!HI:P-SIM_;W,CB9]CK%+YF!\F<GITJU?>&-5N9_&3(;(+K=FE
MO;[IFRA$31Y?Y.GS9XSTKJC<S#4UM19RF PF0W6Y=@8$ )C.[)!)Z8XZU9H
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MC>^-N.M=X^G6,DDCO96[/*,2,T2DN/?CFD&F6"LC"QM@8UVH1$ORCT'' Y-
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ME9 !UCD8CM][(XYKU-5"J%4  #  [54;2M.>Z2Z;3[5KA#E93"I=3UR#C(H
M\YU*YEL?%/C#4+"-H]9.A6]Q:0LY+M)MGSA<_,1@<8/2K<ES<6U]X:O?#4\M
MT+[3KB2XC,K2"<+"&CD8$GYO,VKNZG>0:]#-O";@7!AC,X78)-HW!>N,]<>U
M1VUA9V;R/:VD$#2G,ABC"ESZG'6@#AO"U[I&JZ=I.IV^M3RZF^G.+RW%QN\Q
MRH+M,AR5*L" > -V.A K-^%^H"6TT6PU8-!<II4+Z6JRGRKB'8N]L<;I W!!
M^Z,8ZDGTE--L8VG9+*V4W!S.5B4>;_O<<_C2?V5IV(Q]@M<1_<_<K\OTXXH
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M#D>V,=JZ[^SK'[!]A^QV_P!CQM^S^4OEX]-N,4^WL[:T#"VMH80V,B- N<#
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MG:R&-GCQ+D/%(N02,,1D8/0\4 65^($3V]FT6D7DLUSJ#Z=Y:,FT3*K,,,2
MRL%R&'&.N*W;J^?_ (1>>^OM.N(V^RM)-9K(OF+\N64,& SUY!K*O- UK46T
M2XO+ZS>YL;_[;*$C98S^[:/RT&20,.3DD\]L' W]4M9+W2;RTA95DGA>)6?H
M"P(R?SH YBP\6*D>CZ9IFB7D[7.CK?6RM.F!& @"L[-G(WC)/ZU3UGQ1-J^B
M>%+S3;5_LFKW\231R2!6*[78Q-^*<]B 1T-7](\+:AIFHZ+=&XM9!INCG3"H
MW#S#E#OSV_U8XYZGGBJUIX,U*UT#PSIHN[5FT:]%TS[6 F #C:!_#Q(>>>E
M$T.NV?AW2=2^PV=U<Z;H\K"\<S[VA) D=8PW+*BN,C(P.!DC%6F\8/+KLFEZ
M=HMW?&.*WN#-'+$J&&4L XW,,XVDXX)JO-X0O$7Q%96EW"NG:\SR3!U)DMWD
M0)(4[-D $ XP?7I5W3?#LVE^)KK48'@^QR6$%E%!SN00ERI)]]^/PH SK;X@
M_:;72;L:%>K:ZG</:POYD983*7PI7=T/EMSG /MS5ZT\6O=V=T1I-TM[;:@-
M/EM@0X1R%8.77($>UP2V./2LZT\&:C;:+X?L#=VK-I6I-?,X# 2@F0[0.W^M
M///W??A+GP=JTC:D\-_:+]KU>/43$Z,T<B+&J&&09&0=@;ZCI0 7GCJ>72K6
MXTRR1Y6UN/2YPTP*J?, 8JP'S!AT/&,Y[8JVWB/3-,UKQ'<WEK<VTNGV=M+<
MR-+O616\S8(UW$ Y!'0$DBJ7_"#ZF+&ZC&I69F;6TU> _9V"!@RDHPW9QQ@8
MZ>]3ZGX(FUJY\0_;KR-8-7L[>W#0J0\3PEF5\'@_,V<>W4T :,GBHV>HMI]_
MITT-VUH]Y;HDBN)U3&]03@!UR,CISP35?1O&JZK=:-&^EW-K#K%F;JTFD=&#
M85692 <CAA@GK@TZ3P]J.H7=OJ&IS6C7MI936L'DA@A>4*'D;/(X4849QD\G
MC%;3?"5]8OX2W7-NZZ#:/;/@-F;=&J;A_=X4''/7'O0!JZ]XC.B7NF6B:;<7
MDVHRO%"(F10'6-GP=Q'4*>>@K,OO'UOI]O-+-8OYEIY0O;83H9HF=58JJ GS
M"H<$X./3)R!I:WHUUJ6LZ%?02PHFF7+SLK@YDW1M'@8Z<.3GVJ@_AW7;/Q'J
M%YHVK6L%AJCK+=0W%N7>*0($+Q$,!DJJ\," 1GGI0 _5O&L6G:;J>I6]C)>6
M.F/Y=S(D@4E\#(0'[V-PR21WQDC%3W?BR.TF\11-92,^B6J7<F'&)8V5V^7W
MQ&W!]N:XWQOH>HZ!X0\6M'J-J='OF:[\J:,^<DKE=RJV[!4D9Y&>2/>NBUCP
MMJ&HW^N7.FZA9I:ZYIJVDOFQL[(560*R$'&").<^G>@"TNLVESXITT+I]VUW
M/I,MU!()@$,>Z/<FW=@MEEY(&/7K5;3_ !]'>Z1;:K+I5Q:65X(UM)9YHP)9
M&+#;][*X"DDGC .,\9L6OAO4;76M(U W-K+_ &?I;V++M9/,9BAW=\#]V..>
MIJC%X(OXO FE:+'J44.I:3*D]I=I&2A="<;D)Z$,RD9[Y]J +MMXXM9XY(S:
MN+U;U;&.%'#)/(R[@R2="FT,2>HVGC/!K^$)KF3Q9XP2Y66,QW< $3SF54S
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MBR#(+%CN*\G(XQ@<9( ^;7+"R\4W;7]K/:W%KH_VJ:X:;=$(0YR H."00><
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5DWFK$:]::);;?
MM,L+7,KD9$4*D+G']YF8 ?1CVP=:N2-O);?%K[7(#Y-[HHAB8]-\4Q9E^N)
M?P/I0!%H'C:UDN;RPUS5+&*_&J3V=M&/W>]5;"\$GD\]3R>E;<6K&+Q*^BW6
MWS)8#=6K@8WH&"NI]U++SW##T-<5=>'[Z]T'Q+X>;3IDN=1UB2Y@G*?NUC:1
M6$N\<94 \?>R ,5OZG;27OQ/T!X0=NG6%U+<-Z"4HB#\2CG_ ( : .MHHHH
M*SI==TN&^%E)>Q+<&58=I/ D895">@8CD*3DYK1KS'7++6;K4+G;H5V/(U^U
MNT%JL:Q30JT>92=P+R$*0<\ *.F,D ] &L6!OELA<K]H9S&JX.&<*6*@]"P
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MS:V$%F^P&)\VZ1Y9^B;6!/.#QD9- '9W^N:9I;!;Z]B@^Z6+GA QP"QZ*">
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M),\32,R;NV0RKGW]JM01?VCI>KZBGAG4[&_ETY[5C>R&2:1B#B-/G;*@D\G
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M2Z_?M#YNT>=!T4D#.<=?>@#N**\UL_%'B74_^$?LQ=6=K=75U?6-W,ML74O
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MV@:Y=_+W+L(^8G(V_*!T ]^:A\#ZS=:WI^IS75RUP(=4N+>%FB\LB-& 4%<
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MQ%BQ4DGY2@Z\D=:[+1](;2[K4YC<3.EY<F=8Y)FD$>>N-WW<_P!T<#C%0?\
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M,R,R[U"#;E_ER?ES@ ^AHD\7Z#%8I>2ZBD<#7(M"71E*39QL=2,H<D?> ]:
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MRB'EJEX#CS$Y;Y$  VYP0PSS@5I+::E_PL"WUC^S9!:7&E"VD+2QY@D$I?#
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M4L6.&_=MU.,XP2.:]/HH X36M U77M>U-OLDEG;W_AY[ 7#2(?+E9F." V>
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M\P^)(]0C'VJ-RT(G20G<S=<+CGDG\Z].HH YOQII]]J.CV9L+9KB:UU&UNS
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M[.=[IKFT@6XFCBM)9"L9SAAA>1\IR1P,5#X)MKY/#D%YJLRSZC>*LLTH4@,
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MKIMOJ%E,);6YC66*0#&Y2,@\]*Y73M*U2V\3:;?R:>_D6^A?8I,21D^;N1L
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^7>&SP&*8QGT8#J:R;.P%DW@Z;5K<O8Q:K?1V[3PERELR2_9U.03S\NT?[M
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MOEJX#*>)5^;&!D\8]!0!VEEKEK=?V=%(1#>7UI]J6V8Y95PN[/T+@5HAT+E
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M,\9P=I!&:K:_;Z-I_B&?0];,]CHD^EPVVFF*W$D8P7$D:DHQ63E",8)P.X%
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MV@TP:G!' ;T+$6BEWI'.1G9G R#@@-W/'&1F[J.HVFE6,EY>S+%!'C+,>Y.
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MB)7(12S,\A&69B69B>F223^-6:\H\0ZAJ.K^"_%3:E%;2+9:U'#;B/)*;)8
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MS%([JV $/S#82!T/J.E '445BW^M2)K]OH5C'$][+;27;-*2$CC5E7H.22S
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MH[><%D5$9D:;!XVAU(V]2.?:N>\$:F(;K5]$TJ*V>>/6KR6>-GV+;PF5@I
MY)(P /0Y(XR =S-9V]W?0SRMYC6IW1QY&$<@C=C^]M) ]B?6KE>86^L7/A>\
M\97]II]M)8P:U$;D&4QL%>* '8H4@GYMQR1^O'3WWBFZ!UU],LHKE-$P+A9)
M"K3-L$C(F 0"%(Y/4G'&,T =/O4.$W#<02%SR1Z_J*"ZJRJS %CA03U/7BN
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MV4!&!@<\>FT+RU8P@7,),PS$ X_>#_9]?PHNKVUL8A+=W,-O&3C?-($&?J:
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M#<22PXXR-/P0E]::I%9;S?Z7%IP%K>36QAN;8!E MYN &..0< C:<CGGOJ*
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MC<N[&!O]#39=%99[!I;"1[";Q8]U;1-;LWE6S0L&8C'R(TF3@X'S ]Z]:HH
MY'P1#]FO/%,2V[P1-K#RPJ8BBLABB&Y<@ @L&Y'?-8_B'PQ?7NN:SHUG$8[#
M7[=;M[H+\MM<PX!/U;$/O\K'M7HK,J(SNP55&22< "EH \SUM-2U7X6ZAJ.H
M:?,FK:@ENC6J1%W4(ZC: HSC/F/[!ZDO[.!-?\7);Z>PL[G0(518[4^7+(OG
M<  8+ ,G YY%>D44 >7V%T=)NM#EUG3[V72;GP[#8J8[227R9Q_K(V15+*7&
MT=.=F.U6#IEF/%C1OI$D=C#X:6WABEA:18R';$>X@@N$(XR3SWKTBHIKF"W:
M)9IHXVF?RXP[@%VP3M&>IP"<>U '->%3/#\+=+66TGEN8=*1'M6!21G6/!3G
MD'(Q7':3B75+*5["\%F_AB2U\DZ?*L4+*R$0_,NX[0",L3D].N*];HH \HM[
M%M'\!>#=1M]+N8Q:_9_[66UM<7.%@=-S*5RVR1]V,''4>M=MX1MK"*QO+G38
MKU+>\NFN2UVC1M*[ ;G", 5!(]!D@G'.3T-1175O/)+'#/%(\+;9%1P2AZX(
M'0_6@#RY+*_NO!B:')!.GBBWUD3"8Q-][[5O,X?&"GE$\Y_V>O%6]>\,ZG<Z
MIKVBZ=$8K34=FKV]UM&V"[CX*C/0LZ0M]"]>AK?V;R^4MW TF<;!("<_2K%
M'FGB"WGU?X?)J5]I<@U#4;VRN&MO),CPHLL?RX )&$5B?3<U5M8LKM+_ ,9K
MH^GS[&339DA@AV"X6-R9D3(VLQ0!2.<Y KU2B@#RK58X=1TB^US0[+6+KSI[
M-M36XMWC>YABD!>-8RJ[B%R"0.1QD\@;VA7$%[\2M6O[2VN1:W6EVH6=[22-
M797ESRRCG!7K_2NWHH X#4YWL_&?B!-5M+B:UU#3(XM/D2V>9" '\R+Y0<$L
MP.#U&/2LS0K<I)\-VFL+A&M])E@NC):NOE_N44*Y(X!(;&>O:O4JB@N8+I"]
MO-',BLR%HW# ,#@CCN"""* /*;#2)+;X8K=6.CRC4+?4'DN(X[79<R6PO#(4
M7<,D% I"]#@"K.H)#-83>(=$L=7NX7U"SN-26:!T>YCB)!"1%5+%?D)P/FVX
MR<5ZE45Q=6]I&)+F>*%"P4-(X4$G@#)[F@#S[7Q8WVB?VOI&E7@ADUJQO+F0
MVLJO,$ECWN(B-V JCD#G!^IT(+6'5/'VNQ75I*UA>Z-;0'S865'^:;<F2,9
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MK<7BFX,$QAQ(A>5]^6))^8]<8_&MZS\/B"\CO;B_N;R]BMC;0W$P3,:$@L0
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M53N=@H+G.<$!CMZ#E37/6'BZXU#5KS3A+:6U[;-.)+&XA=9E121'("6 D1@
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ME56*$J3R%'4G'.,9IUWX-CFUE=5MM7U*QNI($M[LVS(!=(N=N\%3AADC<N"
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M\R(H8\#;M 78H QZYR3FI)/",)OKR[@U&\MY-0@2"^V%#Y^U=H<Y7Y7P<97
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MG;-(L(KU&GWL9 PD)4@$8)\O@]O0]KFM>!;36KC5Y)-2OX(M5@2&ZAA9-K%
M0K E201GH#@]Q4TO@^&:?5II-3OF?5+)+*<GR^$4, 5^3AOG;VYZ<"@"O'XB
MN->NI-/TV.V1DTV&\G-TAD7,P;9& ".RL2W/;@]JO@JZGLO@YI%U:PQS7$.E
M*\<<LHC5F"Y +'A1[FKT?@J"VO;2]LM4O[6YALTL99(_+/VF%?NAP4(W#G#
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MT63:&! 3".O)#<YXXYQ8-5_L_P")GB+3K/R$U+439^0)E/E_+&QD8X(R0O0
MY)]@2.@N?!=M)KLVJ6>I7^G_ &J-([RWM758[E4&%SE25('RY4@X[U%J/@*P
MU*YU*XDO;R.6]>"17B**;9X?]6T1VY4@$CG/!- &/J<FIV7Q$U6XTP6/VI/#
ML,KM.C;&*S3'[JG/.,9SQ[UJ:9XKN_$,MK;:6EM;W$FDP:E*UPK2*IF!V1@
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M9L1&KF8QL2!C!+I@CCTZ5HVFA7%_X0U^&."6RO;?6KG4-->XA:(*ZRF2-AN
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M?,R_(RY [Y&<T >FRZI8164=XU_:I;2@>5,TJA'R,C#9P?PK,\':Y/XB\/\
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M6SB,0_:%WECG  SG/!_(UI5YEH5S<Z;X1^']T\.G7$EY]EL_->U/FQ1/#O\
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M!Y]S:H\N!@%\88_B0:Q[;Q7J1\2Z583BSDAO[F[MW6!&(A\H.R8ESM=L)\P
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MX^T1R)]UE8#:, D8VXY/&2:Q[#PM]MU3Q?INIC4)+'4$MD2[F.'E*1X9@V,
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M3YPJWVGR*DP3[KJR[D<>@(SQV*L.<9-J]U.QTU5:]NHH P)&]L9 ZGZ#N>U
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M >A(% #- L+G3-$M[.[O)[R:+<#-<2;Y&!8E0S8&X@$#..<53T[1Y-*U;5Q
M6%GJDOVH.F,PS% K\'L=JL#SSNSVSJWFH6FGHC7=Q'"';:F\\L<$X [G )X[
M U6?Q#HL<=M(^K62I=(9(&,ZXE4 L67GD  G- &9:>"K"RL]#M8KR]\K19#)
M:Y9"<E67#?+R-K,.W6GG09-+L-832YIY+K5IGF+3E=L4CJ%+\ ?* J\<YQ[U
M;B\5:!.UHL6LV#F\;;;A9U)E.2,+SR<@CZC%69]9TVUO([.>_MXKB1@B1O(
M2QZ+]3V'4T +I&F6^BZ-9:7:@BWM(4ACSU(48R?>L*S\ Z=8S:?)%?:EMTZY
MDN+6,SC;%Y@8,GW<E3O/4D^]:@\4: US';KK-@9I)C;H@N%):0?P#GKR./7B
MLSQSXI7PYX:U*YM+NS74;:#S4BG^8'T! (QGG'J1WH >_@BQ?3+C3S?7WE7&
MH?VBYW1[O.\P2<?)TW ''MZ5T;H7A9!(RDKC>,9'OR,9_"LRZ\3:'IYE6]U>
MQ@D@"F99)U!CW9QN&>,X/Y&I[;7-*O-0>PMM2M9KQ$\QH8Y59POK@'IR/S%
M&38>";'3ET-8+R^VZ*KI:AF0\.-I#?)SQQ36\#V+:2^F_;[\0O?_ -H$AH]W
MF^9YO79TW\X_I6LNO:0]Q+ -3M/-B0R.IE480'!;Z \$]J9:^)=#OKA;>UU>
MRGF:'SPD<ZL3'P=W7I@@Y]Q0!7N/"]M-J<^HPWEY:W-U MO=- R 7"KG:6!4
MX89(#+@\_2EMO"]C9:Q9ZC:O-!]CLOL$-NA7REARIVXQGJJ\Y[5-H'B'3_$F
MGF]TZ821"22/W^5V7)'49VY&>QIEWXK\/6$S0W>MZ?!(L@A9)+E 5<_PGG@T
M 49?!%C-IM_8M?7WDWU\+^4AH\^:&5ACY.!E%X]OK2ZEX)T_59M4EN;N^W:C
M%!'+L=%V^2V^-EPO!#$GN#GD5L/J^FQ27,<E_;*]J@DG5I0#$ASAF'8<'D^E
M5KKQ3H%DJM=:UI\(:$7"E[A1F,D /U^Z2RX/O0!FR^!--N(]72YO-0G.K0QQ
M73/,,DH,!QA0 W3MCC@"K@\+VK:M#J,]U=7,T=F]DRS%&66-R&;<-O4D#I@=
M@ .*NG6M,%P;<W]N)1N^7>/X>6_+OZ=Z6+6=+G:S6'4+60WJEK4+*I\\ 9)3
MGYL $\4 9NG>$;+3DL8ENKN:#3MWV&*9E9;;*E1M.W)PI*C<6P#4-MX(L;6Q
MTJTCO;XQ:7=M=V^6CSO;=G=\G(_>/^?L*UHM<TJ>Y:VBU&V>95=B@D&<(<,1
MZA3P?0]:BM?$VA7MU!:VNL6,\\ZLT4<<ZL9 N<E<'G&#^1H FUK2+77M&N]*
MO-_V>ZC,;F-MK >H/J*SAX3@^WW%Z^HW\EQ<6(L9'=HSF,%FS]SKEV/ISTP
M*M:)XCTWQ +LZ?.LHMIV@;!Y)7@G'IG('KB@>(]-/B5] %POVY(!.R$XP"2
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MTHE',$/RCD?WB6P/HQ[8(!!#X*L+?6[C4;>\U"&*YF^T3V"3XMI)>[E<9R2
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MO\FNSFFBMX7FGD2*) 6=W8!5 [DGI3+.[M[^SAN[29)K>9 \<B'*NIZ$'TH
MYWQ0UVFLZ$T&G3S0^9,);NVA$DMN2F%"YX4/D@MC@#MG(Y/P[IFH00^!8KK2
M;V(Z==WOVCS(2?+#+($8D9X)9<'\>G->E7&I6-I<06]S>VT,\[;88Y)55I#Z
M*"<D_2G7.H65G)%'=7=O \S;8EED"ESZ*">3]* /-)=,O/\ A&]5CCTN[$\O
MBE;U%%LX9HA<H_F#CIM5C^E6ET^1]7U;1]8\/ZI?K=:B;RTN8YI!:LI*LF\A
MP$*$8Y&<*,9KTFHKJY@LK2:ZN95B@A0R22.<!% R2?8"@#S&[TR\;P]XBCCT
MN[^T3^)8KN$"V;<\2S0MO''3:C_Y-,URUU9=#\=:-+I%_=W.J3/<V,\,!=)H
MVC154M_"R;,8;'08S7J<4L<\*31.KQR*&1E.0P/((J(W]H-173S<1B\:(S"'
M=\Q0$ MCTR0/QH XBYM;B;Q'XFNCIMUY=UH,-O$3;L=[CSMR# .3\Z?Y%5+7
M2[\GP1%%:75O);:+<6T\OD,HMY7BC4!CCCYD;\L]Q7I5% 'F_A>U#VVFIJ/A
MG5K?5='M7@>>XDD>%/W>QO)^8AP^!@ <#TP,Q>'M,O+2W^',<FFW43V%O-'=
M_P"CL/)9H=OS''=O\:]'NKJWLK=[BZGB@@3[TDKA5';DFHK+5-/U+?\ 8;VW
MN?+QO$,@;;G.,XZ=#^5 &!\/X+JQ\-G3[RSN+>:VN[G=YJX5PT\C@J>XVL#G
MIS]:YR\BAN]=^(NGG3I;N>\AMX8E2 L'8VP"@MC"\D'+$ =>U>FUG66BVMAJ
MM_J,+3&XOV5KC>^0Q4;5P.V ,<4 <+)IFI:-J%S!)8WE\;CPS!8)/;Q%U:>+
MS0P8_P .=X(SU[<\5-X?TZY&N^%&O=+N4CM_#C6<QE@)6.8F'Y2>0#A'_P F
MN[?4K*/48M.>ZA%[*C21P%QO91U;'7'O1-J5E;WUM8S74*7=SN\B%G&^3:"3
M@=3@ T <7I=CJ5IXKC^P"].ESWET]U97UN=MJQWGSH)2!P['[F3Q(>F#C(\.
MVNJ0Q> K271=11]'DFAO'>':B$PN@()/*DD?,..:]5JK?ZE9:5:FZO[J&V@#
M!?,E<*,DX Y[GTH \WT6'5#KGA:\GT._M5M3>1W,"6X6&U+C@(!RR\9W<Y[>
M@-)TR]M_#_@N(Z9=QS6FM33W*_9F!CC83C<W'0^8GY^QQZ9=WEMI]I+=WEQ%
M;V\2[I)96"JH]23TI\,T=Q!'-"X>*10Z,.C C(- ',>"X+JR.N6MU9W$).K7
M5PDCKA)$DD+*5/?@_A67XFTG5;WQ/K<=E!.O]I>'OL=O=*/W:3!Y3AF_AX=?
MSXZ5WU% '"6=I=:OJG@^Z33[FPDTF*7[8)HC&$!B\ORE)X<%L'*Y&$SGI5OX
MFVEQJ'@FXLK2TGNIY;BW(CAC+$A9D=CQT^537844 <1I.GS>%?%MWY%C/<Z/
MK)\];E8F>6UF  *2<;C&1RN?NG(X%8,-IJD&G:;I?]C:BTUCXG>ZE=8?W9A:
M:5PZL3AAM<=.G?'&?2[+4K+4?/\ L5U#<"WE,,IB<,$< $J<=P"/SJ.[UO2K
M"X%O>:E:6\Q ;9+,JG!X!P3WH \_U/3=7DD\57%GI]W*?[9M+Z.$;HC=Q1)$
M'"-QSE&QSU4>U=5X6AM))K_5+;1]0T][SRQ*^H,_G3,@(&59F( ! !XSSV )
MZ*.1)HDDC=71P&5E.00>A%.H Y;QM#/.N@B"VGG\G5[>>3RHF?9&I.YC@=LU
M:\1G3-0B?1=5T>\OK:XBW_N[5I(R<XV[A]QN^3CZUO$A5+,0 .23VJO8:A9Z
MI:"[L+F*YMV9E$L3!E)4E3@CT((_"@#@X-/UKP[=>#KF_AN]2M[*PEL[LP*9
MI(97V;7('+ !2A(!]>]6/#6D:S-I.H1PW=]H+G6+R<9MHF,L;RLR\.&P,'M7
M9V.I66IQ/+8W4-S''(T3/$X8!UZC([BK5 '&Z_J<ZRQZ+<Z1K.HV:Q*;NXMK
M0,+D_P!SJ!@]6QQSM[G#=.\\_$YK^XMY+=-1T.+R8Y<;D:.4ET..-P$J$@>_
MI751ZE93:A-I\5U"]Y BO+"K@LBGH2.V<&H;J?3)]3M]/GGA-^H-Q#$'Q*H'
M!< <@?-@]B"1WH \^MX-5DUS0+A]#OK?['K5TT\$,"K!$KI,%=3G+[BRL7SC
M)/3I72:;;R3?%+7;Y 1;PZ?:VCGLTNYY"/J%=/\ OH5UM0VUK#:1&.!-JEBS
M<Y+,>223R2?6@#G-<MYY/'OA>XCMIW@MUNQ-*D9*Q[T4+D@<9(-)X*BG@D\0
M^?;7$'GZO//%YT3)OC8* PR.^#[UTTL\4"JTTB1JS*@+MC+,< ?4D@"I* .#
M\9V6H-JT][HOVV/4UL$01_9S-::@NZ3]Q(,84@D_-E<"3TS63XGLM4,?CVSC
MTB]GFU>UA>U:"+?&V( C#=T!#+TZG(P*]2HH \_D-W:>)=:CU'PY>ZGIVMP6
M_D".%9%7;'L:&7)P@S\V3Q\QJOJNF7<MUX\ TR=C>:+%;6ICMV*R.(Y5*(<=
M S)_D''I%5Y+^TBOX+&2XC6ZG1WBB+?,ZKC<0/;</SH K:7YR>'+,&%C.MJ@
M,4@*G<%'!STYK@O#5OJ7_"1>%[N;1K^UCATZYMIXOLXCAM')B(C49SL&UL,<
M[N.3T'IU% ',^,+$WJ:?Y<VHVEQ%,TD%]81&4V[["/G3!W(P)!&.XZ=1AZ?#
MKD>N>%M1U'2W,HL+RVG-K%M1'>2,HS#/R!E0L?0Y'7BO0B0!DG %5K'4;/4[
M<W%A=17,(=H_,B8,NY3@C(]#0!YQX?M]4;7_  G=S:)?VBV\%W!<0B!8X+1F
MV85.<E?E/S'.>Q["KI]IJ^E:)X8FGT35I8=+:ZMKZWMBRS R-\LJ!6!=1C''
M9^,\UZ-_PDNA?:C:_P!MZ;]H#!#%]J3>&],9SGVK4H \\CTB.#6_"4UCH=W:
M64=Y=W,B2*\C1>9$P#.<MM+.<XSQGG'.,^33+P>'-1CCTN[$TGBI;U%%LP8Q
M"Y1_,Z=-@)_2O4Z* /-DT^1M7U71]8\/ZI?"YU(WEI<QS.+5D+!D+D. A0C&
M",X48S5;4=,O9/#_ (NCCTN[-Q=Z]#<0 6S;I(U: [AQT&Q_R]QGU*B@#E=&
MANK;Q[XCDDL[@6]\MM+!<;,1D+%M8$]B#VZT_P 8V%^_]E:QI%N)]2TV[!2+
M./,BD_=R*3V&&#?\ KIZC>XABD6-Y55V4L%)YP.I^@]?>@#B_"_AW4])U:\T
MZX9GTRSD:ZL9VZO).OS\=MK>=QZ2CTK.\(6+1QZ19:OX=U5=5T0%3>2RR-;C
M"E3)$=Q#%Q_"!_$>.*]"LKVVU&RAO+.=)[:9 \<J'*LIZ$4]IXDFCB>15DDS
ML4G!;'7'K0!YC9Z/J=O\+=&%OI-R;W3[Q9[FR4&&:6-969E4\<X8,.>2/6NP
M\+06C-?:E:Z1?:>;UD:4W[/YTS*N,E68E0!@#H3@\8P3T5% ')6]D[_$[5+N
M2RE\B33+>&*X: ["Z22,P#$8R-R'_P#57.^&M+N9+'3])O\ 0M4BUS24>--0
MFFD-LK;"OG1MOPVX$?*!W.>E>GT4 >46-Q<K;_#[2[S2+VQNM/OUMYS/& C.
MMK,I*-GYPV"V1^/-.:SU2&S731HVH/+;^+/MS.D/R&!KDR!U8G!^4]NF.<5Z
M)J6BVNJ75A<W#2B2QF\^#8^T*^TKDCOPQ'/K6C0!Y=XCTV_NK/XA10Z;>2-?
MO;?90MNQ\[;'&K;>.<%3^5;'B..>Q\2Z7J\6E:C>:4UI+;RQZ=O2:!V9&5RB
ME6((7!],"NYHH \ZTNRF\,^*+&XAT*]BT6;3#:V\,*M.UI)YS2$. 21O#+DY
M(!7&< &MSX=6MS8^!--M+RSFM)X@ZM#,NUA\[$<?0BNIHH \POM*UHVOB2WM
M].N7D7Q!#JJI@!+N!?(8HK$X).QN/5<'J*Z73K.6]\?3^((89X+)M+2T831-
M$TLGF%P=K 'Y5XR1_'@=#755!>WEMIUE->7DR06T"%Y)7.%51U)H YKQ#;RQ
M^-_#>JM9SS6=K#>12R0PM*8GD$6SY5!;G:PR!QWZURXT34]!-CJ@TN^GTXZE
M?3R6%BY6:WBG(\M@JD9QM.5!X\P^E>IJRN@92"K#(([BEH QO#-E;66D$6FF
MS:?#-*\P@G<M)ECDLV2<$G)QGC/8Y%;-%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<A\3O/_X0
M'4#!,(N8@_RYW*9%!'7CK77UFZ[HMMXATJ73;QYEMY2I<1,%)VD,!G''(!X]
M* ,E+V\M/']GI<AM'BNM-FN994M]DC2(\2C)R>,/T]JYOPEK-Q9^&?#^DV<;
MF>_EU!]Z!"RK'.^0H9@,Y<=<\ \5V[Z#!)K=OJ[7-R;R"W>V1LKC8Q!;(VXR
M2JG\*RW\ Z0^C6FFB6]C%E.]Q:7,4^R>!W)+;7 Z$LV0<]?88 *EGKVO2:AI
M>@:C'!9ZG<+<3331@,/)B*A2JY(#MO4D$D##>HJ3X<K*FD:LL[J\PUJ^#NB[
M0Q\YLD#)Q]*OW'@W3;B/3V$U[%=V#L\%ZEP3/E_O[F.=P;C(((X'3 J]HF@V
M>@07,5FT[+<7$ES(9I2Y+N<MUZ<T <I<^+-7@T'6KP/;M-I^NI8)F(X>)I(E
MY&?O8D/(]!Q4&M>*?$5BOBRYAN+ 0Z#/$4C-LQ,T;1HY4G?P?G(S].!WWKWP
M)I-_)?F66^6&^N$NIH([@K'YJE3O '0G8N?Z'FI+KP7IMY!K$$T]X8]7*F['
MF#YMJA1@XR/E4#\/6@#'\1ZM>:O8>,["SFCMX=*LFC<-'O,SO 9#GGA=K #'
M.<GMBHK'6]7GTZ'2-$B_TJRT:TG5BJ,'DD1MJMN=<)\G)&3SVQSN7W@K3;Z\
MN[MKB^AEO;86U[Y$VP7*A2H+@#&X GD8].G%,N/ >DRRV$T,^HVEQ96XM5GM
M;QXY)(1T1V!RP_4=L4 4(M6\47_BI-*673[$+IMM?3(8#,59I&62,,' /W#A
MOT/6K7C.?4(M2\+Q65Z;=+C5!%*NP,''E2,,^P*#C_"M:V\/6=IKG]JP/,LW
MV5+,1[AY8B4DJH&.Q).<YYJ36-#M-<2T%TTR-:7"W,,D,A1E< KU'J&8?C0!
MY^^IZIH3^,M6L9K80VNNQ&:&2$L9@T5NK -N&WAL@X/-;U]K^OWMSJZZ!:I+
M)I=VEN(I-@28[$=][%PR\/@8';/.<#0N/!6G7-GJEI)<7AAU.X6YN0)!EG7:
M!@XR/N)_WS]<K=>"M,NM;DU4S7T4\ZJMVD%RT<=V%&!YJCAN..V1QTH B^(O
M/PU\1G'_ ##IO_034FCMJ<RZ2MY8V<=G'9^8D\=P9&67"*O!1<95G[GTK5UK
M2+?7=(N=+NWE6VN4,<HB8 LIZC..,^U58?#L<7V17U'4)HK4@QQ22+LRHPN0
M%&['!&<\@'M0!AZ/K^LS^,+OPY?W%HLUI(UQYL<>!<6Q"[%4;LAP6^;T&./F
M!%K2]7UC78HM4T^:S2S&HRVTMM,I!\B.1HRP8<^82H8#@8./>KK^$K%VTV4S
MW0N-/FDGAG#@2%GSOW''S YY'0]^@IEMX-TNSUF?4;>2\C$\_P!IDM%N&%NT
MW7S/+Z;LX/ID XR* ..TK5-4T:.ZN[::W^Q2^+9[2:W:$EG$MSL+!]W!!((&
M.WOQM7WBC4[37+:-9;::"765T]XXHRR1QLIP6D./WN1DJ,@#@CO6H?!6G&S:
MU-S>>6VH?VD?G7/G[]^[[O3=SCI^%,D\!Z1),\GFWZAK_P#M%8TNF5$GSEF4
M#IDDY^IQB@# _P"$J\11P37\L]@UO;>(1I;PI;,#)$TRQ;@Q<[2-V>_3\!9U
MOQ9J]O/K45EY$=[8W=O!:6,L1=KN.39F3 ()Y9\;2 /+.>^-EO!6G/93VAN;
MSRIK\:B_SKGSPX?=G;TW ''3BN?GT75Y=?U.5K?Q';37%R7BGT_485MF4*J(
MS*[94X4;AL/L#0!?O==\17=SJUMH<$<UWI4L4)5E18YW,:2-N+/N12'P,9P1
MG+=!V)F1+8SRE8T5-[DL,*,9/-<Y+X)L;O44U.YN;Q+Z2&.*^-I<-#'>;1C]
MXJ]>_IP<=*VM5TR+5M+FT^:26*"9=C^2P4E>ZYP>#0!YQ;:DVF>.=+\12K>Q
MQ:\6LKU)[>6-(B3FUP64+D#Y#@]6)KJ[K5=6U+5];TS19K6"YTN*$H+A"RS2
MR*6 ;'(3  R.<D^F#IZ]X?M/$>C'2]0DG,#,C,T;!')4A@<@<'(!XQTJG>^#
M-.O=4CU)[G4(KOR1!/);W)B-S&.BR;<9ZGD8//6@"CHUQJ4_Q&UV*>]5K:&Q
MLG6!5RJ[_.SM/U&<]^.F*IZI#JD_Q0F32;RWM+DZ$A\V> RC_7O@;0R]^^?P
M].HB\/V,&O-K$/FQ7#P) Z)(1&ZINV97H2-S ?7Z4V]\/VUYJRZHEQ=6MX(/
MLS20.!OBSNVD$$=23D8/O0!RVF^,=5N+3PQJU\MO;Z=J$LEE>JJ$^5<AF1"&
M)X1F0CD<97GFNMT*ZN;[3%O+EE9;AVD@"IMQ"2?+S[E<$_6L;6]&%WI\'A*V
MT+=HLL2+)<F51'"JN"5VYWE\#(.#R02>M=4JJBA5 50, #H!0!QFE^(-?UDZ
M;JEC:(VF7%T\<Z2>6H2$,RAU;?N+@@9!7G) QCFO9^+M1CUK3([N2"XMKR&\
M>4V\9\M##@J(G."XV\$X()Z$=*VK'P5I6FZK->VLEZD<LQN#9?:6^S"4\EQ'
MTSGGTSR!D"H=/\!:/ILNFO!)?$::9/LJ/=,5C1^J8[K[>V#D<4 1:5J&M:OI
M>F:P9K(Z=J%DTT\!!#PED#1B,_Q8Y#9QZC'2L#P-JFJ6&F>!;&2:WDL-3TTH
M(EB(>(QQ!PV_=\V1D$8';\>HTKP1IFC"1+*>_2 AQ!;M<EXK7=G=Y2'A>IZY
MQDXQDU)9^#]/L?[%$,UUMT9&CLU+@A59=I!XY^7CG^= %?QSHUMX@T[3],NC
M(L<]\H$D;;7C81N593V((!'TK"TO7;UM<T?PSXA*_P!NV%Z6$H&%O8/L\P6=
M/Y,.Q^M=QJ&F)J#VKO//$;:43)Y1 RP!'.0<C!/'O3;S1K&^U+3]1G@5KO3W
M=[>7H4W(48?0@]/4#TH X^X\9ZB/"LWBVW\IK&"^:%K(Q_,T"S^23NSD2<;O
M3'&.]1MJFLV<OQ"O%OHICIGS6\4\&Y% MDE"X##CDC\<^U=*OA#3$EN IG%I
M<70O);+>/):8,&WXQD?, Q .TD9Q1<^$M.NIM9E,ETG]L1"*[1)B%8; A('0
M$H N?RP: ,V#7-4UBYDTW3IK>VO(-*@O"\L>Y9)90VU<=D&SG'/S#&,<O_MC
M6!XL@TN1K!3)HCW9*1LX6=713\VX%D^8X& :L77@C3+FXL;D7&H6]U:6XM1<
M6MR8GEA'2-RN,C]?>KC>&K,ZK'J,4L\,T5F;&-8V&U8B0< $'G*@Y]J .8\.
M^*==O)/"%Q?RV<D&O6LC/#% 5,3K'Y@8,6.<X(QCC(],DTOQ7K>IW>A"%K99
M+ZXN([^S> L]DL>[&<,"#\H4EL@EP0.QW8/!]E80:.+26Y+:*CK8H\@VC*[<
M,=N2,<9[?6N;\.Z%K-N]FH3Q'I]Q%(KW GOX9;,_-F15&YG*GY@. 1D9(- '
M2^,M(O=7TRT73+V&UU*UNTNK3[0NZ.61 QV..N",GCD8SVKD+WQ->2Z%XO\
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M62>QN6VEH9-Q(SM)!1@0&'<?2@#9TG6MN@6%UJERKW-VN56&$DN<$X1%RQP
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M"W(+J"2"$&><8SCOGI7&Z?X:U31;3P)9_9)+D:7-++=O$RE80\4JA1D@D R
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MI"BR2I"A"%LNYVJ. >I/7I7G-WXNUC2[9XKN_D>[TO5S'J(6&,;[ E2)L;>
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M/V1XS"XD$W!V;,;LX(/3ISTYJU;:C;7E@UY 96A4N"#"X?*$JPV$;LY4C&*
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M.2=4N941G3;M<*K !AM7Y@ >*T+#0[#3=0O+ZUCD2XO"IG9IG8/M&U>"2!@
M#@"L_P 9W.L66@-=Z%-&M^DT*1PRJ#',7D5-K$\C[W4$51A\4G7O#5MJ.G32
MV-RM]!:7ELZ*7@=IDCDC8,." QP?H?:@#H-2T:QU:6SDO(W=K.<7$&V5TV2
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MT71K/3+50L%K"L28&,@#&?J>M5;;Q/I%WIKZA%=-Y"3_ &9@\+I()<@>7Y9
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MJ9HB3*&E.T_/QQ(O/3(//0G,M]"UK2YM)N9?#::M ^BVVG75JTT0DMI8MWS
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MU.UN)(8[B,3+'&ZEW9PP&[ P I)&!SV'9V%[#J5A!>V_F>3,@=/,C9&P?56
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M(^V64$Q@C ?') /0G'..N.:FH X*TT'5M1LO"=G?V+6,NAR!Y[A9499-D+1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/BV+60GR;/1?.A4]-\DVUF^N(U'XGUJ_X:\/P:5I>FF:W9;ZWLUMR9)FE\O
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MI4<,$*6,*QV]RUW$H'"3,6)<>^7;\ZMW=I;WUI-:7<*36\R%)(I%RKJ>H(H
MXS5]2U?1]=N--BU&:>"XT>XO(II(XS);RQ%1GA0"K;QP0>1Q6OX-&HS^'[+4
MM1U66]DOK.WFV/$B+$QC!;;M )R3GG/M5R'PWI4-M- L$C)-#]G=I+B1W\K^
MX'9BP7D\ U>L+&WTRP@L;1#';0((XD+EMJC@#)). * .&T?Q!J<WB/P^AU![
MRRU-+PO+Y2)#+LPR-$/O@ <9/WNO/6L7PS<:SH_A3PEJ-KJDDEK<WZV4VG-"
MGEF.25UW*V-^Y?O=<8!X%=Y9^"O#MA/:S6VFI&]I(TEN?,<B(MU"@G 7OMZ
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ML;13/$R. 0"&0@C@GOWH Y73K#5M9L[G2]7O4GO=#U6*2WOA$%%P%5)%WJ,
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M6D1WDETEH0\D_P!I=/-?RC+U\SR\[-V><XSD9ZT <T=3\0ZS/JEQI5_:6O\
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M@\]:WO[8U.X\5V5LMZT5M=Z!+>&)8T(28/$ P)&>CG@Y%;<GA;1Y6OV>T/\
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M=-C74'8.TBLP5F'1BF=I8?WB,^]!\(Z(UM);FTD,4EU]L=?M$G,V[=O^]UR
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M@D'MG/.9_%\6MV_@KQ5#JM[;W%L4@DM$63?-$"X#!R$0$9'RG&>H[5UR>#M
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M'POI5E=PF*XMK2*"1=P8;E0*<$'D9%:M !1110 4444 %%%% !1110 4444
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M-YI]-G=R/MJY >-CT)B.1@=<Y['-CPY?3Z_866MOK4MK<KJ,T-S:YW(0'=!
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MI%238DJ$8W[0,%>-Q8'DU<T"6#4?']E?0ZA=W$$OAR">-Y)&7S,R$;BF< G
M)'K0!W\T\<(.XDL$+[%&YB!C. .3U'3U%9.B'1=;2W\4V%E%Y]Y  ET\(69H
M^P)ZX]JQG@#?%\NT\X T4.$\Y@F?.Q]W..<#CN:YGP3+>:=IWP],5_<M#J,,
MT$ULS#RMJPO(N%QP04'/7DT >LT5Y]X7O]5UVWT/Q -5BA6=V2]MC.T@E8@_
MNA'@"-D(ZCG"G.>35W6$OK_XA0:.FLWUG93:1+,R6S*I#K+&H(.TD'YO\Y-
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M $]^O%6(+P3WEU;""X0VY4&22,JDFX9^1OXL=#CH:\QGGO\ 43HUOJ%W=/\
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M9P&WXQTZ8 H [FBO*X'UA?#7@O4?^$DU0SZU-91W(9HRH#0.QV@KP2<9Y.2
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MWZ1QA#E8X0J/EDR XDRXR<]L<CFAJ6M7L>LP7-GJ4\T7_"116$CEMD:H0%>
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M-L>.!M';CCBI%T+2DN+.=+"!);)/+MF5,>2O0JN.@X' ]*DU+4K;2K47%RQ
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M;L8[T 2:QX;@O+&^-A';0:E<6AM5N98_,^3^XW/*\GCWS6/X=\%QZ9JD%_\
MV-I.E20;O^09-(_G J5PP*J O.<8;D#GBNBT/7K+Q!9RW%F7'D3O;S1R !HI
M4.&4X)'IR"001S4'BR_M=,\+:A=WLU[!;QQ$O+8_ZY!ZJ>Q]Z ,^7PN]YXYO
M-8OH+62QFT^.S11*WF?*[LVX;0"K;P",D?+SFMR[T;3K[[.;BSB=K;(@8#:T
M8(P0I'(!'! ZUE:CXRL=,O[RP-GJ-Q<6=JMW*L$&[]T2PW D@'&UORXR:W+*
M[@U"QM[VV??;W$2RQ-C&Y6&0?R- #7T^S>P%BUK";0*%$&P; !T&.F!@5(MK
M EW)=+"@N)46-Y /F95)*@GT!9OS-8UEXMT^_O[.UCBN4%[YWV6:1 $F\HX?
M'.1ZC<!D=*M:UKUIH,=I)>).RW5REM'Y,1?YW.!G':@!MMX7T*SU.XU*UTFT
MAOKD$2SQQ!7;/7D>O?UJYIVFV6DVBVFGVT=M;J25BB&%!/)P.W-<[/\ $#3;
M:WU"6>PU2,Z;(%O4-N,VZD!A(V&P5P0>"3C/'%7=3\7:=I4MRLT=S)%:+"UU
M-&@*0B4X0G)!/J=H.!UH OG0M+-^U]]AA^TNZR.^W[SKT8CH6'8GD4^/2;"+
M4Y-22UC6]D4(\X'SLHZ GN!GI6-J7CC3M,N=4@>TU&9]+C2:Z,-OD)&P8[\D
MC( 4D]_3/.)+WQE86E_)91VM_=W"V8O0MM!N#Q$XR"2!Z_RZ\4 :EUHVFWM[
M'>W-C!+=1QM$DS(-ZH>H!ZXJ&'PYH]O]B\G3H(_L.?LH5<"#/79_=STXJJ_B
MW3C86EW:K-=BZM1>11PA0YA(!W'<5'<#&<GG .#5/_A8&D2FT%E!J%^;NS^V
MP"TMBY>/<JG'3D%N1['O@$ U;3PUH=AJT^JVFE6D%_/GS+B.(!VSUY]^_K5G
M4=*L-7MU@U"TAN8U8.HD7.UAT8'L?<<T[4-0MM+L9+R[?9"F!P,DDD!5 [DD
M@ =R:R_^$LL8VO([F"ZMKBUEAB:"6,;I&E_U80J2K;CQP>,'.* -*VTJPM;>
M2"*UC$<HVRAAN\P8QAB<EN#WJ&VT#2K.WD@M[&*.*2/RF4#_ )9]D]EY/RCC
MFLV\\;:9I]GJTUY#=PRZ4BRW5L8PT@1AE7&TE2IP>0>,$'%/'C+3$FU&*ZCN
MK0V%K]M<W$.W?!S\Z\YQE2,'!]J *GB#PG]MM-"L=,M;**QTZ_CNFA=V0!%5
MEVH%4X/S9'3&*WCHNFMI\U@]E#):SDF:*1=PD)ZEL_>/ Y// K%U_P 06L7A
M[4);Z/5K"*$1EY+<+YN'/RE&4L,9&"<UI2^(+:/49;*."XG>"6*&=X@I$+28
MV[@6#8PP.0" #[&@"1O#^DR6$UC)80R6TY!FCD&[S<<#=GEN !SZ"ENM TF]
M>T>[TZVG:SR+=I8PQC!Z@9[<#\A6/IGC)+J/5IKRQFM(K/4#8Q;BA,CC:H7A
MC\Q9C[ 8R>#1)X_T>&*X,T=VDUM>16<\ B#O&\I'ED[205.X8()_/B@#4B\,
MZ%#%911:39I'8N7M5$*@0L>I7T_^L*</#NCBSN;/^S;<V]U)YL\93(D?.=Y_
MVL@'/7(%86K>/(K/P_KE[;:==F\THJDMK.JHP+@%'/S8*'(/!SUXS75),[VO
MG&WE1]I/DL5WY].#C/XT 4Y/#^DS6+64MA#);O()71QNWN,89L\L1@<GT'I4
MT&E6-M?S7T-LB7<RJDLP^\ZKT!/?';TS6/:^-=.NX='ECM[L1ZK.]O;LZ* L
MB;MRO\WRGY&X]L=>*34M=LGETU96U*VWZK]EB:' 6:1=P*N03^[R&ZX)*^U
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M"HP4 4G//! =>W>L3PAX@:'P?9R:A<3WE[/>WD,09E,DNRXE Y8@ !5')('
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M(E=1=3FUM)K@0RS&*-G\J(9=\#.U1W)Z"DAN4E6'<#%++'Y@ADP' XSD>VX
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M(2BY+[>&*CN <CU)4XSQFQ;W$-W;17-O*LL,JAXY$.0RD9!!H X74? -Y/\
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M:YA62UF9_.VVS#?@J-G Z<]>U2:=X3\16EOX=L6BT_R-%U.2X\W[0VZ>)EE
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MG/[UZZ^J]E86>FVPMK&U@M8 21'#&$7)ZG JQ0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6!XJU^
MXT"WTY[>Q>Z:[OX+0[64;0[@'[Q&21D#MGK6_6#XKT>\UBPLA8M +BSOX+Q5
MG8JC^6^2I(!(R,\X- #+[Q?9V,5_.;2\FM]-P+Z6%486Y*AR"-V6*JP9MH.
M>_2M6[U&.VTB34HHI;N)(?.5+;#-(N,_+D@'CWKEF\*ZM OB2SM9;-[/7MTK
MO(S*UM*\8CD(7!#KA00"5]/>NMT^RBTW3;6Q@SY-M"D*;NNU0 ,_@* ,ZU\3
M65Y9Z;=QQRBWO[5KM9&* 11 *2S_ #<?>4<9ZU!!XOLYKC38WM;N&/5$+V,T
MJJ%GPNX*/FRK%>0& R/?BJ>C^"TL-,UK3)[@R65YYL%JB<&WMI-S;![AI'_
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M%1]IA7[QC^;J,C*MM//2G:?X[T^]U*SLYK*_L1?6QN;.>[C58YU50S $,2"
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MLX88FEF\XKF-5!))VDCH,\$UFP>*;>74;2QFLKRVFOH&GLQ,$ G"@%E&&.&
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MU,L4>V-H@"P^_P YSQBK<'CC3FU.>QO;:]TUH[1KU);R,*DT"_>=2"3QQD,
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M  S6+_PA.L)IFJ6\3:8CS:U!JMK&A=8QL,1,;?+\H_=D @'KG Z59UOP5?\
MB"^UQKJ>V@@U+3(+1)(G8O'+$[N&VE<%=S#C/0>_ !MGQ5;Q7SV-U8WEM=BU
M:[BAD"$S1K][858C<,C()!Y':J^D>-K/5[K2X4L+^W35;4W-G-.B!)0 K,O#
M$@@,.H /.":AFT'5=4O[34]26R2\L;&>WA2"9F2224*&<DH"H 3@8/WCZ55T
MKPKJUBW@T2-9%=#M'M[@K*^9"T:H"HV?[.><=: -*&5_"ME?7&IW]U=Q7.H#
M[,L\BLR>8554#': N[) )X!ZUM6-XU["[M:SVS)(T9CF"[N._P I((/4<U5U
M^PDU/2VLUM;.[CD=1-;WF?+DCSR,@'![@XZ@56\)Z'-X>TF6QDF9XOM#O;PF
M5I1;Q'&V,.W) P3STSCM0!0C\?63R+G3=22#^T3IDEP\:!(I]^P _/D@MQE0
M1ZXJU>^,M/L8KJZDAN7T^TN?LUS>H%,<+Y .1NW$*2 2 <'/H<8C^$-:;2;B
MUS8>9)X@&K ^>^ @F$NW[GWOEQZ4^3P7J)TC7?#ZRVS:5JUU)/YS.PE@65@T
MB!=N&YW;3N'7D<<@&CJ/CFTTZ;6(SI>I3_V0B2W;0I'A8V4MO!+C( &<#GVZ
MU;L_%5O>:NVFBQOHI6M#>6[2*@6YB! )3YL@Y9>'"GD5D7WA35+AO&"PFR6/
M6K)+6VW3/F/;$T>7^3_:SQGI5JVT'58?$NEZHRV9CL])>Q=!.V6=FC;(^3I^
M[QZ\]..0"OI/B_3K?1_#\=I:ZQ=IJBRBT,Q625B@9B'9GZG!Y)QZD 5?M_&N
MFSZ7#>&.>&66ZDL_LLQ1)%FC+;U)+;!C:3G=CICD@5C:-X/UC3;?PA%*U@W]
MB/.9RLS_ +P.C*-OR=MV><=*C_X0W7[>(7ME<:>FJ6^L7.H0)([M#+'.6W1N
M=H(.&Z@'D4 ;-KX\TB\L4GA\SSFN9;4VSO&KK)'RX+%MF "#D,0=PQUI;#QS
MIFJ0V9L8;B:XNC.%MLQK(&A($B\L%)!9>A.<Y'&3534]"\2W3:5K%O<:8NLV
M4DF;9]_V9XI%4-'N W9^16#8ZYXQ3]:\-W^OV%K!JMGIEY\LCR!97A-M*=OE
MM#(%+< -D\$DYZ?+0!T$^JQVV@OJ\D$_E);_ &AH@H\P+MW$8)Z@=LUAV7CV
MRO+VSMCIFIVYO[4W-B\\2*MR%4,RJ=W# '.&QG&02,$V;ZUN-/\ AU=6E[=M
M=W,&E/'-<MP96$1!8_4\UD>'=%NM7TSPA?WHMXH--L%>+R9"[2N\ C!.5&T!
M2QQD\D>G(!L6?C&POET%X;>[V:W$TMJQ51C:A<AOFX.!VR/>J=M\0+&YL6OC
MINI0V8<Q?:)DC5#*)Q!Y>=_!+$')^7&>>"!EZ-X1\0Z?_P (I%.^F&'0/-BR
MDLA:=&C**W*_*>>5YZ=:T=,\-:E9^"IM%N;?3+J22[EE:*5V:&6*2<R,K93(
M.UB <'D T :<OB>&VN;*"ZT^]@>[O?L4>\(0)-A<$D,?E*@X(STYQ3$\6VDL
M5T4L[UI;?41IIA"*6:4A6R"&P%PP.21T-8">"-3L-,LX]/F@)L-8&H6EE<7,
MC1Q0^68S")"I8#YF8?*<9Q[TH\*^)8X-0\NXTXM=ZTNHR0>9(B3P^6J-"S;2
M1RH/0@XP1@D4 :S>.M/2QBN39WQWZD=,>-8U9HYPVW!PV"/<9JIJGCPV_A_4
M[RVTF[6]L+R*SGM;@QAHFD*;6)#E2")%(P3UYQR10A\%:U!;"!6TS8OB!=65
M4=T C!W%,;3@]AVX_ 3ZGX/U:_@\4HLEDC:I=VUU;9D<A3#Y7RO\O&?*ZC.,
M^U '2:_K,NB^%+_65L9))+6U><V[,H/RJ203G'&.<$^V:KV_B7?%9P&PNI=2
MFM/M36L9CW*G W$E]H!)X&<G\#BSK>F7&M^$]1TN1XHKF]LI8"RY*(SH5^I
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MD =<1YV@@CJ #USG-3>']6%QXB\,^5JL\EGJFGW;.TUX3+/\T91W4'$;?,P
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MQ0R?,6P,'O\ *3^(]:\SL[NUU"+X<:S)J#SWEU=LUTSW!(,IMI=XVDX&U_E
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M:X!4@G&?D7YL;AC@]* /69[>"ZB,5Q#'-&>J2*&'Y&G1QQPQK'$BHBC"JHP
M/85RG@EI(KOQ+IYN)YK>RU4QVXGF:5D0PQ/MW,22-S-U/>LW6KV]T_Q5)<SB
M2\TEKZUA\VTNF26PD/E@1O'T>-RRDXY^?H<# !W<<\4S2+'(KF)MC@'.UL X
M/O@C\ZDKR&VO!HFF:G]FN)8HY?%C6U[(+ART-LTH!;D_+G*J6ZX;KTJ_XCU3
M4O#=]XCBL+BY.E16ME/(Y=I&M#).4EV$Y(_= OCL>>,T =WXAUR'PYHL^J7$
M$\T,)4.L(7<,L%!Y(XR13]>UB+P_H5[JT\$TT-I$TLB0[=VT#)QD@?K7"^,%
MTY/!GB273-8DO89HK9_(^T^=%"?, !5N2-_4C/;/>HM5U#^T?A]XV>^::+6X
M;6>*]LWF8I!\AV>6N<;&7!#8RV3]  >FQ2"6)) " ZA@#[TYB0I(4L0.@ZFO
M,]1NM1\/ZKJPTB>[N)6\,M?)#-,TH,Z-@.JL2!P?NJ #@#%:-I/)#K_A"?2;
MVXN;74[64W@DG:59(Q$&67DG#!RHR,9WX]* .IT#6X/$.CQZE;PS0QO))'LF
M # H[(<X)'53WI-%UR'6SJ B@GA:QO'LY%FVY+JJL2,$\?,*\[T#4VM]+\):
M;-,T&G7^IZDL\BN4#NLLICC+#H&.3C/.W'0D&"VU./18=4ABOQ!82^+7@N[F
M21G\J-H%*[F#!@ID"+G<..": /7Z*\PU""6UMM-@M_$]S>03>(H8]UM,Z"*-
MU):'=O;<. 1DY7/&*GUD7/AR^WJ]WJ&B6HMXI3'?R?:[%M^=Q!/[U&W 'G.!
MCD"@#T*[G>VLIYX[>2X>*-G6&+&^0@9VKD@9/3DT^)S)"CM&T9902C8RN>QQ
MQFL3QL\D7@77IH9I8)8M/GDCEAD*,C*A(((((Y KF4MVU7Q;8V5Q?Z@+:;PV
M)I(HKR2,%]Z#=\K @^XQGOF@#T2BN<\ WUQJ7@#0KR[F::XELXS)*YRSG&,D
M]S7+6UW?Q:A)::@9Y_MMM>/8:G97CF.X'WMLD>08Y$& "..H&.E 'IE%>8Z/
MJQO+GX>QOJTSO>Z/+]K5;MLRMY,>"V#][<7YZYS6?X?%_P#V%X#UN#5]2N=0
MO[A;:\26[>1)H2KE\H3@%=N=P&>.230!ZW-#%<1-%-&DD;?>1U!!^H-$,,5O
M$L4$211K]U$4*!] *\CMDOAX8L];M=8U.75H-?>UCB>\=TEC-XT9B9"<$;"6
MR1D!>N ,7;W4]1NO"7B/5X[JYB\0:;JLD4$2RL NV55BBV9PRNA7M\Q;/7%
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M2-R&&&P_8\8ZYIFJZG-<:IX3TN"UNGTV_@EDD03@-(%B&U2VX$XW9//) ZT
M=4N@:,L[SKI-@)G?S'D%LFYGP1N)QDG!//N:N2VMO-:M:RP126[+L,3H"A7T
MQTQ7'Z#JVF:+8ZG;Q+JLDEMJ:V!6]N/.EGG*1[=I+$ $,O<="3CFM;_A)9%6
M6.31M02ZCNTM!'Y>4<L P</T\L \MV((QG&0#3_LC3#9?8CIUI]DSN\CR%V9
M]=N,5:1$BC6.-51%&%51@ >@%<9>>.G?3;&XTVP>1YM9&ESJTB?NV#X;!SAL
M@'!]\G'2K7_"1Z9I^K^)+BZAO;>2P@MGN3+)O1PP?8(E#$ D\=!DD4 :T6@V
M<;WD;0PS6-W*;A[::,.HE.-S#/&"1G&.N3WISZ):1VTT>G06]A).OEO-;PJK
MA>^,#KZ9Z'G!Z50E\61VE[<6-[I]S!=QV;7L409&\^->&"G=C<N1D$CJ,$U%
MI'C.'5;W2[=M-O+5-4LC>6<TQ0K( %++@,2" XZ@9YH Z"SL[?3[*"RM(EBM
MX(UCBC7HJ@8 _*F+IE@E\U\MC;+=M]Z<1*)#QCEL9Z<5A?$5Y(OAWKTT,TT,
ML5G)(DD,C(RD#(Y4@TRW\8D7\FF3Z+J,-X+1KJU1_+/VQ%P&V$,0&Y'RM@\B
M@#>FTC3+EIFGTZTE:?;YI>!6,FW[N[(YQVSTIT>FV,5P;B.RMDF*;#(L2ABO
MIG&<>U9NF^)[?5K/1;FTMYG358S*@RN84 R2_/8D*<9P2!5GQ'JDNB>&M2U6
M&W^T26=M).(BVT-M4GD^G% #XM"TB"TDM(=*L8[:5M\D*6Z!';U*@8)JW]EM
MQ;"V\B+R -HBV#:!Z8Z5P4FKZC_PEWANZ%K>2S76CW+O91S@*[AH<-@ML7[S
M<]><>U;4/CG3KG2M-O(E*RZA'))%!/*D141D*^YB<##$+QG)/ID@ Z411B5I
M0BB1E"L^.2!G )]!D_F:IG1-),31'2[(QO)YK+]G3#/_ 'B,=>3S4?A_7+;Q
M'HL&IVB2QQR[@8Y0 R,I*D'&1U!Y!P>M<EXFO-:\/^+7UG3GN;O3+:T234=.
M\QGW1L[@RQ G 9=H.!@$9H [.XTC3+NR2RN=.M)K1""L$D"M&I'3"D8%6T18
MT5$4*BC"JHP /05RD6N:;'J&I:__ &C))I,>E6]VKB9VBVLTVY@F<9(11C&>
M/6KI\4>7J,>G7.FW%O>7%J]S:1R.F)PF-R;@<*XR,CI@\$\T :UKIFGV4C26
MEC;6\C AFBA5"<G/) ]:2VTO3[)I&M+"U@,O^L,4*KO[\X'/6N0L/%"ZMH7A
M+4=4L+R.74KJ,P&WF"QK(T;,-V&!*8W<$'D<CI6VOBA)9X3;:?>7-E)>-9?:
MH5#*LBDJS$#D1AE*EO4>G- &@-$TD0I"-+LA$C^8J?9TPK?W@,<'WJ4Z98-J
M(U$V-L;Y5V"Y,2^8%]-V,XKE8O%NGZ79:K>II^ILJZT+*='D$C"9_+7<H+G"
M99<!?R&:N'QO:06VLR:A8W=G+I3Q++ ^QF?S<>7M*L5^8G'7@]?6@#<_LG3=
MEPG]GVNVY_UX\E<2_P"]Q\WXT^XMR=.DMK58T)B,<:D85>,#IV%9VG>(1?:_
M?:*]A<0W5E''+*Y9&CVOG9@YW'.UOX>-I]LP>-7U:/PU+)H\,\\R2Q--#;OM
MFDA#@R+&>S%<@8Y].<4 .\*>&8/#OA^QL'M[1KFWMEMI+B*(*9@ !D\9YQDC
MFM:#3K&UMGMK>RMX8'SOBCB55;/7( P:XG1_$FF3:=JVN:#?7EXMI9L9M)N[
MA_,@E7)^82$E<@$'J/EXSS6QI?BF6ZT_2(GLWDU6^L1=F!750$ 7<Y.< %G
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MV=8G[3_H=O\ Z5_Q\?NE_?<8^?CYN..:+?3[*TMFMK:SMX;=LYBCB"J<C!X
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M<\G/%C2/$<^MZ):ZE::7(?-O'MY(FF4&)4E:-G)Z'&S.!SS6\0&!! (/!!H
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MGS)A$"(E9<87&5R03G;T&>)O#?A[7O#X_LM=0LY=$@E>2V/EL+C86+")C]W
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M_P">GF[A\N2<*.<5Z8\$,DJ2O$C2)]QRH)7Z'M2O#%(Z.\2,\9RC,H)7Z>E
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MI^N0M:R&Z8F$XM\XR>,Y8?3(KV($$ @Y!Z$5&;:W.<P1\G)^0<U( %    '
M H \=\0"U6V^(&IK/MO++5+>2WD68KY3B* 9 !QGJ/S%6/&6L6*WVMSP7J0W
MMC?Z?E[B8>8B[XB?) P4BVL2S$D,2PP!S7JQMH#G,$9R<GY!S2FW@)),,9R
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M* .8^&MR;GP#IS-.9MAFB#L^X[5E=5!/LH KK*:D:1+MC14'7"C%.H ****
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M*8^X7&,[LX(.*N7?A*RN/&-AXFB9H;RW5DF"_=N%*,J[A_>7<<'T)'IC-M_
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MVK*)"[(Q?[YQR@XYZGF@"'3/&D>M6^E+IUGNO=0M'O/(FEV+"B,$;<P#?QL
M,#GD\8K%UC7(?$%KX:O8HY;>>#Q'':7$#-S%(F\.AQPPR 0?3!JYI'@2ZT,:
M-<6FIPM?Z=!+:.[VY$=Q [[]I7=E2&P003WXYXL2>"7%K8I!?1I-%JYU>YD:
M D32DL2H 8;1\V!R< #KUH R/&NM2:QX9>>RMLV,&L6UN+KSRK%DN41R$ P5
MW;DY/J<8YK;U'QO'9W%P+>PDO(+6Z6UN/)8F4,2H9D0*=P7<,\@\-QQSG3^
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M>XN+JT>T26&S,:*K*5+LF\[G/U '8=<T-0\"ZA>Q7$(UF%8KG1AI<@>T+&/
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M]/>6PG\2W%B;@SC=&SSE$PIR67. >1C/&:Z'5?"3ZQK,%[=3VW^BWD5U:S+
M5N(%3;NB#YY5B#GCHQ&#P13/@B].FM:_VI!N.N#6-_V4XR)A+Y>-_J,9].U
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M6^J.;'G$_P#K!]G\OOY93 XXQNSWK2M+/29_''C"ZNHOM%Q8?9[F)()"71Q
M=QC&?O9R/J: /2"RJI9F "C))/2J":D]Y!IUUIL*7=G=D,TWF[-D14L' Q\V
M3M&..N>U>7>'KC3;O6K.&U:UDM+_ ,,RIY$0\SS)%:/"RMTDE +;C@$9.13]
M&FTM/#_PQ:UDMTD6XCCG\LA?G^R.'#>IW;0?? ZT >O45Y&[RW?A>ZR53QQ;
MZR0G.)]QN/E [F+R2/\ 9V@^E5/$4.FBS^(5X&B-U9W\$MI)YF6A?RH3N3G@
M[MP)'H10![/1GC-<QXYO[*V\*&:ZW26DMQ;J7279& TJX:1@#^Z_O>JY'>O.
MKZYLO[!\4VGVN#;%K]C+ +?,2*CFW+,@SPI&\Y!Y^8B@#VRL>'7&E\776@M:
M[?)LX[M9_,SO#NR8VXXP4/>O.-8GCT:^\96VCXCLU.FS7,-H>5B9V%PZ@<Y*
M ;B.>]7[?4M'MO'NJS^'9;$_:=#MEMS:E3&\S3R(OW>.I3/M0!Z+I][]OMWG
M";(Q*\:'.=P5BN[\2"1[8JW7"7\=II_C32M+U98O[ &D-%:_:L&(W"L P;/&
M_P L#&>V_'>N8MK..:7P?9:Q)YEJ^IZA%;">4[I+/9*(0V3D@C:!GJ"!WH ]
M:O;ZVTZSDN[N98H$QN9CZG 'U)( ^M9]MKC3^++_ $-[79]EM8KE9O,SO$C.
MN,8XP4/>L'XC:?96_P -Y;<6T?V6RDM=BLNX1(DT8)YZ )G)],US^LP:#J7B
M/Q,K"TEM(_#<+0*& 12&G(91TR,J0>V01UH ]6JMJ%Q-:6$UQ!;BXDB0N(M^
MS=@9P#C&?K7E,FIZ?=C2K?Q3J/DZ;?\ A^V^RW,J*\;3X;S@&8$++S&?7BO1
MH!%8>#D62YG:*&RV^?>D"1@$P"_3YCW]Z *NC^,;+Q!X2DU[38V?RD8RVLC;
M'B=1ED;KAOY\=C6Y9SO<V4$\D8B:5 ^P-NVYYQG KS+5=,NM*\/Q>+?#<8N1
M<:8D.JV41R+F,1X$JX_Y:)^HR*T3+9R>+'L_$H@&F2Z- ;#[40(B06\[!/&_
ME/? % '=RWUM#>6]G),HN+@,8H^[!1EC]!D?F*2SFNIEG-W:K;E)G2,++OWQ
M@_*YX&"1V[5Y=I$)AU/X?W'B)$:Z:SO(A-=H#(YW1F!22,E]G('7.>^:AAU*
M#3]-FF=]^AQ>++E=1V'>J0$,$+XS^[#^63VP!VH ]7O9KJ&.)K2U6Y9I45PT
MH3:A.&?.#G YQWJS7F&M_P!@P:%IEQH\_P#H,GB6UGCD\S]T294+^5V\L<].
M =U8_B.'3/LGQ$NPT1NK.\@EM'\S+0R>5$=R<\'=N&1SU% 'L]5M1OX-*TR[
MU&Z8K;VL+S2D#)"J"3Q]!7F/C._TUM=UZPOM6T]&U#3(%L);NX$0LWS)\Z$]
M1G#Y7G*@'MCOI)-/T_P;),1'>Z=#8L[>7AUGC"$G&,@AAG\Z (K/7KV>?31<
M:28K?4,F*:.X601CRRX#C P2!_#N'OTSK6=];7\+RVLRRQI(\193QN1BK#\"
M"/PKS?2;:/PYXETBS\*ZT-2T'4)'2;27E$_V--C-YD;=40$ %6[MCJ>,O39;
M73M M(8XH(K*'Q+/'K2QH%\N'SIO*$N.B F,\\8QV- 'LE8_B376\/Z9%>BU
M^TJUS#;L/,V;?,D6,-T.<%AQ7GVJ33Z7)XAN=-#/X76^L))TM?F14S_I7EA?
MX<;"P''+>]2^)9O#Y\(WUWX=N8O(N]4L)-ZM_HWF":/.P<#@*"VW\3G. #O/
M%6N-X:\,WVL+:_:OLD?F&+S-FX?7!_E6Q7D.KZG93_#'Q;!=K!#XCCC:/4@6
M!:60XVNA[QL,%0.G3J#4GB(MINM^)X?"Q"W%QX?BN-EJ^7ED$KAG&#DR>6>O
M4\4 >L2,PC8QJ'< X4G&3Z9[5E^&=;'B/PU8ZP+<VXNH_,\HONV\D8S@9Z5S
M%B^GGQKI-]X:EMUTN339FU+[.0(@H*>27QP'R7Z\X#>E<SX;U.UM]%\!QZM+
M"N@O:W"2/,1Y(N@1Y8D)X'R[\ ]_<"@#TOP[KC:]9W<SVOV9K:]GM&3S-^3$
MY4G.!UQ6Q7B]CJ%EIVE1[IA%X>3Q)?I=ND8DCB4L_DEU((\O..2, [3V%7;G
M3]!1O"MO;7\EWIMQK<S(TSA8S$\$A*1@8'E;R !TYQTQ0!Z.^K3Q^)H=).G2
MFWFMFF6\$BE=RL 4*YW#@@YQCD"M2JMK8VFFV$=M:PB&""$11A>JHHX&3SQ7
M!^ I6AUF*R/V'4(CIWF6^KV?RO+'O4;;A.<2\YSGG#=\T >C45Y'X^U&Q%[X
MC"2)!J-D;)PTY+2D!E;= ./+0 G<W.3D''>/Q%#I%[/\1YW:&22'38+BV)D^
MY*(9"KJ,\-NVX(YYQWH ]8OKAK2PN+E(_-:*-G";MN[ SC/:LRP\0_;_  WH
M^JK;;9-32!DM]^2OF ,><<[5W-TYVUQ,^J6%WK6IP>(Y8&AGT:!M*:X(V2Y1
M_-,9/!DW%<X^; 6M;P++_:'ASPX(&5UT[1H3R<KY[QA0/8JJN#_UTH [NBO)
M-,<WF@^%Y[=@GBN+4XTU$9Q/C<WVD2CKLVY//'W,=JW/AUINE2OJNI0I')>0
M:M?0QRB0L4B,Q(4<_=( (_\ KT ='/K\KZW=:5IMDMW<6<,<USOG$6T/NVJO
M!W,=I/.!TYJS8ZY;W=KIKS*UK<:@I,5M+CS 0I9@0/0#GMGZUR?BG3]#U77Y
MYUUIO#WB/3XU$5^DP3?&1N 96^61 <Y!Z>V:R8+MM2U#X?ZOXEM+6.[F2[BD
MD>$!7;'[HC(ZMC<J^K<4 >JT5Y'&\MWX6A92J>.+?60KC.)]QN?F![F+R23_
M '=H'I6CIUYH]]K=]8:ZTB>)+;6FEMD7*SO$'_<E#U,7EX![8W$]2: .S\/:
MXVNP7TCVOV9K2^FLV7S-^XQG!;.!UHT;7&U74=9LWM?(;3;H6Q/F;O,S&KAN
M@QPXXYKS;1-4M+?Q'='6#;3:%-KMXMM+N!6&[+DJ9!W5ESM/0$'/4$1>(1IL
MEIX_U'S(6O+74[>2TF\SYHF$4 W)SP<@C(ZX([4 >S5C_P!N-_PF/]@&UP#8
MF\6X\SKAPFW;CWSG-</J<UK>/XV@UAT&H*!+I+Y^?R?)7RC;GJ3Y@;[O.X_2
MEN;K5H?$2@.C>(E\'28C!!)NMRG '<[@>* .WO\ 7&L?$FD:3]EWKJ(FQ/YF
M/+,:;L;<<YX[UL5Y'IU]H5SKG@6YTF6U:^-M<QSG</-\TP#B;OOWY^]SDGUJ
M;P?)HFJRZ3<7.I7":_:021:I:&-8WW%,2_:#MR4W#()/4C% 'JU8WB;Q+8^%
M-*74;_=Y+31PX09/S'EOHJ[F/LIKG?A1IVG)X*TS4X$5KV:V$4\^\LS;78A3
MSVS5F_@7QAJVI6EO=6,EE9P/82QR*9,R2J#(>&&,+M4'U+CUH [$$$9!!'K2
MYKRO2M6&I?#I]%N]:MK;5-(O$L)+B4!XI&BD'EEQGF-P%!.>I/I3!--=Z9:A
M$T;3M0M[ZY'V.Y._3[\JJAS&W&W[V0<'!#C'6@#U>BO+](OK*]U73XM?L8[+
M1Y]!B^P6]\P,2.&82KN;@OM\O!Z[1D=ZI:7J)TV/PW%XUD/]CRV%S'#+?#,?
MF>;^Z\TGHQ@ P6YY;N30!ZI--=)?6L45JLEM('\Z8R[3%@#;A<?-DY[C&*LY
MKSHKIUAXK\"PVDD_DI;7B1"YD)E>,(-F=W)SSC//-8GAK4-,NO$GA:2U>$6]
M]:WT,\+?/,S$H0EP_P#')]XE2/EYZCF@#UBROK;4;1;JTF66!BP613P=K%3@
M]QD'FK&>,UXKH]]I^F>#O"XN&BMM*2XGAU61(%98IOF$8F&",=1\PX)4\<&M
M5)=+T>Z\.0M?27'A*>XNW%Q=[1;B4A3$N< "(9D"9XR!CHIH [WP]KC:[#?N
M]K]F:TOI;,KYF_<8SC=G Z^E8EQX]>T.NR2Z+.]MH<@2\DAF5F"E ^]5.,@*
M03T/7K3/AJUD+#7HK%H_(36[K8L9X"%AMQ[8Z=JR-'TRR\3^)/'>G3:E,+2>
M]B$T%M(@\Y/(0$$X+8R"IVD=Q0!Z/:W4-[9P7=O('@GC62-Q_$K#(/Y&IJ\J
MUP:,?$>K:!KUY)IL)AMQHY2(;O*" 8@8J2)!(&X7D_+UJYING:3>>/O$K7F9
M9[.&RN(RTG[R.18WW. #C<.,]N?>@#TFBO&/M&IV7A[5;334M=0N$TJ.2#5M
M*RKSVXD4,)4'*S;-Y!!YY[BMN_&G2:Q-<Z!+;?V--H5PVH?9V AR-OD$XX#\
MO[X!]* /3*R]"U:?5K6XDN=/EL)H+AX&BDD5\[<$,&4D$$$?0Y':O/?"Z:?9
M:O\ #Z:U>*.XO=#D2[99,M,5CA*A^<G!#  ],$#I77^-(5.C6L,5_:V$INT,
M)NH]UO(X#,(Y1D?*V#^..] '3T5SG@>Y-SX90G3X[%H[B=&BA??$6$K;FC;
MRA))'IT[5T= !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M1\IP3G/;&.A.CKFM1Z-!:DQ^;/>726EO'NVAI&SU.#@ !B3@\#H: -/ '04
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M1AJ+L7(D"ECEB-IR0%(QGN3GL'P^,;^69?\ B03^1-9/=13#S BLH!\N1FC
M4D'@@L,@CW(!UNT$$$#!ZBE P,"N)LO&VJ7C:#MT*!5URR-Q:$WWW7"*Y63Y
M.%PW!&X\?=&>)[/QP;K3[0M8;-2GN[BT:V5VD1'@9ED;<J$E?E&/E_B'3DT
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M9OB=E.,#:05]35AO%$UAI\=EIVG/?W5IIL-Q)&/,^;<IVHI1&^8[&ZX'3U.
M#L:*KV%U]NTZVN_(F@,\2R>3.FV2/(SM8=B.A%<SXC4KX\\&.LD@W7%TC*)&
MVD?9I#RN<9SWQF@#KB 1@C--V*5VE1M],<5Y]\3]72?PKKVG6]^D!M;1GN"L
MH5W<KE8AWZ$,WMM'.XXVM?\ %<FB6<ES!:0W%K%9-=>?)<B-)2N?W4> VYR
M3Z=/7@ Z@J&Z@'OS00&&" 1[UFP^(-*E%HKW]K#<74:21V\LRK(=X!4;<Y).
M:Q%4I\7"!)(5?0RQ1I&*@^>!D G _"@#KJ3 '85Y%XBU5K+1/%MU?>9;^(K*
M_,NG2F-M_E!D\CRSCE"/E8#@DMGDUV%E=_\ "0>)-?@NXPUMI<<5LD+<KYCQ
M[Y&([G#*H],-_>- '6X5E(X*G\J"H*X(!'I7F?@?Q)>Z7X7\&V=]I*KIFH6\
M=K#>K<;F$NPD!X]O ;:<$,?<#-3ZQXHN?#/_  E&EVY&^V6UDT[<,B/[2WE;
M?]U7!8#T..@% 'HPP.E%<OXET+33X8D2XTV[U1+>%MEM"Y,DCD??ZC+Y_B//
M)QU.<9M1^S?".P\0V%[)>W.F623BYD!5YA'@2HX//S!6!!S@X/4 T >@%02"
M0"1T]J6HX)DN+>.:,Y210ZGV(R*Y:_\ &C6NGZMJEOIXN--TFX:"Z<3;9#LQ
MYC(NW!"Y/4C.T^V0#J_E3)X7)Y[9-*%"] !WXK@]10^(?B$-*O+2TO-'DT;S
M5CDF;&'D ,@&WA\  8/ Y!&:Z[499=-T*YELXT>2VMV:))7.T[5XR>3VH OY
M QSUI" 1@@$>AKS&.]U*_O\ X=ZK+:V\VIW-E,^1-M63=;JV6;;\O))P V.V
M:Z"S\<?:]-L6-ALU&YN+BV-L':14:!F60[E0DKD#'R_Q#IR: .O  &!P**RO
M#VK7&LZ8;BZTVXT^=)GA>&96&2IQN4LJEE(P0<"M6@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L7
MQ#H<^LG39;:_%I-878N4WP^;'(0K+AER,_>R#G@@&MJL/Q;X@?POX?EU86@N
MDB>-&C\W8?G=4!!VGNPH PO^%?7$5NCVNOR1:C;ZE/J%I=&V4B/S2QD1TR X
M.X@\KT&,=]2]\+WEZFDS2:RQU&PO#=&X: %7)C:-E"9PHVMQR<8R<\YTX+O5
M!>QQ7FGVT<#JQ\Z"Z:3:1C (,:\'GG/;WK1#*<88<^] '-_\(FTWB"RU>]NX
M9I[&>:2"5+;9,4<,!$[[CN10_3 ^ZOOG8U?2[;6]'O-+O%+6UW"T,@4X.&&.
M#ZU::09=(RC2A<A"V/IGK@>^*R/"VO'Q%X?M-2D@2VEG\S, DW[=KLG7 STZ
MX[T 5;/PS=)/IEQJ&I1WEQI<+QVC_9BGS,H4O)\YW-M&.-H^9N.1BYX6T1_#
M?ANST=KH70M4V+*(]FX9R,C)YYK6$B&0QAU+J,E0>1^%'F(6"[UW'.!GDXZT
M 8^O:!_;$^FWD%S]EU#39S-;3%-Z\J5=67(RK*2#@@].:S+_ ,%-?VUX3J")
M>WM];WEQ/]GRI\@H8T5=W ^0=23RWKQU?F)YGE[UWD9VYYQZXH,B*ZH74.WW
M5)Y/TH YB[\)7%U<^))O[2C7^V[-+1A]F)\D*KKD?/R<.WIV_%8_"=U'J-C>
M+JJJ]II3Z:NRW()W;3Y@._@@HO'UKJ*P[[Q396'BO3?#\JMY]_&[K)_"C 95
M3[L%DQ_N&@"A%X0N(=0N]4BU"W@U.YABBDF@L]B2[)-Y:1-_SEAE<Y& 359O
M ")9RP6EY!:F758=4=(K7$2O&4(5$W_*"4!)R<DGI79.Z1H7=E51U+' %5IM
M2LX-0MK&2=!=7*LT4>>65<9/T&1^8H Y^;P8Q_MRVM]1\G3=;9GO+<P;F5G4
M)(8WW#;N [AL'D4L_@]WNM;D@OHH8M3T^/3UB^SD^2B!P"#OYXD;TZ#\>GEE
MC@A>:5U2*-2SNQP% Y)-5=-U :AIL=^8_)@F7S(MYP3&1D,P_AR.<=N_/% '
M-ZAX'DU31(M'O=0@FLTM88%W6?[R)TR/-B;?\C$8['!'U%=B.!3=Z% X8;3C
M!SP<]*565U#*P8'N#F@#B[;P)=V]SI[_ -NEH[#4IKZ(&U&]A*) RNV[YF_>
M'#8' Y![:%CX3:'7[36KR[AGO;:W>W\Z*V\IYU;&/-;<=^-O' Y.:Z/S$\SR
M]Z^9C.W/./7%'F(&"EUW$X SSGK0!F>)=%/B'P_=:6MVUJTX7$RKNQM8-@K_
M !*<8([@D55T7P]<Z7KFIZI<:F+E]02'S(EMQ&JLB[<KR3C';MZFM[<O/S#C
MKS2YR,B@"AJMC<7\,4=O<Q0A9-TJ30>:DR%64HRY''(/7J!7/6O@--/AT9;"
M_P#L[Z9=SW* 09CVS;PR*A;Y  _R\G&.<UUHEC+,HD4LOWAGD?6G;AG&1F@#
MDD\#*EA=:/\ ;@="N+S[4;0P?.N9!(T8DW8V%QTVYP2,]");;PE>6&MWUQ8Z
MY)!I=_<?:KBQ\@,WF'&\I)G*AL#(P3UP173B1&=D5U++]Y0>1]:%D1V95=2R
M\, >1]: .+?P#,-3GU2WU9(-2;4C?17"VO**R*CPD;_F1@BYZ<\^F+%_X,N+
M]?$ROJD:C7K=('VVI_<A4*9'S\Y!/XUUBR(Y8(ZL5.&P<X/O31/$8S()4* 9
M+;AC\Z .=C\+75GJT^I:?J<<$]Y:QV]X'MBZ2-&"$D4;QM8 D<D@C''%,B\$
MV]K=:#]EN ECI%G+:+;O%N,JR!0Q+;A@_(.W<UTQEC6,R,ZA!_$3Q^=.+* "
M6 !Z'- '$V?@.^M+;1;$:^)+#1KP7%FC6?[S8%=1&[[\-@/@$*.G0U=T?PE?
MZ)=R0VVORG1?/:>&P-N-T;,Q;9YN<E-Q)VXSVSC-=2K*ZAE(*D9!!X-(9$#A
M"Z[B< 9Y- &1X9T.3P_ILMG)=K<A[F:X#+%Y>#)(SD8W'."Q_"E\1Z GB"RM
MX_M#6US:7,=W:SJN[RY4/!*_Q @D$=P3TK6,B!@I==QX SS0)$9F574E/O '
MI]: .9O?"4FH6NN&XOH_M^KV8L9+A+<A(X0K#"H7)S\[');J1Z5O:=;266FV
MUK+*LKPQK&75-@; QG&3C\ZL[EQG<,?6JMK<7)6Z:^C@@6.9EC*3;MT?&&;(
M&TGTYQZT 9UUH,\GBJ'7;6_$#K9M:21/#O#KOWJ0<C&#UZY'H>:RM-\#S:=:
M^&(!JB2+H3NRDVI!F#(R8/S\<.?7G%=-<3W2W%F+:*&6"20K.[R[2B[205&#
MN.0!C(JSYB>9Y>]=^,[<\X]<4 <OX?\ "=]X?D6TCUZ671(79[:Q,"AXP22$
M,N<L@)X& > "2.*Z:>"*YMY+>>-9(94*.C#(92,$'\*<9$! +J"3MP3W]*HI
MJB#6FTN=/+G:(SP'.1-&" V/0J2N1_M*<\G !E:-X<U/0;)-+LM:C;2X1MMT
MGM-\\*=D$F\ @=!E#C SFG-X9GM=>N-6TK41;2W=M';W23PF82&/(20'<I#@
M$CG(/'%=$K*XRI!'J#5&ZU-(=3M=-B427=PK2[,X"1*0&=O;+  =R?3) !C:
M=X-CTC5='N+&Z"6NF6#V*0/%N9U<HQ8ON'S90'IW-8&AZ._B"'Q9ITUXB:;=
M:U*TL0A/F21X3.U]V-K;2,[3_%@^GHV]<9W#'UK/EN=34ZD(K2V;RHPUGNN"
M/.;:20_R_(-W&>>.: ,:?P<_G:XEGJ/V>QUL$W<!@WLKE-CM&VX;2R@=0W(S
M[59T[PQ_9NO7M_!=*MM<6<%FEND1!B2+=L(?<>?G/;L*TS/J!N;=%MK;RGMV
M>1S.<K*-N% V_,O)^;CH..:-+U2+5+>1T4QRP2M!/$QR8Y%Z@_F"#W!![T <
MUHW@:[TJ[T*:36_/72(9K=%%H$,L<FT_,=Q^?*#+=_0'FBV\"W%MH>CZ4NL*
MT6E7R74+-:\LJ%BJ'#]?F.6[X' []B\B1*&D=4!.,L<<T,Z(,NRJ,$\G' H
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M97(!.YPRJ<\#@\#)K,M]/NV^(1LM8U);Z2;0)+>2>*W$"Y,HX R<-MR<9]\
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MYI?C.UUOP=/K^GP%I+>-VGLYGV/%(@RT;<'!_#G(-;\-P3:12W(CA=P,J'R
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MR",2+M92I'[QL=?;%=A110 4444 %%%% !1110 4444 %%%% !1110 4444
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MS&US&Y&]XCT;8,_+R20>G>"S\;17.H7\3M;1+I\DXO+=W*W$$<>[$FTCYE8
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M&2<#KDDT 6_#^N7>I7VL:?J%K#!=Z;<)$Q@D+HZO&LBD$@'.&P>.U;CE@C%
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M[O5M'BNK[3I=/N2S));R \%21D9 )4XR,@<&M2JNGVDEE9I#-=2W4W+23R@
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M +5>VT&Q0[>;*J[5)QDY/ SQ7 RV[PS^,-.U?3YW74;:/[ JQ-*)(Q $$*L
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MS2".4)C+(I96X!Z ]J;XATI[C_A(+V&SEETZ]U739+>-;=FW.CIY\JKC(!4
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M=.: /07U&QBFDADO+=)8UWNC2J&5?4C/ ]ZADO)&U&P6WGLFM9D=GW2?O'P
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MI)+(%4_B:62]M81&9;F%!("4+2 ;@!DD>O )^E>;^%VN].N?"UUJMO<C3_\
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MBT"R>,W'AV)(O*A,:2R+)(2@;&-VQ@/7FH[V./7M%U35=!T_66U3[#'!,EU
MT!*)*KF *5 =MOF#(R!G&><4 >EVE]9WZ,]G=P7"HVUC#('"GT..]17-Q<1Z
MG8PQR6BPR>9YJ2N1*V!E?+'0\YSGM7/^%#IFHZK=ZU80:JLT\"0W$M]"T&2I
M.U-A5=Q7)RP! Z9/9->AS\1/"=PMO(WEK=K),L1(0-& H9@,#)SC)H Z:&_L
M[B=X(+N"6:/.^-) S+@X.0#D<UCZQX@DTKQ+HUA(MNEE>I<--/*^TQ^6F[Z
M<]37/>#$OK36+2UC9[W218R&"6ZMFBNM/^9/W$AP V>W&?D/4<U?\76T3^*_
M"]W>VAFT^![D3.T)D2,M& A; ..1P3QF@#JOM]G]B%[]K@^R$;A/Y@V$>N[.
M*K7-^SQV$UA=6#PSSJK/++Q)&0<^61P6SC';K7FZV%[X=CM]12ROH]!&N7-R
M+>TA)DMH9(]J2"+!(7?O; &0).E7;O3K&&T\.SZ787X@?Q$+S=/ ^\*RMODV
ME<QH6(X( [XYH ]!;5-/6986OK82O(8E0S+N+@ E0,]<$<=>:?/?V=M*L4]W
M!%(_W4DD"EOH":\IOM-C70/%CPZ7*+IO$4,UL4LVWE \!W)A<E?ED.1QP:E\
M4O92ZOXJTJ\FN8[751:[[@V$\WD[44G841E(Q@C)7#$G!% 'K"L&4,I!4C((
MZ&H(-0LKJ1X[>[@F>/[ZQR!BOU /%,BDM9-(26S"O:- &A\G@,A7(VX]L8KR
MJ6QU]_#>I:3I>_4[9=)46=Q);F"ZC02)FTDZ!F*!@. >N>O(!ZQ:W]G?!S:7
M<%QL.'\J0/M/H<=*=/=6]MM^T3Q1;L[?,<+G ).,^@!/T%<E:H-4\>:9K.EQ
M2Q6D>F2PWC/"T>[+(8HR"!\RXD./X?;-1>.([$^*?!DE]!')%]NG5]T>_C[-
M)U&.F<$]AC)Z4 =<FI6,EM%<I>VS6\K!8Y1*I5R3@ '."<TUM7TQ+:*Y?4;1
M8)O]7*9U"O\ 0YP:\MN]!2")WCTV3^R[CQ5;W-K MLS!(0$$K[0/E0L&/8$<
M]#72+;P:-XVU*.]L,:->:;%%9^3;%HDPTAEBVJ.&8N&QCYO?% '8W.H65F";
MJ\MX $\PF655PN0-W)Z9(&?<4LM]:06HNI;J".W8 B9Y $(/3GI7E&@Z7#I>
MO>&+3Q);))*OA^X5Q/%YFW]]'L5^#RJ';SWX[U:\/:=J'ARZ\-3WMM<+HL?V
M](XS&S&S\V7= 7'5?W8*Y/W=V#C- 'ILE_9Q6JW4EW EN^-LK2 (V>F#G%-F
MU/3[:VCN9[ZVB@D^Y*\JJK?0DX-><0:1=VMHSPWMUI+'6;N[TJ1K4R0Q1LN-
MDL9'RHY,A'W<9&,$XJ)+J[M[G3I_$&E7UIIU[I M#'I]J\R0RB1]R% K.JR*
M4(&/X0#TH ]*U#4(+&U,LES;1,P/E>?*$5VQP,_X53\*:Q+X@\*:7J\\212W
MENLS(F=JDCH,UQ]A&N@>)!;7NG7PTF;1H;73M\+W'E;2^^%]H.&8%#SP=H&3
MBK_@+5H=.\)^$]%O+>]@O;FSV(LEK(JJR+DJQ(P#@$C/7% '1^)=?MO#/AZ]
MU:YP5MXV98RX4R-CA03W-166KRPK-+J]]I*VCL/LES#-M$HQ\P(8D9!XR"<^
M@K/^)4<D_P /-9@AAEGFE@V1QQ1EV9B1P  351YA;>/+NZU&WDETB^TN.&TD
M\AG12K.98B #AFW*<$?-MQSC% '6W.H65F ;J\MX 5+YEE"_*.IY/2B]U"TT
M[3YK^\N(X;2%#))*[855]<UYAHWAYX;[P/9:UIS7!BL;V.83VYD6-'9##'(<
M$<+\N#Z&O0?$MH]QX0U>TMH=[O831Q1(O4F,A0!^5 &8?&43:WHL<3VO]E:C
M93W37+RX,?E^7P?X1_K.>>U=#)J%E%9"\DO+=+5@&$[2 (0>AW9Q7G]HD-]K
MG@:26PN#;VVE7*2F>S=5C<K !N#+P24?&>N..U9.E27>C:-X8N[BTU./3+67
M4(+E;>U9I+8O-F%S'M+;=@89 X#^] 'KD4L<\22PR+)&X#*Z'(8>H(ZT^L3P
MI8V>GZ!%#I]O<V]F7>2*.YR'PS%LE3RH))(7C /0=!MT %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5EW6A0W?B"QUE[FX6>RCDCBC
M4KL*R;=V<KGG:O?M6I10 4444 %%%% !1110 4444 %%%% !1110!%<P?:;6
M6#S'C$BE2Z8W#/ID$?I571-)AT+1;32K:662"TB6&)IB"VU1@ D  \>U7Z*
M"L[7='@\0:)=Z3=2S1V]U&8Y3"0&*GJ 2#C\JT:* (X(S# D1D:0HH7>^,M[
MG  _2I*** "BBB@ HHHH **** "BBB@"*6VBGDB>5-QB;<@). ?7'0G^52T4
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5@_\(M$FHW-U;:K
MJELEU)YL]M%./+=B "1E2RY 'W6%;U% #(88[>"."% D4:A$4=% & *?110
M5EZEH4.IZIIFH27-Q'+ILC2PK&5VEF0H=V5)/RL1U'6M2B@ HHHH RY-"AD\
M30ZZ;FX%Q%;-:K$"OE[&8,<C;G.54]>U:E%% !1110 5$]M%)/'.Z;I(L["2
M<*2,$@=,X)&>N"?6I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !61JGAZ'5-1M[XW^HVLT"%,6MTT:NI.
M<,O0_7K[UKT4 06=E;Z?:K;6L>R)23C))))R22>22222>234]%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
+!1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>aquestiveamendedandresta006.jpg
<TEXT>
begin 644 aquestiveamendedandresta006.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4,GGG!Q"<=",'IWJI+-83^'[Y+F:SGMK#Q?;L#M B@@9XCD D[(SE^^,$]J
M/84FN6U&:![3;:I&C1W'F ^8Q)W+MZC&!SWS[59KRO7+RYM]7\:?\([*6NAH
M-K);QPODK\TN2B]B$P0![5?<Z>_B+2[CP_/&-*N=*N'U'R),)Y8">4[X/#[B
MPR?F(W>AH ]%K(U37/[,UG1M/-JT@U.=X1*' $96-I.1U.0A%><^$C:6LOPW
MNHK@"ZOK"6*Z<S$M,!""%;)YPPX'8UU'CN*UEUGPDM\P2S.I2+*S2%%YMY0
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M CCB(C42E9) ,%RH&ZG%%XPJY'3CI3J* *=AIT5AY[J2\]S)YL\K=9&P!^0
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MO&=OX?B=DCBLS?W+*<%AOV1IGL"0Y/\ N@=":Z"N7N+%K#XBP:TW_'K>Z?\
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M0MTAE@N-/G$%Q%)M.&*JX(*D@@AA4FI:O#ILEI R2375Y(8[>"/&YR%+,>2
M  "22?U(!R/#'A^^T;5];N9Q81V^H2Q31PVH8>65B5"O( P-O7OG.!TI_B70
M]0OM4T76-)EMQ>Z7)(1#<LRQS1R+M=2R@E3P"#@].E &+X8\1K8VVOS:G)=
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M*C^YGC/7VK<UGPA=Z^-=N;F2WMKN_P!).F6ZQNTBQJ2S%F8J"<LPX X"]\T
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M,R@\R;3NVMM )SCM7/P:9J.N:#=:;:V^CI*FHV]])=6U])/%.XE$C@N4SO\
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MVL,'UQCIS4%MJ5Y9^#_!OC2ZO+N:*"VBCU1!*["2*10OFE <,R-@DXR06]J
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M)Y&CPDRLX"D!B<'RVY'&<5TEE=S7,EVLUC-;"&8QQM(5(F7 .]<$\<D<X/%
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M:-L1[@<<$?N^/][VP>YHH XW6/!MUKFI:S-/<QV\6HZ=#:(8B6>&2)VD5^0
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M')AE6+RPR$=05QD''3/M73:'8S:9H.GV%Q*DLMM;I"SQJ55MJ@9 )/I5^B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCD$4 <#IER9M2EN=1M-6BU*32?[/A$NF-#')M#.0"&<%SR0,C@'%1C2]3LO
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MO._'%EJVH-XFL[;1;MA+;VYMY+2-<76TY;S'SDE3D!/QP<\>F*JHH50%4#
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MW%G);S/JEY,OFQ%"R23,RMSZKM_*IO'UC=:AX,O(+*W>XG62"811_><1S([
M>IPIP*W[R[@L+*>\NI!';P1M+*Y!.U5&2>/84^*5)H4EC;<CJ&4^H/2@#RWQ
M%9ZIJZ>-I+?1-0":GI5K#:;X@#(ZF7(QG(/SCKT[XJ[XHT;4]7U;6DTJVGA^
MU^&Q9P2M&8T,OF,WEY(&#M;'H,UWCZI8IJL6EM<H+Z6)ID@_B**0"?IR/SJY
M0!YQ<IJ7B#7-)FM=&U#3L:/>V<DDT0C%M*XBVC.>0"IP1D'MGG":':M<Z=!]
MM\+ZI:ZKIMC);O-<RM)&I*;2L/SG>&('08 'KC/I%% 'GEOHK'X>^%;.:WU.
MPOK2.%3<641\ZSF2%E+,N#O4DLI&"#O_ !I;*VUY=6\(ZAJ6GO-+"M_#<R6T
M009D=/+D9,_)O";B.Q./:O0J* /+M)M]6_MOPQ>W.@WUJ+22\2YABA58+;>I
MP$ .67ONYR3QZ!=$TJ_M=%\"POIEU%+8ZC-)=+Y!!B5DF7)XZ$NGY^QKU"B@
M#R>"TUF'PUI&B7.BW\NH:;KT5Q/,D8,<T8N#(9E<G!R&Y'4'.:L>(=+U"[M/
M'\<.FW<C:A-:FU40G]\%CB5L?0JWY5ZA10!Y[K]GYVM>)[B6SN_[.N?#:VV]
M%\K>X,Q**S# ;#KC/'..Q%.\+7'F>)+.YU.VU2WU#^SET^(SZ<T$3[?WC?-N
M8%CMR.1P#CK7;:CIUIJVGS6%]")K:9=KH21GG/4<@Y .1573= LM,D$D3WD\
M@&%:[O);@H/]G>QQ]1S0!F_$33KG5OA[KEE9J7N)+5BB+U<K\VT?7&/QJMXF
M+ZM:^%;RP@EN(?[3M[QFB0L%BV-\QQV^8?G77U#;6L-I&8[=!'&6+;0> 3UP
M.WT% 'FFHZ5?2>'_ !?#'IETUQ>:[%<VZB!LRQJT!W#CH/+?\O<9TX$O;36M
M>TN_\.W&IVVJ7JWEK<&-6@(V1@++N/R;#&#R,X' SQ7?44 >;:_HVI:B/B'!
M;64[-?VD"VA9"JS,D9#!2>,YXJMXBL-;\37VL2:;I5];"\\.BVA>Y41;I!*S
M&,Y.02"5Y]<].:]2HH X6TN;K4?'.D:N-#U&TMH])N()C-!M\IR\3!<9R?NM
MC&<]L\UD:#I5_!9> 8[C3+I&T^YN6N@T!_<ADE"D\=RR]/Z5Z?)(D4;22,%1
M069CT %5].U&TU:PAOK"=9[68;HY5Z,,XR/RH \TGM;JTTEY#87XND\52WUI
M''!EG0L[;O+)4NI0MP"",Y[5U/@F2W+:N!%?PWMQ=_;;F.\M&M\%QM78"2"N
M(\=3R"3C-;6KZ%8:VL'VQ)1);N7AF@G>&2-B,$JZ$$9'!&<&IM/TRVTR-E@\
MYF;&^2>9Y9&QTR[DD@<X&<#- &7XTTNXU/PW,;%=VHV;I>V7J9HCN5?^!8*_
M1C6'I6@:Q;^*WDN$_P")=J834[P;LB*Z0X\L8[<Q'/?R3ZUWE% 'F>N:1J5[
M:?$&.WT^X=[V6WDM1Y9'GA(XPVW/4Y1A[UISQ7%UXUO=2.F7BV\N@?9T9X"3
MYGF.VSC/."IQ^'48KN:* /-?#%EJFB77AJ^OK&[:T3P]'ILR)"SO:SH03E "
M=K8QD CY1GCFH[+0]2T >&;R2PN98+;4KZ9[:W3S'MHIQ)Y:[0>@W+G'0GTK
MTZH[BXAM;>2XGD6.&-2SNQP% [T >91:;JZ:5!,^CWH:W\6RW[Q!5+F%I)/F
M !Y'SC^?(KU!260$J5)&2IZCVK-A\0Z3</IJ17T;-J<9ELU&<S)MW9 ]-O/-
M:= 'F&J:9J,WA;QS:QZ==O/?:J)K5!"V94VPC</;,;?E[BM.^L[B;Q+XKNEL
M+EH;O1(;>!_(;]XX\[<HXZ_.G^0:[RB@#S[2[&[M]1\!NUA<HEAI,T%V?(8"
M)VCB 4\=RC?E[BJ%AIFIVWAOPNQTJ\:2PU^XN)X%CPZQN;C:P!QD?O4^F?8U
MZA10!Y?>VVKW&J6\AT&]C-IXD%P8[>-%A:'# 39SEV;(+$].1QW-4TO5&\(>
M.=*72KM[B[OY9K8J@*S*^PKM.?8Y],<UZA10!Q!BNK+Q3XCGN]/NKRPUBT@^
MRF.$O@I&R-"X_@R3N!;"_,<D51\.:'?Z'KOAZ._@FG%AX=:TFN%B9U$N^,[
M0.?E5@/I[XKT6B@#F?A[:7-AX#TBSO+>6WN8(?+DBE7:5()XK(\:VVI7FH:C
M:6VDW$D5SHDL,5S:QJ6EE)?]T[DY5!PP QDD\GH>]JGJ6JV.CV9N]0N4M[<,
M%+OTR3@#ZDT <5I%K=+XDT^\N=+NXXH_#:VKEX"=LH<$IQGG S^G7BJ,.EZI
MIGP\\)ZE;6ICUW15B@^S3Y3S5DQ%)"3[Y4@^JBO3ZS9]"T^YUN'5YHY'NX8_
M+CS,_E@9)!V9VEAD\XS0!/I=B--TRWM YD:-?GD(YD<\LQ]RQ)/UJW110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !6%XBU>73[K1K&%Q%)JE[]F\\@'RP(W<D \;CLVC/&3G!QBM
MVLW7-!T_Q%I_V+486DB$BRHR.4>-U^ZZLI!5AZB@# N=5U?3=2TO0[N^@EGU
M+4)HXKN-!OCMTB,@##&WS3C'3&.<5E:EXIUZPCUBP2XA:YTW5+*W6Z> 'SH;
MADP& ( 8!R"0!GC@9KJW\)Z5)IL-DZ3OY,XN8[A[AVG$PZ2>83N+8XY/3CIQ
M1<^%-*N[)[6=)F62Y2[E?SF#R2H5*LS Y.-JX'0;0,8% '$^*-6UJ/P]XZTV
M;5&9]/@ADAN8HEC?9*IW(>HQP>>N#U[UO75QX@D\;+H-IK,<, TU;OS9+17<
ML)MI!P0.1QQC'UYK7N/"6D7;:L;F*67^UHEAO TS8=5!"X&?E(!/(Q4MKX;L
M+35H]3C-RUW';?90\ER[YCSNP=Q.3GG)YH YJU\2ZI_PDFBPM=)=6NH7=Y;R
M&&(>0HC5V01L0'9@$ 8\J26P>*N^']2UCQ#IFD:]#J,$5E?*[3VS(O[M3D1B
M,XSO5@ =Q(// X%6[;P+H5I/:RPPW*FTN'N;=?M<NV)GW;@J[L!3N.5Z'-3:
M9X.T;1]1DO;**>,M(TJP?:',$;MG<R1D[5)R>0.YQC- %#X;/=3^"[:YO+V:
MZEFEG8M*%SGSGST Z]?Y52U34+K3?B#J=V]Y<26=CH'VT6BA=IP[[@.,\[!S
MG/X<5U.CZ'8Z#;26^GI)'"\C2;&E9PI8EB%#$[1DDX''-)<:#I]UK4>K2Q.;
MM(#;DB5@KQYSM90<, 22,@]: .:A\0:K;-X2O9[E+NVUTK%/"L:@0N\1E5HR
M.=HVD'<3Q@Y]=7QSJE_HOA&\U'39(DN86CP9$W AI%4]_?KS]*LZ;X7TO2FM
MOLT<ICM-WV2*25G2W##!V GC@D#T!(& <53\?:9>:SX,OM.L+5[FXG,85%D5
M.!(K$Y8C' />@#G]8U[Q)H%YK]E/J$-UY6AS:M9SI;*GE/&<&,KD[E.003SU
MY[UJ'7-4;Q%;627"".XT&2^PT0(696C (Q@XPYXS6W'X?L)(KHW,,L[WMO\
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M0R6\\3E)(F(P<$=B."#P>XH XF3Q5X@,45FEQ;QW4'B(:1-<&#(FC*[U<#.
MV",@=P<8KOM/ANK>PAAO;L7=RBXDG$0CWGUV@D"LV;PII4\%K"T<P%M=_;49
M9F#-/DG>QSECR>O%;= 'G?\ PF]WITFIG53<07UE9W=T-/FA417*1_,CP2@?
M,-HY!)//08K4@GU^0R2W,D<VDW.G.^Z0QAUFQD>7LZH5SPQ)&!R:UX/"^F0M
M%O26X2%)(X8[B0R+&K\. #V(XYS@<# XJOI7@K1]%MYH+(78BDC:%4DNY)!#
M&>J1AF.P=.GH/04 <CH7_'M\)_\ KR?_ -(Z]/K#M_"6E6HT<1).HT=2ED//
M8^6I7:0>?F^7CG/%3:!H_P#8MI<0":619;AYU629I?+#8^4,W)&03]6- &%X
MC\1W>CZ\(;J6>QTR00K!?) LL'F%CO2<X+1Y&T*>!SG/:LS7O$NNZ3_PD=DE
MRTFHV<D-UI\:PIF>U8$LH&.67RYN?]E>.Q["^\.6&HSSR7/GLER$$\/FMY<H
M7[N5Z?7&,]#D<59DTFQFU>+59+=&O8H'MTE/4(Q!(_-1^9]30!SMQK\]SIL^
MJ:?JD*6$LMM#;221[M^XKO:,*I+.0VU5P1N4YXZ8LOBO7TTN_P#+F1+BT\0V
M^G*US I9HI##]X(0N?WIY'8#H:ZV3PCHTGAZVT-;9HK&U9)+=89&1HG5MRLK
M Y!SSFL#Q+X+C73'CT6RNYIKO4[6[NL7ASB-T+,"[C#%4ZCDG% &AH&HZS#X
MNU;P_JUU'?+#;PWEM<I"(B$=G4HP''!0X/IUJUJ^KSKXITG0+>4VYO89[B2=
M5!8+'M 5=P(R2^3D'A3ZY&G8:7;V,L]P@D>YN=OG32MN=MHPHST &3P..2>I
M)IFIZ)9:M+:37"NMS:.9+>>)RDD1(P<$=B."#D'TH XE_%7B!HH;-+BWCNH?
M$7]CS7!@R)HRF]7 S@-@C('<'&*[ZPANK;3X8KV[%W<HN))Q$(_,/KM!(%9L
MWA32IX+6%HYE%M=?;499F#&?).]CG+'D]>.:VZ //(O%VJ2>%M'\61RA[:]O
MHX9;#RUPL4DWE+M.-WF+E2<D@G<,#C&-JQO9?!OCE[C4)KG9K2Q(LH7"@-;X
MZ '@8&/;UYKT&V\*:3:3!H89%A6X-TEL96,*3$Y+JG0'))QT!Y SS45WX+T6
M\344EBN!'J,JS7,:7,BJSC;\P .%)V+G&,X% &!?^*M5\/7GB6"\N8KP6=M:
M7-NYA$8C,TCQD$ \J"H/)SC.3WI/$6J^+-!T+7[X3Q"&"S$]G)<K&TRR X=2
MJ84K@J0>HY!SQ73S>%M)N;J^N+J%[A[^V6UN5ED9EDB7. 5S@8W-R.>:I1>
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MA"4/\7&">^*DU+1=6EU2/4=*M;ZPU-?LR,WFQM;7<8V[EF3<<%,OA@,],$T
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MC;NX(VYSD$=:X_3- \0:9'X*DNH9;^73OM,=R?.0O$LBD1[F8C=M&U21D\<
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MKBR\):/:75NUO<6]G%#+$Q4E65 IY4D=1ZUFIHC:[<ZO<:O;7MLMQ_HJ0^>
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M4#YB0"1@XS6MK&D:CK=_?ZQ%IMQ _P#8,^GQV\C1B2:60@@<,1A<=2>K<=*
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M6LCPK;W%GX3TBTN[=[>YM[.&&6-BI(94 /*D@\CUK7H **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHKG/&M]J&DZ&NK6-P\<=C/'->1JBMYEL&'FCD'!"Y;(]* .CJE8ZO8ZE<WMO
M:3&26RE$-PI1EV.5# <@9X(/'K7&6?B34+G7]6T8:C*7N9HGTF?RXN8"Q64K
M\N&VF.0Y.<C;ZY.3J=YJ>CW'CW6-/U!H'L;ZVE,7E(PG_<0@JY8$X(_N[3GO
MVH ]-6_MVU)]/#-]I2)9F7RVQL)(!W8QG*GC.:34=1M=)TZ>_O9?*M;=#)+)
MM+;5'4X )KCO$7BG4= UOQ$P<7%K8Z$E_!;L@ 60O(IR0,D?(">?6G^)X=0B
M\)>(I)=:2^L9]!N&2-XT#^8(VRZE0/D(9>#G!QSS0!VL,R7$$<\3;HY%#J<8
MR",BGUQ/AZ]U.U\4:?I5QJ#75G<Z(+Q8VB11"Z/&F%(&=I#_ ,1)XZU>\1WN
MI0^*/#=A97[6T%_)<1SA8D8D+"S@@L#@@CZ>H/2@#J**\R37?$-OI)OI-9>8
MV'B :8Z&WB N8C<+'E\+PV&ZKM''0U>U'Q%JEMK,+6]^9[=M=BL'2.)! D;
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M"\H\LG:VXK\NW[IQ4NF76N:IXSU:V.L^596#6DJP101L)%DC9F3>1G;GH>M
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M/Y;WDPMX!L8AY,$[<@8' /7T-7J\ALEO)_!?@N6349Y;B?Q!GS9E5BIS<9/
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MKRS5'GCV,-H?.TY(P<[3T]*NUYKK!U"W\4^,[K3]3DM)[31;6<2+$CEV07!
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MW';3W#(9+@6JR^4YB\X]$+XVANW7KQUXH MV.EVFG-*\".99MOF2RR-([X&
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MG8(</\@&X;3P<CKQU--N?%&E6EBMY)-*T!MENV,=O(Y2$C(=@ 2HX/7T/H:
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M^DIJFG7(NK-P2LD2LQ.#@C;C.01TQFIK"_M]3L(;VT=GMYT#QNR,FY2,@X8
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M4D16ADB##!#D91@V<C)!SQ67I?A74M#F\$VJ6[74.D03I=3HZ !I$P-H8@D
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MB7<08\]<<]^_KWJ[0!YS9>%-7/A/3/"MW;$+I^H12_VB)$*211S>8K*,[PY
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M+S4;OPIXGTV\O)I!I6K6L,5R H,T;O X5^,%EWXR,9P,]\^E:CI5EJT,<5[
M)1%()8V#%6C<=&5@05/7D'O5:X\-Z3=Z8VG3VF^T:3S70R-\[YW;F.<L<@')
M)Y H S/'B30?#77A'>7"RQ:?,PF# .2$)Y('?VQ6(]A//XZT6UCU.ZA<^'[C
M-R@3S<>=!P,KM';MT'XUWD]E;W5A+8W$0FMI8S%)'(2P=2,$'/7(K/M_#&D6
MD\$]O:M%+! ;>)UF<%8R<E?O=R ?J >U '&Z'XFU?6[+PU82W2I<W^FS7$LP
MD$+3/&ZI\IV,,X)8@ =NP(/:^'1J2Z%;1ZO=V]WJ$>Z.:>W^XY5B,]!S@#/
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MJ]SX/\8:9K5LEAKMA91-+<V$A\JZA8L%(SRHX<$'G\.*].U#2;'51"+V#S#
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MX9TO4=:.HVMS8M8*]O&\OG,LQD5?.!"(/+Q("1[#& :[ >'=(%ZUY_9\)G:
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MFYD59%4\*Q^;@98CCJ?<U/HFFMIUG*9EA%W=3/<W)A'RF1O3IG "KDC)VY-
M&'=7M]K/B?6]#M=3?39;*RADMG158L\F_P#>,"/F52JC;P.N>HQG7=[]E\;7
M-\]_!&8_"WFF\*9C4B4GS-N?N]\9Z5T^K>%M#UR\@O-2TZ*XN(%*I(V0=IYV
MG!&Y?]DY'M4MQX>TJ[O9;NXLUDFFMC:2%F8JT)ZH5SC;STQ0!QUKJWB#^T=2
MT^WNW:5M"CN[5K_8O^D,SIOX&%#$*=ISCT'(HA\0:M=V%]'8PZB-4M;B 76D
MWCQI.L9#%A#)]U]P5B#G^%N1QCI8O!7AR$?)I<63;FU+%F+&+^Z23D^GJ!QT
MJTWAO2F4AH)&<R)(96GD,NY00IW[MW )QSW/K0!!X2U2/5]"%Q'<74S+/+&X
MO(A'-$P<_NW4=U&%]\9YS6Y5>SL;;3X##:Q"-"S.W))9F.2Q)Y))ZDU8H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ JIJ&HVVF0I)<N1YDBQ1(HRTCMT51W/\@"3P#5NN<\6:/>ZB
MVD7VG;'NM+OENA [;1,NUD=<]FVN2">,CWS0 ZX\::-9Z?>WEU+-"+"98+J)
MH6,D+MC;N !P#D8;[ISUK5TW4HM4MFGAAN8E61H]MS T39!QG:P!P>QKB=>\
M*ZIJ=MXCO;>U"WFK-9I%;/*HV) X;<Y!(R<L,#/1??'H*$LBL5*DC)4XR/;B
M@#)@\2:?<'<&D6W\J69;EUQ$R1D!SN[8)[XR,D9%5I/&6DV\ES'<FZMW@M#?
M;)+=]SP#@NH )..XZC/(%<N? ]_="_@MEDT>VU*RN8=0MUG$EN\T@PLD29)0
MY)+?=].>M6X-(UV[\.ZC:WGAS2;*^:PEM1-:R*QN)&7;N!VC8G<@DG\N0#1G
M\6Z7J$6GO'<ZI9QRWUO'#(MFZK<%\%5W,I!1@>2".G!K2O/%.F6%PL<[RK$;
ME;0W(C)B29N A;MR0,] >"0:QM1T75+CPUX7M([0&XT^[M)KE/-7 6+&[!SR
M3CC]<55L?#NK:?KFH6K:+I5[87=])>0ZE,R^9 )&WLC(5)8@D[2#CIG% '4V
M^O6EU=I!"LS*\LD"3!/W;/&6#KGL058<XS@XS5B_U.VT[R%F+-+<2>5!"@R\
MKX)P!] 22>  2:Y73_#E_:^+DU2T@DTV.2XG;48DN UO=J0WEN(\G;*3L).!
M_%US6EXDTB^N=8T+6M/59I=+GD,ELSA?-CD0HVTGC<.",X!Y&10!3\1>-(K7
MP5J^JZ4)&NK,M T;Q'=;S=/G4],9!]#D=0:W-'M9K<7$\E]>303L'CAO% :#
M PPSC."><'IVXKD]9\)ZG>Z%XM>WMU^WZ]+$8[=I0%B5$1!N;ID["3C/4#G&
M:[U&=X0S1F-R/N,02#^!Q0!S]WXSL;?1+G5(K:[G@BL7OXBL?$\2@'<IZ=P>
M<$#G%3V_B6"6RL6>"X:\NK?[0+6.(E]@QN;!Z+DC&3SGC-<G:^#-333]5M+*
M)M,M-0TB>WET][CS+=+MQ@/" 243ELCCJ/EXK1L=(UNPUS2]<:R20C2ETV[L
MXYU+1E6W*ZEL*>2P(R.V,XH WXO$^EW5E975E*UV+T,;>.%"7?;][@XV[>AW
M8P>.I K"E\3I>^(_"]Y8:BXT>]@O'F1U"*3$HY;< P*G<#DXXK.M_">N^';G
M2]7TN&WO;J.2]-Y9-/Y:E+F428C<C&4*J.1R,]*L>)_"VJ^*+W1&ND^SBWCN
M&FEM9AF"1]IBVYQOVE!G( /IS@ '::??)J5E'=1131QR#*B:,HQ'K@\C\:SK
MWQ7I>GFX:>23[/:RK#<W*QDQ0.V,!V[?>7)Z#/)%6- EU:71X/[<MHH-15=L
MWDN&1R/XE],]<'ITYZUR<_A;5AI7BGP^D4<MIK5S-/!>&08@$V-X=3SE3DKC
M.> =M %W5M4N]0\9GPW!/?64?]G&X6YMHQD2EPJMD@@J #QT)//2M37_ ! ?
M#D&EI)!/=RWEW%:;XT[GJQ [X!P!W]JJV^D7MMX]COTMR=.CTE;%93(N[>)-
MV2,YQCOUSVJ;Q=I=]J5OI4FGQ1S36.I0W;1/)LWJN00#@\_-G\* ,6W\8+H_
MB#Q0FL7-Y+96MU;K&WV<LMM&\,;'<57"KN<\GGZX-='JWB?3M&6X>Z,QBM0K
M74L<9=;<-T+X_/C) Y.!S7*:QX9UO4+'QQ#'9H)-:\G[+^^7;\L*1G<>PRI(
MXZ8^E6+G0M8@\4ZC>0Z%IFIV6K"*1C>2*KV<BQK&01M;>A"J<*>N?K0!U6N:
MS;Z'X=OM9E_>06ENT^$/WP!D 'WX'XUE:7:Z[J?AV"_GUJ6VU*[MQ,L<449@
M@9AD)M*DL!D DG)YY';5U?18-:\.7>BW)Q#=6[0,R#&W(QD#MCJ*RM!;Q%IV
MDVVE7VFQ37%M&L*WT<ZB&55& [ _.I('( //>@"U-XCMM,MG2^\Z6>SMTEOS
M;QF00 C[S8^A.!DX&<8J.\\::/:7D=H&NKF:6V6[C6TM9)M\3, '4J#D<CIT
MK._L75].UWQ!/!!'?V^M0QD,9 GDS+'Y9W _P$!3E<D<C!J/0/"][H/B'20J
M>=86.AKIIN"X!:0.K9VYSM^4_P">: +O_"PO#XF1#)=K&;LV33M9R+%%,&V[
M'8KA23QS_(BKUYXKTJQ:9IY)!;03K;SW0C)BAD.,*S=N6 )Z GDBN*T[2[OQ
M'X=\1:&MMM@N/$5R7NBZ[41;G>W'WMWRD#C'(.:T)_">JMH?B3PUY226FKW<
MT\-[Y@Q$DS;G#J>=RG=C&0>,D<T =%)XPTI-9GTH"\>ZMY(XY]EI(5BW@E69
ML8"X'WNGOUPEKXPTR]'^CK<NSV1O[=?*(-Q "!N3\2O!P>1Q533M)U.S\2>)
M;J*)8X[R"!+.61PWS1QLN6 YQD@_3/2L?1/#OB!->TS4=0LH$<:3-8WDS7GF
M.TK-&V\#;C:2APHP #VZ4 :5EXKMM9TSPQ?S2WVG2:E,IAA2+*S$Q,VQF*D;
M<9.<@DKQ6K/XKTJWD_>22"W%S]D:Z\L^2LV=NPMV^;Y<] >,YXKF+#P[KL.@
M>"[&>QB$NB74;3F.X#!HTA>/<,@<DOG'H.N>*0^$-4?PMJ/A&6-6LKF^::*_
M$@^6%YO.8,OWO,!+ 8&#P<B@#>O/'>B6,U]',UW_ *!,D-VXM)"L!8 AF..%
MPPY_+.#707-Q#9VLUS<2"."%&DD<]%4#)/Y"N!UKPSK-_8^.;>&T7=K31_9"
MTJ@86)(R6YXY0GOP17:ZFM_<:%>+IY2#4)+9Q;^< 524J=N[J" <>M &='XQ
MTEHKJ20W,7V>S6_97@8LUNV<2*!DD?*>.H[@4[3?%VE:K?16D#7"236OVN%I
MH&C66+C+*Q&#C<N?K7)IX:\0-=7UT^FQ(UYH!L'W7WF2&?+<L2.0=P[\ ?A5
MI_"VJ7CZ'#+"8(K?0KC3;B42*2DDBQJ&49Y \LG\1[T 6;SQ,]YXO\)1Z?/=
MKI]_)<%LQ 17*+ [*P.,]0".1D8(!'-;/]LQP7UW/<2N87N$L;2%!N,LB@LV
MT>N2P/8"(DX&:YBSTCQ2I\)"XTJUW:#YD<KK=C;./(:)608R,Y!P<8_6M34O
M#FH)%X;OK(I/?:1<-//$S;1<>8C+,03P&R[,,\=N,T 7Y_&NBVVGSWEQ+-&M
MM<K:7$9@8O#*Q 4, . =RX;H<C!-:VFZC%JEF+F*&YB4NR;+F!HGRI(/RL <
M<<5Q.L>%-3OH=;OH+4"[U2_L9A;M*H\N.V:,_,<XW':W3/5>>M>@#YD&05R.
M0>HH Y!?$45_X.U3Q%<WMS9Z:RS+!+:Q[WBB1BGF@8.6)4MDC &/<G274[3_
M (26UM/M]\T_]FO.+;ROW<B;D'F$A>7&0, ]SQ7,Z9HEZ?A%J7A**,-J4$-S
MI^UF"CYBVQR3_"496_'UK9BTO45\8Z9JC69%M;Z1):2?O%W"1GC8 #/(^0C/
MN* *Y\0QV/@B#Q+9ZA=W]C;NS3O=(%>6'S2KG&T8*<D<#(7!ZY'4ZA?QZ?I=
MQ?LDDT<$32E8AEF &>*X*?1=1L_@_-X;G@5=3O/,M(HU<,&::5B"".P5BQ]
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M-3?5+:_ALII,*R0Q>5L=AD!F#.<C('R^F: +FO>)S<P:>^EW=Q;2PZ]:V%[
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MNVEL;(7S6YCP[PL&*LO;!VM[C'(%9^IZ/X@D\1:EJ&GB%9I-"^Q6]S(5V_:
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MRE\@0^8LRYR$.[CC"_.!CI7-&UN;_P"&&A:S?ZQJES<7=SIWFJ]TP0?Z2H)
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MBTU'1+J9;6-)"$1(HU= R='$G)^8'[W'04 >D4UI$1D5W56<[4!.-QP3@>O
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MRG((IU<O\.8TC^'>@;'=R]A [;Y"^"8UX&2<#V'%=10 4444 %%%% !1110
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M?8T98TC4D@#<2<DMD_0#MDZ5[8VNHVKVM[;17$#XW1RH&4X.1P?0\UY]X?\
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M2&_C>6"W)1),(0'SO8*-I(!YZGO5_1==L_$&AQ:MIWF2P2AMJ$!7W*2"I!.
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MECQP3RQQDX]*YIO$>H7&K>"]0:"_7[?8W$DUC RD3-Y4;*0-VW&6."Q&.^*
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M[4(YIM.N8K=4:9XV5!(Q5<D8Y(!Q^52Q6\$#2-##'&96WR%% WMZG'4^]24
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M9BJKN&,D@$_I63/X=UB;5]:O=MB%O]'CL(U^T/E9%\S)/R?=_>?7CIS78T4
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M$D@\'GH>M3WNAZJ/$NF^(;62WFNH;>6TNK>1C&CQ.RL-C '!5E'4<CTKJ**
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+RW-TR[Q")5WE?7;G./>@"S145O<V]U&7MYXYD#%2T;A@&'4<=Q4M !1110
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MC<1A@> >*@UBVFOX?%).CZ@ZW.N:?<0JUC(2\2BWWL!MZ81LCJ.AP>*]=HH
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MN=,=?#_B PZ1=BZ?Q/%<0[;&3>T0FA;>ORY*@*YR..OK7K.<KN )XR!TI:*
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MT\8D $,PV_O(R!D-E%/)(XZ<G.E8:+%9WTM_+<37=])$L#7$^T,(U)(4!5
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M-BDN)X2&7Y@0"KJ2#GN,]Z[:_P#.T;0M0OK*PBN=1\LS.EM#M-Q(% SMSDG
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M&4R7SEL#U-9>E6VH:19^&IM2T/69[$Z%%I\T5F)!+;3*<G>B,#M8'&>VT9H
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MUC3=-<+?7]M;,5W8EE"_+G&>>@SQFLOP-9_8O!.BPR6C6US%8PQ3H\6QPZH
M0<CUS^?O7,^.[?4;V?Q!96VD7;&YT0Q07%I '-R_[S]V[G[H7((7@MN/)X%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:ZX/!'!!# Y]ZI:SXOCT6>;[183_ &6">"WDG8A=S2D >6#]\+N&[!XYZX-
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ME8^KA=PSCISC.#0!U-%<Y8^*9=0U^[TRWT6\V65U]FN;EGC"1YC$BMC=D@Y
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M'<\@C\ZZQB0I(4L0.@ZFL+1_$<VN:-8ZE::7+LN+J2"5&E0&!4=T+GGYN4'
MR?F]J *OA[PK_8^N7FIK':V?VN%$FM;+<(9)023-M( 5CG&!^)-37>A7D/BW
M_A(=,E@,DUH+2YMYR0KA6+(X8 X(+,,8Y![8KHJ* .-_X0NXM-/\/6EE<0,-
M+OVOYGE!4S.WF;@ ,[03*Q'7& .:Z+7M,_MKP[J6E>;Y1O;66W\S&=F]"N<=
M\9JU=W4%C:37=U*L5O"ADDD8\*H&234U '*6'A[5[;7[#5;B>RE>VTMK!DC#
MH&)9&##.>/D _$GVJGI7@S4-.L_"5NUS:O\ V%)(SL-P\X,CIP,<8#Y[]*[>
MB@#DM-\)36_B>#7)OLD%VD4D5U+9@K]NW8VF5< 97&<\DD]AQ6UJ5OJCWUI<
MZ=<0*D*R+-;SAMLP;;CD?=(P><'J1CFK&IZC;:1I5WJ5XQ6VM86FE(&2%49.
M!Z\5!IFHWEY-<)=Z8]HL:H\<OFJZ2JP)X(P01C!!'<8)H Y>X\ SW,>JWL5Y
M!8:O>WL%]"UNA:&"2$87(.-^[YMQP,[NG'-K4O#?B#6=*MI;S5;*'6K.[CN[
M1K>!OLZ,@8;64MN8,'8$Y'48''.I-XFMEU30K2")KB'6!(8;I&&P!8S)]3D#
MT[UN4 <KJ7A_6M7TJS-U?V?]I6U_#>KLA80#RS]P#.[GGG/4]A574_!$^LW'
MB,7EW&D.KVMM"KPJ=\+PEBKX/!^9LXSVQDYS7:5AV_B,:C<W4>E6,U[#:2F&
M:X5U1#(OWD3)^8CH>@SQG@X *4_AW4=2NX]0U*2T^W6UA-:0"'=L+2[=\AR,
MC[@PO..>3GB#3O"E_93^$V>>V9-"LGM),;LS;D1-PXX^X#CGKCMFNCTK45U7
M3UNU@FM\O)&8IU =2CLAR 2.JGO5V@"IJEO+=Z5=VT)0230M&I<G W#&3CZU
M6T'3[G1_#&GZ8YBEGLK6.W#*2%?8H4'ID9Q[X]ZU** .4TS2=7\,_#]=,M;B
MU;4;5"(9C$\B-E\\H,-GDC /H:VKJP.M>')M/U)/+:]M##<+&<[2Z88 ^V3B
MM&B@#C8/#_BR7P[=:3?^(;96%HUM:W=I R2DD8620ENH'9<<G.>E49OA]>ZA
M_:"7=[96T-[I<-D4LK=E\F2-W='7+<C<V>>N.W6NQN=1/V.[DTV#^T+BV?RV
M@CD5"7X)7<W (#9_3K5^@#CK_P /^)=;\):EI6K:EI[7-U;&V1[>%TC /61@
M226]A@#GUK1M]$O4\8KK<KVXB_LU;)HE)+;@^_=G'3G&/Q]JZ"B@#"U71KJ]
M\3:'JD,D(BT[SBZ.3ND\Q-O! XQU]_:L&T\$:A9366H17=M_:%EJ-Y=Q@[O+
MDBN6+/&W&01D889^[TYKNZ* .+N_!EU.KW"3VXO;C6(-4N"=VS]UM"QKWZ(!
MN/<DX[!=2\(ZA?IXO07%JBZ_"D*$[CY.(O+R>/FXY[>GO79U#-=06\MO%+*J
M27#F.)2>78*6('_ 58_A0!S;>'=1;7O[2\VUQ_9!T[R\M]XMNWYQTR,8_6JE
MCX-O;>/PI#-/;21:)9R6DN"P,X:,1Y''R\+GOUQ[UVM9.CZXNK7VKV@M9('T
MVZ%L^]@=Y**X88[8<4 8FA^%];L=+_L'4M5MKK1(8&MH?+A9;B2(J559&SM^
M53U R<#WS;\,:/XBTF&"QU35K2[LK)/*MVA@9)I5 POFDL1P/0<G!SZZ'B/7
M%\.Z3_:#VLEPGGQ0D(P&WS)%0$Y[98=,U=2>X;49H&LV2V2-&2Y\Q2)&).5V
M]1C Y/!W>U &7X@T2[U/4-%OK*YAAGTVZ:;$T9975HGC(X(Y ?(^E8=SX,U*
M?1]8L1<V@;4-734E?YL(%>-]A&.3^Z S_M=..>YHH X34/!>LWM[=3#4K$[]
M4M]0A>:!GD18V1O))W#Y!M.,>IZ9)K=T;1+O2M=UJ[:YADM-1G6Y"",B17\M
M$()SC'R9Z=_;G>JM9SW$XG-S9M;%)F2,-(K>8@/#\= ?0\B@#E/$_@_4]=N]
M6,6H6HMK_3?L:+<0L[6S8;)CP0 &W#<>ORCKBNKM([B#3HHY6BDN$C"L5!1&
M8#\2!^=6:* .:;PI%J?@X:!K(C? ^6:W)!1@<K(A/*L#_+WQ52#PC>Z>WAR]
MM+R*74-)LOL,WG JEU$0N>1DJ=R!@<'N*["JUS/<17%JD-FT\<LA6:02*HA7
M:3N(/+<@# YYS0!RLW@JY6VMI;6\@34$UHZQ,TD9,;NRLA4 $' 5@ <\[>V>
M(K_P1>Z@VOR&_BM[B^O+:^LYHU+&"6!452P/W@?+!/U(]ZZFXU$_8[J738/[
M0GMY/*:".14);(R-S<9 .?PQUJ_0!R.K>']?U[PE?Z;J-]8"]NU1 8(G6&)5
M;.0"2S$_4=O3EUYX:U&ZU/7[P2VJC5=-CL53<Q\HJ)/F)QR/WAXXZ#UXZRB@
M#RG65.G:KI>F3:IHME<V.D+:L^H/+;K<!C@^7(KJ6'[L$J<@;AU/3T#PU)-)
MX?M?.M;:V**8TCM<B+8I*J4! (4@ @>GKUH75WO-/-[IMBU[%YRI%B14\Q=^
MUI%+<;1R1_>QQU!.M0!Q^L>&=7USP_>Z!J%Q87%I=R/_ *2Z-YD,;.6 "'(9
ME! #9'0''J:CX);4=0UM9+M!INKZ=%9S(4)E0QAPK*V<?QYY!^[[UV%% ')'
MPI=:L=/_ .$@G@E^P6LUNK6^09FE3RVD.?N_+N^49Y;KQ2Z)H7B/3](&EWVJ
M65U;VMN;>U:.%D>4;=JF4Y(X'91R><UUE% '#^%?!FH^$I+,6-S:FV^QQP7U
MO\P6:5%"K,G'R,5 #=<\=QFBQ\&:E::5X<LFN;5CI&HO>.XW#S0WF?*!C@_O
M3SS]WWX[BD)PI(!)'8=Z .*@\#W$>A2>&9+F%]#-Z+E#@^<L?G";R2.A^;C=
MGIQC/--U7P/>ZI=:[<"^AMY;RZM;RSD52Q@EMPH7<.-P.WGIC/?K71^'=<7Q
M#I U!+:2W'GS0F.1@6!CD:,YQQU6M6@#AKWP7JFN7>K7&J7]I =0TZ&TQ9QL
M3%)&[NK@L><,P.,>WN9K_P />)M<\):EI.KZGIS7%U;&V1[:!T0 ]9&!));C
MH, <]<\=G10!' )!!&)@HD"C=L.1GVS4E%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<;\1"JV>
MA,]S-;QMK-K'(\<[1?(S$$$@C_ZW:NRK$\2Z#+K\6GQI=1P+:7L5V1)!Y@DV
M'(7[PP#^- 'F^OVG]CZ9XSMK&\N8M(AGL&MR+E\0SLX\Y58GI@H2I)'S5TTM
MG8Z=XYL-&N$*Z'=6,\\*7$S21RW9D4MDN3DA,D#MEB*[<6ELL"P"WA$2\J@0
M;1]!2RVMO/"(9H(I(AC".@*C'3@T >36BS7$_A2VU.^NFL9-6U"VMW:Z=?/M
M0DHBW'/S9P #U(QSS3K*2XTG4+?3I)Y7\)'Q#-;K)+(64)Y'R1%B>8_/++R<
M97!KO]:\.MJ^L:->_:(4ATV21S;R6_F"7?&4(SN  PWH:V3;PFW^SF&,P[=O
MEE1MQZ8Z8H \TDBO1-KFGZ?J%M#8)JT TU+TEK>5_*WRVY(Z)NS@#@-QCM55
M=?A!T6VU6*'1])D>_@G2\/G6PNUE&%WY4;,>;LSQVQD#'J9M+9K<6[6\1A P
M(R@V@?3I0]I;26XMWMXF@  $90%>.G'2@#S"^ADL]%L38:G!KUM:6-P[VU_*
M8WN("_\ K8).?F0#:K'/RD'/.3O^._)U'X/ZK-Y$FQ],\Y$F7YU^4,-P]1_,
M5V$MI;3[/-MXI-F"N] =N.F/2I2 RE6 ((P0>] 'G\,^F7OB]M-NVMSHC:2L
MNG .!"[;W$S*<XWCY.1R!R,9-;/@A[ZY\ V!U>:5YFBD!FD8J[Q;V$;%NN2F
MTYZ\YKHI+2VFC2.6WB=$(**R A<=,#M4K*KJ58 J1@@C@T >0^$S'!!\.;]+
MJ5KJ^$\-P[W#-YJB&1@I!.,!E4_7W-3V-U<W?A70M2AE9?%8U=(;Q-V)&8S$
M31..NP1Y(!X 4$8P*]2%G; J1;PC:<C"#BE%M MPUPL,8F88:0*-Q'H3UH \
MAU)($\.^*]0%Y.+NQ\2(MM-]K<F$%X 0,MZ%A]/I6M>I;Z=JGCJPM;F6*W&B
M17047+Y64B8%P<Y!.U,G//&:]&^QVN"/LT."<D;!R:7[);$G_1XN1@_(.10!
MYIIUM9ZMXBT:UO;B26WF\*)))%]J<*QW1C<0&],_S[5FV.L6U_X5\.0:A>[[
MR30)9 UY-^Y8@JNX#J\X(P.00"QZFO7!9VH/%M#TQ]P=*<+6W79B"(;"2N$'
MRD]<>E 'E>B7-G>:WX$U*ZF@GNKCPXZB>5P3+<*;?"[N[!BW'7.:L^"[NSUB
MXT.^?7%77H5>/4+&)-L\DFTB03@L3M5AD$@ < 8R!7I@@A41A8D C^YA1\O;
MCTH2WACF>9(8UEDQO<* S8]3WH XSQW;6,VO>#_M21,SZJ4.\]5\B;CZ9Q^E
M86I7#W6C>-GN97AU_3[N3^SMK8EC4*IMA$/[KGC ^\2P.:]0DMX9B#+#&Y'0
MLH.*1K:!YTG>&-ID&%D* LH]CVH X/2;"'4_B-K"ZG)*]Q:VVG7*PK=.%CF'
MFEB%#=,@<=.>G-3>+]2M[?Q9I]CK-W:VFD7-E+Y<EXF8&G#+D,=R@-MY4D^N
M.:[=8(5E,JQ()#U<*,G\:)K>&YC\N>&.5,YVR*&&?H: //(%6T\0>!+>+4I=
M1*6E^L-S<G#S@*FUCZ@C&#W'-9WAJ^CU6UTS4;?64_X2BWMYENM/CCVS2S;"
M'6X4L3M5QD$@ < 8R!7JC00O(LC1(SK]UBH)'XT);PQS/,D,:RR8WN% 9L>I
M[T >=^%YO#^OZ7IEQ%?23ZNVG/#J%JLF7D<J/,-RG7(<$ G'+8'!K)\-S64>
M@_#(V=RBLTXCN$BFX+_99,AU!P6R%Z\CBO6H[>&*222.*-'D.795 +'W/>F_
M9;?Y?]'B^4Y7Y!P<YX_&@#RPW5U=^$)+])&3QC;ZUY14-B3>;G BQWC\DCCI
MM^;MFJVO+#'8>/+\7<XN=.U2![5S=/\ N6\N \?-ZEA^8KUW[-!]H^T>3'Y^
M-OF;1NQZ9ZTAL[4YS;0G<<GY!R: .=\?WUU8>#Y[JT:1466'[1)"3N2W,B^:
MP(Y'R;N1T&3VKF/$ 6UN_$BZ1<>7I#>&Y;B86TI6..X&?*92I^5F4-G'7:":
M]."J$"!0% P !QBHDL[6* P1VT*1$Y,:H I/TH Q?".FV5IX>MKBV:1GO;>*
M6>5IW?>WE@;ADG''IBO/['98?#N?Q#;SW,ES%?S6]U<>?)*8[3[<?,^7=SA!
MG/7!)!&:]>6-$C\M454Z;0,#\J;'!#$I6.)$4]0J@ T <5H>4.J7?A+4M.U8
M7#0L;<2F*S@."#L*!\,1@E?H3C/-'7]3<>(;/3_%EQIVFVMSIKE&E9GMO/WD
M, [%,.$V$$@$9;'OZ'#!#;1".")(HQT5%"C\A1-;PW*!)X8Y5!# .H8 ^O-
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ML_AAY&L)+%[>XN(Y;<2>:%=9&W>6P^\N<XXXZ=JXOPGJ]D_BGPQ)9W\9@O\
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M#R/+I<9EF\PAB?+&26!SGWS71M;0.Y=X(V<C!8H"33A#$L1B6)!&>J!1C\J
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M^'((;?4I=2ME9_)NI#G>FXX"G)RHZ Y.0!R1S6Y2 !5"J  . !VI: "BBB@
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M*5(8DC![XJY=^%M7CURVUK2M;BCOS:BTO/M=J98YU#%PP564JREFQSC!QVH
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MR21QL^Q51,;F9L$@991P#DGZD8WA+3K.35M7\0V+3&RU"4/:K(A51E5,KHK
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MP L".0.&Y'H:LZA;:7HLWBB?3;8-X:FALA+':N5@%R92';*Y 4)L,F!R#@T
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MBSN%X\L.#N'0G(.,Y !ZC?SW45B\MA!%<S@KMCDE\M2,C)W8.,#)Z<XQ5DL
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M/@$]U9RW-HT4Y*.T0!>)B5R" 00V#GG@8Y .HHKA+'Q]>L- O-5TB&STK6X
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M'CW&5IB"[,01R2,\#J3^&GH&LQZSH.GW[F*.:YLXKJ2$/GR]Z!OKCGK6B+B
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M4LY(8YH)8)BYRPRR,".J\<]#GH*S]0\8P)%I\VEB"]@N-533I9!+CRR7*E@
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MKTI#/"-^94&S[WS#Y?KZ4 >?Z?I5[IOCRSL+2\4"T\/1V?VB2T9D<K(<#A@
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MM0N?M-KK%Q+<2!(_+:,OC.TY/3 (]_6DN-!EBA74=5OQ?7-A8S06[K!Y?WP
MS,,G<YVJ.,#DX'-6G\1&/Q@FCO' MFVG/>BZ\[NLB)@C& /FZY-;<MQ###YT
MLT<<7]]V 7\Z .'\'>'6U'PCX6;5Y1+'I]FA2T: QE)#%Y9$F2<E59EQ@=<F
MM+3O!BV=II>GSW[7.FZ3.)K*)HL.I4$1AWS\P7=Q@#HN<XYO^(-=ET=M(\FW
MCGCO[^*T=S(1L#Y^8  [NGJ*9XM\1'PWHLM[#'!/.C1_N))MA*LX0L!@DXW=
M./K0!0F\#0:C<I/J]REVZV<UD9$@\J66*0;2)'W'=@=.!SSUIL'@FXGT&ZT7
M7-?NM4LI+8VL2M$D3(AX#,1]]Q@88_ES75O<0QRI%)-&DDGW$9@"WT'>C[1#
MYHB\V/S"<!-PSG&<8^G- '-:?X5U"'6M,U2_UUKR:PM9;50+58_-1RARQR?F
M^09(QGT'?;UG3SJVB7VFB;R?M<#P&3;NVA@5)QD<X)JW--%;Q&6:5(XQU9V
M _$UF:_KUOH6DB]?;(9)8H85WX#M(ZHO/IE@2?3- &5)X*CNIK,WEVLUO!I4
MFER0B';YL<@4,<[N#\B_K^$UAX5EMSI7VW4?M@TA&6R+0[6!*; TAW?.P4D<
M;>I.,XQK:7/J$T,QU*"WB9)2(GMY=Z2QX!#\C*GDC'/3KS5G[7;&-Y/M$6Q
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M3O#T<&H[;[04\JUN3#D/&4",CINY! '0CD BNH2YMY(5FCGB:)CA75P5)SC
M/UIT4T4REHI$D4$J2C @$=10!R]SX+$\2LM\$NGU2/5+B8P9$LB8VJ!N^50%
M48R3@=<\U=G\.RR^([O6%O55KBP%CY1AR% 9F#9W<G+'\,5>GU1%UF#2H5$E
MR\9GDR<"*('&3[D\ =\'TJM%KKR>,+C0&LR@BLENUG,@.\,Y3&W''*GO0!G6
M'@U[$>&%&HAUT&%H8P8,&93'Y?/S<';Z=_RKIYHEFADB?.UU*G'H1BN7N?&L
M=O'J%^+4-I.G7@LKFY\W#!LJKLJXY5&8 \@\-@<#.U%JB_VW)I4ZB.X\K[1
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M4DJBC^$%B223]2    5O NK7&L^$[:>\<O=0R2VLSG^-HI&CW?4[0?QJG?\
MBZ\T_6[>UFM;<13:FE@(@^Z0(ZY68E20N3P$8 D#.>U:_A;1#X>\.VNG.ZR3
M+NDG=>C2NQ=R/;<QQ[8K'F\!++/*RZU?1Q-JHU6.-4C/ERYR>2I)'H#T]^*
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M@#).,G-"^#+F7P_?:3J'B._OTN;5K-)9DC#11,,'[H&YB,?,V>GUR 0CQ1K
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M3[RNT@')4''J<5TEC;/J?Q'FUZ%9!80:2MDDCH4\R1I=[8! )"A5R?5L=0<
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M#(H=)(V#*RGD$$=14E<'I_B;5KF'PE::?::9;KK&D&ZY5]D#*D9PJ@CY?WF
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M9R3R+NCB69=SKR05&<D<'D<<&J'BCQ+#H TZ$SP13W]VENK3,,1J02SD9&0
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M!Z "HIM9TRWO5LYK^VCN694$32 -N;[JX]3V'>K<TT5O"\TTB1Q1J6=W8!5
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ME8:GJ.FO) EO<QVLB[;F-!A=VY20P'&Y2&QWK=L=2L=4A>:PNX+J))&C9X9
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M6C);J'F83+B-3T8\\ ]CTH QYO!:WFB2:=?ZYJET\DD3O=2&/S,1.'10 FT
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M&8M$BCE< X4')/J1S75>#XM7@NM1AO[B:^LT$0M+ZZMC!<2##920$#=MX^;
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MQ,&5@#C@CKR* .?^'=M<67@'2+2[MYK>X@A*/%,A1E(8\8/MBNHHHH ****
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M&']X&XD(+EBP)9B5!))ZCW-6=#T6VT#2TT^T>9X$=W7S6!(+L6;D ?Q$G\:
M/-3/J=WX.TV>[O5NK@^*T2-GCVX*WKJ,X/3@<#& ,5O_ /"7:II\FKZ?>&"Z
MO+;4[:QMYHHO+5A.J,,J7ZKN8?>&<#IUK7/@?3!#Y,<]['$-0_M%(Q-E4FWF
M3Y00<#>2<=\\\8%/N_!6DZ@NKK>&XF757CDN 7 VO& $9"H!4@*N,>E $^@S
MZX]UJ$.KVZK!&Z&SFR@>1".0ZJS $,",]P1QUK(_X2JXB\8G2+Z3[ QN"+>*
M>W.R[@$><Q2C@R;NJGL,8[UT&C:+#HMNT:75Y=ROC?<7LYED8#H,GL,G@>I/
M4FH&\-6DEW'--/<S1QW9O([>1@42;GYAQN[DXSC)Z4 <_IOB?7KZTTS7ELE;
M1;J![BY4^6#"FPLA0AR6/12"!G.1CI5[2]0U_4]/TS5TN+ 65_9&XDC*'= S
M*&C"'^,8)#9QTR,=*L:3X)TK1;MY;22]^S;V>.QDN&:VA9L[BD?0=3QR!DXQ
M3M#\&Z;X?D_T.6]:W3=Y%K-<,\-N&ZB-3TZD<YP"0,9- &/I/BO5=0B\$RR?
M9E_MRVD>Y41'Y76'>"OS<#/8YXJ@OB3Q1)X U;Q++<Z65MH+P+;_ &-R&>*5
MU!)\SH50C'T.3TKH+#P%I6G2Z:\-SJ!_LQG-DKW)*PJPV[0,<J >^??.!5A/
M!^GIX7N_#OGW36%T9?,!==^)&+. << EF_/C% &9#=:K<?$G[.+]%M1HJ7"P
MM#E59I"">H[J/PXXZU2T3Q=JFJ:;HEJL2+?W]O=7,KVT2X412A %5W YW ]3
MP#ZY'4?\(W:#5K?5%GNEO(;7[)O63 = <C<,8)!)/3OSFLQ_A]I!TO3[*.XO
MX7TZ1WM+J&XV3Q;SEP& Y!SR"#0!EW_BO7M'TRPDUZW33"\4HN;R*$W$$4P8
M"/S I)1&7D\\'C(QST/B+Q#_ &!X/N-: CN&CB0IM;Y'9RJJ<C^'+ Y]*<_A
M>U: 0QW=[%&;=K>4"4/YRL26+EP<L23\W7D^M7;C1-.N]";1)[5'TYH!;F Y
MQY8& ,]> !SUXH QCJNJV/BVVT*ZGAF34+*6>WN5AVF*2,J&#+G!4AP1WXP2
M>M4_AG!))X+T^YNGBGDWSF-S%ADS*^[YLGJ?I6]9>'X+.9;AKNZN;J.W-M%<
M7#*SQ1Y!(&% Y(!)().!DG%2:%HEOX>TJ/3;269[>(L4$S!BN6+'G SR3UH
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MI)0,FX[8PO!8L,G@'UV+SPAI]_I]S:SS7+-=W$=S<3AE$DKQE2F3MP -BX
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MO, =)<D;^V]QQ@YR<YJQXJ\-R?V9:1:=!=W%Q-K-M>W=PC+YI".NYR3@9"J
M !V  H Q?$NK:NWAKQWH&M/;7$MGI?VF"ZMX3$'CD5QAE+-@AD/?D5T%_P")
M+C1_$+Q3)#)I]OH$VHE5C(EW1L@(W9Q@@GC K3NO"EA?Z=J=K=2W,C:H@CNY
MRRB21 ,!>!A0 3P .I/4DU*?#5G)JL>HS2SS2I9M8E)"I1XF(+!AMYR0/RH
MSX;_ ,0+IZ:J]QI4EG-IK7&)28A%/M#* W.8\9R3R,9]JYS5O$%_>Z)XLTJ[
M9)HAX9:]CF$!B)9TE5@ >2F4R"0#]>#71V?@'1[32[G3#+?W%C- ]LEO<73.
ML$3#!6/^[QQGDC&,U)'X&TH2S27$U_=-/8'3IS/=,?-A^;@XQSAFZ8ZYZ\T
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MK # ZGL#@\\UOW^JZY<ZEJNCZ/*[7NG6T3I(R1;997#$>8"1A/E ^0 ]>>U
M'9 !0   !P *6L;5-1U&S\'W6I6]FD^I161F6VC;>K2A,[01]X9].M<K<>+]
M3TX:CJ,-S'J>CV>C"_:3R0"9SNQ%N7  X#8P2!UZB@#T.BN/;5=6L=?T*PFO
M1=0:U!*#(L2J;>9(_,#)@<H1D8;)&!R:9X;UW4]4BMM/NKD#5K2\GBU+9&H7
M9&>"HQP&WQ$=\,?2@#LZ*X?1-<\0Z[#I&LV:H-.O=QN(Y_+"1(<A"A4[RP;
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MN\B$GYI-H+-@>P!JW7G/G7U]XC^'NIW=XLOVP3SM"L8"1EK5F 0CG !QR3G
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M<Q:]MHQ)+%Y;953T/3!S@XQZ'TH B.@67]LQZJGFQW4=J;1"CX58B0=H7IU
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M3$BM]WW(W'/.:],HH \TL-#UF'P[X6M9-)G6>RUV6[N%WQ_)$S3D-G=SQ*O
MR>M:QT6>/XA31V[I_9-XL>I7D/=;B,[4..P<A&^L!]:[6L[2M#TO0HYDTVSC
MMEFD,DFW)+,3W)Y[GCMF@#*\7:=J%S/H>HZ?"UR=,OQ<2VJL 98RCQL5R0"R
MA\@$C.#7/:YX:U34+7Q7J-K92>;J4EBT%HS*KN+=U9F/. 2,@ G^$9QFO1R0
M!DU2MM6L;O4[S3H)]]W9A&GCVD; ^=O)&#G:>GI0!R-Y8:K=>(?$-Z-(N%BO
M-"CM8<O&290924X;C_6+STZ\UE6>CZQI4MB]WX;N=4M+K1K6RG@BN(U>VEB5
ME*L"X5D;>>03T/'->H44 <?I&DW=EX[-Q_9@M[!=$M[)'B*^4CI)(Q11G=M
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M:9';V,4::7N^Q@?\LMRE6Q]033;KPUI5[?7=[/#*UQ=VWV2=A<2+NBY^7 ;
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MMEKN5G78P9 KEMRA2,@ @?F:FG\*:/<VYAFMY'S=+>&7SY%E,R@*'WA@V0H
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M?269(P/M1VY3(7)XEB// ^<=N-ZVO]1B\>MHT]Z9[1='6XPT2J3+YFPL2!W
MZ=.:TX/#>CVL.GPP6$21Z=*TUJH'$3L&#$?7>WY^PJ1]"L)-8?5FCE%\]O\
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M(VMK5O[3A94R+G=LV'CC#)*>,?P]C6K?:4EE=7FNZ7IPN=8DB5/+:Z:))MO
MSU4$ G#;<]LX-2:!I9TZVN9IH(8KR^N&NKE83E0[8 &<#.%"C.!D@GO0!A:J
M]RGQ0TS%]=+;II%U,;>,(58K)#D8*D\@XZYXX(YS0MO%&K/H/A?Q&+KSHM7O
M(8+BR\M-D:3$@;& W;D.,Y)SAN!QCLKO1-/OM4L]2GA8W=F&6&1963 8@D$
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MS+'!K M8)?LY*0HT<6P.R+M4;W(!;UJ73+'Q'HVLZK9QZ?;7.G:A>M>Q7K7
M'V??C>K)C+$$$KC@\9(K.U+PYK5SHGBVUBL"9=3U6*ZMLRH 8U$(.?FX/[IN
M/<>^ #O[JYBLK26YG+"*)"[E4+$ => "3^%8>F>.-"U:_L[.UN)O,OH//M6E
MMI(TG7:&.QF #$ \@'(Y]#6KJI)T.])4J3;2'!ZCY37">'='NO$/A?P(TML]
MK;Z;91S&<NI,F;;RU"8)(!W[CG'W0.>P!UR>*])>\M[42RAKF-Y+5O(?;<*@
MRWEG'S8'.!U'(R*K6/CG0]3ACFLY+F6.4(87^RR*LQ8D!4) #'Y3D=L'.,'&
M+X1T;5M*@LK'4?#>F*^EQF--3A:,O<JJE5*+@%&(QN+$=_7A-/\ #-TOPVT?
M0=5T<W,ENRI<11W"HZ8W$21.&&&!VD<CO0!U/_"0V!@@<>>9+B22**#R6$K-
M&2'^4C( (/)XZ<\C-5_&>A)9VET;J0Q75R;2/%O(6$PSF-@%RK<'@X/'&:YV
MP\/>(]-U#1=6FDFU)K(W=L\,TJ?:#;2LIC8MD*TB[%W<\@]21RC^%=3B>VN8
MK7?)/XD_MBXB$BCR8]A3;DG!;&TG'&2>>A(!V.CZW9:[!/+9-+^XF:":.:)H
MWCD !*LK $<$'Z$5>FD6&"21M^U%).Q2Q_  $GZ8KBHFUCPR/$VIKHYN1=ZF
MEQ%%]I1"T1CCC)'7YLH<+WR!UKM9698G94+L 2%4@%O;GB@#A[SQ2+7PYX9:
MQOKV^CU2YBA^WFV/F/&0S%L!<!CMQC&<$G'%=7IL4VG:7B^U&2Z";W^T7"+&
MPCR2 V,#Y1P3@9QDUQ5EX<UJU\)>"=.;3RUQI%W%+=A9DP%1'4[3GD_."/QK
MM=<TTZSX>U'3!(83>6LEN'_N;U*Y_#- %%_$EE>M<6%M<3VU\UHUS 9("A>/
MIO3>,'!(X/J,CFJ?AOQ'N\%:#=ZC)-=7]WIT=PZPQ%Y'^12[;5'3+#\2 .N*
MIZ#I^KBS8:CX7TRQO+>U:$W%L\;-<L1CY, ;%/4[CGH,=ZR+3PSKNDV?AFY7
M1+74WLM+73;VPFF0%2-I$D;'*GD$$'!P10!V7_"6Z.^GP7MO<-=0SV[74?V>
M-G8Q#JY &0!TYYSQUXJM;^,K&\\166F6B33076G_ &Y+I8V*%"RA<''3!)).
M .!UZ9)TG7M$\06FKZ7H]E/!-8"SN=/MYE@6W(D:160D ,/G8'@$]<=JLWFA
M:M<>*+>\:&$P7&CR:?</#)M%NS.K94$988R![@9Q0!L6_BC2KB_@LUG=)+F)
MI[9I8V1)T7&YD8C!P"#]#GIS6)<^)WN_&?A>#3[FY&GWXN&=6@VQW"K$65E8
MKGKSP>1@X(YK.TGPQJ]QH#Z'J6A:783PV,MF-7@9':7=&8PZ  ,A.03D]L<Y
MXET[3/$DM_X0:]TB* :,LL-U(+I&5P8?+#H!S@]<$ CI[T =IJ6IVFE6Z37<
MA59)4AC55+,\C'"J .I)-4X?$^F7%L)8I)&<W36?D^61)YZ@EDVGN "?3 SG
M%1>*X=6GTZV&D1"5UNXFN(Q((W>$'Y@C'[K=.<@XS@@X-<K;^$[XZ=J5CJ6A
MB6VN-::]C-M>XFA4Q\21N2I#JP Y.2"WX@'?V-[#J%HMS!O\MF9<2(48%6*D
M$'D<@U8K'\+VFIV&@06VK7+W-TCR 22$&0Q[SLWD<%]NW)'?/7K6Q0 4444
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M7 XZ9;D'BLK2-:U[6[OPO;W6JW%O]LBU"*Z-NB+YQ@D5%D7*G:6&3Z<\ =:
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M20R@@''<JH!.><50CU[5;FQG6QM=2-Y:WR"^TBYF5+E8C$?EAESAP6 <'.2
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M** "BBB@ JGJFDV&M6+66I6L=S;L0VQQT(.00>H(]1S5RN:\9Z_<:)9Z?;V
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M-$MW+K.N[,;#'RL-I&#R<<9JI+\1=&ACN6>UU8/:11SW,7]GR!X4<$[F&.
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M N1@*H520,G'4=2:I7?CFT6+1Y=/MI[M-1O6LSM3:T+JK%E9200XV$8]C[9
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M\Q ]^Y/ ' U:H:-K-EKVG+?6+LT19HV#J59'4E65@>A!!%7Z "BBB@ HHHH
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MQZ@ ]ZS-9\,ZU<MXVAMH;:2'7;94MY&GVE'\@1$,N.F1G.>G:N[ "J%4  #
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M;LR/#;%5E$*[V4G&,@=.HZ^M '*:EX<UJ^C\:C[+ KZW91V]OB<$*XB9&W'
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M^TEM+N".>WF4I)%(H974]00>M4I?#VCS);J^FVQ6W0QQ 1@;$/51C^$]QT-
M%+P1JE]K7@K2M1U(#[9/ #(RK@/@D!P.VX -^-8?A_49M;TJRU]M7GAO5O9X
M[FR#91R&=1;^63A2,*=V-W&3P37=(BQHJ(H5%&%51@ >@K.A\.Z-;:Q+J\.E
MVD>HR@[[I80)&SUY]3Z]Z .'LM:U.;PSX3\1P7L\MYJ-_#!>VY<F-UD9E= A
MX4QXX(P?D.<\U4N+S5X]%U'4EUW4/M%GXE%I%\Z[/*:XCC*LN,,-K'KTQQCG
M/H]OH>EVMXUW!86\<[.TA=4 ^=OO,/0GN1R>]0GPUHC6\D!TJT,,LWVB2,Q#
M:TN<[R.[9YSUH X'Q!J&JZ18^.[:UUB^Q86UK<VTLD@=XVD#[P&(X4[ <#IS
MC%:[KJ6E>-+G3_[4N[^PO='FNI4N6#>1*C*H*X VJP8_+T^6M/Q9X2CU?P_J
M]MIEK9PZCJ4(ADN)<KN4'C<0"3CL*V;;1[&&WD3[#!&9XPDRK\P*@<)DC)49
M.!P.>@H \_TV\GT'P3X%\0-=SKI4%E;P:C")"(UCDC55E(_V7(S[,?05W.A.
MZ:;#+>S.L]](TZ13R$L@8EEC /\ =7 ('<&JEYH5S(+;2+*+3K;PYY86> 1M
MYAPV=B ?*$(&#W&3BK^J:)::O<Z?/<Q1L]C.)XG*9=6&"-K?PYP,^HXH R_B
M)=W=AX#U6[L;N6UN(8PZ21$!A\PXS^-4;JSCD^,-C(9;@'^Q9Y,+.X&1/",8
M!QCU'0]ZZR_T^SU2S>TO[:*YMGQOBE4,K?4'K47]C:;]OCO_ +%#]LBC\I)]
MOSJG]T'KCCI0!C^,M7ETM-'B658(;[4%M9YFD,853&[ ;ARNYE5<^_8\USFM
MV][9Z/;VUYJ:WP3Q)8F$;B[6Z--&1&SGEB,YR><$9KT"_P!/L]5LI++4+6&Z
MM91AXID#*WU!JFGAK0X]-@TY-*LULK=Q)% (AL1P<A@/7/.>M '(M?ZEK5YK
M+V^L1:==:5J?E8>9L)$NW :$<,)%)P3SEN#P!5K2KZ773>7TFM36-W8:V]L\
M*ME/*238L)CS@[UP=V"V6X/ %=+-X;T2XUB+5YM*LY-1B "730@R+CIS[=O2
ME/AW1CK8UDZ7:'4P,?:O)'F=,?>]<<9].* /.[74&T'3=:GCNY4$_BAK.::>
MY<B*(LH))).WLN[J PYX%:6H7VIZ!+#93:R)+74M7MH%*RL\EE$ZL67S6Y.]
MDP">5W\'H:[1] T>3[=OTNS;[?\ \?>85/G]OGXY_&HHO"^A0:*^C1:19+IK
MG+VHA78Q]2.YX'/7@4 87A6V6T\=^,84EED4/9D>;(789B/&X\G\:S_'>JW5
MNNOMI^HW"W&FZ0+D11R>4EL^7*N2#^\9MH 0@@!3DC=SV>GZ%I.DRR3:?IUM
M;2RJ%DDBC 9P.@)ZFF7WAW1M3NC=7VEV=S.83 9)859C&<Y7)'3D_F: .1UO
M6=0L=22_NOM,FC$6RM<V$Y#64F06$L61O1MRY/) [5T_BR]&G^%[ZX-])8D*
MJ+<1QAW5F8* H) R20!DC!.:G7P[HR2*Z:;;(5"* L8 PGW 0.#M[9Z=JN7M
ME:ZE9RV=[;Q7%M*NV2*50RL/<&@#E_"=[>/XF\2Z;<R2>3:O;O##)<&9HM\>
M6&\\]0#C) ).#BEN;V35/'=]H,UU/:P6NF1W,*PRF-I6=W5GR.2%VJ,=,L<@
M\8WK'0])TR=Y[#3;6VF=%C9XH@K%1T!([4:AH6E:K<03W^GVUS-!GRGEC#%
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MFR@:WN,^?&Z!A*2,'=G[W  Y]*B_X1_2#8S6+:=;O;3 "6-TW"0#H&SU ]Z
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M3Q 7#XC$2Q!@3LY_U9 /?K@=*G\0>#-4UZ]\0OYMM;1ZC8VL-NXD9F26"1I
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M2.Q78P^4^:% (PV,DYXXQFZ)X5UW1H?"DK)8SS:1836,T2SLH8/Y>'5BG/\
MJ^00.O4XY )=3\2IK%OX5U+2;JZ@AGUI;6XA;,;<+)OCD7U#(.*V+GQKI-K?
M002&7RIKS["MRNTQB?)781NW?>!7.W&>]9+^#M0BM]+\AK5YTUU]8O2TC*N6
MWY1/E.<;P 3C.W/&>)-&T#7]&U*YLD72YM'DO)+J*[<M]HB5W,C1[-N&.YB
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M=-<& ".*4E57<2<X)8#(!QWQQ61>^%?$EYJ<=S+_ &;.]MK0OH+B6=]_V<9
MB"[,)M![$AB,G!.:=<^$M;FT/6;)5L1+>ZXFHQDW#8$:RQO@_)][]WCTYZT
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M[>/>+<S%OM%L7.YT"[2'^;.TDC&><XQ0!U.J:E;Z1IEQJ%UO\F!-S!%+,?8
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M<[DMO$8!4%!G_5Y.<=?;)TK>Q_L+5/$EYK%QIT6BZG.DHEGGVD$Q1Q%&# *
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MHCG#$,PSPK'"Y/'3D9X_6?.OO$NNI;PZ/+"\$%IJ5M-JC6K/M4L0W[MMRXD
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MV\*"Z=A$PC9#N/EC(^;/ [?C0!LW/B^SL;O^SDL=3N[E+%;T+%$&+Q9QG<6
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M<X5>2<D=^:OZAK%]IO\ PE&R\N?LB>(+.":9IF8VULZ0F0J2<J/F;ITW9&*
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M% !1110 4C*&4JP!4C!!Z&EK/U75X-)2V$BM)-=SK;V\*8S(Y!..>   Q)]
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MR(VYQC/YU8_X36S$-G>FVF&E7EU]DAOLJ5WEBBDKG(1F& WN,@ YH Z4 *
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MT>_^S:=?K97<V8\1EMF'QNRP_>+TR<=<=*=JGCJ/39];C_L:_G71D26[=#&
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M% &I;Z3IMI9265MI]I#:R9WP1PJJ-GKE0,'-68HHX(4AAC2.) %1$4 *!T
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M% !1110 4444 %%%% !1110 5A>)M!FUE=-N;.=(;[3;M;NW,@)1R 59&QR
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MNWISUM% ')OX;U*VU77+K3YK40ZW$GGI,6S;S!/++I@?."N/E.WD=>>*&I^
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M$1?*>?N_N@./7/'2N^HH Y#4?"-SK6L7T^H30?9;W1CIDHAW!P2Q8NN1C^+
M&>V?:I+/PYJ4DVARZK+:RR:(C^2T)8?:)#'Y8=@1\GRD\#=R>O&#U=% '#:=
MX-U.RTWPM://:,=%O)+B1@S?O0RR+@#'!_>'_OGWXZ3Q-IDVM^%]4TJW>-);
MVUDMP\F<+O4KGCKC/2M6B@#E8?#^I1>($U,M:%5T@:?Y>]L[PV[=G;T[8_\
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M.*4O(I<G(R<;=S +Q@]LUUO@NYG:?5K*]TV.QOK:6/SEMI?,MGW(-K19P5!
MR5(X)SWKI%L;-$V+:0!0GE[1&,;<YV_3/:GV]M!:1>5;01PQYSLC0*,_04 >
M6:YK5JFN-<V^H^5-;^);:"9[FX E5/W:NBJ,;8,$GG.26/'!KK?'VIRZ;H-I
M,LKQ64NH6T5].C%?*MF<;VW#[H/ )[!C72-9VKR/(UM"SN5+L4!+%>F3WQVJ
M62-)8VCD171AAE89!'H10!Y5=MIL&I?$9=-NTC']AP31_9KC;M94G.5*G@ [
M20..?>KD%E;ZUXMT2RO+J[:WF\-"9HH[R1 SB2+#?*PY^G7'->A)IUE'$8H[
M.W2,@*46)0"!T&,=J<EC:1R+(EK KJ,*RQ@$#V- 'FNCWL.L:G"]YKT=GKUG
MJ\BRV:*1<NHD8"(@O\T1C*G(7  W=035GPI?:9K<6G3W^I2Q^)H;N=+NUCFQ
M*[9=6CD3KY2C!'0#:"#Z^A"TMA=&Z%O%]H*[3-L&_'IGKBA;6W2Y>Y2WB6=P
M \H0!F'H3U- 'D>A7=OIWAW0;2-TBL9->N;?5-CXV+YL_E(_/RJSA <XSP#P
M>9]?-Q:+X@MH+VXATJWU?3!:-'<,HB>21//C4@_= (.WH-QX%>JFTMFCEC-O
M$8Y23(I08<GKD=Z;]@L_LZ6_V2#R4^Y'Y8VK]!T% &/;:=H&DZQI]G'=/'?+
M'.UK;RWKNSJ[!I#M9CNP?7..U=!5.;3+:?4+2\D0&2TW>3A1\I(*DYQGH2,9
MQSTZ8N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9W"$+M5>5(9LDD#[O&<\:=WH-I=ZU;ZN7N(KV"%H%>*4J&0D-AAT." >?UH
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M;O"6:59/(C;YLC;@-D<'D5M^#O#$L>CJFLPW4;1:E<7B6DLB-'N,SO&_RYZ
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M+["LJYVMG';)XZ<\U#)HG]H>(TU*^0-%:VLEK;QO@[O,(\QSCCD*H ]-WKP
M4O"EO:R>!-#OM2,<KFV34)9I>GFR(7=SVZNWTI/#WAV!++7FEMO)M=:NGG%I
MMVA(RBIDKV9MI<]QNP>11;^$5D\-VWAZ\N;Q+73V46TUK<&)I(U_U88CG*C
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M^5L G!*X)&3@UJU5T^PATVR2U@,C*N27ED+NY/)9F/))/>K5 !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %<UX\UJ_\.^$[C5=.:#SX9(5VSQEU8/*B'H0>-V?PKI:Y+XE6%WJW@>[
MTZQLY+NXGE@*Q(!R%F1VSD@?=4T .N-?U+2O&6D:)=O:WL6I1S-N@A:.2W,:
M[MS#<P*'IVYQUK7A\1:3<Z<VH0WBR6BR^2955B-^[;MZ==Q ^O%<G/H,TWC3
M0]1T#17T>.W9SJ-SM2%9X=O$113ESG!R1A<=:M6NC7-OX^O;2)D.BRLFKR1Y
MY2Y.Y-N/[K%1)_O(?6@"]IGB&5=6\3QZM=0)::;=Q10N$V85XD8 \DEBSX]S
MC K1;Q/HR6K7#WRI&MP+5]R,"DQQA&4C*L<C (YR/6N0O;/68;KQ7<6VCR7
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M ]ZO>+-(N[[X=ZKI%IFYO)-/>"/<0#(^S Y/<FL^".]F\<V6K2Z5=PVRZ+)
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MXH Z6T\3:7;:?]IOO$%E<1S7DL,,RJ(UR&.(QR=Q4<%N^,\59/BS0AI\=_\
MVC&;21/-$H#%53)&YL#Y5R",M@<'TKB4TC5!I5G&VE71>/Q6^H,FP<0&9W#]
M?1AQU]JT=9L;ZV\7:D]QH5_K&DZM;11*+.X""-E#*T<J%U!1@V<\]3ZT =9?
M>(-*TSF\O8XE"J[-R516.%9B.%4G@$X!P:K0>*M-GUW4]*WM&^G1I)/+(I5!
MN#$_,1C "@YSCGV-<S!9:EHFN:K92^&SJ>F:K#;^0(2C0PE(EC:*3>00@V@@
MX/!/!/%5_$/AS6]0NO&%I:6C ZI9VAMK@,HB9H@=T9YR-W"].C4 =M%XATF7
M[1B^C0V\0FE$H,96,]'PP&5.#\W2H+3Q=H-^I-GJ45P0(R%A#.S>8I9, #)R
MJL>/[IST-85]9WFMZY::VFGW5H+32KJ"6*10'EDEV;8P >0NUCGIDC!/.*T.
MARR?#WPMIUW::G:7=E'"C3V1Q-92I"RF0 9W#.5( .0_2@#MX-0M;FP^VP2^
M9;X9MZJ3P,@\=>QXK*TCQ=I>KZ'#JT;O%!/(4B5XVWN<G 5<98D#.!GOZ5-X
M635(_#MLNM;#?AI-[K&$WC>VUV4<!F7#$#N37#Z+H^N:;IWA">72[G_B23W$
M-W;@H6=9 RB5 &.X+D>Y#' H ]&L-1M-3MOM%E<)-$&*$KU5@<%2.H(/4'D5
MRFB^-[6.^U.QU[5;.*YCU:2SMEV^6"@5-H/)P221DGD]*T?#&E3VFJ^(=3EC
M:"'4[Q9H;=N"JK$B%B.Q8J3CKC&>>!S5[X?U"\T;Q?X?;39?-U?47FM[A@#$
M(W$8$A;/!4J3CKD# H [B\U[2]/N%AN[Q(F+JA+ [59ONAFQA2>P)&:N7-S#
M:0-/<2+'&N,LWJ3@#W))  [DUY]-I%[%K6M:7J/A^\U>QU.Y6XMKE;G%O]Q%
MVSJ7&-I0'(#$C&.170^.+#4;S1+>72X&N;BSO(;HVR2^4TZ(?F0-D8.#D<]0
M* *_B;Q5Y/A:ZU'0[N%IK6[@@F62([D+2HC*5."K8?/(_"MR^U[2],E$=Y>)
M"<JK,P.U"QPNYL87)Z;B,UQ6L:;-J7A'4YM/\-WUI=WUS:,T=RX:XF\J5&+/
M\[  *N!EL\?2EO--O5\0:Y9WWAZ]U?3M8E2>WDCN-L*GRT0I.A<8 * YPQ(/
M3(Q0!VEWKVEV-R+>ZO(XY-Z1G(.U&;[JLV,*3Q@$C.>*J6'BO3+^\U:!9&B&
MF2^5-)*A1<A58G)&,?,![]1Q7/V-OJFFZOK6DW?A]]2M=0O_ +9:WA\MH%!"
M<2AFR"A08P"2 ,=*I:GH>NR+XM@L]/E:6;4[;4[1S,J1W*QB F,,&W*Q,3#H
M,<<T =O#X@TJ>&[E6]C1;,@7(E!C:'(R-RL 1D=,CGM61HGB&?5/&VMZ:)E>
MSM+:VDC0P-&Z,YDW!MW/15/0<&N>U+2[[5=*;5M,\-WEI>17=G<36]].#/>K
M!)O,>2[# _AR1D]AQG;T);ZX\>:MJLFDWEK9W>GVL<<EP$4[T:4L" Q.?G';
M^E &M_PDMB?%$F@?O!=16ZW#L48* 20!G&/X6YSCC'6K%GKNF7]T+:VNT>9H
M_-12"OF1]-Z9'SKR.5R.17*>)="U74?$FM1VD$JQ:IX?^PQ7:LH2*4/*<-SD
M##KT![^E2VFGW^KZGX2NIM/FL)-'CE-WY@  9HO+\M"#\P).[(XPH[\4 ;^J
M>)++2=8TS3)Q*;C4&<1[8V8*%4L22!Z@#'OGM6-X<\8PS2W=EK.HVRWW]K7%
ME;JJ; P1L(.^"<'&3R>E6?$=I>MXI\,ZC;64MU#:2W"SB(KE!)$55CN(XSUK
MF7TC5#HEU$NEW7G/XK74578,F 7"R;^O]T'CKVQ0!WMQKVEVEZEI/>)'*\BP
MC(.WS&&50MC:&(QA2<G(K+\=ZUJ'A[PQ)J>G- )HYX8RL\9=2))50]&'3=G\
M*Y^WTJ]CU?4M)U/P]>:A!<ZBU[:7GVG_ $4(S[QYBEQM9#T 4DX&/6M?XE:?
M=ZMX,GT^RLI+R>:>W;RD .529';.2!]U3]: ))=>U+3?&NDZ%=/:WD6I0S.&
M@B:.2W,8!W.-S HV< \<^M;(U[2S>I9_;(_.DD:),@A7D7.Y%;&TL,'*@Y&#
MQQ7(2Z!--XWT34= T5]&@@+_ -HW&U(5N(BN%B**<N<\Y(PN.#5.S\/:M+X.
MTOPO=6DR7VGZE'*U]QY9CCG\SSE;/5EXQ][+'(QS0!W2^(-*;4%L1>I]H:5H
M5&#M:11ED#8VE@ 25SD8/I5>W\7>'[J[:U@U>UDF42%@'X C^^2>G'>N,EL-
M<GU;3IY-!ND:S\0R7#K;F)(/)990)% 8%F;<K,S#.2W3I4C^']7OO OB[3K>
MS>WOKS4[BZMTFPHGC:4.!GMN52O/3/- &]9^)I+[XA+I5O<(]@=*:[V&!D??
MYB*&RW52"<$#'UK7N[Y(_$.GV?\ :D$+R1RN;)D#/. !A@<_*%Y[<YKG]/?4
M=1^(%GK#Z'?6=K_9$EM(UQL'ER&5&VD!B3]T\C^56=?M+N;QKX>NX;*6>VMH
M+Q9G ^53(J!0?J5/3IWH W;+6+#4)O*M9_,?RQ*/D8!D)P&4D893V(R#56;5
M;>#Q"]O+K%M&D5DTTMDRC>H##]Z7SPH!QC'.<]JY_P &Z9J6EZF(8_MHT,67
MR6^HJ#+92[E_<QR=7CV@]R!M7!JUJ%K=_P#"P3?K93O:#1);;S47(,ID5@OK
MT!]O>@#7T_Q3H>J74-K8ZG!/-/#Y\2H?OIQD@]\9&1U&:D7Q%I#7@M?M\0E8
M.4W9"N$^_M8\-M[X)QWKA]'T75(+3P!!)87,+Z=:30WCA1^X9H=@SSS\WIGU
MK1\&KJ5GI>EZ1JOAN2.ZT:(PF_81O&RJI4-"02Q9QC(P.ISV! .@L_%_A_4!
M(;35K:8)&LK;&S\K-M4CUR> !R21ZBID\1Z1):O<)>H42?[,R[6$@E[1[,;M
MW^SC-<-:Z'K<'PNT*"#39AJ&EW27$UAYOE/,JNVY5<'&<-N!SU%7+BWNS;0:
MCIWA:[MS<ZA$]UY_ERWH549?-&YV 8?*H.=P4MTXP =?'KVF36<=W%="2*21
MH4$:,SF1<[DV ;MPVMD8R,'/2DE\0Z5#8QWC78,$J-(C(C,2B_>; !.T=SC
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M*N3& -K'Y<$9ST)Z5MV_BG2+O2WU*"XE>U2X^RLWV:4,)=X3;L*[L[B!TZT
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M[=[<K]G=U4*B_*"Y<D$=?O#%:MEJ$&H)*T'F#RI#&ZR1-&RL #C# 'H1STH
MAO=%L-0N[&ZN8G::Q<R6Q65T$;$%2<*0#P2.<\$U2;P=H;VLULUM,89KL7TB
M_:I?FG!#!\[LYR <=,@4W4/&FA:7<7UO=7,PEL462Y5+65S&C9PYVJ?E^4Y;
MH.YYJY=Z_IUE@/,\C&'[1MMXGF(B_OD("0/3UP<9Q0!6F\'Z'/KAUE[-OMK;
M?,99G5)2OW2Z!MKD=BP/Z4DW@_0Y[6^MI+69H;^X%U<K]JE'F2C&&^]Q]U>F
M!\H]*U[2[M[^SAN[29)K>9 \<B'*LIY!!K F\?\ AJWF>*74'0QW/V25S;2A
M(I>.';;A,Y !) //H: .ADA26W:!]^QEVG#D''U!S^.:R+;PEHMG_98@MI4&
ME!A9#[3*1$",$8+<\<<YXI;GQ7HMI;ZG//=.D>F.$O";>3,1(##(VY(P0<C(
MYK"F\81Z'XQ\06^L7TQTZWMK2:!$M3)Y._S?,8^6I.WY5R6X'KS0!OVGA?2+
M*99+>U9%29KB.'S7,4<C9RRQD[5/)Z#N<=341\':&;-[4VTWDO>?;F7[7+S/
MNW[\[LYW<^F:IS:S.WCG1H;6^\W2KW3+BYV(JLKE6BVNK 9/#GOBK.D:_8'1
M+:Y_M2;41<SS1PR&V*R2%7?*B-5!^7:1G'1<F@":X\*:-=-JAGMI7.J1K%>?
MZ3+^]0# 'WN."1QCJ:>OAG2EO?M@BG%Q]E%GO^U2Y\D?P_>_'/7WJWI>JV6M
M:?'?Z?.)K:0D*V"IR"000<$$$$$'TJG)XHTB*_\ L;71\S[2MF6$3E!.5#",
MOC:&((XSW ZT 51X&\.JEJBV+JEM;&SC47,H!@/_ "S;YOG7V;(%6+?PEHMJ
M^FO!:NCZ;"8+9A<296,X.TG=\XRJG#9P0,5!)XX\/Q32Q/=R@PW0LYF^RR[8
MI3MP';;A02R@$X!SP>#1?^-M TV>]ANKJ99+$I]J"VLK>2&&0S$*<+CG=T]Z
M )5\(:(FFK8+:.($N3=Q_P"D2%XYB2Q=7W;E.23P>Y]34D_A;2+FR-I-;2/$
M;A;ICY\@=Y5(*NS!MS$;5QD\;1Z"I;_Q!INFM(L\SLT4/GRB&%Y3''SAVV X
M'!Z]<'T-)%XATN>\%I#<F69K3[:@CB=@\.0-ZD##<D< D\T 12^%M(EN+VX:
M&?SKUHFG=;J4%C$08R,-\I! Z8J]8Z;:Z<LPMD(:>3S9G9RS2/@#+$\GA0/8
M "LO_A-=!,6GR)>22+J,+3V8CMI6,R*,G: N2>1\O7GI5BW\3:3=Z9:ZA;W+
M2PW;%(%6)S([+G<H3&[(VMD8XP<T 7;O3;.^N+.>YMTEELY3-;LW\#E2N1^#
M'_(%1P:/IUM;WEO%:1"&]DDEN8RN1*S_ 'RP/7/>JT'B?2;JPAO+:X>>.9G6
M-(H7:0E#AQL W J1@Y'!QZBJZ^-- =+%HKUY1?H\EL(K>1S*$^^  N=P/!7K
MGM0!;TWP[IFE-$UK#)F&(PPF69Y?*C.,JFXG:.!T]!Z"J5GX'T"PGLYK>TE5
M[*1I+7-U*P@+ @A 6PJX)^4<<]*+;QOH%X;+R;N4K>2^1$YMI542Y(\MV*X1
M\@C:Q!]N15NY\2Z5:7D=M/<,C23BV63RG,?FGHA?&T-VQGKQUXH JR>"M!EL
M9+-K23RWNS>[OM,N])R<F17W;E;)/0CK5W2M T[19KN:QBE62[<23O)/)(9&
M"A03N8\X Y[U17QQX?>X6$7<NXW?V(L;64*D^0 C-MPI)( R1D]*FTKQ);ZM
MKNK:7%!<(^G2+$[R0LJL2H8X)&.C#'.3U''- %J_T.PU&\M[R>.1;NW5DCGA
ME>)PK=5W*02IP.#QD9ZU#-X8T>>+3XFL]JZ>Q:U\N1XS&2"#RI!(()R#D'/.
M:=J7B/3-)OH+*\FE6ZN$>2&*.WDD:0+C=MVJ<D9' YYZ5%%XKT>XL;&[@N7F
MCORXMDCA=I)"F=XV8W KM.<@8QB@!@\':&+9;86TWE+>?;POVN;_ %^[=OSN
MSG=SZ9H_X0[0AKSZTMD5O9'$DA69Q'(XZ.T8.QF'J1GOUH_X3'0O*TV1;QG7
M4E9K3RX)&,NT$D !<[L _+USQC-10>.?#]P+8QW<NVXG^RJS6LJB.;=M\N0E
M<1MN&,-@_G0!IZ9HMCHYNC8QR1_:IFN)MTSR;I&ZM\Q.,^U1#PWHZP+"+"(1
MK>F_ QTG+%]_UR3_ "K/E\2Z9IMUK]S>:M,UOI_E?:(&M6Q:94]"%RP;KGD#
MVJ[:>)M(O;J[MHKHK):1">7SHGB'E'.)%+ !D^4_,,CCK0!-=:'I][JD.I7$
M+M=P1/#&XF<!4?&X;0<<X';L/2J\?A71D@>![4W$;VQM"MS*\V(3U0;R<#@?
MD/04MKXHTF]U"WL89I3<W$(N(4:WD7?%_?!*XQ_B/45<U#5+32TA:[D*F>40
MPHJ%FD<@D*H ))P"?H": *NA>&M+\.0O%ID$B*P )EG>5@HZ*"Y)"C)P!Q4V
MHZ+8ZI/:W%RDGGVI8P313/&Z;AA@"I!P0.1TKG]<\2--I^AW^B7S+#<:S!9S
MCR@"RF0I(C!URI!!'8U<T+4+VX\7>)[&XN6EM[.2W^SJ44>6'BW$9 &>3WS0
M!9O_  CH>I:3%IES8AK:*7SH]LC*Z29)WAP0VXDDELY.3GK6CIVG6NE626EG
M&4A3.-SEV)/))9B2Q/J233;[5+33Y(HIG<S3!C'#%&TCL%QN(503@9&3TY'J
M*YW7_&5M#HVEW>ES22QZC?16RSPV[N44OA^-IPX ("D9SV."* +^H^"]!U6Z
MO;FZM)=]]$(;L17,D2SJ!@;U5@&(' )&:==^#]$OITFGMI2ZVOV0[;F11)#S
MA' ;YP,DC=G&:MZ<ES8:7(][?3ZA@M*CM;;)1&>50JH&6 XZ GTS7(R>.'OX
M_".K6LMQ:V&HW<D=Q ]N273R9'4#*Y8Y5?N=3QS0!NW7@7P]>0Z?%)92+_9T
M?DVLD5S+'(D?]S>K!BOL21700PQV\$<$,:QQ1J$1%& H P *R[3Q-I5[IHOH
M)W:(S-;[#"ZR^:I(*>61NW#!XQT&>G-6=+U>QUFWDGL9C(L4K0RJR,CQR+]Y
M65@""/0CN* ,QO _A][AIC:2[C=_;0HNI0B3Y)+JN["DDY. ,GK4DO@_0YK2
M]M9+:8PWUR+NX7[5+^\E!!#?>X^ZO3CY1Z4W4/&>AZ7<WMO=7,PFL8UEN4CM
M99#&C9PYVJ?E^4Y;H.]7+O7].L]N^9Y2T/V@+;Q/,WE?W\("<>GKVS0!0O\
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MQ=%B*[1LWM]]NG!QFNE@\2:5=:9:ZA;3O/!=Y\@1Q.SN1G<-@&[(P<Y'&.:
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MUJ>8MXCDTR2!HH@DD/GR1C.%!W  8((''3KGK_$=Y+#=Z3:07DD3W,[@V\"
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M];CTV)=0D;>\H) 9L8W%<[=W^UC/O5R[TBQOKZTO;B%GN+,LUNXD9?+)&"0
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MV'VZ6*TNM":Z\M%3]W+YD:[E)4GHQX.1[5L2^&-(G.H&6U=SJ$8BN\SR?OD
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M>YYX[XKI;[Q#86$DJ,9IWA@%Q,MO$9#'$<X<X[':< 9)P< XKEM5\/ZO??\
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M T\>$)&P;<DGH/O+]<_6L6/2Q/XAO]?U:&.TMY["/3Q;SNI)3>S,7()7DN%
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MT>;US]['&/7O5Z#P[J$'BY-6L;>;3B]W*U^L=P&MKR'#!&\O/$OW.<#^+)-
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M#Y<@5@PR">01VKH: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME@9184*_*R9&[S 20QY&X8Z8J7P/"5U7Q8[7-Q*PUF1 )92PQY4)Z'\OI@4
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M9%*O'(H96!Z@@]17 7^M:II]Y:W6IS33:8PM%.HZ9)F."4[2XEBZ[)-PPW.
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M,^1Y2R.IV[0^<L..O.<GZUYCX=U763;>"-1N=8N[I]4FGM[J&3;L=1'*P(
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ML]2G SW+'T%6?$=TRZAH]C'=S))=2R?Z+!\C7"K&2?WF08U4E6)')P  <XH
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MVYO9;R:U5[F6'[.\F3EHO[G7[OM3(?#VDV\EC)%9(C6"&.T()_<J>"J\\#
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M<'U'%4SXUTB.<QW1GM5-F]]%),F%EA09=EP2<@$':0&P>E6'\2VL43M<6US
MP:%8TD"?O3*Q5 I#%3DCU&.] %ZPTNRTL3"RMUA$\AFE"D_.YZL<]SW/>F7V
MBZ=J-Q'<W5JCSQJ464$JX4]5W#!*GN.AJ6QO1?0NX@F@9)&C:.90&!'T)!'N
M#S66/%VF&2U)\Y;2[N#:V]X5'DR2@D;0<Y&2I ) !(X)R,@%G5/#6B:S906>
MHZ7:W%O;D&&-HP!%@8&W'W>..*T;>WAM+>.WMXDBAB4)'&BA551P  .@KFSX
M\T@22 PWXBBOAI\TYMF$<4I*@;B>@)8#\>< @U=\6:^_AO0GU!+22Z;S8H@J
MD *7<("<D<98=/\ ZX %O/"'A[4+JXN;O2+6:6YV^>63B0KT+#H2,=3SCBG7
M7A70+W5+?4[G2+22]MP%BF:(94#[H]\=L].U<W-XHFTCQEK;WBZE-90Z7;70
MM8XPY@RTN\X' X49Y)..,UT-[XIT^TMOM$:S7:"U%XXMU!*0'.'()'7!P!DG
M!P.* +,OA_2II+Z22S1GOT$=V23^^4# #<\C&1CT)'0U.=+L6T^*P:VC:UB*
M&.)AE5V$,F,^A (^E4M1\16]IX1N/$5HC7UJEH;N,1$ R)MW \XP,<_T[57C
M\4QKI=M/-97+7<EK]J>VB"EU3'+<MC&>@SD]@<' !>UG0-)\0V\<&K:?!>1Q
MOO02KDHWJ#U'X4JZ#I:7-G<)8Q)+91F*V9!M\E#U50. #@9'? K)7QWI$\EO
M'8QWM\]S8_;X1;6S-YD60."<#//0].G7BF+XTAO=5T&UTZTGGM=8M9+J.Y4*
M-J+M[$YR-X)R/IGL :DGA?0I==76WTJU;4UQBY,8WY' /N1V/45%=>#_  [>
MW5Q<W.CVLLMPRO,63B1E((8CH3P.>M<[X0\6B/3K6TU62^GGN=3N[..\DBRF
M]9I B%N.=JX&!CC'%=%XDUA]+AL+>W(%YJ5XEG Q&=A;)9\=]J*Q^H H V@H
M50J@!0,  < 5DIX6T.*PCL8M+MXK>*7SHTC79Y<G]Y2.5/;([<5G>++J]TN/
M0/L5[+$LFK6UM,"%;S8V;!!)!/;MBC4-2N+WQW;^'(;B6V@33GOYY(B [DR"
M-%!(X'WV/K@=L@@'16MI;V-N(+:)8HP2=JCJ2<DGU))))ZDFJUUHNFWM\E]<
M64,EVD1A68K\X0]0#UQ_B:X_1O'EY/%H5G<6$MU=W5Y=65Q-$%"Y@$@+ $CE
MMJMCH 3["ET#Q:+"74K?5I;^Y4Z]+91W+1;HXLLJQJS#  )..!QGG&: .I@\
M-Z/;&Q\FQC3[!G[(%)Q!D8.WGC(X^G%)9>%]"TW5I]4LM*M8+Z?)DGCC 8D]
M3[9[XZ]ZKP:J]KXQDT*=RZ7%J;VU=NHVMMD3/?!9"._S$=A5G4]8AMIVT^-+
MF:\:!IC':JI>./IO^8XZ\ <DX. <&@"Y?:?9ZG:FVOK:*Y@+!C'*H920<@X/
MH>:AM-%T^QDEE@MAYLJA'DD8R,RCHNYB3MY/'3FN5\)^+=O@G0I+\W=_J-SI
M[W;[%!=D0C>Y)('\2C'4YX%;UMXJTZ[U#3+2 3M_:=J;NTFV8CDC !/).<@,
MO&,\T /TOPKH&BK<IIND6ELMT")ECB&'!_A(_N\GCIS3+7P?X=L=-N=/M=(M
M8;2ZXGB1<"0>A]1R>.G)J_8ZC'J%I)<0PRA$DDC 8 %RC%3CGID'![_2N+T?
M79;]KG6]1N=1LQ::K/:) I4QW WF*.'8"<ONP<C!SGG'0 ZS4?#FCZMID6G:
MAI\-S:1$&..4;MA'0@]0>W%.?P]H[PV,+:;:F*P;=:IY8Q"<8^7TK$U[Q$MQ
MX:\30VDMS8:MIMA),T;A1)'^[9D<$94J=IY!/0C@U7MM1O1XL\,1/?3&WNM%
MFFFB9AM9U\G#GW^=NM &U'X0\.PSI-'HUFDJ3&X1UC *R'.6'IU/3N<TZ33)
MM'TF2'PQ:6,4[2^8([EW6(Y;+D[03D\GIR>M10>+=-GFL%"SI#J)(L;ET CN
M2 3A3G() )&X#<!QFH4\:Z;):VMP(+L)<7YTX!HU!2<,5VL-WR\@C/M[C(!K
M:/IPTO3EMR4:5G>:9T7:'E=B[L!V!9CCVQ1J6BZ;JYMSJ-E#<FW?S(C(N=C8
MP<?4<$=ZR=;UVRCB$<\NHVJQZE;VHEME'SR,R$+GGY#N4-G'4CK4=_X\TG3Y
MM22:&_*Z9(D=Y(ELVV$, 0Q)_APP/'U (H T%\*Z MK%:KI%F((IS<QQB(86
M4YRP]SD_AQ6K-%'<0R0S1K)%(I1T89# C!!'I6/JGBG3]*DO4E6>;[!;K=7A
M@0-Y$1W89N>>%8X&3A3QTS8N-:BB\.3:W#!//"ENUPL878[J!GHV,<>M #+?
MPSHUH]J]MI\4+VL;10-'E3&K=0,'C.!GUP/2HI_"'AZYTA=*GTFVDL4D,J0L
MN0CDY++_ '3DGIZGUKF%\4WTNN^%;UXKY8=0TJXGDL(5#!W A*E0#_MM@L?R
MKIK;Q7I]]IEC>V:SSF]5V@MU4+(=AP^0Q &T\')QG [B@#6M+2WL+2*TM((X
M+>)0L<<:[54>@%35GZ+K-EK^EQ:C82,\$A9<,NUE92596'8@@BM"@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "N/^(32):: T**\@UVT*HS;0QW'C/:NPJM>:=8Z@(Q>V=O<B)M\?
MG1*^QO49'!]Z .)UWPEJFK6_B&[@B@CO=5-G''#)+@)' ^[+L ?F)+<#/\//
M6MS5]+U"]\4>'-2AAB\BP,[7 :7#?O(]@"C'.#UY%='10!Y]!X5UN+1-*LV@
MMO-M=>?4I,3G!B,TDF =OWL/C'3CK6AX?TKQ)H5U<:4J6,FCM>RW4-Z9F\U(
MY)#(T9CVX+99ANW 8.<9&*[&B@#R_7]+U'2=%U"2>&#=>^*;2\ME$N05::%0
M&..#E.<9ZULZKX?UV\O-6UK3S%::A<P6UK#"9MI,,<A>3<Z@[68,R@C.  <Y
M/'77FGV6HQK'?6=O=(C!U6>)7"L.A (ZU8    & .@% 'F]WX-UN?2?&-I#:
M:= -:6(VZ)<,0C"-4;<=G^R3GN376^)]&N/$/A.ZTV.1+:ZE1&C9QN59$8.N
M?4;E /M6Y10!RFG0>(TTZ>631]'L+XH(DCMI=ZL2?FD)V#@=0G.>Y],N+P1?
MV^B:]X6MI8X]#NHRVGRL^Z2WD;EE*XP4W_,.>Y'3%=_10!P4_AS7]>\,7UA?
M66D:1>M$HBELV,@DF1U=7/R*53*#Y?F/)]!FUJVF>)_$W@_4+*_MM/LKQXT\
MF&*X:5'='5\LQ4;0=N  #C)))[=G10!P=YX;U[5[OQ+/<P65JNKZ(MA&HN&<
MQ2#S>OR#(_>#)_0]:NQ:-K,NM>%;ZXMK6-=-MIXKE4N"V"Z(HV_*-WW,GIU[
MUU]% ',Z;X9FL/%^HZ@)D_LRX8745OW2Z9=DC_BJC\7:LSP]X>UK1;UM.DL=
M)FTZ.Z>>#4B?]($;.7V%-O+ G;NW#CG&>*[FB@#G/$&C7UQKVAZYI_ER3::T
MR26\C[1+%*H#8/9@54C/!Y&16+JOA#4KKP]XB2W2W_M#6KZ.Y,;2D1Q*AC !
M;!R=L>3@=6QT&:[VB@#F]0TW4KKQGH6K1V\0M;*"XCF#2_/F79C Q@XV<\CK
M6!/X2UXV]_<6WV2.^C\0?VQ9(\I*2KL"&-R!E25W<C.,BO0Z* .*US1_$>MZ
M?I^H&WTV/4["\%S%I\DIDA=-C(R-)M'S$.2#MP"![FG7WAZYUC28(-4T'3_+
M:8RO;6DY1[8A0$>.4*N7SG)^7@XYQSV=% '.6_A^]N? $GA_5]0>>ZGLY+66
MZSN;#!@"3QN(! SQG&>]4;/0-5NY/#;:M%!$^AAF9X9=PN)/*,:E1@;5(8L<
M\YP.>M=C10!SO@_2[_2+"^@OXXD>;4+FZ3RI-XVRRLX!X'(W8-8&N>$]<O(/
M&%I:1V;1:U)%+!(\Y4J5CC0JPVG _=DY!/4<>GH-% '#:]X3U+7]6UF4F*U@
MOM(BLXI-^YDF21Y 2N.5RP'7L:U_#5MK"9EU;2M*T^18_+(L7W^<V1ELE5VK
MQPO/7D\5T5% ')RZ'J6D>,KWQ!I$4-U#J<,<=_:22>6V^,$)(C8(/RG!4X]<
M]J?XCT;5O$&E0NAM[:]L[R"]M8&<LA:)MVV1@/XAD< XZ\UU-% '!^(/"NIZ
M_'K]\(88+V_T@:7;P--D*-SLSNP'JPP!G@>^!)X@:ZA\5>!B+97N%DN0\0D
M_P"7=LX)'/MG&?:NXJM/IUC=74-U<65O-<0<Q2R1*SQ_[I(R/PH XIO!FI0W
MT6O6Q@_M-=8DU%K5G(C:-XA"8]V/O; #G&-V1TYHUCPCJ=_!K5Y!% M]JE[8
MS>2\V%CCMV1@"P!RQVMT&.0,\9KOJ* .-\5:'KNM7=Q#"EI-IMQIDENL4\[(
M(+AL_O"H4A^"H&>A!QC-)I6@ZU8:WHNH20V;+#HPT^Y19VRC*RL"OR_-G&.V
M*[.B@#SS3?".M:;:>'KL+;M?:1>7CO;B8[)H;AW8X;'##<N,C&01GG-2WGA#
M4Y;MM1BC@^TW6N6VI31&7 CBA14"@XY<A<GH,G&>,GOJ* .>T'2KZQ\0^([V
MYCB6#4;F.:#9)N("PI&=PQP<IGOUK UGPIK.H67C:WABM@=;:/[*6F("A8DC
M._Y>/N9XSUKT"B@#C_[$UBRUO7KNT@MYX-;AC8I)-M-O,L?EG/!W(0%.1SD'
MCFF:1X3O?#^N:(]FT-Q8VFCC3)7DD*N"KJV\+@@YP>,C%=G10!SVM:5?7GBG
MPYJ%O'$UMI\LSSEI,-AXB@VC'/)SU%<]IOAKQ,NN:#J6I16$MS8S7(N[K[2S
M/.L@(#*-GR@<83./I7H5% 'FR>#O$%IH>F1PPZ;/=Z/?SS0PS2DQ7<,K2%@W
MR_(V'&.N"OO6M=:)K-V_A^X^P:?;-9ZE]LGMX)?EC3RGCVAMHWM\V<X'IVS7
M9T4 8GB_2)]?\(:KI5J\:7%U;-'&9"0NXCC..U97]D:W-XFGU:>TM4671A9>
M6EP6Q+O9NI4?+A@,^O:NPHH \W3PGXE&@Z9HTJ6,]I#HGV!XGN6"1W &WS<!
M3Y@QC .,$>^:TM$T#6K#6-'O;FWM=MGH7]G2+'<$DR;D((RHXPG7U/XUVU%
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M' SCUP,GG Z5=HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
K%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>aquestiveamendedandresta007.jpg
<TEXT>
begin 644 aquestiveamendedandresta007.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?8H1 -S,V#@?,HX!.6'N14\&:/+H?A>SM;B266Z*!YGF(+DX  8CJ54*N?\
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MK$(P3D_-]T'M6-<_#S[39ZZD4EKI\FJV\<;QVD9\GS48MYQ0D<MP"!V'4DT
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M/!]I##*N2<*VWH3_ +6.M>EZ*L6F>"80EY?7T%O;.4N)!F>5!G!'J<8QZC%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'YC8WNQP% [DDTNIZI8:-8R7NI7<5K;1_>DE;:![>Y]JY[XC?\BFO_81L?\
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ME<=\@'=T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MGJB[U.U?88%)9>#I[#2;O2XM'TM[.[B\F5)M2N928\$; S*2JC)P 1BNZHH
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M49E8Y^7.<JO>H/[*>]\7Q:S.I6*QMGMK56ZLTC*9']AA%4?\"[8) -RBBB@
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M)X%MOM=G>6FK:I975O:K9R36\B!KB%?NK("A&1SA@ 1D\U<F\):?-JOVXR7
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MC0/JL-AY2*SN(Y ,2-(#M1MQ^X1G ]\UUUM"UO;1Q//).RC!EEQN<^IP /R
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M@9&?NY/<T 8_B/5'\0?"_P 3:FCVSZ9-I]P;150^9A4(W.<X!W _+C(XS@Y
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MV$UQY0F\J.X1F\LC.[ .=N.<U*FL:7)';21ZE9NETY2W99U(E89!"G/S$8/
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MR3W4?FV\:7"%I4_O* <D<'D>AK#U>W=_B3X?N_L<TD%O97BR3K S*C,8MH+
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M!Y98L=P.\<X'3I5[PAXE/B!KL-=QM) D8EM7MF@N+:4[MRR(Q/'W=I'OR>M
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M>*KK3Q<V=YID-G#<"Z@A/S/(6&S<'(& H;H3AA]38N]8N[CQ6_AZPDAMY8K
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M>0NY6*DC/(!*YK<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4\Y5><]JK6G@RTL=+@TZUU"_CMH;=[7;NC;?&QR0V4(..<'KR:U4UK39;_\
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M*=8:SIFJ3W,%A?V]S+;$+,D4@8H3TSCUP?R-2WFH6FGJC74Z1;R0@/); R<
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M&[ 8< ]&(]:]6HH \XDL[G1]0T;7],\.7XT]9[IKNR4^9<@S!,3E"Q^;<AR
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MDLK*??+?6%W!&Z[!=I"L>] 3QR4(YZ\=CFO3:AN[NWL;62ZNI5B@B4L\C=%
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M.@"GX:LK>RTC;:Z;)IT4LKS"WF<M("QR6;DX).3C/?US6Q110 4444 %%%%
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MYDOF&,%)" RF';R5(W9#$D8!SUI/'KW:P:$MK?36HEUFUBD\H+\ZEL\Y!Z$
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M217,]I9%#;V\]U(\2;/N_(6PV,#&0<5/=>%=*N[V\N7BE4WR*EY''*RI<@#
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M7<!TR/RK6:"\ECE2/NF\-N*G'3/TQ6B?#6E_;[&]6!XY[*$P0F.5U'ED@[6
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M=OM,F?+.T[6^;YAE5.#D# J[K.BV&OZ:]AJ,)E@9E8;6*LC*<JRL,%2#R"*
M.#FGU'1=7^(E[!>^;=VNF6UQ#+-$I/RQS, 0N >0><#MU[Z1U+Q#J/B:RTNT
MU2"TBGT9+YG-H)&#^8@/4CJ"?3&?Q&N/!6D;-2$GVV5M2MUMKMY;R1FEC (
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MGM&+V]Q;SO#+$2,':ZD$ CJ* .8,FJ2>(_ IUH6XU(-?+/\ 9VRA(B(R/3(
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M23S[5K>-]-O-5\,/;V$!GN$NK:<1!@I<1SH[ %B!G"G&2* %7QQX<:RO;O\
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MXQOQG'S$9JSXHT/4_$MGHT::7<:<K:A)/.;:6-9;=&AD3>Q#8+[G!(7/'KW
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MR!(F\M(V296(.T>6""H;KTS3-9\-ZSJ%_P"+EM;7RA>6ED+*61U$<KP,S%2
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MR 9615 +*Q[-[8W/$M[-9VMFMO>"VDN+N.+"QAY)0<DI&""-Q ZG@ $G&,T
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MVO##9:D;);540J5BF127)&[+'+<$8&WCKD ]3HIDR/)!(D<K1.RD+(H!*GU
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M 6*@D@=N:VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[MRDDGH1U/K4T_AG2+G2YM.FM6>WFE$\A,K^8T@((<R9W;@57!SD8 Z"F_\
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M4&Q]C+DKC=N(&W[QR,#D4 2ZAX/T/4[R:[N+1UFG@^S3F&>2(31X("N$8!@
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M#BO#/AO4K.TM]#U'P[IX%B&CBUL-&S2)@A65<;UDP0"3@=3D]*M>'],\1?\
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M]M]!:+;LS3-*$  W!,GY5)4' QT''% '.6^M:K'9>#-634)+I=<DCANX-J[
M9(6DWQ\9785(QSD9SD\U5TV_UAO"EUK-YXHN4D%W/8QJUM$RDB[,:$*%!,A
MVCG;\PR.#7:V7AS2=.D5[2T$6PL8D#L4B+?>\M2<)G)^Z!UIG_"*Z)_8\^DF
MQ5K">0RR0L[,"Y;<6!)R#NYR._- 'G^OZCJEQX<\7V4]W=Q+8:A9I""ZF18Y
M/))1F P1\Y]>N,D5OZQKFI:#XCU%5N9KRVM/#LM^EM(J_-*CXSE5!Y _PK>_
MX0_P_P"3>Q?V7"4OE5+G.290N,9.<YX'/7(!ZU9AT#3(+]+Z.U N4@^S!]['
M]UG.W&<$9Y^O/6@#EX]3U2VO?"4J:E+>0:Y&T=RI5,*QA,JRQX'RXVD8Y&".
M_)R]#UG739>$-3NM9N+DZCJ,UE<P/'&(V3$Y#<*"&!C7D'';%=U8>'-*TPK]
MCM?*"*R1 2.1"K=1&"<(#QPN.@J*+PIHL%O901696*RF,]L@F?$4ASEA\W7E
MOS/J: *OB#59;?7] TA9S;1ZE+,))EQN^2/<$4GH6/?KA3CDYK/GEU&UN-.T
MB77Y+RY>6Y)2WB6.:5% *[GSM4('7<>K'''4'H]8T/3/$%D+35;-+F!7$BAL
M@JPZ,I&"#[@U6D\*:%)%8QMIL.VP+&VQD;-WWN0>0W<'.>^: .+T_5+O6;3X
M:ZA?R"2[FNYC*X4#<PMIQG XYQVJ6RGU2VM/$TFDPF>8>)9/,@CD6.66,11E
MEC+<;L#/T!Y!YKKK?PGH=I'9);:>L*6,C2VRQNRB-VR"1@^A(^G'2GCPQI"B
M7;;.IEN?M;LL\@/G8QO!#9!QQD=J (/"VKPZGX<^V"ZN9 DLRRF]B$<L)5VR
MDBC !087WQGO7.^'=;U.;Q)H4,M_-=V>I:9/<-+)&J+,Z-$5DC4<HI$AP">1
MC(SR>WM;"ULK4VUO"JQ,69E.6W%B2Q8GDDDDDGK698^#O#VFSVL]II<,4MH&
M$#98F,-C(&3TX&!T';% &1XUU74]*F$\0O/[*2U<W$VG['FM')^65HVY=  W
M3T.0>V;<76M:QJOB:/3_ !-<6MO9V5K=V31PQ$9>-VY+(24.T$CK[UVM]HFG
MZC.9KJ%FD,1A8K*Z;XR<E6"D!AST-<_;>%/-\7ZY>WUHO]G7D%O!"D<[*&6,
M,&5T7 *G<, Y& : ,?3_ !!K_BR(6MK<1Z=?_P!C6MZ@\S9^]E5B7VE&W("
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MMI+R6WD@9F!)5U#$KA5&WC&._8 V?"\NLQ>#H+K7FGGU,QM+(CHBL.NU=JJ
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MA7&<DX^[UY''(IC^+-,@^WK=?:+::QM_M4T,D+%_)Y^=0N=R\'.,X[XKCI?
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M<$$A1S3/A= D/PWT-E:1C):HQWR,P!]@3P/84 =<\B(4#NJEVVJ"<;C@G _
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MQEPH(^;( Y[9R1@8&: .BK+7PWHB62V::39);)+YR1I"JA9/[XP.&]QS7*^
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M7P_<Z4FES:+8/8(^]+8VZ[%;U Q@'D]/6M.""&UMX[>WB2*&-0B1QJ%55'0
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M^ 0L9))(&0<9XJS9>-M+U"V1[9)WN7O'L19@+YOG(-S+][;@*-V[=C&.>0*
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M-V-^P';GDMWQU.*V%\9Z7-INGWEJ);C[?;&Z@A4HCF,8R3O95!RP&,]>G0T
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MYM-=$E,@7#;UW*5P3D8(ZXH YV/P[K^D:_J!T@Z9)I6HNDK&[+>;:2"-8R5
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M&,31'2;#RVD\UE^S)@O_ 'B,=?>GOH^F2ZE'J,FG6C7T2[8[EH%,B#T#8R*
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M-KXHQ+)\-]9W%P%C5OE<KT8=<'D>QXKHI-&TN74(M0DTVT>]A&V*X:!3(@]
MV,BK,\$-U!)!<1)+#(I5XY%#*P/4$'J* .08E?B-:V$%]=M92:'<,8_M;L-Z
MS1+NR6/S %AGK7,:";RYT[X?W4NKZHTNJK)#>DWLF)4\AWZ9P#E!\PPW7FO3
M!HNE*Z.-,LP\<7DHP@7*QXQL''"^W2D30])C%N$TNR46Y)@"VZ#RB>Z\<?A0
M!YS%K=UIUHEA/J<L6G#Q+<:>]W=3.YCB",T:-)N#8+[1DMZ G%=MX4MY+6SO
M(&UK^U8UNW,;X)\A2 ?*W%F+[<]2<\X[5H'0])-K<6O]EV7V>Y.Z>+[.FR4^
MK#&"?K5FTL[:PM8[6SMXK>WC&$BA0(JCV X% 'F^H:G?W?AWQEJ8O;JVU?2+
M^5+2-)6 14"F)?+SM82#U!SO]AC3TNVN-4\?ZRMW?ZC$MG'87*6L=VXC21ED
M+ KGE3C!7H?RKL)-*TZ:^6]EL+5[M<8G:%2XQT^;&>*='IUE#>2WD5G;I=2C
M$DZQ*'<>[8R: .4\?6\,M[X3::25%_MI$+).T> 8I>ZD<Y YZ_F:Y_Q+?7D&
MG?$@V^IWJ?8X;>2U9+I\PDPACL.> 2<X%>FW=C::A"(;VU@N8@P<)-&'7<.A
MP>XJO)HFDS&X,NEV3FYQYY:W0^;CINX^;\: .0GTTR>/;W23J>J_8KC2!=R1
MK?RJ?-$K+N4@Y3@_=7"\#BL?2->NM6LO"]CJNK_95OM#$XGED>,W$X(#?.KJ
M=P7!QG^(G' QZ3_8^E^=YW]FV?F^7Y6_R%W;/[N<=/;I44WA[1;FQCL9](L)
M+2)MT<#VR&-#ZA<8!H X'5+G5M-TF&X?4YM>L+33/],GL[AK:YC 9\72*&VR
M JIZGG9D<,<]UK^H0V?A34=0>ZEM88[.27[1$FYXQM)#*IZD=<&K,^CZ9<RI
M+/IUI+)&@1'>%6*J#D*"1TSVJW+%'-$\4J+)&ZE61AD,#U!'<4 >8V]]?+JV
MMZ9;ZNMH9-%MI;<W%ZTXCF9I%W,W520%W;>!U!/6NF\&W\]Q/JMG?65U9:A:
MR1^?;RW1N(AN7Y6B<G[K $XX(.<BMB/P]HL4?EQZ18(GE>3M6V0#R\YV8Q]W
M/..F:MVME:6,9CM+:&W1CN*Q(%!.,9X]@* .(U:_OM/\6M-=>?<Z3+J%M EQ
M9W3*]E(PC BEBR R.S Y&3^\Y' JGH5Y/KKV6H2>)5M-0AU*6&[L07+L-[*8
M#'YF!QM(8+D ;O4UWQTK3C?&]-A:_:R0QG\E=Y(& =V,Y XI$TC3(]3?4TTZ
MT6_==K70A42L/0MC- ',?#*&"#P[=+'+(T@U&\#H\[/M N90.&)Q]>_?-07=
MN(_BM=7$(GDN$T'SHXA<2 ,XF( P&Q@X''3OC-=I;V-I9O,]M:P0O._F3-%&
M%,C?WFQU/N:9_9MA]O\ M_V*V^V;=OVCRE\S'INQG% 'GMAJ-]-H7@G6[2_N
M9[[4KJ*&_C:9F24.C&8;"<*4*DC &-I'2LK4-/>]^&_C+4+K4M3GEM9=3MHD
M>]D*"-)6"@KG!P%')[$CIQ7JL&DZ=;74EU!86L5Q(27E2%59B>N2!DYI8-*T
MZVMYK>"PM8H9\^;''"JK)GKN &#GWH XB33;6_\ B!I]FMW="W/A^;+PWCAS
M^_CX\P-NZ^A[8Z<5O?#^_N=3\ :)>7DS3W$EJOF2N<LY'&2>YXK5CT/28F1H
M]+LD:./R4*VZ JG]T<<+[=*LVEG:V%NMO9VT-O OW8X4"*/H!Q0!YA<W=\-%
MU'9JE^CQ>+XK6.07+%EB,L2E,D\KACP<BNB\/W<>D>(?%=G=:E(NG6<MM)&U
M]=,XB,D8W#?(20"W8GJ>*Z,Z#HQ1T.DV!1Y/-93;)AG_ +QX^][]:BO_  YI
M5_:WD#Z?9J;P!9W^S(Q< @@G(Y(QD9S@@&@!WB-G7PQJDD4LD4BVDKI)$Y5E
M(4D$$=.17!:?)>:9<>#M436=1GCU+3G?4DGG:9-BVX<2JIR%*MM&0.=W.2>?
M0-3T]KCP_=:;:;$,MLUO'O)VJ"NT$]3Q5;PWH%OH>C6=M]EM%NH;9()9H(P/
M,V@#.< \XS@]SWH X?0-2EEU[3(!J=R]K?\ A^2<F6]9I)6#Q[)6&<1N0S<*
M?;MPFC.8O!'A?4+K6=6EOM8-I&RO>-MF<([;2Q/[L$#YBO)V@<DG/H$7A[1(
M%18='T^,('"A+9!MW_>Q@<9P,^M/?0])DT]=/?2[)K)6#+;FW0Q@CN%QC- '
MG5IK=]_PC8!U/?'!XF>VF479,CVWF-B-)"0QQP>N2JD>U/U2/4[/PAK%^-5O
MXA+K-N+%EO69HK=IHDVGYB.=TG!SP5STP.LU_P +"_@A33H-+C5;DW%Q:W5F
M'ANF*E?G P<C.0>>0.*31_!FF645S]JTK2/])V;[:ULU2 %-V&VG.6^8_-QP
M!QQ0!SGB<1Z3_:&FVFK:DTUMI%Q>A;C4'41;G.V0/G<[!AM53P .HSS'9++X
ME\10VMUK>HQ6\_ARVNW%K>M$!,796<;3P1@9 XXY!KT&XTC3;N:*:YT^TFEA
M4I$\D*LR*1@@$C@'T%8/_"'V[>+CJ,EEIS::NG)8Q6IB!\O:[-D#;@#YL8'I
M^% '(Z)]LU^^\#'6+FX,\VD7_FRQ2-$\RAX0K;E(8;E"MD$'FNQ^'MW<WO@B
MPEN[B2XF5IHC+*VYF"2N@R>YPHYK=DTRPFN8[F6QMGGC78DK1*65?0'&0/:G
MV=C::?!Y%E:P6T.2WEPQA%R>IP* .3\!W0CT+6[Z^D$<@U>^>Y=SC9MD(Y]@
MBJ/H!7.ZY'JFEQ:?XZFL88VM;PW5VRSL93:3!8RA38!E$$9^\>4)[UZ F@VJ
M7-_F**6SOV\VXM98PR&3 !8 \<A1D>HSUSFY+IUC/9?8IK.WDM, >0\2E,#H
M-I&* .7\>3L++P[=6CAI?[;LS"R'.X.Q5L'T*,WX&F>!;M(] UJ^U&5(F&KW
MKW+RG 3;*0,D] %5?P KH&T.U>[L&\J*.UT\E[6VB0*BR$%=V!QP&8 >Y/7&
M&C0+,7%^'AAFLK]Q+<6LT8=#* !O /'(5<CU /7.0#.T:;3]1\27&LB[MVNY
M[9;>VMUD!=+=6+%F Y!9FR<]!M'!S5?P.\GV[Q9#R;>+6Y?)]!N2-W _X&S'
MZDUO6NAZ9IADDTK3+"SN'3;YD5LJ9'OM )'M4FE:9#I-E]GA)8M(\LLC?>DD
M=BS,?<DGZ=!P* .$O]0NK^P\=7$M_=6>HZ-*YLUBF9!%&L*O&VT'#!VW9R#D
M<=JL00/>?$O0[J]$\-Y)X?DGFB6XD4)()(,KM#8QG.5Z'N#7:SZ5IUS>)=SV
M%K+<H %F>%6=0#D8)&>O-*^FV$E\M\]E;-=J-JSF)3(!Z!L9H Y?XB0136_A
MXRO(JC7+524F:/@MCJI'X'MVKE=?1HF^(FI6=_=PS6$5K/;/;W+*-RVZD%L'
MYQQT;(/I7JMW96NH6[6][;0W,#$$Q31AU)!R.#QUJN^AZ1)]HWZ79-]HQY^Z
MW0^;CINXY_&@#E-2N[L>,]2BCU22TC;PVTZL\A:*"3>1YNWH, #/TJUX.O;L
MZIJ.FZI:7-IJ5O! \B&[:XMY$)<"6)F.1N*MD'!^4=>371'1M+,AD.FV9=HO
M(+>0N3'C&S./NXXQTJ6ST^RT]&2RM(+96QD0QA <=.E ')>(-"?4_$LM_P"'
M=:;2_$MI;HLJL \-Q"2Q194[C(8!AR.>O%8MKXKN=83PY%J30:/#?QWJRE7=
M8I;F.15 5U93AAYC#GGWQFO0KS1M+U"3S+W3;2XDQC=-"KG'IDBEN](TR_L5
ML;S3K2XLTQM@EA5HUQTPI&!B@#A+*]-OJ^C^']7\127EC)8W+17PD:#[5,LH
M4*7#98HA/\7/4Y(%.AM;9/'?A8OJMU>A=)ND6\DN&4SE980I^4@-G/T;@G/%
M=Q=Z+I5_9Q6=YIMG<6L6#'#- KHF.!A2,#%2RZ?93R6\DUG;R/;',#/$I,7&
M/E)'R\>E 'FUCK%]%!IUG/>W1LKGQ/>64]P\[%Q&K2^5'OSD LJ+UZ#'>FZ]
M=:I96GBFS@U&]2TL=2TX6<XN&+QF:2/S8MQ.64!LX;. ^.@%>C#1=*6SELQI
MEF+:9MTL(@78YZY*XP32OH^ER6:V;Z=:-:JV\0M I0-USMQC/O0!SWAOS;3Q
MMXETL7=U-:116D\:7$[RE&D$@?!8D@'8#CH.V*=\0O\ D!:?_P!AC3__ $IC
MKHX=.L;>ZDNH+.WBN) %>5(E5V Z D#)%%YI]EJ"*E[:6]RB-N59HPX!]1D=
M: .<^)O_ "3G6?\ KDO_ *&M=95>ZL+.^MOLUW:07$''[J:,.O'3@\5,D:11
MK'&BHBC"JHP /84 >87VJZC<^$_$VLQ7EU#KFF:I+%;PK*P5=DBB.(QYVL'4
MKU')?/IC;MK.-OB_=RLTXD&BP2%1<O@,9I01C."/;&.^*ZM]*TY[\7SV%JUX
M,?OS"IDXZ?-C/%*--L%OC?"RMA>$;3<")?,(]-V,T <IXXMX)->\'O/)+&G]
MINK,L[Q@ V\IZJ1@Y YZ]1W-<Q>^;:6'B[6+6]NX;FT\21&+RKAD3YOLRMN4
M'#@JQ&&S[8KU6[L;2_C2.\M8+A$<2*LT8<*PZ, >A'K59M!T=XY8WTFQ9)G$
MDJFW0AV_O,,<GW- '#7U[/J^J^(+:3Q*NC7VFWL?V=27W)$$1E(C$BK(')8<
MJ<YQV&++ZAJ%AXOB>\6>[L;G4'CL[NTNFVI)Y;+]GFA)P "&(89Y )QUKLI=
M&TN>^@OIM-LY+NW&(9W@4O&/16QD?A3H]*TZ*\:\CL+5+EF+&985#EB,$YQG
M..] '!^$+R76AH&M'Q,HNI%=+[3QO8RR%3OC9#(0A1@2"%& /0UI?$X,VC:,
MJ2>6[:Y8A7P#M/FCG!KJ;?2-,M+^:_M].M(;R?\ UMQ'"JR2?[S 9/XT^^TS
M3]314O[&VNU0Y59XED"GU&10!P5Y%/:?%_1H;ZZ.J&]L+F*+8/*>P4 %G^3L
M_"[C@@CBI_#\E\=3/A*[NKZ2XTN\>YENWN)"T]J<M#E\\Y+A2.A\IJ[.#2K*
MPCF.FV5G:32+C=' J@GMNVXR/QJMHFG7UJLMUJUS;W.IW 599+>(QQA5SM50
M23@$L>3U8]!@4 </:WD=M#K$374\+W7BUH(TA?9YS%$/EL_55(4Y(YP,#.<&
M"*^U&7PAJ^H0ZA<RS:#K<LPBAO'?S+9'!>(G.779OQN]!7HCZ!HTD$T#Z38-
M#.XDEC:V0K(XZ,PQR?<U8ATZRMEG6"SMXEG.9@D2KYAQC+8'/''- 'GNFZA=
MW7B*^TG[1?FUUMXK_39OM4I*6RG$H#9R@.P$8Q_KU':KL=]?6/C*W%_Y]SI]
MUJ,D5I>VMVQ16V.OV>:$G QAL,,\J"<$DUW*V\"O&ZPQAXT,:,%&54XRH]!\
MJ\>P]*@CTK3H;MKN*PM4N68LTRPJ'+'J2<9R?6@":UN[:^MUN+2XBN(6)"R1
M.'4X.#@CCJ*X>&_OK+QG -0\^XL;O49H[.^M;IB@;8X^SS0DX&W:V& (RH)P
M2377Z/I%IHED;6SBCBC:1I&6*,(NYCDX4< >WYY.33DTC3([E[E-.M%GD+,\
M@A4,Q;@DG')/?UH \P\,B6PTGP3>V]Y=JUUJMQ:31>>WE-$?M#8\O.W.Y0<X
MS[U<T[6VD\2^&KBWU2>6TO[V^CD>XNCF=560@&+[J*K*H7O@<@9(KT!-"T>-
M(432K%4@?S(E6W0"-O[R\<'W%":%I$4WG1Z58I+YWG[UMT#>;R-^<?>Y//7F
M@#S:Y(_X0K6^?^9O'_I='7:_$'_DG/B3_L&W'_HLUJ?V#HY@> Z38^2\GFM'
M]G3:S_WB,<GWJ\T<;Q&)D5HRNTH1D$>F/2@#S/4&U3PWJ$4^B7M]>M<:%=74
M]M<3-,BR1HABD53PF68KM7 /8<5K^%F2[U*QU.S\4+>V]U8_/9JSR;SP?-.Z
M1MA&=IP .<=A76V.F6&F(R6%C;6JMC*P1*@..G04RQTC3-,DFDL-.M+1YVW2
MM!"J&0^K$#G\: .?U:_,WQ!TW0KJ>2"QFT^:XC"2M%]HF#JNW<I!.U2S8SWS
MV%<;X?U,6>B>'=+;45MK"[O]31[F61L/(L[F-&=64_,"YZ\E1UKU2_TO3]5C
M2/4;&VO$C;>BW$2R!6]0".#44F@Z/+8/82:58O9NV]K=K=#&S9SDKC&<]Z .
M'DADMI?!=O+K']K>7KDRI=$'E?(GPNXLV[;]W=D].><TJVVJZMHGC6WL=2OA
M?6>KN;$BZD!&V&%Q%D'.PDL,=/F)ZUW;:1IK+;*VGVA6UQ]G!A7$/^YQ\OX5
M);6%E9/*]K:00/,V^5HHPI=O5L#D_6@#@]0\2RW/@R[\7V,US!:RI:Q)N9R(
MHC(HGDV9^\-[J3U_=YS5'Q#Y]CX9\07FG^*Y+A'CMIH8[29S]F)D"EA(9&.'
M!/RDXX)'>O35MH$MC;+!&(""OE!!MP>HQTJE'X=T2'3VL(M'T]+)GWM;K;((
MRWJ5QC/O0!R.IA=-\46GA^;6+BWLKRUGN8Y;RZE)EFWJ"BR!U(VJ<A<X^8\<
M#$>DW<TWB+3O#NIZY+?6\>CF>*[C=K?[;)YI1FRK9.U57H3G<6]".WO='TS4
MK6.UO].M+JWC(*13PJZJ1TP","B\T?3-02!+W3K2Y2W.85FA5Q&?]G(X_"@#
MG?A<5_X5SI023S OFC=G)/[U^M=?4%I9VMA (+.VAMX021'"@10?H*GH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ K \5Z]<Z#;:<]K9FY:[U"WM3AE&T.X!ZD9)&0.V3D]*WZPO%
M6C76M:?:)920I<6E]!>()L['\MPVTD<C([XH BOO%]O90ZC.+*ZG@TS'V^2+
M:?(.T.PQN^8JK!FQG@\9/%:=[J:P:%/JEK']K1+<W$:HP'F#;N&">,$=ZYMO
M"NJ0'Q%;6MQ:-::Z#)*TFY6MI6C$<C*N#O! ! )7!&,FNB&D11>'!HUNQ2%+
M3[+&QY*J$V@^_% '$_V_J-YJ7@74VMKWS;ZSGDELX90%G;R48';NV 98X+8(
MKH;?QOIUQI-G>^7)#-=2RP+;3NB,LD199 Q+;0 5/.3U&.M4--\+ZS:R^$WN
M)+!QH=M);R>6[CS 8UC!&5_V<]NN.V34B\&:]8VMG=6%Y81ZK9:A=W,:R%VA
MEBN'+-&^ "",C!&>5]Z .K\/:_:^)-+^W6BR(%E>&2.3&Y'0X89!(/L02""*
MX236<:UJ>B^(-1U'1M;GNI?[,NFN'2UGB+?NE3!V9VX# C=DGG.,>BZ:E^EF
M#J4L,ETQW.(%(C3_ &5SR0/4]3D\=!S&N>&]8\0>'[_0=0&F7%O=2R^7=NSF
M2!&<E"$VD%T4@ [AT'X@%S7/'&F:$]VLJO,++9]J$3INCW 'A2P9B%(8@#H>
MYXJ:Z\66\7VF2ULKR_@M)8XKB6U0/L9PI "YW-@.K' X![D$#/\ ^$>\0Z7X
MAO+K1+^R-AJ(B-REZKM)#(B+'YB;>&RJKD-CD=:6#P]K^E:_J3Z7J%G_ &7J
M<JW$WVA&,\$NQ4<ICY6W!0><8/8]" 6?^$S@_M;4+$Z7?K'ILNR]NF$8B@7R
MO-#D[LE2N.@)'<#C-9_B!9%IX8;.62X%B][;H)8R)50<J2K'8PR#@]NF2,5+
M%X7N)[KQ:M\\(L]>PH\ER7C7R%A.<@#.%S^./>FZ7H_B=]'FTK7-0T^2%;5K
M:.:UC</-E=H>0-PI Y(7.3W'0@"V7B^9M TR[N-*NGN;G3_MT@38$"JJ%CN+
M8&2XVJ3GUQBB;QU;YTU;'2=1OGU*P-_:K L8WH-A(^9QA@''7CL"3Q6=%X3\
M0?9=&MI[K398+/3S920.KF-7 4+.H_B?"G@XQN.#U)FT'PGJ^EW?AB2YEL9$
MTC3'L)/+9P7W>7AAD=O*'7'WNV.0#4A\7P2P:RS:?>13Z5*L4ML_E^9(S %-
M@#$$-N&,D9/%:VHZBFF:5-?S03R+"F\PPIOD8_W0!U.?PKE1;:;K_P 08M0T
MN_2:.TB:+5(X2&1I8W_<*_HZL9&]?E'MGH?$NGW^J>';RRTR\%I>2J!',20!
MA@2"1R 0",CD9XH P=<\=-8:%XBFMM/D_M'1U3S(7="HWKE6R#R!W'7(Q[UU
M+W4J:;)=&TD\U8R_V<LNXD=L@E?UKB+CP)J=W:>)X#+IEJFL6D,<<=O&VV&2
M,$8[97GKC)]!W[B)+B6P$=X8A.Z$2>3G:"?3/)^O?VH \]3Q)J&IOX!UEK:\
MC>^:9I+2"4;9P;5V7Y=VTC.,%L8QDXKI;?QMI\VEQ74D4MO.]W+9?99W166:
M/=O4MNVX 4G.>F,<D"LO2O".LV,'A"&::PD&@%U8HSKYJ&%HAC(/.&W'\O>H
MO^$,UR"(WEE>64.J0:Q<:E;;R[PNDV0T4G (X;J.XH ZCP]XAM/$EC-<VJ21
MF"X>VFC?!*2+U *DAA@@@@X(-8=S\1K.TCNKB;1]46QLKTV5Y=[(]ENP*C<<
M/DKEARH.!UKIM+344M-VJRV[W;MN9;<$1QC &U<\GIG)[D].E<!I>E7/B33O
M&&C!K9;&ZUR=)YO,/F*G[LL N,$D# .1C.<''(!U*>+//U^\TBVT749I+.5(
MKB51&$0.F]6R7Y!&/<9Y K-TKQ?86VBZ"+33]6GCU26>*V$KK)('3S&*NS/W
MV-CD@#&2 *U=)T>^T_Q)K^HO]F,&H-"T*+(VY?+C"8;Y<<XSQG'O6)I?@[5K
M&T\+PR263'1[R>XE*R/^\$BR* OR]1YO?^[[\ &Q9^,;2\L8Y!:7,=X][)IX
MLGV^9YZ9+#(.W 52V<XQ[\55U#Q%:SVM@][I^K6S'6([(*I\K;,'PI8AAOB/
M7C((ZBLU_!6M(KWEI=V4.IP:U+JEH6+O$RR*4:*3@$94GD9K4U70]<U;3]-%
MQ/8F[M]2@OI%4LL:K&0?+0X).<=3CDGCM0!!??$.UL%U*5]&U5[72[K[/?7"
M)&5A&U6WXWY9<.#\H) !) XS?O?&-I8W6V2TNC;"[@LS=  (9)0NPJ"<LOSK
MDCIGO@XYFQT^[UZ3Q]H\#VR6M[J9@FF9SYD:M;PJY"XP3C.,D8-6=4\$ZS=R
MWBQ76GO%]MM;FSDN YDBCB:,^1QPJY0G(ZDG(YR #6T"68^//%D#SS20Q_9&
MCCDE9ECW1L3M!/R@GG J;5?%W]G:S/I,&BZE?WD5J+O9;"/#QEBN06<<@J>#
MR>P-2Z3HU[9>*=;U2X>W:'4%@""-FW*8U*G((QSG/4X]ZQ[B6\7XN3K8I;22
M?V#'E)Y2F/W[X/"M^6._6@!C:[#K?B3P3J>F75P+'4([IC&795;$7 =,XW*<
MCV-:]GXPM+G4K*SEM+JU^W1S2VSSA5W+$0&W+G<N0<C(Y'H>*S['P9<Z5/X6
M6UG@D@T<7!G9R5:5Y@=Q4 $#YB3@GV]ZH:?X(UI+W1Y]1N]/F:T%S%=SJKF6
M[64 ;R3_ !8&,=!V..* .BM?%EO<O9R&RO(["\@>X@OF0&(HH#9<@Y3*G*[L
M9'H>*BTWQMIVI:Q:Z<D<B/>0-/;2;T8.JX)!"L2C8(.& X]P15+0O#6O6NAC
MP[JM_9S:1!;M:12P(PGFB*E%#Y^5<*>V<D#ISFYX8TWQ-IL%O8ZQ?Z?/:6<8
MBAEMXV$LX PIDW<+@=0N<G'(Z$ U+_68[/4+?3HH9+F^N(WE2&,@8C3 9F)(
M &64>Y/UQRVO^,&N_"]I=:3#=!I]5AL+E,JDL#>>J21GYN&/*Y![YR.#6UJN
MAWC^*=/\0Z:\)N(+>2TG@G8JLL3E6X8 [6#*#T.>1Q65<^#+W^QEM[66V-U-
MK2ZQ=-(S*FX2B38N 3T4+D^F<=J +6MV!TGX>^(&MKG4(G-G<748DNF:2W?R
MRP57!R ".F2.O:HM&\8J/[/TN\TS48;B:P$]K+-LVWFQ 7VG<2&YSAL'%=#K
M6G-K'A[4--,@A>\M)+??C<$+H5SVSC/M6-9>'+V:ZT>XU4VR'2;9X85MG9_,
M=T"%R648^4'"\_>Z\4 3V/C&RU#_ (1]HK:Z5-=A:6V9@N$VIO(?YL@X],BD
MM?%-OJVEO>6]E=RV,EK).D\+I\RK@%>&!5^<X..AZ$$#$T7P?KNGOX5CN+G3
MC!H(EB!CWEIHVC*!N0 K8/3D<=3GB:P\&WMI?W&HHEC9W-S8R07<=I(XAO)F
MVXE9-H"$8;H"3OZ\<@%BP\6VL%CX>L['3=4NCJ6F_:;,,Z,[(JH2KNS_ 'L.
MN23CW)JU!XXTVYTG3[U$=)+[S/*MYG2-E,9VR!B6VC:W'!/)&*HZ5X5U33[C
MPH[O9NNB:;)928D;,I98U##Y>!^['_?7MS2M?!GB#3+#2+C3KS3UU739KOY)
M2[03PW$GF,K$ ,I!"X(!^[[T ;%CX[T_4X+%K*WGEN+Q)W2V9D1_W+!77EL%
MLL, $@CG..:MCQ3#)?FS@L[B:>-8'GC4J'B$I !*D@D#JQ'3W.16=KGAF_\
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M-[26,EVAFMV+JS @ @MCOT'O70Z)'KWE-)KTM@9L!5CL0_ECU8E^<GT[8[T
M8<=_<>(OB#JVBFXG@T[18(#+'!(T;3S3 L"74AMJJ.@(R3SGI6E,8_"[W=]<
M7UW/9S^1!;6LDAE<3%V7:A8Y.\N@Y/&.H'2"Z\/7]EXLF\1:(]L9;R!(+ZTN
M69$FV9V.KJ&*L 2/ND$>G6EU_0-1\0Z0%EN8+2^@N(;NT6/,D<4L3;AN) +
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M=4LU>2"ZMUN(5X#,K*& YX!YKSZ?Q/?ZOHGA367M[NUDFUSRC#!-Q-'^^ 3
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MPUM-&Y4X<8/!4D,I!!!!JG?>,[*Q@O;QK>XDTZPN/L]W=Q[2L39 8XSN*J2
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MCX15:)MI^7K^Z_\ 'O;D T]7\=Z5H\UP)@TD5K.D%S)&Z9B9MO.PMN8#<N2
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M=LBR;\;<$G^ ]<5R%_?V%_XC\3:5KFKS:9-;&!M/>.?RG6(HK;X@>&8R;P<
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M#9Q2+N+Q&,N=Q/&<[R#C!'K6E>^(+A=3NK#3---_/9+"]R@G$3!92P&S(PQ
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MN5VX^T3@L1,??]Y-Q_M#TKJ:* .(U?P9J&I0^*XDN[6,:XT)0D,?)$:*O/\
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MM0F325F@U;2^'N+<2('$J=1-MW$$'GYNXKV)412Q55!8Y) ZT*B+DHJC<<G
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M;Z=>-I&HO?6$UTTL;@+Y*$@;EAQQL!]. 2?>NEVJ005&#U&.M"J%4*H 4<
M=* /)-.DTJ['CR*Y\4MI:2ZK,,PW,:DKY48W $$GG(XZXP.:?X=O;AK;P3#X
MCTZ#3]*ET^>,6SIMA^T!E$6]6X!,08@-W8]Z]8VJ.P_*D=4=2KJK*>H89% '
ME%M=06<%A9ZE*O\ 9\FMWBZ7)>29M1;JAVAP?]8,EA&,C. 0>!6?I#V&I:;X
M$M+VY$@&I7]K-&TK+\@6<*A&<@?<&#V('>O:"H.,@''(XZ4;5]!^5 'D&OOI
M4.G^.M'U800W%G8;-(AN&Y%LMM\GDEN2=X;<1SG /05U?BB.'4/@UJ.Q$N$.
MC,Z8 8$B+((]P1G\*[-HT<@LBL0",D9X/6G4 >;VUSI$_B6QM;T61\/3:,&L
M"VT6SS;SYV/X2^W;[XW8[UL^$%U _#E4OGFEE\NX6%I<F1X=SB(G/))3;[]*
MZUHT90K(I4<@$=*=0!Y!X9T^V6S\!WF@.#J_V98]1V3%LPBW(991GC;($4 ]
M#P.E7/!,VF:K>:)=/JLR^);5'CU"S2)4E9]N)/M'&2@89!/&<8ZXKU%412Q5
M5!8Y) ZT!%#%@H#-U(')H X#QG?6,/BVVL_$-W%::+<Z>RP2W,8:$S[_ )P2
MW"MLVX)]\=:KKMLO$WA"UM;V:ZFCT>^6WDO2!++_ *GRRW3KCN,X'UKT=U1P
M ZJPSD C/-+@9S@9H \C\/3VNI6-I?Z7JDY\5VNGSQW%DD2K(T_E'/VD8R0)
M ,$]R,=:T="?PSK^B1S6):?5?[)D@OK8<MN*C=]I4]7W@@%N22<9&2/2@BJS
M,% 9NI Y-"JJEBJ@%CDX'6@#QW3M3TBVT#P9'>W%I;Z#-I1BGF:%7@^VA(N)
M<C:&VAQD]\CK6EI\NF:;KNCZ5JU^]SX>.ER'3[C5"/+FE\XYY. 2(]NS/.TG
M'6O4&C1DV,BE?0CBAE1P-RA@#D9&<'UH X_X6/"WP\TY('#+&\Z<')'[Y^#[
MXQ794@ 4    =A2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVEXV0.60;#\P!^Z<#CK5J3QF;#4=0@U?3Q:PVVG-J<<D<_FEX5.&#+M&U^G
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M=IPNY3WSC![\=C7D^FR7SZK/>65W;M?O>RW TN]T643(Q8@ R!@JG9A?,VX
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MQ SR.VYFD/7)[XZ?0"HK;PZT7B#6]1GNHYH-5BBB>W\DJ4"*R_>W'.0QSP*
M,VV\<F2:VFN-*N(M+N+22[%XJR,(%1-^)<H%7*YP0S#(QZ$V(_%5ZVI:';RZ
M5''%K*2/ YNLO&%C,@#KLP"1@<$XYZXYKZ5X,OK32I-$U'7Y;_15MWMH(/($
M<@B92@5Y 3OPIP.!V)SBL==,U#1/%7@NRU'6%U!+9KF.)Q;"(JGD%5\P[CEC
MP,\ GMF@#:M/&S76F:#?'3@BZKJ#V!7S\F%E,HW?=^8'RCZ=15)O%46CV'B+
M4;?05$EMK,=K<HEQS.[B%1)DKC/[Q!CVZU)!X$O;>/3;9=;C^QZ;JC:A;1_8
M_FPQD)1VW\\RG! ''4'M+>>![FZL-:M1JT2#5-2BU M]D)\LH8R%^_S_ *I>
M>.I_  GN/%>HVSO92:,G]J)"UPUNEP\B>7N98_G2,G+[3P5&,'FMBSU9[OPY
M'JPTZ\CD>W\[[%)'MF#8SY>TX^;/%9NL>&M0N]=MM;TC61IVH);_ &6??;>=
M%/%NW %=P((8D@Y[D5I7NDO>^&[K26OKA9+BV> W8/[P,RD%QC !R<X&!Z8H
M P%\=2*=6BDTZ%KG3]-&HF.&[W@CY@T;-M&UP4/8]:DL?%^H7=_;6CZ+'')?
M:8VH60^V9\S;LW(_R?(?WBX(W?ATJN/ M\S7#RZW!OGT;^R66*PV(JC=AE7?
MQ]\\9Z]P.*M#06T:YTS6;G40\.BZ7):ND=HQ:1"$)8 ,3G]V. #WH L:/XJ;
M6K#1;B"R59=0\PS0F8[K41Y#Y^7DJ^U"..6%2:]XANM)U?2M-M-,%Y+J1E6,
MFX$85D0MSP>..OZ'H:GA+3+0:AJ^O6B7"6^ISB2WCF1DVKM7>ZHP!7>X)((Y
MP#WJMXL,I\;^#Q;S112I-<DM(A=0#"0,@$8R>!SU]>E $4?Q!N7LH"VAE;_^
MU_[(N;4W0Q%*1N#!MOS*1@YP.M:,7B;4KB2[M(='A;4K"V2:\MS>?*C/N*QH
MX0[B0N<D <KZG$,W@IY%@>/442Z&KC5KB4VY82R ;0H&\;5"X'4GBKLWARYA
M\1WFLZ7?I:RWT"0W4<L!E5BF=CKAEPP#$=P1CTH RH/'MQJUQ:0Z#HPO?MFF
M?VC"TUT(1C>%*-\IP021QGGVY%C2/',>OP:8FG67^GWMO-.]O<2[!;B)Q&X9
M@IR=YP,#G!/%9%GI/]B?$#3=*T>XBABM- -NK7$9DW'S5.#AE^8_>^F>.XU[
M;P.FESZ5=Z5?>3>V,<T,DDT6];E)7\R3<H*X._Y@0>.G(H B7XA6AM+1I88K
M.XEO)K"9;R?RXH)XNJ&0*0<\;>!D'L>*LWOBZYMU,$&DF;48K&.\N+4.Y";]
MVV,,D;98E''( X'K3E\(&*R>U2XM9HKJ:>>_BN[3S([EY6#$[=PV[<8'7CCK
MS5"W\!7FD2:?-H.OO9S6]DEC<>?;"=+B-"2IVEAM92S8.3P<<T 6;CQ(^M65
MW96.EL\JZ:EU=0WCF!H?-5ML9&TG?\K9!P!@<\U/X#:1?AIX>>-!)(-+@*J6
MQN/ECOVJ.7PC>0ZW-J6F:QY+7EHEK?+<P>=YVP$+("&7:X#$=QSTK4\/Z/-H
M/A>QT<7:SR6=LL"3F+:#M& 2N[V]: ,+1/'5QJK^'I)]'6UM-<B=H)/M6]T=
M$+D,NT#!53@YSQR!4R>.%-CIFK-8@:+J-TMM%<B;,B[V*QNR;<!6('\1(W#C
MKAFF^!YM.MO"\']J1R)H.\#-J1YX:-H^?G^7ACZ\TZQ\#_9--L]&DOQ-HUE=
MK=6\!AQ( K[TC9]V"JMC^$$@ ?4 K7'CV]M[2_O3H2M::?J@T^Y(O!O.610Z
M+MPW,@R"5^I[3W?B::2U\3V&IZ+$9--L1</ EUO2X@=7XW;!M.$8$8/;DTEQ
MX'N;C1]8T_\ M:)1J6IKJ!?[(?W9#HVS&_GF->?<U:O?"=S>7^O77]I1)_:^
MGI8E?LQ/E!0XW??Y_P!8W'';\0"M!XGNUN=,TC2M#B8W&D"^@#W?EH@&Q=A.
MPG WCD ]N.X=:^.DU'3-*GLK$M=ZA:-=B"1GQ$JD*061&/WC@?+C@GCH;%CX
M6NK+5]-U :E"[66EG3@AM2 ^2AW_ '^.4''UYK,MO %]IECHO]EZ^+;4M+AD
MMA<-:;XYX78,4>/?V(!!#"@"U'XWEN;.U\C1KF/49K5KF2SNUDC:(!B@4[8V
M/+*V#@ @9]!6S;:O/?>%EU:&PEM[A[8RBTO08F1@/NOQD<CTK*OO">I/J%CJ
MNF^('MM4A@:WN)I[831W,;-OP4W+MPQ)7!X!QS7116973?LDT\D[-&5DE?&Y
MR>I]!UZ#@4 <MX?\67U[HOAR*>W@FU?5;'[6 )BJ"-40L[';E3N< * >O7BM
MOP[KR:]:W3&W-O=6=U):74!;=LD3&<-@;E(((.!P>@K$L/ ]SIUOH#PZNC7^
MBQ-:PS-:X26W*JI1T#YS\JG<&ZCICBN@T31H]&ANL2>;<7ER]U<2A=H:1L#@
M9.  % &3P.IH X2^N)9M6\9:AJVEVM[%H;0W%NOVMT>+RX1* C!,C)))Y'7!
MR*ZL^*)/[7AL$L QFTI]2C;S\?=9 4(V\??'.>W2HSX1>:3Q0+F_5X-?38Z1
MP;6A'E>5P2QSP,].M5K/PAJD.I6M_<ZW!-/;Z8^G +8[$*L5(;'F$Y^09YP>
MV* *D'CW5)=(T?57\-JMIJLEM';XOE+YF!SD;>,8'?D$=.0$UCQ4)O"GB4:O
MH,,SZ5,L%U9BZ+1RJRHZL'V ]'7C;VJ\G@RXC\->'M'75(_^)-/!*LIM3^]$
M7"@C?QGN<FF:CX'GU"S\36YU6.,:[+'(Q%J3Y.U$3 ^?YLA!Z<YH O3^*E3Q
M-)H4$-NUU$82T<MQY<DD;D;I(UVG>JC)//8CCC/+:/KD_AH^()DTU)=._P"$
ME,,\OG[6C\SR4!5-IW8+#()7CIFNDUGPE)KUPIOKRW>*.XAN(&%J1-;LFTL(
MY-_RABOIQN/6JMQX'N9]*U:Q_M:)1J&J)J1?[(?W95XVV8W\C,:\^YH WO$.
MM1>'M%FU.=-T43(K$DA5#.%W,0#A1NR3@X -9C>*YHFTDO96\D&I7_V.*>VN
M_,0@QLXD4[?F'RD8XP?6MO4K6ZN[ PVMTEO/N0^8\7F*0&!92N1D, 1U[URP
M\ "VLE73;R"SN8]6&JQ!;8FWC?9L*"/>"%())PPY)/'2@"Y'XR#F[A:R"W<>
MK?V5!&)LK+)L63<6V_*-I)/!^Z<9K&\6WE[=6FDR7NDM;75IXCM8X@LH=9UW
M AD8@<'..0,$&K<O@"XFM;[.N,E[+JBZM;7*6P'V><($Y7=AE(!&..">3UJ_
M>^&-2U*RL%O=:22[MK^&]>46F$8QG*HJ!_E'J22>?H  7?#^NSZM<:I9WEDE
MI>:;<B"5(YO-1@R*ZLK%5/(8<8X(JE?^+I((=:N;'3Q>6NBMLNV\[8Y*H'<1
MKM(8JK#J1DY%7](T.73-:UK47NTF&IS)-Y:P[/+*QK&!G<<\*.PYK.G\'R_:
M-<6RU$6]EK8S=PM!O9'*;'>-MP +*!U#<C/M0!2DUZ[UG7]1TY(K:71FT2.\
MC?S"&99?,PQ&W_8'&1@<Y.<"IX(\1SV6A>$=+O;!8K6\T=7@NA/N8F*)"V]-
MOR@@Y!#'IR!6VWA)H=8:\TZ^2V@;2TTTV[0;P%0N4(;<,8WG([X'(J"R\$R6
MJ^&8Y-1CEBT2U>UVFV(\]60)R=_R\*/6@!MIXUN;V>Q,&AW$EG?V[S07"^9A
M,+O42YC"IN'0AFYX]ZT/"?B"^\2:9!J4^E+96=S;13V[?:1(S;@=P(VC&.,'
MG(/;I5+0O"FK:+:+IW_"1-<:9;(T=E#):@/&N"%61PW[Q5!X&%Z#GBMCPSH[
M^'O#>GZ.]R+G['"L*RB/9N51@9&3SCWH YJ^\4Q:$_C'4(=#0W.FM ;AEN,&
MZ!C!4YV_+A2!CFMBT\0W\^O:AHT^EQ07<%K'=V^;K<LL;,R_,0GR,"AR!N'/
M6J&J^")]3C\3QG58XUUWR@?]%),(10O]_P";('M6F-!NQXHGUP7\/F2Z>ED(
MOLQP"K,^_._GECQZ8YH Y#P9>11Z/X8U.>P@E\1:Q;M''.+AE,R8\V1Y3M[$
M<<,02 " 36S<^/9+6WN%;22U_::G!IUS;+<#"F4J$=&*_,"'!&0O<'%.M/ L
MECHOAVVAU1?M^@DBUNC;_*Z%2K(Z;N05/8CD U)?>"7O(9Y!J$:7USJ5OJ%Q
M/]F)5C"4V(J[QA<(!U)Y/KP *OB?7/[9CT9_#]NFH264EV =0S&-LH0 L(\\
MA@<X[XQU(ATKQU/J)\/3R:1]GL=:+11R&Y#21RJC.04"XV_(P#;L].!6O+H5
MP_BV/7DO8E,=@]F(3 3G<ZONW;AW4<8Z9YK*L/ ]Q8Z=X;M!JL;C1+AIU;[*
M1YV5=<'Y^.)#SSVH F@\8ROKUCI4^G)!+?&X6)&N<RQF,$@R(%^4.HR"">U8
MMOXDNK_P78ZCKNDVMVLVLK JI.0(S]L,:-@K_ 0N/7'.*OZ;X%O;"ZT>5M=$
MRZ7<SRQ@V@#RK*&W"1MYR_S?>P/IGFGCP-<IH":.FL)Y$.IB_A+6F2H$YGV'
MYQD[CC=QP.F>: +5_P",'M[76KZST\7=CHTICO'$VV0E55Y-B[2&VJPZD9((
M^M.]\=W4;:VUAH\=W!I=E#?F5KORQ+"ZN_ V$AL)P.A[D=[,W@V3.NV]KJ(A
MT_7"SW<!@W,CL@21HVW#;N4#J&P>?:DF\%NS^(%M[^*&#5M/CL%C^S$^0B(Z
M @[_ )N)#Z=!0!T/V\/H_P#:,$$LRFW\](D'SO\ +N"@>IZ5S2>.Q&^J175@
MGG6&FKJ#):W'G<98-&WRC#J5YZ]:VI=%>;PD^AM>O&[61M/M4*[&7Y-N\#)P
M>_6L2T\&ZI:WPOEUZ%+D:8FGKY-@$1=C%D8+O/')RN>?4#B@#<T+6#K5N]S&
M+1[8[3#<6ESYT<H(YYVC!!X(JE%XJ%SXDNM&MX8&FM9UCFC>XV3;&0-YJQ[?
MF3YL9![&I= \-1:'J&IWJ&!9-0:-I8K:'RH@R@C<%R?F;/)SS@>F37O_  FV
MJ:Q:WUY=0/\ 8[U;JV=;;;/$!_RR$F[E">HQT./0@ KVGC6:_N]/-IH\\]A?
MNZ17*"0[, [7D'E[51L=0QQD<>EKP-J^HZ[X:34-2C@262><+Y+EAA9G4#!4
M8P  .N<9XJ'P_P"%-0T"46D>O/+H<4C26UD;<"2,$DA#+G)0$\# /0$XX.AX
M8T*7P[ICZ>UZ+F!9I9(/W.PHKNSX8Y.XY8C/' ''7(!QUY=P/K_BZ^\26<$M
MAHS6TL3).QDAVQB11'\HY9CSR.N#D5T[^)KJTUBWTN_TV.&XO+:2>S,=QO61
MHP"\;$J-K $'."",^E07'@I+^7Q,NH7BRVFNJBO%'"4:'8@0$-N.3P#TZU/#
MX;O)+JRO-2U**ZN["VD@MI%MB@W.%#2.-YW-A0."!RWJ, '/S>.-?O?#>DZO
M::-;VEMJ-U8K$\MYN9EEE"LNT)QV&>>&SC(Q4$NKWGAWQ1XVU.WTN*Y%M:6=
MU=)]I\L*JQR%]IVG<W7 ( ..HK=7P5*G@?2_#RZFHFTV2WD@NOLW!,+JR[DW
M<YVX.&%%WX-NKS_A)=^JQYURS2T<_9>8@J,FX?/R2')[=J .@O+I6T.:[2$3
MQM;F01,VW>NW."><9%<KI/BF;[+X<TW1] B5+_1Q>6T;7>Q(541CRR=A. )
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M8$ X]AFK5%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% &5::,\&L7&HW.HW5XS%A;Q2A ELK8RJ[5!.=HY8DX'N<
MZM%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0< [ <'D<].E '>6=W#?V-O>6S[X+B-98VP1E6&0<'D<&IZQO"/_ ")>A?\
M8.M__1:ULT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDEN[B.!'D6)6D8*"['"J/<D@58H **** "BHHKJWGFEABGBDEA($J(X+(3R
MP[?C0MU;O=26R3Q-<1J&>(."R@]"1U .#^5 $M%%% !15*TUC3;^ZEM;2^MY
MYXE#O''("P4]&QZ<'GI5V@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M1VEW<M+%#&PP40'H,<<Y(' /)I=/\$V.GWFF7(OM2G;3$>.T6>XW"-' !7@
MD *,9R?4GB@"3Q=JEWI-MIDMJ+=A/J=K;2B:,M\DD@4E>1AAGKS7.:SXL\16
M*>*[F*73_(T&YBVQFW8M/&T<;E2=_P IPYYYSQP._9:UHEOKD%O#<RSQK;W$
M=RGE$ [T;<I.0> 0#BLV\\%Z??0:U#-<WA3675[L!U&2JA1M^7CY54?A0!MZ
MA/);:;=7$7D^9%"[IYS[$R 2-S=AZGL*X5O'E[I?]JO>K'=Q6NCQ:C&ZPM"&
MD9F0J,\F/(&&QG&>O%=O?Z;;ZGI%QIE[NFM[F!H)LG#.K#!Y&,'GM6)%X$TD
M2O)=2WUZ9;'^SY1<W!82PY. P&.1D],>O7F@"+6-8UKPU87VHWLEA=V:6\?D
ME5:-A<-($P1DCR_F4YSD<]>M)K6M:UX9LKZ[O7L;J!C;Q6;A61A-)((VWKDC
M8"RG(.<9'O5BU\#Z5#H]SI=U-?:C:SP_9RM]<&0I%_<4\;>@YZ\#G@4Z+P5I
MG]BW.EWL]]J4-Q&(F>]N#(ZH#E0IXVX.#D<Y ))P* ,S5O$FL:+J6I::[VL\
MBZ/+J=I<-"0 T1P\;J&Y'*D$$=2#GNVT\0:YG0+:[N;$W.O 20M';L!;QK#Y
MDF<L=[$X Z#DG!QBMM_"UK-!=+=7=W<SW-H;)[F5D\P0G.5&% &<G)QD\<\#
M#;OPA87FEZ99//=I)I95K.[CD"S1%5V]<8.5X((((ZT <MH=Y?Z6OB8_:;03
MOXD\J29T890PP_<09+2$8PH[Y/3BI1XPUR32K>2,6BW'_"0_V3(9H&&Z/?@-
M@-\K8QD<]^E;1\!:65E/VO41.]^NH_:!<?.LX39N'&.5X(QCGZ4Y? FF1J5C
MN;]1_:(U+F??B<<@_,#QGGW[]J ,M/%VIV4FHZ;>M:37T.L6^FP7"1&.,B9$
M<,R;B<J&88SR0.F<U?O]8UO13';7?V6XDO=02UL981AMAC9R71B%W#8X&&P>
M/H;%YX(TK4$U9+M[F4:G-'/*?,"F.1 H1XRH!4@*N/I]:+CP5IMYHC:;>W%_
M=,TB3"\EN2;A)$^XRN,;2O;  Y/')R 6_#]QK<J7D>M6R1-%.1;2*5!EB(!!
M959@K Y!YYQGBN>UWQ-KNF7WB"QA-HUU#:17>DH;=CYX9BC1MAN6W[1D8QO!
M-=7I.DQ:1:F%+BZNI&.Z2XNY3)(YZ#)]AV  _,TEUHMC>ZQ8:K/#NN[$2"!\
M_=#@!OKT% '.3>)[N^\,:EK6ERVLMK;Z0+E/.@+!YC&9"K888 7;D?[?7C%0
MV&HZK>^.M%4WB):RZ ;I[<1?+N,D0;OUYX/8=N36_%X6TRW\.7>A6R/!977G
M"01D;L2DE@"1Q]X@>@QZ4U/"ME'>:==QW%VEQ86IM(Y%D +Q94@.,8."JG\.
M<B@#BO!6JZII>B>#X?,M7TW4;B>T,(B/F(1YT@??NP>4QC;T/6NG^(5U?6?A
M<2V%U]FD-[:QNVS=N5YT0CJ,?>_I4UKX*T^SM=(MHKF\\K29VN+8%U.&8,#D
M[>1AV_/Z5J:WHUKK^E2:=>&18G9'W1-M961@ZL#ZAE!H X74;C5]/\5^+[W3
M[FT2YM-&M)W::W++(4^T':%##:#@\Y./>M63Q/K&K-+;:';*+N+3;>\PRHRM
M),&*H=SKA?DY(R>>V.=63PC9RS:G*UW>EM2M%L[@F13F-0P&"5SGYVY_VOIB
MO<>!--FFL+B*\U*TNK.V6T%Q:W/E/+".B.0.0/P/O0!M0SWLNB1SRQ1VU\UN
M'>,GS%CDVY(R"-P!XX/-</I7BWQ*]IX3U:_.G26&O%+=X88'5X)7C9U<,7.X
M$J<C P.YZUWLD26FF-#!$VR*+8D:#)P!@ 5R?@?PQ):^%?#ZZK]K%YIT "6\
MY4K;R[2I9<#DX+ $DX!.* ,ZT\7^(%T*'5[R73F2YOVTN&%+=UQ,;HPK(S;S
M\H4$E>IP/FYXN:QXROO#.H:I8WRPW7DV,=[:3*IC!WRB$I)R>C,IR.Q/<9.S
M'X,TM?#D^A2FXGLII6G_ 'C@.DC/YA964 @[SN'H:EE\*:==V][%J7FZ@U[;
MBUGEN2-S1#)"C:% Y8G( .><\# !0U;5];\.VUW<WC6=W;NUM%:,BE'$LD@C
M;<I.-@+*1\P/4$]ZIWGB/Q!HJW"ZA9Q;+BZMK739Y-JDR2N$;S%1VX4G=D$9
M''!YK3B\$Z8=$NM*OI[[4H+F,1,U[<&1U0'*A3QMP<'(YR!DG IO_"#:9+HE
MQI=[=:C?K-L_TB[NB\R;#E"C<;2IY!'?KF@#E]2OM4T#Q)XTU)+BWGNK/0;>
MXA9X2%(5ISM8!N>0>01QC\>@N?$.IIK[6$1M1&VAOJ"%XF)6565<'##*\].#
M[U:3P5IS2W\MY=7U[)?V0L;EKB;[\0W=E  /SGD#]<FFV_@FQM[E;DW^IS7*
MV36(FEG#'RB0<8QC/ [>_7F@#'T[Q/K[Z/X?NKM[2:;7XX3;QV\&TP'R&ED)
M+R ,3M&!QC)^]CF6Z\1^(M'TQ9]:L&A@2]>.:[MH1,R6^W*2M&C-MYX;&<8S
MCGC7N/!>EW7AFQT&22[\BP\LV<Z2[)H"@PC*X Y XSZ=<U/!X:BMHK?R=2U%
M9X69FN6F#R2E@ =^Y2",*O&,# Q0!<T2]_M'1+.\-U;W1FB#^?;?ZN3W7DX'
MMGBN+A^($]O9ZE/J&V&_T^RDGN-*GA,4B.& 0HY.'B.2-PSU!XSBNWTO3+71
MM,@T^R39;P@A03D\DDD^Y))_&LI/!NF/$D5ZT]_'':264:W3*VV%]NY<@ G(
M51DDGCZT 8/B+4_%MGH/B*5E2"VBTF6YM[S8BR),H)*!5D;((Y#=N^>*['1Q
M.-&L_M$JRR^2I+JFT'CCC)_G619>"--M-)N],ENM1O;:YMFM,7ET9#'"PP40
M]AC'/7@<\"MO3K%--T^&S2::98E"B2=]SGZF@#SFQU2YT>P\27UVUM>2_P#"
M1?9X!) 0%G?R8UD)W' 4'H.>.M;&L>)M8T2]UC3F:UGE@T:75;.X:$@?NSAX
MW4-SR5(((ZGKCG6'@S3&T[5;"X>XN;;4YVN;A97&1*<?,I4 J054C'3%2R^%
M;2YMKV.[NKNXFO+7[%+<R,GF>3SE!A0!G)R<9/KP, '+W][XG<^%)IM5LT34
MM0C_ '4%JP"J;=WVL2_S89>VW/Z52_M75-!;QCJME):^1;:]%YT,L19I@T=N
MC ,&&S ;(.#S^O;W7A>RO--TRREGNA_9DB2VTR2;9%*J4&2!S\K$'COZ\U5N
M/!.GW-EJMI)=7OE:G<K=7(#KDNNW&#MX'R)_WS[G(!NW\DL6GW,D!C$R1,R&
M12RY [@$9'XBN'T_Q+KNH1>#8;9]/M_[:TM[F5C;,WE.B1M\H#C*_/T[8ZGI
M7=3V_P!HLY+=I7&]"A=<;N1C/3&?PK$L_!]C8OHS075X/['MWMK0%E(", "#
M\O/"J/P^M #_  =J]UKGAF"]OA$+KS9H)3$I56:.5X]P!)QG9G&>]<)XBN-2
MN?"GQ'%Y>K/#;W/E11^5MV#RH6 !ST&3QCKSFO1]#T6WT#3OL-K+,\/FR2CS
M2"0SL7;D =68G\:S;_P3IFH+K"237D<6KE6NHHYL*6 5<@$'!(103[<8R: *
M9UO6K77=;TJYEL97ATQ-0MG6W953+2*48;_F'R YR.IK+N/&E]9^'-!OKGR[
M"WOM+CG-]]E:2WCN652J2;3F-.>OZC'/4R^&;>?4[G4)+N[-S<V0L9&R@'E@
MD\#;URS'/O\ 2H$\'V<>F1:='>WRVB60L&CWH1)" 0%;*]0"1D8/O0!K7\4=
M]HMU"]SY44]NZF=&QL#*1N!]LYS7 Z5>W^@:GH'A_P 7:7$1;RB#2=8LQ^ZD
M?RV14=>L;%21Z$].E=_-IMM-I$FE["EJ\!M]J'&$*[< _2L]/#-N9[)[J]O;
MR.Q<26T-PZLL;@$!B0H9B 3@L3USUYH QM-\1:_J_P#9VJ65BCZ5<7#I.K[%
M\N$%E#JV_)8$#*[><D#IDV-#U;7->L-)UJVEL4TZ_1WDA=3O@4@^45(/S-G
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ME2Z$J>1R.F>U<EJ.G7>O:'>ZAIGAN_L]51+?<NI3GS+CRIEE,*DNWR_*PR<
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MG)&[G!(ST)%4_"VH7^F^'['1M4TB]74;*!+8F&+?#/L&T.LGW0" #ABI'3%
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MMOLV82I19$W$MU(&2,DX XZ5T6I:_IFD!C?70B5%#R-L9A&I. SD A%)!Y;
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MVGPW]A.D]K,NZ.1.A'3^>1BJVH>(=*TJ5X[V\6)HT627Y681(QVJSD A 2"
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ML4*6<<TI=;92,83/MQDY(&0#@FK-OKNFW/VH)=*C6BA[A)E,31*1D,RN 0N
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M9LO)M^[R,;=O48Q@\]234!\%Z7)HTFESS7]Q%*\;RRSW;R2OL8,@+L20 0"
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MW-PU[;_99YY)<R-#S\F1T'S-TP3G/6FZGX1TO5M,LK*Y^T@V)#6MS%.T<\)
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M7RVTKJ!.JW9F"[@2/F7'7OUKOM,TRTT?3H-/L(C%:P*$BC+LVU1T +$G%6Z
M/.O$GAO5/%%UJFI64$EE))HPLH8[G"F:3S1+A@"<*-NW)_OGMR;6K0ZUXJ\,
MWK0^'FTO4Q'"5%W)&'G>.59/+#HQ_=_*PR2/O9P.:[NB@#S34M)U+5],&J:?
MX7FL-0MKJUGDM[N=&FO%AD#F,,&(VCJ-Q&3V'=VJ:3K&OS^,)(M'NK9-4T..
MVMC<M&I,J^=\I <X^^O/2O2:,XH \],&L7VOOJ)T&]@@?P^]F!(\6X3%\A2
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MVI6.K>$-,COVDM;VRG:421)N+)&A7D <#=T'IS65I/B'Q UCX:U.ZU19TO\
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ME[]O15N90%GW%MP^;@9)..F2>*34O".G7EOK CCE$^JA/M+FZE4,5P%/#<8
M'"XR!CO0!K:K)-#I-Y+;R".9(79'*[L$ D<=ZX?2]:U_5[GPM;?VL+==3T W
MMQ(ELA?S1Y/S+D8'^L/&,>WIW)L8Y-,^P3O++&8?*=RY#N,8)+#G)]16=:>$
M]'L9K&6VAG1[&U-I;'[3(?+B.,KRW/W5Z\\#TH C\$ZK=ZWX/TZ_OF5[J1&6
M5U7:&979=V.V=N?QK?JCI&D66A:;'I^GQO':QEBB-(SXR23RQ)ZDU>H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME:UD1-C*X8D,A&#E<]^#FNLU?1GU'P=>Z)$T5L]Q8/:H8EVI&2A48'91Z>E
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MQC65L;49P-JL<C@GN/45Q%SH7B!+:[T^+1WE4>)4U5+@7$022'[0LI"@MG<
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MG ;C<!N&""",@YZU?JOIXD&G6RRQ-%((E#1L02I Z<$C\C5B@ HHHH ****
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M#MC9@9'.%!(&!]3BN0M-1US7))]0L]1M[46.L26T\4LWR^3'*4\MH]GWF7#
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MB<HWR\K\Q'8\]35S6==U7POJOB!1?S7T<.B+J$:W"KB*7S'0D;5'R8 ..>E
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M+=S<M*+>*9+>>Y5,QPR/C:&/;[R\@$#(R16%XX\3O;Z!=-I,]VDMM>P6\ES
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MX\S;&RA\?[0 ;\:LV.K7DEE):W.K7;SOXEN;.)%P)+B--Y$6\%?+ "Y+#LI
M!)KN9-'TZ6XLYWLH3+9#%LVS!A&,87TXXX[55?PMH,MLUO)I-H\+7'VHHT8(
M,W_/3_>Y.3U.: .#@U?6+C2=)C.K7,4G_"43:=(T;JY:%7E"J69<M@( "1SC
MD&IAK][I27NG3ZE<-:KXFCT[[7,^9(8'A23!?_>.W<>0&Z\"NV7PMH*8V:19
MIMN/M0V1!<2_W^/XO?WJ1_#FC2V][!)IEL\-\VZZ1XP1,WJP/4\#GV% '+ZO
M?7'A^>TL!K#3VU_JPA9YY2IM4:%F6$R\MEG48)YP^..#6_X:M[ZU@OK:_P!1
M2]*73>5AB[01D B-G/+$9SD\X(S4X\,Z&-#.BC2;/^S&ZVOE#83G.<>N><]:
MMZ=IECI%C'9:=:0VMK'G;%$H51GD\4 >9:KJ^K:2NJ:>MW?7%[H^H#46Q,V9
MM-(#L#ZX&Y..<KGN:V=>U&\'A=M<L-1N8X[O5+3R-CY4V[31Q\9Z*X+/QC[P
M]*[=K*U>>6=K>-I98A#(Y499 20I]OF;CW-07.CZ=>6,5C<V4,MK#M\N%ERJ
M[?NX'M@8],4 >=ZQ JR?%)S/.Q73@%5YF*C=:L2 I..N<>G-;'A^2\LO&&GZ
M>=0N;BUN]!^U/%,P*I(CQJ"@ ^48<C ]!WKI[GP]H]Y///<Z9:RS7$(@F=XP
M6DC'\+'N/:I(=%TRWNX;N*RB2XAB\B*4#YDC_N ]EX''3B@#F]6@5_BMH+-/
M.J_V;=MM69E7*R0XX!QW.?7C/2N9\/27FFZ/X9O;?4+E5N?$%U9RVVX>4T;3
M7!/RXZY4'/7\*]-N]*T^_N;:YN[.">>U),$DB M&3UVGMT'Y#TJLGAK1(X((
M4TRV6*WF,\*!,".0\[U'9N3SUY/K0!R6D7^J:[]GU:/5HK1[?5I+>[@>=F!0
M2M&(#%C"MC:0W7//0XJE)XFU?14U![^*Z;4%TZ\NK&:.8S6=^%PZL!G]VRKC
MY<#()Y/%=VGAK1$UQM:32K1=38<W0B'F'C&<^N.,]<5)::'IEA)OM;**(A65
M<#A0QRP4=%!(!..N.: ,+P^+Q]5MK]-:BN--O++<+?[0TYE<$'SE) VC!P5'
MR\C@52\2K<O\4O"@M)H8I?L=_P#-+$9%Q^Z[!E_G73:3X;T707G?2=+M+)IS
MF4P1!-WY=N>G2GWF@:3J-['>7FGP3W,:E4ED7+(#U /;\* //M)L]1N?$?CS
M2#?,FORI!.NJVA\N-?D(A39SLVXY!+;@2<]*W?#NLR>)K3[<#/ EE9-;75NS
MG N^DB-GJ4V]>_F>PK>FTQ]+TJ>/PS9:;;7;N'"RH4B<Y&XML&2<9Y]<5+IN
MDI::4]I<>7,\[/+<LJ[5D=R6?CTR<#GH!0!Y[HMW*?!?ABQMKZ=9AX=-P;:%
MS"!A4 F:4'("G("@');)&!5M-=O+;2_!_B'4KZY>QU'3U@OUC<@"=X0\<@"]
M&)#+QW=:[(^%= *VBG1[(K9J5ME,((B4]0OH.!QTJS!HVF6NG0Z?!86\=G R
MO% L8"(RL&4@>H(!^M '&>$M0U.]@&F:C=3IJ>B23?VC(\I8.3_J=W3*LK;^
M.Z>AJQX3U>[CU-]/UX75KJ,5B)I&DN/.M;I0P!GB?/RY)&5P,9'%=D+.V62X
M=8(P]SCSF"\R8&T9]>.*S9?"^D-IMQ8QV%J(IH1 4DCWH$!R$VYX4==HP* %
M\5+YGA#6-LDB'[%,P>)RK A"1@CD5R>@W3O=^&/#K7-S%93:"+S<L[*\LH\M
M=@<'("JQ; /<=A7=6EA!9Z7!IR+OMX85@"R?-E NW!]>*J#PUHJV=M:)IEM'
M!:L6MUC39Y1(P2I'(...* ,_P5J%_>Z+=KJ$C7$EE?W-G'<$ &>..0JK''&>
M,''<&N,%[)K_ (>\&>(+B[F:YN]=A:6+S#Y:'=(/+"=!MP!G&>#DG->J6]O#
M:6Z06\210QC"(B@*H]@*R3X0\.M=/<MHMB9GF%PS&$',G]_'3/O0!R^F7^J:
MZZZG%JT5G)::Q);W,+3LP,:RM&(#%C:&*[2&ZY.>AQ5KPU?3:_I^GZ[)K4MM
M<_;IHKJTSN1L.Z"#9G"D84[L;N"3P:Z0>&M$&N'6QI5H-3(P;KRAYG3&<^N.
M,]<40>'-%MM9EUB#2[2/49<[[E8@';/4Y]3W/>@#A]*NS#9W-LEW-#+=>*KR
M-88.'N0&=BF_(V#C<6!SA<#).*@AU;6+G1]'B.KW,4A\3SZ;(\4@9FA5Y@ 6
M*Y; 0 ,>N,D&N\?PKH,MLUO)I-H\+3_:2C1@@R_W_P#>.3D]3F@>%M!7&S2+
M--MP;H;8@,3?W^/XO>@#DI6U.ZU+6?#MMKDMO<Z7;0FVN[FZ*R89=QF=0N)1
MN^4YX^7L3FM#XB[YOA5J<CSMYGV16:2%FC#'(S[[3D\'MUKH-3\-:)K-Y;W>
MI:5:7=Q;_P"JEFB#,O.<9/;/.*O7=I;W]I+:7<$<]O,I22*10RNIZ@@T <)J
M6G&?XA36T.H7EN$\/$^;#-^\)$[8^<Y/!_EZ<5037K_5/"^ES'4K@Z@WAPWT
ML43^2%?:N)V<')Y# ( 023G KO8_#NCQ2B6+3K>.00?9PR)@^5_<X_A[X]:B
M/A3P^1:J=&LB+6,Q0 P@B-#U4>@]J .1T>635/&OAB_NKJ<S3^&OM#A9F5#(
M7@)^4'')/(QSQZ"MOQC=:I:3V4UE;3WMFD<S7=I9W'E7)'R;98^1OV_,"N>=
MXZXK8B\.Z+ ;$Q:7:(;!2MH5B \D'KM].@J>]TFQU&6*6ZMDDEB5E1^0RJV-
MP!'.#@9'?% '$6FLR76IW?V?5+F73Y/"\%]%([E27+2#S/\ 9)"KD=*9H6L7
M6NOH>D7VI3P-<^&H+Y98Y#&\T[\,VX8)*X!QT^?D' KL[KPYHM[-;RW.EVDD
MEM'Y4),0_=I_='MP,#M4%UX1\.WME:65SHEA);6?_'O$T"[8O7:.P/?U[T <
M@]G->^,EB.M7+R+X97=?6N(FF83'YQC. 3SQ_+KT?A_6[N?X9V&N7"FYO#I2
MW+@#!E<1[CT]3_.M=]$TQ[MKIK&'[0T/V<R!<-Y7]S/]WVZ5/96-KIMG'9V4
M$<%M$-L<48PJCT ["@#S>&5KV\^'.MO?3W=Q>&6:4>82C.UI(QVKT7!RH Q[
MY-7_  O>:GKUKH&N_P!L1QQW:,E[;"=G\UV0Y14P!&R,#]WG"G.>M=/;^$/#
MMK<I<0:+8I+'*9HV$(^1SU9?0\GI4MIX9T.PU2XU.TTJT@OKC/FW$<05VSUY
M'KW]: //=-OG\/\ AJ[FBN9$2Y\3W%G---<-MB0W#C<6.=I. I;&?FSUYK5O
M;[4O#]S;V5YK"M9:AJT,.1*SR6<3QN=AE;D[G0 $\@.>>AKKT\.Z-'87-@NF
M6WV.Z):> Q@I(2<DD="2><U'%X6T&'1'T6/2+-=,DY>U\H;&/J1W/ YZ\"@#
MD?$VGM"NDVKZS=W:?\)) %'FLK0(XR(F8'+X/(+<C</:KJ)J6IZ_XQTBWU>Z
MB,=K:FQD#_\ 'N[I(<C Y&0,YSFND'AK1!I$>DC2K3^SXV#I;^4-@8'(;'KG
MG-6+?2K"TO9[VWM(HKF=5665%PSA?N@^N.WI0!P]OXHO;SP9=^(+59A<Z3I4
MJS6[.S WB@[U<9YV%/Q#^U;&@+>-J]O?)K4=QIMY9;EM_M#3F1P0?.5B!M&&
MP5'R\C@5TT-I;VZ2)#!'&LKM(X50 S,<L3ZDFJ.D^'-%T%YVTG2[2R:<YE,$
M03=^7;D\=* .:U&#4-6\>ZEI"Z]J%E:#2H;B,6SJICD,DBY!VYQ\H)'?UQQ6
M)HU]KGB:7PM#>ZS?6?\ :&B7$UP;0K&6=)(@LB_*<$AL^G/'!KJYO"[WOCJZ
MUB]@M9+&73X[-5\UO,^5W8Y&T J=^",]N:W#I&G&^@OC9P_:K=/+AE"X:-/[
MJ^@Z<4 >?7&NZK-X+U/Q+;W=PNJV&J20K:;SY>U)Q&(63H2RD'.-V6R#C IN
MKR:Q,/'=S%XCO[9]$D$UFJ,@08MDEVL-OS*22,>_<UZ =#TLZ@U]]@@^TNXD
M9]OWG' 8CH6'8]16)IOA0KXDU_4M3MK.6+4+F*:$+(S$!(T0!U*@'E-PZX)_
M&@#*M=4U#Q#=>(;>YNKC3+G3[*VDMUA<IY;R0^89"/XAORN&R/DZ<FLZY\2Z
MT=$T[7=2ANAI\VE6\UT^GRE9;"5MQ:5HLC?&PV^I4(>.]>A7FAZ7J%R+F[L8
M9I@ABWLO+)G.P_WESV.127.B:9>7)N+BRBDE*+&S$??122%8=&4$D@'(YH X
M?5=;O$U9;JQU*>:-?$5M8NQ?RXT1MBO (\D.1DL7(!R>"<5M^&SGQSXTQ_S\
M6G_I,E:MQX4\/W5S/<7&C6,LT[K)*[P*2[+@@GCKP/RJ[;:78V=Y<W=M:Q17
M%R09Y%&&D(&!N/? X% '&7FI7NI'QH1?SV-SHO%FL;[0@$(D$CKT<,Q8?-D8
M7C!R:BTZ?5O$'BJTBNM4O[".70K/49+6W94"3-(VY>5)V_+@@\^]=G=:'I=]
M=_:KFP@EG*"-G9>74'(5O[P!YP<BI!I=BNJ'4Q:Q"^:/RC<8^<I_=SZ=\4 <
M_P"+IKU-;\+V]KJ%S:Q7=^\$ZPE1O7R)&[@]U%<]:Z]J-K'#I4M]</ _B>32
MVNY'S(L(0NJ;^N2V$W=<'UP:]"N],L;Z>WGNK6.:6V;? [C)C;IE?0X[U7_X
M1W1_LMU:G3;8P74GG3H4!$DG7>?]K('/7@4 <%X@U36=-M?%MC;:E=+#I\MC
M):7!;=(@F8!XBQ!+ =1GG##FKE]%J">(?$FF+KNJ"WATJ*_B(F =)29@<-C(
M7Y%.T<?AQ792:!I,VGO82V$$EK(XDDC==PD88PS9^\>!R?0>E*^A:7)<33O8
MQ--/$()9",M)&/X6/<=>/>@#DM.U?4K[5?!#R7\P74]&EGN8TVA6D$<)#XQU
MR[>WM67H6H:LMAX-U.;6;VXEO]2GL[B.5P8WCQ.1\H Y!C4Y_#IQ7H$?A[2(
MGM'CT^!&LXS%;%5P84/55_NCV'H*9'X:T6&&UACTRV2.UD,UNBI@1.>K*.QY
M/(]3ZT <98ZS>2^(O#TD&IW%S9:E>7T,DSOL6=$61EV19(0(4"AN"<$D<UG6
M$MUIGPX^UV>HWD<_]OF-R9BY9#J!C(.[)Y5CDC!/>O08O"GA^&X6XCT6Q299
MS<*X@7(D.?F''!Y/YTY_#&AO'/&VDVFR><7$J^4 'E!R'/J<\Y]>: .3O=5O
MM0M/&URM_/8WFAR,+-$?:J*D*R*[KT<.2WW@>!QCK5">^UG4Y/$4LNJ7]DT&
M@6NH1V\+A!!,R3,1TS@%!D'KWS7H%QH6E75W]JGL())RH1G9>74'(#?W@#R,
MYQ2S:%I4\]U/+8PO+=QB*X<KS*@_A;U')X]S0!32\O;SP*E[%<Q6]_-IHE6>
M0?)'(T>0Q]@3FN UW4[BZ\(>(+"^M[^PU*W^PF6TN9O/10;@ 2Q2$G<K$'TP
M5Z5ZB--LAIATT6L7V$Q&'[.5RGED8VX],<8JJ_AO1I;62UETZ"6&0H720;]V
MW[H.>H7L.@[4 <=>ZE=:-J'BZREUV\CMX;.TGAN)5$SPR2M(A"#@?,54 < $
M]A5/5;V];0?B3IMR\@@M=-#P0RSF9HM]NQ8%CSU .,D DX.*[Z?PYHURUTUQ
MIMO*UU$(;@R)N\U!T5L]0.WI42^%= 2.>-='LE6XB$,P$('F1CHK>H^M &#;
M_P#)1M _[%Z?_P!&P4W7+!M2^)UA;+>W5F&T2YS):N$?'G0\!B#C\/2NICT7
M38KR"[2SB6X@B\F*4#YDC_N@]ATX]J6^T?3M2FBFO+2*6:$$1R$8=0>H##G!
M[CH: //=&\0:O>G1=%U&\W^?]OC2[:<V[7A@F$<9#(,Y*%FP,9QGIP>RT>2_
MT_PD7OKQ-5O+5)=TT0QYQ0M@>[<!2>Y!JWJ/AW1M7T^+3]0TNTN+2$@Q0O$"
ML>.!M';CCBKUM;06=M';6T,<,$2A(XXU"JJCH !T% 'F=O,VJ#X<:Y+?S7%Q
M?71EG'F$Q[VM920J]%VG*C&/?)YJW;WVOS:7JHM9WU"XM_$,T(MY+@023P*N
M?*C< !6'WAT^Z1GFNLB\(>'8+E;B+1;%95F,ZL(1\LASEAZ'D]*F'AO1@CHN
MG0*'G^U$J,'SL$>9D<[L$_-UH X>/4;C6[SPS:V>L:Q9V]X^H0W4<A5)XVCS
M\C$@_,A^7.3P >O-3K=ZKJDFL1VVM+9W6C7RPB2>=N(D"',D0 #B0;CN/.6X
MQC%=H- TE9K686$ EM"QMWV\QECEB#ZL2<GOGFF7'AK1+O68M8N-*M)=1AQL
MN7B!<8Z<^W;TH Y#4I_$-]=:W;65Q=IJ4.J01V36Y_<);$1%P_!4,%:0G=\W
M*X[5#XCUB]M+B_N;#5+F8V.IV-JQ+^7'$&:)7BVCB5F#EB2!C< #E<58NO 4
ME]K%]<7VDZ#=M<SO(NHMYD=Q&I^Z"BC#%1@ AUSC/7-=-)X1T"X,CW>E6EU-
M*D:333Q*[R[,;2Q(Y/ Y]J .3DO=3M[KQIJO]JW\XT*5I;6S#*(Y!]D5]C@+
MDKN;(Q@\4QB5\1^"=4CO+B_EN+"[F)>4LLK^2C94=%SGHN!TXXKO;31].L)K
MB:TLH89+D@SLBX\S P-WKQQ]*IV?A+P]I]Q#<6FC64,L#,T++",QENNW^[^%
M ''Z5J^JSZ)IGBN'5(IHY+&66YLQ.TGVJ41%]BI@")E92,+VR#GK4=LQO=4^
M'&KO?S7,U[YTLQ,A,;.UH[':O1<$D8&/?)%=Q8^&M$TS4KC4;'2K.VO+C/FS
M11!6;)R>?<\GUJ*W\(^';2XCN+?1;&.6*0RQLL(^1SU*^G4]* *OB.X9M9TG
M3H[R=9)UG?[)"YB\T*JC>TH(**I8< $DD<<&N2T;5=7UJW\!B?6+M/[1M;D7
M9A*J92B<-G'7W_$8/->AW^C:9JLMO+J%A;W+VS%H6EC#%">N,^M06_AG0[1K
M9K;2K6%K4L8#'&%\HM]XKCIGOZT </HNOW]Q-H&AWE_.T=Q?ZE!)=%]LLRV\
MC+'&7&#DC!)&"=GN:W/A[#]GA\1P^;)+LUVY&Z1MS'A.I[_6MJ3PKH,MC]B?
M2;5K;SOM C\L8$N<[QZ-R>1SS5K3M(TW2%E73K&WM1,_F2>3&%WMZG'6@#SB
M_O\ 5X--\3:FNMWYETO7XH;>/>H3RR;<%& '*XD88_'KS5^_U?4+W2/&VHI?
MSV=]H5Q*MI&KX14BB612R='#DMRP/!XQBNPD\-:++#<PR:9;-%=2B:="F1+(
M,89AW/ Y/H/2I)M!TJ>\^URV$#SE55G*\N%Y7=_>P>F<X[4 5KZ#4-:\(,MO
M-+IVI7%H'C>-L&&8KD ^P/!%<HOBN\N_!5[XELDF\[3-+='MF=B/M8'[P.,\
M^7M'/?<?3CT6H8;2VMHI(H8(XXY':1U50 S,26)]22230!QIFNK;Q#X;M[74
M+J[L-9M)A=;YBQ^6,.LR'^ DG'RX'S# &!7/>%]2FM?"_@G3!=.$U6"9I7EN
MW0M(H&U XR5SEC@8R5^H/I6GZ)IFE'-C90VY"[%V+C:N<[5_NKGG P*JR^$O
M#TVEOIDFBV+6+R><8/)7;O\ [V.Q]Z %\,Q7UOI)MM0U%-0GAFD3SUZ[<Y56
M/\3*#@GOCGG-;%06=G;:?9Q6EG;QV]M$NV.*)0JJ/0 5/0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !5'4M5@TS[*LJN\MU-Y$$2%09'VLV 6('W58\GMZXJ]6'XHT@:YI\-G+IUM
M?VIF#3Q3R%&"A6PT; <.&VXZ<9Y% &'JNO7,?BWPW-"FHB"YAO5EL%4;G>/:
M!E<XSDMR3COFMBU\7V%]8:=<VEO=S/J#R)#;B,+(&CW>8&W$*NTJ1R>O3-8V
MF^%]<LM1\-SW%S'>)I:7B223W#-+ME(\M<[?G*JH!8XS4%AX8\26-AIEH5T^
M:VBO;R:\M&N75)EED9XR3LYV[CE2,'KV% %K4?$']IS^"]2TN[N([._U!HY(
M_N;U\F4E7'J&0?E5[P?=74][XGBN;J:X6WUAXH?-;.Q/)B;:/098_G6-I?A#
M7+'2?"MG(M@3H^HR7$I29@&C*RJ-HV=?WN<=..M=#X:TF^TN^U^6\6 )?ZBU
MW#Y4A8A3&B8;*C!^3/&>M &'-XFET/QIXF%TFJ7]G!:V<RPVT7FB 'S=[8X
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M+^(+F62?S,MLCO&D("X^\2N.N #GKQ6VGA&\O--\8Z;?M##!KEQ))#)#(79
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M[RI<RPZ=)'%=S0H&6%W *@\Y/#+G .-PSWQJ7^H_8M%N-2%M-+Y,!F\@85R
M,X^8@ _6O.-0,EYKOB*2VM=)N]->ZB6\@DU7[,7>%4SYBF-OXAC(*A@H!!')
M]$F1]8\/2)L:W>\M"-DHYC+IT;W&>: .,/B:_N-3\%ZBT-]&FH6<\LUC#AA,
MWE(RD 'IEC@L1COBNCM?%]A?6&GW-K;W<LE_++#%;",+('CW>8K;B%7;L8<G
MZ9K'TWPYKL$_@^2YBL -%M)+><1W#-NS&J KE!G[N3G&,XYJO9>&/$EE9V%O
MML)K9-1O+B[M#<NJ3),[.F6"<[2QRI&#^% &F_CB.>;PX=-L+FYM]8EE7?\
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M&CZC,EJ(+31VL)0LQ+;RT;94;1D?N_4=: -B_P!=M].UG3=,GAG\S46=()5
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MFEVYX8;W4GJ/+!K=\-V\MOJFHD:\FH6LR12Q6RN\OV?(()$C.Q(;&<9XP<4
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M **** "BBB@ HHHH **** "JQT^R-\+XV=N;L+M$_ECS /3=C.*LT4 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M='CU 07/[SSY&W;XU96 (4J%R,\N/H0#NZ@FO+:WN+>":XBCFN&*PQNX#2$
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MG^;8X8-MQC;GVJEXCU[5H+3QY%;R6EO/IFG13P7,4!WG<DA.[+=1MX/;/0T
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M:)FEM5B+_,V&'.$ .0!EUQ[]9K\]S;>'=2N+.58KF*VDDC=DWA2%)SC(STH
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M^@8'''(!W=%9N@:A_:NBV]\+NUNUFW%9[3(C==Q (!)(XQD9X.16E0 4444
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MPK537]'E-B(]4LV-^-UH!,I,X_V.?F_"K4=W!<O<0VUQ$\T#;)54[C&V,@,
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M$JN%/H<'@T 88\$60LDM!?W^Q-2_M,'='GSM_F?W.FXDXKG7TK6)=<U*=/\
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M@)*YQN'J,\9'% &9'X/L5GTV22XNIEL+)[&..0H5>)PH8. O.0B^G3ZU5L/
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MFU%C%;RCC;*%+;#Z[E5B#_LXYR*L7^M:7I3HFH:C:6K.K.JS3*A*J,L0">@
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MR31-*TJX\^X@TR2*2W:5\OF,8&2!R,$@C&"#BK-GJD3W&JO+JMA+;6LH&(B
M;8! 665MQ&<Y/; (J>'6M,N+>>>*_MVBMVV3-Y@_=MQPWH>1U]10!7@\.:?;
M/K$D"/&^K/ON65L'.P)\OIT)^I)K/O?"8DM[R:/4-1?4IK5+1+Q9DBF1%;<
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MC2;71-/%G:!A'YCRL6QEG=B[$X  RS$X  '85>K.T+6[/Q#HUMJ=C('@G17
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT6GPJD!5,':\*N=W/."WM6SJ6N:W=:AJNG:!"&NM-AB90ZH5DD=2P#[G4A,
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M<G@;2HH4BBFO41-0.I*#<%\3Y+9^;/&23COGG- &-+K_ (FCTCQ,(9+6YO\
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ME&L5U,S*)&C7.$X "@9/0#DD]Z *']J:S#XALM N;VV-Q>QSW@GBM]OE0IL
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M2(S(R +$YY:,[_O$<X!!KN9H8[B"2&50T<BE'4]P1@BN9MO &D6HM-L^HO\
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M\HC#H#\K$ G:2N,C)P:U:JZ=I\.F6:VT+2N!DM)-(9)'8]69CR3_ /JZ5:H
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MP#G_ /54VG>*-#U:_:QL-4MKBZ6,2F)'^;9ZCU]\=.]<JMG<6OAWXA/<V<L
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MXOG@8J/D9@3DL>>0-H/-5KCQA'8>,9+>]OH(M'_LL7<9:(J^_P PJ<]SPI/
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MVNI75OYEU: B%C(VU>0<[<[200""02".*R],U2_A\::AX>O)3=1)9Q7MO<%
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MLMY)+&^E_;[:\\M!)$0^QD; VGL0<#OUZT ;UIKVEWVH-86UVCW(C,H3!&]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "J&KZ-9ZY9K:WR.425)D:.1HV1T8,K!E((((J_7/>+O$,N@6-F
MEI$DNH:C>1V-HLF=@D<_>;'.U0"3CKC'&: '3^#M(N$U5)%N&358UBO!]H?]
MXBKM Z\?+QQ3+WP3HU_?P7TJW<=S%"+=I(+N2(S1#HDFTC>/K5B2RUNW^S/!
MJS71\Y/M*3PQ@&/(W;-H&TXYYW<<=>:D_P"$FT@745N;H@S3FVCD,3B)Y1D%
M!)C:6R",9Z@CJ* -555$5$4*JC  & !6/<^&-/NM<_MEGNTO_(^S"2*Y=,1[
MMVW .,9YJM)XZ\.QSW$+7LFZV>1)\6LI$;(F]MQ"X'RG/O@XS@U+IOC'0=7U
M%;"SOM]R\/GQJ\3H)(^[(S !L9YP3CO0!/#X=L87B<-=.T=P;K,EP[EY-NW+
M9/(  P#P,#'2J<G@C0I=-O\ 3Y+>1K6^N#=2QF9_EF)W;TY^0YY^7%6[?Q/I
M%U=6]O%=$O<JSVS-$ZI.%&28V(P_'/!/'(XJG#X[\.3I+)'?L8XE=G<V\H4;
M9!&5R5QNWD#;U.1@<B@"0^#]*;3X+.0WDJPW*70EENI'E:5""K,Y.3C P#QQ
MTI+OP7H]])?23I<&2]FBN)76X=6$D6/+=2#\I7 Z8J+5?&VF:=HE_J$:W$[6
M4R6\L @=721]NT,",@'<ISTP>,G JU%JUK-XE-N-3E1A8>>UC+;&,!=X_>EF
M4$'^'&?PH K-X%T-C.=EWF>YBNY/]+D.Z:/;M?ENORJ3ZX&<U6\1>%_,L-6F
MTVV>YN]3>'[7&]VT9DC0C[C=$8*" >!ZUK6WB;2;NYBMXKA_,FA,\ >%U$Z#
MJT9( ?J#\N>"#T-5[#QKH&IW%G#:7KR&]+K;N;>14D9,[EWE0N["D[2<X&<4
M 9>B>&Y9&N$OH=633;BW>">QU74?M?F;L<CYF"@#<,ALG/3BMK0?#&G>'8V2
MR-T^5"*;FYDF,:#HB[R=J^PIVOW\-C%8B74I+ SWL,*.D/F>:S. (SP=H;IG
MC&>M5;GQOX?LY[F&>]=6M)E@N"+:4B%FQMWD+A5.X?,>.>M &MJ>FV^KZ;/8
M71D^SSH4D$<A0LIZC(YP:KZSH-CK^BR:1J*R2V<@42*)"I;:01EA@]0#^%6K
M^_M=+L9KV]F6&VA7=)(W0#^OTJG%XCTJ6*^D^TF/["RK<K-&T;1E@"N58 G(
M(QCKG YH IWW@S2-0O;:]F^V+=P0^09X;R2-Y8LYV2,K N,^M7AH&G)K::O'
M$\=VENMM^[D94,:DE04!VG&YL9'&:CB\3Z1*MZ?M11[)T2XCEB=)$9\;!L(#
M'=D8P#D\#FDB\4:1+%<.+HJUM.MO+$\3K*LC8*KL(W$D$$8'- &I/!%=6\MO
M,@>*5"CJ>C*1@C\JP+7PO#)X?L]%U)6E3363['<I(5D 3B-P1R' X/8\]B14
M\WB_0[?3[J^GO3%#:2B&YWPN'A<XP&7&X9R,$C!R*<GBC2KB%3#/.7D>2-(U
MM9/,)3[Q";<D#(YQCD>HH ;=>$]*O=/GL[A)W2XG2XGD\YA)+(A4J68'/&Q<
M#H-HXK;4;5 R3@8R>IKC?"'BU;GPEIUWJMY)<7EY<720[+<F258YI ,(B]D4
M9X_4UJMXST$)8,MZT@U"%IK0102.9E7KM 4DD9^[U]J +E]H=GJ&JV.I3F;[
M38[S;E)2H7<,-P.#D<<YK-7P+H231R+%=+Y5XU]$@NY0D<K;MQ5=V #N;('!
MS5Z#Q+I-UIEKJ%O<F6"[8I $B<O(PSN4)C=D;6R,<8.>E)#XFTFYL(;VVN7G
MBF+K&L4+O(2APXV ;@5(P<C@_6@"M+X-TB>PU&QD6X-OJ%R+JY7[0X+R @YS
MG(^ZO P.!5F7PW87%S)+,;B199HKB2%Y28WDC"[&*]B-BGC )'(-6K#5K'4]
M*CU.QG^T6DB%U>-220,Y&W&<@@C&,Y&,9JC;>+M$O%TQH+MW75"RV9^SR 2E
M<EAG;Q@ GG'0T ;=8,O@[1)HM1BDMI&CU";SYD,[X$N0=Z#/R-E0<K@Y%)?:
M[9//IZ1ZI-:%]1^S ?96(N'4-NBRRX R,[A_=.#UKG_$'C:2;PSK]UI3W-E/
MI5\EOYLMN0'&Z,-]]<#[YXZ\ ]Z .QL-)MM/FFG0R2W,P599YG+NRKG:,]@,
MG@=R3U)J74;"VU73;G3[V+S;6YB:*5,D;E88(R.1Q5;3->T[5[J[MK.9VGM"
MOG1R0O&RAL[6 8#*G!P1D'%4+OQ+&?$-UX>A2YBNH[+[3]H$#%5+$A<$@K_"
M>3QGCKD4 6(_"^GQ7=A=JUT;BQA>""1[EV(5\;LY)W$X')ST%00^#=(M[+3K
M2);D0:=<&YM5^T.=DAW9.<Y/WFX.1\QK/\%>,+;6-$T."]NVDU>\L%N&+0,B
M2L%!?:VT(2">0IX]*VH?$FE3ZC!8)<MY]R'-N6B=4G"_>V.1M; YX)XYZ4 5
M+CP3H=W9ZC:W$$LL>H7 NI]TS9$P  =3G*, J],=*<W@_2GTE--E-Y+$LZ7+
M22W4CRO(A!5F<G<<%5P,XX%0^+O$#Z*VDVT7GJ^H7R6[2Q6[2%$VLQ*X4@M\
MN .3R3CBG0:]::)9O!J^LO=R6\F)KMK0H(@YR@E*C:A"LN2=O4$@9H /L-WJ
MWB6WN=1TJ*"VTF21K.=IED>=F7:&  ^08+9!YSM]*Z.N7?4-0;Q]>:4MZRV?
M]CK<QJ(T/ER&1EW XR>%'!R*9X5\2_:/!6@7VJW#2W]_:K(5BA+/*V,L0B#H
M.^!@9'K0!"= N[SX@:K?7$-W!87&GP6J317"J)"K2%P0&W#AUP< CG!'?;@\
M.:;:ZM;ZE;Q/%-;VHLXE1R(TA!!"!.F,@>_%,C\5:+*NG-'>%UU&5H;8K$Y#
M2+G*'CY6&ULAL'@^AIT/B?2;BUGN8IY6CM[H6<O^C2@K,6"[-NW.<L!TQS0!
M&GA328[B:1(I!%-<B[DMO,/DM,"#OV=,Y ..F1G&>:O7&DV5UJEGJ4T"O=V2
MR+!(>J!P WY@"L=?%&E:>FL7E[K,DEM;7JP2![8J+5BJ 1Y"Y()8'<<_>QFK
MMMXIT:Z3476[,8TY0]UY\3P^6I!(;YP,J0"0PX.* '7'AK3+O4KR_N86FEO+
M7['.KN2CP\G9MZ8RS>_)JG8^"='L+JRN$^V2O91/!;^?>22!(WQE,%L%<*!@
MYZ5=M/$>F7NI_P!FQ2RB\\H3>3);R(=AZ-\RC@X/X@CJ*DU#7+#3'D2YDDW1
MQ>=((X7D\N/)&YMH.!P>OH?0T 4M#\':/X=F9].2X5!D10R7,DD4 )R1&C$A
M,^PK8N[6.]LYK67=Y4R%'VMM.",'D=*S]0\2:5I<C)>7+1JDB1R2>4[1Q,^-
MH=P-J9RO4C[P]152Y\;^'[2>YAFO75K6=8+@BVE*PNV-N\A<*IW#YCQSUH ?
M=>#M&O/#MKH4\,K6=GL^RD3,)("@PA5P=P(' .>E-;P;I#1V((O/.LI&EBN?
MMDOG%F&UMTF[<V0 #D] !V%.B\56;^)-4T=TFB_L^"*:6XDB81X;>3EL8  3
MJ3@Y..E+)XPT2 7GGW4D)M+?[5,LMM(C"'IY@4KEEXY(SCO0 VS\'Z7IL,$5
M@UY:K 9C'Y=RYP)6#.N"2,9 (';J,&GCPCI$4EK):12V<EM;"SC>VE9"8!T0
MD'D#J">0<D$9-/L?%6C:A=2VT%X1)';BZ/FQ/&K0_P#/168 ,OJ02!2P>*-'
MN)Y81=^7)%;?:V$\;Q9@SCS!N RON/ZT "^&=,CO-/NH(G@?3X&MK58I"JQQ
MMC(V]#G:O7T%4X? VB6Z6*PI=1FQ>5H&2[D5@)3ND4L#DJQYP:N1ZU:ZK+=:
M?I]V\&I0Q+*(Y[=T8*3\K;7 +(2""1[C(-2>'=:C\0:';ZBD?EL^Y)8LY\N1
M&*NN>^&4C- %&V\$Z-8P6$5FMS;G3_,%M(ER^Z-9,;UR2<J<#@\# QBK,WA;
M2IK:PM_*DCBL+C[5 (Y6!$O/SL<Y8DLQ.<Y).<TGB#Q';^'WTU)H+B5K^Z6V
M3RH6<*2"23M![ X'4_@<86G^,HK#6O$-MK>H2&"VU&*"W;[,2(4>*-@'*+A1
MN<@,^/KQ0!L1^#-&AUV75XHIXYII1/+"ERX@DE'21H@=I;@')'49Z\UOUE:E
MXDTK2"_VVY:-(BHED$3LD.XX7>P!"9R.I'4'I5.Y\;^'[.>YAGO75K298;@B
MVE(A9L;=Y"X53N'S'CGK0 ZR\&:-IVL2ZE:Q3QO+*9V@%R_D>:>L@BSMW>^*
MTDTFRCUF75U@47TL"V[R]RBDL!^;']/2H?$6M0^'?#]]J\\4LL=I"TI2)2Q;
M Z<=/KT%<Y/XL>U\96@FGN1I<^CRW/V46;&3S5EC7(4)YAX+<8QCGIS0!KS^
M#=%NK?5(+B"66/4YEGN0TS9,B@!74YRI&U<8QT%-3P5HNZ]:XCN;QKZV6UN3
M=7,DGFQKG ()QD;CSU':K@\1Z6^GVM]#<-<0W<7G0?9XGE>1, E@J@M@9&>.
M"0.IJS9ZK8ZAI4>J6=PL]E)'YB2Q@G<OTZY]L9H QH_ FBIHESI+_;9[6Y54
MD,]Y+(^Q3E4#%LJH]!BKDWA?2[F^N;RZBDN)+JT%E.)9"RR0\G:5Z=68YZ\U
M%IOC/0=6N;."RO6D:]C:2V8P2*DH498*Y4*6 Y*YR/2K \3:0UW#;_:B#/,T
M$,AB<122+G*+)C:6X(QGJ".QH J67@K1+/2KG3##/=6EQ%Y#I>7,D^(NR*6)
MVJ/08[>E6]"\.6'AZ%H[-KJ0L N^ZN7G8*.B@N3A1Z"J<GCGP[$9/,OG58KK
M['+(;>4)%+P,.VW"9+  L0#ZT^3Q1I5WI^K^1?S6SV$):XD:U</ &4E9 C+\
MR\$@X(.#0!J:II=GK.FS:?J$ GM9AAT)([Y!!'(((!!'((JM#H%G"MP2]Q)/
M<1""2XDE+2F,9PH;L.3T[DGKS5 >+]&LHK:WN+^>XN38K=@I:2,\T>!^\"HO
M?.2 ..>!BK4OBO18[6VN1=F6.ZMFNX?(B>0M" "7VJ"0!N'4=\=: +FD:5:Z
M)I=OIMD)%M;=!'$CN7**. ,GG%%[I<5]<07#2W$,\ 81O#(5X;&01T(X'4'I
M68WBZP.OZ;ID*SS+?V;7D5Q%"[1E 4"D$#OOSGH.^,BETO7K#^RGNWU:2]C>
M]E@C=K<H^_>1Y*H%!8K@CID[230 I\':,'L'BAFMS8PM;Q>1.Z;HB02CX/S
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ML5SN&T#<"N,'(X/!YIL_B;2K>PCO7GE:"2W%T#';R.RPD9WLJJ2H^H'0^AH
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MNI+);M-EI(SSQ_*"X5%Y)W [0,CGC JXOB/2Y-/M+Z"X:XANXO.@^SQ/(\B
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ME2NV0" V> ><9&>YZUW-4=.UBRU62]CLY&=[*<V\X:-DVR!0V/F SPPY''-
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M]]+J,4GAN;5#;O&BA9HBG";5!P0YX)/3K5R#5]4M;OPA<_;WOK?6U\NYC9$
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MY/)INK::!IH98\+>X4F/(7)XD3KP"KCMQWMOHVGVFJ76IP6RI>7>//D!/SX
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M@D?-Z$C\3ZT <+<:C=>(_#GA7Q!+>R@77B"W/V4!?+C43,JITSN&!DYY.>V
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M':HW%N!GT% &QH7VQ])BFOY9'GG+3;9%4&)6.5CX ^ZI )]0:TJ** "BBB@
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ME:II^HSBXCO+@H#:DHJLK(5)905RH'TXZB+6/#6LWNF^-[>&QR^L3Q/:9E0
MA8XT);GCF,GZ$4 =IK6MV/A_36U#4I'BME949UC9\%B%&< X&2!D\<U3'BK3
MWMC*D5\6'F$P&SD67:APS;" <>A[]LFJ_C73K[6O",UE8VQ>ZEE@<1LZKM"2
MHYR<XZ*1QGG\ZS_$.D:I_P )1::Y9:-::M ]G]DN+*YD1'CPQ=75F!7^)@1]
M,9H V'\7:.+"*]@N'NH)+7[8#;QLY$ ZN0!P.O!Y." #@TMUXKTFUL?MOG23
MVPMEO'DMXFD"0,"1(V!P" 3Z\'C@U@C2=?T/Q'%JFF:58W5O=6$=I<V4,P@6
MV='=U*$K@I^\8' !XSCG%,OM#UJV\32:BNB:9K=O?VD,,\<TBQ_9I4W#*[E.
M8R&Z#GCI0!M_V]IYU^0QZC=S;-,%U]EB@+1-$6XE4A<LQZ84GCMFKEGXAT^_
ML],N[9Y)(-2&;9A$WS#:6R>/E& >N/SK+L]'OK;QS#?FUC6RCT=;+?%M51('
MW85,Y"XX'^347A_PI<:9)JMK/*O]G[Y8],5/O0PS8>0?@YP/0(/6@#5@\4Z5
M<:A;6:S.CW<;RVKR1LJ7"J,L48\' (/N.1D<UAW?B=[OQAX4ATZYN1I]^]P7
M!AQ%<HL#LK*Q&>H!'(R,$9'-4-$\,:N=$&A:EHFEVCVUI):+K$#*SS QF-71
M0H9&((+9/8CG/#M-TGQ*;CP<EYI4$7]AEXKB5;I2DJ^0T0= !G!R#@@$=/>@
M#3\1Z[/HOC30XVGNFL;FUNVDM((/-:1T\O:5"J7)^<^W?MFKUMXUT.[ATR:"
MXE=-2F:WMSY#C]ZN<H_'R,,'AL=#3-<T^_;Q7H6LVMJ;J&RBN89HD=5D_>B/
M:R[B 0-ASR.O>L/4?#J67@K6$O+J*UU&ZO)M6MRC9\BX#!XPG=B-J@XZDGUH
M [:VOX+NYN[>+?OM)!'+E" &*AL ]#PP/'K7#:[XTN+KPQJ][IQNM/?3M4AM
M2[Q ;U\Z)'SN! SO;I@@8Z5V6A6<]CI$*794WDF9KEEZ&5SN?'L"2![ 5Q5_
MX:UUM#\0Z9%8QR?;-:2_@E$ZC<GG1R'(.,$!&'UQVY !UEKXJTJZ&H?O9H6T
M\K]H2X@>-E##*$*P!(;G&!R>.M6-.UVRU*^N[&(RQWEH%::":,HZJV=K<]0<
M'D>A'6N1UOPMJ^KW_B>2"&. 7T%B;1YV5D:6WD:3:Z@D[22!WXS^._X:M[S,
MEU>^'K#1I60(8[=TD>0CJ2RJ!M]!R>3G% %2QU:]\2^)M9L[2\>RT[2)5MF>
M%$,D\Y7<^2X("J"!@#).><<5HQW-QH@N3J]^;F&6X1+(^4!(VY0/+VH!N;<&
M.0!P>V#65::1J?AGQ1J]]861U#3-7D6YDBBD1)K><+M8@.0K*P /W@0>QJ3Q
M#I>L:I_9.IV\,:W.FWZW2632#,D>QD92WW0^')';C&><T 7)_&>B6FG7E[<S
MRPI93+!=(T#[X7;&T,H' .X8;[ISUJ!O'NBI.;<IJ7VKRY)%M_[.G\QU1@I*
MKLR>2.G;FL/7?"VJ:E;>)+ZWLRMWJSV21VSRH"B0.&+.0<9/S# )Z+[XO:C<
M3P_%72I(K*6=CHESNB1D#*/.A]2 ><#K0!MVWBO2+[3K"]LKAKI+\,;9(D)>
M3;][Y>HV]#G&#QU(J&3QKH45C:79N93'=7)M(PMO(S"89S&RA<J_RGY3@G'&
M:YS3/"&J:!J&CZO!$ES)&][]MLXY -JW,GF?NRV 2A"@Y(R,GVI7\*:G"UK<
MQ6N^2;Q(=8N(ED4"&/84V@D\MC:3CC.[GH2 ;[>-]%C@,\CW*1QQQ27!>V=3
M;K(2J>8",KD@]N!R<#FC_A*H)/$&LZ0\%W$NG6T4KW"P,WWQ(20 #T"#'')S
MP<5@>,] \1ZX==M(;2*XM;BWA^P,;D1JC*<N&7'S,3T)X [CG.HFF:O!XHUR
M_P#L,;V^IZ? @*3C,<D8E!3! SDN.>!C/TH OZ;K]BNB:08[RZU&2\M!- QB
MS-.@4$R%0 !]Y<].2!U(%(WC30A;Z=.MS+(FH.\5OY=O(Q9U#%D("Y##:1M/
M.1C%<]H7AS6M"D\,ZA]D\][/1QI5[:I*FY<%6$B$D*>5P02#@CTQ2V_A/4K*
M\T:X2W#E=<NM5NU21<0K,DBA%R1DC>N<>A]J .PT?6K/7;)KJR:3:DKPR)+&
M8WCD4X964C((K%^(>IZAHWA"?4-,NVMKF*:! P1'!#RHAR&![,:CT*TUK1UU
M5AI:R->ZT]P UPJ[8)"H+\9RR@$[>_K4WQ TJ_USPE-INFV_G7$LT#C+JB@)
M*CG))]%(H @UW5[A?%&E>'(Y[Z%+JVGDEN8(<ON7RPN#MQ@%R3QV&>,@[,FI
MQZ+!I]C?7,MYJ$T95?+A^>X*+EWVC@>OIR .U9][8ZA<>.M&U5+)_L=M9W$,
MK&1,JTAC(XSSC8<_7C-2>(;76+C5]*:SMTN=.7S1=Q>?Y+;B%V$MC)0?-E1U
MR.#C% #CXUT/R],>.>>8:G$TUF(K:1S*JC)P O4?W>OM2V_C+1KF/2WCEGQJ
M4SV]OFW<?O4R&1LCY&&UN#CH<5S'AWPUKFFKX-CNK! -(2ZCN#'.K<.N%(SC
M/K[#'?@)/HLUKX U2TU!DL=06_N=2L',BLPD\YI8BH!Y.652!ZD<YH [VVOX
M+R>\MX3)OM9!%*2A #%0W!/!X8'CUKC-/\5:CI/C&[TC7I?.TRZN_(TW4&55
MVR[%8P2;0!D[OE..>1R:ZW1+*6PTF&*Y*M=OF6Y9>AE<EGQ[9)Q[ 5DGP_'K
MFGZYINM6#+:WUR9$RZDXV( P()VL"N1Z<4 2V&JFRM[Z;4[^68#4&MH%:-=Q
M.0%10B@L3GW_ "S4&K^.+#3M"U._BBGFN-/=89K4QE9(W?&W<.RG(.X9!'3-
M8D?A'Q!;:%IGFW:7^IZ5K!O@SMM^UQ89.3T#E&SSQN'7G-/USPGJ6L6WBB^A
M@$-WJ<-K%!:RR*#B!MV7*DJ"Q) Y. !SR< '1IK%F_B<0-?W<,JZ>UPUG-"8
MX@F\#S2S*/F'3&[IG(I8O%6E7,YMEEN$D>T-W$3;OF6$8!=!CYL9'&,\CC%8
MNJ^']3USQ!<336WV6VN] GTYY%E5C%)(P(XX)  Z^OMS5S0&\3?V5'::OI5M
M ]I;>29(;@2&Z8  %!@;%.,_,<]![T +8>+=(M=+T6)K^^OY+^U,MK*UH[27
M*JH);"KC=R.,9YZ5?M_%6E7>F65_!,[I>RF"WC\LB1Y1N#)M.""-C9SC&TYK
MF-"\.ZQIX\#K/8_\@>RF@NRLJ'#,BJ-O/(RN?Q%9TFF:EINGZ-9?85.LKK5W
M?VT:W:))Y3-*Y*DAE/$JJP(_B..<$ 'H&D:[8:XD[6+3-]GE,,PD@>/9(IPR
M_, "01@XS7&IXCO=2UC6]'_MQ]*U^">1;"PEBC$<T0_U;J67+[AR<-P>V!SO
M>#08(+^TFTRXL;L7#7-QYT\<WFO*2Q;<G /'W<# QQ@BLGQ1H-_XHT.]TS4-
M!BFO?-F_L[4%F0"W!<^5(3D.I4;<A0V<>_ !NKXI@_X2N]T22":);.U2YDN7
M0B/#%^_0 !#R>_TJQ:>)=-O+VWM%>6.6ZA,]MYT3()XQC)0D<X!!QUP<XQ7-
MZEX3U2^U35X"ZO::KH4>G/>F3#QR+YH+%.^?,!_.G_\ "/:GKH\/KJEM]A?2
MH95FE256$KM"8OW>#G;\Q;YL'@#!YP :\OBG3KM1:6MU-%/=VTLUE/Y7RS!!
M\S1E@0<9!YZ@Y&1S5;PAK[:EX9T&*ZGGFU.[TR*YFE2+.TLH^9B!M4DYP#UP
M< X-5/#MMXHLO#\&BZCI=L%T^U-LMU%<!OM05-B;5(&S/!)8]N <\4? WA_7
M_"$=G:-:M/83V<?VM#.C-;W*(J$H2?F1@HX_AQQUQ0!:\%>,([K1])M=5NKB
M;4;R6XB6X>W(CD=)),)O"A-VQ<X'I6_)XJTF*=$>9Q$]S]D6Y\MO),V<;-_3
M.05STSQG/%<IIWAO6K?0_"EI)8XETS5Y+NXQ*A C;SL8.>3^]7CV/ME8O".J
MMX1D\'SP@VPO_-CU$2+@P?://Y7.[S.J],9P<T :^G:W):^(O%PU34&-AI[V
M[1>8H B5H@Q VC)Y/'4G@<U#:^(Y#X^U*"YN;B#3+;2([IH;J(1B)O,8%@<9
M(VJ.I..1QTK/UKPKK6I3^*GMHDB>[N+*ZLFED&R5K?82K@$D E./KGVI-5\.
MZ]XFU+59YK&/3$O=#6R0R7"R%)ED=QD+D%>1^'OQ0!TEQXTT:S%]]K>YMWLK
M87<L<EM('\DY'F!<9*Y!!].^*T-*UFTUF&:6U6X$<3[2TT#QALJ&!7<!N7!'
M(XKCKC1]:U7PGK-M+X7TS3-0N=.ELU-O*C&9W&,[@!MC!YP23STXY[%+1[KP
M\+*</;O):^2X!!*$KM.".* *L'BK2KBYM(4FD"WN[[)*T3".XVC)"-C!X!(]
M0,C(IND^+-+UN\:VL#=2,IE5G:TD1%:-MK*690 P/8\USUAX;U:?1O"^CZC;
M+%_8-S%*]TDBE9UA1E38,[@6RN=P&.>M;7@S3K[2],O8+ZW\EY=1NKE!O5LI
M+*SKT/7#8- &1J/B5HO'%WH>HZS+HBM%&=,?RH_*NB1\Y+NI!8-\NW*\>I/&
MI'XBN-/U70=!U"":;4+NS,MQ<1Q'9O0(&QC_ &GSZ ?6F:Y8W&K+J>G:MX=C
MU?3)64V@62,%?W:@[MQ!7#;L,I)YZ<#.7IGA?6])N/"#.Z7QTZPGLKN4S;2O
MF>60P)&6 V$>O3\ #HU\5:2UQ;1^<XCNIFM[>X,;"*649!17Z9^4X[''!-++
MXHTJ*\AMGFD FNC9),(R8S/S^[W8QG@CTR",YXKE;#PEJO\ PB^D>%KR%1%I
ME]%-]O61=LL,4F]-JYW!S@*01@<G)X!T/#=AXCT.6;17L;:735O9;B#43.,^
M5)(9"ACQG?EB,YQSGM@@#O"_B&3[-=PZG<SW=R=8O+2#;%N<I'(0,A    !E
ML <CU%5M%\7I8W>M6^M7EU,(];:SAF-N2D*,L0179%"J"S8!/K5#1/#GB'0=
M?N-9MK1G^VZC<_;+1YT(:VDD:2.1#G"NI;!7H<GT!I][X;UJ?0/$EHE@?.U#
M6XKZ &9,>4KPL<G/!Q$W'N/? !UNH>*-+TQKG[1+)Y=H5%U*D3,EON (WD#C
M@@GT!!. <U0&J7$?Q&EM'OB=,_L878C;:$1O-VEMV,XP.Y-9DOA_5X(?%NFP
MVJW%KKS2303M(H$#RQ"-UD!.<#:"-N[(XXJ._P#!M]<WMS8P[DL9/#1T=+MG
M&1)DX8KG.,?K^= %N7Q+)=^./#=O97%TFGWMO<RLDD&V.8*JE'4D9[GC/H<<
M@G93Q9I+WD%MYDP:YB>:U8P/MN5098QD#YL @X')'(R.:YJ+2/$>I:AX;:_T
MN*T73[6XM;N1;I6!+QJ@>,#G'&0#@^OJ9?"6CZQI<%G9ZCX<TM9-,B,:ZC R
M%[H!2JE%P"C$8W%CZ^O !T6A>*-,\2)YFF&YDA,2S+,]LZ1NK$@;68 $\'('
M2LOQWXBU#0-.CFTN 3RP$7EVF,D6D;+YN/\ :(8 >VX]JN>!M,O-%\$Z3I=_
M"(KJT@6&0!PP)'<$=JCAT0ZK?ZI=ZQ:W41F801(EXR*UNHX!$;@$EF<G/]['
M:@#7GU>RAL+:\\WS(KHHMOY8R92_*A?J.?I58>([%DAV)<M++YVV 0-YF(FV
MR';UP"0/?(QG-<EI?AO4T\%IX;UC1C>6EK=E+<BZ59?LH+&)E8,-LB?*.O0=
M:)?"FJ7.DV5KJ27]Y-;/<M::A#=JE[: LOE!GW .2N=W4' Z]: .LF\3Z;#$
MK@SS?Z,MVR0PL[1PMT=@!D9P<#J<' .#2S>)M+CM8+B&9KI)[<W48MD,A:$8
MR_';D?7H,FN?T?2/$.AZS)J-U&FJR:AIMM#=F%U0I<PJP) ; V-N/3D$?=YK
M/TGPKKW@RXTB?2[:'58TTP6%Y 9Q"482-('0L.5R[#'7&* .E3Q#I=YK.ER0
M:M/Y=S82W<42Q8AFB^0^86*\%<CC(/S<BGP>,-*ND=H/M+M]B^WQ)Y# SP?W
MTSUZC@X/(SC-9VHZ5KD_B32M0@@@$EMIMW T@8>6DTOEE  >2H*8)QZ<5EZ/
MX=U\:W97]]81Q,VC2V-U*]X)&\TLAW8 QM)4X4< =ATH Z+2/%MMJ7A_3=2:
MWN%FOK<31VJ1,SD;59B!W4;@-W3) ZD5/#XITJ]L;.XL9Y+G[<KM;I!&3(P3
MASM(^7:>#NQ@X'4@5QMOX;\0V.F>%[DZ+97T^E6+:=<Z?-<*1(A$>)48C:&W
M1]#V/8UJ+HNL:7XCTO7++2K1H_L<MG=:?:R+&( \@D5D) 5CD8;IGJ* -'P!
MJ=UK/@^*\N[J6>9[FZ032($<JL\BKE<  A0.,#Z5QMSXNU_3_#VLZPNL&[N[
M#79+"WTZ6&+%U&)0@0;5#;\$G(/;I7;>"=-U'1_#C6FI6\<<XNKF8+%*'RLD
MSR#G [-57P7H-QIC:Q+J.G1Q7%SJMS>0291V\N1L@9'(/J.GN: -6^\4:7IL
MA%U)(D:3);RSB)C%%(^-JNPX&=R^PR,XS58^.-#%W=6YEN0;.22.YD-I*$A*
M1^8V]MN%&WH3U[9K#B\/ZK9Z_JENV@Z7J6GW]V;J*_N&7=;[L;E="I+8()7!
M] 2.UZPTC48(O& FTR*8:E<R3VT,TBE)E,*1['P3C)0Y]C0!M-XBL(HKB2Y\
M^V\CR]RS0L"?,.$"C^(D\ #)SQUXJO/XPT>TM-2GNI)X#IB"2[B>!S)&I&0V
MT Y4X/S#(X//!KDF\%:REE+'ILEQ%9VEW:7VG:?J%P)"CQ,6>,."V(R-H4$G
M!!Z"K?B/PSJ>O)XAU&*S:"YOM&&EV]M)*FXDL[%W()4#+ #!)X/KB@#JM.\2
M:=JFI3:?;M.MS%$L^V:!X]\9) ="P&Y<C&15;5?&6D:/?3V-P;M[N" 7#PP6
M<LK>621N&U3D<')' QS56UTW4!XZM]4DLVCM!I M&8R(2)/,#XP#TP,9]?SJ
ME<7%Q;_%JZ-O9271.@Q?*CJI!\^7&=Q''Z^QH TKCQWH,$=FZ7%Q<"\M6N[8
M6UK)*98UQDKM7DC<,CJ.^*LW/BS2;0R---(L$4RP37'E-Y4,C8PKMCC[PSV!
M.#BN<T'PEJ&@ZGX600K+;Z=874-S*C@*))G1_E!.2H*L.G3%1S^%=6;0_$OA
MKR5EMM7NYIX+[S%VQ),P9PZD[MRG=C (/'(YH ZM/$FFO<:K;AY1+I2A[L-"
MPV*06!&1\P(!/&>E0QZQ9R>)GA.H744B:<+A[.:'RXDC+?ZTLR@[NQ&<#'(!
MJCJGA>XF\4:??V<BK:26_P!DU-&/,L2,'C^IW!E/^S(:J>(?#.H:WXAU78OD
MVE[H+Z:MSO'RR,S'.W.=N#_GK0 Z7Q+)=^.?#EO97%TFGWMM<RLDD&Q)@JJ4
M=21GN>,^AQR"=E/%NCM=P6[3O%]HA>>WEEC98YT099D8C!P.?<<C(YKFH](\
M1:GJ'AQK_2XK1;"TN;6[D6Z5@2\:('C YQ\N0#@^OJ3PYH>M6.FPZ??>&M&$
M^GVSPQZ@&5OM>$*+A=NY-W&[)]1SG@ [#3M8MM3D9($G4B))@98BH9'SM8$]
M<[3QU'<"LR_\<Z'IL^H0W$EUNTXI]K*6DK"$,,AF(7[N.=W2J?A'0+S0]1N1
M"EU::,\">7I]S<";R)LG=Y1!)$>,<$]>PJAK'A[5[P>.TALLC6;2."S8RH 6
M$10EN>!DY^GY4 =3?^(M/T]Y4D:65H(1<3"WB:0Q1'.';:.AVM@=3@X'%4CX
MNM'\2:?I5M%+<17MDUXEU$A9"H9 N".H._)/0<>M9UEI>KZ1X@U'48K W=OJ
MEG;HT7FHK6\T2%<-DX*$$<C)!!X.:K:)X2U+PWJ/ACR$CO(+'2I;"YD\S859
MGC?< >H^1@!]/K0!M:3X@T\Z2MPNHW5\)[V:"'S8=LK2!VS&J!0<+M8<C@+D
MGO5FV\4:9>6BSVSRRLT\EN(%B;S?-3.]2O8C!R3QTYY%<?!X;\1Z?9Z?J%I9
M1O?:?J]Y=_8Y)U43P7#/P'&0' <=>,@UHZ[I6OW\ND:VND6-S<VDDPETF65<
M-%(%'$A&W>"@;ICDC/<@'5:3J]EKFGK>V$IDA+,ARI5E920RLIY!!!!!J]6=
MHEM);:<!+86M@\C&0VUMC;'GL2  S=R<=?7&:T: "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***Y;
MQQ=W]I;Z*+"_ELVN-6M[:1HU5MR.<$?,#_GKF@#J:*\LU34M=T.+Q18KK%W<
MII\VGS6EU+M\Q1-*%DC8@ ,, D<<!OI5_P 1ZQJ=I<>.X[34IX18:/#=VVW:
MWE2%9BV,@\'8O],4 >B45P>H_P!N:3:65U%<:EK4$P>XO+:*9([A!L0!H0 N
MY5.24SDEQUZ4S2]:EOM:2.WU6XN-/G\-QWB2/\A:3>5,F/X20!D=,T =_17F
M-OKNHZAX5TB3^U;A[]_#IOI8HL1D2;5Q.[^@(8! #DGD8'%K3[[5M=UKP];R
MZQ=V\.H>&S>3K;A%_>[H?F4[3@_.?Z8H ]#+JI4,P!8X4$]3C.!^ -#.J*6=
M@JCJ2<"O+=*O+W6[CX=WE]?W!GFBN_-9'V!V1"-Q XR1G/U-=)\2$9_#5MLG
MFB_XF=D"8GVY!N(P0?7K^>* .OI&8*I8YP!G@9/Y5PLM_?:C>>++2/4KBSET
M2*-;1E8=3#YGFN",."<C!XPO8Y-=1X<U"?5_#&E:E=0B&XNK2*:2,# 5F4$C
M]: ,^+QWX=FB$HO94@-P;7SYK2:.(2AMI0NR!0<\<GK71UX<$FN?"LMAJ;I'
MX6O/$5U'J%Q$I\V'%R2F23@(S@ MCC(]<UZ3/=W(^(\.G?:I5L9]&FG:(-@>
M8LL:A@>H.&/2@#8O=9L]/U+3M/G:07&H2-';@1DJ2J%SEN@X4UH5Y?I>H76J
MV/PSOKV=I[F:ZF:25L98_9I^>.*T=#U'6==BT_6X=2@MXQ?R0WD#SEE9-[)Y
M/E[!M<';@YR>^0: .ZN;F&SM9+FX?9%$I9VP3@#V%1Z=J%MJNFVVH64GF6MS
M$LL3[2-RL,@X/(XI;[_D'W/_ %R;^1KBM"O;VS^$?AK[!9W=S+-8VT3&T56D
MB0Q@LX#$#( P/<@\B@#KM/UFPU6XOH+*X$SV,_V>XV@X23:&*Y[X!'3OQ4EU
MI6GWUU:W5W8V\]Q:,7MY98PS1$XR5)Z'@=/2O,=%U@6,/C@06]]H4:7,/E3S
MVZ/Y!\B"-4VACESQCMR"3VKH='UK5+75_$UL]E?7R636KV]DLR23*)$^8;W8
M ],X+''.">* .IUC6;#0=.>_U*?R;9" S["W).!P 3U-27VI6VG"$3NV^=_+
MBC1"[R-@G 4<G@$GT YKD_'5Y-??"W5+B>PN+&1D7-O<%"ZXE4<[&9>>O!K3
M\1Z3J$^MZ)K>G- [Z8TPEMYY#&LD<BA20P!PRX!&1Z]* -6VUK3KO3)-1BN5
M^RQ%A*[@H8RIPRL#@J01@@C-1V^NV=SK+Z2@G6\2V6Z9)(60"-B0#DCGD'CM
MCFO,;.2\F%G>2H(K#7O%ZSHB,2CQ)'E&!(&0[PAAP,@ ]ZZ75-.GU3XGW5O#
MJ=WIY.A1'S;7:'SY\F.6!X[^_K0!VC7D"7R6;MMF="\888#@=<'N1QD=>:L5
MYC=:SJ5[\-_"^MW3!M435+7$B+M\W,QA) '9T8GCLU=9XUUBXT308Y[=_*::
M\M[9Y\ ^0DDJHS\\< G&>,XH Z*N=L+[0]7U^*Z@M'>\-J9+:]: [98=P!V2
M=,9QQQG@X(YK,EEOK?Q5JF@_:[F73I=(^VH[/F2WD#E"H?J0P&><XP<<5<^&
M\/D_#GP^?-D??80/\[9VYC7@>@H V-9URQT+39K^]=Q!"RHYB0N5+$  @=.H
MZ^HK1KR#5(77P=\0':ZN)&&M! )9-P 'V?!Q[=/I@5L:MKVI^&+[Q3&-0GNX
MK;3[6[B:YVDP-)))&[#"_= 4-C! P: /1ZRM1\1Z9I6HVFGW<DXN[L.8(X[6
M64R;1EL%%(X!S5'1(=3@UJ9I]2AGT^YMED@M_/,[JX/S.KE5^1@5XYP>G!Q6
M3XM6X?XB^"1:RQ13?Z=AI8S(H_=+V#+_ #H ZVQU2UU%ID@\\/"0'6:WDA(R
M,CAU!(]QQ5RN4U>#5#X>U6*378[754S-!<VT6T*O_+-2A+'!(*XR23G'-8B^
M++N+P'?Z[+/);W_VR.UN[>0[AIA,B1N,'KA6+Y.0<@],"@#MM:UFST#3)-0O
MVD6W1E5C'&7(+$ <#IR1R>*T*\\\=6DUGX/\0I_:[W4$JVLD-O*-S6_[U03O
MSE@Q&0#TP<>RWVJ7VC:GXJLI=?N$@BTZWNH;JXB65K>21Y$.U0 #DJN%Z9H
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M9Z#I_P!MOFD6#S$CRD9?YG8*N<=!D@9/%.UG5[30=(N=4OC(MK;(9)#'&7(
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M:A=V=I#,8TA;YE"!B$^]V!Z9(X/.85\67 ^S6&-1L+FYUF"RNX+TAWLU>,L
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MQB/<WSH" 68X(."?N@=:N6OB&RO+73;F$2&'4(3<1/@86,*&W-SP,$?F!UH
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M&T"M=RQ)N6W#="W.>G)"@D#DC!%6]7U>WTC0+W6)/WEO:VSW!V'[ZJI;CZT
M00>%]$MHK&.#3H8DL6+VRQY7RF/!88/4@D$]\T0>%M"MM<DUJ'2K:/4I"2UP
MJ88DC!/IDCOUYK-T*VU;6/#=KJEYJ]Q;ZA>P+<*L"IY5OO&Y4"$'< " 2V2>
M>1VM'7TTNT%O>+/>7ME:1S7YM4#^4"#EB.,Y*L0!DX'2@#;G@CN8'AE!,;C:
MP!(R/J*BL+"UTNRBL[*$0VT0VQQJ3A!Z#/0>U8EUXXTBWGMX84O;Z2YL_ML
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M!E\HEY0[ *.!A1U.?2M^S\4Z;J-Y;6UDTD[75B;^W9%&V6(%0<$G@Y=1@XH
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MV\N;BXN-(MI)+AUEFW+P[J00Q7H6X'.,URNH^,+S4M!L]2@CO--6/Q!%:2*
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M+>T6U@B6*!$V*D?RA5]!CI6-;^,--NK"VN84N6EN;I[*.U,>V7STW;T() !
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MM5^BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N.^(<"S66A!I)D!URR4^7,R9!E'7:1GV]#R.:[
M&JU_I]EJEHUK?VD-U;L03%,@=20<@X/H10!YAKJSVUS\0M0LM1N[::PM;6X@
M:&7&YD@)!8]6''0\')S5OQCKMY#:ZY>6&I7 N-.MK20HLIBCM68[L8!/FEP1
MPPP .N:[I_#NBR"Z#Z39,+M0MP# O[X#@!N/F ]ZCG\+:!=2-)<:+82NT(@+
M/;J28QT7ITH PM&@C_X6GXFE,TQ(M+$HIG<KSY^1MSC''3'')'4U;UFXNH_'
M_AVT2[G2UNK:\\Z!7VJQ18]IXYR-Q[UN1Z1IL5]'?1Z?:I=1Q"!)EB4.L8Z(
M#C('M3YM,L;B_@OIK2"2[MP1#.R O&#U"GJ,^U '+_#"%(_!-NPEF=WGN"WF
M3,YXGD'\1..G/J>M<O=/=6%GXMU>TO[J":T\21;(XY-L;!OLRL'7^(%6(P>G
M;%>H66F6&F^=]AL[>V\Z0RR^3&$WN>K''4U5?PWHDD5Q$^DV31W,HFG1H%(E
M<=&88Y/ Y/I0!Q6OZS=Q:E<75AJ5Q(+?7;.S<F4QQQ!C$KPB,9$F0[,68#&[
M@G;Q=&J7UGXR@74OM+V%U?O'97UI<%H&^1E$$L6?E(()# ')4<CFNFG\+:!=
M3SS7&BV$LL^WS7DMU8R;<;<DCG&!^0J>+1=,@NS=16%NDY<R;U0#YR,%O][!
MQGKCB@##\8RW<>J>&(K:_N;5+K4C;S"%@-Z&&5L'CU45R=U<ZG9>'O$=Y'K6
MI-)HNMI!:!YRP\LM 2K]Y!^]8?,3@8Q7IMWIEC?RP2W=I!/);OOA:1 QC;U7
M/0^XJJ_AO1)(;B%])LFBN9!+.C0*1*XZ,PQR>!R?2@#D+R_U'6=1\100:W'I
M5WI-V@B+RL!%$$1]S1#"R*^7'.?0=*T/"END?C;QBYFG+"]A55>=V&#;QL?E
M)QUSCT' XK?N/#FB7FI6^I7.DV4U[; "&XDA4NF.F"1GCMZ5:CTRPBU*;48[
M.W2^F0))<+&!(ZCH"W4CI^0H Y&:WC_X6MJ$C33C&A12!?/?;N,LJ_=SC' X
MQC//6L#P=+=Z99?#XPWMW+'J&FR)-;/)F,A(0Z;5Z @C&>ISSFO2KG1]-O;Q
M+RZL+::Y2-HEFDB#.J'JH)YP?3W-11>']'@-F8=+LXS99^R[85'D9Z[./ES[
M4 <?X3O;_6H?#^O?VY&HN49;VT\UW$TA0DH$/$;(P/0= <YZUI>+/M<OBCPQ
M80:G>6<%[+<Q3BV<*6 @=ASCKD=>WUYK>M/#NC6&J3ZG::59P7UQGS;B.%5=
M\\G) [GKZU/<Z787EU;W5S9P37%L2T$LD89HB>I4GI^% ' O<:CJ$VN6,/B
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MF-2-G!]N">7]HV#S-O\ =W=<>U/CL;:*ZDND@07$@PTI&7(ZXR><>W2@#D=
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M@CM4M !112$A022 !R2: %HJ&VNK>]MUGM9XIX6) DB<,I()!Y''!!'X5-0
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MJJ!DDD] * 'T56N-1L;2S%Y<WEO#:D B:2550@C(.XG'3FIHI8YHDEB=9(W
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M +S<$Y]6;UIEUX/L;V;7GN+F[==;MEMKF/<@5%564%,+D'#'J30!S\T>J_\
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MCCCK6FWAJV_MZQU:*XN(6L;9K6&WCV"(1L5)&"N?X%[]JGUW1(-?L([6:>>
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MIR7Z6#7]LMXYPL!E7>3C. N<YQS]*\]\->';K3M:\+6>JV,D_P!ET"6UGD:
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MVN 25&1G'\>,]<.B6YN=7\"3KI]_$MM;3QS/):.ODDPJHW9'R_,".<=,].:
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M=\MM/:V>A2:BSQ0E)&9'P5R6/!QP/>@#LJ*XY?$.K6M]X=6[-K+!KB,@,43
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M'W3G!QR =Y169X>U(:OH=O?+>6UXDVXK/:@A'7<0."20<8R">#D5IT %%%%
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MC:*T-Y> Z-;-;6F60X1E"G=\O)PJC\/KE1XUT(7VIVTU_% -.=(YY)FV*&8
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MZU=GUW2K6>*&>_@CDE*J@9\<M]T$] 3V!Z]J .4L/#$^K6=W87]SK_\ 9-S
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M5H+B5[=06BC7=E^>.,CC!SZ&K=[X.L-0L+VVN+B[+WTT<US<!E$DAC(*#[N
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M5;M]:TR[O39P7T$EQM+B-7Y90<$CU /!QT/6HX_$&DW#3Q0ZG:^9%%YS;G&
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M'=V5Q%<6\@RDL3!E;MU%3T %%%% !1110 4444 %%%% !1110 4444 %%%%
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MTA*L$R%PO08!/3UH Y'PYH5WI7BK2X;RWDF6T\.0V#W7E$QF9'R5#$>@S_\
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M6UD:YA1$1P^3'L!^50#@#'/OUKT2JU_8P:E83V5SO\F="C^7(R-@^C*01^%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *P=?\1SZ/<P6UGH6H:M-(A=ULPN(ES@%BQ &3G _
MV36]4%Y=PV%C<7EP^R"WC:61O15&2?R% &/X9\2OXB^WK)I%YILEE,()$N2A
M)8J&P-I(X#+^=;]8/@ZTFMO#5O-=)MO+YFO;D'J))27*_P# 00OT45O4 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !5/5=,M]8TR;3[K?\ 9YP%
MD"'!9<@E?H<8/L35RB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
C **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>aquestiveamendedandresta008.jpg
<TEXT>
begin 644 aquestiveamendedandresta008.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P!9(TA&"3T+8K&U;P5?7\/BNVAU*WCMM>"G#P$M"_EI&3G=@C"9Q@<GKQR
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MW;L[,RR?-\RD.R\8X.: -_2=>74-4U#2KBW-MJ%AL:6/?O5T<$JZ-@9!P1R
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M^RX=XHS&K@,=K;225RN#@_ITK4H **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHKE?'-]96EOI$=^X
M2*?4$0-+($MPP1R/.)'*<<+QE@O(ZT =517&?#6[2;0M0MUN$E^RZI=Q*J9
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M# N4QCZ@UYWJ%[IT7A_6=;\*:P]U%+!;B\BTY L4,?FKO?"\K+Y9?/0X7)Y
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M]K5;F\'FVYF+(T8)/'EX,H3/'''8U =+TB35_!NDOJ5QJ&GSQ7Z*T\Y7SX\
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MZG"VG,X0/#,ZL8W8A0N5)!)) &.N:@L=<^V^)=5T8VK1-I\<$GFEP1()-^,
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MH4/EM%[8R&[[LY.,5DZ25TY/!4VBR)_:5[X;G5AYN[SI$AA,88$\X;('IR*
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M*?P-8>()Y9C<P:A&R33LK3P@_N2PR"24P<]30!ZO#-=/?7,4MIY=O&$\F?S
M?.R#N^7JN#@<]<U9KS3[9H>D:]XX_M.<'3;2*P=X3*7/RJ2$ )R<L%&.^<=Z
MS&=-,\-7VLB6!-0O98)[VTL")!8V(E0,@5.I"$[S_%\W8"@#UZLBQUS[;XEU
M71C:M$VGQ02^:7!$@EWXP!TQL/YUY[?7>FV&DW6I:)JYN]&NM1LO[3-H +:V
MAW8D*[?NDC;O ['G&:W/"4ND#XC^)UTF6T,,MG8NJVSJ4./.#%0..XSCN?>@
M#IH-<\[Q7>:$;5D:WM(KH3%P0ZNS+@#M@H:UZ\ZURPT2_P#B/J<.ONB6K:'
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MQ)>7WA;3+[6]*L[SS]>%LF)R/*;[6T:. 4_@P,<\XSQ0!Z*40DDHI)Z\4*J
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M0<GIQDW],\6OJ]]=VUE;VKO:RS130/<E9X60D*73;PKXR",XR.O8 Z<*%&%
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M<%)/+ #CL3[%D?CV>Y32UMM(#7-WJ$^FSPR7.W[//$KL1G:=R_)UZX.<$\4
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MDBHN<98X% ',:5X2O='U&5;77IAHKW+72Z>8%W1NS;RHESG86).W'?&<9I=
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MRNW1ET=X0TB9CBO/D \SLIV!P,^K#O573;J+2]$TB29+JVT&#5]12Y:*UW"
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MX\E4./NJN6*@=.3D''J-% 'DVHWD<OPY\7V%[!&GB-()$O)$&?MC%1LDC/\
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M3')(),AG[,VTL<GG!)K(\.W$5E;_  YU#4-R1IIMU9S2NA)$A$6R-N,Y^5@
M?2O7'D2, NZJ"0HW'&2>@^M.H \@TI6/A/1_LE[;Z?>V]WJ+10ZE;G[+,IG;
M,;YQM)5@01VW#U%:FA?9SXR\.WESH_\ 9YG\/".&%HBWER+(F%#8ZA>YP0/2
MO2B0H))  Y)-".LB*Z,&1AE64Y!'J* . \3VNBR_$S11K,-HUM+I=VKBY \M
MR)(2H;/! YQGO[XKG-/T2UCF\'V>H6RO8?VIJ(MH[A<E;-DE$*MGG:<K@'U
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M2\%IJEAJ<<]\5O-3>%KBY2$#"Q$%%123@ C/)/WF]L=2H8(H<@MCD@8!/TH
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M&5A,BJ"B9)"\#GKU-)?Z";KQ'8ZU#>R6\]K!);L@1665'96P<].4'3MGIUH
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MSL)'MY8MF)%+ \-OQCID# %5/#FH:JFH>"I+C5;JZ76='>6ZBFV[-ZQQ,&4
M#!^=L^N: /0I94@A>60D(@R2 3^@ZU5TS5K+5])AU2QF\VSF3?')M*[E]<'G
MM5VN3^&7_)-M"_Z]_P#V8T ;VDZO9:W8_;=/E,MOYCQ;BC+\R,588(!X((J]
M7)?#UE3PS=LQ 4:I?DDG@#[3)76 @@$'(/0B@"K%J=I-Y'ER%_/9A%A3\X7J
MP_V?]KIR/49MUS\7@GP_ ML(;#R_LMTUY 5E?]W*W4CGIP/E^[P.*XBWO_$$
M?AK3O$*Z]>7%RFM-9O:.J>7/$;QH=I 4'=C!!'3'2@#U>L_3=:L]5N-0@M3)
MOL)_L\XDC*8?:&XSU&&'-<)=ZWJ<'AS79UU&<36?B2.T@8MDK$985*'U&UVZ
M\\U4OXK^'_A86K:?K-U83Z=>?:8DC"&.1DM(FPX()8'&,9'6@#T1=<LWUNYT
M=?.-Y;VZW+KY38V,2!@_Q<J>F>E6K&[6_L8+M(IHEF0.(YXS&ZY'1E/(/M7&
M0RW%QX^O9F+VMS)X9MW.T#,3&68\9!'!]15/PYKMYK,?A;2[^_FC-]H7VUYD
M?9)<3?(,!AZ EB!UR.P(H ]'HJAHJS1Z/;1W.H#49XU\N2[$83S64D$[1P.G
M:N(&MWW]OZ/<6VI37-I>:U<V<DK82-XU27$:1\_<:,#?P20>H- 'HU%>6Q:E
MK,5M'J+ZW>2O%XJ.F^4VP(\!N?*(8!1D[3P>V!CODU74M:M['Q;J":Y>A](U
M>)+:/Y FPK 2C +ROSL,>^>M 'J5%<'=ZI?ZG)XS\N_FL;C1,"S5" %Q")!(
MZGAPQ)&#D87C!R:J6NOZG>'699YYK7/AJUU%80V/L\SK*6*YY'*KP>.* /1Z
M*\[T^ZU76-:\/V<NM7L,%[X;^US"#8I,NZ$;@=N03O/],5%X9\1WNMIX6TW4
MKZ2,WVE37$DT;>6]S+&ZH &'3"EG('7CMD$ ])HK@3>ZE)J]EX8;6!=3?V:\
MOVQ9?LK7$JR%"1M5LE,#('!SDYIEHVMW7B?2M(OO$,L@DT6=[F2R"HLDJ31)
MO4[<@D,?UQB@#T&BO,-$U;66T_P5JEQK%U/)J%Z]C<Q.%$<B!)L' 'WLQJ<Y
MZD]N*O:)?ZSK]OI^M0ZI%:K]NDANX6G+@KO9/)$13".IVD'.3CG(- 'H-9NK
M:]I^B6RW%],R1&98"R1L^QFY&[:#M&.<G@5P&C:GK*Z=X3U2?6KRXDO=7FL9
MXI-GEO'F?' 4?,/+7!_#IQ6UX'L(Y[?7TN9KBX7^V[I=LTQ8$(XQGU[<=.E
M'3Z=K=CJEW?VMK(YFL9?*G1XF3#>HR!D'!Y''!K0J**VBAEEE1,22D%V)))P
M,#KV]NE<7XJU>_TG69+FY^U_V(J0J;NQD!-E)N)8S1=61@5^;G !X'6@#J=-
MUJSU:XOX+4R;["?[/.)(RF'VAN,]1AAS6A7D^IS7NG#QUJ]CJ%Q;2V6KP.D<
M>W9(?*MP0X(R002,5I^)];OK6ZU*[T_49I#8ZC90$#"10!WB#Q$<^:S"3))
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MPRP_>-[]LD"@#U*D)P"?3T%<KX<GO(?&'B/29[^XO+>VCM9X3<%2R&02;@"
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MWWQ6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1165KNOVOA^"UENXKB1;FYCMD\B/>=[G"Y]LT
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M.?O%B,#OZY!%9'BSQ;%>^#_%,.GSW=AJFF6HE8!U#J&!*LK(S @X(X.1CG%
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MPMH4&M2ZQ#I5M'J,N=]RB8<DC!.1T)'?K6=_PG5BK:G%+IVJ0W.GV_VI[:2
M+)+!G'F1C=AAP>,@]L9XK5MM<M[N335ABF<:A;FYC8;2JQ@*<L=W^VO3/6@"
M./PQHL4%K!'81K%:S&>W0%@(I#G+*,\'D\^Y]35NTTG3["ZNKJTLX89[I_,G
MD1<&1O4UD7&O3OXR?PXMC<"+[ ;EKI'08RVT$?-D 8;MG..,#-8O@/Q;]HT'
MPU8ZBM_)>:A:EDO)URD\B@LR[B=V<9.2,'!P: .]K/N-#TV[NWNI[57E<*)"
M2<2!3E0PSA@#R,@XK,A\:Z3/J=C9*90M^SI:7'R&.9E!) PQ89 )&X ''':J
MVLZO=W?CG3_"EG.]LCV;ZA>31XWF(,$5$)Z98\GK@<8)S0!K2^&-&GBO(I;"
M-X[UQ)<JQ)$S#&"PSR>!^0]*CNO"/A^]GGFNM(M9I;@()GD3<7V8VDD]2,#G
MKQ398/["N7U.;59TT:WM)6N(;F0R!&!5A(&;+<!7&"3U&!1'XHM?MZ6-Q:7E
MK<RV[7-O',BYG1<;MFUC\PR,J<'GI0!9;P]I+27;FRCW7D0AN,$CS4 P%//(
M ) 'H2.]7;2U@L;2*UMHQ'!$H2- >%4= /85RD/Q'TN:QL[X:=JZV=ZT*6\Y
MM/ED:0D #!)R".1],9S5RT\<:7<0:@TT-Y9W-A-'!-:7,06;?(0(@ "0=Y.!
M@_E0!>;POHKVTULUA&89Y_M,J%FP\N<[SSRV0#GU ]*F.@Z6T]W.]E'))>1B
M&Y,F7\Y ,!6!Z@9/7U/K6;=>--/L8=5-Y;7D$^EVXNI[9D4R&$YPZ[6*LORD
M=>".<4Z+Q=#.T,<>E:IYL[L((WA5#,JH'+J68#;A@.2#GC% $D'@SPW:Z3-I
M4.C6B6,S!Y(0G#,#D$GKD8X].U//A#P\4G3^R+55G9'E"IMWLF-I..N, _4
M]:S/^$W2ZO/#2Z;87%S:ZRLD@E^12BHA)7#,/F!QGM@'&34NG^(]-ACU.59=
M0D?^UC9B&X.6,Y5,1Q GA,'/. /F)P.: -NWTFQM=0GOX8 MW<*J2R[B6D"_
M=!R><9./3)INIZ)IFLB#^T;.*X,#[X688:-O52.1_6LB[\<Z98V.IW%U!>12
MZ8\:7=MY8:5 ^-C<$@J<\$'U[C%7]+\16^IZI>Z:+:[MKJT1)&2YC"[XWW!7
M7!/!*L.<$8Y H 1/"F@Q6\=O%I=O'%'<?:D2-=H$V<[^/XO0]NU6(=#TV"[^
MU1VJB7S6F')*B1L[G"YP&.3D@9Y/K7-:U?76H>-F\/O_ &A:V(TQK@W-K<+$
MRN9 HEW!P=J@'@@\DY4C%:=CXKL9#I4+B[6'45VV5[.BA+HA=PZ'*EE!8;E7
M/;TH N6'A?0]*O;F\L-+MK:YN<^;+$FUCGDXQTR>3C%"^&=&338M/73XEM89
M?.BC7(\I\YW(<Y4Y)Y&.I]:X6YU'4H_!VMSKJ=YYUKXF%O')YIW"+[5$FS/]
MW:Q&*[/4?%=EIWV]C!=7$.G &^F@0,MOE0WS D$X4AB%!(!% %Q]"TQ[:& V
MBJD$IFB*,59)#G+A@<[CN;)SDY/K4=QX:T6[@M(9]-MY([1B\ *_<)^]]<YY
MSU[YJK+XNL8[N\MTM[J9K:Q74 T00B:$Y^:/YOFZ'T_49DB\1VMY9V<\-O=/
M%>V37B-&%)6,!>N&ZG<,8S^AH DB\+:' +80Z9!$+:5IX?+!79(V<N,?Q')Y
M]Z6_\+Z%JFJ0:G?:5:W%[  (YY(P6 !R![X/(STK&T[Q?IUOI?A^WMXM7OCJ
M5F9K-I%$DLJJH)WL2!NP1R3CGDBK]KXPTV\TW3KR%+@OJ$[VT%L4 E\U-V]2
M"<#;Y;Y.<<=3D9 -]E5T9'4,K#!!&016#;>%; :-!HU];0WEA9.K68E&6C5<
M[!]5!V@@\CKWS:T/7[;7X[I[:&XB-K.UO*LZ!2LBG#+P2#@^G%<Y<^+HM,TO
M4[W3[?4;UUUI+&5+EU_=.[1J=@9AA/G&!ZGL.: -FZ\*:<^F76F65I;V=G?N
M6OA"FTRJ?O+Q_>&03V!..:WE550(H"J!@ <8%8X\1P->R6J6=T\D$L,-SLV'
MR'D"E0PW9Z,N2 1[\'%N_P!5AL)K:W,<D]U<EA#!%C<^T98_,0  ,<DCJ!U(
MH K#POHHB6(6"!%N?M:KN;B;.?,Z_>SSGK5NTTNRL;JZN;: 1S73!YW!.9&
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MK]S$+2/4-6:T41O,WEQQP,&&6"Y+$[NW<>E==HVJ0:YHMEJMLLBP7D"3QK(
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M6V20@@+*0S?=Z<C)QP >KUE:OKD6CW.EPRV\TG]H78M$=-NU'*LPW9.<84]
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MH Z/0=<BUZTN9XK>:#[/=2VKI-MW;XV*M]TD8R/6M2O(;=#:6O\ :<%U<QW
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MGWYZYQM/ Q2Z=;7.L^-X8=7N;Z*7^P;*]FM8KN2-4N?-?<=H88^Z 1T/<9H
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M2[BL[=+F3[\RQ*';ZMC)KE;KQ19:/=>*[]M,OVGTR""6[7S@PD78Q4HI?:H
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MS!NRY(!QD$9YZUT=IXG^W3V3VVFW4VG7DLD,5Y&-P!7=\[J/NH=I ;Z<#(H
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M4=>F.,<YMR1I+&T<B*Z,,,K#((]Q7&6_B^#2O#MA$5^U7<&E074\9G5'*E.
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MXN(["XN;6WU%=,D>)D#>>2J\*Q V[F"Y)'/;'- '41QI%&L<:*B*,*JC  ]
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MA=Z5IEU"@2?4(I)8X+F98M@C(5]S'CAB%XSDGTR1K:!K4'B'18-3MXIH4EW
MQ3+AD925(/;J#R.#UH TB 001D'J#6;8Z):V>E'2F2.?3E&V*"5 P2/LASP5
M'0<= !SC-<'K&KIIWB'5K'Q5<:EIB7LN-)U>&XD2VC0H J94[4<-N)W#GOQB
MNHU7Q=;:(DMN%6[GL[5+B=%G5692#@(&/SL=I('TYY&0#5O=%MKRS@L"D<>G
MQNK-;1H%5]I#*O' 7(!(QSC'3(.E7-3>,(GMYY],TZZU%;:WBN9TA7$@61=R
MJJ'EGV_-MXX(YR<477C"*U'B#=8S$Z+;)=2C<!YD;*S_ "YZ$!#P<<T ;C:?
M9->B]:SMS=@8$YB7>!_O8S1-IUE<.[SV=O*\BA'9XE8LH.0#D<C/:L";QB_]
MKQ:99Z)>W<\EG'>C8\:KY;L%)RS#D<\=3CC/6LBY\4G3]*U*ZTC3;@3?V_'8
MW"W5QNP[O$K,O+  A@ HP!U]J .VCTVQAF2:*RMTE1=B.L2AE7T!QP*C32-,
MB2=(].M$2X;=,JP*!(?5N.3]:PI-?TZP\1ZK)?6UU:SV>E17-Q*\VZ,Q;GP%
M4,1D$,,X!/'M4;^/[&VDOTN[=H_LMH+SS(I5EC9-VT@LIPK D9!XP<Y(H ZE
M;6W2U^RK!$MOM*>4$ 3:>HQTQ3_+3S/,V+YF-N['./3-4],OY-0BE>2W$01P
M$=)!)',I4,'1AU'..@Y!K)\1>+H_#J7DT]A.]K8PI//.2$4JS$;8\\.PVDD9
M'&.YQ0!L-I&FLLBMI]H5E;=(#"N'/J>.33I-,T^:Q^Q2V-L]I_SP:)3'Z_=Q
MBL#5/&9T_4=4LH=&O+J33K1+R1D>-5:)M_(RW^P>.I/;O5E_$<&H&*TTZVEN
MY9[%;UE67RBD+_=^;J&;G ']TY(H WHXTBC6.-%1$ 5548  [ 4ZN6^&T\MS
M\.="FGDDEE>V!9Y&+,QR>23U-=30 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7/\ BG0+G64TZYT^
MZCM]0TV[6ZMVE4M&YVE61@.<%6(R.1705D>)O$$/A?1)=5N;:>X@B9%=8-NX
M;F"#[Q'=A0!S5]X+UC4;#Q9%/>V*R:\L0 2-\0[8U0\D_-]WT'KQTJ[KOA*Y
MU^[BFN!91S0RPRVM[%N6XM-NTNJD#YE;!X) ^8Y!Z5NP:G<R7L5O/I-W;K(&
M(F=HV0$=CM8D$\XXQQ6E0!QL_@IK_P 0QZG=BUBE5YUEN;7<DEU;NKJL,@Q@
M[0R_,2?N# &:F\/Z'XETFQCTV\U6RN[*SB,5JRPLDLJA=J"4Y(X']T9) .>N
M>K8E49@I8@9"C&3[<UE^'-;3Q%H5OJL=N]NLQ<")R"R[79.<<?PT <_IG@_4
M-/M_!\)N+5QH"NKD;AYP:)H^...&SWZ8]ZC?P;J;:9<6OVBT#RZZNKAOFP )
M5D\OIURN,^_2NYHH XC5/!VHZC;>+H1<VJ?V]Y80G<?)"QK'SQ\V0N>W6HM>
M\%ZSK,FL?\3"Q"7Z6_E>;$SM;&,J2BG(^1F7<3C.2>.A'>44 <;J'@NZU*\U
M_P [4(DMM9M(8I#'$1)%+&I 9?FQC)#8.>F/>DN_#'B#Q!X8O-*\0:O:>:\:
MK!-8V[* Z.KK*X8G)W(ORC ^]ZC'3:MJMGHFESZCJ$WE6T(RS8))R<  #DDD
M@ #J35"37[FWBMY[K1+V*&>:*$'=&S1F1PH,BAN!EAG&<4 4M.T/7/\ A+(=
M=U2ZT\LNGFSDBMHW^8[PVX%CQTZ8/I[U<\3Z-=:U#IJ6TD,9M-0@O&\W/S"-
MMVT8]?7M[UNT4 </J7@W4K[3_%-JMS:H=;N8YT8[CY058UP1CGB,'MU]J[&X
MBFN+"6%9?L\\D142)SY;$8R/7!J>B@#B?#_A#5M*UG2M0N;RP?[+ITEC,L,#
MAI2S(WF%BW+$IDD^IZ]:V?$VC76LII8MI(4-GJ$-XWF9^81DG:,#C.>O;WK4
MO)[B#[/]GLVN?,F5)-KJOE(<Y<YZ@<<#GFK- '$ZIX.U'4+7Q? +BU0:_L",
M=Q\D+$L?/'/"Y[=<>]0:[X+UG67U?_B86(2^B@$7FQ,[6QCVDHAR,(S+N)QG
M)/'3'<7,DD5K-)#"9Y40LD08*78#A<G@9Z9-+;O)+;122PF&1D#/$6#%"1RN
M1P<=.* .0OO">IWA\5[KFTSKMBEHK ,/**QLA8CG.=Y.,\8QD]:FB\-:E'K$
ME^9;0AM&330FYOO*6._..GS=/;K76T4 <'9^#M>T9-%N=(U*Q6]LM-CTRZ2Y
MB=X9XTY1Q@@JP)8X_P!K%;,&@ZA'XOM=9FNH9DCTYK.3(*L[,ZN7 Z 97 7T
M[UT=% &1XGT-?$GAV\THW#6[3!3',@R8W5@R-COAE!Q6/?>&M;\0^'9[+7-3
MM$O,QO;264#!(Y(W#JY#'+$E1D< #('7-=?10!R.H^%K[6#J%[>26L>H7&E2
M:9"(BS1QK(<NY) )R0N!CC;U.<AO_",:LE]IMW#=6D<MEH\NG*2&;YVV8DQC
MH#&./<\UV%% ' S_  \:73M=AM&M-,_M..'%M;;FMUFC<N9=O&"WR@@#HN<D
MUM#0=0F\5QZQ<SVQ3^S'L9$C# [F</N&<\#&,?C[5TE% '"V?@[6;#2O#$<5
M_8R7F@L8XR\3B.6(Q&+GG.[!SZ=O>A/!.J1Z:(QJ-HUS%KS:O$Q@8(0SL2C#
M=GHQZ?KUKNJ* .)U7P=J6HCQ8HNK51KMK%;*Q#?NMB,I8COG<3C/&,<]:DU?
M3KO3KZ]\1S^2\$&B/:-!'&TS%@=^X+@;AGC;Z=Z[*B@#S/P1*\.H:=%;7?AW
M58TMQ:M+I]S+)+;Q!<]&9@BEE4$?+V] *],I H7. !GDXI: .+^(D_DIX:V2
MPI*=<MR@F;"G ?K_ (]LTNJ>#+G5;/7)FN((=3U.6UD4@%HHA;LKQJ3P6R0<
MG ^]TXY[)D5OO*#CU%+0!PUYX*U35AXE-]J-I&=;L8;;$,#$0L@;!Y;D?/\
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MBSLE0C!!Y/RGCGKWKM:* ,/P?HEQX<\*:?I%U<13RVL?EF2)"JD9]R:W***
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ)[B&.>.!I
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M(\'Y5;.TYZ<[3^56: "BLJ?Q+HUM/)#/J,$;1OY;ECA5?^X6Z;N1\N<^U:M
M!114-U=0V5I-=7#[(8(VDD;!.U0,DX'/04 345'!-'<V\<\3;HY%#HV,9!&0
M:DH ***JV^IV-W>7-I;7<,UQ:[?/CC<,T1;. V.A.#Q0!:HJJFI6,NI2:='=
MPO>QH))(%<%T4G )';\:M4 %%%1M/$DRPM(HD92P7/.!U/TY'/N* )**H7&M
M:=:PP2S72!;C/DA06:0#DE5')&.<CM4UCJ-GJ=O]HL;J*YAW%?,B8,N1U&1W
M% %FBBB@ HJG;:K8W>H7=A;W"R75F$-Q&,YCWYVY[<[3^5":K8R:M)I27*&^
MCB$SPC.50G )[=: +E%%4[O5;&PNK2VNKA(YKR3RK=#G,C8)P/P!H N453U'
M5;'288YK^X2".25(4+9^9V.%''J2*N4 %%%0W5U;V-K+=74R0P1*7DD<X50.
MI)H FHHHH **** "BJUUJ%K92VL5Q+L>ZE\F$8)WOM+8XZ<*>OI5F@ HHHH
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MNKJV2[M9;>4N(Y5*ML8J<'K@CD56T?2+/0M+@TW3T=+2!=L2/(S[5] 6).*
M.*A\6ZI+X8T/Q4DPDM]0OHH9K#RUPD4LOEKM(&[>I*YR2#\W XQJ>&+O7=5U
M;5);O5(C:6&ISV@MDM0/,4*A4ELY&"?QY]L:MKX5TFSF5H('6)+@W4=N96,,
M<IR2ZIG .23CH"<@ \U9TO1++1WO'LUE4WDYN)]\K/ND. 6&2<9P.G'% '):
MEJ/B>ZUCQ5:Z=JUO:KI4,,]NK6@?>61F*,2>AVX)Z],8QR[2O%&I:M>@^88(
M;GPY!JB1A%)AE<MD D<C@=<U9@\-S7GC+Q)<W]M=1Z??Q6\2,EP%6945@ZLJ
MMD Y] <9]<5LWWA72=0O8;N6&6.6*W-KB"9XE>'KL95(#*#V/% ')VFN>(]9
M_P"$3@M]5ALWU?1'NYI1:*Y651$=P!.,9D/%5;[Q%XKM="U_6X]3MI$T34Y(
MC:?9 !<Q(4RI;.5.&.,=^N<\=G9>$=(TZ;3);6*=&TR VUKFYD8)&<97!;D'
M:O7T'I6/X>\+NTVN-K%I<1Q76K/>1PO.&CE7Y2A*JQ&05S@]>,YH BO/$>JW
MFF^*]2T^Y6W;09I(XK9XU99O*B61O,R-WS;B!M(Q@'FF7/B^\CU.QDO#<Z9I
MUZ+1[6X$*R0$OM+Q3-@M&YSM!X'(/K7277A;2;N\N[F2&0&]54O(TE94N0HP
M-Z@X/''N.#D<4^Y\.:==W$TDRS,D[QR2P><WE.T>W82F<<;5Z8S@9S0!SMGK
M7B#67CU'36B6UCU.2VN()F01^0DK1MSC>)/E##G'.,=ZDT3Q'>3^*/[*U66X
ML[PF=DM985\FYC#?(\$H'S87&03GGH,5JQ>#=$@UV75XH)H[B:432QI<2"%Y
M?^>C19V%N^<=>>O-6;3P[I]G<P3H)G:VW_9Q+,SB'?\ >VY/&>GL.!@4 9<F
MIZAJ_B77-&L+S["VF6\#(XC5_,DE#L"VX'Y!M P,$Y//2N;35+OQ1>?#O5VG
MFLGO/M#O%$J%4<6\F67<IZ\CG/!]>:[F]\.Z??:E_:#K-%=F'[.\L$S1F2/.
M=K;2,C).#U&3@C--E\-:7+<:9.(7B;2U*V:PRLBQ KM("@X/R\<]J ,;QB+I
M=:\)PVM]/:13:FR2)"$PW[B5@3E3T*_3GIG!'-M?ZIHT?B[5K&\2..V\11B2
MW,(83!UMT8%CR.&XQCGUKT35M$L=:6V%['(QM9A/"T<K1LC@%<AE(/1B"/0U
M0F\&:+/:7]K)%<&'4+E;JY47,@WR#;@]>/N+P,#Y10!F7>M:ZNO>*;"R\JX>
MSL+:>Q@VA#OD,H(R3R3L&,\9J]X1UU-;BOB+NZDD@F"/;7MN(;BV.T?(Z@ '
M)R01P0>IQ5N;PMI<]Y>W<BW!GO8HXIW%S(I98SE,8/RD$DY&#R:N6.E6VGRW
M$T0=Y[DJ9II&+.^T87)] .WU[DT >=W[:IX)L[^66"+7/!=Q/)<2E#BYL?,D
M+.?210Q)_O#\*VKS6M>U6[UJ/P^\<<VEW$<4:2E!%+F-)"9,C< 0Y *X^[GG
MI6R?"&DM ]LPNFLY)#++:M<N8I&+;CE2>A8Y*CY3W%)?>#=$U#6CJTT$RW;J
MJ3&&XDC2X5?NB55(#@>A!XXZ4 9UOJNK:Z^K3:=?V]F=,U 6WDRJ&C=$"-(7
M.-W(9MI! &!UYK+-YJME>?$2]AU25I-/4-;)-&C(F+99 ,  X!)'7ODY/-=-
M-X/T:?77U@P3)=2[3.L=Q(D4Y7[IDC!VN1[@U)<^%=)NKC5)Y(I@^J1"*["7
M$BK(NW9G:#@': N1SCO0!C6&N:AK>K0Z1'>-9R)H\%]).D:,TDDI(& P(VC:
M2<#DL.1CG+TWQ3K^N2>%XUN8;%M12]BN]D ?]Y =N]-QX!() .??-=:WA;3/
M,LI8UGAGLX/LT4\4[K)Y/'R,V<L.!US@\C!IP\,:4ESIL\4#Q/ID;1V@CE95
MC5AAN <-G R3DT 5O!6J7FK>&UGU"19;J*YN+9Y50*)/*F>,-@< D*"<53T,
M ?$GQ9@=;>P_]!EK>TC1K+0[1[6Q61(7E>8AY6?YW8LQRQ)Y))_&FVNB65GK
M%YJL(E%W>*BSLTK$,%SM&TG QD]!WH PT _X6[.<?\P*/_T>]=;6<-$LEUYM
M; E^W- +<OYK;?+!)"[<XZDGI46DZ,-,OM4N5EE*WT_G>4TS2*I[D;ONY]!P
M,#% ',Q>)-4'B31X_M:75I?:E=6DABB7R%5$D9 C$!RX\L!CRN=P'3CIK_P]
M::CJL>H337:NMN]N\44[+'*C C#J.N,D@]B:I1>!=!@G@ECM[A3;W37<"B[E
MVQ2-NW;5W8"G<V5'!SS71T <)J?A?5=-ETNZ\+ZJ9]4TRVDA,&JRF7[7 [AB
MK/U4Y48(] #Q61<ZY+K.C:<]K%=Z'>#Q+#:ZE9J4;$V59N2"&'W6!'!SSFO0
M+W1+2^OH[YVN(KN*,Q)+!.R$*3DC .",@=0>E5I/"6CRZ9]@>"7R_M0O#()W
M$IG!SYAD!W;N.N>G'2@#G[KQ#JUSI?BK4+"\$+Z!-)%'!)&I6?RHED<R<9&[
M) VE<8!YJ6UUW5O%$FJ1Z1=)IUQ906SQ1S1APSRQ"7]YD$[<$+\N#D,<],;<
M_A/2)[FYF:"1?M:+'=QI,P2X51@;USAN.#ZC@Y'%,U'P=HNIZLNISP3)=>6(
MI#!<21+-&.B2*I =?8Y].E '(RZTUE\2=8LXYQ;2ZFFGPQWVT-%&VV5L<Y!9
ML$*#P?7H#<U6&_\ ^%B78L=1-M/'X=5O/,*NQ(F<C@_+UZ\?3'6NAOO!NB:B
M^I-=V\DAU)(TN1Y[@,(SE, 'Y2IZ%<&IAX8T[[<]Z3=-<O:?8VD:ZD),62=O
M)ZY).>OO0!SVB>*+_P 27&BV G^Q2W6@QZK/+"BDL[D*%4," H.XG@GE>1SG
M-.LW>MP>$)K]$6\M_$DMI,T8PDC11W"%U'8';G';FNOC\(:1!#IL=O'/ VFQ
M&"UECG<2)&0 4W9RR\#@YZ#N*ED\+Z3)%IL0@=$TZ;S[8),Z[9"""QP?F)W-
MDMG.XYZT <+KNJ7?B/P:NL?:S%;?V]!"EH$7 2.]6,;CC=N)7=UQ@XQWK:?6
MO$&JS:C/HS1(-.U(VS0S,@B:-"OF;R07#$$D$8'W>#R:T[CP'H-Q)=%H;E(K
MJX6ZE@BNY8XC,&#;PJL &)4$D>E32>#-$DUUM8\B9+J0J9ECN9%CG*_=,B!M
MKD>X- &?X9N]=U76-5DNM4B^QZ?J<]H+9+4#S$"(5RV<C!;\><]L/\911:TL
M?AV:"YGM;B-I;U;=<L(P"$'ME^1_US(K;TO1++1Y+Q[-95:\G-Q/OE9]TA !
M89)QP!T]*DM]*MK;4[K4(S,;BZ"K*7E9EPN=H"DX7&3TQU- ''^&-=UBY^'%
MQ%%"9?$.D[K&:&0A6>6/ !YXRR%6&>"33(_%E[<:-/=:<VI7C07ZQWEJ;5$O
M[2+R\E?+("NVX \ Y4G&2,UT9\(:0;W4[L)<K-J11KIENI%WE,;" &^4C P1
M@U(?#.GES-NN1=&=;@W(G82%U0H,D=0%)&W&.>F: .?TKQ2^N:EI>E6.K%X[
MFSN;UKY(561@DHC6/:RX5AN^;*_P^]0:5XNU+4+ZQT*YD2"\>_O;.6\C0#S5
MM@""BMD!F#*3G(&UL#ICI6\)Z1MM#'#)#-:222PW$4K+('D),A+9YW$DD'(/
MX"F7W@[1-0TV"QEMI$2WF-Q#+%,Z31RDDLXD!W;B223GG/- &7>:CKVDS>&[
M6ZU"UGDN=5:TNFBB ,D9CD=,_P!UL*N<#J>.*J)XDU1?$6DQB\6YM+[4[FSD
M,42^0JJDC($8@.77RP&/*YW#MQTC^%]*>+3HS'-C3IOM%N?M#Y$F""['.7)W
M-DMG.356/P+H,,T,L=O<*8+MKR%1=R[(I&W;MJ[L*#N;*C@YYH Y;1M9U'3M
M*(>^N+JXU#Q'<Z>LDOE@QA7EY' &XB,* > 2,#M6F^M>(-.O+'1]1FA6?4M2
M,-M=?(9$MQ&TA+J!M\S*%1Q@Y!QP0=BX\$:!=65_9S6;O!>W!NI$,\GR2EMQ
M>/YOW9W<_+CFED\%Z+-I":=+'<2)',MRD[W4C3K*.D@E+;MP''7IQTXH S?!
MD4L/B;QG'-<-<.-1B_>,H4D?9HL9  &<8' '2N??3-0US5_B1H]C%9D7LT$#
MRW,C#RPUL@W!0IW$#D<CD"N^TKP]I^C7-Y<V@G\^\97N'FN'D+LJA0?F)YP!
M1IWA^PTO4K_4+59A<W[*]RSS.X=@, X)P, 8XQ0!RJW&NJ+[P]H-P?M6A6UM
M!$\NPK.YB#;I=V6VGI\N#D-R>UBRU#Q#J?B[4[-=3MK>UL8K*Y\I( X<2!RZ
M;R>AV_>^F!USL:IX.T;5]635+F&=+L1B)W@N9(?.C!SLD"$;U]C5N#0-/MM4
MO=1B21;F\C2*<^:Q5E4$* N<#&3T'>@#A3X^OM-T;4I]0:>+6;*R5YM-O(%5
M5D9U02QNHP\.YO4G&,G)K:U'5M8T;Q!'I?VW[5%>Z;<7$,TL*[H)8=N>% !0
MAQP>01U.:V(_">D+"T,T#W49M39 74K2X@.,H"QS@X&2>>!SP*?;^&=.MXF3
M_2)";<VHDEN'=TA/5%8G(' R>IP,DX% ',>'M>UR:[\(/?W\=S#KNEM/+$(%
M01R+'&^Y2.>=QR#QZ 5UMOH5C;?8]D7_ !Z/)+%D#B1]VY^!U.]^!Q\QXZ8K
M6WA32;2327ACG4Z3$8;(&X<B-" I&"?FX '.>E;= ',2ZG>ZIXLU/0K.\:P^
MP6<,PE6-7:220OC(8$;%"#.,$ENHQ7+G5+[Q1'\/M3EGDLIKB^F66.%5*K(D
M$ZEUW ]=IQG/!]>:[N]\/V%]J2:BXFBO4B,'GV\S1LT9.=C%3R,\CN#TQ4<W
MAC2ICI>('B72SFS6&5D6([2O0'!^4D<YZT 1:_>3V<NF6UK=+ ;F=E=(T#3R
M@(S8B!!7.[!8MP!GD5RMAXGU_4-/\)L+N*"74;^ZL[IC;JQ(B$V&QG /[H'C
MC/MQ7::KH-AK,UG-=I,)K.0R02PSO$Z$C##<A!P1P15&U\%:'9?8OL\$\8LK
MF2ZMU%S(1'(^[<0"W3YFXZ<GUH YMM?\0Q>%M1OQ>F>31-6DANV2!-US:HPW
MG&,!PA)XX^4\<UUVC7TFJ7-]>Q7(ETTN(K7:!M;:/G<$#)&XE?\ @)]:I3Z9
M/H5M-%X?TI;QM1N7DNOM-X0D;..9"&SD9 RJUK:/I=OHFC6>EVJ@06L*Q)QC
M( QGZGK^- '":GI>H:?XEUOQ=H$;S7]K=I%>60/%[;"WA)4#_GHN25/U'.:F
MMO&$$NFB_P!(F#1:UKL-I#.5_P!4'B3<2#_$-K+@]&QG/2NWLM,M[">[FA,N
M^[D\V7?*S@MM"Y )XX51QZ53F\+:+-IUU8-8HMM<W'VIU1BA$V0=ZD'*MD Y
M&.: .'\9ZSJ]MI7C#17OY2;73XKRWO$1%D,<C,C1O@8ZJ<$ '!]1FN@U+7-0
MT3Q2EK+<&ZL8]%NKYT,:B1WB>/'( '1B, "MB7PQI=QI]_9W4+W":@@CNGED
M8O*H& -V<C';&,$D]2:6/PUIL>HVU_MG>YM[=K9'EN'?,;$%@P8G=D@$DY/%
M &?HTVM7UOIFIG5;9[6_L?,>)HA\DK*&3RL8)4#=D,2>![USVE^)/$&J6/@D
M_;X8GUA+C[4XM@3E8V8%><#I_CGI75:/X.T?03)_9T=Q&K*RQQM=2.D"MR1$
MK,0F3_=Q1:>#M&L5TI;>*=%TK?\ 8Q]ID/E[@0W4_-D$CG- '.VWBC6%T"V:
MYF5V379=,O+]8E&R%)'42%?N@DJBDXP-V:WO"5YJUZFIR:C,);>.]DALI/*"
M&6%>CDC@Y)(R  =N1UK*U[PEY-G:P:5I]Q<VOV^2^NHXM1>&X\QE;YXW+#'+
M$D;A6OX6TJ[TV.X:>2_6&7;Y=M?7INI(B,[CO).,Y'R@D#;GN: ./U,:KX-M
M]6N3!%KO@VZN)Y[J-#MN;+>Y,I':10VX^H_#-6;S7;G2/$?C'6A>7%U;6&D6
MMU#:D*$;(G('W<@9&<YSSSD  =2_A#2I(9[=A=&TN)7FGM3<N8I&9BS97/0D
MG*C .>0:LR^'-+GU6;4I;8M//;BUF7S&\N6,;L!DSM; =ADCN: .=OO$6I>'
MM1TAKFX_M*TU&SN))%$:J8Y(HO-RA4?<8!A@Y(^7FK>FW&KW^F:?JTFIV\ME
M?Z<99K<H!MD9 Z^40,D ;@=Q)X!]:U=.\-:;IA@\F.606\1@MQ/,THAC.,JN
MXG X ]< #I572_!6B:,LR6,5S'%(K(D1NI&2!6^\(E+8CS_LXH YKX6ZM)JN
M@:79QW+VR:9IULDEHR+OF+1J1)DCA.H&#R0>F,&CX3U#5-*T7PJ\=XC6-]JM
MS926GDC@%[A@^_KN!3Z8/3O7:VG@S1;";3YK6*>&73[<VMNZ7,@*Q?W#S\PX
MX#9QVHA\&Z-;VFGVL45P(=/N6NK9?M,AV2G=ELYY^\W!R/F- '-2>+M4;P>/
M%\$P,*7YB?3C&N##]H\C&<;A)T;.<9XQ45[K<GA[7/&]]"J&8W&G01EQE5:1
M%0,WL-V??%=?'X4TF*YEE2!Q'+<B[>W\UO),P(/F;,XSD ^F1G&>:2X\):+=
MMJQNK5IUU956\225BLFT87 S\I  P5QTH X_5]0N?"_C/7-3EN6OFMO#B2QF
M9%7!\YQ@[ !MSSZXS5KQ!JGBS1-&UO4([N$VL.F-<V\DZQM*LRGD*J  H01R
M<D'US70V_@S1H+B2>1+FZEDM/L4C7=U)-OAR3L8,Q!')Z_XU!;^ = M](NM*
M$5V]G<Q^2R2WDK[8O^>:$ME%]AC/&>E &OI,&H0V\C:A?K>/*_F(5@$8B4@?
M)P3D YY///M6A4<$*V\$<*%BJ*%!=BQP/4GDU)0 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:\O[
M:P6-KAV!E?RXU5&=G;!. J@DG )X'0$]JLUSWB[2UU>QM(&M+R8+<B03V4XB
MGM2$;$J$D9()QCGACP: ,[4_%?V;Q-X?:&\8:3>PW?FQ?9B79XMH "[=^<DC
M:!GBMN/Q1HTUA97L-YYL-Z6%L(HG=Y"N=P" ;LC!SQQCFN7T_2_$::SX6N=3
MMI+IK%+Y;BY!B4XD8"(LH89<JHW;01DU5TK2_$6GV&CVTFBS&!+^_DNA%-"L
MR+)*[Q%7W_*I#?-M(;@=1D$ W=4\1/+=^$[G2+Y'T[4[XPR;4!\Q/)D<<D94
M@H/0]:L^%=2OK^[\10WLXF%EJK6\!"!=L?E1,!QUY<\GFN7TC0-=M=%\&VD^
MD2K)I>IRRW.)XV"QE9E#9W<Y,@XZX!XKIO"EC?66H>)'O+.2!+S5&N;=F=&W
MQF*-,_*Q(Y0\'':@":Z\:^'K*2Y2?4 IM9EAN"(9"(6."-Y"X4<CYCQSUJU:
M>)=(O;F[MX;U?,M(Q+,)$:,",YPX+ !DX/S#(XZUQFMZ!K5YIOC^"#2I6?5W
MC^Q?O8@) (8XR>7XY4]<<59\1^'M6U[6]3\BUDMH;SP^UE'<2.FU9BY8*P#$
MXYP2 1UH Z8>*M%S="2]\AK2#[3,+B)XB(O[X#@;ER,9&1GBFR^+=$@L[^ZG
MO&ABT\*;H2P2(T0894E2N[!'0X['TKEVM-:O=#O[F#P9:6&M+9&W!N)(93,Q
M925C.2-G!/SX&=O'6L[4O#VO7=IXR2#1;S_B<:;;Q6WVB[B=S(H<,'.\@'Y@
M>#MQT]* /0=/\0:7JM]<65G=>9<0*KNAC9,HV0&4L &4X/S+D>]0SZLTOB>'
M0[9@KI;_ &RYDQDJF[:BCW8AN>P4]R",^VLK\_$,:F]A+'9'1TMC*SQ\2"0O
MMP&)Z'KC%,@M9+'XIWES)_J=2TN)8F/3?"[;E^N)%/Y^AH UH/$FD7=]'907
MFZ:9I8XCY;!)&CR'"N1M8K@Y )Z'T-,T?5VN=2U/2+D@WFG.F7 QYL4BY1\=
MCPRGW4G@$"N.L]*\1R:[X?O;S194DL=1NFN3'<1+ (Y$D5&C0-]WY@22-Y)/
M6M[1[62;XB>(M5 (MEM[:Q5NSNFYW_+S%'UR.U &O/XETBVOC9RW>V83I;MB
M-RBRN 41G VJQR, GN/455N/&OAZUGGAFU$*]O.MO/B)R(G;&-Y"X4'</F/'
M/6N5\0Z3XBU"\OP-&EE$6KVEW;/!/%'%+!&\1;(W M+\K9WC& ,'L4UG0=<O
M-*\=0Q:3*9=5N(7M!YT6) L42$Y+<<H>N.U '=0ZYI\^HWNGQS,;JQ17N(_*
M<;%;)4YQ@YP<8SG!K,\3ZS+%\/M3US1[GRWCL'NK>5HNN%+ [6'?W%9OBC2;
MBZ\0:1=6#B":_1].U"-C\S6I4R$\=&7:0#_TT]ZV_%>F3ZKX,UC2[)$\^YL9
M8(5)VKN9" /84 1Z/XLT?59390Z@CWL-NLTJ,C)E.[J2 &7/=<BI/^$LT0-.
MKWIC,-O]J820NF8?^>BY4;U]USU'K7-ZIX:O_%/V=FMI=+-OH]U9!IV0NTDZ
M*@'R,?E7:3G/)(QWJ*UT[4[[0[M;KP?'9:I%ITMKY_G1.9G9-N(B&X4GD[L=
MA@]0 =7IWBK1=6O%M+*]\R9[<7* QNH>+CYE+ !@,@'!."<'%+%XGTB>Z%M'
M<NTS0F>-?(D_?1CJT?R_O!R/NYZCUKDQX>U>YD\-PO8S6Z6^@W&GW,WF1GR9
M9$B4<!LG!C;D9[59\)V.H0K8KJGA**TOM,@,1O1+')YIV[?W.#D;L G=MQTY
M[ %73?$EYJVG:7KDOB*73+:[NA"UH^G;E=FFVQHCE0>0-I;+#+9^7%=?>>(]
M)L+GR+F[$;"5(6;RV*)(^-JLX&U2<C@D=1ZBN*M]!UQ/ASH&EMI$POK/4K>>
M:+S8OE1+CS"<[\'Y>V<YK2T^UUW2]9UC3GT1;ZQO[\WMO?-+'Y<0;:2LB$[L
MH5XV@YXY'4 &U%KUA;W6MS7&LB2&SEC22$P[?LK,H 0$#+EB01U/S "LWQ7X
MH,?@G6]1T*],=YIWROYD!#1O\IPR.!C(8'D=Q6=?Z;XABO?%MU8Z29/MEY9R
M6^]H298XUC60H&8@.-I*[\#.#6??^'==GT3QO:P:-<[M5>&2T$MW&[/^ZC4A
MF+G!!0YR<=,$T >F7-S!9VLMS<RI%!$I>21SA54<DDUF-XIT>-+MI+F2(V<(
MN)TDMY$=8C_'L*[BO!Y (&#5;QEI-[XA\&7MC8XBO)%CDB64X!9'5]C$9X.W
M:?K52/2[G6O%MGK5WI\EE!!ILMK+#.R,TK2LA*G:2"JA#]2PQ0!LP>(-,N;^
M"QBN':YN+;[7$GDN-T7'S9(QCD?F*J/XRT&-XD:]?S)H&N8HUMY2[Q@@$JH7
M)ZC@#..>G-<?!X-\1VMGIDD-P%O=+N&T^U;S.NGL63>?]L*4;'_3):Z.73+J
MV\>Z;>6NG2'3;329K3>CH K%XF50"P/2,C.,=* -=?$6ER:=:W\-R9[>[C\R
M P1/*TBXR2$4%N,C/'&<&J4_CGPW;V]M.^J(8[J!KB QQN_F(OWB H)R.XZC
MTKB]-T#7]'TWPW=R: ]\;.WN+.\T\3Q"1!)('61#NVG[H!&1U]JWH-%O+?Q-
MX8N+?0DL[*T@O!-';M&$MS,R%1C<"3\IW%01D]Z .MN=1M+2S6[GF"0MM"L0
M<L6("@#J220  ,DFLN]\5V$&AZMJ%LSSR:;&YF@\EUD1@NX!D*[E!&#DC&.>
ME0^,M,O[^VTNYTV/SI]-U&*]:VW!3.BAE903@9PQ(R<9 K)O]#U"\?Q;JL-C
M,DFIZ6MC;VA= \C*DGSM\VT<R #)SA30!K^&KF^NK!-7O=4>6TGM8Y##/:B'
MR)-N7*MA24Y&,@]/O&J/BWQ48?!FLWNB7<D-[9VBW*-):L/E8G:0'4 @[3SS
MTK7L(+F/P9!:S6)-S'8")K65E^9A'C:2"1@GC.:X6]\+:\OA?7])TVWOY=/N
MM/2*TLKZ>)Y8)MQRB2;N8PN/O$X[9YH [R#Q3HLYO@+]5-A$)KDRHT86,YPX
M+ !D^4_,N1QUII\6:(EK?7$EXT4=C&LMR)8)$:-&!*MM*@D$ \@=CZ5SFN:=
MKT^OZMJ&FZ2KF;0%M(/M31%&F$CML9=QSPW<;<^U9=YH.O7*>*S%HM[_ ,3;
M0H[6'[3=Q,_G 3 JWSX7F0'CY0/0\4 =Q;^*M&NX7DM[IY@LGE;8[>1F9MH?
MY5"Y8;2#E01BG1^*-'GLX+N"[,\4Z/)'Y,3R,50@.2J@D;20#D#!..M<[KNF
MZL'\-ZK;:,U^+&"2WN].,J))MD5/F4EMI*F,<9Y!-5]2\.37%I9/9:+=:/=Q
MI/+;S:7-&KVTC%3LD!8+('QEN",CK_$0#N6OK5-/-^\Z):"+SC,YVJ$QG<<]
M!CFJEOX@TVZGFMXI9?M$,0G:![>1)#&>C*A4,PSQD \\=:R-?T35M<^&\FDO
M)!'K$EI%O*<1&9=K%?925(^AIL=E?:IXLTS7Y].GL186$\3PR.A>620H=@VL
M00NP\DC)(QWH 9X0U;4?$L,&M?;I8[5S,LMC)9[4P)&6,I(0#D!?FY8$GHM;
M+>)-,7S-LLTFQ)'_ '=M(P<1G#[2%PQ!XP":H> K&^TOP?:6.HV;VMS$TNY'
M=&^](S#!4D="*Q=+T#5;76B]E#=V.GW*7!O;&YE22!)&SM> @EDW,22.F"<@
M'% '0:5XMT_4M!T[5&$\(OT5HH# YD8E=Q"J%RP [J"/>KD?B'2IM/BOHKM9
M()9#"FQ&+M(,@H$ W;A@Y7&1@YZ5Q6B:+KVF0^#KV;2YMVDV+Z;>6@EC9P&6
M,>:F&VD;H^F<X/3M36\-Z[I5W%XAL;$W,PUJXOY-,$J*_DRQ>5P2=N\8W8SC
MYB,^H!MZCXG-QJ'AJ31[Y6L[O4Y+*Z3RL-E8I&*D,-R,&09& :Z6PU&UU.%I
M;1W>-7*;S&R@D'!P2!D9!Y'%<1XHT+5/$UIHT0TN?3T-_)/<?9IHUEMT:&1-
MS$-AGW."0N1CCGOTWA:75VT=+?6]/%K>6W[DO&4\N=5X$B!2=H( .TXQTH F
MG\2:3;7/D37>T^<+<R>6WEK*<80R8VAN0,$YR0.]8=WK5_JWBW4- TV]GTZ2
MSMX94F^PF1'D9I-P?<N-F(P 05R2<$XK(F\,:Q-X5UWPG+:.XO;^2:#4 Z;/
M*DF$NYN=P=<GC') QQTZ'3;*_A^(.M7TMC*ME<V=K#%<%T(9HS*6X#;A]\=O
M6@"Y=^([>#Q1;>'O*N?M-Q:O<"58'9% 9%'(&.K<GH,<]16-X+\90:CI.FV^
MJWXDU:[DG13Y)57*2/\ *& V!@B@[<YQS5W4;+4(_'^EZM;V+W-HNGSVDK)(
MBF)FDC8$AB"1A&Z9YQ]:YS3=!UN#0O"-M+I,RS:?K$MU<KYL1V1MY^#D/S_K
M5X'/6@#MF\1Z4NH0V+76V:>5H8B8W$;R+G*"3&TL,'C.>#Z&J'B/7[BRU?1]
M"TX1_P!HZJ\FV652R011KN=R 1D\@ 9')]JP/#NB:A97$6DZEX9AN/L=XT\&
MKO*C1LF\LKA<[Q+AL=,9YSCKK>*=$OY=?T/Q)I4(N;K2VE22T+A#/#*H#!6/
M 8$ C) //(H U5M]7M-0M,:@+JQ);[3Y\2+(ORG:5*A1MSU&">1SUIUMXETB
M[N8K>*[S)/&TL&Z-U69%ZM&Q #@ @_*3P0>E5KW[=XAT>]L$L[C3EN;66$RW
M)3<I9"HVA&/0G.3Z<9SQ@V>CZK?P>$8;W3GLYM"<27$@D0K(4A:,+'ALD,6!
MY P!@\T :X^('A8P-.-57R54L9##(%&)/+/.W&=W&.O(/0YJY8>+-"U)KY;;
M48R;!=]R)%:/RTP3O^8#*X!^8<>]<+J5A?:5\$[^SO[%X+E+MG\IG1MP>]WK
MRK$=&'6M#Q1X3U'Q7=ZO>6\36$DNCBPA$Y7,K^:)?FVDX4;0N?\ :;C'4 ZZ
M+Q)I,LDT?VEHY(8?M#QS0O&WE?WP& ++VR,\U4M?&WAZ]B66VU#S4?RMFV"3
M,AD!*!!MRQ(5N!DC:<XQ67=:?J6M:WI^LR:7/9O8Z=<Q/ \D9:664( @(8@J
M-I.20.1COBK;:=KUAX%\)V":3(\UD8(K^&.2+SD18RI:)BVT'=CD,#M)Q@T
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MR[<A,'.\C;[US6J^&M5N%U>_M]/E:34M8L+I;421AHXH#%N=LMMW-L8X!/\
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M.%X.3T'<C(KF;GP[K!T3Q;X=:R:=-8NIIK6]WIY:+-C[X)W H<] <@#%.OM
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M3-!$YC81O(N<HLF-I;@C .<@CL:X'PCIESKW@GP'&MG)!'ITD=X]RY7!54<
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MX'*]%P,=&YSC&3H&IWWB+Q?H6I2W5S:B[\.&Z:V3:8U9I(\X#*3@\'/7@<T
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MHVQT/S@<?RKF+?6-=BOKS0_$EO%!K*:9/+9:OIY^2>-2N[Y6!V.#L..GICN
M>B @@$'(/0BEKSGPQJ=[]A\&:"-0N$%[H8O7N"J%SMCB C4E<8^<DD@G@<T_
M3?%>J7.H6F@WESY<[:M>6+7ZHH:9(4WJ0"-H=MP!XQ\K8 R, '4Z^=%O#9Z)
MK&YQJ$FV&']X!(R O@LO P%SR>U6[[5;'1Q9QW<S1_:IDM8"59]TC<*"0#C/
MJ:X/Q7>:AH4GAJYO93K-U9:E=.!;QA)'3[-,RJP'&X*1G Y[#L;'B%Y;SPYX
M8NH]8%^;K6K.6.Z$:A &8D;54#@9[Y/')H ]#JMJ%_;:7I]Q?WDACMK=#)*X
M0MM4<DX )XK@I/$^JZ4^J:9-?/<R1Z[::=#>S1H'BCG2-R6"J%)7<P!QC)&<
MU)K^H:A;_P#"7Z!<W#WEJ/#\E]!/(JAX]RR(T;;0 1E<@XSUZT =W'=PS6*7
ML;,T#QB52%))4C(XZ].W6H]+U.SUG3(-1L)O.M+A=\4FTKN'K@X-<CH^I76H
M:A::!!>264=KH=M=%XU0O(\F5'W@1M79Z<EO;G$\&:G?OX<\+:!93BW>729+
MHRAU1V*R!0%W(XXW$D8].<9R >J45Y[]H\63:OH6C7.O0VUU<Z?=M=364*2)
MYL3QJK+O7K\WS C'4 #@C?\ $.KW%EJWA_289C"=4N7BDN0H)54B9\#((W,0
M!TZ9]J .CJGJFJ6>BZ9/J-_*8K2W0O+($9]JCJ<*":X#4O$7B"SN-0TR/4#Y
MECK5A;1W;0(3+#<%"4<8QE=Q&1C(QWYK;\96US9_"GQ#!=WTE],NG7.;B1%1
MF!5B,A0!P,#@=J .N1UDC5U.58 @^U.KSC4-<USPC>+)+?'5;.?1KJ]6W>!$
M-O) BM\I49V-N PV2#WJW/<^)[?3KK4UU>V>QDTF2>)MR.XG5=ZO&!& 4(SD
M'/;% '>45YU:^(=9TVYTNXO+^34(KWP_-J$ENT2($EB6)OD*J#\V\@@D\],=
M*T]$F\17\FF:@^J6S:9J%F3( Z%Q(RAD:$>6/]K(8MP!UP<@&K<^,=#M;R*U
MENI?,FD,412VD=9'#A&56"D$AC@X/'.>AK=KRK1KO4M'^%FFWMIJ4PD?5$B8
M/'&PV/>E' ^7/(8G/7/3%=)%J6IZY/KCV6K)I[:5J MQ%)$K1F-%1G,F1N^8
M,V"", #WR =1!?V]Q>W5I&7,UKL\T&-@!N&1AB,-QZ$X[U'JVK66AZ7/J6HR
MF*T@7=)($9]H]<*":Y*[U[4K>_\ %\#ZLD$=D]HMI)) &\KS0,J HR[$G"YS
MSCK6-XAU34+OP;\1-/OGF9+&$"#SQ'YBJ\"N0Q3Y3R3COS0!ZD"" 1T-+7/>
M+M;F\/\ A5[Z *)3)# KL,K'YDBIO/L-V?PK,NKG78?%%UX>MM3E?[5I+W=I
M=211E[:9'"8.%"LC;@>1G@X/H =I17F-CX[NA=Z)?W=U<'3;BR>"]C\N/$5^
MJL=F0N=Q\N0;>.2GKBM9G\0'Q5IFARZ[-%Y^CRW%P\<$)83+)$,J2F!]\CD$
M8[9Y !W%%>;Z'XHUK7[30[#[4L5[=:9)=2SH4C:5UD$>5!1E]6( [CH,@S"X
M\5SZSHNBW.O0VMU<:;<O=2V4*2)YT4D:AEWKU^8Y!&.H '! !VFJS64=EY&H
M*SV]XXM"@C9PYD^7!V@X!SR3P.YI^FZ98Z/816.G6T=M:Q#"1QC '_U_>L;Q
M?J%]ID&C26=T8C-JUK;3#8I\R-W"L.1QQW&*S4U^_M_&<>GZK+=6D,]XZ6<B
MQH]I=1[&Q'O W)(",D$C)4XXXH [:BN2\5ZG?6]XUO8:A)'(FG3W'V>WC1I-
MP(VR,S@J$'(QU)/&<&LRRU;6];U;P_;+JTEG%J7AXWTWD0QDK+F'E"RG'^L/
M7(QVS@@ ] HKDM \1WDWPPC\07@%Q>16,LT@5=OFM&&[#IG;V]:HPW7B9K%-
M5&K6K6%SICRCYD9A-LWHT0$8&W .58GC'OD [NJMWJ%O8B SL^)YE@39&S_.
MQP =H.![G@=ZX?0]5UN6]\*"[UB6=-=T>2:9/)B40RJD3!TPN<_.<ALC/8=*
MS]!U'5;'P'X2NH]4N)'OM5BAN/-5&WH\K;AG;GG&<YSR>: /4<@DC/(ZTM>=
M65OKUQ_PG1TG6KE=1BU BT$B1.FX00L%P4X!SM]ASUY._P"&M>;Q/+%J%G<2
M#3TM$62)E7)N&Y96.,AD& 0,#+=.* .FHK&\6:Q)H'A:_P!4B"&2",%2_P!U
M22%W'V&<GV%8-]<^(M(AU&>ZUJSBLI+:,VLLV)I8Y=X5MJI&H8$,N!@_,1V.
M* .WJCJNKV6BV@NM0E,4!D2(.$9OF9@J@X!QDD#)XYKAI/%VJ:=)KEK<2R*(
M=1L;6"6Z6/?;I<! S-L^4XR2,^HSFIO'%OJ-MX5U:*YU5;R-KRP>U62)1)"#
M<1@[]N P+ D<#N,T >@D9&*Q631O!ND7MZ0]K9*[W-P^9)?F)RSD<GD\G%4?
M#]YJ"^+/$&CWE_)>PVB6T\$DL:*R^:'W+\B@$ IQD9YZFN9\6ZE=Z_X1\?;;
MV2VATM9;1+=$0[PL2LS/D$_-O(&",  ]: /0TU&V?4%L59S.T'V@#RVV[,XS
MNQC.>V<^U6)8UFB:-]VUA@[6*G\QR*XZ;4]2B\4S:=%?,EJ- -W&@C0^7*'V
M[@2,G@=#D5F:=K>NIH/A:ZNM7-Q/XA6W3+QQQ+ WD/(VTA#\SD*/F!YSC&0
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M:5ILQCNIW15F2"281,8XY'QM5G PI.Y>I[C.,BH[+Q;I&HZHVFVLMQ)<I-)
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M9+86SB8;A(H7:<YSG(]<UF6_@3PW:Z1<Z5'IV;.X"K(CSR.<*<J%8L64 \@
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M(QB/&_"KR.#G'3'.*M/XBTP16;Q3M/\ ;8#<VZ01L[21  EP ,XPR_F!U.*
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ML+BP6R)MV@N)%D96').Y25;.<Y!ZDCC&*WJCM[>&T@2"WACAA082.-0JJ/0
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M(FA659&4JC=5&#QG /X#TJM!X6T:U33T@L_+33V+6BB5\0D@@[1GC@D?0D4
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M;1V\(*Q1J%0%BV .@R>:EH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M<; "N2._3]%O]!\2:UX.U;3KG2]%L;VYLVM5-K*2LK-C+D[ 47CA?F)SSTH
M[+3-335(II([:[@6.4QC[3"8_,& =RYZJ<]?KZ5>J. R&",RH$DVC<H;(!^O
M>I* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH ***YGQ?J<]A+H-JDCPVVH:FEK<3(VTJI5B%!'*EF5
M5R.>3CG% '345Y;XBO\ 5].M?%UE:ZE>);V,MC):7'FEI(S*X$D1<Y+ #!Y.
M0'],5Z'9VB:/I\P>^NIT#/,TMU)YC*#R1G'W1V% %^BO-?#VI7D_B'0X?[4N
MY;34]&GG:6:XR\S!XMDOE\K$3O; 4]#@@$8%7PM>:D\/@"]N-6O[B35X)H[Q
M99R4<"!G!"] P*CYASSUH ]-M+*TL(/(L[:&VA!+>7#&$7)ZG JIJVMVVC-8
MK<I,WVVZ2TC,:9 =^F[T%<CI-Q?+JUQX/NKR]DN[>]^V"Z:9]\EB?G4[L_WL
M0D?4UH?$&,RVF@1K*\1?7+11(F-R\GD9!&: .PHKRV]U;4_#%UKEA_:ES-I4
M5Y8(+R\E+M:K,3YJF3K@ )SU42=>E3ZX-4TK2[QH/$LKJ^I6!AC@E9VMTDE1
M'4R.6+*W) /3Z$4 >EU!>WEOIUC<7MW*L5M;QM++(W1549)_(5YQJ.M7WAR7
MQ9 FH7+VMK/IY$US*9#;1SL%F8,>0 ,D=AVI/%5E-'X)\8>9K?VRU?3_ +1!
M;1SR.8#L8$^86)97QG:>.#B@#M;/Q&+S5AIYTC58&*[_ #Y;<>3M(R#O#$<\
MC'4$<@<5M5Q=Y)<:9XL\+6MK=7;6TUK>&2W>=G$K*B,N2Q))RQQD\5#X2N_[
M<TOP_KC:_<+=W4<BW=J)"R2RE260(3A#&0<8 .!SG- '8V%Y]NM1/]FN+;+L
MOEW";7^5BN<9/!QD>Q%5M3UNVTF[TVVN$F+:A<?9H61,J'VLWS'MPI_*N&T3
M5+F[T/P_;7.IWDUW<W]^HB\XQFY6.24?/*"&14&T_+DG &,56L=1N=3\-> ;
MF\N3<7']O,C2,VXL%6Y5<GOPHY[T >J45S/C/5)]-AT:**1H8;[5(;2YF0X,
M<;;CP?X=Q"KGMNXP<5A7T.MSW?BW0],O[S%M:P7>GRF=B\4S!R82^<LK;!P2
M<!_I@ ]#HKRVW\4W%[K"7=I+=_V=XAL!!IVZ9R(KL;=^!GY1ASGN# _2K6KQ
M7G]N>)[)-:U2."RT."Y@"714K+^^^;(Y/W%SSSWS0!Z117FT>KWVOW5OI<^J
M"QFFT&VO()!,T)>60/YD@VD;MI"?*>.3QS4]I#J&I^,;>PN?$5])"-$M[II+
M.3R4FE$I!<#G 8+R.X- 'H59NF:W;:K=ZE;0),LFGSBWF\Q-N6**XQZC#"LG
MQ9JDMGJ7AW3_ #GM[74K\P7$Z,5( C9E0,.5+,%&1SC..M<>=0;P[=^)EBNW
MC@E\16MO/<SRL3%&\$6<OG(&<)NSD ]<\T >L45P%Q!KME;W$-AJ\6IL;Z.6
M.P-TZ.8S&Q:!9R2V25\P9/ &#P:KZ3XBBU75M'TF:YU&TL[BWO&V7,S1SM<Q
MS!3"9 <G8"W0\@ GI0!Z/6)JOB:VT:"\GO+.^6"VFBA,@ARLAD*@%#GD L 3
MQ@URLUM>7.O^'=&'B?4YK:?3KQ9KF"41-,T;1A7R!]X;CSWQ[\YOB>>Z?3_'
M%E+?7$L5M?::L'F-N\H,T+'';J2: /5Z*\PUS4=6\(ZEKT=IJ=[>62Z7'>,U
MT_G-:2--Y993C@%-[;>@V' QQ4FM:E?>'=*U+4[3Q D]I<16VR-96N/LH>54
M:X5W+8&UL@'C*Y]: .Y36[9_$<NAA)A=QVRW18IA"A8J,'N<@U9EO/*U"WM/
MLUP_G*[><B9CCVXX8YX)SQZX-<CIUI%:?%FY6&>>5'T*)AYT[2D?OG'!8DX_
M&KNKW%U'\0O#]K'>3I;75G>>;"KX4LGE[6QZC<: .JHKRO0KS4DT_P &:G)K
M&H7$U[JD]G<)-.6CDBQ.0"O3(,:D'KVSCBNM\7:LVG76@6TD[6UE?ZA]GN9U
M;80/+=E7=_#N=5&1SU]: -75];MM%^Q?:4F87EU':1F-,@.YPN[T%:5>?>((
M!::?I=N-4FU!4\3VFTS-N:$&16$6[JVW/4DGG':JNH:U<IK5M=6>IW$D7_"2
M)82N\Q1 N-KPK%RK!<??.#GID<T >ET5Y?>ZO>V_AKQ#(-2N4FM/$L5O;L9V
MW+&TL *<GD;7?@YX-:EUJ5_8>,$^WBYDTVYU!(;2\L[DE(F*A?(FAR, MD[Q
MGEAG% '>5!>7D%A;F>X?:FX* !DLQ.%4#N22 !7 ^&+Z^UV+1M<.O)!*\[QW
MMD9'?S&.X&'RR<(R$9! SA<G()-:WB661O'?@NU;/V9Y[J5AV,B0'9G\&<_A
M0!UD2JJ96/R]WS%<#.3USCO5>WN[:>]N85&RZAVB5&7#;3G:WNI^;!]B.H(K
M@/%VLW5O/K-UI^I7)ET^\L8B/.,4=N7>/,80<2EE<DE@  W!..-K59GA^*/A
MIK=OENK"]2XP>"BF)E)^C'_QXT =A13(I8YXEEAD22-QE70Y##U!%/H ****
M "FA$#EPH#D %L<D#I_,_G3J* &LB/C<JMM.1D9P?6G444 %%%% $%I96EA$
M8K.VAMXRQ<I#&$!8]3@=S27EA9ZC"(;ZT@NH@0P2>,.N1T.".M6** $50JA5
M "@8 '04M%% !1110 4444 %%%% !1110!1GT32KJ^2^N-,LIKM,;9Y+=6D7
M'3#$9%7J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** *=_I&F:J$&HZ=:7@C.4^T0+)M^FX'%6HXTBC6.-%1%&%5
M1@ >@%.HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"\
MLK74+5[6\MXKBW?[T4J!E/?H:GHH SY-"TF6P:PETVTDM&?>T+PJR,W]X@CD
M\#DU>5%6,1JH" 8"@< >E.HH R8/"WA^U,9M]$TZ(Q;_ "REL@V[^&Q@<9
M-21^']'@6U$&E6,9L\FUVP*!"3UV8'R_A6E10!C:)I^I12RW^MRV<NI3(L1^
MQQLL:1J20!N).26))^@[9K1O;"TU*V-M?6L-S 2"8Y4#+D=#@]Q5BB@"FNE:
M>MA)8"RM_LDH(DA,8*/GKN'?/?-58O#&@P::NG1:-8)9))YJVXMUV!_[V,8S
M[]:UJ* *(T;2Q+=2C3K7S+M-EPWDKF9<8P_'S#'8U7@\,:#:Z7)ID&C6$=A*
MVZ2V6W41N?4KC!_&M:B@"E_8^F>?:S_V?:^=:J5MY/*7="#U"G'RCZ5':^']
M'LM0N;^UTNS@O+G(GGCA57DSUR0,G-:-% &4?#&@M;16QT73S!#*9HXS;)M1
MSU8#& 3ZTY?#NB(D2+I%BJQ3&XC MU 20]7''#'UZUIT4 0W=G;7]K):WEO%
M<6\@P\4J!E8>X--M+&UL(C%:6\<*,=S!%QN/3)]3P.?:K%% %=+"SC2W5+6%
M5MV+P@( (V(()7T.&8?B:@ET32IY[B>73K22:YC\J>1H5+2I_=8XY'L:OT4
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MTV,[' (Z=P5+*1Z,>AYK0HH RKGPYHM_-+<WVC:?/<W"*D[R0*Y<#H"2,D#
MZ^@IT.CQ?VO+J4ZHTGD?984"_+%#G)'U8XSV^51VR=.B@""SL[;3[.*TLX([
M>VB7;'%$H55'H .E3T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3J*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MC^R[B[^V/8';Y?F;PY .-P0N Q7/7/8D5>TOQ1HVL6$]]::A;M;02O')(9%
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M8'GN)HX84&7DD8*JCU)/2@#G-'\%Q:)<L+35M1_LT2-+!ISLAAA=B3\OR[B
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MMM0FNULIX?+P_GN\9.0"5Y5P/7OQBM@>"K%4N[5;FX&EW=U]LEL/E,?F;@Y
M.-P4L 2N>N>@)%=-6'HVMW.HZ[KNG7%M%"--FBC1HY"_F!XP^3D#'WAQ^IH
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M#MCONH&E4XFGPN RXSZ\X]#VZ72?#=MI.IWFI+=WES=WB1I/)<2@[@@(4X
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M%D,;,N6RQ8[LY&.!CD<]:;I7@?3M&AD@M;S4C;[&CMX);DR1VJMP1&K# X)
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MF!Y7D6.60L(]S%B%]!EB?7GKTH XQ?$FIZ-)XNO+FZCNA#JT-E:Q/$55&D2
M+D@_=7S"2.IYYYKHK36+^V\:GP]?-%<1S6)O;>XCCV%=KA'1AD@_>4@\=P<]
M:DN?!FD7CZQ]H6>2+5MK7,!E(3> H#J!T;Y$Y[%>,5=L-%ALKLWDEQ<7=X81
M!]HN"I81@YVC: .O).,GC).!0!C:C<:E_P +-T>SBO52R?3KB9X#%D,5DA!.
M<CG#8![<\'-<SX3U75-(T3PX4DM6TZ^UBZLG@\H^8-TMPP</NQP4QC;T/6N^
MO]!M;_6++56EN(KNS1XT:&3:&1RI*L.XRBG\/3BL^#P5I]O8Z=9I=7ODZ?>-
M?0 NF1*Q8DD[>1EWX_VO88 ,D>)]7BL?$,XM%N&T_61:L;*V+.MOY<3,^S<2
M[ .?\.,5T?AG5DUO1([Z*^M[U'=PLT"% 5#' *GE6 P"#WSTJ"+PI;6\EW)!
M?7T4MS>_;G=77(EVA./EQ@J ,'(XK0TO2K;2()8K?<3-,]Q,[XW22.<LQP /
MR H \[U1[_PA#JR:K8)K/@^^NI;B6[ML&XLB[DMO7^-5;HPY7'L!6_?^(M<O
M[K5H?#=K'<2::\2*CA-D[-&DARQ=2H*N " >03STK2E\(6DUI<V+WVH'3[J6
M22>S,JE)-[%G7)7<%))X5@,?C3;WP5IEYK3:JD]]9S2QK%<QV=P8H[E%X42*
M.N!QD8..,T 58]:UK67U5M'-E"VFWB6Q@NLD2X5'D+.I^7AR%P#RN3D' RFU
M76K6?X@W0O;><:8-UO#-;DH +990O##CYB#ZDY]JZ";P7IDNN3:I'+>V[7(0
M75O;SE(;G:,+O0=>..,9'!S4ESX2T^YGUF4S7<?]L1"*[2.7"GY!&2 1P2@
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M2W3Q$G:-B*H!;DDL22?3ISD;?A+7+C7-+N&O8HX[RSO)K*X\H$([QMMW+GD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8L#&1\Q!SM]3TJ+2];-II7AZ+4[Z4:3<:SJ$%U<3SL02LDODI(Y.=I([GG:
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MBW>8^2?F$FT;NN6Q6/H^J"UTSPW:7,WDZ3>ZYJ4=U+OVJS"68Q1LW8,W;OM
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M!:2&&<E2PGB!PRXW*5?N._3BNF7Q*DVN7>F6MN)Y+.:.&Y42@2)O56#[,9*
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M W44DEC9S-(TMK [2@+(6C!+@= ?7%8,WBU[=_LUSIPM+]A)(EO=7<2!HE(
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M&&*_0GI4/]EVQU@:H44W2PF!6"@$(2"1G&3R!U/';J<NTZ[EO('>:V,#*Y4
M.'5Q@$,K#JISQ6%>>-;:TL[G4S:R/I%K=FTN+M7&48/L9PO=%8X)SG@D CF@
M#I);>&?9YT,<GEL'3>H.UAT(ST/O5?\ LC3=A3^S[3:6W%?)7&?7IUKD;]9]
M?\?WVAWL$G]GQ:;#+&T5R4:)FDD_>J1R&^10/3!]36MKNMW^F^(O#VF6EJDT
M5_+*LKM+@X2)FP./4 Y]L=^ #<:PLVO$O&M(#=(NU)C&-ZCT#=0*DGMX;F(Q
M7$,<L9ZI(H8'\#7GGAKQ')HT=U!<6EW<6DWB2YL1=O,&\LM,4C&&.YAG SVR
M.O.-V[\<V5M>"-(O/@6]%C*\4JF1)-VTMY?4H&X)ZC!.".: .F$$0@\@1((=
MNWRPHVX],>E1W%A9WCQO<VD$[Q',;2QABA]1GI7+_%*>>T^'&KW=K<3V]Q#&
MK1RP2M&RG>HX*D'H35JR-@^MQ)8_VPL\4+RXNGN4BD'"[2)>"<L#D D8]^0#
MH9+:":2.26&-Y(\[&902N>#@]LU#_9>GFT>U-C;?9I#EX?)78WU&,&L70_%W
M]N7KV4>FS0W-O+)%>Q2.-UJ5QM+8X._.5QU SZU);>)3J$EF]MIMU-IM[-)!
M'>1'.TKN^=@.50E2 V?3@9H V'T^RD2%'M+=DA_U2M&"$_W>..G:F'2=-*NI
MT^U*NVY@85PQ]3QUYKA?!GB273=&TNTN[2[EM[S5+NS2]>8/B3SYB@()+$87
M&?6NA_X2]$UFRL)]/F@6]NIK6W:1@KLT88EBAY"-L;:V3GCIF@"K<>#[J?5+
MN9Y](NK2YDWA;[2Q-+"-H&Q'W@;0!P"O'O73VEE!9:=!81+F"")855N?E48
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M-/;/;2%F4Q,0<88C.1U!QD>Q%6: "BBB@ HHHH **** "BBB@ HHHH ****
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M*&V20(3)M#!-QX!(9>OK0!RUSX)OY[?5C'J,5M>3ZLNK64Z(6$,BHB!74XW
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MGM7TI\+$ R,WED\8X)W?K7/:'=:?+>^%;"<VS:%/HA,8R##+>#R]P;L6";B
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M2^:J'/9L#/Y"N>NO"VJZC:Z?]NUV.:[M;Z*\:06>V-O+SA%0/\H.3DDDG/H
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M/3G%:VE>+Y]3U+38AH]P++486EBNE60B+"A@)<H%7<#P0S#(QZ&H[7P4\/\
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MK^9(JA/,C)/[MBH Z,.!UH IZEX^O+!=>F71%>VT22/[2[76UFC=%?<J[/O
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MQ0*%)W.V#@$@*..I'2N>M_'DUY8Z!<6ND"1M6N9[3:;D 121B3/.WYE)B/.
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MFFO=+<[)99!((O+_ -9(SD8W'H6(H XGQ7JFHZGH7Q%L;V"V^R:;;;("DA+
MF 2 XV]?FSG/& .>M;\7C%M-GO+75[ 6L5II8U))(IO-+Q+\K!EP-KY X!8<
M]:-4\%3Z@WB9(M56&WUZ)4E0VV\Q,(Q$2#N&1M XQU[]JEO?!@U/49I[^]22
MWGTAM+EAC@*DJQR7#;C@Y[8- $,OC:YLS?->Z'<K#;6+7BSQ+(R':<&-BT:[
M6Z'C/&3VJ<>,4-G!.L5M<"\N%@LI+2X,T<_R%V.53(VA6R,'H/6G:=X?\06N
MGO;W?BAKJ6.,1VLWV,)MP0=T@#?O&P,=5')XYK-G^'2,;FZLK]-.U)[R*]@E
ML[8+%#*B%"?++$'<&8-R,\>G(!T/A[6KC6;>Z:ZTV>QFM[AH2LBMME P0Z%E
M4E2#Z#D$5R6II:#XO2QW&GR7D#:$LIACBWC?Y[#?M_O8&,]:[;2;2]M+4C4;
M_P"VW3MN>58O*0<8 5,G _$G)//IE7'AS4&\9/XBM=3MHW:Q%B();-G 0.7S
MD2+SD_E0!R?ASQ3>:3X/US4_*EO+:RU20"SN;AA<6-ME1B3(8Y7EMIZ+W.,5
MO^,K_P"W^%?%5FL$<EM;Z/)+]H$F?WC1NP4#'8!6SG^)>*6+3=,\'VNIWVK3
M7%_/K=T!=O':/('8J55!&@8A<#'.>O)YI=+\(-#\.)?#OGR0S7EJ\4LLP\UX
M]Z[0#R-Q1-J#G^$4 17_ (LF\-^'HISIZ26]KI<=RTLMP(A*0O,<?!W. I..
M.H]>+EYXMFM=3N[,:=&=FF'4K5WN=@G53AE^Z=I&1GD_>'OBCJ'@.[OH[N(:
MVJ1WFD#2Y@;3<5 # -&2_P F=WS#G.!R."-2\\*1ZC_83W=VS3Z6^6D1-HG0
MIAD(SPI(0D<_=Q[T 5X/&?VG0K?5X+'SH&TM]1F2*4L\>!D1@;?F8G<.W*-6
MEH&N?V[ ]S%]DDM"J-#<6ESYR29SD?=!!&!D>_X55TWPJNC:?J]OIUX\,M]+
M++#*5W?9=^6"J,\JKL[ <?>-2:%X9CT;5=2U(- L^H",31VL/DQ%DW?/MW'Y
MCNY.>P^I *EYKVH6WCZ/32ELNEII<EY*[2$-Q(BEL;3T&<#/.3ST%-A\9L4T
M*\N=/\G3=;=8[6<3;G1G4M&)$VC&X#L3@X'O5W4/#9OO$L&K"Z"1_8I+&XMV
MBW"6)F#<-D;3D8Z'@]CS5'3O!CVMGI&G7>HBZT_1YA-9H8=LGR@K&';<0VT-
MV SA?0Y +7CG5[_0_"-[J&G+$;A-B@R,0%#.%R.#DC=_GH>>O;O4-,^(NIWE
MIIEO/=#P_#-+$;HHF5FES\^PDD@ #Y>W)%=;XET0>(O#UWI1N#;F=5VRA-VQ
ME8,#C(SR!QFL]_#%[+K-YJ<NJ0M+=:8-/91:$ 89VWCY_5SQZ <]R 02>-Q/
M:6LFF6#7-Q<:;'J/DN7&$D!V+E$?YCAAT XKH=+OO[5TBUO6M9[;[1$':WN4
MVO&2.58'N.E<K%X&U#3AH\VD:^+2]L=/CTV:1[,21W,*?=RA<;6!R<@]SVKL
M+:![>TCA,SS.JX,LG)<]R<8[]A@>F* /,/#R6'V;Q0+O0I[X1ZY=PI(B B--
MP 4-G*A<YX' Z5U>L>)KCPYJ=GICZ8T\%S"8[*Y\\YFN% VPL-GREN2&)QP?
M2C1_#.L:(FJ+::S9'[??37I,FGL2CR8R!B49 Q2ZOX/?6["2TOM1,NVV2.TE
M,1\RWF7DSY#<ON"D=,8QT)R 7+O7;N._.F6=C%<:DEG]KEB:X*(H)*JH;:22
MS!@.!T).. >6DO\ 4$\?G4;/1Q]MF\.)-):7,XBV'S22K, WS#&. >G:MJ[\
M*ZM)JECK%IKZ6^K16OV.ZF:S#Q74>[<,Q[QM8$D@@]SQCBK'_",7*Z\^J+J8
M=FTW[!MF@W,?F+>86##)R3P !Z8H J3^-W_L"RUBVTY?LUSIOV_?<W B4':"
M(0=IRYR>W:G#QA>7>HV%EIFD).U_I7]I0O/=>4H&4&UL*Q'W^HSSV[BG;_#^
MZM;73[>+7!Y=MI+:4^ZTSNC/\:9?Y'X )Y! ''%7M)\(W>EW^EW9U6*9[#2C
MIH!M2 XRA#\/Q]Q>/KS0 6'C5=4M/#K6MEBYUJ&29(YI=JQ"-07!8 Y.2 ..
M>3VJ"P\=M?Z=8RC3?*N[U[A8H#*S@+"VR1B50G&X@# .<@\5S^J:/+X>L?#>
MAOJOD1V$<TB:A)I;RQ,Y("J=K91\,_.X CL>VK;>'-4U73].N[?4;?3K_2IG
M2PNK?3C%%+ ZKN5K=VR 2,=1]T,.M '4^'M6EUO2$O+C3[BPGWLDEO.I!4J2
M,@D E3C(.!D&M2JNG6T]K9K'=7;7=P26DF*[0Q/HHX4=@/S).2;5 !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%8WB;4_P"SM)*17,<%Y=NMM;.YX5W.W?CN%SN/T]Z &:#XHLO$
M-[J]K:AEDTVY\APW\8*@AQ_LD[@#WVYK;+J&"E@&/09Y->;7<$G@GQKH.HS7
M-J;&]@&D7"0PM'L"@M#(V7;.#E2W& W-):W.DW>O:MI?B""9M;75Q<V(5'$D
ML(*F%HW'\  P><#YL]30!Z#::C:7TMW%;3+(UI-Y$VTYVOM5B/R85:KSSP_J
M.B>%[[QE=:@([(Q:J9'<6YR(G2$*?E4G:6)Q[Y/8UUWB!KZ7PKJ;:.V;][.4
MVC*>LA0["/QQB@#4#JQ(5@2O! /2@.K' 8$^@->::<MA>ZAX0NM%6*,QV\J:
ML@ !6'R?F2<?WA)MX;G.X^M:/PKTO3(?"5GJ$%M"M\RRPRS ?/M$S$*3Z="!
M]* .Y9T4J&8 MP 3UH9U7[S ?4UY/\1[FVDE\46ZQ&._BTV!XWD1I'E"LS P
MCH@4_>89YQTQDOUJUT;4]=\:33P6\R/H4$D7F+P9,3_, ?XQE,'J,CUH ]6R
M,XSS2@@]*\TN5FTRR\,>-+&T^VWALHK"]1<%YA*JA#GU67:#[,WI7>:-ID>C
MZ1;V,87,:_.RKMWN>6;'N23^- %T.A<H&!8<E<\BC>NX+N&XYP,UY%IM]93>
M)_#5S!$8%.IW\-Q"T3O,A=9?EF<]2S!2%[#'7&:IZ3I6FW/AS2)=+2(>)+?7
MW$3QG]ZD0NWW@]Q%Y>XD?=_$T >TEU#!2PR3@#-8=OKUU=:YKVE16,7G:;##
M)"QG.)S(KD _+\G*8[]:\RNM)TN\T;Q3'91PCQ)#KTO]F%#B:)]Z%=@ZA>N<
M<8!STXZ'56MY-6^(T<QC8-I-N K8Y81S=/<$K^)% 'HD$SFTADN1'%*R*757
MW*K$<@-QGGOWJ1G1"H9E!8X )ZUY7%J&F076DP>)5#:+>>'H(+21XR\0FY$J
M< X<J4QW^7 YJIXS>Q&G:QI\-M/!<P>'HOLQO%>6:15WE1&#]UE(!=^3G&<8
MS0!Z/8Z\]SXGU?1YK=(5L([>1)O-SYHEW]1@;2-GJ>M+/KDD'C"RT,VJF.ZM
M)KD3^9R#&R KMQ_MCG/;I7"7EMX?U7Q+K[Z_#'-!=:5:-9^>IW2D"7<80>6<
M97!7GYACK4MDFJVVK^$[:\E_XG4?ANYC<R,"1.?)VACW.5/UVF@#TT.K,RA@
M67J >12LRH,LP4=,DXKS/P-_8VI7VCW<5UJ0UVRMF@OK5H5C*,5&\3D1@M\X
MRI+$DG//-;GCE&:?3'M]0L;:[C\YXH=2CW6MP,*&1SGY6P>".?O<'F@#ISJ-
MH-333O/0W;PM.(@>?+!"[OIEACUY]*G\V,!R9$PGWSN^[]?2O+]-DLH_$VAZ
MA<:*UH9?#16"V$>Z02(Z81&QDL%Z'@XYXJIX8EL;GQ!HPMHX_LMYX?G@,"0L
MPWAXB(Y'(_>2#+;B<=3P,\@'JEEJ-IJ&G0ZA;3*]K,@DCES@,IZ&K6<C(KQC
M2KVPT_POX*>]+VNBK9R07\L=JK)%>;8PIE#(PZ"1<XX)Y->E>$+*ST_PU;6V
MG37<MBI<P/=\,4+$C P,+S\HQTQVH ?H.NOJ\NL1S6R6YTZ^:TR)=X<!$?=G
M Q]_I[5L!U90RL"IZ$'@UY7+?V5O!XD-T@EA?Q3%EBQ$48V0XDEQUC#(<CH2
M,9'4-L-*_MOPKXLLK55>^LM8>]L ;<HJR*L<B;5/168,,>C'UH ]7R/44M>6
M6$%S?^(7E_LOR]-\86R3R(T0S (L;P__ %TC8?1C]37:^,HH/^$%UN.1$\O[
M!,%4@8SL.T#WSC'OB@#<\Q-I;>NU>ISP*"ZA-Y8!<9W9XQ7E=S#IFAZ+X5U$
M1&VT>Y53JES;PK)^]\D+&\H*MD [@21P2#UIRR:3H-SX?S/=2^$II[MQ-=Q_
MN5G;88OE"@+'S*$R,9Y'&#0!ZF&4]&!^AJMJ$UU#I\TMA!%<7*C*12R^6K'W
M;!QQ[5Y-%]CMM&2_6-8;&R\9M(TACVB"'<1D\?*O*CMCBDUJ2RN?#7Q%\I 4
M>_AE@'ED!B8H<,N1SDACQUZT >QEU!P6 /H32!U+E P+#DC/(K@(M-TC5/BG
MJ[RV]K<,MA93P%L$><KRG>/]H#9SUP?0UD^#QI&I3:2U_=7Z^)-/21-0M7A1
M,,5(E,S>6-T9/S ECDE>] 'JH="VT,N?3- =63>&!7U!XKQC1]/TD>'? 4Q@
MMQ<OJ<L%PYX<PE9\HYZ["=@VGCD>M6&FBTO3]62W5X]$M/%&ZZBM(@XBM3"/
MF"8(V"4AB ".#Z4 >OAT90P92IZ$'@U6OM2L]-LFO+J=(X%(7<3U8G: /<D@
M8KR^_L= _L_2IM-N9[JQNO$<$XDF"I&,C]YY0"KA.F<#&<^]5]7L["'1/&UG
M;6T LK76K*XB@CC!2)<VYE95 X'$F<?[7O0!["70,%+*">@SUIU>8ZM+%;^)
M!=Z;]AU"U-S9*^ERQ;)XL%#'+;'NHW!BN,<-R,FN_P!-UK3]7DO([&Y$SV4[
M6]PNTJ4D7J.0,_4<4 72Z*P4LH9N@)Y-*74-M+ 'TS7DGCN\M6O/$:)&8;ZU
MDL9-\B-)+(JNC;XCTC1<D$C.6SG'?4M--T_4_''BVXM[:WEOHH[6XL6=>4F$
M3?. >A#$9_6@#T8.K,RA@67J >12D@8R0,]*\S\#?V+J5]I%W!=:D-<LK5H+
MZU:%8_+)4;Q.?+!;YQE<L22<\\UK^-K:RN?$O@]+J.)P;^57#]T-O(,'_9+%
M1@\'('>@#M ZE-X8%<9W9XJM?:E9Z=9_:[J=(X-RH&)^\S$*H'J22!7E5E+'
M8M'$JH/#EKXHN5NHD \J*)D/E$CH(A(<_P!T'![4[7;",:1XHGAACDT!=6T^
M>T"H&C0B2(W#I_L<G)'&=_O0!Z]VXYJK83W,NGP27\,5O=,O[R*.7S%5O0-@
M9_*D'V)]*X6(6)AX4KM3R\>AZ#%>3>'[;3[JQ^&D-Y'#(!!<QS))CIY1PK@]
ML\8/6@#UF[U*SLA;?:)T3[3*L,(S_K';H!Z\9/T!JR74.$+#<>0,\FO'8H=/
M70='\V&!K&Q\73H 8PR0VY:;:.G"'*8[=/:KH_LS4-?O]-UNYU&VUJ/5?M%C
M%# HDDB# PF-S&2%V_*PW ##9QS0!ZKO0'!89)QC/?K6/XLUYO#7AJ]U:.W2
MY>VC,GDM+Y>X#K@X/\J\RO[33(]%\4WL<5N+VW\31/:R@#?&/,M\E/0$!\D=
M<'/2CQ3=V=QX?\>66L)&VM&X:2R61,O); )Y)B]5'S9V]"6SUH ]E+JI4,P!
M;@ GK67XEUEO#_AS4-52!+A[2W><0M+Y>\(I8@'![#TK@=<ETK4/$NM:9XCN
M[ZW2\$$FE/! &:6/RUXA8QL0XD#' (/S U2\1W-JVF^/M/U] =4:V9M.%RH+
M20" ;/*/<B0.6V]"230!ZW!.)K.*X;"!XPYR>!D9J.QU&TU'3X[^UF62UD&Y
M)0>&'K]*BL1%>:!;JR"2*6V4%77A@5Z$&O+/#4MO::%X$^T0QQZ1$LT6IEXM
MJ1W>P",RY&."&&3T)'M0![$"" 0<@]Z:70.$+*&/09Y-<KX'MI+8:X(N-);4
MG;3E'W1&57=L_P!CS-^,<=<<5QWBZ]M&U/6'1#;WEIJVGNYD1GF90T/[Q#TC
MBP6''4[N1G! /6RZ@X+ '.,$U2UO43I.BWE^D23/;PO*L3R;-^U2Q&<'' ]*
M\H\26FF36OQ'ND@A:YBD@FLVV_.DGD1_-&.H;>#DCG(P:T]?O[";4O&=MKGE
M,;C35.D&5=RRQ>22PB/=O,R3CG[I[# !Z1I5Z=2T>ROBGEFYMXYB@.=NY0<9
M_&JWB#5SHWAW4M4AA2Y>QMY)S"9=FX(NXC.#@X'I4/AB16\%Z0XW "PB!XP1
MA #U[UYFLC6WA?7;'=8ZC;GPY/\ 9=4MEV3%2 %AN%Z>:2>#U.&XSF@#UZRN
MA>64$^ K21JY4'.W<,XHNKDPV5Q/ J3/$C,$+[02!G!.#C\J\R7^SM*UT36=
MN62;PG-)<1V;;9;F12A7YAR9,%\'KUIOAV\LH_$<KVTD"6D_AM-OV>)EBRC-
MP6/WF4'!8XYXP#Q0!U=AXQEO1X1;^ST2/Q! TI/G9,!$)EQC;\W3&<CZ5U9(
M R2 />O+-#FC6U^%2M(H:.V=7!/W3]D*X/H=W'UXKHOB9';R>&[03!<C4[,J
M2<$#STW$'J/EW9/IF@#L596SM(.#@X/>HIKNWM[66ZFGC2")2TDC, J@=23V
MQ7E.J1G3Y_&UKH,"I;+)I\\MK9KC=%Q]HV*O<H,-C^=7=7LK;4;[7Y=!C@N-
M)N/#DJSI;*&BDN03Y. .#(%W>X&W/:@#TJUN8KRTANH6W13(LB'&,@C(K!TW
MQ#?ZK8:I+;Z= +JQU%[+RGN2$<(RAGW[>."3C';%3^#GLY/".EM8K&L/V://
MEIM!;:-W;KG.??->>:D]M+X*\5%FC9U\3K)'T)_U\/S#_@(;GT!H ]=+HOWF
M Z=3Z]*4,I8J&!(ZC/2O*->L=)O-1^(S3P6TS#3(9(=P!_>B*7YE_P!O)7D<
MY(]:O:3%IMOXST&6(6Z?;= F-Z^1^_;="09#_$W^LY//WO>@#MX-6\J+3XM5
M$%K?WLCQ1V\<WF LH9CAL#/RKD\<=*TR<#)Z5XWHT-@N@_#RYN[>)[>"]NHI
M6>+?LW)-L4\'JVW ]<5W_CRYMK7PK(]W \UNUQ KX8JJ RK\TA'.P=6'<9'>
M@#HQ(C)O5U*_W@>*4.ISA@<'!YZ&O%M1:U?0_%MLSHP&NV,\'EPM$N&-L6>,
M=@0'.0>0"<GDUT=KX?T;5/$?C3P\D-O%I]Y:6C".%0%60K(&D4#C</D)/KC-
M 'H^1ZTC,J#+, /<UQO@H7FJ;-0U:S6&]TR)M+!V !G1L2R)_LMM3'IM/K5?
MQ;I^EZE\0?#%MJ$$$\<MO>1RQR#(<%4VAO49W8![CCF@#N2ZA@I8;CT&>307
M16"LR@D9 )KRGRM*N==U'1M9N-0M-6AU)9M.BMX%#R1*5,)BD,9(4 ;3\P ^
M;.,FJ.MW]E/X=\06FJ1C_A(X=85L21$R"'[4@B9&QQ'Y9 !SCDCJ>0#V7(]1
M5;S;O^U!#Y$7V,PEO.\WY_,W8V[,=,<YS[8KRSQ;):6G_"R;&9%2XO+.*>UA
M\LDRX@(+J .<,#D]CUK7NGL)?'4LC^3Y<WAAA(7  ;]X" <]\?I0!Z()$()#
MK@#)YZ"@.I4,&!4]"#P:\@M+6QT?X>>$M62W:*U<6JZW/;Q"238L+JID!#95
M)&7((.,#T%3WMAH*66AR:=<37-C<>)$G62<*J89&\SR@%7$><9XQDF@#UCS$
M(!WK@G .>I]*"ZJ5#, 6X )ZUXQK6G:3!H?C\6UM;(]G?1R:>L:C]PYBA),0
M'W27#9V]2#Z5JZY)I6H>)M;TOQ%>7L'VLP2:4]M"KF:(1I@0/L8AQ('. 1]X
M&@#U(NBG!8 YQR:KIJ-I)J<VG),K74,:2R1@\JK%@I/UVG\J\B\16&G-:?$:
M8PQ-=P-;R6KL 72401Y9,='W@Y*]P:W-0CTO_A,O%$ER?(%YH,3PW5O%F3 $
MXD>-@.H!7G_='I0!Z2KJXRC!A['-#.BE0S*"W !/6N,\"RW U#5+:XBTV=HH
MX,:GIJ[(;I?GP&4<+(H'(!/#+T&*YKXD7-O))XIMTB,=_%ID#QO(C2/*%9V!
M@'1 I^\PSSC., D ]89U7[S =.IH9U099@HZ\G%>6:A:>&-4\8^+%UA+=X)]
M,LY81*,%F(F^9 ?X_NX(^;GCK5;3]-L&\0:/:>,X[9IF\+QBY6]88:02 ?-G
M@N!W/.1D=* /1=3UR33_ !%HFEBU62/4WE0S>9@QE(V?[N.<XQU%7[.:ZD%Q
M]L@BAV3,L7ER[]T8^ZQX&TGTYQZUYIH<5Q8#X<VVH/()(YKW8)R=ZPF.40AL
M\@[2@Y[\=:JI=QZ=IEY.(R^C0>+9GU!(4W 6Y4[6*CJ@?83]* /7?,3R_,WK
MLQG=GC\ZQ]7UV33-6T2T6V26+4[EK<R^;@QD1O(#C'.=A'45R%[<^'+:WTV7
M3H"-.O=8:9;J;?\ 9$E,39;9QN4GA1PN\YSQSA6"VDNA>&X=07-A9^([V.Y\
M^,QQQ1G[2$5P0 JG<HP>/F /7% 'IGB;7GT#1!J4-LETGGPQ,IEVX$DBQ[@<
M'."P../K6P75652P#-T!/6O(]1L8M,\)^)4L5$.AS:U9/IT0X3 D@,IC']S<
M'(QQ\I(XJSJYTR_\1ZYI/B&[U"WNY[B*;2S;0J6FB"(4\B0HQ#!PV0".23W-
M 'I]W=06-I-=W4J0V\*&221S@*H&232Q7,4UK'<*X$4BAE+<<'I6)XYM3>>
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M"MO/-)=6\+Q/-M94DE6/>% ).-WM]:U=3U&VTC3;C4+Q]EO A=R!D_0#N3T
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MAP!V '8?C3FO[-$1VNX%21BJ,9  Q'&!SR:?-=6]L"9YXH@!DEW"X&<9Y]Z
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M.NP+%/%Y*ML(C$>X'K]T#CUYYZ5;C\.3QZ]%JPOT\V/3C8!/(^4C<&W?>ZY
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M4/AKX@V=B775VU*]:#!PV7B5HB#_ +I4 ^U=[+8PSWL%U*"[09,2G[J,006
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M=TVDQ&.18))6N@I=@$."J!">3U)(Z8&?3+2QAL_.:,%I)W\R61N6D; &3]
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M2/9M _V?W:9SSP>>:74O!$6ISZO-)J5Q')J1MF)C51Y30-NC*@@YYZ@YS[4
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M?R-R+F0.A0[_ /@+'IBM/0M!30?MJ0W<\T-S=27*Q2!<1-(Q=@" "1N8]2:
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MY(;:)TC"F)E";&PO/R@#/7Z=[&@^#V\/JMO;ZU?2Z?;[OL5G,$*6^<_Q !G
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME]SA2V/J0IQ_DUE> -(.G:/)(;HW4+.T%C(>HLXW80KGN,$D'N"*N>(M*O\
M4=8\/75HD#1:?>M<3>9(5)4Q/'A0 <GY\\XZ4 0VGB'3I=:NYII=2M'ATN*[
MGM[M#'%#$2YW;>S\,&_W<=JGM_%-EJ-_;:6L-];W%]:?:H&,8YBZ;\@G;C*\
M-@\CBLK7[*:PU?7_ !!>I9_V4^B"T(E=CDJTC'<H'W3YF.#FLWPO_:%AJ6EI
M>:;9W$PLC9VUU#JXN"D:KNQM\I<*2B@MEC]WK0!:\">,/M/A[PY::B+Z6_O[
M5F2ZEC^2>10690Q.=V 3TQP<'BM+1?&JZCID=U<Z=<6\EQ?S65M#NCS*R-(,
M [\9"Q,3D@9X&>*R]%\):UI]GX)@F2S)T-I?M)6=CN#1/&-GR\_?SSCI3H?"
M-]_PC[Z)J6FZ=J%C_:<]QC[0RN8Y'DD#J=HV2*74<'^]R* .UL;Q;ZT6X6*6
M')93'*N&4JQ4@CGN#6#8:W_:@UW4&>9;"PGELXE@!+,8Q^\?CJ=V0/3;GO5_
MPQIU]I/A^WLM0O'NYXB^))'+ML+DHI8@%BJE03WQ6)X>TVXTVS\2Z)M4SO>7
M%S;!VVB2*?YE.<'@,64_[ON* %DUU-,\,^']>MKJZGTR86T4QNVW2-%+A4E8
M]G#,I)'4%O;'57M[;:=8SWMY,L-M;QM)+(W15 R37#:AH%XWP[\/^#YA&;UC
M9P3&)BRK' R-))D@<83'(ZLH[UU/BG0QXE\+ZEHQF,)NX#&L@&=K=0<=QD#B
M@!D'B6VEU%=/DM;NWO);=KFWAF509T&,["&(R,C*D@C(R*Q?!MQ>^(D77+J;
M4;:2.ZNHVA,J^1,@E=%79DX*!5Y&TDYY(-6X=(U34=;T;5]6AMX9]*MYE"03
M%Q-+(JJ2"5&$PIZ\_-VQS8\%Z3?Z)H'V'4$@$HN9Y@89"ZD22O(.H'(W8H M
MW/B"VM]0ELT@N+B2#RO/,(4^5YAPI8$@XXSP#@5F6/C..637GOK.:TMM+O/L
MHD;:WF-MCP %8DLS2< #H1WXJIXC\+7FKZR+^TBBM+^%HOLFJ03LDB(""Z2*
M!AU^]@'.<_P]:J:AX,U>[C\1012VD:W>I1:K8SEV)$J"+"2+MX7,1Y!/WAQQ
M0!T8\5Z=%-?P7WFV$]C +J:*Y SY)R ZE2P89!'!SGC'(K$\7^)7;PIXCAM1
MJ&F:E9::UW&S*%.TAMK*P)'52",@CTINN>#KWQ3+J%Y=M'I]S-I?V"W6.3S=
MC>8)2[' R-R( /3/3.*EU/3O%GB'P9JNFZA;Z9;7=S9O:HL-PSH[L,&1F* J
M/10#UY- &C?:NUQHNJ06ANEEMK)F:\CV[4DV$X!)Y8=QCC(JGX3\5PW>G:)I
M]Z+Q;R?2H[H7-RF$N-J)YA#$Y)!8$Y SG(R*K:=X=US2K#5M(MUM9-*N[=VM
M4DN&WVTSJ=Z9V\QECN!ZC)&#3(O".IR_\(S!=+;K!I^CS:==M',2Q,D<:;D^
M7D?NR><=: -VW\6Z=<7&GILN(H=2S]AN9$ CN"!N 4YR"5!(W 9'2LGPWKK6
MEAJ[ZE=7%TZZ[/96RL=TC_, D:C@>OH  2< $TRP\+:K)IGAK2M4^S"+0;B.
M47$,A)N/*1DCPN/ESD%LGM@9SD4G\'Z\D#74'V,7UMX@DU>VB:9O+FC<,IC9
MMORMM8\X(S0!<T3Q"\.O>+7U*6\2WMKJVB@M[C!9&>-<(H!Q\S,,<]QDU>E\
M?Z/;BY6>.\CGMKJ&UG@$0=T:4CRV^0D%3GJ">A'7BL6^\(^(-3FUZ\(T^UN;
MJZL[VS5IFE020*HV2#8/E.",CUZ5;U#1/$.KZ+"LFGZ397*W]K<&W@G)0+#*
M')+^6"2V, 8P/4Y- &PGBZV=' T[41/%#Y\UN\2K+%'O9 Q4L"02C$;<\#/<
M5KZG>_V=I=U>^1)/]GB:7RHR S8&<#) _6N6\7>%[S7KSS[6"*WO8K=18ZG#
M<-'-;2[F+!L#YX_N_+SGG@9S74W]JUYI5S:;P'F@>+>1QDJ1G]: ,72O%8O=
M&T>>:QG_ +0U&U%PEI%L+,NQ69P2V @+@98@\CC-:NCZQ9ZY8"\LG8H':)T=
M=KQR*<,C#L01BN2TOPSKNER^&]2\NS>[TW3CI=U;).Q62+"8=&*C#;HP<$=#
MC/'/0^&=$?1;6^,S(;B_OIKZ98R2J,Y^Z"0,X 49P,G)P* (F\7V(URYTE+6
M_DGM9(TN)$MSY<0=2P=F[+@=?_KTD'C/29K^WM9&DM_M5N]S;33;0DT: %B"
M"2N%(.&"G'XU!;^'[Q_$'BB:[$2V.KPQ11M'*3(H6,H<C  ^]D<FLG3?"^O3
M^')_#VK0Z3!"+&2R&H6A+2W :,QJQ0J-AP<GYCDC'2@#?B\66DM_I]H+.]4Z
MBCR6<CQJ%F55W$_>RO&.& /(]\);>,--NK32+F..Y$.JW#6UNS(.)%WY##/'
M^K;GGI7,0+KD/BOP3;:Y!9136Z7<0>UF:03;80-^"J[<XZ<_6G6/A/Q%:VN@
M6!BT\P:/JTET)?M#;IHF$V#C9\I'F@8R<GN* .E?QCI<=_:6S^:(KNY:T@N<
M*8GF&1LZ[ARK $C!(X/2D;Q=;MITU];6-Y<0+:RW44B;-LRQD @'=P>1PV.,
M^E97AWP_KNB71TU[;2I=,BN7F@U#)^T>67+B,IMP6YQNW=.<9JO9>"[Z.[NI
MH4ATM;VRGAO[>WG9[>XG< +*L9 "$?,21@\XYZT =7X=U.76?#UAJ,]LUO)<
MV\<K(2,990<C!/'/&>:TZR/"]G?:=X9TZQU&.!+FUMXX&$$A=3L4+G) ZXST
MXSWK7H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MF^UQQD%7(&2WWB0.O^- '1ZAXCT^S-^DR2RP6* WTJ(&2!2N[YLG)^4Y( .
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M\*B0XA<^?DIZ9VK^54=9N[I_A9X5U'S7EU 2Z7*DC-EI)&:-6R>Y(9@?7)H
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M&TR?3'TV73[5[%^6MVB4QL<YR5QC.><^O-0'PSH+12Q-HFG-'*$$B&U0APH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P )#';VTUA97MFH<NL\K121R?+L>-U4E2/FZ8Z_A6_'''#&L<2*D:C"JHP
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M*26HC$CB.X@=0"2VW*M\JD<$<8SSFNRN]36TU"SLS;3R-=LRI(FW:I ).[+
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M5^DL5QYKAYH51U4%-F%8!Q_$0<=J]#J.2>*%XDDD56E;9&">6;!; ]\*3^%
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MEO-27<!AN-N""2._RFM:LO3-<AU34M5L4@GBETV989?-VX8L@<%<$\88=<4
M4KO1]1'C:#7+,VKP_P!GM9RQS.RL#O#@K@$'."#G&.O/2L32?!^KZ?8^#K>5
MK%CH<LKSE9G_ '@:-T^7Y.OSYYQTKN!/$;AK<2*9D4.R9Y"DD _0E3^1J2@#
MC_"VA>(]!2'2)KG3I=&M&(M[A0WVEHLDK&RD;1C@;@3D#H"<BSX@T76)/$&G
M:]H,MG]KMH9+6:WO&98YHG*MPR@E6#(#T.:T[C7(K'3-1U'4+>>SMK%GW-*
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M*ML7T&1P/:@#SJYU5->O]7LYO$G]BM#!;3Z?),7200M$K^:H\Q0QWEPP(/0
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M8/%LD< X20AFX7IR,\<,\+27(7X>W<FHW\TVJV<T=YYMV[K*! 7'RDX!!'4
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MMN,'YLC=GH>F10 V0W/B'QWK.CWD=[#:6=O:M!+;W/EF%F:5C(-IR2VU1T/
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MPO[K&1ZY]JO:IX4O-7MO$%Q-);1ZCJNF_P!FQJK,T<$6'YW8!8YD8]!T ]R
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M!U91M8#8P!RK\YP?0]^*GOM:6WU2/2[:W>ZOW@:Y\I6"A8P0N23TR3@#O@]
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M"VE^#]<U6+5VOM3,$6^.](ADF9"XDD0/T^^ ,=.".E=/%H.I1:[KVHF2T?\
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MA1H(O)#1O'@]3('SCJ?E/3%.T^RDUKQO';ZW-=K<?V#97<UM'=R1JEQYC[B
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M^V: .\_M2Q.K?V4+F,W_ ))G\@'YA&"!N/H,D5;KSC5;NZ\.^.KC5+JY:_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME)P&<@$("0>6P.#Z4 0:=X5TO2VMA;I*8K,L;2&24NEON!!V ]."0,YP"0,
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M437DCK$C@ H 3@KA0,'/Z#!I7@C1M%:7["+N.)PPCA-U(T5ON^]Y2$D)G)Y
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M#@'"+R.>/KGH** ,:;PMI=U>WEU=1R7#WEH+.X65R5DB&<*5Z=68Y'/-4H?
M>BPZ+=:23?36MS'Y+B>\DD81?\\U9B2J^PQ7344 1P1""!(E9F"*%!<Y)QZG
MO4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MYZ5%I*Z;J_B/P[#>7"W%O/X5W2QM<$HY#P]1G'][\O:O3V@A8@M$A*@J,J.
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M?++:-?I81@P6\0D'F,%4\,4SO4<[1SCBO51&BG*HH/J!21PQQ)LCC1$_NJH
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MTJ/1);BWNI5#S0M@A89&'#DXW GGCZ5ZL5#=0#]:9###!'M@CCC0\X10!^E
M'FFCW6FRZEX:LKC[(V@3Z(3#]WR)+P%-X/\ "7"9QG_;[YJG8ZJ^G#08O$5Q
MGPU)=ZA##<7;9C=5<"V\UFX*E/,VEN#\I[ UZNT$,L0C:*-XQT4J"./:EDBC
MEC,<B*Z'JK#(/X4 >4Z\YL9O",7A:X-U*@OVLOM4P+2H4SA&/48R$)!'"]1U
ML7]YX=U/1_!)TF5$LIM80,ADVR ^3*&#G.=V>#S7IYC0D$HI(Z''2D\F+_GD
MG_?(H \ECOAIUG?6D$N-%MO%H@NU5\K!:M&K8//RQ^:1GM@D=,U-XC'V71OB
M)%9R(-#_ +-0Q*K#RH[AD?S%3L,CRR0.[>YKU011[6 1<,.1CK0L,21")8T6
M,=$"@ ?A0!YQ>:CI]SXCU:QUZ:!;;^R(7TH3N C@J_FO&3P7W;!D<@ 8K#TS
M5-..C^%K'6]0M;71[CPY"D$URH,/V@#$B[B0%D"[,$\CG'7GV)X86V;XXSL/
MR[E''TH>"*1%1XD9%((4J"!CI0!YG:Z3IM]XTTG2;V^N[^ ^'V(-S<,DDVV9
M-CL 0<X&>Q/4\UZ'K+WD>AZ@^G+NOEMI#;KC.9-IVC\\5;V)OW[5W>N.:=D9
MQGF@#S#3I(+B/P3>Z//F\N 4U7$A#O%Y+>:9^^Y9 O)Y#''>M/X6V%@WA:UU
M:-FFO9!-!),9V?*B=R%P21Z=L_G7<K#$C.RQ(K2??(4 M]?6G*BH,*H4>PQ0
M!R_C2ST'58K#3-<F>U::4O9W<<WE/!,HR"K]FP3CL>GI7"ZQ+J,W@CQ;I.L7
M<&LV^E/;-;:IY8S("P9E?'&]!U([-S7L+QI("'16!&"",Y%(D,4<7E)&BQ@8
MV*H Q]* //Q-I%[XJU>PU5[9-)_LV&32FW!8O+^?SI(CT#!MOS#D +BL;3-6
M(_L6S\?W"P6]UH(,4MZVQ&GWD/N+<"7R_+(SR,MCDFO67ABDV;XD;8<KN4':
M?4>E$D4<H DC5PIW#<,X/K0!Y)X@NY-/\1V0T]I[JW@\.XNDFD_TJ2T$R;RN
M?^6A4;N0"1GH<8U]0/A_5?%7@N*SEMI=+FL[TQI%)A74K%@'!R<X.0?0YKT4
MQH6W%%)]2*:8H5P3'&/3@4 >3Z#J/_$O\)6MW,)-"-_J-K.TC[H]ZR.+9')Z
MKMS@'C(7VI=3=K7PQK,1G']DQ^)+1=.9WX$?G0,ZH3_ K[P/3!'05ZN8(FC:
M-HD*-U4J,'\*7RH]@38NU>@QP* /(O%=_8WND?$*UUN6%=4@5_L$<S ,+?R5
M,9BSURV_.WJ3@^E6M5O]+U'6=0TS7-8BT^&:SMWTJX8#+(4^9H'SQ(),].3\
MO4"O4G@AD8,\4;,!M!*@D#TI7BCD9&>-69#E21DJ?;TH \^T;3K#4?B-K4=Y
M--<36EMIUQ$LL[!EE ERQ4'&>F1TYZ<UW6I:C:Z3IMQJ%[,L-M;QF21V., #
M-6 B!BP50Q[XYI2%<%6 ;U!YH \K\0PZCH>F:7XTN#9B6PO#=W1B<EWAG(62
M//1MJE /^N8JWXPOU&H2ZK:26.KV*6,+SV)DVSI&7?;-;/R"QR01CG8HSVKT
MAD39AE78.Q' IIMX&9&,,99.5)497Z>E 'GCW,MIXU2<+::I;7.IF))$;9=V
M,WEE=CC^.+ )[8!S@XS6;IUQ-=^&_#=]!(5\5C54BOESB9CYA%PD@Z[ F3@\
M !<=J]6$,0E\T1(),8W[1G'UH$,2RM*(T$C#!<*,D?6@#SCP]?:1JEXD6K7;
MQ>*[/5YB\*/MG8>8X1<=3!Y14\?+@9ZU0BU/3[73]5BNKEFA?Q:T*E[G$0^5
M2!,QS^[^4\=S@<5ZMY48E,HC7S"-I?'./3-!AB*E3$FT]1M'- 'C/FZ?<:%&
MMY-:3V^G^, NY@!'!"TG& Q.Q#G@9Q@UIW-UIVI:UJ^G:GJXTW4X;V.335CC
M N&A"H8OLY)Y#8(*@=VSUKU0QH0047#')&.II#%&TBR-&ID7A6(Y'T- 'C?B
M?4+"\\->,TUF6%-;MM2*PQS.%D2 .GE&,'G84R3C@DMFO94=)(UDC961@"K*
M<@CU%-:&&1Q(T4;-C&XJ"<=>M2 @]#0!YAHFD6GBC5?'6FS:G.MI-JH$\%LZ
M#S4\J,$$[2P!((.".A%1:Q)I<OB#6M!UG5%TEHA;_P!D$)B40B-,?9FS]_S
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MJ%KG$\0"$B385^9"< $'H0?8'B'4';Q)X?T!25CU!YIK@CJT4* [/HS,F?4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_7%:HD0R&,.I<#)7/('TKR#PK:VME'\.)[:*&&^DM)X;F3&';]P<+(>N-X4
M'H0 *GTV.2[\/>&(XE\OQ9::HGVX$8G7YS]H:3OL9,G)X.5QVH ] T'7)=7N
M=9AFM4@;3KXVGRR;PX$:/NZ#'W^GM2:9K[:AXFU?2?(C6.QB@E2=)=_FB3?V
MP,8V>IKS^_NI88/$LL:O+9#Q1!)J"1J6+68CA#G Y*Y7!QU 8>M,U">)]0\:
MW/AV)IHYK73IC]BBSY\:R/YP3C:Q\O(QSGI0!ZVLT;H761"@X+!A@4Y65QE6
M!&<<'O7CNO0>'+[PGK6J:/=75TMTUF)&:$11ATF7&Q0B_O F[)'( YKU.STW
M2=.TR2"SM;6"PDW2ND:@1MNY8D=,&@"\)8RVT.I;&< \XI/-C\KS?,3R\9W[
MAC'UKQK0M,TL:)\/'>U@$[W,L-TS*-[1F*4;).Y7=L&T\=!WJ[;7.GZ=:7=J
M8(ULT\5N(#@_9[53'N5V1>J;MP X&XCD8H ]9#HRA@RD-R"#UIV1G&>:\FT[
M1VU7P5J7V.#?JFBZW<WFGB6 Q@,LQ<( 1PKKD8[;A[5W7A4+>64FO-;>1/JS
M+<;64!UBV@1J??: Q'8L: -TR1J0"Z@D[<$]_2AI$1E5G4,WW03R?I7C>N6.
MG?V=X]NDMX/M<.JPRVCA1O1MD&6C]#N#9(ZX.>E:VI&WN?\ A-[36%#WTX\W
M2FQEI8O)7R?(/4L) QPO(8Y[T >G/)'&"7=5 &3N.*-Z%RFY=X&2N><5Y<=-
MM;CQ-?1:_!:SW/\ PC%N+LRJK*UP#)O/H6&1SU (]:B\.PV=M=?#JZ5(DN[C
M39([Z7 WR'R$^60]3\RX ;H1@4 >FV,]U) S7T4$,@E=%6*7>"H8A3D@<D8R
M.QJP)8S&9 ZE!G+9XX]Z\>@M]/DT#087BA*)XMN,+@#;"99C^"$%/8@BK7G:
M;I4.NV@M8Q8+XF@,2*"(+<&.(^8RKUC#JW' +=QU !Z=>:I96$$,UQ<(D<\T
M<$1S]]W8*H'KR?RR:M&1%=49U#/]T$\GZ5XT4MGT*[%Q#YD%GXOBF<O:E5CA
M:1"6"D<*<DD>_/6K]\-,OM;UG2-<EU*VN9KF*?2UMK90TL(1#&(7,9*%65@1
MD $DG&30!Z1KFKV^@:%?:M=!FAM(6F95ZM@9P/<]*987NH-+<C5+2VMH5*>1
M-%<;UE!'(((!!!X]\\>E8?Q1BAF^&VMI+&DCFV;RE9=QW]!M'K]*HW#:=;^-
M[=;^*T7P]-I)2R9U7[,)C(3*O]T,RE?J ?>@#NV=$&795'J3CWI<C&<\>M>0
M6&D12W'@BRURW69"^H1K'=+EOLQ#>0KYYQMVX!]AUKLO'*OIWA6V^R03#3[6
MZM_M45K&'9;56&["X.0/E)&#P#0!I>)M?;0?#[ZK;01W:K+%&5\W:,/(J9!
M.<%LXXZ=:VFD1&56=0S?=!/)^E>4ZO%HP\#Z[?:)=W5S;7][9REI$"1-()H]
MWEH$7^%06(&,CU!J363IM]XCUW2?$5QJ$,MU-#+I;6L"L9HA&FT0R;&(82!S
MP1RV>Y- 'J1D175&=0S?=4GD_2L]]52XAU./2S#<WMCF-HGDVKYNP,%9@#C[
MRYXXS7#1SZ9-KNMZ/XEM;B357U&.XL,(^^:)0AB\J11P%93G! !+$]35#5+2
MPBTWXGVTEG$MW())(08.65K:/:5..\@./5@>] 'JJS!88WG:.-F !&_(W'L#
MQFGLZ(,NZJ,$\G' ZUYY!-9GQ,Z>(5@?2KK1;=+![@ PG&[SD!/&\Y0XZD >
ME8^@:6C:SX4@\1P1S3#1+I9Q>*"2OFQF)90W4A!T;NI/44 >N @@$'(/0BEK
MDOAFV?A]I<>XGRA)'@GE0)&"CVPN,>V*ZV@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBLS6]1GT
MVUAD@AB823K')+-($2!#G+MDC/0# Y)84 :=%>?3^,=5O]-T::QBMX))M=;3
M;D,6PVQGY7C(#>7SD9&<>]=KJ=U<6.D75U;VAN[F&)G2W5PGF,!]W<>!]30!
M<HKA+GQ[<6NG>)Y8[6TNY-%M8KI7BF98IT=7/!P>A1NF0>.16SIFOWT_BB;1
MK^R@A)LEO8'AF+_(7*%7RHPP.#QD<^U '145CZWJEUITMI';Q0!)RX>XG?"1
MD#*KM'S,S'@ >A/L<"T\<7^IP^&&L=*M]VN6TLH\ZY($+QJ"0<)R.>O7V'6@
M#MZ*X>'QQJ,VG:+*FE6YN;_4IM-F0W)"QRQ^:"0=O*GRCSU /0T^/QK?+9JU
MSI]N+B+78]'N%CF)7YV0"1"5R>'!P1Z\T =K37=8T+NP50,EF. *YB3Q1>+<
M^(+:/3XI)-*G@C5C.$5DE56+L6QM"!B3USMKF_%6N+XA^'OBF*>"$R:;=1PB
M1 2DG,3JZ@\CA_?V)!H ]-HJO?7L.G:?<WURQ6"VB::1@,X502?T%<W'XLNX
MY=!DO+&%+77!MMV24EH93&9$1^.=R@\CH1C!'- '645S'A/7]7\10+?7.G6E
MK8L9HP4N6>3S(YF3&-H&TA2<YSD=.:37?%?]E:['I*_9HKB6W$UL;MS&ETY9
M@8D?H'& <'KN''4T =117#:IXRURUF\1?8M$M)X="96GW7C*TL9B$AV#9][:
M>AXXZG/$UUXWFGAN9="TZ2_-M##,8O+D+3>8@D"*54A3L93DGJ<<=: .SIHD
M0NR!U+J 64'D9Z9_*N9?Q+J5[_:#:+I8NCI\D44T$TGER2.RH[*N>%*JXZGD
MY'&,U"=:DM_$'BE;70[>2]L;6VD#QRA7NPPDVAV( 4+M/K@$_2@#K6944LQ
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M+&64]?NJ./7/6IKWP=%JFHW-SJ%SYT5SI9TR:%8]H*$DE@<DALG_ #UKIJ*
M,+P_H5_I"A;_ %ZZU41IY4'G1HFQ./O;1\[<#YC_ %.9=0T-K[Q#I6K+=>6V
MGK*J1>7N#^8 #DY[ #']:V** ./7P,T6FV=O!JKQW-EJ4NHP7'D X>0N74J3
MRO[UAV(X]*3_ (00BUGA_MB=S-JZ:L6DA4_O%96"\8X)49_3%=C10!RU[X.-
M[_PDH?4-JZ] L$H$/^J4(4^7GKM)Z]_RJ1?"MQ!J$U[:ZJT,MS916=P?(#96
M/=M=.?E;YVZ[ATXKI:* .2F\#+:WEC=>']5N-&DMK1+%ECC25)8%)*@JX/S
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MNSQR:N)):KK&OZ'XDTR]NKB\O(KBQ*Q2,)XU2/RU651A=CH<Y( R3W->DT4
M>7:MY-KJ/CZ0Z6]W#+]A)BC1P),<._R<L%)RP7G@@]:I:B99M)^)$:)=S&]M
M8I(&^QO&)B8 OR#;ZC ')('?K7KU% &+K AN?!EZ'598I+%QM*[MWR' QW.:
MX32M+T\7OP],FGQ#&DR)>;H/XO*BP)>.NY6P&[@]Z]5HH \?L)YM)TG1KB2.
M]BT>TU744G^S6WF&W#RN8'\LJWR;21D#@.,5<E6V\/RZ'>6ZZO'X:9KO=+]F
MWM#+*499#$8R40XE PHQN[!J]4HH \T@TVQTG6/!DEI97W]F(;U(VG@9G7S
M&3(VY0$[BH(&!Z=*RKFRMWT/4X?L8*CQA'-&@A/$7FQ%G48^[M#?,., U[!1
M0!Y3J]I!%#\0[:U5[2V=+22(6]N2CD( V%4?,"0%;'8FMKPG<Z/JGC/5=7BG
MMO[1N;:%!;+#(K*D>0S[I$0G)90<#@*N?;K-9TB'6]/^R337$&)$E26WDV.C
MHP92.HX('!!'M3-.TAK.437.I7FHW"J426Z\L%%.,@"-%7G YQGCK0!SETR6
MWC[5?[=AWZ9>Z;%%9R/&6C^4OYL73[S;E..K #&<5A65A<V5I\.;?6(G>YMY
MI?/,J;C%&8)1&)#VQN1>>]>IT4 <]XRA6XT:*,WTUA)]JB>*ZCB\P0R*=RLZ
MG@ID8.?7.1UKCD:Z>7PO?:GI<2BVUFZ2::RMW>*8-#*%E5<$A7=OIGG/(KU*
MB@#RB[M;R[\*:[HTL4B^*#J[SVK[#O=C,&BF1O[BI@$_PA2#CI6A%+:-K>O:
M)XBTR[N;RYU)+JQ*0R%9XU"&+;(HPNPKSD@#G/4UZ/10!Y,+BXL/&NLZA<VS
M7FA'6$$T"PLS*Q@A5+A0/]8JLK @ X^\.5XD\0V=IJ%W\0Y7M5N&DTB$6;F+
M=N<12_ZLXY;<4Z<Y(KU6B@#SNQF1/$5XWB"-I=/O]&MH[222,NA #>=%T^^2
MRG;U; ZXJCIMGJUB? -M>^9_:,%C>*[2@MY3-&!$KGL>B\]2#7J5% 'D.G7$
M4NF^!();&[75]/U,+J"M:2&2.0Q2B1F8+T9\-G//7MQ<T".VO;NTT[6TU4:]
MINHRW!C^S;8SEFS+YH3!C9&Y!;GICI7J5% 'E6BZ)I?_  @-Y*T+:?>#49E2
M\AM09H5-[OC.".8^(V(Z%0:Z3PQJ\]I:3KK$$/GSZG]FCO+"!S%>L8U(EP,[
M!QM8YVY4\UV-% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9V
MHZ+:ZC=VMZS2P7MIN\BYA8!T#8W+R""IP."". >HK1HH IZ?IEOIHG,.YI;B
M3S9YI#EY7P!DGZ   8    JY110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
E110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>aquestiveamendedandresta009.jpg
<TEXT>
begin 644 aquestiveamendedandresta009.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W^BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M&7]V"V\\].JC.>>:MKXMTQI;3)F6VO)S;6UV4_<RR@D;0<Y&2I ) !QP3D9
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M:01KCD@<9R1QZ^U<_=>(;JR\>1>8FHR6DFC/.-/CB#L)!,HW +WQGDGO[XH
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M>^+M5T06,R)81PL9SC#%]Y]>F%&..N?:@#>HKF/&]W=V-AI4MG=2P%M6LX9
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MC0DD[5X&0,XS@9ZX&<5;HH \UAL;W69/B#HUM!'LO[[[.;AW&(M]M$K$KU.
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M$V$(0.I'4COV6\\+ZU/H7B*R2W@\W4-:COX"9^!&K0L0W'#?NCQSU'->A44
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M$:QH"<X4# J:L[0M9MO$.B6NK6BRK;W*;T$J@,!DCD GTK1H **** "BBB@
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M]*T-7OH].\1^.;J2]FLE32K ?:(%#.A+3@%0>,Y( SCKU%=HWA_16CDC;2+
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M"SOH%@N[2">)&#*DL88*1T(!Z$>M5[C0M(N[*.RN=+LIK6-_,2&2!617Y.X
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M4$811] .*L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5R7CR[GL8-"N();I3_;%LCI;NP,J$G*$
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M$DK*C",Y1T8(3G);(*]&Z\<MT[P9>:5J>@W$$EM(EDUY-=%G92\EPVX[!M/
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M,*9 "KY#$%?F''7(QQUJ/5/#&OW-_P"(KNPN[6UEU*WM(X6$KY7R68LK$*"
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M L<EP_)D8#DGN?J>: .=@\6Z=IME?W?V;5I$_MK[#*LC"5HYF*+\HWG$>6&
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M[4;2#5XO,LKJXC41RG;O*<,2&QGJ #@X)XS2/A2YMM9EUUDM+*417 O7LY6
MOE*D)YD>T*&'#%N3D>AXJ>$-%N==\'>"9+T6Z66G6T5RGE2,SRMY)C4$;0%
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M"T;1^2)-I;C<6!V]\>]1MX*UY89KJ&]L$U2+6WU:T.'\I@Z;&CD[@%2>1G%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!67K>N1:&+%IK>:5;R\BLU:+;A&D8*"V2#CGMFM2N0^(:"33M$C+LF[7+%=R
MG!'[T=#ZT =?17F$M['I$WB?2Y-0OTM(]7L8K8?:F9@94B9HS(Y)6-FW9.>
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M_E&C57B8L,@LW7Y3P>?;'-36OBZVN]2T:VCM9Q#K%F;NTN7*A6 4,4QG._#
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MXMXHVMK-[IFE1&1'5=JE@&?YB.%&3CJ<<50U[Q%;:'H^J7_EM=-IL/G3P0L
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M)O6-R"R\D<XX[5J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M(UW29*J+MMJ\]!MQ@>E>KO:6TD2126\3QH0R(R A2.A [4C6=JZ!&MH64,6
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MO>,)_#TT1;^R+*4+:/NP@ED\TH%/&$.[C')SU.:;K[Z:WA37]3T7Q(D\,MM
MS0Z<Y2&%_, #G#G:[ D%3UQR,BO68+2VM1BWMXHA@+B- O Z#CMR?SIBZ?9)
M"84M+=8BV\H(P%+>N,=: /-?$-I!;W?CK2X&D>VD\-B[,,DS29F_?C>-Q)R=
MJ9]<"KUI+9CQ!X#6PN@;>:SN@R13DQN1$AZ9P2"3SUKOTM+:-]Z6\*OC;N"
M''I2"RM08R+:$&,80^6/E'MZ4 >426]I;?#[XBW%HYAFAOKU4DAF967:JD#(
M/KV[U=UB_M+_ %W5=)UG6X-*'V2WDTZ:7*OL*?-) V\#>'ST!)P!R.*])%A9
MA646D 5NH$8P?TI6LK5S"7MH6,)S%F,'RS_L^GX4 >6ZU?6][:^.+'7;G%W:
M::OV!;AO*8QFWSYB#(^9I-P;'H%/I7;0213_  YBDCG_ '9TL$2Q2%<8BZA@
M>/SK<FL[6X=7GMH974%0SH&(!X(Y[&I&BC>,QLBM&1C:1D8^E 'EVDQQZG=?
M#^"ZNIY(KKP]*9XQ<N!*0D&,@'KRWU[YKJ/AU,UWX"LA+,TX5[B$,[EB469T
M4$]3A0!72"PLP5(M(!M&!^[' J2&"&W4K#$D:DY(10!G\* /'-.BTY?!?AZT
MADCCE'B<1SI')M=/](F"@X.5..G0U:UAQ8>%/B#96]W-%!87\1MPMR^8M\<+
M, <YVEF;CIR:]6:RM'SOM86RQ8YC!Y/4_6D-A9G=FT@.XY;,8Y/O0!PFOW,]
MEXIEOBL&IZ<MW9Q2I'*4NK"0E-FP='C8LI*C!.3UQQO^-+30]1TRTT_796@B
MNKM8[>X27RVAG"LR,K_PM\I ]SCO6Y]AM!.DXM8/-0823RQN48QP>W%2R11S
M+MEC5U]&&1Z4 >5W.K>)="T[Q+I4VH?VNNG6UO/'J<4>)TA:3#QR;3RZQAF!
M!!QSWI=0O[2PTC4]8T+7DO+&3[(;V+30?+MX?-422##,4<QELXP<#/!&:]0M
M[6WM(?)MH(H8LYV1H%'Y"B&TMK:(Q06\44;$DHB!02>O H \R\6P^';CP;KE
MUI-\MW:-/93.D4P>V@82H"4QPI*\L,^AXSS<U6[GM?%>IMX?F,TJ^%I)K.%)
M2Z&02$(57)'8=.M>@QV=M%;&VCMX4@((,2H O/7CI2BUMUF$P@B$H& X09QC
M'6@#SVP>.6_\&76BW+NM_;R#4=LI)EB\G)DDYSO63:-W4%B,UC^'2L&F^ ]3
M2\N'N[K4Y[6622Y=_,B*W'RD$X(RJGZ\]:]8CL[6)I3';0H9CF4J@&_Z^OXT
M@L+,;<6D VG(Q&.#Z]* ,?QTP7X?>)"2 /[+N1S_ -<FJQ;.O_"'1/N&S^SP
M=V>,>76K+%'.FR6-)$/\+J"*3[/#Y'D>3'Y/3R]HV_E0!SG@+RY/AIX>#E3&
M=+@#9Z8\L9S6?\-=5@C\#>&=.O;R-=0GLB]O!(X$DD2D[2!U("[:ZJ[TV.YT
MZ2QC(MX)05D\I=I*GJ 1T)]?Z\TATBS^TV,PA5?L*E;9%4 1Y4KQQG[I(QG'
M/3I@ Y_Q$^SQ_P"$$$\B"9KM6C$K!7 A)'RYQD>O6N-TW9!I7A_4TO;AKL^*
M)K3S7NG;,33S*4.3@@C'Z5ZW);032+)+!&[K]UF0$C\:C_L^RV@?8[? .0/*
M7K^5 ' Z'J&F:K=LNJZC+;^);/6I5:".;;,RB1A'&%/)A,14G QP6SG)K,N[
MA8-(\1W:S>7]G\80M)*K[?+0O;A\GL,$@]L5ZK]F@%R;GR(_/*[3+L&['IGK
MBF_8K0)(GV6'9*,2+Y8PX]_6@#RK6?$0M=3\6O8W^;/[3IOVAX)2?*MV.)Y$
MP>.,@L.A.>HJU,VD1^*_%JZ9=0I&_AV*13:W&,$&8DJ5/'\)./7/>O34MK>-
M&1((E5@%8!  0!@ ^V.*9'86<49CCM($C*A2JQ@ @'(&,=,D_G0!YOID$.J:
MSX-MKNYGD@N?#+/-$+EPLA'D8) /NWU[U3TO6DB\/>"9M3U&*:Q;[9%-!<W*
M+YVTE8V+2,%;9C&"<_,",D5ZH+"S&,6D' P/W8X'I6)K'AJ>\O;:YTZ[L[98
MHVC:UN;$3P/N(.[:&0AOE SGIVH 9X$LVM?"4"37XOWD>1VE%V;E0"QVH&)(
M^5=J\<9!KA]3CO\ 2QJ6G6T,TTN@7_\ ;*.S,?.LF^8Q$Y^8_P"L4 YXB'H*
M],T;2(M'MI401>9/)YTQAA$2%]H7Y4'084=R?<UH&-"6)126&ULCJ/0_F?SH
M \]\0D+X=T[5UEE@DU#7+*< 2,G[MID"J5S_ ,\P"5/<L:Q->CT^VC^*J PQ
MW36X=$+88JUJA) ]"W?UKUJ6V@G55FACD5>@=00*1[2VE+&2WB<L "60'('0
M4 >::A)=Z+K.JIH$DSW<WA=KM(C*TA>=7PK@$GYL'MUX%7K,P2ZWX2FT2;SK
M34+.;^T4\PN)HA$"LD@/5Q(5&X\_,0:[U+.VCD$B6\*N!@,J $#IUHAM+:V:
M1H+>*)I#N<H@4L?4XZT >3^'M8@>S^'*2ZD&NO/G@NPT^7_U,P"R<YSN P#W
M'%=/\,X[&#2M4M[;REGBU6\66-6^9%%Q)L!';CI78)9VL;EX[:%7+ERRH =Q
MX)^OO4B11QERB*I<[F*C&X^I]: /*O$$H72/BI)'</%)$\;J\4I1@PM8L<@@
M]>,5J:C:VNI>.M1M;FXF>V;P]'.8A=.%#>9(-P ;C@#]#UKO#8VAWYM8#O.6
MS&/F^OK1]@L\Y^R09QMSY8Z=,4 >9^')"MQ\.[XWD[W>J6$B7CO<,QGQ;AAD
M$XX8?AS5%Q:3>'M*EOIA+#;^,9HS-<3%MD?G2@98GIC:,DUZT+&S!4BT@!3[
MN(QQ]*5;*U6,QK;0B-B"5$8P2.AQ0!Y5J^M6"ZPMU::BL3V_B.V@E>XN!YHC
M^1710,;(,'OG))/'!IMXMC::!\3Q!*+>^CFGF3RIBD@7[/$P;@@X+'\:]8:T
MMF=W:WB+N5+,4&6(Z9]<=J5[6WD+EX(F+XW[D!W8Z9]<4 <-'/!J7BR_TW7)
M0MF-(MYK#=)M4J=_G2J<_?!V?-U QC&><;1$N]6U+P;#K]Q<O-=:+=-<QM.Z
M><%>+8S*".2IR?7G->H26-I,D:2VL#K$<QJT8(0^H]*62UMY9/,D@B=\8W,@
M)Q]: .:^',S7G@#3S-,T^#-#O=RQ*K*ZJ">_R@"N0TZ32M-\+ZI(S-&LWB>6
MVS%,(T;_ $G*I*Y!VQD##<<@X[UZM%;PPQF.*&.-#R510 ?PJ,6%F(WC%I!Y
M;_?7RQAOJ,<T >23ZBO_  A/BN./4TS9Z]#Y MIRJQQL\'"@-]P[GP.G7%;G
MB']YXH\9)&<S#PQ$T80_,&#7!!&.<@X(_"O07L[60,'MH6#,&8% <G&,GWQQ
M2K:VZ2^:D$2R8QN" ''UH \XT[5K*^\4>'DCU-'2X\.3"8Q7.-T@,!&2#]\
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MK:Q<RVUR;Z2*2-#;8: H@088L<Y ]!0!RVEV+ZMXY2#6IKDW2:%87<MN+J1
MMR)'W':K#'*CCIZBJ%E>7=WX3T+58977Q3_:Z07:;SO9C,5FB=?[BID@'A0H
M(Q7J8MH!.9Q#&)CUDV#=^=(MI;K<M<K;Q"X8;6E"#<1Z$]: .$6UEL?%VI^&
M=DKVFL-'?P2$DB*-<"=,_P (!5=N.AFXZ5G>(-2O=*OO'\NG3S^9!96#*J2,
MQA5C()&09.W"9;CTS7J.U2X<J-P! ..0#U_D/RJ-;:!)6E6&,2-PSA!D_4T
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M4N'W;GPQXW*. <D^F2-"R\%ZEI,VAWFGZG;"\T_35TNX\Z!FCN(5P58 ,"K
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MRWXE6EY=?$+P%<6UC>7$%C>/)<RPVSNL2EHL%B 0.A_*D6UNS^T.=3^PWOV
MZ7]G^U?9I/*\S.=N[&*]3HH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M64*W4!@#@_G4]9?ANZOKWPSIEUJ=O]GOIK6-YXL8V.5!(QVY[=JU* "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ I"H888 CWI:* $557[J@?04V6&*=
M-DT:2+UPZ@C]:?10 FQ=H7:-H[8XI"B$ %5('08IU% #?*C_ +B_E041CDJ#
M]13J* &A$4Y50#["G444 1RP0S;?-B23:<KN4'!]J>55AA@"/<4M% "!0HPH
M 'L*&16^\H/U%+10 @ 48  'M2>6G]Q?RIU% #0B+T51]!1Y4?\ <7\J=10
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M=H'[K##.<D>M/O=4U?2/$=CIAOA=PZE97$D<TD*@P31!3G"X!0ANAY! YYH
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MQ<3PPJHC:15CYP03SO8=>!TQS6EH6M>(-<32-;MC$-,NY&^TP3-&%2,DA=A
MW;PP (8X// XH [BD9@JEF("@9)/:L'Q1K4VE#2;: A)=3U".R$Q&?*!#,2
M>,X0@9XR1P>E<WKFI:DVG^.-"N;MW^PZ6;JWNU1%=HY(Y,H^!MR"AY '!]1F
M@#LM/UW3-4NI;:SNA)-$BR,A5E)1ONN,@;E.#AAD>]6+74+6]FNHK>4.]K+Y
M,PP1L?:&QSUX8'CUJEX:@:'PYIN^9IG-K%\[JH.-HP/E X%<AJ7B?7K;1_%$
M\5W )].UF"T@8VX($3^1D8SU_>GGF@#T6BO/K[Q5JOA^?Q/!=W45W]B6Q>WE
M>$((S<NT9W!>JJ5W=<XR">]:&O:KK'A>TNIIK^&[BN)K:"S::,"2%I)!&[/M
M"@H-P([YX)Z4 =C17!:YK^M:'?:WIL=V+CRM#EU6TN9H5W1O&=K(P4 ,#E2#
M@=^M1MJ'BF*]\,PG7+=EUMGWYL5_<@6S/@'//S+GG^7% 'H-%><6/BW6HKU?
M#U_<1R7W]MMIW]HI$%#1"#SPVW[HD((7'3G.#THUGQ1KVF6WB.RBN8WN=*NK
M'R+N2$'S8KAU7:P&!N7+<@<C' H ]'HKAM;O]=TB.XM_[;6YN(K&XNU$%JBR
MY!RA<-E!&HR,Y#,>G2HM.OM0U7QSH=PU_+$EQX<-V;=%4QAVDBSP1G!R.^>.
M".: .UL=0M=3MOM%G*)8M[Q[L$?,K%6'/H015FO/=(\6:G>VOA^QN+A5O-4U
M"_@DNDB4;8[=Y<!5.1N(51SGC/4U%?\ BG7[,:AIZ7,)N=/UNRL_M3P ^=#.
M8R P! # /@D8SQC% 'H]%<SX;U#49-?\0:3J%V+L6$L+0S>4(VVR1[MI"\<$
M'!ZX/-)/J=YJ7B[4-!M+QK'[%8Q7'FK&KM(\C.!PP(VJ$YQ@DMU&* .@N[VW
ML81+<2;%+!5 4LS,>@51DD^P%1Z;J5GJ]A'?6$ZSVTF=KKD<@D$$'D$$$$'D
M$5YU)JM]XGM/ .I33R6<\^I21RQPJI42)%<*77<#UVG&<\'UYKL/&CSVO@/7
M9K.XDMIX;">5)8@ P8(6[CN?QYXP: -1M5L5U:/2C<I]NDB:=8><E 0"WYD?
MG5RO.?LMX_BWPM!!J+Q3MH5S_I+1(S*-UOT& N>G4&I-'\6ZKK%AX?LRQ2^O
MK2YFFG@$:LQAD6/Y0^5YW;CP>G'L >A51NM9T^RN1;37*_:"N_R4!=PO]XJH
M) ]SQ4/AY]5?1(/[;^SG45+),;<Y1L,0#[$C!(['-<U\,I'N;/Q!=W7.I2:U
M<I=%OO*5(5$^@3;@>AH [&RO[34;?S[*YBN(=Q7S(G#+D=1D>E6*Y;4+Y;#Q
M/IF@Z>PM3JCW-S/-&%)!C5"0H((#,74G(/ /&3FL";Q3X@6/[$ES"EU;>(H]
M*DN6@!$T3A65L9 #88 X[CC&: /2**X)I/%DGB6Y\.Q^(H%>+2X[I;O[ NXR
M-)(O*YQCY1G],=:B\+^+M3\7/9632_V;<'25O)Y(45B\AE:/Y0X(V#RR?7YA
MR,<@'H5%>:V?BCQ%K8\-P0W=O837[7UM=.ML)!YD&Y=Z!CT)7./U-6M1\1:Q
MI]_"%U!+M4U>UT^40P*(@DFQ6WDC(EW,S80D*-H- '<WMY;Z?8SWEU)Y=O!&
MTDKX)VJ!DG YZ5+'(LL:R(<HP#*?4&O-VU#5M.T_XC:G!JDKSZ?/(T"SQHR+
MMMHG   'N/3N03S6W;ZQJ&M:[=Z/;7ILGL].M[@RK&K&667=U# C8-@R!@DM
MU&* .OHKSG2_%.N^(9_#"QW,6GC5+&[>X5( Y62%T3<A8]"6)&<\8SFNF\%:
MK=ZUX3M+V_='NBTL4CHNT.8Y6CW8[9VYQ[T =!1TK!\6:W+HFFVKP;1->7UO
M9)(PRL7FN%+D=\#)'OBL+5M1U.&]\0^'IKV26,:,;^VNPB+(@RR-&V%VGE<@
MX!P3W&: .IL=?TO4KQ[2TNUDG2)9MFUEW1MP'4D893_>7(]ZTJP/!,#1>"M$
M+S-,QL("&=5!5?+7Y1@#@>_-;] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5;W4+?3UB,[,&FD
M\N)$0LSM@M@ #)X5C] : +5%9,/B32[BZM;5)I1/=)*\*/;R*6$9P_5>"#V/
M/M1!XFTFYT^WO8+AY8KB5X856%]\CH6# )C=P5;/'&,T :U%<3J'B^)]9\+W
M>GZB[Z3>RW4=Q&D!9G:.)B%V[=X8.,;1SD8Q74:3J]EK>GK?6$ID@9F3YD9&
M5E)5E96 ((((((H O45ST7C?0)KB*".[E+271L@QMI0BS@X\MF*X5L\ $C/:
MIY?%>C06E[=2W3K#8W(M;EC!)^ZD.W (VYQ\Z\].1S0!M45S]]XVT'3I;^*Y
MNI@^GE1=[+65_)##(9L*<+CG=T]Z;<^)[&\AU*RTZ]DCOX+-[F-C RAD' D0
MNNV1<X&1D<T =%17(>$/&EAJVG:)975Z[:Q=:?%.WF0-&L[>6ID*-M",02<A
M3QSZ5K)XITA[R*U%Q)YD\;RP$P/MG5.6,;8P^!S\N<CD9% &S16/HGBC2/$6
M3I=Q).GE+,)#!(B,I) (9E /(.0.1WI;GQ/I%I,T<]T55)UMWF\IS$DIQA6D
M VJ>0.3U('4T :]8T_AFPFN+R=9+R%KU@UR(;J1%E^4+T!P/E4#*X/'6L?4]
M8O=1\87'ANQOKK3GBL$N$N8[,R RM(P&[<I!0!/4 Y(SD<=#?:I;6)CMIII3
M=2QLRI;PM(^%QN<*H/ )'7C) YS0!GZAX*T/46L':WEMI+"+R+>2RN'MW2+C
M]WN0@[>.E+?^"]$U"[M;IX)H)[:$6Z/:7$D!:$?\LVV$;E]C6'X8\22:CX<\
M+7&HZS,EY?W$H&VV&+O:9,(2%PG #<8/RUN6_C70;FYF@BO'W0&596:WD5(S
M'C>&8K@$9Z$\]J +;>'M-;5DU-8I(KI+86H:*5D7RP25!4':<%CC(XS52+P;
MHUO8:=9V\,T*Z:Q:SD2=_,ASP0&)R00<$'(-3Q^*-(>2\C>Y:"2SC66>.XB>
M)E1L[6 8 D$@CC//'7BL_5_'6EZ9I6IW2+<37&G^6);;[.ZNID^X2" 0I_O>
MQ'7B@"_)X6TF6*SC:&4"TNC>1%9G!,YSEV.<L?F/7/6K.G:-9:5<7T]JLBR7
MTWGW!>5F#/@+G!/'"@<>@J&Z\2:;9JQF>?*0_:)$6VD9XX\D;G4+E1P>H&<'
MT-5K[QIH.GM"LUZSF>V-W#Y$$DOF1#&678IW?>!X[<]* +^J:+9:R;0WBRM]
MDG6XAV2LFV1>C<$9QD]>*E?3H)-5AU%C+Y\,30J!*P3:Q!.5S@GY1SBH(=>T
M^XNTMHI)6:25X4<0OL+IG<N_&W(VMWZ@CL:-3U[3])E6*ZE?S6B><1Q1/(WE
MIC<^%!.!D?G0!I5F:SH-AKT=M'J"2NMM.EQ$$F:/$BG*M\I&<&HY_$VDP6R7
M'VAY87MA=AH(7EQ">CG:#@'M]#Z&K][?6^GP":Y<JK.L:@*6+,QP  .22: *
MVH:)9:I-82W2RL]C-Y]N5E9=KX*[C@\\$CGU-9]QX)T*[L+ZSGMI)(KVY^V2
M[IWW"?C$BMG*-P/NXZ5G:YXG:#5?#<UI=SQV-Q?S6UW"UL0S[89#C:5WYW*,
M =??-;$/BS1KC3X;V.Y<QS7)M$C,#B4S#.8_+(W!AM.01P!GI0!<TK2;71K/
M[-:F9@6W/)/,TLDC=,L[$DG  Y/0 54G\+Z;/K4FL,;M+^2$0-+%=R)^[!)"
MX# 8R2?QK(USQ(T^G:'?Z)?,L-QK,%G./* +*9=DB,'&5((([&KFAZA>W'B[
MQ/8W%RTMO9R6_P!G0HH\L/%N(R ,\GOF@"P/!^A+I$VF"QQ;S3?:9&\US*TV
M01(9"=^_('S9SQ1<^$M)O;&ZM;J*:;[4T;RS-,WFEHR"A#@Y7:1D8QCGU.<K
M6M<NKGQ8_AVTO+S3RNGM<BY@LC*?,+A5X*$%  <XZDXR#5W3?&VA7UF)8]0>
M5$B5VG^RR(CDOY>%RO+%^-@R<D#% !+X%T&:.^CDANF6_:)[G-Y+F1H\;23N
MSGY5Y[X&:NZEX:T[5+RSO)Q.EY9@K%<03O%)M/WE+*02#@<&HY?%NBV]IJ-S
M/<R1+IRAKM)()!)$I&0Q3;NP1GD#'!]#41\:Z&+B:V$URUQ'$)A$EE,SRQGC
M=& F9%XZKD"@#0T;1;'0-.%AIZ2);AV<*\K28+$LW+$XR23CWJ >&]/^TK,?
M/?9</=1QO,S)',V[+J">#\S<=!G(&>:M6VJV=[H\>JVDIN+.6'SHWB0L77&>
M%QG/MC-<]9^+K/6M)T#4%O+K31J%THBB-J3Y^58B(L5( (YW _PG!ZT 7X/!
MNC6]II]K%%.(=/N6NK9?M,AV2G=ELYY^^W!R/F-1V_@70;6>UEA@N%-I<O<V
MZ_:Y=L3ONW!5W8"G<V5'!SS2R^.?#T)E\R\D5(;K['-(;:79#+\N [;<("6
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M^=<.ITJ-9;T>1(?*0@D-POS#"DY&>E5E\66;^)DT:.&Y8M8B\\X0.5*D@+C
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MB,X  '% %L>&-*2XTR>.!XVTP,+01RLH3<,-D9PQ(ZELU4N? VA7=Q<S207
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MOH-1M1<6Y<Q[W3YXV1@RL58%6 (P0:LT %%%% !1110 4444 %%%% !1110
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M[ZU:W>;5+JYC!=6S')(64_*3@X/2M6^UBRTZ]L+.YD=)K^4PVX$;$,P4L06
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MOG&:] HH Q/"EGJMCH@M]6N)+B9)I/*DF*F4Q;CL\PK\I?'4BMNBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "L#Q9=:I9V%M+I=O)<D7 ^T6\$BI-)#M;(B+<%@=IQU(! K?JI?
M:;:ZD(1<HY,$GFQ,DC1LC8*Y!4@]&(_&@#SY;O\ X2#7O!LUIJEW^]BU)3</
M"J3I@H"A4KM5UQM/R]C]:LZ/KFI7^C:'!<:I,]Y+=7L#I#&@FNEAD= V[A4
MPK,>,G '7!ZY/#>DQW%I<):E);02"!UE<%-YRYZ\ECR2>2>M5QX-T 1VT?\
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MB[26P25QY3,,''/IQ]..E ')6/B751#9Z5+>^;-+KEWIOVR9EC9TB#LBE@A
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MMA:,HRJM$,X4J" <9..,CMBI%\+Z.DDLB6A5Y;86CE9G&Z(9PGWNG)_,^IH
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MZV<@M'O902#D9P1W /X5 WA[2GN[FYDM1++=0"VG,KLXEB&<*P)((Y/YGUH
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M122JL@.U@,G@@]36G0!Y[_;VI#7M)D@U&2ZL[S6I[*1Q&BPF,)*0B#[Q*&,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5S+L9(3") #(%."6(3=C.&['!H ],HK#\.6^I6G]H6VH7\=T%GW0*',CP1L
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MJ@QP2/C:&YS_ !+D@$#/.* (KO0KJ3[-HUI!I\/AM43S8SO,ORON\M5^Z$(
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M/YEU'(-PE?CYF!_BX'/7@>E5[SQ=IEB)Y91-]BMK@6UQ>*H,4,A(&&.<X!8
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MTBYBBC7SY8&549L#<1C!-0:7K=KJUUJ-O;I,LFGW'V>;S4VY;:K\>HPPK2H
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M"?PIU '*^%;#7;811ZQIVD6S6T?EFYLFW-='INP4&P=R,DD^@',OB'3=8O\
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MNKM]'TRTLY;.VT^UAM9MQEACA54?=URH&#GOZTZQTNQTQ"EC:0VZL #Y: 9
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M\L&'RW/F#;M;=_%]: ..\&FX\5^&X/$.IW=VLVH%I8H8+EXH[>/<0B@*0&.
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M4E/M/GE6X//\/'U]J -S4/%UI81ZE.+6YN+32W"7T\(4B$[0S<$@MM5@6P.
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MEERO_3/OZ^W.AX8T[Q/IT%O9:S>Z?/:V<8BBEMD<2W  PID#<+QR0N<GN.A
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MOAE+V.>\N8S#]IG) V#")G )R(U0>Y!/>@#7'BB&>[U33I].U"WGM;0700[
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHKE?&NJ_P!FOH4<]P;;3KO45@O)PY3:GEN54L/NAG"
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MX&.1HSG!(ZJ>]<?X5U"QUJ+3[R\UB>'Q##?3QW5HD^'9MSJ8GC.?W:KAA@#
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MP#V/..E &U'86</D>5:0)]G!$.V,#RP>H7CC/M3Y[:"ZB,5Q#'-&>J2*&!_
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MG20,4+&/KLW KN_'&.:T->\0+H4FFHUC<7)O[H6L?DE?E<JS#.XCJ%/MZD4
M:\<:11K'&BHB@*JJ,  =@*KKIM@DAD6RME<R^<6$2@^9C&[./O8)YZURTGQ
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MX VY4\G/(XZ8YH PI/#U_:>(]5U32[BWVZM#&EQ'< _NY$4JLBXZ_*0"IQG
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MSUKFM,\+ZM9W_AZZN+FRE_LBPDLRL:LGF;A& ><XQY0_[Z/ISV"G<H/J,TM
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M]B6]V8DE:1M_FR*\BY.=VP#D<G KTPV=J<YMH>3D_(.32I;P1OO2&-7QC<%
M.* .'T#4?#MI=7NO6GB2TDTYK-&N8[?Y;>$AOE=_F.V0YQ@X)QR,BNQO+:VU
MG29K9GWV]U"5$D;=F'#*1^8(ITFGVSV<MK'&D,<N=WEHHR3U.",9_"IK>WBM
M+:*V@0)#$@CC0=%4# 'Y4 >1V6I:EI[:+J\EC)*^E%M"U! IS/.241P.GWEB
M^;TG(SP:Z2ZLH]*\8^"]/\]CNM[Q)5\PA96$:DMMSC.2WYXKNO+3!&Q<$[L8
M[]<TUH(GD61HD9UZ,5!(_&@#QO3X],3P7H%I$\44H\4>7<)$^QT_TF8*#@Y4
M[>G0XJ[<WLFC+XALK2:1-)MO$5FET%E)^SVKQQ-+SG*J6)SZ M7JK6MN^=UO
M$V26.4!Y/4_6G+;P+OVPQC?PV%'S?7UH \L\5Q36\/C2'2&/]E1Z-'=!86^2
M"ZR^?+Q]TE%5B!Z@]^;.JW^G:MXHUF"VNX+N"X\,,VR.0.DCAVYP."V,>^,5
MZ5%;P00^3##''%_<10%_(4D5M!  (88XP%VC8@&!UQQVY- '/^!_L,O@+2!9
MO$838Q"1H7Z/Y:[N1T/\JX3PV8H-.\ ZE'=RM=W6H3VTTKW+/YD96<[2"<$9
M5#]>>IKUU8HTB\I8U$>,; ,#'TI@L[48Q;0C!R/D'!H \LBNKJ[\(6VHQR,O
MC"+61#*F[$A<W.UHF'>/RCG'0* W;-5-62PLO#WQ-6*1+:_CNWE41R&.0(88
M2#P0<%B?8FO7Q;0"X-P(8Q.1M,FT;B/3/6E>W@D+%X8V+8W94'..F: //=3U
M'2;OQ1K>D^)=0^Q1/9V[:7*9O+.PJ=[PG_GH'],GA:I:M>6E]KVMZ3K>M#2I
MT%N^FR3J1<>68T.Z%MPR_F;P0 23@<C KTYK6W<Q%H(B8CF,E!\GT]*62WAE
MECDDAC>2,Y1F4$K]#VH YKQU>7]AX$N[FS,WFH(O.>,8D6+>HE88Z$)N/'3J
M.E<[K=M"^IZO;Z1Y<NC7/AR:6Y@B.Z$2@_NG ' 9AOZ=0N>U>EU%!;06R%((
M8XD)R5C4*"?7B@#RZPATC4+[X?6L<D+VSZ7<^8L,N S>5!N!*GUSD>Q!JKIV
MM+;:#X9AU&^B317NM0M99[P&6$.DS+ DA+#C8&QN..%] :]:^R6WR_Z/%\HP
MOR#@>U!L[5H&@-M"8F^]&4&T_44 >8-I]@^I>#]-_MFYU#3KB>^C5_M+(LL?
ME,0JD-\R@G:#G.!C)%=%\2+&W3X5ZQ;+%NBM[/\ =AR7*A,8.3DD@#J:ZXVT
M!*$PQDH %)4?+CICTJ1E#*58 J1@@]#0!YQ=6FBZKX]^S+)%)8?\(Z[*L,Q5
M"//ZY4\CJ?3OVK$AUBVO_"N@PW][OOI/#3RA[R;]T6PJ[E7J\^5P#D$ D]37
MKOV2V)R;>+.-N=@Z8QC\J46MNI0B"(;,[<(/ESUQZ4 >8:,UKX@UOPLM[>R7
M45UX79[A?M3;9) T )8!NN=V?<'/2NH^'5Z]Q\.=)N)IWG98&4N6WL0K,!SW
M. *Z;[';<?Z/#PNT?(.!TQ]*?'%'"NV*-47KA1@4 >3>&]5L)_$?AI[;45%K
MJ.G7:RAKG,\IS&5,[*0/-Y;@#*\C)J/PL8H;3X=WZW<QN;V2X@N)'N68RIY,
MIVG)[,JGZ^YKUH6MN!@6\0')X0=^OY]Z3[':C'^C0\<CY!Q0!Y)8>3!I>C:F
MEY,;I?%<MJLKW3M^Y:XD4IR>05Q]>#5F>ZNKOPEJ5ZLK)XPM-9:.,!L2!OM
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M15'+'V%,LM6L-0FEAM;I))H0IEBZ/&#G&Y3RN<'J.U %VBBB@ HHHH ****
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M&21GG(((Y!! ((Y!% '">*M7U?3T\3Z-_:$SA-!DU*UO%1%EB*[E:,X7:0<
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MB)CGYR4=F(&<X"\^U %JT\<'Q+<:%8Z%MAEU*Q.HSRRKO-M "$( Z%RYVC/
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M[N>0WX=L#B@#U.BN#O->U6]L?%][97QLY-"F>."W,:,DGEQ+(3)D9PY)'!&
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M3M#9"J@\O(=6P,%B#S[8 .\HKR_3]:\1S:-X7U&379&DU'4Y;">,VT6PINF
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MT[4!#%/*B*[(T4<@#; %R"Y&0!6!?^)]6D\,>(_$5G>&)]'OIHDLC&AC=(6
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M%""OJ0?8T =$"",@Y%%<G\-[J:X\&PQ2L6^R7-Q:1N3G='%*R)^2@#\*ZR@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "L_5M$T_6XX$OX&D^SRB:%DD:-XW (RK*01P2.O>M"JM]J
M%OIXA\]FWSR>5%&BEFD?!;  ]E8_0&@#+C\&:!$$$5@8PEV;Y D\BA9CGY@
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M*ZAT7HK@'$@'^T#63J?B=]$\>SV][<W4FG?V2MRMM!:F9E?S2I8!%+8VCG/
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M6LKE0LR2S22,P'0;V8MQVYX[8JQJ/B'3M,DG2XDE9K>(33B&%Y/)C.<,VT'
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M;B>ZDN+>U6YE6.SD=O*.?GPJ\C@Y(X&.U7)?$6F1I;,DS3FYMS=0I!&TC-"
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MS\K9*AP&4\^AKTZB@#@I]%U>WU'0]>L-"M(&M9K@W.E6TD:,4F15+[N$:0%
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M)>*[>:7C;(4<!3L;"K@#T%>@U4U#2['58HXK^UBN$BD$J"1<[7&<,/0\G\Z
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MD$KCKP,CJ(-1\.ZU<:%XMM(].8RZEJT=W;#SHP&C7R023NX/[IN/<>^/1J*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M=71AE64Y!'J#3J "BBB@ HHIL<L<R;XG5UR1N4Y&0<']: '4444 %%,26.4
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M3($D^THI)!;>I <$GYO<T 0VNK:Y<>/+NP=+=+>/2H+E;5V.5=VD!!89!.4
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M,<F)9AQT(4F+.",]!V.>QUW4GT?0[S44MWN&MX]_EHI)/J<#D@=3CG K!M_
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MG-=30-EF#*J\;AC(&\XXZBKVG>+K[5+G3+BSTR2?2[Z1D+K#(K0)SMD9B-K
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M&CH;74)+4PSQA6^6"48P749(( (YR!F@#V&"\M;F26."YAEDA;;*L;ABA]&
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MQ#<*6@ECE4,5)1@P!'4<=ZDJEI%A_9NEP6K,'E4%II ,>9(Q+.WXL2?QJ[0
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M$^KK%KEM<Q:?]MTN^AMVG#F.'RI%C?S"&;.55S\H/S$8'6L/Q'K<FO\ P_\
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MH&4QMP?7/:M^T\4ZOJ4]E=Z=IGVC3)[Q[>0",J\<:LR>=O+8/*Y*[<X/7CD
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M79,K;!ZG!X'!H \]L;#6CJ5S=6\NN66JRW$LA@GL8);<9<X'GE,F/&!P^<#
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M5Q<JF^63<)5R0RQD'E\].O?BK7]J:?\ ;A8_;[;[63@0>:OF9QG&W.>G/TH
MQ-*\%V^DW.C3QZE?2G2K)K*%9/+PT9V_>P@Y^1>F.GN:JWGP^M;F+4[6+5M0
MM;#4;D7<MI%Y959MZN64LA(R5!(SC/Y5I>'=9N]4OM>M[M(5_L[4#:QF($;D
M\J-P3DGGYS^57[O7-(L&E6\U2RMC%M\P37")LW?=SD\9P<>N* )+ZR:]L#;"
M[G@?*$3Q;=X*L&SR".<<C&.36#/X'L[B5IVO+B.YDU"'499(51=\L0 3(VD8
MXY[DD\UO0ZKIUQ?26,%_:RW<:!W@296D53T)4'('(Y]Z(=4T^YO)+."^MI;J
M,$O"DJLZ@'!)4'(YXH P+WP-:WMQJ%R=3OHKB\O8+[S$,?[J6$*J%05P1A0"
M&S3)? 5K/I^K63ZKJ)CU2ZCNYVS'N$B[.5^3 R8US].,5N-KVCJMT3JEG_HJ
M&2X G4F)1U+ '@<52M/$5OJ\&C7>F:A8"WOCN:.9_P!ZZF,MM0 _?!VD@YP,
MT 6(-!CA\2SZ[]KN'N)K6.U:-MFS8C,P(PN<Y=N_>FW^@+=ZY!K$%]<6EY%;
MO:EHPC*T;,&((8'G*@@C]:L+KVCO<Q6R:K8M/,S)%&+A"SLO4 9R2.X%27&K
M:;:3>3<ZA:PR\?)),JMSTX)]C^5 &#=^!+%X=-.G7U[IEWIWF>3=VS*782',
M@<,"K[F^8Y'7FNALK,65BELDTLA4',LK;G9B<ECVR22>F/08IKZKIR7$=N]_
M:K-)C9&9E#-GI@9YSVJ6YO+6S$9NKF& 2.(T,KA=S$X"C/4D]J .<M_ UK;Z
M?I=DNI7QCTV_:_A)\O+2,7)#?)]W,C],=>O%/T_P9#I>J33VNJ:@FGRW!NO[
M,WKY"RD[B1\NX#=\VT-C/;M6E_PDN@_9_M']MZ=Y/F^1YGVI-OF?W,Y^][=:
MLW6J:?8S)%=W]M;R/C:DLRJ6R<# )]>* .>F\!64UE<0'4+Y9I-2.J0W*E ]
MO<'NGRXQU&&!X)K1T;PZ-)U34=1;4;N[N-0\LS><(PN47:" JC'%:2:C8R74
MUJE[;M<0#=+$LJEXQZL,Y'XTC7:SZ:]U8303!HRT4@;>C>G(/(^E %74=!LM
M3U73-1N%8SZ<[O%@X!W#!##N,A6^J@]JKV7A:PTW1-0TJS:6&&^DFD=E(+*9
M2<[<@@  X QVJ#PEXJM?$.B:9+-=V2ZK<V<=S-9Q2C<FX YV$E@.>];":II\
MM\UC'?6SW:@DP+*ID '7Y<YXH QX/!]O;/H<D.H7J2:/:M:1."F98B$^5_E_
MZ9KR,'CWJ&#P-:P:=IMDNI7QCT_4&U"(GR\M(S.Q#?)]W,C=,'GK5KQ+K=SH
MESHGE"W\B]U!;6=I<Y12CMN!R /N=_6M.#5M-NK W]OJ%K-9C.;B.96C&#@_
M,#CK0!C)X*L42YM%N;C^R[F[^V26!V^7YFX.0#C<$+ ,5SUSV)%5]3\!6VI-
MJZ'5+^WM=4ECGGMX3&%$J;!O!*D\B->,X]JL>(?$WV+1+;4M'FL[R)[^WM78
M-O7$DJQM@J?O#=^E)XW\4KX9\.WUW;7-C_:$$0DCM[A^7Y_N@@GO^5 %^V\/
MQ6OB*YUF.\NO-NH8XIX24\N0Q@A7/RY!PQZ$#VI;G08[CQ';:W]KN([BWMI+
M9(UV;-KE22<KG.47OVK59@JEF("@9))X K+F\2Z+!IMWJ)U2T>ULTWSR1S*X
M08R,X/4]AW[4 9-IX$L]/M=)2TO[Q+K2FE-M=-L+E)#ET<;0K*?ID8&#4]QX
M,LIK&&!+NZAGBU#^TOM493S'GYRQ!4K@AB,8P!CTK:T[4+?5-/@O;619(9D#
M*58-C/;([BFQ:OIL\\D$.H6LDT0+/&DREE ."2,\ '@T 8EYX'T[4#K@O+F[
MECUA8A,A91Y9B'R,A"Y## .23R*)?!4-]H=QINK:MJ.H23;-MW*ZI+"4.Y"F
MQ0 0><X))ZYZ5KPZ[H]S<);P:K8RS/&95C2X1F9!P6 !Y P>:?'K&F2V8O(]
M1M'M2_EB99U*;LXV[LXSGM0!!HND2Z5"XN=3O-2N'P&N+K:&VC.% 10 !D]L
MG/)-8^I> [74IM48ZKJ,$6HSPW,L,1CVK-%LVN"R$_\ +->"2..E;>N:Y8>'
M=+DU#49UB@4A1DX+,3@*/<FHUU6-]5(34M-:Q%IYQ029E!W??SG'EX[XZ]Z
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MCUZQ62TFM+ P>1+;MNW;U8D,<D9!&.*W;N[M[&TEN[J9(;>%2\DCG 51U)H
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M;9,&4S94_(1U&>F.OXUP$EK?W]QXE\BRU*47_AA8('EL6@5I )AY8! VXW*
MK9;GN.:]0N[VUL(#/>7$5O".KRN%'YFGV]Q!=V\=Q;31S02*&22-@RL#T((X
M(H S_#\YF\-V#B">-EMT7RYXS$^0H!!5@".1W%>?:#]J;6_"=U)HVHVL$%M>
MP3VOV%UBM&;80@)&6'RGYB2&(XZXKTVWOK2[EGBMKJ&:2W;9,L<@8QMUPV.A
M]C5B@#RCP_IL]II'@ ?V3>0SVM_.UU_H4BM$K1S+E_EX!+(,GV]*W=-TBZL_
M&5YHB1J=#69=9CP?N.Y8>3CL/-4RCZ8KM+JYMK2 RW5Q'!%T+R.$ _$UD>&[
M?1K&"2#3-3-_*WS2337OVF5AT&6))P.PZ?F: *OQ"M;B[\$7T5K;RW$H>"01
M1(6=@LR,V .2< \"LN\5KCQW<WPTZ]-M+X>:+S&LY,,_F;@A^7[V.=IY[8SQ
M7=T4 >7:+I;Q)\-EETBY1K*TD6ZW63CR7, 'S_+\IWCOW&:K0PZCIUM;WQTO
M56T^T\07\LUO;P2),L4K/Y<J)@%E&[MV8UZU5>2^M(;R&SDNH4NIP3%"T@#N
M ,DA>IQ0!E>%+.RM=,F>PL;NS@NKE[G9=E_,=GP6<JW*9.?EX]<#-<)J$5Y#
MINN:9_9>HR7)\317R^5:.R- 9XGWJP&&X!R 21@Y& 37J[,%4LQ  &23VJ&S
MO;74+9;FRN8;F!B0LL+AU)!(."..""/PH \NO[&RU&Y^)&G?V6US>74D<=L%
MM2V9&M8]GS8PN'PQ)(QU-:=O9WFF:AXCLM;M;J^BU#3[>.WFB@>990D/EO$2
M =IW[FP<9WD^M=EIVB6^F:CJ-]%-.\NH2K+.)""-RJ$!& ,?*H'X5IT >8:-
MHEW8:S;1ZK93W,T'A:.TFN/LKR*TP8[D#@$,<''O77>!(IX/ 6@V]U#-#<0V
M,,4L<T;(Z,J@$$$9[5T-% 'D\=G=?\(KI6F3Z3?M):^)C+.ALI&7RC=2/N^Z
M0R[6!R..:EU.SU..Z\3W%EIE_) FM6=Z8(H7C:YA2*,2>42 &8,N>#R5^E>E
MRWUI!=P6DUU#'<W&1#"T@#R8!)VCJ< $\58H YKPI#822ZAJEAI^HVWVYT:6
M2_$B/,ZKMSL?E<# S@9_#-80+P:[XBT;6=!O-134KU+JSE6W9X94"1A4:0<1
M[&3/S8]1GOZ%10!Y7K O9M3?9H^HP_9O$MO<O%;V;LDL0*@W!?!W$@=%/ '(
MZFI=;M+V?3_B9'%I]\[WRHMJ!:R'SS]F1/DX^;Y@1QZ>E>GT4 9=[%=7OA6Y
MAL7:"[FLG2!W!0I(4(4D'D8.*XW3[2YU&+P.L%A=65YHYQ>^; R"*-8&1XPQ
M&&#/LQ@G(&>U>@07EM=23QV]Q%*]N_ES*CAC&^ =K8Z'!!Q[U-0!RG@5)H[?
M6UFMKF R:Q=S()X'CWHTF58;@,@BL[4H[FW\6^*&-C>21WVBPI!)%;O(C,@G
MW+E01N^9>.IS7>44 >7V.F7B-X+CM+&ZM)XM N+::7[(Z"&9HX=H<[>#O5CS
MW&>]7/!D%O=RZ+]KT/6+;6-(MVMY'NO,6&'*!6V,3MD#%1@#/'/&*]$HH XS
MQ?IUY#XH\.>*+6UENXM+:>*ZMX5W2>5*H7>J]6*D D#D@\5OQ:U#>QEK6WNW
MC"%I'DM9(]HQP &4%B3V ^O;.I4$=Y;374]K%<1/<6^TS1*X+1[AE=PZC(!Q
MF@#S'PWIUS96GPX!TF\BEM(YUN\V;J8BT++\YV\9;;R?K1H NWUWPE<OH^HV
MD4$-[!/;?8G6*S9MA";B,L/E/SDD$],=*]5HH \FM-.F_L#PQ!-I%Z3;^)I[
MB6-K&3]W"7N"K$;>%^>,_C[5Z#K^G7$_A#4].T<);7,EG+#:A,($8H0N,=.?
MRK2NKNWL;66ZNYXX+>)2TDLK!50#N2> *E!#*&4@@\@CO0!P-E;S:IJ?@VZM
M;"ZLGTN"1;U9;=H_+0P[/*Y #?/M(QD87/I6IX#2:*RU=9[:Y@9]7O)D$\#Q
M[D>4LK#<!D$&NKJN;ZT6^6Q-U"+MD,BP>8-Y0<%MO7'(YH XG4XKF#Q+XPS8
MWLB:AH\*V\D5N\BNR+.&7*@C=EUXZG/2LZUTR]$WA..RL;JTF3P[<VLLOV5T
M$,S)#M#G;P=RN>?3WKT^J]S?6EDT*W5U# T\@BB$D@4R.>BKGJ?84 <+X-AM
MKR?1WN=#UBUU?2K9K>5KOS$BARH5@A)VR!BHQC.!SQWM?$"W:ZU+PLOV.\N(
M(-3$]P;>WEDV1^4ZY)0'')'O790WEM<3SP0W$4DMNP29$<%HV(! 8=C@@\^M
M34 >6R:%J4OB/Q"?"UO=V5C?:/)'++=H\?F7F"(RAD^<8!Y/W1]:OP07.I3^
M#[FRTRZMI])MY1=Q2PM%L7R-GDY8 -E]N,9&%SZ5Z'10!Y5X>%Q_;GANZDTC
M4H+:/2+FVEM_[/D6.U?,1\H97<0 I^8D[B..>*CLM*N]/^&OA.>'1K@2V%U;
M2:G;+:E9WB0L3\A 9]KE7QWQD5ZS4$UY;6]Q;V\UQ%'-<,5AC=P&D(&2%'?
M!/% '#Z=JR:;XB\7ZZVEZJUG*EG)&4T^0/-A"K;5(!)&1G/..>@KL;T_VAH-
MR;;+_:+5O*[;MRG'7ZT[49]/B@6'49X(HKAUA599 @E9C@(.><GC'?.*N 8&
M!TH \QT6&:6Y^'GGZ5?JNGZ9+!<&:QD AD$42C.5XY5@#WQQP1FC81:AI.E:
M!>3:7JQL+.^U%+F"V@D6:)99F,4JH &*A<CCH'KURB@#%\*V-G8Z*$L+&YLK
M:65YDBN6;S/F;)8JW*Y))V]L] <@;5%% !1110 4444 %%%% !1110 4444
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M6;63K):7%G)Y<MNP&T;3@C&"1@@@BK^F:<FF68@6>XN')W23W#[I)&]6/ Z
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MPHQ5FR-N<DJIZ]N*S)O 6F7&FSV;W=^&DU!M2CN4D598+AB270A0!U/!!'-
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M=LRF2.,P2B$A!D$[F.1D\ 'K4/\ PFFMSPV,$,-A'>G7)-&NS)&YCW*CN)$
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MGM+VXL-3E6."2V;YHT2,E5PXP=N<#N>O6NKO/#<%]#I,<UW=_P#$KG2>%E*
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M0BSQE,.N5)S^[7()(XZ X- %%_$^M0ZKXCDF;3UTK09-\X$+F66+[.)<*=V
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M1Y92KKNR&#+U!Y!Z<5HSZGXAM&M8[JXTM3=O(R&*"1W50BE4$>[+G<6W,,
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MYUU'*E\-0^U1NHE:?)^<Y7;R#C&,8X &!3+GP5I=\VL_;'N;B/5XHXKB)W&
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MP>'M'@TNVGN)H+=0D1N'#,J 8"\ <  #^>:TJ "BBB@ HHHH **** "BBB@
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M#J]E*$9$;RYE8AF7<HP.Y ) ]CZ4]O$>B)#;RMJ]BL=RK- QN% D"@EBO/(
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M:W5O+;S1-*&BE0H5!E8C@]L$5U% !1110 4444 %%%% !1110 4444 %%%%
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MV%@UK*(S:9>1)$9F0DMP>.OZ>MS6EG\.://<Z/933R37:S70MHU:8J<!V1.
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M*S=;T*Q\0626M^CD12K-#)$Y22*1?NNC#D$?UK2K!\5^(6\/V%K]GA6>_O[N
M.RLXW.%,KG@L1SM !)^F.] $,G@;1YK;58)C>RKJH07C/=.3*%4*._' '3'I
MTXK0@T&UM];?6%DN&O'MUMG9Y,AHU)(&.G5B<]>34,EOK]M]F>._@N\S(+E'
MMPF$) 8QX/&.N&W<=\U/_P )#I7VV.T-XHDDE,$;%6"/(,Y0/C:6&#\H.>#Z
M4 4M,\%Z/I&I27EFMRBM(TJVIN7-O&[9W,L1.T$Y/;C)QBET7P=I&@7+2V"W
M*1AF:*W>Y=X8"WWO+C)VKG)Z#N0, FB3QOX:BGEA?5[</"\B2=<(R+N8$XP,
M+S[\XZ&IM-\6:%J^H&PL-2AFNO*$PC&063U&1SC/..G>@"M#X(T:VT^TL[=+
MB);*8S6D@N&+V[<C"$DX7!(V]"#R#4UQX3TRYM8X'$XV7BWQD64AWG4@AV/<
MC XZ8 &, "K%OXBTFYNH[:*\4R3*SPEE95F5?O%&(PX'?:352'QMX;G\SRM6
M@81H\C$!L *XC/..NX@8ZG(QU% &^.E8$O@W19XM2BD@E:/4)OM$R>>^%ER#
MO3GY&RH.1CD4S5/&FE:;HM[J0::86DJV\D*PN'25L;592,KG<IR1T(ZY%68=
M5@N/$?V>/5%XLO.:P: JZC</WI8X(]-I^M %JPTFWL)YKA6EFNIE5);B9MSL
MJYVKZ #)X '))ZDTZ]TR.]N+>X\^X@F@#!'A?'#8R"#D$<#J.U06WB+2;NX6
M"&\4N\1FCW*RB6,=70D .HR.5R.1ZU7LO&'A_4KFUM[/4XII+O?Y&T-B0KG<
M <8R,$XSG'/2@!G_  ANCK)I[P1SVQL86MXO(G=-T3$%D<@Y8$@'GO55OA_H
M0TW3+.%;RW_LS<+2X@NY$FC#?>4.#G:>XZ5LZEK>F:.UNNHWD5N;A_+A#G[[
M8)P/P!J.V\1Z1=Z:^H07J-;)+Y#,58,),[=FTC=NR0 N,G(]: (H_#.GPZC;
M7\)GCGMK9K6(B4G",06SG.22 23DY'6K6BZ/::!I4.FV(D%M#GRUD<L1DDD9
M//4FLW5/&>E:;H-_JH>2=;)O+EA2)Q(LAQM5E(RF<CDC&#FK^J7LJ^'+V]LG
M,<J6SRQ-+$1@A21E3@]N] &?J7@G1]3N]0N)1=1-J,/D7J6]PT:7"[=H+*#@
MD XSZ<'-6%\+Z>E]'>1O=+-'9FQ1O/9L0D@XYSDY .3SQUJ#2_$D">$](U#5
M)S]HN=/BN9?+B9R?D4N^U 2%!/)Q@9%79?$>DQ0I-]L62)X5G$D*-(HC;[KD
MJ" IP<$]<'TH IR^#-&F\+V_AZ6*5K"VVFW_ 'S"2$K]TJX^8$=CFFW'@G1[
MO1TTZX^V2^7,+A+I[J0W"R@8$@ESNW <=>G'2M-M:L%OA9F<^<9?)XC8KYFW
M=MW8V[L<XSFJNM^)+30KO3+:XCG>34)S#'Y4+.!A68D[0>R].I^@. !DOA+2
MY["TM)/M3?9;@74<YNI/.,N"I8R9W$D,1UZ<=A0_A+2GN+N01RK#>2K-=6RR
M$0S2#&&9?7Y1G& V.<UD:/XQABU'6K37-1B5X=7^QVN(BH"F.(J&(SC+.0"Q
MY/%;\_B+2;:^^QS7BK,)4@;Y6*K(_*(S ;58Y& 2"<CU% #[31+6RUF^U6)I
MOM-\$$^YR5.P87 Z# )''XU-J&GQ:C'$LDDT30RB6-X7VLK $?B,$\'@]ZS;
MCQEX>M;B:";5(5D@F6"888B-VQ@,0,*.1R>.>M6_$&M6_AW0;W5[I)'AM8FD
M98T+,<#IQT^O0=30!-IVF6VEP216RG][*TTKL<M)(QRS'W)_#TK(U#P/HNIW
M%_+.MT/M[QR7"174B(TD>W:^T' 8;5Y]A5R'Q-I<LOD&:1+C[,;IH6@D#"('
M!;!7.,\5-;:[IMY!8S6]QYD5\"ULXC;$@ SG..!CG)H R[[P)HNH2W[N+N-=
M0A$5Y'#=.B3@+M!8 \MCC/?OFENO ^CW5Q--_ID+W%J+2Y\FZ=?M$8!5?,Y^
M8@$@$\]N15U?%&BM*\?V]$9(#<9D5D#Q#JZ$@!UZ<KD<CUJ.S\7:%J$J16>H
M+.[VWVJ-4C<F2/ )*\?,1D9 R1GD4 +8^%M.T[4;6^MC<"6VM!91!IV<"$$'
M:<YSR <GG\*AM/!FCV.LS:G;+<QM-,;A[87+_9S*>LGE9V[N^<=>>M1Z1XWT
MC5K'3;D/+ =2=DM8Y87!D(R< [<9VC/MSZ5N07MO<W%S!"Y:2V<),-I&UB P
M&2,'@@\>H]: ,D>$-,,"PRO=3)';R6L/F3DM#'( &"-U!( Y))&.,5!JGA&&
M]T^]CBNKM;Z[6)&O?M#)(HC)*<IC(4L3CC.3D]Z9XA\026WB#2M"MY9[:2^2
M9VN8K8R% BC&W*E3DL,]< =L@U=L]=M;9+6QU'4H9K\N+9YTA:.*2?'* \J&
M_P!G=F@#; P ,YKG])\&:/HFH/=V*W,:EVD2U-R[01.V=S)&3M4G)Z#C)QC-
M6I/$NCPVUW<R7@2&SG%O<,4;]U(<8#<<?>7GIR*:_BK0TU8Z6VHQ?;A*L)A
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MY1/+;I<N+>27_GHT0.TMP#G'49Z\U/#XJT6Y5S;WOGE':-EBB=VRH4L< 9(
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MZCY-C<;XVL7M#G>7(C$38#,<#D?-D],5NR>*M#BT]KZ748H[=)Q;.TF5*2Y
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M!)Y(4R[3L#=-V.,UQ;W_ (EB\:67A]]5LR)]-DNWF6RQAT=%P!OZ?,?RH Z
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MF&\D]_E8JHSS\GO7=UF1^(=+EU2/34NLW4GF",;&VR&,X<*^-K%3U .1@^E
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M=H-7TJ"WM%>2+<75900PW\'YP?3'?/%>FUFWNOZ9IU]#97=T([F<%HHMC%I
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M QW!D(XP#G QCK573]'O[?5;S2=2\-R7T+ZG)>VNHM.IMU1Y3("ZEMP="2
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M1>Z59:=-!+Y-BRM:NMQ()82HP"L@;<#CCKTH R/ 4<L-SXLCFG:=UUR3,C*
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M/+G=8Y2OW2\8.UB,<$@U?TW1;#29KV:SCD1[V8SSEIG</(0!NPQ('  XQT%
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MPNRJI(8YGC695^Z)%4A7 ]&!].E37'A?2+J[U"YEMY/-U&$0W6RXD42*%V]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JEJ.DV6K1PI?0^:L,JS1C>R[74Y5N".0>1Z5=HH  ,#%%%% !
M1110 U41,[5"[CDX&,GUIU%% !1110 50T_1-,TJXNY["Q@MYKR4S7$D:8:5
MR2<L>_)/YFK]% #51%9F55!8Y8@=3TYIU%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %9^JZ%I>MK$-2LHK@PL6B9Q\T9/7:PY&?8UH44 5[
M*PM--MA;V=O'!$#G:@QD^I]3[FK%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %<\WB.YN=3U2STK3HKLZ6RI<![KRW9V0.%1=I!X(Y8
MJ,Y'8FNAKS;Q39Z)>ZOJ.I6NKOX>\2V&(UNT?;]J 164,AXF7Y@N!DY&/04
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MVT:NJ?V2WBV!].!. L!V^84/:/?OZ<?ABNL\%Q6MEXC\76-BD4-I'?1/%!"
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX!P=H!R?[P&.N,R+QO?ZO>:=#H.EVUPE_I?]HPO<W1CP Z*48!#@C=VSSZ4
M=M167XDU670O#6I:M#;I</96SW'E/(4#!5+$9P>P]*PT\3Z[+K<>E)I5B)KK
M3_MUL[7;;54,JL),)G/SKC;GZ]Z .PK*_L9GUXZE/J-U-$F&@LFV"*%]I4N,
M+N)()ZDCD^V,72?&KZY;Z+%:6D<=_J5K)=.DKDI D;!&Y RV78 =.,GM@UCX
M\O)+>S6WTF)KV35WT>YB>Y(6*959LAMOS(0H.>" >A/% '<45QEUXOU:"*[B
MAT=;G4=/CC-W;6_FR!Y&4.8XW"8SM((+8R3CWKK#<G[";H0RD^5YGE;?GZ9V
MX]>V* )Z*X/_ (6%(_A'4?$-I#8W<5E:K.\,=PRNC\[HI 5RK+QR1SSP*U-6
M\8IHFKZE;WEL/LMEI?\ :7FH^68;F79MQC.5X.>] '3DA5))  Y)/:@$, 00
M0>017$^+IM4N?"/B2UU/2H!:'19ITN(Y0ZK)L;]V00#D8#!@,'V(JUX<UV].
MJ6.AWME#$DFE+>6\L<Q<E5*(RN"H /S*>"1UH Z'5=.CU?2KK3II)8XKF)HF
M>%MK@$8X-4;/1I[>6"74]:N-0,#9A$T<485R"N?D49;#$>G/3.*EU?6/[/NM
M.L88UDO-1F:*$.V%7:C.S,?0*IX'4D#CJ.6\327EY;^'I=5TU+6[@\201H0X
M<.@8@2*>H##!P>1WH [ZBN2N_%]S8ZY:V=Q90I'<:B+%4\[,H4J2LQ R I((
M"G!QS[4MAXQ.H:E>VT,4+264DZ7%GO(NHQ'NVML(^97P"".!N'7G !UE%<78
M^/8;K0YM67[+<0 01HEM*QD6>5]GDR)C<I!*\XR<GCC!6X\:7NG6NIS:AI,L
M4%HT&R\\F58F21@K,0RAAY?5L9R,<CL =G16=HFHMJFG_:B]K)&SGRIK67S(
MY4[,#[^G8\<]:R[WQ+=FZUJ'2K.*Y;1T5IUEE*&5RF_8F <';CD]SC'>@#I:
M*XN+QIJ&JZE96VA:9;3Q7FF)J44MS<F/Y&=5*L APP!/K^%=)KNJ?V+H=YJ7
MD//]FC+F- 22/7@$X'4X!X!H T**Y*/QFCV%M/$UI>"^N_LUE+9NTJ2CRC(S
M$*"RD!7!7DY Z9XK3>,]8@MK7S- V3SZJ-.'G2/"L@8$K*FY,[3C!!Y!!^]0
M!VF]=^S<-^,[<\X]:=7%GQ VG^(I'US2+*WNK;0I+V>[MY3*PC20;HP2JG;_
M !?6I/\ A+]3B\^670+F:W&GR7D;P1RC#J,^2=R#)(Z$=<'CID ["BL3PWKR
M^(+>2Z@GLKFTPOE7%I*6#$YW*RGE6''!]>W04M3U+4E\?:3H\:VS:=<V5Q-,
MCDY8JT:G/!'1S@=\G- '3JZNNY6##)&0<TM>9>!=;N]'\/>&+)K"#^S;^[N+
M-)5F/F(^^9P=FW&WY".N>E;UMXQO+ZYL9;'29KG3KNY:#S$CD#1*"P65B4V;
M"5YP<@$'GD  Z^BN'LO'&I2Z2^K7>D6T5D+A[)!'<M)(]P+CR$ 4)]TGDGKP
M?E/&9W\9W=G]JCOM)E1_M-O;6,NUXH[IYFV@?.H*[3][@\<C/2@#L:8LL;NZ
M)(C.G#*""5^OI7,3>)+Z._U;19;>"/4K:Q%[;R*Y\N6(DJ3TRK*P(QSG@]^(
MOA]IT)\+:)K$]I NHS:9"C7,9)>5"JOER0,L6R3UZ]>30!U]%<EK'B^YTC5!
M#+90B W]O9JIF_>R+*57S@!G"AFQ@XSM/(XJ)O&&HQW^NF;3+9--T.5A>3_:
MB7,8@$H9%V<GD @D>Q- '945S>D^(-1O=9CM+C298[6:V\Y;I(Y D;@C,;;T
M7)P<@CK@\"K>MZZ-+NK&RBC,EU>E_+&QW"J@!9B$!)ZJ,>_6@#32UB2[ENL$
MS2*%+$]%&< >@R2?QJ:N*3QCK#RZ+;/X?$%UJ%S<6S+<3-&%:)&<.N4R48*#
MG (Z8-5+KQ?K-SINF-;V]K;73:__ &7>+YC,I*.P.QL9VMMZD9 .,=Z .^#J
M79 P++C(!Y&:4LH8*6 8]!GDUY_KOB&ZTZ'QS/8:=96NI:;90RF[#%C.#&Y!
M;Y1RH! '/7K4]X_D_$#PS>WJ0QS?V3?-,\>3\JF$CG )P"3^)H [JD+*I4%@
M"QP 3U/6N/M/&UQ*UG>3Z5,ND7-I)=-=+%(/LJJF\>864*=RYY4GGCG.:S+F
M[NM4\8^ M4GL[>&*Z^TR1;6S*BM;,P5CC!X()QP#QSUH ]$JAKFEC6]"OM*>
M9H8[R!X'=0"0K J<9[X-9?CS5+_1O!6I7^FF-;F*,;7?/R@D D>_/'^12OKV
MH3ZI>Z5I]K:RWUA;1SW >9@A:3=LC4[<Y(0DL1QD<'/ !MV5N;.Q@MC)YGDQ
MK'OQC=@8SBIZS/#NMV_B3P_9:Q;(Z174>\(_WD.<%3[@@C\*R(/%-Y)-K=G+
M8P1ZAI]U%!#")B1.LN/+?.W@')'0XV-Z4 =517(7WC*XAT[6M5M+&.XL=&G:
M&Z'F$22>6 92G&/ER< _>VGIP36_X2^ZMM?\1W-P87T73M-MKN,1D[RKB5L@
M$<LVT#L!@>] '<45SVDZ[J-YKDEA=Z5)';_9Q.EVL<JQAMV#$=ZK\W(((ZC/
M Q3O$OB6'P])8)</#;Q7<C1_:KDE88V R%9AT+= 3@<'Z$ WZ*Y*[\67R*UM
M::<LVI06$5Y/"GF2)N?=MB5D0]2C?,<#IP<G$#^+=>NM2?3M-\/P_:AID.HB
M.\NC$P#E@8V 0X<%"/3N2.E ':45P<WQ"E?PQ%KUKI\:6S::]]MN)L-(Z9W0
M( "=PVDEL8''OB_+XIU:X\00Z7I>E6LHET^+4%EGNBGR,X4J0$."!G'4'U'<
M ZVBN1A\7W1\1:?I=Q8PQM?37,*QB;=) 8E9E,F 1\ZKG'49'6J&A>+]1.@V
MTVHQQ2WM]J5S:6XA#L!Y<DQ)*A2<*L>!C)/&<<D '>,RH 68*"0!DXY/2EKS
MC7M1N=8TW1YM1TI[.YM?$UI"C2(P$B^8N)$W ,%8'H1U!'-;K>*[J&[U^RN+
M&%+S3A&]I$)B?M:R<1D';QE_D[X- '544Q"_E*9%'F;?F"G(S[9KD=/\:7,^
MK0V%UIZ++/837GDP2^8\+QLH,+8^4O\ ..AX/&.AH [&BN<\*^)AXF@:YA>S
MDMQ&C$P2DO%(<[HI$(!4K@<G&<]!BK.NZO=Z9);I;P0E)5D+3SR;45E VH%'
MS,S9.,=-IZ]* -JBLSP[K"^(/#>G:PL)A%[;I-Y9;.S<,XSW^M9T'B'4=0D^
MT:7IJ75@FH-8RGS@L@",4DE /&%8'Y>I R/2@!MGX6:"&6Q.O7USII9]]I*L
M3'#'<49]F\@[CWSSUKIJX#0KI]'E\8RV5I$^-?52"ZQ1Q*T,&Z1B>R@ECCDU
M8'C](]'N[VYABA2UU0Z=+<Y8PH-H83-QD*0RCZD<XYH [>BN/O?&AL8],%R=
M/@.H+,8;E[@FUD*,!&@D P"ZG<">F#P375P/+):1R21A)FC#,F[(5L=,_6@"
M6BN#T'Q?J3:+:OJ$=O-?ZAJUQ8VJHY"_)++DMQPJI'QU)XZ9KH-%UZ2_U?5=
M'O+=8;[36C+F-BR2QR E'7/(Z,".Q'4T ;E(74,%+ ,W0$\FL'6?$,MEJ8TN
MQM_.O/LQN3NCD90N[:H^16/)!Y[8[]*YY[\7OC3P?J]WI\FG7$NF7S3PSKB2
M+'DY5N,D#G'U]Z /0**XVT\;W$QLKV32IQH]U:R737*Q2#[,JIO7S"5"G<O=
M2<'CD<U;BUS7)[.*\CTF 6MS8-=12F?/D/@%$D'4Y!SE>A!'O0!T]%8/@N_O
MM4\&:/?ZB8VN;FTBE9D).[<@.3P,')/%;U !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9'B#0(]=@
MM#Y[VUU97*W5K.@!\N1<CD'JI!(([@]JUZ:[I&C/(RJBC+,QP />@#EM2\%C
M5+'5$GO@M[J;P-<7"0X 6$@HBJ6X&03R2?F;VP[4?!4.KWFL37UXS1ZI9Q6L
MB1)L,?ELS(ZMDX8,Q/X#\2U\37FHS>)(+.*P\S3'C6WEDN3Y4H>-7#,P7Y1\
MW8'IUKI'NH(F"2SQ(YQ\K. <DX'YGB@#,T+2=1TY"=3UN?59@H1'>%(@J_[J
M]6/&2?3C'.:^O^&9-5U.PU;3]3ETW4[-7C6=(UD62)\;D=#P1E01Z$5MK=6[
M7+6ZSQ&=!N:(.-P'J1UIOVRU$DL?VF'?$NZ1?,&4'J1V% &/+X:>34]$OCJ,
MCOI9E8F6,,T[2*58D@@#J< # ^G%96F> I-.ET9AKMS(NDF98%,* LDG4,>I
M;U;OZ \UTEAK>G:GI2ZG:W<36;9(F+@+C.,Y[ _UJX+B$Q)*)H_+? 1]PPV>
MF#WS0!S,?@^9;[^TFU0#55LQ:"\BM@C. Z-ND&2';Y .PP6XYK1T3P]#HUYJ
M5XIB\_4)5EF$$7E1Y5=N0N3R>I.>36B=0L@(B;NWQ+GRSY@^?'7'/-6* ,*[
M\/.?$?\ ;NGW@M;Q[;[+.KQ>9'*@)921D$,I)P<]"00:J'P9%#;:#;V5V88M
M'N#<H'CWF:0JZL6.1U\QR<=S^%=%-=6]LR+/<11&0X0.X7<?09ZT37=M;AC/
M<11!1N.]PN!G&>?>@!M];R76GW%O#</;2RQ,B3H,M&2,!A[CK7,7?@."^@U@
MRW20W>J"W\V:UMQ&H:%]Z.4).6+=23R !Q7475U':P&1Y84)X3SI BLW89__
M %UF^%-:D\1>%]/U>6!8)+J/>8E;<%Y(QGOTH J?\(M/#JUWJ5EJK0W%_;I#
M?%X PE* A9% (V. 2.XQC(.*J-X$6RO+"Z\/ZI/I+VMDE@X6)95F@4Y4$-_$
M"20WN<@U-KGC.WLM$U&^TLV]])I]U':SH9<!69D4XP#G'F#TY!&>*Z6*>&8N
M(I8Y/+;:^Q@=I]#Z&@#E-6\!6^L7DLUQ>N5;3ULH\IEXRK;UF#YSY@;G-:$5
MEKL&J:3NU=KBUAB=+U6MT43_ "_*^<Y#[L<#C&>G .Q'>VDL+S1W4+Q(<,ZR
M JI]">U(]]:1PM,]U L2ML+M( H;IC/K[4 9_B+0VUVVLTCO7M)K2[CNXI%0
M.I9,\,IZCG\P#VK%'@1UC=!K,KAM835OWD"G]XI!V_+C@D<^W3'4]B"" 0<@
M]"*H7^J1V]E>O:O;SW5M$TA@,P!R!G!P"1^5 '/ZCX#74;C5+E]2DBN+N\@O
MH)8H@#;30H$0C)(887D'KD]*T='\.W&G:[J&KW6J-=7%]%#'*BP+&@\O=@@<
MG^(]ZM>'M936M#TZ]8Q)<W5G%<R0(^2F]0W3KCGK5Y;N&<S);30S31<,@D'R
MGL&QDC\J ,S5_#_]H:MIVKVMS]EU&PWI'(4WH\;@;D=<C(X!&"""*H'P9&);
M&:.]*S6^I/JDSF+/GS,C(>_RJ%; 'LO)P<U++QK>76C>&+]M/@7^V+XVDJB8
MGR?]801Q\W^K]NO2MGQ9K<_AWP[/J=O;QW#1/&I21RHPSJN> <XW=./K0!DW
M'@/[1;7H&K307<NJ?VK;74,0#6TVT+P"2&7:,$'KD_AT6DV-U8VI6]U"2_NG
M.Z2=T5!TP JKPH_^OS5N*XAGW^3-')L;:^Q@=I]#CH:2"ZM[H,;>>*4*VUC&
MX;!]#CO0!AS^&777+_5-.U VDFHPI#>(8A('* A77D;7 )&3D'CCBFZ?X1@T
MK6=.O+*?RK:PT[^SHK8QYS'E6R6S][*#G'K6[/=6]J%-Q<10ACM4R.%R?09J
M:@#.U[2O[<T"_P!),WDK>P/;O(%W%58%3@9ZX)JA%X<FBUVRU47Z&6UT]K$(
M8/E8$JVX_-URB_K6S]MM?/:#[3#YR_>C\P;A]13A=6[!")XB'.$(<?,?0>M
M'*:?X$_LN#1FM-2*WVE++%%.T&5EBD.61T##/.""",$#WS/)X+3%BT5Z4F@U
M1M5FD,6?/F8,#D9&%PQ '7 7GCGI&NK=+A+=IXEG<96,N S#V'4TV6\M8&VR
MW,,;9 P[@')SC^1_*@#G[WPG<OXCGU?2]<N=--XB)>PQQ)(LVP85EW#Y'QQG
MG@#CBN@EM]]B]M'(\68S&K@DLO& <^HIXN(69%6:,LXW* PRP]1ZTT7=LTBQ
MBXB,C[MJAQEL<' ]N] '+7?@.WU-=4?4+I6N=1T_[!-/;P"(LN<[V&2&?..>
M!QC%$G@8ZA=W5QK.K2WWVO3#ILZ+"L2LNXG<,9(//KU]N!U<,\-S'YD$L<J9
M(W(P89'7D4DUU;VVSSYXHMYVKYCA=Q]!GJ: .93PCJ$GAZ]TG4/$5Q?">T>R
MCED@13'&PP20N-[XQ\Q/;IR<V[3PT]MKUAJC7P=K33S8>6(<!U+*Q;.[@Y1?
MUJ77-?33+[3=.C:$7FH2.D9F;"1A8V<LW<CY<8]36CITM[+IT,FI6\5O=E?W
ML<4F]%.>S8&1WZ=Z ,WQ+X<&OQ6<D-[+87]C.+BTNXE#&-L%2"IX92I((JO>
M>%[B^L]/CN-7DEN+6^COWG>$?O'3HH4$!5[8'/OG).]%=VUQ$TL-Q%)&I(9T
M<$#'7)%(+J*7S$MY899D4-L$@XR,KG&< ^N* .4D\!R-.677+E(EU;^U8D\E
M"5D.=REB,L.2!Z#UP*M3>$&N]2M[^ZU#?<VGG_9KA(-DR"567:SY^95#\# Y
M"GMS;\+>(AKWARPU*Y6&VGNPQ\@29QARN!G!/3TK:26.1F5)%9D.&"G.T^]
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME_;T0;3+S3(HK.25-T0PS^='Z;FW(<=6 &,XKMJ* /*M-L)[/_A74&LQ%[F
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M5WJ%P]PEUIW]G30;0JM'DMG(Y#9)YS4VG^&A;7-A<7E]-?RZ="T%JTJJI4,
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M+68B[=E4YEFP#M&23P,]L?A4O_"Q_/TW2KI8X-.;4;1I(6O]WE/<*Q4P>8"
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MTZ>\\@:G C20Q1^7N#R*&RIW_(02,9!/I5Z+PA-#?W]^NO7_ -LO4MQ+)LB
MW0MD$ *.""5(Z8)[\U);>%!937%Q:7ODW%U<M<W(6%?)F)C"%3'Z84'KDGG/
M:@#2LM2WZ"NI7<EN5$33/);/OC*C)W*>X(&:Y^+QA>+;>'=3N;6#^SM>DCBB
M5"?,MVE4M%N/(8$#!P!M)[UO:/H5GHN@Q:/;INM4#@JX&#O8LW X RQX' '%
M9FG>#8+"WTZS:]GN+#2Y?-L8)0/W9 8*&;JP4,0OX9R0* &^%M=UO7I9Y[BS
ML(+&&XN;5O+F=I#)%*4!&5 VD YZ&FZIXK:R\4)HN^VMI7$36XNPRB[#-AQ&
M^0H91_#R22.G6M3P_H:Z!:7-NEU)<+/=2W1,B@%6D8NP&.V2<56UGPNFN>?#
M>7;O8SR12-;M&IV,A!!1NJDX&>OM@\T 9Q\6:C<W(ETS36N[1-0:REC6%]^U
M',;RB3[GRL#\O<#J#Q4-OXCU[4K?7)FTS2S9:=-=6TL<D[EI3&H*X^3&#D@Y
M_+UOV_@X66M75W::Q?P:?=W!NKC35V&)Y3RQ#%=RACR5! //8XJQ9>&!96&L
MVBWTKC5)Y9W9D7,;2##;?;CC.?QH R+/Q5-+I6DVFEV4$-U+H\-_Y26[R11J
MXPD:JG09##/8 <'/#;CQQ=P2V%M>6L.CWEW9I-%%J&=DLY+!H!("%5AM!YZ[
MQP*LOX$$4>D2:=K5]87VF6BV*W4*QL9H!C"NK*5.,9!QP<U;U3PA'JMC/I]Q
M?S26%S;+;SPS(LA;!8F16(^60[NO(X& ,4 7O$>MIX?T=KUH_-D:6."&/=M#
MR2.$4$]AEAD^F:STUW4(_$=QX>N5MOM9L?MUK<QHPC=0P1U9"2002O0\@]L5
MIZYH5GK^B3:5=^8L,@7#QMAXV4AE93Z@@'\*@M] 9+R74+F]:XU%K7[(EP8E
M41QYR<*.,DX)^@X&,4 8OPVLQ<>#M"U:\BMY;]K$*ER$_>;'(9@S$\Y89/O4
MNG^+)]5U6]TZ"6S@O+9YTDLKA&6:(*2(Y,$CS$;"G*XQN R>M;?AW14\.Z#9
MZ1%<23PVD8BC>0 -M'3..#5./PM&VK65_>7;W4EBTS6S/&H=1(""I8?>4!B
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M2!WH Z.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^=)5_CC[@8.<G@=:CUCPMK5]IWC2WAMX=^LW$4EJ6F  "QQH=W''^K)XSU%
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M3A(,MPBC:GR;?E;&-QW'H<=<@ ZJ_P!5@L)K>W99);JY+""WB +OM&6/)
MZDD#D#J163)XYT6.UM)]UTYN;IK-8DMG+K.H):-ACAOE/'?MD4:YI%\WBC1]
M?T]5G-E'-;SVS/M+Q2;3E">-P9%X.,C/(K$;PEJ<5W9WD4,32R>(&U>ZC\W
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M213RK8Z@J64_6LWQ#X:OE;0KS1[:TOY-*62*2TO6VBXCD"[CNP0'R@;)'<T
M='HVLV6O:<M]8R,T19HV#J59'4E65@>A!!%:%4-&MY[?3U%S:VMK*[%VM[7E
M(\]@<#<?4X'-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH ***Y[Q7=B$:3;"ZGBEN[Y8DBA?8;C"
M,VQGR"B\9)'/RX .<4 ;TDL<*AI'5 6"@L<9). /Q)HEEC@A>:5U2-%+.['
M4#DDFO)!/)JNE:"M[>SRM;^+);566\<D1!I@HW@@MC: &//'N:ZWXG1I)\--
M8(=]JP*P9)6&1N'4@\CZ\&@#?36[9_$DFA>7,+I+47>\J-A0MMX.<YSGM6E7
MGFI:;%=?$"XMH[V]BC3P\<2073B3(G;K)G=P??M@\<51TS7KW6X/#FGZAJGV
M5K[0([I9C,\)GG. Y#(RDLHP<9_B)QQP >HT5DZ)'.WAFUAN=4^WSB'8U]$G
ME^<1QO YZ^HX/45YYH,VKKHW@374UK4;N[U*=+:\MYIR\4L;(Y8[.@9=F=W7
MKF@#T?1=;MM<ANI+:.:,6MU):R+,H4[T.&Q@GC-:5>50:M)I=K<I]I6UM;SQ
M==6US<,Q4(I#E06!!7+J@SD=?>M3=/82VFE2>(YK][G5'\B"&1D^3R2YA><L
M6VKP^<ENBX(- 'H-%>7:7J>NWWA33)K64ZI-!=7JSV:WS137$*3.BE)1@L5&
MW[Q&[OS5[0]72^\0Z=Y>H7_]FW/ALS$74S*Q=9%4NW/#@9R1]<T >AT5Y1I%
MQJ&N67@&&XUK4D&I:=<_:W@N2C2,J*0V>NX$GFKJ75YJESJL:^)/[.O=)U(1
M*LCNS>4NW:&CW 2"1<\D$DMQT  !Z539)$BC:21@J("S,3@ #J:YOQOJEQI>
MF:>8I&AANM2MK6YG4X,4+OACG^'/"Y[;L]:Q-1%U%J7BS13<74VE+HZWB%[A
MRT$K>8"@?.[!"!L$^O8XH ZK2M?BU>95ALKZ.&2W2Y@N98@(IHVZ%6!.#T.U
ML-@]*=J_B"ST:WBFF$LJ27<5H?) ;9)(P5=W(P,L,U5\$VZ0>!]$"-(0]A Y
MWRL_)C7H6)P/8<"O/#;11>#K](YYQ(?%XC!>=I"H74  0')&<8YQSWS0![%1
M7F&H:S>^'9/%5M'J%R;.UO-/_?7,S2FVBF*B9MQ.X#&3U^7.1BNK\-V\UMJ6
MI9UQ-0MI1%+%;AVD^SY!!(D9F)#8R!GC!QUH LS>)[:'7I=%%I>RWL5N+EDC
MC!'E%BH8'//((QUXZ5<TC6;'7+-KK3YC(B2-#(K(4>.13AD96 *L/0UR,\-W
M-\9;M;.[6V?_ (1Z'+-%YG_+Q)VR*YG1=7N=)T^^T_S&+2>*UM=2U:)L+/YN
M"SC'^K/"1D _+G@YYH ]CHKSC5-2N='U/Q%IK:G?)IHCLG@E#F26*6:4H85=
MSD;]HY)^3=D$<5FZGJNIP:+XQMTU.XMY;#4K06_E7;2M$KB'>H=OF(R[<'H3
MB@#UACM4M@G S@=36?H6M6WB#2(M2M$E2&1Y$"S*%8%'9#D GNIKF #;>.;7
MPS-J.H-926$U\C2W;B2:4R % X(;"+DA0?XL]A4GPTGM[?P+IL#W2&22YNTC
M\R0;I2+B4G'J<<\4 =I17,>.FN[/0DUBTFN$.ESI=SQ0R,HF@5AYJL >?DR?
MJON:YW2]2N[KQ!?Z,US>F#598M0TZ?[3(2MH"?,PV?E!V<8_Y[KGI0!V^E:W
M;:O<:E!!'-&^GW/V:82J!EMBOD<GC#BK*79?49;/[+<*(XUD\]E'E/N)&U3G
M)88Y&.XKRW4_/LK?QQJUI?7=O<V6M0/$(IBJ$^7; [E'WP0<8;(],&M7Q)KF
MIZ-K/C":TN9W%KHMO<PQ,=ZPL7E#.J]. H/_  &@#MM;U>#0=%N]5NHYI+>T
MB:6185#-M R< D5=BD$T*2KD*ZAAGT->>^*8[,>#/$MQ8:[/>6]SH,CK;/.9
MU&%;]Z&))7<"!C@''3@U?T4W%CX\CL%OKN:VN=$6Z>.>8NHE60+N4'A,ANBX
M' XH [:LVUUNVN]>O]'2.9;FRBBED9U 5EDW;=ISS]P]JYWQM<ZG:W"W%JD]
MW8P6DC7=K9W9@N8@3Q,F" ^ K#:3_.N?U#&HZKXLO[6_O8 GAVTNH)8)6A8L
M%N&1B1S_ ,!/!SR#0!ZI66^NVZ>(6T3R;@W0LS> A1L9 P7 .>N3TQ7G_B+7
MKN?P_?7=OJ=RM]:>'8;UU2<P1P2,&82#;_K&8J!M(V@+U&[!Z"UF^T?$^QF+
M!B_AYF)'KYZ9_6@#H]#UFV\0:);:M9I*MO<*6195 ; )'(!/I5;0KS2M:>YU
M>SL!#=+-)9S32PJLQ,3%2I89) (XYK-^&7_).=&_ZY-_Z&U<8D%[9^'M3UO3
M=3OH[^W\2W"0VJ2_N9MUX4,;1]&R&/)Y'8@"@#U^BO.(KZ\UJ^U*4>(4TV\T
MW6&B,)9S^Z5P$0Q;@K"1<8."<MP> *Z'QMJ[Z/IEA)YQM[:XU&"WNK@';Y43
M-\QW?PY.%W=MV>#S0!TU%<#K%X^BR6MK:ZS<W%G?ZU!!.S3%S9QNA/EB3)8;
MF5>IR _&,@UE>)+W5M-3Q596NHWJ6EHVGS6TWGL7A:60+)'O.21@ X)XW>F*
M /4Z*\XO[2X77_%.G+K&K+;0Z5%?1 7KAHYCYP+*V<@?(IV@[?:H[![[Q'K>
MAVUWK&HP17WAA+N9;6X,6Z4M'E@1R#\QZ?3H2" >ET5Y?X7UK5=2N?#NCZQ>
M7#036U\RW*2-$]X\,P2/+*0?]7E^#SP:?;7WB2;36B@9]2_L_5;R!;=KLP3W
MMM&=H99!C+(6P<D;MO)S0!Z;45S.+:VEG9'<1J6*H,L<>E>:VVM_\)!<6VE1
M:Q<V,$FBQ3VDMU*\4\DFYTD9BK#<Z;$R"2.2>0:N65]/JNK7VC:EJ\LHL]%@
MF@GMW:W^UEP_F3X4\C*H .5&3ZT =KH^J0:YHMEJMJLBV]Y"LT8D #!6&1D#
M/-7JY+P--)#\*M#F@C\V6/2HF2,?Q,(Q@?GQ6%8:I?R:)X)UVUO[FXN]4NHH
M;^)I6:.0.C&7"$X0H5)&T# 4@T =C-XCMX]2-G#:7EUY=REK/+;QAT@D=0P#
M\[@,,I) (&X9(YK9KBO!%E#!K_B^1'G++JQ0![B1QCR(3R"Q!/N><<9Q3Y)Y
M=9\::]HUW>75G%:6,$EIY$[1$[]^^7((W8(4<Y QTY- '945Y;X=N]5\3:GH
M":KJ%_ +WP[)<7$5M.T(=Q+&JR#;@J2#G(QUQTR*;HGB"]U.P\)V&I:F81?:
M7+(9Y)GB-Q,CJN-Z,IW!23C/.2>PH ]4HK%\/B[MO"\"SZB-8N84=?M2IL\\
MJQ [GG@#/?&>]<98ZMJ,_AKPAX@M[ZYEU#4+^*"]A,K&-Q(6$J",G"[,$C !
M&PY[T >FT5Q/@JVN+N\U6_NM5U&=K35;RUBADN"8_+#@*"O<C'![9I=2AGO_
M (BRZ8^I:A#9R:*9C%;W+1 /YNW<"N"#CT/Z9% ':T5Y=X<O]19/A_J,VIWL
M\^JQRQ7B23DQRA;=W4[/NA@R#Y@,G)R32VFL:G<^$- \20W=R=6N-4C@NK4R
ML8V#S&.2'RR=J[1T( (V9)ZY /4**\N-SJ5IH_C#7$U74IKC2;ZZCMXC,6C1
M/+3DIT;;DL,],?7/2^'8V_MMKJW\11WUA=62NEHLCS#<&'[T.SL5!!QMX!QG
ML: .LHKB=3AGO_B'=::^I:A#9OHHF\JWN6B"R>:5W K@@X Z'],BL7PY?ZBW
M_"O]1FU.]GGU:WD2\22<F.7%NSJ=GW00RCY@,G)R30!ZA17F_A:[N]?@T/6C
MXC6*>8O'>V2N[&1RIW1["V(V0C((4$!>>#6=I<NHR:#X,U!];U1KB_U22RN&
M-TQ#Q$3G&T\9'EKAL;AV/3 !Z/K.MVVAQVCW,<SK=745HAB4':\C!5+9(P,F
MM*O);]KA]*O=-DOKJ2.S\7V=O;RS2F22-"T#XW/DG!<XSFK&J:EJ7A2\\06L
M.J7<^E1&P=KF[E:5K+SIBDPWGYL; &Z_+N!% 'J5%>8Z\-0TW2K^:T\4RRI+
M>Z>T,=O*SFW#S*C_ +QF8LK@D[3P,'L:L^)5O_#@E:*XU+4=)M[-I+KR]0<7
MEGN=V\\9(\U0 1M)X"<=Z /1:*YOQMK-SI/@74-5TXL)4B1ED"Y,:,RAGP?[
MJDMSZ52 GM?'5GIMI=W5QI>H:9-+.CW+N8F1D"R*Y.Y=P<C@@'&1R* -BQ\1
MV^HWL4-M:7CV\PE\J]$8,#&-MK#<"2O(.-P ..,U)KNOV?A_1[[4[D22Q62>
M9,D #.H^A(K"^%MO'#X!T]T:4F0R$[Y6<<2N. 20/PQ7):_;PQ:)\5&$LQD#
M8"O<.PP;:)C\I..IX..!P..* /7P<@'UHKS;6M2U+PUJ_B$6-Y>7 7P^+]4G
MD,NR8.ZEU4\*,<[0 ..E;GAQ&;6UO+;Q&E[87=B'6T61YLL&&)@S.VWAL%1@
M'KV- &I?^)+;3];M=(>VNY;NZC>6!8D!#JF-W)(QC(Z^M3Z5KECK+74=K(XG
MM)/*N8)8RDD3$9 93ZCD'H>QKE_$D<\OQ3\*K;3K!)]BOCO:/?Q^Z[9%<M+J
M]_X;N_'Y$OVK4XWLY9]5B7 2)R$VE.0K1H6/?/4T >QT5Y]KFH3>'M;O8X=4
MNX]*ET*>ZEE9VN6M9$9525-Y)Y#'Y<X)7/K69=ZEJ%HOB^U2_NH!!X=CO;<?
M;6FDCEVS'=N/W6(125!(XR"<YH ]4K-T?6[;6UO3;QS1FSNGM)1,H4[U )Q@
MGCYA7'"6;3]1\*Z?-JFH/;ZWOFN99KELF1(5*Q(PP4#$EL C)7'0D5H_#V)(
M%\30I*\BIKMP TCEV^['U)Y/X\T =E17F>LZS.FK_:K+4[AUC\1VUC(SW!C1
M =BO"L0X<8))9L')XS@&JEY<ZA%I7B+5$UG43-IWB***V7[2WEB-FMP4*CAE
M(=A@Y [8.<@'H^NZQ;^']$N]6NHYI+>UC,LBPJ&;:.N 2*FO+^.RTN;4'21X
MHHC,RH,L5 R<#UQ7F?BF];7/#/Q$6\NIXIM,WP0VR3L@6(0JRLR@X;>2W)!X
MX'2N_P!5(/@^^(.1]@D_]%F@"[IM_%JNE6>HP!UANH$GC#C#!64,,^^#5JO+
M-'N9-"3PI+_:EXEK=^&Y9KD22&1(_*BA972/H"H9N@Y[Y/-6_#]U<W?B2#3)
M-1O/LE]X?6XR]ZS2L^]0)>I$;$,3A21T]* /2**X#PQJ&HWE@ME<27,NI>'E
MFBO<RO\ Z3,,B+//S!U^?!Z96F^$;FXU8^'];3Q*D@NK=A=V89W\^0IDC:6(
MB9&!^ZH]/2@#T&BN3\8S:K!<V4NGPR7L$<4S7-A;W;6\\B_)B2-@1N*<C:2
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M<,S7,ZV\* J-\C D#+$ <*>I]NI KEM8UFZ'BKPM<0V^IH)FO8Y=/#@&4HI
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M8M$I3;A3G;DACPO3GCN:Q3XCC?4FM+6PN[N.*Z%G<7$"J5@D*!OF&<[0&7)
M(!/UP ,\6Z-=:WHT<%D\*W,-W;W48G)",8I5?:2 2,[<9P:Q]6\+ZQJ-]K]P
MK6(_M/15TU,RN-KCS,L1L/R_O3WS\OOQUE]=26D*216DUTS2(A2';E0S %CN
M(X&<GV%6: .4MM U2'Q#HVHL+,QV.ER64BB9LL[&,Y'R=/W?Z^W.-8>#O$FC
M6.B7&G7&FG4].%S#+#,[^1<0S2>9C<%W*P(7'!Z5Z)10!5L8[L6*+J$D<ERP
M)D,((09/1<\X'3)Y.,UPEGX-\16>D:)HHETR2ST;48[B"Y:5Q)+"A;"LFS 8
M!L9#$'':O1:* .0T30_$FB7LUA%=:>^A-=R7,4K!_M,:NYD:+;C:1DD;LYP>
ME4)?!FN+9726EY8Q7,&M2:MI\C[V5B[,2DHQP,.R_+GKGCI7?44 <?J>C>(]
M8L---VVF+=V^I07CQ12.(E2-L[58IEF/J0 ...,F[-H^HGQM)K48M6MSIGV-
M4:5@^_?OR?E(QVZUT9( R>!5,ZAODL/LUO+<V]WEOM$179&NW<&;)S@\ 8!Z
MT <CI7A#5]/M?!<,C6+?V#O$Y65_W@:)HQM^3_:SSZ8]Z8GA#6EA@4FPRGB)
M]8/[]_\ 5LS'9]S[WS?3BN]HH X.\\&ZS/)J]U;75G;WLFK1:I8,69T#)$L>
MR0;1PP4YQG&[VYU;JY\5V6A/=-'I,FJ&1 MHC2&+9W56QN9SV)  XST)/3T4
M 9/B?2'U_P +:II$<JPO>6SPK(PR%+#&2*R+KPQ>ZY.MQJIMK:2'39[&%+:1
MI0&F"AW)*KT"  8[GFM.]\1QVU_-9VUA=WTMMY7VD6RJ3")"0IP2">F2!G Y
MK6GGBMH'GGD6.*,;F=C@ 4 <;HWAO7X-7\/7E^VFK'I>GRV,B02.Y?=Y6'!*
MCKY?3MZGMK^#-'OO#_A>STB^>W=K1?*1X"Q#J#PQR!@GT[>IJW!KD,_B6[T/
M[/.D]M;1W)D;;L='9E&W!)ZH>H%:E '!7'A#69M%U>R#6 DO=;34D8S/A466
M-]I^3K^[Q^/M4LO@_4AI_B/1HIK4Z9KD\LYE=V\VW,P E4+MP_.2IR.O/2NX
MK)N=?MXM5;2[:WN+Z^CC$LT5L%_<J?NEV9E49P<#.3C.,4 37]E(VAR6-E%;
M.1&(TBNAF)U& 5;@\$9'0]:XT^ KZVTB[M]->VME&H6M_9:>]P\D$+1,K,H8
MKE5<@\!<#MUKL]-U:/4GNXUM[BWEM91%+'.@4@E0W!!((PPY!QUJ_0!Y_>^"
M]<U*37;J2[L;:[O+BSO+-HB[B&: +@-D#*Y7&1]<#I5_6-&\3>(/"T]E>MI<
M5Y+-;L(X9)/*01RK(3N*[B6VXQ@ <=>_8T4 <_IVD7UMXQU?5Y_LXM[ZVMXD
M5)&+J8M^<@J!@[_7M[U3NM$U^R\77>KZ'/I[6^HPQ1W<5Z7!B>/(61-H^;Y3
M@J<=!S7644 <D/#NK:?K>L7NGS6MS%J\$0F^U.R-%,B>7O 52&!7&5XY'7GB
M'1_"%WH.KVDEFUO+96FBKIL?F2LLCNK;MQ 4@ GWKK6N8Q)+"A#SQ1B1HE(W
M8.0OYE6 ^AI+*X>[L8+B6VEM9)8P[038WQDC[IP2,CV- '%Z5X0U?3[/P9 [
M6+G0=XG(F?\ >9B:,;?D_P!K//IBFP^$-9BT+3;$FP,MKKC:FY\Y]I0S/+M'
MR=?GQ^%=[10!P>K^#]7U&T\8PQO8K_;C1& M*_[L+&B'=\G^QGC/6M670-1D
M\5W6IA[5;:]TM+*=2S%XW1I""O # ^9WQTZ<UT]% 'G]IX4\3Z78^';BPN-+
M.I:39G3I897D\BX@PG.X+N5LQAONXYQSU-^^T/Q,FK6&N:==:;+J*V[VUY;W
M.](71GWKL902"IX&1R.N*W=0UR'3M8TG39;>=GU.1XHI5V[$98VD.[G/13T!
MK4H JP1WB:<$GFC>\*'<ZKM3<?0>@Z#.3@<UPDG@&_\ L&MQV:6&G'5-,>UF
MM;>>0VSW#\&?;L&P@9X YSSTR?1:JW%ZL4-V84:YGMHRYMXB-['!(49(&3CC
M)'6@#EKSPUKL^J&]M;JTM)1H4FG1RI(S-',Q#!P-HR 5^M5]/\)ZU;:I/?.F
ME1>?HXL9(X9)#F4,QWERN6SNR6(SQCGK7<0R-+!'(T;1,RAC&^,J2.AQQD4^
M@#BM/\*ZK:#P6KM9$:%;M!<%96_>9A$0*?)[9YQZ>]:WBC1[W5QI'V,VX^QZ
MC%>2><[+E4SP,*>3FM^B@#A;OPMX@,^M36D]DGV_5(+SR6F<++"D:(T3L$RN
M[9GC/H>,U9TCP=+'I7B32M4%D;'5[B25$M01Y:O&JD8( &"O&/KQTKL:* ..
MF\):E/X(@T]]30Z]%+#=_;F0E'N(V5@6'4KA0OT%;NBKK9A>37#8I.V L-D6
M:-<9R=S $DYZ8XQWK4HH XS5/"^K7%YXK-K)9&#7+%8%,KNK1N(VCY 4C;\P
M.>O&,<Y#)_!]]?W=J+MK9+0:#-I,_ERL7S)LRRY4# V=R.OM7;44 <YX:M/%
M%I%#;:[<:;)%;1^6DMH'WW&!@,X883CD@9R>X P<[59+I/BOI7V2."63^QKK
M*32F,8\V'H0K<YQV]:[2H3:6S7 N&MXC..!(4&X?CUH XNS\$WND7NE:K83V
M\M_!)=M=Q2LR1S"X?S'"L 2NU@N..0.<59E\%O/X8UVS::./4=4NGOUD0DI!
M/\IBP<9(4QIS@9P>!G%=C10!R>G>#6T_Q1%JHN@T3VP-U'C'G70+ 3?BLD@(
M_P!WTIFDZ'XDT;4KJSM[K3WT.>\DNTD</]IA\QS(\87&TC<6PQ.1GH:ZN:>*
MWC\R:18TW*N6.!EB !^)('XU)0!@>%M(OM'75A>_9S]KU&:\C\F1FPKG.#E1
MR,5 ^B:E8>+K[6]+-K-'J-M%%<07,C1[)(MVQU(5LC#$$<=,YKIJQ=3\1QV%
MW-:6]A=ZA<V\*3SQ6BJ62-V*J<$C<?E8X'.%/MD Q-&\&76A:GX=-M);RV>E
MV$]K*SLRO(\K(Q8+M( RAXS_ !>W.WXHT_4]3TA8-*N(HIQ/%(Z2NR)-&K M
M&S*"5##C(!].AK:HH \];P1K TS6H(GTR)[G5+?4[2./>L:M'Y),;?+P/W6,
M@'KG Z5)?^#M;U6#Q:+F;3X7UNVA2(1L[")XUQAB5&1GN!GV[5WU% '(MH6M
MS^(;S59ET\&YT@6/EI._RN'=LY*?=^?&>O&<<X%31?"6KZ#<:)?6[V4UQ:Z/
M'I-W"\SJCK'RDB-L)!SNR".C=>.>YHH XBR\&7NFWWA^:"2UD6RN[N[O"SLI
M=[@/D(-IX!?C)&0*GU+PK?ZCJ'BMS+;1P:SI:6,+;V+1LJR#<PVXQ^\['M[U
MV%% ' :_!]ITC1]$DU.TM?%=O)!+:):R;W3G8S@-@E-GF9. ,9]*[FUMHK*S
MAM;==D,,:QQKZ*!@"G^5'YWG>6GF[=N_:-V/3/I3Z ."/A#6C920[K#>WB(:
MN/WSX\L2!]GW/O<8]*WM&T>]L?$OB#4;C[/Y&HRPO$(Y&9EV1A/F!4#G&>":
MWZ* .<M="NT\6:[J%Q]G-CJ5K! H21O,7RQ("2-N.?,]>,>]5O"VD^)]&M;;
M2[^ZTV?3K"/RK>>(.)IT4;460$;4P,9()SCZUUE% ' IX.UQ/#*6T5S8P:I:
M:M+JEI)N=XF9Y)&*/\H.-LC*2/K5[4]&\2:SI^G&[;3%N[?4K>\:**1Q$J1-
MNVABFYF;U( '''&3V%9=UKD-KXBL-%>WG,M]%++%*-OE@1[=P/.<_,O;'/6@
M#'U#1O$-KXKEUC09M.>*]@CAN[>^+C:T9;;(A4'/#$%3C.!S4-SX9U>6_P#$
M,_FV<HU/2HK&-WD96WH) 78!2 #YF<#/3WXZFQNI+N!I);2:U99'0)-MR0K$
M!AM)X.,CV-5-(UR'5[G4X([>>%].NOLLHEV_,VQ7R,$\8<4 <S:>&?$FBZC9
MW^E3:8[R:;!8W\%R\FS=#D))&P7)X9OE('UJU+H?B73_ !'-J6CW>G7$5]!%
M'>I?!U*R1@J)4V YR#RIQT'-=9-/%;H'FD5%+J@+'&68A5'U)('XU%'=2/J$
M]L;29(XD1EN&V[)"V<JO.<C SD#J* (=2T^2_P##]WIK3YDN+5X#,R]V0KN(
M'US7,6'AG6]/OM%U5&L'O;33O[,NK?S7$<D0*E65]A(8,N<%>C8[9/;44 8_
MAO1/[#T^XC=U>XN[N:]G*?=$DKEB%]AD#/?&>];%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<
MWXPO(;=-)MY+B:)[J_6-(TE\I)B$=MDC_P *<9..20!@YKI*@N[*TOX1#>6L
M-S$&#!)HPZY'0X/>@#RJTU&XN]&TB+^U[@LGBN6S+07C_-!OEVH3G++A1@GG
M &*;JZ36&A^.)8-3U)6T6^1[#-]*?))BA<@Y;YP2S<-D<G&,FO46T?3'.6TZ
MT8^:9N8%/[P]6Z?>XZ]:1M&TMQ,'TVS83'=*# I\P^K<<_C0!PFL7IU/Q!XB
MTR[\2)HEQ9M"]DS%@ZQ&-&\Q )%#Y?>",'H >PJAX@%R4^(-Q_:>HI+IMK!<
MVH2[D00R>07R%#="PSM.1[5Z9+I.FSSV\\NGVDDUM_J)'A4M%_NG'R_A2/I&
MF2-.TFG6CM/_ *XM I,G^]QS^- '"W^HKJVJ>*;#5+IX1::3%+9QK.8@RO&S
M/*,$;CNPN><8QW.6:!,QN?AW#%=S>1<Z!*)8DG8(Q2*#!V@XW#<W/6N\GT72
MKDP&?3+.4VXVP^9 K>6/1<CC\*=_9.FAHF_L^TW0KLB/DKE%]%XX'L* /,M
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M3&*].:PLWLC9-:0-:%=OD&,&/;Z;>F*C.DZ:UF+-M/M#:@[A 85V ^NW&,T
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M#Y1=$9]P8+YA49+=#@\58NK>2VET2WM_$US>V]QX@,1-M.Z+'$T$C&$-O;<
M5!!)RN<#&*]#&D::()X!IUIY-P<S1^2NV7_>&.?QI!H^F+#;PKIUF(K8Y@00
M+MB_W1CY?PH \NOXU;0[VTN+JYDMM/\ &%O#"TMTY:.(O"V"Y;. 7;!)XKUJ
M#R_L\?E/OCVC8V_=D8X.>_UJM_9&F>3/#_9UIY5P=TR>0N)#URPQS^-7  H
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M=Y3-@1!"K$$L3C&>#UXYK%_M*XB\9^*&OK:^%O#HL$K6L=SNSEIMS1'< I(
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M4R&PL@R/E)YSP36WK6EPZWH=_I4[,L5Y;O [+U4,I&1[\UBZ;8^,8--DAO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !351%9F5%!;J0.M.HH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH 1E### $>AI:** "BBB@ HHHH **** "BBB@ H
MHHH *1E5U*LH93U!&12T4 -1%C7:BA5] ,"G444 %%%% !1110 4444 %,2*
M.,DI&BD]2!C-/HH *" 1@C(-%% #4CCB!$:*@/7:,4ZBB@ I-HW;L#=C&:6B
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *HZEI<>JPF"XGN!;,-LD,3[!(/1B!NQ[ C/>KU% $<$$-K;QV]O$D4,
M:A$C10JJHZ  =!4E%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>aquestiveamendedandresta010.jpg
<TEXT>
begin 644 aquestiveamendedandresta010.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI<L<2D,-QW%U)]#VQ^-(OA[Q+=>'+_2M6URSN6FLY+.&6*U:/.]=OF2_,=S
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M9=7R S!,<HI.&.1C!X(%0R^+Q;ZS:6-QI\D,=W?/8PM(^V1F56._RR/]6=I
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M1Z=*;=>&;[4YI;[4+BU^WC3I;" Q(WEKYF-\A!.<G:N%[8/)SPEAX6O;2_\
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M<4 >TT5Y9KEWINH^)-=TO7=7_L^9F@DTJ54'FM%Y:$&V;N_F!\A<DY YK/\
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MUFY2X=_LV3%M5%P/GYXC7]:ZY9HGB\U9$:/&=X8$8^M(T\*1M(TL:HIPS%@
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M9&#*>A!R*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MR:K')I<93(VDQ>88Q_=+>9C'&-QZ&O3+VUMIO#]S;6T,3P/;NL<<:@H<@X
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M@^U_[W(&<]2*]1=UC1G=@JJ,EB< "DCECFC62)U>-AE64Y!'L: //+9-.O\
M7_#5[HT<,=DEA/'JJ!0JK#L&V.8=F#] W/#^]8_A_1M.C^&.@74,T&EZHYB1
MKV2 ./,0NRI.#@E.W)&/EQC KULR(KJA=0S9VJ3R<>E.H YWP1/-/X;7S["W
MLY$N)U9;4DPRGS&)DCSSL8DD?6NBHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K,UO4;C3;6"2"
M*)A).L<DLT@1($.<NV2,] ,#DEA6G6/K^A-K1T^2*^ELY["Z%S$Z('!.UE(9
M3P>&/T/- '/+\0%71+>^O(XK)6U&;3Y[F4.883&7 =N 5#%0!G&"W)XYZ_3+
MF6[TVWN)UA621 Q$,F]/JK=QZ&L"P\(3Z9#/%;ZQ)+'-=SW,D=U;H\<@E)+*
MRC;GDYSD?ED'7T'1K?P]HEMI5J6,-N"%S[L6.!V&2<#L.* ,./Q==+XDT_3+
MFSAC%]=7%MY:R[I(/+5F1G(ROSJF=O! 8=>:YBTOK[1='O5T@6\(F\8M;,&!
M "/.H(&.F>A]B:Z2T\!&SGTUUUR[:/3KZ:[MT,4?24/O5FQEC^\;YO\ ]=2-
MX'#Z;=6IU.19)M5&K1S+$,QS!P^,$D%<CH?SH 9?^+[^)[T:;I;W[:?<);SP
MQ12%I6*HS[&"[1M#]&/.#TX)='XEUVZUO6+.UTJP,&E3JDKRW;*75H1(I7"'
MG+ $'IVS4A\&S1:W<WUEK][:V]]M:_M52,B=U4+O#$9C9@ "5_#!Q5VT\//:
M7^NW:WNYM69793%Q$5C$8QSS\JCKW_*@#'T+QGJ.I7'AQKS3;:&VUVS:>$Q3
MEGC=4#D,"H&""<8/;WXDT[Q=?7>MVFES6=M%<7EK/,J++O\ LTD;*/+D895C
MAP3M/&,8Y!J:S\%"TC\.Q#479-#@>"+]U@R*R;#N.>"%'!'?\JCT?P*VDW.B
M3?VW=3#2(9;:%&AC4-$^WAB!G/R#)[^U &?X=\8:A/X8T%[T1RZEJRRRHR12
M.JJIRQ*J">"R@ =CUXKJO#VIWFJZ4+B_TZ2PN5D>-XG!PVTX#KD [6&",@'G
M%<^GP]^SZ1IEI9ZY>6]WI4KM87:QH3$C9!C9<8=2#SGT'2NJTVSDLK-8I[N6
M[G)W23R@ NQ]@  .@ 'I^- ''ZKXWU;3XO$EPFE6CP:#,@FS<MNEC,:.2OR\
M-A^_''?J+ESXRN-(U'58-8LH8X[33?[2B:VE+EDW%2C9 ^;('3CGVI]_X)&H
M6OB2W?465->93,5A&8@$5,+S_=4=>^:GO_!\.K:G=76H7/FQ76F'39H%CV@H
M26+ Y)#9/^>M %&\\6ZQ86^K32:+YL5GISWT<^V6&,LF2T)+IG=CD$#!]J6+
MQ/KLVL6NFKIM@)+[3C>VSM<OA-I0,)/E_P!M<8^GO4T7@^^;0+[2M0\27E^E
MQ:/91R31(#%$XVDG:!O?'\3>G3DYMP^&I(=8T[4A?@R6-@UBBF'AU8H2Q^;K
ME%_7\ #DI=8N=?U;P-K=GI]LFHSI?)Y<LA"*53:P+A22H()''Y5L6/CJ>XA6
MSN; 6^LB_EL)8H]\T:M&@<R+M7<RE2I P#\W.,9JQ9>!SIUIHR6VIM]ITB2=
MX)9(0RN)<[U=01GJ<$$?C3KWP+!<6D36NHW-GJL5Z]^NHQJI?SG&ULJ1@J5P
MNWT H IGQCKQETJT_L".*[OKNYM!]IE>)28XV=9%!3.Q@H//(Y&#UJU;>+;F
M3Q!_8EPEE;ZE$T(DM'D8-,C(K/)"Q #JI++C&?D)..E6CX6GDO='O9]7FGNM
M.GDN&DDB7]\SQF,C P%4*<  >YR<Y?J'A8:KJ$4U[=B6"&]CO8$,(\R%TVX5
M),\*2N2,9.2,\T 7/$.MQZ#I?VMX_-D>:*WABW;=\DCA%!/89/)] >M9P\07
M\>NWN@W$%N+Y+'[=:S(6\N5-VU@1U5E./7((/'2M/Q!H=MXBT>73KIY(U=E=
M)8CAXG5@RNI]00#5:'0)?MD^HW5XLVI26@LTF$.U8X\DG"Y/))R>>PX&* ,?
MX<6*3>$M#UFZMX#J,FGHOVI<^8Z/AVWGN2W/U^IJ;4_%UUIFL16TUG"(9-2A
ML5C\W=*R28 FXR%7<2-K8)VDY[5M>'='_P"$?\/V6D+<&>.SB6&.1DVL548&
M?>L*Z\!FXN+IDUN[BBFU2/5%C$4;;)E*G[Q&2ORC [>] %6\\<:K:Q:S='2K
M3[)I&I)9SG[2Q=T81?,HV8R/-S@X'&.>M:<_BF>RUO6=.O;>*(6ED+VS96+&
MY3D'C'!5@%(&<[E]:ANO!'VO3M<LFU-@FKWB7<K"$91E"#"\]/W:]??UX2^M
M(/$GBO3EDL;U)-$G:26ZDA:**7*C"(3]\%]C<9 \OGJ,@'2K<O;Z7]JU )$\
M</F3A"65,#+8/<#FN>C\4W\>EP:[=Z=&NB2Z?)?22QR@R6RA ZJP/WBRD_=Z
M$8Y'-=1+%'/"\,JAXY%*LIZ$'@BN6TGP0+#37TB[UB[U#1EA>WM[*9441QLI
M7:S@;GPI(&>@]P" !R>*+V"_T2&^LH%BUJ-OL[1R']S*$\P1N<<@J#\P[CIW
MK+L_'.LW-AH5^VD68@U6[DL0@NFW)*#)M).S&W]T<]^<X[5MZ?X5:U_LL76H
M->+I",MCYD0!4E-@:0@_.P4D9&WJ<C/(JVW@C[-I6BV"ZDS)I5\U]&YA&9&)
M<[6YZ?O&Z>WIR 4Y?&^I6NDW\TVF6SWEAJ\6FS)'.P1A(8]KJ2N>DHX..AYH
MO/%^OVI\10_V5I[3Z+ EVY^U/LDB9&8*/DSO^1AS@=*MW/@@W,6I1G4V47^I
M0ZB^(1\KQ[-JCGI^Z3/?KZ\6;KPFUU<>()FO]O\ ;5HEI*!#_JU564%>>N';
MKWQZ<@$ UD7?BW3XH-,M1-=:-+=V]Y*<R*-T?[L@#A<L"<'G%<_I7B;Q)>:+
MX(N&EM"^KW#>>3N^<>3(X'L,KVST'O75V?A@VNL:9J)OB[6.GFP">5@.A*DL
M3G@_(OMUJA:^ Q9Z1HMC#K%T#H]SYMI*8XR538R;",8/RN>3WY]J %_X2^\N
M+J*33]+EN[(Z@UE)LBDWJJN8VEW;=FT,I^7.<<YSQ1;>+[R^NK*:QTN6YTZY
MO&MF9(I T2AF7SBQ785RO(!R 0<GD">R\'RZ=J]S-::W>1:7<W)NY--"(5\U
MCN;#D;E4MR5'OV)%&E>#Y='U&7[+K=X-(>X:Y732B;4D9MQ ?&X)N.=N?TR"
M =17(:OXLO\ 2[[7K3[#;M+86*7UFID8&[0E@R].&# +@9R67UK9T"WU.VM;
ME=4O7NV:Y=H'DC1'$1QA2%XX.['?&,\\4FI>'K34];TS5)BXFT\OM"G D#8.
M&]0&5&'NHH YCQ-K"^(/A]K3Q1V\UE)X?>\,G)P[QL4 !]-I/J,#UJ>R\6SZ
M03:ZO:0Q6D&B?VG'+!*7;RX]H96! &[D$8X[>]:,7@JSM?"6J>'K2>2*#4#.
M'<C<8UER-JCT52%'T%$G@Z*ZOHY[RY\^$:6^ER0>5M$D3XW'.<@_*/UH 9#X
MGNX=2T.#4;.%(-:1O(>%R3#($\P1OD<Y4'YACD8QWJYXHURYT&VL);:TCN3=
M7\%FP>4IM\QPN1P<]?:HM-\*_9'TK[9?O>II"LMEOC"L,KL#.0?F8)E00!U)
M()Y%OQ!HAUV"SB^TF#[+>0W@(3=N:-@R@\],CF@#FK[QIKMC;>(V?2K!I-!V
MS3XNGVRQ&,2 )\F=V,CG R!Z\6_$OC.YT*&YNQ9PFU@@AG19)/WER&;#[0N2
MNP8Y88)...M6+[P;]N'B17U JNO1+#,!"/W2A-GR\]=OKW_*JFI?#\ZDFJ1M
MK5S%'J5K#!.B1(?FB&%92<D#N5]>XS0!?G\3RV'B+4M-U"&&"""P-]:S!BQG
M120XQC@J=O )SN%;EG)=R:;#)=0QQ7C1AI(E<E5<C[N['8\9Q7,:C8P>(?$6
MF64UI?M+HMP)Y;Z6$Q1RCR_NJV 'W,4) X^0YQQGKVR5.T@-C@D9H X;3_'&
MJ3Z)#K%YI=K#:W$QM8$BG>21I_/,0! 3[N 3D9/'3FG7OC/6-.L[N2;0R_DW
MMM;Q3-O@2X29U7<H=<AE)P0>.AS5U/ T!\&GPY-?SLJ3FX@NH@$EAD\TRAAU
M&0QX]N*R?%ND:G;>$DBN-3O=5U"34+(^<EJ,HB3HQ(CC7  &YB3U^F  "'Q%
MKE[?^'_&?A_7=-M8;NVT>2\A:"4RQRQ,C@$;E!#*RXZ>XJ_JOBJ[\.: DZ6D
M#06NE)=@RR_-<$#YHT4<C"C)8@CYA[FM2\\*+J=MK#75YNN]5LA8O.D6T10X
M;Y44DX/SL<DGD^@ JC?^ C?+>(=9N(DO=+73;E4B0[E4,%9=V=OWSD#K[4 7
M+CQ%?W4^HV^AV,5U<:?;Q3/%-)L,KR*66)3T4[0/F/&2..I%;4_%U]%)J$>E
MZ5)=SZ<8UFMA'(S2.R*Y1652JD*Z\D\GCCK3CX+N(=574;#Q!>6<\MO';WQ2
M*-A<A,A6P5PC@$C('3M4D_@Z1-=FU+2M<O--2[2..]MXU1Q-L7:K N"4;;@;
MAZ#OS0!T%S<RQ:9-=06KS2I"TB6^0C.P7(3)X!)XYKC)O'MW;V^M_P"AVES-
MIVE+J:F*9A&X._<F[!R5*'YAP?;%=;JVE0ZOH-YI,DDD4-U;O;EXVPRJRXR#
MZUS4_@&6Z6\-QKMP[WFE#2YB+>-5\L%L$ #@X=OQ]N* +%IXEUB?66TR33K-
M9Y],_M"SVSL0<,%*2';P<LO(SCGKBI=#\4S:W9:++%;Q)/>"1KR$L<VWE_+(
M/<B0JG.,YSVQ3GT8Z5J47B"2XFN#8:8UH;>"V+-(F5<E0"26R@P!2>%-*@BO
M-7UR*TN+7^U9Q*L-PI1D4* 24/W"S;F(Z\C/- &IK>H7&FV4<T$,3[IDCDDF
MD") A/,C9(R!Z#DDBN"UG6Y-?L-"O%L8?MUEXG%FF255F0.,@D;E#<$C!(]\
M5V_B'0CKD-CY=[):3V5VEW%(B!P64$893P1AC]#@]JR%\"".VD1=7N6E_M7^
MUH9)(T(27G(( &Y3DYZ=L8H JMX[N]/@U>'6;"*VO-,G@2>6!FE@6&;[LW0-
M@8;(QU'7!R+W_"6NT>GPQ?9I[F_$\L,UMON(3#&RC> @).=Z<=LGGCFZOAV6
M*2XO(M0*:E=3I+//Y0*.J*56/9G[F">,YR2<YK)?X>P0PVTNF:E+INI6]U-=
M1W-M$NQ3+CS$\HY&PX7CU .<T )'XOUN6?0[1M!CMKO4OM*.ES,R>6T0SD#9
MDJPP0>O.,=ZIR^+M9OK'P_+;Q6MM-<:U)IUY'N9E+1>:#M;&=I,6>F><5T!\
M,2MJ>CW\FJ2S3Z=YK%I8P3.TB[6)Q@  =  ,>]4E\#!+"WMUU25);?57U2*9
M(ER)'+EEP<@C]XV/3CK0!M^(-:A\.Z!=ZK<H72W0'8IP78D*J@]LL0,^]9-W
MXFO]+UC^R[ZSMGGGL9;NT>*5E1VCQOC;()! 92&QSSP*V=:T:TU_0[K2+\.U
MM<Q^6Y4X8=PP/8@@$>XK-_X1F6>1;G4-1^U7L5G)9P3>0%"*^-[%<\N=JY/
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MSZXYKHOB"+S_ (1A7MK>6XABO+>2]@A4L\ELLBF10HY/ Y'<9% $EKXGEO\
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MEIXIEGN(K2WW,+=HB%D1"I#()"&X!Z$CD4 >JI>VLD$<Z7,+12G$<BR JY]
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M)XI6B;;($<,4;T..AID>H64R2O%=V[I"<2LL@(3_ 'N>/QKS76=%:ZO]5O\
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M@#U&*>*=2T,J2 ':2C X/IQ4E4='L#INE0VSLK3<R3NHP'E8EG;\6)/XU>H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHK!\5:W>:';:=)9V\$YNM0M[1Q*Y7:)'"Y& >>?_ -=
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M^R?:FTN:_LKI(FV9CP'1D+$Y&5(.[G/08Y .N>>&*6**26-))21&C, 7(&2
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ML**S]$O+C4=+CO)Q&!.S/#L4C,1)V$Y)Y*X/MG':M"@ HHHH **** "BBB@
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MF_?N'RC&?F].,'!Z5@3>.K:X;0KG2I[2?3[^_>TGE=_F0*DK;A@\ ^5GGL:
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M"ND:MJEU:64E]9Q7#!Y1&NYD#$+N/09K4N]1L;"%9;R]M[>)ONO-*J _0DT
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MK64D,5G.?*V1[F&<+@_,Q()'![5OZ,]OK.A11Q^';VUU:STE[*0W%LT(A)0
MQJQ&'RR@C;D8&21G!] HH YKPE+*OP\TQ#97(GM].CA:WGB:%V=(P"N& (Y!
M&?Z5R/AI;E_$.@3#3=0MX?["GM#"UC)%%:R;HB(LL,X 4_,Q(8C@]J]3JM'J
M%G+?2V,=U"]W"H>2!7!=%/0D=1F@# ^'0EC\ Z-:SVUS;SVMJD$L=Q"T;!U
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M,;0Q5 Q P#R>W-4K/P%I=C-I\D-UJ.W3[B2>UC-Q\L6\,&0#'*_,>O/OCB@
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M""<VCG:"TBF,KYG/*#YLCOQZ:U[X/L-1TZ_M+JXNG?4#&;JYW()) F-B\+M
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MUP+H.8#%(&$H0X;;CK@\'TK*LSIMGJJS:7H$]N\D16XF2R,*A%!8#&!N;/
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M'M5T7]H;F"W\]/.GC,L4>>708R0/09'YCUKA]&TF;4/$VMKJ.FZBVFZII-O
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M$KG<HVM@X7&,G ^?CH:?;1ZCJ?B>*[71[^WMW\/26>^XC$>V4NIVD$Y'0_\
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M3RMK$LI&00W/ .>HH ZRBN3UK4-<;QG::'IM[:VL-SITUQYLEL9'1T>-<_>
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MKN*(1ATN-V-R%L;EV,!S@Y6NGT&76S<:A#JT:^2DBFSE8H)7C(Y$BH2H(8$
MC&1V'- &W17)VNJZOK;WUUIES:PQV&J-9O;SK\KQ1D"4LPY#'DKC Z9SG-9=
M]XPU)?#.L>)[1H_L^EWLL)LF0?O8HI-CY;J'.&8=AP"#UH ] J*YN8+*VDN;
MJ9(8(E+/)(P55 [DFO/]<\3>(K4^,)[6[LXX=#CBN(8VM23(IB\PHQW<>F1[
M=.][5-9N]:/B;3K.=;6/3-/1FS&',LDL3/@YZ(%P.,$DGD8Y .RM;F&]M(;J
MVD62">-9(W7HRL,@CZ@U+7 ^$=3O0_AK15E5;2;PO'=#Y!N21?*0$'TPQX/>
ME\.>*]1\0V^@6;SQVUY?Z;+?3SQQC^!U0*BG(Y+9.<\#WR #O:*X1IM>_P"$
MR\+6VH:C LC65V]U':)F%Y(VC&1NYY#$>W.*=I7B37=2M-+U^. '1[F-Y;J.
M3RP(H\$H8R&+%@0 0PYYQMZ4 =?=:G965S:VUS=113W;^7!&S8:1L$D =^ :
MM5YI<7U]K0\ :W<7">5?ZDLXME08B#6\Q0!NI(7AL]3TQTKL-?OKFUGTZ"WN
M8X1<S,D@5=\[@(Q B7!!.0,EN N3[T ;=%>=P^--4/A31]7OHIX[:4W"7]W9
MV_FF!HY"B,R<_(=K%B,XXZ9S74S:E<?\(0^J6MU:SW(T_P"T)<*A:*1@F[<!
MD?*3[T ;=%>?V/BK6+2?1KC4YX+FUU'1)=0:*&#8T3Q)$QP<G.1(>W4<8Z5;
ML-9\23Q6>IE+;^S;JP>XE>Z>.-(9-@>,HRL28SR#NY &?44 =K56]U.RTWR/
MMMU% ;B58(0[8,DC'"J/4DUQ%OXIUD3ZA;>?'*4T(:E%/+;%5\T%@VU<J3&<
M#&[!]R*JZE-JU[X5\.:EJMY;S_;=3TF>..&#R_)+.A8$[CNR3GH.] 'I=%<7
M<^(-4T_6M;TBYGC:Z>*.;1B(@!(';R\-ZE9"N[_9(-;^N7=SIGARYN(;FU2Y
MBC&)[O*Q[L@9(7GOP!U.!0!JT5P:>)M;"^)((+:XO)--FM3"#"JW#PR!3)A.
M 7"[RH(!/ (SUW_"NLQ:[IDUU!?B\C6=HP6A,4D6 ,I(A PX).>!V/>@#=HK
MS*X\5>*;;1;_ %\W-A);:9J\EI-9K:D&>)9A'D-N.U@""!ST/)S@:-]XJU1]
M#\2:[821+'H=U-"+1TR)DA ,FYNH8_-MQP.,@T =Y17$7'BRXB\206EV\NG6
M]U+;_8));?=!<HZJ70N,[)<E@ 2!P.N:?I/B6\N_$DFDWL[6&H9G*V=S;?)+
M&"?+DA<??&W!89SR?NXH Z&V\1:/>-8K;ZC;R-?AFM55^90N=Q ]!@U9OM3L
MM-$!O;J*#SY5@B\QL%Y&.%4>I)->;0:EJGB$_#^_,]O!J-R;TF40[D0^4PR$
MR.PXY_.GZAJVI:CHBVFK&&2\TSQ396;3PIL68"6)U?;D[3AQD9ZB@#U"JU_?
MVFF6;W=[.D%NA4-(YP 20H_,D#\:Y.37M?U*:_FT6!66PU$VK0R^6(W1"HD+
M,6W*V"2N!CID'.:U/&^JWNB>%KC4+!H5FBDA'[V/>"K2*AQR,'#=>?I0!O-#
M&\J2LBM)'G8Q'*YZX]*?7 ZWKWB*&^\7QV=[9PQ:-817L :U+%\I*Q1CN[^7
MC/Y"NBU.^N9O!%UJ-K*;:Y;3VN$=0&,;>7NXSQ0!HRZG8PZE!ITEU$M[.K/%
M 6^=E7J0/0>M6Z\QMX]0EOOAX$OA]JDTNX87$D6[:##">F1D^Y/N<]*OZ7XO
MU._L-%LY!G4+V6]CDFMT0$BVD*$JKMM!;Y3SG #<>@!W]%97AV75Y=* UR*%
M+Y)'1C$1AU!^5B 3M)7&1D\UJT %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G:UHMIKU@+2[\U565
M)HY(7*/'(C!E92.A!%:-5[N]M[%$:X<KYC[$55+,[8)PJ@$DX!/ Z GM0!@R
M^!-'F@U&)VO2-1DBDNB;EB7:,+M//3[BG/?'IQ5N?PM8W-UJ-S+-<F74;5;2
MY(D W1C=@ 8X/S-R/[Q]JEE\2Z1#;13O>#9(DDBA8V9MJ'#L5 R IX)(P*2X
M\4:';/"DFI0;YH/M,2H=YDBX^90,Y'S#&.N: *-WX&TFZ&G,);ZWN-/@^S0W
M-K=-#*8?^>;,N-R\#K5FY\*:==1R0.9Q:30I!-:B3]W(B= 0<D=>2"">Y-.M
M?%N@7UQ9P6NJ02R7@S;[22).,XSTW8!.T\^U6&U_2TU"*Q>[59Y9#%'E2%>0
M#)0/C:6&#\N<\'B@"'_A'+,W:3R27$J1W1O(X)'RB3'/S#C(^\>,XR<XS4VJ
MZ)::O):33>9'<V<AEMKB%MLD3$8.#T((."""#Z5)J.L:=I @.H7D-M]HD$47
MF-C>WH*SO^$V\-^3YIU:$()O(?<&!C?(&'!&5ZCEL#D4 /N/">EW.G"SD688
MNQ>^<DI64S@Y\S<._;TQP, "H;GP9I=U%J\4KW31ZNJK>+YWWPJA0 >H^4 <
M=>_-7[OQ!I5A=&VN;Q(Y%:-7^4E8RYP@=@,+N/3)&:K7GC#P]I\]S#=:M;QR
M6S*LZY)\HMTW8' ]2>!QG% $%[X*TJ^U1-2>2^BNO*6&=[>Z>+[2B]%E"D!N
M_P"=:%GH5I8ZS>ZI THGO$C252WR;4!" +CC )Z>O-0ZAXLT+2[B>WO-3ACF
M@C$LL?+,J'."0 3C@_@,U8N]=TRRM8[F:Z7R9(O.5HU:3,> 2_R@_*,CYNG(
MH K7?A/1KV/6$GLU8:P%^V'."^U0J_3&!^-3ZEH=IJCZ>TQE3[!.+B 1-M"N
M 5!(QS@$C'3FJUWXQ\.V3HEQJ]JK/$LZ@/NW1L0%88SP<C^?2M.]U"UTZ))+
MJ41B1Q&@P69W/154<D]>!Z4 9\?AFQ6ZBFE:>X6&66:&*=PZ1/)N#D<9Y#L,
M$D '@"H-"\':7X=EW6+WAB7(@MYKIY(K<'J(T)PO\\<=S5Z/7],FLHKN&Z$L
M4LC1((T9G9USN78!NR-K9&,C!S5NVO;:[LDO()5>W==ZR= 5]>: .9U72;^\
M^(FF7\4=U%9P:?/"UU"\8VN[QD AB21A6_A/.*T5\*:9'+I4D(FB.F.\EN$D
M_C<$.S9^\6W-DGU)ZTFE:Y:'1K:YEU9-1$\DJQ3V]N?WNUVR%1<D[0,$^V>]
M:B:A9OIB:D+B/[$\0F$Q.%V$9#<]L4 9MWX5TV[O;VZ/GQ'4(Q'>QQ2;4N5
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M?):/SMPB<[8\D;VP/E7(/)P#@T 2V.CV]C>37OF2SW<T:0O/,06*)N*KP ,
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M4>VLVNG,J(R*ZIM4L S9;^Z,G'4XXH LT5E>)-;7PYX=O=8>VDN4M(S(T<;
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M8\\E5(!/TRP_.@":BJUA/<7-HLMU9M:3%F!A9U<@!B <KQR #[9JS0 4444
M%%(S!5+,< #))[5B:+X@EUIH)HM-E73;JV%S;7F\%64D85EZJQ!##J,=P>*
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M1L>N1P>XK@_"12!/AO>K=3-<W\,T5R[W#-YRB!F ()QPR@_7ZUZO%:V\%O\
M9X;>*.'_ )YH@"_D.*06=J"I%M""IRN(QQ]* /*8]6&GZ6\DMQ%%I4GBR^CO
MYG4O&BEI-GF $?(7V9R<=,\<'0^R$:=;Q:#K=CJBMJ$T\%I=G_1+A=GS01,"
MW"EBR_> ((_AX]'%I;")XA;Q"-QAUV###W'>D>RM)(%@DM87A486-HP5 ]AT
MH \KO]1>?0;75+6V2>R@TC?=:1=7&VY@BWN#-!+T+?*1G^(*O/->L12"6))
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M>&K'4V>2WGO=;LKA@)"F$:= %89[1XR#QG<>]>@E%9"A4%2,%2.,>E,E@BG
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MF"7@D],D+^0KE-46WCTSQIJT<[)=V?B*%H)%F*^6<6P)P#CD;@<]N*]@>-)
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M*;^/O9QSCM5;4?'EUIYUR3^PP]MHMS'%=2&[ )1U1MR+M.2 X.TD=.O:IH_
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MF"-9$MXBTGD$J0P\O)&.,#*GL*]"\%VFG6>BRC2+JYN=/EN9)H7F "X;!(B
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MWFMCI6WX_>YM_#<,D$;M:1WMLU^D:DDVHD'F# Y(QU']W- '4AE9=P((]0:
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MOGP0CI@$-@@\9'49]=RN;\ 16L7@+0A:QPIFQ@,HB4#,GEJ&W8_BR.<\UTE
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M_/'Z$LB,?4J*ZRB@#G-;\*?;UTJ72]0DTN^TH%;6=(Q(HC90K(R'AE(5>_4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M[)$S^5&<_.^T?*.#^1]#4=UXMT6SE=);HE8_)\V2.-G2+S3B/<P&!NR/S!.
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M\+Z?HMPL/E,T+1R/*<@\,@X3C.#R2>@QSLZ9JUOJL4[P+-&UO,T,J3Q-&R.
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M90Q2-QN!P04&.WJ#TKFQXAUK1[Z]T*YU!KM$UJWLH=0N"L;B.6 R[&95QN!
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MV.E 'DEI;:S<?"KQ.MG<V2VIO-1\Z.6(AVB\U_,"R;BH8C."5(&:Z+P_K/\
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M&EF$0M)-M4!HUD\QTV-N4DLO4?=XP>:Z&7PIHD\5]%)8AH[_ &_:D\Q]LNT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY8D@34-?@2W2)I?DB1(RBEF Y.2Q.!Z#WKKTAEFTGR)E$4K0[& ;<%.,=>]
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M(,N5'.3G'8=S5=_!^O1P?;((=/DOK?6KK4(K6XD+13PS;@48[?E<!N#@@$4
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MVLL[*[+&I8J@RQ ]!7F7B*_U?3K7Q=96NI7B6]C+8R6EQYI:2,RN!)$7.2P
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MQ,73"G>"5VGOP*T68*I9B H&23T%>4Z['+#=_$*_LM1O+:6PL;:X@>"<C+I
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M>&]#F,QDT>P<SS">4M;H=\@Z.>.6]^M3WFD:=J)A:\LH)VASY9DC!*9X(![
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MC[>M &I150ZKIRP03M?VHBN/]3(9EVR?[ISS^%/LK^SU*V%S87<%U 20)8)
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MXBM+ZVN)+9MLZ12JYB/HP!X/!ZU%'KFDRQ7$L>J63QVX!F=;A"(L]-QSQ^-
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MR>> 2IP>]74U73I+#[>E_:M9YQ]H$RF/KC[V<=>* +=%0VMW;WULES:7$5Q
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M,CB@"Q152YU33[.=(+J^MH)I,;(Y9E5FR<# )YR>*L2RQPQ-+*ZQQH,L[G
M]2: 'T5FKXAT5BX76+ E(1<.!<I\L1P0YYX4Y'/3FIQJNGMIZ:@+^U-DXRMP
M)E\MA[-G!H MT53;5],2P2_;4;1;-_N7!F7RV^C9P>A_*J=QXHT:VU+3K!]0
MMS/J"E[<"1<,@'WLYZ$X ]2>.] &Q1659ZM$(YWO=2TPJ;QH(&AE '4;8VR>
M9.>0/4<59MM6TZ]M9;JUU"UGMXB5DFBF5D0CJ"0<#'>@"Y156VU.PO9&CM;Z
MVG=?O+%*K$?4 ^X_.GW=[:6$0EO+J&WC)P'FD"#/IDT 3T5S_B+Q59:+I]C.
MMU:EK^XB@MW>4;,.P!DZ\JH.>#Z<C.:MV5[<VND37FN7-@J1%I!<VQ(B:'JK
MG<3M..HR1Z&@#5HKCV\;P37WAN:TGLSI&JQ32332MAH=D7F#)SA>HSGI72KJ
MFGMIZZ@M_:FR<96X$R^6PZ<-G% %NBHK:ZM[VV2YM9XIX)!E)8G#*P]B.#4M
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%5KW4;'381-?WEO:Q$X#SRJBY],DT 6:*J6FJ:?J#.
MME?6URR<L(9E<K]<'BK= !1110 456_M&R.I?V<+J$WWE&;[.'&\("!NV]<9
M(&?>K- !1110 4444 %%5KS4;+3_ "?MEU#;^?*L,0E<+YCL<!5SU))Z"K-
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M$\D;V,G[N$O<$,05X4[TY]_:NN\&0R6^H>*5>UGMXY=7::'S(&C5T,40W+D
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MZ?<S,>=BC@9.W/ R=O.<5LT >6G2KZPT/3D^Q7AA?Q4+Z"WCMW<V]J9BPW*
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M([4U_"EC]ILKNVFNK6\LXWB2ZBD#2.CG+*Y<,'RWS<@G/(Q0!S-GXQUS4Y=
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M$&.#3+IY=2GA-H!"<S!8HUR#[,K=<>O>@#T"^UO3-,=EO;V&#8@>0NV!&I.
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M<]P'7_(K&UG3;R?4?'K)I]PXO](BMK1A$2)9!'*I4'ZNO7C\J .SU#6M-TM
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M:FKB-&\27^N2Z'IGV@6UQ<Z#%JMQ<)&I+,^U0%!! &2Q/'H!BJ-GXMU_4I=
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M :9XIUAI_"][>SP26FMZ;)<R6T4&WR66)9!M;))SD@@^U26'B37IM/T[Q"8
M^D7%B]U=1.8QY?[O>@A*L6;IM(;Z\=* .[JM<W]I9S6L-Q.L<EU)Y4"M_&^T
MM@?@I/X5R%MJ7B:]M;:^1PEA>:>\KRN(@892F]#" 6W+UR'R> ?452T+5]6L
MO#?P^S>+.FJ>5'<&6(%\&V:08;/JG4@DYZT >BT5YO\ \)-XBCMYM0DO;1H;
M7Q$-,>!;;'F1-,L>=VXD$;LCW'.<X%K6_$^MPW&MPV+1Q7]E=V\-E8O%O^UQ
M2;,OU#'EG^Z0!Y?/>@#OJ*;&'$2"1E:0*-S*NT$]R!DX_.G4 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\H, <]#G=[8]ZRM3\&:A?V/BJV6ZM4_MR>.5&(8^2%1$P1_%D1@]NOM7;T4
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MU&#7$W=W9ZEK^LZ?JVLC3=8MM11[%53%RT0"&,0$GYE;!!4 Y);/7->I
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MJ0V<J/%%K-ZJ[7W87SF*\^XP?>NQD@AEB$4D4;QC&$901QTXIRHJ#"*%!).
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M>"U\.PPVFI2ZC:J[^1<R'(9"Q("GN@Z \\ <D8K=I  H    X ':EH ****
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M,L;94-(>0K$@X84 .TOQ/J]Q\9-;\,W%XO\ 9=A9+=)^Z4.21&<,V.@WGT/
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0!I45!:72WEE!=(DL:31K($F0HZ@C.&4\@^H-47\06::WI^E@2O)?P23P2H
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=H[EM_,=N<!\[EZ]B,=L5Z:Z+(C(ZAD8896&01Z&LZ'P[HEL;<P:/81&V4I
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M(I1HGX!'RD_, ?I6[X>T;4M/UK7-1OY+0C4YHI5BM]Q\LK$J$$D#/W?3\NE
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M=6QMY;J!)2N00=R@Y&">.>^#QTK;K$\(Z3>Z%X7L-)OI;>62SA6!7@# ,J@
M$Y[G&?\ .:VZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *RO$&N1^']/CO)K::>-[B*W/E;?E,CA
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M;-=FWA*AO+5@O&X@%B3P.^#R*H_\)=-<*LNF:#?W\!FDMR\31J4D0X<,&88
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M-K=O_P )%I%Y:ZF563Q#<6T[7%S^]9 DH*,G 6-650H.3]T\$\])\4[*]O?
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M]6:R?#VO1^(+"6X2WD@>&=[>5'Y&Y3U5APRD$$,.H-3ZU?MINDS7$:JTYQ'
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MQMA;*<K"(5V ^H7&*Y^'QS:7%]8Q6]OY]M?2/#!-%*K,& ."Z#E%;!PW/49
MS4.@>+=2U#P[:W]SI9,]W>3P)Y3YCC5))1ND;;\JJL>-V.3CCF@#HX=*M(-3
MEU!(D6>2-8LJ@7"#MP,GH.OH,8J>ZL[6^B$5W;0W$8.[9*@<9]<&N67Q_#+I
M>E7EOI=S.=1O9+!$CD3"S)Y@(W$\@^6V#TQR<4J>([.WUZZN-4TVZTZ[MM%6
M\N6EG#HD09LJ%5BI8$-SC)^E '426-I*8C):P.8O]66C!V?3TI@TVP$$L LK
M813?ZR,1+M?ZC'/XUS;^/K2V>]%W:NJ6UBU\)()5F0H#@HS#A7&1QR,<Y.#6
M]I6I2:E'([0(L8VF.:&82Q3*1G<C #([=.U %R&"*VA2&")(HD&%2-0JJ/0
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M',$C!!BV1A,9/7(&>U3>(?$]MH6B:KJ*1&\;35#3P1. 5R <$GIP0?QK;!R
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MT97N8F#!(I5'#!<J<Y))08QFM_3[R]NK69[O36M+B*1HQ&90ZR =&5A_"?<
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MDUU(\,HP8U4X.R(@G,:G(')QR.U=!)&DL;1R(KHPP589!'TI5540(BA548
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MEX?]$7>47.,Y+8!&,_2LFQN;&ZO;VRMY[26UO?"Q<6T,GF"212>7/227!Y.
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M&0$#'M0!SW@![Y_!]M]NEDF*RS+!+*27D@$C")B3UR@4Y[C!KIJ** "BBB@
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M=]C'S.3F0C=Z <4Z]\"W-V=7E76!!=7>HQ:E:316_-M+&BH,@L0X(7D<=30
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MT<K;Y=CABLASF0$ @[L]<UR'A[7IO#ZZBK:>\UA+XFFLVN#/\T1DE")A3DL
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M^8AL\0>6R#!W*>3N ^4[N,Y/I7/2^!M2DNVD&MP[%UD:K&7LRTF>?W;-O^8
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M09P:U;+P,UG+X?4:B);72;2>U:*2$EI5EVYPV_Y0 H &#QWJK9>!M5M+30K
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M3;U;S:]N9#(0K+MR'&!ACZU-XJT.7Q'X<N=)BNDM6G*9E:(R !6#?=W#T]:
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M [31M;LM=T2SU:SD/V:[B$L?F?*P![$>H/%7]Z;]FY=^,[<\XKSJX\->'O\
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M\$=V;*%I3$9=@8*.1N //X5Q]Y/J&J^ KWQ*FFSP:A/%;QO;Q1CSA;QR+YZ
M'.2?WV/4;>*SM470;GP/XPU/0+Z[NDO=-\N7,2QPF0*0H50B_O,'!QD] >U
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M#)[UHT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(7.&"NZD+L^4D\$\@'IQ4*>+]9D;7)DT."2TT>>>&;R[IFEDV0K(NQ=G))8
M^F>,XH Z^W@AM+:."%0D48"JN>WX]:DW#.,C/I7((+/X@Z*R22V-S9)+%-;W
M5I*QPXR3QD%'7WSU!([5-?\ AFWL;#Q!?6!\B\N\W<;H3^[G125DY)^8GKC
M(XQC.0#JJRM.T9K*_N;VYU&ZOII2PB\_8!;QEMVQ JCC..3DG:.>*CTC7'U7
MP;9Z[#:M++<6*W(MT(!9BF[8">.O'-82^.;E?[6C:RM9I['2EU)?)N#L;[X:
M,MM/*E"-PR#GM0!VU(6564%@"QPH)Z]^*X^S\:7*7MN-7L8+6TN=)?5(Y8IC
M(R+'L+AQM&.'!&">AK,N+NZU3QGX#U2>SMX8[H7,D6U]TB*ULS!6.,'@@G'
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MPL'N[:=)+QB93$.@'EXVL,@Y_+U9INN:C-KGA:RLK:TMM,N]$-V;96(V8\D
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M*PY!8+C/N:I?$&WM_"GAE/$&B6L-G>Z?<P;1;H$\Z-I%1HF ^\I#=#W (YH
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M7NMFZ#"ZMH[9H/*X"H6(.<]<NV>/2LW0_!USH:_8XM?O)-(BW?9+)HU!@SG
M,@^9E7/ /3 ZXKI/MMKAC]IA^4X;]X.#[TZ2ZMX98XI9XDDD.(T9P"_T'>@#
MS_Q?X5>#PSK^I22?;=5FT>2P4V]KL>XSR"X4G>^0,$8QSQS6ZOA>#6H4N-8G
M^V!M.>RC58C$%CE \PD9)WG:HSQC' '-=&]S;QSQP23Q)+)]R-G 9OH.])]K
MMMF_[1%MW;<[QC=Z?6@#F+;P5-+H=SHVMZ[=ZK926[6L2O&D;1H1C)91\[C
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M#6MZ+)J?[O5KB6XDE$&#&9&W,%&[IZ9_6MS3]3FEMKJ74K9+!K>8QMNE#(0
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MME/V5T\B3;%Y:.=N 5.[KT_'GU.B@#RG1%TC5-,@FF374U33]+GMKR$6WDM
MICQ(I81@.2P!7ECGGUJMJ45Y+X,\6:?=+::LJZ5&MKJ5M;[&G(WA(G3D>:IY
M^7LPR!7K]% 'E_BF^M(-=N%N)T:#4= %K^_@E:./<SX92B,#GG<IV_=7GT6P
MTS0#XG\+);I:7FG0Z'/$UP85\N1@\6"_& Q*R'!YSN[UV=UX<:76)M2M-:U.
MPEG5%FC@,3(^W@<2(VW@G[N*UK2UBLK98(0=BDG+')8DDDD]R223]: /*= F
MC@T7PG:7%G.C+#>Q)<-!))Y/SX$0C QO9,8+ @*IP#FE\-((X?AQ<7=E<8@L
MKFUE9[5R4DVQ[%/RY'W6P>G!KU1;VT:YDMEN83/&NYXA(-RCU(Z@4VVU&QO&
M"VMY;SD@D"*56X!P3P>Q(% 'EL4<UM87,EO;.=-@\7O<7D,41YMCT<*!\R!]
MK< _=SVI/%6GBYL/&=W:1>;I=V+)K=8TW++<JW[QXP.IV[,LO4@^AKURB@#B
M]%M[2S^)FK+80Q0VLVEVI_<H%C>0/+GIP6"E??!%)>O';?$*].N1JVEW6EI%
M:22INB#!G\V,]@S H<?Q!0.<5VM% 'D>DZ"IO? UEK]DMPZV-]%,EU%OQ&S(
M84DR.H7@!NX/<5V?CN.YB\(DV%I)/%;W%O)/:P+EI;=)%,B*HZY0'CN,BNIH
MH \UUF6QOK1=;T"PN9+&35+.;57$$BBXA3(.(V )"?NRV!R!WP<9WBZP%Y8^
M-[RPB$VEW>GV_EB--RS7@+9:,#J0OE@D=_<''K=,::))4B:1%D?.Q"P!;'7
M[T >?2Z9HK?$*YS8VC64FA MF(&-Y!(QR>,%]K'WP?0UC:);6LD'@*77;57L
MXM$GMYC=Q;HTF_<[4?<,!L*V ?2O7:* /)X-);3-.\+H]LT4,?B:6:SC=#OM
M[-O.V YY5>4X/3*@\U4N]/LH]"\1W$-E&MY'XGBEMG2'YPGG0$LG&=N!(<CC
MAO>O8(IHIU+12)(%8J2C X(ZCZT^@#R77KI)=5N6BL[F![?Q+93RJEM)*TJ
MQ*9]^" A7@*N.AZY(J35+6 :1\3+.2P;[1/OFMU-L?G#6L83:<8)+@X YR#Z
M5ZG'-%*TBQR(YC;:X5@=IQG!]#@C\Z%FB:9X5D0RH 70,-R@YP2.V<'\J .
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M3[3K,7D7=RB*#Y>PH%0=  "V,YY8FMBVLQ#IL=E,_GHL0B8LH&]<8Y ]J .
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MR-I [I*@C4&(L!^[8.&;YBH&[.16U\3(D_X5EJ2RQ[_+CB.#\Y!#KT/4GWH
MZNVO[.\>9;6[@G:!MDHBD#&-O1L=#[&HX]7TR:&>:+4;1XH/]<ZSJ5C_ -XY
MX_&O.M=T&:\U/6;WPK9>3&^A&VD6*+R5N)?,#*@! RP0.I/;> :AUB'3]?\
M"WB'4K#2M:?4)M'>T9;RUD1@_5(A'M&]@2?F4''KS0!Z4VL:8L;R-J-F$20Q
M,QG7"N!DJ3G@XYQ3Y]3L+6**6XOK:&.49C>255#_ $)//45Q6LZ;';Q:1<Z)
M(VD7PMY7206!>"7*QAHYU R"VU<'AOD.,]*@T22YM=:>?Q!I$EO9ZAHEK%!
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MTTMJ5^4P1J61B.F=XR/?UJAXZ\V;4-5LXM-N_,N-!ECCNH+9YC<,2_[C."B
M<$DC)W#!&.0#N;K5-/L=WVN^M;?:H9O.F5, G )R>F>*+C5-/M4WW%];0KY?
MF[I)E4;,@;N3TR1S[BO-[%=*E\96+:MI^]9/#$(=+BS9FW"1E.Y2N=Q&0,C)
MZ52\/Z3;Z-KGA6SUVS5F31+L%)H?,,:^?&8U?@_=0A>>_'>@#UB2_LXK1;N2
M[@2V8 K,T@"$'IALXYJM>WS"UM)[&ZL-DT\2^9/)\CHS#(0CJQ'W>Q->=Z!I
MFH>'+KPY<75K<+HD<NH".+RV8V8EDW0%U RHV KT^7?@XS1<:1<VVDK(+*X:
MWD\6Q7MG$MNS-#;^:A9MH&44D.W;AO>@#TF35M-AE$4NH6B2&01!&F4'>>0N
M,_>]NM00>(-+N->N=%BO(FO[9$>2(.,C=NP/J I)'8$>M>;:_I?FZ?\ $1H=
M)G:>>Y@:T*6;EI,119,>%Y^=6Y'<9KKM,WP_$O6I'MKD17UC9M!-Y#>6VSS=
MP+8P"-R\$@\B@#I;O4;*PV?;+RWMM_W?.E5-WTR>>HI]W=06-E/>7,BQV\$;
M2R2'HJJ,D_D*X/QR99M3U&SBTZ[WW&A31QW4%L\QG8EOW&<%4[$DC)W#!&*V
M?[,D\0_"_P#LO][;S7FE?9\SHR,CF/;\P(R.: )=-UC6M9T:/6;.PM4MYX_-
MM;2>1A+*A&5+.!A"1@XPV,\GT@LO%S_V]/9:L+33[:/3K:\#RR;2'E9U*,6P
M!@ITIGA77EM_#MAINH65[:ZI9VZ6\UJ;9SED4+E& VLIQD,#C!Y(K(UBS^V>
M+/$<USIDL@?P['#&3;-(IDS,616VX)^9>GK0!WEUJ5C8[/M=[;V_F?<\V54W
M?3)YZC\ZAENY8]9C@,]DMK]F>1T=R)]P9<,!TV $Y/J17F%_]JF\-?8#I5^E
MW+X16$3K9R2//)L8& Y!6/:W)R QW#!&.=:.,3>)=*NI-/NO*;PS-#,\EF_+
MEHB$;*_>PK8!YH [^VU"RO69;2\MYV159A%*K$!AE2<'H1T]:)=0LH+J.UFO
M+>.XDQLB>50[9] 3D]*YSX<Z;!8>!M&/V 6M[]ABCN=\'EREE'(;(!."6Z^M
M<YJ%G=RZ+XWT2]L[B74[Z[DFT]UB8B8,JB JX&!L*@'D;=N>E '4:OXG>/Q
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M6MYXU\.ZC9:7?P6T.D74$H;3Y4\DYA*QG*]MK =O3K0!Z&[K&C.[!549+$X
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MXV+(4$UPI?+@$#.$*+G\.W&5J5A8GQKXD?6-)>ZM[S3+>.V_T1I1*5\W>B$
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MOEP<-YLZAR ",9+$GJ3D^N:PKV]U71O$WC;4=/%BTUGIMG<S^=&VV78DS$*
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M<EF8\DDDDU:KA!K>N6NM^,Y5*WT>FB 6]I%;L6PT8?@!N2-Q)&,MCC' K?\
M"^NQ^(+&>[AOK.\@$VR.2W1HR!M7*R(Q)5PQ/![8H W**X:X\;WD?AN7Q3##
M;OI$-ZT#P%6\XQ+-Y)D#9QG(+;=O3C.:OZ;K.O:CXKU6P5-.2QTR[2*5B',D
MB/"L@V\X# L.O!&>G< ZJBN=OM9U&XUJ_P!(T86HN[*R2Y8W2LRR/(7"(,,,
M#]V<MSC(XJLFOZQJ-YJ=A806<%]IEK ]Q'.&D5YY$+^6""N%  &[G.[IQR ;
M$^AP7.MQ:I-<WCF) $M3.?(##.'\OH6YZ_3N :MW5_9V(4WEW!;ASA3-($W'
MVR:Y[2_B!H5_I^DSS7(M;C4H(YHK=U8D;SC&0,?>!'X5G_#R0ZM+XAUJ] DO
MWU:>TR_)AAB(5(AZ =?<L30!V+7]FDL,37< DF;;$AD&9#C.%'<XYX[4^XNK
M>SB$MS/%#&65 \CA1N8X R>Y) 'UKA?$>D0Z3KGA9=)@@A>;69I55AA$9K:7
M=P.V1NQW/<=BX\5ZBWAFXGN[/3I[FRUR/39P8V\IQYZ*)%4DD'YU/)."* ._
MJK=ZE8V!C%Y>V]L96VQB:54WGI@9/)Y%<Q>^)];FGU Z%IBWBZ?>+:O 5PTV
M ADPY<!" YP"ISM]^(+2UFU+XD>)+34&M+JP^PV:M;RVQ8%"TY"\L1D'DG!S
MQP* .OGU&RMI/+GO+>)^NV255/Y$U);W5O=(7MYXIE!P6C<, ?3BN(\5AA\3
M?![1VBW+_9[\>6S!<C;'W-:<\FL6?AW4]1TO2+.UU02/(;6;E9E3@'<I W%0
M,'IT!]: .IHKCH/&;S>$7\2(D4EI<S10V,07#Y=UB'F?,0#O8\#& .>> V;Q
M/KFF-<1ZCIL866YMK;3[G;Y:R/,^PATWL1L/.<_,..#0!V=%<CK.M^(="L;B
MXNH=/DC2_M8()45AYT<KHC97<=C*6/.2#CH*R_%WB;5X-*\;VUI+!;R:59Q2
MV\ZQDMB16)'WOO#;P?TH [UKJW2Z2U:>(7$BETB+C>RC ) ZD#(Y]Q4M<O-J
M%_#XSTW2I4L)))].N)ENQ P=&1XQ@#<<*=XR,\[>HJ+0/$NHZO:6D,J6L6J+
M>SVU_"L;%8A$3N(^;/.8\'_IH#B@#K:9++'!$TLLBQQJ,L[G  ]S7(Z3XGUO
M6)=*OK33%ET>^=MYVA7@CYV2;B^&Z#*A01GOCF#697O_ (L:%H]USI\5A-?I
M$WW99PP49'?:"2/0G- '8VMY:WT7FVES#<1@XWQ.'&?3(ICZE8QWR6+WMNMV
MX)2 RJ)& &>%SD\5R'B1Y-,^)'A2?3\)+J1N+2[11Q-&L>]2P[[",@^Y'>L"
M2&^G\">.;RXGLY9[2\U&6*1K4EXW2,KN0E_E.W@>GO0!Z3!K>DW-T+6#5+*6
MX+%1%'<*SD@9(P#G..?I5^N&MI&TW7/"4<EEIDLVH6[Q27BVVR9%CA+*JG)X
MY(Z]SP,U?TC7]6U:RTW6X8;,Z-=K))(IW"6", E&SG#$X&5P,;NIQR =517'
M:3XB\0:M)I5W!I<;:7J-N93(5VFURFZ,EMY\P'H<*,'FLZP\9>()/!]IXEO;
M6R%E<K&6%K!+*]L"Q#R,H.64 #@<C)/.* /0J*S/#^I?VOHL-\+JTNUE9]D]
MIGRW4,0I ))!QC(SP<BM.@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH> %P JAB!CKGJ36W=>$-.U2VU%=2>:[DU&*.&65\(R(A+($V@;=K$MZY/T
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M?SK&][.((@3@9P223V  - %.7PC;2BPF:_O3J5C*TT>H%E,K,R[7##;M*LH
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M&KF/:T1*GYL(#GY%Y!'2GQ^&(/[3M+VXO+FZ:RGFGMEFV?NFD#!@"%!*@,0
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MVT@X!!4 \'&>U=50!S.D^"K/1[EQ;W]^VG&1Y8],DD4V\3,23M&W=C))"DD
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MM1MRPE;<1G()Z# H SD\%VL&MW.H6^I:C!;W<OGW5A'*OD32<98C;N&<#(!
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M3[AKE&#(?-D*%"7RI_A8C P!VQ@52D\#6<NGWEFVHZAY=WJ*ZE(P,6X2AE<
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MJFJ:GJ)EV;;JXE430[#N0H54 $$ YP23USTK676[&!TM+^^LX-16W\^:W\X
MHH'S-@G.T>M2W&M:9:V<=W/?6Z6\B[TD+C#+C)(]1CG- &3-X.AO-!N--OM5
MU&[EF:-S>RNGFHT;!XRN%"C:PS]WGG.<U%)X%LKF/6UO-1U"Y.LVR6UVTC(,
MA00&7" *?F/3CVK:N=;TNTM8[J?4+9()4\R.0R#:R 9+ ]U (.>G-*-9TPRO
M$-0M3)'"+AU$JY$1Z/U^[[]* *4?AJ-=9L-5EU&^GNK*VDME,ACQ(KE2Q8!!
MSE5Z8 QTJQ9Z#8V.NZAJ\",+J_$8FR?ER@QD#L2 N?7:/2JTOBW1DU33+!;Z
M&2348FFMW1P49!C!#=#DL,>M%GX@L([=YKW7=,ECEO7@MY(G"+G/RQ9+'<XZ
M''4]A0!6TCP7:Z+>L]KJ6H_8/-::+37E4V\3L225&W=C))"EB ><=,:6K:%:
MZM-9W+O+!>V3E[:ZA(#QDC##D$%2."""#]0#5F34K&*2>.2[@1[= \RM( 8U
M/0MZ X/Y46.I66IQR/9744ZQN8Y/+;)1A_"P['IP: *=MH,4>K#5;NYFO+Y(
MC%#),% A0X+!%4 #.!DG). ,XXJBO@RU70]9TDZC?M!J\DTEPQ,6X&7[X4[,
M '/<'%*=>NM1\4WNA:3Y"'3HHWO;F="X5Y 2D:J&7)VC<3GC@8.>([/Q5]GU
MG4]&UHP0W=C;K=K-'E8YX&)&\ DE2&!4@D]L'G@ MMX8@>\T6Z>^O&DT@,(<
MF/$FY-AW_)S\OIBJVC>"[30[AA;:A?MIXD:6'39)%,$+,23M&W<1DG"DD#.<
M9QCGD\>W?]BZ7K;7NE_9=5,$*6Y!#VLLDB DG=AE5')/0Y Z \=)H=_?2:I=
MV]]K6D7BQQ"2.*T0K*J$DJ\GS$#(P.!CC/M0!%HG@JWT%]EIJNIM91EC:V<L
MJM%:EL_<^7)QDX#$@>E6-.\*QZ5H&GZ19:G?QQV#[X9B8RY&"-K?)@K\Q[9]
MZT+76]+O6E6VU"VE:%!)(%D'RH<X;_=.#STX-0GQ-H:V]S<-J]DD-KCSW>95
M$>>A.>F>WKVH DT;1K71+22WM=Q$L\EQ(S #=([;F.  !] *T:J6.IV&J+,U
MA>07*PRF&4PN&".,94XZ$9''O5N@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N;\8-=(FDO;Z?)=(
MM^K2RPPB66U78X\Q%/?)"YP<!B<5TE% 'E%KIFH)9:?;SZ1J \CQ;+>-YL._
M]R6E(<E<Y^^O/J>,X.);W3]72;5[NUTV[EAA\3P:DUN(BK7-NL4:L4!P&(==
MV.^SZ5Z1)J5E%J,.GR74*WDZL\<!<;V5>I ZX'K5J@#@K'49].\0^+-?;0]5
M>TF@LWB"6VV2;:K*V%8@Y&X9SC@&NVBNHYK%+M YB>,2 ;"6((STZY]JAO[O
M34D@L+Z> />,8XH)&&9B!D@#OP.:?9:E9:CY_P!BNH;C[/*89?*<,$< $J<=
MP"/SH \W\.:7>VUK\.X[K3+M&TZ.X6Z#6[?N&,95<\=SBNI\"6\]KI>I1SVT
MUN6U:\FC66,IF-YF9" >Q!!KJ:* ."@LM2M/&$=QI@O1:3ZC*U[8WD!:*/Y7
M'VB&4CY=W'RY.=YX%8^F6>J0:=X4TU]&U#S=+UR5[E_)P@0BXPP8G#*=ZG(X
M_'BO1EUK3&U-=-6^A-XP8K#NY;;]X#U([@<CO5^@#@/"Z7=M%#H.K^';F:\L
M+^:X2_DB#0,&D=Q,K_WRKD8 W9/89(R[;3;V/0=,3^S+Q9D\5/>R#[,^X0F>
M1O,/'38P_E7J=% '->.;74;C0(I=-MVNIK.]M[MK52 9TCD5F09XS@9'N!61
MJMS+>6"ZI8^%;F)I[^V:>2:T7[4 N09A'R24&T+G/<X('/>44 >76FD73V6I
M075KKEC*?$#W=K?0QAY8MT/RR[5W;U/*L,8^?\G(OB"QN](U76-*O;Z'R+JT
MG_LM7BE5FF#).8E8$"15!8=CUQTKT>TO[2_$QM+B.802M!+L.=DB_>4^XIMO
MJ5E=W=U:6UU#-<6I43QHX)B)R0&]#QTH P]&NK30ET?0(-%O;&"X21H!C?'#
M@L_EN^XX<C)QR.",]*B\8VTMSJ7A9H[2:X2VU9;B8QPEQ&@BD7<<#CYF7^?:
MNG,,33K.44RJI56(Y /7'IV_*I* /.=3T]X?$NMV.I>'M3U/2M66(VQLI&$0
M"QJC12 .H097<">/F-7)M.O9O&&LQV\$]NL^@164%SY;^6LRM,<!R.V]3G^M
M=U10!YOHMN+K3H&N_"^K6NJZ;826SRW+N\:DIM*P_,0X8@8P, #L<9C&FZA8
M^!?!ES#I-Y*^E"'^T+& &*X($#QL5P06*LY.,\\UZ957^TK+^T_[,%U";[RC
M-]G#C>$! W$=ADB@#@KO2XI%T.XL- O[:*3Q M_<).CR2$>4RM+("6VG<5&.
MO&<=<5;BQU>"35+^UTN[G2W\4)J1MA$5:YM_(1"4!P&(;+ =RON*]1HH \]U
MN.ZGM[#7M-\.7J00ZE]JN[2,>3=7"F%HC+M4@[AN& 3DA:;/H]O/9P7.GV.M
MZ'-->27<5Y&CS3)*4"EYHCN^5^05/H#QGCT2B@#(\,MJ'_"-6)U6WC@OO+_>
MQQ)M7.3@A>V1@X[$XK@[73;W['HD<FEWG[GQ7<WLBM;/\D+&<JYXZ?O$_/V-
M>@MXAT57=&U:Q#(2K9G7@CJ.O4>E6+34K*_EN8[2ZAG>VD\J81N&\M\9VG'0
MX(XH P/!UO/;WOB?SK:>%9]7>XA,D10.ACC&X9'/S*W^361JUG?QZOXW5=.N
MY4U+2HDMI(H]RNRQRJ5R.^YE&/?/3)KT"J\=_:37\]C'<1M=6ZH\L0/S(K9V
MDCWVG\J //3I%_<76BPVMK<VS#PQ<6+3&!D6&9Q%L#'''*,?P]Q2:;9PZGHQ
M&H^$=82_LM,FM9Q/,^U@T>UHH#O(;?@8(&!Z@X!]+HH \LN=-\2KIUVD/VW6
M+.RFLKFW>XB-M>3QH[,\!/REBHPRM@9)QR:[#PM#:22W^IVVCW^GM>&/S6U!
MF\Z9D! )5F8@ 8 /&>>P!.IJ&M:9I147]]#;;B.9&P!DX!/H">,GC-7F944L
MQ"J!DDG  H X'5+&&?XI27VH:1<W6G#1EMA+]B>5?-\YF(&%/\)Z]/>H?#OA
M&YNO#GB31KN&>PT:[N6.DV\K9EM5P"'')VCS!N52<C%=Y8:A9ZI9I>6%S%<V
MSE@DL3;E;!*G![\@BH=7T:TUNU2VO#/Y:2"4>1</"21G@E""1R>.E '&I#JV
MK?#'6K^_M_,U?4]->!8K<%]P$;(@7'4,Q9QZ>9[5F^(K35+W2M2L8=%O0T_A
MQ8898+<;IY KYBD9N5"D@A>"=QZ\"O1KK4-,T2UB^V7EI86XQ''YTJQ+QP%&
M2!^%.L]4T_4&=;*_M;EH\;Q#,KE<],X/% '(:GI&HW-]HFH6-K(AO;)M+U%)
M0 T<++N$A'JI5@ >\F*BT?0KVV\*:M8:S9S7<5E:S:9:11M^\N+49(*GLS*8
MU^L>:[^B@#D_!\&K6UYJ$%[<W%]8(D(L[V\MS#<L/FW1OD#?MX(; SN/7!K-
MU[2=4N_$WB2&S@G3^U-!2UMKM1^[253-D,W\)^=?S]J[ZJJZE9/J;Z:MU"UZ
MD8E> ."ZH3@,1V&: ..L[.[U?4O!URNGW-A)I$<GVP31% @,/E^4I/#@M@Y7
M(PF?2M+QI;W4DGAZZMK2>Y6SU:.>98%W,J>7(N<?5EKJ:* /+-8TV^N-'\=K
M%I=XT]]J$$ELHMVW2JJ0C(..Q1_R]Q5N^LI'U[7M/U7P_JFJ6.KRQSVLEO(Z
MPD>4B&.4!@(]K)G)'0^HQ7I%5[W4++3;8W-_=P6L"G!EGD"*/Q)Q0!C>-/#K
M^*/!.IZ''((Y;F$+&S$X#J0RY/7&5&:-*\07-S80Q76CZA!JH0++;O;L(PX'
M.)L>65SSD'..V>*U;'5M-U0.=/U"UNPF-_V>99-N>F<$XJY0!YGKVF7EROQ%
M5--N9)-0LHHK0K;L?.80E2%..<,1_.JWBVVU;4K'7[2WT2^W3V%L8'M[< W9
M7EO,8\Y0Y 3@\D\YX]5JO)?VD-_!8R7$:W5PKO%$3\SJN-Q ]MP_.@#B-6@N
M[GQ/KUTFG7GE7/AM;:,^0QW2[I3LXR,X=?S]C72^$K;[+X2TB)K9K>:.RACE
MC>/8RLJ $$>QS6A<ZE96=S;6US=0Q3W3E((W<!I& R0H[\"K5 'FM[I6HMHO
MC70+BPN+BYU6YFFL)UC+12"15$>YQPAC*@'=CA1C-;5M:W5O\1[:26*YEACT
M06KW9A;8TOFJV-V,9(!/I7844 <OXUM[J5=!N;:TFN5L]7AN)D@7<PC"NI..
M^"PKE-<TV^NM,^((BTN\,^H7$#6H%NV90L42\''9E;^?>O4Z* /.-0LY&\0Z
M[9ZIX?U75-.UDQ2VKVSNL6/*1#%*-R[,%,Y(_B/<8KM=75D\.7D:1N[_ &5T
M5(U+L25(  ZFM*B@#QQO#<TGP]T"TT?0[NU\6V<=N([K[.8!;R#:)&=V #+C
M<"/FSGI717-C?V\WC73[W3[B\&L+OLI8XBZ2!H!'Y3$<)M9?XB!ALYZUZ#5>
M\OK33X1->W4-O$6"AY7"@D]!SW]J /*_$.CZV/#^K:)_9EW/<#1+6!+JTB#?
M;I$4[O,<\_*>B\$Y/7.!U-A;37/C_6KU["X@2XTVU2"::W. Z-*S#/3(W(>O
M;VK?E\2Z'!:374NKV2P0 -*YG7" ],\\5I/(D4;2.P5%!9F)X '>@#RO3X-5
M70?!VE7&AZB+_1]4C^V/Y.4("2@RK)T8,6!R#WY]_1-)UE-6:^1;2[MGL[EK
M=UN8]A8@ AUY.5(((-7+2[M[^SAO+29)K>=!)%(AR'4C((J*:>RTJ!I96C@1
MW))[NQY^K' ^O'M0!PVM66H+>>/HDTV[E&J::BVDD4>Y9&$#Q[<CON(&/?/3
MFH;G2-0O-0M(;.UN+8R>%+C3UF,+(L4[&/8I..,;6^GXUW1UW2%TJ/56U2S3
M3Y "ET\ZK&P/^T3BEMM=TB\N5MK75;&>=P2L45PC,0.N #F@#EO"4:7MY975
MSX;U2PU.RMC;RS7LKE$SC*19<AU) .0,8'K@5)XVLYKW7O"FRTNYH+:_::X>
M"-SY:&)U!++TY(Z<UVE% '$^+=!MK7P_9VFE:465M7M;J>."$N7"S*TCOU).
MT')/)Z57UVWELO%\\]SHNIZCH^I6$=N!IQ8&*16D+*Z*R_*PDSN/<<UWU% '
MFVH:/?Z?/%)X?M;RSNX;>U@.GO&;BSNXEZ(SD?(R9(W[AT'7M#KNE:O=7'C-
M[&PN)#+=V%Q%&4*"[CA$?F(I/!SM(]_H:]'OK^TTVU-S>W$<$ 94,DAP,LP5
M1^)('XU8H \PUNTU3Q)K&N3Z9I=] +SP\EO$]U"8 TJRR,8VS@@D';^/IS2Z
MG;#7?"^O7EMX8UFUU2?2);$F],CR,S<K$@+-N4-D[L =/4X].HH X&6PN9_%
M :WL;A87\-/9JY@9$$I8%4)(P#C-=!X*$\?@K1K>YM+BUGMK.&"2.=-K!D15
M/'ID'ZX]*O#7=)-V+4:G9F<OY8C\Y<E_[O7[WMUJQ>W]KIT'G7<ZQ)G )ZDX
M)P!U/ )X[ T >;QZ+JL_@I?"T]I<KJ\&K"9;WRSY97[5YWGB3IG83QG=GC'-
M=)X4LWB\0>*9Y[*6(SZD)H)982N]/)C3*DCU#C\?>M.?Q;X>MK:&YFUFS2WF
M4/'*91L(()'S=.0#CUP<5JP3Q75O%<02+)#*@='4Y#*1D$?A0!S.O072>./#
M6HQV=Q<6T,=W#*T*;O+9Q'M+>@^4\URUOIMZFA:>G]F7BS)XK>^<?9GW"$SN
MWF'CIL8>_:O4Z* /-]%TZ47JZ-K/A_4[B[M-4>\@O3,_V1@96D6;._ 8!B-N
M,D^Q.-[Q[H=[K&DV%QIL:RWVE:A#J,,#,%$QC)RF3P"03@^N*ZJB@#)L]<&H
M"-;?3M0CE)'F)=6KPB(=\LPPQ_W2V3[<C@CIUZ-%N NF7@F;Q<+\ 6S[C#]I
M#^9TZ; ??M7J=(2%!)( '))H \UUC2]6NKSQE+86%P[R76GW,"$-$+I8-AD1
M7XY.PC_ZU3WMK%J7A'Q3>:?X>U:UO=1TUK;%X)&GG?8X5=A9B -V-W Y]!7=
MV&HV>J6OVFPNHKF#<R"2)@RDJ2" 1Z$$59H I:2Q.C699)$98$#(Z%6!  ((
M/-<!HFEZ>)/%!UO0+N1KO5YKBWD.G.[M$53:RL%XY4XSBO3** //_%UA?>(;
M>UN[739(-1TV#[8%EC<B8,/FM"5X8,!ANH!V]><&JW5X=?TS79=#UF?3;G3S
M;2V]KO6>TEWAOF16!*D<$C(^4=J] HH \X@LYO#&N6SIX:O9="NM*6R2UMA]
MH:T82.VQP6Z,KC)R0"N,X -6IK6ZTOQ9;W$>B7"VLVA"RBBLXPZ02*Y81DCA
M1M( )P.#7>T4 >:>'K#4[$?#Z:?2KU19Z7/9W*^6-T,C+#C<,\ [&Y/I5FR\
M.W.K>$_$VGM#-:74VK7-Y8R2QE"K^9YD,@R.FX _G7H5% ' ZI9:Y?>"H=4;
M3Y&U62[M]0NM/CD*.41E_=*V1A@J@]?O ^M;?A:&TDEO]4MM'O\ 3WO#'YK:
M@S^=,R @$JS,0 , 'C//8 GHZJV.I66I+,UC=0W*PRF&1HG#!7&,J2.XR* .
M7M=/N/#?CS7-4>WGGTW6D@D\R")I&@FC4H595!;##!! (!!!QQ4<.F7-YXNU
M?Q9-;3PP#2QIUG"T9\V50Q=G*=1EB  >>"2!7;44 >:+97R?#?P99'3KW[59
M7>GFYA%NY:,1,ID)&.@ /U[9J;Q/H^IZQK_B2/3X)T-YX=2T@G:-D1Y0\K%-
MQ'&0ZC\?8UZ+10!Y]J0O?%?AG4)++PS<:?JWV$0EKR,0NY5U?R$;.2APPSP.
M1[XH:U9C7?"/B"[LO#.LVVIW.FFS/VXR-+(V<K&JEFR 23NX'/!/./4** (+
M-8A:QM##Y2LH.TQ[". .1V. !^%3T44 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5A>*M5O-'TZ"Z
MMK:XF@\\+=O;1>;+##M;+JG\6&"@\' ).#BMVJ>H:<M_]G;[1<6\EO+YL;P,
M <[2O((((PQX(_E0!P<U]/K?B+P9>6&IVD[SP:CY=ZD)*%?W8!V9!W8 !!/!
MSZ8J]I?B;5=1T/2))KBVBN)[FZMKAH8BTLIA=T!BCY')0%B>%&?J-N#PCIUK
M>6%U ]Q'+8F=HB&&"TS;I688Y+'GT';%00^!=*@%EY4U\CV4T\T,B7!5AYQW
M2J2,95CS[=B* .;76+G7]/\ A[J=XB)<S:LXD$8PN5AN%) R<9VYZUO>"_\
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MSNS%F9CW))))]ZR++P7I6GZQ-J%J][&DLQN&LQ<M]F\TG)?R^F<\^F><9 H
MY74-<UJ]T@?Z;%;RQ>*X[!F@AP'C$Z@9!)/N>>>G2H]2O=7T?6?'FJ:=<VR2
MV%I:7,@E@+^=LA8E>&&T'!YYZ^U=<W@O3'T^YLVENREQ?#42XEPZ3A@^]2!Q
MR!QTI9_!NG7"ZNLD]X5U:%8+L&4'<BKM !(R/E)&<Y.>>>: ,V]\0:WJ-WJ=
MIH$ ^TV-O#(BNJ,LDDBEPKEG4A,8&5&<Y/;%%GJOB/4O%]WIJW%A:6]I;V5T
MZ& R,1(9/,CW!\9^3AOIQ5Z[\$:9=ZA;W_VC4+>ZC@6WDEM;IH3<1+T63;C=
MCGG@\]:T+/0+2QUJYU6!Y5FN(8X'CR/+V1YV #'&-S?G0!0\6ZY<Z"EG/Y=P
MNG,SB[NK>#SFMP!\K%.NS.<D XQVSD4]-\07][KUM8+>VEQ;W&AK?"X@C^4R
M[PI9>?N'.<'GWKHK[3!>W-O<K=7-M- KJK0L.0V,@A@0?NCMQ66/!6DQ2:>]
MK]IM/L-L;1!;SE-\)()1^Y&1G/7.>: ,;P]XKU+Q';:':"6&UO;W2/[2GF6/
M(SN50J*3TR23G/  [Y%=TURX\>:4DES8VVK'0)Q/-#&TL2L)HL[%)!//KTYZ
MUL?\*^T9+#2K:WEO[9]+0QVMS!=,LRH?O(6[J<#CIZ8K1C\,V4&J0:A!+<Q3
MP6K6D>'# 1L0QSN!)8L 2QR21]: &>$M;FUSP;INL7:(D\]N))1&#MW#@X'I
MD=*S-)US5M0T?3/$OG6G]E7-O)<7-L5.^)-I:,1D?>88PV>#SC'2N@T31K;0
M-'M]+LVD-M;@K&)&W$#.<9[]:SM(\&:5H=TTMFUV(-[O%9O<,UO S9W%(SP,
MY/TR<8S0!C0>*M433O"VM3&&6SUV:*&6V1,&W\Y2T95L\[< -GKG(QTJGX^\
M9)/\/?$#:*U_%=PPJK2264T&Q&D5'96=0"0I)X/O74Z?X2TW3?LL<)G:ULY6
MEM+61]T=NQ!&5XSP&8 $D#/&*V+BWAN[:6VN(DE@E0I)&XRK*1@@CN,4 4AH
MVF2>'5T<01'3#;B%8QC;LQQC^>?QKS^\U35-#O?'>L:?-;K'9ZC;R2120ES,
M/(@!7.1MX)YP>?U[:P\+6VGVZ6<5[?OIZ#:EE+-OC5>RY(WE>VTL1CC&*AN_
M!FFWL&L03379CU>19+L"0#<5 48XXX51QZ4 9/B?Q/J>CW-]+;RV\D=I<6D8
MMXXR_P DKHKF5N-C?/\ * <X )!!X36/$NKV-UXT6!K/_B4:7%>VI: G)*RL
M0_S<_P"K&#QC/2M*^\":3J,E^\\U]_I[127"QW)17DCV[9-HXW?(OMQTJ>Y\
M(:?=R:JTD]W_ ,32U6SNAYH.Z)00 "1D'#-SU^8T 6] .J26 N-4N[>=IPDL
M2PP&/RE*C*DECNYSSQ]*Y63QEJ/_  BB^+H?*:P%\87LC'\WD>?Y.0V<^9GY
MO3MCO7<6=LME9PVJ.[I"@16<@L0!@9K(B\(Z9#)*$\X6DMT+QK+>/)\[<&WX
MQD?, VW.W/.* ,?2K>>X^)GBA+F>.:W%I9!H7A!!4^>0O)[')]ZLZQ-J ^)'
MAZUAOC':2VEU*\/E@AF0Q#.?7#D>U;-KH5O::[>ZQ'-<&YO41)E9@4*IG8 ,
M<8W-^?.:-1T&TU+4[#497GCNK$2"%X92GROC<I]0=JG'M]: .!\):GJFD:)X
M9*36[:??:M=63V_DG>-TMPP??GJ"G3'0UO:=K^OZPUAJ6GVJOITMZ\,\<GEJ
MJP!V3>K;]V\%02",')';)T8/!>G6]EIUI'/=^3I]VU[;@R D2DL22<<C+OP?
M[WTPMGX+TJPUB;4+9[V-9IC<-9BY;[-YQ.3)Y?3.>?3/.,@4 9GQ2WCPC"8U
M5G&IV6T,< GSTQDX./RK.U*ZN;?XL:!<ZS;1V*-:7,-I):2&87+X#,DC%5*A
M0,J,$$GJ*['7M M?$=E':7LDZPI*DP$+A270AE.<=B :CB\,V(UBWU:YDN+V
M^MD9+>2YDW"$,,-M484$C@G&<=Z .;A\7ZFVA>'O$A\F2RU:[B@DM G,*3-M
M0JV<EE.W=G@\XQ4B>)]47Q'I=LTUO-;WVH7-FXAC)BC5$D9-LAP6?]WA@,@$
MD<$5MV7A'3+ PQP^?]CM[@W-O9L^889"2<J,9ZL2 20"<@# JM#X"T>WEMGB
MEOU%K=O>6\8NFVPN^[<%']T[VX]_2@# C\6Z_;>']1UV\N+"2&VO9]/CMDMF
M7=)]I$,;EMYPHSR.>._IH64-W#\6I5NKI;DG0E*MY80C]^<CCMGI]>_6M=/!
M^E#0K_19UFN;&_EDFF29\G>[;V(( (^;YO8],5 O@RTADFNQ?:I/>O8M8B:2
M]8.(SD\$=&!/#8SWZT ;NH7B:=IMU?2*S);0O,RKU(4$D#\JY23Q#K&G^'$\
M47,EG<::VEO>S6Z JZR; Z+&>=RD9!+<\ CTKI=+T][/1+;3[J9KMHX1%))*
MV\OQ@Y)Y;ZGKWK*TKP1H^D02VT1NY[-HWBCM+JX:6&&-N&5%/ !!QW...A-
M%,^(-2TO5] COI(KJUUB&0L882#!*D?F_+@DLA 88.3D#DYQ69X[U^QUWX6^
M)S9+=@0VOS?:+.6#J>,>8JYZ=JZK3/#-EICVC)+<SBRC,-F+B3?]G0X!"\9/
M  RV3CC/)J?7=$M?$6CW&E7K2BUN%VRK$VTLOIG''X4 <I>:1JY\1MXLC2VL
M18Z/) BLQE:X<_,-X&/D7''.<GM26'B/7O[-\/RW<]O/-K\<30I;6X1H/W#2
M2<N^')P,9QCG@XQ79RZ>LVE/I\DTS1O$8FDR-Y4C'7&,X]JR;KP;I5YX<L=$
MF-SY%AL-I,DQ2: H,(5<8(('&?SS0!C77B'Q%H^F1S:S9R1P)>2QSW=G"LTB
M6X7,<C1J6QDG#8SC&1C/$R>*+E-5\.[KNRN["]TNXNII[>(_.T0C)*'/"G<>
M,9XZUM0^&H+:.W\B^U!)X2Y-PT_F22E@ =Y<$-PJ]1Q@8Q@4RW\(Z7:7.F36
MXEC&FPR06\88%-LF-^X$<DX&?I0!R-Q?W^M-\/\ 6[B>(0W^HB=;98_]4&MI
MF0!NI(4X;/4],=*UM+U_Q#K0T[5+"V0Z=<W#QS)+Y86.+<RJZL'W%P0,J1SD
M@8Q5RU\ :19_84BFU 6UA<FYM+;[4WEP,0PPHZ[?F/!)QVXR*GL?!6EZ;JDU
M[:27L:2RM/\ 8Q<M]F64\EQ'TSGGTSSCI0!SFG>*O$,EIHFHW5Q8O#=ZS+ID
MT$=N5)422HKABQP1Y8XY[\UL>!9M0N5UV2^OC<E-7N85S&%P$;:.G;  Q[5:
MC\%Z=%8V=FEQ>>3:7IOXAY@R)BS,23MY&68XZ<_2M#3-"L](NKZ>T,X^VSM<
M21M*60.WWBJ]LGF@#G;SQ)JES;>*+S3)((QH,C1+!+'N^T,D2R/N.<@'=M&.
MF,G.<!EGK^NZ[XECM=/N;.TLGTRTU-1+;,\FV1VW1GYP,X7KV]#UK<NO">G7
M5[?7.ZXA&HH([Z&*3"7( VC<,9!V\$J02.#5B#0;2WUZ36(GE6X>V2U* @1B
M-22JA<<8+$_C0!7UO5Y;35]&TBW98IM3DE7SF&=BQH7; [L> ,\=3SC%9K:Q
MK-KJFD:!>S6@OK^6Z;[5 I($$0!7Y3P)"&3(Y Y]JV-?\.V/B.V@BO#-');R
MB:WN+>4QRPN.-RL.G!(]*@E\)Z=+;V2[[I;FRE,\%[YQ:=9",,Q9L[L@X(((
MQ@8X& #+T[QI]E35+?7$F:?3K\V?FV=G+*)0461&VH&*G:PSVR/?%4=.O1K'
MQ>F>;?Y%MHL4^GQRH4($K'?)M8 AN IR,CIZUV>G:9;Z9%*D 8M-*TTTCG+2
MR'JS'UX ]   , 55U7P[9:M=VUZ[36]_:@B&[MGV2(IZKW#*?[K B@# ^)MC
M:KX&\1WXC473Z:T3..K(#D ^N"3CZFI5UC6K;Q%JVDSW%G,4TM;^V<6Y41-N
M=2C#=\P^4'.0>M:M_P"&+35-(N].O[BZN$NT\N>5G =D_NC  4?[H%.D\-6T
MNIS:B]U=&YELQ9.VY?\ 59)Z;<9R2<^] '.:9XIU35K#0[2V39?7>BQZC-)#
M&AP6V@!5=E&W).>IZ#CK4%[)KMWK_@5M1>&ROG>Y\^"("1$E6!P2#GD$9X[9
MK;F\!:3+9:5!'-?VTNE1>3:75M<&.9(L ;"PZK@#KZ5>E\,64EWI=RLMS&^F
M;S;;9,\NI5BVX$L2"<DD]<]>: ,3XIPQP?"G7XXHTC06_"HH 'S@]*VXSJL^
MH0K>V5G!;I"SQ3Q3F5EE.%'#(N/E9O7/MWGU_0[7Q'HT^E7S2BTN %E6)MI8
M9SC...@Z5&- 4S0RRZEJ$Q@R8U>5=H8J5W8"C) )QG//- &%X8U_6-1\07NB
MZE/:+<Z6SFX,28%TC']TT8R=H !#9SAN*9I?B/7M5ATS6K:U5M)N6<W"/Y:^
M5%SM9&#EBX( ((YR<8Q6TGA2PCO-+NXY;E+C38WBBD5QEU;&X2''SY(R<]^>
MO-1:;X+TK2=2DN[1[Q(GE:9;(W+&VCD;DLL?0'))] 3D 4 5M"U'7-<L-'UF
M*YLTL-1@:6:$K\\&Y<QA#_$PZ-NX/)&.E9NC^+=6O['P3<2M;@ZT\L=TJQ'
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M'#<<>XX.16O:6"6<]Y,L]S(;J7S66:4NL9V@80'[J\9P.Y- %NBBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!N4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 ':LC2/#MKHMY?W5M-
M<M)?R^?<>:X8/)@#=C''  P./:M>B@#"N?"6EW<UT9%E%O>2K-=VBOB&XD&,
M,R]?X5R 0&QR#6[110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
?%%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>aquestiveamendedandresta011.jpg
<TEXT>
begin 644 aquestiveamendedandresta011.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVM9IR?+B0_,SN=QZLH[G+>@)&@GA^]MO%9UFWOHW1].CLY8YXR7<QL[*VX$
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MHT"W$B>8VU<GEH#$5SC@ 9[9J+2=.TNY\,^(;\:DMK=QZI=VL=]),TBPHUP
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MYH;@^;DR*(<A3ST# 8'8UWWCRZU"R\#:O<Z8)?M<<&5,0^=5R-[+[A=Q'TH
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MF=K5[ABG,ZMR"WNQ_#V%8GAJ6UBL?ASJ0NLWUS/);3S/.6:2,0R@(V3R 53
M[''<T >LV<UU-Y_VFT^S;)F2+]X'\Q!T?CIGT/(JS7CD\UJ=$O$^VD*GC6-
MPN2"$,T8(SG.,9^F*GOKQ=#E\8VVFR%-.M=0L);B* E_*@94\]@H.<$ [@.V
MZ@#URLBPUS[;XCU;1S:M$VGI _FEP1()-^, =,;/UKSV^NM-T_2KC4-%U<W>
MB76IV?\ :1M !;6T.2)-FW[N<)O ['G&:W/",FD#XB>*4TF6T,,EM9.JVSJ4
M.!*&*@<>F<=S[T ==K.K0:)ICWLX+*'CB15ZL[N$0?BS#FETR[O;I)Q?Z?\
M8I8IC&H$PD65< AU( .#G&" <@UR_P 4$L6\,6K7BP'&I684RXX!N(]V,_[.
M<^U4H]+TB^^*-_:'8\<&F6=Q!;I.RHLBRRD,%4]@$]L'WH ]#HKR73YY;SPW
MX=O()-OBU=62*^7.)B?-(G20==@3)P>  N.U4=033U\.>)K];G%W9^)T%M/]
MI;="#+ #M.>,J6!]A[4 >T5!<WEO9K&UQ*L8EE6),_Q.QP />N0\-+9V/Q$\
M2:=8NB6YM+.X\E9,CS"90[8SU("9/?C-'Q'BL3'X;N-0CM_(AUJ#S))P-J(5
M<')/ !.W]* .MAFNGOKJ*6T\NWC">3/Y@/G9!W?+U7!P.>N:LUY%XDGM5@^)
MJ176T)I]L\:B8@JWE/C SQSCBM-=-T.;X@K92-$]G>:%]HN8FN"4F=9% =QG
MYB%9N3]>PH ]*HKQG2-<MWT+P@GB'4(4TBXTJ2/[1>*)(3<*RC;(2<!M@."?
M]KUKT[PK;QVGABQMX;VYO88T*Q7-S]^1,G:3ZC&,'N,4 :,=Y;RWD]I'*K3P
M*K2H.J!L[<_7!J>O)=:8Z=J_Q#?28HTUDP6\T A4"<QF,>:Z8YSC=R/XL=ZZ
M"P-H?'6D3^&I(FTRYTV5[Y;=LQD IY+D#C>27&3R0#Z4 =G>7EO86LEU=2K%
M#&,L[=!S@?B20*;YUS_:?D?9/]$\G?\ :?,'W]V-FWKTYSTKE_BC#!+X"NWN
M(XW2&XMI,NH(0">/<W/3Y2V3Z9K*NYM-_P"$YOH[:YB6T?PR658IMJ >8<%<
M' & .1VH ]&HKR#1+73)&^'1>12^HZ6\=YF<YN%$"$*_/S ,.AXZCVJ.TU>"
MPT>PAN;M$\/0Z[?VDTCCS8H5#OY"OD_<],\#Y?04 >QUD0ZYYOBRZT$VK(T%
MI'="8N"'5V9< =L%#57P;;6=KH;IIVH2W]BUQ(\$K8*!2<[8B.L8)('Y=!7.
M:[8:+?\ Q(OX=?=%M'T*$J))S&"5FER1@C)7(/MD4 >B45Y5;1ZGX>T'PMXL
MO;>YNKR"#[%?Q,"9I(I#B)R#_P M%/E@GKAVS7HFAZ=_9>D06SA/..9)V08#
M2L=SD>V2<#L,#M0 :AK$%E#?;!Y]S9VWVE[=6 ;8=V.3P,[&_*I-&U$:OH=A
MJ:QF(7EM'<",G.W>H;&>^,UP6HKI=GX\\7/<+:PW4VB0R0LX57<A;@.RGJ>-
MH)^E9NB>5I]QX+DTF1!?7WAR82#S=WG.D4)C# GG#;@/3D=* /7*R?$NN)X:
M\/W>L2V[W$-HGF2)&P#;>^,\&N)\#SZ1JM[H]_;:PYUB*U:*_LHXPLA;:-_V
MD?>RKCACW/'!K<^*DL<7PP\0>8ZKNM65=QQDG& />@#0?Q2EIJ&FVFI6$]I_
M:3^7;3;E>-I-NX(2#D,0#CC!QUKH*\KUF6(>(O!USINKG7;I;Q(S8/(DBQ1,
MI#W $8&TH/XFR.:@NYY[OPQK4N\)XRM=7=;?YL3!O.'E*HZF(Q$#'W2-Q/<T
M >MT5Y%X@U>P779KB*[CM[FT\1VD<[7,F9U3,:MMZ>7!M)ZY#%F/&:L16Z2-
MX]U+3-]SK.G74LFG@3,YC9K1!D+GG)+<$=1CM0!WUYKGV/Q/IFC&U9OM\4TB
MS[QA?+"Y&.O\0K7KRW3+SP[/XR\$W.DW-J[S6%TLK+(#(S;(B/,YSOSNSGG.
M:](T_4;/5K&.^L+B.XM9<[)8SE6P2#C\010!%K6K0:%HMYJER&,5M$9"JC+.
M>RCW)P![FB'58;S0H]6L@;B"6W%Q$%(!=2NX=>E9&KW#:IXBM='LIK1Y+("]
MNHIFSZK$I YZ[G]BB^M<]X+OH]$C\0^#;RYMUETIGFM@K\?9I 7 &>?D)93Z
M#% &]8^,UOD\+.NGNB:_$TBL9 ?)Q$9,'CG@8[5U->4:!=6_]G_"<>?%GR7&
M-XZ_9&&/SX^M=YXQEU*#P;K$NCASJ*VDA@V#+;MIY7W]/?% &W7*7/C5;:TN
M=4&G22Z+:M<QS7<<HWHT.X']V<9!92H()YQD '-9%G]@G\3>&Y_#SQ-875A.
M=32-@5>+8NQI1_?WG&3R<L.QKF)H-&_X4CXFECCLMPNKW#*%SD7$GE_^.GCV
M/% 'J%GJ6LS:NUI=Z#Y%JH)^V)=JZ'@$ +@-GJ#Q@8ZG-;-<%JK6UGX]\-QZ
M4\"%]-O_ "H8W C9OW13"@XZEN?K69X:O],U/1+"\TZYD;Q?;Z?,ES K8E-Q
ML^?[0O4CS%^7=P"1B@#U"BO*-"FT+5+*'4;;6G^WIIDL=_:Q#RW!V?,;GG=N
M5QPQP22>H)I-,TRV'P^\+WVG7MG%J=[%:[QJ#M)!>R);O^ZDYXP"Q&!P47@X
M% 'K%%8'@N[6]\*VLZV+6.7E4VYDWA&$C [6_B3()4^F*Y35)K>ZU'QK:ZY(
M(KJ"))-,9FVLD7E#:\)Z[O-W9*\YP/04 =IJVM-87MKI]K;+<ZA=QRR0PO)Y
M:E8P-V6P<<LH''>KMK=/+IT5U=0-9NT0DDBE928CC)#$'''KFO/4BCF\:>!S
MKD5J=7?1YVNQ(J[C,!!C/OG?C\<5VOBBW2Z\)ZO \0E5[.4;"N[<=AQQ]: (
M7\2P_P!MZ+800-+!JUO)<0W0<!0J*K=.O(85N5Y+IRZ'?W/P[M4>U>V?3+GS
M8XW 5V\F'<&P>>001Z@@]ZJZ=K$%IX?\.QW][&F@B^U"UFFF'FQ1LLK"W63)
MQMV[@,\?=/8&@#V2BL#P=;6MIX>2*PU":_LO-=H)Y,$%"V<(>Z#)"^PXR,5O
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4V2-)4*2(KJ>H89%.KC_B#J=U:V^B:9:326YU?5(;*6
M>-MKI$<L^T]F(7 /;)H ZTQ1L%!12%(*@CH1TQ0T4;1F-HT,9ZJ5&/RK(D\*
MZ4/LS6EK'9R6\R2A[==A?:0=KX^\#_M9YYZBLD^.<:99:Y]A4Z'=78M1<";]
MX@:0QK*4VXVEL<9R 0?4  ZXHIQE0<=..E*JJOW5 ^@KC#XRU=EUR>+0;=[7
M1YIXIW-]@MY<2R J/+[[L>W'7G"6WCNYBO\ 35UG24L;'4[-[JUN4N?-(V1^
M8ZR+M&T[<D8)SC\@#9F\/&?Q?'KDEQ$T:61M/LS09R"X?=NW=<J.U;4D:2H4
MD174]589%<M%XPF']A7%UIRPV.N$):RB?<T;LA>-9%V\;E!Y!.#QSUJOIWC#
M6M1TNXU*/P[&;>)YH0$O@6,L<_E="@PF 6+=1M/'3(!V14%=I QC&*/EW=MV
M/QQ7G^K^.;YO#FO2Z=#:"[TV[@MC,LY>-TE\O#H=O7$F,= 1G)Z'3NM=MM-\
M67+ZEIMO#+:Z(]Y+?1REV$2O\T8!4<9!/OZ4 =9Y<?F>9L7S,;=V.<>F:/+3
M!&Q<'J,=:YF/Q7<QWVC07NG1PQZS&QM'6<MMD";Q')\HQE<\C/((]":.E>.K
MV_70KFXT:*WLM6N9;176[WO'*OF$?+L *GRSSD')Z4 =I'&D2!(T5$'15& *
M&5"0S!<CH2.E9NN:U'HMM;NT32S7,ZV\,8!^9R">=H)P%5CP#TKB_%&JSZSX
M6F^W:3+9SV6M6*1NZ.$E4W$6'C+JIZ$@C'!R.: /1O+CX^1>!CIVI&AB==K1
MH5!S@J,9]:Y74_&<]M->?V?I%QJ$5C<K;SK DC2,3M+% J%3M#C@L,X/3C-K
M_A([VZFF?2]*^V6EM?\ V&9A.%DR"%D=5(P54GN03@^V0#HE4*,* !Z 5B'P
M^7\8/KLEQ$Z-9K:"V:#. KEPV[=URQ[5AV/B^_@_M^;4K>%TM]7&GVD<,C$E
MF6(*N-F<9<L2,GKA>E61XTN(1<Q7FCS0W NX+2S)#I%=M+]W:SHI&W#;N#@#
MC.0* .L=(Y1LD57 P=K#/T-+M3?G"[O7O7%^%UG7XC>+_M%O##(8;$GR7+*_
MRR_-R!S_ (56U"34;+XHZA+HVF6]Y=/HD#LDMQY"MB:7^+:V6(  XQQR1B@#
MO0BJ<A0#Z@4B0Q1JRI&BACD@*!D^M<GIOCG^TIO#SKIWE6&M1R!)Y)L-%.@)
M,)7;C/RM@[N=I]L]!H^H2ZI8?:W@2%'D<0[9"_F1AB%?H,;@-P'/!'- %PI&
M%Y5<#U'2E\M.?D7GKQ7E?B'4]1UCP7XDDU*VMB++7(H+?RG)*[)X5P,J.Q/.
M>=QX KJ3XSDLIM<@U73T@GTT6[(MO.91,)V*QC.T$-N&",'KQF@#K0 !@# I
MBQ1H[.L:*S?>8#!/UK%T77;S4=4O;&[TJ:V6!$DBN0DGE3!LY +HI#*1R,="
M#[#F_$L5M_PM30A-IQO4ETZZ,D*QJ^XJT>UB&(!QD\^] '?+%&ARD:*<DY Q
MUZT"*,,["-0S_>('+?7UKS7PWXFCT<>+)Y?/CM;>_ABM-(N&(GMVD"H!@YVH
M[G*X) &3[5TMQXJO+'4[S2KG2?-U".P-]:QVLVX7*@[63+*NU@Q7UX.?:@#I
MO+08PB\=.*=7#W7C^2VT[Q).MC;7,NB01W!\B[)CF1U8\-LX(*,.A^O8:2^(
MM1_M"VTR?2[>*_O#))!']JW*+=%7,CD+PVYPNT \]\<T =%'%%'_ *N-%QQ\
MH ]Z58HT.4C13ST&.O6N0^&RLFBZJKP) RZU>@Q1MN5#YI^4' R!]!]*N6OB
ME=1\1W.BQ0VQ:WG:&XAEGVS*FS<)1&5^9"<#@]\^U '1[(V'W5(R>W?O2F-#
M()"BEP,!L<@?6O-/!.N7.BZ#H=HVG1?V;>ZI=V2SB?#I(9IV7]WMQM^0C.[/
MMZ]$/&$J>(K#3+G3TA^VW4ULB_: 9H]BNRNR 8"N$)'.<$=>< '3B.%9&E"(
M'Z,P S^)I[*K*58 J1@@]#7D5[;0+X&\4*L2 1>*08P%^X?M,(X]."1^->@^
M-(DE\#:^DB*Z_P!GSG##/(C8@_G0!M>7&ZGY$*L.>!@BG(BQH$10J@8  P!7
M$:)XKDTZ&QL-5LH[:U70_P"T(KA)]Y,<00.'7:-IPP(P6J_#XLF%SH8O].6"
MTUM<6TBS;VC<IO5)!M !*@\@GD8]Z .F,<3NKE$9T/#$ D&C9&21M4GOQ7G_
M (3U:/1M):PMX%DNKWQ!?VUK!NV*-LLC,2<'"JBD\#T'>KW@994U_P 9+-!%
M!)_:B$I$VY?^/>(Y!P.O7IWH [,Q1DDE%Y&#QVI&6, LP4#N2*Y^]\2W O-7
MMM+L([M])C1[E7G,99F7>$3Y3SMP<G RP'J1@7^JGQ/XC\)B"UMKK1M2L+FZ
M\FYD(#C;$,LNPC*AV '.<GD4 >@91,+E5]!TI#'&TBR%%+J/E8CD?0UY5!IU
MN]IXN&I:%9WMGH<JBVA>\<M&D5M&PC5BF=I!8G)Y+$$$$FNNMO$4LEK!9:+I
M<4MQ#I<-Z;=IO+1%<$1QJ=IR3L8= !@>M '4-&CLK,BLR'*DC)!]J=7)7_C&
MZA2:.ST6:>^MK..ZGM&WEE9P2(@8T<;_ )3UP.1UR<=);W4EWID5W%;O')+"
M)%@N,QLI(R%?@E3V/!Q0!+Y</FEMD?F<$G S[4[RT\SS-B^9C&['./3->9>%
MKV--*T35[[3K>;7K^\N;:TG6=@TA:21G\P[1\JK'P/FZ#&*V=0\>3Z=%J<4N
MDJ]_IMW:P30I<?*Z7#!8Y$8KSUY4XP0>>] ':[5^;Y1\W7CK35AB5%18T"+T
M4*,"JVG37\UEYFI6D5K<[F!BAF\U< G!#;5ZC!Z=ZY6W\?->>&[_ %RTL[2>
M"SLI;J6%;LB6)T&3#(NS*/@'UY![<D [0HA.2JD_2CRTX^1>/:N:G\8QV>HK
M#=VHBM/['DU9YQ+N*JA7<NW;Z-G.>W2J^IZCJ.HZ%?PWNBHEC<Z3+<+.LXD"
M-MXC=2!\V"#D9'!],D ZP1QD9"(0>>@I0B@DA0">O%<1X.U^[AM_#&BW>GQQ
M0WFC)-:SI/O9O*2(,'7: N0X(P36GXIU?5--U/P[;Z?';LE]?F";S9"I($3N
M "%.!\G)]L8YR #HUBC2/RTC18^FT# _*E2..(8C14'3"C%<H/&<\UW;FRT>
MXN[&6^:R:6))"R;7*&4_)MV!E.?FSCGVJDWCG6!H^M:LOA^W-II+7<<Q-_AF
M> X^4>7T(!Y]NG<@'<LJM]Y0?J*0(@.0J@^H%<FOBG69=;728]$M?M%Q8_;K
M5GOB%V!@K"3$9*G++]W<#GKWJ"+XA0S:;H=SY$%K)JT$DD8O+CRXQ(A \KS-
MI&XDG&0.%/':@#LA%&)#($42,,%@.2/K2^7'_<7\J@:YF33#=-:NTRP^8;="
M"Q;;G8.V<\5RL7CIUDU*&XT]&FLM+&HE+2?SB>6#1'Y1AP5QQGK0!V(10<A0
M#Z@4I4,,, 1[UD>'];_MVW>ZB:SFM"%,-Q:7'FI)G.0> 5([@^OX5E:IXLU.
MTU36[&ST>WG;2[..]WR7AC$B-YF1PAPW[LX[<\D=P#JS&A))1>>O%'EI_<7\
MJY;3_%]S=ZKI<$VEK%:ZM8O>6<B7&^0[ A*NNT!21(,88].U,T[QC=W^K+I9
MTR!+V73GO4A^UY,;*RJ892%^5AO7IG'/'J =6T,3IL:-&3.=I4$4\D#J<5S.
MC>*Y-:L-'GBL$2XOGD6XMVG.ZU$>1)GY?F*MM7&!RPYQ5+X@*RS^%IX;=9KE
M-;B$8+!<YCEXW=AP,]>G0T =EM&[=@9QC--2*.($1HJ G)VC&3ZUQ\'CJ6,W
MUEJ>E_9M7M;N&U^SPRM-'+YJED=7";MNU6)^7(VGBMG0-:N]6:^BO-,GLI+6
M8(KLCB.=2 0Z%U4^Q&.".] &RP!4A@"I'(/2DV(>=JG/?%<%X[U=]5\(>,;.
MRLX9X-.M)(KB667:1)Y6\[!M.2@93DD<\>]7;CQ9/86<EMINF2:A/86<,LT2
M"3+EDR$3:C#=M&><#D#U( .P\M./D7CIQ2&*-D9#&I1NJD<&N+7QA>6^OZ[-
M?6ZQ:1I^EV][L)(F0.)6.5*_?.P#;D8QWJ6Y\9:E9QZD\V@2E+33GODE!E2)
MMGWHF9XAA\<C (/MB@#L0 J@   < #M2/%'(5+HK%3E=PS@^HKCV\7ZS"ND/
M/H%NJ:M<I!;8OLD!H6D!8;./ND'!/MFJ\GCO4[?3K^\N-#MUCTO4!97^R])Z
ME &B_=_-Q(I(;;Z<T ='=Z3<7NM13RZH_P#9\01_[/$28:56)5R_WL9P<=,J
M/<5KUQM_KZ:7K?BFXCT:!KO3=+ANVF$^UKF,>:0A^7Y<;&QUZT^W\:RQWI35
MM.CM+9M)?58Y8[CS6\M-N]67:,,-X(P2/>@#KBBL<E03C'(I-D8(^50>W%<<
M_CN2Q$MSJ>CW,.G)8M>?:HTD(4KC]TVY%&XY&,$@G(]S75KV3XK:+->V-O;2
M2:/=',4I<G]Y#\K?*/NYZ^] '<!(T=F555G/) P6/]:<RJPPP!'N*XKQB)8O
M&/@ZXM+6.>\%Q=)&KOY8.;=^"V"0._0_0TQ?'UW'9F6\T5()+35$T[4@;O*V
MV_;LE4[/G0[UZ[2,_C0!W"JJ_=4#Z"F^5&91+L7S ,!\<X],U3L=0DO;[4(O
M(1;>UE$*3"3)D;:"W&!@ G'4\@],5R6KZEJ%_J/C32+F"V?3;328W0;SN!=)
MSNQMY)*CN,;1UH [G9&V6VJ=V#G'7'2G!%4DA0"?05PGAGQ/-IVGZ%IVI64<
M%I)H8NX;E)][%84CWATVC;PX(P36II/BJ[U'5+&!]%N$L[VW::.Y5)"(2 "%
MDW(%!(/!!(R"/0D Z5(8HR2D:*22<A0.O7^0IRJJ*%50H'0 8KA?B5'%YGA2
M1[;SRVNPQ.BJ"9$,<I*<\$$@'!XXJCIVKV^E?$/5_EFTC2K?2/M$MA<#:)75
MLF:) 2NT*"IVGD]N,T >D;5#;MHSZXI/+0DG8N3WQ7,P>+9ENM#%]IZP6NMC
M%M*DV]HY-F]4D&T $J#R">1CWJ*P\8W%UKEGI<^G107%Y;SS)%]IW/"T97Y)
M0%PI(<'@G'3!ZT =7Y:<?(O'3BG9&<9Y]*X?3O'=]=Z)9ZM<:+%!!?O';V2"
M\W/).\A0*WR?*H W;N> >,\4[PPLZ_$CQ?\ :+>"&0V]@3Y+EE?B;YN0.?\
M"@#LTBCCW;(U7<<M@8R?4TOEIC&Q<?2L6[UR<ZY/H^F6L5Q>6]JMS+YTQC10
MQ(1<A6Y.UNW  ZYK"B\?7>I_V0NC:*EQ)J=K<31K<77E>7) RJ\;?*>[8!&<
MD= .0 =OL0$'8N1TXI%2-9&*JH=N6(')^M.0L44NH5B.0#G!^M<K>ZLEIXRO
MHTTB"2\@T;[2ET9L-)&)#^Z/R_*,@G//6@#J!%&I<B- 7.6('WOKZT-#$\9C
M>-&0]5*@C\JY/1?&-YJ5[H,=WI4=M;ZW8&[MG2Y\QE*JC,KKM  P_!!/3D#.
M!:\6ZOJ>EW.@1:=';LM]J2VTOFR%3C8[X!"G .SD_ISD '2#:!M7 QQ@=J1H
MHW969%9DY4D9(^E>9VVM7'A>_P#&5]!ID,UC#K$1N?W_ );*KPP E%"G<06R
M<E?KZ=%JWC*>SFU!=.TB?41ITR0SI"DA=V*JS"/:A4D*ZG!(SR..M '5%%+;
MBH)]<4ZL[6M8@T319]3G1V2(+A!PS,Q"JO/0EB!SZU0GUK6K1-0\_0?,:W2-
MX'@N08YMQPP)8 KLZDX/'/M0!O>6@Q\B\=..E(T4;1F-HT*-U4J,'\*XX^/X
M8;#6+B>"'&F7<-O)/%,7A*RA")2P7(4!^>#TZU=?Q8ZQ62+;P2W-\TIMS;RM
M-$\2 9D#(A)'S*,8ZGKQF@#IP   !@#M165X>U:XUG25NKK3I]/N!(\;P3*P
MY4XW*6 )4]0<#@UJT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5D^(O#]KXDTL6=R\D3QRI/;W$1
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MO!'!"@2*-0B*O10!@ 41RQS)OBD5U]5.11--%;PO--(L<4:EG=S@*!R23V%
M'(7G@::YL-9L8]7\NVU*_6^VM;!C$X='(SN&03&,=, GKP1-J7@E=7N]<EO+
M]@FJVT$)$,6QH6A9F1U;<>0S9Z=A^-E_%2/K'A^WMH8Y;'6+>6=+DR$% B!Q
M\N.X8<YXYXKH#-&(O-,B"/&=^X8QZYH R]#TS5+&-CJ^M-J<^T(KBW6!5'KM
M!.6/<Y[< <YJ:EX=O+OQ79:];:C#"]I;R6Z0R6ID!#E2Q)#KS\HQ70JP90RD
M%2,@@\&L-_$,ESKUUH^DVJ74]DB->2RS&..$N,JF0K%G(YQC &,GG% &5/\
M#VUU"/6Y=1OIIM0U8Q%[F-!&(/*.8O+7G&T@'DG/>I=4\%RZY;WC:CJ@-_/8
MFQCN+>#RUC0L'8[2S9W%5R,XP,<<T[4/%>H::\27&CI&S:G;6+$W.5*3%0)$
M.WY@"2,''(-;]]<W":;/-IR6]Q<(/D66;8A(/.6 .,<]J .5O/ =W?Q:ZL^N
M MK-E%:3[;,*J;-PW(-W PYX)//<]*T]4\,W-[?Z3JMIJ2VNJZ<CQ>:;??%-
M&X&]63<#C*@C#<$=ZZ!Y8XV17D56<X4$XW'T'K6'JNOW,.K-I&E6L-UJ*69O
M#'--Y:LN[:$!P?F)SR>!CWH E\-:#)H%M>Q27QNS=7LUX6\H)M,C%B, GN:I
MW7A1[_6+/4+N\AD>RNVN;606V)D!#?NS)NY3YNF!D "K/BGQ!+X9\*W6MM9"
M?[,BO) 9MAP2 0#@Y(S5F&\U87<"76G6J02;MTL-VTACP"02IC7CC&<]2* ,
M*V\#S6^EZ18_VHC#3=3?45?[,09&9I&VGY^!^];GZ?BRV\"7-M<Z>XUUVCL-
M2FOH0;9=[>:'#*[9^8_O#AN.G(/;LA(AQAU.>G/6D\V,RF+S%\P#.S/./7%
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MJZOG:P;!P<'.#Z4Z@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5>'9FWL0@ 3KQG('I75T4 >8>'8K#1/%\!-NHT74VFGT4D BTD)'FC&/D$F
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ME%>13[A365X-6PU"[T=;Z;4T\4:8T@NX# J8<@B1I'$8W1M]X98Y)7O7J=%
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MU5G.%!."QQGCUX% ' :O?6D'C76+37X"\-SIT:Z7YD!D1QA_-5< @.25R.I
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MG1XL"(!HY;W+\QXX+;-F2/\ 9[BO7** ,[1=/TVPL=VEV\$,5P1,YA  D<@
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M'!<Z3I7@B2+4;I[46\@U#R#''&D;8/[P  -L4KM'/SCW-=VJA5"J % P .U
M'F2ZEJ?A[6/'=_I.EVES:VE['<W,;3&)RHM8F?8 I!;J>2/QS6Y>>-KB:.[D
MT/3I+\VB0NT/E2%IC(BR;%95*J=CJ<L>2<<=:N7/A$3W>M%=0DCL]:V_;8?+
M!8XC$9"/GY0RJ <@GK@BF3^#7379-2TC6;K2DN8XXKNW@C1DE"#:I7<#L8+A
M<CL!Z4 =()'DMA)''AV3<J2';SCH>N/UKBM,\<:G=:%8ZQ=Z7;0V^HLD%JD4
MSRR>:78'<H3[H52>,DXZ#/';["D/EQ$*0NU"PW <<9YY_.N57P+!_P (7:^'
M6U&X!LY!-:7L2A)89%8LK=P2"2/<'\: *MQXRUFS1%FT,;FU2"Q2:0O"DR2X
MQ(@9<Y!R"#TQG)J&^\:ZY86GB*232K!I-!99+G;<MMEB:,2#9\F=VTG.<#('
M7/&K/X3O+VRLTO\ 79KJZM[R&\,[P(H8Q'*J$7 "YSGN<]>F&W_@S[?'XEC?
M4&5=>14FVPC,05!'\O/]T=^_Y4 2S^([NYOM5M-'MH9I=+@CEE6=ROFNZEUC
M7 X^4 [CG[PXZU6L/&HU"_\ #[I;I'I6MV;SP7#L0ZRJH8Q,.F=NXYS_  'Z
MU:_X162#5+G4;'4FMI[VVCM[W$(99=@(6103\K@$C/(Z9!Q3K_P9I5[X;T_0
M@KPVE@\+0%&^91'QC/\ M+N4GT8T 5F\4W1-G:I;H+V[MY+M,12R*L(8!"50
M%LMN'L.>N!EEAXGOM;>WTT:2MGJ,EB;J\M[[)$2ES&J8 R=Q5CGC"C.#G%7=
M>\,/JNH6.IZ?JD^EZE9J\23Q1JZO$V-R.C<$94$>A%0OX0D36+35[+6+F&_C
MMS:W,LB+)]IC+%_F7  8,201@#.,8XH K_"\8^&^C@H$PDGRCH/WC<50O[:X
MU?XB:KIM[:65Y8C1H2MO.S!<-++D]#AB47)']T>E=/X9T)?#6@6^E)=RW20;
ML22*H/+%L8 ]ZC&@RIXGN]<2^ DN+1+3RFARJJC,RG.<DY<YH Y[2?&^IWFD
M:+?3Z99P)K1BBL(UN&9@Y#,Y?Y>%54R,$D\#C/$FI^.;S2;77HI=.AEU#2&M
MRRK*5CFBF.%=>"00<@J?3KS5R+P-!%X6TC1A?2^;I$J365X$ =&3.,CHP()!
M'&0>W6GZEX+35+#58[B](O-4,/VBYCB PL1!1$4DX&<GDG[Q]L %6Y\3^((=
M4U?3%TS3C<V=FE]&YNGV-$Q<;3\F=V8S[<Y[8/2Z+J2ZSH6GZHD9C2]MH[A4
M)R5#J&Q^M9L_AJ2?6;_4S? 2WM@MBR"'Y552Q##YNN7;]*T=#TP:+H5AI0F,
MR6=NENDA7!944*,CUP!0!S=YXWEM]%O?$,-I'+H]C>-;3?.?-9$D\MY5[<-G
MY>X&<C.*J26DVN_$#Q!I]_;65W9)IMJ$BF+$*&>8@CC@EE7)']T>E:A\$0>1
MJ&GK>.-'U"Z-U/9F,$ABP9U5\\(Q&2,$\G!&:T+?0I+;Q-J&M)> O>01P&%H
MOE01[BI!SG.7.?7VH \^L&C'@2R\0:MHVG:G<)JKHDDQ.]3+>F,MRIS@[<#T
M4=,"NVE\0:E=3:B=%TZ*\33KM+26-Y=CRMA&?83P-JN#S]X@CC@FLO@<KX0C
M\._VFQA2Z%T)O)&_(G\_'7&-_P"G'O4Q\'R1Z]>7]EK5U:6NH,LE]9QHA65P
MH4LK$$ID  XY/J#S0!!=>+[PW,[:9I<M]!:WWV.:..*0NV"%=U8+L^4D_*3R
M%/(XKI=3N9[+2[JZMK4W4\,3/' '">8P&0NX\#/J:P4\'RVVN7EY8ZW>6NGW
MTWGW>GJB%7DP Q5R-R!L#./?!%:^OZ/'X@T"^TF::2&.[B,321'YESW_ /K=
MZ ./U3QMJ']B>+%L_L9N])T]+N&ZC+&-PZN>!W*F,X()!X]Q7;Z:UP^FV[76
MPS&,%BA)!_.N;D\#?:VUAK[6+F<ZMIRV%SB*-!A0X#+@<8WGC^==)IUK+9Z?
M!;S7+7,D:A6F90I;\!P* .;?Q==P>(;+3[BS@1+N_ELA&LNZ2,*CNDC$9 #A
M,A3@@$'GFJ4/CC56$5S-I5HEG_;;:1+MN69PWF^4'7Y0",X)S@\GCCFS%X",
M4UJ4UR[$5IJ<FHP(8HR5:3?N4L1EO]8V">GO4G_"$'^SS:?VF<'5_P"UMWD#
M/F>;YNWK]W=^.._>@!W_  E5Y%<:_97%I E_I[1?9(A(<72R\1-G'&7RAZX(
M/6NH;SOLYV[//V<9SMW8_/&:Y5+2V\0>-K?5?L%[;MI"36[RW$31+.Q8;0H/
MWU&&8-T!(QWQUU 'G&F^(KZ[\(^%]1UBPL;^2_U2- [$CR&:1MKJI!Y7! Y&
M!CFKFH^.-6LK;7[Q=*M&M]%OE@F'VEM\D96-LK\N-V),\\<8YZU<@\"_9M&T
MS2TU:9H--OEO(-\*DC:Q94.,9'S')ZGCI3KWP1]MT_Q!9OJ3*FM7"SRL(1F,
MA47"\^D:]??\ !EQXRN=(O\ 6+;6+*%/L5C'?Q&VE+[T=V0(<J,-N7J..:T=
M(UK4KO6I[&[TUTMU@6:*\6*1$+9PT9$B@[AP<C@@]L8J#4O!T&L:E?W.H7)D
MBOM.73I843;A0S,&4Y)#;F)_*K>@Z)?Z4O\ Q,-=NM5=$\N)IHT38G'7:/F8
MX&6/IVR<@!K6O'3]0L]-@CW7=W'+*I,3R!$CV@DJ@)/+J.W?GC!Q4\0W-Y>^
M%#J7AV.WNKNZGB_T@G?;.D4AW1@KG#!>O!PW2M;Q%X:;6KFPOK34I]-U*P9_
M(N8D5_E< .C*W#*<#\0#39?#$DUUHMS)J<TLVF3/.7EC!,[NC(V<8 &&. !Q
MQZ4 <1JM_J6K^$Y[K4DMIIK7Q1%!!Y8(V^7>+'@9Z# Z^YS73_\ ":7%D^LV
MVIV4*W=A<VT$:VTC.LOVC C_ (=W!/. >G [4Z7P+OM+NT359EMY]4&IJC1*
M?+?S1*5!X)!<=^W'O4FH>!X-4EUQ[J^E']J^0V85V-;O#_JW1LGD$ \T 4M1
M\9ZQI>F:K<RZ)Y@LY;=8IF$D"7"2N$.T.N0RD\@\'@Y[5UFFOJ+VI.J06T-Q
MYC +;2M(NS/RG)4'..O%8%UX0O=2\/SZ;J7B&XNYYGB+7+0(NU8W#J%1< $L
M!DG)/Y8ZI=P4!B"V.2!@$_2@#AM5\=7ND66ORW%C;";1[J)'B\QCYEO(%(E'
M'8%R1_TS;FK'BO7F@\-:]=-IMCJ6GV<48,<SG;,2 S C!! #(1ZY(XQ6Q>>%
M]/OO$(UBX5GD-HUH\1^Y(IS@D=R T@'LYJC+X*MCX!_X1**\F2W,(A:X8;Y"
M,Y)Y[F@"CJ-]J%WXJU_1IQ;/I<.CI*(B"3\_F@D]B<H/H*J>"-=OK73?!VD7
M5G MI?Z.K6\L<I+AHHXR=XP  0W&"<8KH+KPP\^MW&JIJ,D4MU8+93QK$I1]
MI<JW/(QYC<9]/QAL?!_V&7PXPORZZ%;/;1 Q >:K*J98YZX4=.^?I0!HZ_K:
MZ+;6A$8DN+R[CL[="VT&1SU)[  ,3]*YW6?'%[H=OXAAGL();_2;5+Q-LI2.
MXA<D;AP2I#*05^G//'1>(-!@\0:?';RRR02P3QW-M/'C=#*ARK '@^A!Z@FL
MO5/!BZS8ZNEY?9O-4MTM9KB.':$B4DA44DXY9CDD\GV  !NZ9)J4L4S:G;VT
M#^:?*6"4R9CP,%B5&&Z@@9''6KM,B5UB19'#N  S!< GUQVI] !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'19_9Y-,U:&68W+28:,)&) ".@X(SD\>E;.IVBMX?N[.WA&W[*\<<2KQ]T@
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MQNVESSS@FL/1)&C\/>&+*XL+N.;^Q[FW%R;:25E)91Y 3!"L0 =S _*N!UR
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ME;TF&]Y"#NWDJWRD* P';-(L$]O9W\EI;,]A:^,6FOH88]W[@!<G:.H5RC$
M?PY[4 >I)?6DEK]J2Z@:W_YZK("GIUZ56DOG>]LQ:3V+VKO(LY:;Y\JIP$ X
M)!'.2,"O,_%NG?:X/%E[:0--IMV; PK'$6\VX63]Y)& ,G";06'7!]#71ZGI
MFG67CCP@^GZ?!##ONVD:W@"J \6 6*C W'UZF@#I-/\ $FCZG;M/:ZC;/$)7
MB#>:O+*Q4XYY&0<'O6BL\33-"LJ&51ED##<![BO-]*T!M5\"ZEID5N]MK%CJ
MES=6LDL!0).MS))"02,$$8Z9^5O>NK\(RRZGIG_"075L;>YU14E$3<F.(+A%
MS^;?5S0!M3WEK:O&EQ<PPM(=J"1PI8^@SUK(USQ"NG:GI^DP2VRWU]YA1KAO
MDC"+G+ $$Y) '3J3VP>=O56/Q)XNMM<MI);;4+2(6!\HN)8Q&0T2X!^<.2=O
M4[@15>TL[JUUCX?0ZNIEO;?3YTO)63>$<Q1@!VZ9R" 2>2#0!V,VN1Z1HMK>
M:^T%E/*T<+QI+N7S7(4*I.,\GTZ9/:JEEXF6;Q+K&G79M8+:R2U>"?SO];YP
M?&<X&?D& ,U5^(D+2^&H)! \RP:C9S2!(R[*BSH6. "3@ DX[5R^N6=KJ%YX
M_E>P,OFZ+ MGYEL<EQ'-P@(^\"R<#D$B@#TVXO+6TV?:;F&'S&VIYCA=Q]!G
MJ:F9@JEF(  R2>U>5W4T9U%[;Q"NJ'3-5T>W@@DMK0S!R PEB;",RN2P/;ZY
M KM]2M(X_ =S:20R,BZ<8_*G/F.2(\ -UW-G'U- &J-1L3OQ>VYV1B5L2K\J
M'D,>>![TY[ZTCM!=O=0+;$!A,9 $P>AW=*\STO2[%=0^'Y?3XQMTF5+LM!P'
M\N+ DXZ[E; ;N#WJAIL\VCV6B7,\5_#HUM?:G%-]FM=YMB\Q,#F,HQV;-P!
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M$L[?BQ)_&KU !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3;3A;/3-2^S6Y<%ML#E"85.1PNXCOP<>E=)JMA<P?$3PZ$_L]7O([J2Y*VI
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *B%M$+IKG;F9EV;B2<+Z#T]\=<#TJ6B@ HHHH BCMHHK
MB6=5_>RX#N222!G ]@,G@>I]:EHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *R[K0X[S6H-1FO+QDA50MGYN+<NI)#E<9+ GUQP.,@5J44 %%%% !1110
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MH **** "BBO/-4\0I9^,M0TSQ!J=[HR3;!HUXK;+9AL&[)QM+[]V1)D8QCW
M/0Z*YZY\10Z#80V]Z9;R^@LUGN! 4W;0,%_F90<D-@#DX.!2/XSTQ[#[98QW
M.H1"S6^?[*@)2%@2K$,1R=K?*,M\IXH Z*BN9M_%;W7BJ;2HM-N6MH]/BO1<
M#;EA(6Q\I;</N$8QG/4 <ENA^(]/.@:-]B;4;YKZ)GM4G96N)$7[S.6('&1R
M3W ZF@#J**YEO'6E+:6EP(KQS<WK:>8DAR\5P,YC<9X/RGIG/4<5I:'KMOKL
M-TT,%Q;RVEPUM<07"@/'( #@X)!R&4@@GK0!J45R?CYS9^';O47UZ[TL6\+-
M";8J-TW.W=D'<,X&.!USZCH=*FDN-'LIIIX9Y9($9YH#F.1BH)9?8GD>U %N
MBBN,\=W\VG7_ (:,=_<6D%UJ0M[DQ.1NC,;MC\U'(YH [.BN8M-7T^PMM6U-
M-2O;RSM=D4D;@R%9 -WR=SN$B#TX^M65\6:>!J0N([BVFT^2**:&55+EI /+
M"[20VXL ,'KUQ0!O45PGC+Q'(_AC5/LHU'3;[3KJT$@(VDK)*@^5D)# J6&
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MDCN;&417$,NTLA(W*<J2I!!R"#0!KT5EWVN0VE\;&*VN+R\6#[0T%L%W+'G
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MXZZB@"CHUO<6>BV5K=+&)X($B?RW++E5 X) ]/2KU%% !1110 4444 %%%%
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MPWEGLKZ[AN4\0;&VW;D[3J)0@@MT*DY]>IS7I</A[1+:;SH-(L(I?-,V]+9
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M.3N*_=W9YQZULTR&&*V@2"")(HHU"I&BA54#H !T%/H **** "BBB@ HHHH
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M9D)WX_AX()7G.:75-"\279TO5[>]T]=;L99&\EU?[,\4BA6CR/F_A4AL=0>
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MS@H!*\-\C8(.&Q^8(%'P,UQKUE;^(+U]1BNO-N593<#R9E,KJ%\L,1\@4 '
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MLUK+/Y;R>6A?8F,MCL,D#]:Y#2-/\1>&=/L+%#IMSYVIS27(42;O)EE9R4[
MKOR=W&!CJ178S1":"2(G =2I(]QB@# M?&-G>#0C#:7A&MVS7-J2$& J!RK?
M-PV"/4>]5M+\>6>J2:05TS4(+;57DBM[B94"^8@8E" Q8'"-SC''6LS1_"7B
M&P?PL+B;3&CT&&6W C:3,Z&,(K<K\IXY'./4YX?IW@_5[/2_"UH\EDS:/?27
M,K+*^)%99%POR=?WO?\ N^_  [P_KL>E6VO/J%U-*!K\UK;+--N;[JD(&<X
M W'DX !J_:^/=+NUV(DBW7V[[!Y#.G,NPN,/NVE2H)!!YZ8SQ69+X,UDVE[+
M;7=G!J*ZVVKV3DL\>2NPQR# ."I8$CU]JT[[1=7UK2([;6[71[X2RYN+,EQ"
M(PI V.5+;]V#NP/08ZT 6IO%<43Q0#3KQKY[>6X^QYC$NQ&VD %L,<] "?KT
MSOJVY%;!&1G!K@+CP'>7/AVVTB[-K??9X7^S74]Q(L]G*78H8Y I8A5*+R1G
M8/I7=6D,EO900RS-/+'&J/*PP7(&"Q^O6@#!N/&EA;PF\:"X.EK=_8WOU"^6
MDF_RR2,[MH?Y=V.OMS7-^*O$M_>^'_'=LEO=6)TB(K#<PSA6W>4L@.5;<"=P
MXZ8'//%7E\$7HT"]\+O-;/HMQ>FX28LWG)$TOFM'MVX)W9 ;=T.<<<KK/@_5
MKV/QA;VT]D(->1?+:0N&B80I$<X!&/DS^...M &K!XPLX[B]MM0MKJP-E9"^
M:2X"XD@Y!<;6)'*GA@#R.*JR?$+386U!)+6Y,ME8MJ!2)XI"\*_>P5<C<O=2
M0>1C-1:MX/O-<U2]DNI((;6[T4Z:QBD9G1RQ;> 5 (!/KVITFD>+=3\+ZGI>
MKW6E-//8RVD;VX<+(SKM\U\C@@?PJ".3STP 68O&D;3Z>D^BZG;0ZA.L%M<3
M+&$8M'YBD_/D @$#C.1C -3V7BZVO[>YDBL+P2V^H?V<\#>7O\T$9(P^-H!W
M=<XYQ3-4\/7.J>"HM*,L4&HP1Q/;SJ2RQSQ$,C X!QN49XZ$U%I?@Y=*\42:
MG%<EK:2WCWPL.7NE#*9S_M%&P?7)H CM/$VF68UB<K?(Z:LMDZ74P(,S)'@(
M2Q54PP/4=^,G%7[CQ3;VD4 N;:6"[G>58[::2-&(C.&;<6V[>5P<\[AQZ92>
M%]0":[%<6^EWEMJFI_:WMKAF*/$8T0HWR'#90," >?I5&#P3K>CQZ;=:+?VW
MVNPEN%BM;R222$6LQ4^3YF-_R[%(./;&* .N\/Z[:>)-'BU.R$BQ2%E*2 !D
M92593@D<$'H2#VK3JKIZ7B6:?VA+%)='+2&%2$4G^%<\X'3)Z]>.E6J "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>7]WFYWE8]P0-%;^9N)906?&6.2@7L10!W&B:Y%KBWYCMYH#97CV<BS;<ED
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M:>,7E258=!U.2[M@AN[0!/-A#NRCC=AON%N#]W![XKH+&XEN[""XFM9;661
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M01YYYH Z#P_K,/B+0++5[:.2.&[B$J))C< ?7&1FM*N2^&!!^&?A['_/FO\
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M-->T%H^GVC6P;<(3"I0'UVXQFLX^)$DUJZTRUM_/ELY8HKA1* Z>8%(?9U*
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MXW?.2.F01GG(-:UKX]CN39R-H][#:W.HOIIGD:/]W,'9 " Q)!*XR.!D=>:
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M0ATN_?7'O=0OXI[:)F:RMXX-GE%EP2S;CN.-P' X9NN1C8HH *I_V3IN5/\
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MF]1X'A%P)(@9%$1Z.2H.%/J>.#0!J451DUFPBO1://\ OC((L!&*AR,A"P&
MV"#C.<'-6+JZ@LK9[BYE2*%!EG<X [?SXH FHK!U'Q?I.GZ)J>J&9Y%TY"UQ
M"L;"5#C(!0C*Y[$C&.>E9<_C 6GBZWBNKN.+1Y=)DNPK0L'\Q947ZG@MP![T
M =E16<^NZ8EA;WHNUDM[B/S86A4R&1,9W*%!)&""3CC-4[KQGX;LX(II]9M%
MCF@-S&P?=NB&/F&.W(H W:*QCXKT06LMR;]/)BN!:R/L;"RG&$/'7D<>X]:9
MKVMVEGIU\O\ :\.FSP1HS7$\)=8MQ^4[3@-G!&,_RH W**H7&LV%K="VFN-L
MI=(SA&(5G.$#$#"DDC )&<TV37M+AOX[*2\1)Y)/)3(.UI,9V;L;=^/X<Y]J
M -&BJ>HZK8:1;K<:A=Q6T3.L:O*V 68X 'N36=%XR\.365]>1ZQ:FWL2!<N7
MQY>>F0><'L>_:@#=HK)A\3Z+<Q/);W\<P2<VY$0+L9 NXJJ@98[3G@'CFE/B
M71OL]G<"_B:*\E\BW=02'DSC9P.&R",'G@^AH U:*Q-<UJUM=/O5&KPZ;- 8
MU:XFA+K&6(P,' 8D<8![U%XK\0Q:+HFI/#=1QW\%F\Z!HFD"8!VEP/N@D$ D
M@=?2@#H**PK;Q)9VWA_3[W5+I8Y);..XF8(2%!4%G8*#M7)ZG %-\1^([;3-
M$O9K>]B%TEFUS$?+,JA<':[;>BDCJ2!^5 &_16=H%Y+?^&]+O;A@9KBSBFD(
M& 69 3QVY-9]IXFTNWLVN+WQ!9SQ2WTEO#*%$:@[N(NIW%>A;VSQ0!T-%4=+
MUC3]:AEFTZZ2=(I#%)MR"CC!((/(."#^(K/N_$MN->N- MRZZA'9_:=[PLR+
MDD+Z ]#W'3'6@#>HKE/!GB^UUW1='2ZOH&UBZL4N)(E&W)P"V.W&1D#D9K9C
MU_2I=06Q2\3[0X<QJ00) OWMC$8;'?!..] &E16=!KVF7"R-'=J%CB$[.ZE%
M\LYPX+  J<'D<4^PUBPU.:XAM;C=-;D":)E9'3(RI*L 0#V.,&@"]17+:]J^
MJV?C'P_I%E/;1V^IK<^8TL!=D,2!AC##KGO4.F^,#%J?B*RUJ6U$&C>4SW\"
M,L9612=K+EMK+CGDC!!XH Z^BJ+:E;R>1##<!9[N)I+?=&Q#  '=CC@9'<=1
MZUA>&/%:7/@S1M2UFX07E[ 92L49);;DL5103@#&3V[T =7168GB#2I9[6&*
M]222[@-S;B,%O-B R67 Y'(_,>HI;77]+O;6UNK:[$L%W*8H)%5B)'&<@<?[
M+?D?2@#2HJC9ZS87\XAMI][M'YJ_(P#ID#<I(PRY(Y&1S5XG R: "BN>M/$V
MEV]DUQ>^(+.>*:^D@AE"B-0=QQ%U.XKT+>V>*T]+UC3]:@DFTZZ2=(I#%)MR
M"CC&00>0<$'\10!>HK O_$UO%KLN@P%UU 6;7(=H69%YPOH#GGOQCWJGX,\7
MVFNZ+HZ75] ^L75BES)$HVY.T%L=N,C('(S0!U=%9T.O:7/J"6$=XAN9 QC4
M@@2A>&V$C#8[X)QWJQ>ZA:Z='&]U*$\QQ'&H!9G8Y.U5&2QP"< = : +-%<A
MK?BZ.UF\.7MEJ%M_9-]>R07,C+V6*1NI/RD-'@C&<\5LVGB71K_3EO[._CN+
M=I3"#$"S&0=4V@;MW?&,XYH UJ*S6U[35LH[O[3NBD+A D;,[;"0WR ;N"#G
MCBJ\GB[P_&MNQU:U(N83<0A'W&2,8^90.O44 ;5%9R:]I<NG6U_%>)+;77_'
MNT0+F7@G"J 23@'( XP?2FCQ#I+Z=!?Q7B36TX+1-"ID+@?>PJ@GCOQQWH T
MZ*@L[RVU"SAO+.>.>VF4/'+&VY6![@U4_M_2_MJ6GVQ!+)*84R"%>0=4#8VE
MA@_*#G@\<4 :5%9%OXIT*ZU,:;;ZI;RWAE>$1(V3O10S+]0#G\_0U=O=0MK!
M8_M$NUY6VQ(J%V<XSA57)/ )X["@"U17#Z#XHFU/0K6ZN]:M+>6769;6)_(X
MN8UF9%C5<Y!90.><5U0UFP-\MD)\SO(T2C8VTN%+%0V-NX $D9SQ0!>HK(B\
M0:?J)>WTZ_B:Z:%I824)5U!P77H'4$@94XY'/-8W@OQO8:[H^CPWFI6S:W=V
MBSR0+\NXXRVT=,CT'(% '845Q6K^(KNV\.2ZCIFL6M]MUB*V+I!PD;SI&8NN
M"RAL;N_H*T[WQ)9Z5<:[=7&J)/;Z;;1RS6<,.Z2W^^<DC.=V.F!C;GO0!T5%
M9&G^)=-U":TMDF*7ES;_ &A+=D8-L[GD#@'C/T]:OVE[;WT3R6TF]$D:)CM(
MPRG##GT((^H- %BBLVXU_2[6Z^S3WB))YBPDD'8LC8VHS8VACD8!.3D>HK#U
M37KN[\53>'-,N_L5S'9"Y6=[8R*TC.556!'W,*<D$=1@C'(!UU%5+O4;;3HH
M/MDP625O+140LTCX)(51DG@$X&> :I-XJT%(+.=M5MA'>[OLY+_ZS:"6Q],'
M\1CK0!L45C1>*]#FM[2>/4(VCO)C;P$*WSR@X*8QPW!X//!K1BO;>>[GM8Y-
MTUOM\U=I^7(R.>G2@"Q15#4-:T[2R1>7(C*Q^:X"EMB?WVP#M7_:.!6-X@\3
M)9ZCHFFVT[)_:CO_ *5%$9-D:Q,X9.""20H[\$F@#J**\]M_$.L7<VJ6#Z[:
MV=SHYB$UU)8D0S KO=F#'Y<*1@!AR">00!U4.N65KHMA<7>I)<F:V683Q0G]
M\H4%I0BY(7D$]AD<T ;%%9EQXBTFULH[R2^C-O)%YZR1@R Q?W_E!PG(^8\>
M]077B[P]93K#<:O:K(Z1R*H?=E7.$/'8D\?G0!M45%<W4%E;/<7,J10H,L[G
M %9EQXFTV+3-1O(Y3(;!"T\&QED0XR R$;AGL2/>@#8HKF_"E[J6K65MJT]\
MDMI=VD4AMS;E&AF(#,%;C*8.!D$\=3724 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%4[75
M;&]O;RSMKE)+BS95N$7/[LL,@'\*N4 %%%9LWB#2H)Y89+Z(-"<3$9*PG_;8
M<)_P(B@#2HJ*WN(;NVBN;>5)8)D$D<B'*LI&00?0BI: "BBB@ HHHH **K7V
MH6NFP+/=RB.-I$B#8)^9V"J./4D"K- !7#>*M*MO$27]IK'AR[FDMW_XEE[:
MA?,^XI!5PV4(?(^;"G ZUW-% 'F@TWQ!I-]IUSJ^G7VN)<:/!97IL+C:Z3QE
MR2P+H&5O,()SU7WJS!8ZAX<UZ;9X9>^TG4=.@M1;6C1L+5H]X\I@[ &,B3[W
M3KQS7H54[+5;'4I;N*SN$F>TE\F<+GY'P#C\B/SH YRVL[_3_'LEZVF,;.;1
MH+?S+;;Y<3QO*S)C(.,.N,#\JP/#>C:UHMMX.OKC3[ADT^SN+*]ME :2$N59
M9  ?F'R '&3@_6O3J9+*D,32R'"*,DXS@4 ><-X=U&W:SG%C,RS^*CJS0J 3
M;PE&7+<]2<-@9/S>QKH_"EI=6NJ^)WN+66&.ZU,W$#. !(GDQID?BC=>:OVW
MBO0+Q8&@U>T=;AMD+>: )6]%)X8^PK8H X+QUX0U;4]'\03:9K%ZTM];;!8+
M% 5?"X"!F7<!G)^\.6)[UU-E)>64MEIDZ7=YFW9Y-0=8U4,",*P7')SQ@8XK
M4HH *X]K6\T3X@:CK!LKBZT_4K.",R6R[VADB+\,O7!#\$ \CG%=)?ZK8Z6+
M<WMPD/VB9+>+=GYY&.%48]2:N4 <)XFTW4M6\'>*&ATZ;[5J:K';6I*^8555
M +<X&3N/7IC//%375I>2>,M1OX]/N3:RZ"MLC[ -TH=VV8SG.&'M[UVM% 'E
MUEINLZ-;>%[J;1=1O;>'18]-O+6SG\N:WE3;\V-ZAE."#SV!JQJWAV[@MX6T
M'3[O2=0M[ ):I;;9;:;+NWV:="2N!G[W &]L'U]#NKJ"RM9;FYE6*&)2[NW1
M0.IHL[N"_LH+RUD$EO<1K+$X!&Y6&0>?8T <1+I>K1^*UO\ 38[NVDFOHCJ%
MM(!)9W,850TRD_<<  #&"2HX(YK8\;:=J&H:1:2:;'Y\]CJ%O>FV#!3.L;AB
M@)XSW&>X%=+4<\\-K!)/<2I##&I9Y)&"JH'4DGH* //O$7A[4-?/BC4;*TEB
M^VZ$-/@@E 1YY09&R03QC<%!/OVP3I6T=]+XYL-6ETJ[AMDT62W8NJDI(948
M*0I/)53T^G6M^+Q%I$LD48OHU>8XA$@*>;QG*;@-PP,Y&:LZ;J=EK%BM[I]P
ML]L[,JR*#@E6*MU]""/PH \RT?2=<T+3/"]U/HNHW45MITEA>6EI/Y<\#EU9
M77#J'4[<$9]#VK>LM&EL_%?AN2WT1K.PM;&[C9$PRV[2O&RJ3D\X5LXR 3UQ
M78VNH6M[+=16\N][67R9A@C8^T-CGKPPZ>M2SS16T$D\\B10QJ7=W.%50,DD
M]A0!PVO>#KW5-;UBRA;R='UFV2>>56PT=U$-JD >O[IL_P#3(CO3-7TO7-0^
M%>H1W=D9=?U*)&FMXB#A_E 4$\ !5&>>N?6NQT_6;#5)+F*TG+RVK!9XWC9'
MC)&1E6 .".0>AJL/%6A,9PNI0DP.4F S^[8=0W'!'H: .:UG3=2D\1OJ>BQW
MUK>M-;"2*10]I>Q#;EG!_P!6Z#=R,'Y1C/:OI.E7L&H2:/JOAZZO!%J<E[;:
MBUSFUV-,TH<J7RLB[B,!3D@<X)->A0S1W$$<T+J\4BAT=3D,",@BGT <A\33
MCP3(?+,N+VR^08RW^DQ<<\<UC>*=!OM8;Q1J5C83@WFB+IT$178]Q+N=MQ!Q
M@ ,JY.._8#/<ZMHUCKEF+34(GE@$BR;5E>/YE(93E2#P0#^%7E 50HS@#')S
M0!R&I6E_%XA\-:Y!9S2V=K;S6US;HH\R'S%3#A>^"F"!DX/&:HCPA=W?AGQ(
M@!MKN_U)]3T]6(S;RKL,;''0EH]Q]F(/.:[ZJUGJ%K?^?]EE\SR)F@EX(VNO
M4<T <=XATS5;_P"&M[&;%Y-8U$QSS6\1!*N70[,G ^5%"Y[[?>JNIVFL6^H>
M,HAI-W>P:Y9AK.:':=C"#RS$X8@KSR.QW'OQ7HE% 'F46G:KIMY:R7OA[4=0
ML;W2+:SE@M;E5>WEB#@HZ^8JLC!SSDXY]:D.E:MHUQXBLTT26>TU3388K/[&
M59+=HX#&83N(( /(/0Y/?BO0+W4;33D1[NX2(2-LC!/S.WHHZL?84ECJ5GJ*
MR&TN$E,3;9%'#1GKAE/*G'8B@"GX8AN+7PII%O=V[V]Q#9Q121.02K*@!'RD
MCMZUPXTC5/[.C0Z5<[AXM;42NT<6YF+[^OH>G7VKN)/$VBPWAM9=0BCD"R,"
MX*H1'_K,.1M)7N <C!S26/B?1]1U232[:[W7\89GMWB='0#;DD,!C[RXSUSQ
MF@#/\.6EU;^*?%5Q-:RQ07EW#);NX $BK B,1_P)3UJ"]M;^W^(%QJ*:?//9
MW&C+;"6(J0LB22,002#R'&, UUU% 'FNB:+JEO:_#^"73[B%]-M9H;Q@!^X9
MH=@[\_-Z9]:7PQI=[%8:?IFJ^%[EK_1X6B6]FN=]NX"% T7SDY<8!&T8!.>@
M!])HH \K?PUX@.BW^FZ2;QK 6D,MI;:FP$MO,DJO]G64<M&57&<D#C#=:ZWP
MQ&+J[FU-_#UYI=P\2PR/?S"2:3!SM!#M\@R<$XSGIZ]/10!Q'BW39;_QKX8N
MFT>74+"Q%T;G]TKJI=%"<,>>1VZ5'X<\-SP^)M>E73#IOAN]MUB737*[99>0
M\@C4D(".".">I%=W534]-M-8TZ:POHC+;3 !T#LA."#U4@CD#H: .7\$Z??6
M5K<F_D^TIIIDTVQD7YF>"-S\Q_VCA4(]8O>L70M.UNPT7PI8SZ)<[(+.>"Y>
M'RQ/%(2NU-Y8;8V ))0Y)5?Q[NYNM*\+Z*))WBLM/ME"@X.%'0#CDFM*@#S7
M3] URW\!^$I;:P,&O:*T<?DSLN&1AY4H)4D;<-N]?D%:_A;PU?:)K%[:3,9=
M)MI&GT]W;+,\P!DR.VUA)C_KJ?2NSJM::A:W[7"VTOF&VF,$O!&UP 2.>O4=
M* .%\.6FK^'W:6TLM2ETF/3G<:7=!6EM)\J1##(3\R$ \9(&U>>U=SIM\NIZ
M5:7Z121)<PK*(Y -RA@#@XXSSVJQ)&DT;1RHKHPPRL,@CW%.    & .@% 'F
M*Z1JG]FPQG2KG</%K:B5VCBW,S/OZ^A''7VKI_#EI=6_BCQ5<3VLL,%Y>12V
M[N !(JP1H2/^!*>M=/10!R.I6E_!X];48]/GN+2;1VM?,B*G9()"V""0>0>,
M UAZ-HNJ06W@""2PN(7TZSFAO&P/W#-#L&>>?F';/K7I54UU6Q;5VTE;E#?I
M#Y[0C.0F<;O3K0!Q/@W3+R%=(T[5O#=TE]HR>4-0FN?,@P$*!X?G)RPQD;0
M"<] #O>*QJ!ET=K/3GNX4O,W#P*AGA7RV :/>0 22%+#D*3CU'244 >7Z=HN
MKV=AHK3:/=A=.\0W5W*F])',,GG[7'S$MCS%SWZG!JY=>&7N)=4OI[34+=-2
MU6.X@-BX6>SV0;!/@=V8'*X)P_(SD#T2FR.L4;2.<*H+$^@% 'F@L_$]A<:1
MJVHZ?=ZLD<=U:7"6+BWGVM*&CF*!E&6"C<N>"<]JTK32);+Q/X:FMM$>RL+2
MRO5>./#"!I7C95."<L=K9QD9/6NTLKRWU"Q@O;63S+>>-9(WP1N4C(.#S4]
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MGSLP@15W@#)"J"2.Y.*G\/:0-"T6'3A+)(L1<J9)6D*AF+!=S<G .,GT[=*
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M\1Z5I]R(+JZ\MC*L)?RW,:2-C:K.!M4G(X)'4>HJ&W\6:)=ZJ=,M[WS+P3-
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M_*\$# W9YP" :&E:U?\ B/7=16SO9[*'3=0$)@DL24GB$:,X9F4%7)<XPPP
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M$VV_G[BJ#+ G&X X!Z&N@\%6%]IVFZA%?VCVSRZG=7"*SHV4DE9U/RD]CTH
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M$9_BPJG(X/3IBG67BK1-0OX+*TOEEFN(C- 0C;)4 !)1R-K$ C(!)'>N<L-
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MIJ]E?:C>V%O*6N;$H+A"C+LW E>2,'(&>,U5OYM&UFZN?#%\HGDDMA--;.C
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M !1110 4444 %%%% !1110 56O["VU2PFL;R,R6TZ%)8]Q7<IX(."#@U9HH
MBMK:*SM8K:!2L42A$!8M@#H,GFI:** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *HQ:/8PZM-JL<3"]G18Y)?,8[E7.!C.,#)QQW/K5ZB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*4*[ A.T#)!W<$8X'ITWA_18= T.#2X"WDQ%]H+LVP,Q;:"Q)P,X&3VK4HH
MPU\'Z&EK#;+:RB&"[-[&OVJ7Y9B2V_[W7))^I-2KX9TA;R6Z6T(::<7,D8E?
MRGE&")#'G:6R <XSD ]16O10!D2^&-'N)=3DGLQ*=301WBR2.RRJ!@ J3@8'
M3 &*9IOA32-*OH[ZU@F^U1P?9UEFNI96$><[?G8\9K:HH S;_0-.U.>2:ZBE
M9I8?L\H6=T62/).UE4@,/F;J.YJIJ'@[0=4N+F:[L2[7, MIU69T25 " &16
M"D@$X)&1V(K=HH P+WP7X?U"ZMKFYL-TUM$($=9G4M&/X'PPWK[-D58F\,Z3
M<7%_/);R&2_@%O<D3R*)(QG"X#8 &3TQU/K6O10!6M["UM=.CT^*(?9(XQ$L
M;DN-F,;3NR2,<<U3T[PYI>E&(VENZ^3&8H0\SN(4.,JFXG8.!P,= .PK5HH
MQ!X1T4:3>:7]EE-E>N\EQ$;F4^8S'+$G=GDDY]:L-H&G->V%XT4K7%@K);.U
MQ(=@88;^+G( ZYZ5IT4 8FF>$="T?4);ZPL!#-*S.0)'**S?>*(3M0GOM IN
ME>#= T2ZFN-.T\0/+NRHE<HF[[VQ2=J9_P!D"MVB@"KIVGVVE:=!86<9CMH$
M"1J7+$ >Y))_$U:HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M$\1[63/S>I/6JUQI[2:UKFCZWH&K:A'?WJW5K/;RRBVD7:FT.RL!&49!R><
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MK,I"*<X8\\ X.#WQ7G_ARQCFTW3K74_"VL#5M&M)('>::40_ZHHWE-N*OOP
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M:5.]"05(P?O<XH [Y]:TM+%;YM1M1:N2%F\U=C$9R <\XP?R-3"_LS8"_%U
M;,IYGVCS!Y>S&=V[ICWKS93KUE<Z-JNLZ5?7ELB7EK,=*CDBE!>962X,2D,
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M:AU/Q9XBLX?$MXDNG^1HFH11>6;=MT\3+$Q&=_RD"0\X.3C@=P#J?^$2T/\
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M4"ZU+8O>W!M8E98OG"J@#R#.,_,<]N ,Y$FG:_KFHZE::)=PV^FZJNG?;+W
M$RJQD,:JF&Q@E68\G P.O( .ILKZUU*T2[LKB*YMI,[)8F#*V#@X(X/(-6*Y
M'X8!A\.]+#[=_P"^W;1QGSGZ5UU !1110 4444 %%%% !1110 4444 %%%%
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M5]_$VA1PVDSZO9+'=JS6[&9?WH4$L1ZX .:2+Q/H<T%G-'JELT=Y(8K=@_\
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MU&W9EC:7[^ 44X9P3PR@\$C(% $^EZ?%I.EVNG0/(\-M$L,9D(+;5& "0!G
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M=$@+MYT192P3<0!D9X(YSU/>N@TS7M-U-Y+>VO[>:YMT5IXT<$IGN?;(/Y4
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M3:A9K9W,DEQN,B#< <8P#AV' QSP,\TR?P'I=P,/<7X5M.&FS!)]HF@&=H;
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M-FMU#RKR&13T8@\X.#@]#VH J:;X7L]-:S*W%U<"PC:*R6X<-]G4C!"G ).
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M-I/H>F?0U*EO=:OKOAK53I]U8_V5;7'VQ)(BIR\:J(E_O\C=E<CY1SS7;T4
M<O\ #RQFTWP'I%G=6CVMU!!Y<L3IM(;))^O7.?>N6OM*U0^'=<TPZ3=O))XB
M6\0A RRPFY27(P>?D!S^76O4:* /-=<TC5[W4O%LVGV4[--_9T]L&S$MR8'W
MN@;C!( &>.M=)X7C@N+JZU6/0M0TV:>-(Y7U&0F:4KG P7;Y5SP>^3BNFHH
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M,>W+E&60JN<YV8.W.,]QDUTD&JV-SJ=UIT-PKW=JJ//$,Y0/G;GMSM/Y5<H
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MW:.$XRBL3D X'/4X&3P*+;PII-I+I4D,<ZG28C#9YN'(C0@ C!/S< #G/04
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M]9KITM#Y"-;7<?EG"I)@E90W)#'L0 <U3T[Q/J\^A^$[R6Y5I;_5I;*Y_=J
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MPF#1VRL&)Y'#<8P<^O2MV\UGQ!J=UK2Z$\4<NE7BP+',R"*0!$=O-)!< AV
M*XQ@=>:V)O!FBW%IJ%K)#.8=1G6YNE%S(-\B[<'AN/NKP,#Y1277@O1+S6O[
M6E@F%VRJDQCN9$2X"_=$JJ0),?[0/H: ,JSN/$6K^)]?LX];CM;;3KF-(U2T
M1BRO;J^"2>S,#GOBLBR\;W\;^')=1NRD1>2RUM?+0+!< LB$G&55G1P!Z;?Q
M[RQT2RT_4K_4+=91<7[J]PS2LP=E4*#@G P !QCI4$_A?1KB"_@EL(FCU"X2
MYN5/221=N"?^^%_7U- &*^JZS:ZMX2AFNLQZI<3_ &B)X5#A?)DD1<@#!7"@
M\<D'Z5E'QO>Z:=3;53<0W]G97=TMA-"HAN53YD>"51\RA1R"2?FZ<5VU]HME
MJ.H6%]<+(;BP=I+=EE90C,I4G .#D$CG/6JT'A?2X#'NBDG2*.2*)+B5I5C1
M^' #$\$<>PX&!Q0!2T:7Q VKPR74\4^DW%KN!D:,.)N"#'L'*%2>"21@<FI-
M5U:<^+-,\/VTQMC<V\UU+.JJ6VQE5"+N!&27R20>%]\B;0?"6D^&RW]FQW"C
M;L19KF2584SG;&'8A%R!P,=!Z"K&K^'M/UN:TGNTE6YLW+V]Q!,T4D9(PP#*
M0<$<$=#0!P.C:CJ6C^'XC;W2%YO%TMK<NT0S*CW3*V.RY]JW5\17T?C :7J$
M\]@9;J1+/? KVMW'L;:%D R) P!*L1T('45J)X)T1+1;58;D1+??V@!]KE)\
M_=NWYW>O..E6O^$>L([@7/ESS&.X:[CA:9F19CG+*I. ?F/'0$YZ\T </I_B
M3Q0-&\.Z_<:C!<6][J*V-S9K:A/E>9HPZL#G<" <=,>XR;<OB[5&\'GQ?;S9
MACU Q/IQC7!A%QY&,XW"3&&SG&>,5H^"?"K:?X?T^/5[:9+NTGEF2&2<21H[
M.Y#J 2,[6_ YP.];*>%=)CN994@<)+<B[>W\UO):8$'S-F<9R ?3(SC/- &$
M?$UY:^+OL&J27-FK7,GV53 K6]Y$(VPJ2 9$H(!*L1T( Y%0Z;XAU^XTW3/$
MK-$^D7%F]S=P,R?(/++J(=HW$@C:0Q.?8UTZ^'=/6[6X*S/LN6NTCDF9D29L
MY<*3@?>;CH,YQGFJNE^"]#T:]DN;&VEC#LS+ T[M!&6SN*1$[5)R>@Z$CH:
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MX@-RTF[._&=K#CKFEUS0-<O+3QO'!I,SMJ=W;26G[Z(>8J)$K'E^.8VZX[4
M=G:^)M'O&OA%>@&Q :X\Q&CV*<E6^8#*G!PPR#C@U-8:W8:G=7-K;3/]IMMI
MFAEB>)T#?=.UP#@X.#TX-<7XE\.ZWK&L:]-9V1B6XTVS2VDFD38\T,[2E& 8
MD Y"YQCDUJZ6U]!:WFKQ^"Q9:@(5C^S^?"9[@@YVAP=H0<XR<G)X'< Z^B@<
M@9&/:B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH :T:.RLR
M*S(<J2,D'IQ3J** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L^^T/3-2O[*^O;*&>YL
MF+6TDBY,9.,D?D/R%:%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %8$GB.674-2MM.TU[W^S&5+K
M;,J.7*!]L:G[QVL.I4<XR><;]>:^)K/2KC6=5U?2?$ \/^)-/ 2>0R 1W*A%
M9?-C;AUPP (Y&.^,4 >A6-T+[3[:[5&03Q+*%;JNX X/YU8KR>^UF*_NM.C\
M:/'I%KJ.B1/$)XAY27!+><H+?<?!C([C'K4KW.D6^K2Z+XKO9SI\VD0)I=SJ
M'RO)]\2,#CB<YC/][@<4 >EB]MS?M8K*INEB$K1@\A"2 3]2#^1I+":ZN+"&
M6]M!:7++F2 2B38?3<.#7"6D&D6_Q.N/M<<<3SZ#;-&UT )G(:8.2W4L$VAC
MZ=:Q/"U_&VD> X]2DCDT2:SN$D:5@T1NLC8)">,[?,P#W]\4 >OT5X_*B1VV
ME075R1IQ\6M'IQ,Y7-IL;Y5.>4#Y ]L8XQ76> &M8+OQ3I]D\8MK75V$,,;
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MA>-R048JH!)#=,UT%_<7,5C-)80PW%TBY2*2;RU;GNV#COV[59+JI 9@"QP
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M!S6G^#+Y-$FT/5]?EU'2C;/:0Q"W$4@C92HWN"=Y"G .!SR03C!8^$=5@O\
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MD*V-P Z<BMK4M#FO_$>CZLEXD2Z<)AY)A+>9YBA3\VX8P!Z&MD.K,RA@2O4
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MVLI)D%U<AC#$3RP49)^@XY]Q0!ACPM=3:EHM[>:E#.=.MIK>1!:[1,) H/\
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MY=+FEF<R09,[2(R'HPV !S@<XP.O?HJJV$UU+:![Z"*WG+NICCE\Q<!B%.[
MY( .,<9Q0!R>G>!+VPNM'E;71*NEW4\T>;0!Y5E#!@[;CE_F^]@?3O4\/@RY
M34!JIU.!-66R:T-Y!9[#,24(>4;SO(V=./O'V ZY65E#*00>X-59=1MX]033
MA*AOI(7GCA+8)52H)/H,L!_^J@#DY_AU%*E]-;WR:??W%U#>0RV5OLC@GB!
M?RRQ!+!F#<\C'U.M_8>KS6$<5[K%O=SM+FX$ME^XFCVLOE^5OX&2&R23D>F
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MVS8\F02-VW=M)497/MT)%-D\&0_V]=:E:ZIJ%I#>L'O;&%U\FX8 #)RI920
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M\1G3I[";4S'B"X $@5$ W,H)"LQZ@'D*N>:TG\2:%'%<2R:SIRQV\@BF9KI
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *Y3Q[9O=:?I+"TDNH;?5K:>X2.(RD1*QW': 20,] #75T4 >6ZMHM^M
MQKVMZ1IUR;&6[L)S9PH8I;H0L3*Z(<'."N.A8Q]^,];X4BT^6?4=5L=/U&V-
M\8S-)?B1'F95*_<?D8&!G S[XS72T4 >::E:"37O$.CZYHVL7UOJ=Q'/9O:>
M9Y$JB.-0C.IQ&59,Y;'7-4_$.E3S67Q($.D7;SW?DBT*V;DS$0H/D.WYL.IY
M'<9KU"VO+:\$AM;B*812-%(8W#;'4X93CH1W%3T <7'YD7C[6;B:QO&M;[2K
M812"U=D)0S%E/'#?,ORGDYZ5A:!:7UA9?#F6?3;]19VL]O<I]F?="[1J%##&
M5!((W'CWKTZ::*WA>::1(XD&YG=@%4>I)Z4VWN(+RVBN;:9)H)5#QR1L&5U/
M(((Z@T >7SV^J0V6J7<6F:E)%!XI:]F@BA=)9[;RPNZ,$#?AL, /[E3W=LL'
M]G:]I6CZL=._MA;S48IHY3/-^Z9!+Y+?-A6*' &3MSC@$^G44 <?X1W-XI\6
MW(L[J"WNKJ"6!YK9XA(/L\:DC<!_$#GO67K^G:K<:]XPM;""Y2?5-%ABL[A8
MSY9=1,&4R=%/S*.3GYLUZ)10!PMI#+J_B#PGJ%G8W-D-/M9DO5FMVBV*T:J(
M>0-WS@'C(^3/<9N^*[9[CQ1X1;['-<007TLDS) TB1CR)%4L0"!\Q7K76T4
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M7_A,?M7EFQD/[CS@Q?&W[NW/->E:1I-OHUD+:W>>7)W/-<2M++(V -S,W).
M!] !VJ_0!Y;K=G)Y/CP?9+Z&*>[LI;8QVCXE=5B'RC WC>N"%Y(SC/%;GA*Z
ML;[Q5J^H$7,.I7T41-O/8S6X6.(;<J9%7><L,XZ?*/<]/K&CVNMV0M;HS*%D
M66.2&5HWC=3E65AW%)IVCQ:>YD-S=74Y7;YUU*78+UP.P' S@<X&<X% &%>B
M:T^)UG?-:74EK)I$EN)88&D57\U&PQ4';\H)YZXP,GBN5\/Z=<VNE^ ,Z5>0
MSVM].UUFRD5HE:.9<O\ +P"63D^WI7J]% 'F?A:S$LNFZ9K.CZP=:TJZ>7[0
M_F+;9RV9EDSM8,K'Y>I)P1W&]XRM#=:QX4(LI;E(-4\V5DMVD$:>3(,L0#@;
MF7K_ $KKJ* /*I[.[BT[4YUTV^\JW\71:AL6TDW- &C+.BXRPX8_*#T-1:[;
MW6HV/CLQZ1J+B]N+*2U5K*0F4*D0) VYXVG(ZCO@\5ZU10!P%Y8HWC37+A=+
MG-O+H$<,;BR?:SAI<H/EY.UEX_#M6;H-F;6]\,W.L:5=- GAB.R?S+&20I.I
M7<C+M)!P&ZCGWKT]W2-&=V54499F. !ZFH[2[MKZU2YM+B*XMY!E)8G#*PZ<
M$<&@#RS3]-U'PI'H$FHZ?JDNFBVNH#'8*\LED9)_,C5E3)*[,*<9P5%:5GH%
ME;^*/#%O#H-S'ID&G7D>RX@>98O,>,HKL00"5#\$\=*]'ILDB0Q/+(ZI&@+,
MS' 4#J2: .:\=VE]<>'H&T^![C[+?6US/:Q#+3PQRJSH!W.!G'?&*R+VUFN]
M<\0ZU96]T+*?0A:LGV:16N)\N5PA&XE5(&<?Q8[''=6]Q#=VT5S;2I-!*@>.
M2-@RNI&001U!%24 8OA!7C\&Z+%+%+#+%8PQR1S1LC*RHH(((!ZBN.T^#4K&
M[DBM4O;K29;6[;R+NR<3Z>[<[$? \Q68X P3P""0*](EEC@B>6:1(XT&YG=@
M H]23TIMM<P7EM%<VTT<T$JAXY(V#*ZGH01U% 'FFBV-S9#X?F/2+M9+329X
MKI?LKILD,48VN=N%)=3U[\U'X=%P-=\-W4ND:E!;1Z1<VTMO_9\BQVKYB/E#
M*[B %/S$G<1QSQ7JE5+K5=.LKB&WN[ZV@FF8+''+*JLY/0 $\YP<4 >96.E7
MFG?##PM<0Z->"YT^:%]1M88&CN7C4." " S%6<.!WQQ6C-IEE<V27VE1:[I,
MUSJ(NH[YK>21UF$+*9)(7!(C*_(<@9)[<$]K_P )#HOVT67]K6/VIG$8A^T+
MO+'. !G.?E/Y&M*@##\*MJ,OA> ZC;16M\3+O$4912=[8D"GE=PPVT\C=BN*
MT_3=1NO"GAG1I+.Z@UO2]4BDN)GA8*H1V,DHDQM8.I/0\E\>N/4:* /--;\,
M:O/J&O:7IL9BM)W36K.XP,)>*/\ 5CTS(B.2.Q8=ZGUVSNM1\(Z;=W>ESM>W
MVK6=[<VR0-*T*"1"58 '&V-0#[@^M>B44 >7:Q8ZD=0\72Z?IMZZ?:].NEBC
MA:/[5'%M,JQL0 6PO;K@4:G:K=Z?+KNBZ+K!#ZA97&HQW22":[BA8DJL3\DJ
M-IX'S8QSBO1[_4[#2X?.U"]M[6+^_/($'YFK*LKJ&5@RL,@@Y!% '&^&Y?M/
MC_Q%?QV5Y%:WEI9>5--:20B0IYH;[RCD;EX/-,U2U@B^(TE]J.FRW-C+HPMT
M=;-IU+B5RR?*IP2K#KC-==;WUI>23QVUU#,\#[)ECD#&-L9PV.A]C5B@#S(:
M#J7AKP-X=U**WWZOHCG%L7&9()7(:WW=,A63'7YD&*[_ $BQ;3M+@MY&#S %
MYG'1Y6)9V_%B3^-176AVU[K%OJ4\UVS0* MN+AA 2#D,T8.TL#T)]!Z"IGUG
M2X[EK9]2LUG3[T33J&7C/(SGI0!P^E6FIP:XMO9BYN-*N#=L\%_:LDFGR-N)
MV2D .CL< ')P00< XSM 6]=? %L--U*"73;.>UNI);.15@E\@(,DCD;A]X?+
M[UZM10!Y[X/E!TK2+#4_#U_'K&BPO'+<2VS[4.TJ\B28Q(9/1<D[LGI69X9T
MVYL[3X;JVE7D$MHDZW>;-U\HM"R_.=O&6QU^M>JT4 <EXYMGNF\.(MG-<I'K
M,,LHC@:4+&%<%FP#@9(ZUS-U8ZFDVLSVVG7AMH?%%OJ$D MW4W%NL<8<Q@CY
M\.N[ ZE/I7J=% 'FVNZ==7J^-]2L+6Z-KJ&BK:QQ"W</<W(60;@F-W"LBYQ_
M*IK66YT_Q0\VHZ=?36-]HUO;VCI:22")TW^9$Z@$H6W*<L #MZ\5WD]Y;6LD
M$=Q<11/</Y<*NX!D;!.U<]3@$X'I4] 'CVAQW>DZ?X=?5M(UI].DT-+"1+6W
ME,EO,K$L'C4;MK@J,XQ\HK>TW0;2W\;:5 -#GCTZ'0GMT6XA:9(CYJE4:0@C
M<%!XR<=,UZ'2,RHA=V"JHR23@ 4 <K\1[>6[\$7D$%K-<S-+ 4CAA:1N)48D
M!03P 3FN?UG3VN=2\?RC2KF0W>C116S_ &)SYK^7*"JG;R<LF0/;TKT:UNK>
M]M8KJUFCGMY5#QRQL&5U/0@CJ*EH QK6*:?P7%#Y<@G?3PFR12K;O+Q@@\@Y
M]:XK2()IA\.%GTJ_4:?:O%<^=92 0N+=4&[*\?,, GTR..:].HH \EMH=1TR
MQL+UM+U5M/L];U!YK>V@D29(I7?RI43 +* W;LYKOO"MG9V>E2M86-U9V]Q<
M27 2Z+>8Q<Y9BK<IDY.W\<#.*W** ."\(B7P:=2T/4K2\\HWTUS9W<-M)-'-
M%(VX E =K@D@@XSQC-6]:DOAXI\.:RUE<MI4!N8I46-G>)G51'*R $@<,O3*
MA^<9('957%]:-?M8BZA-XL?F& 2#>$SC<5ZXR1S0!YE=:)<)''*VG7,EG<^+
M$OH8!:NYB@P [LH!* L&;! Z^]:-S;:/:_$[4(+G2TDMVT&$"**S,@YFFR,*
MIP2/SKT2LR/1+>/Q%-K8FG-U+;K;,I(V>6I+ 8QGJS'.>] '!^%=,U7PM?:
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M9+ NWREB4DJ  N>"3WH X]?&?B:+1X=>GBTM].BU1K"Z@BCD$I3[08!(K%L
M@[?E(.>>1T%Z^\::A'X>U;Q':1VSZ?I=Y)!);,C>9+'$^R1@^["MG<0-IX S
MUX3PCX:>72)(]6^VHBZM<7BV4RJL9_?M)$WW=Q'*MC=C(Y':ME_!FG-)?*)K
ME;*_G%S=6(9?)EDR"3RNX;BHR P!].3D I6^M>(+[Q5J]C;-IBV6FO Q\R-P
M\L<D9;&=V%(..<$>U4M/\6:O>7YL'DLC)-HKWZ3PP/Y<<JLJE5);$J?.,,,
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MOD?W8X&35J@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBL;Q--.-)-I;)<F6\=;<RV\3.848X>3@
M'!"DD>^* *7A?Q:OB'4]8LGM_(:SE1K?/_+>V=?DE'J&(?\ #%:$OBC0()_(
MEUJP243" H;A<B3CY.O7D<>X]:Y;5-(O/#OB[0-:L#J&H1[&TZ\B2W0[+8C*
MM^[1>$<#CDX)QWK,UW2[VYTSXA+!IEV\VH7$#6N+9LS!8HER..S*W\^] 'HT
M>JZ=-=W-I%?6SW-J UQ"LJEX@>A89ROXU/;7,%Y;1W-K-'/!*H:.6-@RN#T(
M(X(KC?$^G7H\1:=?Z0=AU>,Z7? DHPCVM(LH!_C0"0<_WO:NFU:PEN/#=]IV
MGNMM+):206[#@1L4*J?;!Q0 Z#6]+N;AH(-0MI)50N464$[0<%AZ@'@D=*98
M>(-&U2Y^SZ?JMG=3>69=D$RN=@;:6P#TW#&?6N/LK&\U&/P4O]GW5C<Z(<WI
MDA91&JP-&T:-C#AFVXVY&!FM;X>6+V7A2**XLI+:Z6XN2RRPE&P\[NIY'(*E
M3_\ JH WKO6M,L;@6]W?V\,IV_))( 1N.%SZ9/ SU/ K%GUS4T\5:SI:&U\J
MUTN.]MV,3$AV:12'^;YA^[[8ZUS'CBUU2^;Q-9VVC7A\V"V:"2T@!%YM(+%W
MZY4Y 08/?G/&S+'<OXUUF^^PWBP3:%#"C&!CF0/*Q3C() =>GK[4 =!X6U*?
M6?"6CZI=!!<7EE#/($&%#,@)P/3)I[ZYICQSK#J=FLD<32%GD&U%'&\\C*@D
M G..V:I^"()K3P)H5K<PR0W%O80PRQ2*5975 ""#[BN5T2QU.Q26VMX[^;1F
MTN8);7UJPGL)#MQ CX!D4\\<XV#GID [6UU>VAT:PN+[4K21YX583P_*DQV[
MBR#).W'/4X%)_P )/H&R)QK>G%)=WEL+I"&VKN;!SV')]!7 P-=Z+:^!YUL-
M1:^L]'>VN(8[1IC&-L0(:,$,#N488<?*1W!$VFV,"KX(MM/M=0FM]*O9A=&X
MLGC>%C"_+J1\OS2*1Z @YP,T =Y'KVDS:=%J,6HVTEG*VR.9) 5=LD;1CJ<@
MC'7BJE]XOT2QATZ9[^!XM1G\BWD1P58\[B3T &#GWXKC;:+4;,.?[&NS$_B6
MYN//6T+2V\3JVV6-6'\1.TG!P&/%066G:I:Z/I'F:1J&;#Q1/=2H4#/Y3F?#
MC!^8?O$R1QS[&@#T5M>T=;>:X;5+(0PRB"60SKMCD.,(QSPW(X//(IDGB+18
M;\6$FK62W9E6'R#.N_S&SM7&<Y.#Q7GNNV>J+I_C338]&U">>_U&"\MVBAW(
M\>V 'YLXR#&P(Z]^G-=#8V$]QXS\53FTF@^UVMJMK<RP$#>J.#AL=5++_3I0
M!TT.M:7<7CV<.H6SW**7,2R MM!P3CN >#Z&GV>JV&H.Z6=Y#.\:J[+&X)"M
MG:?H<'!Z'%>>Z!8+<:796^I^%-6&J:18RV\CSSR>2?W11A"V\AM^   .!Z8&
M=KP;:ZI8:C<VLD]U=Z0MK%]FN+^V,5S$06_<L2!Y@4<[L=\9- '37VKZ=IF/
MMU[!;Y4M^]D"X4=6/H!Z]*BO/$&C:>^R\U6S@?RO.VR3J#Y>0-V,],D#/O7/
MO%<Z9XXUNYOK*YN].U.R@2!X86E"F/>&B8 ';G?N!.!R>:Q_#>A:AHFK^$HM
M0MIY3I^B3P33+$TBQ2,\95-P!R0JL./3WH ]%M;JWO;6*ZM9HY[>50\<L;!E
M=3T((ZBJL>MZ7+>&TCU"V:X&_P#=B09.SA\>NWOZ=ZQOAY:W%EX'T^TNK:6W
MGB,BM%*A0K^\8C@]L$5RNG0ZHVN^&;N;0K^U6SOKT7%O%;A8;<2+( 5[L"2"
M7Y!).,=* .]M_$^@W=S!;6^LV$T]QN\F..X5C)M)#;<'G&UOR/I4L6O:1-92
MWL6J63VL3^7).LZE$;.-I;. <G&*\\L=,O(?#OAZ(Z7=I/!XEENYE^S,"D1E
MF(<\=-KI^>.QK;31[JV\>7-A $.BWS)JTZYYCG0[2N/1V$;_ %1_6@#LY[F"
MU@:>>5(XEQEW.!R<#\R0*J1ZYI,KPHFI6I>:0PQ+YH!=P,E0.[ =1U%4_%MI
M%?>'Y+>5+XJTT1#V.?.A82*1(N <[2 V,'@=#7'R6^OI::1>:C;SW_\ 9VO^
M:UQ!9E)KBW\AHQ*T0YW!GVG Y"YQB@#OTU?39+:>X34+5H;>0Q32+*I6-QCY
M6.>&Y''7D5A:]XJ%K;Z3=Z7>64UK/JD5E=,WS;%).[D,-K#'.0:Y5K76X4O=
M3BT6^=;?Q1_:+VA0"2XMS"$R@S\S*?FQZK6IK4']I6FEW5GX?N;9)=>M[R=&
MM<2.J_?ED49QT YYXH [73M5T_5[=KC3;V"[A5S&SP2!P&'4$CO3;S6--TZ5
M8KR_M[=VVX$D@7J<#.>F3P,]3Q6'X8MYX/$GBR22VFBAN;^.6!GB*K(H@C0D
M9'/S*:RIDNK/Q+XBL-2\/7.K6.L2136LB1"2$@1JABE)X0!DSD\<D]: .PNM
M9TRRNH[:ZO[>&:1E54DD )+?='U/;U[55N/%GAZUF>&;6K!949D:/SU+!E7<
MRX!SD#G'6N-N=.E;6M=TC6?#^IZE!J5VMS:SV\SBV<;$ 60AP$*,G4CH!C/&
M=;1].E?7?&CO8R(UW<H]M++"5$@%LD>58C^\&'X^AH TK3Q/::Q;:'=Z?JEC
M#'?L&\B<@RRJ8RVQ &&'&5)X. #67=>++B_U+6+72=6T>S&E21K(][\R2*4#
M.V0PP%W ?53D\\96G6M__87P[ADTN^BETR>-;I7@.8PML\98XSQO8#WZ].:O
MQV]T9_B 38W>V]P;;-N_[X"U2/Y>.?F!'Z]* .H76;*STBSN=1U*S_>P+(9U
M;:DOR@LZ@D_+SGJ< \FGW6O:19)&]SJ5K$DD8E5FE !0\!\_W>1STYKA=/&H
MZ'>:)=W>B7][83Z!!ITL<$&^2WF0Y8.AP0K X)Z?*,\<U%XGT_4);+5M,L_#
ML]K'+X?\BU%C"K!V DQ []%"9&%&-Q8X)X% '=#Q)II\2G0!<)]N6 3LA.."
M< #U/!.!V'O5BTUG3;ZZ>UM+^WFG1=[1QR MMSC=CN,\9Z5Q-QI^JW>MW)AL
MKN ZAX96RAG9,"&8-)]\Y^4C>I]?QJUX1ACO+JPN+GPWJEAJ=A;&WEFO97,<
M>0 R1$N0X) ((& !V.!0!U=[K>EZ;,(;W4;6WE*&0)+,JL5'5L$]/>H8/$VA
M74]I#!K%C++>+NMT2=291S]T9YZ'\CZ5DZU;2R?$'PU=BTFD@MK>\$DRPLRQ
MEQ'MR0."=K?Y-<O::9>0^&=&A&EW:30^)VNY$%JX*PFXD8.>.FQE_EVH ]%&
MM:8U^+$7]N;HL4$7F#<6 R5'N!R1U YIL>O:1-92WL6J63VL3^7).LZE$;.-
MI;. <G&*\^E@U6;5M,E.AWT)M/$<LTL,$"B$1LLH$H;JY?<I+9P,D?+WV4T>
MZMO'ES80!#HM\R:M.N>8YT.TKCT=A&_U1_6@#9\9ZQ>:%X6N-3L#!YT3Q#$R
M%E*M(JGH1@X;.?;I5ZPU[2-5%R=/U2SNA:G$YAF5O+/^U@\=#^59?C_3[G5/
M!&HVEI;M<S/Y;"%<$N%D5B #UX!XKG/$6@WVOWVKZIHMI)#OT86:K-&UNUU)
MYHDVX8 @!5*Y./\ 6<=#0!WEEJVGZE)+'97L%P\./,6-P2N>02/0]CWIM]K.
MF:;(([Z_M[=BH;$L@7"DX!/H,\9/&:P?"ZVM_J<FKIH&JZ?=FV%O-+J4C[R
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M@$]#^/3F@#T*/Q%HLL-G,FK61COB5M6\]<3D=0G/S'V%7(KRVGN)K>*XB>:
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MH6@22"55<L0!@/&V %()Z<DYK1U/Q'?PW<-LUREC&^C->Q7+(")K@$ Q\\8
M()4<G=P1B@#M:*X.+6/%,]]X6L;BXMK*?5=.GN+I?LAW02((C@ N>GF8Y[C)
M]*CTGQ=JFI:?H-G)G[??B]$L]LB G[-+Y?RJYV@MD-WP >.X /0"0 23@"JF
MGZG9:K;&XL+F.XA$C1F2,Y&Y3AAGV(KE;'6]=EU32_#NI/#:ZE+!<7%Q<0!6
M)CC=50*#E5=MZD]0,''4$2_#=9$\/WZS2"25=8OP[A=H8_:'R<=OI0!V%%8'
MC*^U'2_#5QJ>FOB2S*SS)L#%X5(,@&>AV;B/<5@IXLO)?$&L:;#>!UFAB?1I
M1$NURS!'Y_B".RY]L]QF@#LK;4[&\O;NSMKJ.6XM"HN(T.3&6!(!]^#5NO+]
M4N]5TK6?'NIZ;>Q12Z?9VMRWFP!_.*0NVT\C .#G'//&,<[ZZ[J6MZAKEIIM
MPEG)I=O Z!HPXEEDC,GSY_@QM'&#][F@#L:S=(T*QT19A9K,6F;=))/.\KGD
MD#<Y)"C)P.@R?4UQ,WCV[ETK2]5N!-I>G7^GQ31WBP"6&*X8G<DYP2J?<VMP
M.3D\8K2GUW7M2FU.30XU/]G7XMO*E,8AD50ADWL3O4X8D$#'3.<F@#MNE9]C
MKFF:E=R6MG>1RSQHLI09!*-]UUS]Y3CAAD>]5_%@E/A'6##,T+K9RL'4 GA"
M>]<Q8W-_9:!X<M[>_3S)M*\S$<*M<MMCCV!01M$8+'<S$<E1G)H [^BN%T/Q
M3J'B6/1K-)X[*[N]$74YI8T#9=B% 4-D!0<D]3R!D=:9K?B36-#BM1J\Z6D;
M68$FI6<'G6L=WN((ER"R1\+@X').3Q0!VD>H6DVH3V$<ZM=6Z))+$.JJ^=I/
MUVG\JLUPVK>)-7M;OQDEO<6VS2])BO;,F'(!*S$[OF^;/ECT^E);ZGXCG\0:
M=IIU6W6/4M):\#BT&8'1HP=O/.?,[^GX4 =C=:A:64UK#<SK')=2^3 I_C?:
M6P/P4G\*;8ZG8ZF;G[%=1W'V:8P3&,Y"2  E3[X8?G7%Z=XKUB[TKP;=226X
M;4KZ2TO L7W]B3?,O/RY,0./>JUEK,FC3^)/(3,U[XI6T0\?*7@AYY(&< @9
M.,D=>E 'I%%8F@2:WYM_#JZJ8TE!M)"4$K1D?\M%3Y00P(R.H[#FL:[U_5+T
M>*9=-N([=M";RXHI(PPG=8A(V_/(4[MHVD8P3ST !VE%<'IFO:[XB\0QQ6EY
M;V-D^F66IB-[7S' E9]T9.X=0N-W;TK>\1ZS-IL^DV5NK>=J5T8 Z[<H!&[G
M;N(7<=F!GUS@XP0#3OM3L=--N+RZC@-S,L$(<\R2,<!0.YJW7G6MR:RVF:5'
MK2Q^;'XFM%@=2NYX?,!4N%. _)!QQQGO5_\ MW7]4FN[G1XU\NQU-[22&4QB
M)HHVVR%FSO#]6! QT!!ZT =M17):9JNKZ]$-4L;RVAMXM3EMI;69>/(CD:-C
MN SYI*[AR!R 1WKFXM8U[3/#>MZA#J:SW"^(C:#[3"&&PW"1<8QCY2/7I0!Z
MC17(07VKOXE;PS-JJ_:(;$WSWD5JJ%P\K+&H4EAA0IR>IXZ<UDV'BS7]7D\-
MPI+:VDE[->VMX1 7'F0;AO3+="5R!V]3C! .\O-0M-/6%KN=8A-,D$9;^*1C
MA5'N35FO/8?%.M_V#ILLD]NUP/$7]DW,GDX\Z,7#1[@,X4D >OMBM6SU75];
M:]N].N[:".QU5[.2WG7Y&BC8+(6;&X.>67&!]W(/)H ZVJUWJ%I8O;)=3K$U
MU,((0W\;D$A1[X4_E6?XGOK_ $[1S<Z?:S7,BRIYJ6ZAI1%GYS&IX9@,X'\^
ME<ZGBNYGL_#ESI^IPWEO?:P;*=GMRD@3;(P5@<;'78 >.>O% '=T5Y_>^)M=
M>ZNX;*2**_AUI+%+!X=^ZV;;^^QD,?E8OG(4 8]35?6_$GB2R7QA<0WUHL>@
MM#)%']E_UJF)9"C$MQU(R.>G3N >D45PGBOQ/JFDG4KFSN(G6R%JRV\4>\ .
MX#^>Q'RD@C:%.>Y!%5[V_P!5L]=\>7D6IR?\2[3H9K>)HU**1'*X'3ID<]SG
MKTP >AT5Q\.NZI-K^EV:S1!+W0Y+U@T60LRF( C!!Q^\/&:R=*\3:^_AOP]J
M=]>0S2:\8(8XH;94,#&.1V8,S88L$  . ">_0@'HU5+/4['4)KJ*SNHYWM9/
M*G"'/EO@':??!%4?#TFM%+R+653,<Y^S297S'A(X,@7Y0P.1QP<=!7"WVHZI
MHEYX[UC3[F&-;+4;>1X7AW^</(@!4G/RC!/3G- 'J=9TVBVL^N6VL.9?M=M$
M\,1#X4(Y!88Z'.U?RKEO$_B75-)N;^:UN8I([.YM(Q;Q1[E5)'17\YB!ACO^
M4*<XVDC!J>?Q+=6WC$:7?RRV"2W2)9,\ :WNXR@RHD )67=NX)'   .<T =1
M>ZG8Z?);1W=U'#)=2B&!6/,CGH .]6ZX_P"("S-%X<6W=$F.N6X1W7<%.'Y(
MR,_3(K,/BS6M(OM2T74)8KRZBO;."VO(XA'N2XW<,I;;N78P'.#E: /0Z*XB
M?7/$&DNMI?QAA>ZC%:V,Y,7G;&C9VWJ#LW QLJGH<CC@@P7^L>+-+@M8IY+6
M-I]9@M8I)8U>1[>3H75&"A@01QU [&@#OJ*YOPOJ6H7.HZ]INHW"7,FFWBQ1
MSK$(RZ/$D@! XR-Q&?I6=J7B#4[:Z\:PQ3J!I.G17EH3&"59DE8AO49C'OUY
MH [6BN!U/Q;?6#6,E]+)86-S9P/%?K )+?SVSO28X)C&-FT\#DY)QBK#:[K^
MIS7T^C1J4L-2-J\,IC$3QH0)"S$[PV"2"!C[N0>M '5ZCJ=CI%K]JU"ZCMX=
MRIOD. 6)P /4DU;KR_Q3JMWXA\$:S?I<B*UM]62T6V$8.Y8[E$)8]0Q8$C&
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M1LC\S4]KJ=C?75W;6MU'--:.$N$0Y,;$9 /OBLCPQK%[?7FMZ9J&V2XTJ\$
MG1=HF1D61"1T#8;!QQQGC.*X_5M0U31M4^(&KZ;=0Q&P:UN&CDAW^=MMT)4G
M/ (STY_+D ]2HKA/%?B?5-).I7-G<1.MD+9EMXH]X =P'\]B/ER"-H4Y[D$5
M8OO$MU9>+QIM]++80S7,,=C*T :VNE(7<AD )27=O !(! 7&<YH [.JEMJ=C
M>7MW96]U'+<VA47$:')C+9(!]S@UF^*-:ETB#3HK?:MQJ-_%8QR.,B,ODEL=
MR%5L#UQ7$WU_J7A[5O'-]!>>;<P'32CR1+\RL2I#  #HQY&.WX@'IMU=6]C:
M2W5U,D-O$I>21SA5 [DTMM<0WMI#<V\@D@GC$D;KT96&01^!KD=6U2[DU/Q9
MI$DBM:0:*MQ$-H#*SB96&>X^0?K5+3=8N]#T_P %2W%RB:'>:?%;3%D \J?R
M5,9+?W6PP^NWGF@#O888[>)8H45$7HJC I]9NA37=SI,5U>.3)<%I44H%*1L
M<HI [A<9]\UI4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5GZQHUGKEDMK>K)L25)T:*0HZ.C!E8,
M.0016A56^U&UTV))+N7RQ)((HP%+,[GHJJ,DG@\ =C0!1@\,Z=!=:E/B:0ZE
M&L5TLDI9755V@8/3Y>/?OFJ5KX%T>S>WDB>_\R"U>SC=[R1B(6Q\G)Q@;1CT
MZ]>:C\0>,;6Q\+'5=.D-QYEPEM&PB=MCM*L;;AC(*DGY3@Y&*S)-:U1/$,/A
M[^U[@M>0S74%Y_9I$D2CREC1E*[6&YV);"X  .#S0!O6_A#3+;^R/*-P!I,3
M0V:F4D(C+M(/][Y0!SGI3[?PO8VP7$MU(Z6ILXI))=SQ0D@E5;KSM7DY/ YJ
MEIGB2TLM$-UJVOP7V+MK=[J&U:.-9,@>6 ,]#P"3S6T-8L#%=2_:,1VLGE2L
M58 /G&T9')R0,#/) H R9_ VC7&AV&DL+I(=.(-E-'<,DUO@8&R0<]..<U97
MPKIR3Z9.K7/FZ:SO [3LS%G!#LY.2Y()!)S4\7B/29K:ZN%O%5+2013K(C(\
M;G&%*, P)R,#'.1C.:RO#NOW&K>+?$=DTV^TL?LWD(T!B:,NK%@P8;L\#K0!
MN:OI-GKFE7&FW\9DMKA=KJK%3UR"".000#^%<UK7@V*+2]4ETN"YN[^_@BM[
MA9[^0&:-6^;#$X#[2P4G@'';-=#J6N:;I+;;VXV/Y33%51G98UQN<A02%&1D
MGCFKT,L=Q#'-"ZR12*'1U.0P/((/I0!QVA^'[B2:47<>M1Z?- \-Q9ZOJ"W0
ME##&  SX'7G<#VQW%RW\ Z+;Z/=:5NOY;2XA-N5GO))#'">L:%B=B].G7 ]!
M5"+Q1-J.J:K*FI?V=9:/>I'*L]H?+FA$:,^YF *N3)A<'L/E.:Z6'7]+FANY
M1=JBV;!;D2JT;1$@$;E8 C(((XYSQ0!#_P (U8-J7V^0SRS?8S8MODRK0GDJ
M1]><]:M:/I-MH>EP:=9F;[/"H1!+*TA"@8 RQ)P   /:H(O$>E2I<%;H[[:1
M(I8FB=94=L;5,9&[)R,<<]JKW6N6<SZ68-76U\^],(CD@):X*A@T6& *G(SG
MMMH 6'PGI5O,QC246[7/VS[)YA\D39W;PO;YOFQTSSC/-6]*T2UT>6]DM6F)
MO9S<S>8Y8&0@ D>G ' XXJD_C3PY'(R-JL(VW/V5VPVU)>/E9L87J!DD GBE
M?Q-I-YIVJO:ZM% UE&?.F>,_N,J=KE6 W+QD'H<=: +EUHEK=ZW9:M(TWVJR
M1TAVOA0KXW CH<[5Z^E4#X,T?^WI=71;F*:=UEGACN76":0='>,':QX'4=N:
MJ?VS>KXH\,6<=]'<V.H6$\TCB$*9618BKCT!WDXK8@\0:7<ZA'8Q78-Q*K-$
MI1E$H7[Q1B,/COM)Q0!Q4/AS6GO+P_9];L+V:YEF%S:ZLIL@68D-Y98MTQE=
MG)KK9/"UA+=ZC=&2Z6?4#"9W28KS$08RN/NXQVZ]\UIWE[;V$'G7,HC0L$'!
M)9B<!0!R23T YK/D\5:'#I\M]-J,45O#,()3("K1R$@!&4C<IY'!'<4 17'A
M'2[N"5+@3O-+=1WCW(E*2F6, (VY<8P% P,#\ZDB\,:;%+JKE9I!JJ".[224
MLLBA-@'M\O''X\U=TW5++6+4W-A.)H1(T98 CYE.".1ZU _B#2X]0BLGNPLT
MLIAC)1@CR 9*!\;2W!^7.>#Q0!FV_@71[9XY$>_,L=FUB'>\D8^2<?+R<8&.
M/3KUYK:TO38-'TNVTZUW_9[:-8H@[;BJ 8 R>N!Q6%X<U^>:VUJ75KE&%IJT
MUG$R1XRHVA5"C)))/N3FM2'Q%I-Q9O=17@:-)OL[+L82"7_GF4(W;O\ 9QF@
M">?2;*XU>TU66!6O+2.2.&0]55]N[_T$?KZU0D\(Z._AB3PZMNT6F2;MT,3E
M<AF+D9'/4U7O/&^D6R6#Q/+<B\O#9+Y4+DQR+DN'&W*L I^4C/MU(M1^+=!F
MU+^SH]2A:[$K0F, _*ZIO()Q@?+SSZ'TH +CPKIEY>W-U>))<O=68L9UE?*O
M""3M(Z=23GKS4VG:!9Z;-'.KSSS10_9XI+B0NT<60=H)]<#)/)P,DX%%MXBT
MF[G$,5XOF&$SH'5D$D8ZNA8 .O(Y7(Y'K4%CXPT#4[FUM[/4XII+I6:#:&Q)
MMSN .,9 !.,YQSTH LWFB6M]JUCJ<K3"YL0X@*/@+O&&R.AR .M9J>!M'C%K
ML-XCVMQ-<12)=.KJTIS(-P(.&)R1^6*L:;K=F;"ZNY-8CO81>R0HZ1;=AW8$
M( Y=ATR.36AIVJ66K0/-8SB5(Y&BD&"K(ZG#*RG!4CT(S0!EV7@[3=-MX(;"
M6]ME@\[9LN6; E8,ZX;(QD#'IVY)K3BTFRM]%72((1%8I!]G6-21MCV[< ]>
MG>FS:U807?V62<^;YB1';&S*KMC:I8# )R#@GN/6J5CK=D+?5;N;68;FWM[T
MPEA'L%N<)B'C[YRPYZDL!0 DWA+3KJVNX;I[FX-U:_8I)))27\CGY-W7!R<G
MJ>YZ5S^M>'[TZ[$T=CK,UG#9QV]O<:7J@@D&"2PE#.@(^[@C/0UT,WC#P_;P
MWLD^IQ1"R&;E9%97BZ8W*1D9R,<<YJ:#Q-HMPU\L>HP_Z#'YMR6RH1.?GR<
MKP?F&1QUH IZ=X9VMIM[J%U=S:C8I-'#(\^\HDC9*L< .<!!DC^&HI? .B2Z
M5;:?B[1;2X>YMIX[EDF@D<DN5<'(R6.1TY^E6+SQCI%II.IW_FRR#3H1//"(
M'$@4@E3M(!P<'YNG!YX-6;+Q%I]Z\,*R2)=26INA T+AS&" 2 5!."0./44
M5KCP=I-Q'I^/M44]@S-;W4=PXF!;[^Y\Y;=WSG-5E\%VEF;-=-GO+=8=0:^=
MC>2'<S-N<%22&#9(P>F2>3UMS>,_#L%I:W4FJPB&[C>6!L,3(J@EB !GC!J:
M7Q/HT(A:2^58Y3&%EV-L!D *!GQM4MD8#$=1ZT :LD:2QM'(H9'!5E(R"#U%
M9-IX6T>Q&D>19JITB-HK,YR8U90K<]R0.36M)(D,3RRNJ1HI9G8X"@=23V%9
ML'B+2;B22-+P*\</V@K*C1DQ?WP& W+[C(H K77A+3+Q]8:8W!_MB)8;P"4@
M.@!4 ?W>"1QCK2OX3TYKC[0C7,,SVRVDSQ3%3/$N<*^.I&3AAAAD\U/I'B71
M]>9UTN^CNBD:2G8#C8^=IR1ST/Y5-=:U865QY$\Y$@*!ML;,$+G:NX@$+D\#
M.* *EUX6TV[1X2)H[62U2SDM8GVQ/"N["%>P^8C(P<<9J";P5HTVN2:L$N89
MIMOVB*"Y>.&XVC"^9&#M; XYZCKFIK;6;-+K6Y9M:@EM[)U\V,H$%G\@)5F_
MBS][VSBG/XLT*(W:S:@D+V<?FW$<RM&\:8SN*L <?AS0!H:A8Q:GIUQ8SEQ#
M<1F.38VTE2,$9[9%9!\':46TY\W8>PMS:PLERZ$PG'[MBI&Y?E7KZ59LO%&B
MZC<RV]KJ$3R1P"X8$%1Y7]\$@ @="1T/!Q3!XLT9K:YGCN7<6]L+MD6!][0G
M.'52,LIP>1D4 4#\/M"%EIMO#]MMVTU3':W$%Y(DR(>J;P<E3@<>W&*O7/A;
M3KF-X2;A+>6U%G- DIV2Q#=\K YY^9LL,,<]:32?%6G:K:Z8X:2"XU"V^T0P
M21."P"AF ) #8W#IZBED\7Z!%:6]S)J<2Q7,CQ0DA@7=,AE QG(*L,>U #;G
MPEIEU+J<C^>/[2MEM+E4E(#1*" H'\/#,..>34D?AJRBO[.^22Y%Q9VK6D+>
M9G;$<9&.A^ZO)YX%))XMT.*RAO'OU%K+&DHF\MRB(_W6<XP@/JV*MR:UI\5Y
M]E:<^;YBPG;&Q4.P!"E@-H)!!P3G!'K0!FV_@S2K6VTRWB-R(M,N&N;4&8G9
M(V[))[_?;@_WC1/X+T6ZLM4M+F*6:'4K@7-P&E.?- 4!U(Y4C:O3TJYXDUZW
M\,Z%<ZK=1RR1P@82-"Q9B< < X&<<G@4MUXATRSC#W$[H/*\YE\ERR1YQO=0
MN57@\L .#0 _1]&MM%M3#!+<S,QR\UU.TTK^F68DX'8=*K7?A;3;R^O+MA-$
M]]&(KQ(I2JW*@8 <>N"1D8..,XK7AFBN(8YH9$DBD4.CH<JRGD$'N*SHO$>D
MS7R6<=ZIF=Y(T^5@KM']]5?&UBN#D Y&#Z&@!;?0;*UUN35H1(MS) ELP#_)
MY:$E5"]!@L?SHUW0-/\ $>GBRU&-V19%EC>.0H\4B_==&'*L/456M_&/AZ[N
M;>W@U2*22XE:"+ ;:TBD@INQ@'Y3@$\XXS4\7B/29K.^NX[K,%A(T5TWEO\
MNG'52,9R,C/IF@"LWA'37T^ULWDO'6WN4NUEDN6>5YEQM=W))8C X/' &,"F
MGP9HYUZ75T6ZCFG=9)X8KET@G=>C/&#M8\#J.W-;DEQ%#;/<32".%$+N[_*%
M4#))STP*S)/$^D012RSW+PI$8Q(98)$V^8<(3E1P2, ],T 5X/!VD6VMS:K
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MRE/+;S!-U\OR\;MV.<8SCGI0!0OO FBZC)?/<B\)ODC6Y"W3HLAC ".0"!N
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MGG32EI%A/5 >V>YZG R3@4EMX5TZTGTF6)KC=I,#6]H#*2$C( (/][A5'//
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M_%!?7UKIDCSVWB8ZK':O(BFZ@,>PA3G ;DD!L<J*V-2;5KN"PO;7PU)!')J
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*;W8,PRL:X.7(R!D$#J>!3X/#>E6NJ0:C!;O'<P6_P!EC99G"K%D';MW;3R
M<D9S4NKZ+8:[:);:A$[QQRK-&8Y6C=)%.5964@@CU!H XV'Q1K:Z%J4C^87L
M]>6PDG>-#)#;%H]SE4^4LHD(X&.AP<&G3>(M:TZ'5IY;GS[+^T[>QT^YDB5
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MPDEU<K=RNMW*"95  8?-QP ,#C P1BB7PGHT\,,<ELY,-T;Q9!.ZR><006+
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *K7M_;:?"LMS)L5G"( I9G8]%51DD^PJS7,^,=/U6?\
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M+>3A4$$^G:9*#N*6S;BC'W^95/M$M2^$K'4!):'5/"EEIMW90F)[U7CD,IP
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M>C@9QUS7,Z;H7B71=-\-7\.DM/<Z9+>QW.G_ &B-7>*>0L'1MVW(PO!(ZD4
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M[6L2)+.YE,>""N%*;3D =2.W!H:?X@\0:K-X9MY=2>V>YN[^RNY(88\3>0)
M)%W*<$E<^F>U 'I=%<WX)U"]OM'NTO[EKJ:SU&ZLQ.ZJK2+'*RJ6"@#. ,X
MIEYJ5S>>.?\ A'8[J6SB33/MIDA"[Y&,FP %@1A<9Z<EAVX(!T]%>8V>O>(=
M8/AJU;5'LY;JZO[&ZF@@C(E\@2!95#*<$E,^F>U>DV\4D5I%%+.TTJ(%:9@
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MS; V045BV <X^<8'7'-:EYXFTZPO;RTN//66TL_MLFV)GS#DC<-N<\@\=>*
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MX7R]W[PE>,#D#(.:I>%];E2PU,ZE=37<JZU=6=L" 9'"L=J   <*">P !)P
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M<]Q+;PBXN$MX]YBC.<,1[[6P!DG!P* '?\(_I8O+"Z6U"2Z?&8K7RW9%B0@
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MHWB#5"ENEM!)I\FE/;F"6YV"*Y/&]@H/F+C&!V(S@=1V<DT<60S9;:7"+RQ
MQG ')ZC\Q531=8M=?T>VU2R\S[-<*6C\Q=K8!(Y';I0!QNF:)XIT"]T^_M+&
MQNS+I5OI][:O=E/*>'=LD5]ARN';(QGTS5C7_#.IZEJ$=[;1_9M8ACB6WU:U
MF\L<'+I*F?FCZD##=<<=3W-4]2U2STBT^TWTPBC+K&O!9G<G 55&2S'L ":
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MK6U63I?B&VU:X$=O;W:I);K=03R18BFB;HRL,CT^4X;!SBM:@ HHHH ****
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M/I5H[6L?E0$Q#]VG]T>@X&!VH XW0=9NM=;0M)O]1N(6N?#4%\LL<IC>>=@
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MD6F:G%?G1])TJ2(,"NF2.PF!!&&RJ@+SG&#R!R,<[-GX2\/:>EXEGHUE;K>
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M1-/U);F74M<:R;49(U@ LU;RTC4DX!;DDELGZ#TR0"KXOU=],.B0><;>WO\
M4DM;B<':44H[  _PEF55SVW'&#@UD:G?7&AW5AI7]L-<6]]JKQ-)/*4-NIA+
MI;F49;)8#!^]@@>]=EJ&G66K6,EEJ%K#=6LHP\4R!E;\#51O#.AOHG]BMI-F
M=,_Y]3$-F<YSCUSSGK0!QM\NMV3Z)I\GB.9_/UU[5S;L"R0-!)((V=AEF7 ^
M;Z9YJ?2=,-IX^U^W_M/499(=)LU2::X+.2?/&2/ND\9Z8SDXR376)X;T2.VL
M[=-+M5ALFWVR+& (6_O+Z'D\]>34T^C:;<W_ -OFL;=[ORC!YYC&_P LY^7=
MUQR?S/K0!YQNFUGPK\-;V^N[F2YN+V#S9!,REB;>8EN#USWJ[K7B'4=$NO&D
MBWTSQ62:?Y)DPPMEE8K(X&.P);G/W><UVG_"-Z*+>TMQIEL(;-MUL@0 0GU0
M?PGZ5,-%TP7%W/\ 8;<RWB>7<L4!,R@8 ?/WAC(P: .9UAUT>SOI(O$MT(;O
M[*((1^_DC+2!?D=FS^]SM&2 IRPZ''+Z[=7ESX<\6V-U<SJEAJ]DL""Z9VC1
MS 60OP6&7;@YP3["O0X/"7AZVTF;2H=%LDL)V#2VXA&UR.02.Y&!CTQ3QX7T
M$0W4(T>Q$=VJI<*(%Q*JC"AN.<8&/I0!RM]<W^IZUKVB6>K#3YM-AA-K-)=,
M"@*;C*R])1NRIW$CY>Q.:Z77E-UX)O\ S926:P=F>$E,G83D=P#Z>E/O/"GA
M^_FM)KO1K&:2S 6W9X%/E@= ..@]*T[JU@O;62VN8EE@E4J\;#(8'J".XH \
M^T.ZDAC\$:"9[F.RO])-R[B=@TDB118C5LY4 ,S8!'0=LYJ/J>N20VEDVJW<
M:P^*6TQ;A-H>>WV,PW''+ _+GN5YR:] ?0-)>QM[)K"#[-;$- @7'DD# *8^
M[@<<8XHET'29H;:&33[=H[63S8%*#$;_ -Y?1N3SUY- %/4[6_L/",EIIU^\
ME\D:QPW%]+\TC%@ &<#@MG;G'!(-</J.HOJ6F6UM(FHV%]!XEL$FMKN02M;$
ME,;')(=3RP)]3Q7IUY9VVH6KVMW!'/!)C?'(N5.#D<?4"J;^'M(EB6.73X9%
M683CS!N/F  !\GDL   >HP* .+_M.YT^;Q%I4NLWOEP:M9P6KMB2=Q,D3M"K
M$C&XE@&)^4'/:J5QJ^LIH6M1KJ=Q;RV?B2WM(BDWFLL3M!E"[#+ >8W7Z<BN
M_G\,Z)=+=K<:7:RB\97N-\8/FLOW2WJ1@8/:F'PIX?*2I_8UB%E=))%$"@,R
M !2?<8&/2@#F+G[:OB*;PI'J]UE=.^UVT]S=E)7=Y) QW*OSB/"84\8/(/:K
MJFK:OI<,%YJ-U-?Z9'9P+<:AI<NQK:7)W3-#D;XW!4Y&< ' [UVNK>'-%UU8
M%U72[6]$!S%Y\8?9],_3GUJ2;0M+N+CSY;&%I-JH3M^\JG*J1T(!Y /2@#+\
M:ZM<:3IEB8',*W>HVUI-..L,<C@,V>W]W/;=FL:_>[BU;Q/H1N;F;3!HZWL;
M-,Q>WD8R*4WYW$-LW8)/?MQ7;W=I;7]I+:WD$<]O*NV2*50RL/0@U6CT738[
M.:T6SB\B<8F4C/F#&,,3R>..>W% &;X%@6#P)H(5Y&WZ?;N?,<M@F)>!GH/;
MI70U!9V5MI]I':V<*06\8"I&@PJ@= !V'M4] !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=2U6#3
M/LJRJ[RW4WD01(5!D?:S8!8@?=5CR>WK@5>K#\4:0-;T^&SET^UO[4S!IX9Y
M"C!0K8:-@,APVW!XXSR* *D_BV5=>T73HM)N]NH"=G:38IC\H[6&-W7)!SZ=
M,YXL'QAIJM;R,DXL;FZ-I%?;1Y+2[BH7.=P!8%0Q&">_(SC67A;7+&Y\,W#7
M<5X^FF[BE-U.Q<12D;,-M.]D55'.,^HJ&T\%ZBGAFW\*7#6[:;;7R3)=B0^8
MT*3>:JE,</D!2<XQSUXH Z*7Q591W4<8@NI8'O!8FZCC#1K-G&T\[N#\I;&
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MOVVF>+8[:XM;6]U2ZEN;&=)"WEEHD0;@5X.4SQGK[4 6[CQOIUG:ZG-=VM]
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M#<0>GU/2F7_@K6+[2[*&XEBEU>TLDCM=:2Y:.XAGRV2Q"_O$QMX/WB#D#.0
M='>>,=/L;?6YIH+K&BLHNP$4D!E#AE^;D;2#Z^U.UGQ?INB+<O<+-*EHBR73
M0A3Y"MR"06!/'.%!('..1GG=?\):_>_\);:V7V%X-=@BVSS3,K1.L0C(*!3D
M':#G/&3P<<VY-"\16?B6[U"QMM(NK?4TB-PEW(P-K*B!-R$(=ZE0.#M.1U%
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M;V*+3W<Z,--N5:=P(F5MP=?D^<<D8^7ZU'I'A77-+3P?)ML'ET>PEL;E?/<
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M>[LH[^5@Z*XGEV(Q9MY^5< @$#@9K3L?&^Y-7FU"PEMH;35/[/A)>/YV/EJ
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MTP0R,\@4QA=K%3NW*!SUZXK.TK4[@_$37UN_M=K:P:9;3>3<3!D0EI=SJ Q
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M_6@"H?#VB$DG1]/),QN#FV3F7^_T^][]:D_L72METG]F6>V\_P"/D>0N)O\
M?X^;\:IV_B"WU*\DM+>VN9(A<R6<EQ&R[8Y$5BP;#;E^Z0#CKCL03S'@;Q4R
M:%H%CJ,6H2R7\D\,>H3,'1Y%:1MA);?G:IP<8XQF@#KD\.:''816":/IXLXG
M\R.#[,FQ&_O!<8!]ZDU#0])U?R?[2TRSO/(.Z+[1 LGEGVR.*S;;Q=:7.IV5
MB;2\A%_)/';2RHJB1H<[^,[A]TD$CD#Z9XV2\OD\(WDHU"]\R#Q9]G1S<N6\
MK[:J;"<Y*[3C!XH ]*?3[*6^BOI+.W>[A4I%.T8,B*>H#8R :CL](TW3I&DL
MM/M;9WSN:&)4)R<GH/7FJGBQI(_!^M212RPRQV,TB21.4965"001R.16+X?\
M96_EZ5INI6M_:2SZ>)X;N[5?+N0B R$,&)! Y^8 XYH Z>[TK3K^>WGO+"UN
M)K<EH9)HE=HR>I4D<?A5<>&]#6.*-='L%2)#'&HMD 5"<E0,<#/..E9NG>-]
M+U+6+338UD22]@:>U<LC+(JX)&%8E6P0<,!Q[@BK'B:_M;%=*%V+[;/J,$,;
M6DFS$A;"A_F&4)ZCG/I0!KW5G:WUL]M>6T-Q;N,-%,@=6'N#P:K'0]),R3'3
M+/S$555O(7("\J.G0=O2N0\?^(F;PEK0TM;X-92I#)>6T@C$<FY<KD,&( 8
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M/.!][VYLS^'-3DU3Q%=&#3+B'5!:JMO<.S*R1\.KC81\REL$9P<5V%% '/\
MA+P_)X;L;JT\S%L]R9;:U$S2K:QE5'EJS $C(9L8&-V.V31E\-:I:ZGXA?3I
M+1[37$#.+AV5K>7R_++ !2'! 4X)7D8SSQUU% ')0>%KG3];\-261@.GZ-82
M66))&$CAA& <!2./*]><]JV=?L)-3TPVB6ME=1R.HFM[S_5RQ]QP#@]"#CJ*
MT))XH7B2215:5]D8)^\V"<#WP"?PJ2@#@[?P3J>GVND+9W4!.FZI)=PV]Q-)
M(D,#QO'Y2N1N.W?D9 ]/>G/X)OSHVL^'/.MFT?4KMYQ,7830I(X>1 FW#<[L
M-N'WN1QSTVN:Y%H4-I+/;S2I<W<-H#%M^1I'"*6R1QD]LT:_KD7A[31?3V\T
MT1FBA/D[<J9'" G)'&6'3)]J ,2UT#Q!I.O:G_9=W8?V1J5Q]I<S!_/MI"JJ
M^P ;6!V@C)&#V/?.F\%:S'XGU'Q'I\UE!J4MZDL!,K[7@\M(Y(91LY!\L,,9
MP<?CZ!10!QE]X8U>\N?%<H^Q(-:TZ.SB'G.?+94D4EODZ?O.WI[\/T[PWJ^C
M:P-3LC92M<Z?!:7D$LSJHDA!".C!#D88@@@=CFNPHH XJQ\%7&E3>%8K66"2
MUT=+@7#.S(\C2J0Q4 $#DDX)]O>J%GX,\16>D:)HHGTR2ST;48[B"X:2022P
MJ6PK)MP& ;&0Q!QVKT2J4^HA;99K2WDO@9Q P@*Y7Y]C$Y(X4@Y[\&@#G=$T
M+Q'HE[-80W>GOH374ES%(P?[3&KN9&BQC:1DD;LY /2G:;X>U2RT#5[*6/39
MY;W4)KI8Y&9XGCEEWM&^4_NDKG!]:T]4\1)I]W-:6]A=:A=00+<S06H4NL;,
M5! )&XDJW Y^4^V='3[J6]L8KB:SFLY'!)@GV[TYQSM)'OU[T 8WA+PX_AN*
M^@1A%9S3B2VLDF:5+5=H!568 X+ G&,#/%&N^&3J^N:7J$<XB$ D@O$Q_P ?
M%NV&\L_\#1.O8MZUT51O/%'-'"\BB27.Q">6QUQ]* .9T+PI-H6@:EI\4Z3O
M*98[3>2!%!EO*B)QT7>>W>JFG^%-6T__ (1"1);)I=%L'L+@,[X=66-=Z';U
M_=]#CKUXY[6B@#@H/!^L1:/IMF6L#)::X^J.1,^"AE>3:/DZ_/C\/>EU/P?K
M%[9>)X(WL0=7OX+J(M*_R+&(@0WR=3Y7;^][<]Y10!S]CI%]!XTU+69OLXM[
MNTMX%1)&+JT9D))RH&#YGKV]Z-;T:^O/$.A:K8R6X.GM,LJ3EAE)%"Y& <D8
M'!QGU%=!10!P7_"'ZS_90M=UAYG_  D']KY\Y\;//\W9]SKV_6KVF:%XCT?5
MKVWM;O3VT2ZO)+P/('^TP&1M\B*,;6!8G!)XST-=?10!G:Y9S7^D36L,%I<&
M0J'AO!F*1-PWJW!ZKD X/.*Y&W\%:OIL%M;V-Q;'3H]0><Z5<7$CPK"8PHC#
ME<D*^7"D;<G'8&N_HH X#3?!FLV-MH-N\NGNFEZM<7I*,Z;TD\W  VG!_?=.
M@V]3G-/O/!^L7.A>(;!6L1)J>JI?QL9GPBAHCM/R=?W7;^][<]Y10!Q\.A^)
M=-U[47TV[T[^R]3F%S+YX<S6LA55?R\#:X.T$;L8/KWW/$FBIXB\-ZAI#S-"
M+N%HQ*HR4/9L=\'!K4HH Y9-/\57_AZ_LM8FTO[3+9O;1_9B^R1F7'F.2N5_
MW0#U/)XQD7O@W7KO3X+!I].DMAHG]G>7,SLL$X4KYR#;AB1@<X*XXSR#Z!10
M!P&H^"=2U33K&"==/BOK.UACM=2MY7CGM)%X8KA?G7&/E) )SD#/%Z7PG=7'
MBNWUL):6ES#=%GO+65EDN;?!Q%*FT*W51DDXV\5V-% &)XHTW4M3TV"'3)X4
MD2YCEEBG9D2XB4_-&S*"0#]#G&",$US"^"=:CM;BW1]+"2:]#JR*A= J(4)3
M&TX^Y@?G[5Z%10!P>K>"M4U*[UVZCN;2WFN;RTO;%MS.$DMPH D&T<';V)QG
MOBIQX<UZ]U^^U&__ +-ABO[*VM)X8)GD(5)':0 E%SN5R.@Z^V3VM% '.7NB
M7\7C&+Q%IK6\C/9?8KFWN)&C!4.71U8*W()8$$<@]1BLNR\&7NFWWAZ:"2VD
M6QN;NZNRSLI=[@-NV#:> 6XR>@KMZ* *VH1W$VFW45H8A<O"ZQ&893>0<;AW
M&<9KA#\/;N*VOO[+FMM(9I;>[L[.*1YK:&YB9F9\$+M5\A2JCMGV'HE% '&Z
MKHOB;7/#WV>^?2DO#=6TPCA>3RD6*59#\Q7<2VW'0 <=><Z&K:'=ZEXIT?4?
M]'%I:6]S#.ID;>WG!!\ORXXV=R.OM7144 <=X=T7Q7I&FQZ1<7VFR65E"8;2
MX16\Z50I6,2*1M7'&2"<X^M2^&?"LFAZU=7T<5M86]S HEL;*5G@:;.3*%95
M"''& .>_2NLHH YW4M#OO^$MLO$6F- \L=J]E<6]P[(LD3,'!5@K88,/3D'M
M63/X,ODTFU@M9+5KDZX-9NVD=E4MYOF%$PI/HH)QTSWQ7<44 072W$EC,D!C
M2Y:)A&7Y4/CC/'(S7!3?#RXDTK7[2S^R:7%JEF(Q96\KR6ZW&23* 5&S/ PH
M]Z]$HH Y2+1=:L_$TVO6_P!@DEOK.."]MGE=$5XRQ1D;:21AB""!GKQTK,M/
M!.K^&YM)NO#UU9336]F]G=Q7N](YE:0R[U*@E2'9N.>#C/>N^HH X3Q!X(U#
MQ!J]I>7%U!OMK"2*.YC=HY(KDNDBR(-I "E,8).0><]^NTD:F-,@75_LQOE4
M"5K9B4<_WAD C/IV]:NT4 <;_P (G=MXKAUU([.TNH[B5I;BUF=6O("&"1RI
MMVDC*?,2Q&SCKQ5T[P?J]GI7A>TD>Q+:1?R74K+*^'5A*,+\G7][W_N^_'>4
M4 <!8^#_ !!#K&C7]W<:;-/87EQ)-<DN9;F.174$\?*5# !<D#'!'2G/X/UA
M_#]W8;K$2SZ[_:BGSGVA/M FVGY.O&W]?:N]HH HZO8-JNA7^G[Q$UW;20;\
M9"EE*Y]\9KFT\(W>I0:5#K)MHX]-LI;9!:RLYD9XO*+DLJ[<+NXYY;KQSV5%
M ',>%].\3Z=!;V.L7>G36EG&(HIK97\VX &U3(&&%XY."<GN!P;'BK1[W68=
M,2S, -KJ,%X_G.5RL;;L#"GDUOT4 >>:CX+U]M+\1Z-8SZ<]AJUTUY%-<2.L
MD#NRLZ%0I#+D'!R",]#6FNA^)M/\0ZA=:7=:;]@U1DFN%N Y>VF"*C-'@8<$
M*IPQ'(KL** .&U;PAJU_!XRACDLP-=BCC@9Y6S'MB$9+@)[9X^GO6G#HNJV_
MBV;6(S9F*XTV*UEB9VW+)&TA&T[>5/F=3R,=#7344 >>:=X,\0Z)9>'+C3;C
M3FU+2[22QN(IW?R;B%BK9#!=RL"H/0UI:OX<U_4[J!I;NPN;=K*6&:*96"13
M.<B5% .[ ^4;B"!SG)-=C10!Q>E^%]7L[GPC)</8LNBV$EI/Y<CY<LL:@KE>
M<>7GG'7VKI=:TJ#7-$O=+N?]3=PM$Q'5<C&1[CJ/I5^B@#B[#P3<P:QI.J75
M^LMTEN4U4@<7D@8/&?HCYQWQ@5'JWA+5=03QG'&]DJZ[!'# 6E;,>V/RR6&S
M\>/I[UW%% '&_P!A>)M.\03ZAI%QI9@U"*$7D-WYA\F6-=F^,J/F!4#*G;TZ
MBG7OAC56U37Y[:>TEAU;38[4F=F5UD19%S\JD8/F9S[8QSD=A10!Q \'W\\N
MB)=M:BVL]&FTRY\N5BS>8L:EERO_ $S[^OMS8T;2?%EMHYTO4KK2YHK>V,$$
ML.]7N/EVJ9,@A,#D[=V3Z#@]?10!D>%M-N=&\*Z5I5V8FFLK6.W9HF)5MBA<
MC(!YQFLJ7P[JEIK6OW.FR6DEMK4:&1;AV5K>58_+W* IWJ5"G!*\CKSQUE%
M'):-X3N-$\1:?-;M"VFV>CIIB[G/FDJP;=C;CMZ_X5H>,='NO$'A/4-)LVA2
M>Z0('F8A5Y!SP">U;M% '#^(?!=[XDU+59)YH+:WOM*BLD:-V=XY8Y6E5\%0
M"-S#C/;WXOMX?U#5M4M-2U@VD,]I8SVT:VKM(K/-M#N=RK@ (,+SU/-=310!
MB^$]-OM&\+:=I>H-;M-9VZ6X:W+%65%"@\@')QGIQG'/6MJBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M"YSVQ6S+I>GSS232V-K)+(NQW>%277T)QR*G@MX;6%8;>&.&)>%2-0JCZ 4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6*5X7*'.UU.&4^X- %BBJKZE91ZE%ISW4(O94,B0;QO91U;'7'/6K5 !102
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M:+6KN")H8[8KY2/;O(?FW')W(.<#J>/3LM1L8]3TVYL9F=8KB-HI"AP=K#!
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M$8(SP13[;P5I=C!I:64EW;3:9";>WN$EW2"(XRC;@0R\ X(X(XQ0!SMKXO\
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MEM7M#Y\'VB(+(&+Q\?, .HY%6!KNF/IUM?QWD<EO=X^SO'ES*2"<*!RQP"<
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MX]E/Y59KS;0-6U:R\(^ 9/MYF&J30Q7/G1@L5:!WP&&.Z=3D\]:FNO%^J?\
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M;3Y[=;8(-H,VUPV<@CRA[8]^: /2**Y#P&UY*NO27=_/=%=8N81YH7@(P4=
M.P QTXI+C6=3U+4_$UIIUVMI)HJ1B)6C5A-(T?F9?/.SD+\N#PQSTP =)J&J
M6>EPB6\FV*<D!49V( R<*H). ,GCBIK2[M[ZSAN[69)K>9!)'(ARKJ1D$&O/
MK;4+CQ#XL\$:L)YK5;W2+FY\@*I"$_9R0,C)!SU_+%;/C\W$&A:<ME=R6@.J
MV43>2%Y5IT&.0>/IZ8/&10!T5MJEC>7]W8V]RDEU9[/M$:]8]V=N?K@U<KS#
M5)M5TW7?'5_IVH+#/8:;:7!9X%<S%(Y6P>@ .#G SSQC%;%QKVM:S=7UEHG[
MB[M;&">/B,JTDJLP#[N=G 'RX/7GI0!V]%86M:[/HG@BZUR>")[FVLO/>*-]
MR%]N<!NZY[^E9FL:IJ_AK3+W5IM1MKZS%FCQJZ!66<N%+#;@&+#*>22,=>:
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M>K&O:MXLT+1]6NC-!Y4;VQLWN51IOGD5)%8)A<?,"&QZ@YZT >@45YSK&O\
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M .BL=4L=2DNH[.Y29K27R9PG\#X!VGWP1^=7*\KNM0U319?&^KZ?=QQK::Q
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MHW$-\Z-9-:78A$6U;B4Q$.,[?E()'//>@#T6J<NJ6,.J0:9)<HM[<(TD4/\
M$RKU/T&17%ZWJOBW1=/O9FN(!&+RS2T>X1'F*2RK'(KA,+@%L@@9QD=>:GN[
M:^@\=^%(;[4/M5R;?4O](6%8R ?*V_+R,@8'OB@#N:*XC1==U6\==#N[L?VY
M:ZB\=XRQ* ;=1O60+CA61HQGJ&;VK:\4:S+I%M8) /WU]>QV:-Q\FX$Y&>,X
M4@9XR1UZ$ O3Z+8W.L6NK2QR&]M4>.&03. JMC<-H.TYVCJ.PJ_7 :AJOBW2
M_LL,US;(+C6(+:&26-7E:"0'[ZH0H(8$9'4>AI@\5ZK8SWFD7-TD]U_;L&F0
M7AB"[4EB67)4<%@"P'8G;D=<@';6VJ6-Y?7=E;W*2W-F5%Q&O6,L"0#^1JY7
ME\VK77AC7_&=SY_VF=I=,@BEF0 )YN4#.%P"%W$\8S@#WK6UK7M9T34M7TU+
MI;C;HDVIVMS-"NZ-XSAD8+M!!RI!P".<YH [JBN"EU?Q%IVAZ=JEW<7%]:7:
MI-<G3[-#-:(8@<A3G>N\Y)QD#H*6'Q)J.M,FGZ-?K/,NDQ7JWD"1@3N[.H)5
M^B Q\@#/S8R,<@'<3S16T#SS.L<4:EF9C@ #O4=C?6VIV$%]9S+-;3H)(I%Z
M,IY!%<C;:QJ^LWM]I$MQ#87>GZ9#+=&W"R+)/('R!N!_=KL^IW=1CF[\/I!#
M\,?#\C D)ID3$ <\(* .IK.M]"TVUUFYU>*VQ?7( EE9V;@ #@$X7[HS@#.!
MFN0M_%>JMH7AKQ)YRRV^KW<,$]D$7;$DS%5*,!NW*=N<D@_-P.,:/A2\UW5K
M[4+B]U.$VMGJ-U9_9H[4+O", K;LY&.>.<YH Z^BN/\ &&LZCISWBV%XJ-;Z
M9+=K!#&'E+KG#2;AM$7!'4,3G'2H[77=3\0W4]A874=A=0Z3;WBML#"268.0
M"&!_=KL&<<G=U&.0#M**XY=4UK6;_5=,L+^UM;_3;2W8,J!XIII$+9.03Y7
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M[8/3T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "$X!/IZ5BZ!XDA\07&JPQ6EQ;-IMT;603[068*&R,$\?
M-6W7%>!O^1A\;?\ 89_]HQT ;5UXEAM?%NG^'GM+GSKV*66.<@"/$8!8=<D\
MCMWZUMUQ6O\ _)6/!W_7KJ'_ *#%7:T %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !VK(TCP[:Z+>7]U;37+27\OGW'FN&#R8 W8QQP ,#CVK7HH
M R+SP[:WVOV6M2S7(N[)72WVN J*X <8QSG Z_ABM>BB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
&*** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>aquestiveamendedandresta012.jpg
<TEXT>
begin 644 aquestiveamendedandresta012.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JAJNHR:=# 8K22Y>:81#;PD>027D;!VH #
MS@\D#O5^L/Q+HMYK":>;.[BA:TNUN'BGB,D4ZA6&UE!&<$AASU44 2^'->A\
M1:6UY#'Y?ESRV[J'#C?&Y4E6'WE.,@^AK(U/QQ_947B%YM-8MHOE/(GG &6)
MQD.O'3@C'JK#L,Z/A?0KK0;:_AN;R*Y%S?37:&.$Q[?,<L0?F.>33-2\*V^I
M^)K75I9#Y:6SV]S;$96X&X-'N]E)<CW- $.M^+QHNFZAJ'V W=M96D=P[P3#
MYBY.%&0.@&<^A7CFH+K63)K>A0ZIH-U;S37\L=G(;I2%Q"[;V"-SE=PVD'!_
M"H'\"R)\.;KPK!J&Z2X0Q&[G0L0@P$X!&=J*B]?X:UM6T6\U/5- O1/!&=,N
M&GD3:3YA:-HR <\<.3WZ4 <S+XUU]= O[X:?:B2/7!IRCS\A%\]8C_!R>>O^
MUGM@[.J^-XM+^U@6@N)+ QK>0Q3 RAF56*QKC,A"L#_#UXR<@5)_!%])I.JV
M$>IVX6XU4:G:LUN3Y;^<LQ5_F^897'&.*L'PUKUIK]W?Z7K5K#!J0C:^BEM"
MY654"&2'YAM)50,-N P#S0!'J7CUK!M<:/1+F:'1ECEN9/-1<Q,F_<H)R3CG
M'L<XXSUKSJEJUP%>10A<*BY9AC. .Y]JY'4?!M[?)XLC6^@5-=@2!2R,3"%C
M\O)Y^8D'/:NEELYYM#DL1<F"X>V,(N(>L;%<;E^AYH P8?',*S7<5[826\MO
MI9U1HD</(L8ZHZX!60<?+R.>M22>,H;?1VU2XCMQ9LT"PW45T'@?S6V@F3:-
MH4XW''&>]9VG>#-:L+JWNDU6PCGATE].'E6; ;B0RR<OR=PR?7]:GM/!<EC/
MJ-Q9KIUL+\P^?8+"6M9-N[>Q4]"X8 X'&T'YJ )]5UF(C1&U'2I2T^JI# T5
MS\B/AMDF01O4C.!C'J!27_CB*SBO+F+3Y;FTL]13397215?SF*CA3P5#.HR2
M#UXQR:D'@.6SL-/M;*YA@AM=8_M-8-K-'$N"/)CYX7DG/J3QV'./>22>(M5F
MM;W1&N#J!F32KZWF2X9X\(A"*^&)V J^PG!4]N #J-3\>2:<^N?\2*ZDCT41
MR7;^=&/W;)O+*,G) [>QZ<9M:AXNFMM5OM.L]&FNY;6Q2^W><B+)&Q8<9Y!^
M0]NOMS5/4/"%_J4/BL-=V\/_  D%O'$ 4+&WVQ[#GGYNN>U6_P#A&M0_MJ]U
M$W5MFYTJ/3PFQOE*ESOSGD9<\>W6@!-/\:QWU[I*2:=-;6>K6C75G<R2*=P5
M5<AE!^7Y6R#GMVIMGXXAOKZPB@L7F@U"%Y;:2"4.1M7<!*O C+#IDGT.#4-I
MX-NH$\*Q2W=O)#HEF]I(!&P,ZM&(\CGY>%SWZU-X<\/:_H5M%ITVM6]UIEDA
M2S7[.4F90"$65]Q!"C'103@<]B 1Z/X[.K/H;'1Y[>WUJ.0VLKRJ?G1"Y4@<
M@%5//J.G>KO@S6]0U_1I;W4+>&%A=W$2"*3<,),Z8Z#H%'/?KQTK-TKP7?:;
M;>$X#?6\@T!I-S"-AYX:-H^.?EP')[]*V?#&AW/A^SNK.6[BN+=KJ:>#;$59
M1)(TA#')R06QP!TH @U#Q4+8ZL]I8O>1:0 ;TI(%8'8'*H"/F8(02"1U !)X
M$!\9M<ZQ%I^E:1/J FLH;])EF1$:&1MNX;CV&3@\FDF\*WD6H:Z^GWL,=KK:
MC[0DL99H9-GEETP><J!\I[C.>U2Z9X6;2?$D-[;31"P@TJ+3(X"IWA8V)#;L
MX[XQCWS0!=\1^(%\/6MI.UE/=?:;N*T"PE05:1@H/)'<_P#ZNM9,7CV&(ZG;
MZIIMQ8ZA8R0)]E+K(9_.;;$48'!W-P?3'-1_$F81:5H^)X8I3K5D4,I^48E4
MY(R.!U/M3M4\$'7!J5Y=7:P:E=FV-O+"NY;;R&+Q]<;_ )BQ/3(..,9H LW?
MBZ6QGU.RGTMCJ5C9?;UMXIMPN(,D$HQ ^8$8((')'7-.MO&-O<:Q9V)BB2.[
MTS^TH;@SC:R<9'3.1G.?3GL15JRT28Z^VN:D\#7GV,6:) IV*F[>QR>26./H
M%[]:P8OAM;16%E;"]DW6E\TL;XY%J=R_9O\ <\MBOUR: +]UXT%M;?\ 'DOV
MU+-;V6TDN C*C;MJ+D?,YVM\N ..2,C*+XUEN]5@L-.T*\N7FLH;X%Y$BVQ2
M-M.0QX*X.0>>/QJ35?#^L#Q-_;F@ZG;6LL]NMM=P7=NTL<BJS%'&UE(8;F'7
M!!J>UT"[M_%W]LR7B31'3DL65D/F,5<OO)Z<ECQC_"@#0UC6(=(BMMZ&2>[N
M$MK>('&^1LG&>P !)/H#U/%<_JWBRY71?$\$%J+?6=(M&F9#)E-K1LR2HV/F
M'RG@@'*D>]:WB;0&UVVLF@N!;7MA=I>6TK+N7>N1M89&5*LP.#WSVJA>>%+B
M^MO$,TD\":CK-F+(LJDQP1A648[L<NQSQG@=J )_"6EQP:=!J1A:&[N[6$3
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M$DL6H06+""16C8RD!'1SC</FQTR""#CK1J/@B?4A?WXU!;36KBZ@NH)XDW)
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MR&/O63HIL;;1O!^IQ7(%X_B&>V:8W!9C$9+@%.3]T_*<>N#U- 'LC$A20-Q
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MFL<[AMZC&!R>N?:K->5>(KBV%Y\2@MYC&AV\J8G/#[)\;>>.=G ]1ZU)J/\
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MT >O5G:_JO\ 87A_4-6^SM<"SMWG:)6"E@H)/)]A7G^O275K?ZO<>"W5K9]
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MMIVDQ1RJBW,A:>XV=/-<[FQ[ G ]@*TJ "BBB@ HHHH **** "BBB@ HHHH
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M='TL:@^F-&D\?G^6[NRARJ9!!(1@>2!DX]ZKZSXQFT;4/*GT]%M_MEO:J7N
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MDJ0?3@@CWKESXSUC3],\5:G=6%M<Q:9J?V:.*.Y*D+MA  RG/W]V<CDD<<4
M=Z(HQ*90BB0C!;')'UI0BC.% SUXZUR]_P")-8TV!FO-'M8"$FD$CWW[I@F-
MB!MF=[Y/&.-IY-00>,[_ %&\TVVTO2(9&U'2!J<+3W9C"@E!L;"''W^HS^'4
M '7K&B_=11QC@=O2D*QH 2$4+P#@#%<;'\0H)].T*X$$%M)J]J\T2WEQY4?F
M+M'DB3:1N))QTX'3M4&K?:=7\?:;I6H:?:S:=+I$\LMM/,2,EX59B-A&Y06
MYZ$\C- '<B*-9&D"*';AF Y/U-'E1_W%_*N/T;Q7).-'@T[1+A])NXBMM./-
M/E*J9C,A9,;6  R&8@D=<U37Q_JY\*#Q(WAV$6+%%51?YD+&?RL8V8[@]1GV
MH [^F)#%''Y:1HJ==H4 ?E7+S^*=3MIFL)=(B_M18GN##'-)*GE[BJ?,D1.6
MP>J\8/TID/B>;7H'LK;1BMS_ &>MS>6M^QB,/F;@L1&TY8['Z@# ![T =:NW
M:-N,=L4GEI@C8N&Z\=:Y;X=2)%\,/#\LC!433XV9CV 7DTR+QJYM]#U&;3U3
M2]:F2&VF$V9$:0$Q%TVX ;&."<$CKV .K,,9D60QH77[K%1D?0TX@$$$ @]0
M:XB+QU?MY4\NBPQV?]LG2)7%X6=7\WR@ZKL^9=V,Y(//0UJ^.=6U#1/"TU[I
MJQ&<30Q$R,1M5Y%0D8!Y^;^O.,$ Z$*@;A5W8].:!&@Z(O4GIW/>O.[N]O\
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M*WS$JV>PQWS5&+Q]=ZG_ &0NC:*EQ)J=I<3QK<77E>7)"RJ\;?*>[8!&<D=
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M-#M>?.&V$LQ P,J.G)%;-QXU:6!#I6G/=W!TZ+4#$PD^[(&*)E$;YCL;K@#
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M0+MZX#C&>,CDUHW7CG[/I$VNI8K)HD%X;66<3?O JR>4TH3;@J'SQG.!GVH
MZ\*H)(4 GOBD6-$9F5%5G.6(&"?K7$ZIXZO]./B"1=%ADMM#FC6Y<WA!>-D5
M]R#9RP#]#@<=373ZYK-MH&AW>K788P6T9<JO5CT"CW)('XT :!16()4$CN13
M3%&R,AC4JW!4C@US-YXKO-+U'^S[_385N)K*6[M#'<EDE,0!>,DH"I ((."#
M[5=\+ZSJ.NZ9#J-WIL5E;7-O#/;[;GS68.NXAAM&W'&.N0>W2@#:"Q[/+"KM
M'&W' _"E(##! (]#7GFN^(KC3+'QO<Z7IEK:ZC8RP)+<&0MYV^--KGY?O*K
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M1U^;CBJNB^#;G1KO2[@:LD[:?I7]F('M<;ERI#</_L+Q]?PZD3PDN!*A*?>
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M=KK,[3D&W#&%FV[N=PW?=XZ8R>O&.O,B ,2Z@+]XYZ?6FM<0HA=IHU0':6+
M 'TH P'\,W,6MWNJZ?J26TVH6Z17JM;[U=D!"R(-PVL 2.=PX''%1V'@]-(U
M73KK3KI8K>PTQM-A@>$ME2RMN+;ADY0=NYKI'FBBV^9(B;N%W,!GZ4\D 9/
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M9.,^O/H=% $5M<17=K#<PL6BF02(2",J1D<'D?C4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS MS&S0NJ2Q$X#HQ&&'T/<=B*U: "BBB@ HHHH **** "BBB@ HHHH ****
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M" W/V3[3Y9\D39V["W0'=\N>F>,YXKF+'0-<BT;P1:3V$:R:).GVC9<*P*)
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M["HE$>&''.-AX]Q7/0^&]:CT33;5K#][;^(GU*0><F/),SR<'/WL.!CU!YH
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MPF(2K,]LZ1N"2,!F !((Y'45B:GXEDT3Q_<P74U[<6 TE+A;6WMC,5?S65F
M1=V,*,D\#\<5I^!M,O=%\&Z=IFH0B*ZMD*.%<,#\Q.01VYJ*\L-2M?')UNVL
MOM=O+I@L]J2JC)()&<$[L?*0V,C)]J +EKXMT>^NM,M[6X>4ZG UQ:2+&VR1
M%^]\V, C(R#R/2M&QOX=1CED@#[8YGA)="N61BK8SU ((S[5PM_X=;1/!.D:
M?:7ULNOZ=<I<V;=FFDD.] O4QMYCK].3TKN].LDT[3K>SC8LL*!=[=7/=C[D
MY)]S0!Q?B3Q?<2:/XR@TX7=E=:+;%DN?*'+^7O\ X@1C!&._4UOZ=XJTRZDF
MM9)I89[:U6ZE:XB:)6BZ&12P *Y!Y%<]K?AS6KA?'%O;6D4L6N0*+:3SPI#>
M0(B&!Z8(SG/2G:OX7U+6]3N5:$VUM=>'GTPS%U)CE9LY(!Y4?Y]: .@/B_2(
MY[B&YDFM9(+7[85N(60O#G&]1CGG QU!(XYJS_;]HJ2F5+B&2*1(C%)$=[.P
MRH4#[V?;@<YQ@XYFRTO5KK2;F/4_".BPW MC!(L<BL+S) 8 A1L0@'KDY(].
M<Z;P9K<>G,MANFMK*_AO-.TW59Q*=JHR21&3YL*0YVY)P10!W6DZW9:RMS]E
M9Q+:S&"XAE0J\3@ X(/L001P0>*YG7-9N;/XB6.F3:^VG:9<:;+<,"(%'F*Z
M*,,Z'LQ./:M_P];SQ6LLUQI%GI4DS _9K8JQ&!U=E !/TZ #FLG4=/U0?$6S
MUN#3FN+*#3I;5B)45B[NC @$] %]NM %+1/&WDZ5KFH:M<-=Z1IUYY-OJD$!
M(GCP,L0@P=K$J64!3[8-=!K>JB*QOK:VEFAO5L)+I)$C!\L '!)(*YSV/7GT
MK#T3PS]BO/%%[K*6EII^N.B#3UES&BA"C%C@#>^>0/;DTGAK2+]? UZ)I_M]
MW<V[VMK+P#);H&2 DGU!+D_[9H N:9XMMK7POH\NHRS3WDFD1W]QY<9=A&$7
M?(0.V3T')YP.*TQXGTQKX6<;32S-9?;T$<+$20\#<IQSU' YYZ5R4OA[Q))H
MNGZ4UG#):)H(L7C-T$$=T%VEFP#O0@# ]>H'47I?#&K3Z-X6>)H[/5-.C%K<
ME9-V+=X]DH!&,MPC#ME1UH W[;Q1I=W86-]%+(;6]A>>*0QD 1J,EF_NC&.O
MKCK5G3M8M]2D>.&.="L23#S8RH9'SM(/?.T\=1W KGM!\+76A0:S;HL$]JIE
M32;9_NI%)^\9&]BYVX_NH*HZ=INJ^$+75+S3+.4:<MM&T&DWM\I6*;<=_ER?
M-LCVG@'J>@% '>NVQ&<@D*,X49)^@KSVZ\:3ZCI'A[5[4W=A!/K0MIH3$#YL
M6Z48Z$D_(.%/4D<UZ!;RM/;12O$T3.@8QMU0D9P?<5Y[:>&M=MM"T'39+&-C
MIFM&[:1)U.^+?*VX XP<2+@>QZ<9 .LL_%.EWMC/=1O,GD7/V22&2%EE$W&$
MV$9R0RD>QS5G2M;LM8^U);,ZS6DODW$,J%7B? ."#Z@@@C@YKB=0\*:W<G6;
MFWM+=ISK<6J6D%RZF.X185B:-\9VD@-CC^[^'7>';>XCMY9[G1[/29)B/]&M
MF5SP.KLH )]N< =>> #.N-9O-4\<2^&["X:T@LK1;F]N$56D9G)"1KN! & 2
M3@GH!CK5\O<Z'-=WFI:JTVDK I4S1KOC?<01\BC=NRH QG(QSFLV]T74=,\;
M/XFTJW6\CO+5;6^M/,".=ARDB$_*2 2"I(X[T_Q-I6K>)_#D\$,:6,Z20W%M
M%.X):2.19 )"I( .W'!/7/M0!>?Q9I<"Z@+EI[>6P@^TW$,D#>8(N?G"@'<O
M!Y&<8YQ50>/M#VV[,;]%N9!';LUC-B8F/S!L.W#9 .,=3TS6=K&@ZEK=SJ6J
MFQ:VN)-#FTR"V>5"S/*<EF() 4$+CG/+<#C-;6TN[&W^'\3VC-=07Z1O"'7)
M*VLH.#G'8D<C\* .CLO&.C7^G27L4TJB.Y^R/!+"R3+.2 (S&1NW'(_#GUIM
MQXST:ST_4+NZEFA&G.L=W$T+&2$MC;D '@Y&&^[[USM]X/U2>_N/$%NB)?'6
M(-12R>0 -'%#Y)1F&0'92S9Y .!GJ:/$/A75-7MO$M]!:;+O58;6VAMGE4%5
MB8L6<@D9)8C )X ]3@ Z(^,M,&5$=]YH65_):T=)#'%MWR!6 )7YEP>^>,U'
M_P )A:2Z_I&G6L$]Q!J5DUY'<I&2I3*!<=_XP3Z<>M5_$5AK>I:G;""UCETR
M2RECDA>X\HQS-C:SX!WKC(VC(SR0>",W0_#^NZ;/X/GELX"=.TI].NT%Q]PG
MRL.#CYO]6>!ZCGO0!MZ5XATX:<TRZA=WOG7\UO$LT.V4RAFS$J[0<+M;J. I
M)/&:?+XTT2"P>[FGE1([M;*5# ^^*9B %< ?+]X<G@@C!.:YFS\+ZW:2V.II
M;+]IL=:O;S[*95_?07!?.#G <!@<' R",]ZDU3PKJ=U_:E_#:_Z3J6JV-U]G
M,BCRHK<Q_>.<;CL;H2.0,]Z .OTG7K'69;R&V\])[.0)/%/"T3KD;E.U@#@C
MD&EU'6[339?*E$TDHA:X:.&,NRQK@%L#W(X')[ UG:/IU[;^,?$.H3VQCM;Y
M;80,74D^6A5L@'CD\?TJGXQ\/SZU<1R6]I.MW!;M]CU&SN1#-;RD]&R1NC.!
MD<].ASP 59/%G]D>+_$']H7-Y-IMO8VES%%%;F3R WF^8WR+G;A5))K<U'Q=
MI&FB1I9I)$BM5O9FAC+B*!B0)&QV.#TR>"<5S\V@:Y)<^)7FMUGDU'18+*.5
M'11),BRACC/RJ3("/H?;-'5O#7B;4-#N-)-G#+;R:"EI K7018;@(RL7 !WY
MRNT]!CL230!T37UY)\1UT]+Z46,NC-<+&H3"2>:JAP<<G![Y%2^ =0N]4\#:
M5>W\[3W4T;&25@ 6.XC.!QVJK9Z;JL?C"SU6>Q ACT8VCB.96(EWJ^!G&1A<
M9]3Z<U=\#:9>:+X-T[3=0B$5U;HR.%<,#\Q.01]: ,.+QG%H?B'Q1%K5U>RV
M=I>0K'(MJTB6T;01N2Y1<*NYCR>?K@UTFI^*-+TJ*6:>21X($62XEAC,BPHW
M1F([=^,\<].:P;S0=6-YXOMXK2.2'7U00W!D79"/LZPMYBGYN-I("@YX&15,
M>%M3T;7+A;31=.UK3;R"",/>2*CVSQQK%\P*G<A55.!SG- 'H(EC,0E#J8RN
MX/GC'KGTK";QEH\<H2:2XBWVSW<+-;OB>),%F3 RV 0<=<'.,<UI7>GB[T2?
M3BXC$UNT!>-<;<KMR!V^E<7I&B:Y'H;V%]X<TJ"ZM;.2V2]MY$+73%"@*C:"
M@/5B3VQ@YX .AL/&6DZE<00VQNB]Q:&\M]]LZB>,!2=A(PQ&Y<@>M9MIXOM-
M:T/1-1EEO],%]?I'"B0D^:=Q"QLQ4@*0.3D<@X-0Z9H6JV]]X+>6SVII.F26
METWFJ<.R1*-O/(S&?P(]\4;/PUKMOX3\-Z5)8QF72M4BGD:.X4AXD=B6&<<D
M,,#ZYQ0!:USQ?<7?AGQFVG+=V%SHRRI%<&(<LD2OGY@1R6Z=<<\5T-UXDLM*
ML!+=F>0P6JW%R88C)Y49!^=L=!PWOP>.#7-ZAX<UI],\=:?#:12)K+/):2B<
M#)>"./:P(XP5))SZ8S1<Z%K%KXA.H0Z#8:M:WUG##-!=RHCVLD8(R"58%"&Y
M YXH VO$'B6VBT2_.GW,SW"6!NUEM(Q+Y2%24<Y!&#@X&"2 3CBM#PS<S7OA
M/1[JYD,D\UC!)(YZLQ0$G\S7+2Z!KNFZEKPL[*WO+36+&*(&.40BVECB,>-I
M_@(P1C..F.]=3X9L[K3_  MI5C>HB7-M:10R*C[AE5"\' ]* ,[2_&EG?VNH
M74\%Q:Q6M\UD@DB.Z1PP0  =6+9X'/2M73M:L]3N+NUA+I=VC*MQ;RIM>/<,
MJ<=P1T(R.#Z&N+E\)Z[]ENEBBMQ+:^(3K-IF?BY4N6,9X^4[689/<#MS71Z7
MI-P_BS4/$5S"UJ;BTAM([=F4MA&=BS;21DE\#!/"^^  2ZCXE33_ !1INB&T
MN)&O(99O-2,LJA-HQQWRXSZ#ZU#9>-]%U!7>![OR4#YF>TE5-RR>64R5^_N(
M 7J<CBDUG3=1D\8Z%J]G;QSP6L-S!.K2["HD\LAAQS_JSQ[BL*/PIK$WP]N=
M),4,&HIJ,E];K.P>*0_:C.BOC/!&%/\ 6@#H_P#A,-(3[8DTDL-Q:2Q0RV\D
M1$F^4@1 #ON)P"..O3!JIJ?CBRLM)DO(+>YGDBU"/3YH?*(:*5G5?F_!P1C.
M<C'6LZ6P\0S:,\]GX?T_2;MIX/-MK>=/,FB5\R 2A0%)'"]QR<@D8SV\)ZZ-
M*UR&.PMD:?6K;4[:,76[>J&$LI)'!_=-R>I/XT >BF<?9?M'ER8V;]FP[^F<
M8]?:N F\:SZC9>$]9MVN[.UOM2:&:W\G=YL?ERLHZ$DY1?NGDY'->@Q&1H4:
M5%20J"RJVX ]QG S7GFF>&M=M-&\(V$]C'G1M0,LSQW"D/&$E0,,XZ^8#CT!
MH ZVS\4:9?:>;N%IABY:T,#PLLOG#K'L(SGO].>G-6=)UJRUJ*=[1WW6TS6\
M\4B%7BD7&58'V(/H0>*X:Z\*ZX\5[=P6-M)<Q>('U6WM;J13'<Q-%Y10D9VM
M@L02" <?AV7A^VGALY);C2K/2Y)GW?9K8JVW@#+,H +?3H,4 17/BW2[76WT
MAA>27J>47CBM)'VK(Q56)"XVY!RW04^/Q3I<FH6EGYDBF\W_ &65HR(YR@RP
M5NAX!(]0,C(JI;:9>IX_U/4GMRMC<Z?!;)*'7.Y&D8\9SC]X,?0U@^&_"^JV
M>GQ:#J.BZ6D5G$T":Q$RF26/:54JFW*O@C))['&<T =1;^*M)N;VVMDF=3=Q
M/-:RO&5CG1,;F1NA !![9!R,CFBW\5:7<7%K"KS+]MC:6S=X6"W*J,G8<<G'
M('4CD BL'1-)\22^%AX7U>UM;:""R:Q^WPS[S.GEF-65, J<8)R>HP!SD)9Z
M!JUW9^%K34K187T"199)HY587#1Q-&HCYR V[<=P7&,<]: -6R\=:'?VKW4,
MET+54+^>]I(J,?,\O8I*\ONP-HYY'%5M#UB[OO'^O6,DMT+6WL[62.WGC"^4
M[F7=C Y!"KSD^G;%9$7A77/^%=6&G)%%%JNG:@+Z.*24&.8K.90I89QD''3@
MCTYK9T6RU=O&NI:S>Z>EI;7=C;PJIN%=U>-I"00HQ_'Z_P#U@!/$>L7.E>,?
M#D8N+C['<I=":VBBWF5D0%<  L3D] <5I6WBG2[S3+2^MY)'6\E:&"'RR)7D
M7<&38>05V-G/ P:K:SIU]<^,?#VH06QDM;$7'GL'4$>8@5< GGD<_P!:YS3_
M  OK=BVE:DML&N-.U2^G>T\U?WT%RS'*G.-ZAEX.!P1F@#2\4>)?.\'W&H:+
M?2P3VM_;VTR^6 Z,9XT>-U89'ROV]00<5/XW\2#3O#6O#3[BY34+*R>4RV\0
M<0.4)3=D$<X'N <G YK+U;PIJ=WI7B">"V'VS6-2M+D6YD4"*.%HOO'.-Q$3
M$XSRP';-,U3P_P"($B\9V-G8QW=MX@A>2"9KA4:"5H!$4<'J/E&",CL<=: .
MEE\3V6EZ4D]ZT\AAM([BZ>*(OY*$???'0<,?7 )Q@4C>,M'_ +5&FQ-=3W&(
M6_<6LCJ%E)"/N QLX^]T'K7.MX?UNQULW8T'2]7M[ZS@BGBN)U4VLL:E2060
M[D(QG SD=/7:TC2+ZR\::A>R6R+9S:?:VT<D955W1&0G" Y5?G&/I0!O7^H6
MVF6OVBZDV(76-< DL[$!5 ')))  %95SXKM$TW6)H(YC>:9$7GM'C(D4E2RD
MCNIQ]X9'!YX-,\8:->ZO86,FG%#=Z??PWT<4C;5FV$Y0GMD$X/KBL^[T*_OK
MSQ!K'V1HKB^TI=/M[5I$W<>82SD$J.9 .">%]\4 7?"#7M]IUIK%QJ%W(MW9
MQ-);3Q!564J&9TX! .<8Z<5TM9?ARVN++PUIEG=1>5<6UK%#(NX,-RH <$=1
MD5J4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 445@>+)M4@L;5]*A-RXN09[1)_)EN(MC96-^S [6
MZC(4C/- &ZSJI4,P!8X4$]3C/'X TZO,[2[CUGQ-X-NX;_4C$\>HATN&,<BM
M&RC8Z]-RY*D]\41>(=5N/!FF>*X;J8WTNII#/99S&R/<>28=G9E!'S=<KR2#
MB@#TRL[2=9L]<ANGLS(5M[A[63S(RA#I]X8//>N9TB^NM?2?4CK4EC/9:U);
M2P8#)Y22%!"4S]YQM;=R<MQQQ6+X:U-O^$JU'1KB6>RMY]:O)H9T; NI%(S!
MG^' ^;U;L1@Y /1K#3+'2XY(["UBMDD<R.L2[0S'JQ]SW-6ZQO%5Z=/\-W4Z
MW[6+_)&DZQ>8P9G50%4D98D[1GH2#VKE(M1U]G\4:?9N6FL[NT-K;7%U\Y1T
M1Y(A*>C,-P!)."W!Z&@#T2D=@B,Y!(49.T$G\AR:Y_P?JB:KIMTX^W1RPW3P
MRVU\/WMLX"GRR<G<,$$-DY!%8\&KW]KXRAM=6^UI#<WTR65Y!()+6X4*^('7
M_EFZX/..2AYH ZK1M7M->TF#4[%G:VFW;"Z%2<,5.0>1R#5^O)_"<U[IND^"
M9X=0N##?7]Q:36IV^44(G<$#&=P9 <Y]>W%7!XAU6?P5;>+(+J;[?_:@AEL<
M_NV0W7D^1L[, 0=WWLCK@XH ],HKS'7]2UO3[CQ#H]K>7<NIAXM1TL!\%[?!
M,D73H#'(,]<NG/2K6N:Y=7O@R\\2Z-J=S!;S36B694@@H9(T<X(."2[*?]P>
MIR >B45RGA^:]@\:>(=)GU"XO+:""UN(C<%2R-)YH< @#C]V#CMS237EQJWC
MC4M!>[N+.&UT^&> P/L>1Y&<&3/<+M48Z9)R#Q@ ZRBO,='UC7-?F\'K=ZG<
M6O\ :-E>_:EME11(T+HJR+\IQN!SZ<\8ZUU7@._N]1\'VL]]<-<7"RW$#3.!
MN<1S/&I..^%&: -+6-=L=#LC=WCOY2S1PMY:%RKNP50<=.67KCJ*TJ\?O8'7
MP1XK8W=Q(_\ PDB1@RR%\ 74 !Y_#\ *U]2U_4O#<_BV+^T9KF&T%A)%+=%2
M8!/(4D;(7   W="!@\8XH ])JA?ZS9:=<06TTCM=3Y,5O#&TDC@=3M4$@#(R
M3P,CFLW0H-2MM7O!<ZC%-93Q1RV]MY[3O$>0S;RH)5N, YY!QQ6-I3-'\9_$
M*WIQ)+IMJ=/W=X06\P+_ ,#(S^% '4VFK6.J7%U8Q^:)X$1IX98FC95?<%Z@
M9!VMR,]*GT_3K+2K1;33[6*VMU)*Q1*%49ZX Z5@>--7_L33A<6K+%=37%K:
MS7  )@ADF"ESGCC+XSQD_6L+Q)J.K:+=>)K"RU"Y^SQ>'WU.WE8AWMIE+#:&
M8$E6QG!SC:<8H ]&HKSNZCU>VOO"T*>)=2*ZO</]HW"([1]E9L)\F0,KD9)Y
M/>J=MKVLZ???\(_=:A/<6_\ PD(TY=2DP)#"T'G",L!C?N(3=UY/0XH ]0HK
MR_7=7US3O^$BT^VU.X2*PO=--K<':[A+B55>)F(RP'4'KAADFK'B6>_T>UUB
MWL]?U&[N;#29;U1(RH8&+.RN[@ ./EVJFTC"G.,@T >C%U#A"PWD$A<\D#&3
M^H_.H+"]34+*.Z2&>%7SA+B(QN,$CE3R.GY5Q=@);WXDQSR7EPC2>'X9MJ2?
M(K-(0<*>.P/U%4?#_B'4;^T\'Z=>WLS?VI]N:XN0=KRF)CM3<,;<@YXP<)@<
M9H ]+JIJ>HV^DZ;/?W7F>1 NY_+C:1L>RJ"37G<^L:ZJFP&J7""U\3PZ<ERJ
MH6F@<*VULKR5W8SWQSGFNC\+R7,NH>)]'O+VYNX+.]2.&25\2!'@C<KN7!X+
M''?F@#IK6ZAOK."[MG$D$\:R1N!]Y6&0?R-35P_C*]O](;?;Q71T:"R(F.FR
M!9K%N=LWE\;T 4\=MIX-=)JUQ<3^&KJ?2;F&.YEMBUK-+P@9A\A.1QR1V_"@
M"Q-IVFG4(]5GM+4WL*&-+IXU\Q%/8,>0.3^=7*\FUG4I-2\/W=M/_:VG7UKJ
MFG+<6-Q/N,0>=!E9 3YB-R1SU'L!6])?7NI7WBRRCU*YLY-%BB6T97Y!,._S
M7SP^6R,'(PIZ')H [NL^+6K.;7KC1D,GVRW@2X<-&0NQB0"">#RIZ>E<9H^N
M:AXND>RN;V72+O\ L.UO81"=I$LH;=+@_>52%&T\<G.<C&;K6LR:7XX:5[E_
ML]SHUE#<ZK$H MU:6;]]M[ M@9Y"[LG(&" >J$X!)SQZ"J&C:S::[8&]L3(8
M1+)#^\0H=R,4;@\CD'K5R",10(BN[@#[SMN)]R:\PT75I[+3-,T^)UBCU'7M
M2B>1IC%DB69E0. 2I8CMR<8'6@#U.L_2-9L];AN);,R%;>X>VD\R,H0Z'##!
MYZUQ]O?:M:^(-)\,ZGJHE6YFNY#-#(1(4C5&C@+X!+ 29+#!(4>IK.TFXOM,
MT6\CM9II(V\6307<B\S-"9"&VXY+9VYVC.-Q% 'H^H:;8ZM:FUU&SM[NW+!C
M%/&'4D'(.#Q5E5"J%4 *!@ =!7G<^J:YHNGW,UY>7 M+O6TL[-KLB,PVK8^8
MMLW#+;EW/DX*GCK2:RWB#2+7RO[=*"36;%(4C<320PRR*K([NH+#.2.^#@DB
M@#T:BLV.+^Q= E$^ISRBWCDD:\N\.RCELMM !"CVZ"N(TS5M8_M/[+%J3[;G
MPV]['/>L,-.&4+.5Y\M3NSL!P!C@$4 >DU!=7,%M#)),21&AD*JI9L#J0HY/
M;I7,>#]5GNM0O[#4(-0LM2MXH6FLKN3S4&2X\V*3)W*Q&.V"O054FA)^*&K,
M;FXVKH<4@C\T[,F253QTQP/QH ZW2M2MM9TFTU.S+&VNHEFB+#!*L,C([5<K
MROPC<W^E6/@(1WUS/;ZAI+K+:-MV#RX5=-H R#G(SGG-:_A:^U?68?#VOC58
M!;7D3?;+<SF03.4)VHFT"-D8'@$\ YR>: .]HKF=>U.9?%GA_0Q))!;:@MR\
MLD;;6<QJI6,,.1G<6XP?D^M<U/JVMVVC:O=->W$L7AW60'D& US9 (TBM@<E
M%<\CD[/<T >ET5YUINM7EUKVHZ*;RY(U">*[TN?S,G['DB0J1V_=M@\Y$J9J
ME>ZEK-OIOB+4UUR]+Z7K\4$$1V;&B9H 48!>1B1OY]>: /4JJ7>EV%_-;S7=
MI%-+;MOA=UR8V]5]#[UQ5SJ&L:S>:^MAJ4&GW&D7JHAEG(6.(*CDO%M(=7!;
MDGZ8QS=T)=1U#QCK_P!HUJ^-OIFH(L-LNP(RM;HQ5OER0"^1C!XZF@#LZK7]
M_;Z;:-<W4FR,,J#C)9F8*J@=R6( ]S6#K6I3-XST703+)!:WEO<3N\;%&E:/
M9B,,.1PQ8XP?E';.>/U2XO\ 4?#S6VH74\AT[Q5;V4-P&VM-$)XBK-C@LN[;
MGU7/6@#TG3-4BU2&9XX;B%H)FADCN(BC*PQ^!&""""0<]:O5GZHMU!X>O%L;
ME(KM+5Q!/<'*JX4[6<^F<$UY]>^(K^+0]3YU32]7L;BP$MI<R^:$62<(SI)R
M'1P6'L5/2@#U&L_6M:L] TQ]0OC(+=&5"8XRYRQ"CITY(Y/%<5KWB>_T74?&
M+1W;>39PZ>8]^&%MYSNDC@'T&&P>/E]*/'5I):>$M<"ZQ)=6\ZVDD-M+\[0G
MSE!??G)5N.#P-IQ[ 'HM%<IH<][;>.=<TB;4+B\MH[6UNH_M!4LC.958# '!
MV*<=NU4_&NIZCI5W)<E;MM'CL\S3:?(/.L7);]\T?'F)@>^-K<4 =J'4N4##
M> "5SR <X/Z'\J=7ENHZK<:)J'C_ %RRN)YI;:UM9(%=RR*&C)SM]%R6Q]:T
M]=UC4O"^J0OI]Q-J5K<Z1>7313-OQ) BLL@/4!MVT@<<C % ';WUY#I]C/>7
M&_R8(S(Y1"YV@9. .32:?>PZGIMK?VY8P7,*31EA@[6 (R/H:Y'$DWATZFFO
MR74%[HLC-;OAA-(4W>:I_@ !(*@8Y'?K6^&^IMJ=C:6US+/:W&GZ=:HE@6PL
MD1B4K/Q]X-R/;&#S0!VU_J%OIML)[E]JLZ1( ,EW9@JJ!ZDD"F:7J<6JVSS1
M17$)CE:*2.XB*,K*<$8/4>XR#ZUS7Q#M_/A\/_OIH_\ B=VB_NWV]7Z_48XJ
MI/J%]J#^,(H]1N+.?0U5;/:W3$ D$C@\.&8D<Y&%XP<F@#O:*\[T>\UCQ%XG
M@6XU6^L8GT6QU)K6#8H25W?<G*D[3MP0>?>NF\47;0+IEO'=RPR75ZL8AA7]
MY<@*S&,-D;.FXMGHI Y(H O:KK5GHPM#>&0?:[F.UBV1EAYCG"Y(X R>IHLM
M:L[_ %34-.@,GVC3RBSAXRH!<$C!/7@=1Q7GDFH7M_X6T[[=,99K;Q=';!BV
MX[$NRJ@M@;L  9QDXKI] _Y*#XP_[<O_ $4: .LHKB-3CU/5/']YHT6O7UC:
M?V1'<H+;8"DAE=<@E2<?*"?Y@<5G>%->U?5+[PM_:%T_^GZ3=O<JIVK*\<D:
MK(/0E6)XQ]Z@#TBBO+=-U36=6T_P4AUR\B_M&YOH+F2+9ND5$F*G)4\C8,=N
M^,TMZ-=$?C-(_%6HHV@I%):.PB^8BV60^9\GS G/IU/7C !ZC17 :=JVH^)K
MO6+:>ZGTRXLM/M)85A;;LDEB+M(0?O -\N#D?*>,FLMO%>LR:'INNZI%=1Z=
M<:;;RSSZ>_S6,I+%I)(NKQL"OKM /'>@#U.BO/\ ^T=8UNYU>:RU."QFTO4_
M)(DG.U8D*_*\6W#!UR0V<Y/!XQ4]KJ]_;>,8;/5OM<<=S>SK97<$@DM;E0K[
M877_ )9R*!Z<E#R: .YJM:WJ74UU$L,\9MY?*9I8B@<[0V4)^\.<9'<&IT=9
M$#HP93T(.0:\SU76-9@T;Q<\6KW*RV6N6\$$FU,K$_V?*?=Z?O&Z8/O0!Z=5
M'6-6M="TBZU2],@MK:,R2&.,N0HZ\"N#U77]3\,S^+8O[2N+B*TBL)HI;D*S
M6_GR-'(PP ,*%W 8P,>E7?&%J]IX,\78U>2[MIM(>2*VE.]H?D8,P?.2&XP#
MP,''L =W'(LL22+]UU##/H:5F"(6.< 9.!D_D*XDWUW'XGO;$7DJ6@\/1W2H
M'P$DWNI8'MPJ^U4O#>NWNNW'AS2[V]F3S_#L6I2R1OY;W$K%5/S#^[R2!U+#
M/ Q0!UEAXEL=3T^POK..[EM[V=H8V6W;Y"I8$N/X%RA&3ZCUK8KRKPW=WMAX
M4\$);WTRI/K-Q;7"@+B9=UPWS<9ZH#Q@4^74M:AL-2U,ZW>N]CXE2SCB.P(\
M+31(58!>?E<^F.O7)(!ZE17GVMW?B*YO/$-KITUVFH07%LFF&V7=$$94+^8<
M% W+D[^0-I'49Z7Q5'(G@?6$%S.)(]/E(F5MCDJA.<J!@G';'X4 6I-=L8]9
MLM*+NUS>0O/ 50E&1,9.[I_$/SK2KS*&Q:75O %LE[<Q;]'NR94<&0 I;\ D
M'%&C^)-3O+#PSIMS=EY+YK^-YY)S \S02[$7>JDABN6. "2O7J" >FT5C^&X
MM0AT86^IZA'>W<4CQFXB[@,=H)P 6 P"<<D5P"7_ (@B\-Q>(4UZ\N+FVUQK
M,VCK'Y=Q$;PP[2 H.[!!!&,8X% 'J]%>=3ZW?+KFG7%KJ,UQ;S^('L)7)"1&
M/9(#$L?.=C)S)P21W!J:*^U&UUS4?"EQ?W3WES=1W%A<LWS"T;EP.V4V2+GN
M63/6@#OZ*\MU[4-9M[3QW=0ZY>HVBS126:C9M'[B.3:WR_,N6(Q[\Y/-7=9U
MK5?#.K:[Y5]<7J1Z"VHI'<!6$<RNRY4 #"XP2/:@#T6BO-M=GUO3_#VL:M9Z
M^JVKZ-)<VZQW'GN94P?-1F0 *00" ,<C&*FN9M1@UG4=.?5KV:&Y\//>G<X5
MHI5;;E"H!4$']/6@#T%'61%=&#(PRK*<@CU%.KGO D7E> ]!_>22;M/MV)=M
MV,Q+P/:NAH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JK?:=::BL0NHMYAD\V)@Q5D?!&Y2""#@D<
M>IJU5+4M4M]+BA:?>SSS+!!$@!:60YPHS@= 3R0  2: (G\/Z1(+,/IUNWV)
MVDMRR9,;-]X@^I/)]3R:6+0-*AOFO([*)9FE,Q(SM\PC!?;TWX_BQGWK$UCQ
MB(?#/B.YL;:==3TBWD:6VE"!H6\LNCM\V"A'.03GGN"*O>&K26.U&H2W&I W
M4,9>WO)Q(J,!RZ\MMW9Y ..!P.: +/\ PC.B#7#K7]EVO]I'K<^6-Q.,9^N.
M,]<4QO"NAO"T3:=$R-<_:R"2?W__ #TZ_>]^M<YJWB.2_P!:\(RZ:;^.QO-1
M9/.!"PW,?DR'H#N()52,@9 R*N1>+--TW3]4U KJT\$6JFUN#-M/D2'8N%!8
M;8LLOTR3TH Z6_TVSU33Y+"_MH[FUE 5XI1N# <C.?< YJ@OA+0$\TII-LC2
M[-[(FUFV'*G(YR" <]<@&J_B/6[2TTK64N5U&.&TL_-GN+,@.BL&^X0<AP 3
M[<'N*74=<A2UFLK6.]N;E;'[0_V?;YD,9!"LQ8CDX; &2=IXH V+2RM[&)H[
M:((&8NYR278]68GDGW-5H]!TR*Y:X2U"R&1Y<AFPLCY#.!G 8Y/S#!Y/-<UX
M;\5I;>!] DO6N+[4)M+CNI%5T,C#:,L2[*"23ZY/..AJW'\0-+NS"NG6NH7[
M3V(OXA;P#YXLX/+$ $'/!QTQUP* -6+PQHL$5I%%81I'9R&6V120(7.<LHSP
M>3^9]34J:!I45\]ZEE$L[R^<Q&=IDQC?MZ;\?Q8S[U3B\4V%]::<]@MQ=R:E
M;&ZMXH0H?RL#+G<0%P64<GJ?K6%X*\2L?"FF+=M>7NH7EQ>^5'(R^:RQSN.2
M[ ?*NT8S^@X .T-I;M>)>&%#<I&T2RX^8(2"5SZ$J#^%5)M!TNXTF/2I;&)K
M"/;LM\80;3E>!Z$ _49J9=1A.CKJ<BR10?9_M#+(AWHNW<05&>0.U8Z>,[$K
M=>;:7T#V]@NH^6\:EG@.?F7:QY^4Y!P: -:#2;&VU":_B@"W<R*DLVXEG5?N
M@DGG&3CZGUIM]HVG:C<17%U:J\\2E$E!*N%/5=P(.TX&1T-9FF^,M/U*^M[;
M[/>6OVJS-[;RW,81)8AMW8.205WKG('7(R.:Q[SQ#+J'BSP<]D-0AT^^EG(=
MB%BN8Q [*< YZ[6&X#UH ZMM$TU[JUN?LB+-:1F*W9,KY2$8*KCH" .GH/2I
M-.TRRTFU^S6%NL$&YG\M,X!)R3^))/U-9?B7Q!/H4ND10V$MT=0O5M<HR#9E
M6;^)ADD*<=O4] >>LO%9T35O%!U+^TKFSM]4BC$@ =+1'ABZY(PNYSPN2,YQ
M0!U,_A;0[DW1ETRW8W<JS3_+CS'7!#''4@@'Z@'K4W]@Z69[N9[*.22\B$-R
M9,OYR 8"MGJ ">OJ?6L[6O&FE:$;DW7FO%9LBW<L6TB#=@C<"P8\,I.T' (J
M]KVO6GA[19=6NUFDMHMN[R$WGYB #CTR10 [1O#^D^'K=[?2-/@LXG;<RQ+C
M<?<T_4M%T[5_)-_:1S/"VZ*0\/&>Y5AROX&L9M?M;O7=%AFM]9LIYKBXC@BD
M3RXY=D9),@SRN.5]\<"I)/&VFI]G=8+R6WN;Q[&"XCC4I),I8%1\V[JCC.,'
M:?;(!K#1M._L^:P:SBDM9P1-'*-_FYX^;=DM^-1#P]I7V&XLS9J\%R@CG5V9
MC(H& K$G)7!(P3CDUR6D>*_[(NO$"ZG_ &C=6T>O&U6Y(WI;*Z0A 22,+N;H
MH.,Y(&:Z'2_$,^H^*M9TEM/EBBT[RE$Q9"&+*6SPV<$$8X['..E %37?#$M_
MJ/AO[)#;BPTNX:21'G='"F)D4)@'D%@1R.E;4FA:7+IK:=)8PO:L_F-&PSE\
M[M^>N[/.[KGG-9TWB26'QJNA&PD^SK8&[DNBZ!0-X4'EL@#YL\9Z<8YIUMXN
MT^XN--0Q7,,.I@_8;F5 ([CY=P P25)7+ ,!D4 6YO#ND7%BUE-9));O()G5
MR3O<8PS$G+$8')ST'I27WAK1=3N1<WVF6]S-Y!MS)*FXF,_PDGJ.3U]:75]=
MM]&N-/BN8)V%]<+:QR1A2JR-G 8DC&<'^74BH[CQ':VTLD3PSF072VD2J%)G
ME*;]J?-V7DDX P?0T 2IX=T>.:UFCTZW26UA,$#HF&C0_P ((Z4Q?#.C+IL.
MGKI\2VL$GG0QKD>4^2=R'.5.2>1CJ?6L;6/'45EHFHW-K87#WUA<Q6MQ:2[%
M>%I&4(S?-@J=P(*DY]N<7-6\9Z=HT4\EW#<?Z+&LMVJ>66MU;GYAO^8@<D)N
M./J,@&C+X?TJ:VM[>2RC,5O-Y\2Y(VRYSOZ_>R2=W7)-36FEV5C=75U;0".>
MZ8/.X))D8# )]3CCZ5#JNMVVDZ!/K+QS7%I##Y[?9P&8QXR6 )&0!S]*K1^)
M[.36#IODSK+]A%^KL4V-%G&0=WKP?\"#0!<O=$T[4)S/=6RR2&/R6.XC?'G.
MQL'YEY/!R*L75G;7MG)9W,*2VTB['B8?*R^F/2L"/7;:Y\0V:I#JRWDNER74
M5HQ58W3<GW@6QYF2H'/ )R17.?\ "6WVJV_@G6A#>VL=_>2"2UB8,)T,$K*,
M*>>0OWL<C. * .VD\.Z3-97%G/8QS07)4S"8F0R;<;<LQ).,#'/':DG\.:/<
MRI)+I\)981!\HVAHAT1@.&7_ &3D4NAZY;Z]92W$$4\#0SO;S0SJ \4B'#*<
M$C\B1S6<OC73VU&]M#::@J6$K17=RT&(8-L?F;F;/"E>AQU],C(!>U3PSH>M
MSV\VIZ7:W4MOQ$TL8)4>GN/8\4^X\/Z3=7%S//91R2W,'V:9F)_>1<_(>?N\
MGCIR:RSX\T>*>XANA/:O#9M?#S0A$D*\$KM8X(R/E;!YZ5-?^+[32[4W%]8W
M\*>?# ,1+)N,I 4C8Q!&3CU]J -JTL[>QLX[2UC\J"-=J("<*.P'H*S9?"F@
MSZ3+I<VEV\EC+(97@<;E+DY+<]&SDY'/-4[7QQI<_P#:27$-W87&GF/SK>[B
M".1(<1E<$@ACP.>O!Q2P^-])EDOH)!-#=6;Q(]NVUG<RG$>PHQ5MQXZ\'KB@
M"Y)X5T*73+;3FTNV^R6K^9!&J[?*;^\I'(/)YZG)K&U[P5;S6$%MI&D:0UM]
MK-U=6=RIC2X8J0#O56*D$YZ'TX%/UGQN=/TZYD@TF]-U;7MO9RPS!%V^:RA6
M#;MK##<8)YZXY(V-?UF31/"U_K(LI97M;5[@V^Y0PVKD@G...^">G&: ,O1?
M!MC:V%]:WFF6<5I?*BRZ='*\\ VY^;+@<G(Z*/NCTS6A%X2T"#3(M-BTN".S
MBE$Z1*" )!T?W88&">1@5'#XD#0VD36%U+J,UK]I:TB\O>J# W$E]H!)X&[)
M].#C0TC5K/7=*@U*PD,EO,"5)4J002"I!Y!!!!'J* +;Q1RPM#(@>-E*LKC(
M8'@@YZUC0^#?#=NJK%HMFH6%[<?NQGRW&&7/H1Q].*B3Q?9RV$FH16=Y)9+;
M2W23H$*R)&0&Q\^0><X;!X/<8J:+Q182WEA;E9H_MUDU]#*X 3RU"ELG.01O
M7M^- &A9:79Z>SM;0[7=55G9BS%5SM7)).!DX'09/K4=UHFF7M\M]<V4,EVL
M1A$Q'SA#U7/7')_,^M93^);?4(?LT,-_;_;+*2YM+HQ@+(@ Y!!)4X92 P!Y
MK-\$>*UN]&\-:??QWQO;W3$F2[G7Y+AU13)AL[MWS9R0 >H)H Z*#PYI%LUB
MT-DB&P!6TP3^X!X(7G@$<8].*;8>%]"TO5)]3L=*M;>]GR9)HXP"<]?IGOCK
M4VH:Q#I]U:VABDGNKK>888BH9@@!8_,P'&1WSS]:R(O%CS^*+73%TVXCMIM,
M^WM/*44H"R@9!;(QDY[YQC@9H W-0TRRU2*..]MUE$3B2,G(:-QT96'*GW!I
M8].LXK![%+:,6KA@\>.'W9W9]2<G)/7-95OXNT^XGTU3%<PP:GG[#<RHHCN#
MC< ,$D$J"1N R*=#XHL[NZM((H+PP7SR16UXL8,3L@.<$'(^ZV"0 <<'D9 -
M1+"TCG@G2VB66"$P1,%P4C.TE1[?*O'L*HR>&-%E@N8)+"-HKJ83SH2V)9!C
M#L,\G@<^P]!6#X%UZ:;P[IMO<-=ZA>RR71DDW!S&BW$BJTA8C P,#UVG XKM
M: ,BY\+:%>:O!JMSI5M-J$  2X=,N,=,GOCMG.*MVFE6-C=W5U;6ZQSW3!YW
M!.9& P"?4XX^E8T?C?3GO+V$VFH)#82R17=T\&(8"D8D)9LYP0>..OID95/'
M&D"ZN[:Z,MG):V1OV\[:0T"\,P*,W0]0<'D<4 ;%_I=EJBQ+>6ZRF%_,B;)#
M1MTW*PY4X)&0>]0S^'])N;*&SFL8FMH9/-CCY 5\YW\?Q9YSUSS5"/QA8G41
M8SVM[;RFS-]^\C!'DCJV58]QC'7)''--B\9V+BX\RTOH7AL%U$1O&I:2 Y^9
M0K'GCD'!H W;BT@N[*6SN(A-;RQF*2.3Y@ZD8(.>N15)O#VDR65S9RV4<T%T
MH2=9B9#(H^Z"6).!V&>.U9UGXTLKVUM[A+#44%V8A9K+"%-T70O^[RV#A022
M2 ,>F*XV_P!8U1O#/C>X6\U&VFL]6B2 22XDA4K!E 02 I+-T/>@#T"W\,:%
M:^?Y.E6@^T0B"8F,,9(^?E;/4<G.>N>:A@\'>';;2I-+@TBVCLI7#R0JO#D=
M-WKCC&>F*BUKQEI>A&Z-R)I([/8;MXMI$ ;!!(+!CP02%!(!%64\26L]]);6
MT,]PL4Z6\LT6PI&[JK#/S;L89><8YH MP:38V^H2:A% !=RQK$\Q8EF5>@))
MY R?S-,O-$TW4+AI[JU621HA"Y+$"2/).Q@#AER3P<CFH-,\0V^K31BUM[@V
M\JR-%<D*8WV,%(X8D')X! Z'TJ6^UF&SOH[".">[O9(FF%O!MW"-2 6)9E &
M2 .>>W0X 'MHNF/J$M^UA;M=31>3)*8P2Z<_*?48)'TXI-/T33=+&+.T2+Y!
M&.2VU!T09SA?]D<>U<QKWB_[3H>BW>C1W,T&HZC%:R-'MC=!OP\9W,"KG:5]
MN>1P:W4>'POX?GN;JYU"XAC8RA;AO.F3<>(P1RV"<#)/N<<T %EX1\/Z;%=Q
M66D6MNEV"LXB3;O4]5XZ+[#BIH/#ND6US:7$-C''-9P^1;NI.8X_[@Y^[[=*
MSKOQOIUA8ZM<W5K>Q-I4D:74'EJSKO *D;6*D$,.].;QE:1G5DDT_4DFTR!;
MF2%H5#R0MNQ(@W<CY&X.&XZ9H UM0TFQU40"^MUG$$@EB#$_(XZ,,=QV/:HK
MK0-*O;K[3<V4<DQC$3N<_O$'(5_[Z^S9'--MM=M[Q]-6"*9QJ%N;F-AM(6,!
M3EOF_P!M1QGK5/4?$4]EXNTS1$TZ::.[MYIVF1DX"%!@ L#QO!/'IC/. #33
M2;&/57U-;=1>O&(FFR=Q0=%^@/.*-3TC3]9ACAU&SBN8XI!+&)%SM<=&'H>3
M^=8-KX^T^[LGO(].U46J%D\UK;"M(LWD^6.?O%B,=L=2,'$USXWTVSL-0NKF
MVO8SI]U':7,/EAG1WV;3\K$$'>O(/>@"Z/"F@K"8DTJVCC-P+K;&NT><#D/Q
MW!Y![=JN6^E65I?W-]!;A+JZQY\H)S)C@9]<#@>E9*^,]."ZK]I@N[233?*,
MT=PBJ664XC9?F(PQ!')&,<XJCXM\37ECX1U&[L["\@N89H[8E_+RF\QC>#N(
M(Q)@$9YZ]#0!-<>&9K[Q[+K%U% U@VFK9KMG=9<B1F.0 !M.[!&[MTK8O?#^
MD:@+,7>G6\HL_P#CW!3 B&,8 ';  QTX%83:Y8^%H[]IY-5N-J"\GMIITF>S
MC((P"SY(.QFVAF/7 &0*M+XVT^;5%L+.SU"\D:*"X$EO!N3RIB0LF21\HQS[
M>N#@ O0^%M#MOLGD:;!%]DD:6W\L%?+=OO,,=SDY/>LFP\*,WBCQ#J6J6UM)
M;:C+"\2I,[96.-4Q(F I&5R <@9KK3P*Y#_A8NDJRN]GJ<=K]M:QENWML10S
M!]F'.<@%N,X(Y&<4 ;][H6F:C="YNK..2<1F(OR"T9Y*-C[R_P"R<CVI+C0=
M+NK@SS6:,[(L;<D*Z*255E!PP!)P"".:YZPUG^SO$WC!M0O9FL[66T$*.VX(
M9(Q\J#MN9@/J15Z+QQI+G4(Y?.@N+!HED@<*SN93B/9L9@VX\#!Z]<4 7I_"
M^A7.MQZU-I5J^I1XVW)C&[CH3ZD=B>14L>A:9#<M<1VB"0R/*,DE1(^=SA2<
M!CDY(&3D^M<M:>(FL_&?BB?5)+RTTZQTVVN&AN6#+%S+N90A(Y"CIR2,5M+X
MOL5U&6QN[>[LY8K/[=(TZ+L6#G+EE8@8((QU_2@"[H&B6OA[2(]-LT5((V=E
M1!A5W,6(49.!SZU'+X8T6>.ZCEL(W2[E6>X4DXED&,,W/)&!S[#T%0:=XLT_
M4=:&DA)H+M[?[5$LNS$L>0"058X()&0V#STJW?:W#:7WV&*WN+R\\DW!@MPN
MY8\XW'<RCD\ 9R<'T- #O[!TLW%U.]G'))=Q"&X:3+^<@R K9ZCD]?4^M5K7
MPEH%EI,^E6VE6\5C<?ZZ%5P)!Z-ZCM@U0D\>Z3Y&F2VD%]?#4XI9+5;6#<S>
M6,LI!(PPQC![]:VKS5[;3]*34+H21(^Q5C9?WA=R J;?[Q8@8]: (;GPUHUY
M+;2W.G0S26T9BB9P250_PY[C@<&HW\)Z!);65N=)M1%8Y^RJJ;?*!Z@$<X/<
M=^]9VK>-H=.TW7'%A<C4=*M#=O92E%9H\'#@ABI7*G."2,$8S@'-EUZ_B\:Z
M7*UOJ4B7&BSS-IT15MTBRQ ,!NV X+<ENAQU.* .EB\+:';P6L,&F0116DIG
M@2,;1'(>KC'\7)YZ\T-X7T5[>:!K",Q33BYE0LV'ESG>>>6R <]>!Z56B\8Z
M9<Z9I][:B:<W\+3P0#8DA1<!L[V51@D#KU/&:I#XB:3-;Z=+96NHWIU"WEGM
MX[:WW,WE$"1<$CY@3C'ZT 9E[X&FO==OKJ\T?1+T7,V]+Y[B6*:--H559%7Y
MRH YWC/M7;P6:1Z9'8S,;E%A$+F;YC(,8.[/7/?ZU%J&JVVF:<+VZWHA**J;
M<NSN0JH!_>)(&*XU=;F7Q%XS^WG5K>RM-,MY?)#@O#N$V]XMK$ X .0>J^U
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCWNN^$[O2[ P?:)M@#3N44;75B20I]/2N@K,T_6[?4=6U338X9XYM-=$E,@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 8^][]:?+HFE7#W+S:992-=!1<,]NI,P'3?D?-CMF@#G4.?BK9$G)/A^0_\
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M-[IMI<6B8VP30*Z+CIA2,#%%WHFE7]M!;7FF6=Q;P$&&*6!66/' V@C X]*
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MU*]>P3S!&##,I8%9/GX.4;&,_J*RM,\'Z_;:MHE_>76FS36$]PUQ<8<RW22
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% #?+02F78OF$;2V.<>F:=110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MF>$.#*<,H$@(;&P<@\=2.:YF/Q?>ZM;RZAIFKZ!:645Y+;2+?$EE57**X(<
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M<'<3G-;.D6]S9?$+6&EL9D@O+*S$4L:$P@QB4,N[H""R\=3GIC- '6D@ DG
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MU=K:XBF5',;&-PP5AU4XZ$>E354TRS-AIL-NS!Y%&Z5P/OR$[G;\6)/XU;H
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHK%U_6)-.N=)L;?8MQJ=W]F22096,"-Y&.,C)PF ,]2/
M3% &U17)7.M:YIT]GI=VEM-?7MY-';RVP',"(7#%790).V,X[\]*H3Z[XNMO
M[&M+F"PM;J]U.6R+R1[]T8B=XY=J2$*<+RF3SW - '=NZQHSNP55&22< "JJ
MZI8/IL>HI>0M92JKQSAQL<-TP>^>U<?I=UXA'BWQ%!=ZE:S/::;9L%%LPBWL
M)B2HWY +#)R22,#C%9USJ.I:SH_PYOQ-;6[WMU%(\:0$H'-M*W W#Y1Z?3GB
M@#O=,US2M9\S^S-1M;SR@ID\B4/LW9QG'3.#^57ZX*?Q--H5WXGA^S6(2RFL
MX[;RH3&"]RV-TG)SAGR2,9&>YK6O[SQ!I5KJ$D]SI;1!H!:3R!D(#,%D#(,Y
M(S\H!RQ('7J =/17F6L>)=9N?#6NI'<BWFT_6+6T6;[.4:6&1H.&4GY3B4@]
M.!T!-;5_KWB*>[U:RT.UBN;S2S$C!D0)/(R+(0=T@**58 8!P<\GI0!V=%8G
MB37SX>\)7>M20!GAB5A$6XWL0H!([;F&2.U9=_KNL:/KT>E7$EK<?;-/GN;:
M<0%1'+#M+*R[N4(88Y!&".>M '7T5SG@R^UG5M"L]6U6>S9+ZS@GBBMX60QE
MDRV26.[.01P,<CGK4$&L:SK$M_/I#62Q6&I&S>"X!_>(A42L7!^4\DJ,8X&<
MYX .JHKBX_$/B#4IS=:18)-9P:E):31OL4>5'(8Y'WF0$,"I8#;C''O6;<ZY
MXJN_#_BN^CO]/MH]*:^@7R[5C(WEH&1@2^%/X'U]J .^EOK6"[M[26XB2XN=
MWDQ,P#2;1EMH[X!YJIJ/B/1=)D*:CJMG:L 21-,%Q@;N_?'./2N?M-4U*UU'
MP?82R6LT5_:2M)(82)%*1*PP=QZYYXYQ7/Q7.HV'A;QUJKO87<UCJ-S/&EQ:
M%E+I&F#]_CY1@>GJ>E 'J2LKH'1@RL,@@Y!%+7*/K6K:G?ZGIVC/:0W6GV<,
MH^T(66665695.#\J849(R>?;FAXE\5ZOHL5Y<(;)OLD=L_V>)6EW;V D\QN
M@Y^3N<$X/0 '=45Y_=^(-0T;Q'XSOKBY6>STVSM7BMBFT#<)"!NSQ\W4D'\,
M5?GU7Q=9#49#I(NH$LQ-;LJHLAF#89!&LC;AM.X<@\8SR#0!V-%8'A/78]?L
MKJXBOXKI([CRU A:&6(!5RDJ-R'#;NPXQ7,W/B74="U#QM?W-PES#836T-M
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MQ\7ZM<:)X:O9!:>9J.KR6%PJQ,!L5I@&7YN#^Z'7/4T ;\GA;0(HVDDM0D:
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MY%MY+3Q&2"9FQYL?G*<*XY"@\'@\YP #MZK7VH6>FP">^NH;:(L$#S.%!8G
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M"Q&>1QR>/7GG H ZRJU_J%EI=HUW?W4-K;I]Z69PBCTY-<5/XTU >%G\60+
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M=52SN 82P9<-N57^[N!&"!DCVQ0!O:=H]OIMQ>7*/)+=7CJ\\\FW<Y50J\*
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M(6A$()NP _RIS\N,!L\_=QWH V?#.D+IMO>W36:VESJ5T]Y/$"#L9N "1QG
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MI()$2$X#.1PBD@\G X/I0!S.A:+=S2O'.VO_ -F2Q/%=6NLRP2+(K+C:H3+
M^I)QC(YSQH6'@32;+3;C3II[^_LI8&ME@O;DR+#$>J)TP.!SR1@<UL7>LV-G
MH<VL--YEC%$9C)"#)E1W&.M<Q+XTQK/AV8SI!I.HV,\\J21'>'01D 'J?]81
M@#G'>@#3T[P=::?J-C?'4-2NI[&![: W$X;$;;3M. ,_=')Y]2>*T-5T*UU>
MZT^ZFDGBGL)6DA>"38?F4JRGV(./7T(IR:]I<NF6^HPW:S6MR/W#1*7,G4X5
M0"21@Y &1@^E36>IV-_IR:A:W44MFZEA,K?+@=>>V,'/IB@#*3P?IL;SHCW
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M^U='XYL-1O=%M9-,@-S-97]O>-:A@IN$C<,4!/&>,C/<"NE5@Z*RG*L,@TM
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MO+L,8(CG+A1EC^ H \YNO#>NR>&-?TFQ-[=:?)81_8HM1"BXCE5B3 '_ (U
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MTO2&"W]VL/W=Q*L0@9MJER 0@)! +8!(- &5X,M+JSCUL75K+;^?J]Q<1"0
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M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
M\3:S-ID^C65NPCDU2^6U\X@'REV,Y(SQN(3 SQDYP<8K?JCJND66M6BVU]$7
M1)%EC96*/'(IRKJPP5(/<4 <+XBU/4I=!\?Z)<W3N=-TTSPW:HJM)')#(=C@
M#&0489 '!'0UV^AP-#HMF'F:9S G[QU4'&.!\H P,U!-X9TRXTV_L)TEDCU
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M ))(I$B<HJ*"&DP[!>,=">AKHIO"FDSPPQR12GRKL7P<3N&:<='8@Y8_7C
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MBO3J"#[3)D3EBV_.<_>)..G/2@#F(/\ A(F_X3F;2M5GDO[2_P#]&AECC96
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M2-,[5* XQR>F,C@Y'%-N?"FD74^J2R0S!M5B$5X$N)%60;0GW0< [0%R,'%
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MS,0R[2>"".N#["N;&@ZW_P (^EO_ &1/YP\3G42GFQ?ZC[49=V=^,[3TZYH
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M>O!'&.E:.J^*]1TG4?$T370,-M<Z?!;O(BXMA<$*[' &0,Y&<]* ._) !).
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M81$C+/F&W#!R03@@_P .T@]S0!ZM4%[>0Z?8SWEP6$,$9DD*(7(4#)P "3]
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MRTD+2#RV;:VYAD$?=^M.^+$MRGPRU)X"P5O*%P8B21"9%$F/;:3GVS0!O?\
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MH:5:WMM!+]MU%[YY9/,5FB5/+4@?( HY .<$Y//)-7Z "BBB@ HHHH ****
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M#0R,0 '7&5SN7!/!R.>:T+#5K;4;![R!;@1(SJ1+;R1OE20?D8!NWIS0!/\
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M&'X^[DDC!YX]ZMT4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%87B3Q9IOA
M9M,&H2;?[0O$M(^>A;^(_P"R.,GW%,\:>)O^$/\ #%UKKV?VJ&V*>9&LFQL,
MX08X.>6'I0!T%%<5_P +"2TU/P]::KIK6T>OH#93Q3"5=Q"D(XPI4_.HX!'-
M1>)_B%=^%K6*\O-!)MI]1-A ?M6'<@L Y79PIV$]<].* .ZHKC/$?C>]\+:#
MJ6JZEH7R6,D2E8[K(E5R &0E!T)P00.E3ZKX[M=&T/2;RYM9)+_5RBV6GV[A
MGE=P"!DX  W#)/ SWH ZRBL#^V=7MKBQAO\ 1(T%Y+Y0DMKOS5A.TM^\RBD9
MQC(!&:H^$_&K>*-;UW31IWV8Z-<?9II#/OWMEAE1M''R'KCK0!UM%<GXV\:_
M\(;_ &8S:?\ :UU"Y6U0B;85<],_*>/?]*U+'5=0FU=[&\TV.%!"9$N(;GS4
M8A@&0_*I!&0>: -BBN1\7>.#X2U;1[6XTWS+74YQ;K=F?:D3D@8<;3@<YS['
MTK<N=1N(M;L]/AM$E2>-Y))?.VF)5('W=O.2P Y]?2@#2HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MCI110!Y5XXTK_A8'A[79;5[&6&V'EV<KSD-$\1)9@,8&]LKG/*A36+K_ (H/
MBK]G*Z><G^U0L%O/"PQ(TB3)EMO4Y4;OS]*]OHH \(B$VA^+/!NMZ\\FK^'Y
M+***SF89&F7!1<Y"  \CJPR![I6]\=9$ET#P^D;!V_M>&;"G)V!7RW';D<^]
M>LT4 ><_&V1)_A1J*1.LCSO!Y2H<F3$J$[<=>.:YSQ/8W4-Y\._%\,4EWI>F
M111WODJ9# I"Y? R<#G/IM%>TT4 95IXDT?498X]/OX+W>"2UJXD6, 9RY'"
MCMSWKS'X9ZKI^F^,OB%-?7MO;1SZH9(7FD""5=\O*D_>'(Z>HKV.B@#Q3XKZ
MO!K^@^$[V#>D3ZQY@ZAA"K,HDQU ( //3-=_X9U#3+*Z'A^QU,ZK.[7%X\PE
M\W9&TF?G<<;LN !Z#/:NLHH Y/XD^%_^$N\#:AIL:9NU7S[4]Q*G( ^O*_\
M J/AZVI7WA:RUC64VZC>6T08'J(U7"Y]V)9_^!X[5UE% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MTOB#QYI7AWQ!IFAW,-W->ZDZI L"*5!9MH#%F&.:XSXHZ)+J.DZQK&G-C5M
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M=3D6*!52,MN894,-_&1S7%>(?"M[!I.B^/\ PAC^VK&UC-Q#'RMY"%&00.I
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M:1XAD';(H8Y'7&,$]L>U=#!>6U[HWA5+:>.9IF@D0(P;*K&2S<=AC&?4@=Z
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MJYAWR1JNT=2 P'8, &_&@#HJ*** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ* *UKI]E8[OLEI;V^[[WE1A,_7 JS110!171=*2^^W+IEFMX3G[0(%$F?\
M>QFK%U9VM] 8+NVAN(B<F.9 ZG\#4U% %>VL+.SMC;VMI!! <YBBC"J<]>!Q
M3;?3-/M"YMK&VA+C:QCB5=P]#@<U:HH H?V'I!C$?]EV6P'(7[.F,^N,5=CC
M2&-8XD5$4855& !["G5E7/B32K74VTQKAY;Y(_->WMX7F=%[%@@.W/;.,]J
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M)_A6C10!3N=)TV\??=:?:3MG.Z6%6.>!GD>P_*K@    P!110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI%974,
MK!E/0@Y!H 6BBB@ HHHH **** "BBB@ HHHH ***1F5%W,P4#N3B@!:*** "
MBBB@ HI&=40L[!5 R23@"@$, 000>010 M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 44A8*0"0,G R>M+0 4444 %%%% !
M1110 44FX%BN1N')&>E+0 4444 %%%% !112*RNH92&4C((.010 M%%(64$
ML 6Z GK0 M%%% !113?,0[?G7YC@<]3_ )!H =1110 4444 %%(&5B0&!*G!
M /2EH **** "BBD5@RAE((/0B@!:*** "BBB@ HI-R[MNX;L9QGG%+0 4444
M %%(6 (!(!/ &>M+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7K6DJQ2F1&(17#*2 <$..HZ@U1D\%JRV;17H2:+53JT\AASYTQ!7&-PVK@X
MY.%'/7.EHNAOI%[J]PUT)O[1N_M141;?+;8J8!R<C"+^.: )]?B6;P]J2,6
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MI?-*EV9O,')*@\#J3^ !J77C"ZL=7M+2[T^&(7&H)8B,7&Z7#+D38 QL+ @
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M&,J .I/:M;3Y;9M6U71->TJ\GU%M9-]9L()"DJ;@89!*HVJ$4!3D\;<8.<4
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MI^%KRQM&@@L[&>+4HG@*>7"8@!#(".HDP0O^R30!WT%Y:W+,MO<PRLJAB(Y
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MT >NQ2QSQ++%(LD;C*NAR&'J#3ZPO"-E8V.A[--BNX[.6:2:,72E6.\[B0A
M**220N!]!FMV@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBN*^(UY.EOH&EI(\5OJVKP6=TZ,5)B
M.69,CINV[?H30!UT5[:3NZ0W4,C(<.$D!*GI@XZ5/69<^'],N$LQ]CAB-E*D
MMNT:!3&5.<#'0$<$>AKF_P#A-[K^P;#Q,L$#:+=7BVYC ;SHXVE\I9=V<'YL
M$KC@'J<<@';T5PQ\5>(Y(O$5W#9:7]ET6>XB=7EDWR!(5D7&!CJW/],<LA\;
M:K8WFE2:Y9V::;JEC)<PR6K,SPM'%YK*X/!RN2,=",<]: .\HKCH_%FH11^'
M+V[MK8V.O,D<:Q[@]M))&9(PQR0X(!!( P?6J^F^*/$E]H=UJYL])2WADG@V
MM.R$/'<>7O+-A=@4,Q&025XZ\ '<U']HA^T_9O.C\_9YGE;ANVYQNQUQGC->
M>:UXOU:7PWXC6TEAANM-O+>W%RL#IYD<OEG(1FRK?O",Y/3(ZC&O?^(CHWB:
M\&HVEHR6>AO?R7<,9$K*C_,@SG"\$XR><4 =A17))XFU*VOM!2^@M6AUM&$)
MBW V\WE^8J,23O! (W #D=.>,_2/&FLWD7AV]O+.Q2SU:[ELV2)G,B.OFE6!
M/&/W6"/?.>P .]HK%UW4[RPGLHK86Z).7#S3 R%2%RJK$I#.3STZ!37/67C3
M5M5A\*FSLK*-M;MII',SN1"\:@\ #D<_4]..M '=T5PL?C34QX?T[5[BWM(X
M!J3V&ILH8B';,T7FKS]W<!G/3=GG%=3IE[/?3W[L(_LL5P8;=E4@OM #D\]G
MW+_P'WH BU?0H]6N+2Y6^O;&ZM-_E36CJ#AL;@5965@=HZ@].*M6&G+8HY,\
M]S/)CS+B<@N^.G0  #)X  Y/')K$TS7=6UF*RU.PM;632KBZDB=&8K+'$I91
M+NS@Y9?N8SANO!K/7QO='0],\2""!M&OKQ;?RP&$L4;R&-)"V<'G:2N!@-U.
M.0#MZ*X"3Q?XD&D^(M52QTK[+HTEW&Z-+)OD,*AE(XQSSGI^'>63QMJ6C:A%
M_;]G:+I]UITU]!):,S.GDH'='#<$[3D$8]/>@#NJ*Y%/$^HV]WH'VVWM3;ZX
MI6+RMP-O+Y9D5&))W@@$;@!R.G/%+2O%7B/4/#\6M26NDPVDLAA),S Q$7!C
M9SNP"H4$[0<D@ =<  [NBO.;_P 6ZQ>Z&SVLD-M/;>(K?3))/(<>;&TD7(5F
M!3(< @D\9Z9R-2^\4:QYFHII&GK?RZ9.EO+"L+#[0^Q'?8^[$> XQNW<C\:
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MNG02Q1S7]K'), 8E>907STP"><]J *WB'0XO$6B2Z7-<36\,K(6>';N^5@P
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M5(FU6Q6223RD4W" L^ =H&>3@@XZ\B@#B?"FF:E:3VJ6.H:R(@H6YCU'2H8
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M07D"!LWDF(X\]"^"" >:9X@UJ'1=(N;AKJTBN4@>2&.XD"B0J.F,Y/.!QZT
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MY\4ZCI5M<&VN_#;VFPPM&;FX^<KA6 )*J<9Q_$!V.+%B%O?&NDWL^EWIM(]
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M((49/H2U,U.6XM]=\6I?:??3P:KIL:Z=)':22J5$3!HFPIV'>Q;#8^]7HU%
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M97S'+ @Y#<="#6/)*VI?&9;&\^:VT[2!=6D+?=,KR%6EQW( V@]LGUK<\/\
MA>+P^H5=3U*^")Y4 OI@_DIQ\JX ]!R<GCK4NK^'+75KVUU 3W%GJ-H&6&\M
M6 <*WWD(8%64X'# T 5/$]Q9>&K2\\4BU5KU(5MN/E\W=(JH&/H&;KV!-4M0
M\1ZMI&L3:7<BSGDETV:]M)TA9%#Q8WHZ[SD?,I!!'<>]:]UX:M-3TRZL-6FG
MU!+F+RI&G*J0O7Y=@4*<@'(&<@<\#$0\+0.LK75_>W5R]HUDMS,8_,CB;[P7
M" 9.!DD$\"@#G!XG\5)H_A[4771V&M36L4<8CE!B\R)G8D[CGD#''0X]Z6/Q
MMJUEJ-SH6J0V3:LNI6UE!<0(ZP.DZ,ZN4+$@A4?*[N2!R,YJ?Q'H,MKI/A/2
MM/-_+%IVHV[&9$#R10QHZ[B0N#C*CISZ'FMBZ\&Z;>V]PMQ)</=3W,=V;W<H
MF26, 1LI VC:!@#&.3D')R 8.N>,]8T6W\26S164M_I4$-W!+Y;".:*0E<%=
MV0P*L.N#P>.E:.HZKXBTPK%<S:4))%N)8VB@DD8A0NQ!&&W'JVY\X  X&:MW
M_@VRU/3]2M;N[O'DU)8TN;D%!(R)]U1A=H R3P.YJ?4/"]OJ.IVNHO?7T5S#
M;/:NT+JOGQ,065_EXY4'*[3[T <Y8>(-6UK7_!UQ'/#;VNI:1+>S6WE%AO'D
MYYW#M(0/3G@YX?I_BZZ,45H;>RBO[O7;K38VCC(C B+EI&7.22$/&1DL*U[+
MP38Z>NA^1>WX;1X6MX',BY>)MN4?Y>GR+TP>/<TW_A!M.^PO;FZO3)_:+:G%
M<;D$D-PS%BRX7&#D\$$8)% &/JOC36-,M]?MO)LI-0TFXM )"CK%/#<.%4XW
M$JPRP/)'&>^!N:'J^IS^)=9T;4S:.UG'!/%+;1L@*2[_ )6#,V2"AYXSGH*6
M]\&V.H6%[;7%U=F2^FBFN;D%!)(8BI0?=VA1M'  [^IS)-X6BEOM4O4U348+
MG4;>.WDDA=%:,)G:4.S@_,W//7Z4 ;U%(HVJ!DG QD]32T %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;VD9ED6%0S;1R< D?SK*MO'&FR:G-8W=O>Z<R6K7L<EY$$2:%?O.I!/3(R"
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M$TUH]VLWR["J,JD=<YRX[5Q.J6,.I>)?&L%WJU_;Q6EC;7$'EWTD8@;9*3(
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M:2W9B20 .X/(QFN=\&>)DLO V@PSR>;?W4$TJB[N0F520@EG8GG+*.Y)]@2
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MO<6:AU;S=@#-&>0%< @XSCK\W%2>%_$DOB:QBOUTFYM+*>".>":9T/F;LY&
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M4%I %F4+*OEC#@# #>HQQSVJQ10!673K%+$6*V5N+0#'D")?+QG/W<8ZU9
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M5UD?S'#0J0S]-QXY/O5NB@!D44<$2Q11K'&@PJ(, #T I]%% !1110 4444
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M&0^Y7C"L&)P4(9L$#!QU- '5T5SGCO6[[PWX0O=7T\6[3VVP[+B,LK!G5>S
M_P 507>OZEH_BO1M(O3:7<6J^:JM;Q-%)"43=N*EFW*>F>,''6@#JJ*S8O$&
MDSV$E]%?PO:Q2>4\JME5?.-I/KD@8]:MWMY!I]C->7+[((4,CM@G  R>!R:
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1139)$BC:21U1$!9F8X  ZDF@!U%9D/B'1[AXTBU*V9I2!$/,
M'[TGIL_O?AFM.@ HHHH **** "BBJW]H6O\ :?\ 9WGK]L\GS_)[^7G;N^F>
M* +-%%% !1110 5PGBO2K'Q%]NM]7T&^^U6K_P#$KO[*(F4_(I!1U.4(<D?/
MA> :[NB@#S,V.O:9?:=<Z[INHZREUH\%E>'3IB'CN$+EMRAU#*PDY;IE?>K$
M%E>>'-=FC/AFXO='U'3+>UCM[79*+8Q[P87WL!L(D^]TZUZ)10!Q]K:7FG>/
MI+MM,D6SFT6W@#VR@Q1/&\K,F.#T=< #FN?\-:5J^C6W@R]N;"Z,-C9W%E>6
MZQEI+=G*E9 HY8?)@[<G!^M>BZEJ=CH]B][J-U';6T>-TDAP!GI5N@#S-O#]
M_ ;.;[%.T<_BMM5\D1[C;P%&7<P[$MAL=?GZ9!KI/"=K<6VJ^*&GMIH8[G5#
M<0%T*B1##$NX?\"1O\FNHHH Y?Q3J=TDJ:9'HFK7EG,A-S-91H?EZ>6"S+@G
MN1T'3DY&C9:I*T>F1_V)>VR70<;2J8M54?*),-QD8  SSQ5RWU.QNK^ZL;>Z
MCENK0(;B)3DQ[L[<^F=I_*K= !7,^.]&N=7\-.^G#_B:V$J7U@?^FT9R%_X$
M,K_P*MM=3L6U5M+6ZC-\D7G- #EE3.-Q'89K)OM*\)R:U%;7MAICZG>;I$22
M%3)+MY9NF?QH I:OX>U+4/AOJ>EPNJ:M?V\CR'=\IF?YF3/]WG8/;%0_9+K7
MO$NA:LEC<6(L;*Y2Z6=-AWR*@$0_O $%LC*\#!YJ]=Z%X-L;FUM[K2])BFNY
M/+@C:W3=(V"< 8] :M_\(?X:_P"@#IW_ (#)_A0!QFG:=JB>%/ 5E-I-Y%/I
M5]#]J5D!V*D,B,_!/R[F&.YZXQ3;O2M0?P]XAACTRZ,]QXDBO(5$)R\0FA8N
M/^ H_OQ[BNU_X0_PU_T =._\!D_PILOA/PO#$\LNB:8D: LS-;H  .YXH XG
M6XO/UCQ-8_V?K$VF:C<6[7$EG:"?+(D>[:P<%#A54@J2""1UP/21*NIZ2)K2
M8JMS!NAEP00&7*M@\]P:Y2U\ >!-8,.M6>F0R138DC:":1(7]_+#!3GZ<UM#
MP=X94 #0-- '  MD_P * .1T[1=2NO#OA'19[&:UO]$O89+F8K^["0A@65^C
M>8,# Y^8Y Q70>%H+B#7_%,D]K/#'=:@L\#R1D"1!#&A(/\ O*>#S5N;PKX5
MMX7FGT;2XHHU+.[P(JJ!U))' JC;Z;X$NIHH8;'16EF/[I/)0&3C.5!'S# )
MR* -#Q%LF$-C>Z,VI:5<I(MT!$)/+QMVDKU(Z_=!.<'M7"1^&-8T_1-2CT6"
M_ET>VU*VN].TZXF:.9HDP940L0R#/*AL'*^_/>?\(?X:_P"@#IW_ (#)_A1_
MPA_AK_H Z=_X#)_A0!R-_874UI#K^C^&[^&:'4K>[NK:[DS<WB1HZ'AG894.
M"H)!)3Z9N:Y!<ZAI5GJMEX>N+;RM9MKZ:W$2"YF5" TC*#RV,<$YPOX5T7_"
M'^&O^@#IW_@,G^%'_"'^&O\ H Z=_P" R?X4 <-K&FZK?Z?XS T2]_XF.H64
MUNC(I,B(L&[@$]!&V<\=NO%=5K-M/-XV\*W<%I,UM;_:3-(L9Q'OC 7=Z9/Y
M=\5?_P"$/\-?] '3O_ 9/\*/^$/\-?\ 0!T[_P !D_PH XK^R]53P)_9+:3=
M_:;?7A/P@8/']N,Q=<'H$Y[>@R:L#3+G^V-6TG5?#VH:C!>WYO+2Z2=A:E25
M9?-&\;2A']TDA1BNEC\/>$)=0FL$TC2VNX(TDDB%LN55LA3T[[3^56/^$/\
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MKR/D/(Z]N^-[_A#_  U_T =._P# 9/\ "JNI:%X-T>Q>]U'2])MK9,;I)+=
M!GH.G6@"O\3+&ZU3P#J6GV-K+=75QY:QQ1KDMB12?8< ]:RKS0VG\8:#?^&M
M&DTHP3'^T;KRA DEOCF(IP7).,<'&,YK:U+1?!FD0^=?:3ID*;6?_CU#':OW
MFP 3@9&3T'>K4/A7PM<01SPZ+I<D4BAT=+="&4C((..1B@#&BT:YM_'UU9P;
M#HMTT>K3IGF.X4E=N/1V5),^L;>M=9JD$EUI%[;Q#,DL#HHSC)*D"L:R\ >%
M+"-DAT.T8,Q8M.IF;Z;G)./;.!5G_A#_  U_T =._P# 9/\ "@#D])L]0\WX
M?FXTF\A_LNSD@NC)%GRF\A8P>">"P('Y\ BJ$&FZQI]EI]^-)U">"SU?4)+B
MSMW:*8PSR,4D3!7. 1QG.&-=O<>%_"EI \]QHNEQQ)]YFMT 'Z5!IVA^#=6A
MDEL=)TR98I&AD M5#1NO564C*D<<$=Z +OAJS@M-,=K?3)=.2XF>?R)GW2$M
MR6?DX8G)QD]>><UA6MG>>%O&^MWYLKB[TK6C%-YMLGF/;S(NUE9!\Q5A@@@'
M'(-;?_"'^&O^@#IW_@,G^%'_  A_AK_H Z=_X#)_A0!E>*HM4U2QTV^L;&9H
M]/U."[:V;"RW$2[@V%/0C<& ."2O0<5@^*=#O]5MO%^HV-E<LFI6%M:P6YB*
MO/(C,6<J<%0 P4%L?=/;&>S_ .$/\-?] '3O_ 9/\*J)H7@U]4DTQ-+TEKZ.
M(3/ ($+*A. 2,<<T 9WB&>&'Q]X-G-M*T?E7IPD!9D^2/G:!GVX&:R+/P[JF
MD:EI^MQV4K62ZU>WDMC&N9(HITV(X0=Q@L5'($AXR#74S?#[PG/?07CZ%:>=
M "$VJ53GKE =K?B#5K_A#_#7_0!T[_P&3_"@#C-3T&^?^T;V*QN'@O\ Q#97
ML=J(R66*(Q>9(R]BVQC@\XQQDXJUXWLM4OYM<L[71KAXKK16BMY[1$!FD/F9
MCE<D$ $@A1UW-UZ5U/\ PA_AK_H Z=_X#)_A1_PA_AK_ * .G?\ @,G^% &)
MIL-_;^-+749M+NUMIM"AMV?:I\J1)'9E8 YSAAC&<UB^']*U?2;3P=?3Z?=>
M3IZW=O>VPC)DA\ULI(%'W@,8.W)PWUKM?^$/\-?] '3O_ 9/\*/^$/\ #7_0
M!T[_ ,!D_P * .-DT"_BN[:[%E.T-QXJ_M3R1'DP0^24+L.Q+?-CK\W3(.-K
M0WN]'N?$MP^E7TJW6LK)"D48!>-TBC\P9(X!5B>^!G%:%IX>\(7YN!:Z1I<I
MMYF@EVVR_)(,94\=1D5J:?HFEZ4[OI^G6MJSC#&&((6'OB@"Y-((87D*NP4$
M[47<Q]@.YKS_ %;PS?:WX'O[A[K4(-3N6-^EKY4>8KE<&)?N;OEVHN0W('I7
MH=5K34+6_-P+6=9?L\S02[?X)%QE3[C(H Y"ZDU+5[OP5J$^E74$T%R\M]$8
MC^X)MY$.?4;G&",\<^M:'@ZVN;:Y\2&XMIH1<:O+<0F1"-\91 &'XJ?>NHHH
M X7QGIU_-JDM[HPOH-42Q5(F2+SK6^&Y_P#1YE/ Z_>)7'F'GBL_7=!US49?
M&MG;V;I+JMM;/;S;AY3E$ :,G.1D@KTZ-GI7I5% 'GVNZ/J'B^\CO+&WN--D
M31;RTD:X0QMYLRH$C]PI5B6&1TP3VE@FO-5\,W"S^%;FQU*#2I+-I)8D+%RH
M'EQ%22R%@#G@<#\.\HH X#P%;ZOH+1:;J%G<S6]S:0RI>-%\T#A K6\GLI!V
MD<8/T)W?&/VT:?8M9Z>UYMOHFE,<2R2P(,YDC5N"P.!WQDG'%=%10!Y3'I&J
M+9202:/?@#Q9'?\ [P"0F#<K%R03G '/Z9J?6=)UF74/$=W9:?<2H-8T^_2
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M&'J*LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MQ3KVCW6B7FJ3V][I^JZ?+.T,-OY;V\D</G<')W!@".0.<8QTK?U#PXEKX?\
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MG%(EU(-3$?VDO=2,69 -K D\,-J\^PJVOAK3AJ8U!Q-+-]D-DPFE+J\).2K
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M+(762)<[5(/IN;GKR:6U\,V-JJCS+F5TMS:Q233%WBB.,JI/K@9)R3@9)P*
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M<\Y/- &7\,?^2::!_P!>B_S-=95#1='M-!TFWTRQ#K:VZ[8E=RQ4>F3S5^@
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MGAI#(@4@_?'R_=R 2W/3)=VVOZEX%TRQN=$DCU&SU"T\R.$QA'CAF5C(GS8
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M6GT/QIID.D3S/J&HK=6LBR1[94(AX&6!!'EMG(';KFIO$_AS5]>U/Q*MG;/
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M,+7\LZR1M\NPF##%OFP"<@ #CKB@#3\5:OJ6FZWX=M+&XABBU*[:VF\R+>5
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MDC  R<\=:I^&M>N-7\2^)+5YA):V,L"0*8#$R;H]S!@W.<^M<[#H>N6GP_\
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MDN02"QZG!/7J>M:M !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M P,,0!D>N:Y2V\4:LVA>%_$?VD30ZO=PP7%D(UV1K,2%V,!NW(<9R3GYNG&
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M:22$3W>[R5"DAMHR>0,#CUQ5FN%L+_4=/N? ]BMZ\MI?6DGGI)&A9MD 9<$
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MCZFNJU>WMI+5II53SHHY/)8\$$H00/P[>WM0!8L+ZVU/3[>_LY1+;7,:RQ2
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M-W @NI<1R'/*C=P/F;Y>GS'CFM^B@#!N/!F@W5EJ%I/9-+#J$XN;@//(290
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M&^,;L9 ;!(W-ACR,GFK]E:16%C;V=N&$,$:Q1AW+':HP,D\GIU-3T4 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M>.1].,=E10!R/BWP9<^+?"4VA7.L%#<2K)+/]FW8VD$*B[AM''<D^Y/-6HM
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD:$'*QE  S;1G+8'/6NBLM&FTO4-,AL8+=-)L;%K1,S-YO)CQ\NW!XC]><T
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MQ^%[_7+Z.*WM1JDZ2"SM23% JKC ) Y)+$X  R .E '6T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<[SYD,I W*['[N3P^>,'%^YMW_X69)>R64[VPT0P><+=F7?YI;:"!R=O;\*
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M,H=6\S<7!497;SD@=,F@?%>N)IGFQ_V>)_\ A)?[*;]PP5HS*$W ;N&[D\T
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MI-.]Q?)&DP<KM(0$+@ #&,G\ZBM_%GA^[N;>VM]8LY9;EF2%4E!WLI(('O\
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M6>GA/M4X0OG8H!9FQR2%&20._I5.X\4:%:6]M//J]DD5TC20.9AB50I8E?4
M T 4;?P5I]M9Z9:QW-YY6FW;7EN"ZDB1MV<_+R/G?C_:^F"3P5I\MC=V;7-Y
MY5U?#4)?G7/G!E8$';P-RJ<>WUK>MKNWN[.*\MYDDMIHQ+'*I^5D(R"#Z8JA
M%XFT69)774[<)%"+AF=]H\H]) 3P4_VAQ[T 5Y/"UK)>ZC>"[O$GU#R3*Z2*
M-IB.4*_+QC]<\U'<^#M-NXIO.EN3<S7<5Z]TKA)?-C "'Y0 ,!0,8]>_-7;#
MQ'HVJ78M+'4K:XN#")Q'&^28SCYA[<CZ9%7KFZ@LK=I[F9(HEP"SG R3@#ZD
MD #N30!E1>%K".?5Y'DN)EU:,1W4<LF0RA-@QQD?+QG//4\\U5L/!&F6%U;W
M'VC4)Y(+-K$>?<E@T)Q\I P.,#'ZY/-6[[Q/IMKH.HZK%.LR6*.98QD,KJN=
MC C*D\=1WKESXOOX'T8S:G:M#K1C52MN0]JWE.\F.S#Y5 SR,G.<4 =!;>#-
M/M+?1H8[J^*:0^^TWRAMOR&, Y'0(2N/QZ\UI'1;$^(%UPP_Z>ML;7S,_P#+
M/=NQCZYY]S6;H6HW"+J:ZOK^F7CV3 3&VC\H6XP?]82QY(P3TQS6E!KNEW$5
MS)'>Q8M2!.'.UHB1D;@<$9!&/7M0!F#P7IB:[/JD4U]#]ID$UQ:17++;SR#'
MSLG<\#/8XY!KHZR#XHT-;9IWU2VCC2<6[^:^PK*<80@X(8Y'!'?-7-.U.RU>
MS6\T^ZCN;=F91)&V02I((_ @T 9=GX/TVR\N*)I_L4-R;N&R9@88I22V5&,X
M#$D*20#R!P*N:1HEOHSWS6\T[_;;EKJ42L#^\8 $C &.@X]J>^N:7'>K9O>Q
M+.TGD@$\&3&=F>F['.W.?:L"[\0WFH^*+_0='O+>UN;*"&56GA,BS.S/N1NF
M %CZ@YRWM@@&_K>CVVOZ-<Z5>-*MM<ILE\I@&*]QG!Q5&7PI:37.HW$EW=F7
M4+1;.X.Y.8UW8Q\O!^=N??Z8L:[XBL?#ZV1O&8->7*6T052?F8\D^@ R?PQ6
M+IGC*"/6=:L]:U&SA$&H);6?'E[E:*-QG)/.7QGITZ4 :\_A?3;O0K'1[I'G
MM;)H6A\PC<#$05R0.>!@^H)]:9KWA:QU^YM+N6>\M+VTW"&ZLIC%(JMC<N>Z
MG X([5<OM<TS395CO;V*!B5!WG 7<<+N/1<G@9QFK5Y=0V%E/>7+A(((VED<
M_P *J,D_D* ,BX\*6=Q;R6WVF\2WFM?LD\0E#":,EB=Q8$[CO;+ @\]:4^%-
M/%]>7<+W,#7=LEK*D4N$*JI53M(ZA6(_IGFJFB:CKOB#1(-:A>SLXKN/SK6U
MEA9SY9Y0R.&')&#P.,_Q8K037(+'2[236IHK6\:V6:XC&2(S@;R>N%!XW'CW
MH Y;6/#US97&C6=G;ZY)INGV)MH+C3+N-9E.5&UU<J"H5%P1DYSGWU+'PH]T
M+&\U*^U/[99M*+>1[A1,(9 NZ.5D&UN5SD<CC!XR=74/%.@Z5C[=J]G 6A\\
M!Y1S'D#=].1S43>,_#2W$<!UVP\R2;[.H$ZG,G'RY]>1^/% %:T\#:38VVDP
M6\MZ@TIW:V;[0=P5QAD)_ND8X&.E:.EZ%:Z5_: B>65;^X:YG68A@78 -C '
M! ''M4E[KFF:=*8KN]BA8;=^X\)N.%W'HN3P,XS4-YXGT/3[W[%=ZK:0W(**
M8FE&X%SA01VR: (!X0T;_A$1X8-J3I8C\L1ESD<[@0W7(;G/K5G1-"AT2%T6
M\OKR5\!I[V<RR%1G"Y[ 9/;N:=#X@TFXN3;Q7T32[790#PX0X?:>C;3P<9QW
MK(@\76&LZ397UCJL%BL]^L"?:H\F8"4IL5200S@<=<9Y% &CXBT8ZO:VCPE5
MO+&ZCO+8OPI=,Y4GL&4LN>V[/.*:^@07>JRZP\MW#=3V?V-TW)A(\EL8P1G)
M)SD_E5JZUS2[*X\BYO8HI-RHVX\(S?=#'HI/8'&>U5KSQ9X?T^:>&[UBSBDM
MV59E:49C+=-WI_3O0!G2> -*-MI4<%UJ-I-I</V:WNK:X\N7R>/W;$##+P.H
M[5I6WAJRL]:BU2&2X6:*U^QJA<,ICW;N<C).[DL3DGO6P#D9'2L]=<TM[Y;)
M;V+SW=HT7/#NOWE4]"PP<@'(P: ,RP\%Z9INK2WMK/?)%+,;@V/VEOLPE)R7
M$?KGG'3/.,@4G_"%:?\ 9S#]JO=IU+^U,[US]HW;L_=Z;N<=*O6WB?0[S45T
M^VU6TFNV9T$4<H9BR#+#CTS_ #]#6J3@$GH* .<O/!.FWTU_-+<7HFO+F&[:
M1)0K1RQ "-DP.,!0.^:9)X%TN6PU>R:XOS#J[A[L&X+%CM53C(.,A1GZ<8'%
M:2>)M%DAMYDU*!H[F8V\#@Y$D@X*+ZMP>/8^E9?B?Q*VF2:=]BNK94_M6&SO
MA*A)C5QN/.0%.,'G/!H TIO#MK<:K8:G)-<F[LXFA#B3;YJ,5)5P  1E5/;I
M5+1_!.G:%*QL+K4$@!8V]J]R7AM2V<F-#P.IQG.,G'6I+WQ)IMQX=NK_ $_7
MK&V2-_)^URC>D<@(RI7(R>>F>XI$U>\'Q N=(E>'[ FF)=IA,,&,C*<MGD87
MT'6@#0T+1K;P_HUOI5F\K6UNNV+S6#,%],X&:CU?0+76;FPN9I;F"XL9&>&6
MWEV,-R[64^H(_P#K8J:RUK3=1N9+:TO(I9T02&,'!V'HX!ZJ>S#CWJ6]U*ST
MX1_:IQ&925C3!9G(&3M4<G !)QV% %;0M"M/#M@UE8M.8#+)*!-*7*EV+$ G
MMDFM.H;2[M[^TBN[2>.>WF4/'+&P96![@BIJ "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .-\
M?NL4_A.1XFE5==B)5%W'_52\@=\=>.>.*PM:\/WD\?B"_MM.G:+4]6T^:*V$
M7S,D+1F20J?NYVMP>3M'K75ZO<>&M1\RZOKU6&@SB>5HYG46\NTX+;3R<,>#
MGK72 @@$=#0!R5S#>:=\01K)M9Y],NM,%KF",NT$JR%^4'.&#=0.J\XKG-)T
M?6O!\VA:@VEW-]:I#>036EKM>2S$TXE3:N0" %"G!X]Q7J%% 'G=_9WNEZUI
MNI1^'+UM*DLGM7L=+D"26C&3>I*HR@A@<-@D COW@ETF?0M6M9$\-ZA+HESI
MJVGV/3K@[[1UDD8*X#@,K+)@G) *^G->ET4 >?6-A?>'?$LK#0[A],O-*@M;
M:.UQ*+-HR^86R> =X^;ID54\/Z9J=K;?#M;G3+J)M-MYDN\IGRB8=BYP3U/X
MCOBO3** /+[72M0C\/Z/"=,NEFA\3R7LJ^4<K"9Y6#G_ ("Z^_;M5<M'#=WD
M=U8:Q_8\&O/JBSP6@F7<C[B?-5\[-X)(V9 RM>L5A6W@_1K2=I((;E(V<N;8
M7DWV?<3DGR=VSKSC;B@#=KB[\3+\2WU*"WFN$TW0I!+'" 6D>20,D8R0-Q$3
M'&>X]:[2L9M3T*SO'TV2Y@CFN78.LA.)'VY*ECP6V8.TG.W'&* +NE:@FJZ5
M:WZ0RPK/&'$<H =,]CC(S]*\_;P_?7GA[5?#SZ=-%=W.O27D=PR?NTB-SYHE
M#],[. !\V3@@#)KLK/Q/H-QJ,>DVM_#]K*_N[8*58J%W @$?=V\@]#VK:H X
MG5-&N5\=I':%/[/UJ$/J49/(,!7# =]ZLL;>V*[21Q'&SD,0HR0HR3] .M4-
M.T+3M*N[RZM(&6>\D,DSO*SDDDD@;B=HR2<# ]JT: /,+71=8M?A=X;CATNX
M-]I5Q'-=6"/Y4LJ+O#*K CGY]PYY(]:N3V\RP6NHZ;X7O8%N=2CENFG"RWB
M1LOG!79@#RJ9SD*6..E>ATR::*V@DGGD2.*-2SNYPJ@=23V% 'F-CH=Y_93V
MUU::UIEQ%K-Y<VM];8DDAWLQ5BH+;U96P00<Y^I%_1H/$&G:_IFLZU9M*DVE
M-9S_ &2')AE$Q<.8UR0'4C.,X88/%=KI^KV.J&X6SN!(]N_ES(5*O&V,X92
M1P0>G-2WU]:Z;937M[/'!;0J7DED.%4#N: //-%\.ZAI.J^%C-93>5!/J-Q(
M%7<MHLY)C0D=\'!QG!SVYKI/ EK<V6A7,%U;2V[G4;N54D7;\CSNZD?56%=)
M#-'<01S1,&CD4.C#N",@T^@#@[BQO[34_&-O<:?/>P:S&KV;QIN5CY(B,3G^
M#!&<G PQYSFEL](O],U_P7!+%/<IIFE36EU=*A*"1EA"\^YC;Z=Z[LD 9/ K
M+7Q+HCD;=4M2K-L5_,&UVSC"MT8Y["@"CX\T^ZU7P)K5C8PF:ZFM66.,$ L>
MN!GO6/)%=W?C&\U-M+O(X)= %LIDBR?,\QVV<9YP5/Z=1BNZHH \JT^PU;1[
M?PY/>:)JMY:?V%#IUS!92%);>:/KN4.NY6R1G)^Z*]&T2RBT[1;2TALULHHH
MP$ME;=Y0[+G)R1^7I5^B@#SN>VU2.U\<O!HKW4EW>1S6L-Q""LZ".)&(#<$C
M8Q .,D"LV\T?7KF;Q+/9Z9?N\SZ=>V_VQT4W7D,&>,X.%)QTP .,XKU:B@#@
M?$$5UXB\(:O<67ANYM+J<VS%)XT2YN/+E5B" 3D*H(&3R2<<8SW4$IF@25HG
MB+#.R3&Y?K@GFHI=0M8+^VL99U6YN5=H8SU<)C=CZ9'YU9H \NM=+U2+PWH&
MG3:1=B73_$)N)CL#*8O.E?>,$Y&'7\^,X-6+FUU6VNM?G@T::>.XUZVN$;R%
M9UA$4:M-$K<%U9#C/UP:])HH \K&CZNFE:F/['OR8_$\&I(KLC/+"&B+%?F.
M2 IR/RKTYY3]C,K12*?+W&/&6''3 SD_2F7NH6NG1QR7<ZPI+*D*%OXG<[57
M\2:LT >9:!I&HVEE\/(9=.N8GTY)TO/W?^I+0L@SZY8CIGUJ?P?IES$NDZ9J
M_AV_&HZ.2HU":X+VV I7S(_G.2P_AVC&3GI7HU% ',^-K#4+O3]-N-/B:X>P
MU*"\EMD(#31H3N5<\$C.X#U45RWBO0[_ %:/Q/J5E87+1W]E:6L5L8BKSR1R
M,S.5." %(4%L=#[9]/HH 9$5:-612H89P5VG\17"VUAJ-EXM6ZTU;Z.SEOYW
MO[&ZBWPJ,/\ Z1 ^,JS''R G.\\#K7>T4 >8:1I.HV^A^"H'TRZCFL=6FGNE
M\HYB1A.-Q^OF)TSU]C5CPWI=S'-:Z/K'AZ_FN].O6GBU"2X+6A&]BLJ_/PY5
MB-NWJ>>,X]'HH YOQ_9W.H^ M:L;.WDN+JXM7BBBC&2S'I6'K=AJ3ZTVI:(E
M_;WY^SJT$L.^TOHP1G>"/W;)EOFR#P,9Z#T"B@##\9:5=ZYX-U?3+"0)=7-J
M\<1)P"2/ND]@>GXUBM!=:QXAT'6?[/NK(:;9W NHY(B&+2*H$2C^, @G(R/E
M'/-=M5:74+6&_M[&2=5NKA7>&,]7"8W$?3</SH POA]8SZ;X"T:RN[5[:ZM[
M58IHW7!5AU^O.3GWJ'Q1H^HS:YI6IZ2H\YUDT^\;.-MO(,[_ '*,H('?<1WK
MK** //M,T'6-*\,ZW8FQBOO[/MY[+2+><[EN(&^<!L]008X\'_GF?6J$>F7E
MSJFHS7>AZO/8WNA0VSA]D;EED<LJA6^0@,-H '3\:]0HH Y?P?;ZM:OJ,-]<
MSWEFKQBRN[N'R[B1=OS+)P"VTX 8@$\UA>.K'5M1E\0V5MH]Q(ESHWE6T]HJ
M SR?O,I*Y(("D@JHZ[FZ]*]%I"0 22 !U)H J67FRZ1!NCDMY6A VR8W(<=\
M$C->;6%GK4>@>$M'N-"OC>Z-JL;74JA3&ZJL@,JN6&X-N!]<DY[9]+T_4K+5
MK7[587,=Q!O:/S(SD;E)5A^!!%6J /+]5TG49]$\76ZZ7=2/>Z[;W,">5_K8
ME:W+,.V/W3]?0>HK7\107EIXN@U3^R=1U'2KJP%K)'I\A22&0.S99-RY5@V#
MZ%>:[FB@#SN"RO/#6O!D\,W%UHU]I<5FMK:[)3:,C2'RV#,!M82<G.,CTYJ:
M^T74W\17$=M8FUBO?#@T^*:WQY5K*&?CJ"  ZXP.U=]10!Y]9:=?ZA;^#(I-
M/N+&YT-@UXSI@*%@:,HC#APY*GY<\#G!P*V/A_93V'A9+>[M)+:X6ZN79)$V
MG#SNZGWRI6NIHH Y348+VP^(-GK9MYKG37TY[)_(0NT$GF!PQ4<E6 P2 <%1
MGBN>T_P[?Z=>^&FDL9FACUF^OGB5-PM(IEE\M3CC(+KD#H2?3->F44 5M0$H
MTNZ%M;QSR^2XC@?A9&VG"GV)XKS*TL-7:[BNI-$U%%D\-S6+*T:*L4V4(C5%
M/RJ,$#CGWZUZM6=J.NZ9I! O[R.#.W);.$#':I8CA03P"<#- '(:/IU[!J?@
M5FL+B-;'1Y;:Z8QD"*0I" I_%&Z<?F*V?&EC?W-MI%W80M<?V=J<-W/;(1NE
MB4,&"YX)&X,!WV^N*Z>J@U2Q;56TM;J,WRQ>>T /S!,XW'T&30!Q>H:3>73>
M--5MK6X$>IZ6EI;P&,J\\JQR#<5/(^^JC./NGM@U+<VUXW_"",MA=D6$H>[Q
M$?W(^S/'S_P)@.,^M=U10!YKK6C:S=7GB^:PL9&DDN]/NK5)/D6[$&PN@)]2
MA'/7Z5;UN/4->T274]-\-W-K=1W-K<203[8+F]6)\E-RMD8'W23UZ<8)[6]U
M*RTY8S>744/F-MC#MRY]%'4GV%)9ZG8Z@TBV=W#.T6/,6-P2F<XW#J#P>#Z4
M >?ZMIIU+P_<W5AX:U&WGO+^QDF2[R\\RPS*S%@6; 5 0,G)YXZ9]*7&T%1@
M'G&,4M% 'F)T'5I_!=YX3GM)_P"T#JAFBOMO[MD:Y\[S]_0, 2-OWLC&,'-=
M+ID%S'\1M=NI+6=+6XM+6**8H=CM&92PS[;U^O:NIHH YCQK:7=Q;Z-/:6DM
MU]CU:WN98X<%O+&X$@$C.,BN6UC2M2NM'\=I%I=T9]1O()+5/+YD58X0<'IP
M4;O_ #KU"B@#SF^T^Y_X2#7+/4?#VHZMIVL21SVTD,Y6$?ND0QS+O7: 4!S@
M\'U&*[?5=,35M O=*D8I'=VKVS,O.T,I7(_.IK#4+75+)+RRG6:W<D+(O0X)
M!_4$59H Y#PG>ZAI'AZQT/5-(O1?V$*VH:"+?#.J#:KK)]T @ X8J0<TQ(=0
MTOQIJM_?6$UW9ZG8VZ(;=#*(I(]X:(CKAM^0Q '7.*[*B@#S?PYX<U#1=5\(
M6UY;23+8:3<V\\P7>D4DC1E4W=P K+GV]ZH/8-K>B^/="@LI);J^UB2.*3RO
MW:G9%AB_0;/O<\^F2:]7K/TS1;+2)+Q[-9%:\G-Q/OE9]TA !;YB<< =/2@#
MC9M+U*UC\9Z5<6-Q?#609+*=5W+)N@6+RW/1-I7JV!@Y'I5O0M'N].\:H;F"
M6:.'0+6Q^V,AVR2QNY;D^N5.?ZBNWHH \PT:SUEM=\+7ESH-Y:_97NX[F*-8
MT@MMXXV*&Y3ONY)SWZ!(-+U6+P3HVF2:3>+<V.O132@(&!C6[,C.N"<C:0??
M.!FO1;_4['2UA:^NHX!/*L$6\XWNQPJCU))IT&H6MS>W5G#.KW%J5$\8ZIN&
M5S]1S0!P-WH^IG1_&F@36$UQ-K%Q--8W 7,;"5%5=S?P&,KSG'"C&:COM%U
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MDR,YP!P/7BUXF^W#6]$:WTV:XMMTPFN;9$,T)*@*JEB-JMR"PY&!R,YKIZ*
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M3Y$AC!A2/8Y4;R QE!3YL94<C@BNIAT+3;?4K?4(;5$N;>T^QQ./X8<@[?S
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M]J6=U+""0 65D<+@$Y7(( X/(.*GO+[Q3::OH5C_ &O9,-7EFRWV'!@58-X
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M!$$?"+&Q!9=O3!VK^0H X2Q>_P!(\/\ Q!U"WNXWET^]N)8DFMU9-T=M"RG
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MRSKD5]<0EXS*$5"IDD.\@MR. 2< ?05=:T+6+K1_'MO!I4[2ZI<QO9C?&/-
MBB0G[W'*-UQ0!UNH^-/#FDSW,%[JL$4ML5$ZX9C'NS@G .!QR>@XSC-0OK%V
M?']AIT5Q$^FW.ES7055!RRR1 -N[C#GI6!YDDOC/QI FF3W376G6:",!<9*2
MC8Q)XSGKTX/ME+?PIJEI>:+IX$AAM?#<VER7Z,NU)F\H @$[L?(3T]* .P@\
M1:3<W4=M#=AI9E9X?D8"8+]XQL1A\?[)-);^(]*NM,&HP77F6AF$ D6-^9-V
MS;C&<[OE^O%<I8:+JE]IG@[3[O3Y+*XT&>-[F8LI0B*)HP(R#DAR5/L,YP<
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M**YO9+=A%;7*J5<D?=8'@_0\>M "-XJT2.UO;F6^$,=BJO<^=&\;1JPRI*L
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MWWV*WN@UP8O.1&1E\R/.-Z$@!UY'*Y'(]:NW-Q':6LMQ+O\ +B4NVQ"YP/0
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ML8QGD8''%<>)KW4=8^'>K75^9C?/+.T*QH(XV>TD8!"!NP 2.2<\4K^(]?\
M[+#IJ,8G'BG^S"[6ZD&'S@@&/IWZ^XH ](HKSZ;Q!KVFZ?XN@%PVH7&DW4"P
MSM"H<0R)&SDJH 8H&<CCG SFMOP_=ZI=>(]726\:ZT>!8A:3-$H\QV7+C<H
M8+@=!_%CJ* .DCBCA0)$BH@Z*HP!3B 001D'M7'^,]<U#19HY5-W#I7V=S->
M6<*3-;29&UY$()\O ;E1VYJI/K6O:Y<ZO!X=N[=)=., B9V3RIM\22[GRI;8
MP8@;2/NDT =!8>$M#TR99+.Q\H(VY(O-<Q(>N5C)V*?H!BMNN*L;G7M7\7:Q
M9+K8M;.Q-K(J0V\;EEDC)9=S#IG&#CL/H3PUK6J:D(=*O+UO[6L;V>/4F6-
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M5!4JP*H$ . "<]15;4_$NM:2UJVLRM9VKVT*R7]A&L]M%<[B)!+E2R(?EPW
M&3DT >@T5YIJFL^*5M/&%_::S#$N@7)>*!K1"LT:P1RLCD\X^8@$8.>_:KTF
MN^(M>DU9="DBM+C3V@"13LFQBT22GS05+;3O*Y4C[N: .]HSSBN-M]5U;7GU
MF2PU."P?3+Y;<1.BO$R*J.[2$C=A@S8*E<8!]:?X5%TWB[Q>9K^YGCAOHXXX
MY-FU08(F&,*",;B!S]<GF@#K\T5QVKM<CXFZ*JWUREO_ &;=RM!&$*L5>'L5
M)Y#$=<^F.<YMOXJU:3PYX<\3K<^;#JE[##/8^6NQ(YG*#80-VY#MSDD'#<#C
M !Z'161XEO9=/T.6>"\BM)2\<:RR(7QN=5PJ@'<Y!(48/S$5Q=]XHU^VT7Q,
M8[IX[C3-3M8(7N88V?RY?)RK!/E/^L;!'.,=Z /2Z*YC0;[4AXMUW1[Z^-Y%
M;0VUQ#(T2HR>;Y@9/E R 8^,\\\DTW6M4U&;Q,N@:=,;>7[ ;OS4*;B2^P8W
MJPP,9/&>1R.X!U-%<';WWB>Y\0Z7HU[JEO:S3Z1--=-91)(%GCEC3<A<'^\>
M""!R,=Q2T?Q%K\MCX0U.ZU))5U2\>QN;86Z*APDI$@/W@V8@3@[><8% 'I-4
MK/5K&_O+VTMIQ)/9.J7";2/+8C('(YXYXKSN3Q!XIM]!N?$']JQS1Z?K4EG)
M9?94 GA%SY/WNH;!!&/3G-3WNMR^']:\;WL 7S6O=.MT=QE8S)'&F\^PW9_"
M@#TJBN-N+O7(O%%WX<@U)W-SI;7EG>2PQEH)5<(58!0K*=RGIG[W/3%73?%U
MW>Z(FH!Y#+I>G33ZK;%4W&X3*^6>./FCE/&. OK0!WE%<!+KOB/3-'?Q'+-;
M7>F?V5)=&)W7)E">8GE;5!V$ Y#$D  YZULZ,_B ZQ%+=7EO<:3<6FY=SIY@
MER"#'L490J>Y)''- &S/JUC;ZK:Z9+.%O+I7:&+:?G"C+'.,<5=KBO%D-S<>
M.?"D5I=FTF9+T"81ARG[M.@/&?J"/8UFZ=XJUQY8-"NITDO_ .U+JQ-\BI&9
MDBC#@@$%0YW '@CY6P/0 ]'JA?Z/8ZG<V=Q=Q.\MG)YL!$KKL?!&<*0"<$CG
ML37'RW_BNTO- TZ\U.U2:[U&XMI9(HUD9H1"\D9;@!9, 9 &,X/(.*CL_%.K
M"&#3)KD37<FN7.F"\*I&S)&C.IQMV!S@+]W'7C- '>W5W!96[7%S((XE(!8^
MI(  '<DD  <DD"L_2_$NDZU>7%I87+27%N/WT;0NAC.2,-N48.1TZ]#T(KB_
M$46O-H=C#J^H*)8_$5HD3VYC+-$TT90R#9@.OL #P2#6CJ^HZK!K6OZ6FI2K
M#!H"WD,B1H)%EW2*6SMQD[!VQSQB@#N0<C(HK#\&I(G@O13)<23LUC VZ3;D
M9C7C@#CZ\^]<5>>(/%-MH6M:]'JT<B:/JTMN;+[(@6XA615*ENH;!X([]<YX
M /1+75K&]U"\L+></=66S[1'M(V;@2O)&#G!Z5=KSZ>]ET_Q+XZNH;N"TE2"
MP"3SJ65"5<#Y0"2>< 8.20,&JFJ>*->L](\8^5=2QS:4;9[62ZAB,@6102&"
M_*><D<9YYH ],J*XN(;6$RSN$0$#)[DG  '<DD  =37.:3?:G#XXU+1;V^^V
M0"Q@O8F,*H8B[R(R#:.5^0$9R?<U%J]S)/\ $KP[IK$BWCM;J]V]FD79&OY"
M1_SH Z"RU:QU"[O+6UG$D]DXCN$VD>6Q&0.1Z<\5=KRO6+W4](O_ (A:QIM]
M]G>PDM9_+\E7$V+>/*L6SA2,],'WK>U#5?$&JZKKEAH,\5O<Z685C64IL=GC
M$F9 5+;3G;\I!^4\^@!VU%<)%JNNW'B37 =42.RTN*UNOL\,"/YJM&[/&'/.
M#MX;KT]\SZ#?>)-3;1M3-Y;'3=0M"\R.R'8[)O0PA5!.#D$,QX]P: .KT^_M
MM4L8[RSD,D$F=C%&4G!(/# $<@U#;:/8VFJW>IPQ.MY=A5GD,KD.%SM^4G Q
MDXP.YKA=,\1>(-1T_P %$ZFD<FK3W45VXMT.X)'*RD#H"-@Q^N>0;6GZ_JTN
MG):SZH&NHM;N-/,B0+Y]U''O("+C8'X7)("A0QXH [FZNH+*V>XN9%CB3&6/
MN< >Y)( '<FJ^F:O8ZQ%,]E,9/(E:&561D:-QC*LK $'D'D=Q7G6HZCJ.N>
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M-4B741I5\D]Y:1 @L'@!*JV0#D=P1UX] #T".-(HUCC1411A548 'L*=7/\
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ME\VUN$WQO@C(]P>0>V#5N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8[@#D\<$<%ND>&]<L](\'VD^G*'TG499I_+G1@(RLJ@C)&>9 <>@]>*]'HH
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M'/SJ6*@X)'&1UUX= U2UUW4[:3P]IFI6%_>&[AU"X9,V^_!971@6;:02N.O
MR.HZF/POH,6HMJ$>CV*7;/YAE6!02_\ >Z?>]^M:K,J#+,%&<9)Q0!YUJ/AS
M6KC0_%EI'IS&74M6CN[8&:, QKY.23NX/[IN/<>^-58=9T77/%.K0Z9'<PWB
M0W$ >[6++)$$*,3G;R,YZ8[UV-(RJPPP!'H10!!87+7NFVMV\#P//"DC0O\
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MJTLO)ES.&$9CA)1 HS\S 87CIG&>@JU0!YZOA74[6;3+B.U,C-XBFUBY19$
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ML-4NI[W1M3/V9F";YXA'%*86.W!SO900 1QZ5UB>$= BV^5ID,02Y^UJ(B4
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M&) ).3C)XR23]2: .7EOKW6]5\364&LMI4^D20K P4,J*8UD,CJ<;@V67DX
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MV:]A5527;CA?NY X..V1QCBIG\/:3+)J+R622'44\N\WDL)E P P)QP.!Z4
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MGUYIDG@[P[-<2SR:1;/++<"Y=F7.91_'CL3W]>^: .#U_P#Y%?XH_P#7X/\
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MC@=<8SQG-0^%/$)\3:.;_P"QS6H\Z6-5D Y"2.@Z$\_+S[UC'PU>CQ='J]E
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M/[,L+*TN%5E!$.[S=VT*,G.T>IK0N?&6FV=IJD]U%=PG2PC7D1BW/&CC*O\
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M:%X"7,)) =0N<C((/H>N*R-8\):KJ=[XJBC-O%;ZQ;V[03L^3'+$N K)CD9
MR<],U%?:'KVL>#M8LI= TG3;ZZLFM4%K*&$C-U<MM&U!V7D\^W(!V6EZK#JT
M4TL,%U$D<GEYN(&BW\ [EW#E2#U^M7JBMM_V6+S8_+DV#<F<X..F:EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K6FGV5@T[6=
MG;V[3R&68Q1A#(YZLV.I]S5FB@ HHHH **** "BBB@ JK::986$L\MI96]O)
M.V^9XHPID;U8CJ?K5JB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "F2Q1SQ-%*BO&XPRL,@CT(I]% %>RL;33K5+6QMH;
M:W3[L4*!%7Z <"K%%% !1110 4444 %%%% !4-W9VNH6LEK>6\5S;R##Q3('
M1A[@\&IJ* &QQQPQ)%$BI&@"JBC 4#H .PIU%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 56M]/LK2XN+BVL[>&>Y8-/)'&%:4CNQ')/UJS10 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% "$X!/IZ5BZ!XDA\07&JPQ6EQ;-IMT;603[068
M*&R,$\?-6W7%>!O^1A\;?]AG_P!HQT &K?$,:,_VNZT#4AH(E$3:L-FQ23MW
M[-V_9G^+'/;.1GM001D'(KF?%-FGB2V/AB, PS%&OW'2*$,&V_[SXP!V!)[#
M/2KC:-N,8XQ0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !VK(TC
MP[:Z+>7]U;37+27\OG7'FN&#28 W8QQP ,#CVK7HH XUOAKI+2SR?VGKZM.Y
MDEV:K,H9CU) .*ZZ"".VMXK>% D42!$4=E P!4E% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>aquestiveamendedandresta013.jpg
<TEXT>
begin 644 aquestiveamendedandresta013.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUOJ\,#OK5[;7%T^!BUA:.) ,] S,23GDY]...0#,NO%ZV6K6UI<6$D4-Q?\
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M;4VN-V0(U.&!&,Y_.L_7M6O;OP[K-M<:7=6:OH\UW#<QRDJI"GY&9<;9!P<
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M!!!KG'\#ZDL$D]IJL%OJD>KS:I:S>261?,!#1.N?F4J2,@@]ZZS2H-0AM/\
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MV2UNXS!I2W/FAXSNG><Y=A@X7YLG'/7'O0!-<>,39WUK#=Z9+;QW%]'8*99
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M* "BBB@ HHHH *@NKRWLHTDN95C5Y4B4MW=V"J![DD"IZXKXE0V;:7HT]]'
M8(-:LVDDF VQH9 &))X P<&@#M:*\MOI[6[M_&L.HNL6H6P$FD%3M>.#R5\A
MH.^3(&^[U8X/I7HVD&\;1; ZB +XV\9N /\ GIM&[]<T 7**X7Q?;V-SX\\+
M6^H2E;6YAO4DC:9D23"H0" 0#U/UZ5RD5K%#::!97%W(=-/BF>"QWW##?9^7
M+A<Y^9-PP#W&/6@#V6BO-'M],@U;Q-HNK;;:UM+&#^R1+(<QP",Y>)B<[A)G
M)!SPOM3!_:^B)X5\2WEH\^HWEBNFZA$5Y,[H#$[#L=Z[&/\ M^@H ]%FFNDO
M;6**T\VWDW^=/Y@7R<#*_+U;)XXZ51US7/[%FTM#:M,M_>I9[@X41E@2"?7H
M:YF_M8-&\9>";&*8!UBNT*E]HE;RA\Q7.,EB?SKE+?4M+O-&\(7E[<6Z^(4U
MV,:CYKA9TDS('5P>0H.  > -N.U 'M%%>5Z3<V&JZRD6HZLUKXFLM8D+6T<8
M%Q(GF-M7)Y: Q%<XX &>V:]4H R-)US^U-5UFP-JT#Z9<)"S,X;S-T:N",=.
M&%:]>2:YI^F7>H_$ W<CIJ44D4NGB.=EE$OV6,1M&H/+%QM&!SC%:.FZ?#J7
MQ O(=583W\&E:?<F+[0P N5:0EL ]B%]L'WH ]*HKR;39Y;OP]X8O+>3;XK&
MJ)%J SB9OG(N$E'78%R<'@ +CM44&L6#>)]"O;2ZCB9]<O+>X6:3-R<I, LI
MXVJ650D9!X"X.>* /1]<US^Q)-+4VK3+?7L=GN#A1&7SACZ]#6O7B\&IZ9>Z
M)X3O+^>W7Q$FOQC41*X6>.3>X97!Y"CY< \ ;<=JU-,N+#5=9\G4]6>T\2V6
ML2'[/'&%N)$\QMB@GEH3$5SC@ 9[9H ]4HK@?A[I^FSSZOJ2,9[NWU>^@CD\
M]GV1F7A<9QC !YKO'"E&#'"XY.<<?6@""PFN;BT$EY:?9)BS Q>8), ,0IR.
M.0 ?;.*LUXWILEG<^'?!,<EX65_$%W$V+D@LFZYX.#S_  ?F/6GPZE!IBR61
MG5/#L/BN2WN@'S'#"8@R(W]V,RD9SQV/!H ]*TG7/[4U76; VK0/IEPD+,SA
MO,W1JX(QTX85KUXY-J-GILWBV32YHAIB:S9/=FU_>!+8Q1[VVKU3=U XQD=*
MGU9-&BT":ZTK6S<V5QK5@Z_9Y!';Q,94#K%M..5^9AG@G/'- 'KE%>0ZO8:1
M')\1+9&18K/3X[NVB$Y"PSF&0F11GA]RISUS]>;;IINM>*774+A;B.7PM%/(
MC7!VE][?-C.,XP?R- 'I4TUTE]:Q16GFV\F_SI_,"^3@?+\O5LGCCI6%=>)M
M0>2[&B:&VJ+:71LY<72PL) @8D!AC:-P!.<YSP1S7):'J"W5Q\,9YKWS)Y]-
ME$I:;.\B!>HSR<YYZYS67=QZ5#\/_B++:?9HI8]0N41X&"L !'M7([9[=* /
M9AD@9&#Z4M>;:IJ.BW7BC6=+\3WBV\$]G;MI,I?:60J=[0-_STW_ -WYC\O7
M%9'C'5;))=;:.Y-OJ%A+IYW7DF9U&Z,DQ 8*)ACN;)!.X8'4@'JSWT;27=O;
M%9[NVC#M &P?F!V@GH,[3_.I;62:6TADN(/(G>-6DAWAO+8CE<C@X/&:\UD&
MD1^(_'S$VT4\UC%/$ZD([*8&W.I&#C(&3ZXI-$O+>YN_"]IK+0R://X:B-N9
MR#%)<C;Y@.>"X0#&>0-V.] 'J%%>0Z?&T]UX*MM6N99(I+W48H/-G8--:A)!
M"6Y^8%=O)Z@CKFNN^',L1T34;6"4/!::M>00J'W".,2MM4>P!X]J .PJM<37
M,5S:I!:>=%(Y6:3S ODKM)#8/WLD 8'KFN9^*+)'\-]9=Y3$5A!5@Y4YW#'_
M .JL_5;+2]'\5>#A82")+K49Y7_TAF$I:VDRW).<D+^/UH [^LC1-<_MBZU>
MW-JUNVG7GV5MSAM_R(^[CIPXXKSA)].U+6/[-NM;T]-1@\0RR2W$EZL4LL 9
MAY&W<'ST0+C;A0P)XJ#6_L(L/'.IB=!>V>N0/;RB;!B;9;C*\\$X8'UP1VH
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M1WUG>=0:U0S&08<G'&[_ &L8S[YH WJ*Y+QLD\CZ8EI=:>+I9))([+4A^XO
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M7CE>94:,ARJD##\_+QM.,]*S?'=Q>WG@C6XM3TM;=K6XMO(F602),#)&=R\
M@C)4@C\P: ._(##! (]#2>7&<?(O (''8US%]XNFLY?%$?\ 9R.VA6<=V/\
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M"C.6QY,WFHRAB%96P,AE ;IWJ[0 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6+XAT.;6O[.DM[[[)
M-8W:W2%HO-1R%9<,N1G[V0<\$ UM4A(52S$ #DD]J .-B\"3PQ0QC62ZPZRV
MK+YEL,EF+$H<,.[GGZ<#N_4/!$M_8^);5M41%UV59'86V3#A$3 ^?GA!^.:Z
MU98VB$JR(8R,[PPQCZTY75QE&# $C(.>1UH Y:;PGJ">(+G4]-U^2Q2_5/M]
MNMLKB1U4+OC)/[MMH _BZ#TIE_X+DO4\31_VDJ1Z[ D##[.2855-G!W_ #'!
M[]ZZJ26.($R2*@ R2QQQ1)+'$F^2143^\QP* .4F\&W:ZC>7ECK"VYU&S2UO
MXVM=ZR%%*K(GSC8P!QSN!XXJ32O"$^EWNCW*ZFLITS2SIJ![;&]3L.XX;@_N
MUX^OX=.\L<8R\BJ,%LL<<#J:))HHD#R2(B'@,S  T <E:>")K72]!L1JB,ND
M7S7BO]FP92?,^4_/Q_K6Y^GXS:-X2OM$NWAMM>F.B^>T\-@8%W1LS%MOFYR4
MW$G;C/;.,YT-1UR6Q\3Z-I(MD>'41,3-YA!0QINQMQSG(YS^%2C6!J&F_;-%
M:VNP+CR29)MB8639(00#DC#8]<4 8<7@B>+2["R&JH1::LVJ!_LI^9C(TFS&
M_@9<\^F*NVVE7'AQM;N[6=[L7]PUS!:"( B9E48+YZ94<\  G.>W0M+&LBQM
M(H=_NJ3R?H*/.C\WRO,3S,9V;AG'TH Y7P_X?U3PY'H&F6M^'T^TM6CO8C ,
M22')\P/U!WG[N,8)SVSIZ_H4^KW&EW-M?_99M/N?/4/%YL;Y1D(9<CG#$@YX
M-;5,2:*4L(Y$<H<-M8'!]#0!YMK6A2Z!I-CIC:G<M;2:I/?&\.F_:$A)+N%D
M5.<EY,AAM&5[=#>L-"U/5],MHAJ5O'%87L=Y:7$>EM DS8?<KPL^6&6W!LC)
M.>V3W:RQNVU)$8X#8# \'H?I6-J_B!M-UK1M/CABF74+HV\C>=AH3Y;R [<<
MYV$=10!D?\().-.GM/[9+"36%U4,]L"0PD$FWAAG+#KZ=AUI]_X(FOK'Q':M
MJB(-;G29V%MGRMJHN!\_/$:_K784Q)HY'=$D1F3AE# E?KZ4 <YJ?A-]9OHI
MK^\ADC@NX;N BVQ+ R;,JDF[A6*<C!X9AGH1<T+07T2XU,B],UO>7DEVD1B"
MF-I#EANS\W/3ICWK7$T3-M$B%L;L!AG'K0LL;1>:LBF/&=P/&/K0!R/B#P/-
MKESK3+K+V\&K6B6TL9MQ(T>S.THQ/"_-DKCD]"*T5\.W2^(I-9.HH\LFG+8E
M&M^.&+;^&]6/'I^=;JS1NBNLB,C?=8,"#]*4R( Q+J OWCGI]: ,SPUHQ\/>
M'+#1_M'VA;.%85EV;"RC@9&3S65IOA*]TG5+@VFO3)HTURUW_9_D*61V;>P6
M7.0A;)VX[D9YKI);NV@AFFEGC2.!2TKLP 0 9)/IQS4=KJ-I=V%M>Q3+Y%RB
MO$S'&X,,C\<=J .?N/"$\VHV6K)J:1ZO;W#R/=K;G]]$W!@*[_N8"]^J@]22
M<32=(EUVX\:Z=)>+%I][JA$J>2=\D1AB5BC[@ &P5S@]#BO10<C(Z4QI8T(#
M2(I)  + 9)Z"@#EW\(7=OKUW?:3KDNGV=_L-Y9K KAF50FZ-B?W9*J >#TS4
M6H>!Y;^S\26QU1477)4D<BVR8=J(F!\_/"#\<UUK31HZ(\B*[_=4L 6^E0++
M=G5)86BA%F(59)!*3(7R=P*XX &.<]S0!AZIX3DUJ\BEO[R&2.&[ANX"+7$L
M#1["5CDW?*K%.1@G#,,]"(](\)7NC7\B6VO3?V(UPURFGF!=T;,V\J)<YV;B
M3MQ[9QG-[_A(&/C2+05AB:&2QENOM"S9(9'1"A7''W\YS^%;,I<1.8E5I IV
MJQP">P)[4 9F@1ZK%;7*ZM=_:F-RYMY#"(F\HXV@J#V.X ]2,9YS5.X\,S3:
MUK&HK?HO]I6*6?EF#/EA=^&SNY/[QO3M6Q:7$C:?;RWH@AN'B#RK')N16QEM
MK$#('KBK*L&4,I!4C(([T <6/ =PD-E%'K;*D&C_ -D2#[,#NCQ@.F6^1N!G
MJ#@<# JS9>$+S3;C2[JUU=#=66FC37::UW))&"""%#KM(*CN>/SKJ9)8XL>9
M(J;C@;CC)]*&FC0H&D12YPH+ ;C[>M '-1^#8[63P_\ 9+PI'I$TLY$D6]IW
MD5PY8@C!)D8\#J?3BJUQX'FN-%UC33JB*-2U$7YD%MS&=Z-M W\C,:\_7\.@
MDUW3(KB_ADO(D;3XEENBS ")6#$;CVX4GZ8]:H3>)2-<T"R@MTDM=7BED6<R
M$,FQ X&W'?([_A0!'/8#0=:U3Q/+>2FVGMHA<VT5J9&)CW ,NW+8PYR #T'/
M6F>#]'M[$:EJ4$4\,>I733Q0S*5:*/)(&TX*AG:1\$ CS,'D5T@EC:5HA(ID
M49*@\@?2@31%P@D0L02 &&3C@T 8^NZ%/JU[I5Y;:A]EFT^=I5#0^:DFY"AR
MN1R 3@YX]ZR+#P+-8)H\8U@RIIFH3WL?F6PR_F^9E20PZ>:W/TX'2NO66-X_
M,616CZ[@<C\Z%FB>-9%D1D;[K!@0?QH XZ7P%*\<LL>K^5?KJS:K:W"V_$4C
M#:R,I;YT*Y'4'GK6MH6@7.E:MJ^HW.HK=2ZE)'(ZI!Y:HR1JG'S$XPO<_GUK
M1O\ 5K'3=/>^NKF-+="%+[ARQ. H]R>,>M,.JI%K4>FSJ$:XC:2UD#9$H7&]
M?9AD''<<CH< &?J'A=-2\1/J5S<*UM+ILFG2VIB^_'(P+'=NX/&.G3-0:=X2
MDMDT:&^U'[;;Z,<V8,.Q\A#&ID;<0Q5&(X"\\UT],$T39Q(AVC)PPX'^0?RH
M Y2'P9<1WPU-M4C75ELC:?;8;38TOS(V^4;CO(V#T'S-ZC&EH7AN'1+[4[U#
M")M0='E2WA\J(%1C<%R?F.3DYYX]*V!/"8?.$J&+&=^X;<?6@SQ+%YIE01GG
M>6&/SH P8],?3/&]WJJ*S6VJVT4,Q49\N:(MM)]F5R,]BH]:H?\ "#S_ &4P
M_P!JIDZU_;&[[*?O[]^S&_IGOUQ77/-%''YCRHJ=-S, /SI6=$QN91GIDXH
MY#4? G]I2ZU+)J;13:A<P7D$L,.&M9H554898AONC((&<GI5C4/"NHZOX9NM
M,U'7/.NKEHR]R+4*BJC!@%C#<9(Y))//T Z5IXEA\YI4$6,[RPVX^M9&IZ])
MI_B#0].%O&\&IM,IG,N#'LC9_NXP0<=<T 9NK^#;G4;W6)H-7%K'K&GBSO$^
MS!R2JNJNA+?+_K#D$'(Z$'FHT\$W5I>O<Z?K7DM=6,=E?+):AQ-Y:E4D7YAL
M< D=Q[5K>(M>?1;"RNX+>.YCN+VWM6)EV[1+(J;A@'=C=TX^M;/F(<_.O'7G
MI0!RMAX-GL&\-%=45_["M'M4WVW^M#(JY.&XP$'ZU'9>")K/3O#]F-41QH]X
M]TK?9L&4L'&T_/QQ(WZ?CV ((R#D&JB3W7]H7,<T<"6D<:-%()<NQ.[=N7'R
M@8&#DYY]* /---_M!]5N+RSNE747O)9QIU[H3^8C%B #,"%7Y,+YG(QW/?T'
MQ)HW_"0^'[O2A=/:FX4 3(N[;A@>0>H.,$=P2*TUD1V95=6*_> .<?6FB>)M
M^V5#L.&PP^4^AH Y"Y\!S7\7B!;S66<ZU:Q0R^7;*@C= 0&49/'^R3^)[7IO
M"LMUK,6HW>HB4OI[6%Y%Y "SH6W<<_)R2._'?/-=(&4MM##.,XS3!/$W25#T
MZ,._3\Z .:T_P>]K;:/9W>H_:[/1G\RR5H-KY5&2/S&W8;:K'H%R<&H&\$3-
MX+O/#AU1=MS<O<>>+;E=\QE(V[^?F.,YZ5UAN(517,T85CA6+#!/H*J:SJ/]
ME:1=7BK'))#$\B122>6)"H)VYP?3T- &)J?@I-9O]6GOKW,6I6$5DZ0Q;&C\
MMF=75MQY#.3T[#\9+<7OA?3)+[Q#K=SJPB"QJT%B00"0,F./<68G&3V X YS
ML:-?G5=#T_46C$;7=M'.4!R%W*&QG\:MO+'%M\R14W'"[CC)]!0!RWAGPV=-
M\+W=O923V$M[++-"9%W-:HS$QIM/0*N/E[$D5H:'X;BT;4M3U -#Y^HF,S);
M0^3%E ?FV[C\QW')SS@>G.R\L<?WW5>,_,<?YZBGT %<@_@;[1I6MV%SJ3$:
MG??;TF@B\M[:8%"I4[CG!C4_G75B>$LRB5"R_>&X9'UIV]<XW#.,]>U '*W7
MA"_U70Y+35_$,UQ?B2.6WO8+=8?L\D;;D94R03GKD\CCBK<6B:S]B5;O7DNK
MLR RL]F!#)&%8>68@W0[LDYSD#L *SKGQQ)!IUWK4=A'+HMH]S%-()\3!H2R
M@A2,$,ZE1SD9!]<;UA?7YDN!JEO:VT(91;S17&]901R,$ @@\>_Z4 8^G>'+
M[P\=+L]'O5CL1=3S7EL+8")ED);"$G,84GY5&<YYX!IOC]QJ&@77A^W29]0O
M40PH(7*D>:H/SXVC'4@G..>E=6\L<9 =U4GU..^/YD4>;&93%YB^8!G9GG'K
MB@#F-8\(7&HZGJMU:ZK]DBU6P%E=1FW$A.T.%96+#'^L((P<CI@\TRW\&W6G
MZE:ZAIVL^3.MC'8W8DM@ZW"1YV,!N&QQD\\CGI6CKGB!M)U'1[6.&*87]ZMI
M(3-AHMR,P;;@Y^X>X_&MMMP4[0"V. 3@$_6@#RO4-$DT&/P_H<FJ2Q1:;8ND
M=[+I#7$,K,0NW"'*,%4]6Y#]^:Z33M#U'4?["O;JZMXO[(GD:!8[!H!-&T9C
M'[LOF/ 8\>P.!TK6\+:^?$.A6]_-#';3RM,I@67?@)*R9!P,_=ZX[UL^8A4M
MO7 [YH Y"7P1/+I%_8'58P+S55U,N+4_*PD639C?TR@Y],U/%X2OK/7+RYL-
M>FMM-OYOM%U8B!6)D( 8QR$Y0-@9&#WP0:ZJH_/BWLGFIO7[R[AD?6@#D[SP
M1-=Z;KUD=415U>^2\9OLV3$5\OY1\_/^J7GZ_A<?PU>)K6J:E9ZN;:34(H0Z
MBW#;9(P0&!W?=(/*_KVKH@ZD@!ADC(&>M-:8$R1Q-&\ZKGRR^/IGJ0/?% ')
M/X7O](BU&ZT.\AM=1O[F*618+,"!MHP04+';NZL^<^@SUZNZB>>TFABD6-W0
MJ'9=P7(ZXR,_G67X5U__ (2/P[9:G)$EO-<HSF 2;MH#%>N!GIUQ6U0!R47@
MR:+P_P"'=*&IH5T2>&9)#;<RB-2J@C?QP3DU'=>")KK2];L3JB*NJZ@E^S_9
MLF,J8SM'S\C]TO/N?PZ:PGN9+-7OXX(9R[J4AE\Q<!B%PQ YP 2,<'([5866
M-X_,613'C.X'C\Z .8_X1*^@UV\O=/U^6TLM0=9;VS6!6W2!0I:-R<QE@HSU
M]1@U+<>%#?:U9:A>W<4K6-VUS;.MOMG12&_=&3=RGS=,<X%6=&U]M5UO6[!H
M(D33I(E26.7>)5>,.&Z#'!QCGZUL+/$\7FI*C1_W@P(_.@#-\/1ZK%IA36+O
M[7<>:^R8PB%FCS\N4!P#_3&><U17PYJ$'BO4->M=3ME>\@B@,,MFSA5C+$<B
M0<_,<UT!N(0I8RQA5;:3N'!]/K2O+'$"9)%0 9.XXX]: .9U/PK?:K#IGVG6
M%,]EJ2ZB9/LW#LN0J!=_RJ <=2>,YR35F#PW)8>)+O5M-OEMX[Y0;RT:'?')
M*.!*OS JV, ]<X&>>:UKB:Z2]LT@B@>VD9A.[RE60!25V+CYLGKR,#GFFV&J
MV6IV\MQ:7"2PQR/$TBGC<A*MS[$$?A0!S^E^#[S2=%6P@UG$B7[WJ3K;8Y=F
M9D*ECE26([''OS5@^&[R35KG69=1@&JO9&Q@FAM"J0H6W$E2Y+-G'5L#'3KG
MH1-$8?.$B&+&=^X8QZYIRNKH'1@RD9!!R#0!SVK>%(]5\#MX::=(D-ND(F6(
MG9MQA@N[J" 1SUK:L8KB"QABN[@7,Z(%>81[-Y'?;DX/XTVZENX[FS6WBA>&
M20K.TDI5D7:2"HP=QR!QQQFI_.CWA/,3<20%W#)(ZT <OH?A*^T&4VUOK\KZ
M-'(TEM8M NZ+))"&0'+("<@8!Z#.."Y/",T6L:?K$.I*FI0^8M[,+?\ X_4<
M@[6&[@+@;>N,#''%=33/-C\WRO,7S,9V9YQZXH YG1O"5WHEY+%;:W+_ &*;
MA[F/3_)7=&S,7*B7.=FXD[<9[9QG*VGA6\LH+R.+4X6%WJ4M]*DEINC=9%(:
M)EW\CD$'/4=ZZ42QF4Q"13(!DIGD#UQ09HPX0R)N)V@;ADG&<?E0!Q4?P]?3
M8]/ET+6&TV^LS. ZVXDA:*:3S&B\HGA <;<'C'>NPLK=[6SCAEN)+B102\TF
M 78G).!P.3T'0<5*9HU8*TB D[<%AU]*&EC1T1Y%5G.%!."WTH X^7P-<>5-
M';ZT8E.KG5H5:V#JKEBS(XW#>N3D<C&!U(JS8>$;BRCO8'U<SVU]J!O+B-[<
M#>& W1Y!'!(&>.G&.3GIVEC1U1I%5W^ZI."?I5!]6CN8]3ATMX+F^L04:)Y-
MJB7:&"LP!QU&>.,T <^? /\ Q(KO1TU62&V^V?;-.,,6&T]P^]0I)(90>Q X
M)'3&-&+1-9^Q*MWKR75V9 97>S ADC"L/+,0;H=V2<YR!V %;:SA+>)[AHHV
M8#/SY7<>P)QFI'D2,9=U48)^8XX'4T 97AS0(/#>E&PMF'EF:2;:B;$0NQ8J
MBY.U1G@9K7I 0RAE((/(([TM !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<GXZ>>%-#G9&?2XM3C;
M40%R!%M8*S#^XKE"?3 /:NLHH \@\3V43:7XQFME1M&N+BP>T$?W#<!U\YXL
M>VW)7N&]#7J>FZ=I^FVGE:9:V]O;R,9=L"A58MR6XXYJT)$9V0.I=<;E!Y&>
MF:=0!YWKMGH$_P 4]FN06;6\NADL+H#8["; SG@D#.._I6!I_FZ%8>&X?$SW
MD&CM8W$,4KVXF$3--F-90R-M)AV@9&1@CUKTS^PQ_P )9_;_ -J?S/LGV/R-
MHV[-V[.>N<_ACM6O0!Y9IFAZ%#XPTBSE@:?3X] G0'4U!9E$\9029 _@!(##
M( Z#%4-&N;=_#GA6QNX'\XZ3<Q)--$\J@[E7R5C''F%0,$] ",'->Q4UI$1D
M#NJESM4$XW'&<#UX!H \MT"X6=/AB)BQ9+":.7S5((;R%7!SZD$>YK/6"Q@^
M'JV_V5(KVU\1J9 8-K)B_+#G':,YXZ*?2O8GD2-=TCJBCNQP*=0!Y7?BPOO$
M&MZ1K\^I0W\M]'<:<+:!29HPJ&(PR>62I# @_, ,DGJ:O0-):^.8FMVMM3M9
M]4FW0R1[;RPEV.K."/O1$ CG& R@$]*]&HH J:K+Y.CWLODS3;+>1O*A)#OA
M2=JD=ST'O7D^F36,FH HB"RN/"KQ"-+=Q&I1@0C,P^=E!(+'OV!.*]CHH \D
MT6VBL9/ LNEPPPZC-H,\4S@ ,\@ABV+(>^'4@ ],$#I46EW>G7$7P_(A<:O:
M7ICU$-"WG1RFWE$GF<9^:3G)Z]:]@IL<B2H'C=74]&4Y% "2OY<+N$9]JD[5
MZGV'O7DGAJYL)/$'AF981#9S:3=P30M Y$1W1-Y<TC#YW'SEB<#J<#.3ZXLB
M.6".K%3M;!S@^AIU 'C&@Z9I@T;X=/):0"=YI(KLL@W-&891LD[E=VP8/'05
M9@/V*WE2&(?V':^+)&NX8E^2.W*?*VT<>6)2&...,]C7KBR([,JNK%#A@#G!
MZX/YTK,J(7=@JJ,DDX % 'DFO66VW\3W]E&'T07^FW4)A7<@D25#<21X[;=N
MXCN&[@U#XEELM1M_B-);Q>;%<Z=:/ _DG;*X63E3CDY(P1U[5[""& (((/((
MI: /,;ZPL!XFUNUTVV@,=YX9):.% 1/,'<J3C[SX.<GGFJ$Q@/A?1+C3)[%9
MH-&V2Z?J%N1!>J57S$4\%9<KC(SGI@X./7:* *VG2--I=I*UN]NSPHQA<_-&
M2H^4^XZ5Y3K&EZ#>ZI\0[:\M8'OOW362!?WHF-LA4Q#KO+X^[R>,UZ_61IFA
MC3=9U;4A=/*^I2)))&R@!"B!!MQST ZYYH \P\52R+INLVEW%(FL6]A8--*T
M;RO<,F&+Q'HBJQ;)'4YZ=]'Q.]TVO>+)M!1S>3^'[<IY*E9'/F2%P.^_RR/<
M97VKU6B@#SG2+O1+OXEZ3>:)&@MI-"FAW0P%0I$L15&XX( ;@\BNVUY87\/Z
MBMPJ-$;:0,'&0?E-:%-21)$#QNKJ>A4Y% 'E&CV>G7=W\/$O;>WE5?#\L=PL
MR C(2#:K@\<$/@'N#Z5U?PT*CP+:0KP(9KB-4_N*)GV#'8;=N/;%==10!P7C
MY7%ZEQ;75F;F*QE#6&HQY@O(F(W(K=5D^48QG.1P>V'?R6-]JVI:;XH74[!-
M0M[9]/BCMQ(Q3RES$C^6Q619 QP".2#7K-% 'EFH:= =2\>VDE@9+RYTB)[8
M/!O>0B"0,0P&"=V,D=\>U6[2:S?5OA\UD$2,6UP#B,H QA4<C ZMD>YS7I%%
M 'E/A%=,U&725U.745\2:;YBWMN\"H Q!$K2/Y8W1M]X98Y)'>LW2M-TM?#/
M@:0VL N#J\D4[%0'\DBX!5CUV'*#!XY'K7M%% 'D$KC3+/65M(I$TBU\3K+=
M0V<0;9:F%<LJ8(*"7#$ '[K>E2ZC8:"^GZ=<Z=)<75G=>(K:X,D\81,GB0Q@
M*N$P!N(&"<^]>M44 >/:S96<6D>.K.TM(A:0:K97$4$40*(H%OYK*H'3A\X]
M#76>) EQKG@<::H7&H/(FQ-H$(@DW<=ARH_$5VM5180_VB;]\O.(S%&6Z1H2
M"0OID@$^N!Z"@":<0FWD%P$,)4^8),;=O?.>,5X]I=A;:;\+=!U6VL6#)-"N
MK26\ ><VZLV0P()8*Q0[2#P.F*]EHH \ME?0;.S@O=/:[NK"_P!8BE-U<1E;
M:&;RV_>>6BKE>%'3:7(.<@U3TT%M$-O!J2:?=VFO7LEJ;^T(MGRSX213C:"K
MDC&,9]P#Z]33(@D$9=?,(+!<\D#J<?B/SH \RT>[']L:+-KNFP:?H\VD2101
M2?-;Q7'FG< 6& 'C"E<]5R!WJAI>DQKJ?@^WU6!9(!-J2P)<KDBU)/D*^>V,
M8!]AVKUQI$1E5G4,YPH)Y8XSQ^ -.H \CTBZLK/3='M)( L,>MZ@EM*Z,\-L
MN^78#&O#;E;" \<Y'H:VD16DNC>"4U2$G3[34+^&Z^UPE8XP1,$5]P  .5&#
MQV]J]C:1$*AW5=QPN3C)]!1)(D2%Y'5%'5F.!0!Y-/8+I?ARZ2W3R=)D\4VL
MVG18PJPB6$NR#M'N$C#MCD<&MK6-*ET_Q;/;Z?:AK'Q5$(+EXU \F5/OO_P*
M$O\ \"0>M>@UE6>BFVU>XU&?4+N[>0L(8YRNRV5L$J@4#@[1R<GCZY -***.
M")(HD5(T4*J*,!0.@ KRCQ=!:M<_$F,11EI]'M=BA03)*!-T]6!*>_(KUC>N
MXKN&X=1GD4Z@#RK5+5K;6]5C\,(D-Y=>%W*&VP#+.')4Y'63!.">><U8F_X1
M[Q'X4UFXT#39C?-H,MJ\8A=!&0I*Q,I !D#$XX)&#SR,^FTV21(EW2.J+D#+
M' R3@?K0!Y?97^F:CXGTN= LMJWAB:"65H3L+!X3M8D8XPW7IR*RXM%T:+X9
M>$;HV-NEY)=::MU+LQ*0D@W[CU^4%L^@]A7LU% 'EVN6NBZ5XBN-'U2.6PT"
M\TY8K#[+:*\(<O(9D \MMKL65N,9P/057N'M;.?Q%IFNQSLLFC0QZ2;]-[R1
MK"=Z@XQYGF<L!R>#V&/6:0,I8J",CJ,]* ,7P<V[P3H7#*180*0RE2"$ (P?
M<5SMZ;/_ (33Q#;>)HT-C=6$*Z>TRY5HP&\U$_V]Q!P.3\OH*[VB@#R71M$2
M]UWPM9>*K2*ZNV\.R1W:7*ABS^9$45\]6"ANO<$]J]:Z5&D\,LDD<<L;O&<.
MJL"5^H[4YY$B0O(ZHBC)9C@"@#R6R@FELK[38$MM9M;C1;O[)=I%MNH,[3Y-
MPO0L6(P>"2K<=35S0K^POO$WA&2(>9&- GMYW,+;0P\C*,2,<8;(/2O3R0JE
MF( '))[4(ZR(KHP96&0P.01ZT >.R6NG'X+^(UCMK?SVNKS8JQ#>2;B0QX&,
M_=/'L>*U_$4NE6_B1;;5GDM_#][I:PV<MM;+)#YA=_-3[C;68,A&,9V^HKTR
MC/..] 'F=CH.C3^/K.RN[0W,4>@1*HOU#2,Z2Y7?QS(% //(%5-!6TU"[M;:
M_FU%/%FG7TLI@$ 7+%F&]I/+^:%E(/+8(P!S@5ZO39)$BC:21U1%&69C@ >I
M- 'CMA>64^E^"!/"XUZTUA1J0>!O/24QR^87XSAFP<]#QCIQ[)1UIOF)YGE[
MUWXW;<\X]<4 >/:3HMG/HNB+96J1^*;;6V:1@NV>*+[2YD\SN(S$3P>#N&.3
M700:(UAXJO/#$=BAT74)UU<,$&V,*1YL1^L@B(']UV]*]#K*TC1?[+>>6;4+
MO4+F8X,]T5W*@)*H H  &X]LG/7I@ U:\RTR-QXC%G&+35K&Z>]9':/;=V+-
MN9TE[/&6X!..J]1BO3:* /(/#EW#+_PKF&!7-Y9VD]K.3 W[F00;=CG'&&[?
MXBM;P3=:/=V^C+>VMQ'XFTM)5O3(CHT3E2)7E;A65B,C).201TX])HH \=\,
MVUG:67P]O(X8H[TWEQ'<2[<2;#',-KGKC.S /&<>U>P.$,;"3;LP=V[ICOFB
M.1)8Q)&ZNC<AE.0?QH61'W;'5MIVM@YP?0T >.Z9:6$WA_P1!-!"RQZ[=JZ,
MOW8B;G@CLIW1\'@Y'K4@E33;.Z2*'&A6WBQFO(88\I';% 0=H_Y9^;@G QP?
M>O8** /'[R=%N?&%SH\$LEB=0T^YG%G!GS;<*AE* C:_<D<Y&>H-/UJUT"Y\
M+:GJ.DSW5W%>:CI\IDEB$<?F+,@8Q*$7#;!\Q _'@UZ[10!Y1J>D:(=5\=PB
MQLOL_P#9,,D$8C79YVR8%D'3?_JQD<\CUJ2QM=+U/Q1ILFIPVURDGA9//,ZA
ME:0,OWL\%@,]>17J=% 'DWA\QO%\+Y)P#<1V\T,K./F4?9RH5L].<#![U6@>
M/2O#JD6T\-M9^([DZL+>URR0&2?RV(*D,JEHVQ@X&"*]BHH \HNO[.TJRL=2
MT^XU.7PW+JKW%[/]G5E1FB($BQ^7CR@^,_+C=R.1FNU\&6FG6FCSG29;N6QG
MNI)XWN%"@[L%O+4*NU-V<# [D<$5T5% ''>+E@'B[P9,RIYB7\H+D<JAMY!R
M>P+%1]2*XJ.STVWTHWD-O EU#XQ!BE50'2$W0SM/4)L+'CC!)KV:B@ ZC(KS
M7PI/IMZUG9:I:3_\)9I]]/)+F-U8.S./,9Q@-&488R<'Y0.@%>E44 >2Z?%-
M>>&O#T"H8_%UIJR&\R,3*?-/GNYZF-DR<]""H':J=S9:;%HNNWD-O MY!XJC
MDMI50;XT\^$DIW"[=^<<8!KV:B@#QK7;+3FT[Q_=1VT#7,>HP2V<BH"RMY<)
M+1^AW!LE>I!STK2UEM-OO$>NZ5XAGU"/[;)#+I;6L ?SXA&FT0R;&*LL@8\$
M<MGU->GFXA4,3+& K!&)8<,<8!]^1Q[U)0!YHDVFRZYKFC>)K2YEU*6_CN+#
M$;[YHE5#%Y<BCC:RMGD $L3U-4]4M;&.S^*%M+9QK=2QO+ #!RRFUC"E3CO(
M./\ :'K7J]% 'G-K-:CQ(BZ^L+Z3<Z'!'8R7 !AW#=YR9/&\Y3CJ0H]*R- T
MI?[7\(P>(8$FE72+Q91>+D[/-C,*R;NI"#HW<'N*]=HH Y+X9D?\(#IT>3^Z
M:6,*>JJ)7"CV^7;CVQ76T44 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5S/C34]2TRTTHZ:T*-<ZI
M:V\ADS]QI "!CUZ'V)KIJR?$.AKKUC!!]IDMI;>ZBNH944-M>-@PR#P1Q0!P
MT^J7WAK7_'>JV5A:2K:I:75TK2&/<!#EMN%.6//)QVZYXZ+5?%UU'-?PZ/I[
M7L]C%'(\/ER$S,Z[A&I52%.W'+=SC'>G7G@HWL?B*.34W(UR!()B81N0*FS(
MYQD@G/&,]ATHF\'7(U@:GIVO76GS301P7JPQ(RW 085@'!V. <9&>.U #(O%
M&KW7B*]T^#2[6*VLHK6YGDN+AE=8I=Y;Y0A^=0AXSC@\TFG>*]3U2?39+727
M>RU*W:6.8QRJ+8[=T?F,5PP8<97H?4<UIV/AU;+7]0U,7)DCO;>&W>!DR L0
M8+\Q.2?G;.>M5/#OA*?P\T=NNNWMSI=MG['92JF(0<@*7 W. "0 3QQUP, &
M=8^/)KAO#7VBT@@&K336MPID):UGC)!3ISEAMR<<D>M6+S6WDN_#4EUI5G/'
M?:E)';3,Q+0J(Y"DJ@KU9%/<8#=ZEO/ .EWD&M1F2>,ZI<QW)9&P8'3:08_0
MEE+$^IK1U3P^NH7.C2QSBW32KCSXHUCR&.QD"GG@;6/Z4 <#KE_J6K>#-=FU
M)+:5K/Q###;B,'*;+J% !GIQGGW-=C9:]K%U>Z_I;6%F-3TZ..2W"SL8I1(K
M% S%01@H03BJ]UX%$]EJ=DFJS);7^H+J!0Q*?+<2+(0#P2"R#KVR/>K5QX>N
MXKW7-3M-3EBO-2MHH088%)B,88*5W'!/SG.>.G3% '0J9OLP9D3S]F2@<[=V
M.F<9QGOC\*X.P\>ZM-::#JEWHUM%I6JW0LMT=T7EBE9F5"1M *EACKGG/M7;
M6/VF#2;;^T)1)=1P+]HD1>&<*-Q 'OFN'\"Z!/>>#]#34WE2.QN7N4M);8Q.
M)0[E-Y;D@;MP&!VY..0"=/'.I1:;JFK7FEVD>G:=<SV;A+IFDDF201H%!0#:
MS'&3C'IQSIW'B'5+/6_[%FL[62]N+*2ZL721A'*R$!XFR,@C<N&Z'/08P1/!
M5K)X?UC1;ZY>XMM4N9;ERJ[&C>1MYVG)Z-@C/ISFKUEH,D>IV^I:C>_;;VVM
MVMH9/*$856*EF(R<LVU<G@<< <Y *NA^)9M>L-'N;6"'=>6KSW",Q'D%<*4S
MCKO)7D?PL>V*R_#_ (H271M!M+#3+2QNM4ENO+MXS^Y@6*1O,?@#=SCCC)?M
M70:/X=M=#GU2:S9MU_<&X(?E8R>2JC^[N+MCU<UBP^ 1:V&D):ZM+%?:3/-+
M;78A4Y69B9$=,X93GV(P/3D Q_"VKG0[;5;9K:-;N\\27-O'' C,BD1AV;"C
M<1M0G '4@<<D;=MXNOW:UL+G2S;:G=WTEK;^:&2.2-$,AG 8!MNT?=Z[N,XY
MJ-_A\KV5RHUJ\2^?4CJD%VB(&MYB-IPN,%2,@@\$&K5YX/FO;>PGEUNY;6;&
MX-Q#J!B3@E=C)Y8 785XP/KG.: *G@&.2*_\7)+%#%(-:;<L/W/]1#R/3/7'
MOWZU?^(44<WPY\2+(BN!IMPP##."(V(/U!&:J/X7U;3K/5)-+URX&H:A>I=%
M_(BV!@JJ001PA"#/4X'&3UW]>TH:YH%_I+3&%+V!X'D"Y*JP(./?!- '-6WB
MZ?2'EMM8M(8K6WT7^TXY()2[>6F%96! &[D$8XYQ[U<7Q-?P:CHUM>V=NBZU
M$YMGC<GR90F\1OQR"N?F&.1C'>I)?!T-W?K/>W/GPG2WTN6#RMHDB8@L<YR#
MP/\ /-2:=X6-K)I1O;][U=)1DLM\85AE=FYR#\S!<KD #D\$\@ Q[7Q[<.F@
MM=6EO U_?2V%W'YC%K65&*XZ<@L%7)QRZ^M:,OBF=9+6V6!//O7N&MF6.24>
M1$P7S"J DY++@#C#9SVHOO FF7R:\#+-&VKLDA9&_P"/>10N'C]&W(K$]RH]
M*GUOPHFI+I<NGW\VE7NEY6TN(55PJ%0K(RMPRD <>PH H1>+M40:%)J.C_88
MK^[:RN#*S PR?-Y94$#*OM !.,%AFK5QXHEA:WB$"&6]N9H[4JCR#RX\YD*J
M"3R. .H(.15J_P##,>J>%YM&O;ZXFDF 9KPX$@E#!E=<  %6 ( Z8%1ZWX4B
MU.TTU;&]FTR[TM@UE<P ,8QMVE2K<,I7@@^U &/_ ,)CK[3:59C0(H;R^N+F
MV'VF9XUS$C.L@!3=L8 'GD<C'>NTMC.UI"UTD:7!13*D;%E5L<@$@9&>^!6
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M;FUT^V$D,Q0-F28!A@]L1X/_ &U![5F?#BV@@D\6&*&.,_\ "072950/E 3
M^G)XKH/#7ART\*Z''I5@SF*-F8/(<L<GC/K@84>RBH_#OAYM ?4S]L-P-0O9
M+UP8]NQWQD#G[O QGGWH KZIXBN].\1/IK06R0R:?+=VL\LA =XR-\;<<8#
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M/V<UK*TCQ71?4(X'E E?:9%"*"H:0EB"P( ! '- ':27=M"JM+<1(K*64LX
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M4\?Q >U+J*V^J:-J>M^'[?5[R=UM1?1S6QA,T4<JLT(38H=]F\'&>#MR<@4
M>@WWB+2-/TF74Y]0MS:1-L,B2*P+] HY^\3VJ;4M9T_2='GU:\NHTLH8S(TN
MX8(]O4GH!W-<'XE_LO7/"&O:IHNF73O<&T>:5K:5#+Y<B_=C8 DJ@.2![9..
M-_QS"=4^&>M)96TDK2V,AAB$1#GCC"D9S[8S0!T+ZE8QVT=Q)>6Z0R'"2/*H
M5CZ YP:M9XS7!174*^,VN]0@?^Q;W2$BLY);=A&K!V,L94CY2X*'!'S!1C.*
ML:#:7VD_"4V]_9W-W/#97!6SW,LKQ_.8XLCD-L*KZ@T =;#?V=RLC07<$JQ?
MZPI(&"?7'2A=0LG+A;N!C&@=P) =JGD$\\ ^M>3_ "7,^J'[-<2VUSX4$,:_
M8)$B#H7Q&H9<DC( W$DD\>E:VAV-K;^(O")ALEC630)H;LB' 9SY)"R''7(?
MAN>#0!Z&+VU9(W%S"4D;:C"088^@]33KBZM[.$S7,\4$0."\KA1^9KB/"NEW
M5GJ\GA^>'_B6:!.TUE*>0ZR@^4OUC5I5/_ #5CQ)?_V/XVTO4-2M[B716LIK
M?S(H&F$$[,A!95!/S*"H./4=S0!UL][:VT GN+F&*%L8DDD"J<].33GN8(PA
MDFC0/G9N8#=@9./7@$_2N"M(H-%\4Z2SV$MIX=.D/;6:S*S+;R>;N(?.2A>/
M;C=_=*]>*Q]-T5K:[\&17]FS01ZE?M$DT))@M627R5?(^4<I@'ID#M0!ZBFH
MV,GD;+RW;[1GR<2J?,QUV\\_A2O?6<<JQ/=0+(S^6J-( 2V,[0/7!''O7DTF
MG6T/AS59(+ +<Q>*4EMBEN=ZQ"Y1MR<9";=YR.,9IE[I.E:C8^/[&*QBEU:3
M4C_9XCB_>"4PPE#&<<8?EB.@Y/% 'KK7MHHD+74($1Q(3(/D/H?2LI=<G/C<
MZ&8(OLQT[[8LX<EB?,"8QC 'YUPOB 2V3>/;.Y@N);K4=$B^SF.W=Q.RP2*Q
M! QPV.OJ*O2^7-XB9IX;T6S>$VBD\N%EDSNR47(XDVY('7VH ]!@OK2Z5VM[
MJ"94^^8Y VWZXZ=*2&^M+BW:XANH)(4SND20%1CKDCBO*[I-=.DZA;*L>LV]
ML;"1[ZTMS'+=VJ2DO;N@X,BJ#D+U#8(R<5<\3V:ZG+XJU'3HC-IUSX<>!PL1
M*SW>6\K:,?,ZCCCD94=J /1EU*P:3RUO;8ONV[1*N<\<8SUY'YU,D\4KND<J
M.\9PZJP)4^_I7":IH%K#X)LM9T:QMX=3TQ8]1C98PC2LB 2(YQG+)N4Y[X]*
MZGP["XTYKZXB,5UJ#FZF1A\R;@ B'W5 BGW6@#0^V6OVO[)]IA^TXW>3O&_'
MKMZXI!>6INS:"YA-R!N,.\;P/7;UK@/#,MK,\6CZUI=X_B"QU6:ZWF"0*2SO
MB<2@;2OEMC!/8+CI6=:VE[=^#],TIX98_%5GK"RR.8R&5OM!:2;=CE&B+<]#
MD+UXH ]/%]:% XNH-A?8&\P8W>GU]J)+ZSBD\N2Z@1]XCVM( =QZ#ZGTKRK6
M6:WT?Q=I;6=VUW)X@@O(XX[5WW1&2V.\$#!^ZW3G(-,\0Z;;3VGQ'EBT[=<2
MM ]F1;'>S>3'DQ\9SO!SCN.: /4(M;TZ;6Y]'CNHVOH(TDDB##*AMV!]?E)Q
MZ8/>K$5_9S"8Q7<$@A.)=L@/E_[WI^->?:Q!>2^(O%:Z;!,+S4=!A%A,D38:
M0"?.'QA6^91R1U%4IDT?7/#VLZA:VFJM>KH<UG)#=69B6([<I#MV*'<-TVYQ
M[9&0#TW^T++R99OMEOY46/,?S5PF1D9.>."/SK*UGQ!)I]WH*VL<%Q;:I>BU
M:42?=!C=PRX&#]SUKDIH[;P]!X/U>/3&72U7.I-;6I9UE,(6.615&X[3N4D@
MD;JL:C#8Q)X2.E6$]M9?V\;D(T;@A6CFW2%6Y12[]\=1TSB@#O%O;5KMK1;F
M$W*C)A$@W@>NWK5>TO)?]*:^ELD5+DQQ&&7/R\;0^<8?)Z#VKS9+@R:]HD\>
MGWMK]G\177G6ZVDK>7O28;WD(.[>2I^4A0& [9J"[LH6T#6819$C_A+HIXD$
M!_U?FPEG48^[M#\CC - 'JIU.P$1D-];>6)/*+>:N _]W.>OM6=XNUJX\.^%
M=0U>VMXIY+2(R>7(Y4$?@#^7ZUPNK:3I[77Q#1--B*OI<7V4+;Y#2>3(#Y?&
M"V?+!V\YVUT'B>"YU+X/WD-O#-<7,NF*!&J%G9MHR,=<]>.M '717EM-YHCN
M(7,)Q*%<'RSZ-Z?C2#4+)HY)%NX#'$ 9&$@P@(R"3GC(YKSG4M(TZYU.]U'1
M;*)-..@W$%X8H-J3R,5,2;<?,XP_;(R >M);Z?'I>B^!M2@TX)91&$ZL(H,2
M;A;LB/* ,D)(V3GH>>U 'I"WUH\<4BW4#),<1,) 0Y_V3W_"G)<02>9LFC;R
MSA\,#M/OZ5Y;JMA/"^KZK;PRG11X@TZ^B6.-CPC1^?*B@9*D\D@<[6/O1JS"
M^@^(4J)>PPW LY(9?L<F)0L:#&, L"1@CKM)XH [[6]=6P\+ZGJ^GM;7C65M
M).$\[Y6V*6(R,^E6++6+2XTU;J6YMXV2!)K@>8,0@KN^;G@?6O.+FXTG5K?Q
MKJ=O)$VJWVBM!':1VTJOA8V7*F2-68LSJN .RU?L+&"+Q3IJVEF$2;PS)%*4
MAP&EWQE58X^]]\X//6@#O-*U6SUK3(-0L)EEMIT#HP/8C(SZ'!'%7:Y?X=$#
MP!HD/D2PRP6<4,R2PM&1(J ,,,!G!XS[5U% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %1RW$,&SS
MIHX][!$WL!N8] ,]2?2I*XWXAHWD>'I(8HI+A-<M?*\PX&23WP2!ZX% '945
MP4_BWQ%:6WB&WET^RDU314BN2(=YCN+=PQRH)R' 1N.<D>]=-IVK-JFHM]DD
MAFTY;6*7SE4Y9Y,L #G&-FUO^!K0!KT5RFJ^+'L?%*:,TEM:/((3;_;$8+=[
MFPXCDR%#*/X3DDD53NO&5_;:+KM[]GMFDTK5DL=N& E1C$,]>#^]]^GO0!V]
M1QW$,LDD<<T;O$=LBJP)0]<$=JYU]=U:_GU/^Q+6VG73;Q+22&9BK3MA&DVM
MG";5?C(.2#TXKE9]6OO#.K>.]4L+:S>VM+VVFN(Y"P9U-O%N"XX!Y)R<\]N]
M 'ITDB0Q/+*ZI&BEF=C@*!U)/855O[*UUK2+BRF8O:W<)C9HI""R,.H8>QJO
MXDNFLO#&J7:6\-R8;260PS_<D 4DJW!X(S7.0^(]:GO[/2],LM-B$NB)J$;2
M%]J'*C9M7MS@#/OGC! -^PT%K26-[K5]1U'R3F);MH\(<$9^1%W'!/+9K4@G
MAN8A+!+'+&20'C8,,@X(R/0@C\*Y'2?%\WB.+1K:SA@@NM0TO^T9_/4R)$F5
M7: ""V68]QPIK%\%ZU-IOA/1]*AB1;V[N-1?*PM*D:QW+[L*I!/+J!R.,GM@
M@'IE%<3'XI\0M<Z#93Z1;6EWJ,ES%*)W;"F)2RNH'.U@ <'GG''6JT/C37!8
MP7ES9Z>(HM9_LF[$;/N=C-Y7F1Y^Z 2#@YSSR* ._J,3PFX:W$L9G50[1AAN
M"G(!(ZX.#S[5PNI>--;LH_$-TME8&VT2^CAD4R.7EC98V..  V).O3C&.]6=
M9UN\M-9\2PVMK8PW5EHJ7D-X8R[N,RX5^G *' SWS[4 =K17$6/B+4QIVDZ<
MCQSZE+I:7KS-;22#!"A055LDDYRV>W3GAX\6ZO=1QVD6E&SUA;!;R>VFB:8(
MS,ZK'\A& 3&WS'H,<'/ !VE%5-*NKB]TJUNKNS>RN98E:6V=@3$Q'*Y'7![U
MF7>M74WB230=-^SI<PV8NY9;A&=0&8JB@ @\E6).>,#@YX -ZBN!@\<ZMJJ:
M"FF:?9QW&I_:XI%NI6(@F@R&'RCE=PZ]2.PKJ-6O[[3M%BN!':_:-\23,\NV
M*(,P#OR06"Y)"\$\#O0!K45PH\=SQZ+?7MS J)9:J;">Z6VD*1QA0WG-%]X#
MYE4C/&<YQ74Z-?R:EHL5X)K2X,F\QRVKYBD4,0I!YQD $]<'([4 :-%>?6GC
M77I]-T/46L-.\G4K^2P,0D<,KAI0K[L8V_N^1@GG/'2M"V\4ZJUGJD=Q!8K>
M:=J:64LX<I"(V5&\W#')($F-@.21P>: .QHK@W\;:FOAR^U9;:W*:9J;6EZQ
MBD7]P&7=,J$Y!56R5/H>:ZJPOYK[4[]4,365N4C1U!W-(5#-SG! #+R.Y([<
M@&E2,RHA=V"JHR23@ 5R-]XLOC9^(=0TRWMY;;0I6BFBESON#&BR2;6!PF V
M!D-DCM6>VK7FM:]K,/GPR:,VA0W<4#P'.)1+U.[&[Y1SCIQ@=2 =Y%+'/"DT
M,BR1.H9'0Y# ]"".HI]><^$/$-]I>D>$;&^AM?[/O-$$L3Q%C)&88HR=V>""
MK=!TQWK6TSQ+K>I3:=/!I2R6&H6S3!RCQ_96VAD#L<APV<94#!]0: .PHKSR
MW\9^(W\&6GBNXL],CTZ5+>65$,C21QL^)'/084$,!Z YK27Q;=MK&OZ4!:FY
MLS ++Y&Q.)3M!//9\JV.F,^U '6K/"\\D"2QM-& 7C# LH.<$CMG!_*I*XR?
MQ#<V.K^*]FDP2W&G6MK*'MHRTMP'\S[P')"[20HSWP>:(/&RW%A:RVMU9W_V
M^^^RVDUK&Y  B,C%X\E@PVN-N0?N],\ '9U'#<0W 8PS1R!&*,48':PZ@X[^
MU9?A[4-3O[:Z&JV'V66&X:.-PI5;B/@K(%))7.<8).".M<#I^M:IX6TKQ!J=
MK8V4NCVFO7/VJ/<RS;#* 2@ VC;G.#UYZ=P#U:BN/N?%6J2W%T^CZ:;R&SOA
M:2P")M\@! D99,A5*Y/RD'(7J,XK9\0:U_8T%F$CWSWMTMK"-I8!B&8D@<G"
MHQP.IP,C.: ->BN*O/$OB6QT+4=1ETB+&G3YD)C9/M-K@%I(U+95E&[*D\[>
M#S4FH>*]1M?"EMKMM;V=S'>7D"6Z;V7]Q+*J(Q//S$,#V ]\4 =C17GNJ>.-
M=T.'Q';W^GV#7^FV*:A;M%(_E2PL67!R,[@5(]_:M:;7]9MM0BTJXALTOKE)
MKF)H(Y)UC@3RP RC:2Q9\9! P,]\4 =917"77C?4+&RTTZM9P:)<W<,N7O59
MH//5MJQEP0$W#Y@6[<8)J[<>+9(O%":+(]K:3LT/DQW*L/M:-M\QHI,A<KDC
M;R25]Z .JBN(9FD6*:.1HFV2!&!*-C.#Z'!''O4E>;VM_>Z#:^.M0TJUAE:U
MUCS9(64\QBW@+E0"/F RV.^,=Z[+3]5;4M3E%J\,NGQV\3B9 <M(XW8!SC&S
M8W3^,4 +?:%%?:]INKO=7"3:>)!%&FS8V\ -NRI/0#H16K7'>*_%M]X>:]F6
M"V,%I'#(L;$O)<*S[7/RG]T%XPS @GBHM2\3>)!JOB&STK3]-D_LB*&<>?*^
M9E968J,#ACMX/0>^> #MJ*X2#QCK>N7L-OH5C8*+G1X=4A>\E?CS"1L8*.O&
M/U]JAT_QQK>OMI$6DZ=80RZCILUUB\E?$4L4B1LIVCD98@'\?8@'H-%<1>>-
MKJ'0-0\1P6\$FE:?=O;S0X/FO'&_ER2*V<#!R0I'('49XMMXFOH-6US39X[8
M7%M#%/IX"M_I*R$JN>>OF80X]0>^* .LIDTT5O"\TTB1Q(,L[L JCU)/2N2U
M+Q/JRSZE;Z18I>W6EM''+"(7_P!(D9%=E5@<1_*XP6W<^F,G*\9ZQ<:]X,\9
MPVD-NMKIMK)!,+A"SO)Y(=MN#A=H<8.#E@>F,D ]!>>&* SR2HD*KN,C, H'
MKGTIZLKH'1@RL,@@Y!%<MXKC23X5ZNLB*P&CRG##/(A)!K.L->\065WI6D7%
MII^W4;!GT^6-W;9)&BDI+G'!!SD=,'@T =W17*Z#XGNM<M-&9(X8[JX$IU"$
MJ<VYB.UU'/42%5YZC)[8I?$5_JD'B[PO965U#%;7<T_G*\18OLA8@$AAQ[>H
M![8H Z6&XAN YAFCD",4;8P.UAU!QT/M4E>7Z-J]]X=BU.:VMK,Z:WBF2UF0
MEA)B654RF.!M+ X.<\]._03^*M4GN9WTC33>06M_]CEA$3;W"L%D=9,[1M)/
MRD'(7J,X !ULDT4(!ED1 >A9@*R]<TBU\4:0^GR7DL<#21NSVS)NRCAP,D$=
M5%8'Q<1'^&&L[D#X6(@$9Y\U*S-4D6U^)'A:4Z6VA1.TL+7)"8O&9/EMSY9(
MZ_,-^.G'- 'I"@A0"Q8@=3U-+7$2>-[E?#\7BA(('T5KW[.\>#YRQ>=Y(EW9
MP?FP=F.AZYJ:]\6WUCKEM:RP6WDS:HMAY2$O(J,N5E9U)522/N$ XYS0!V-1
M_:(1<"W,T?GE"XCW#<5!P3CKC)'/O7#-XVU>VM=<U.ZLK!=-TB\FM9$25_-E
M8*GE[>,#+. 2?7VYDMXKU/B[:O??9#(^A3'=;QE>?.BR#DG..QXZ]!0!W-%8
M5[K-P_B9= T\P)="R-[)+.A=57?L50H())(;G/&WOGCG8/'.L:FVCVVGZ=91
M7=[)>6TZW,K%89[?((^4<J2,YZX/;K0!W]17,/VBUF@$LD7F(R>9$<.F1C*G
ML1VK/U6^OM.T(72QVINE\M92\NR&/+ .^6QE5!)QP3C'4U4\+Z_-K9U:*XC0
M2:?>FVWI&T8D78CAMC<KP^,9/3/>@#1TC28M'LOLZ3W%R[-OEN+E]\LK8 W,
M<#G  X X J_7,KKNK:C+>R:-:VT\%CJ LI(96*O(%*^8X;.%V[C@$'.WMD50
MO_&EW#HVL:]:6\$NG:3=R6\T+ ^;*L;!975LX4@[L @Y"]1G@ [6BN"U3QGK
M5NOBB>SM-/:#0XX[@>8[[IXVB\PC@#:V._./0YXO+XFU:/6[BPGM;([]*;4K
M78[#;M8*4<D<_>!R .XQWH Z^L;3=)M/#]SJ%P;^4G4[L3.+AD \UE5 $PHZ
MA5&.>E<YI_B[Q!>GPT3:::JZ_8F>+YG_ '$@C60EO[RD$\#!X'/>D;Q7=7>B
MZ7<7FF6$L_\ ;ZZ;.&RR(ZSF/S8P1G/&1D\>] '>T5YCK6O>([?1O']S%J%N
MITV7RK;$#9C4PQM\IW\'YSSSSSTXKH=1\1:K#=7FFZ?#%=:A96J3R8MW*2LY
M?9&,-\F0GWB3U''6@#K:*XRZ\6ZO.MU'I>DG[?9VT,LUG-&SLTKIO\G>I 0@
M8&XY&3TP.;WC'4]0LOAYJNJ61^R7L5B\ZB5=QC.W)'!^\.F>1GUH NZMI=IK
M%_:P3ZE<Q>4KN]C#.%6Y0D ^8N,LH.!QCJ0>M;%>>RIJ:_$73WM#8OJ,GA^;
M=-*C*A_?Q8) )8]AU[D^U7-.\;W&LZ;HWV2V6&^O[!KV0&%YUBVLJ8VJ02"Q
M/.> .^: .VHKAO\ A*?%$]UH]A'HUE9:AJ%C<3O'>2L1%)$R+@[1]T[@1WY]
MJL#Q5JUU.)=-TS[5;1:@UE/$L3;MJ.8Y)%D)"_*P)VXY Z@G% '8U7N;ZTLC
M&+JZ@@\QMJ>;(%W'T&>IKD+KQO<Q>'[CQ/#!!)H]M>-;R18/G-&LOE-*&SCA
MLG;CD#J"::MI+JOQ*URPU'[)=:=_9EJ&MY8"P*-),<<MC.0"3CG X&* .YJ.
M2XAA>-)9HT>5ML:LP!<XS@>IQ2RB3R'$+(DFT["Z[E![9 (R/;(KRFWO-4U3
M1?A]JMT]M<ZC<:DSJ[(4QN@G)!.2<9[#'0"@#UFBN*M?&EVUK]FNK>'^T_[7
METL&!'>,E$,AD"YW8V#[N>O?'-;OA[4-3O[>Z&JV'V66&X:.-PI5;B/@K(%)
M)7.<8).".M &E/=6]JJFXGBA#'"F1PN3Z#-2A@V<$''7!KA?A^5UTZ[KFHQK
M-?2:G<6J^8-Q@AC.U8EST'<^I.36F\EOX<U2Q\/Z1%%#+JDL]RH=28X%15+D
M*",Y9EP,C[Q],4 =117!S>.-3CA^SI86IU"#6X])N0TC!#OP5D3@G!5@<'IS
MUIYU_P 8MJU[HL-CHK:A:V,5V7\V7RW+M(NT# ()V#Z9[T =S17&:+XUF\4_
M88=*BAMKB;3%U"4W*EUCW,4"  KGYE?+9X '!SQ4@\<ZMJB:%'INGV<=SJ37
M<$JW4K$030!@P^4<KE>O4CTH [ZLS7M.M-3TIXKVZEM(HF6?[1%+Y9B9#N#9
M/'!&>017.ZAXMU32[^"&[M[(;M0M;)X8BTC$2[%,NX'"#>Q 5P"0I/>J4VMZ
MM%8^/KF[%C?VVF.ZQVDT15&06Z2;3R<@ACD8Y)Z@<  Z_3-*^RNMQ-J5WJ4V
MPJDUR8_E4X) $:JO.!SC/'6M.N7@UZ\U"_DTK28[2*XM+"&ZE,R,4W2[MD:@
M$8&$.6YQD<&LRR\<:EK<GAY=,L;6$:O:7,I-R[$P20LJLI"CY@&8^F<=J .[
MHK%\)ZU-X@\-VVHW$*0SNTD<J1DE0\<C1DC/."5)'UK:H **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M K+UW1(M=M;>)YY;>2VN8[J&6+!*R(<KD$$$>HK4J*XN;>TB,MS/%#&" 7D<
M*,GW- &)+#%X;CN]3:UO]5O+V2-)S;0AW( VJ O "+D_F2<YJ3PCH47AWP]#
M91P^2S,TSQ[MVPL<[,]PHP@]E%5=0\4K9^(M&MUGL3I-]!<RR79DX3R@O(;.
MW'S<GVK:?5=.CLH[U[^U6TEQY<YF4(^>>&S@T 9NK^%XM:-Q%>7DKV5Q)%(]
MLR*0K(004;&5SM&?TP>:S]1\!0:@=6C&K7UO::G<1W4MO$(\+,I3Y@2I//EK
MP3C/:KVL:_-9ZCX=2S^S3VFJ79@>7<6^7RGD#(0<?P>_6G^'-9NM6N=<ANHX
M4.GZBUI'Y6?F01QN"<]_G- %5_!D8URZU&VU?4+:*^VF^M(BGEW+*H7<<KE"
M0 #M(S[4V_\ !%MJ$'B"&74;M4UQD:XVA,IM54 3Y>.%'7-;,EX\>MK;FZL5
MMA:M*\3/B<$,H#8SC8 3DXZD4^WU?3+NX6WMM1M)IVC$HBCG5F*'^+ .<>_2
M@!-2TT:GHEUIDL\B+<P-!)*@&[##!(R,9P3VK+M/":6>HV]]'J-R98--&FH&
M5,>6""&/R_>R![>U,U_Q2NFZIH]C9SV,TMWJ"6EQ$TF9(U96.X*#QT'7U%;9
MU*P%^+$WML+PC(M_-7S",9^[G/3F@#FK3P#;Z<FC-I^JWMM=:7;FSCN (V:6
M D'8X*[3R 0<#!I@^'EO%IEC!:ZQJ,%Y87,UQ:WR&/S(S*Q:1<;=K*2>A![5
MTBZWI+3Q0+J=D9I698XQ<)N<K]X 9Y([^E$>M:5-9R7D>IV3VL;;'F6=2BMZ
M%LX!]J ,W_A%4-_I%[)J5Y+<::TD@>383.TB[6+_ "^G0+@#CTJHW@:!M-EL
MCJ5WLDU3^U"VV/<)?,$F/NXV[@..OO6X=5LY[>]-E?V4DMJ&60F8,L+XX$F#
M\OO6+J7BQ--CT*TEOM-6_P!4 !GWY@0")G,@&X$H2N%Y&=PYXH 2\\#V][9Z
M[;2:E=A-9G2:X*A,H555 3Y>!A%ZYJY-X6@NM5U"_N+NX=K^P&GS1@*%\L;N
M1QD'+MW[U8TK5UETDS:C>Z9]HM\K=M:7&Z&,@GN>5XP<'ITYZUJ!T,8D#*4(
MW!@>,>N: .3D\" 1:5):Z[J5KJ.G0?9H[V,1%Y(>/W;J4V$?*"..O-37W@M)
M[ZSU"QUG4=/U"WA-N]U"R.UQ&6W$2!U*D[B2#C@DUMQ:QI=Q#--#J5G)%  9
M72=2L8/(W$'C\:1-:TJ0SA-3LF-NH>8"=3Y:GH6YX!]30!2@TN]M?$%M+#?W
M7]FQ69ADMY65E=]V0^<;B_7))QTZY.'7WAY+C7H=;M;N6SOT@-J[HJLLL1.X
M*RD=0>01TR>H.*T%U&R=+=UO+=EN3B!A*I$I_P!GGYOPJ2XNK>TB,MS/%#&"
M!OD<*,_4T 8,/@ZSM;K19K:YN(AI)F,:?*1*TN?,9R1DDDD\8Y-7?$&A1Z_9
MP0M=3VLEO<QW4,T.TE9$.1PP((]B*MQ:II\S(L5_:R,Z&1 DRDLHZL.>0/6E
M_M.P^Q"]^W6WV0G G\U=A.<?>SCKQ0!B6?A%M.ENI;76K\27%]]N?S!&RES'
MY; @*,J1@X[$#&*TM%T2VT'3&LK,D*TLDS'  WNQ9L < 9/ '05FZGXG^QZY
MH$4,MD^EZB)S+=&3(41Q%PRL#MQQR36_:W5O>VT=S:3Q7$$@RDL3AU8>H(X-
M '-P>![>WTO2K!=2NS'IM\U]$Q";F<ESAOE^[F1NF#TYIMSX%@N);N==4O8I
MY]2CU-9$$?[N9$"# *X*[0!@Y]:VAJ/E:E?K<WNGI9V\4;[?,Q+$3NW&3)P%
M.!CZ-5BVU.PO9Y8+6^MIYH@#)'%*K,@/3(!R,T <VVF1>%K/4(UMM5UQ=9NG
M:2!8XW"NZ88L0%"HVW!)X&1T%;/AK18_#WANPTJ,[OLT05FR3N;JQR>>236?
M=^*57QCH^C64]C<0W8G^T;)-TD31KD# /&3QSZ&MI=5TY[F6V2_M6N(5+21"
M92R =21G(% &-<>#K:6YU8PWEQ;VNL#_ $ZVCV[9#MVLRDC*EEP"1UQD8/-2
M3^$[=]6FO[:\N+3SK!;"2&()L*+NV'E201O;H<=,UH)KNCNY1-5L6<1>>5%P
MA/E_W^OW??I4B:OILEK!=)J%HUO<-MAE692DAZ84YP3]* ,6U\&6UJV@_P"F
MW,B:+:O:0HZIB2-E5#O^7DX4=,4W0_!O]@J+>#6]2EL80PL[28HR6V01P=NY
M@ 2 &) ';I6E>:S!+H4]]I6IZ6VT[4N)Y@UN&!Y#,I_KUIT7B'2YO$$^AQWD
M1OX(TD>+>,C=NP/KA22.PP>] $.E>&;33/"4?AMI);JQ2W-MF;&YHR",'  Z
M''2J]EX-TRQNM%ND\UI])MGMXI&;)DWXW,_]XY!/U8FMBUU.POGE2TOK:X>+
M'F+%*KE,^N#Q1::E8Z@9!97MM<F(@2>3*K[">@.#Q0!E2>%PVJZKJ,6IW<$^
MHI C&,)^Z\DDH5RO^T<YR#FJ-[X!L;Z.ZD>ZN(-1GNX[T7MJ%C:*9%V*RC!'
M3(.<YW'VQO7=U+%JEA EQ9)'*7\V*9B)7 7(\L9YP>3GM2QZUI4UQ%;Q:G9O
M/-N\J-9U+/M)#;1G)P0<XZ8- ":3ITFG6ICGOKB^N';=)<7&T,YQCHH"J !T
M _4DUDCP;;?Z; ]Y<2:=>WAO9K-@N&D+!B-V,["P!Q^&<<5TC,J*69@JJ,DD
MX %5K?4["[AEFMKZVFBB_P!8\<JLJ<9Y(/''- &%_P (;''KMW?VFK:A:VM]
M()KRPB9/*F? !;)4LN0!NVD9K1\1>'[;Q)IBVD\T]N\<JSP7%NVV2&53\KJ>
M1GKU[$U:CU;39;66ZCU"T>WA.))EF4HGU.<#\:(M6TV=[A(=0M)'MP#.J3*3
M$#R"V#Q^- &=;^')%AMTO-7O+Z1)A-,\RQCS]OW5(50 H/S +CD9.><\QXD\
M+/I'A*33M+EU">*;5K>YB@BA$GV1?M"2/Y85>%&"0#G^E=Q;:MIMY<?9[74+
M2>?RQ-Y<4RLVP]&P#G:<C!Z<TZ'4K"XO)+.&]MI+J,9>%)5+J,XY4'(YH P]
M1\&VVLV6JI>WD[3ZI;I;37"(JLD*Y(1 00O+,3G)R?H!+K?A4:O)IUW'JEY8
MZG8!EAO;<)N*L &5E8%6!P#C'4"M)];TI!<EM3L_]%0O.//4F)1U+#/ ^M4;
M3Q#!J]MH][I=]8?9KU@S)._[QE,9;:@!^^#M)!Z#- $=UX6^TV3V;ZG=/!-;
M-;W*S*DGG;B27.1@/DG&/E']W &(Y_!MK<0QV<MW,^G1RV\L=LX5O*:$(%V/
MC< =@SW.3@C)K;.I6 O19&]MA=GI 95\P\9^[G/3FHVUK2DG6!M3LEE>7R%C
M,ZAFDP#L S][!''7D4 9!M(_"G]IWZ0:EJAU2]$LMO;PI(48H$R!QA,(H.2:
MM>$M"B\.^'+;3XXO+89D=-V[:S'.W/<*,*/916O/<0VL#SW$L<,*#+22,%51
M[D]*@CU33Y9XX([ZU>65/,CC692SK_> SR/>@#GM9\"6^LW&L.VJ7]O%JT<:
MW$,6S;NC&%8%E)'0<9P:S[/1[VZ\:>*(VN=0M[6ZM;6#[0UO@3[4=7*N5VAA
MGJ..>G''4/JB27UB+74--:UE\WS0TN9'VCCR\'!P0=V>PK"O/'5M/9:9>Z)-
M:75O<:M'I\Y9LE5,C(6&#WVD@G@C!H K1Z//;_$41Z:+JQL8-"BLXI5MBT0*
MR.=H9AC(4J1S^?2MBQ\'V6F:GIEY9W$\:Z?9O9Q0_*59'968L2,EB5!SGU]:
MVK*_L]2@\^QNX+J'<5\R"0.N1U&0>M-NM3L+&1([N^MK=Y/N+-*J%N<< GGD
M@4 83>";,KJ%JMS.-+U"Y^U7%CA2C.2&8 XR%8C)'UQC-:5[X?LK_7M.UB8-
M]JL%D6/:<!@^.&'< @$>A&:U&944LQ 4#))/ %4H-9TNZN1;6^I6<LYC\T11
MSJS%/[V <X]Z ,B]\'K/X@GU>RUC4-.>[5$O8;9DV7(484G<I*MCC<I!QZ=:
MK:AX"MKN365MM3O+&UUB$Q7MM"$*,VS9O7<I*G;@''7 KH8=8TNX=D@U*SE9
M8S*RI.K$("5+'!Z @@GU&*EM=0LKZ-Y+.[M[A$.UFAD#A3Z'!XH K7&CP7?A
MV;1;F6:6WFM6M9)"0'92NTG( &<'TK.CT9-'CCU.YEO-4GTVT>*V1(EWA<#=
MM5<!G8*HS[8&,G.Q;:G87JRM:WUM.L/^L,4JL$XSS@\<4EOJFGWD$LUM?6T\
M4)(DDBF5E3 R<D'CB@#&\+Z5%#=:MK@L9K*75IUE\B;AT54"_,N2%9CN8CW&
M>:O:OH,>K7VF7OVNXMKC3Y6DB>';\P9"C*=P/!!^HJY!J>GW5K)=6]];36\1
M(DECE5D0CKD@X&*YVU\52W^K>)+.VN=+\C3K:&6VNC(3'OD$G^L8'& 4&<8[
MT *_@:!]/N;,ZE=[+C4QJC-MCR)0X? ^7[NY1QU]ZD3P8D&N75]:ZOJ%M:7L
MOGW>GQE/)FDP 6R5++NP-P4C-:S:SI]I;(U_J=A#((%FD8SJJ[>!N&3]W)&#
M[BK$NH64%NEQ->6\<$F"DKR@*V1D8).#QS0!0\3^'XO%&@W&D7%S-;P3[?,:
M';NP&# #<".H':J\_A6*_P!3T^^U34;N^.GR>=;PR"-(UEQ@.0J@EADXR<#T
MK;M[FWNXO-MIXIH_[T;AA^8JE:ZJ+[6+RSM@IBL2L=Q(?^>K*&V+[A2I)_V@
M/7 !EP^";.""2Q6YG.DO=_;/L!"[%??YFT'&=F\;MOKWQQ5>3P# \[NNL:C'
M$=4_M6.)?+Q',22V"4)(.3P2<9KI(-3T^ZEEBM[ZVFDB&9$CE5B@]P#QTI+7
M5=.OI3%:7]K<2!-Y2*97(7)&< ],@C/M0!BCP582:5KFFW=Q<7-KK$[W$ZOM
M4H[ #Y" ,8VJ1G/(I=.\*26>MVNK76MWU[=6UHUF/-6(!XV96^;:H).5'.:U
M[S6-,T\N+W4;2VV ,WG3JFT$X!.3P":=<ZII]E%'+=W]K!'(,H\LRJ&'J"3S
MU% %'4/#T=WKEMK5M=2VFH0PM;F1%#++$Q!V,IZX(R",$'ZXJI#X-L[6]TBY
MM[JXC.FO/(J_*?/>;/F,YQU))/&,9_"M>YU?3+-]MUJ-I VT-B6=5."0 >3T
M)('U-0:1XATO76NQIUW%<?99C"^QP>1C)'MG(SWP: $\0:''X@TY+5[F>V>*
M>*YBFAQN22-@RG# @C(Z$5%HGAU-$O=2N5O[JY;4)EGE$^S <(J$C:HZA1QT
M'8"ENO$EA'J\VBPW=N=52V,XA=QQ_=![Y/)P.<#/I5?PEXG@\0Z%ID\UQ:)J
M5U9QW4MI%(-R!@#G:26QSU- $2^#8H==O+^UU6_MK6^D$UY81E/*FD  +9*E
MER -VTC.*)/!5F_]IVZW4Z:;JD_VB[L@%*NYQOP<94/@;A]<8S6VFJ:?)=R6
MB7UJUS&"SPB92Z@=25SD"F1:SI<_F>3J5G)Y<?FOLG4[4Y&XX/ X//M0!CWG
M@RWO1XA5[^Z5-=B6*X50G[M0FP;/EX^7US4LGA1)-3COSJ-R)DTYM. "I@QL
M02WW?O94>WM6O%J>GSV;WD-];26J$AITE4HN.N6!QQ534/$6F6&@7FL_:X)K
M2VC=RT<JD,5!.T'.-W&,>M &?:>#H+(^'O+U"Z(T*%H+<,$^=2@3Y_EY.T#I
MBH1X&@%C':_VE=[4U4ZL&VQY,OF&3'W?N[B>.OO3=/\ $]Z7L+J_;3I=*U$Q
M103VCMNAG<$^7("2",@*&!') V\YKI;Z5H+"XECE@BD2-BCW!Q&K8X+'TSUH
M P+WP39WP\01R7MXMOKBC[1"I3:C[%3>IVYSA%X)(Z\4V[\&/-J=OJ=MK^IV
M>HK +:YN(1%FZC!)&]2A4$$G! &,UKKK-C;64+ZAJ>GQR_9UGD83JJ%> 77)
M^YDC!]Q1<Z@?M&FFVO-/$%RY+>;)\TJ;"1Y6#@G.#W&W- &3=>"XVUA=2TW5
M]1TR5H$M[E;=E87$:?=W;U;# $C<.>:V-4T:UU;P_=:+-O2UN;=K9MC?,JE=
MO!.>?K6:GBJQU72I[G1=3T[=#<B R74O[OB3:W0YY ;;ZG':MB74[""[2TEO
MK:.Y<@)"\JAVSTPN<G.#0!DVWA<V^L6NJ-JMW-=6]BUD&D6/#*S*Q8@*.<JO
M3C K,3X>06NGZ1#I^LZA9WFE(\5O>Q^67:)SED=2NUAD \C@@5O6?B/2K_5;
M_3K:]A>XL2!.H<?*<9(_#C/IG%6[;4["]BEEM+ZVGCB.)'BE5@AQGD@\<4 9
M:>%XX]9TS4_M]V\MA#+" Y4^;YI5G9SC.25!XP!V&.*K0>#8[36[J\M-6U""
MRNYS<W&FJR>3)*>2V2NY02,D @'OQQ3].\3?VEXTO=(MY;.XLH;&*Y2:"3>V
MYG92K$''\.?QIVL^(I-(\3Z18SM:Q:?>0W$DT\S;3'Y04]2< ?-W]* (AX)L
MUCN[-;F?^RKNZ^V2V)"E/,W!R <9"%ADK]>@.*N?\(_Y>O:CK,5]<BXO+5;8
MQJ$PBIN*E<C[P+D\DBKPU?3"ELXU&T*W7_'N1.N)O]SGYOPJQ'<P2S2PQSQO
M+%@2(K@LF>F1VH IZ%:WMGHMM;:C=275T@(::3&]AN.W=@ %@N 2.X-8EGX$
MM[&UT:VCU2^:'2+DW%JKB/C*LH0X7D .WOSUX%='/J5C;7$=O/>V\4\A 2*2
M559B3@8!.3D\"F?VKIQB\W^T+7R_,\G?YRXW_P!W.?O>W6@#GKCP#:7%G>1'
M4;V.>;43JD-S&562VGQC*<8QCC!SP36]I.G2:=:F.>^N+ZX=MTEQ<;0SG&.B
M@*H '0#]234LVI6-M<QVT][;Q7$I CBDE56?/3 )R:P]*\4I-J^L6&J3V-JU
MKJ"V=J#)M,V8D<#YCRWSXP* )E\+BRU:\U#2=1GL#?/YMU;JB/%))C!D"L,J
MQ &2#@XY!I]]X7@O)M/NUN[B/4;"5I8;SY68EQM=6&,%6&!@ 8P,8Q6XS!$+
M,P4 9))X%95CJ\*:7:2ZGJ6F?:)8V<O;S 1/MR6*;CD@ $GTP: ,^X\%VL\$
M2_;+F.8:DNIRSJ$W33+C&[(QM  &!C@#GO6>;"^N?B9JDT,MY:02:5!;BX6V
M)1F#REMK,,;@&4CMST/;K%U*P>P6_6]MFLF&1<"53&1G&=V<=:Q?#GB;^U_[
M=DN9;-;;3[XV\<\,GR-'Y:/N+$XS\Y'IQ0 1^#;*QNM/NM(FEL)K*S^PJ4 =
M9(,Y"N&')!Y!ZY)SG-+#X-L[6ZT6:VN;B(:4TSQI\I$S2Y\QG)&2223QCDUK
MIJ^F2V\=Q'J-H\,LGE1R+.I5WSC:#G!.>,5"/$.B- DPUC3S$\ODJXN4VM)_
M<!SRWMUH P[OP%!=3WCKJ^H0Q7.H1:D(D\LB.="AW LA)'R#@DCVJQ<^"[>Y
M7Q!&-1O(X-<3;<1+L(4F-8V925SDJHZDCKQ6Q=:UI5DTBW>IV=NT94.)9U3:
M6SMSD\9P<>N#3+F_,&K11M>6$=J+:265)7Q-P5PPYQL W9)]J ,\>%4@U*'4
M;/4+BVO%M%LII%5&$\:\J64C&X$G!'J<@CBDM_!]G97NCW%G<3PKI-O+;P1#
M:582;=[,2,EB5!SD<Y]:MZ;XFT?5='&K6]_;BR+$>:\BJ!R0,Y/&>HSZBKCZ
MIIT=BE\]_:K9N,K<&91&P]FS@T 5?#VAQ^'=)73H;B:>-99)0TP7=EW+D< #
MJQK5ID,T5Q"DT$B2Q. R.C!E8'H01U%/H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KF_&5J;FTT_
MRKN]LKF*[$EO>6L!F$#^6XS(F#E""5.<?>'(KI** /-;&._N]=\'SZMI!1X%
MU$SM#:/Y(9F&R3!!V;]I8 \C-5=$^T:?IWA^"32+^$)J&H@7*V,C/:*TKE J
M;> ZL,,05 'OQZI4<]Q#:P//<31PPH,O)(P55'J2>E 'EFB6UY%X?\!V\NG:
MA')9:M*;A7M7!B79.H9L# 7+J,].>*ZSP='+'J?BHRV]Q$)M8:6(RPL@D3R8
MEW*2!D95AQZ5U$4L<\*30NLD4BAD=#D,#R"#W%/H XS48,?$Q+EK*=[<Z%/#
M)*ML[(6,L;!"P&"<*W%<WX=TV>SM/AR$TRYM[BV@G2Z8V;KY3- 5_>';QE\=
M>M>GPWUI<12RPW4,D<+M'*Z2 A&7A@3V([@]*2RU&RU&-Y+&\M[E$<H[0R!P
MK#J#CH?:@#RRQ:Z.@>#].N]*U$:KIFLHU_FRD8 XEWR[PNU@Q;=D$]:OZ-:I
M/>QZ1KFEZQ)JECJTEY%*%<6SYE9EF$@^7&UL%2<DY&*]-HH \C.E9\,F,Z-<
MESXM^T%/L#[O(^U;M^-N=OED\],'%/\ $VGS30^/H8-*NY%N39&V6.RD(E95
M4,4PO)&.2/2O4KR]M=/MGN;VYAMH$^]+,X11]2>*GH \]OK-5\4>)#;Z;.+.
M?P]%$FRS?9)(K3?*,+@L R<=>:BM8KB.+X:A[*]!M(<7/^BR?N#]D:/Y_E^7
MYCCFO1Z* .$O=(NK;QO+I]K$ITG7U%U> '_5/"5$G'<2J8T/XGO73>)BX\+:
MMY=@=0<VDH%F"09_E/R<<\]..?2G:;H=OIEW=72W%Y<3W#EB]U<-+Y:DD[$S
M]U<GH/;T%:= 'D=S%<74GB)Q8:E/%>^%UAA+:;)&IE7SOW:KMR,%E #9;GJ1
MS6UI6GHGBOP_C3)H[5O#LMM<$VC*F\M$0CDK@'A^#[^M>A5!>VHOK&>U:::$
M31E#)!(4D3(QE6'(/H: ..\&Z;>VM_-I5XNZR\/2-;V$I;/F+(H9,^C1Q,$]
M]QK3\96QN;73O*N[VRNHKOS+>\MH#,('\MQF1,'*$%E.<?>'(K2MHM.\.:?%
M!)=B-&D"^==SY>:1CW9CEF)_H!5V.[MIKF:VCN(GG@V^;$K@M'N&5W#J,@<9
MZT >=VLVI6^J>$M6U72Y8O+34+><V5K(Z[W=2C[ "R"0(6YZ9P<5GZ/)J&BV
M/AK4;K2=1-C9WFI)=PI:NTD+2RL8I0@&6&TD97. YKUJB@#SV>QMCK_@\VFA
MW%OI\=S>3M&UJY$>]&P[C!V%G.0#@C(Z=!K^ (9+;2-2ADMIK=1JUX\22PM'
M^[:9F4J"!\I!R,5U,DB11M)(ZHBC+,QP /<T[J,T >:>(;*674?B (].NI!=
MZ'%% 4M'833!9QA2%PS NG3U]JCN-.OCJ<"Z/97%M<2>$[BUCE%L\:I<$QE%
M9L *V0QYZ<UZ?10!Y?93-?:EX(^R:5J%I+8VEQ;3^;82(+5S"J@%BN,;AU!(
MZ4>%[>VN;72;?5=&UE=9T6W>*8SQR>2A\LH[*V-LH? P!DG.>V:]0HH \GT'
M23%8?#5)](N%>T$HNP]D_P"Z)@8#?\O'S[>O< ]J8=.>2TCADTF[:-?&+7 1
MK&0@0%B2^-OW#GKTKUND9@JEF("@9))X H \IUS3YY-"^(%M#I=VWVB_AEM8
MTLY#YA\N$,R +S\RMDCTK3URTU*Y\0^*HK"WNEFU30(HK*<1,$,B^?D%\81O
MG7J0>17?6MW;7ULMQ:7$5Q ^0LD3AU.#@X(XZ@C\*FH \LFM1XBT/4+O2-'U
MBWUM=*>T9;Y7A"C()@7=A7S@@$9 ]1FNC\*G3]3U=]9MM-UBWNS:"VGDU&.2
M+: VX1A6P&(.[YAD#IGFNPHH Y+Q% S^._"=PMI-(D+70FE2!G6-6B( 9@,
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MB5A_Q]VSG8)3WV@?9V]MCFO48[NVFN9K:*XB>>#;YT2N"T>X97<.HR.F:FH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5R&!G^5'D.X'Y,*_&0>5]ZG?P9I[OJ$8GN5L=1G^T75B"OE22<%CRNX!L#<
M0#^)RDW@RRDUZYU2&^U"V%YM-[:02A8;DJ, L""0<  [2,@<T 49O$NO7=Q=
M2:)I:7=O9ZA]DDB8*&D52!(P<R#:1DD J<A>O/ GB77M0N!<:1I:7-C'J3V<
MR,%5O+20QO(',@Y!4G;LY'>KI\%62Z[<ZE!?ZC;QWCB6[L89@+>=P -S+C()
M &<$9QSGFB'P79VVMW.H6]_J,,%U/]IGT])A]GDEZERN-PR1D@$ ]P: .7\2
MZO=^(O"D&J0FV33?[=MX8XVC)E*QWBQ[]V[ )92<;>AZYK0UGQ3J6E?\)M-;
MVVG^;H]O!/"[1MF4,C-B0AN<8P,8J_-\/;!X[FVBU+4K>QGO%OOL<3Q^7',)
M!)N7*%@"PSMSCD\59O\ P59:C_;HFOK[;K420W05HQA4!4;?DXX)]>M %5?$
MFKV>N:C8WUO;70CTK^TK=+1&5^&93$22=Q.!A@%Z]*CT7Q/JFIZUI%MFPFM+
M[2_[0EDAC;,)RHV9W$<[N"?[C<>ES5O#\T+7NLV$MY=ZH-,:RA@,J1JXY(Y"
M@AMW.<C\*R?"FEW]E>VOV2Z\0)9IQ<P:K!;JA7:0 "BABV=O()& <GU -/5[
MQ[GX@:%HI/\ HRV\^H2KV=D*)&#[ N6^H4]JJWWBW43IGB/5=-BM6MM"GDBD
M@E5M\_E(K2X8, G4@<'[N>_&QJ^DO)KFEZY;)ON+'S(I(QP9(9 -P'N&5&'T
M([U#/X.L)Y]39+BZAMM5P;ZTC91'.=NUCRI92R@!MI&?KS0!0M/$.MZOXIGL
M=._L]+"*WL[S?/&YD:*4ON7AL!L)P>@[@YXN>(]9U6PUS0M-TU+,_P!IR31,
M]RK'RRD3."-I&>G3OTR,Y%^TT"WL_$%WK$4\_FW,$<#PG9Y82/=MP N1C<W?
MO6/XJLKN\\5^%9+<7:1VUQ.\UQ!%N\H-"RKG((P6('3H>W6@"G8>+-9FM;BV
MO8]/@U"RU4V%U,H<QLGE^8KQ1YW,S J-@)(R3SBJ]OXSUR]LM#^S0V"7%_J5
MUITK2Q2!5,0EPX7=D?ZH$J3WQD=:WIO!5C)]FECO+V"]@O7OOMD3)YCRLI1M
MP*E2"AVXV\ #&*AM? =A9R6;0ZAJ.+2_EOX5:1& DDW;@<IDCYW[YYZ\# !7
M\/7>O3>.-9M-3O;61+6RLRT4$#*@=Q*6*$L<<CJ0<C XQ4][=ZG_ ,+-TZPB
MNXEL'TN>=X&A)W$2Q*3G<.<-P<<<\'/&M'H-O#XDGUR*XN4FN(4AFA##RI-F
M[:Q&,Y&]N^/;(%)?:!!>Z[9ZP+FZM[JUB>$>2RA9$<JQ5@0>,HIXQT[CB@#A
M?!NKZGI&A>%XMMFVF7^HW-D8PC>:K%YW#ALXQE,;=OOGM6[8^)=?U:2POM.T
MM)M*N+IX9,A5:*(,RB7>9.<%02NS/.!TR;EMX'LK6QTFS2_OS%I=XUY!N:/)
MD;?G=\G(_>/Z=?84[3_!5GIFI37-KJ&HI:23-<#3O.!MTE)W%E7&1\WS;<[<
M\XH Q+/QAKW]B2ZQ>1:<;<7DFG1PPHX=IOM0@1LEL!>I(]NO.!;N?%&O:0+A
M=3TV)5FNK:UTZXP$61YFV$.@D<C8><Y^8<<&M)/!6F?\(U>Z!/+=7-E=RR3.
M974.CN_F$J548(<[AZ&F?\(39SZ-/IVHZCJ6HF781=74P,T10[D*%5 !!YSC
M)/7- %>;7=5BUC5= G>V%TFG?;[2[BA8*4W%65D+YW C@AN<]..>9_>:7\&-
M(\2[;=]3TW3[6XMYTAVN(\(6C+$DD,"P/0'/0&N[3P[$&NYIKVZGO;JW%J]V
MXC#K&,D*H"A1RS'IR3[#&;>^%%?PI9>$H))Y-.4112S3E=RV\94[. ,E@H7I
MP"2>P(!J^)+S4K+PU>W^D10RWD$)FCBF0L)-HR5P"#DCI[USJ^.7;7'@62VE
ML9])%]8R)"VZ23 )B)W8+8>-@HYP_P"?<5S=MX&T.TMM+MXH&":9=M=V^6Y#
MD,,$]U&X8'^POI0!D^)O%>L^';*\GD&GO)96D,[11QNYF8L1)T;]THQA6;.3
MGTQ5R_\ %<UGXM71II+>Q\R6$6INH'VWB-CS-DH8*'&2 I&<@=<\3:QX%L-:
MN-5DFOM0ACU6!(;N&"10C[ 0K<J2",]C@]P:LW/A2WO2R7=_>W%N\T-PT$I0
MJ9(MNT@[=PR44D @=>F30!:U_4+G3K."2V-LIDN$B=YR2$4]2J@@NW0!1R2?
MPKF+7QIJ4MG82M#;;GU]](GS"Z;D#, ZJ6RAPHX.:Z?7=!AUV.S$ES<VLUG<
MK=03VS*&1P"O1E92"&(P0>M91\!V L9[:/4-11I-1&I1S>:K/#/G.5RI!!).
M0P/7Z4 8GB'Q+K3Z/XACMY[>VDT[5[6R65(F)>*0PDY^;@_O2,CL.V<AFH7&
MKZ;XR\4WFGO8_:K;1+6>1IH6*2%#<' 4,",XZECCT-;[^!+"6RU:VEOM0?\
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M%XR2A0A0HQEOX>=QSFK^D>'(])U2^U(ZA>W=U?+&L[7!3!V#"D!%4 X)Z<4
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M$!"X#1G& 3^=0IX$T>#3;:TM3<P36UV;Z.\63=/Y[9W.S,"&+ D$$$$<8X%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRE9=N%(^7)!.=O3G@ M6WCZTN7M2=+U&*WN-0?3?M$BQ[8YU9DVD!R2"5(R
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]R: .TN]<BL_$6G:,]O,9+^.5XYAMV#RP"P/.<_,.V/>M&6XB@,8ED5#*X1
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M&0?FVYYQ5'3Q9V>@^$)9]0OI+O5X(9)$N;]A!,4MB3YA;.T#=G:H^9@N>F0
M>F2W$4#1++(J-*^R,$_>;!.![X!/X5%;7,L]S=126<L*0N%CE<J5F!4'<N"3
M@$D<XZ5Y+I]S;ZCIO@6XU&_\XPZO>V[SM<L-JA;@("V[(X5,$G.,<UH:GJ][
MIC>+3%=W/V6+7+**:4S,QMK9TA,I4DY4?,W3IDD8Q0!ZG17F/BAKK3IO%MMI
MUW<QZ<OAUKW]W<./L]R"X0HP.5W*N2 <';GN<Z>AJUEX]L[>.[NI(KS0?M,R
M37#R!I%D0!P&)"G#$<8'Y4 =M)<Q12I"6!F=69(P1N<+C./S'YBJ'A[6X?$6
MC1:G!!+!'(\B>7-C<I21D.<$CJI[USFKPVB_%K09KA_+9],N0A,Q4,PE@VJ.
M<'J>.]<QH*&RT?PCJ-O=7"33^(+FUD43MY;1-)<Y79G;U4'.,Y'6@#UZBO,M
M%OO[:O;:YN/$:6>LVNK21W%DH;SG42,ODE#)@H4VD$+P!NZ@FM[QKJIT_4-!
MM[F[CL]-NYY([B>8'R]^PF-'(9< G/?&0* .OHKS:\T^Z3PQ;C1?$$^I:K;Z
M@TFFE96$<P#;F@;YSOC4;AN)., 9R,&*]O;:]\*^$[BPU/4(EN=8AANF-TZ2
M[VWB2-^>"&&-O\.!MQQ0!Z=17DUY>7GAB?7[2'4+D:!#J=BC7%Q+)-]E609F
M7>6W;0?+S\W <U-JL8M=,9[#Q-)=03:W8;!9S,L=N'E17C5M[9!'S;2<#.<<
MB@#U.BO-6CN[>[\7:1IVJ& 0W=BUJ+ZXDD3?(%+1EB2P60C:<'^(U5/B)XS8
M6E^CZ+;OJD]K?K=3--!',(5:-!(&7]VV<@9 SQC Q0!ZI17FKV^HV]A91:3J
MT/B%(I;J06<L[0_:(LI\L4NYLF(MM!8G[Q&05R-?4]1>Z^#=WJ&EFZ#/HCR0
M&<YF \HX)/=N^>YH WTUG[3917EC9SW<$LRQH\94;D+8,HR1E!USU(&0",$Z
ME<'KSBU\'^$FLYY88QJ&F1KY4K(&C,B J0#A@1V/%<_XC,T5K\0+U-1OUFTN
MY@EL\7D@6%O)B8X&[!!)/!R.3@#)H ]<K+M-<BN_$6HZ,+>:.:QBAF:1]NUU
MDWXVX)/\!ZXKD+[4++4/$7B;2]:UF;3)K7R&L'CN/*=8BBMYD0Z,QDWJ>#T"
MU6U]I!JWQ D@>6.>/P[;R1M&Y5U=5N2"".00<4 >F5EWNN16.OZ9I#V\S2:@
M)3',NW8OEKN(/.<XQVQ[UPMUXAFAUR.?3+W[5<#PG/<) LY=99U,10[<X+8S
M[X)J.RFTRX\1?#Z^M]0-Q+=VUP99&N2QE<PC)()X;=D=L=.P  /2;&YENH7>
M:SEM665T"2E26"L0&^4D8(&1WYJS7DT,UQ+H6BJ=2O@6\6SVC.+N3<\7FS (
M3G)X5<9Y&.,5--=W.F:'XJMK;49([>QUV".,3W1W>2X@9XED<Y7<7< D@#=U
M'4 'J=%<EX2A,FLZW?Q7;/8321K9VPO?-6%=@WG:K,BY?) Z]>F<5S'C#64B
MO=8N+34I([FQU&PC)EN=ABRT6Y(D&,HRN2Q;KDC! R #TUKRV1YU:>,&!!)+
MEON*<X)].A_*I8W66-9$.48!E/J#7DFN6UA(/BCB3,K62S1J+AOG'V7=N SR
M,CZ=NE;FGSV][XHL-$EG=M*;1!/:A;AMLLV_$OS Y+*-N!GY=Q(H ]!HKR73
MS?ZN?!MKJFHW[1W,FHV[/'=/&;J! XB=MI&25 .[J<YSS3->MWM;3X@/%J6I
M!M(BMY;(F_E/DN(%;/WN<GL<CD\<F@#UVBO--9OTU/Q#K>E:CX@BT9XH();&
M5V9&"%,F6,B102'W \'H!TXJSJDM_H'B%726ZN8_$-HMK"9"^V"] X.S.(U9
M26('3RS0!Z%6;!K,<WB"ZT<V=W%)!$LJSR1@13*<9V-GG!(!R!^-<5XB:YT*
M\:96EU'2+."WBN$2[=;RS(8XE7)Q('R-PZG;CD<5Z(L,:RO*L:B1P S@<L!T
M!/MD_G0!2U/5XM-DM+?RVFN[R1HK>%2 78(SGD\  *>?IZU-IMX^H:=#=26E
MQ9O(,M!<* \9SC!P2.W8UR?BRSM[CQWX-\TOEYKE<+,RY @<\8([]ZR+&^_M
MC4I6N?$::?K%CK4D;6H#>:\8E(2+9YF&C>/;R%QU;J": /3:9,[10NZ1-*RC
M(12,M[#.!FO--#O?[:O+6ZG\1I9ZS:ZK)'<6*AO.<"1E\DH9,%-N""%X W=<
MFKWA:[O+?Q):VNH@W7VNVGDL]3MKAFBNTWHQ\V,_<D4%0#R.2!CI0!W%E>V^
MHV45W:R>9#*,JV,>Q!!Y!!R"#R",4EM<RSSW4<EG+ L,@1)'*D3#:#N7!)QD
MD<XZ5S/@)I-_BB,Y\B/7KD0^@!",V/\ @9?\<UR^M7-S'HOCCR]1O4:VUNU6
M%Q=/NC5A;Y4'/W?G;Y>G/2@#U>BO+=:OKOPW=>-(]/N;PPP6=C<D-.\SQ!Y)
M%F=2Q)!V+GZC-3^*)--B\)>(=0T#7+F;-K#-MM[PO';D-]]6!RI9<YYYVY(H
M ]+HKS37]4237_%L5IJDFQ?#0N(Q!=L DH,WS+M;@X"9QVQFH[O3$M[#P9+'
MJ6IAM4OH%NV_M"7]Z#:N2,;L#)4=,8[8H ]/K-\0:S'X>T"]U>:WFGBM(FE=
M(=NXJ!DXW$"N OC =6UGPY=>(SH_V"&W_LZ6XFD,HB\L'S48R#>V_>#D$\ '
MCBJ/B*^35O"WQ CU>[==0L$,=O"TAB*P^2A1@F?XV+Y]?N] !0!ZR\["S:>.
M)Y6\O>L:D;F.,@#/&3TYI;65[BTAFD@>"22-7:&0@M&2,E3@D9'3@UE:K(LG
M@N\EAG91]@=TEAE*D80D$,IR/PKC--C;5-5\&VUU>WK07?AMI)XTNY$$K 08
M)PPY^9N1R>_% 'IM%<O\.[J>\\!Z9+<3R3R@21F61MS,%D91DGJ< <UU% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %0W-I;7D8CNK>*= <A94# 'UP:FJAJFHOIT=OY=I-<R3S"%
M%0?*A()W.W\*@ Y/T]: 'MI.FL92VGVA,O\ K,PK\_UXYHFTG3;CR?.T^TD\
M@8AWPJ?+'HN1Q^%<X/']L^G6%U%IMW.UWJ$FFB.%HVVS)OR,E@"#L.#T]<5'
M_P +#@BM+EKK1[^&]M+^&QN;3*,T;2E1&^0V&4[AC&3[=Z .HGTK3KF"&">P
MM9882#%')"K*A'3:"./PITFGV4LYGDL[=YF789&B4L5Z8SC./:N<A\=VL<FI
MV^J6%SIMY8&$M!,Z-YJRMMC*LK;>6X/. >II\'C2*=K^!-/N);JTDAC"6Q$R
M2B4[597'&T'.[/W<$^F0#=&D::HC TZT B.8P(5^0^W'%(-'TL(J#3;/8K;U
M7R%P&]1QU]ZYZ7Q];0Z5=WC6%Q*UGJ2:;.D#HX$C% &!R-R_O%[9SQBGC6A-
MXET>*_T34+3498+MH%:X0H%0J&!"OM8D;",CC/7K0!T(TVP"SJ+*VQ<?ZX>4
MO[S_ 'N.?QHFTRPN&MVFL;:1K;F O$I,7^[D?+^%<UIGCV/43H\C:1>6]IJL
M\EM#/*R$+*N\[2H8GD1MSTS^=27'CFWA5)XM/N;FUDU(Z6CQ,@9IPQ7[K$ +
MN!7.>O;'- '13Z?97-S#<W%G;RSP',4LD2LT?^Z2,C\*DN+:"[A:&YACFB;[
MR2(&4_@:BU*]&FZ9<WK03SB")I#%;IOD? SA5[DURNK^.9;/1_$S06"_VEHM
MJMP\9F#1X=6*G<.<C:V5QV]\T =3_96G>7$GV"UV0DM&ODKA">21QQ^%-;2-
M,:.2-M.M"DK!Y%,"X=AT)&.34MA--/80RW$7E2N@+)N!Q^(K.\0^(4\/163R
M65S=?:[I+5!!MR'?IG)'I_CCK0!>?2]/E5EDL+5U9_,8-"I!?IN/'7WJ2.RM
M(;A[B*UA2=QAI%C 9A[GJ:YRS\:_:1J-O+HU]#J=A/##+985V_?$"-]RDC9U
M)/;:?2HG\?6T=C+/_9]Q*\.JII4J0.C@2L4PP)(RIWKVSG@@4 =-/IMC<RM+
M/96\LC1F)GDB5B4/522.GM2-IE@TC2-8VQD=/+9C$N67&-I..F.U<W:>*-7N
M?%UOI4VAR6D;:?)=21R3QM(")0@^Z2,8R>O.[MBC0/$=@VAZ:NG6=TLM_<72
M6]K<3[G!CD?S&=R6PH(/0G&X 4 =+#IUC;VSV\-G;Q02??B2)55N,<@#!XIU
MK9VMC#Y-I;0V\6<[(4"+GZ"N9NM?M[EO#[W^D:G;S7&I-;Q([>7Y4RK(,L P
MWH0K$<$$8/%5I_B-%;0W%Y+H>H)IUG?M8WEV6CQ P8+N*AB2N2,D9P#]0 #K
M)-,L)99)9+&V>25=LCM$I+CT)QR*;_9.G?N_^)?:_NT,:?N5^53U4<< ]Q6/
M>^+HK#48K>>QG2"34(].29R%+R. 0RJ?O1Y8 L#USQ@9K'NO%,MQH_C-]5TN
M9M/TN62!EM;@+(T8AC8\Y4@_.3D'CH,XH [@6\"PQPB&,11XV(%&U<=,#MCM
M4=Y866HQK'>VD%S&K;E6:,. ?4 CK7/7?BUK/47TNTT6\NYXM/6^7$J!6C)(
MQN9LYX/7DG\ZG@\76U^NDKIUN\\^IV)OX8W8)MB 7[QYP<NHQZYZ 9H Z(
M8 P*IKI.FH8BNGVB^428\0J-A)R<<<<U6\.:]#XET.WU:WMKBW@GR46XV[B
M<9^5CCG(]>*Q+OQ+8Z1J7BN\_LZ_>?2[2">YQ,"LL>V0J44OA<!6ST)]#@4
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MX5O4<<&N7C\66.E6.K7L6EZB0FMBRG1I0[>:_EKO&7("?.N%7\ADUN:+K_\
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MYTZ'2=.NK_\ M&P:^MG1D1652H*G<V5(+C.1^= '2VUK;V<7E6MO%!'G.R)
MHS]!4U9N@:S!XAT*TU6WCDCCN4W".3&Y""00<>A!%:5 !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M87B;1[[5XK 65S!']FNEFE@N$+17"!6&U@#G@D,.V5%;M% 'EFK:5>>'/["@
MFOK&66X\5->0_*8AB19F(.2>[8XSCCK5CQGI;:9IMQJEQ/;IJ&IZUISD$GRX
MQ'+&J+DX+  %B>.IZ8KTED5L;E!QZBJ,M]Y+W\E_;"WL;1!(+N1U*R+M)<X'
M*[<=^O:@#G=6\&3:\VIWT]XEIJ5S%;I:R6_[Q;;R)#*C9(&\ESD\#C ]R^]T
M/Q1JVAF&_P!4T];P30OY5O"ZV\B(VYD?+%B'Z'M@8P><[ UU#XK&@_99 QL3
M>+.2-I4.J;0.N?F[XK7H X&;P/JSV>JVXO;#%[JEOJ*[8601F+RB5QD\'R@!
M]<^U=!J&C7EWXKT?6(W@$=A!<1M$S'+F4)T.. -@^N>U;U% '#V/@W4K32?#
MEDUS:,=(U%[UW&X>:&\WY0,<?ZT\\_=]^.:L+]I-4N;JRN/#]W*=2FNH]+F>
M:*[$FXJ/W(8J)-O\6SON/<UZ[2;1NW8&?6@#-\0Z==:MX>OM/LKUK*YN(BD=
MPN<H3],'VXYYKEI/ NH747B".:[T^WBU?2DL?+M;=E6!U$@!&6Y7]Y]3[5WE
M% &!:'Q!;ZOI]M.]E+9?93]I\J%U*R \%6)(QT&.O4\#BLOXC3^3:^'MLL*2
MG7+4IYS84D$]?:NSIK*K#YE#8Z9% '':EX0U"_;4K^.\MX-0OI[5GB(9H6A@
M)(A8\%@VY\G Z@8P.:C^"-7VWBB]T\K/K-OJJA870*8A'E.IX/E@#TSGVK?T
MSQ'-J]@]S::5,6BU%[&6)I4!C"2;'D)S@@8)P,D]JWZ ,"YT2];QE:Z[;7$"
MHMDUI-#(A)(+AP5(/'(QR*P(/ ^L6.F:0]CJ%I'JVE75U-$TB,T,T<[LSHXX
M(^\,$?W1Z\=]378JC,JER!D*,9/MS0!S6H:#JNHG0IKB\MGN+"_%].0K(C?(
MZ;$'.!A^I)Z>_',Z%IDGB?2_%.D^?:G3KC7KCSW5R9 @D5BH'3YL8W9XST.*
M[CPYK:>(] M=5C@>!+C=B)R"RX8KSCCM6HJ*GW5 SZ"@#A;_ ,%ZS=W]Q,NI
M63 ZM!J,,DT#-(J1LI$)(8?(-IQCU[<FI[WP?J,]AXML8KVU^SZZ6="\;!HG
M>)(VR<X( 3('?/48Y[2B@#EAX>U$>('U/S+7#:0NG^7N;[P8MOSCIDXQ^M<C
MJ-L_AX^&-&FU;2+.ZTO3&C%Q?M+!'-G:@V2JRG.$)*9(Y4\\$>K,2%)"EB!T
M'4UE>'=:C\2:)%J2VSP*\LL?E2$,5,<C(<XXZKF@"'PD\A\/PQ/;6<$<!\J'
M[$6\F2,8PR;@#CM[XR"00:R=6\):AJ$_BMH[BV1-<L([--V[,6U77<>.<^83
MCV]ZZR"Z@N6F6&59#!)Y4FT_=; ./K@B@W4"WB6AE7[0\;2K'GDJI )^F6'Y
MT 8-IH-]%XJL]7EDM_*@TLV#1J6))+JVX''3Y<8]^M2Z[H-Q?:OI&LV$T:7V
MF/(%2;/ES1R*%="1R#PI!P<$=#FM^B@#BKOP9=S W$4]N+V?68=5N2V[9^ZV
MA8UXS]U0-Q[Y..<#M>HYHJ&2Z@AN(;>255FG+"-">6P,G'T% '"6W@;6K32M
M-T6'4K$Z=I>I1W=K))"YE,:N6$; $#(SC(ZCL*U-*\.Z]HVI7-M:ZK:G0I[M
M[L1O QN(B[EWC5L[=I8GDC(!/L:ZQR51F"EB!D*,9/MS67X<UM/$6@VVJQP/
M L^_$3D%EVN5YQQ_#0!A7'@VZU"/Q3!=7<<4>M2QS1209+V[HB*AY&&YC5NW
MI[TW4?#OBC7?"E]I>K:GIIN9XUB1K>%TC #!B[ DDL=H&!@#)ZUJV?B2;4;7
M6'L]*GDN--O39_9S*BM*0J,6!)V@8?/)[5OT <7KO@JX\17^KR75Q%!!J.EQ
MV(\HEGB=':0/R "-S=..GO4]EH7B$^)+'6]2N]->6VL);-XX(W E+,C;LD_+
MR@XP<>_;7T'7%UU+]EM9+<V=[)9LLC DLF,GCC'-:U '#Z3X,U+38/"D37-K
M)_8<D[.1N'G"1'7CCC&_/?.*QM=T^70+*WMKR_TRV>\UV?4H[FZ$BP19W,$,
M@*E&RP ((W8(Z9%>HTA 88(!![&@#F/!,TS6=U&R:9) )/-2[TV1Y(IV<DN2
MSY+,#C)R>H'8BJ7BCP?JFO76K^5J%J+:_P!-^QQK<0L[6S?-DQX( #;AD]?E
M'7%=KTHH Y$^&=4;5;^^DN+-FNM(CT["AE 92YW]^/WAX]NO-9&I:7:3Z3X?
M\'_VB%\0Z:MOL>U!W)"%\N1\D<*T8<?4J/2NQU761I]U:64$'VB_O!(8(2^P
M,$7<Q+8..H'3JP[9(MV%Q)>6,%S-:2VDLL89X)<;XS_=."1Q]: )XXTAB2*-
M0D:*%55&  .@%<HWA*:?Q5:ZW+]DANK:XD<W=MN66X@8,%AD&,$#*_,2?N#
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M'X G\*?-+'!"\TSK'%&I9W8X"@<DDT <GJ7AWQ#J-K87_P#:MG%KUC<&>$I
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MRR:7<)(6^S21R!0T>T'< -B$'.<@^N!TFG17D5FHO[A)[ILM(T:%$!/9022
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M-6$D<A0CYU[@]/;I74?9H-Y?R8]Q8.3L&2PZ'ZUE^*M#D\2>'+O2([M;7[2
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M45M_J)6!!4J6.]=I(/(SFNFTFTO[6U/]I7XO;MSEY$B\I!Z!4R<#ZDDD_0
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M+<[(HD).%4ODDEF))/IQQ6G#H5PGB]M>EO8GWV"6;0+ 5^ZY?=NW'NQXQ^-
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M=+QXE)_?P*?WD9'<;<D9[BMW0]/U>SC9M9UA-1GP$5HK80( .Y7<<L>YSCT
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M1]Q")[*SNP]VK.@\"ZA&_F2:U;ECHYTHK'8;$VY.U@/,.#SR,\GTZ4 6-/\
M&[S7.GC4=,%C:W^F/J,$PN?,(5 A=74*,8#@@@G([ \5:B\57 MHM1O-)>#2
M);%[[[6LP<Q(JAMLBX&UBIR,%N01[U6C\%.7T,7-_%-!IFFRZ<\8MROGI(J*
M3G>=O$8]>IHTGP??6VC/H>JZXVH:2ML]I#$+<12>4RE )'#'>0IP, >IR<8
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M21O&7^93GKD$8%:A\-7\NKZ+J=QJZS3Z>9FDW6V!*9%"G: _R* !@<^Y)R:
M,B;QIJEY9:!-96$$$EYJTFGW<,MP3L>/S-RJP3D$Q'YL=.W/':7U[!ING7-]
M=OY<%M$TTK==JJ"2?R%<I'X'NHM/M(8]7B%Q:ZQ)JL<IM"5S(9"R%=_(_>M@
MY[#K74W]A!J>EW.G78+V]S"T$HZ%E8$']#0!AP^+)1>Z/#>Z<+>+6$)LY!/O
MPX3>$D&T;25ST+#((],Y/A*S;7-2U/4]6LX&N['6+A;>XCG8O'MPGE_=7*!>
MQ.">2N:U=/\ "EQ#_8J:CJ*7D>C _9"(-C,VPQJTAW$$A21P!DG/M5SPYH4^
MA+J*S7D=R+R]EO/E@,>PR')7[QR!0 :QXA_LZ_AT^WMUN+V6%YPCLRJJ*0.2
MJ.<DL,<=CSZXTOCV:VLM'OKO0KJVM-2#1YF++)#< ';$R;<_.PPI[Y'J,Z.O
M^'+V_P!7LM8T?51IVHVT;P,TD'G1S1,02K+N4\%00013=2\*/K5B;'5;\7=L
M;=T >(AA.Q_UV0W\.?E  V^M ":EXEU+3[_1].&B+-?:E%*P078"1.B@E2Q7
MD<CD#UP#5.Q\?)>6<:OISV^JF\FLI;-Y"PBDB&YSO522N"N"%YW#CJ1GZC;Z
ME9>*_!-I/JL%U?01W:R74EN5$F8U +*'X+8/.>2.G:K]SX%E\F&ZT_5C::W%
M?2W_ -L\@.CO(-KH8R?N%0JXSD;0<YH (_'%Y(=*B_X1Z>.YO[R>S,<TIC"/
M&C.&4LH+(P7(; X/0D8I5\?11Z7'<W]K#93_ -IR:9,)KG]Q%*@8Y,NW[IV@
M E1RP'%7)?#6H7-[HE[=:PDMSIUR]S(3;865FC:/:H#_ "*%8XZ\\G/-16WA
M*\M;>]A_M"TGBO-0FO)X9[+='(D@(,9&_L<$'VZ4 27/BN>$PVJ:<C:E);O<
M-!YS%%0-M7#K&Q.X\CY<8!Z<9JKX\$OV*&/33;W]W9?:X[/4)3;2.VXJ8D!4
M[G!7IQP5/0\5X/ %UI":9+H&M_8KRRBEMW,MMYT4L+R&39LW @*3\OS9 XYJ
M]KO@^;7M.DT^]OX;BVEMQ&3<6N^2.;+$S1L&&UOF&!C VCMP0 U'P3;:A_;7
M[^XB_M-X9/DN91Y4B9_>KAN&Y'RC"_(N:D>_?2O'UOI:Y-KJMG+<1QYX2>)E
MW8] RN"?=<]2<]+&GEQ(FYFV@#+')/UKG)]-EU+QI'JX)C@TRREM[=RF=TTI
M7>0.X4(H]RQ':@#;TV>[N=.@FO[,6=TZYEMQ*)?+/IN  /UJU69X?74UT2W7
M6)UGOAN#RK$(MXW':Q0$[25VY&>#6G0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1THKBOB2EJ;'0
M7O"JPKK5J'<MMVJ6.[D=!CK0!V@92,@C'KF@NH7<6  [YKQC7M+L+'1_&(TU
M8H]">>P:U2$XB6XWCSC%C@?+MSM[Y]#73W-GI.C>-=/MY[6T@\-W-C,\.]1]
MG-VSJ6+9^7<R="?]H#J: /0:K7TMW# C6=M'/(945EDE\L!"P#-G!R0,G'?&
M*\R&DW5MX(@UL0--)H.J37FG*ZY=[!9&&S)YP8B2OT2M#Q7:6\'A>SO[B&.&
M[O-:L[M]RA67,Z<'W6, 'Z$T ==XJUQO#?AF_P!72V6Y:TA:;R6E\O>!UP<'
M^5:P<%5)(!;H,UXYXLN[*XT7X@66MK$=8W,]@DRY=[81KY1A]0"')V]"3GK5
M_6Y](U#Q%JNF^([VZMH;R"!M*DB@#&2/8,B%BC$2"3)P,'E: /0/$VLMX>\-
MZAJR6ZW#6D#S^2TOE[PHR0#@]O:M.&3SH(Y<8WJ&QZ9%>.^(KFT?1?'FGZ^
M=7$!;3UNP#(]N(%\LQGN0X<MMZ$G->FZ7KVF75S%I,-VK7R6<=RT.T@^6< -
MDC!Y_F* $U+7)-/\1Z+I?V57CU)IE\[S<&,QQE_NXYSC'45L;AMW9&W&<UQ?
MB^*SNO&G@^VO!$\+377F1R'Y6!@8 ,.X)XP>#TKE=,N$M+32XFV?\(W:^([Z
M*Y0<Q11EI/L^X=!&&((SP/E/I0!Z^"" 0<@]Z*\OF\/2ZIIOBU-+CC>RAO(K
MW1  #&+A$5W$?;8SC:<<9+^]1V$,]_XA>4:7Y>F>,+9)V5HAF 18W[_^ND;
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MK@KJ3J!^_; V2+@#Y"NT =L$'GJ_X8K(O@.S+YV--</#G_GD9W*?AM(Q[8H
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M1U369$ M[VSU;3V<RJSS% \/[Q#_ ,LXL%AWR2W3.#6\4WMC=:#X]M-:6/\
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MXXF#F+<I^['YA5L=!QFG37=M:'Q5-I8)TI=<M)[O['$''V8PQ[W5<$,N[D@
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MM#U+Q;K&JZ=>Z8TD\$*K9VL@9X@H(=R,#&XE1Q_<7/)P)?&5OIT_C3PP=92
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MZ#9+)%;-I^G^,)44,@:."W,DF!Z*AROMTH ]AN+B&UMY+BXE2*&)2[R.<!5
MR23Z4V"YBN;2&ZC;]U,BNA/&01D?SK'\76R7G@36H$MQ*'TZ;RXO+SD^6=N%
M]<XQ[UQFD7&E'5]&2_2T'A^;0E6U:5%%N;G=^^!R-N\KM_)AZT >HT5S/@"&
M]M_!]K%>M*=LDPM_.SO^S^8WE9SS]S;U[8KIJ "BBB@ HHHH **** "BBB@
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MY4@C:!C R#G\!4$_C">TUZSL+FQBC2ZU!K%5\_,RC8S+*5 P%;8< D'!!]0
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ME-NUAW!."1UZU)H/BK4-9U.YTV728[6\L)'2^1K@D1#CRBIV#>'&2.F #GG
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M@TQ9[N&^)1D:5&98BN#\P ))/ XZY.*311S?L_A9$5U'AH, PSR+;(/U!&:
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MIM^FH6,$VY!*\*2/&K9*;E!P:;97DO\ 9D$VJ-:07#_*XBFW1[LGA6(&?RH
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M%R,<XP!@=NY/6K^G:UIVJV<=W9W<4D$C,J.&'S88KD>HR.*NK(C,RJZEE^\
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M8X ] 3GG-*;P1+-I.H6!U10+W5%U)G%MRK"19-H&[IE%_#-=9'/#,2(I4<@
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M/H\-\QO\+E4S&PB=Q_=5R"2> <'M6WHVCKH]JT9O+J]GD(:6ZNF#22$  9P
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MP<>NTR.6.92T<BNH)4E3D9!P10!5TRPTZPM2-,MK>""9O./D*%5V('S''4D
M<U=HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPR5)(^=L9Z>]27?@A+S3-?L7U&58]:N1<3,L:YC.$7"^V(UZY[T =6RAE*L
M01@@]Z\L\,:[J7AKPK8SC3K1]"_M:XM9624B:/S+R1%<+MV[0S 8SFO4D#!%
M#L&8#D@8R?I7-6G@R&VMTL9+V6?3(KUKZ.V=%!\PR&4!F'WE#G<!@'@9)'%
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M3WL+O<R20MG'!(##(!P1@C(SS6I573[-K&S6&2YENI>6DGFQND8]20  /H
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M&;J" L)<KB258R05ZD;O6M$W[0:E=K=7-A'9111LN9<2JQ+9W@\!3@;?7FN
MU>VLIO"6HWNCVVJ2C4-4LIW::WD5IG6:,NZQ;00 J\G:,X/ID[5KIUM?>/\
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MUIUE<W,FM64GD1/*T<4ZN[!#@X .3SQ]:I2^,H8/%-O#/?:?'HDVE27OVAF
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MWQ%9:U96J"^M)-2-I%/<6\4@+1EE!.5SD#)JTFOZ/))-&NJ69>!/,E'GK\B
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MGU."2W*^9"S32.GW@RD[7P001R:L2?#_ $R:TOH)+S4&>[O4O_/\X>9#<*%
MD0[>#A1UR/;'%:DGBOP]%'<O)KFG*EJX2<FY3]VQS@-SP>#^1]*DNO$6B61(
MNM7L82(?/P]PH_=Y #]>F2.?<4 93>![6:/6EN=5U*=]9MEMKN1VB!954J,
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M6PT5([/3IM/MWD>5;>9RSC<Q)+9)P223C/&?7(K8HHH **** "BBB@ HHHH
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M$<?\L%1EC_ C+_60U9\!D+\.O#A[#2[<_P#D-:U[S3XKS2Y=.W/#!+$83Y6
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MN(5=!*\+JQ#HRO@'"MW!!%9]]X,U:;2M>TZ&YLC#J.IK?Q,^\,GSQN5; /\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK-%.'9,!0/F7<A&[(//2M+QU?WNE^!=;O=/(6YALY75R^TQX0_,.#DCJ!^M
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M2W%U:QS'RVR&W(#GH,=3QSCU-;E !1110 4444 %%%% !1110 4444 %%%%
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M0K+;&1X-N[_5MN "L2"PQSC\NTJD][+;W-VUW!'!I\$*RB[:88;[V\%<?*%
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M1;RZ:[DM7MLS1NYW.L<FX *S9/*DC)QCK71S7MM!=6UK+*JSW)811]VVC)_
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M\%6NG6VD7']D7\U[82W3RPNP7REW8)6'  \L'.,<9S71E0000"#U%*    ,
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MC., YQUKU; ]*3:N[=@;L8SCF@#@? .FZ5<:EKNH(J2WEKK-W'%()2QC1MO
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M641[-RHH4$C)YP*S[WPS//X@O=5MM1$ O+!;*:%H-_W2Y5@=PQ_K#D=\#D4
M8'@SQ)/8Z+X3TR_L4AM+K1$E@NA/N;]U%&6WIM^4$-D$,>G(%:^E>+[C4]2T
MV-=&N18ZC"TL5TJ2$0X4,HER@5=P/!#$9X]#3+7P4\'_  C:2ZA'+#HMD]EL
M^S$>>C(J$D[_ )3A!Z]ZF\->&-2T!8;27Q!+>:7: I9V[6X1T7&%5Y ?G"@X
M' [9Z4 3>.+V#3_"%[<W>FQZC;)L\VVDDV!@74 YP>AP?PJCJWC#4;'4-=M+
M718KC^R;..]=WO/+$D;!R0!L.&_=G Z'N1WU_%&AMXC\/7.DK="V^T;<RF/?
M@!@W3(]/6L^[\*7%U?:]='4HE.KV"63*+8_N@H<;A\_/^L;CZ?B 1W?B(:U;
M7ECIEC'=;=-2ZN!<2^6%656*)PIRQ"L3T X]:R/#'B1]/\$^'-/L[0W=Z-$@
MN60[PH7:%491'.6(;MC@UHV_@F\T^\6YT[64A>:PBL;U7M-ZS"-2J2*-X*.
M2.K#VJ&V\!W^F0:-)I7B VU_IUBNGR3/:"2.X@7E0R;A@@\@@]SZT 6(/&.I
M7VH65C:: T=Q=Z8U^J7TY@,;*Z(8W&PD<MU .>..<B/2_'5SJ"^'[F31U@L=
M:9H8W-UNDCF".Q!4+@K^[8!MV>G K3C\.7,7B2VU@:GYCP6#V96:'<7+NKER
M0P'WE'  &,@8XQGV7@B>RTWP[9C58W&BW37"L;4CS<JZX/S\<2-^E $,'CN]
MD^SS3:+''9OK#:1+(+O<ZR"0QAE79\R[ASD@C/0U3USQ'/I=CXVN=+TRVMM1
ML98$EN&E)\[=&FU\;>JJR@#IQU]=$>![@:<EI_:T>5UHZOO^R'[WFF79C?TW
M'&?2I+_P2VHQ>)XY=2"KKAC;*0<P%$55ZM\WW 3T[T 2:KXMN[&2\MK72OME
M[96ZS3P0O(P);<0B,L9RQ"Y^8*.1[XAO_&\L<5R^G:-=7DEI%%+/;E)%ERZA
M_+"A&&\*0<,1R<?22X\*:L-;&KZ=XA^QW5Q D-^/L:R1S[2=K*I;Y&&X@<MQ
MC.>ZS>$;^#7I=2T?Q!-8I=Q1QWL4D"SF4HNU9%8D;7V\$X(.!D<4 =1#*)H(
MY0KJ'4,%==K#(Z$=C7#V?BZPTK29[DZ=;::DNN7%E,[SD0K*"VZ5WV\!F7'3
MJPKN401QJ@)(4  L<G\3WKE[/PI>65G<VZZE;2I<ZC/>SQS66Z.19=Q:)EW\
MC+ @Y[#@T =!IUS->6$4\\*0R/G*1R>8N,D AL#((P0<=ZQ4\5_:/$EUHMM#
M;M<6LR1R12W&R8HR!O-5-OS)\V,@]C]*O^'-#A\.:'!I<#[XHF=AQ@+N<MM4
M9.%&[ &3@ =:SM0\)MJNKVMY>74,BVEZMW;,+;$\0&/W8DW?<)ZC'0D>A !6
MA\;22:9I]XVFJOVG5VTIT%QGRV$K1[P=OS#*YQQUJY#XDO+V19M.THW>GB_:
MRDE6<"1=K%'DV$8**X(^]G SBLP^ [L!((];5+*'5_[5@B^R LK&1I&1FW?,
M-S'! &!US5S3?"=[I.JW36FN2)H]S=->-8^0"ZR,=S!9<\(6Y*X[D9&: )[/
MQ)>:BUK=6&E&XTN>[DMO/6<"1 A93*4(QLW(1][."#CM56S\:2W]YIQMM(N)
MM-OI6C2YB20F,#.UW&S:$;'4,<9'OA^C>$[W1+R6&VUR3^Q#<O<QV'D /&S,
M7*"7.=FXDXQGMG&<F@^$[_09OLL.O22:)'(TEO8F !X\DG89<Y* G@8!Z G'
M! *]EX]2]T.[UB&TBEM;:UDGECAG+30NN/W4J;<HV,D]?NGKP33\4^);ZZ^&
MVNZEIC691;<B&[M+PNK(R\LI"\,"<8X]<CI6A#X,N8]0_M0ZG"FK"R-H;R"T
MV&;YD;?*-YWD;,=OO-ZC$%U\/TN-(\06<-W!:/K>SSS;VNV)-HP66/?]YNYS
MSQQQ0!/IDD.D^+)])MM$M+2YO; WTCV]RQC9HW6,#;L !PPRP';D' K)?5D\
M1ZC\.]<%J+=[NXG;9NW% ;:7C=@9Z>E='>^'KVX\06.LV^IQV]S%:O:7'^C;
MUDC9E;*@M\C KP3N'/0UGZ;X'GTZS\,6XU59!H3NZL;;'G;D9,??^7 <^O.*
M .FU23R=)NY?(6<)"[&)FVAP <C.#C-<EI7BF<V_AW3='T&!$O\ 1A>VT;79
M2.%5$8\LG83@"0#(!/'3N.POK=[NPN+9)!&TL;('*[@N1C.,C/YUS>E>#[C2
M[K0YUU..3^R=,;3D4VI'F*=GS'Y^#^[7CZ_@ :_AK6U\1>';/5A ;<W"$M$6
MW;&!*L,]^0>:U:Q_"^B/X<\/V^E-="Y\@N1*(]F0S%NF3ZGO6Q0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !2$@=2!2US/CS2GU'PU)<VT*RZAILB7]F"N29(B&VC_> *_C0!TNY?
M4<>]8NCZ\^I:MK5C/;QVYTZZ2W5A+N\W=&L@/(&#ANG/3K7%Z987$_B6X@;3
M FE^)UCU-E,0 @$1 9''JZ^3D=B[^E97B6VL9K7XA79BA>\@O+=[.3 +HRQ0
MC,?H=RD9']W':@#V)G1"H9U4L<*"<9/M61)KDL7C*VT$VJ^5/8RW8N/,YRCH
MNW;C_;SG/:N/U%[.XUCQ?;:\(W%S;1MI3N,^9#Y72$]W$F3A><E3Z5'#_:\>
MNZ#%<R@ZZOA6>-V9AG[23"0"?4E2??!H ]+61&9E5U++]X \CZTKNL:EG8*H
MZDG %>:^!_[%U*_TJ\MKC4AK-G:-!>VSP+%Y1(&\3D1@L=XXR2223SS6UXGF
M^S>,O#\NI!?[#,=PDCR#]U'<$+Y9?/ ^4. 3W/N* .PW* "6&#T.: P90RD,
M",@@\&O'Y]/@2TTR*[1#IC>+&:P5^BV91L@?],B^<?PD%>Q%>JPV&GZ=I0L8
MK>"#3XHROE;0(U3N,=,=: %L)[F6P@DOXH;>Z8?O(XI?,53SP&P,]/2K2LKJ
M&4AE/((.0:\<\/VMA<V'PUAO(H9 J74<R2 =/*;"N#V)P,'J37:?#GRH]#U&
MUM]JP6^K7B01I]U(_.8H%'9<'CMB@#KC(BD NH). ">I]*#(BNJ%U#-T4GDU
MXYJNE:+>K\0;=X(6UA+W=IJIQ,LYMXBAB[@F3&2OX\4_Q7=)_P 3E)D,6JVD
MVFO+(T;R22[6B)DC/2.,98''4[LXSR >OM+&GWG5?J<?YZ&H=/U"UU2QBO;*
M59K>4$QR+T89QD>W%<-HNDZ)JOQ"\42W%C;7#)):S0B6,':WDX9@#T.3@^_!
MJ_\ "M;>/X>:5#%"(IXHA'<KY>PB4<$-QRP[T =3;SW37-XMS##%!&X$#K+N
M+KM!)88&WG(ZG@9JRKJQ(5@=IP<'H:\>\1Q69TSXB1*D6&U&TDB51U;9"&9<
M=\A\D=\^]=7H,%A8_$S6K?3D@AMIM-M92D( 5Y-\N6XZMM*9/7D9H [5Y$CQ
MO=5R<#<<9-#2(@)=U4 9Y..*\Y^($UI+J=]8RV^+E]"G\J66-I1+DG,<2#@/
ME02W4#''<4]/@TC6/$^ER:C%;W$4OA9?.^TKP[AU^\&ZG )&>W(]: /4]PSC
M(I00>AKR:P@>U^'WA#Q?%;M<W^BVZ)<H%W2R6Y&R1.>=R\, ?[I'>O1M TXZ
M=I2++&B74[-<7.P#'FN=S?4 G ]@* -'S$WE-Z[AU7/(I<CCD<UYOI_[KQI'
M"GV+5K&YO[O[T>V[L'(DWA_[\)P5!./O)UXK%\-75J+?X=6V#]LL+F>WNE$3
M;H&\F5=C<<'../H: /8'D^\D91I@N0A;'TSUP/?%9/A;7O\ A(O#UGJ;P+;2
M7 <F 2;]NURO7 ST]*XWP==:1>)IT6J03+XKTV>9KO*.CJYW!Y';@&,J01DX
M^Z!T%8_ARWL;73_ -]%'%'?-J5Q%/, !)Y92?Y6/7;DIP>,D>M 'L3,J*6=@
MJCDDG % =6Z,#]#7->-XQ+I=FHU&+3YQ>(T$T\8D@+A6(64$CY#@C.>#M(YK
MC[2\BM[_ ,'ZIJ&GVVF0Q7&HVTLD.3 6;=@HV/N.P8J#Z\4 >F7LUU$D!LX8
M9MTZ++YDNS;&3AF'!R1V'&?6BUU&TO;F[M[>99)+2013A3G8Y4-@^^&'YUY/
M;FU_X1C228Q&8/&+,@>,H8T^U.> 0,#:1GT[UUOA&&SM?&?B^$6R17;7RRH1
M#@F)H(N0<="P/?D@T =F[I& 7=5!.!DXR:&=$&795'N<5Q&H/:+X_OX?$B0G
M2[C3(TL6N0/*R&?SD!/&\Y0XZD >E<SIFCQW=_X'L?$MNMQ,^FWL<R70RS(6
MC\E9 >IV] ><@]Q0!ZQ>R7$5C<26D4<URL;&*.1]BLV. 6P<#/?%.64"%6F*
M1L5#, ^0/7GN/>N>\?00?\*XU^ QH5&G3+$F/XMAV #USC'O7+FRT;4?&D?V
MZ&TG@?PRN\2@%&8/WSP2%]>0* /3J:)$9V174LO50>17-_#R5Y?AWH!E=FE6
MQB1]Q^8,% (/N,5Q'AV^M)?$_A.ZM8GMTD-]#+#Y3M+&S8;9-(?O.6&X@XQ[
MCD@'K;NL:EG8*H[DX%*&4]&'YURGC>-I$TPPZE:V5W'.TD'VZ/?;3,$(*2<C
M&0QP1R"/PKFM+O+6U\0>%]1O].32X+K1[JT\H*60OYL16-3CD,JL5'<'B@#T
M>ZFNHYK06T,,L4DNV=GEV%$VDY48.XY &..M%EJ-IJ)N1:3+*+>8P2%3D!P
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M[;O7(SQGTH5U8D*P)7J >E>-S:-HTOP]\=WRV5J]W;W&I"&7:"T<9)*[?1>
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MJKD?=8 K@>M:VJW5F=!LM=O; Q_VMJ5O+NF4A;= /W33 <E0%!*DXW/C(ZT
M>A!T*!PRE3T(/!I5=77<K!ATR#FO&%%I+I:6LX!$/C)64/"8@L3/N)4'&U2"
M21V!YZU;O&327\3Q:=;?\2BVURSGNK2TCX^S>7'YQ5%ZKN'S =<,#WH ];61
M'3>KJR?W@<BA9$9 ZNI4]&!X->::S<Z0FD?VQH,=R=&FU2&?5);:(LC1A"I9
M(V!!"L(BV%(.#U(.*.H66@?V9I]SIEQ/=65UXCM;CS)E5(P20)#$ JX7 !8@
M8SGGK0!ZQYL> ?,3!;:#GOZ?6E:1$*AG52QPH)QD^U>.:[I6D1V/Q'BM[.U7
M[.L<MC&B "*4P+EH@/NMO R5YR*T-:GTR_\ $&IZ?XEN[R*WU"VMSILL$"R"
M5-@W+$VQB)!)DX!!Y!H ]3:1%^\ZCIU/KTJO_:-I_:@TSSE-YY)G,0/(3(&3
MZ9)X^A]*\KUG3-,FN/B +JWCEF31K=HC.%9_.$4HW#'!D!*\CG)'K6UI7V1O
MB)IEY<1(\MUX?A\J<Q;C)*'.[#8^\%(SZ"@#T-F5%+.P51R23@"L[7=9@T+1
M+C4YE,B1!=JJ?OLS!5&?<D<U@^+9FMO$_AJ:^4?V&))UNF<9C28H/)9^P'WP
M"> 2/:N1UFRBB\">)@\<;:6VLQOI2,H($9DB+^6/[F[S<8XQD]* /3]-N-2F
M:Y74;*&W\N3$+PS^8LR8!W= 5.<C!]*NB1&9E#J2OW@#T^M4+Z.1?#MW'HRQ
MI-]FD%H(@ H?:=N,<=<5Y_X6;PS?FTU!I[W[99V#P:E:SVZQI$I WK/^[&XA
MAQDDDDGGF@#U#<#T(I!(A;:'4MC. ><5YGX/M++2-:DT:_MD,-S:-+HS2D/L
MM79F,!..&R<]3D8&3MK&\):;I]QHO@"]T98O[;CE3[;+$<R?9O+<2"4]=OW
M,]RN* /91(AD*!UW@9*YY H$B%@H=2QS@9YXZUY5X472]2N=,35+C4$\3Z=+
M+]MMC J<G(D:1_+^:)ASRV#\N.<51T&UTZST?P/>P10Q7PUJ>*28 "00G[0-
MI/4)RG'3D>M 'L8D0N4#J6'5<\BA9$<L%=25.& /0^]>4PG48;J[@T=[74Y+
MBUOWL;I%\N\L96!;9-V92^ &X.<=>M&FKX;U;3+J^M+_ %:"Y32);6^2.W6,
MVRE>1(!&NZ16SMY)ZGD9H ]621)!E'5AZJ<TRYN8+*UENKF5(H(4+R2.<*J@
M9))K@O#VOP:"FKSZZ^G"" VR?VMIT9$-T&W!=R+G:Z\;L$@!EZ#%=-XSMOMG
M@?7H!#Y[/I\X2/;N+-Y9VX'KG&/>@!A\2@^(]+TY+=#::A8RWB7)DP5";."N
M/20<Y[=*W6D1(_,9U"8SN)X_.O,+6+1-1U_P;$8;62Q&C7/F1O&!&6/D?>4C
M!R58\]U/<5E:7?Q6'A[PF^J331:%&+ZVEE2)94@E\T"'S RMA=@90<<;O0T
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M@'D>'XY6-KG,N)GP#D?>S\OY=.@VT\0:S+/J%J=*,8CLC<P7A25(MV<&-MZ
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M73'QM/9#5K?4K&%;^RO+>TBC@G+),TX7R_F*@CEN>.Q(STH [*BN*UKQM>:
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MVN(M.,:XC9F+%?,^\4W$D+^9(X-J7Q+:Z5:B76;[3T\Z^-K;^1+D'+X4'/\
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M]ZWXI8YXDEAD62-QN5T.0P]01UJ)=0LGO#9K=V[72C)A$@+C_@.<]Q0!R:^
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MT+<YPV['6H=1\Z#2]>TPV%\]U_PD\-Z%CM)'!A,\+APP&#P#P"3P>.#7K=%
M'DFNR:?)J/B71]0FN8[2]U&VN7N)+">0Q[$A8A2J%2,( ,L"N6R".MC6;*VO
MKKQ[(E@9XYM#@CL76V++(WE3<1'&"<M']WVKM(_"D4%Y<2V^JZK#;W,K32VB
M3CRRS'+$$J77)).%8>U;L<:0Q)'&BI&@"JJC  '0"@#A=)\V/QSI=U-;712X
M\/Q0B4P.0)5DRP8X^4@'^+%7/&=M'+KOA6YN[4SV%O>RFY8PF1(PT#JI8 '
MW%>3P#BNPJL-1LC??81>6_VS;N^S^:OF8]=N<XY% ' 0>$)+O0O$8L(19+)J
M?]HZ*CIL$,L:(0X4_=5I%;CCY6/K74^$I)M0TK^W;JW-O<ZH%G,1.3%'M 1<
M_3YOJYJ[K&BQZU%#%->7L$4;[G2UG,8F4@@H^.2ISTX^M:*JJ(J(H55&  ,
M"@#AM8#VWC[49WM;EHKG0!%%+';NZEUDD)7< 0#AEZ]<\5AZ+I\EL/  M+*2
MUNDT:>&XD^S,OER&&, 2''!WJ>O<5ZM10!YMX+2VO9="2\L=8BUS1X&AF6XA
M:..$E-KG?M"R!B 0,DG.>Q-;?CN'S&\..MN\KPZU;R%HXBYC0$[F. <#ID]*
MZZB@#R'5=-C_ +$\;O%I<OVI]:AEM2EHV]E @^9,+DC*OR/0T_Q"\YT7X@:9
M?6%W/?7Y::P=+5Y%GA\I1&%8 @%64\'&"<]Z]6-S MTEJT\8N'0NL1<;V4$
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M.< #GGBKE%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<OXUOI(8]%TR-BJZKJ<5I,1P?*PSN/\
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MA9;965722,..&)((Y!YY]JI^+_$NH: E[+;):>7:Z>]XHD5I'F9<DIM4@HH
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MAEZE6).>,#@YXLZ?H,.FZSJ6HPW5R?[0D666W8KY8D"*FX<;LD(O4D>U-O\
MP]%=:Y!K-O=3V>H10-;-+$%(DB)W;6# @X/(/4'/8XH XS4M?O\ Q%H_A2\A
M\FRDDUU;:Y@=#(!+&90>0RY7<F0.O3D8KL]1NK/PGX:O]16UB6.WCDN9(X$$
M8DD/)/L6;OSUJI-X-LGLM)M(+JZMXM-N_MD?EE"9)?F)9RRG.2[$XQR:V=0T
M^VU73+G3[V,2VUS$T4J'C<K#!H P8-1\4S7UU:_8+81_9/-MKN2)HXQ,#@Q.
MN\L01R&&._'K4T#Q9J6N:#?ZF(+6)K&%HIK=@=RW: F120QP@X [G.>F,WM/
M\(O8:=-:'Q#K%P3#Y$,TTD9DMX^,A2$Y)P/F;)XX(J.]\,6VGR:IJMA)=1M<
M:?\ 9I+*!%,4I12J-M"[MP!QD'H .U &38>--:C;PW>:O:6"Z9KEMN5K8OYD
M$GD^;\V>"I"MP.GJ>M7+#Q-X@U!=/O;?2HWTZ_M&GWLI3[*=F^/<VX^8#T.U
M1@^U+X0\._\ %.>&Y=4>ZDGT^R1([:YC">3(8PCY&T$D#<H)[$]<YJSI'@B'
M18VM[;6-4:Q0.+6TED1DM=P(^7Y<G ) #$@>E &=H'B_6;^;PO)?6]BMMKUH
M\JI 'WQ.L8?DDX((SQCCCDU'9_$(OI=]?7'V<365L7NM,:-H;BVF+*%1MQ.Y
M221O QQGOBMBQ\%6M@/#ZQ7]ZRZ'&T=L&\OYU9=AW_)S\O'&*:W@73KN/9JD
M]QJ)^P/IP>?:',+%2=S*HRV57![=N220"M<>(?$E@FIR3Z,US;P6RS03PP%2
M6W;70Q[V9BH^<8(R 1P:9-JH\2>!-8U"TU"SN3;K)+975HI0QND8=2RL25</
MD$'MU'-:%EX2DM+![:3Q#J]U* BPW,\D9DA565@!A,')49+ DBH[WPV8M*UF
MVL69K[7"5N+DJ%5,H(R^  .%&0.I/Y@ U]"U(ZSX<TW5-@0WEI%<;?3>@;'Z
MUPTVOZM/I-BUE]AT^23Q.UA.L,!*R!9F&[[P/S%,MZY[5Z%96<.GZ?;V-LNV
M"WB6&,>BJ !^@KGO^$&M!IALQJ-^&&IG5(YP8]\<Q<N<?)M(R3P0>M &[J=S
M<V.BW=U!;&[NH+=Y$@C&#*X4D*.O4C'XUYWXDU]/$G@#4KB&ZLKQ(;FQV".)
MH9(I/M";DD1BS(1Q^9KT>\L_M>F3V7VB:+S8C%YT; 2+D8W D$;AUZ=:Y^^\
M#6>I1WYN;ZZ^T7YM_/N(EC1F$#;XQC;C[W4XR>G P* *X\2ZS!<^([&X@TZ2
MZTV&"X@<.8HBDN[[Y8\;=A).1D=A6-XCUV;6?!?CS3[I(I/[.LB8YD@>(2*\
M)8'8Y)!!SSGG@BNBU/P/::K-JTMQJ%\'U**".384'EF%M\;+\O4,2><@^E,F
M\"6US%K:3ZMJ4AUJW2"[8F($A5V[E 3 )7CICT% %:%%'Q1TM@H#-X>ER0.3
M^^AIWQ 63=X8>WCB:X76X1&93@ F.3J0"<5L1>'(H]?M-8-[=//;69L@C;-C
M(65B3A<YRJ]".G2IM;T2'7(+59)YK>6TN4NH)8=N5D4$#A@01@D8QWH YB/Q
MKJ=G<W^DZI:6QU6WO+>VBDM0WE2K."RMM)R" CY7/) Y&<UT.@7VL7<E_%JU
M@(!!*!;W"+L6XC(SG868J0<@Y//455OO!6G:EI]Y!=37375W-'</?(X29)8\
M>6R$#"[<<#'KG)))TM'TI]+MV6?4+O4+A\;[FZ*[B!T&% 4 <]!W/6@#G_%7
MBW4/#\E[*D5HT%J(&6(AI))E=]KDE3^Z Z L""0:Z75]3@T;1KW5+G<8+.!Y
MY O4A5)('OQ6#J_@2TU>XU>1]2U""/55B^TPPLFTO& $<94D' '&<''(KH;F
MP@O=+ETZ\!N+>:$P2ASS(I&#G&.H]* .%N[J]/C7PAJFI?9%1[*\F*P1L&B'
MEHQ4L2=X /7 Z'CGC5TCQ#KVJSZ7<1Z:G]F:C;-*9?+(-H2FZ/<2_P"\!SC@
M+S[5)8^!XK2YTF:76=2NUTI)(K:.?RB/+=0I5B$!;@ 9)S[U-H/@V'P^ZQVV
MK:E+8P[OLEG/(K1VV<CY3MW$ $@!B0!0!RWAZ_EL]"M;R\BM;V_N-=O+>RD-
ML2\,C2S[VR6R1L1@ ,<8&>]:MWXH\2V%O +G2K5)9=7AL8Y)-R)/%(1APH+%
M"#D$$GIGGI5X^ K!O#K:.]_?LHNVOH+D.BS6\Y=GWH54#[S-U!X.*FE\'I<V
M=I%=ZQJ-Q/;WD=X;ES'OD>,Y0$;-H4>B@=^Y)H S&\8:I96>NK>VL,MQI-]%
M!+-:0.Z"&14?S#'DL=JN<@'MFIX?%\MW'IL-C<65[-J/VB2&YM8VDB\J(J,[
M-X.[+J"-PQSZ8K17PJL6H:A?0:K?17%]<QW+E?+PK(@0 #9]TJ "#GZ@U2N/
MA_I\L,3VU[>66H17DEZE]:E5=9)  XV[2NT@ %<=AWR2 ;/A^\U.^TB.75[
M65Z'9'C!RK $@.O)P&&#@\C.*U*JZ=8C3[-8//FN'R6>>=@7D8]6. !^   &
M   *M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;N"Y1&*,T,@<*PZ@XZ'VKS?5['4SJ'BV>PTV]DC%_I]VL*1/%]JCB">8(V(
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M->17L8G!L7,UNHG+^:(P S[>" ,CO@X(J!K+41I&M9T[5)-GBBUU %[4^9+
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M;(Y(V0;4D)Q(N'P2!U'X"7XCF['AZT%M/'&K:G9*X>,MNS<1XZ,.,]1W''%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTMK\6*W]N;HLR"/>,EE&64>I Y(ZBL9O&.FZEI-_/IVL65FUM=?9A/=\IN#
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MS:U?WEQ9ZCIL.GZ?>R07,<W5H449D#YP#N/&1C'O6^/$&C_9;FZ.I6J06O\
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M0<$CU /!(Z&L_P 0^('TN]TO2[.))M4U65H[=9"0B*B[I)&QR0H[#J2!D=0
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M+-?745O&SK&K2L%W,QP%'J2>U '(>#++4M.U-;56O)M$6R'D#4;<I<6;[AB
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M-8A6"[57 #(JE0!Q\ORDCCU]:NWNAV6H^'I-$O!)-9R0^0^6PQ7''(QSP.:
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MM_\ VCY@EPZ7&_?O4@#'/;I0!SDNO:EHFL>,[ZYO/M45@+2.&%HPJ@N@QWX
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M\T 9,&K^*[K7=,T>XDT_3[FXTF6YN-D)F\J9)(T.T[\$'<<#MWSBFZ#XOO\
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M,\&495G5>IC8C#@=?E)XYK"T;7+_ ,2:Q>M9WDMI!I^H&!K>6R;9-"J+G+,
M5DW,<<\ #*GK5*QT;5+^R\'6=WI\EE/H4R/<S%E*,(X6CQ&0<D.2#T& #G!P
M*U_!]G?6<_B WMC+;"ZU66Y@+LAWQLJ 'Y6./NG@T 7]?\16OAY+$W$4\C7E
MTEM&(HF?!8\D[0>@R<=3C K"M/&<-CXA\0VNMZ@D=M:W4$=L3"5V+)$C?/@'
M W-C<V!]*T/&=C>WEMI$UC:/=O9:I!=211LJL47(.-Q SSZBN9UO0]:OK#Q]
M'%I$QDU80BS'F1_O"L*(>=W&&4]<4 =QJ7B#2](+?;KH1! ID?8S+$&. 78
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MC9&1XVQG#*P!'!!Y'(-<-J&CZAJFCR:EIWA<V%_'<VT[6MS.@FO1$QRA=6(
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M  <L1GBJ/BGQ)K.F:;J5U:ZG%-<:?IT%PT=G"IC#DDLTA?/RL -JJ=V,GT-
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M2-CX#8Y'/!!X]:XJPUK6UM/"R7>L&6;Q&(F\S[/&@M0MN97"<8+.0!\P.,G
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M83VLP)CD"D;@"1T(!Z@U;KD_AG_R3O2/]R3_ -&-764 %%%% !1110 4444
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MP7J"<;0?XNE %ZX\)Z-=C51/;2N-5 %Z/M,H$H V@<-QP,<8XJ;_ (1O2CJ
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MFKU5=-U*TUC3;?4+"836MPF^.0 C(^AY!]C5J@ HHHH **** "BBB@ HHHH
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MKRP'4[>Y6\:*&/+M&O#C*G!_3VKN5\/Z:E[%>K#(+F*W-LDGGR96(XROWO4
M_4 ]J@M?">BV9L#;VC1_8-_V7$\G[K?]['S=Z .1M]?UK_A'M%D?4I'G7Q&=
M,GD,:9N(5N'C^;Y>#A1RN.]0+JMYH1\8WXU"9R-<@M0;AEV0K(MNI?.TXVAS
MCJ!QD&NU'A/1%MH[<6C"*.Z^V(OGR<39SO\ O=<DGZDU)+X9T6>;4)9M.AD;
M44"78<$B48 Y!XS@#D<\#TH Y?4M2\0>'%G%WJ%J\%Y=VL-J7F#26HD;:Y9O
M+ VDCY25."3G(&*Z'0(=9MKS4H-5O8+B'>DEHBR;Y8D(((<[%R-RG:<9Z@GB
MEMO!OAZUT6XT>/2XC87( FBD+2;P.@)8D\=N>.V*N:/H>FZ!9FUTRV$$1.XC
M<SLQZ<LQ)/  Y- 'GVN2:A9ZO\0M2T_4IK.:PLK:Y3RT1A(R0NP#;@?EXZ#!
MYZU:\6^)=4M;#5[[3M0?S;&QM[@00QJ$MV8ECYI;._>, *.@&>,@UV$_AG2+
MI]1>:U9SJ2".\_?/B90, $;NF"1]"15>Z\%>';UI3<Z8DIFMUMI=TCGS(UX4
M-SR1GACR.QH Q]:UW4-+\4>7?/=V^E27-O';WELJ20H25W13KC<A8G ;IAEZ
M<YT?'M_?Z9X3EO--NVMKE+BW4.$5@0\R(001TPQZ8/O6@/#6DB8R?93R\;LG
MFOY;-& $8IG:2-J\D?PCTJUJFE66LV1L]0A,UN65RF]E!*G(/!'0@'Z@4 <'
MJOB75O#3^+HFOY+U;*&QEMY;B-,PF=WC8G:J@JNT-@^]7-<O=5TW6+O2$U&Z
MFM;O1;FZ24[1+;2Q;1D,%'#;QVX(XQ74-X=TI[B]GDM!+)?0B"Y\UV<2QC("
ML"2"!D]NY]:=9Z#IMBCI#;E@\0@)FD>4^6.B9<DA>3QTH I>"HW3P-H8>XEE
M9["!MS[<KF->!@#@>^3]:XV#5_$)TC3=1.O3M*_B&33'1H(MCQ&X>($@*#N
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M <#WY]ZWJKV-C;Z;90V=HACMX5"1H7+;5 P ,DG %6* "BBB@ HHHH ****
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MT)W+]-PSC-01^--&EU"XLU>Y#6TKQ7$C6LBQPLD?F'>Y7"C;T)X/:LS3M/\
M$>BZYJUI;V=K<Z;J%ZUY%>O/M:WW@;U:/&6(()7!P<C)%1IX8O[[3O&VGW"?
M95UJ>1[:;>K85H$C&0#ZIG'H: -E_&.C0274=W-+:-;6AO7%Q"R$P#@NHQR
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MQ).EO+<",F**1\;59NV=RC/09&<4OBF_MM-\.W5S=7UU8PJ%!N;6+?)'EAC
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MG2;.:*&[,<9A<KMC#QLKJ"!T4E0/8&LZ^?QAJGARX9--M=/O_P!T%@%T)&E
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MMXQ\P*DC!XK7OK_4M9U+Q';VVL1:7=:3<QB)GF8"*(1H^]HAQ(K$N,G\,8H
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M.(L'?!.W(Z< GG%7+40P11VT<Q8JN0'E+N1GDDDDGGBN4\:_\C-X)_["S?\
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M_P!1NM5\#:9=WLYGN61E>0G);:[*"3W. .:Z6@ HHHH **** "BBB@ HHHH
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M<+V%5C#/)&-HY8L!N^89R<>^< @&O;:%I5G$\5OI]ND3Q>24" KY?]P#LO\
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M2*5L8!YW'&Y<D @9YZ' !3T;P5IEG:21W.EV"1O*DRV<"EH(77.&7=_%S]X
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MN%CRV6<[E^7 /(J34?%UMIVI+IITW4[B^:T-VMO;P!V*A@",[L9!/KCWR0"
M:]_IEAJL"0ZA9P742.)%2:,. PZ$ ]ZBDT/2Y;\WSV%NURQ4M(4&6*_=)]2.
MQ/3M67!XUTF]TNQOK+S;G[;$\L,*[4DPAVOG>R@$,0I!/7IFH(/'^E7JZ:;"
MWOKQM2MY9[9881EO+(5U)) # G')Q[T ='>6=MJ%J]K>01SP/C='(NY3@Y''
MU -5)O#^D7&GRV,^GP2VTKB22.1=V]QC#$GDD8'/7@51M/&&GW]GIL]G#<S2
M:@DKPV^%23]V<2 AF RI(!&3[9&33;_QGIVGV9N'AN7V6BWDT2A \,3 D%@S
M#)^5OE7)^4\=,@%Y?#>AI;W4"Z18B&[4+<((%Q*   &&.0 !CTQ38O"^@P:?
M!81:19):02":*$0C:D@Z.!_>]^M01^*["YE5;&.>\0BW9I8 I"+-CRV(+!L8
M()(!P/H:?XPEF@\%ZW/;SRP3PV$TL<L3;65E0D$'ZB@"_;:98V=U<75M:0Q7
M%R09Y$0!I". 6/? ]:C;1=-:^:]:RA-R[K(S[?O.H 5CZD   GD8XK%T+Q9:
MS1VUC>)=V\Z:8MZ9[I0J31J%#N#G/!(SN /.>13AX[TK[0\#Q722?8VO8@55
MC-$N-Q4*Q((R#M;!YZ=: -"7PMH$]U/<S:-8R33NLDKO I+L""">.3D#\AZ5
M.="TEFO6;3K4F^79=$Q ^>N,8?\ O#''-95IXVL+RSANA9W\27(C-KY\:Q_:
M=Z%_D);'"@Y)(''?(R6/CC2M0>S2)+D/<WLEAM95_=3HI9D?#'^%201D'CGF
M@#7MM%TRRN(KBUL+>&:&#[-&\<84K%G=L&.V><>M+>Z/IVHSP3WME!<36[;H
M7D0,8SZJ>Q]Q6/-XXTR"V>>2WO0$U,:6ZK"&99B5 Z$Y7YATY]JDA\9:>]O?
MO/!=VL]E<);26LR#S6DD"^6%"D@[MRXY^N,4 7I?#FBSQW<<NEVCI>.'N5:(
M$3,.A<?Q'@=?2K=U86E]826-W;13VDB;'AE4,K+Z$&N.TWQ"]MXQ\5R:E)>6
M]E:6UDZP7+!A&SF4'8%)'S84<'D\5=N?B%I%G!JCW,-W'+IJ1R3PA4=BCG"N
MI5BI&<@\\=Z -3_A$_#OERQ_V)I^R:-8I5^SKAT4Y"GCD9YI;W2?)6:^T:TT
M]-9\I88I[E#C8#]UBOS;<9P/6K6FZA_:4$DOV.[M=DK1A;J/8S8_B R?E.>*
M74]3MM)L_M-TQ"ETC15&6=V8*JJ.Y)(% $>CZ>^GV;"9XY+J>5I[B2-=JM(Q
MYP/0#"C/.%%.O-'T[4)A-=V<4T@0Q[V7DH>JGU4]P>#63=^-=.L+?5GO+>\@
MGTN$7%Q;,BF3RCG#KM8JR\'G/!'.*U-)U5=6AEE2SO+9$?:IN8MGF# (9>>5
M.?8Y!XH 9>^'-%U&Y%S>:7:3SB$P"22($^6<_+].3^9J2+0]*M[FWN(=.M8Y
MK:/R8'2(*8T_NKCH/85QB^+3X?\ $7BTZ@FJWMC:7,#;HHS*EI&8$9B>1A<D
MG R>^*WQXSL9-9;3+:SU"ZE00.TD$&Z,1S$[9-V?NC;R?YX. #8T_3+#2H6A
MT^S@M8G<R,D,80%CU.!WJ*/0M*BOFO8]/MUN7D\UI%C )?&-_P#O8XW=:SXO
M&&G2/8-Y=PEIJ,IAL[QE7RIGYP <Y&[!VD@ XXZC+1XRT\V:71@NEC.I_P!E
ML"BY2?S/+Y^;[NXXR,T :UMI5A9W%S<6UG!%-='=/(B &4],L>_XTRPT73-+
M;=8V,%N<%1Y: ;5)R5'H,\X'%9=_XTTVP%U(T-U+;VMVEE//$@*I,VW"]<GE
MU&0, MUZXPO^$J;0O$OBR>^74[JPM5M9MB+O%JC1DNV"0 .Y R>.AQ0!U,/A
M7P_;3K/#HUBDJS&=6$"Y$AS\PXX/)_,^M<G9?#QOM >_T[0S=>:97U:V1X[E
MV+;M^T !7/KN('H1Q71Q>(Y9_&LNA)82F".R2Z^TADPP=F .-V<?(1TSGL!R
M:?CF_N--/AZX@GND5M7BBECM\DS(5<E2!UY XH V&\-:(T,L+:5:&*:;[1(A
MB&'ESG>1W;/?K5F+2["'49=1BLH$O94$<EPL8#NHZ MU(_PKGC\0-,CTV^NY
MK+486T^=(+RVEB59;??C:[#=C8<CY@2/R-= FH))JLFGK%+YD<"3._&P!BP
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MX(.X@'CD-@CTJK9>(H]2'A&:^CU"TN]24R11Q,/)D;R"YWX8Y7&2H/.0,@4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "N?\6:1?ZQ;::E@+<M:ZE;WC^?(R K&X8@85N3BN@HH
MYG4K"YA\86_B*4VRZ99Z9<03[G8R#<R.2%"X( C]<\UR'A%KJT_L"26QTF[M
MT!CLC::J7:W$N-Q2(Q] .HWL54'!QG/JM86@7.DWE[JHT_3%M+BRNC:W#>0B
M%VVJ^05ZC#CK0!SL'A'7(M&TRS8:?YMKKSZFY%P^#&97DVC]W][Y\>G'6M[P
MYI%_I&HZYY_V9K2]OWO(71V+_.J JRD8&-IY!.<]L5T-% '.:KHE]<^+],U:
MV^SM;16D]G<I)(RL%D:-MR8!R?D(P2.O6L?3_!VI)H.B^'KY[9K+2+R*=+I)
M#OFCB8M&NS;\K?=!Y(X..O'=T4 9OB&RN-3\-ZG86OE^?=6LD$9E8JH+*5R2
M 3CGTK"T[P_J]GK^E:A(EDT=GHIT]U6=LF3<C9'R?=^3KUYZ5U]% 'G6B^#_
M !#X?'AV\M_[/N+NPLI=/N[=KAUCDC=PX='V9# J,@KR.]-A\'>([*SL;NW_
M ++DU&RU"\N!;RR.89X;ARS*6V95A\N#@CBO1Z* .2GT/6KO5/#E_*FG1FPN
M9;BXBBD8*@>)HPJ?)\V-V23C//3MFW'A'7)M!U:Q T\37FN+J49-P^T1B5)-
MI_=_>^3'ISUKO&EC65(F=1(X)52>2!C)'TR/SI] ' ZQX1UK4;+QI!']@5M=
M\O[.6G?Y-L2QG?\ )_LYXSUK:CTG5%\<3:XT=I]G?2TM @G;=YBR,_\ <QM^
M;&>O'2NDK&T[Q'!JEW%';65ZUK,DC17WE@P/L;:1D$E3GIN R.F: .9@\(ZY
M%X$T71&&GF[L+^"YD87#[&6.?S< ^7G)''2K^GZ-XCT?6]3BLGL)-(U&[:\\
MZ5V$]LS@>8H3:5?)&021C/.>E=A10!Y]>>%?$EWJD5U,=-GDMM:%]#<RSOO-
MO\P6+;LPFT,. 2&(R<$YIVH>$-;N/#WBS2(#8%=5NY+BVE>9P0'VDAP$.,;3
MTSG/:N_HH Y,:)J]AXCUC4[%+2:+6((O-BFF9?(FC38""%.Y"N,]#D>_%31?
M!U]X?U2R-JUM-96>AC35:25ED>0/NW$;2 "?<UV]% &)X/TFZT'PAI6DWIA-
MQ9VZPNT+ED;:,9!(!_2N>E\&:DVBZ]X<#V[Z7JMW).MR9")(4E;=(NS;@D'=
MM.>XSC'/>44 <[HVC7UAXKU[4)5MA9WPMQ $E9G'EIM^8%0!GV)J3Q=H]YK.
MDP16!@^TV][;W:+.Y1'\J57*E@"1D \X-;U,DFCB:-'=0TA*HI/+$ G _ $_
MA0!QQ\-ZS:W'B)+;['+;ZZ@D8R2L#;3&(1OQM.], $<@\8[Y'4:5IT>D:+9:
M9 Q,5G;QVZ,W4A%"@G\J@T/6[?7K.:YMXIHA#<RVSI, &#QL5;H3QD&M.@#S
MW2_"OB6#6-"U*_&F37=C]I2[N?M#F2Y$@&'Y3CIC9T&>#VJ33O".MVFD>%;2
M3[ 9-(U"2ZG*SOAD82@!?DY/[WOCI[UV6K:E%H^D7>I3QRR0VL332+$ 6*J,
MG )'8>M2V=TE]8V]W&&$<\:RJ&Z@,,C/YT 9_B>SU2_\/W%OHUPD%ZQ0JSN4
M#*'!9=R@E=R@KN R,YKC;CP)K4S:Q-;C2[*2:\L]1LHXG=D6: +\C_*/E)4_
M,.3G...?2:* .6TG2M9/B^^UG4K:QA@N[""V,,5PTK*R-(3U100=]0:-X4U+
M1/#>JZ?::@BW3)+!IDQ&1;0_,85/J5+GGT ]*W8M;MY?$EQH?DSK<P6R71=E
M&QD9F48.<YRI[=JTZ /.H_!^O&XO;@V^E0O>:&=.D"W4CDS9;YV<QY;.[))Y
MXQSUJX_@_4KN31HKHVB6UMHD^EW)CF8OF18UW("@! \ON1U]J[FB@#BK'0/$
M=[X5G\-Z[+81VHL7L1=6CL\DX*%%<JR@)@<D G)[@=5M=(\4W'AZ]T_4X=&C
MG-E);1S6SM_I#LNT.^4_=CN0-V3Z <]==W4%C9SWES(([>"-I97/1549)_(5
M2TO6?[3FFC_LZ^M0B1R))<1J$E5P2"K*2"1CD'!'''- &#9^'=7M]3\+7+K9
M%-)TV6TG G;+.RQ@%?DY'[OOCK[5DV_@WQ%IMAI%S:C2YM1TZYO6:VFE<PSP
MW$ID(W;,JP.W!VD<&O1Z* .2.AZU-XAT#5)DTY19)<_:(XI&4*90H"I\GS ;
M>2<9ST'2LVV\(ZY:Z9I"K_9[76GZW<:@4,[['CE,W&[9D,/.],';UKOZ* ,C
MQ/H:^)/"^HZ,\QA^UP&,2@9VMV..XSCBLZ'1M5U#6M'U;5X[6*XTJWF55@E9
MQ-+(JJ6R5&U<*>.3\WMSOP7;37MU;FUN(A 5 FD4!)=PS\ASDXZ'('-6: .?
M\&Z1?Z'H)L=0%MYHN9Y@;>1G4B25Y .57D;L?A6?J>B:Y;>+9M8T>+3+NWOH
M(X;F"_=D,3(6VR(P5LC#$%>.@YKL*9++'!"\LSJD:#<S,< "@#D?$/AG5M:@
M0QW%M%=Z:D<NE7"L5_TD?>>10O"D#;M&>&;OC%62;4U^)VG,UI:O>'0)?.B2
MX(0'SH_NL5R1G'4#CZ8/40:Y;S^(KO1!#.MS;6\=PSLHV,CEE&TYSU1NPJX;
M*U-V+LVT)N0-HF\L;P/3=UH X./P5K&AG2[[2#I]W>0K<I>VUVS)%*)Y?-.Q
M@I*E6X&1R*V/[#UAO$NAZI(+ I96MS'.L;LGS2E" @V\JNS&203UQ74&6,3+
M"742LI<)GD@$ G'XC\Z)98X(7FF=4C0%F9C@ #N: //X?!%Z_ABPT?5+#3[M
M8);J4R17;QR0R/*7C>*38"" S ].W7I4EOX9\4:1J-O>V\VFZO)<6,%M?_;V
M9#YL8($J,%;((8Y! )P#FNLAURWF\1W.AB&=;FWMDN6=E&QD=F48.<]5;MVK
M3H XC6/"-]J.IP7D2VUOJ%LT M]5MY6BE"+M\Q'C PRG#84DCYL<=:Z/Q)87
M&J^&-4TZT\K[1=VDL"&5BJ@NI7)(!.!GTK4JM;7;7%S=0FUN(1;N$$DJ@++E
M0=R8)R.<<XY!H Y"?P?J-_=V:W1M8[4:!-I-P8YF9PTFSYE!0 @;.Y'6GZ=I
M'BDZ%<:=J4.C+(EH]M'/;NV;EBNT,^4_=C') W9/H.O:UF?VW;CQ,N@F&<7+
M6C78D*CRR@=5(SG.<L.U '-77A;6E\->&!9M8'5]#1%,,S,UO<*(O+==VW(R
M.0<<$5/J.B:[>6^C7RP::NH6&H?:S9I*R0[#$\902;,D_-NR5]O2NQHH \]/
MA'7VM;A&_LXO)XCBU<8G<#RU9&*?</S?)@?7MTIVK^#=:OM3UC4+>6RBF?4+
M/4+$-*S!F@0+LD&T8#8/(SC->@56OKMK*!95M;BY)D1-D"@L-S ;N2.!G)]@
M: .'O_".O:W<:_/<_8;%]1M;,0>7.TWE36\C2+NRB@J21G^1JQJFA>)M>\'Z
MCI]U;:+9WMQ&L2);RN8SA@2[-LR.G"@''<GMVPEC:9X0ZF1 &90>0#G!/UP?
MRI] &1>7VJ0:SI-O#:VKVMQO%V?-8R187*E1MP5SP2<=1W-0>+="N-=TF!+*
M9(KVSNX;VV,N=ADC;<%;'.#R..F<\UO56NKMK::UC6UN)A/+Y9>)05B^4G<^
M2,+QCC/)% ''Z]X3U/7H]=O&2T@O[_2/[+@B,S%$4EF9V8+ZL, #HO7GCLK-
M)8[*!)U195C57",64$#L2!G\A4]% '&W?AS5S?\ BE;?[(;;7411,\C!H,0B
M)LIM^;@9'(ST..M3:-X7N-,\0:BY$)TN?3K6QAQ,QE A#C)&T#D/V/:NLHH
MX33_  ?J:Z'H6@7[VS6>C7D4Z74<AWS)$28ALV_*?NAN3T..O%>X\)>(?+N;
M*!=.-M_PD"ZQ%-).X9U\X2F,J$.TC!&<G/''IZ!%+'/"DT3J\4BAD=3D,#R"
M*?0!Y/-/)+J6MW5O;:/>Z6=3\^6U;53 S30[5RT9C;YM\>?O -A3BMW4?#&L
MZG'XQ:-+.,:]91PVPEF8-&1$4/F (<?>SP3TKL3IM@;S[8;*V-U_SW\I=_\
MWUC-3&>,2/$&#2H@<Q@_-@YP<>^#^5 '-V6B:I:^+X=5(M#;R:5%93CS6W(\
M;NV5&W# [\<D8QWZ59\4Z1>:K#I<ECY)FL-0BO/+F<H) H8%=P!P?F].U:EI
M?I<V=I/+#+:27*@K;W("R*<$[2 2,@ ]">E5]&UNWUM;TP13Q&SNWM)%F4 [
MT R1@GCF@#%DTS3[(Z[J7B:YLK6+6Q':R1R3A8UC5&54W-C+'<Y_09QDV? V
MFW.G^&;=KZX>YNYU5VFD7:S(%"QY'8[%7(_O%O6M^>V@ND"7$,<RJP8+(@8
MCH>>]4=,UNWU2_U.SBAGCETZ=8)O-4 $E X*X)R,,.N* *.NZ1J%WXBT'5+#
M[,WV!YA*D[LN5D3;E<*<D8Z<9]16"?".N'2GML:?YI\1_P!KC_2'QY?G^;MS
MY?WNWI[UWCRQQO&CNJM(VU 3RQP3@?@"?PI] '%Z=H&OZ5K-];P+I<VD7=Y)
M>)<REOM%OYC;W0+M(;YB=I)&,\@XQ6_XET&V\3^'+[1;MF6&[CV%UZH<Y5A]
M" ?PK0N9Q:VLLY1Y!&A<J@!8X],U6T;5(-<T6RU6V618+R!)XUD #!6&1D G
MGF@#.TT^)TLX[._AT\SHH1KZ*=B'QQO\LIPQZ[=V/>LB7PMJL">*-/M'MI+#
M7F>42S2$/;/)&(Y,J%(<<!AR/0XZUVU07MRUG8SW*V\URT2%Q#  9),#[J@D
M D_6@#GM'\.7>D^*YKM! =-_LRVL(?WK&4>27.2-N.0_KVKFO"FD7?B#P1I=
ME(D$=C#JTMTTPD)=A'=R.%"XX)8 $YZ>YQ7I8Q+$-R$!EY1AZ]C44%K;6$#)
M:6L<,8RWEPH%!/T&!F@#B?\ A"M1/AW4?"KO;OI-U>M/'<^8?,2%Y?-9"FWE
ML[@#G'(/;!T[;0]9M]1\6W,4UK;OJI5K*9'9VB=8%C!=2H'50W!-;&@ZU;^(
M='AU.UCFCAE9U"S !@4=D.0"1U4]ZTJ //M/\(:V-2-U=QZ=!]HT5]/N6BN)
M)9&E)SYA9D!;/?/(]ZM67AO7$3P8+A-/!T/*W 2X<[U^SM""N4&3SNP<8Z<]
M:[>B@#@;;P5J*^&$\)SO;OI<5\LT=V)#YIA6<3!"FW&_(VYSC'/7BB_\(ZW=
M:-XHLXQ8"35M3CO("UP^%11$"&^3@_NNV?O>U=JEVSZC-:&UN$6*-'%PRCRW
MW$_*ISG(QSQW%8UOXNBO;BS6TTC5;BUO &AO8H5,!0MC>6W94=#R 2#D \X
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MWL8^][]:>VBZ4^JKJK:;9G457:MV8%\T#&,;\9Z>] %/QC_R)&O_ /8-N/\
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M17ES<>/I!K^J6K:3Y<]F(KME6)OLRR<K_$I;/RG(Y/%7M-CU#6/&4D=_?ZE
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M'Q%%!);_ &AE2$)>(JQF/.W[@5LD9)YKT]M%TM]5756TVS;457:MV8%,H'3
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M&V@7)6*&,(H_ <5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;Y5A:W%G.]N[EIUD14W@%0%.%Z9/UH T8/'^EW%[#:QPSLUS;/<VQ1HV\Y4
M)7 ?*-@@@-CCW!%:'AOQ(OB6S2\@TV^M;66"*>&:Y5 )5<$X7#$Y&.<@=1C(
M.:S-#TGQ78Z4-+U&\TR>WM;<P6\L0=9+@!=JF3((3 Y.W.2.W?6\*Z7<Z)X4
MTO2KMHFFLK9+=GB8E6V@#(R ><=* ..\5>);^^\->.8$M[JQ;2%V07,,X4Y\
MM'SE6W9._IC&.O/%=-%XGBGNM0TV;3M0@N+:S%T%;8&GA.Y=R$/P<J>&VD<5
MD:QX.U:]M_%]I;3V7D:[M:-I"X:-O*2,YP",?)GWSVK1ET+4Y/$]QJP%F$ET
M@6(C\YLA]Q;/W/N_-CUXH 9IGBJPCT71XK&"^NGN=,%[!#)*K3M$%7J7;YG^
M8=SWYKJHW\R-7P1N .#U%<#+X%O+GPGI6B7EOIMP;"P2WBN!,\<MO.HP)8W"
M9&< D<=!77RP:E!X?^S6=Q'-J26XC2XN<A6D"XWM@'OSC\* .7;Q%J%O\0;1
MYI!_PC^HF33;<=EN8OFW$_[1\U!_US'K6QJGBM=.UP:/'I&HWMV;;[4HMEC(
M9 X0X+..06[X]LUEZYX"M[WPDECIEG86FK0^5);WA'S1RHP8/O"[F.1SD<Y-
M:,&D:JWC*UURZ%DJ+IK6<J12L3O+J^Y<J./EQ@^OM0!C7/BX7GAGQ%=:KINH
MV]G8WKVI-G,BR!595X8."#NY..QQS70:GXH@T][U8K&\OOL"HUW]E0,8]W(&
M"06./FP,\?4"L"^\&ZO/X?\ $VD13V/EZI>O=02.S@KO96(; /3:0,9SGMCF
MZVA>(K'Q1J&I:3=:>MKJRQ-=1W(=FMY40)OCP,."H'!QR* (EU9-,\=^(Y[R
M\G73[?2;6Y*22,RQDM,&*J>A(5>!UQ6KI'BVQU?6I](1'BNXH%N0"\<BO&3M
MR&1F&0>"#SR.HK+U;P;=ZOJ>O-+<QQ6VI:;#9QRJQ,L;QL[!R, 'E^F>WOQL
M:!%XD5<^()M.+HFQ18J^)#Q\[;NAX^Z..3R>, &-XHGN=#\7^']7:\NAI-Q.
M;&\@\YO+21Q^ZDVYP!N&T]OF!K6BA.H^)[Z?[1=+:VL2VOEI<.J-*1N8X!QD
M*R $=RW<5:\2:)#XC\.7^D3G:EU$4#]T;JK#W# '\*-%TZ?2- M[1Y5N;Q4+
M32L=HFF8[G;.. 6)/3B@#$^&5S<WW@*PO+VZGN;F9YM\L\A<G;*ZCKTX '%7
M+[QE8V$-Y=M;W,FGV-Q]GN[R,*4B;(#'&=Q"D@,0#CGK@X7P/H=[X:\*6ND7
MSV\DMNTA\R!B58-(S]P,?>Q^%9,O@R__ +.\0:''/;'2M9N9)S*[,)H!*095
M"[2&YR5.1C=R#CD UU\6)+XBN-&M])U":6VDA6:9%C\M%D!*OG?DKQZ9]JT-
M0UB&PN[2R$4D][=[S#!&0"50 LQ)(  R!]2*S](T.[T[Q5K.H-]G^QWL=O'"
MJ.Q=/*5EY!&.=WKQCO1K>AW=SXATC7=.DA^U6"RPO!.Q5)HI ,C< 2I!52.#
MW% &=?>.Q]DT^33M/GEEFU9=,N87**]O(#EE(+8)('!!Q@YSTSFP^*'\/:[X
MOFO(-2NK"UO+<L1('6T1X(R3\[]-S$X3..>.E7;CP7>_9A<VTUK_ &B^N+K$
MJN6\HD#9Y8(&>$ YQR0>!GB+5/!VKZA9>+X!+8JVNM$8FWN!'MB2,[AM[[,X
M'KCWH UM=\<Z7H+W:SAY19;#=>4Z;HPP!X5F#,0"&(4'@]SQ2+XS2?5;S3[+
M1-4NWM'1)GA6+: \?F(P)<9!&/<9YQ5=M$\2V/B2^O\ 2;K31::IY;W45T'9
MK>546,O'@ ."JKPV.15_1=&OM/\ $FO:A</ \&H/"T6UR7'EQA/F&T#G&>*
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MA3Z** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@"*>V@N5"SPQRJ#D"1 P'YU( %    '  [4M% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJC21&6/?*OS(!RPYY49&3[US$6C)KGBW6;][>9-(O])CL9DFB:(W$FYR3M8
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MP^[Z?-++)<RS7=Y;0>?):R.C?=&#P=VS<00%'T( .E?7M'CBMY7U6Q6.Y4O
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M4B/C/S<\<<\UP^N_:/$>C3:II/AV]M[I)K26Y2ZM_)FNHX90YA"GEL#=[$D
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>W]IIMO\
M:+VX2"$ND>]S@;F8*H_$D"K%<]XSU6]T;0X[RR:$/]MMHG$L>[*23(AQR,'Y
MLYYH Z&HKFY@L[:2YN9HX8(E+/)(P55 [DGI7 Z[XE\16DGC&2UNK)(M"BBN
M(D:V+&53&7*,=W'3&1[<#O=U/6;O6V\2:=93):IINGHS[HPYDDEC9\'/1 H
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M2;2GTXB[6'[4;N!DN7#VTI9FW1'/R<LW3UK1L/$^AZI%>266J6TJ67_'RP?
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MF%69XI'=XSZ95@O/')KTFB@#S?5;#5_%.L7DL.D7NGI>>'+BP$MSL7RIG8$
MX8G'!Y IRVMWJV@ZC)-X3O;+5ETN:T,EQ.)2[NN/+A.]LH6Y).!P.O./1J*
M,SPY#);^&M+@E@:"6*TBC>)A@HRJ 1Q[BN>U"QU&'QAKMS'IT\]M?Z/%!%-$
M5($B&;*D$@Y.]<<=_8UVE% 'GNCZ7J-K<^ 3+IUP@TS2I;>\.T8BD,<2@'!Y
MR4;IGM52PT"[;PSI]K=VNK:?>07U[/%>6>#);%YG9"5&0Z,KX(P??'4>FT4
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MEIYSJ#N$S%@Q*DX5>1R3SG(]3JM;ZA:W5U=VT,H::T=4G7!&PE0P'/7@@\4
M<P8+Y_'EYJ;:=<I;2:)' K$*?WHDD<IP3SAASTSWJ_X$L[G3O NBV-[ \%U;
M6D<,L;XRK*,'IP:Z&B@#S;7M'U.[A^(<<.FSNVJ6\4=F0H_?%8=AP<\8;UQZ
MU<BLM2LM4\2&?3;B\MM9MHFMMH!VNL/EM"^3\O(R"?E^8\YKN+JYALK2:ZN'
MV00HTDC8)VJ!DGCV%+!-'<V\<\+;HI5#HV,9!&0: .&T'0-3\/\ B'0%EMY;
MN&#0%TZ6YC9=J2JZDYR0<8!Q@'I6Q\0+&[U/P)JUC8V[W%U<0[(XDQECD>O
MKI:* .,O[6\E\;76H)87+6LF@M;+)L',ID+;,9SG!^GO6;I&DZC;?\*\6;3;
MA3I=D\5X=H_<N8 @SSSE@>F?6O1:* /,5TC51HL$7]EW7F+XK.H%-HR+?[09
M-_7^Z>G7VKIO#UI>V/BKQ/Y]E*MO>7<=S!<Y78Z^1&F.N<Y1NW;Z5U%% '+>
M(+._B\6Z!K=O!)=6=HEQ!<Q1<N@D"[9 O\6"F"!SAN!UKG9_#VHQ&.Z6PG=;
MKQ2FJ&!0"8(0H4LPSU)&[ Y^;ID&N_35;&35I-*2Y0WT<0F>$9RJ$X!/XU<H
M 3H.GY5YQ%H.L3?#[5[*WL7AU$ZM+?0PRL(_/477G*NX'C<H ZC'>O2** //
MY--AUG2[NYF\+:M8O.T"2NUP/MF4?<'0AVXC/S#G)YP/6 Z;XC6VT:>[AGU,
MV&NF991&D5Q+;>0\:O(I*C<&;!Z' !(ZUZ/10!R/AVUNK2\\6S7%A/&+N_-Q
M 2H/FIY,:<<_WE;@XKG=#L=>\-VWA._?1;N\2UTAM-O+2$IYT#ED8.H+ ,"4
MP<'T->H44 <6VGWUOXJ\,W\&B^3:16EU;R0VQC"VID:)EW#(&,(V=N>>F<BM
MKQA;3WO@O6[.UA>>XN+&:&*-.K.R%0.?<BMJB@#A[&RO8O%MC?2Z=<BWC\/B
MU=]@.)=ZMLQG.< \]/>M7P%976F^!-&L+ZW>WNK:U6*6)\95AQVX-='10!YE
MJEAKEUJ8?^P;G_1?$45THMC$D,D ('F?>!>0C!8MTQV[I?Z/JDOAWQ5;QZ7<
MF>\UZ*[MU"C,D2O 2V<\<1OP<'IZUZ+%J%K/?W-C'*&N;94:5,'Y0^=O/3G:
M>GI5F@#B?$&CW,OBZREL&58-9@-IJD3<$Q1_.'QZX+Q$_P#35?2NVZ5G66A:
M;I^I7>HVUL$N[MMTTI=F)Z=,D[1P.!@<5+<ZK8VFH6=A/<HEU>%EMXCG,A52
MQQ] "?PH X#5?"6M9UJ&P 6WM+L:SI&&P6NCAFCQV7<LG!X/G>U;.I6>J6D6
M@;-->Z)N9);^6V"&:%W1B?++D;5+,5+#D+TQUKIKO5;&PNK2VNKE(IKR3RK=
M#G,C8)P/P!JY0!YG;Z'?V_PMECGMI+#5-(N[C4+1YG#?.LTDBG()RK*Q4YY(
M8UW6A6DUKI49NE"WDY-Q<@'.)'.2N>X7A1[**74-"TW5;VRO+VV$TUDQ: L[
M *3CJH.&^Z#R#C%2QZK8S:K-I<=RC7L,:RR0C.51B0"?K@T 8%U;7UM\11J:
MV$\]E+I/V8RQ%2$=92^""0>0>, USV@:+JEG8_#V&;3;B)],69;W@?N=T+H,
M\\Y8CIGUKTRB@#SOPAI5Y;KI>E:OX<N?MND$JNI2W&^W( *B2,;R=S#MM&,G
M/H=7XG''@2Y/EF3%W9?(,9;_ $J+CGCFNOJCJVCV.N67V/4(GEM]ZR;%E>/+
M*P93E2#P0#^% '"^*/#&I>([O7=2TR!K=Y=-M[:%)QY9N9(Y_-((/08 3)_O
M'L,G;BL)M:\966MO8SVEM!ILMK/'<* TK2,AV$9Y"[6R>A+#&>:ZQ0%4*,X
MQR<FJEMJMC>7]Y8V]RDES9[/M$:YS'NSMS]<&@#SJ+PIXFL;33Y;1A]KT2[:
MQT\,^1)9.2I=OHK1G'_3#CK6KK6FWFC>(["[MM(OM3TC^SA8/#93[9865LJV
M"ZAE(.#SV!KO** .'TO1Y;#QKI,L6C&TT^#1I;8+'AD@=I4=4SG^ZIR1QFMO
MQII%WKW@S5M+L9%2ZN;=DC+' )Z[3['&#]:T7U6Q35H]*:Y07TL33)#SDHI
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M&:O<:[X,TK5+S8+FXMP\I084MT) [9QFN>TGQ'J]QK^C6KWJ7,&IVMU(9DA
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M;1R*KHP*LK#((/4&LC3_  MI>F?9Q;)-LM59+5))F<6ZMP0@)XXX'H.!@<4
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MGW6%PUS;R"XD#K(V=Q+9RV=QR"2#FF1>#]&@UR;5XH9HYYI1-+$MPXA>4?\
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M?"1\R9RA8#@-M(R!QGIQ6?)X!\/2:1%IGV:=8()O/MV2ZD$EN_/^K?=E!R>
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MB1B0&<J"%!(/)QT/H:PM.TW4H_&6D7TNGRQVL.AM9RR%XSLE+QL%P&)/"-R
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M<H)"N[:7 V@XYQFN*?1M7@US5(=0\-6^MVNK&*;SQ*@CAD$21NDBN<[,H&!
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M_#FD:O=175[9))<Q+L2969) N<[=RD'&>W2KUK;6]G;K;VL2111\!$& ._\
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MD-Q.&\J*&,N[!1\Q  / R.3QR!W%<?X<\2/>^&=%N=2UFZCGNM6F@BD%J/\
M20LTJK$XV83*J/[I^7ZT =.WAC1VO)[K[(0T\JS31K*XBDD7&':,':6X')'8
M>@J.Y\(Z'=ZY_;,UB#?$+O=9'59-OW=Z [7([;@<?A4<7C/0YKZ>T2YF$EO)
M)%.S6TBI$T:!VWN5VK\IR"2,X.,U-'XITAKBY@EN&MI;:W^U2+<Q/$?)Z>8-
MP&5R,'T/6@".Y\':%>+>BXLW?[;,EQ.3<2Y:1,;6!W?*1M&,8Z"GR^$]&F_M
M'S;>5_[2B6&\W74I\Y , 'YO0D<>IJCJ_CK3-+TK5KH)<R7.G6PN'M6@='*M
MG8V& ^4D')[8.:TIO$5A B;_ +2TK0F<PI:R-(L8."Q3;N STR.>V: &R^&-
M)FFAF,$JS10?9A+'<2([1?W&96!8?[V:F;0-,:]T^\%MLFT^,Q6OER,BQ(0
M0%!"XP .G851N_&V@6<=G(UX\JWL#7%K]GMY)?.10"Q7:IR0",CJ*WHI%FB2
M5,[74,,@@X/L>10!S\7@7P[#+$\5C(BQ7/VN*);F41Q2\_,B;MJ_>/  '-2P
M>#M!MM;EUB"P$=[,YD=EE<(7/!?9G;N_VL9]ZFU3Q-I>C^:;V=TC@V^?(L3.
MD.[IO8 A>HZ] 03@<U4O/'.@6#WJSW,X^P2+'=LMI*PAW $%B%P%P0=W3WH
MMP^&-)@TR?3HH)5M9I_M#J+F7/F;P^X-NW*=PW<$<U<L=-M=.\XVT9#SOYDK
MN[.\C8"Y9F))X4#V %9R^+M&,M]$9YD:R@^TR[[:49AR1YB97YUR#RN14>G>
M,]#UB_BT^SO)1<7$'GVY>W>,3)@$F-F4*^,C(&<?@: +]]H6GZC>PWL\4BW<
M*-&D\,SQ/L/)4LA!*Y&<'C/-,_X1S2A=Z=<I:^7)IR&.T\N1T6)2 " H(!R
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M-HXK.3S+8I/('A;&/E?=N QQ@'&.,8I]OXLT>ZL=1O(IY_)TYS'=;K656C8
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M>.W2&-H(2PRJG*[VQD G<,G.,=*N2^(K32[7;J4DGVFWMDFO?)A:00 CEFV
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M<GEB3U-7:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MQ-X:-MYL&K7DT]O?>8NV-)F#-O4G=N0[L8!!^7D<X;J_AK6+FS\=6UO8._\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 0G )]/2L70/$D/B"XU6&*TN+9M-NC:R"?:"S!0V1@GCYJVZXK
MP-_R,/C;_L,_^T8Z +&J^-VT>_M_M>A7ZZ3-<K:C4LIM#L=H)3._83QN(^F<
MC/6UPOQ-.L66CPZW9/:7%EI4R7<^GS0DFX"GJ'W<%<[@,=0#SC%=R#E0<$9[
M&@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #M61I'AVUT6\O[JV
MFN6DOY?/N/-<,'DP!NQCC@ 8''M6O10!@V_A.TA9A->ZE>VYF\];>[NFEC5L
M[AUY(!Y )(&!QQ6]110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>aquestiveamendedandresta014.jpg
<TEXT>
begin 644 aquestiveamendedandresta014.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M(]M'%#J%S-=6(OX8K>T=V>([>G;/S#CM^53VGB[2]2LK"YTUI;UKZ-Y8(85
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MD)DW'YBHRN><+^)SB@#L:*YI_&^F10M-+!?11Q+ ;DR0%#;><<()%)W \C.
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M8W<Y&.N*V@<J#@C(Z'M0!YM'X3\00^ M1\,1VUN8EO0^FEKG[EN)UE".<<$
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MD$@C\""/PI] '/\ @G2KS0_"=GIM^D:W,!DW>6^Y3EV88.!V-=!110 4444
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MO=#;1AI]G%8.<F%+=0J^ZC& WH<<5I7MC::C:26E];0W-M(,/%,@=&'N#P:
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M (O%MVMM:Z=#]JG@DNK^*"-(&V&=N6\LOD%%(4DD<X&!G.#Q]KK>H_\ ".R
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M45M;06=M';6L,<$$:A4BB4*JCT ' %2T %%%% !1110 4444 %%%% !1110
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M"<Y*X48)R< 8INKQRV&A^.)(-1U%3HM\CV&;Z4^23%"Y'+?,"S-PV1R<8R:
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MD"%FZ[L]3U]..E9VG7IUG4&EN/$B6&K66M21R6@#&5D$K*D.SS,%&CV\A?\
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M(\"N8M/&MI+?06]Y:S6(N+*2_C:X(#+%&0&\Q>J'# X.>,\Y&* .F50BA5&
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M02IP>^0>,B@#132]/C>%X["U5X%VPLL*@QCT7C@?2EATRPMYYYX;&VCFN/\
M72)$H:7_ 'B!D_C6/KNO7NG>)- TRVLA-'J$DPD?> 0$C9L 'WP<^V._'-^'
M_$KZ+_:,=U;7US:/XCFLOM;S!Q"7D"1CYFW$9(''3/UH [EM'TMK%K%M-LS:
M,=S0&!?+)]2N,5:BBC@B2*&-8XT 5408"@=  .E<SJ'CK3["Z9/+,T,5VMG,
M\<BET<D GR\[BH)P3VYX(%;>JZK#I-O%)*K223S);P1)C=)(QX SQZDGL :
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MV\CK%I,,\S<LQ B#,?<]:P/&.N2ZE\/-5O+=)K=$@@N(+JVN<K(&DQ@,AY(
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M$S20")D8Q @X"%DW<=V/'>NDT/7$US^T@MM+;FQO7LW60@EF4*=W!(Q\U:U
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MTMD-"#L8],GU..*_D!P!&5;:&/92^P'MV/!KJZ;)&DL;1R(KHPPRL,@CT(H
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M @(:9E551E.[Y> <CGK6[0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q3^)+F[\
M8ZKH"ZK!I=];!#86\\(9;M60,7)."PW$KM0@C:3GT[6N)\4:4OB*#4;#6/#,
M]ZD;YTZYMVC#C**<ABP9&#YY/! '7I0!OOK<.EZ9;R:Q(8[K[,);A8HFD*8
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M5DR<KL*YX!R,8YXK2T'1[[3?&EY++;2M9_V5:6D=VS)^\>(R;N-VX9WCMZT
M7K3QQX:OKRTM;;58GENV9(/D8*[*2"H8C&[@\9R>O<5=;Q'I*7B6S78#R3FW
M1RC>6TH_Y9B3&W=P1MSG((ZUY_X<TVXU_P $:#81V<D:VVLM>-=,5VJL=U(Y
M*\YR<;>G<GIUMQ>&-8D\&_\ "(W%I)YD6I"5-1WKL:(7/G^9UW!\97&/O>W-
M '6?\)EX>^W2V9U.,3Q2/'*"K8C9$\QMS8P,+SDG!P<=#23>,-'CT^_NUFFD
M%C;"ZEB%O()#$02K!2H)!P>1QP<D8K&M=.UJW@\<-#I:?:+^=YK%;DHT<_\
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M@$DY&  <YJ33=6L=7AEEL9_,$,IAE4HR-&XZJRL 5/(X([BO/KCP]XFBL-T
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M5&<=: .ZB\1:5/(8XKDLXM%O=HB?)A;HXXY'TJI<^-O#EI;VL\VIH([JV-U
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M(:.-+90J[78KN=P<9Z,JXSP5:H-0U6XG\:VGAV"Y>T1K"2^DFC52[X=45%W
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M4A\MC"SD?=^894=<GWJVFJ:KKVI:KI=CJ8T^ZL;*WDB;RD<222JS;G# Y08
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M[Q++J5DEVUB+32+>X;RD1C)).C,3\P/RJ% P,=3STK9^'_\ R3GPU_V#+?\
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MW> "H.,993CL3Q'XCU_1AXEL(+\O)8PVEW:W;PH6"RR&-HW  4\J2#@'!]J
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MP!Z))&DJ;)$5U.#AAD<<BG5YG<^)/$/AQ]+U&[OO[4M-0TJXNI+;R$C\F2*
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M>)+*Z01RQSRO+E!T4%V) '8#&#R.:73_ !GH>J3VL5I<S.UW;FYMR;:55F0
M$[&*X8@$94<CTJ/1/&5CK&BQ:CY5S")IY(HH6@<N^UW VC'S':A)QD#G)XH
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M);2&4^6VU_DQN&#P<CN/45-::SIU_HR:Q;7<;Z>T1E$^<*$&<DYZ8P<YZ8-
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M$Z29SNZX4\>N*EU?PSK-];^.K**T39K"K+:3-,H#,((TV$=0=R'GI@BO0J*
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M?*TH50!E5+$X4D#@8' XXH YR2?Q#%ID^JQ:Y ;*;29)H]LBRN9E7>LD>8@
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M]I=:?<RVT42D1)<,HPHR3SLSC\<5Z"_AC2&DN72V>'[2Q:=;>>2%96/4LJ,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !112%U5@I8!FZ GK0 M% .1D44 %%%-CD26-9(W5T89#*<
M@_C0 ZBBB@ HHHH **** "BFK(CE@CJQ4[6P<X/H?SIU !1131(A8J'4E>HS
MTH =1110 4444 %%%% !13?,3S1%O7S"-P3/./7'I3J "BBB@ HHHH ****
M"BBB@ HHIJR(Y8(ZL5.UL'.#Z&@!U%%% !1110 4444 %%%% !1110 44U)$
MD!*.K $J=IS@CJ*=0 444V.1)4#QNKJ<X93D>E #J*** "BFI(DJ[HW5UR1E
M3D9!P?UIK7$*SI TT8F<$K&6&Y@/04 24444 %%%% !13?,3S?*WKYFW=LSS
MCUQZ4Z@ HHHH **** "BD)"J68@ #))[4(ZR(KHP96&0P.01ZT +1110 44U
MI$1E5G52YPH)QN/7 _*G4 %%%([JB%W8*JC)). !0 M%("& (((/((I: "BB
MB@ HHHH ***:LB.6".K%3M;!S@]<'\Q0 ZBBB@ HHHH **** "BF^8GF^5O7
MS,;MF><>N/2G4 %%-21)4#QNKJ>A4Y%.H **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "O,_$A?0/$6K:AX@T'^V/#M^$/VV!
M/-ET\*@4JR]0F07W+T))ZUZ96%/H=^9]1:UUAHX;]]SQ2VZR>5\BH?+.1C(7
M/S;AGM0!E?\ "2K;6EOIN@ 7[6^EPW4<IBD=948,L8&Q3@MY;<GIQP>T\?BC
M4]22XATS20FH6MC%=SVEV^QA)(&*P ]C\ARQX&1P<G$;^ X[.;39] U:ZTB:
MRLUL"R(DHF@4Y 97!&X$DAO<U-<^#9!K,>J:7KE[I]RUNMK=LJI+]I122K-O
M! <$M\V._2@"*UU?6[CQW=Z>\5NEM'I4%RML[D%7=I 0S $$Y0#(&,=,U5\-
M^*$O-'\.6.F:=:6-QJ-I+<K O^IMHD(!P!C.690!QW/;!VU\-B#Q$-8M;Z:)
M_L*63PLH=75"Q0DGYL@N<\\\5FV/@6/3+/0UM-1=;W1E>*"Y:($21/\ >21<
MC(Z'@C! ]\@%4^.[UH+5(M*A-X=9;1[J-K@A8Y0I8,IV\J0 >Q&>AK<\,ZW=
M:N-4@OK>&&[TZ]:TD\ERR/\ (CAAD ]'''J#523P9$R69CO&2:'5#JLTAC!,
M\Y!'(SPN#C YP!SP<Z.C:&=(O-6N/M)F_M&Z^U.I3;L;8J8'/3"+^M ',^,_
M!?AZ_4O-ID,^K:M=1VXN9,LZ@_>*^FV)7(Q_=%=XB+&BHBA548 '0"J4^FK<
M:Q9W[R$BTCD5(L<;WVC?GU"A@/\ ?-/BMKE-4N+E[Z22VDC18[4HH6)AG+!L
M9.<CKZ4 +J&G6NJV3V=["LUN[*7C<95MK!@".XR!D5P&B>&-#O?'?C>SFTFR
M\B,V8B58%'E9@R2G'RG/.1WKTFL/2_#S:;XBUC6/MAE;5#$98C'@)Y:[%VG/
MIUSG\* .,TK6+OPRGB"YMK"U;35\3&&?]X4<"5H4RB@8X+@\D9YKH+WQ?>B>
M[.EZ7+?165X+66*.*0O)]W>R,%V#;NZ$\[3R.,K/X(\_3-3L6U)@E_J2ZD["
M$91U='"CG[N8U]^OKQ*/!\L&N7=[9:Y>6EG?R":]L8T0I+)@ LK$%DW #.#G
MW% %?XD:G=V&@V%K:3/;MJFIVVGR7$9PT4<C?,P/8X!&>V:UYO">C/!;10V$
M%L;::*:)X8PK*4<..1R02O.>N:LZ[H=EXBTB;3+]6,,N"&1MKQL#E64]F! (
M-0V>F:G&D<5_K+7<49!!6W$3R8Z;V!P??:%S],B@#"N/'$D.A2>)([6*31(K
MQK:0[CYNQ9?):4=L!P?EZ[><YXJ3_A)]=FU;6[:VTJP:#2)MDKR7C*TBF$2*
M5Q&>?F .>G;-3)X(MTMKK31=N=%N;O[8]D8P2K;Q(45\\1EQDKC/)&<5,^B'
M2U\2ZC]I><ZFOFM$L/*LL0C 7&2>%'XT 8UEX]U%!H%[J^EVUMI6M6^^*>&X
M9WAD\HRX=2H&" V,$].:NQ>,;D6_A_4;BRB73==D2*#:Y\R!I%+1;^Q# 8.,
M;21][K5;PCX<:]\*>&&UAGD&GV2+':2VYB*2&+RV\P'DE5+*.!U.<G!K1T[P
M;'96VF6,M])<Z?I4WG6,,B#<A (0.V?F"!CC@=!G.* *5AXK\07VGZAJ":+8
MF"TFN;8H+TAFDBEV9RRA0F Q))!XZ5GZWXUU(^&_$_V$VPN]+>%$ND#;)$E"
MG<H/0C<0.2. >>E;)\$J_AC4=$?4Y@MY>/>"=(P&CD:7S2,'(*[NQ[<5'<^
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MP^48&!][KQFMSP]J=]JFG22W^G265S%.\.UPP64*>)%W ':PP>1D<CM6')X
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M&&0E3N.".047\/?F@#)M?%NJ:S>>#)[2."WMM5BGEN(7))W(G*Y'\())'')
MZ5O^)]=O-$_LI;.RAN6O[Y+/]Y,4V%@Q!X4Y'R\^GH>E4;'P,NGVN@10ZI.L
MFBF412B-<R)(,,K Y&?<5JZ[H9UM]-871@^P7B7BXCW;V4$ 'GI\QSW]Z ,B
MWU>YA\6"#5='LDOX]%:YDN;1S(Y D ,2DJ#MSSCN:CT[Q;>:I=Z!;OIUI+::
M]8O=C$QS BA"RL-I#G$BC^$9!%:6J:3/!K%UXEMFEGN8M,DM8[*)5!DYWC#'
MHQ8 #/'M7+>$++4+2>T73[^YEPH2Y2]\/FU(7!R6EVH6;=SP6R3SU+  C\!:
MW?:7X>\(Z>]E;_V?J!FMHI%E/F(ZB20$KC&TA".N>A]JN:?XRU&R\.W.IZR]
MN(_[8GLFN51S';(LCIO<#G8-BCKU;)(K5L?! L;/P_;+J3NFBSO/$6A&9"RN
MI#<^DC=/:K%GX5GTU)X[+5Y5BDOY;T12PJZ?O"Y>-@,%E)<GKQ@?B :^D7DF
MH:7%=2&W8R%BKVTGF1NNXA65NX*X/XU>K+\/Z';>'M*%A:X\OS9)B NU0SN7
M(51PJ@M@#L/6M2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "J&JZUI^B0P2ZA<I"L\\=O'N8 L[L%
M 'YY/H 35^N2^($1;3-*G^SR31VVKV<TOEQ&0K&)1N. "<#O0!TKWUG%)#')
M=0(\W^J5I "_^Z._X58KS*\C,MOXXT[5+.:2YU$>;IO[ELS1F%5B2/CAD<'C
M@J3GC.:]!TB*Z@T6QAOY/,O([>-)WSG=(% 8_B<T ,L[R4QS-?2V2XN6BB,,
MN05SA V<8?U []*LPW=M<0M-!<12Q*2&='#*".O(]*\E:QMWT80M8$QKXR,R
MI]G.! 9\EP,<(5[],5-JEO/:S^*ET^PE;3DUBPN;BVMX3B:V5(O.V*!\W*G<
M!UP0: .YTKQ)_:?BK5=+C^S/:VEM!/%/#+OW^89 0>PQY?O6Q'J-C-;R7$=[
M;O#$2))%E4JA'J<X%>8:NTVI:KXONM!L[J4W6F6+HT=LZ?: DDAD0%EP6,?R
MX/7..:C\00:5KG@_Q)JFF0:I=75U8I"YN;,Q9D5OD58]B[G7+?, <#C- 'J3
MZG81K.SWMLJP$+,3*H$9/0-SQ^-22WEK H::YAC!4N"[@94=3SV]ZX.73=);
MXA7+G3X#9/H0!/V?]VTGF,?3!?:WUP:Q_#EC#-<?#\ZA9;F@T6>*Y,\!_=L!
M%M5\C@_*V ?0XH ],NKN7%C)92V30S3*)&EE(W1E2?W>,[FSC Z8S6'<^)[N
M[UC4-.T(:=-/IQB$R74Y3S-XRVTKG&U<$\'/(XQSQVF6X3PUX)4VLBRVGB"7
M(,+!H8=UQC/&53#1^W*UMP0VSZ]X^\VV!CECB\LM"=LN+?#;>/F^;@XSS0!V
M,&H+#I%M=:G<V4+O&ADDCF_<ER.=C-C(]/:IY[ZSM1&;BZ@A$APADD"[OIGK
M7F.D7G]C1^%)]9LKM])?PZEEE;5Y?L]S\N]71064LH"]/X<4>(H((;.\TFQT
M:\LT;PW)#:GR)9WD7Y]L ^\J$84MGYOF R,9H ]&;7-.37%T8W4?V]H3/Y6X
M9"Y &?<YX^AHLKUQI0NM3GL8V#,'D@FS" &('S-CG&,^^17&:24_X3'2;NZM
M+CR;GPZD(DEM7P9%?+!B1\IQS\V.*R/#RW.GZ7X+N)K:9-*M+J_2[0Q,/(=W
M?R79<9"@%AG&!O!H ]4%W;&&.87$1BE($;[QAR>F#WI;>Y@NXO-MIXYHR2-\
M;AAD=>17E%[HX\^.1[0OID_BN.XM(VA)"0F/$KXQ\L;/N/H<YZ&NM\&0I:ZY
MXMAA@\FW;4UDA41E$(,$09EXP1N#9([@T =1<WMI9A#=7,, <X7S9 NX^@SU
MHGO;2UW?:+J&':N\^9(%PN<9Y[9(&?>N#\=/YNJ:A9K8W EGT&:..YCMY)O/
MR6_<J "JG(!)(R01TQFJ>E6MC>^)]*N+ZPWQGPPJ2M<VQ \P,O#;A][:&X/.
M/:@#TBXO+>VMOM$UQ#'$1\KR2!5.>G)K+\):W-XB\/1ZC/#%#(T\\12)BR_N
MYGC!!/7(7/XUP'A:YN-*'@R?5[>Z_LY-%:T4M [?9[K<O#J!E247:"1ZCO75
M_#./R/!B6_V:6W$=Y=[8Y(6BPIN)&7 8#C:10!OP:YIUQK5UI$5U&U[:HCRQ
M!AE=^[ ^N%)([ CUJS;WEK=EQ;7,,QC.U_+<-M/H<=*\W\2V>I/K'CBWTVUG
M%_?Z5;?8W2)L2;1*) ' P&P<=0<L*V+58M4\:Z#JNBPO#:PZ?/%??NC& IV>
M5$P('S*VX[>HP>F1D ZC5=9T_1((9M0N4A6:>.WCW, 6=V"@#\\GT )[5F6'
MB83^(M9T^\-K;P61MQ!-YW^N\U2PZX&>. ,_C53X@PE]'TZ?R))DMM6LYI?+
MB,A6-9E+' !) '7%<IX@LK?4#\1)38-+)+IL(L]]L=Q<0L,)D9W!MH('(.*
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M?^ RAW'IA:Y^.?S-=T*==.O+5;?7[OS[86DK>7O28;WD(.[>2K<': P&.,T
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M/VG&[R=XWX]=O6N?NO$MS<:]>Z1HHL9KNQ2&26.XFV^;O+Y12.A54))(/4#
MZUQZVE[=^#1H\D,J>*[?61,)#&=V[[3O,X;'*>42,],?+UXKIM$2-?B7XGD\
MG:)(+,1R&,@.RB7?M;&"1N&<>M '72S101-+-(D<:C+.[  #W)J$:C9&.*07
MEN4F_P!4WFKA_P#=.>?PKF?'<UU9C1=05+M]/M;[?>_9(A+(B&-U6385;<%8
M@G@D=1TK'FT72M1\--9:4E\DVHZB;RPN[B)D,,XPYG52HV*"#\N!N)P.&S0!
MZ +RU92PN82 _EY#C[W]WZ^U$-Y:W%N;B"YAEA&<R(X91CKR..*\KU&XM+WP
MCX=34=.\BYM->@AOD>(MNDWL))%)&75SEMPSD'GO3M1TNXL9O$6I:#9S?V(]
M[83/;V40_?",DSM$A&&X,?088H>M 'J,=_9S6XN(KN!X"VP2+("I;.,9SC.>
M*5+VTEADFCNH7BB)$CK("J$=03VQ7EVLV6D:AH=SJ6G07]T+W5K":26YM63>
MR2H'98]BD8C'S,!@^IP:M7-C:KJGC&WB-QI]K))ITD$UG;Y"2*P^=5QM8*P3
M?[ YH ]&&H636K72W<!MU^]*)!L'U.<4-J%DEJET]W;K;OC9*9 $;/3!S@UY
MC+>ZQ;1V6H:E S65IJT@O+[2;8L+@& *ER(B&X!.UL \@D5:DT^VMK.RN-!O
M[O39&N+JZMIM1MB;>;?LWK(A"F-6).WA>A(Z@$ ]*1UD171@R, 593D$>HK/
MT[7M,U47;65Y#*MI*T4K*XP"H&?P&<9]0:9X8DFE\+:6\]@-/E^RQAK09Q#A
M0-HSS@>AY]:\[DAO+?3M3CBL+DI;>*C=WT*VS?O+3S0V5X^<?=; SPIH ]4M
M[JWNXO-MIXIHR<;XG##/U%)<W=M91B2ZN(8(R<!I7"C/IDUS&AV[2^/-9U6P
MR-)N;.W5F (2:Y!?++ZX38"?P['#/%4Z)XETB*2SG_>6URBWJ0/-L+; 8@J@
MJ&8<[F! "D#J: .IEO;6!0TUS#&I0N"\@ VCJ>>W(YH^W6FZ)?M4&9@&B'F#
MYP>A'K^%>4>%+.WGNO YO]/;_1]#G@N#=6K *X,6U6W#_9?&?0XJQ8:?-!\,
M-*UBVMV34O#T\]U%'(A1O*$CAXN>0&B/'_ : /4HYXI6=8Y4=HSM<*P)4^A]
M*9<7EK:-&MS<PPF0[4$D@7<?09ZFJ6@6LD&F^?<1[+N\<W-PIZJ[=%/KM7:G
MT45Q?B(PCQ7K&G^((]3.F:K:116K6EIYRR !@\60C%&W'<.G7.1B@#T">_L[
M7=]HNX(MFW=YD@7;GIG/K@XIR7=L]Q);I<1-/& SQAP64'H2.HKS2YTFS_MC
MQ:D^G%PV@V\:&:+S"\H28,-V/F?E 2.>14FE6-O'K'@EEL@OF:+/%>MY!&YB
ML/RRG'4LK\-W!H ]%CO[.:80Q7<$DI3>$60%BO3./3WK)\.Z_+JUIJ<U[%!;
M?8;^>T.V0E=L9QN)./Z5YSX2TJROO#G@"XTFV1-6MKA);J>./:ZP!'$@D;&=
MK?* #UXQP*NHMY';2W*V\\EC!XNENKV-8F):W).V3;C+(&*MQG[N>U 'IPU&
MQ-NEP+VW\ASA9/-7:Q] <XJ7[1"9?*\Z/S-N_9N&=OKCTK@3X97Q'>^+TB/E
MZ9J*V[6DH7"B[123,GT/E9(ZE3Z&J]P=<UOP#J.N/82+JTR0Q-:Q8+M##(/-
M5>H.\^=@<Y4J* /0[>]M+N)I;:ZAFC0D,\<@8*1UR12VUW;7D7FVMQ%/'DC?
M$X89],BO,=0$&H:1J6N^'X=9NY7>T:^$EMY3S1Q2AFC2-D4.X3=G@@CY>>E=
M5X172[J\U+5],.H2?;?*\^>[A,(D=01\J%%Y P"P'/ R<' !TES=VUG%YMU<
M101YQOE<*,_4T2W=M BO-<11JP)4NX ( R2,^P)^E<KJDDEE\1K6[U%"=(ET
MM[>&4H6CBG\P%@W]W<@4 GKMQ7)V&A"*Y\'6^I6!DMEU#4#'%- 6\FU=9?)2
M3(^4<I@-TR!VH ]:1UD171@R, 593D$>HJ*"]M+J22.WNH9GC.)%CD#%#[@=
M*CN(X[+2)8[:TW1P0%8[: ;,@+PBXZ=,#%>7Z(PEU;39$AO[6VD\,SVH$-E*
MHM6#1D1AF&691N^9CR1QC.* /5(;VUN)'CAN89'0X94D!*GW Z41WMI+/+!'
M=0O-%_K(UD!9/J.HKRKPU-IVIW>@M]IA@U6PT=[&TC>TEC,DI52&)DC4 KL)
MP"WWFP<=;?A=--U&#2_[0M=6&K:59R6]U!=6OEQP@IB0,P0+*&8 @;F)SGL:
M /28[^SED\N.[@=]GF;5D!.S^]C/3WJOI&M:?KMF;K3;F.XA$CQ[D8'E6*D\
M=B5.#W'->:^%["*SB^&["Q,-PEO-'>-Y!5ES!C$AQQE@ -W<"NK^'"?9_#+V
M4EM+!<V]Y="59(63K<2,N"0 WRD'C/44 =1<7EK9A#<W,, <[5\UPNX^@SUK
M(UWQ%'IFHZ=I<4MLE[J#.$:=ODC54+;F&03D@*.1U]L5C7!2V\=:V-=@:33;
M[3H8[-VB+H57?YL7 /S$LIQU88ZXK%TJPO+&;X=6^KQR/=6T%P+AI$+>4#$1
M&KMT!Z+R>H- 'H$>HR66@B_UW[-8O#$7NBLNZ./'4AB!D?A62?%\;:[H]O%]
MG_LW4+&:[^TM+@IY?E\$=!_K/7M6AXKMI+OP?K5M%$999;"=(XU&2S%#@ >N
M<5Q=HEG?Z[X):6S9K6'2;A91/;,JHY$.-P8<$E6QGK@XH ]$DO;6*T%W)<PI
M;$!A,T@"8/0[NE2QR)+&LD;JZ,,JRG((]0:\@TJ>XT?1?"UU<Q:A#I5M)?V]
MP;>U\QK9FFS"S1E&.W8&4$+P''8UZ-X2L;/3O#T,&GQ74=F7=X5N@5?:S%L[
M2 5!))"X& 1P.E $2>()]3UR_P!,T>"&0:>52ZNIW(19",^6H RQ P2<@#(Z
MG.+NGZC<R1WS:I;16/V6;RP_G;D=-BMO#$# RQ'([5RGAYQX/\1^)++55DBM
MM2U%]2M+PQL8G$BJ&C+ 85E*]#C(/%6_$]W<37GA[4DMKA]'M=1+78\ILE3&
MRI*4QG8KL#DCL&Z &@#K%O+5[9;E;F%H&P%E$@*G)P,'IUIAU/3UB,IOK81@
M%BYE7  ."<Y[$X/O7EWB'2_-LO$MS%;/)IEWJ^GS6<:Q%MS*\7GR( ,X(!R1
MUVL:U-0TSPW9?$S3HY].T^*RET:Y8K]G41%C-$<L ,=VY/<^IH ]!EO+:"V%
MS+<0QP$ ^:[@+@].>E#7=LL22M<1".3&QRXPV>1@]Z\O\/6-]X>N/#,NH03I
MH<9OTA61"?LGF2;H#(.J_N\J"?N[L'&:AET81PZ8MS9,]B_BR2XM(FA)\JT9
M'!R,?+&7).#@884 >I?VG89@'VZVS< &']ZO[P'IMYY_"JRZ[83ZI>Z5;W<#
M7]I$DDD9<?+NW8![_P ))] 0>]>;^-((8(?$NEZ=I$UGY=M:&);6S=Q<JC;@
M5(!1%0EN  2><]CN;8/^$P\5-<V4IAO],MGA:2U;:X59MV25P#DJ,'G)'% '
M86U^(M'MKO4[FRB=XU,DD<W[G<1SL9L9'I5IKFW18V>>)5D^X2X ;C/'KP,U
MYGX::?36\&7&I0RKIB>'_LA+QG%M=?N]V\8^4E5*@GT([\U;71#!/X8CO+(M
M:#7KV6WCEA)\BS9)O+5@1\JDE< ^H% 'J\%Q#=0K-;S1S1-]UXV#*?H15-M<
MTY=<71C=1_;S#YQAW#(7( S[G/ ]C6#X!C6"#7X$B,,0UFY:%-A1?+8@@J/[
MI.<$<=:I:U!=+\0;I[2&1+BZT!H+.X$+%!.)&(RP&%(RIYQQ0!VD5Y:SSR01
M7,,DT7^LC1P63ZCJ*@U?6+'0M-EU#49UAMX\99B!DG@*/4D\ 5P6F0/?VO@1
M;"VFMM3TQPFH*\95H8A"RS*Y(_B?9C^\?F'0FNA^(]M)=> ]22*!YW4Q2!(T
M+MA94)( Y/ - $Z>*%7Q9=Z9<-:16,5A%=QW1FX;>[)@DX Y3U/6MRYO;6SC
M62ZN88$8X#2R!03Z9->?:G!8ZGXOUB>6R\VV;PZB0F:V.-^^4[0"/O89>.N#
M69;7#V<.@_VXNIII=WX=M[,R0V9G\N< ^;'(NQF4L"HZ#)3':@#UOJ,BN4?Q
M9)=:S>6NFOIS1:?<Q0W7VB?875E5F9"./E##@CD@C([[6@VD=AH-C:0QSQPP
MPJD:7#;I%4#@,?7&*X"\L6O=.^)UO:VC//<AOLRB(@R_Z*B_)Q\WSJ1QWH ]
M)>Y0^9%!)"]RJ;A$9,?3.,D#WQ7):;XTO+ZP\'W364"+KSLDN)#F(B)Y!M&.
M?N8R3^%4M*U&"\\>65_##=?9/^$?:(SO:R(H82JVTDJ,< ]?<=:RM"CEB\/_
M  SCD@F1[:X;SU:)@8?]'E7YQCY?F91SZB@#T_[9:F[-H+F'[2%W>3Y@WX]=
MO7%0S:OIL"7#RW]JBVREY\RK^[4=2W/&*\\\/QPWE]::9K,6K_V[IVIR7(06
M^V(DNW[X3!,%"C<@MSTQTIFGV]\([C3[8?VII\VDW8MWEMREW8EMI\B7LVXX
MQD!CMSR.: /2-,U*UU?3;>_LY!)!/&LB$'D @'!]#STJW6#X*D1_!>CA(I(C
M'9Q1NLD31D.J*&X8 ]<C/M6]0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !116/K^M'23I\$2;[F_N
M/L\7R%PN$9RQ4<G 0\#')'(ZT ;%%<5=^)?$ECX<O-4N-)B7^S[HB<%&4SVH
MP3-&N[((4D[&/\)YZ9CU_7M7?P7:ZM8W-K"+R_M1"RQEB;>69%7)W?>*L"<>
MI'O0!W-%<=J'BC6%EU*#2+!+ZYTN2.*:$0N/M#E$=@K9Q'\KC&[=SGIU-/5_
M&6NV1\3R6]C8>3H4<5PPF=]\J-'O*\<!L=^0,=\\ '>T5R=GJ6IW/Q'NK+[3
M%_9L>F07*0^4=P+O(#SNQGY!SCIQCJ3;N-:O;O7]1T?2!;"XT^VBFE>Y5F5W
MDW;$&",<(26YQD<&@#=GN(;6!IKB:.&)!EGD8*H^I-$,\5S"DT$J2Q.-R.C!
ME8>H(ZUYW<Z_=^)I? >I6+1VL-[=RLT$R%]LJ03 @D,-P!!QTY /M6QXD-UH
M)\-6&A&UL;6YU0021+!\N&223@!A@%E)([YZ]<@'617$,[2+%-'(T3;) C E
M&QG!]#@BI*\N35K_ ,-7/C/4K*VLWM+;686N$?<&=6A@5MF. ?FSDYSZ=ZZ+
M4O%.J&XU--$T[[:VFW"020>6Q:=BJ.P5\A4PKC&0<D'IP: .OHKGO%.NWVBP
MZ4UC:P3/>WT5H5GD*;=^<'@'T_#T-<]>>.-<TRSUZ"\T^Q?4])GM1F)W$,T5
MPX56&>0P.00?2@#T*BN6BUK67UQ?#\HTZ/4OLTEZ\J*\D2Q>9LC&TE26/.3G
M V]\\9\'CB]FLM)OI+2""WDU-M+U(-EC;S!F0%3D J7 &2.-XH [6:XAMU5I
MYHXE9@@+L%!8G '/<G@"I*X_7-<N8=/@NGLK&ZM9-:@M8A,AR$,RQ^8!R"P;
M)!XZ ]\5)%XLDF\7RZ&SVUM/'/M%K<HR23P[,^;$Y.U_FXV@$@ YZ4 =1#<0
MW 8P31RA'*,48-M8'!!QW![5)7"Z;XL=8%M8["SMKZ\UVYT^-8@?+W1ER\K=
M"Q(0GL22.G6FZGXWU/2[;78&L[674-)N+56.YDBFBN&"JX')!&2",G[O7F@#
MO**XR3Q7JUE-XBMKNPAGN-,A@N8A9J[[HY2P.5ZL4V,3C&X= *V?#6MIKNG3
M7L5[97EMYI6&>U!4%=JD[E))5@Q8$'T'K0!M57GOK2VFBAN+J"*68[8DDD"L
MY]%!Z_A7()XVNFT;2?$7V>!M'U&[2W\L B6))'*1R%LX;G;E<#&[J<<MTFTE
MU3QSXK@U,6EW:PRVF(G@)QB,.F,L0,,2>G4D\4 =N[I&C/(RJBC+,QP />DB
MECGB26)UDC=0R.AR&!Y!![BN'U*[U&[\1>+=.N)X)--M](BD2 PG/SB?)SNQ
MG*C)QT &!C)C\(:UJ=I;^$](N8+0VM_H@EMFC9MZ-%'%D.3P00X/ XQCGK0!
MW<%Q#<Q"6WFCEC)(WQL&&0<$9'H014E>?6?C06/A32[^>UM-+MKF\NH9YXX&
M>WMBDLB@L%((WE?O' R3GK7;:9<27>E6ES,T#2RPH[F!]T9) )VGNOH?2@"U
MN4L5R-P&2,\X_P @TM>6QZ\MMX_T[Q!]L9[+6G;39(2#MA0'-LXX_B(<_P#;
M6NHU'6]=_P"$Q;0M,MM/*BQ6\$UR[]/,V,,*.N,X_P B@#II[B&UA,UQ-'%$
MN,O(P51DX')]R*DKS4^(-6B\&Z_J.HQV&IBWUB2V$,T)"!5N!&."3G'RD#U&
M<DUTEQKNK7EUJ\6A6MM.^E31PO#.Q4W#E5=@K9 3"N,$@Y.>!C) .B2XADGD
M@2:-IHP"\88%E!S@D=LX/Y5)7G\NJ0^'O&7C34S"&\NRT\[%XWNS3*N3[D@9
MYKHM'U/6+C6+JTO[#%HL2R07J1-$&8DAHRC$G(X.1P0>V* -I;B!Y#&LT;..
MJA@3^5-:ZMU9E:>(%?O N./K7%:M!#X9^)>F:ZL2)::VG]F7;A0-LX^:%R?]
MK#)_WS4E]:6]WX-\5:VT$1?4K.=D;8,F!(BL?/<$#?\ \#H [6.1)5W1NKKZ
MJ<BG5SWA-)$^'NB+9B))?[+@,8=?EW>4N,@=LUB:?X[N;B7PQ]ICMH4U5I8+
MM=C;K:XCR-F<XP65E!/<>_ !W$EQ#%)%')-&CRL5C5F +D#) '<X!/X437$-
ML@>>:.)68*"[!06)P!SW)KDY=;NGU+PL;BQL94U*ZF$4Q0[X4$4CHR@YPS*H
MSS_$1[URVIWFIZEX2O+C49;>ZFM_%$4$&V,IM\N\1  26P" /USF@#UFBN?T
M#6;^]UG6M*U&*V$^G/$5DM]VUTD3<,AN<C!!]?:LM_%>KQZKX@\RUL$TS0GW
M7+[W,KQ>0)?D&,;N1UXH [2BN.7Q+X@02S_V(UW;'3Y+J/R(VC*S*,K"=Q._
M=T# #D=.:I3>/+@^')]7TR73=3CCN+:#"[X61I) C*Z$DJPW#KCK0!U.MZ%#
MKHL1-=7,'V.Z2[C\@I\SI]W.Y3Q],5JUPLWC;4M%U#5-/URQM3<0007%H]H[
M%)5EE\D*V1D$.1DCJ#G':K$WBO5M-:Z6_P!-#(TMO!8W(C:%)9)G";65B2NT
MD$GG(Z<\4 =E17#^+-4\3Z;X=U)R;. Q7-K'!=Q(?WT<DB(XV;B48%L9R<CI
MCM?\=W^IZ5X$OKNSN8HKV-45I1&<?,P4E1NX//!R<4 =317,G6M3NM6U+2-.
M^QM>:9;12SO+&P2623<510&RHPO+$G[PX.*@G\43:I\+;GQ-I0%M.=.DN8UF
M7?Y;JI)&,C."I&?QQVH ZDW$*W"V[31B9U++&6&X@=2!UQS4E>;D:FWBWPE-
M$UI)J,VB76Z>5&"D9MR"P!);&?4=3TK2T[QM<ZIINC+';)%J-_!/+)MB>9(_
M)<1MA003EF&.1@9_$ [:HX+B&Z@2>WFCFA<962-@RL/8CK6=H=]J>H:#'<ZA
MIPL=0(97MW;Y=P) (/7:< ^HS7):+XKU*XT_PG!IVF:9:KJ]O.VP;EC@,8SA
M5 Z<_C[=: /0JQ[[2[37;R&4ZE<F*T<I-:6\X$4K?*=LJ@9., XR.#SD&L+3
M/&=WJ%KI-HT%O'JU]=W5JQ&YHD^SLPD<#()!VC R/O=>*R?#FK2Z$NMV[10F
M\O?$\MK&(8F*!O(1RVP'/W4)VYZG&>] 'I=%<1<>*_$-G;VHN-(@26;5X[!9
M)"T:S1/RLBKR5/4$$G&.]5;[QEXATZQ\1S26NF.^@3+YY4R 3Q-&D@"C^%MK
M]22,CI0!Z#4$TL3/]D^TK%/*C%%#+OP, L <YQD=B.17(ZOXIURWU37[2PM=
M/V:7I\5\CSLY,@82$J0,8)\OKV]ZL0ZZ]]XGT)%L+51J&DRW<5PXW2Q?ZHE,
M\?*=XSSSMH OZ/%H_A+2;;0AJT>VTBP@NYXQ($]\!>.>N*WJ\F6:6#P1KNM:
MC8:7JTMEK-VT:74!(5O/,9/)/\. !QP ,\5V=WKFJW5[K%KH5M;3S:48T>*<
MD&X=E#E5;("85A\QSDGH,<@&OJ^F'5K1;<7][9;9%?S+.41N<?PDX/![U8BC
MMM-L$C39!:VT049.%1%'<GL *Y37O%M_HU](&M[;R([NU@$62\DB2LBF0E3B
M/#.0 P^;8<'D54DUG5TN?';7!L[RUTR,"*UEB*JR>0)-IY.<AB#QS[#B@#NT
M=)8UDC971@&5E.00>A!IU<G8>(;K4;BUTG3([2WN%TJ&^D,D;&-/,X2-5!&!
M\K<YX '!SQGV?CC4M7;P\EA86L+ZHMTDPN)&/D2P':P&!\PR#Z9]NM '>45A
M^%=:N==T 7EU!''=QSSV\J1$["\4C1DKGG!VYY]:QM+\7:E=ZQ;Z=-!9F:YT
MV6\ B+;89$9%,1D!*R8WX++T*GCF@#M:HZM;V-_I\NF7\H2*^1K<KYNQGW Y
M"G.<XSTKD-%\;ZI=+X:N]1M;**QUJUDE_<LY>%DC\S))X((!XZCCDU2U#4;O
M7;CP'K;Q6T=I>:F)8$"'S8T:"4IELX.5Y( &#@<]: .RL- :TDC>ZU?4=1$1
MS$MVT>$.,9^1%+'!_BS^=;%8VNZG>6$]E%;"W1)RX>:8&0J0N558E(9RW/3H
M%-8NC>,I_$-OH5O:P007NI6#WTWF@R)"BE4( R"Q+,,<C !SZ$ Z^"XAN8_,
M@FCE3)7=&P89!P1D=P:DKR_POK%]X?\ #%A*T-JME+K]U:WK!6Q!ON9%5EY
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MH+:&/=A3+*P49/\ =!.3["L]]>U*/6M1T"?[,+Q-/^WVMU'&P1TW%6#(6)#
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ME$4R)O*/DG<"N<,,?=Z<UCV7C;6W\(VGB6_L[.'3[E8B6@269K8%F#R.HZH
M!T.1GF@#T&BLW0=0.JZ/#>_:+2X65GV36C9C= Q"D<G!( R,\'(K2H ****
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M9#+GY=H&<Y],<T <T/ MF+-HOMUWYZZF^J07/R!X9V8EL?+@J=Q&"#P:DO\
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M7;V3A=L;ABZKNQDHK'<!V(') Q5_3M!33M<U35%O)Y9-2:-I8W"[5*+M7;@
M]!W)J[<ZE86<T<-U>VT$LF B2RJK-DX& 3SS3;C5M-M)_)N=0M(9<J-DDRJV
M6.%X)[G@>M &9>^%HKO6+[44O[NW>^LQ9SQQ["C*N_:W*D@CS&[XZ<<5':>$
M(;2XT*9-0NF.BVCVEN&"8=&55)?Y>3A%Z8Z5KIJ^FR32PIJ-HTL*LTJ+,I9
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M4*$-D'C:QZ8K*F\"6TMM=VHU2^2WN-2&I>6/+(CE\P2D#*YP7&><^@Q75T4
M9-AH26&NZGJPNII)=0$0DC<+M7RP0NW ST)SDFHK?PS;0WNN3S3RW,>LD?:8
M)0NP 1B/"X .-H Y)K;HH Y;3/!CZ;ITM@?$.K7%N(&@M!*\>ZT4C *D+EF
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***IZKJEGHNE
MW.I:A,(;2V0O(Y[#_&@"Y156]OX;+39M0<-)!%&96,0W'8!DD>O'-<U#\3/#
M4NDV>K//<P:9>2^3#>36SB(ODC!;'R\@\G XH Z^BN>UKQGI>@B]>]2\\FQ1
M'N)H[=FC0-]WYAU/(X'J*9#XWTR>S-VL%^(/L)U!7:V*AX!@EE)ZX# XZ\]*
M .DHK!TSQCHVJ>&#XCCN##I #-]IN%\L$*2I.#SU!'OVJ!/&^FMIBZH]KJ46
MG. 8KJ2T<+(#]T@?> .1@L .1S0!TM%<_'XPTR3Q;)X85;G^U8X_.:/R_E$?
M'S[LXQR/?VJWXB\0V/A?1Y=5U+S5LH2/-DC3?LR0!D#GJ0.* -6BL&S\66-[
M/IL:6U^BZD,VLLELPC?Y#)][H,J"0#3O%'BO3/!^G)J&KF=+1G$9DBB+A6/3
M..1GGF@#<HK-O-:@L;*UNI(+ATN72-%B0.VYSA> >^>O0=ZHV_C'3+KQ5<^&
MHDN3JMM%YTL1CP%3C#;LX/WE[]Z .@HK T'Q?I?B/4-1L=/%P9M-E\F[$D6T
M1ODC;D]3E3TSTK?H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N*\>6#>*;6X\-I:W-Q";9I9S;N@V2,"(=
MVYER,AGP.Z+ZUVM58=,L+:\GO(+.WBN;C_73)& \G^\>I_&@#S+X?^()]4^$
M^KZ1J&5U70[>>QN8V/S *C!"?P!7ZH:\WMY;L_"?P=9ZSM7P;<WL@O+BV0^?
M"PFDP&))&T]<@9X(],_1,?A;P_$]R\>B:<C70(N&6V0&8$Y(?CYLGUI\?AS0
MXM+DTN/1[!=/D.7M5MT$3'.>4Q@\\T <M\5Q /A#KC6^PQ-;QE60Y##>F#GO
MQBGV2J?@=;N0-P\-@ XY -N,_P A^5=3+H.D3Z6FERZ79R:>@ 6U:!3$H'(P
MN,4]='TQ=,_LQ=/M18;=GV81+Y>WTVXQCVH ^>=3M[Z?]F#P^]JCO;0WK27B
MI_SR\V89/MN*_I7T(MWIESHL=QYL#:;<1+L8D;'1@ H_'(&/>G6.D:;IEFUG
M8Z?:VMJV<PPPJB'/7Y0,<U7LO#.A:=,LUEI%E;NI+(8X5783U*@#C\* //;/
M_DYJ_P#^P(/YI6A\8-0M[OX7>*+>!P[VC6\<V.BN9(VV_7!4_B*[&;POH%Q?
M/?3Z)ITEV_WIWMD,C?5B,T?\(OX?^P26']B:=]CDD\U[?[,GEL_'S%<8)X'/
ML* .:\%?:-.T33;G6+R":&YM+"/3PL>TH3&5V 9)+?,26]">@%='XJT"#Q1X
M7U'19\!;J$HK'^!^JM^# '\*=;^%] M;B">WT33HIK?_ %,B6R*T?&/E(''X
M5K4 >8_"6]U+6O#]G;ZM!)')X>>2Q8O_ ,M)E^4'_@$9VGU+>U5M$_Y.6\2?
M]@B/_P!H5ZG#;PVX<0Q)&'<R-L7&YB<DGW-44\/:-%J3ZE'I-DM](,/<K HD
M8>[8R>@H \Z^$G_(Y_$?_L,M_P"ARUZO6?8:#I&E7$UQI^EV=I-,<RR00*C2
M'_:('/4]:T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^7'@_P"\<R?K7G=C?S2?!G1?#UY;QVND:IJ;1R:PS%Q;%9-V"F!@G'7=T!H
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MQ/..,G)QD9YK6HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9CR1YB;?E#*,@@GM0!U5%<WX'UC4M=\.+?ZE% DCW%PJ^3(6X6:10,%1C 4
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M@W.KC5-_V,_*1*LNS'F<C*@9]*9<^!;^>YGD77$5'U:/58]UGN=74CY&;?\
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M[79Q(I+M@@MGOTK9T'3-9L5_XG.N#4W1/+C*6P@&./F<!CN8X'/ '/'-;=%
M'/S>'KF'Q-<ZYI=]';37END%U%- 94<IG8XPRD,-Q'<$>E5=.\%KI.I:'/97
M@6UTJSEM!"\.YI?,*LSEPP .4!^[W-=510!C^)- 3Q#IT4'VAK:XMKB.[M;A
M5W>5*ARI*]QU!'<$UF:EX,&M6VLMJ-XIO=3L5L?.@BVK#&NXC"EB2=S$G)YP
M!QBNKHH Y)?"-_<ZI<W^IZO%.]UI1TV5(+3RU +,=RY=B/O=#G\.@CE\%W=W
MX;@T._U"RO;5+,6K)-89&5&$D4;\JP'N<GGC@5V-% '(7'@2.\NKD75^TME<
M:,ND/&T?[TJ"3YGF;N6RQ_AID'@[4Y+W2)M5UJ"\33K:>T*K9&,SQR*JG<?,
M.&PG4#'M7944 <SX:\-ZMH206=SX@:^TVS79:1&W$<@7&%$C@G?M' X'8FK.
MJ>'Y+GQ!8Z[87:VU];1/;OYD1D2:%R"5(!!!#*""#Z\&MVB@#D;GP2TFDPVE
MOJ"13?VJNK7$SV^_S91*),!0PVC( ZG@#OS71:E8#5-&O-.FDVBZMW@=U'3<
MI4D#\:N44 <I9^%+^WU#0;R;5H)7TFSEM0HLRHD#A!G_ %AQCRU]>I]@*$7@
M&^LM.TK^S]>6#5-,FN'ANOLF8Y(YW+O&\9?D9Q@AAC:*[JB@"KI]O/:V:1W5
MVUU<<M),5VAB?1?X1V _4G)KG+SPC?ZIH"Z#J>JP7.GED\QOLA$S(K!@H;>0
M#P!NQG'OS76T4 <AJW@JXU&?Q"T&L&VBUF.+>HM]S1O&H4'.[YD(&"N!G)YJ
M"Y\!W-_#XA2[UB,_VU9Q6\@AM-BQ-&" RC>?EY^Z3^-=M10!R5QX6UD:U'K&
MG^(([6]FMUM[\-9;XIPI)5E3?E&&Y@.3QUSWWK[2+?4M!GT>\:2:WN+<V\K,
MWSLI7:3GU[Y]:OT4 <U8>&+E)M(EU/4([QM(C9;5E@,99BFS>_S')VY'&!DD
M^F+7AK0I]!MKV&:]CNOM-[-=Y2 Q[3*Y<K]YL@$\5MT4 <U)X<U%?&-SXAM=
M4M4::S2S$$MDSA55F8'(E&3ECVJM-X!M;O3M92]OKB;4M6V&>^ "M&8R#$(U
M'"JA ('.>Y-==10!R=QX8UK4_"^I:3J_B&.YGO+9K43QV7EHBD8+; _S.?7(
M [ <YJ:QX$O=5&J(=;2./4=-2QE!M-QC*!L&,E_E4ELE><XZCK7;T4 8%_X8
M34[W1;VZNF-QIS'S&C3:)U(!*$9X7>L;8R?NXYSFJ47@:&V\+:SHEI?SP#47
MF*3*.;=7)(11G[JY/&>YZ9KK** .(N/ E_=IK'G:U;J=5TM-.E6*PVI&%W@,
MB^9P,2'C/7OCBK^K>%KZ]31[JQU=;+5]+5DCN?L^^.1& #JT9;H=JG[V0174
M44 5=/MKBULUCN[MKJX.6DF*[ Q/HO\ ".P'/N2<FN3TSP+?:?=Z-*^N),NE
MW$\J9L\/,LH.[>V\Y?G[V!]*[:B@#$\,:%-X=TZ2P:]%S;B>66 >3L**\C2$
M,<G<<N1GC@#BJ<_A-KW7K+5+RY@>6QNGG@FCM]DX1@P$+/NY3YO3D ?6NGHH
M XBU\"7UM'I=LNM1&STO4GOK:/['\Q5O,RCMOY(\T@$ <#D'M<T#PIJ.@.;.
M#7"^B1RO+;6AM\21[B6V&7=\R G., ]!G'!ZNB@#C+?P/=0:5I-C_:T+#3]5
M?4@_V0CS"SR/LQYG',C<\]!3_B26/AVS2.14E.J63*Q7=MVSH2Q'&0 ,GV%=
MA10!RNH>$9-6MM<>>_B%[JUB+#SD@)2&$!N%7=DG,C'.?3TYI:IX$O=22_C_
M +;1([_2ETZ4&TW%-H;YHR7^4'=\R\YP.1P1V]% '(#PCJMKK3ZGINOK;/=P
M10Z@C68<2M&,+)'EOD;!QSN'3(.*?)X3U&V\076H:/KSV5M?B/[;;R6XF+,B
MA \;EAM8J "2&'&<5UE% &3XBT"#Q%X?GTF:62)9 I29#EHW1@R,,]2&4'WK
M-NO"MSJ1NKF_OX'U"73I-.CEBMBJ1H_+MM+DDDA>XQCZUU%% %'1[%]+T6RL
M)9EF:U@2'S538&V@ '&3CIZUPNA:/)XAM/%.FS7<2Z;<ZW,TL8B)D>/*'"MN
MQM;;C.#QG'MZ110!R&J^"KC4I_$4BZL(!K$$$0"6^3#Y1)&3O^<-N(88&0<5
M7NO $^HG6&O-9 ?4H[8JUM:B/[/- <HZ98\ @?*??FNWHH Y.\\*:GJ^A/:Z
MKKQ?41)%-;7=K;");>2-MRL(RS9.?O9/(XXJTFBZW)8!+[6K>[N6D'FAK+$$
MD05@4\O?WW9)R>0.,#%=%10!C^&M A\-:2=/@8&,S23!$7:D>]BVQ%R=JC.
M,UL444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC#.!(N2."2":]GHH \G_ +#T!M:\&:7F6\TUX+]$%^1NDC;:4!&!\F2=@(Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJ#[9;?;OL/
MGI]J\KSO*S\VS.-V/3/% $]%9&J>)]'T6]M;/4;SR+BZ.VWC,;L93QPN =QY
M' ]12VOB;1;V*]D@U&%OL"EKM"2'@ !)WJ?F7@'J.U &M17/#QSX=-Y%9B_8
MW4T7G1P_9Y=[Q\_,%VY*\'GIP:<_C7P[&^GHVI*&U'_CS'EN?/YQ\G')R1Q[
MT ;]%9NJ>(-*T9[>._NUBFN#B"!59Y93_LHH+-^ J'_A*=%\NZ<WNTVD?G7*
M-$X>!/[SH1N4<$\CH* -BBJ&D:SI^O6"7VF7 N;1R0DRJP5L'!P2!GD$<54N
M/%NB6NL'2);QAJ(3?]F6"1G*_P!X *<CW'% &U15+3-6L=9MWGL+@31QR-$Y
MVE2KCJI! ((S56U\3Z-?:W<:+;7HDU*W&9K<1L&C'')R.!R.>^10!KT5DW/B
M72;0WWVBY:,6"A[HF%\1*1D$G;C&.<^E5Y/&GAZ'0X];DU)5TN1MJ71C?RR<
MXZX]>,T ;U%8=YXOT+3Q8F[OO)^WX%IOA<><3C 7Y>3R./<5MJ0R@C.",\C%
M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MU0;]4@O1:QB3DV\(+@(OH..?7%>B26^F^'8M5U=(A$)O](N1&!\[*N,@=V(
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<#2*T[0[1CEF^=_7!/N>1D ZJBN8UOQUI6AO="</*EDZ)=-&Z9B+!3]PL&;
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M!*L,C([=:LT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME$&\;R@.-VWKC)QFIZC^SPFY%SY,?GA-@EVC=MSG&>N,\XJ2@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BF++&[.J.K-&=K@')4X!P?3@@_C5"X\0Z):7#V]SK&GPSI]Z.2Y167Z@G(H
M TJ*J/JNG1Z?_:#W]JMEQ_I#3*(^3@?-G'7BJ9\5^'!G.OZ5\O7_ $R/C]:
M->BJ(UK2FO\ [ -3LC>9Q]G$Z^9G_=SFB^UK2M+DCCU#4K.T>3[BSSJA;Z G
MF@"]16?)KNCPVPN9=5L8X"VT2M<(%S@'&<XS@@_B*MP7,%U L]O-'-"PRLD;
M!E(]01Q0!+162WBCP^C.K:[IBLAPX-W&"I]^>*T8;F"XMDN8)HY8'7<LJ,&5
MAZ@C@B@"6BLU/$.B2B<QZQI[B 9F*W*'RQ_M<\?C3H]=T>6RDO8]5L7M8SAY
MUN$**?0MG H T**9#-%<PI-!*DL3C*NC!E8>H(ZT^@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M &:WEB:*1 >AVL <'L>E:- 'G>M:!XFU.]GD>SMY_)U>UO+21[O8H@1HR4"
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M+#.> <C .>G'6O2:YW2;_1#K$B:;8-')?>8YO(K?$=PT9VMEQW!X^;&<<9%
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M/;M+G89(Y%D4-CL2N/QJ[J.M6>EW>GVMSYHDOY_L\&V,E2^TM@GH.%/Y5H4
M<5J^F^(_$_A_=/9VNFW]M<V]U;6QN/-5Y(G#X=PHPIQ@8!QU/H(==\.:EKK:
MWJ2V9M[FZT-]*M[9Y5)+.68LQ!("@E<<D_>X[5W=5OMJ_P!IFQ\FXW"'SO-\
MH^5C=C;OZ;N^.N.: .,U@W5IXA\! VC//&;A'A5USQ;$'!)P?S%0GP?JEOJ$
M7B"V2,WRZU)J+V1D !BDB\DJ&Z>9M ;TR2,XYKM[C3+&[O+>\N+2&6YMB3!*
MZ M'GKM/;/M5N@#S[6?"FIWT.N7T%J!=ZK?6,RV[2J/+CMF0Y8YQN.UNF?X>
M>M7?%FD:]K%W=06]M#/IMSI<D"(]QY7E7#;OF< '>,%<#D @^N:[2B@#@[;P
MUK!O]-DGMX4B?03I5T4N,F!L@[AQ\W /3O[<U/X/T?5M/6SM=4T'2+9]/C\K
M^T;=E9[D!=H*KM!3(Y.3[8YX[6B@#GO%FC)K=O:6\VG/=PI(7,D$_DSV[@?+
M)$V1R#D=1P>_0\P/#?B6QO-,U*XLK+Q#-]A^Q7D5W(J.NV1WCD#%2"<.5;CG
M&>:](K/O=:L[#5=.TZ<RBXU!W2#;&2I*H7.6Z#A30!QGB'PWXAU&TU#38K.Q
M>RN-(:WMXX9O)BM[@[]V5V_./F7:3TVDX!)-:5MIFKP>*++5I+&,)!HC6C*+
M@8\[>C@9_N_)@G'4]".:[&@@$$$9![4 9V@ZA<ZIHMM>7EH+2XD#;X5D\Q00
MQ&5; W*<9![@BM&BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "N:\<37UCX?_M:QGF0Z=*EU/%$?
M]= K RH?^ ;B.^172TV2-)HGBD4/&ZE65AD$'J#0!YW8ZY=W7B'4=(6\N3%J
MCQ7.D3^9G_1@2)BI[ ;&93SD2)69K$M[IS^/]6L=1N;::POK:6-(R-KD00Y#
MY!+ CC%>H1Z=9PR6\D=M$KVT1@A8+S'&=N5'H/D7\A5.;PUHUPEZDVGQ2)?,
M&NE;)$Y'0N.^,#KZ"@#EM1O]6UG6/$=A8ZE%IUSI3Q>1(]P4$:&-)#(\>TAU
M)+*<G&%XP>3F:[?ZRJ>.;F/7+V(Z1;PW5HD6U55O)+D$;<E<CH>QYSQCNKWP
MKH.HW]M?WNE6MQ=VP"Q32IN90.0,GK@\\YYJ2;P[I%PU\TUC$YOP%N]V?WX'
M #^H XY[<4 74E+V2S$JK-&&R>@.,UY=<>+=7T/1-3^W)>0ZY;::)LNXGM;@
M>8B-=1-V WY*$# (XZUZG'!%%;K;HF(E78%SGCIBJ5KH&E643106,0C:+R-C
M98"+_GF <X3_ &1Q[4 8:7%YIGCO3=.@NY[O3M0L)II%F?S#$\93$@;J WF8
M(Z9QC%7/$ETRZAH]C'=S))=32?Z+#\C7*K&2<R9!C5258D<G  !SBM/3]&T[
M2A_H5JD7R",$9)"#HH)Z*.RC@4:EHVFZOY']HV,%S]G?S(O-0'8V,9'X<'UH
M X+P_KNJW4?@>2XOI':\N[ZVNOF!$RQK/LSP,D>6ISP3BJ=W<W6IV%HMQJ%T
MZP^,C:(5F(/E+(0JDCKC QGZUWS>$_#[6*V1TBT%LLYN5C6, +*<Y88Z'D_@
M<=*=_P (MH/V.6T_LBS%O-/]HDC$0 :0'(;ZYH \]UQ[RPG^(>J6&I7-M/IY
MM9XO*88=EMT/SY!W ],>Y]L=')?WFM:[XHL!?3V#:7;P&T,3[<%XR_FD?QC=
M\N#D?(>,DUT$GAG194O$?3H62] %RI!Q, , ,.X &!Z#BGW/A_2;N6.6XL8Y
M)$B\C<<Y:/\ N,?XE_V3D4 </HFH:UXIUG2ENM5OM/2ZT""_DAMMBXE\P D9
M4\$#H<\'&:N6FL-!I7B6\UC5[P6VFZS*BLA D=!&FR)=H'5G& .2?K79#2;!
M=4&I"U07HB\D3#[PC_N?[N><=,\U5?PMH<BNKZ;"P>Y%VV03F8<>9_O>_6@#
MCA?ZYH]AI*ZM>LEQK6HA)(9KG:+*)HY&CA\P D,2@!;')) QP1.;[5M,U32M
M O\ 55DBU#5)D,T<A,D,2P^8D!D(!+$X^;[VWWYKK)_#6BW5E<6=SIL$]O<[
M?.25=X?;TSGT[>E-;PMH+:-'I!TJU_L^-@Z0!,!7!SN'<-GOUH Q/ D'V;4O
M%\/FR2[=:.&D;<V/(AP">^.F3SQS534]-EU3XG7UO%J=YIY_L* ^;:,JOGSY
M<<D'@=<=ZZ[3M$TS2&G;3[&"V:=@TK1H 9"!C)/?I27NAZ9J-TMS=V<<DZQF
M+S.0Q0\E"1]Y?]DY'M0!P.G^)-4LM)\+^*M:O93I]Q$UKJ"@8C#DD0W&!V;;
M@CI^\4XKO=#BNHM(A-Z\C7,N99%D;<8RQSLSZ*"%_#-4]2TS4-0OH+(IIZZ
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MSHFO&W.K:9;7AMSF)IDW%?49]#W'>@#C=3UG5M,^S7>IW$MUI@MK=9M1TN3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ***K:AJ%II6G7%_?3K!:VZ&261NBJ* +-%<OIOBR\U?1E
MUJRT"ZDTV13)"#*@N)D[,L9XP>H!8$CM5/6OB)!HUKX<N'TRXE77C&ENJNJM
M&[A2 X/3[PY&>] ':45@QZ_>F>]@ET:6.2WM_/C/GHR3X)#*K#HPQT..HK*\
M*?$?3O%^DZA<V%K-%?6&?.L+@A) !T/?@X(^HP<4 =G17&:WX_&A3>'H;C2I
M7EUUUBMUCF7Y')7 <G']\<C/?\=1/$-V#J:3Z/)"UE;BX4F=&2898$*PS@C8
M000.HH WZ*\\A^+-B?"5KXJN-(O8M&GG\DS*R.T1W%<LN<XR.V?I7=SWUM;Z
M=)J$LRK:QQ&9I<\! ,D_3% %BBLO0-=M?$OAVTUG3OFANHMZ*YP0>A4XS@@@
M@_2LKP=XUB\8MJ7V>PEMDT^X-M*97!+2#K@#M[T =3137+!&**&?' )P"?K7
MG,'QATYM%GUJYTB^ATRWOSI\\X9',4F <E0<E>1R,GVH ](HKD+GQVL7C6+P
MO!IDEQ=SVGVR*5)E$;Q\]ST/!X_6I]"\>Z/K6FZM>/YM@=(E>+4(KH - 5SG
M)4D$<'H>U '445QR^/@_A9O%*:-=G1%!?S-R^<8@<&41_P!WO][..<4SQ!\1
M]/T*UT2_6W>[TS5Y%CAO8W C1FZ;\\@8R>Y^4\<4 =I16;>:E/:ZG864=GY[
M76XLRR >4JC+,01R.0..["N?TSXAVE_JGB.SFLI+5/#REKV=W#+@!CE .3PA
M/.* .RHKG-.\4RW\&DW7]E2K9ZK@V\R3*_E@H7'F@?=) QQN&>"15;1/',.L
M^)=:T4V36SZ-C[5/)*-G.<%?4<'KB@#K**Y"R\=KJ^C7FMZ1I-S>:5:LX$V]
M4>X"?>:)#]X#GJ5SBHM6^)&FV/@RV\5V%K/J>F3'!^SD"1.N<J?3!SZ8].:
M.THKG[7Q7;:II>D:EI$8O+34I!&KB0*8S@D[A[;6!'7-0IXO%W/JXTW3I;Z'
M2)C!=>5*HE,BJ"PC0_>QG')7)!QF@#IJ*BMIQ<VL-PH($J*X![9&:EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHK-O-?TK3YWAN[Z*)XU#R[CQ$IZ%ST0'!Y;%
M&E13(9H[B".:%P\4BAT8=&!&0:?0 449Q5:PO[;5+"&]LY?-MYEW1OM*Y'T.
M#0!9HHHH **JR:G8PZC#I\EW"M[.K-%;EQO8 9)"]<#UJU0 45%=74-E:RW-
MS((X(E+.YZ*!U)]JSF\3Z(L%E.=1A\J_8+:/DXG)Z!/[Q/M0!K450O=;TW3I
M7BO+M(72%IV# \1KU;Z#(_,>M6;2ZAOK."[MI!)!/&LL;@$;E89!Y]C0!-11
M10 4444 %%%% !1110 4456LK^UU&%Y;27S$25X6.TC#HQ5AR.Q!H LT444
M%%5K*_M=029K67S!#,\$AVD8=3AAR.Q[]*LT %%%% !114<\T=M;R3RMMCC4
MN[8S@ 9)H DHJ*UN8;VTANK=]\$\:R1M@C<K#(.#ST-2T %%4]1U6QTF**2^
MN%@265(8RP)W.Q 4<>I(JY0 445#=74%E:2W5S(L4$2EW=NB@=30!-14-G=P
M7]E;WEK()+>XC66)P"-RL,@\^QJ:@ HHJM=W]K8R6R7$NQKJ800C:3N<@G'
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MM\J %B=H)P!G /I0!>HK-T;7]+\06\EQI5XEU#&P1G0$ $J&QR/0C^76M*@
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MH,:_*-H' ]\GWKH:JZ;IUOI.G6]A:*ZVUNBQQ*\C.54# &6)/ %6J "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *R/$=_!I^FQR3ZC-IX>YAC6>*'S"29% 0C:0 WW<GIGK6O7.>-]
M.O=5\/+:6%L9YOMEM*5#JN%CF21N6([*?QH =?>-]!TZ>^AN;J97L&076VUE
M80AAD,Q"X"XYW=/>K>J>)=*T<3&\N&"P1B:=HXFD$,9) 9]H.T'!Z^A]#7*:
MSH&L7L?CQ(=.<_VQ:QPV9,L8W,(2AS\W')[]JGALO$6D>([VYMM&34++5K>
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M6FZFGC>35+:R^TVL^D&S++*JE'$A;D,1G(/&._7'6LC2_#>L06_@:">Q>/\
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M;O25T^"T:2/>[ R,68ABHY< <] ?:M[PQ;7%EX6TJSNX##<6UI%#(A96PRH
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MN[CAC,DCPNJH" 6)! ') H QH?'6@3M:B*YN&^UV_P!HML6DO[], D1_+\[
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M2;B#M&T$%0>,\>O3Z5ILNC^&;+2X95EEL[-+=)).C,B!03[$B@"M:^+]%O&
MAN9&#6S7<9\B3$L*D NG'S $CIZ@]#3-/\9Z'JD]K%:7,SM=VYN;<FVD59D
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MZ\\COGJ:Z&RU+7]<=M2LM0M;:.TU>6VN()9OE\E)3&8RGEY#D;6!W=6'8XH
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M\N%S*F4^[G'KWSWK5UO5)U\6Z'H*3/;PWT5Q-)*F S^6%PBD],[BQQS\OUH
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M'6&\-V\NO3327\K.Q$T:(RIN(3Y548)4*2#R"3]  ;R@*H S@#')S0S!1EB
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M^[M.2<[JUO#UYXAU.+1-<34K.2ROK5FGMVFW"20IN3RP(QL*D,"-QXSG)&:
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MY>[UR"/3((SGBL1_&5KJ/AW4;RY;4=)AM[_[()XH=S@K*$QT8#+#!SP W7-
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MO=5TJU&GQI+<6NH6UV(W?8'$<JL1GL< UJ7=Y!IMA-.D$LRVX"F&TB\QQTP
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M.)93*8B(FW$C ;H6&WD=LCUILFH1I<V<*QS2B[W%)8HR\:@+NRS#A0>V>IH
MR/%VFWNIP:4ME )6MM3M[N0%PN$C?<V,]3Z#^586K^&]7OH/'44-HN=;B2.T
M+2J!D0B,EN>.1GOQ[\5W]% ' 3:!K%MXDN;V+0=,U6TU.&'S%O)55[25$"'^
M%MR$ ' YR#0WAO5K#Q%J)AT72-5L-2,<@GN=J&TD6-8V!4J=R80$ $8Y'O7?
M,RHA9F"JHR23@ 5175X9#9&*&YDCO&*QRI"2@ 4MN8_PJ<<$]21ZT <U/H.K
M1:CXM\FVAEM]6M$6!Q*%(=8?*VE<<<X.<]/RINDZ)JMEK7AZ[EL_W6GZ&UC/
MME4GS28CQSR/W9Y]Q[X[:B@#RN'3-4TBR\)Z9%9Q2:[8?:IO+CO4C<1,2#M+
M*RLIWKD$9R..A-=CX+"P:-+9?V;+826UPZRI).DQ>1_WC/O7@Y+DG@8/& ,5
M(/\ A'_%\EY;W6FP7ITRY-NXO+4'9)M5CMW#T8<]ZVK:UM[*W2WM8(H((QA(
MXD"JH]@.!0!RNIZ-J,_BO5M0CT^"YM;C119)'/(-LL@=V*L.RD.!GZ\5-X0T
M*[T*>_B5KJ+2'$?V.RNIQ,]NPW;PK9.$.5P"3C!Z9K7.NV?]N3Z.!,;R"U%T
MRB(X*$D#:?XCD'I5NRNA>V,%TL4T0FC601SQE'7(SAE/(/J* ,*YTZ^_X6!:
MZPEL9+.'3)K5B'4,7:2-Q@$],(1GU(KG?#_A;6]!'AN_-LLL]A:3V%Y:K*N2
MDCAP\9) )!49!(X^G/HU% 'G[^$=4MH;2\MHH9;L^(GUB:W:;:JJZ.FT-@\@
M,I/'7=CM7<7JRR:=<(B;Y6B90H.,DCIDU7TG6K36A>&T\W%I<M:R^9&4(=0"
M>#SCYA6A0!YU;>'?$D.B:'I,EK!+:6^CFRGB-SL"W "J'8@'>F <+ZG)'3%E
M/"NLMX3\*1Q-#9:SHZ10,ZOO B,?E2X.!D[<.!ZJ*[RJVH7T.F:=<7USO\BW
MC:238A<[0,G ')H YWPOX6E\.ZCJ0#*=-65SID"GF%)-KRK]"XX] />L=O#&
MM2>"M2L!:QK?-K#:E!&TPVR+]J$X3<.AP,>F:[RQO(M0T^VO8-WDW$2RIN&#
MM8 C/X&IZ . NM!U^^_X3.62P@B.M:;';VT8N0Q5Q&Z8;C&/G!)]N,]:T(-*
MU"+Q+H.HS6ZQVUCI4MK<,TJ_*[&(YZ\@>6>?<5UN]/,";AO(R%SSCUHEBCFB
M>*5%>-U*LC#(8'J".XH XWPUI*Q^*]7N+6[CGT>.8SVL:'*QW$R@S8/3 X(Q
M_P ]G%:OC'1[W6O#YATV6.._M[B&[MO-SL:2*17"MCL=N*U[*QM--M([2QM8
M;6VC&$AAC"(OT X%.N[@6EG/<M'+((8VD*0H7=L#.%4<DGL* .6U'_A+=2T4
M2)86]E<?:(2]FEWEWA5LR 2A0%8C &.@!Y!/&)+X3US_ (1SQ)IT>GVR-J&K
M17MN([G(" PE@20.?W1Y[D_C7H\,HF@CE"N@=0P5UVL,C.".Q]J?0!P>M>%=
M3UK4?%!1%MH]3L+6&VED96 EA9W^=1GY26 []#4%[X;UK7_#%[;MHFDZ'J.V
M(Q>0XD$TD<BR#<RJ-L9*8QR?FYZ<^@HZR(KHP9& *LIR"/44Z@#D=-L]<N?'
M":Y?:9%9V[:6+5T^U"1UD\PMQ@8(_'_"K7B32+ZXUK0=:T]5FDTN:7S+9G"^
M;'(FQMI/&X<$9P#R,BNDHH \^U'PIJ<[7M_#;*;F_P!:L[]K?S5 BB@\L8)Z
M%R$)XXR0,\9KT$'(!QCVHJM?WBZ?83W;0SS+$I8QV\9DD;V51R30!ROA73?$
M>B6ZZ!<6MJVG6TTABU(3Y>2(L6"^7C(?G!.<=^:H6'A'5!X8TCPO>1)Y&F7T
M4POUD&)88I-Z87[P<X53D8')!/2O00<@'U]:6@#SM_#6M-HUU;"R7S9/$BZH
MH\Y<>2)UEZY^]A<8]>];E_X;N)_&EMJMO(B64\"QZE$>LC1.'A(]P2P/MQ6_
M87JW]KYZP7$(WNFRXB,;_*Q7.#V.,@]P0:LT <'<^']6M?%6JS0Z)I6JV&JR
M),)[M@'M)!&L;!@5)=,(" ".<COFHM7\,ZO>6WCB""U7_B<P116;&10,K"(R
M6_NC//?C\J[J\O(;"V:YN"5@3F1\9"#^\?0#N>W4\9J<$$ @Y!Z$4 <#<:#K
M%MXEN[Z+0=,U6TU.*'>MY*JO:2H@0Y^5MR$ ' YR#5:_\,>(;:P\7Z196EO=
MVNN1/)!/YPB\F1H%B9&4CI\H*X^AQUKT>B@#C=8T^YU+4/!^G,BK+8W2ZA=;
M&W"-8XF0#.!]YW 'KAO0UNZ#J=YJ=K</?6*6DL-R\($<WFHZC&&#8'K@CL01
M6FL:([NJ*&?!9@.6QQS3@   !@#M0!Q[Z/JNG^(O$5U:VR7MKK4497,H7R)4
MC\O#YZH0%.1DCGBH?#?A:\\/^(=/ 3S;"TT.+3?M!<9:1'+$[<YVG/Y^W-=M
M10!!?6<&HV%Q97*![>XB:*13_$K#!'Y&N!M/ NL+_8EQ=WL<E[$K6&HOSB:Q
M"@!/J3&I/O*]>BT4 <CJ&CZE+XKUC4(K7?;W.C+8Q'S%!,@:1N03P/W@Y]C5
M#0O#VLZ!>Z-J'V47/EZ'#I5Y;)*H9'BY5T)(!4DL",@]#ZBN]HH P_"6AOX?
M\/QV4K*TS337$@0Y56DD9RJ^PW8]\9K<HHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG_%LNJ0V
M-H^E0_:7%R#-:+<>1)<1!&RL;]F!PW49"D9YKH*JWNG6FHK$+J$2>3)YD39(
M9'P1N4CD'!(R/4T >=QW,?B#7?!LEO>ZA&LD>IH[S )<1E2@:-LYPRD;<^V1
MZU/HNKWM_H^@VESJ=S-=RW5]"8D.R2Z2&1T#/*""@4!"2,DG'!YKM5T#2DFM
M9EL8EEM0P@=<@Q[CEL'U8]3W[U ?">@-#!$VDVK1P2M-$K)D([?>(^O?U[T
M<18ZC=ZMHOPZO+Z;S[E]5D5Y#C+;8;A03@#G %=)X+_Y"?B__L./_P"B(:UH
MO#&AP1VZ0Z7;1);3-/"L:;1'(>K#'0\GGTXJW9Z79:?+<2VELD+W,GFS,O\
MRT?IN/J>!S[4 <-XCNM7L]<UC1K74+H76JVB3Z*1)CRYE;;(@S_",HYSGY2W
MH*?'XC.J>$KGQ!%J5SIT'V6"V4[3*4N&(#@*3RV66,$GA@<UW<EK;RW,-S)"
MC3PAA%(1DINQG![9P*KS:+IEQI<VF36,#V,Q9I+=D&QBS%R<>I8D_6@#S[4-
M8UBUT7X@11WMQ;/ID"3VF9A+)#N@WE=[ YY&>IQDX/2MC6-6N?#WB+2]0N;B
MXETO4+1[;R-_"W87?'CW<!E _O8[FMX>$_#ZQW,:Z1:!;J-8IP(P/-0=%;U'
MUZUH/I]I)!!!);H\4#H\2L,[&7E2,]Q0!QMS/J9UVV\+-?,)SI7VD3&[:)Y9
MBY5BK!26V8!V],-R#VZ33OMS>%8EN]12>^6W*R7ELH =P"-Z@@CMGIBI-8\.
MZ-X@2%-7TVVO!"VZ/SD!*'O@^_?UJ\;: VGV41*L&SRQ&HV@+C&!CH,4 >;>
M'-4U=1X'O9]4O+QM7L)3=0R%2CE81(I4 <-D=>^:DL]=U2;PSX5\2PWDTMUJ
M5_##>6Q;,3)*Y5D5?X3'V(P?D.[/-=M#X=TBW-B8;"%/L (M-H(\@'@A/3(X
MX[<4^WT'2K2[-U!8PQS&1I<J. [<,X7H&.3D@9.3F@#S=I;S2_ WC&^LM3O(
MKJ'69U20R[SM$JKCYL]CC(YZ5T<]Y<:WKGB?3AK,FE3:4(/LTB$8C5HQ(964
MD!P267!X 7L<FN@F\,:'<+>++I=JRWKB2Z!C&)F'0MZ] ?K1>^&-#U&_MKZ]
MTNUN+NV 6*:6,,R@'(&3UP>>>] ')W6HZMK=[X@BL=4AT^YTFXC$3RS,HCB\
MM'WO%MPZOEQDGH.,$9.G\3E9OAUJI$LD9"(<QN5S\Z@@X[8/2MF]\,:'J.K0
M:K>:5:3W\&/+N'C!88.1SWP>1GI5^]LK;4;.:SO((Y[:92DD4BY5@>Q% '!:
MK8R2^/KZ&#4;RV,?AQ6$L,@\PD328RQ!/7^7IQ46FZ_JGB%-#TV2Z$-Q>>'X
M;_S%N#;M),W#,"JG.W .WI\W(/;M4\.:/'*98["%)#!]F+*"#Y7]SC^'J<>I
MS4%WX/\ #M_86EC=Z/:36MG_ ,>\;QY$0]%]![=* .6@76]0\3Z=I%UXFN=K
M:(TTTU@$19)4F1=ZY4XSSG], T_2-0U?7?L^K0ZG#:F#5I+>[A>=F!C$K1^0
M8MN%?&TALYSST.*[--&TZ/4(K]+.)+J&+R(Y%&"D?]P>B\#CI5=/#&AQZXVM
MII5HNIMUN1&-Y.,9SZXXSUQ0!Q$?B#5;CP7I_BN"ZF_M!]36&:RW?NV1KGR3
M#LZ J"/F^]D9)(.*V?#]H%^)7BR3SYR56T.UI"5.Y'ZCV[>E=''H.EQ7SWL=
MC"L[R><S <&3&-^WINQQNQGWJ2#2;"UU"XOX+9([NYQYTHSNDQP-WKCMZ4 <
MEJ^GR:G\4([9-0N['.A/F6T95?\ UZ\ D''KQZ>F:RM#\1:QJRZ)I%_=#SKB
MUNV%QYYMC=M%-Y:LK*IYV?/@=<YZ#%>@7VBZ=J-Q'<7=I')/&I1)>5<*>JY'
M.T]QT-1:GX;T76;*"RU'2[6XMH"##&\8Q'@8&WTXXXH XJ\LKV74O <>IZJU
MW>+>7,,US;.45RL$W( Z-Q@GZTR\U_59O!^M^)+:ZFCU+3=3EACM W[O9',$
M$+)T)9><_>RPP<8%=W)H.E2M9%K&$&Q&+7:-OD<8^3'W>...U#:#I37[WQL8
M?M#NLCMCAW7[K,.A88&"1D8H Y!KC53XA\6W/]JW[QZ,8KBVLD*!')M]YC;Y
M<E23VP?<U;\-2ZE>W&CZN-8AEL+ZT)EA-P9O/D(#!T&T",CY@5''.,9%=3;Z
M58VE]<WL%LD=S=8,\HZR8X&[UP.!Z"JNE^&-#T2[N+K2]*M+2>X_UKPQA2W.
M<>PSS@4 9FH7\UWX]M_#TDTUO:-IDEX#"YC:602*F-PY^4'.!UW#/2N7M=5U
M[4G\.V4^KW4/F:K?Z=-/ $4W,<23!9/N\-\@Y'&1G%>BW^DV.IM"]W;+)) Q
M:&3)5XR1@[6&",C@X/-1OH6ENUD38P@V)S:[5QY)QC*XZ<<4 9_B&9M'\(E3
MJMQ#*@AMUNV19)I&+JF,<#>^<9X +9XQ7'ZE<WMUX7^(^G7<\ZQ6$#&",W!D
M:-6M0Y0OU89)X.>I&2*]'U#3K/5K&6RU"VBN;64 /%*N5;!R/U -4%\*Z"L=
MU&NDVBI=H([@+&!YJ@8 ;U&/SH Y3[$(O&'@E?MEYL;3;IR&N&P2H@(X_P"!
M$?2E\-W^L>(+31M>35HK9)Y'2\@,YDWDY'E+&5PCH1P1V4[LYS78OH.E2_83
M)802&P.;4NNXP]OE)Z=!^0]*AM_"VA6FK3ZK;:5:PW\^?,N(XPKMGJ<CH3W(
MY- &)\/%O[[0K?6-0UB^NYI1-"8I2GEC;.X# !0=V!C.<>W3%?5]6O\ 3?%1
M^W_:QI4MY;Q6][9R[DMV.P&&>/L'8\/S]]>F*Z_3M,LM)M!:Z?;1V]N&+".,
M84$G)P/<\U$VB::]\]XUHAG>197;G#NH 5BO0L !@D9&!B@#@VUO4H]$>7^T
M9_-B\6BP1B_)@^TA/+/J-A[\]ZU;"^N-=EU6Z.M2:?<:9K#6YC'*"%& ",F1
MGS <ACDY88Z8K>F\)>'[BZGN9M'LY)IY%EE9XP=[J00Q'3.0/K@9J1_#.AR:
MVNLOI5H=24 "Y,8W\# .?4#@'J* //)Y;W3K/Q5K%GJ%S!):^)XP(4(\N0.;
M9&#C&3E6(Z\=J['XA7EYI_@;4KRPNY+6YA5&22/&?OJ".0>Q[<UHOX9T62"Y
M@?3H6BN9A/.A!Q)(,8=AW/ Y]AZ"K=_IEEJEBUE?6Z7%JV-T4G*MCIGUH XJ
M\AU$>+-9TA=>U-;;^R([]2)%#I*7E7Y3MX7Y5.T<9'ID55T[7M4\0KHNFO=B
M&XN_#\-^)%N# TDSY#,-JG.W .WI\_(/&.Z;0M,>ZDNFM$-Q+#]G>4D[FC_N
M$YY')X]S52[\'^';^PM+&[T>TFMK/_CVC>/(B'HOH/;IQ0!RL=]K6J:@_AZ3
M5X/MT.DQ31W<$[0":5FD5IE 4[P"B?+]WD\'(Q+I,5Q/\1%>ZU.2:<^'K>1I
M8)"(GD,CJ713P < @8Q74ZGX6T'65M5U+2+.Y%KQ )(@?+'H/;@<=*LRZ-IL
M]_%?264!NX8C#'-LPZ(?X0>PH \\TC5-9U#3? GF:S>*VH3W45VZ;,RA8YF!
M/R]1M'M[59MM7UB/0?)^V7%PEMXD>PFE)S<-:B0C QRS?=!(&[:"1R,UV</A
MK1;9;-8=.AC6R9GM@H($);[Q7TSDYQZFL;Q#X.CN[*&#3=.TN6#[6;JZL[S<
MJ7+E2-V\!BK9.<X.<<T 6?"ZZG#_ &K-JEU<FT:]9=/6ZPK+!@8SD!LEBP&X
MDD!?QM^+Y[BT\&:W=6EQ);W,%C--%+'C*LJ%AU!':L2U\ 6,FCWMC=6%G:07
MGE[K2WD>:*(H2=ZEMOS\]=HQ@<'%==>6=O?V<MG=Q+-;RJ4DC?D.IZ@^H- '
M#QR:EJGBBPT]M9OH+:X\/"Y=8&53YF]!N!VYSS_D9K=\%7]SKG@'1[R^F9[F
MYLT,LJ_*6;&"W'0]^*T$T#2X[A+A+-%FC@^S)("0RQ?W <_=]JLV&GVFEV4=
MG8VZ6]M&,)%&,*H] .U 'F"^)-2TQ+$7M]<ROH6I/;ZX[285H'?;%*P]Q(C\
M8&%<'@5L:B^JO>>%XTU:_M$U>]N#,B,NY8VAD=%^8$@J H^N37:RZ783I>)+
M9PNMZ +D,@/F@#:-WKP,4EWI5C?7-M<75LDLUJV^!VZQMC&5]#CB@#A-7>_M
M[CQ7I+ZM?3P6OAN.:)GD"N),3 MN0#D^6"3]:L6,UW97?@*TM[^Y%M=VLHGB
M+!@Q%N&4Y(SP>@SCVKL3H^G-?3WK6<37-Q%Y,TC#)DC_ +I]1R>/<U!#X:T6
MV^Q>1IT$7V$$6NQ<>3D8.W'3(X/J* ."T[4M833]#U.76KV>23Q%+I\D<A7R
MWA\Z5,$!1R JX/;'%7[FX\17]U?0VES>17\6N)#&\ S ME\A;)(*9"%B<_-N
MXZ8%=:OAG15@B@73H1%#/]IC09PDN<[QZ-DDYZ\GUKD7\ 37>H7DE]I6BRS7
M$\D@U:*66*X4,Q*GRU7&Y1@9WCIF@#5^)4TL'@2Z1&;;--;V\S]_+DF1'S]5
M)'XU/XAN[NU\5^$X+>ZDBMKJZGBGA7&V0"WD89XSP5'?%;>IZ7;:OI%QIEX&
M>WN(S&_/S?4'L1U!]140TF*Z^Q3:I%#<WMF28IP""&Q@N!_"2.N/7&<4 >?P
M:CK$5K;ZB^MWLLD?BHZ=Y;E-CP&Y,1# *,G:>#VP,8YK;TR^N->-]?'6I+"X
MT_6GMGA'S)Y2/M$13."9%P=W)RPQT KH?^$8T7R/(_LZ'ROM'VK9SCSLY\S_
M 'L\YZYI3X:T1M<&M'2[4ZF !]I\L;^!@'/KCC/7% '!7M[<Z=:>-;RSN)()
MX_$-J Z''RLMJC ]B"K$5:\0^*+_ $74_%HAO&$5O'IJQ%R&6U,\CI))SZ##
M8/' [5VK^'='D@OX7T^!XK\[KM&7(F/JWJ>!S[#TJ.'PMH,"SK'I%F!<0B";
M,0/F1\_*V>HY/YT <L]HUE\1-4%O>W6X^'5=)'D\QD(E?D%L^F<'(JKIE]JN
MJ?\ "!Q2ZS>QIJ>BRS7?EE09'6.$[LXR"2YY_+!YKL;7PEH%DQ:VTJVC<P_9
MRX7YO+_N[NN.:EA\.Z1;O:/#811M9QF*V*Y'DH>JKZ \<#T'I0!Q>E:UJ\_A
MWPPUQ=3SPRZE=6E[)'GSY4C:=8\;?F/,:EBO. 3TS73^$(M733;E]7N+F5GN
MYOLJW 4.MN'(BW8 .2N"=V3ZX.:S?$'@N.YAL+?3M*TBXT^WDEEDT^\+1HTC
MXQ(KJK%2/GXVX.XGJ*UO#&@)H-I,B00VHF</]EMY7>*(@8^4M@DGN<*.G'<@
M' 7(U*QT;QEKFFZM=6UUI^M32PVR;3%,0(OD=<9;=G;UXXQ[]!JFIZCHGB6\
ML9;FX=-:M5_LD.Y(@N0=CQC';YU?/8*_85U7]@:5]O>]%A"+AY!*[ 8#..CE
M>A88&&(S[U6CT_4[O7Q=:G]A^QV<C/8+"&,A++MW.3P" 7&!G.[VH 9XEO[C
MP[X)U&^MF>:>RM&97D^8D@?>;UQU/TK NX]033=8N#JT,^F7>B3216_VAKAF
M<+_K5<J,*0P!4<9QC%=VZ+(C(ZAD8$,K#((]#618>$O#^EVEW:V.D6EM!=C%
MPD4>T2#G@^W)XZ<GUH X^POKZ^&D^';>Y%L?^$=MKF!A<M"S.P*E@0IW;-JG
M;T^;D'C%JQO=0UG4[K0+W7/)N[;2()H;NS^032N75YP.-RJ53Y?N\G.<C'2W
MWA'P_J=I:6E[I%I<068Q;I(F?*'HOH.!QTX%2:EX7T+6'M6U'2;.Y:U&(/,B
M!V#^Z/;VZ4 <G#'+)X]OY1JMR[_\([;RK/&^U68O*-ZH<J < XQC-4=-U+5+
M?PSX0O;G6;Z=_$,EI!=22,NV$&)V^3"@JSD*I.?<8->@W.AZ7>7JWMQ8P272
MQ&!9BGS",]5!].3^9]:;_8.E?V.ND?8(#IZ@!;<KE%P<C [8/(QTH X#Q!JN
MM:8/$MA:ZE<K#8W.G/:SDAG59Y522)F()8#J._S#)Q5R\O=4T[_A/+.+5[Q_
ML.FQWMK-*59XI&CE+8.W&,Q@XQQDXQ78R>'M)FL6LIK&*2W>02NCY;>XQAF)
MY8C Y.>@]!1)X?TF9[MY;&-WO(Q#<ELDS(.BMZCD\'U/K0!RUIJ-UKFJG0YM
M3GLI%T.WNX)(WVO)))N#2G^\$*K\O3YCG/&-K7?,D^'>H,;YYI/[+=OM</[H
MR,(R=XP?ER1GCUJS?>$] U**SCOM(M+A+,;;<2Q[O+7^Z/;VZ5K/#')"T+QJ
MT3*49",J5QC&/2@#S>"&^DF\&:1;:WJ%I:WVD3--Y,B[@RQPE2K,I((WGU&.
MU/N]8OH-6LYK35+BYB_X2!-/EE=@D>S;M:$1\AB""2^%.>F179VWAK1;.2SD
MMM-@A>S4K;%%QY0/4+Z9P,^N!4<OA+P]/<S7$NC63S33">1VA!+2#HWUX_'O
M0!PMWJ.L0:;KNJ#6[UI--\11VT,9*!#$SP*48!>1B1OIUZ\ULW6K7]EXO6+4
M3=K875\L-E?6DN^$$J%\B:/^$[\D-@Y)'('%=(_AG19(+B!].A:*YF%Q,A!Q
M)(""'8=VR!S[#TJ5="TQ+LW*VB>:9/-)R<&3&-^,XW8XW=?>@#SN&_UHZ-IV
MH?V]?FX;Q(^G-G85:$W+Q<KMP2!C![$#BIM7U/5M,T'Q_;6^KWA;2O+DM)Y&
M5I4WPJY7<1TR3CN,]:[D>&-%%NEN-.A$*3_:509PLN<[Q_M9YSUS3IO#>C7
MO1-I\,@OL?:PP)\_'3?ZX''- ',>(=7O]+US[1=_:SHNZW07=C+G[&^X%EFB
M_B5PR_-S@'H.M%MJM_;^,(K+53=QQW5[.EE>V\HDMIU"OMA=?^6<B >GS%#R
M:ZEM TM[CSVLT:0[-Q).'V?<W#.&VXXSG%.BT/3(+HW,5HBRF1Y<@G =\[G
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MD'!_6@!]%%% !1110 4444 %%%% !13)98X8FEE=8XU&69S@ >YI] !1110
M444QI8TD2-G4.^=JD\MCK@=Z 'T4QY8T9%=U5G.$!."QQG ]> :?0 44R66.
M&-I)76.-1EF8X 'N:<S!5+,0% R2>U "T4U'22-71@R, 593D$'N*=0 4444
M %%%,$L9E:(2*9% 8IGD ]#C\#0 ^BBB@ HHIGFQ^;Y7F+YFW=LSSCUQZ4 /
MHHHH **** "BBB@ HID4L<T8DBD61#G#(<@XX/-/H **** "BBB@ HHJ(75N
MPC*SQ$2L5C(<?.1G('J>#^1H EHHHH **** "BBB@ HHHH **BBNK>>22.&>
M*1XCMD5'!*'T('2I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[U(VL&//3@@8QBIK[P9!J5QISWMW)=1VD4\<B7$:M]I\X8D+XQCV"@ ?3 H
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MP13M+%PV2 #CD\5L_#Z.6#X?:#!<0303PV44<D4T;(RL% (((!H UTUK2I!
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M+;.\4R".,*C.!B/8R$_,1C.>_(!NZ?XJ0Z_K6G:K<6-H+.[BMK4M)L,V^)9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO%<JJS)O56#A2>,CID=^>>?:I:* "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ K&U'PW;W^J#4H[V_LKORA"[VL^T2("2 RD%3@LV#C/)YK9HH @L[.*
MQMQ##NQDLS.Q9F)ZDD\DU/110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 A. 3Z>E8N@>)(?$%QJL,5I
M<6S:;=&UD$^T%F"ALC!/'S5MUQ/@@[=>\;M@G&L$X'7_ %,= &OXG\667A>.
MR^T1R337ES';Q11]?F=5+GT4;ASZD#O6_7B7BWQ#)=:/'=WOA_7H;^?5+-V,
MU@RI'&DP*PJ2>3U_WF8]L >SV=S]LLH;D0S0^:@?RYDV.F1G##L?44 34444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ':LC2/#MKHMY?W5M-<M)?R^
M?<>:X8/)@#=C''  P./:M>B@#/UC1K/7;2.VOD9HHYX[A0K%?G1@R_J*T***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
1HHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>aquestiveamendedandresta015.jpg
<TEXT>
begin 644 aquestiveamendedandresta015.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 55!!\# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JAJNHR:=# 8K22Y>:81#;PD>027D;!VH #
MS@\D#O5^L/Q+HMYK":>;.[BA:TNUN'BGB,D4ZA6&UE!&<$AASU44 9:>/H9-
M-T^[ATR>=KO4GTPI%*A"RJ6&0Q(W*=A(/YXJ>W\:Q/97)N;"2"_@U$:8+3S
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MD$L&[=,8Q^-5[7PSXD/ANXT:^\1QD+9M:6MS:V[1R#*[5DD.\Y8#LN.YZXP
M4/$OB7^T_"_BW2Y(6M;ZRT9KS,-R6V[D? )&"K*R<J?;KFM+2/$KRW]CH.I:
M5<V1O+(R6D[2JPG"*N\?*<HP# X].^:I_P#""7]P=16YU&RBBO\ 1!I3QVMF
M4$>/,PRY<\?O#QWQVK7L_#]X;[3K_49K>2XTVV>"U2%65"SA0SMDD\A0 .V3
MR<C !@>#?$2:?X%\.VTDB2WUU;RR)]IN-@*H^&9G()ZLHZ$G/H"1UV@ZO'XA
MT.&_6WGMA+N5H91M=&!*D9'N.".HP:Y:U\#:OI>EZ"=,U>VCU72$E@$DENS0
MW$,C!F5U# CE5((/;WKL[&&Z@L52[N%N;KEGD";%+'G 7)PHZ 9)P.23S0!Q
M?@S5I['P3I:+;RW3S75ZIFFD(CB5)I3NED(.!P .#DD5IV7C>*_@\/W,5BZV
MVLO)"DKR@"*5 QV-@'.=C $=<51LO!6JV-EHD,>J6C'3KJYF=);=FBE\UF8'
M;N'S(6.#GUZ5-!X'N$\"Q^'Y=37[3;W/VBTO8H=IB<2^8IP2<GD@]L'&* +N
ME>+O[6M0\-D!.-2DTYX//!*.F=QR!CHI;W&._%=-7.Z5X1M=(\27.J6TC+#+
M;11+;?PJZC:TGU*+&O\ P$^M7-!?5G@N_P"UGA=A=.+>2*%HMT/&,J23D'<,
M]\ ]Z ,&3Q^T5O/=MH=U]DMM3_LVXD\Z/<KEU0,%S\PW,._?OSB[%XMF+ZS;
MS:+="^TP1-]FA82M*LN=A!7IR#GTP3S6?-X+U";1=2T_[=;!KW6%U,/Y380"
M5)-F,\\H!GWZ5)JW@_4M1N]?N(=2AMFU2&UC4"-FV>2Q8JW(W*X8J1QP>] #
M[CQT(-.UVY73OM$NB2*+J.WN ZE"H8NK8&< G((!&T]>^_!JGVG5!:0QI)&+
M5+AITDRHWDA0..<[6.?;Z5SL-G%X3NM9UC7M1L_L&I>1&T45HRJC!!&% RWR
MD#&,=ZO^!M$&A^'(XBT[&5RZ"?[\<72*,^FV,(,>N: ,2ZU'4-*^(FOO8:9=
M:H?[,M)3 EP%"_/-DC<>I & !SCM6B?']A<:?!=::B7#2V*WXBFF$+>6V0JC
M(.7)5ACI\IR1QFY<Z%J,?B>\UG3KNW0WEG':NDT18Q%&<JZX/S?ZP_*<=!S6
M6G@B^T.ZT^X\+:G!;&WL4L)XKZ S)-&A+*_RLI#@LYZX.[M0!T!\16,?A;_A
M(KCS;>R%K]I<2H5=%QG!7^]VQZUR\^I7$/Q(T^[U*![&W71+J=P;@R*%5XB=
MR] RC.<9Z]373:SX?CUWPI=:%>W,C"YMS$]Q@;MW]_'3KSCIVK#/A'5]2U&U
MN=<U*RG2/3KC3YUM[=D,R2[,MDO\I^3T(_H 6[3Q7#JU_'IK6CK'>VC30S03
M;PH &4D*X\M\'(Y(.#@\5@^%=2@3PS\/8KVUN+FXND(AN?.($<@A=B6&<ME0
MPY!'.>M=!H&B^(],M$L]1UJUO;>UB\JU*6QCDDXPIF.X@X'90,]35+3O!E]8
MV'A*U-];O_8#EF;RV'G@QM'QS\O#D]^E &A9^*WO+:_/]G^7>6>H"P:V:;YF
M8E<,#C[I#!@?3)J&[\<6UO=[8K;[3;I>_8I6BE!E1]VTL(\9**W!.0>"<$<U
M<'AF)/&;^($G8+);JDEN!\K2KN59?J$=E^A'I5&R\-:UI>LWHL=8@71;VZ:[
MD@DMR9XG<[G6-PP 5FR>02,G'K0 R'QT7CU"ZFT:Y@T_3YY[>XN7FCXDC( 4
M+G)W$X!Z#C)ZX<?'=M;RWL5Y:,'MXXGB:VD$T=P9'V*BO@ /N(!4],@YQS38
M_!<LWA[7](O;U0NJ7DMVDMNI5H&=@PZGDJP!SQGVJ.\\*Z]KOA^6RUO7+8WB
M-&]I/9VI14DC<.LCJ6.XDJ,@8 &<=: &Z5->-\5=42ZA,'_$GMW$:W!E0DRR
MC<N0,= ",#[OXU=U3Q;=VFMWND6&@75_=6MHEWA)HT#HS,."3URA&.I/MS3]
M,T+5X_%<FO:E>V3O+I\=F\-O RC*.[[@68_W_3^63DM-<O\ %O4H]/N+,3'1
M;="LQ)PWFS'. ><9!*\9R.10!=7Q_87FFVMUIJ).]Q9"^$,\PA(0D@+R#ERR
ML .GRG)'&47QS+=WEI:Z;H%]<S75@M^BR.D)"%U5E(8\$9[]QQZU6B\#W^A2
MZ9/X9U2""6ULA8W"7L!ECN$#%PY"LI#!F<\''S8K6M_#][#XMM]9DOHYDCT\
MV4BLA#NQ<.7R#@<C&W'3O0 VR\86UZ+JX6.,6%JTZ7$XFR]N8B0?,3&5SM)'
M)X],XI(?%H^U:2EUI\D$.KH6L9/,#%F";PCC@(Q7)')'!&:H3>!%U+5?MNHM
M;"1[>XMKB:T0QR7D4BE0LG8[0<YYR0#QTJQ8^%;U8]#AU*\@N8]#.ZV9(RK3
M.(S&C/R<85CD#.3SQC% $6G>/#?C2)Y-&N+>SU.[DLHYGE0E)5,F 5'.#Y3<
M^OJ.:MIXO7^W;#3;C3Y+?[?//!;F1\2YB#'<T9&0C!&*L"<\=,UGVG@N_MM(
MT*Q-];,=+U1]0+B)AYH8RG9C/'^M///0<<U':^"=6M[_ $VX?5[67[#J4UX)
M&M6,LZR+(I#MOY8"3 ., *..U &!=F1/!/B%EGN-T'BE5C;SG)"_:HEP3GD8
M)&#7<-XI6'5=:L+JT\AM,M5NU9I.)XB&^9>.@*D'T/K63/X*OYM!U73?MUL&
MOM6&I"3RF(0"5)-F,\\H!GCKTIVIP:=XF\9:=':SR&\TF1AJ(C1@OE$*XB8D
M8.9!$P'HK>] '86LDLUK%+-#Y,KH&:(MNV$CIGOBL/4/$MQ;>(GT2STB:[NA
M9&\1O.2-' <+C)Y')]/TY%M7U;_A*G0O"VD&USM\E@Z3;ACY\X8$$\ <;>>O
M->71;L^,O[=BG@\L:>;-864YR7#[B?J,8Q^- &?I7CI-4FT%AI=Q#9:W&QMI
MWD4D.J%RK*.0,*V#ZCIWJQ:>,!/K=CIL^GRVTE^D[P)(X$H$1_Y:1D IN'*\
MG\*H:9X*OM.L?"=J;ZW<:"[LS>6P\\&-H^!GY>')[]*BTGP3J^GWNB7$VKVD
MYTR2X+/]E827(E&"SMO^_P!.<?G0!G7U[;7OAG2KJPM[FQ5?%$4;Q/<,Q+B[
MVR9Y(()R<<@9XKH;_P <6MG<R"*W-S!!=K:3F*0&56) ++'C+*I."<@\$X(%
M4E\%7ZZ'!I_VZV+Q:U_:N_RFP?WYFV8SZG&?3M5NU\-:UINMWS:?K$$>CZA<
M&ZF@DMRTT4C8WB)PP #$9Y!QGB@#'\=ZY)J7A/47T^"0VMIJ$-L]TEP4/F+,
MBOA1]Y025.3USP0,UTGC76;W0/"MUJ-A#').C1H/,; 7>X3=T.2-W2L&\\":
MJVF:OH]EJMK'IE_>B^C$UNSR0.95D=00P!7<"1WYQ[UTOB?1)?$/AFZTM;E(
M9I@A64QDJ&5U<?+GIE?6@"M<^)YHY-0AMM--U/ID*2WL<<P!4LI8(F1\[;1G
M!VCD<\\69]>27P?)X@TM4NHS9F[@5V*!QMW#)P<?E6:GAK4[75]3U"TO[;S-
M6@C2\5X6VI*B[!)&-W3;@%2?X1S6I;^'[:S\)+X=MF9+9+/[(CGE@NS;N/J>
M] '&_P!J:G<ZUX%U&2V:6\N].N7>"*?"2$Q1$,<X5?O'L2/>M^U\<6MWI.GW
M(A6"[O7FC6WN9@BHT+%9-SX/ 88R <Y''7$-AX4U2UN?#,T]_:2G1;62V(2%
MD\T,B(#]XXP$![YR>E4XO VK65CI\FGZM;Q:KI]Y=3PRO 6ADCN'+O&Z[@<9
M(Y!_A% '3^'M;37])6]6VFMF$CQ/%*.593@X/1E/4$=016K533H;N"S47]RE
MQ=,2TCQIL3/HJDD@#W)/>K= !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%<AX]U Z?%HC7+>7I$F
MI1QZC(>%6,JVT.>R%]@.>,<'@T 7XO$5S=76OVEII32W>DND:Q-.J_:"Z!Q@
M]%X8=:Z =.1BO%M9ETJ/1/B>FG7,"0CR)(?L\P"Y,"?=P>F[(P..U=0;+2]8
M^*UY#/*+A%TJTN8XQ<MCS%FD(8 'J $_ ^] 'H-%>3^%[FUU5]-N&U4Q^+K1
MI5N[%(PLTDF"'6;/)BS@@G@?+CL*T/!=QX>UVUT:26=I?$$=M)#J=L3^\9RN
M)?M*=2NX?+NX!( H ]!M+RWO[5+FUE66!\[9%Z-@XR/4<5/7C?A6ZL[?P]X#
MMW%NND2&:+4^ $%T$Q$DW;.=W#=POM4FHJ(;5H7NV31U\66L>GL)RH$1*>:J
M$'[@<N!Z8.,8H ]@HKR[Q';6_AZ]D_LZ*SO=/M+:$3:5)(1<P*TCD2VS$G))
M8Y4]=H /05UWCVXU"U\#:K/I8E-TD0/[G.\)N'F%<<Y";B,<YH Z.BO-K_[$
M-;:;09X1H\^A7$E]]FDVQ C;Y+_*<!SEQGJ0#Z5N?#K3["#P=I6H6H+7%[I]
ML;F4RL^]EC YR2 1DCCZ=J .MJ"VO+>\61K>59%BD:)RO0.IPP_ \5Y_?SM:
M^-VE(L]4M)]3@@=5;;>6$I1  .N^+'S$<8#,>:P[*>TTO19(K=((;:/Q5-%J
MXB 4Q6IGEV"3'2/.SKQM)[9H ]CK(\2ZY_PCNCG43:M<J)HHF57"XWNJ \^A
M85Y_K-S<Z1-XDETMG/AN.;3Y+A;8DK$"_P#I(CV]!Y>TL!TW$\9-2>*)O#W_
M  AFLW?A^^A>WN;RP8F*0&U6031\(!P#@ L![$T =]XEUK_A'?#E_K!M6N5L
MX6E:)7"D@<GDUIHV^-7QC< <5Y/JFJ6=Q\./&<5]Y$/B2*VECU%2XRS%?D:/
M_IFR[=OZY;),NIO+I>O:W%X9D_TVX\,FY1(Y2[2SAV"O@DY?:>#WXH ]48D*
M2%W$#@#O65X:UL>(M!AU06S6_FO*GE,P8KLD9.H_W<_C7):=)9OXE\*WGAR5
M/LUQ9S'4A$^0T0C!1I?]L28&3\W+#UK \/ZK;0Z;X0AU">$:%-<ZD)WD8>29
MQ,YB60],$%R >"<'J!0!Z7X?US^W8;Y_LK6S6E[+9LK.&),9P3QZUKUXQ9ZI
M9:;ITH2YBCT$>*+I+R11YL<<;*WE;Q_SS+;>3QTJ[>6NCQ0>'(K76'N].N?$
M+;&$VR+RWA<M'%M.#$&P.^"2* /6J*\PU.&+0=?46<=IJ&FVMQ96[61D(O+%
MLIY9A8DET.02O&?FYZUU?CJ]M;'PO))>F40/<01L4E\M1NE4?O'P=L?9N/NY
M'>@#=O+RWL+5[FZE6*%,99O4G 'U)('XU.2 "2< =Z\4U&6QG\.^+[9YK*>W
MM-:L;B-8E BBC8VY9T!)VJ<OSG!^8]S7K5Q#9W?AZ:&"*&6SDMF6-$4%&0KP
M .A% %*;Q/ -4T"UMH3<6^L^88;I7 50L9D!QU.0/UK>KQS0AHUUIOPQM4>V
M*/'*MRD;A=TGV0A@V.IS@$'Z&EMM6AT[2+:":[2/P];^(KZTGD8>;%#&&D\E
M7&?]7DCKP/EH ]9O)KJ$V_V:T^T;YE27]X$\I#G+\]<<<#GFK->67,>FZ?IO
MALV&KR75F_B5&@D,@6+8P8E(L'!C#<#K@\"M7P9I^FW?B3Q)>EC-=V6M2B F
MX9O*5H(P>,XP<L.?3VH [ZD8D*2!N(' '>N)\9W6G'7],T^]>-7EM+EH_M;?
MZ.WW!@)_RTEY^4 C +'GI7,^&M>M;M?"$7B"[BDTJ70ODDNG!BDO 5#*Y;@N
M$!QGU;O0!Z/X:UL>(M#BU(6S6V^26,Q,P8@QR,AY'KMS^-)X?US^W8K]_LK6
MS6=[+9LK.&)*8RW'KFO,?#FIV5KI?A*TNYXAH#7FI1SM(^8O.$SF%9">,$%B
M W4X/85#&^E#2Q!!=QI;CQKL417&T>6S#C@_=QT]NE 'M=%>5ZQ#HEAKM[X:
MU:]CTG3381_V4TPR!DOYAB=CQ*&*].?NXX%2:E-+8:S#=&2+6((I+"*XM[@^
M7?VTGR;'3^\&)!9<#)W<]: /4**\NCNKRT\0RBT6SU1KFXO_ +%>P-MN;>=5
MD)AG7G<@(VJ>,808Y%0:%<Z)J5A%J=MXAFM]1BTN:/4(K>,++&?+^=[@?>+H
MP)#'DD]P: /6**X?P+--%JFH:?=6M@9X[6W<7VF-_H]U&2X5BO\ !)UR,G(Q
MSC%87Q(U"S,WB*W$RQ:C;:,LL)N'YSF1@;=!@A\CYG!XPO'!P >JT5Y;<P:#
MKGC'5TU:]#64VAVMRI-TRKG=,#(O.. %((^M4]'LUO\ 5O#EIXMED+S^&7,\
M5S<,GF,)8\;AD?-MY/N,GD4 >O45XYI]\VGZ?X=M?$MZ(]"FBO8[>YOT\R-\
M3#R/,+< F$':3VJQJ#Z5:V%GI!U&6[VZ-=/:7.IME)4+X7RTX+R< *P((3!Y
MS0!ZW5:VFNI;BZ2>T\B..0+#)Y@;SEV@[L#[O)(P?3/>O+M*33?$VN>%8-0N
MC=I=>&"9D^U,/,D#0=<-USN/U!]*KZ]/;+HWCY!>%?*UJTV$7!!7*V^1G/3E
M^/KZ4 >Q45Y=?>3IVI>/++2M1%@AT6&Y619&;RY2)@TG&3D@)DCGH>M7O"$N
MDZIXL;4M.OM.1$TZ.(Z?:WR2GS03ND*HQ&,%5R>3WQ@4 >AT5Q_B>Y$?C#P[
M;:B$_L2X6X63S?\ 5-<87RU?/'3S, ]3[@5R$Z[+;3X)[IQIO_"7>5IY^T,N
MZV*G*J0>4#[@/0 8[4 >OU0O=5@M%ND3$UU;VYN6MU8!BG.#STR5/Y&N;\"&
MWM]1\5:=:.HM;75<0PJ^1$K0Q,0!V&XMQZYK,U!=+L_B3X@DN%M8;B;0HI(6
M<*&<@SAV!ZG"X!/IB@#M]#U-=;T#3M56(Q+>VT=P(RV2F]0V,]\9J_7D/AWR
M+!_ ,NFR(+V^T*9)09<^<RPQ%%;)[," .W(J_P"![C2M6O-$OH]7D_MR"W>/
M4+*.,+*S[</]I'WCAQPQQR1CK0!W&I:Y_9VO:-IAM6D&IR2QB8. (RD;2<CJ
M<[<5KUQ/CB&TF\1^$%U!@MFUY.DK-(47FWD 4MD=3QCOG'>N9B,NCB.!9)/^
M$//B/RP[N618##PNX_\ +'S^.>.,=#0!ZY67XCUG_A'O#M_JYMFN5LX6F:)6
M"E@HR>37G>ISW>ER:]]@=O\ A&$U2P\WR3E(8C@W03'1/N;@.!N?IS2>*O+M
M;3QNNF2Q#0Y- #.L3#R5NVWC"8X!*!20/53WH ]6AD\V&.3&-ZAL>F13Z\ST
MW4[.XL/$5MK%Y%8:\ED[&\B8'%H4;RYH?95Z]]P.3TK8\#SS#4-4LKNRL8[F
M".!FNM-;-M<HV_:P7^!^#D<_PGH10!VE9FJZP-.N+&SCB$U[?R-%;QL^Q251
MG8LV#@84]CR17+7TEE=>-M>T_P 2M''9_P!GPOIQF;:H3Y_.=">CAMN2.0 M
M8=O']IG^&K>)4@?4Y8YA/]J4>8X$#E=V><Y(Z_Q'UH ]'AU7R]"_M/5K<Z;Y
M<9DN(I75O*QG/S+P>F1CU'TJ%=<W>+I- -JRE;(7@G+C# OLVXZ]<UC_ !1@
MCG^&VMB2)9 D'F ,N=I!!S^'/-85]!X?U3QU-;[K233_ /A'"R)'(!&1YS'(
MP<$=Q^?O0!Z917CMCK=M<:7X5B\2:C#%I=YH*!+F\4/$UR,!PS$X#[<8)Y^]
MCDUZ7X?MA!X7L[:*]NKI$@V1W5S_ *V1>BL?PP?7UH @M/$;:L]P^D6+7=I;
MRM"URTHC61U.&$><[L'(R<#(X)K2TK4!JFG)=BWFM]S.IAF #H58J0<$C.1Z
MUQ7PSU"ST/P?!X>U6Y@LM4TIY8KF">0(?]8S"09ZJP((8<59U*]M[KQWI]OJ
MJ(-#N=-E-L+E0(I+CS!NR#QN\L97/."V.] '<45X_;0BYE\'V>K7,DEI+JNH
M06_FW# S6?ES"+=S\P(V@'N"/6GW^C:&=2\;:?<S21)8VELUDANWW0L(#M9
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M&EK$\4Z]-X<TM-16S2XMEGC2Y9IC'Y,;,%,GW6R%SDCCB@#8\N)$(V(J]3P
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ML95MF_N5SM/3C-^/Q'>WLIETW2OM=C'J!L99!.%D7:VQY I&"JL",9R0"?J
M=#Y:;2NQ=IX(QP:/+3^XOY5R-UXY^SZ1-KRV*R:);WAMI9Q-^\"K)Y32A-N"
MH?/&<X&?:GGQ?>KK&LV\FE01Z?HT@^VW;7?*Q&'S=ZILY(! (R/8GL =5LC!
MY5<GCIUH6&)$"+$BH.BA0 *X"XO+K4O''@?49["&WCN([J2(K+ND"F#(5QM
MS@@\$C.1[G=\+^*QXG59K>*V$'EDR*EQNEMI 0/*E0J"K<G\C[$@'1^6G/R+
MSUXHVQI\Q55P.N,8K$NM>N'UF\TG2K2*ZN[*V2XG$TQC4;RVQ 0IY.QCGH..
MN>.7OO$,GB>[\%3V-I#+INI2SO);W4I7<Z0R91P$884@GOD@<# - 'H81-H
M5<9R.._K2;(_-+[5\S;@MCG'^%<IXCEF\(^'-+M?#]O!%#_:%M:A))&PB23*
M"%.#USCV!X' %84VJWOAWQ/XWU2UTNWG^S6EG=7:&X\L;5CD9]IV'<V <9 S
MCDB@#TCR8O,,GEIO.,MM&>.G-/(R,'I7*:GXRDA-TFE:9+J$MK;1W#Q 29?>
M"RQKL1ANVC/.!R/?#/'7B6ZT7X;7VNV,;PW1@C\I9DPT+2,J@LIZ%=V<'N*
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M?O HE\HRA-N"H?MG..?:I8?%&K7.N:M8V^A1RPZ7.(IY%N_G<&$2J44KR3N
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M_P"<&A)HI&98Y$8H<,%8':?>@#,UO0H]?\.SZ1>7$H\Y%!GBPKJZD,KKZ$,
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MFVQYJL@3LWRX"CUYS6IX<T-]!M;R%[I;C[3>S7FX1;-IE<N1]XY ).*U_,3
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MZUKR2)%$TLCJD:@LS,<  =R:YU_%D;ZGX<CLXHY[#6ED9;GS,% L1D'RXYR
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MT?0;;2K;PTL-E;M#I6)"B7.['ELQ).'Y"G)P#VQ6U10!XQH6F:8-$^';R6D
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MREE!ZE02V.IQQS7->$K:^@N@FGWKRV31E91<:";'R\+\A!PFX@\8P1C/(XR
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M% 7G'2->OO\ A+-X0G_MZYU*QUV[L8[\(;^VAC0I,RJ%W*6!,9*@ D>@[C-
M&WJVH/INB7FH1VTER]O \RP(/F<@9VCWK!MO%DM[HSZC8/IU_:^=$BW44X2.
M-6.':0,<J4_N]3QTSQT=];276GS6T-P]K(Z;4FC +1GL1GBN8NO 4=S//?+?
M_9M1FN[>[:6V@"QEX=VW=&2=Q.XY)/\ =Z8H K?\)W>'2OM,>G02RIKB:3)^
M]9%;<ZJ)%!7/(<<'IZFF7WC/7;&#Q&6TJP:7056><BZ?;+"8_, 3Y,[L!AS@
M<#UXM_\ "!D13Q_VS<.)M6CU4F2%#B5"IQQC@E1GVZ8ZU9O?!QOO^$D#Z@57
M7H%@F A_U2A"GR\]=I/7O^5 $&I>,;H/?+H^FO>RV*1,\'E2%IF= ^Q652JG
M:RG)ZDXXZUTTUVT6ER7BVTKLL)E$ 'SL0N=N/7M]:YMO!EQ%JW]H:?K]W8//
M#'#?)#$C+<>6-JL-P.Q]O&1[5TMQ:^;I\MI%*\&^(QK(A^9,C ()[B@#S;Q/
MX@B\4_##7[A7L;FWCMHG4PL=\4I8[D=&Y5EPO)QG)X%=-_PDVJP:IK.FSZ5#
M+=VE@E_:Q6]Q_KE8NH1F8 *<IUZ8/M4.H^ H]5AU0W-\J7>I6T=K//!;A-R(
MQ;<5R07).-Q[   5-K'@H:Y=:E/<ZC)&;_3ET]Q#&%VJK,X89)YRQR#P1Q[T
M 9>I>(!KN@>,M)N8K6866E><L\.3'*)(Y", _P!TQGD$@\=*98Q1KXL\"2A%
M$C:%<*S@<D!;? )]LG\ZUCX+EDEUB:?6IY9=5T]+*X)@C"@*' 90 ,<2-@9^
MN:M0>%VAU+0[TWQ8Z3:/:(OE8$BL$!)YX/[M>GOZ\ &?\1DSIVB2I DL\>MV
M1B#''S>:.,X.,],U&/'%YI]SJ6G:UIT,6HVKVP@%K*TD=PL[E$(.W<,,"",$
M\<9Z5T.OZ(FO6,,!N'MY(+F*ZAE10VV2-@RY!ZC(Y''UK-O_  7;:M::B-0N
MI6OK[R2;N >6T)B.Z+RQSMVMEN2<DGG'  +>A:OJ&H7FH6U]I\D"VS)Y-UY3
MQI<*PR<*X!!4C!'/8YYJIJ/B#5X_%%QH>GV%F[IIXO8YI[AE!^<KM("G'(__
M %=*T]%TR]T^%SJ.KSZG<N IFDC2,!1G "J !U.3U/T  AET%W\3RZW'>!)'
ML?L0B,65"[BV[.>3D_3'YT 8FC^-;[4I_#4LVFP0V.O0LT)6<M)$ZQ^9\PV@
M8(##@YZ>N!-8>+[N?Q!8:9=6<$<E]'<-Y:2[FMGB(^1V&5)(;)QROH>M/L/!
M(L(/#<*:BS)H(98<Q &4,AC^8Y_NL>G?\JBTKP&VES:*ZZY=2KI FCMT>*/Y
MHY,95CC)/ RW?V/- &!=75OJGACP[>+I=K8LGBE$\J  JK+=.C,#@<L023@9
MS70S^+[Q[F1M-TN6]MH+\V4R1Q2%R%;8\BMMV?*<_*3R!U'2EC\$>7HUGIPU
M-MMKJG]IJYA&6?S3+M(S]W<Q]\?G4T/@^6TUN[NK+6[RWTZ]G^TW.GJB%7E.
M-Q5R-R!L<@>_(H YSQIJTOB#PA=W5O;VS:?;:O!;H\A)D+1W*(TB]A\P*X[C
M)SVKTNN*N?A]YMIJ.GVVM7%OIE[>+>_9A"C&*7S%D;:Q_A++G&."?3@]3:VM
MU!>W<TVH27$,NSRH'C4"'"X;! !.X\\].U '(>--#O+[Q)I5]H4L=KK=K;7$
M\,A4!9RK0CRI#U*$,P]B<TW3/$6E:YJUCKDELMO<V>G7JWT4J#S;62-[?<C=
M^.<'N#[UUL^G2RZW::BMR$6WBDB\KR\[@Y0GG/7Y%Q^/6J3>$M*;Q-<Z[Y.+
MB[LFL[I!]V9"5.6'J N,^A]A0!G1>+[I4\/WEU91)8:ZRQP%')>!W0O&'XP=
MP!!(Z'CD<UB1^(M0E\$3:CK-A8:BO]L_9O+<D*H%YY2L%(.=IVD?3.<UT>F^
M#TLH-*LY[Z2[L=(D\RQB>,!E(5E3>V?FVJQ X'8G)%5I/ H;1;O24U686L^H
M?;D#1*3$?.\_:#QD;^Y[<>] %J7Q!J5U-J)T73HKQ-.NTM)8WEV/,V$9]A/
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MEFB-W;^9"N^5/,&8U]6&>!]:\S\,PK?)IEE?)JR>*-*>7<)+?9$DA#!I3*$
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MP2!G'7'.,5JUPFL:1K,'B'4=>\':C"U[E(]1TN[&8;AEC4J0W5'V%1GH>,T
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MJFGZ')<R-9CRHUE4OB=F_BSL(";2,ALX!%:-MJUSXAU>^TV>[EM5MM'M[E!
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MP3RVY2,RH7RA)Z$[&Q],=>*SI_&,-]X=UVZOX=3TRULKUK3S[8*91M95X(+
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ME=R#&.#DX(!KJAK]CX7L;D7MUJ-U;6TP-Q<3[9#9"3!5'.=S!0PY&X@$$G%
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MG.#5%?$&FVFJZ])+=WVZS%N)X9AB.,OD((^G+'J<XSCFKY\00)&WFVUS%/\
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MMTMO(FV$Q93+/Q]\9& #P&.:+OQ+93Z!?74BZC:VHL#="YA0%C$P.'C*EOF
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MDA).)%4DJK#.& ))P<]:AF\,Z-<+?+-81R+?L&NU8DB<C@;AGG  '/H*UJ*
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M!!9V5MIUG%:6<$<%O$NU(HUPJCV%3T44 %%%% !1110 4444 %%%% !1110
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MFTA^1E>1UYJ_H6DZAIGB'Q!+,D#66H72W4,BR'?GRHT*E<8&-A.<]QQ7144
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MR5%MY%L[F\NKTB0@!KC<=L8QR%+8YQD#\*[)M-L6OUOVLK8WJKL6X,2^8%]
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MNQG.,=Z +5%4GUC2XXXI'U*S5)1F-C.H#C..#GGFKM !16;:ZCA+^6]O=/\
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MP!GCOW]1S3Q6\1EGE2*->KNP4#\30!C^,@[^"=<BBBEEEEL)XXXXHR[.S1L
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MY\'V"'1?LT]U;)H[,]LD3(0S,K*Q?<I))#-GGJ<T 4_'#3Z#X"O&T0P6!1T
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MC?/ITT5G:(W/D1%-Q*^F\G)/? ]*Z?1](_LFW99+^\OYWQON;MU9V Z#Y0
M,GH.Y/4U5O/#,$VMMK-E>76G7\D8BGDMMA6=!]T.KJP)&3@X!'3..* *NK36
MOAF[A;3[>*.]UV_BMSE?D\S:Q,C 8R=B'C(R0.G)K&UGQIJ^CV_B.V:"SEO]
M)6WGCDV,L<\,S;1E=Q*L"&'4@X!]AT>H>%[35+%(+NXNGN(YTN8[S<HECE3[
MK+QM&,D8VXY.0<G->_\ !EEJ>GZC;75Y>-+J)C^TW2E!(RQ\HH^7:%!ST'<^
MM &?=ZOXLM?$&GZ,?[&,U_'=2I,(Y=L2Q[-N1N^8_/SR,X[57TCQOJ&I26&D
M3V]M;ZU+>7=I<. SPK]G +,@R"=VY, GC)ZXYMZY87EQX\\-RP/>K%:VUTDU
MW'"& 9_+VAB5*\[6Z#C':K[^#-.\FR,,US!>6=S)=17J,OFF63/F%L@J0^3D
M8QTQC P 85QXUUB&.2U6VLCJ%KKD&ESE@XCD27:5D49RI*N,@DX.>M2>(/%'
MB#P[IEY-=?V7)<65B;MEABD?SR';(VALQ*%5?F;(W-[8.Q<^#;*YMTC:[O$E
M&H)J4DZ%-\LZ8VELJ1@!5& !P!3-8\$66M76I32WU_ NIV8L[N*"1 LJKNVM
MRI((WGH0#W!H K6]_J]Q\1;VT2[A%DFE07$4#PD[6=Y!R0W7*#G'3C ZFEX:
M\6W6L67A^PM8+*SO+[3Y;Z3;$3%"B.$"J@8$DEO7@ ^M=!%X8A@UB/5(]0OE
MN5LULY#N0B55+%68;?O LQXP.>F.*I6?@6PTZUTB.SO;V*XTI7CMKK*&0QO]
MY&^7:RGCMD$ @T 9*>-M8G33H8K6R2\?6I='N]^\H'1'?S$P<X(4'!]<9[UT
M'A36+W58-3BU$6_VK3[^2S>2W4JD@4*P8*22.''&3R*:W@ZP(T_9<W4;65\^
MH;U*9FG8,&9\J<Y#MP, 9XQ@8NZ/H<.BRZC)#<W$QO[IKN43%<*Y !V[5'&%
M'7/2@#!O?%6HO9>(]0TN*U:#0I7B>&96WW!CC623# @)PV!P>1GO26OB36M8
M\2_8M,73TLOL-IJ >X1S(8I68,O!QNPN0>@/4'/&E<^#[*>ZU21+FZMX-54"
M_MHF41S';M)Y4E25^4E2,CWYJU:^'K:S\0S:Q#/.));6.U,'R")8T+%0 %R,
M%F[]Z ,SQK>:E:-H":?=QVXNM6A@FW1%]RD,P'##C*\COZCG/,7.K:GX<U+Q
MWJUBMDT5G>6TMQ'*C$RK]GAW!<$;#@DY.[Z=Z[W7-#@UVWM8Y;BXMWM;E+J&
M: J&21<X^\"",$C!'>LN\\#6-[;:Y;RW^H>7K3(USAH\C:JH-I*<?*JCG/2@
M"OJGB36Y+S5K?P_IR7<NF21Q-%(H_?N460J'+KL^5P 2&YS6UXA/F>$M5+H5
MW6,V4;!Q^[/!K/N_!=M<:V^JPZIJ=G-<1I'>I;3*B7848!<;>#CC*[3BMO4-
M/CU#2KC3S))!%-$82T.T,JD8.,@CI[4 < VCZ==_ RQN)HHX;BTT..ZM[I!M
MD@E2$,'5AR#D?C4'A35;OQ1XSTO^VUR]KX>MKZ&!QA6GEQOFQZC[H],GUKJE
M\#V3:+::+=ZAJ%YI5JB1K:3/&J.J !0Y1%9@,#@G![YJ_J?ANSU&^L]01YK/
M4+-2D%U;$*P0]4((*LI]"#CJ,&@#G/$>N1Z7X@UG['I9&LVV@37JW08;9(P3
MM4C&2P=>!TP3SS6CX)TRRE^'NEI+&ET+^SCGNWE <W$DBAG9R?O$DGK]*T+7
MPW!#KDNLW-S/>7LEJ+,M*$"K%NW;0JJ!U/4Y-0:;X331XC::=JVH6VG;B4LE
M,;)$"<E49D+JOMNX[8H Q'L8+#XI^&K2%<QVVAW$49;D[5:)1S]/YUWF><5S
MUYX2AN==M-7AU*_L[BTMVMH5@\HHL;8)&'1L_='Y4R^\.WK63K:ZYJAOI+F.
M4W321J0J]$(5 /+ZG:!DD]>2: &?$.]OM-\!:O>:=<"WN8X<B0IN(!(!QR,'
M!X/:L;4!JT7Q'E:REL?MX\/[FEE@;RSB<D?(&S[?>XZ\]*['6](MM?T2\TJ\
M,@M[J,QN8VPP![@^HJ@GA:-=6.IOJFH271LOL3.YBY3=NW8V?>R<^G;&.* ,
M:S\9:AK5EI:Z;:(E[>:2FHR!H_-5-_ 4#>AQN#<YXP..>.FTJYU*\T&WN+ZR
M6QU)XLRV[.'6.3TRIY&??I6#_P *]L8K728[+5-4LKG2X/LL%W!*@E:'C]V^
M4*L.!U7J,UTT$$6G6"Q)YK1Q+U.9';N2>[$G)]R: .#TOQKXBFL?"^KWUKIO
M]FZW*ELT< ?S89'#;&R3@J2N",9'J:?#XTUR'0KS6[V'33:P7<U@D,0<.\PN
M1#&Q8D@+ZC&>,CK@3^ _#,B>$/#R:LUX)].7>EI.BJ(9L,N?N@M@,<9)'/?
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MGC@V,(P@*H3DD@$D]0/85Q%U=ZK?^$H[B_N8+J=/%<<47[LQXV7NP#.6PN
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MJ/D+@[OWBY&[@AJW_#]WJE[HT,NLV"V5_EEEB5@RG!(##!. 1@X)R,XK'N?
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M51T?3%T;2;?3TN;BY2!!&LEP5+E0, ': .  .GZY-7J "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MY_Q5K=UH:Z3+ ;<0W.HPVMP9E/RQN3D@Y !&.^:Z"N5\=V<MW8:2Z6DEU%;:
MK;7$Z1QF1A$K'<=HR6QGH 30!MV>MZ3J%A)?66IV=Q9QDAYXIU9%(ZY8' J:
MRU&RU*)Y+&[@N41RCM$X;:PZ@XZ'VKSG6-$U%[K7==TK3KDVTUW83_8D#02W
M0@8F5E4X(8Y7&<$F/Z9ZOPK#8R3:AJEGI.HV+7IC\Y]0,BRS,@(&4<DJ ,#/
M&?H : ->[UC3+"3R[S4+6W< $B695QDX&<GC)!QZXJJ=9MQJKYU?3/L*68G>
M/S!YJ\_ZPMNP(\$=NO>N"\21I+K7BG3)+?5GL=3:V%Q-:Z=)<[&1%W;&CSCY
M0O!&0<GD$5T=J%OOB-'J,%O+)IUQH2QI<>0PB8F3>%R1C[ISB@#IH]4T^6*U
MECO[5X[LXMV692)CC/R'/S< GCTJ-=;TI[F6V74K0SQ*7DC\Y=RJ#@DC/0'@
MGM7+^%]#U2QCO=*G5HK72C+;Z5,QSO20;E;_ +9J1&#_ +U9OA.UC>'2(M2\
M.:Q!JVBV[0O/.TK0)^[V,8CN*R!\#"J#U]A0!W%IX@T:_NTM;/5K&XN'C\U8
MHKA69D_O  Y(]ZLWE_9Z?&KWEU# KG:IE<+N.,X&>IP"?PKS7PYIEW9V7PXC
M?3+N&2Q$ZW?^BN/)+0.OS<<98K_.NJ\427$6MZ$T6GW$L6^8/>VT'FRVQ* *
M ,$*'Y!8@@ =LY !KR:_H\,<$DFJV*1W$9EA9KA )$ R64YY  )R.*$\0:-)
M!:3IJUBT5X=MLXN$Q,>F$.?F/L*\Z\.:;>Q1^!(KO2+Z,Z?/>B?S;9CY65<(
M20#@$D8/X].:NVVAW-WX*UN-8I+*^M=8NM1T][B(QA&$S21M\P'RL.#[,: /
M0X[NVFN)K>*XB>>''FQJX+)GD;AU&?>H;C5]-M+J.UN;^VAN)6"I%)*JLQ/0
M $]3V]:H^&%GETA=1O(?)O-1/VJ:(G)CW !4^JH%!]P3WKC[FP,FMZ[H^M:#
MJ^H1:A>K=6D]O)(+:1=J;1(RL!&49.I[ 8S0!M77BR6ZU_4M+TK4-)A?31"T
MGVQ\B7<6,B@JPV[57K@\GD#%+X>\53:W:PZTU]I4>CRJXDB+$30-OQ&"VX@Y
M'4$#G&,T[1Q+!X[\57,MK=);S):^5*;=]LFQ&#;3CG!(Z=>U<K8VNJ6'@GPA
M</I.J2IID\GVZR@1X[A0ZR*'51@MMW=!U#&@#TI=8TQ[!+]-0M6LW.%G$JE&
M.<8!S@G(QBJ-SXNT.VN=+A.HVS_VFSK;NDJE"%5F+;LXQ\NWZG%<A);/HU[H
MVO:9X?U3^RQ>74UW:[7EN=\R*!/Y3$L#D,"HYPQ..2*NW=JT.J>%-1L=!N;:
MRBOKJ22"*'YT\V)P'=1]W<YR<],C..< '5:YK^G^'K:"?4)UB6>XCMX\G&6=
M@OY#.2>P%2SZUI=JT:W&I6D1D"LF^91N#'"D<]">!ZUB^.[>XGT:QDMK::X-
MMJEG<R) A=_+292Q"CDX'.!6%/;7JGQI97VF7ER-93S;)E@9U=6@$8B9AD(5
M9?XB!\V<]: .]OKVVTVQGO;R98;:!"\DC=% KE9/&\+:GX=FBNK)-&U.UGGF
MEE;#0E$1@"V[:/OX(([5J_V;>Q> O[+E<W%\NF?9V?/^LD$6TG)]37*:9#<2
MWW@"272[Z-;"PFBN#+:./)?RHU&>./F5@/IGH02 =V-7TUM.CU!;^V-E* 8[
M@2J4?/H<X-3VMW;7UK'=6EQ%<6\@RDL3AE8>Q'!KRNRM=3TO3-%O)-(U66SL
M]1U$7-K:QR).B32LT4JH,,P .,#LYKT#PQ8VMEHS+8Z?<:?!-+),L-P[-)EC
MDLP8DJ2<G;GC/.#D  N#6=+:\:S&HVIN55F:'SEW +]XXSV[^E);ZYI-VL#6
MVJ64PG++"8[A&\PK]X+@\X[XZ5P?A&SVQZ19:QX?U@:QHNX-=RO*;?(4JTL;
M;MK[Q_" 3ENG&:LZ%:W.B^+_ +<NEW(TO7!)(D2P2%M-DR"=P_A$N S8 PP[
MCF@#J=+\5:-J]M>7-K?0&"UF:&1VD  *G;GV!.0#WQ4X\0Z*T$<PU:Q\J60Q
M(WVA<,XZJ.>H[CM7GLEGJ]KI-SLTG49?L/B>XOYX(0R/<6[R2D&(@C>1O5\
M]5QUJQ>Z9;7 TF\T_0-3ACGUZ"\N1=12O(P6-E:5T;)0<J.<$XSCO0!U][XQ
MT&ST9=5&IVL]F\ZVZ20RJZM(S!=N0<<$\^@YK:2:*2 3I*C0LN\2!@5*]<Y]
M*\QU+3K]]/\ %GDZ;>,&\06E[$BV[9EB0V^]D&/F_P!6_3DX]ZZWQI97^N>
M]3M=,1EO+BWS'%)\I?D$H?3< 5Y]: -:WUK2[I9FM]1M)5@7?*4F4[%ZACSP
M.#STK#\,>(;WQ,8M1M+C3FTQGF26W&3/%M=EC;<"0=P7)! Z\$XYKQQR:MXT
MTG7;:TO+2WM-.GCN_/MGB9BY0I%M(!;:5<\9'IUJQ\.X9[;P9:VUU;7%O/'+
M.6CGB9& :9V'!'<$'\: -U]7TU+O[(]_;+<9(\HRJ&R%W$8SV7D^W-$>LZ7,
MMJT6I6;K=DK;%9U(F(SD)S\V,'IZ5QUM:ZE:>,(Y=-%X]C/J,K7=C>VK;("5
M<&XAFP  W'RY.=YQBL;2[?4(=-\(Z:^CZD)M+UN5KIC;,$12MP P8\,IWK\P
MR.>2#@4 >E'5M/\ MPL!?VHO6R%@,HWD@9(VYSG'./2L+PKXNAU6U2'4[VPB
MU62ZN88[:-PC2+%*Z JA8D\)G\ZR/"PGBA@T+6/#UW+J&GW\UPM[)!F!MSNP
MG63H6*N1@?-D] .1EVFG7<>@Z0O]EWBSQ^*I+R0?9'#"(S2GS#QTV,O/H<4
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MVT4;0W=PIA:,RA 0V5++P<$[3QTSTOA6ULX;.[N;'3;RPCO+EKAEO&?S97(
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M\R>I]SUJ6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,#'TIUIHEA97ANXHG:Y,?E"::9Y75,YV@N20,\X'I0!H4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !12$A022 !W-+0 4444 %%%% !112$@=2!VYH 6BBB@ HH
MHH **** "BBB@ HI,C)&1D=12T %%%% !1110 44@(89!!'3BEH **** "BB
MB@ HHI"0H))  ZDT +112$A022 !R2: %HHHH **3(SC(SUQ2T %%%% !12$
MA1DD >]+0 444@()(!&1U'I0 M%%% !1110 444@(8 @@@\@B@!:*** "BD!
M##(((]J 0<X(..* %HHI 0<X(..#0 M%%% !1110 4444 %%%% !1129&<9&
M>N* %HHI,C(&1D\XH 6BBB@ HHHH **** "BD5U==R,&7U!R*6@ HI"0HR2
M/4TM !12;ANVY&<9Q2T %%%("#G!!QP: %HHHH **** "BBF[UV;]PV8SNSQ
MCUH =135=7^ZP;OP<TZ@ HHHH **** "BD#JS,H8$KU /2EH **** "BBB@
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M[?$9(]/-CY?V<X.6#;OO^H''I^= &:GC:>Z\.Z9J]MIT<<5Y9/<LUS<;41U
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M9FLX(]2N-,@1[B.0LTR%%?<_ RQ8DG.>IYYKKZSM!TQ]%T&PTMIQ.+.!+=)
MFPLJ*%!(R><"M&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "JNH2W<-KOLXX))?,0$3RF-=I8!CD
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "@YP<'!HHH R= T--!MKJ%+
MJ6X%Q=2W;&0*"'D8NP& .,DXK6HHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** ,G4M"74M9TG4C=2Q/ILCR1QJJE7+H4.[(ST)Z8K6HHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#*31!_;TFJ37]W..#!:R,ODV[;=
MI9  #DC/4G[QQUK5HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8>0C=@*6Y$8.>1TS5^V\<23:3#,UHBW,NLG2 <L(PP8CS"" 0"!]T\Y(&>]
M'9T5QD7C6Z1-02[L(EDMM472X6B=W$\A ;=M"Y "G. 6.01[ULZ!JNH:A)?P
MW^GO;FVE"Q3^6Z)<H5R&57 8$'((/<=3F@#:R/6BN!M8H[;XK^);F"U@:XCT
MFVD0-\N6+2Y^8 D9P,G':I]$\9ZIJ4GAQKG3K6&#7;-YH"D[,T<BH'PPV@;2
M">G/'OP =O17 ^'O%VI/X<TR74/*FO\ 4KRYBA,4;L%"22DDJH)( 0  >V3U
M-6&\8:W&NF1RZ$D5Q>:G)I_[Z5XU8!&=95!3.Q@O?D<C!H [:FB1#(T8=3(H
M!*@\@'H<?@?RKS^_\6ZW-HZ>3%:6U[!XAATNY*LS(X,B<J< @$, <].:NWOB
MB#0]9\27%_IELCZ=IMM.]Q <R7 8R!4)(&,,I Y/WJ .UHKE+[Q/J.D:I'I]
M]96SS75E-<VC12L$+Q %XF)!/0@AL<\\"JVC^,=3O;G01=Z9;I#K6G-=VXAG
M+.KJB.58$ 8(?CGC'- ':5&)X65&$L95SM0AAACZ#UZ&N5T;Q1-JVMQZ-?VE
MMFYTXW;K$_F+$P94>%CRKD;P"0>Q&*Y'0H8QX6^&$GEKYBWY16QR%,,^1GTX
M'Y4 >N4=*Y*V\57TBZK:36EM'JME?1VD=N'8K*LFTI)G&<%2Q]MC=<5-\1(D
ME^''B'S41RNG3.,C.&"$@CW!H Z?K169X=ABM_#>F1PQI&@M8L*BX'W16'I_
MBZ^U2XTRXL]+DGTR_9E\Q8I T"X.R1F*[64X&0#QD=: .K-Q"MPMN9HQ,PW"
M,L-Q'KCK4E>07D^I+X:\3:S)%827UEKD@@N'#,\+;DBRA[84X%>K21&?3GBO
M(XG+1D2(!E#^?:@"SD'H:;YB>9Y>]=^-VW/./7%>$6Y2U^#&A74&D2V%TIA/
M]O*J 6W[WF1BC&0@C(P5P<\XKT&206_Q.U&]L[9;F4^'4E5(RJF=A*^T;CQS
M@#)H [BBN''CF[1-90VMI<36&E+J:&*5A&X._='NP<D%#\PR#[8J>R\17NI:
MC!I>J:=:);ZEI+7T/ER&3@; R." .?,!XSW'/6@#KTD22,2(ZLA&0RG((^M)
M'+'*"8Y$<#KM8&N"^%^K/J/@_1+.Q^SR6UG8Q17DC-\RRE%(15[_ "G))P!D
M8SSC4\,V\-MXQ\6Q011Q1B>UPD:A0/W"]A0!UE%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
4% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396361920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Nov. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 30,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Aquestive Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30 Technology Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Warren<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-3827296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">908<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">941-1900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AQST<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,178,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001398733<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392849744">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 77,893<span></span>
</td>
<td class="nump">$ 23,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">8,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">7,021<span></span>
</td>
<td class="nump">6,769<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,972<span></span>
</td>
<td class="nump">1,854<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">96,570<span></span>
</td>
<td class="nump">40,966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,179<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets, net</a></td>
<td class="nump">5,310<span></span>
</td>
<td class="nump">5,557<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">4,230<span></span>
</td>
<td class="nump">5,438<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">109,958<span></span>
</td>
<td class="nump">57,418<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">7,572<span></span>
</td>
<td class="nump">8,926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">5,025<span></span>
</td>
<td class="nump">6,497<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Lease liabilities, current</a></td>
<td class="nump">482<span></span>
</td>
<td class="nump">390<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue, current</a></td>
<td class="nump">1,048<span></span>
</td>
<td class="nump">1,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent', window );">Liability related to the sale of future revenue, current</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">922<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansPayableCurrent', window );">Loans payable, current</a></td>
<td class="nump">25<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">15,152<span></span>
</td>
<td class="nump">18,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent', window );">Notes payable, net</a></td>
<td class="nump">31,253<span></span>
</td>
<td class="nump">27,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnsecuredLongTermDebt', window );">Royalty obligations, net</a></td>
<td class="nump">18,835<span></span>
</td>
<td class="nump">14,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent', window );">Liability related to the sale of future revenue, net</a></td>
<td class="nump">62,730<span></span>
</td>
<td class="nump">63,568<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease liabilities</a></td>
<td class="nump">5,109<span></span>
</td>
<td class="nump">5,399<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">20,266<span></span>
</td>
<td class="nump">32,345<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other non-current liabilities</a></td>
<td class="nump">2,033<span></span>
</td>
<td class="nump">2,016<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">155,378<span></span>
</td>
<td class="nump">163,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Contingencies (Note 19)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value. Authorized $250,000,000 shares; 91,178,193 and 68,533,085 shares issued and outstanding at September&#160;30, 2024 and December 31, 2023, respectively</a></td>
<td class="nump">91<span></span>
</td>
<td class="nump">69<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">300,648<span></span>
</td>
<td class="nump">212,521<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(346,159)<span></span>
</td>
<td class="num">(319,077)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; deficit</a></td>
<td class="num">(45,420)<span></span>
</td>
<td class="num">(106,487)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; deficit</a></td>
<td class="nump">$ 109,958<span></span>
</td>
<td class="nump">$ 57,418<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Sale of Future Royalties, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Senior Notes, Noncurrent And Finance Lease, Liability, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396922608">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; deficit:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">250,000,000<span></span>
</td>
<td class="nump">250,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">91,178,193<span></span>
</td>
<td class="nump">68,533,085<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">91,178,193<span></span>
</td>
<td class="nump">68,533,085<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396321328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Operations and Comprehensive (Loss) Income - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="nump">$ 45,694<span></span>
</td>
<td class="nump">$ 37,377<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Costs and expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Manufacture and supply</a></td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">4,798<span></span>
</td>
<td class="nump">13,352<span></span>
</td>
<td class="nump">16,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">5,269<span></span>
</td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">15,363<span></span>
</td>
<td class="nump">10,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">12,126<span></span>
</td>
<td class="nump">7,385<span></span>
</td>
<td class="nump">34,171<span></span>
</td>
<td class="nump">22,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total costs and expenses</a></td>
<td class="nump">21,832<span></span>
</td>
<td class="nump">15,379<span></span>
</td>
<td class="nump">62,886<span></span>
</td>
<td class="nump">48,568<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(8,290)<span></span>
</td>
<td class="num">(2,377)<span></span>
</td>
<td class="num">(17,192)<span></span>
</td>
<td class="num">(11,191)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income/(expenses):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(2,780)<span></span>
</td>
<td class="num">(1,256)<span></span>
</td>
<td class="num">(8,343)<span></span>
</td>
<td class="num">(4,064)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Interest expense related to royalty obligations</a></td>
<td class="num">(1,359)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(4,075)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestExpenseSaleOfFutureRevenues', window );">Interest expense related to the sale of future revenue</a></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="num">(163)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestAndOtherIncomeNet', window );">Interest income and other income, net</a></td>
<td class="nump">979<span></span>
</td>
<td class="nump">1,514<span></span>
</td>
<td class="nump">2,703<span></span>
</td>
<td class="nump">16,156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(353)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net (loss) income before income taxes</a></td>
<td class="num">(11,509)<span></span>
</td>
<td class="num">(2,175)<span></span>
</td>
<td class="num">(27,082)<span></span>
</td>
<td class="nump">385<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes (benefit) expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(140)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">144<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(11,509)<span></span>
</td>
<td class="num">(2,035)<span></span>
</td>
<td class="num">(27,082)<span></span>
</td>
<td class="nump">241<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive (loss) income</a></td>
<td class="num">$ (11,509)<span></span>
</td>
<td class="num">$ (2,035)<span></span>
</td>
<td class="num">$ (27,082)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>(Loss) earnings per share attributable to common stockholders:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">91,082,081<span></span>
</td>
<td class="nump">64,678,761<span></span>
</td>
<td class="nump">85,224,263<span></span>
</td>
<td class="nump">59,252,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">91,082,081<span></span>
</td>
<td class="nump">64,678,761<span></span>
</td>
<td class="nump">85,224,263<span></span>
</td>
<td class="nump">61,513,736<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InterestAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest And Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InterestAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InterestExpenseSaleOfFutureRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Expense, Sale of Future Revenues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InterestExpenseSaleOfFutureRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358386484656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Statements of Changes in Stockholders' Deficit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Warrant exercises</div></th>
<th class="th"><div>Public Equity Offering - ATM</div></th>
<th class="th"><div>Public Equity Offering</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Warrant exercises</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Public Equity Offering - ATM</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Public Equity Offering</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Warrant exercises</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Public Equity Offering - ATM</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Public Equity Offering</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,827,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">$ (118,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 192,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (311,207)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 993<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 992<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(77)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vested restricted stock units, net</a></td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">8,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,068<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,922,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2023</a></td>
<td class="num">(109,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303,139)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,827,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">(118,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311,207)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="nump">241<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,740,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="num">(102,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310,966)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,827,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2022</a></td>
<td class="num">(118,554)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">192,598<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(311,207)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,533,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="num">(106,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,077)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">55,922,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2023</a></td>
<td class="num">(109,235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,848<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(303,139)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,689,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,981,937<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,407<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,699<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,510<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vested restricted stock units, net</a></td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityOther', window );">Other</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(5,792)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,792)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,615,959<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2023</a></td>
<td class="num">(106,651)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">202,218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(308,931)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,795<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(80)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">774<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercises, net (in shares)</a></td>
<td class="nump">625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised, net</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(2,035)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,035)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">66,740,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2023</a></td>
<td class="num">(102,927)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">207,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(310,966)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,533,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="num">(106,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,077)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,557,220<span></span>
</td>
<td class="nump">16,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,385<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12,381<span></span>
</td>
<td class="nump">74,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(410)<span></span>
</td>
<td class="num">(5,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(410)<span></span>
</td>
<td class="num">(5,187)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vested restricted stock units, net</a></td>
<td class="num">$ (893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(893)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercises, net (in shares)</a></td>
<td class="nump">231,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised, net</a></td>
<td class="nump">$ 539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(12,828)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12,828)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,478,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2024</a></td>
<td class="num">(36,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(331,905)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68,533,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="num">(106,487)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">212,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(319,077)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(27,082)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,178,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="num">(45,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(346,159)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90,478,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Mar. 31, 2024</a></td>
<td class="num">(36,301)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(331,905)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common Stock issued under public equity offering (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Common Stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Costs of common stock issued under public equity offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (158)<span></span>
</td>
<td class="num">$ (359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (158)<span></span>
</td>
<td class="num">$ (359)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Shares issued under employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,716<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Shares issued under employee stock purchase plan</a></td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vested restricted stock units, net</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(2,745)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,745)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,059,760<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="num">(35,479)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(334,650)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">1,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,577<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Vested restricted stock units, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7,192)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vested restricted stock units, net</a></td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercises, net (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">125,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised, net</a></td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">(11,509)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,509)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Sep. 30, 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,178,193<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 30, 2024</a></td>
<td class="num">$ (45,420)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (346,159)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400078736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (27,082)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net (loss) income to net cash used for operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation, amortization, and impairment</a></td>
<td class="nump">571<span></span>
</td>
<td class="nump">878<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain on contract termination</a></td>
<td class="num">(300)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">4,696<span></span>
</td>
<td class="nump">1,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="nump">8,015<span></span>
</td>
<td class="nump">174<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other, net</a></td>
<td class="nump">71<span></span>
</td>
<td class="num">(239)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Trade and other receivables, net</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="num">(3,177)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(252)<span></span>
</td>
<td class="num">(1,299)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">1,083<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">146<span></span>
</td>
<td class="nump">48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="num">(2,408)<span></span>
</td>
<td class="num">(3,469)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(12,582)<span></span>
</td>
<td class="nump">2,439<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used for operating activities</a></td>
<td class="num">(29,270)<span></span>
</td>
<td class="num">(1,438)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(979)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used for investing activities</a></td>
<td class="num">(144)<span></span>
</td>
<td class="num">(979)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromIssuanceAndExerciseOfWarrants', window );">Proceeds from issuance and exercise of warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">8,342<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans', window );">Proceeds from shares issued under employee stock purchase plan</a></td>
<td class="nump">30<span></span>
</td>
<td class="nump">31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options, net</a></td>
<td class="nump">732<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Repayment of debt principal including lease liabilities</a></td>
<td class="num">(18)<span></span>
</td>
<td class="num">(12,548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Premium paid to retire debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,027)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Payments for taxes on share-based compensation</a></td>
<td class="num">(1,100)<span></span>
</td>
<td class="num">(11)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">83,435<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">54,021<span></span>
</td>
<td class="num">(2,356)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at beginning of period</a></td>
<td class="nump">23,872<span></span>
</td>
<td class="nump">27,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents at end of period</a></td>
<td class="nump">77,893<span></span>
</td>
<td class="nump">24,917<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash payments for income taxes</a></td>
<td class="nump">305<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash payments for interest</a></td>
<td class="nump">5,566<span></span>
</td>
<td class="nump">2,827<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember', window );">At-the-market offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from common stock issued under public equity offering</a></td>
<td class="nump">11,817<span></span>
</td>
<td class="nump">5,274<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_PublicEquityOfferingMember', window );">Public Equity Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement', window );">Proceeds from common stock issued under public equity offering</a></td>
<td class="nump">$ 71,974<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromIssuanceAndExerciseOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance and Exercise of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromIssuanceAndExerciseOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfPrivatePlacement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfPrivatePlacement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_PublicEquityOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_PublicEquityOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358505907488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Overview and Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock', window );">Company Overview and Basis of Presentation</a></td>
<td class="text">Company Overview and Basis of Presentation<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(A) Company Overview</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Aquestive Therapeutics, Inc. is a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#8217; lives through innovative science and delivery technologies. The Company is developing pharmaceutical products to deliver complex molecules through alternative administrations to invasive and inconvenient standard of care therapies. The Company has a proprietary commercial product, Libervant&#174; (diazepam) Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">i.e.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, seizure clusters, acute repetitive seizures) that are distinct from a patient&#8217;s usual seizure pattern in patients with epilepsy between two and five years of age, which was launched in April 2024. The Company is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, under the trade name "Anaphylm&#8482;", and its Adrenaverse epinephrine prodrug pipeline platform. The Company has five licensed commercialized products which are marketed by its licensees in the U.S. and around the world. The Company is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm&#174;, and has proven drug development and commercialization capabilities. The Company&#8217;s production facilities are located in Portage, Indiana, and its corporate headquarters and primary research laboratory facilities are based in Warren, New Jersey.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(B)&#160;Equity Transactions</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Offering of Common Stock</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company established its first ATM facility in September 2019, and since inception to September&#160;30, 2024, the Company has sold 19,857,518 shares of Common Stock which has generated net cash proceeds of approximately $60,558, net of commissions and other transactions costs of $3,085. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3 to register the offer and sale of up to $250,000 worth of shares of Common Stock ("Registration Statement No. 333-278498" or the "2024 Registration Statement"), that was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement was a $100,000 ATM facility pursuant to the Amended Equity Distribution Agreement with Piper Sandler &amp; Co. (successor to Piper Jaffray &amp; Co.).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended September&#160;30, 2024, there were no shares of Common Stock sold under the ATM facility. For the nine months ended September 30, 2024, the Company sold 4,557,220 shares of Common Stock under the ATM facility which provided net proceeds of approximately $11,855 after deducting commissions and other transaction costs of $530. For the nine months ended September 30, 2023, the Company sold 3,184,740 shares under the ATM facility which provided net proceeds of approximately $5,274 after deducting commissions and other transaction costs of $392.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 12, 2022, the Company entered into the Lincoln Park Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth in the Lincoln Park Purchase Agreement, the Company has the right, but not the obligation, to sell to Lincoln Park up to $40,000 worth of shares of Common Stock from time to time over the 36-month term of the Lincoln Park Purchase Agreement. The Lincoln Park Purchase Agreement contains an ownership limitation such that the Company will not issue, and Lincoln Park will not purchase, shares of Common Stock if it would result in Lincoln Park&#8217;s beneficial ownership exceeding 9.99% of the Company&#8217;s then outstanding Common Stock. Lincoln Park has covenanted under the Lincoln Park Purchase Agreement not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company&#8217;s Common Stock. In 2022, the Company sold 1,600,000 shares, in addition to 236,491 commitment shares, which provided proceeds of approximately $1,987 in connection with the Lincoln Park Purchase Agreement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company did not sell shares in connection with the Lincoln Park Purchase Agreement in 2023 or for the nine months ended September 30, 2024. The Company has no current intent to use the Lincoln Park facility.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 22, 2024, the Company completed the Underwritten Public Offering of 16,666,667 shares of its common stock at the public offering price of $4.50 per share. In addition, pursuant to the partial exercise of the underwriters' option, on April 22, 2024, the Company sold an additional 559,801 shares of Common Stock. Net proceeds from the Underwritten Public Offering, including the exercise of underwriters' option were $72,868, after deducting underwriting discounts of $4,651. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $894 as of September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(C) Basis of Presentation</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December&#160;31, 2023 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;5, 2024 (the &#8220;2023 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2023 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company dissolved its subsidiaries and no longer prepares its financial statements on a consolidated basis. The dissolution of the subsidiaries did not have a material impact on the Company&#8217;s unaudited condensed financial statements as of September&#160;30, 2024 or the audited consolidated financial statements as of December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397083408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company is no longer an &#8220;emerging growth company,&#8221; but remains a &#8220;smaller reporting company&#8221;. The Company complies with new or revised accounting standards by the relevant dates on which adoption of such standards is required for smaller reporting companies. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of September&#160;30, 2024:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to clarify the guidance in Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for such equity securities. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2023-0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources and assess performance. Additionally, the standard requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. The guidance in this update is effective for fiscal years beginning after December 15, 2023, and interim periods after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its related disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Accounting Standards Update was issued to enhance the transparency and decision usefulness of income tax </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It further requires disclosure on an annual basis of the following information about income taxes paid: 1. The amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes 2. The amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). Additionally, it requires the following information disclosure: 1. Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign 2. Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU eliminates certain current disclosure requirements. These disclosure requirements will be effective for the Company beginning January 1, 2025, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2023-09 on disclosures to its condensed financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397803552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Risks and Uncertainties<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Risks and Uncertainties</a></td>
<td class="text">Risks and Uncertainties<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#8217;s cash requirements for the remainder of 2024 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September&#160;30, 2024, the Company had $77,893 of cash and cash equivalents.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has experienced a history of net losses. The Company&#8217;s accumulated deficits totaled $346,159 as of September&#160;30, 2024. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#8217;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the 13.5% Senior Secured Notes as further discussed in Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the ATM facility and other equity offerings, including the Underwritten Public Offering as discussed in Note 1, Part B </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Transactions.</span></div>While the Company&#8217;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#8217;s on-going business, existing cash and cash equivalents, expense management activities, including, but not limited to the ceasing of R&amp;D activities, as well as access to the equity capital markets through its ATM facility and under the Lincoln Park Purchase Agreement, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/275/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396982192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenues and Trade Receivables, Net</a></td>
<td class="text">Revenues and Trade Receivables, Net<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s research and development projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of September&#160;30, 2024, and December&#160;31, 2023, such contract assets were $654 and $1,662, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September&#160;30, 2024 and December&#160;31, 2023, such contract liabilities were $21,314 and $33,896, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to obtain contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of September&#160;30, 2024 and December&#160;31, 2023, such costs to obtain contracts were $488 and $715, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), MTPA (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), Haisco (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), and Hypera (manufacture and supply revenue, license and royalty revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue and license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-developm ent and research fees).</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the nine months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Assertio (manufacture and supply revenue, and license and royalty revenue), and Zevra (license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees) and Hypera (manufacture and supply revenue and license and royalty revenue) for revenue markets outside of the United States. </span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,684&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the allowance for doubtful accounts:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance expense (reduction)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales-Related Allowances</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:70.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and other rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $28 and $640, respectively, as of September 30, 2024, and $0 and $645, respectively, as of December 31, 2023. See Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Expenses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Concentration of Major Customers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the nine months ended September 30, 2024, Indivior and Haisco, represented approximately 59% and 15%, and of total revenue, including the one-time recognition of deferred revenue for Haisco, respectively. As of September&#160;30, 2024, Indivior exceeded the 10% threshold for outstanding receivable balances and represented approximately 67% of total trade and other receivables. For the nine months ended September&#160;30, 2023, Indivior </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">represented approximately 79% of total revenue. As of December&#160;31, 2023,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Indivior and Zevra Therapeutics, Inc. represented 65% and 13% of total trade and other receivables, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396885568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Material Agreements</a></td>
<td class="text">Material Agreements<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial Exploitation Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. which was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#8217;s requirements for Suboxone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a sublingual film formulation, both inside and outside the United States on an exclusive basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#8217;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive one year periods.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Agreement to the Indivior License Amendment. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive one year periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#8217;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement. During the nine months ended September 30, 2023, in consideration of the agreements between the parties, the Company received a payment of $11,482 from Indivior, of which amount $5,482 represented: (a) payment of the portion of a 2022 price increase that had not been previously paid and (b) an estimated payment in 2023 for certain price increases. During the nine months ended September 30, 2023, the Company recognized $4,396, of which $1,682 was related to the 2022 price increases, in Manufacture and supply revenue and $6,000 in Interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income. As of December&#160;31, 2023, the $5,482 price increase had been fully recognized in Manufacture and supply revenue; there were no retroactive price adjustments included in Manufacture and supply revenue for the nine months ended September 30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplemental Agreement with Indivior</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company was entitled to receive certain payments from Indivior commencing on the date of the Indivior Supplemental Agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable. Through February 20, 2019, the at-risk launch date of the competing generic products of Dr. Reddy&#8217;s Labs and Alvogen, the Company received an aggregate of $40,750 from Indivior under the Indivior Supplemental Agreement. Further payments under the Indivior Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. No further payments are due to the Company under the Indivior Supplemental Agreement. See Note 19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for details.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement were in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the Indivior License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">License Agreement with Sunovion Pharmaceuticals, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#8217;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI&#174;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#8217;s obligation to remit a payment of $4,000, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 16, 2020, the Company entered into the First Amendment to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company form January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#8217;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the Amendment to the Sunovion License Agreement. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#8217;s patents covered under the Sunovion License Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company has also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#8220;Initial Milestone Payments&#8221;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase and Sale Agreement with an affiliate of Marathon</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through September&#160;30, 2024 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on the accounting for the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of Zevra&#8217;s KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Haisco for Exservan&#8482; (Riluzole Oral Film) for ALS Treatment in China</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Haisco Agreement with Haisco, a Chinese limited company listed on the Shenzhen Stock Exchange, effective as of March 3, 2022, pursuant to which Aquestive granted Haisco an exclusive license to develop and commercialize Exservan&#8482; (riluzole oral film) for the treatment of ALS in China. Under the terms of the Haisco Agreement, Aquestive was the exclusive sole manufacturer and supplier for Exservan in China. Under the Haisco Agreement, as amended, the Company received a $7,000 upfront cash payment in September 2022 and was entitled to receive regulatory milestone payments and double-digit royalties on net sales of Exservan in China and earn manufacturing revenue upon the sale of Exservan in China. In June 2024, the Haisco Agreement was terminated, and the Company will not receive any contingent </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">payments under the Haisco Agreement. The termination agreement released all parties from any existing or ongoing obligations. Commissions of $134 that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income. The Company recognized deferred revenue of $7,000 for the upfront payment received in September 2022 on the Company's condensed financial statements for the nine months ended September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensatory Arrangements of Certain Officers</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 17, 2022, the Company announced that Keith J. Kendall, former President and Chief Executive Officer of the Company, was leaving the Company and the Company&#8217;s Board of Directors, effective May 17, 2022. In connection with his departure, Mr. Kendall and the Company entered into a Separation Agreement, including a Consulting Agreement, dated as of May 17, 2022. Under the Separation Agreement, in addition to other severance benefits already received by Mr. Kendall in 2022, Mr. Kendall received a monthly severance payment for eighteen months following the Termination Date, or November 22, 2023. During the first quarter of 2023, net severance payments made to Mr. Kendall totaled approximately $274. By the end of December 31, 2023, all payments due to Mr. Kendall were made.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing and Supply Agreement with Atnahs Pharma UK Limited </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#8217;s intellectual property to develop and commercialize Libervant&#8482; (diazepam) Buccal Film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory (as defined in the Pharmanovia Agreement) during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $3,500 upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which includes Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $2,000 from Pharmanovia in connection with the execution of the Pharmanovia Amendment.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Assertio Holdings, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#8208;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan during the term of the Assertio License Agreement for an upfront payment of $9,000. In addition, Aquestive received a $6,000 milestone payment subsequent to Aquestive&#8217;s receipt of a notice of allowance from the PTO of the Company&#8217;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensing Agreement with Mitsubishi Tanabe Pharma America, Inc.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2021, the Company announced that Aquestive granted an exclusive license to MTPA for the commercialization in the United States of Exservan. MTPA is a multinational pharmaceutical company with a focus on patients with ALS. The product was launched by MTPA in June 2021. Under the terms of the MTPA license agreement, Aquestive was the exclusive manufacturer and supplier of Exservan for MTPA in the United States. In June 2024, under the Second Amendment to the License and Supply Agreement, MTPA and the Company mutually agreed to terminate the agreement. As of June 30, 2024 and as part of the termination, the parties were released from any existing or ongoing obligations (except for the limited post-termination obligations). Upon termination, deferred revenue of $3,317 was recognized for milestone payments that had been received. Commissions of $57 that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2024.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400084720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Financial Instruments &#8211; Fair Value Measurements</a></td>
<td class="text">Financial Instruments &#8211; Fair Value Measurements<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 1 &#8212; Observable quoted prices in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 2 &#8212; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.</span></div><div style="margin-bottom:6pt;padding-left:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt">Level 3 &#8212; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted warrants to certain noteholders in connection with its debt repayment and debt refinancing during 2020 and 2019, respectively. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued as Compensation. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s 12.5% Senior Secured Notes contained a repurchase offer or put option which gave holders of the option the right, but not the obligation, to require the Company to redeem the 12.5% Notes up to a capped portion of milestone payments resulting from the Monetization Agreement. This put option was valued based on Level 3 inputs and its fair value was based primarily on an independent third-party appraisal consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants Accounting and Valuation Guide. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants to purchase up to 4,000,000 shares of Common Stock and Common Stock Warrants to purchase up to 8,850,000 shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase 5,000,000 of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock at $2.60 per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide. See Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Warrants</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on these warrants.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, in connection with the issuance of the 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provided the Note Holders:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#8482; (epinephrine) Sublingual Film for a period of eight years from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&#8482; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#8217;s judgements, the then current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 107<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-107<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-6A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 940<br> -SubTopic 820<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478119/940-820-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396920288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventories</a></td>
<td class="text">Inventories<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358395507440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text">Property and Equipment, Net<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation, amortization, and impairment related to property and equipment was $159 and $218 for the three months ended September 30, 2024 and 2023, respectively. For the respective nine month periods, these expenses totaled $493 and $760.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/360/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358505042160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Right-of-Use Assets and Lease Obligations</a></td>
<td class="text">Right-of-Use Assets and Lease Obligations<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between 3.5 years and 9.0 years, including renewal options expected to be exercised to extend the lease periods. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the year ended December&#160;31, 2023, the Company recognized a lease supporting its manufacturing facilities as a finance lease. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes payable, net on the Condensed Balance Sheets. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not recognize a right-to use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#8217;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#8217;s short-term leases, as well as variable costs relating to the Company&#8217;s lease arrangements, are not material to the Company&#8217;s financial results.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The implicit interest rates of the Company&#8217;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the operating lease liability reflects a range of an estimated discount rate of 14.8% to 15.6% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#8217;s collateralized debt refinancing. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease costs are recorded in manufacture and supply, research and development and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive (Loss) Income. For the three and nine months ended September&#160;30, 2024, total operating lease expenses totaled $457 and $1,345, respectively, including variable </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lease expenses such as common area maintenance and operating costs of $123 and $349, respectively. For the three and nine months ended September&#160;30, 2023, total operating lease expenses totaled $438 and $1,308, respectively, including variable lease expenses such as common area maintenance and operating costs of $109 and $338, respectively.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397046048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets, Net</a></td>
<td class="text">Intangible Assets, Net<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of identifiable intangible assets, all of which are finite lived:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased patent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense was $39 for the three months ended September&#160;30, 2023. There was no amortization expense incurred during the three months ended September 30, 2024. For the nine months ended September&#160;30, 2024 and 2023, these expenses totaled $78 and $117, respectively. In June 2024, in connection with a termination of an agreement, the Company recorded a gain on termination of the contract in the amount of $1,500, which was partially offset by an adjustment to the remaining balance of $1,200 of the intangible asset. The net gain of $300 was recorded within Other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024. See Note 5, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Agreements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396737296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsDisclosureTextBlock', window );">Other Non-current Assets</a></td>
<td class="text">Other Non-current Assets<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the eight $1,000 annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of September&#160;30, 2024 and December&#160;31, 2023, Royalty receivable consists of four and five, respectively, annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sale of Future Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further details on how this receivable relates to the Monetization Agreement transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-current portion of commissions capitalized under ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is recorded within Other non-current assets on the Condensed Balance Sheets. Commissions of $191 were expensed in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024 due to the termination of the underlying contracts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396913600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued Expenses</a></td>
<td class="text">Accrued Expenses<div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reduction in Accrued compensation is related to payments of accrued bonuses during the nine months ended September 30, 2024, partially offset by the current year accrual of bonuses. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in Interest payable is mostly due to the timing of interest payments on the 13.5% Senior Notes. The third quarter 2024 interest payment on the 13.5% Senior Notes was made on September&#160;30, 2024. As of December&#160;31, 2023, interest payable on the 13.5% Senior Notes was due on January 2, 2024. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for discussion of 13.5% Notes and related interest payable.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for wholesaler service fees, co-pay support redemptions and other rebates related to the proprietary product Libervant. and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 720<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396737296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Long-Term Debt</a></td>
<td class="text">Long-Term Debt<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"> 12.5% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2019, the Company completed a private placement of up to $100,000 aggregate principal of its 12.5% Notes which were due 2025 and issued Warrants to purchase 2,000,000 shares of Common Stock at $0.001 par value per share.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon closing of the Base Indenture, the Company issued $70,000 of the 12.5% Notes (the &#8220;Initial Notes&#8221;) along with the Warrants and rights of first offer (the &#8220;First Offer Rights&#8221;) to the noteholders participating in this transaction. Issuance of the Initial Notes and Warrants provided net proceeds of $66,082.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the First Supplemental Indenture (the &#8220;First Supplemental Indenture&#8221; and, together with all other subsequent supplemental indentures and the Base Indenture, collectively, the &#8220;Indenture&#8221;) by and among the Company and U.S. Bank National Association, as Trustee (the &#8220;Trustee&#8221;) and Collateral Agent thereunder to the Base Indenture, by and between the Company and the Trustee. Under the Second Supplemental Indenture, the Company repaid $22,500 of its $70,000 outstanding 12.5% Notes from the upfront proceeds received under the Monetization Agreement. Further, the Company entered into an additional Purchase Agreement with its noteholders whereby the Company issued in aggregate $4,000 of additional 12.5% Notes (the &#8220;Additional Notes&#8221;) in lieu of paying a prepayment premium to two noteholders on the early repayment of the 12.5% Notes discussed above. The result of these two transactions reduced the net balance of the Company&#8217;s 12.5% Notes outstanding in the aggregate to $51,500 at December 31, 2020. The $4,000 principal issuance would be repaid proportionally over the same maturities as the other 12.5% Notes. The Company also paid to one of its noteholders a $2,250 premium as result of the early retirement of debt. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounted for the $22,500 debt repayment as a debt modification of the 12.5% Notes. The fees paid to noteholders inclusive of (i) a $2,250 early premium prepayment and (ii) $4,000 issuance of Additional Notes in lieu of paying a prepayment penalty were recorded as additional debt discount, amortized over the remaining life of the 12.5% Notes using the effective interest method. Loan origination costs of $220 associated with the Additional Notes were expensed as incurred. Existing deferred discounts and loan origination fees on the 12.5% Notes are amortized as an adjustment of interest expense over the remaining term of modified debt using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The First Supplemental Indenture contained a provision whereby, as the Company receives any cash proceeds from the Monetization Agreement, each noteholder had the right to require the Company to redeem all or any part of such noteholder&#8217;s outstanding 12.5% Notes at a repurchase price in cash equal to 112.5% of the principal amount, plus accrued and unpaid interest. This repurchase offer was capped at 30% of the cash proceeds received by the Company as the contingent milestones were attained, if any, up through June 30, 2025. The embedded put option was deemed to be a derivative under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 815, Derivatives and Hedging</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which required the recording of the embedded put option at fair value subject to remeasurement at each reporting period. Accordingly, a valuation study was performed by an independent third party appraiser and updated in June 30, 2023. Based on the valuation study, the put option was valued at $0. The put option fair value decreased by $45 and </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was recorded in interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2023. There was no change in fair value during the three months ended September 30, 2023. In addition, as of the closing of this transaction, the Company issued to the holders of the 12.5% Notes warrants to purchase 143,000 shares of the Company&#8217;s Common Stock. As of September&#160;30, 2024, the put option is no longer in place due to the refinancing of the 12.5% Notes.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 7, 2021, the Company entered into the Fourth Supplemental Indenture, pursuant to which the amortization schedule for the 12.5% Notes was amended to provide for the date of the first principal payment to be extended from September 30, 2021 to March 30, 2023. The Fourth Supplemental Indenture did not change the maturity date of the 12.5% Notes or the interest payment obligation due under the 12.5% Notes. In connection with the Fourth Supplemental Indenture, the Company entered into a Consent Fee Letter with the holders of the 12.5% Notes (the &#8220;Consent Fee Letter&#8221;), pursuant to which the Company agreed to pay the holders of the 12.5% Notes an additional cash payment ("Consent Fee") of $2,700 in the aggregate, payable in four quarterly payments beginning May 15, 2022. The last Consent Fee installment of $675 was made in February 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 12.5% Notes provided a stated fixed interest rate of 12.5%, payable quarterly in arrears, with the final quarterly principal repayment of the 12.5% Notes due at maturity on June 30, 2025.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company could have elected, at its option, to redeem the 12.5% Notes at any time at premiums that range from 101.56% of outstanding principal if prepayment occurs on or after the fifth anniversary of the issue date of the Initial Notes to 112.50% if payment occurs during the third year after the issuance of the 12.5% Notes. The Indenture also included change of control provisions under which the Company would have been required to redeem the 12.5% Notes at 101% of the remaining principal plus accrued interest at the election of the noteholders.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the nine months ended September 30 2023, the Company redeemed $5,647 of its outstanding 12.5% Notes. The Company also paid $353 in prepayment premium as result of the early retirement of debt which was reflected as a loss on extinguishment of debt on the Company's Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2023. The prepayments along with the scheduled principal payments of $6,878 during the nine months ended September 30, 2023 reduced the net balance of the 12.5% Notes outstanding in the aggregate to $38,975 as of September&#160;30, 2023.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from amortization of deferred debt issuance costs and debt discounts related to the 12.5% Notes for the three and nine months ended September&#160;30, 2023 was $3 and $11, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company issued the 13.5% Notes, as described below, and used most of the proceeds from the issuance to repay the outstanding principal balance under the 12.5% Notes of $36,014, including accrued and unpaid interest and a redemption fee.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">13.5% Senior Secured Notes</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#8220;Note Holders&#8221;) and issued $45,000 aggregate principal amount of its 13.5% Notes due 2028. The Company received net proceeds of approximately $4,326 from this transaction after the repayment of the 12.5% Notes and deduction of debt discount, and debt issuance costs.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The 13.5% Notes are senior secured obligations of the Company and mature on November 1, 2028. The 13.5% Notes bear interest at a fixed rate of 13.5% per year, payable quarterly commencing on December 30, 2023; the first interest payment was due and paid on January 2, 2024. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $2,000.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may, at its option, redeem the 13.5% Notes in full or in part:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">if such redemption occurs prior to November 1, 2025, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">1.0% of the principal redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt">the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus 100 basis points, exceeds the amount of principal to be redeemed; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">if such redemption occurs after November 1, 2025, the redemption price is equal to 108.5% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the 13.5% Notes at a change of control repurchase price equal at 108.5% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $100,000 of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $10,000. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the issuance of 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#8482; (epinephrine) Sublingual Film for a period of 8 years from the first sale of Anaphylm on a global basis, and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&#8482; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Both the 13.5% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and are subsequently measured on an amortized cost basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#8217;s judgements, current market conditions, and forecasts.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Royalty Right Agreements&#8217; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, there were no material changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the initial fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the Royalty Right Agreements were issued in connection with the 13.5% Notes, the Company allocated the proceeds to the two instruments based on their relative fair values. The Company allocated approximately $13,856 to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The excess of future estimated royalty payments of $56,926 over the $13,856 of allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At inception, the allocated amounts of $13,856 when combined with the Exit Fee of $2,000, original issue discount of $1,125 and debt issuance costs of $3,517, resulted in a debt discount of $20,498. The debt discount is being amortized over the term of 13.5% Notes using the effective interest method.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense arising from the discounts related to the 13.5% Notes for the three and nine months ended September&#160;30, 2024 was $1,254 and $3,765, respectively. Amortization expense arising from the discounts related to the Royalty Right Agreements for the three and nine months ended September&#160;30, 2024 was $1,359 and $4,075, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized discounts totaled $13,900 and $17,665 for the 13.5% Notes and $38,091 and $42,165 for the Royalty obligations as of September&#160;30, 2024 and December&#160;31, 2023, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,761&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current portion of royalty obligations payable is not material as of September 30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the 13.5% Notes as of September&#160;30, 2024 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358395507440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract', window );"><strong>Warrants and Rights Note Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_WarrantsDisclosureTextBlock', window );">Warrants</a></td>
<td class="text">Warrants<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued to 12.5% Senior Secured Noteholders </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants that were issued in conjunction with the Initial Notes (the &#8220;Initial Warrants&#8221;) and Additional Notes (the &#8220;Additional Warrants&#8221;) expire on June 30, 2025 and entitled the noteholders to purchase up to 2,143,000 shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $6,800 and the Additional Warrants to be $735, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized 12.5% Notes portion applied to reduce the aggregate principal amount of the 12.5% Notes. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#8220;cash change in control&#8221;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#8217;s unaudited Condensed Balance Sheets. There were no warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the nine months ended September&#160;30, 2024 and 2023, respectively. Warrants to purchase a total of 1,714,429 shares of Common Stock with exercise prices of $4.25 and $5.38 for 1,571,429 warrants and 143,000 warrants, respectively, remain outstanding as of September&#160;30, 2024 and December&#160;31, 2023. See Note 13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Long-Term Debt.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Warrants Issued Under Securities Purchase Agreements</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to 4,000,000 shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to 8,850,000 shares of Common Stock at an exercise price of $0.96 per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $5,874 based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#8217;s unaudited Condensed Balance Sheets. On June 14, 2023, 3,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $3,542.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. Management estimated the fair value of the warrants to be $4,671 based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#8217;s Condensed Balance Sheets.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 2, 2023, 5,000,000 of the Existing Warrants were exercised pursuant to the Securities Purchase Agreement with the Exercising Holder, with the Company receiving gross proceeds therefrom of $4,800. In total, 8,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements with net proceeds of approximately $8,307 were exercised during the year ended December 31, 2023. The Company incurred $35 in relation to this transaction.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no warrants issued or exercised as it relates to the Warrants Issued Under Securities Purchase Agreements during the nine months ended September&#160;30, 2024.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the warrants to purchase 2,750,000 shares of Common Stock described above, there remain outstanding warrants to purchase 160,548 shares of Common Stock at an exercise price of $0.96 and warrants to purchase 1,714,429 shares of Common Stock outstanding related to the original issuance of the 12.5% Notes prior to the debt refinancing described above in this Note 14, with exercise prices of $4.25 and $5.38 for 1,571,429 warrants and 143,000 warrants, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_WarrantsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_WarrantsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsNoteDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsNoteDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358395508176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueTextBlock', window );">Sale of Future Revenue</a></td>
<td class="text">Sale of Future Revenue<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#8217;s apomorphine product, KYNMOBI, an apomorphine film therapy for the treatment of off episodes in Parkinson&#8217;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through September&#160;30, 2024 under the Monetization Agreement.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded the upfront proceeds of $40,000 and subsequent first milestone of $10,000, reduced by $2,909 of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Transfer and Servicing </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $50,000 in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately 24.9%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#8217;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfFutureRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Future Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfFutureRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396908128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Earnings Per Share<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net (Loss) Earnings Per Share</a></td>
<td class="text">Net (Loss) Earnings Per Share<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net (loss) earnings per share is calculated by dividing net (loss) income by the weighted-average number of common shares.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the basic to diluted weighted average shares outstanding for the three and nine months ended September&#160;30, 2024 and 2023. Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended September&#160;30, 2024 and 2023, and for the nine months ended September&#160;30, 2024. all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended September&#160;30, 2024 and 2023 and the nine months ended September&#160;30, 2024 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,082,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,678,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,252,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock options </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of warrants </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Employee Stock Purchase Plan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,082,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,678,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,513,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Earnings per share attributable to common stockholders:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; basic</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,912,647 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,339,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 3,280,313 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 605,650. shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three and nine months ended September&#160;30, 2024 and the three months ended September&#160;30, 2023, the estimated effects of ESPP awards were not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396982928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-Based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its unaudited Condensed Statements of Operations and Comprehensive (Loss) Income during 2024 and 2023 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan (ESPP)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation Equity Awards</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine month period ended September&#160;30, 2024:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $6,677 of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of 1.96 years. The service-based restricted stock units granted to employees are subject to a three-year graduated vesting schedule and are not subject to performance-based criteria other than continued employment.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $1,451 of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of 1.59 years.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market conditions vesting-based restricted stock units vest based on a Performance Price measured as the 30-day average of the closing prices of the Company&#8217;s common stock as reported on the NASDAQ Stock Market immediately prior to and including the last calendar day of the three-year performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $1.75, the Vesting Percentage will be zero. To the extent the Performance Price is $1.75, the Vesting Percentage will be 50%. To the extent the Performance Price is $1.76 or greater, but less than $2.50, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $2.50, the Vesting Percentage will be 100%. To the extent the Performance Price is $2.51 or greater, but less than $3.25, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $3.25 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2022 Inducement Equity Incentive Plan</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with NASDAQ Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were no awards outstanding under this Plan as of September&#160;30, 2024.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.112%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The weighted average grant date fair value of stock options granted during the nine months ended September&#160;30, 2024 was $3.98. During the nine months ended September&#160;30, 2024, stock options were granted with a weighted average exercise price of $4.83 and accordingly, given the Company&#8217;s share price of $4.98 at September&#160;30, 2024, the intrinsic value provided by certain shares granted during this period was de minimis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of September&#160;30, 2024, $3,559 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of 1.56 years.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358395511616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three and nine months ended September&#160;30, 2024, the effective income tax rate was 0%, and the Company recorded no income tax expense from its pretax losses of $11,509 and $27,082, respectively. For the three and nine months ended September&#160;30, 2023, the effective income tax rate was 6.4% and 37.4%, respectively, and the Company recorded ($140) and $144 from its pretax (loss) income of ($2,175) and $385, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary factors impacting the effective tax rate for nine months ended September&#160;30, 2024 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396919184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Contingencies</a></td>
<td class="text">Contingencies<div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Kentucky Litigation - Humana</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Humana Inc. v. Indivior Inc, Indivior Solutions Inc., Indivior PLC, Reckitt Benckiser Group plc, Reckitt Benckiser Healthcare (UK) Ltd., and Aquestive Therapeutics, Inc. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 20, 2021, Humana filed a complaint in state court in Kentucky, alleging conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment against the Company relating to Indivior&#8217;s launch of Suboxone Sublingual Film in 2010. The Humana action was stayed pending related litigation, and the stay was lifted on October 30, 2023. On February 23, 2024, the Company filed a motion to dismiss the Complaint. Oral argument on the Company's motion to dismiss is currently set for December 9, 2024. No discovery schedule has been set in the action and there is no trial date set in this case. The Company is not able to determine or predict the ultimate outcome of the state court action in Kentucky by Humana or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">California Litigation</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis, Inc. v. Aquestive Therapeutics, Inc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 5, 2019, Neurelis Inc. filed a lawsuit against the Company in the Superior Court of California, County of San Diego alleging the following three causes of action: (1) Unfair Competition under California Business and Professional Code &#167; 17200 (&#8220;UCL&#8221;); (2) Defamation; and (3) Malicious Prosecution. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action. The Company filed a Motion to Strike Neurelis&#8217;s Complaint under California&#8217;s anti-SLAPP (&#8220;strategic lawsuit against public participation&#8221;) statute on January 31, 2020, which Neurelis opposed. On August 6, 2020, the Court issued an order granting in part and denying in part the Company&#8217;s anti-SLAPP motion. The parties cross-appealed the ruling to the California Court of Appeal. The appeals court held oral argument on the appeal on October 14, 2021, and issued its ruling on November 17, 2021. Under the ruling, the court struck the entirety of the malicious prosecution claim and struck portions of the UCL and defamation claims. On April 12, 2022, Neurelis filed a Second Amended Complaint in response to the Court of Appeal&#8217;s decision. The Second Amended Complaint also added a cause of action for Trade Libel. On May 3, 2022, the Company filed a "demurrer" challenge to the sufficiency of the allegations of the Second Amended Complaint. Oral argument on the Company&#8217;s motion for attorney fees related to the anti-SLAPP motion and on the Second Amended Complaint and demurer challenge was held on June 17, 2022. The Court entered an order granting the Company&#8217;s motion for attorney fees, awarding $156 and ordering Neurelis to pay the fees within 60 days of June 17, 2022. The Court denied the Company&#8217;s demurrer and the parties proceeded with discovery on the claims in the Second Amended Complaint. The plaintiff filed a motion to file a third amended complaint, which the Court granted on November 17, 2023. The Third Amended Complaint alleges additional facts but includes the same claims as the Second Amended Complaint. Trial in this matter is scheduled for March 7, 2025. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Neurelis FDA Lawsuit</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Neurelis v. Califf, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">et al</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, U.S. District court for the District of Columbia</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2024, Neurelis Inc. filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving Aquestive&#8217;s New Drug Application for Libervant&#8482; for epilepsy patients aged between two and five years, and asks the Court to vacate that approval and enjoin the defendants from approving Libervant&#8482; for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the orphan drug market exclusivity granted to the nasal spray product of Neurelis, Inc. by the FDA. Aquestive intervened in the litigation to defend the approval of Libervant&#8482; for this pediatric patient population and on June 25, 2024, the Court entered a scheduling order governing further proceedings in the case. Pursuant to that order, Neurelis filed a motion for summary judgment on August 19, 2024; Aquestive and the federal defendants each filed their own cross-motions for summary judgment and opposed Neurelis&#8217;s motion for summary judgment on September 18, 2024; Neurelis filed its combined reply brief in support of its motion for summary judgment and in opposition to the defendants&#8217; cross-motions on October 9, 2024; and Aquestive and the federal defendants filed their closing briefs on October 30, 2024. No oral argument date has been set in this case. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Suboxone Product Liability Litigation</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of October 21, 2024, the Company was named as a defendant in over 560 product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Sublingual Film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a Multidistrict Litigation (&#8220;MDL") consolidated in the United States District Court for the Northern District of Ohio. One case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. No discovery schedule or trial date has been set in the MDL matter. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of October 15, 2024, the Company was named as a defendant in three proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#174; products caused them dental injuries. Two of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the two cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec, and is proceeding towards an authorization hearing (date to be set). The authorization and certification hearings are where the Courts will determine if the cases will proceed as class actions. No discovery schedule or trial dates have been set, as all the Canadian cases are pre-certification/pre-authorization. Given the early stages of these proceedings, the Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 405<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/405-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 440<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478522/954-440-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/440/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392735392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (11,509)<span></span>
</td>
<td class="num">$ (2,745)<span></span>
</td>
<td class="num">$ (12,828)<span></span>
</td>
<td class="num">$ (2,035)<span></span>
</td>
<td class="num">$ (5,792)<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
<td class="num">$ (27,082)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400638944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=aqst_DanielBarberMember', window );">Daniel Barber [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Executive Officer Daniel Barber adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Barber Plan") on June 14, 2024. The Barber Plan commenced on September 13, 2024 and ends on September 30, 2025. The maximum number of shares to be sold under the Barber Plan is 650,055 shares and no shares have been sold as of the date of this Report; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Barber Plan.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Daniel Barber<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Chief Executive Officer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">June 14, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">September 30, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">382 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">650,055<span></span>
</td>
<td class="nump">650,055<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=aqst_PeterBoydMember', window );">Peter Boyd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MtrlTermsOfTrdArrTextBlock', window );">Material Terms of Trading Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Vice President Peter Boyd adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Boyd Plan") on September 11, 2024. The Boyd Plan commences on December 13, 2024 and ends on December 12, 2025. The maximum number of shares to be sold under the Boyd Plan is 35,000 shares; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Boyd Plan.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndName', window );">Name</a></td>
<td class="text">Peter Boyd<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrIndTitle', window );">Title</a></td>
<td class="text">Senior Vice President<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrAdoptionDate', window );">Adoption Date</a></td>
<td class="text">September 11, 2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrExpirationDate', window );">Expiration Date</a></td>
<td class="text">December 12, 2025<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrDuration', window );">Arrangement Duration</a></td>
<td class="text">364 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TrdArrSecuritiesAggAvailAmt', window );">Aggregate Available</a></td>
<td class="nump">35,000<span></span>
</td>
<td class="nump">35,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MtrlTermsOfTrdArrTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MtrlTermsOfTrdArrTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrExpirationDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrExpirationDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrIndTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrIndTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TrdArrSecuritiesAggAvailAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TrdArrSecuritiesAggAvailAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aqst_DanielBarberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aqst_DanielBarberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=aqst_PeterBoydMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=aqst_PeterBoydMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397083904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim unaudited condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes for the fiscal year ended December&#160;31, 2023 included in the Company&#8217;s Annual Report on Form 10-K filed with the SEC on March&#160;5, 2024 (the &#8220;2023 Annual Report on Form 10-K&#8221;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2023 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2024, the Company dissolved its subsidiaries and no longer prepares its financial statements on a consolidated basis. The dissolution of the subsidiaries did not have a material impact on the Company&#8217;s unaudited condensed financial statements as of September&#160;30, 2024 or the audited consolidated financial statements as of December&#160;31, 2023.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the Company is no longer an &#8220;emerging growth company,&#8221; but remains a &#8220;smaller reporting company&#8221;. The Company complies with new or revised accounting standards by the relevant dates on which adoption of such standards is required for smaller reporting companies. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Adopted as of September&#160;30, 2024:</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for Convertible Instruments and Contracts in an Entity&#8217;s Own Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#8217;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#8217;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#8217;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements. </span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued ASU 2022-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Accounting Standards Update was issued to clarify the guidance in Topic 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for such equity securities. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#8217;s condensed financial statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2024:</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In November 2023, the FASB issued ASU 2023-07, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">ASU 2023-0</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">7</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, which requires all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources and assess performance. Additionally, the standard requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. The guidance in this update is effective for fiscal years beginning after December 15, 2023, and interim periods after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its related disclosures.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740)&#8212;Improvements to Income Tax Disclosures. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Accounting Standards Update was issued to enhance the transparency and decision usefulness of income tax </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It further requires disclosure on an annual basis of the following information about income taxes paid: 1. The amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes 2. The amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). Additionally, it requires the following information disclosure: 1. Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign 2. Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU eliminates certain current disclosure requirements. These disclosure requirements will be effective for the Company beginning January 1, 2025, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2023-09 on disclosures to its condensed financial statements.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition and Performance Obligations</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.</span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance Obligations</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#8217;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#8217;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Manufacture and supply revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">License and Royalty Revenu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e &#8211; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (i</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.e</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Co-development and Research Fees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#8217;s research and development projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Proprietary product revenue, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of September&#160;30, 2024, and December&#160;31, 2023, such contract assets were $654 and $1,662, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#8217;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September&#160;30, 2024 and December&#160;31, 2023, such contract liabilities were $21,314 and $33,896, respectively.</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Costs to obtain contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of September&#160;30, 2024 and December&#160;31, 2023, such costs to obtain contracts were $488 and $715, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396305600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s revenues were comprised of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,409&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,312&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">License and royalty revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,162&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,103&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-development and research fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">492&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proprietary product revenue, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides disaggregated net revenue by geographic area: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,528&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,894&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,598&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,372&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ex-United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,014&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,108&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,542&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,377&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Trade and Other Receivables, Net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trade and other receivables, net consist of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,715&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract and other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,915&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: sales-related allowances</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade and other receivables, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,684&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,471&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provides a summary of activity with respect to sales-related allowances:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:70.793%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.657%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.391%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.659%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">669&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments / credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock', window );">Changes in Allowance for Bad Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the changes in the allowance for doubtful accounts:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:70.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.536%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at beginning of the period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance expense (reduction)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts at end of the period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss of financing receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-11B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397039600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventories (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Inventory, Net</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of Inventory are as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw material</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,240&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,118&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Packaging material</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,731&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventory</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,021&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,769&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358398719248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:58.371%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.647%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.558%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Useful<br/>Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,317&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,248&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-15 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer, network equipment and software</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3-7 years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,206&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,063&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,358)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,884)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,179&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396244352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s payments due under its operating leases are as follows: </span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:85.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.537%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,284&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,318&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,346&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 and thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,095&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,360&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,769)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,591&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397762640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Components of Identifiable Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of identifiable intangible assets, all of which are finite lived:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased intangible</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchased patent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">509&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,367&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,367)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,089)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358505061600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock', window );">Summary of Other Non-current Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides the components of other non-current assets:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty receivable</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other non-current assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,230&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,438&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396923456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Accrued Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses consisted of the following:</span></div><div style="margin-bottom:6pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,<br/>2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,<br/>2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,457&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Real estate and personal property taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued distribution expenses and sales returns provision</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">640&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest payable</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,013&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total accrued expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,025&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,497&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397102544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant unobservable inputs used in the initial fair value measurement of the Royalty Right Agreements:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.484%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.256%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.431%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Valuation Methodology</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Significant Unobservable Input</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average (range, if applicable)</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Discount Rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty Right Agreements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability weighted<br/>income approach</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Probability of Success</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Projected Years of Payments</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2033</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-Term Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term notes and unamortized debt discount balances are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total outstanding notes</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount, including Exit Fee</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,900)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,665)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, long-term</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease, long-term</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Notes payable, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,253&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,508&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,926&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized discount</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,091)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42,165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty obligations, net</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,835&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,761&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Debt Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Scheduled principal payments on the 13.5% Notes as of September&#160;30, 2024 are as follows:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2024</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,540&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,535&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,000&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-8<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396258864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RoyaltyObligationActivityTableTextBlock', window );">Royalty Obligation Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the activity of the liability related to the sale of future revenue:</span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at beginning of the period</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,490&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,259&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties related to the sale of future revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(935)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">220&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,490&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RoyaltyObligationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalty Obligation Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RoyaltyObligationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396263088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Earnings Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table reconciles the basic to diluted weighted average shares outstanding for the three and nine months ended September&#160;30, 2024 and 2023. Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#8217;s equity compensation plans, warrants and ESPP. As a result of the Company&#8217;s net loss incurred for the three months ended September&#160;30, 2024 and 2023, and for the nine months ended September&#160;30, 2024. all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended September&#160;30, 2024 and 2023 and the nine months ended September&#160;30, 2024 as reflected below.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.383%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.556%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.563%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (loss) income</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,509)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,035)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27,082)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">241&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,082,081&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,678,761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224,263&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59,252,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of stock options </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of restricted stock units </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">654,682&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of warrants </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,547,751&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of Employee Stock Purchase Plan </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91,082,081&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64,678,761&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,224,263&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,513,736&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Loss) Earnings per share attributable to common stockholders:</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; basic</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Loss) Earnings per common share &#8211; diluted</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.03)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.32)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,912,647 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,339,130</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 3,280,313 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 605,650. shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt">For the three months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt">For the three and nine months ended September&#160;30, 2024 and the three months ended September&#160;30, 2023, the estimated effects of ESPP awards were not material.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358505984960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Share-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized share-based compensation in its unaudited Condensed Statements of Operations and Comprehensive (Loss) Income during 2024 and 2023 as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:54.163%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.572%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.577%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended<br/>September 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manufacture and supply</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,637&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation from:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,982&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,217&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee stock purchase plan (ESPP)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,577&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">774&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,766&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Restricted Stock Units Awards</a></td>
<td class="text"><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables provide information about the Company&#8217;s restricted stock unit and stock option activity during the nine month period ended September&#160;30, 2024:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Service-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.97&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,430&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(607)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,728&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,539&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock', window );">Performance Share Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:71.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.516%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.518%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted<br/>Average<br/>Grant Date Fair<br/>Value</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(150)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested as of September 30, 2024</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,182&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.40&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Stock Option Awards:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of<br/>Options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,733&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.83&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(99)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,301&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected to vest as of September 30, 2024</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of September 30, 2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,688&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.110%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.112%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Nine Months Ended<br/>September 30,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">107%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Subparagraph (c)<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392285424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Company Overview and Basis of Presentation (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1">61 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 23, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 22, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Apr. 03, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 12, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>product </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 22, 2024 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts', window );">Number of commercialized products | product</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember', window );">Equity distribution agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,184,740<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,857,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,558<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember', window );">Equity distribution agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember', window );">At-the-market offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,557,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 530<span></span>
</td>
<td class="nump">$ 392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember', window );">Amended Equity Distribution Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockAggregateOfferingPrice', window );">Sale of stock, aggregate offering price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementMember', window );">Lincoln Park agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RightToSellCommonStockValue', window );">Right to sell common stock, value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AgreementTerm', window );">Agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">36 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementMember', window );">Lincoln Park agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions', window );">Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementCommitmentShareMember', window );">Lincoln Park Agreement, Commitment Share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">236,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember', window );">Underwritten Public Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,666,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Price per share (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockLineItems', window );"><strong>Subsidiary, Sale of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">559,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received on sale of stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 72,868<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments for stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts', window );">Underwriting discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,651<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Agreement Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Number Of Commercialized Products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RightToSellCommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right to Sell Common Stock, Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RightToSellCommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockAggregateOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Aggregate Offering Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockAggregateOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Consideration Received on Transaction, Underwriting Discounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_EquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_AtTheMarketOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_AmendedEquityDistributionAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementCommitmentShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_LincolnParkAgreementCommitmentShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_UnderwrittenPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397103344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Risks and Uncertainties (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 77,893<span></span>
</td>
<td class="nump">$ 23,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">$ 346,159<span></span>
</td>
<td class="nump">$ 319,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358393749968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Current and non-current contract assets</a></td>
<td class="nump">$ 654<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liabilities</a></td>
<td class="nump">21,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,896<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNet', window );">Capitalized contract cost, net</a></td>
<td class="nump">488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">715<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember', window );">Trade Accounts Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accrued distribution expenses and sales returns provision</a></td>
<td class="nump">28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember', window );">Other Receivables And Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accrued distribution expenses and sales returns provision</a></td>
<td class="nump">$ 640<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ResearchAndDevelopmentProjectDuration', window );">Research and development, project duration</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenues | Indivior | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">59.00%<span></span>
</td>
<td class="nump">79.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenues | Hasico | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables | Indivior | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Receivables | Zevra | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentrations of risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ResearchAndDevelopmentProjectDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Research and Development, Project Duration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ResearchAndDevelopmentProjectDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_TradeAccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_OtherReceivablesAndAccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_IndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_IndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_HasicoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_HasicoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=aqst_ZevraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=aqst_ZevraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358385549168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="nump">$ 45,694<span></span>
</td>
<td class="nump">$ 37,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember', window );">Manufacture and supply revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">10,671<span></span>
</td>
<td class="nump">11,409<span></span>
</td>
<td class="nump">29,312<span></span>
</td>
<td class="nump">32,807<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">2,162<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
<td class="nump">14,514<span></span>
</td>
<td class="nump">3,503<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember', window );">Co-development and research fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">492<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="nump">1,651<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ManufacturedProductOtherMember', window );">Proprietary product revenue, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 217<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_CoDevelopmentAndResearchFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ManufacturedProductOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ManufacturedProductOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396222976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="nump">$ 45,694<span></span>
</td>
<td class="nump">$ 37,377<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">10,528<span></span>
</td>
<td class="nump">9,894<span></span>
</td>
<td class="nump">30,598<span></span>
</td>
<td class="nump">25,372<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Ex-United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract', window );"><strong>Geographic Areas, Revenues from External Customers [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 3,014<span></span>
</td>
<td class="nump">$ 3,108<span></span>
</td>
<td class="nump">$ 15,096<span></span>
</td>
<td class="nump">$ 12,005<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392105648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Trade receivables</a></td>
<td class="nump">$ 7,715<span></span>
</td>
<td class="nump">$ 5,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNetCurrent', window );">Contract and other receivables</a></td>
<td class="nump">1,997<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_TradeAndOtherReceivablesNet', window );">Trade and other receivables, net</a></td>
<td class="nump">9,684<span></span>
</td>
<td class="nump">8,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember', window );">Doubtful Accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: allowance for doubtful accounts</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(14)<span></span>
</td>
<td class="num">$ (40)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember', window );">Trade Accounts Receivable, Sales Related</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">$ (28)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (669)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_TradeAndOtherReceivablesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_TradeAndOtherReceivablesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 40<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481628/310-20-40-7<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358393366624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details) - Doubtful Accounts - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at beginning of the period</a></td>
<td class="nump">$ 14<span></span>
</td>
<td class="nump">$ 40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance expense (reduction)</a></td>
<td class="num">(14)<span></span>
</td>
<td class="num">(26)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at end of the period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableDoubtfulAccountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396370160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details) - Trade Accounts Receivable, Sales Related - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at beginning of the period</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 669<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Allowance expense (reduction)</a></td>
<td class="nump">45<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Payments / credits</a></td>
<td class="num">(17)<span></span>
</td>
<td class="num">(87)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AccountsReceivableAllowanceForCreditLossReclassifications', window );">Reclassifications</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(582)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts at end of the period</a></td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AccountsReceivableAllowanceForCreditLossReclassifications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Reclassifications</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AccountsReceivableAllowanceForCreditLossReclassifications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=aqst_TradeAccountsReceivableSalesRelatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358384978944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Material Agreements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">17 Months Ended</th>
<th class="th" colspan="1">29 Months Ended</th>
<th class="th" colspan="1">47 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 27, 2023</div></th>
<th class="th"><div>Mar. 02, 2023</div></th>
<th class="th"><div>Oct. 26, 2022</div></th>
<th class="th"><div>Sep. 26, 2022</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Apr. 01, 2016</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Feb. 20, 2019</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>May 17, 2022</div></th>
<th class="th"><div>Mar. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestAndOtherIncomeNet', window );">Interest income and other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 979<span></span>
</td>
<td class="nump">$ 1,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,703<span></span>
</td>
<td class="nump">$ 16,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Manufacture and supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="nump">4,798<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,352<span></span>
</td>
<td class="nump">16,152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,542<span></span>
</td>
<td class="nump">13,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,694<span></span>
</td>
<td class="nump">37,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SeveranceCostsMonthlyPaymentDuration', window );">Severance costs monthly payment, duration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember', window );">Assertio Holdings, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromCollaborators', window );">Proceeds from collaborators</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember', window );">Manufacture and supply revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,671<span></span>
</td>
<td class="nump">11,409<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,312<span></span>
</td>
<td class="nump">32,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember', window );">License and royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,162<span></span>
</td>
<td class="nump">1,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,514<span></span>
</td>
<td class="nump">3,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember', window );">Commercial exploitation agreement with Indivior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LicenseAgreementTerm', window );">License agreement term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_AutomaticRenewalPeriodOfAgreement', window );">Automatic renewal period of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Indivior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncome', window );">Deferred income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from collaborative arrangement, excluding revenue from contract with customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InterestAndOtherIncomeNet', window );">Interest income and other income, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Manufacture and supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember', window );">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Manufacture and supply revenue | Indivior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer', window );">Revenue from collaborative arrangement, excluding revenue from contract with customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,396<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeRevenueRecognized', window );">Deferred income, revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,682<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember', window );">Supplemental agreement with Indivior</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember', window );">License agreement with Sunovion Pharmaceuticals, Inc. upfront</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember', window );">License agreement with Sunovion Pharmaceuticals, Inc milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Aggregate payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember', window );">License agreement with Sunovion Pharmaceuticals, Inc milestones | License and royalty revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Royalties related to the sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Monetization Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ContingentMonetizationAgreementMilestonePayment', window );">Proceeds from debt, contingent on additional milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember', window );">Haisco Pharmaceutical Group Co., Ltd, upfront payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss', window );">Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Sales commissions and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 134<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseSupplyAgreementMember', window );">License &amp; Supply Agreement | Atnahs Pharma UK Limited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember', window );">Atnahs Pharma UK Limited, Amended Agreement | License &amp; Supply Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="nump">$ 2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncMember', window );">Mitsubishi Tanabe Pharma America, Inc</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Sales commissions and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_AutomaticRenewalPeriodOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period for which the agreement is renewed automatically.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_AutomaticRenewalPeriodOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ContingentMonetizationAgreementMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Monetization Agreement, Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ContingentMonetizationAgreementMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InterestAndOtherIncomeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest And Other Income, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InterestAndOtherIncomeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LicenseAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>License agreement term period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LicenseAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale of Future Revenues, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SeveranceCostsMonthlyPaymentDuration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance Costs Monthly Payment, Duration</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SeveranceCostsMonthlyPaymentDuration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481174/470-10-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized previously reported as deferred income not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479432/944-30-50-2B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromCollaborators">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received from collaborators during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromCollaborators</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 808<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479428/808-10-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=aqst_AssertioHoldingsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_ManufactureAndSupplyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=aqst_LicenseAndRoyaltyRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_CommercialExploitationAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=aqst_IndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=aqst_IndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_SupplementalAgreementWithIndiviorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_AtnahsPharmaUKLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_AtnahsPharmaUKLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_AtnahsPharmaUKLimitedAmendedAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_LicenseSupplyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_LicenseSupplyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358386129776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments &#8211; Fair Value Measurements (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Nov. 01, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>Jul. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember', window );">Existing Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,714,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember', window );">New Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember', window );">Securities purchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants', window );">Shares of common stock (in shares)</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants', window );">Shares of common stock in connection with securities purchase agreements (in shares)</a></td>
<td class="nump">8,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares of Common Stock to be Purchased by Common Stock Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=aqst_SecuritiesPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358506040288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventories (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw material</a></td>
<td class="nump">$ 3,240<span></span>
</td>
<td class="nump">$ 2,118<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InventoryPackingMaterialGross', window );">Packaging material</a></td>
<td class="nump">2,731<span></span>
</td>
<td class="nump">3,028<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoods', window );">Finished goods</a></td>
<td class="nump">1,050<span></span>
</td>
<td class="nump">1,623<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 7,021<span></span>
</td>
<td class="nump">$ 6,769<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InventoryPackingMaterialGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of packaging materials expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InventoryPackingMaterialGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400547872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 47,206<span></span>
</td>
<td class="nump">$ 47,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(43,358)<span></span>
</td>
<td class="num">(42,884)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Total property and equipment, net</a></td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">4,179<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 20,317<span></span>
</td>
<td class="nump">20,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 769<span></span>
</td>
<td class="nump">769<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 21,386<span></span>
</td>
<td class="nump">21,386<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,685<span></span>
</td>
<td class="nump">2,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember', window );">Computer, network equipment and software | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,049<span></span>
</td>
<td class="nump">$ 2,033<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478451/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=aqst_ComputerNetworkEquipmentAndSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358385450960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 159<span></span>
</td>
<td class="nump">$ 218<span></span>
</td>
<td class="nump">$ 493<span></span>
</td>
<td class="nump">$ 760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358393066960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfOperatingLeases', window );">Number of leases | lease</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">$ 457<span></span>
</td>
<td class="nump">$ 438<span></span>
</td>
<td class="nump">$ 1,345<span></span>
</td>
<td class="nump">$ 1,308<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease expense</a></td>
<td class="nump">$ 123<span></span>
</td>
<td class="nump">$ 109<span></span>
</td>
<td class="nump">$ 349<span></span>
</td>
<td class="nump">$ 338<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Estimated discount rate</a></td>
<td class="nump">14.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease term</a></td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseDiscountRate', window );">Estimated discount rate</a></td>
<td class="nump">15.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfOperatingLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfOperatingLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Discount rate used by lessee to determine present value of operating lease payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358506028272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Right-of-Use Assets and Lease Obligations - Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2024</a></td>
<td class="nump">$ 317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">1,284<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">1,318<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">1,346<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter', window );">2028 and thereafter</a></td>
<td class="nump">5,095<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease payments</a></td>
<td class="nump">9,360<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(3,769)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 5,591<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358394280832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets, Net - Components of Identifiable Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 4,367<span></span>
</td>
<td class="nump">$ 4,367<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Less: accumulated amortization</a></td>
<td class="num">(4,367)<span></span>
</td>
<td class="num">(3,089)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangible assets, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember', window );">Purchased intangible</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">3,858<span></span>
</td>
<td class="nump">3,858<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember', window );">Purchased patent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Intangible assets, gross</a></td>
<td class="nump">$ 509<span></span>
</td>
<td class="nump">$ 509<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TechnologyBasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_PatentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397963264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
<td class="nump">$ 117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDispositionOfIntangibleAssets', window );">Gain (loss) on disposition of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived', window );">Impairment of intangible assets, finite-lived</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnContractTermination', window );">Gain on contract termination</a></td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnContractTermination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnContractTermination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDispositionOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDispositionOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsFinitelived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsFinitelived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397048624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Non-current Assets - Summary of Other Non-current Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_CumulativeRoyaltyReceivable', window );">Royalty receivable</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsMiscellaneousNoncurrent', window );">Other</a></td>
<td class="nump">1,230<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other non-current assets</a></td>
<td class="nump">$ 4,230<span></span>
</td>
<td class="nump">$ 5,438<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_CumulativeRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_CumulativeRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsMiscellaneousNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsMiscellaneousNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392783872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-current Assets - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($) </div>
<div>payment</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>payment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,694<span></span>
</td>
<td class="nump">$ 37,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfGuaranteedRoyaltyPayments', window );">Number of guaranteed royalty payments | payment</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_MinimumAnnualRoyaltyReceivable', window );">Minimum annual royalty receivable</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable', window );">Number of annual royalty payments receivable | payment</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember', window );">Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SalesCommissionsAndFees', window );">Sales commissions and fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (935)<span></span>
</td>
<td class="num">$ (989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty | License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems', window );"><strong>Acquired Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MinimumAnnualRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MinimumAnnualRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfAnnualRoyaltyPaymentsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of annual royalty payments receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfAnnualRoyaltyPaymentsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NumberOfGuaranteedRoyaltyPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Guaranteed Royalty Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NumberOfGuaranteedRoyaltyPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SalesCommissionsAndFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SalesCommissionsAndFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358383550208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Schedule of Accrued Expenses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation</a></td>
<td class="nump">$ 3,457<span></span>
</td>
<td class="nump">$ 4,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxesPayableCurrent', window );">Real estate and personal property taxes</a></td>
<td class="nump">473<span></span>
</td>
<td class="nump">337<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPayableCurrent', window );">Interest payable</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">1,013<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">438<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 5,025<span></span>
</td>
<td class="nump">$ 6,497<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392788416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses - Narrative (Details) - 13.5% Senior Secured Notes due November 1, 2028<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Nov. 01, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermDebtLineItems', window );"><strong>Short-Term Debt [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermDebtLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermDebtLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358391681488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Long-Term Debt - Narrative (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 03, 2020 </div>
<div>USD ($) </div>
<div>noteholder </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 15, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 15, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 28, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 15, 2022 </div>
<div>quarterlyInstallment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>transaction</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights', window );">Net proceeds from issuance of initial notes, warrants and first offer rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,082<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total outstanding notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Consent fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 1,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,015<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfLoanCosts', window );">Payments of loan costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 36,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions', window );">Redemption percentage of debt under change of control provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt issuance costs and discounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Put Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Derivative liability, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on derivative instruments, net, pretax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(45)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ElectiveRedemptionPercentageOfDebt', window );">Elective redemption percentage of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ElectiveRedemptionPercentageOfDebt', window );">Elective redemption percentage of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.56%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 22,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total outstanding notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,975<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 51,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Proceeds from issuance of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentNumberOfNoteholders', window );">Number of noteholders | noteholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentNumberOfTransactions', window );">Number of transactions | transaction</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_PremiumsPaidEarlyRetirementOfDebt', window );">Premium on early retirement of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">112.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtExtinguishmentCosts', window );">Consent fee payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments', window );">Number of quarterly installments | quarterlyInstallment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 675<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Loss on extinguishment of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (353)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal', window );">Periodic payment, principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025 | Senior notes | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold', window );">Percentage of cash proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="nump">13.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Principal amount</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price percentage</a></td>
<td class="nump">108.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFeeAmount', window );">Fee amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from issuance of long-term debt</a></td>
<td class="nump">$ 4,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including exit fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior notes | Redemption Scenario 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed', window );">Debt instrument, redemption price, percentage of principal amount redeemed</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate', window );">Debt instrument, redemption price, basis points above treasury rate</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior notes | Redemption Scenario 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Repurchase price percentage</a></td>
<td class="nump">108.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm', window );">Royalty obligation, term</a></td>
<td class="text">8 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Amortization of debt discount (premium)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,075<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage', window );">Royalty obligation, percent of net sales</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage', window );">Royalty obligation, percent of net sales</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtFairValue', window );">Fair value</a></td>
<td class="nump">$ 13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet', window );">Unamortized discount (premium), net</a></td>
<td class="nump">1,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_DebtInstrumentExitFee', window );">Debt instrument, exit fee</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt issuance costs, net</a></td>
<td class="nump">3,517<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Unamortized deferred debt issuance cost and deferred debt discounts</a></td>
<td class="nump">20,498<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total outstanding notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including exit fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember', window );">ABL Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold', window );">Line of credit facility, accordion feature, net revenue threshold</a></td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit', window );">Line of credit facility, accordion feature, increase limit</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Additional Payment, Number Of Quarterly Installments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repurchase Offer, Percentage of Cash Proceeds Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Tiered Royalty Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentCovenantTieredRoyaltyPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant, Tiered Royalty Percentage, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentExitFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Exit Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentExitFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentNumberOfNoteholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Noteholders</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentNumberOfNoteholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentNumberOfTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Number Of Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentNumberOfTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Price, Basis Spread On Variable Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ElectiveRedemptionPercentageOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Elective redemption percentage of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ElectiveRedemptionPercentageOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Increase Limit</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Accordion Feature, Net Revenue Threshold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_PremiumsPaidEarlyRetirementOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Premiums Paid, Early Retirement of Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_PremiumsPaidEarlyRetirementOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption percentage of debt under change of control provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFeeAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the fee that accompanies borrowing money under the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFeeAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPaymentPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments applied to principal.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPaymentPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of principal amount of debt redeemed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount (premium).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481303/470-50-40-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtExtinguishmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtExtinguishmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfLoanCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan origination associated cost which is usually collected through escrow.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfLoanCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OptionIndexedToIssuersEquityTypeAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_DebtCovenantRedemptionScenarioAxis=aqst_RedemptionScenario2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_ABLFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358391763120">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule Of Royalty Right Agreements (Details)<br></strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember', window );">Measurement Input, Discount Rate</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.15<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember', window );">Measurement Input, Probability Of Success</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMeasurementInput', window );">Measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=aqst_MeasurementInputProbabilityOfSuccessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396028912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total outstanding notes</a></td>
<td class="nump">$ 45,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member', window );">13.5% Senior Secured Notes due November 1, 2028 | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total outstanding notes</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">$ 45,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including Exit Fee</a></td>
<td class="num">(13,900)<span></span>
</td>
<td class="num">(17,665)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Notes payable, long-term</a></td>
<td class="nump">31,100<span></span>
</td>
<td class="nump">27,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease, long-term</a></td>
<td class="nump">153<span></span>
</td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtAndCapitalLeaseObligations', window );">Notes payable, net</a></td>
<td class="nump">31,253<span></span>
</td>
<td class="nump">27,508<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Royalty obligations</a></td>
<td class="nump">45,000<span></span>
</td>
<td class="nump">45,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(13,900)<span></span>
</td>
<td class="num">(17,665)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total outstanding notes</a></td>
<td class="nump">56,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Royalty obligations</a></td>
<td class="nump">56,926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember', window );">Royalty Obligations | Unsecured Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Total outstanding notes</a></td>
<td class="nump">56,926<span></span>
</td>
<td class="nump">56,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount, including Exit Fee</a></td>
<td class="num">(38,091)<span></span>
</td>
<td class="num">(42,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Royalty obligations</a></td>
<td class="nump">56,926<span></span>
</td>
<td class="nump">56,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Unamortized discount</a></td>
<td class="num">(38,091)<span></span>
</td>
<td class="num">(42,165)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total outstanding notes</a></td>
<td class="nump">$ 18,835<span></span>
</td>
<td class="nump">$ 14,761<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-1A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtAndCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt and lease obligation, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtAndCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_SeniorSecuredNotes13.5DueNovember12028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_RoyaltyObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358502149680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Long-Term Debt - Debt Maturities (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Sep. 30, 2024 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear', window );">Remainder of 2024</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2026</a></td>
<td class="nump">9,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree', window );">2027</a></td>
<td class="nump">14,535<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour', window );">2028</a></td>
<td class="nump">20,925<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total</a></td>
<td class="nump">$ 45,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400020880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 02, 2023</div></th>
<th class="th"><div>Jun. 14, 2023</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Aug. 01, 2023</div></th>
<th class="th"><div>Jun. 30, 2022</div></th>
<th class="th"><div>Jul. 15, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsExercised', window );">Exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,874<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember', window );">First Additional Warrant Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,714,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 735<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_InitialWarrantOfferingMember', window );">Initial Warrant Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure', window );">Fair value of warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember', window );">Pre-Funded Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember', window );">Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,689,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,689,452<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,542<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Adjustments to additional paid in capital, stock issued, issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember', window );">Existing Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,714,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from warrant exercises</a></td>
<td class="nump">$ 4,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued during period, conversion of convertible securities (in shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember', window );">New Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WarrantsAndRightsOutstanding', window );">Warrants and rights outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants0.96ExercisePriceMember', window );">Warrants, $0.96 Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants4.25ExercisePriceMember', window );">Warrants, $4.25 Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,571,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants5.38ExercisePriceMember', window );">Warrants, $5.38 Exercise Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.38<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Class of warrant or right, outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Common Stock Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Warrant exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.96<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | First Additional Warrant Offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Warrants issued (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,143,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member', window );">Senior secured notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightLineItems', window );"><strong>Class of Warrant or Right [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod', window );">Warrants issued to purchase common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of class of warrant or right exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of warrants issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsAndRightsOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsAndRightsOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WarrantsNotSettleableInCashFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of warrants not settleable in cash classified as equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WarrantsNotSettleableInCashFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_FirstAdditionalWarrantOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_InitialWarrantOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_InitialWarrantOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_PreFundedWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_CommonStockWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_ExistingWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_NewWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants0.96ExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants0.96ExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants4.25ExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants4.25ExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants5.38ExercisePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=aqst_Warrants5.38ExercisePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358383993072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1">29 Months Ended</th>
<th class="th" colspan="1">47 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments for loan acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18<span></span>
</td>
<td class="nump">$ 12,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,694<span></span>
</td>
<td class="nump">37,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(935)<span></span>
</td>
<td class="num">$ (989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember', window );">MAM Pangolin Royalty , LLC | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="nump">$ 125,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_MinimumAnnualRoyaltyReceivable', window );">Minimum annual royalty receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember', window );">License agreement with Sunovion Pharmaceuticals, Inc. | Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember', window );">Monetization Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments for loan acquisition costs</a></td>
<td class="nump">$ 2,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective annual interest rate</a></td>
<td class="nump">24.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember', window );">Monetization Agreement | MAM Pangolin Royalty , LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ProceedsFromSaleOfFutureRevenuesNet', window );">Proceeds from sale of future revenue</a></td>
<td class="nump">$ 40,000<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
<td class="nump">$ 50,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ContingentMonetizationAgreementMilestonePayment', window );">Proceeds from debt, contingent on additional milestones</a></td>
<td class="nump">$ 75,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ContingentMonetizationAgreementMilestonePayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contingent Monetization Agreement, Milestone Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ContingentMonetizationAgreementMilestonePayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_MinimumAnnualRoyaltyReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum annual royalty receivable by the entity for the use of its rights and property by another party.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_MinimumAnnualRoyaltyReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ProceedsFromSaleOfFutureRevenuesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale of Future Revenues, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ProceedsFromSaleOfFutureRevenuesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_MarathonPangolinRoyaltyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=aqst_MonetizationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396450704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Sale of Future Revenue - Royalty Obligation (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueRollForward', window );"><strong>Sale of Future Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyalties', window );">Liability related to the sale of future revenue, net at beginning of the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,490<span></span>
</td>
<td class="nump">$ 65,259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="nump">$ 13,542<span></span>
</td>
<td class="nump">$ 13,002<span></span>
</td>
<td class="nump">45,694<span></span>
</td>
<td class="nump">37,377<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="nump">220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyalties', window );">Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)</a></td>
<td class="nump">63,730<span></span>
</td>
<td class="nump">$ 64,490<span></span>
</td>
<td class="nump">63,730<span></span>
</td>
<td class="nump">64,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent', window );">Liability related to the sale of future revenue, current</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 922<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember', window );">Royalty</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_SaleOfFutureRevenueRollForward', window );"><strong>Sale of Future Revenue [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (935)<span></span>
</td>
<td class="num">$ (989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LiabilitiesSaleOfFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Sale of Future Royalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LiabilitiesSaleOfFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Sale of Future Royalties, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_SaleOfFutureRevenueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale of Future Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_SaleOfFutureRevenueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_RoyaltyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_RoyaltyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358384465200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="6">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net (loss) income</a></td>
<td class="num">$ (11,509)<span></span>
</td>
<td class="num">$ (2,745)<span></span>
</td>
<td class="num">$ (12,828)<span></span>
</td>
<td class="num">$ (2,035)<span></span>
</td>
<td class="num">$ (5,792)<span></span>
</td>
<td class="nump">$ 8,068<span></span>
</td>
<td class="num">$ (27,082)<span></span>
</td>
<td class="nump">$ 241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average number of common shares &#8211; basic (in shares)</a></td>
<td class="nump">91,082,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,678,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,224,263<span></span>
</td>
<td class="nump">59,252,768<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants', window );">Effect of dilutive stock options and warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,547,751<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average number of common shares - diluted (in shares)</a></td>
<td class="nump">91,082,081<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,678,761<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,224,263<span></span>
</td>
<td class="nump">61,513,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="num">$ (0.13)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.03)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">57,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">654,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Effect of share-based payment arrangements (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,064<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">6,301,364<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,912,647<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,301,364<span></span>
</td>
<td class="nump">5,339,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">3,910,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,280,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,910,376<span></span>
</td>
<td class="nump">605,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants on common shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">4,624,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,464,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,624,977<span></span>
</td>
<td class="nump">4,464,429<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-26<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392780416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net (Loss) Earnings Per Share - Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">6,301,364<span></span>
</td>
<td class="nump">5,912,647<span></span>
</td>
<td class="nump">6,301,364<span></span>
</td>
<td class="nump">5,339,130<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants on common shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share, amount (in shares)</a></td>
<td class="nump">4,624,977<span></span>
</td>
<td class="nump">4,464,429<span></span>
</td>
<td class="nump">4,624,977<span></span>
</td>
<td class="nump">4,464,429<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358506734016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 1,577<span></span>
</td>
<td class="nump">$ 774<span></span>
</td>
<td class="nump">$ 4,696<span></span>
</td>
<td class="nump">$ 1,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">312<span></span>
</td>
<td class="nump">2,982<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">528<span></span>
</td>
<td class="nump">462<span></span>
</td>
<td class="nump">1,698<span></span>
</td>
<td class="nump">1,217<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">Employee stock purchase plan (ESPP)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember', window );">Manufacture and supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">102<span></span>
</td>
<td class="nump">59<span></span>
</td>
<td class="nump">271<span></span>
</td>
<td class="nump">155<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">310<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="nump">788<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationAbstract', window );"><strong>Share-based Compensation expenses [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expenses</a></td>
<td class="nump">$ 1,165<span></span>
</td>
<td class="nump">$ 610<span></span>
</td>
<td class="nump">$ 3,637<span></span>
</td>
<td class="nump">$ 1,334<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=aqst_ManufacturingAndSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358396206080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Restricted Stock Unit Awards (Details) - Restricted stock units<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th">
<div>Sep. 30, 2024 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at beginning of period (in shares) | shares</a></td>
<td class="nump">1,948<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">1,430<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(607)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested, at end of period (in shares) | shares</a></td>
<td class="nump">2,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares', window );">Vested and expected to vest at end of period (in shares) | shares</a></td>
<td class="nump">2,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">5.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">0.96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share) | $ / shares</a></td>
<td class="nump">1.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested, at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">3.36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue', window );">Vested and expected to vest at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 3.33<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358386646496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_InducementEquityCommonStockOptionsOutstandingShares', window );">Inducement equity, common stock options outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Share price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.98<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs of RSU awards</a></td>
<td class="nump">$ 6,677<span></span>
</td>
<td class="nump">$ 6,677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 11 months 15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod', window );">Average closing prices period</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.75<span></span>
</td>
<td class="nump">1.75<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Three | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 1.76<span></span>
</td>
<td class="nump">1.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">50.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Three | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">99.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">2.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Five | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 2.51<span></span>
</td>
<td class="nump">2.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">100.01%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Five | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">149.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Condition Range Six</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare', window );">Performance price threshold (in dollars per share)</a></td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="nump">$ 3.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Award vesting rights, percentage</a></td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units | Market Based</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs of RSU awards</a></td>
<td class="nump">$ 1,451<span></span>
</td>
<td class="nump">$ 1,451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 7 months 2 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation cost, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 6 months 21 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.98<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to non-vested stock options</a></td>
<td class="nump">$ 3,559<span></span>
</td>
<td class="nump">$ 3,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_InducementEquityCommonStockOptionsOutstandingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inducement Equity, Common Stock Options Outstanding, Shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_InducementEquityCommonStockOptionsOutstandingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_VestingConditionAxis=aqst_VestingConditionRangeSixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_VestingConditionAxis=aqst_VestingConditionRangeSixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=aqst_MarketBasedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=aqst_MarketBasedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400481392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Performance Based (Details) - Performance Shares - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of Units</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested (in shares)</a></td>
<td class="nump">1,182<span></span>
</td>
<td class="nump">1,332<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares', window );">Vested and expected to vest at end of period (in shares)</a></td>
<td class="nump">1,089<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested (in dollars per share)</a></td>
<td class="nump">$ 2.40<span></span>
</td>
<td class="nump">$ 2.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">2.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue', window );">Vested and expected to vest at end of period (in dollars per share)</a></td>
<td class="nump">$ 2.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358400703744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Stock Option Activity (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(231,400)<span></span>
</td>
<td class="num">(625)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,301,000<span></span>
</td>
<td class="nump">5,733,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,024,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(357,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod', window );">Forfeited/expired (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(99,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest at end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable at end of period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,688,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.68<span></span>
</td>
<td class="nump">$ 5.58<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited/expired (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Vested or expected to vest at end of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.70<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Exercisable at end of period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either exercised, forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>aqst_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358392091280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details) - Stock options<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected volatility, minimum</a></td>
<td class="nump">104.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected volatility, maximum</a></td>
<td class="nump">107.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358397970912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">9 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Sep. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Effective income tax rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">6.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">37.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes (benefit) expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (140)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 144<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Net (loss)/income before income taxes</a></td>
<td class="num">$ (11,509)<span></span>
</td>
<td class="num">$ (2,175)<span></span>
</td>
<td class="num">$ (27,082)<span></span>
</td>
<td class="nump">$ 385<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45358393443920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Contingencies (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Jul. 29, 2024 </div>
<div>plaintiff</div>
</th>
<th class="th">
<div>May 03, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Oct. 15, 2024 </div>
<div>lawsuit</div>
</th>
<th class="th">
<div>Dec. 05, 2019 </div>
<div>cause</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_NeurelisIncVAquestiveTherapeuticsIncMember', window );">Neurelis, Inc. v. Aquestive Therapeutics, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending | cause</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty', window );">Litigation settlement, amount awarded from other party | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember', window );">Suboxone Produce Liability Litigation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of plaintiffs | plaintiff</a></td>
<td class="nump">560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember', window );">Suboxone Produce Liability Litigation | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember', window );">Suboxone Produce Liability Litigation | BRITISH COLUMBIA | Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyPendingClaimsNumber', window );">Number of cases pending</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationSettlementAmountAwardedFromOtherParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount awarded from other party in judgment or settlement of litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationSettlementAmountAwardedFromOtherParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483359/720-20-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482395/460-10-55-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyPendingClaimsNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of pending claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-4<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483076/450-20-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyPendingClaimsNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=aqst_NeurelisIncVAquestiveTherapeuticsIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=aqst_NeurelisIncVAquestiveTherapeuticsIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=aqst_SuboxoneProduceLiabilityLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA-BC">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA-BC</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>105
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7>V^8?OW'Y?+S9<_G&_]S\O5[P\UWO\'4$L#!!0    ( %:%9%G53%##A@<
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MUB*O/^X9!8\8 ?A^)X1^O# /.+YSL_X?4$L#!!0    ( %:%9%DC 5=V(PP
M /L?   8    >&PO=V]R:W-H965T<R]S:&5E=#<N>&ULK5EM<]LV$OXK&-77
MLV=H6:]^J1//R$[;2Z]M/'%ZO9F;^P"1D(2& A@ E.W\^GMV 5*2+=O)M1\2
MBR2XV'WP[+,+\-6M=1_]0JD@[I:E\:\[BQ"J[XZ.?+Y02^F[ME(&3V;6+67
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M<2=N49N+8"O^O#NU(=@E_Z036>5H )Y3!6PN:(+V>__%_P!02P,$%     @
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MS3YJ'K-!TG%S 3C3DS-5'%;KFD&(L<W8G =KXHFNXMX0X4T2P"2)I10 )I;
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M1H"@-,1HFSFXL4V;1N"VV>V08J?0;)2"R?9 RV%6ESKE*.DPGMS =FIF=N*
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MLQ4'0]>J>4#(-B2[KA4[Y[D)0AVQ3"DQW)A.-JLJ:C>+KZ,L%V[VT\^C L\
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MDI]>JEA3Q&CEH]VGDZ.C(UK\WN>KV*-<N8R/XZY\,&'X5A:.8/!36)\!BA*
MU,^5TQ%!7,17K9=4:8.CV?M86F39[WD[P 1^XC<HADCD.):(N_+!!=+=\;W-
M6['H(*Y[N7TN?C>YH7\*<DU-74KESIT2@VT!:@_9-X23!]SVZ0%P QYF><7U
MD$&QXW,1/3L]I6>/S[?4/'P:L+[5)"D'#F&<@"V%B?$'^M3 /5SK.]'(\""<
M+ERE@1DY#S9O68;.U3NLCVRZD>U)&WPB!SA5TF/B5,$MI.S03*X7E!FEG98!
M%E<ME2$&=A$PFO./ A$"!,EM.4XX)P1$)'W*%1+QH7T(22<#/WS7S%^J*C4#
M@N>P13&B8!RHBFY;MTV6+!!ZH'')K(5Q%$#W2],1Z:"C_*;%(UE*N6=W45B,
M..WR4J">'RVYK6L=UUX>=9,.+1G<2281G/UVY^]\3M=SV1YODB2<AR#0N89@
M-VB_2],'F?+) 0R!TFDXY@EK4SA\I9 !CD2[#?LK-OGB2:WG>(@NAE1!SGRG
M9S4?.F4;/?Y%Y*&:)[6QWQ'SVP+.-^8&O%9RZ?XBW=6)/ZL/DB\ZR[K,XZ.:
MB9Y>Y-<E'MD4&,F(0?+"';5[>C0Y/SL:"/K!3!\D[]K:965.:@\7&#M)VR([
M94<F6);\8^9J8D1@/V>&/<_)+IR1PA 6LA()TAPH+R<W?9#\"?P]I(NNQV5'
ML60>P>J5UM@9<J/K0VRBVR%U=%6<3$-W<P3GBS4EB@L[@_.KQWE$$9KI55T$
MK!+:(-/)54HW.V'\Z0L3):56_PH5(\AN)$&D8'#5%D#+(&B\D(UH<X$(F(O9
M4:JR.=!X)S:,-V_N"E5!83C+5!6?8&7[O<<4RCVI^Q/JR^G:E9V4=0[=,3)2
M.([E)">&U5(S%1,+->H)-?7R[(9J29XI:0X,W?\3]_4^_>[]X&B9)2[PC$4^
MGR((G&>K<36-1NI#G#OP0U#4LG95>>O+3?Q-5:Y\R/#0HP$Z:GP(+>?S1%?&
MEIG4""\1HTQARR(X),1+1E,@P4BU*XBJI?C4+(W=4$>"!#+@GKRLN X;$^/C
MUX?__//3Y]?OI<DPB=HD8!59FVA[J.T0O(+O%8]_1&[9^)64G.$>%JQ^GL+
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MR/H:F9OOFO=T[>+8._D6Y_8[V7#M:JPR>381MT45 2D'?8DZ2+XHZDJ52;A
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M?Y"JBIK]#K7^1,N, [:UE(XS\R0K8?,>-][&(@C@*8('I\9.^6#PY:F8&V:
M8 D PC]5!U(5RH4C*$0@M(UI?_XYVSN:]<\_3Y$+!P!L5W5;'UBZ>YQTQT<Z
M5[ 8H]?%[E3L@ZA5'+70A(_Q @-PQ03D$8$MIP73H#MV]YKL 9E2+:6V95.G
M?SI@(G7X_.%C>F_&*.@!]YEP!L1-*"MHR[9\C*0K.#@\6_+-(SBCX[AQT''O
M/3R(&4:LWS^-.(S"MF-FXGL00+[\WCCWE?A.@TX4>S-')8XSO%TSEU*+CT<N
MQF:?SMPT.S/S?#C@]QG261B6(7HVG5T$U+-1-IG.0A XF;"$0_*4XZZ=' !Q
MT7'Q,?FY-%"@@N<2# VA]S/VDQ4Q(0C!V6@\B7HGT\M]K?_2Y\D_\'DR[WP>
MSO]'GX>7R>?)_-#G8R0^TA685H?#8APIT891*&;M7HJ/83+D[=#*=!!GF,8N
M^'$F1MEX/N7'<SQ.1G-^O.#'Z3D_QL@@^G!JR=/W+!M>SL0/(;3+-A3-0<^Z
MS";G0PS,#JK1\UL?RBRU_"\GV<7YY5<)X%3'XB9]!E6SRY$X=JT:[-Q_<5]8
MA5L^)P M+%Z%NZ_=#PFW\?[\M#W^"O%6VI72W"&6$!WV+V:].)1L7[QIPFUZ
M83SNYN&1[RQD>0/6EP:#8'IA!=W/*S=_ %!+ P04    " !6A619V2-#Q_,#
M  #2"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q-BYX;6R=5FUOVS80_BL'
MU2A20+!DR4X<US;@).O6H6F#9B\?AGV@I9/%E2(UDHKB_?H=*5EQLR3K]L&6
M2-X]=\^]\+1LE?YB2D0+]Y609A64UM:+*#)9B14S8U6CI)-"Z8I96NI=9&J-
M+/=*E8B2.#Z-*L9EL%[ZO1N]7JK&"B[Q1H-IJHKI_04*U:Z"27#8^,QWI74;
MT7I9LQW>HOVYOM&TB@:4G%<H#5<2-!:K8#-97$R=O!?XA6-KCM[!,=DJ]<4M
MWN>K('8.H<#,.@1&CSN\1"$<$+GQ9X\9#":=XO'[ ?V=YTY<MLS@I1*_\MR6
MJV >0(X%:X3]K-H?L.<S<WB9$L;_0]O)SM( LL985?7*Y$'%9?=D]WT<CA3F
M\3,*2:^0>+\[0][+*V;9>JE5"]I)$YI[\52]-CG'I4O*K=5TRDG/KM]+R^2.
M;P7"QABT)H2/:)>1)6PG$64]SD6'DSR#<P[72MK2P'<RQ_QK_8A\&AQ+#HY=
M)"\"WF(]AC0.(8F3Z0MXZ4 T]7CI,WC?*Y6W7 A@,H=_L(8K;C*A3*,1?MML
MC=54+K\_%8;.RO1I*ZZ%%J9F&:X"ZA&#^@Z#]>M7D]/X[0L<I@.'Z4OH_R%9
M_P<'?BH1"B6H3[G<@67NO-;JCN=HP-)AIJI:2904+U4 ;4O+"^[E^ ,DZR$9
M!9O$VI)G)3 *;,$EMPB"VC!? "788K5%[;-\A5F_F(1PT^BLI%;+CV%'D(;S
MV7QX/@C5S)(G,(O/_6\:IJ=G_?\'-&9!K9\U52-(+ =6*6WY7\S?"2=>Z@V<
MI&$\/W]S7!<'%I(",X+7K^;))'E+;Y,P.9O#YA@%[^F*- @M,S!*SRF&VH?+
MEAH1JJXOT/7%(])4VNG8A5UWRE)][=X!F,NLT9K4\T;[U'PC^'0,[WI?))7
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MW;>D>DQ["!\5M>,LA&NRJ"DZL#FDPXR?NJZBHSE3H=[Y:6HH#Q3V;N0,N\/
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MVQ!'W5W'6=1:K%O'"*B<5!J9,*+"> H5+.[93\3U.[(=)E.JCV3B#9Z-F;T
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M965T,3DN>&ULQ5M9<QLYDOXK"(UFUHJHIGB(DGQ&R'8[VAMVM\.RIV-C8Q_
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MIJ:BCI=+N&U:ARQL?D=M<=4'.;2W^DU26V\P[X^(+J9'#[^D\P]G8)-^O84
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M'A.G_*O5,BMFC+*1.1.? N^7 SI\G!@?T!I4=P +08ZYU7\!'J[/U.LV3;T
M< V;A:;82BU[,CJ[CWD^*QZ?*;X*>;_ @8V!>ETX7^JE*I ZYA"$,GPE7.##
MJ'VLFZH5IXENEG5W-^#!W]H\<F$&:WS4P=&V90B;9H@D.27E?FHFK8)K3E$
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M.+$/&>U4N;P;7AP263T17X!XX@AGAXAYYD;7R34DPXL+1-6(DXK'[M$$K#K
M3KC\P9>Z.TQWS+<&ZO;>0])\W[./>NF.)WWF^=E<4#2O..6SIA'Z<H8ET9M+
M]3297O Y^15)/87X=%""/]#IU#E<\*I#/T@[CWXGN#;5DG\-R;@[;^0G@^'3
M\(/+&_F=8;=<?JWY45>H&("J9H%'AX.KZ8G<PO5OFJ+D7QW.BJ8IUOQR931$
MI07X?E% 5>X-;1!^AOKJ_P%02P,$%     @ 5H5D6=/,40<("   &AD  !D
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M+W=O<FMS:&5E=',O<VAE970R,2YX;6RE66UO&[D1_BN$+CTD@"K+LAW;.=N
MXS1HVN8NB"\MBJ(?J%VNEI==<D-R+:N_OL\,N2^R99]]^6+KA1S./#/SS,/5
MV=JZK[Y4*HC;NC+^?%*&T+S9V_-9J6KI9[91!M\4UM4RX*U;[?G&*9GSIKK:
M6\SGK_=JJ<WDXHP_^^0NSFP;*FW4)R=\6]?2;=ZJRJ[/)_N3[H//>E4&^F#O
MXJR1*W6MPI?FD\.[O=Y*KFMEO+9&.%6<3R[WW[P]I/6\X)]:K?WHM:!(EM9^
MI3<?\O/)G!Q2E<H"69#X=Z.N5%61(;CQ+=F<]$?2QO'KSOI[CAVQ+*575[;Z
ME\Y#>3XYF8A<%;*MPF>[_JM*\1R1O<Q6GO^*=5Q[>#P16>N#K=-F>%!K$__+
MVX3#:,/)_($-B[1AP7['@]C+=S+(BS-GU\+1:EBC%QPJ[X9SVE!2KH/#MQK[
MPL6UK)2PA7C?AM8I\5G=*-.JL[T V[1B+TMVWD8[BP?LG(J/UH32B[^87.7;
M^_?@4^_8HG/L[>)1@]>JF8F#^50LYHO#1^P=]($>L+V#!^RER$3A;"VNX*M#
M00#L4(HKAEDY\9_+I>?/_[L+@&C_<+=]:IXWOI&9.I^@.[QR-VIR\>,/^Z_G
M/SWB_6'O_>%CUI^1ID?M[/9RMW'QBQ$_VQM5+X', ><!V0BE GIU(\U&*!.4
M4[G0)EC^ B6@@OZ?Y'Z[7#FET+X)Y(_2R5!:,Q-?4"&.UV-[[>GDAS=OG^AM
ME0M95;1'!R^RE,=65L)1_WD!5YS*%%I=.+N15=#*"VER-$^ED&>C1",W9-J+
M'%&VO3?7K;$W=/@_= ;64:,(G*ID0*0PWJWZ\8>3Q?[Q3[#=V-JZIM1DV=F\
MS>#TW__]\\=?WGZ8XN2M!86N:CK,R68C0*D1!K!IX',0EBT*H1KM;0Z_M1&?
MI/NJC1\=F&NOP$,( [$AC*E8ESHKN[ !4 ,_;@ )USJ=\/[=I4!@'^5&+/9C
M*F?B@Q'J-BNE6:G>%9]* :]Q0H1T.P7#*4:T#4Z VPE0VOCB<#Z=S^>,.,6>
MYYH2"F?&B_;CHE ZVZY*MB^S4J/PNB7T4:&=#T/>9N+7D1^E]%N^R!6RM4*6
MA*QMF\XYVCX'G!)2/2=B&:5_=_V-R_6A"AT%206I >@ "M=WVU#IO#@^8G=J
MI&&IN/I2XW1!M0TL[T #DZW*,1BZFMXPOI8*"4?6X*Y,X_0@W4KA1&HXE(X4
MOE&9+C15+B9IX62MNFK);(M> @=@?%&=!1LH23;@2+*%$LJ4RGW,UX(]W\X
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M@4A0=G40+86*GP!!T2HS$U<)!\3$ZK:[,74%=?>ZWC6J'W<J;V?NW24^=_3
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M*(T=4-V-OIL8V=A;]%(:O)/;8<$9;I4D@.]7$L^WVPDM,/RM,OL'4$L#!!0
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M*\%1CXD WQ=*V>T+;=#=V%_\!5!+ P04    " !6A619"7G4=40$  #0"0
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M<S#)FK\[Z<K7*':O'%UT5>D=E1"L#H+A7T.=H3N!XS$''(B&*2IB1T/8WF&
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MF8<2NB!EIN_$ZA>Z-C0T>K'(5/6)5G79Z-Q#<:FTR-?!D$'.>/U-GM8-L16
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M$OI]L6 Q#-#N<"7U HL(6DFF->5(D8PJ5&2$(\;A >S 2 MXK)E:/".=4D1
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MBCJY.?Y34QY$_-YS.4_-LZC'OA)'_#E6]1BE)>#]YU ;2'"Q$W8OCL^(9WQ
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MW& V]G1 )-)=#N&<'R1.&X0$XB!#C7=E4@9^3-#U:V=_QY5M'<,-/79OS8-
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MET"Z@Z-FS1,AI@BWR151ILN@L!ULD0B@SV-BQ<-S=1]J)1=P*'/16JLH '>
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MX'P4>Z":U=$H1E9N7%?2T/ [,:=MB\H:T'TFI7E3;(!N?R=_ 5!+ P04
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M%T7C ]SY@HAW"Y^@Z\OY7U!+ P04    " !6A619J5(6)JT"  #:!0  &0
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M["R%A\;QH6O+9.^BB:>@6W>=UFAG*TQWYQS>#C?VR^ZB>C>]N^Z_)NH6#Z/
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MFO1@D;=:<'=N!G,K?Z-RS;@B.:R0WNM%V"RRONGJB1:EO2R60N/58\,,/PY
MF@1\OQ+8V,W$W#_MYT;\#U!+ P04    " !6A619,!IK:5$%   #(P  &0
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M$<6*BV)'\6V^!F'-E;XAY)L;2D(JLA/T[X^<J\-.YJ!:][+\%U!+ P04
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M>MB$Z.V;=^@-HB7ZG+&]4*)B84MU3FW-CILSW=9G<I\YDX<^L5)F D5E LD
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M?<_R"UP^$'2KKS1+*N0%2;]NY*47F J0WU=45E8Q4+>D\AKM_P902P,$%
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M+.AM1>T":'^AE-U.W 'M:YW^!E!+ P04    " !6A619]-2\NCD#   B"0
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M965T-#@N>&ULQ=UK4]M8@L;QKZ)BIZ9FJMA@^0J9A"HZNM\OW;LOMO:%8A]
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M=5%4CQ]L)OA>E+]O7\[E_P%02P,$%     @ 5H5D61\E#=DJ!@  .SD  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#DN>&ULM9M;;]LV',6_"N%N10MTMB1?
MTR8&VHC$,BQ!T6#MP[ '1F9LH9+HD72< ?OPHRZ1K%2A;>RX#XUU.3]*.M*?
M]+%XOI7JNUX)8<ACFF3ZHK<R9OU^,-#12J1<]^5:9';+O50I-W91+0=ZK01?
M%*(T&02>-QFD/,YZ\_-BW6<U/Y<;D\29^*R(WJ0I5_]\$HG<7O3\WM.*+_%R
M9?(5@_GYFB_%K3!_K#\KNS2H*8LX%9F.94:4N+_H??3?LZ&7"XH]OL9BJW<^
MD_Q4[J3\GB]<+2YZ7GY$(A&1R1'<_GD0ER))<I(]CK\K:*]N,Q?N?GZBL^+D
M[<G<<2TN9?(M7IC516_6(PMQSS>)^2*WOXKJA,8Y+Y*)+OXGVVI?KT>BC38R
MK<3V"-(X*__RQ^I"[ @LIUL05(+@N6#T@F!8"8:'"D:58'2H8%P)QH<*)I5@
M4ES[\F(55SKDAL_/E=P2E>]M:?F'PJY";2]PG.5WUJU1=FML=6;.XHQG4<P3
M<I5IHS;VIC&:O'XU"WS_ V$\5N0K3S:"7 NN-TJ4V]^$PO XT6_)+^0G,B!Z
MQ970YP-CCRCG#J*J]4]EZ\$+K?OD6F9FI0G-%F+1U@_LF=2G$SR=SJ? "?QM
MD_7)T'M' B\(.H[GTBV_%>M:/NJ0AV[YC7SH$\\OY,,..77+/VZ63CG;=^Y)
MG_CC7.Z?.:[EL+XUA@5O^ +O,N%:$WE/OG&E>&:(5*2H/.3/W^VNY,J(5/_5
M97K)'75S\UKY7J]Y)"YZMAAJH1Y$;_[ZE3_Q/G0YAH2%2!A%PA@(UG)Z5#L]
M<M'G3P:+1Z&B6 NR5G$DR)LX(PN9)%QILA:J?,K?=AGNQ!]K.!(6(F$4"6,E
M;%K \O[_8>[U/<\_'SQT.#FNG1P?XJ0FL=8;L2@L+(MSIV].V+&^(6$A$D:1
M,%;"QCN^V5%<_J_;N4GMW,3I''V,M8FSY5.U[>Q-G8AC_4+"0B2,(F$,!&N9
M.JU-G9ZH"YTBG4;"0B2,(F$,!&LY/:N=GCD?W]KI;>.TRIU^1^SW.6UXML@?
M[CWUV-G&L:XC82$21F<_E-#QLQ):&@IJM&7H66WHV6G'1$[\L5XB82$21DO8
MK#6,.9L\,Q+48LM(WVN^XGK(09&;=JQS%6WW9O>G_F@4G+6O40AMED)I#$5K
M&[B34?A. V_$UCDL<LN/=@Q)"Z$T"J4Q%*UM:]#8&IQH=%2!488C:2&41J$T
MAJ*U#6\")=^98OS_/M7-/]IW:+0$I=&*MMNO!OWGW2JJR;:=36KD'Q0;'=RO
M0E,B*"V$TFA%:V4$TW'' !?5;-O )BSRW6G1K8@V*C:QL,_=1D4K;A])OE2B
M2/D[+80&1E!:"*51*(VA:&V?FVC)GYRJHX4F3E!:"*51*(VA:&W#F]C)=V8=
M\]NB"N>.1S)-I2W+1D;?]Q;HZ0]E:]3UO?S2W?K1/D(3)2B-H6AM'YM0R7>G
M2B_X:&V,9)95/\YO8[,BVE7*]5[G?TQD9K..#NO2?;Q'.P]-E: TAJ*UG6_2
M)]\=/]V*++95NK#5#JTR::RSBXW(?QL>=UH(S9N@M!!*HU :0]':KRLTV53@
MG:AK#J Q%9060FD42F,H6MOP)LL*W%G656:$Y1JBN!&=OD+#+"@MA-(HE,8J
MVEDKB?;S8MGULVS0I%2!,Q1Q5V+R+ZFV%^L[_81F55!:"*51*(VA:&W;FZPJ
M.-7;3P$TI(+20BB-0FD,16L;WJ19@3O-VE^8H?D5E!9":11*8Q7MT,+<I%>!
M.[WRA_WQST_E][8JSS=U>;Z1#R*]$XJ4+U3..BV%YEE06@BE42B-H6AMYYL\
M*SA5GA5 \RPH+832*)3&4+2VX4V>%;CSK/VU&?J^5$5[5K&&XV>_V$,;I5 :
M0]':AC7!5> .KHZLS8<,HZ'O1D%I(91&H32&HK5OA";'"LY.5:JA@1:4%D)I
M%$IC*%I[SD@3: W=+UOM+=5N_=&S0Z"Y547;4_@IM%&&HI6&#7;F@J5"+8M9
M>YI$<I.9<EI8O;:>&?BQF \W:'8OIQ5><[6,,TT2<6^E7G]J1WVJG*E7+ABY
M+F:6W4EC9%I\7 F^$"K?P6Z_E[::5PMY _5\R?E_4$L#!!0    ( %:%9%F:
M+D.B@@(  ,8&   9    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;*U5RV[;
M,!#\%4(-B@1HK:?EU)4%)#:"Y%# B)/V4/1 2VN+"$6J)&TE?U^24@0_9+>'
M7B0^=H8S)'>9U%R\R ) H=>2,CEQ"J6JL>O*K( 2RP&O@.F9%1<E5KHKUJZL
M!.#<@DKJ!IX7NR4FS$D3.S87:<(WBA(&<X'DIBRQ>+L%RNN)XSOO X]D72@S
MX*9)A=>P /5<S87NN1U+3DI@DG"&!*PFSHT_GL8FW@9\)U#+G38R3I:<OYC.
M0SYQ/",(*&3*,&#]V\(4*#5$6L;OEM/IEC3 W?8[^YWUKKTLL80IIS](KHJ)
M<^V@'%9X0]4CK^^A]3,T?!FGTGY1W<1&(P=E&ZEXV8*U@I*PYH]?VWW8 ?C1
M"4#0 H)_!80M(+1&&V76U@PKG":"UTB8:,UF&G9O+%J[(<R<XD()/4LT3J4/
M; M,<4% HLL9*$RHO$*?T?-BABXOKM %(@P]%7PC,<MEXBJ]ID&Z6<M_V_ '
M)_@74 U0Z'U"@1=$/?#I>?@,,@WW+3S<A[O::6<WZ.P&EB_\B]TW-",RHUQN
M!*"?-TNIA+Y0O_K\-811/Z%)LK&L< 831V>1!+$%)_WXP8^]KWUN_Q/9GO>P
M\QZ>8T\?<:UOC@)!,.TSVJ!CBS;)OTW#(/(2=[MKX#@H\/WK+FA/6-0)B\X*
MF^/L!:\)6Y^5UW ,=U<>A?Z!O..@T M.R!MV\H9GY=T11G2"Y6C->7\*#(]6
M];WAX<[U!,7F3O=)BSMI\5EI3UQAJC.TO=1]VN*C QMYP>&V'0?%H_C+@39W
MI\J8"O\-"WUH$E%8:9@W&&EOHJF:34?QRA:>)5>ZC-EFH1\:$"9 SZ\X5^\=
M4\NZIRO] U!+ P04    " !6A619+].J?DL%  "$)0  &0   'AL+W=O<FMS
M:&5E=',O<VAE970U,2YX;6RUFE%OHS@0Q[^*Q:U.NU*W@$T2TDLBW::WNI7:
M4[7=WCV<[L%-G 8M8-8V37NZ#W^&4!PGCE,J\Y( F?DS,Q[(3P.3#67?^9H0
M 9ZR-.=3;RU$<>'[?+$F&>;GM""Y_&5%68:%W&4//B\8P<O:*4M]& 1#/\-)
M[LTF];$;-IO04J1)3FX8X&668?;\B:1T,_5"[^7 U^1A+:H#_FQ2X =R2\1=
M<</DGM^J+).,Y#RA.6!D-?5^#2_F**X<:HL_$[+A.]N@2N6>TN_5SI?EU NJ
MB$A*%J*2P/+KD<Q)FE9*,HX?C:C7GK-RW-U^4?]<)R^3N<><S&GZ5[(4ZZD7
M>V!)5KA,Q5>Z^9TT"0TJO05->?T)-HUMX(%%R07-&F<909;DVV_\U!1BQR&,
MCCC Q@&^U@$U#JA.=!M9G=8E%G@V870#6&4MU:J-NC:UM\PFR:MEO!5,_II(
M/S&[8;(CF'@&.%^"WWZ422'72)R!/V0'?02WV\4%= 7,AN#])1$X2?D':7UW
M>PG>O_L WH$D!]_6M.32ED]\(>.LSN8OFI@^;6."1V*Z)<4Y0,$9@ &,#.YS
MN_LE64CWL'9'NKLOJ].6"+8E@K4>.E&B,W"38IFR7H"_KZ0Y^")(QO\QI;K5
MCLS:U45ZP0N\(%-/7H6<L$?BS7[^*1P&OY@2=R2FE0&U94 V=;U3B.J4!T:Y
M<9&W<L-:KKJ;/,ZB$0R&$_]Q-R6353!$K946:]3&&EECO2*<7\A;Q*+,RA0+
MLI17MBS)(L';>X?, &>4B>3?^H I^NT)!CMQ?8P0&L1[X9O,8!Q'YO@';?P#
M:_S?J, I*(Y4/"?"%/'@(!041_OQ'AI%X6ALCG;81CNT1GN-%VMYB#V;HK*Z
M=NU_1V):EJ,VRU&/MX&1RS(X$M/*$+=EB-W>!N*#"QP&*!SM]65\T)?5S3\V
M-^:XC77\NL8$_X'K)$^R,C-%:!7INC:.Q+1\PT#]FP<]-FDC[J@2KM3T4NR
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M!9.JWYIEIF8N< U0YTO&Y':C';13//H-4$L#!!0    ( %:%9%FSKKOD"00
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M< ^#CF<@,8G%B0+>+V;H^.@$'2%"T;>(90+34(Q-J=3J-<V@5'95*'.>4;:
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MG(L('8KV,F@GBM>FGZZXPNYLACG>GR!T .ZO.5?/$]VB^QLY^0M02P,$%
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MEU>IY=L0R0\>NN"#:AJJZ8TF;.)]-*,ST#%-5+/.>@0V.J:#:BZJ>:CFHUJ
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MR[+R^9MZ@&]9_L?^X=S\/U!+ P04    " !6A619A/.7EV "  #!!@  &0
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M^8+^S&Y\EA"E?YF*S%%[9E0]6Z_3-0U@;*GIF$*R!6ORW3?8=[XWE=P16$T
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M!F-EE[>MJEU(5IGVL&%2-1LSS55W!ZX#U/.,,7E8Z([3_5_$?P%02P,$%
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MK/)5.[A^!:MLO?LW_=:^$0<#;.^% 4X[P#EV@-L.<(\=X+4#O*<#_!<&^.T
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M_NWF1A4O%+R1'%KP)!:0F""QD,0B$HM)3))8 F%:8USL&^/B1/MT+LCN(+&
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MNZ)+C>W9J=:7T/ 8U0)4$Z@6HEJ$:C&J251+*$UOE"Y%MHTQW."8# V/42U
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MNN3;]TZU>H5&WJ@6H)I M1#5(E2+44VB6D)I>J-TT;B/GK!MU@9W!YJ!HYI
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MYJ-H72FW._2R^C;"@L%,P<4# 4FSH#0;2G.@-!=*\Z T'T7K#H0V32(/YTF
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M+, _7Z=I\7I25M"\/VC^7U!+ P04    " !6A619&.>T#U<#  !W#@  &0
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M-K3*]2>Q?P=-/&/#EXI<V5^R;VP]AZ25TJ)HP+B"@O'Z21^;/!P!D*<?X#<
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M]C;P$&QWHAC0%[.4;?F*B^_I?2;/](;B!Q&/\R")4<8W<^T&7U-""H?2XL^
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M1L1]YV6#M%T:^4&7QD,YM/V*MCSF&0M+_6!^%,1!49C%3ILJ]G'JJ94)2O-
M:12*ULU/VTD2?%8)(: M)2C- Z51*%HW46U+248[H<])2,WL[&-@IR</2X65
MTQ<:3V%D.F9O X:J)C1-JZ<B^M&>;\2S;;G9GLNP]K&H=OJ:T69#_Z;<QNZ-
MW^+K)5:,>_B:5MOU+;[Z]< =R[9!G*.0;^14QI4K]2ZK-N2K$Y&DY8[S8R)$
M$I6'.\Y\GA4&\OHF2<3;23%!\[.(Q7]02P,$%     @ 5H5D63O@PW1\ P
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MAOF(%B27=]:495C(4[:Q><$(CLN@++5=QPGL#">YM9B5UQ[98D9W(DUR\L@
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MC_+'+=  1%9!?U]SKEX*V2%R];?$Y"=02P,$%     @ 5H5D61G1W LK P
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MF_]K?/T;4$L! A0#%     @ 5H5D60=!36*!    L0   !
M ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !6A619!"_=!NX
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M=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 5H5D6>NN8^J7 @
M5P<  !@              ("!LA0  'AL+W=O<FMS:&5E=',O<VAE970S+GAM
M;%!+ 0(4 Q0    ( %:%9%G[-Y.XHP8  /L?   8              " @7\7
M  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !6A619GOC\
M+X$7  #7>P$ &               @(%8'@  >&PO=V]R:W-H965T<R]S:&5E
M=#4N>&UL4$L! A0#%     @ 5H5D6=5,4,.&!P  ?R,  !@
M ("!#S8  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( %:%
M9%DC 5=V(PP  /L?   8              " @<L]  !X;"]W;W)K<VAE971S
M+W-H965T-RYX;6Q02P$"% ,4    " !6A6199@M=K7P)  !)&@  &
M        @($D2@  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%
M  @ 5H5D6364.<9F!   , H  !@              ("!UE,  'AL+W=O<FMS
M:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( %:%9%G7G,/8GQ,  $Q"   9
M              " @7)8  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L!
M A0#%     @ 5H5D682H0B:\%P  F4P  !D              ("!2&P  'AL
M+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !6A619%;=+1$@)
M  !L'   &0              @($[A   >&PO=V]R:W-H965T<R]S:&5E=#$R
M+GAM;%!+ 0(4 Q0    ( %:%9%G,(-B+;0(  &(%   9              "
M@;J-  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 5H5D
M68<_-EE[ P  K@<  !D              ("!7I   'AL+W=O<FMS:&5E=',O
M<VAE970Q-"YX;6Q02P$"% ,4    " !6A619IALAA]P&  !J$0  &0
M        @($0E   >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0
M   ( %:%9%G9(T/'\P,  -((   9              " @2.;  !X;"]W;W)K
M<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 5H5D64WF!6?#!   R H
M !D              ("!39\  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q0
M2P$"% ,4    " !6A619R]S>?Q0$  !H"0  &0              @(%'I
M>&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( %:%9%GLPO>>
M,1,  )(Z   9              " @9*H  !X;"]W;W)K<VAE971S+W-H965T
M,3DN>&UL4$L! A0#%     @ 5H5D6=/,40<("   &AD  !D
M ("!^KL  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " !6
MA6190UY_Z@H*   M'   &0              @($YQ   >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;%!+ 0(4 Q0    ( %:%9%GY5!5&1P4  &(1   9
M          " @7K.  !X;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#
M%     @ 5H5D65YV[+)_"   O1<  !D              ("!^-,  'AL+W=O
M<FMS:&5E=',O<VAE970R,RYX;6Q02P$"% ,4    " !6A619"7G4=40$  #0
M"0  &0              @(&NW   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM
M;%!+ 0(4 Q0    ( %:%9%GJY'!CD@P    D   9              " @2GA
M  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 5H5D60^/
MF%3D @  2PL  !D              ("!\NT  'AL+W=O<FMS:&5E=',O<VAE
M970R-BYX;6Q02P$"% ,4    " !6A619=+HYRWH%  !V'0  &0
M    @($-\0  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    (
M %:%9%G7E-R$11<  'Y&   9              " @;[V  !X;"]W;W)K<VAE
M971S+W-H965T,C@N>&UL4$L! A0#%     @ 5H5D6; _4>36!   [0P  !D
M             ("!.@X! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"
M% ,4    " !6A619IE/'2'D"  !B!0  &0              @(%'$P$ >&PO
M=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( %:%9%F$IMNX&P,
M *,&   9              " @?<5 0!X;"]W;W)K<VAE971S+W-H965T,S$N
M>&UL4$L! A0#%     @ 5H5D6=_#2KRU @  RP4  !D              ("!
M21D! 'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !6A619
M&4J$6L,"   -!@  &0              @($U' $ >&PO=V]R:W-H965T<R]S
M:&5E=#,S+GAM;%!+ 0(4 Q0    ( %:%9%F<P%#4AP(  *,%   9
M      " @2\? 0!X;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%
M  @ 5H5D6:E2%B:M @  V@4  !D              ("![2$! 'AL+W=O<FMS
M:&5E=',O<VAE970S-2YX;6Q02P$"% ,4    " !6A619OGAT43H$  #Y"0
M&0              @('1) $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+
M 0(4 Q0    ( %:%9%F]+.<L[0(  *P&   9              " @4(I 0!X
M;"]W;W)K<VAE971S+W-H965T,S<N>&UL4$L! A0#%     @ 5H5D609-ENT^
M!0  TQ   !D              ("!9BP! 'AL+W=O<FMS:&5E=',O<VAE970S
M."YX;6Q02P$"% ,4    " !6A6194<:BR*0%  "P#@  &0
M@(';,0$ >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    ( %:%
M9%G'B"SP$0L  *N/   9              " @;8W 0!X;"]W;W)K<VAE971S
M+W-H965T-# N>&UL4$L! A0#%     @ 5H5D65&' ";! @  >@@  !D
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M=#0U+GAM;%!+ 0(4 Q0    ( %:%9%DOOKEJX (  +D'   9
M  " @497 0!X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @
M5H5D6?34O+HY P  (@D  !D              ("!75H! 'AL+W=O<FMS:&5E
M=',O<VAE970T-RYX;6Q02P$"% ,4    " !6A619D5=-)UL6   %GP$ &0
M            @('-70$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4
M Q0    ( %:%9%D?)0W9*@8  #LY   9              " @5]T 0!X;"]W
M;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 5H5D69HN0Z*" @
MQ@8  !D              ("!P'H! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX
M;6Q02P$"% ,4    " !6A619+].J?DL%  "$)0  &0              @(%Y
M?0$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( %:%9%GY
M$(47FP(  -$'   9              " @?N" 0!X;"]W;W)K<VAE971S+W-H
M965T-3(N>&UL4$L! A0#%     @ 5H5D6;.NN^0)!   WA4  !D
M     ("!S84! 'AL+W=O<FMS:&5E=',O<VAE970U,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %:%9%D)%0&O5 4  -$G   9              "
M@7V6 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 5H5D
M67L6G7J_ @  G0<  !D              ("!")P! 'AL+W=O<FMS:&5E=',O
M<VAE970U.2YX;6Q02P$"% ,4    " !6A619;5%Q7'("  #F!P  &0
M        @('^G@$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0
M   ( %:%9%F%\O7*A!D  +NS 0 9              " @:>A 0!X;"]W;W)K
M<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 5H5D683SEY=@ @  P08
M !D              ("!8KL! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q0
M2P$"% ,4    " !6A619Q5X\7UH$   V%0  &0              @('YO0$
M>&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( %:%9%EBL!;"
M8@(  #L&   9              " @8K" 0!X;"]W;W)K<VAE971S+W-H965T
M-C0N>&UL4$L! A0#%     @ 5H5D65VT9IJ<#   )[4  !D
M ("!(\4! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " !6
MA619%)#E:4('   ,30  &0              @('VT0$ >&PO=V]R:W-H965T
M<R]S:&5E=#8V+GAM;%!+ 0(4 Q0    ( %:%9%E>SY(<( 0  *04   9
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M970W,2YX;6Q02P$"% ,4    " !6A6197"(71(((  "T30  &0
M    @($6\@$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    (
M %:%9%E?X]*Z0@,  ((,   9              " @<_Z 0!X;"]W;W)K<VAE
M971S+W-H965T-S,N>&UL4$L! A0#%     @ 5H5D6;0F,T:K!   $1X  !D
M             ("!2/X! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"
M% ,4    " !6A619/U!I,S0#  !7"P  &0              @($J P( >&PO
M=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( %:%9%F?S8"9]0(
M *L)   9              " @94& @!X;"]W;W)K<VAE971S+W-H965T-S8N
M>&UL4$L! A0#%     @ 5H5D6?0& ;D/!   HA@  !D              ("!
MP0D" 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " !6A619
M&='<"RL#  #N$@  #0              @ $'#@( >&PO<W1Y;&5S+GAM;%!+
M 0(4 Q0    ( %:%9%F7BKL<P    !,"   +              "  5T1 @!?
M<F5L<R\N<F5L<U!+ 0(4 Q0    ( %:%9%E)'%+ET 4  *TR   /
M      "  482 @!X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " !6A619>NU.
M;58"  ".+0  &@              @ %#& ( >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'-02P$"% ,4    " !6A6195:BY9Q("  !S+   $P
M    @ '1&@( 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     50!5 $H7   4
%'0(    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>348</ContextCount>
  <ElementCount>342</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>100</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>13</UnitCount>
  <MyReports>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>9952151 - Statement - Condensed Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedBalanceSheets</Role>
      <ShortName>Condensed Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952152 - Statement - Condensed Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedBalanceSheetsParenthetical</Role>
      <ShortName>Condensed Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952153 - Statement - Condensed Statements of Operations and Comprehensive (Loss) Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome</Role>
      <ShortName>Condensed Statements of Operations and Comprehensive (Loss) Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit</Role>
      <ShortName>Condensed Statements of Changes in Stockholders' Deficit</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952155 - Statement - Condensed Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CondensedStatementsofCashFlows</Role>
      <ShortName>Condensed Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952156 - Disclosure - Company Overview and Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CompanyOverviewandBasisofPresentation</Role>
      <ShortName>Company Overview and Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Risks and Uncertainties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksandUncertainties</Role>
      <ShortName>Risks and Uncertainties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Revenues and Trade Receivables, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNet</Role>
      <ShortName>Revenues and Trade Receivables, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Material Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreements</Role>
      <ShortName>Material Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Financial Instruments ??? Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</Role>
      <ShortName>Financial Instruments ??? Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Inventories</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Inventories</Role>
      <ShortName>Inventories</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Right-of-Use Assets and Lease Obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligations</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Intangible Assets, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNet</Role>
      <ShortName>Intangible Assets, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Other Non-current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssets</Role>
      <ShortName>Other Non-current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - Accrued Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpenses</Role>
      <ShortName>Accrued Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952168 - Disclosure - Long-Term Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebt</Role>
      <ShortName>Long-Term Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>9952169 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>9952170 - Disclosure - Sale of Future Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenue</Role>
      <ShortName>Sale of Future Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>9952171 - Disclosure - Net (Loss) Earnings Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossEarningsPerShare</Role>
      <ShortName>Net (Loss) Earnings Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>9952172 - Disclosure - Share-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensation</Role>
      <ShortName>Share-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9952173 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9952174 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://aquestive.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Revenues and Trade Receivables, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetTables</Role>
      <ShortName>Revenues and Trade Receivables, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RevenuesandTradeReceivablesNet</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Inventories (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesTables</Role>
      <ShortName>Inventories (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/Inventories</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/PropertyandEquipmentNet</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/RightofUseAssetsandLeaseObligations</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Intangible Assets, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetTables</Role>
      <ShortName>Intangible Assets, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/IntangibleAssetsNet</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Other Non-current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsTables</Role>
      <ShortName>Other Non-current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/OtherNoncurrentAssets</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Accrued Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpensesTables</Role>
      <ShortName>Accrued Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/AccruedExpenses</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Long-Term Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtTables</Role>
      <ShortName>Long-Term Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/LongTermDebt</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Sale of Future Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueTables</Role>
      <ShortName>Sale of Future Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/SaleofFutureRevenue</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Net (Loss) Earnings Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossEarningsPerShareTables</Role>
      <ShortName>Net (Loss) Earnings Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossEarningsPerShare</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Share-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationTables</Role>
      <ShortName>Share-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://aquestive.com/role/ShareBasedCompensation</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Company Overview and Basis of Presentation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails</Role>
      <ShortName>Company Overview and Basis of Presentation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/CompanyOverviewandBasisofPresentation</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Risks and Uncertainties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RisksandUncertaintiesDetails</Role>
      <ShortName>Risks and Uncertainties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/RisksandUncertainties</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Revenues and Trade Receivables, Net - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails</Role>
      <ShortName>Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Material Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/MaterialAgreementsDetails</Role>
      <ShortName>Material Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/MaterialAgreements</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Financial Instruments ??? Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails</Role>
      <ShortName>Financial Instruments ??? Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Inventories (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/InventoriesDetails</Role>
      <ShortName>Inventories (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/InventoriesTables</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails</Role>
      <ShortName>Property and Equipment, Net - Summary of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Property and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Right-of-Use Assets and Lease Obligations - Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails</Role>
      <ShortName>Right-of-Use Assets and Lease Obligations - Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Intangible Assets, Net - Components of Identifiable Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails</Role>
      <ShortName>Intangible Assets, Net - Components of Identifiable Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Intangible Assets, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails</Role>
      <ShortName>Intangible Assets, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Other Non-current Assets - Summary of Other Non-current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails</Role>
      <ShortName>Other Non-current Assets - Summary of Other Non-current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Other Non-current Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails</Role>
      <ShortName>Other Non-current Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails</Role>
      <ShortName>Accrued Expenses - Schedule of Accrued Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Accrued Expenses - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/AccruedExpensesNarrativeDetails</Role>
      <ShortName>Accrued Expenses - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Long-Term Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtNarrativeDetails</Role>
      <ShortName>Long-Term Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails</Role>
      <ShortName>Long-Term Debt - Schedule Of Royalty Right Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails</Role>
      <ShortName>Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Long-Term Debt - Debt Maturities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails</Role>
      <ShortName>Long-Term Debt - Debt Maturities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/WarrantsDetails</Role>
      <ShortName>Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/Warrants</ParentRole>
      <Position>65</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Sale of Future Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails</Role>
      <ShortName>Sale of Future Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Sale of Future Revenue - Royalty Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails</Role>
      <ShortName>Sale of Future Revenue - Royalty Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossEarningsPerShareTables</ParentRole>
      <Position>68</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Net (Loss) Earnings Per Share - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails</Role>
      <ShortName>Net (Loss) Earnings Per Share - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/NetLossEarningsPerShareTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Share-Based Compensation - Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationExpenseDetails</Role>
      <ShortName>Share-Based Compensation - Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Share-Based Compensation - Restricted Stock Unit Awards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails</Role>
      <ShortName>Share-Based Compensation - Restricted Stock Unit Awards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Share-Based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationNarrativeDetails</Role>
      <ShortName>Share-Based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Share-Based Compensation - Performance Based (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails</Role>
      <ShortName>Share-Based Compensation - Performance Based (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails</Role>
      <ShortName>Share-Based Compensation - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails</Role>
      <ShortName>Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/IncomeTaxes</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="aqst-20240930.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://aquestive.com/role/ContingenciesDetails</Role>
      <ShortName>Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://aquestive.com/role/Contingencies</ParentRole>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" isDefinitelyFs="true" isUsgaap="true" original="aqst-20240930.htm">aqst-20240930.htm</File>
    <File>aqst-20240930.xsd</File>
    <File>aqst-20240930_cal.xml</File>
    <File>aqst-20240930_def.xml</File>
    <File>aqst-20240930_lab.xml</File>
    <File>aqst-20240930_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="890">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="19">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>112
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "aqst-20240930.htm": {
   "nsprefix": "aqst",
   "nsuri": "http://aquestive.com/20240930",
   "dts": {
    "inline": {
     "local": [
      "aqst-20240930.htm"
     ]
    },
    "schema": {
     "local": [
      "aqst-20240930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "aqst-20240930_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "aqst-20240930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "aqst-20240930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "aqst-20240930_pre.xml"
     ]
    }
   },
   "keyStandard": 286,
   "keyCustom": 56,
   "axisStandard": 27,
   "axisCustom": 2,
   "memberStandard": 35,
   "memberCustom": 61,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/dei/2024": 5,
    "http://xbrl.sec.gov/ecd/2024": 2
   },
   "contextCount": 348,
   "entityCount": 1,
   "segmentCount": 100,
   "elementCount": 668,
   "unitCount": 13,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 890,
    "http://xbrl.sec.gov/dei/2024": 29,
    "http://xbrl.sec.gov/ecd/2024": 19
   },
   "report": {
    "R1": {
     "role": "http://aquestive.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://aquestive.com/role/CondensedBalanceSheets",
     "longName": "9952151 - Statement - Condensed Balance Sheets",
     "shortName": "Condensed Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://aquestive.com/role/CondensedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Condensed Balance Sheets (Parenthetical)",
     "shortName": "Condensed Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
     "longName": "9952153 - Statement - Condensed Statements of Operations and Comprehensive (Loss) Income",
     "shortName": "Condensed Statements of Operations and Comprehensive (Loss) Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
     "longName": "9952154 - Statement - Condensed Statements of Changes in Stockholders' Deficit",
     "shortName": "Condensed Statements of Changes in Stockholders' Deficit",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-44",
      "name": "us-gaap:SharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-48",
      "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://aquestive.com/role/CondensedStatementsofCashFlows",
     "longName": "9952155 - Statement - Condensed Statements of Cash Flows",
     "shortName": "Condensed Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://aquestive.com/role/CompanyOverviewandBasisofPresentation",
     "longName": "9952156 - Disclosure - Company Overview and Basis of Presentation",
     "shortName": "Company Overview and Basis of Presentation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://aquestive.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://aquestive.com/role/RisksandUncertainties",
     "longName": "9952158 - Disclosure - Risks and Uncertainties",
     "shortName": "Risks and Uncertainties",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNet",
     "longName": "9952159 - Disclosure - Revenues and Trade Receivables, Net",
     "shortName": "Revenues and Trade Receivables, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://aquestive.com/role/MaterialAgreements",
     "longName": "9952160 - Disclosure - Material Agreements",
     "shortName": "Material Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements",
     "longName": "9952161 - Disclosure - Financial Instruments \u2013 Fair Value Measurements",
     "shortName": "Financial Instruments \u2013 Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://aquestive.com/role/Inventories",
     "longName": "9952162 - Disclosure - Inventories",
     "shortName": "Inventories",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNet",
     "longName": "9952163 - Disclosure - Property and Equipment, Net",
     "shortName": "Property and Equipment, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligations",
     "longName": "9952164 - Disclosure - Right-of-Use Assets and Lease Obligations",
     "shortName": "Right-of-Use Assets and Lease Obligations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://aquestive.com/role/IntangibleAssetsNet",
     "longName": "9952165 - Disclosure - Intangible Assets, Net",
     "shortName": "Intangible Assets, Net",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssets",
     "longName": "9952166 - Disclosure - Other Non-current Assets",
     "shortName": "Other Non-current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherAssetsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://aquestive.com/role/AccruedExpenses",
     "longName": "9952167 - Disclosure - Accrued Expenses",
     "shortName": "Accrued Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://aquestive.com/role/LongTermDebt",
     "longName": "9952168 - Disclosure - Long-Term Debt",
     "shortName": "Long-Term Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://aquestive.com/role/Warrants",
     "longName": "9952169 - Disclosure - Warrants",
     "shortName": "Warrants",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:WarrantsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://aquestive.com/role/SaleofFutureRevenue",
     "longName": "9952170 - Disclosure - Sale of Future Revenue",
     "shortName": "Sale of Future Revenue",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:SaleOfFutureRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:SaleOfFutureRevenueTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://aquestive.com/role/NetLossEarningsPerShare",
     "longName": "9952171 - Disclosure - Net (Loss) Earnings Per Share",
     "shortName": "Net (Loss) Earnings Per Share",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://aquestive.com/role/ShareBasedCompensation",
     "longName": "9952172 - Disclosure - Share-Based Compensation",
     "shortName": "Share-Based Compensation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://aquestive.com/role/IncomeTaxes",
     "longName": "9952173 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://aquestive.com/role/Contingencies",
     "longName": "9952174 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R27": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "ecd:NonRule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:Rule10b51ArrTrmntdFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables",
     "longName": "9954472 - Disclosure - Revenues and Trade Receivables, Net (Tables)",
     "shortName": "Revenues and Trade Receivables, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://aquestive.com/role/InventoriesTables",
     "longName": "9954473 - Disclosure - Inventories (Tables)",
     "shortName": "Inventories (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetTables",
     "longName": "9954474 - Disclosure - Property and Equipment, Net (Tables)",
     "shortName": "Property and Equipment, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables",
     "longName": "9954475 - Disclosure - Right-of-Use Assets and Lease Obligations (Tables)",
     "shortName": "Right-of-Use Assets and Lease Obligations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://aquestive.com/role/IntangibleAssetsNetTables",
     "longName": "9954476 - Disclosure - Intangible Assets, Net (Tables)",
     "shortName": "Intangible Assets, Net (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsTables",
     "longName": "9954477 - Disclosure - Other Non-current Assets (Tables)",
     "shortName": "Other Non-current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://aquestive.com/role/AccruedExpensesTables",
     "longName": "9954478 - Disclosure - Accrued Expenses (Tables)",
     "shortName": "Accrued Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://aquestive.com/role/LongTermDebtTables",
     "longName": "9954479 - Disclosure - Long-Term Debt (Tables)",
     "shortName": "Long-Term Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueTables",
     "longName": "9954480 - Disclosure - Sale of Future Revenue (Tables)",
     "shortName": "Sale of Future Revenue (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RoyaltyObligationActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RoyaltyObligationActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://aquestive.com/role/NetLossEarningsPerShareTables",
     "longName": "9954481 - Disclosure - Net (Loss) Earnings Per Share (Tables)",
     "shortName": "Net (Loss) Earnings Per Share (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://aquestive.com/role/ShareBasedCompensationTables",
     "longName": "9954482 - Disclosure - Share-Based Compensation (Tables)",
     "shortName": "Share-Based Compensation (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
     "longName": "9954483 - Disclosure - Company Overview and Basis of Presentation (Details)",
     "shortName": "Company Overview and Basis of Presentation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RevenueFromContractWithCustomerNumberOfCommercializedProducts",
      "unitRef": "product",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:RevenueFromContractWithCustomerNumberOfCommercializedProducts",
      "unitRef": "product",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://aquestive.com/role/RisksandUncertaintiesDetails",
     "longName": "9954484 - Disclosure - Risks and Uncertainties (Details)",
     "shortName": "Risks and Uncertainties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R42": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
     "longName": "9954485 - Disclosure - Revenues and Trade Receivables, Net - Narrative (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ContractWithCustomerAssetNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
     "longName": "9954486 - Disclosure - Revenues and Trade Receivables, Net - Revenue (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-113",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails",
     "longName": "9954487 - Disclosure - Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-121",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails",
     "longName": "9954488 - Disclosure - Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Trade and Other Receivables, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
     "longName": "9954489 - Disclosure - Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Changes in Allowance for Bad Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-130",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-134",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
     "longName": "9954490 - Disclosure - Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details)",
     "shortName": "Revenues and Trade Receivables, Net - Summary of Activity with Sales Related Allowances and Accruals (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-132",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:ProvisionForDoubtfulAccounts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://aquestive.com/role/MaterialAgreementsDetails",
     "longName": "9954491 - Disclosure - Material Agreements (Details)",
     "shortName": "Material Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "aqst:InterestAndOtherIncomeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "aqst:SeveranceCostsMonthlyPaymentDuration",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R49": {
     "role": "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
     "longName": "9954492 - Disclosure - Financial Instruments \u2013 Fair Value Measurements (Details)",
     "shortName": "Financial Instruments \u2013 Fair Value Measurements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-209",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-174",
      "name": "aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R50": {
     "role": "http://aquestive.com/role/InventoriesDetails",
     "longName": "9954493 - Disclosure - Inventories (Details)",
     "shortName": "Inventories (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:InventoryRawMaterials",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
     "longName": "9954494 - Disclosure - Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "shortName": "Property and Equipment, Net - Summary of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails",
     "longName": "9954495 - Disclosure - Property and Equipment, Net - Narrative (Details)",
     "shortName": "Property and Equipment, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
     "longName": "9954496 - Disclosure - Right-of-Use Assets and Lease Obligations - Narrative (Details)",
     "shortName": "Right-of-Use Assets and Lease Obligations - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "aqst:NumberOfOperatingLeases",
      "unitRef": "lease",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails",
     "longName": "9954497 - Disclosure - Right-of-Use Assets and Lease Obligations - Maturities (Details)",
     "shortName": "Right-of-Use Assets and Lease Obligations - Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails",
     "longName": "9954498 - Disclosure - Intangible Assets, Net - Components of Identifiable Intangible Assets (Details)",
     "shortName": "Intangible Assets, Net - Components of Identifiable Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails",
     "longName": "9954499 - Disclosure - Intangible Assets, Net - Narrative (Details)",
     "shortName": "Intangible Assets, Net - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails",
     "longName": "9954500 - Disclosure - Other Non-current Assets - Summary of Other Non-current Assets (Details)",
     "shortName": "Other Non-current Assets - Summary of Other Non-current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "aqst:CumulativeRoyaltyReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "aqst:CumulativeRoyaltyReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
     "longName": "9954501 - Disclosure - Other Non-current Assets - Narrative (Details)",
     "shortName": "Other Non-current Assets - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "aqst:NumberOfGuaranteedRoyaltyPayments",
      "unitRef": "payment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails",
     "longName": "9954502 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "shortName": "Accrued Expenses - Schedule of Accrued Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
     "longName": "9954503 - Disclosure - Accrued Expenses - Narrative (Details)",
     "shortName": "Accrued Expenses - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-103",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R61": {
     "role": "http://aquestive.com/role/LongTermDebtNarrativeDetails",
     "longName": "9954504 - Disclosure - Long-Term Debt - Narrative (Details)",
     "shortName": "Long-Term Debt - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-209",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-210",
      "name": "aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
     "longName": "9954505 - Disclosure - Long-Term Debt - Schedule Of Royalty Right Agreements (Details)",
     "shortName": "Long-Term Debt - Schedule Of Royalty Right Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-239",
      "name": "us-gaap:LongTermDebtMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-239",
      "name": "us-gaap:LongTermDebtMeasurementInput",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
     "longName": "9954506 - Disclosure - Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)",
     "shortName": "Long-Term Debt - Schedule of Term Notes and Unamortized Debt Discount Balances (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-234",
      "name": "us-gaap:LongTermDebtNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails",
     "longName": "9954507 - Disclosure - Long-Term Debt - Debt Maturities (Details)",
     "shortName": "Long-Term Debt - Debt Maturities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://aquestive.com/role/WarrantsDetails",
     "longName": "9954508 - Disclosure - Warrants (Details)",
     "shortName": "Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-209",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:ClassOfWarrantOrRightWarrantsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "aqst:ClassOfWarrantOrRightWarrantsExercised",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
     "longName": "9954509 - Disclosure - Sale of Future Revenue - Narrative (Details)",
     "shortName": "Sale of Future Revenue - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PaymentsOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-270",
      "name": "us-gaap:PaymentsOfFinancingCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails",
     "longName": "9954510 - Disclosure - Sale of Future Revenue - Royalty Obligation (Details)",
     "shortName": "Sale of Future Revenue - Royalty Obligation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "aqst:LiabilitiesSaleOfFutureRoyalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:RoyaltyObligationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "aqst:LiabilitiesSaleOfFutureRoyalties",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "aqst:RoyaltyObligationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
     "longName": "9954511 - Disclosure - Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details)",
     "shortName": "Net (Loss) Earnings Per Share - Basic and Diluted Net Loss Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R69": {
     "role": "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails",
     "longName": "9954512 - Disclosure - Net (Loss) Earnings Per Share - Narrative (Details)",
     "shortName": "Net (Loss) Earnings Per Share - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-287",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R70": {
     "role": "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
     "longName": "9954513 - Disclosure - Share-Based Compensation - Expense (Details)",
     "shortName": "Share-Based Compensation - Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
     "longName": "9954514 - Disclosure - Share-Based Compensation - Restricted Stock Unit Awards (Details)",
     "shortName": "Share-Based Compensation - Restricted Stock Unit Awards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-311",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-311",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
     "longName": "9954515 - Disclosure - Share-Based Compensation - Narrative (Details)",
     "shortName": "Share-Based Compensation - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "aqst:InducementEquityCommonStockOptionsOutstandingShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "aqst:InducementEquityCommonStockOptionsOutstandingShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
     "longName": "9954516 - Disclosure - Share-Based Compensation - Performance Based (Details)",
     "shortName": "Share-Based Compensation - Performance Based (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-315",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-315",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
     "longName": "9954517 - Disclosure - Share-Based Compensation - Stock Option Activity (Details)",
     "shortName": "Share-Based Compensation - Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-335",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "unique": true
     }
    },
    "R75": {
     "role": "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
     "longName": "9954518 - Disclosure - Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details)",
     "shortName": "Share-Based Compensation - Valuation Assumptions for Determination of Fair Value of Options (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-277",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-277",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://aquestive.com/role/IncomeTaxesDetails",
     "longName": "9954519 - Disclosure - Income Taxes (Details)",
     "shortName": "Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "3",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://aquestive.com/role/ContingenciesDetails",
     "longName": "9954520 - Disclosure - Contingencies (Details)",
     "shortName": "Contingencies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-338",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "unitRef": "cause",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-338",
      "name": "us-gaap:LossContingencyPendingClaimsNumber",
      "unitRef": "cause",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "aqst-20240930.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "aqst_ABLFacilityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ABLFacilityMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ABL Facility",
        "label": "ABL Facility [Member]",
        "documentation": "ABL Facility"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r206",
      "r784"
     ]
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable Type [Axis]",
        "label": "Receivable Type [Axis]",
        "documentation": "Information by type of receivable."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r64"
     ]
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/AccruedExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r48",
      "r53",
      "r844"
     ]
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r643"
     ]
    },
    "aqst_AccountsReceivableAllowanceForCreditLossReclassifications": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AccountsReceivableAllowanceForCreditLossReclassifications",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassifications",
        "label": "Accounts Receivable, Allowance for Credit Loss, Reclassifications",
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Reclassifications"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails": {
       "parentTag": "aqst_TradeAndOtherReceivablesNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade receivables",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r205",
      "r206",
      "r871"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivables",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails",
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r126",
      "r486"
     ]
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "label": "Acquired Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r600"
     ]
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r707"
     ]
    },
    "us-gaap_AdditionalPaidInCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapital",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital",
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r643",
      "r904"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r517",
      "r773",
      "r774",
      "r775",
      "r776",
      "r846",
      "r905"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units, net",
        "label": "APIC, Share-Based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r321"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Costs of common stock issued under public equity offering",
        "terseLabel": "Adjustments to additional paid in capital, stock issued, issuance costs",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r91"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net (loss) income to net cash used for operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r753"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r679",
      "r689",
      "r699",
      "r731"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r682",
      "r692",
      "r702",
      "r734"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r754"
     ]
    },
    "aqst_AgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AgreementTerm",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Agreement term",
        "label": "Agreement Term",
        "documentation": "Agreement Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r727",
      "r735",
      "r739",
      "r747"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expenses",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r351",
      "r356"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails": {
       "parentTag": "aqst_TradeAndOtherReceivablesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued distribution expenses and sales returns provision",
        "negatedLabel": "Less: allowance for doubtful accounts",
        "periodStartLabel": "Allowance for doubtful accounts at beginning of the period",
        "periodEndLabel": "Allowance for doubtful accounts at end of the period",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r207",
      "r211",
      "r212",
      "r215",
      "r871"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments / credits",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery."
       }
      }
     },
     "auth_ref": [
      "r214"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AmendedEquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AmendedEquityDistributionAgreementMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amended Equity Distribution Agreement",
        "label": "Amended Equity Distribution Agreement [Member]",
        "documentation": "Amended Equity Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfDebtDiscountPremium": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfDebtDiscountPremium",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt discount (premium)",
        "label": "Amortization of Debt Discount (Premium)",
        "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r74",
      "r280",
      "r856"
     ]
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r280",
      "r769",
      "r856"
     ]
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs and discounts",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r280",
      "r621",
      "r622",
      "r769",
      "r856"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization expense",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r220",
      "r226",
      "r616"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share, amount (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r187"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "aqst_AssertioHoldingsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AssertioHoldingsIncMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assertio Holdings, Inc",
        "label": "Assertio Holdings, Inc [Member]",
        "documentation": "Assertio Holdings, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r97",
      "r108",
      "r129",
      "r156",
      "r191",
      "r193",
      "r199",
      "r200",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r384",
      "r386",
      "r412",
      "r480",
      "r544",
      "r613",
      "r614",
      "r643",
      "r670",
      "r811",
      "r812",
      "r861"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r134",
      "r156",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r384",
      "r386",
      "r412",
      "r643",
      "r811",
      "r812",
      "r861"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtTheMarketOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AtTheMarketOfferingMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Public Equity Offering - ATM",
        "terseLabel": "At-the-market offering",
        "label": "At The Market Offering [Member]",
        "documentation": "At The Market Offering"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtnahsPharmaUKLimitedAmendedAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AtnahsPharmaUKLimitedAmendedAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atnahs Pharma UK Limited, Amended Agreement",
        "label": "Atnahs Pharma UK Limited, Amended Agreement [Member]",
        "documentation": "Atnahs Pharma UK Limited, Amended Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AtnahsPharmaUKLimitedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AtnahsPharmaUKLimitedMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Atnahs Pharma UK Limited",
        "label": "Atnahs Pharma UK Limited [Member]",
        "documentation": "Atnahs Pharma UK Limited"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_AutomaticRenewalPeriodOfAgreement": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "AutomaticRenewalPeriodOfAgreement",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Automatic renewal period of agreement",
        "label": "Automatic Renewal Period of Agreement",
        "documentation": "Period for which the agreement is renewed automatically."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r742"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r743"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r741"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r740"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r739"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "stpr_CA-BC": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA-BC",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BRITISH COLUMBIA",
        "label": "BRITISH COLUMBIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CapitalizedContractCostNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CapitalizedContractCostNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized contract cost, net",
        "label": "Capitalized Contract Cost, Net",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r217"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r124",
      "r605"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash and cash equivalents at beginning of period",
        "periodEndLabel": "Cash and cash equivalents at end of period",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r77",
      "r153"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash and cash equivalents",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r77"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]"
       }
      }
     },
     "auth_ref": [
      "r783"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r715"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r713"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercise price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightLineItems",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Line Items]",
        "label": "Class of Warrant or Right [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued (in shares)",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares."
       }
      }
     },
     "auth_ref": [
      "r290"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of warrant or right, outstanding (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightTable",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Table]",
        "label": "Class of Warrant or Right [Table]",
        "documentation": "Disclosure of information about warrant or right issued that give holder right to purchase security from issuer at specific price within certain time frame."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "aqst_ClassOfWarrantOrRightWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ClassOfWarrantOrRightWarrantsExercised",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise of warrants (in shares)",
        "label": "Class of Warrant or Right, Warrants Exercised",
        "documentation": "The number of class of warrant or right exercised."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ClassOfWarrantOrRightWarrantsIssuedDuringPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ClassOfWarrantOrRightWarrantsIssuedDuringPeriod",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued to purchase common stock (in shares)",
        "label": "Class Of Warrant Or Right Warrants Issued During Period",
        "documentation": "The number of warrants issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_CoDevelopmentAndResearchFeesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "CoDevelopmentAndResearchFeesMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Co-development and research fees",
        "label": "Co-Development and Research Fees [Member]",
        "documentation": "The aggregate revenue generated from Co-development and research fees."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r113",
      "r119"
     ]
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement."
       }
      }
     },
     "auth_ref": [
      "r845"
     ]
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "aqst_CommercialExploitationAgreementWithIndiviorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "CommercialExploitationAgreementWithIndiviorMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial exploitation agreement with Indivior",
        "label": "Commercial Exploitation Agreement with Indivior [Member]",
        "documentation": "The commercial exploitation agreement with Indivior."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies (Note 19)",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r100",
      "r482",
      "r531"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "documentation": "The entire disclosure for commitments and contingencies."
       }
      }
     },
     "auth_ref": [
      "r87",
      "r239",
      "r240",
      "r588",
      "r799",
      "r804"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r661",
      "r662",
      "r664",
      "r665",
      "r666",
      "r667",
      "r773",
      "r774",
      "r776",
      "r846",
      "r903",
      "r905"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r532"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares outstanding (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r532",
      "r550",
      "r905",
      "r906"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value. Authorized $250,000,000 shares; 91,178,193 and 68,533,085 shares issued and outstanding at September\u00a030, 2024 and December 31, 2023, respectively",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r483",
      "r643"
     ]
    },
    "aqst_CommonStockWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "CommonStockWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock Warrants",
        "label": "Common Stock Warrants [Member]",
        "documentation": "Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r724"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r723"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r722"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive (loss) income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r137",
      "r139",
      "r144",
      "r475",
      "r491",
      "r492"
     ]
    },
    "aqst_ComputerNetworkEquipmentAndSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ComputerNetworkEquipmentAndSoftwareMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer, network equipment and software",
        "label": "Computer, Network Equipment and Software [Member]",
        "documentation": "Assets which are related to computer, network equipment and software."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r41",
      "r42",
      "r204",
      "r587"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r41",
      "r42",
      "r204",
      "r512",
      "r587"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r41",
      "r42",
      "r204",
      "r587",
      "r759"
     ]
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/RisksandUncertainties"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties",
        "label": "Concentration Risk Disclosure [Text Block]",
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r82"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r587"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentrations of risk",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r41",
      "r42",
      "r204"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r22",
      "r23",
      "r24",
      "r41",
      "r96",
      "r587"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r23",
      "r41",
      "r42",
      "r204",
      "r587"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ContingentMonetizationAgreementMilestonePayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ContingentMonetizationAgreementMilestonePayment",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from debt, contingent on additional milestones",
        "label": "Contingent Monetization Agreement, Milestone Payment",
        "documentation": "Contingent Monetization Agreement, Milestone Payment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current and non-current contract assets",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294",
      "r314"
     ]
    },
    "us-gaap_ContractWithCustomerAssetNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerAssetNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails": {
       "parentTag": "aqst_TradeAndOtherReceivablesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract and other receivables",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time, classified as current."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r294",
      "r314"
     ]
    },
    "us-gaap_ContractWithCustomerLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiability",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract liabilities",
        "label": "Contract with Customer, Liability",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r314"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, current",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r314"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, net of current portion",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r314"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue recognized",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due."
       }
      }
     },
     "auth_ref": [
      "r315"
     ]
    },
    "us-gaap_ContractWithCustomerReceivableAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerReceivableAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable",
        "label": "Contract with Customer, Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right to consideration is unconditional."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r295",
      "r314",
      "r586"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacture and supply",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r70",
      "r441"
     ]
    },
    "us-gaap_CostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostsAndExpenses",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total costs and expenses",
        "label": "Costs and Expenses",
        "documentation": "Total costs of sales and operating expenses for the period."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r262",
      "r289",
      "r435",
      "r439",
      "r479",
      "r607",
      "r609"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r809"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r809",
      "r810"
     ]
    },
    "aqst_CumulativeRoyaltyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "CumulativeRoyaltyReceivable",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty receivable",
        "label": "Cumulative Royalty Receivable",
        "documentation": "Cumulative sum of the carrying amounts of royalty receivable as of the balance sheet date."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer concentration risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r83",
      "r204"
     ]
    },
    "aqst_DanielBarberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DanielBarberMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Daniel Barber [Member]",
        "documentation": "Daniel Barber"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtCovenantRedemptionScenarioAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtCovenantRedemptionScenarioAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant, Redemption Scenario [Axis]",
        "label": "Debt Covenant, Redemption Scenario [Axis]",
        "documentation": "Debt Covenant, Redemption Scenario"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtCovenantRedemptionScenarioDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtCovenantRedemptionScenarioDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Covenant, Redemption Scenario [Domain]",
        "label": "Debt Covenant, Redemption Scenario [Domain]",
        "documentation": "Debt Covenant, Redemption Scenario [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Term Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r88",
      "r155",
      "r232",
      "r233",
      "r234",
      "r235",
      "r236",
      "r247",
      "r248",
      "r258",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r274",
      "r281",
      "r282",
      "r284",
      "r421"
     ]
    },
    "aqst_DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of quarterly installments",
        "label": "Debt Instrument, Additional Payment, Number Of Quarterly Installments",
        "documentation": "Debt Instrument, Additional Payment, Number Of Quarterly Installments"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r47",
      "r48",
      "r98",
      "r99",
      "r160",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r640",
      "r770",
      "r800",
      "r801",
      "r802",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentCarryingAmount",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total outstanding notes",
        "verboseLabel": "Royalty obligations",
        "label": "Long-Term Debt, Gross",
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r99",
      "r285"
     ]
    },
    "aqst_DebtInstrumentCovenantMilestoneCapPercentageThreshold": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentCovenantMilestoneCapPercentageThreshold",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of cash proceeds",
        "label": "Debt Instrument, Covenant, Milestone Cap Percentage Threshold",
        "documentation": "Repurchase Offer, Percentage of Cash Proceeds Received"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentCovenantTieredRoyaltyPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentCovenantTieredRoyaltyPercentage",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligation, percent of net sales",
        "label": "Debt Instrument, Covenant, Tiered Royalty Percentage",
        "documentation": "Debt Instrument, Covenant, Tiered Royalty Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentCovenantTieredRoyaltyPercentageTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentCovenantTieredRoyaltyPercentageTerm",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligation, term",
        "label": "Debt Instrument, Covenant, Tiered Royalty Percentage, Term",
        "documentation": "Debt Instrument, Covenant, Tiered Royalty Percentage, Term"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentExitFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentExitFee",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, exit fee",
        "label": "Debt Instrument, Exit Fee",
        "documentation": "Debt Instrument, Exit Fee"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r259",
      "r421",
      "r422",
      "r619",
      "r620",
      "r640"
     ]
    },
    "us-gaap_DebtInstrumentFeeAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFeeAmount",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fee amount",
        "label": "Debt Instrument, Fee Amount",
        "documentation": "Amount of the fee that accompanies borrowing money under the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r51"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective annual interest rate",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r288",
      "r421",
      "r422",
      "r640"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r260"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r160",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r640",
      "r770",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r160",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r640",
      "r770",
      "r800",
      "r801",
      "r802",
      "r855",
      "r857"
     ]
    },
    "aqst_DebtInstrumentNumberOfNoteholders": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentNumberOfNoteholders",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of noteholders",
        "label": "Debt Instrument, Number Of Noteholders",
        "documentation": "Debt Instrument, Number Of Noteholders"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_DebtInstrumentNumberOfTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentNumberOfTransactions",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of transactions",
        "label": "Debt Instrument, Number Of Transactions",
        "documentation": "Debt Instrument, Number Of Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentPeriodicPaymentPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentPeriodicPaymentPrincipal",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Periodic payment, principal",
        "label": "Debt Instrument, Periodic Payment, Principal",
        "documentation": "Amount of the required periodic payments applied to principal."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "aqst_DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, basis points above treasury rate",
        "label": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate",
        "documentation": "Debt Instrument, Redemption Price, Basis Spread On Variable Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Repurchase price percentage",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, redemption price, percentage of principal amount redeemed",
        "label": "Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed",
        "documentation": "Percentage of principal amount of debt redeemed."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32",
      "r33",
      "r43",
      "r89",
      "r90",
      "r160",
      "r259",
      "r260",
      "r261",
      "r262",
      "r263",
      "r265",
      "r270",
      "r271",
      "r272",
      "r273",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r283",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r640",
      "r770",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscount",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtNoncurrent",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized discount, including exit fee",
        "negatedLabel": "Unamortized discount, including Exit Fee",
        "negatedTerseLabel": "Unamortized discount",
        "label": "Debt Instrument, Unamortized Discount",
        "documentation": "Amount, after accumulated amortization, of debt discount."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r854",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized deferred debt issuance cost and deferred debt discounts",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r286",
      "r420",
      "r421",
      "r422",
      "r619",
      "r620",
      "r640"
     ]
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentUnamortizedDiscountPremiumNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unamortized discount (premium), net",
        "label": "Debt Instrument, Unamortized Discount (Premium), Net",
        "documentation": "Amount, after accumulated amortization, of debt discount (premium)."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r854",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFinanceCostsNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt issuance costs, net",
        "label": "Debt Issuance Costs, Net",
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs."
       }
      }
     },
     "auth_ref": [
      "r814",
      "r854",
      "r855",
      "r857"
     ]
    },
    "us-gaap_DeferredIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncome",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income",
        "label": "Deferred Income",
        "documentation": "Amount of deferred income excluding obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r757",
      "r872",
      "r900"
     ]
    },
    "us-gaap_DeferredIncomeRevenueRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeRevenueRecognized",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income, revenue recognized",
        "label": "Deferred Income, Revenue Recognized",
        "documentation": "Amount of revenue recognized previously reported as deferred income not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r900"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r26"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation, amortization, and impairment",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r26"
     ]
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeLiabilitiesNoncurrent",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative liability, noncurrent",
        "label": "Derivative Liability, Noncurrent",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r313",
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r815"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "documentation": "The entire disclosure for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r319",
      "r324",
      "r352",
      "r353",
      "r355",
      "r632"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Quarterly Report",
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r674"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r706"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r717"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "(Loss) earnings per share attributable to common stockholders:",
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r176",
      "r178",
      "r184",
      "r185",
      "r186",
      "r190",
      "r379",
      "r382",
      "r395",
      "r396",
      "r476",
      "r493",
      "r610"
     ]
    },
    "us-gaap_EarningsPerShareBasicOtherDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasicOtherDisclosuresAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average common shares outstanding:",
        "label": "Earnings Per Share, Basic, Other Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r178",
      "r184",
      "r185",
      "r186",
      "r190",
      "r379",
      "r382",
      "r395",
      "r396",
      "r476",
      "r493",
      "r610"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShare"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net (Loss) Earnings Per Share",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r187",
      "r188",
      "r189"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://aquestive.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective income tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r633"
     ]
    },
    "aqst_ElectiveRedemptionPercentageOfDebt": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ElectiveRedemptionPercentageOfDebt",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elective redemption percentage of debt",
        "label": "Elective Redemption Percentage Of Debt",
        "documentation": "Elective redemption percentage of debt."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation cost, recognition period",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r354"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation costs of RSU awards",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation expense related to non-vested stock options",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_EmployeeStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockMember",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee stock purchase plan (ESPP)",
        "label": "Employee Stock [Member]",
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock options",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r756"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r672"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r752"
     ]
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r120",
      "r140",
      "r141",
      "r142",
      "r161",
      "r162",
      "r163",
      "r165",
      "r170",
      "r172",
      "r174",
      "r192",
      "r209",
      "r210",
      "r230",
      "r291",
      "r369",
      "r370",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r423",
      "r425",
      "r434",
      "r490",
      "r506",
      "r507",
      "r508",
      "r517",
      "r570"
     ]
    },
    "aqst_EquityDistributionAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "EquityDistributionAgreementMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity distribution agreement",
        "label": "Equity Distribution Agreement [Member]",
        "documentation": "Equity Distribution Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r721"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r679",
      "r689",
      "r699",
      "r731"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r676",
      "r686",
      "r696",
      "r728"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "aqst_ExistingWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ExistingWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Existing Warrants",
        "label": "Existing Warrants [Member]",
        "documentation": "Existing Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r636"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments \u2013 Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r474",
      "r634",
      "r637"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease, long-term",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: accumulated amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r218",
      "r225",
      "r616"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r442",
      "r443",
      "r600"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, gross",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r225",
      "r443",
      "r616"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r225",
      "r227",
      "r228",
      "r229",
      "r442",
      "r600",
      "r616"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r227",
      "r228",
      "r600"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      },
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible assets, net",
        "totalLabel": "Intangible assets, net",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r442",
      "r795"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]",
        "label": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_FirstAdditionalWarrantOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "FirstAdditionalWarrantOfferingMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "First Additional Warrant Offering",
        "label": "First Additional Warrant Offering [Member]",
        "documentation": "First Additional Warrant Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r735"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r735"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r735"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r735"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r735"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r716"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnContractTermination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnContractTermination",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gain on contract termination",
        "terseLabel": "Gain on contract termination",
        "label": "Gain (Loss) on Contract Termination",
        "documentation": "Gain (loss) related to the termination of a contract between the parties. The termination may be due to many causes including early termination of a lease by a lessee, a breach of contract by one party, or a failure to perform."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on derivative instruments, net, pretax",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects."
       }
      }
     },
     "auth_ref": [
      "r38"
     ]
    },
    "us-gaap_GainLossOnDispositionOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnDispositionOfIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gain (loss) on disposition of intangible assets",
        "label": "Gain (Loss) on Disposition of Intangible Assets",
        "documentation": "Amount of gain (loss) on sale or disposal of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r769"
     ]
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss on extinguishment of debt",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity."
       }
      }
     },
     "auth_ref": [
      "r4",
      "r29",
      "r30"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_GeographicAreasRevenuesFromExternalCustomersAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GeographicAreasRevenuesFromExternalCustomersAbstract",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Areas, Revenues from External Customers [Abstract]",
        "label": "Geographic Areas, Revenues from External Customers [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Assets, Net",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r787",
      "r788"
     ]
    },
    "aqst_HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Haisco Pharmaceutical Group Co., Ltd, upfront payment",
        "label": "Haisco Pharmaceutical Group Co., Ltd, Upfront Payment [Member]",
        "documentation": "Haisco Pharmaceutical Group Co., Ltd, Upfront Payment"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_HasicoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "HasicoMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hasico",
        "label": "Hasico [Member]",
        "documentation": "Hasico"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentOfIntangibleAssetsFinitelived": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsFinitelived",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of intangible assets, finite-lived",
        "label": "Impairment of Intangible Assets, Finite-Lived",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value."
       }
      }
     },
     "auth_ref": [
      "r220",
      "r769",
      "r798"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income before income taxes",
        "terseLabel": "Net (loss)/income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r102",
      "r107",
      "r477",
      "r488",
      "r612",
      "r613",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r231",
      "r237",
      "r238",
      "r400",
      "r402",
      "r406",
      "r503",
      "r505",
      "r555",
      "r600",
      "r635",
      "r873"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r238",
      "r400",
      "r402",
      "r406",
      "r503",
      "r505",
      "r555",
      "r600",
      "r635",
      "r873"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r157",
      "r359",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r371",
      "r373",
      "r374",
      "r375",
      "r516",
      "r633"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/IncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income taxes (benefit) expense",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r117",
      "r173",
      "r174",
      "r191",
      "r197",
      "r200",
      "r360",
      "r361",
      "r372",
      "r494",
      "r633"
     ]
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payments for income taxes",
        "label": "Income Taxes Paid, Net",
        "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r152",
      "r367",
      "r368"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsAndOtherReceivables",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Trade and other receivables, net",
        "label": "Increase (Decrease) in Accounts and Other Receivables",
        "documentation": "The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r768"
     ]
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Deferred revenue",
        "label": "Increase (Decrease) in Deferred Revenue",
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable."
       }
      }
     },
     "auth_ref": [
      "r601"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventories",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToCallOptionsAndWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToCallOptionsAndWarrants",
     "calculation": {
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of dilutive stock options and warrants (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of call options and warrants using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r181",
      "r186"
     ]
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of share-based payment arrangements (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r179",
      "r180",
      "r182",
      "r186",
      "r323"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r727",
      "r735",
      "r739",
      "r747"
     ]
    },
    "aqst_IndiviorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "IndiviorMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indivior",
        "label": "Indivior [Member]",
        "documentation": "Indivior"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_InducementEquityCommonStockOptionsOutstandingShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "InducementEquityCommonStockOptionsOutstandingShares",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inducement equity, common stock options outstanding (in shares)",
        "label": "Inducement Equity, Common Stock Options Outstanding, Shares",
        "documentation": "Inducement Equity, Common Stock Options Outstanding, Shares"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_InitialWarrantOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "InitialWarrantOfferingMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial Warrant Offering",
        "label": "Initial Warrant Offering [Member]",
        "documentation": "Initial Warrant Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r675",
      "r751"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r675",
      "r751"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r675",
      "r751"
     ]
    },
    "aqst_InterestAndOtherIncomeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "InterestAndOtherIncomeNet",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income and other income, net",
        "label": "Interest And Other Income, Net",
        "documentation": "Interest And Other Income, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r764"
     ]
    },
    "aqst_InterestExpenseSaleOfFutureRevenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "InterestExpenseSaleOfFutureRevenues",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense related to the sale of future revenue",
        "label": "Interest Expense, Sale of Future Revenues",
        "documentation": "Interest Expense, Sale of Future Revenues"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash payments for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r150",
      "r151"
     ]
    },
    "us-gaap_InterestPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest payable",
        "label": "Interest Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Disclosure [Abstract]",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/Inventories"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "label": "Inventory Disclosure [Text Block]",
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory."
       }
      }
     },
     "auth_ref": [
      "r216"
     ]
    },
    "us-gaap_InventoryFinishedGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoods",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Gross",
        "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r761"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://aquestive.com/role/InventoriesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventories",
        "totalLabel": "Total inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r606",
      "r643"
     ]
    },
    "aqst_InventoryPackingMaterialGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "InventoryPackingMaterialGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Packaging material",
        "label": "Inventory Packing Material Gross",
        "documentation": "Amount of packaging materials expected to be sold within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryRawMaterials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterials",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/InventoriesDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/InventoriesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw material",
        "label": "Inventory, Raw Materials, Gross",
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r762"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r432"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r433"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r433"
     ]
    },
    "us-gaap_LesseeOperatingLeaseDiscountRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseDiscountRate",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Estimated discount rate",
        "label": "Lessee, Operating Lease, Discount Rate",
        "documentation": "Discount rate used by lessee to determine present value of operating lease payments."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remainder of 2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r859"
     ]
    },
    "aqst_LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 and thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter",
        "documentation": "Lessee, Operating Lease, Liability, to be Paid, Year Four And Thereafter"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease term",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r433",
      "r858"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-Use Assets and Lease Obligations",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r47",
      "r48",
      "r49",
      "r52",
      "r53",
      "r54",
      "r55",
      "r156",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r385",
      "r386",
      "r387",
      "r412",
      "r530",
      "r611",
      "r670",
      "r811",
      "r861",
      "r862"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r101",
      "r485",
      "r643",
      "r771",
      "r785",
      "r853"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and stockholders\u2019 deficit",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r123",
      "r156",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r385",
      "r386",
      "r387",
      "r412",
      "r643",
      "r811",
      "r861",
      "r862"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LiabilitiesSaleOfFutureRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LiabilitiesSaleOfFutureRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Liability related to the sale of future revenue, net at beginning of the period",
        "periodEndLabel": "Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)",
        "label": "Liabilities, Sale of Future Royalties",
        "documentation": "Liabilities, Sale of Future Royalties"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LiabilitiesSaleOfFutureRoyaltiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LiabilitiesSaleOfFutureRoyaltiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability related to the sale of future revenue, current",
        "label": "Liabilities, Sale of Future Royalties, Current",
        "documentation": "Liabilities, Sale of Future Royalties, Current"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseAgreementTerm",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement term",
        "label": "License Agreement Term",
        "documentation": "License agreement term period."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc.",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc. [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc milestones",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc Milestones [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc. milestones."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License agreement with Sunovion Pharmaceuticals, Inc. upfront",
        "label": "License Agreement with Sunovion Pharmaceuticals, Inc. Upfront [Member]",
        "documentation": "The license agreement made with sunovion pharmaceuticals, inc. advance payments."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseAndRoyaltyRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseAndRoyaltyRevenueMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License and royalty revenue",
        "label": "License and Royalty Revenue [Member]",
        "documentation": "The aggregate revenue generated from licensing and royalties."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LicenseSupplyAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LicenseSupplyAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "License &amp; Supply Agreement",
        "label": "License &amp; Supply Agreement [Member]",
        "documentation": "License &amp; Supply Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LincolnParkAgreementCommitmentShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LincolnParkAgreementCommitmentShareMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lincoln Park Agreement, Commitment Share",
        "label": "Lincoln Park Agreement, Commitment Share [Member]",
        "documentation": "Lincoln Park Agreement, Commitment Share"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LincolnParkAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LincolnParkAgreementMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lincoln Park agreement",
        "label": "Lincoln Park Agreement [Member]",
        "documentation": "Lincoln Park Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LineOfCreditFacilityAccordionFeatureIncreaseLimit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LineOfCreditFacilityAccordionFeatureIncreaseLimit",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, accordion feature, increase limit",
        "label": "Line of Credit Facility, Accordion Feature, Increase Limit",
        "documentation": "Line of Credit Facility, Accordion Feature, Increase Limit"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_LineOfCreditFacilityAccordionFeatureNetRevenueThreshold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "LineOfCreditFacilityAccordionFeatureNetRevenueThreshold",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of credit facility, accordion feature, net revenue threshold",
        "label": "Line of Credit Facility, Accordion Feature, Net Revenue Threshold",
        "documentation": "Line of Credit Facility, Accordion Feature, Net Revenue Threshold"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r248",
      "r770",
      "r809"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r51",
      "r248",
      "r770",
      "r809"
     ]
    },
    "srt_LitigationCaseAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseAxis",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Axis]",
        "label": "Litigation Case [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_LitigationCaseTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "LitigationCaseTypeDomain",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation Case [Domain]",
        "label": "Litigation Case [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LitigationSettlementAmountAwardedFromOtherParty",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Litigation settlement, amount awarded from other party",
        "label": "Litigation Settlement, Amount Awarded from Other Party",
        "documentation": "Amount awarded from other party in judgment or settlement of litigation."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LoansPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LoansPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loans payable, current",
        "label": "Loans Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total outstanding notes",
        "totalLabel": "Total",
        "label": "Long-Term Debt",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r99",
      "r271",
      "r287",
      "r619",
      "r620",
      "r640",
      "r870"
     ]
    },
    "us-gaap_LongTermDebtAndCapitalLeaseObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtAndCapitalLeaseObligations",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Notes payable, net",
        "label": "Long-Term Debt and Lease Obligation",
        "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r481"
     ]
    },
    "us-gaap_LongTermDebtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtFairValue",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value",
        "label": "Long-Term Debt, Fair Value",
        "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Long-Term Debt, Maturity, Year One",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r160",
      "r276"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Long-Term Debt, Maturity, Year Four",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r160",
      "r276"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Long-Term Debt, Maturity, Year Three",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r160",
      "r276"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Long-Term Debt, Maturity, Year Two",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r160",
      "r276"
     ]
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails": {
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtDebtMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remainder of 2024",
        "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year",
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year."
       }
      }
     },
     "auth_ref": [
      "r772"
     ]
    },
    "us-gaap_LongTermDebtMeasurementInput": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtMeasurementInput",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement input",
        "label": "Long-Term Debt, Measurement Input",
        "documentation": "Value of input used to measure long-term debt."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850",
      "r851"
     ]
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermDebtNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails": {
       "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Notes payable, long-term",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation."
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r800",
      "r801",
      "r802"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r28",
      "r800",
      "r801",
      "r802"
     ]
    },
    "us-gaap_LossContingenciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesLineItems",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Line Items]",
        "label": "Loss Contingencies [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r246",
      "r357",
      "r617",
      "r805",
      "r806"
     ]
    },
    "us-gaap_LossContingenciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingenciesTable",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies [Table]",
        "label": "Loss Contingencies [Table]",
        "documentation": "Disclosure of information about loss contingency. Excludes environmental contingency, warranty, and unconditional purchase obligation."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r242",
      "r243",
      "r246",
      "r357",
      "r617",
      "r805",
      "r806"
     ]
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyNumberOfPlaintiffs",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of plaintiffs",
        "label": "Loss Contingency, Number of Plaintiffs",
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r805",
      "r806"
     ]
    },
    "us-gaap_LossContingencyPendingClaimsNumber": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LossContingencyPendingClaimsNumber",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of cases pending",
        "label": "Loss Contingency, Pending Claims, Number",
        "documentation": "Number of pending claims pertaining to a loss contingency."
       }
      }
     },
     "auth_ref": [
      "r805",
      "r806"
     ]
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]"
       }
      }
     },
     "auth_ref": [
      "r204",
      "r626",
      "r653",
      "r657",
      "r815",
      "r872",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "aqst_ManufactureAndSupplyRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ManufactureAndSupplyRevenueMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Manufacture and supply revenue",
        "label": "Manufacture and Supply Revenue [Member]",
        "documentation": "The aggregate revenue generated from manufacture and supply."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ManufacturedProductOtherMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ManufacturedProductOtherMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proprietary product revenue, net",
        "label": "Manufactured Product, Other [Member]",
        "documentation": "Article or substance produced by labor or machinery, classified as other."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "aqst_ManufacturingAndSupplyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ManufacturingAndSupplyMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Manufacture and supply",
        "label": "Manufacturing And Supply [Member]",
        "documentation": "Primary financial statement caption encompassing Manufacturing and supply expense."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarathonPangolinRoyaltyLLCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MarathonPangolinRoyaltyLLCMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MAM Pangolin Royalty , LLC",
        "label": "Marathon Pangolin Royalty LLC [Member]",
        "documentation": "Marathon Pangolin Royalty LLC"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MarketBasedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MarketBasedMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Based",
        "label": "Market Based [Member]",
        "documentation": "Market Based"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r318",
      "r357",
      "r399",
      "r440",
      "r502",
      "r504",
      "r511",
      "r522",
      "r523",
      "r573",
      "r575",
      "r577",
      "r578",
      "r582",
      "r598",
      "r599",
      "r615",
      "r623",
      "r631",
      "r636",
      "r637",
      "r638",
      "r639",
      "r654",
      "r813",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "us-gaap_MeasurementInputDiscountRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputDiscountRateMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Discount Rate",
        "label": "Measurement Input, Discount Rate [Member]",
        "documentation": "Measurement input using interest rate to determine present value of future cash flows."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850",
      "r851"
     ]
    },
    "aqst_MeasurementInputProbabilityOfSuccessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MeasurementInputProbabilityOfSuccessMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input, Probability Of Success",
        "label": "Measurement Input, Probability Of Success [Member]",
        "documentation": "Measurement Input, Probability Of Success"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Axis]",
        "label": "Measurement Input Type [Axis]",
        "documentation": "Information by type of measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r636"
     ]
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MeasurementInputTypeDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtScheduleOfRoyaltyRightAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Input Type [Domain]",
        "label": "Measurement Input Type [Domain]",
        "documentation": "Measurement input used to determine value of asset and liability."
       }
      }
     },
     "auth_ref": [
      "r397",
      "r398",
      "r399",
      "r636"
     ]
    },
    "aqst_MinimumAnnualRoyaltyReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MinimumAnnualRoyaltyReceivable",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum annual royalty receivable",
        "label": "Minimum Annual Royalty Receivable",
        "documentation": "Minimum annual royalty receivable by the entity for the use of its rights and property by another party."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r318",
      "r357",
      "r399",
      "r440",
      "r502",
      "r504",
      "r511",
      "r522",
      "r523",
      "r573",
      "r575",
      "r577",
      "r578",
      "r582",
      "r598",
      "r599",
      "r615",
      "r623",
      "r631",
      "r636",
      "r637",
      "r638",
      "r654",
      "r813",
      "r863",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868"
     ]
    },
    "aqst_MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan",
        "label": "Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan [Member]",
        "documentation": "Mitsubishi Tanabe Pharma America, Inc And Haisco For Exarvan"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_MitsubishiTanabePharmaAmericaIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MitsubishiTanabePharmaAmericaIncMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Mitsubishi Tanabe Pharma America, Inc",
        "label": "Mitsubishi Tanabe Pharma America, Inc [Member]",
        "documentation": "Mitsubishi Tanabe Pharma America, Inc"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r738"
     ]
    },
    "aqst_MonetizationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "MonetizationAgreementMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Monetization Agreement",
        "label": "Monetization Agreement [Member]",
        "documentation": "Monetization Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]"
       }
      }
     },
     "auth_ref": [
      "r204",
      "r626",
      "r653",
      "r657",
      "r815",
      "r872",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used for investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r149"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used for operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r77",
      "r78",
      "r80"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net (loss) income",
        "terseLabel": "Net (loss) income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r80",
      "r103",
      "r121",
      "r136",
      "r138",
      "r142",
      "r156",
      "r164",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r173",
      "r174",
      "r183",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r379",
      "r382",
      "r396",
      "r412",
      "r489",
      "r552",
      "r568",
      "r569",
      "r668",
      "r811"
     ]
    },
    "aqst_NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from issuance of initial notes, warrants and first offer rights",
        "label": "Net Proceeds from Issuance of Initial Notes, Warrants and First Offer Rights",
        "documentation": "The net cash inflow associated with the amount received from issuance of initial notes, warrants and first offer rights."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NeurelisIncVAquestiveTherapeuticsIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NeurelisIncVAquestiveTherapeuticsIncMember",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Neurelis, Inc. v. Aquestive Therapeutics, Inc.",
        "label": "Neurelis, Inc. v. Aquestive Therapeutics, Inc. [Member]",
        "documentation": "Neurelis, Inc. v. Aquestive Therapeutics, Inc."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NewWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NewWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Warrants",
        "label": "New Warrants [Member]",
        "documentation": "New Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r683",
      "r693",
      "r703",
      "r727",
      "r735"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ex-United States",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r907",
      "r908",
      "r909",
      "r910"
     ]
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonoperatingIncomeExpenseAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income/(expenses):",
        "label": "Nonoperating Income (Expense) [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units Awards",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "aqst_NumberOfAnnualRoyaltyPaymentsReceivable": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NumberOfAnnualRoyaltyPaymentsReceivable",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of annual royalty payments receivable",
        "label": "Number of Annual Royalty Payments Receivable",
        "documentation": "Number of annual royalty payments receivable by the entity for the use of its rights and property by another party."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NumberOfGuaranteedRoyaltyPayments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NumberOfGuaranteedRoyaltyPayments",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of guaranteed royalty payments",
        "label": "Number Of Guaranteed Royalty Payments",
        "documentation": "Number Of Guaranteed Royalty Payments"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_NumberOfOperatingLeases": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "NumberOfOperatingLeases",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of leases",
        "label": "Number of Operating Leases",
        "documentation": "Number of operating leases."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Costs and expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Loss from operations",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r612",
      "r778",
      "r779",
      "r780",
      "r781",
      "r782"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease expense",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r429",
      "r642"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsMaturitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Total operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease liabilities",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "Right-of-use assets, net",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeAxis",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Axis]",
        "label": "Option Indexed to Issuer's Equity, Type [Axis]",
        "documentation": "Information by type of freestanding contracts issued by an entity that are indexed to, and potentially settled in, an entity's own stock."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r39",
      "r40",
      "r95"
     ]
    },
    "us-gaap_OptionIndexedToIssuersEquityTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OptionIndexedToIssuersEquityTypeDomain",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option Indexed to Issuer's Equity, Type [Domain]",
        "label": "Option Indexed to Issuer's Equity, Type [Domain]",
        "documentation": "Description of the type of freestanding contract issued by a Company that is indexed to, and potentially settled in, a Company's own stock. Specifically, the pertinent rights and privileges of the securities outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Overview and Basis of Presentation",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r81",
      "r82",
      "r94"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r48"
     ]
    },
    "us-gaap_OtherAssetsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Non-current Assets",
        "label": "Other Assets Disclosure [Text Block]",
        "documentation": "The entire disclosure for other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsMiscellaneousNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsMiscellaneousNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Assets, Miscellaneous, Noncurrent",
        "documentation": "Amount of other miscellaneous assets expected to be realized or consumed after one year or normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/OtherNoncurrentAssetsSummaryofOtherNoncurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current assets",
        "totalLabel": "Total other non-current assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other non-current liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r53"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other, net",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r80"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r719"
     ]
    },
    "aqst_OtherReceivablesAndAccruedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "OtherReceivablesAndAccruedExpensesMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Receivables And Accrued Expenses",
        "label": "Other Receivables And Accrued Expenses [Member]",
        "documentation": "Other Receivables And Accrued Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r681",
      "r691",
      "r701",
      "r733"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r694",
      "r704",
      "r736"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r684",
      "r694",
      "r704",
      "r736"
     ]
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PatentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PatentsMember",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased patent",
        "label": "Patents [Member]",
        "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r795",
      "r796",
      "r797"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PayablesAndAccrualsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payables and Accruals [Abstract]",
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfDebtExtinguishmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfDebtExtinguishmentCosts",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Premium paid to retire debt",
        "verboseLabel": "Consent fee payment",
        "label": "Payment for Debt Extinguishment or Debt Prepayment Cost",
        "documentation": "Amount of cash outflow for cost from early extinguishment and prepayment of debt. Includes, but is not limited to, third-party cost, premium paid, and other fee paid to lender directly for debt extinguishment or debt prepayment. Excludes accrued interest."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfFinancingCosts",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Repayment of debt principal including lease liabilities",
        "terseLabel": "Payments for loan acquisition costs",
        "label": "Payments of Financing Costs",
        "documentation": "The cash outflow for loan and debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_PaymentsOfLoanCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfLoanCosts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of loan costs",
        "label": "Payments of Loan Costs",
        "documentation": "The cash outflow for loan origination associated cost which is usually collected through escrow."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for stock issuance costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for taxes on share-based compensation",
        "label": "Payment, Tax Withholding, Share-Based Payment Arrangement",
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Capital expenditures",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r76"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r727"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r720"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r709"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Shares",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_PeterBoydMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "PeterBoydMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peter Boyd [Member]",
        "documentation": "Peter Boyd"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r817",
      "r818",
      "r819",
      "r820",
      "r821",
      "r822",
      "r823",
      "r824",
      "r825",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r831",
      "r832",
      "r833",
      "r834",
      "r835",
      "r836",
      "r837",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r711"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r755"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r710"
     ]
    },
    "aqst_PreFundedWarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "PreFundedWarrantsMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-Funded Warrants",
        "label": "Pre-Funded Warrants [Member]",
        "documentation": "Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_PremiumsPaidEarlyRetirementOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "PremiumsPaidEarlyRetirementOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Premium on early retirement of debt",
        "label": "Premiums Paid, Early Retirement of Debt",
        "documentation": "Premiums Paid, Early Retirement of Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r763"
     ]
    },
    "us-gaap_ProceedsFromCollaborators": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromCollaborators",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from collaborators",
        "label": "Proceeds from Collaborators",
        "documentation": "Cash received from collaborators during the current period."
       }
      }
     },
     "auth_ref": [
      "r79"
     ]
    },
    "aqst_ProceedsFromIssuanceAndExerciseOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ProceedsFromIssuanceAndExerciseOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance and exercise of warrants",
        "label": "Proceeds from Issuance and Exercise of Warrants",
        "documentation": "Proceeds from Issuance and Exercise of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfDebt",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of debt",
        "label": "Proceeds from Issuance of Debt",
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt."
       }
      }
     },
     "auth_ref": [
      "r766"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of long-term debt",
        "label": "Proceeds from Issuance of Long-Term Debt",
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r514"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfPrivatePlacement",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from common stock issued under public equity offering",
        "label": "Proceeds from Issuance of Private Placement",
        "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from shares issued under employee stock purchase plan",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Excluding Option Exercised",
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Excludes option exercised."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r10"
     ]
    },
    "aqst_ProceedsFromSaleOfFutureRevenuesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ProceedsFromSaleOfFutureRevenuesNet",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of future revenue",
        "label": "Proceeds From Sale of Future Revenues, Net",
        "documentation": "Proceeds From Sale of Future Revenues, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of stock options, net",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r10"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from warrant exercises",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r765"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]"
       }
      }
     },
     "auth_ref": [
      "r201",
      "r441",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r603",
      "r624",
      "r652",
      "r654",
      "r655",
      "r658",
      "r659",
      "r807",
      "r808",
      "r815",
      "r872",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]"
       }
      }
     },
     "auth_ref": [
      "r201",
      "r441",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r603",
      "r624",
      "r652",
      "r654",
      "r655",
      "r658",
      "r659",
      "r807",
      "r808",
      "r815",
      "r872",
      "r874",
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Abstract]",
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r432"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r114",
      "r115",
      "r116"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r125",
      "r487"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      },
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r432",
      "r478",
      "r487",
      "r643"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r432"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Useful Lives",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Allowance expense (reduction)",
        "terseLabel": "Allowance expense (reduction)",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r146",
      "r213"
     ]
    },
    "aqst_PublicEquityOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "PublicEquityOfferingMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Public Equity Offering",
        "label": "Public Equity Offering [Member]",
        "documentation": "Public Equity Offering"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PutOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PutOptionMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Put Option",
        "label": "Put Option [Member]",
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option."
       }
      }
     },
     "auth_ref": [
      "r580",
      "r581"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r708"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "verboseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r317",
      "r318",
      "r347",
      "r348",
      "r349",
      "r357",
      "r399",
      "r437",
      "r438",
      "r440",
      "r502",
      "r504",
      "r511",
      "r522",
      "r523",
      "r573",
      "r575",
      "r577",
      "r578",
      "r582",
      "r598",
      "r599",
      "r615",
      "r623",
      "r631",
      "r636",
      "r637",
      "r638",
      "r639",
      "r654",
      "r662",
      "r803",
      "r813",
      "r850",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "verboseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": [
      "r242",
      "r243",
      "r244",
      "r245",
      "r317",
      "r318",
      "r347",
      "r348",
      "r349",
      "r357",
      "r399",
      "r437",
      "r438",
      "r440",
      "r502",
      "r504",
      "r511",
      "r522",
      "r523",
      "r573",
      "r575",
      "r577",
      "r578",
      "r582",
      "r598",
      "r599",
      "r615",
      "r623",
      "r631",
      "r636",
      "r637",
      "r638",
      "r639",
      "r654",
      "r662",
      "r803",
      "r813",
      "r850",
      "r864",
      "r865",
      "r866",
      "r867",
      "r868"
     ]
    },
    "us-gaap_ReceivableTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivableTypeDomain",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receivable [Domain]",
        "label": "Receivable [Domain]",
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r64"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r676",
      "r686",
      "r696",
      "r728"
     ]
    },
    "aqst_RedemptionPercentageOfDebtUnderChangeOfControlProvisions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RedemptionPercentageOfDebtUnderChangeOfControlProvisions",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption percentage of debt under change of control provisions",
        "label": "Redemption Percentage Of Debt Under Change Of Control Provisions",
        "documentation": "Redemption percentage of debt under change of control provisions."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RedemptionScenario1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RedemptionScenario1Member",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption Scenario 1",
        "label": "Redemption Scenario 1 [Member]",
        "documentation": "Redemption Scenario 1"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RedemptionScenario2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RedemptionScenario2Member",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption Scenario 2",
        "label": "Redemption Scenario 2 [Member]",
        "documentation": "Redemption Scenario 2"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RepaymentsOfDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfDebt",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retirement of debt",
        "label": "Repayments of Debt",
        "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation."
       }
      }
     },
     "auth_ref": [
      "r767"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": [
      "r158",
      "r159",
      "r262",
      "r289",
      "r435",
      "r439",
      "r479",
      "r608",
      "r609"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r358",
      "r600",
      "r613",
      "r869"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ResearchAndDevelopmentProjectDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ResearchAndDevelopmentProjectDuration",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development, project duration",
        "label": "Research and Development, Project Duration",
        "documentation": "Research and Development, Project Duration"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r677",
      "r687",
      "r697",
      "r729"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r678",
      "r688",
      "r698",
      "r730"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r685",
      "r695",
      "r705",
      "r737"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCashAndCashEquivalentsAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents:",
        "label": "Restricted Cash and Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted stock units",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedLabel": "Accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r91",
      "r484",
      "r509",
      "r510",
      "r515",
      "r533",
      "r643"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r120",
      "r161",
      "r162",
      "r163",
      "r165",
      "r170",
      "r172",
      "r174",
      "r209",
      "r210",
      "r230",
      "r369",
      "r370",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r388",
      "r390",
      "r391",
      "r393",
      "r394",
      "r423",
      "r425",
      "r506",
      "r508",
      "r517",
      "r905"
     ]
    },
    "us-gaap_RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from collaborative arrangement, excluding revenue from contract with customer",
        "label": "Revenue from Collaborative Arrangement, Excluding Revenue from Contract with Customer",
        "documentation": "Amount of revenue from collaborative arrangement. Excludes revenue from contract with customer under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r111",
      "r845"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetRevenueDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "verboseLabel": "Royalties related to the sale of future revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r191",
      "r194",
      "r195",
      "r198",
      "r200",
      "r201",
      "r202",
      "r204",
      "r312",
      "r313",
      "r441"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r204",
      "r758"
     ]
    },
    "aqst_RevenueFromContractWithCustomerNumberOfCommercializedProducts": {
     "xbrltype": "integerItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RevenueFromContractWithCustomerNumberOfCommercializedProducts",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of commercialized products",
        "label": "Revenue From Contract With Customer, Number Of Commercialized Products",
        "documentation": "Revenue From Contract With Customer, Number Of Commercialized Products"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition and Performance Obligations",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r602"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNet"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenues and Trade Receivables, Net",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r296",
      "r297",
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r316"
     ]
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Revenues",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate payment",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r105",
      "r106",
      "r143",
      "r156",
      "r191",
      "r194",
      "r195",
      "r198",
      "r200",
      "r201",
      "r202",
      "r204",
      "r208",
      "r249",
      "r250",
      "r251",
      "r252",
      "r253",
      "r254",
      "r255",
      "r256",
      "r257",
      "r412",
      "r477",
      "r613",
      "r811"
     ]
    },
    "aqst_RightToSellCommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RightToSellCommonStockValue",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right to sell common stock, value",
        "label": "Right to Sell Common Stock, Value",
        "documentation": "Right to Sell Common Stock, Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RisksAndUncertaintiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risks and Uncertainties [Abstract]",
        "label": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RoyaltyExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense related to royalty obligations",
        "label": "Royalty Expense",
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "us-gaap_RoyaltyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RoyaltyMember",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty",
        "label": "Royalty [Member]",
        "documentation": "Money for usage-based right to asset."
       }
      }
     },
     "auth_ref": [
      "r816"
     ]
    },
    "aqst_RoyaltyObligationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RoyaltyObligationActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Obligation Activity",
        "label": "Royalty Obligation Activity [Table Text Block]",
        "documentation": "Royalty Obligation Activity"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_RoyaltyObligationsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "RoyaltyObligationsMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty Obligations",
        "label": "Royalty Obligations [Member]",
        "documentation": "Royalty Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r746"
     ]
    },
    "aqst_SaleOfFutureRevenueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SaleOfFutureRevenueRollForward",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenueRoyaltyObligationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Future Revenue [Roll Forward]",
        "label": "Sale of Future Revenue [Roll Forward]",
        "documentation": "Sale of Future Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfFutureRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SaleOfFutureRevenueTextBlock",
     "presentation": [
      "http://aquestive.com/role/SaleofFutureRevenue"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Future Revenue",
        "label": "Sale of Future Revenue [Text Block]",
        "documentation": "Sale of Future Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockAggregateOfferingPrice": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SaleOfStockAggregateOfferingPrice",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, aggregate offering price",
        "label": "Sale of Stock, Aggregate Offering Price",
        "documentation": "Sale of Stock, Aggregate Offering Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consideration received on sale of stock",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwriting discounts",
        "label": "Sale of Stock, Consideration Received on Transaction, Underwriting Discounts",
        "documentation": "Sale of Stock, Consideration Received on Transaction, Underwriting Discounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesCommissionsAndFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesCommissionsAndFees",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales commissions and fees",
        "label": "Sales Commissions and Fees",
        "documentation": "Primarily represents commissions incurred in the period based upon the sale by commissioned employees or third parties of the entity's goods or services, and fees for sales assistance or product enhancements performed by third parties (such as a distributor or value added reseller)."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts and Financing Receivables [Table]",
        "label": "Accounts and Financing Receivables [Table]",
        "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r64",
      "r206",
      "r784"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and Other Receivables, Net",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r64"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued Expenses",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]",
        "documentation": "Disclosure of information about acquired finite-lived intangible asset by major class."
       }
      }
     },
     "auth_ref": [
      "r221",
      "r222",
      "r223",
      "r224",
      "r600"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]",
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Expense",
        "label": "Share-Based Payment Arrangement, Cost by Plan [Table Text Block]",
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit."
       }
      }
     },
     "auth_ref": [
      "r35"
     ]
    },
    "us-gaap_ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in Allowance for Bad Debt",
        "label": "Financing Receivable, Current, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss of financing receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r109",
      "r786"
     ]
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-Term Debt Instruments",
        "label": "Schedule of Long-Term Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r32",
      "r33",
      "r43",
      "r89",
      "r90",
      "r619",
      "r621",
      "r772",
      "r855"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic and Diluted Net Loss Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r777"
     ]
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r225",
      "r227",
      "r228",
      "r229",
      "r442",
      "r600",
      "r616"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Components of Identifiable Intangible Assets",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r616",
      "r794"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/InventoriesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory, Net",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r65",
      "r66",
      "r67"
     ]
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Maturity",
        "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]",
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsNoncurrentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsNoncurrentTextBlock",
     "presentation": [
      "http://aquestive.com/role/OtherNoncurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Other Non-current Assets",
        "label": "Schedule of Other Assets, Noncurrent [Table Text Block]",
        "documentation": "Tabular disclosure of noncurrent assets."
       }
      }
     },
     "auth_ref": [
      "r760"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://aquestive.com/role/PropertyandEquipmentNetSummaryofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r432"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Option Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r9",
      "r92"
     ]
    },
    "us-gaap_ScheduleOfShortTermDebtTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShortTermDebtTable",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-Term Debt [Table]",
        "label": "Short-Term Debt [Table]",
        "documentation": "Disclosure of information about short-term debt arrangement. Includes, but is not limited to, description of arrangement, lender, repayment term, weighted-average interest rate, borrowed amount, and description and amount of refinancing of short-term obligation when obligation is excluded from current liability."
       }
      }
     },
     "auth_ref": [
      "r47"
     ]
    },
    "aqst_SecuritiesPurchaseAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SecuritiesPurchaseAgreementMember",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Securities purchase agreement",
        "label": "Securities Purchase Agreement [Member]",
        "documentation": "Securities Purchase Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r671"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r673"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r519",
      "r520",
      "r521",
      "r574",
      "r576",
      "r579",
      "r583",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r604",
      "r625",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r656",
      "r662",
      "r815",
      "r872",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome": {
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notes payable, net",
        "label": "Senior Notes, Noncurrent And Finance Lease, Liability, Noncurrent",
        "documentation": "Senior Notes, Noncurrent And Finance Lease, Liability, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SeniorSecuredNotes13.5DueNovember12028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SeniorSecuredNotes13.5DueNovember12028Member",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails",
      "http://aquestive.com/role/RisksandUncertaintiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "13.5% Senior Secured Notes due November 1, 2028",
        "label": "Senior Secured Notes, 13.5% due November 1, 2028 [Member]",
        "documentation": "Senior Secured Notes, 13.5% due November 1, 2028"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "aqst_SeveranceCostsMonthlyPaymentDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SeveranceCostsMonthlyPaymentDuration",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs monthly payment, duration",
        "label": "Severance Costs Monthly Payment, Duration",
        "documentation": "Severance Costs Monthly Payment, Duration"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "us-gaap_ShareBasedCompensationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationAbstract",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation expenses [Abstract]",
        "label": "Share-Based Payment Arrangement, Noncash Expense [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r632"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in shares)",
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r341"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period (in dollars per share)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date Fair Value",
        "documentation": "The estimated fair value of nonvested equity-based awards on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan) as of grant date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r339"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested and expected to vest at end of period (in shares)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, in Shares",
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments, Other Than Options Grants, Estimated Grant Date in shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, at beginning of period (in shares)",
        "periodEndLabel": "Unvested, at end of period (in shares)",
        "terseLabel": "Unvested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Units",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested, at beginning of period (in dollars per share)",
        "periodEndLabel": "Unvested, at end of period (in dollars per share)",
        "terseLabel": "Unvested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r340"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Average closing prices period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period",
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Average Closing Prices Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, maximum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum",
        "documentation": "The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility, minimum",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum",
        "documentation": "The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r320",
      "r322",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r330"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited/expired (in shares)",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercised, Forfeitures And Expirations In Period",
        "documentation": "For presentations that combine terminations, the number of shares under options that were exercised, cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited/expired (in dollars per share)",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Forfeitures And Expirations In Period Weighted Average Exercise Price",
        "documentation": "Weighted average price of options that were either exercised, forfeited or expired."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross",
        "documentation": "Gross number of share options (or share units) granted during the period."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Options",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r328",
      "r329"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted Average Exercise Price",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercisable at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r345"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested or expected to vest at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested or expected to vest at end of period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur."
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "aqst_ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance price threshold (in dollars per share)",
        "label": "Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share",
        "documentation": "Share Based Compensation, Arrangement by Share-Based Payment, Market Condition, Performance Price Threshold, Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/ShareBasedCompensationExpenseDetails",
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationPerformanceBasedDetails",
      "http://aquestive.com/role/ShareBasedCompensationRestrictedStockUnitAwardsDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails",
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r333"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Performance Share Activity",
        "label": "Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of number and weighted-average grant date fair value for nonvested performance shares."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share price (in dollars per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting rights, percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r817"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationValuationAssumptionsforDeterminationofFairValueofOptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "aqst_SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock (in shares)",
        "label": "Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants",
        "documentation": "Shares Of Common Stock Entitled To Purchasers By Pre-Funded Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SharesOfCommonStockToBePurchasedByCommonStockWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SharesOfCommonStockToBePurchasedByCommonStockWarrants",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares of common stock in connection with securities purchase agreements (in shares)",
        "label": "Shares Of Common Stock To Be Purchased By Common Stock Warrants",
        "documentation": "Shares of Common Stock to be Purchased by Common Stock Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharesOutstanding",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Shares, Outstanding",
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermDebtLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermDebtLineItems",
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Debt [Line Items]",
        "label": "Short-Term Debt [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://aquestive.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r154"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r61",
      "r62",
      "r120",
      "r140",
      "r141",
      "r142",
      "r161",
      "r162",
      "r163",
      "r165",
      "r170",
      "r172",
      "r174",
      "r192",
      "r209",
      "r210",
      "r230",
      "r291",
      "r369",
      "r370",
      "r376",
      "r377",
      "r378",
      "r380",
      "r381",
      "r382",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r418",
      "r423",
      "r425",
      "r434",
      "r490",
      "r506",
      "r507",
      "r508",
      "r517",
      "r570"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]"
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r519",
      "r520",
      "r521",
      "r574",
      "r576",
      "r579",
      "r583",
      "r585",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r596",
      "r597",
      "r604",
      "r625",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r656",
      "r662",
      "r815",
      "r872",
      "r874",
      "r875",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r892",
      "r893",
      "r894",
      "r895",
      "r896",
      "r897",
      "r898",
      "r899",
      "r901",
      "r902"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r192",
      "r425",
      "r441",
      "r513",
      "r518",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r551",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r663"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r163",
      "r192",
      "r205",
      "r425",
      "r441",
      "r513",
      "r518",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r532",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r551",
      "r553",
      "r554",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r570",
      "r663"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r680",
      "r690",
      "r700",
      "r732"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued during period, conversion of convertible securities (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r32",
      "r57",
      "r61",
      "r91",
      "r275"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued under employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock issued under public equity offering (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91",
      "r514",
      "r570",
      "r584"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested restricted stock units, net (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/ShareBasedCompensationStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercises, net (in shares)",
        "negatedTerseLabel": "Exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91",
      "r333"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued under employee stock purchase plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock issued under public equity offering",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r56",
      "r57",
      "r91",
      "r517",
      "r570",
      "r584",
      "r669"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options exercised, net",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r57",
      "r61",
      "r62",
      "r91"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 deficit",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r57",
      "r61",
      "r62",
      "r84",
      "r534",
      "r550",
      "r571",
      "r572",
      "r643",
      "r670",
      "r771",
      "r785",
      "r853",
      "r905"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/CondensedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 deficit:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityOther",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Stockholders' Equity, Other",
        "documentation": "This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SuboxoneProduceLiabilityLitigationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SuboxoneProduceLiabilityLitigationMember",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Suboxone Produce Liability Litigation",
        "label": "Suboxone Produce Liability Litigation [Member]",
        "documentation": "Suboxone Produce Liability Litigation"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r436"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r436"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://aquestive.com/role/ContingenciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r436"
     ]
    },
    "aqst_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions": {
     "xbrltype": "percentItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or equity method investee, cumulative percentage ownership limitation after all transactions",
        "label": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions",
        "documentation": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership Limitation After All Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]",
        "label": "Subsidiary or Equity Method Investee, Sale of Stock, Type [Table]",
        "documentation": "Disclosure of information about sale of stock made by subsidiary or equity method investee to investor outside consolidated group by type of sale. Includes, but is not limited to, stock issued in business combination in exchange for share of acquired entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails",
      "http://aquestive.com/role/CondensedStatementsofCashFlows",
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit",
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsidiarySaleOfStockLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SubsidiarySaleOfStockLineItems",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsidiary, Sale of Stock [Line Items]",
        "label": "Subsidiary, Sale of Stock [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_SupplementalAgreementWithIndiviorMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "SupplementalAgreementWithIndiviorMember",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental agreement with Indivior",
        "label": "Supplemental Agreement with Indivior [Member]",
        "documentation": "The supplemental commercial exploitation agreement with Indivior."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r726"
     ]
    },
    "us-gaap_TaxesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails": {
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/AccruedExpensesScheduleofAccruedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Real estate and personal property taxes",
        "label": "Taxes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r48"
     ]
    },
    "us-gaap_TechnologyBasedIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TechnologyBasedIntangibleAssetsMember",
     "presentation": [
      "http://aquestive.com/role/IntangibleAssetsNetComponentsofIdentifiableIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchased intangible",
        "label": "Technology-Based Intangible Assets [Member]",
        "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r795",
      "r796",
      "r797"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": [
      "r783",
      "r860"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r718"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r725"
     ]
    },
    "aqst_TradeAccountsReceivableDoubtfulAccountsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "TradeAccountsReceivableDoubtfulAccountsMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetChangesinAllowanceforBadDebtDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Doubtful Accounts",
        "label": "Trade Accounts Receivable, Doubtful Accounts [Member]",
        "documentation": "Trade Accounts Receivable, Doubtful Accounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TradeAccountsReceivableMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable",
        "label": "Trade Accounts Receivable [Member]",
        "documentation": "Amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TradeAccountsReceivableSalesRelatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "TradeAccountsReceivableSalesRelatedMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetSummaryofActivitywithSalesRelatedAllowancesandAccrualsDetails",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade Accounts Receivable, Sales Related",
        "label": "Trade Accounts Receivable, Sales Related [Member]",
        "documentation": "Trade Accounts Receivable, Sales Related"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TradeAndOtherReceivablesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "TradeAndOtherReceivablesNet",
     "crdr": "debit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      },
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets",
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetTradeandOtherReceivablesNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trade and other receivables, net",
        "totalLabel": "Trade and other receivables, net",
        "label": "Trade And Other Receivables, Net",
        "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade and other receivables)."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r745"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://aquestive.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "aqst_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liability related to the sale of future revenue, net",
        "label": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent",
        "documentation": "Transfer Of Financial Assets, Accounted For As Sales, Amount Derecognized, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r749"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r747"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r750"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r748"
     ]
    },
    "aqst_TwelvePointFiveSeniorSecuredNotesDueJune302025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "TwelvePointFiveSeniorSecuredNotesDueJune302025Member",
     "presentation": [
      "http://aquestive.com/role/FinancialInstrumentsFairValueMeasurementsDetails",
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior secured notes due 2025",
        "label": "Twelve Point Five, Senior Secured Notes due June 30, 2025 [Member]",
        "documentation": "A debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://aquestive.com/role/MaterialAgreementsDetails",
      "http://aquestive.com/role/OtherNoncurrentAssetsNarrativeDetails",
      "http://aquestive.com/role/SaleofFutureRevenueNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_UnderwrittenPublicOfferingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "UnderwrittenPublicOfferingMember",
     "presentation": [
      "http://aquestive.com/role/CompanyOverviewandBasisofPresentationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underwritten Public Offering",
        "label": "Underwritten Public Offering [Member]",
        "documentation": "Underwritten Public Offering"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r744"
     ]
    },
    "us-gaap_UnsecuredDebtMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredDebtMember",
     "presentation": [
      "http://aquestive.com/role/LongTermDebtNarrativeDetails",
      "http://aquestive.com/role/LongTermDebtScheduleofTermNotesandUnamortizedDebtDiscountBalancesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unsecured Debt",
        "label": "Unsecured Debt [Member]",
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnsecuredLongTermDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnsecuredLongTermDebt",
     "crdr": "credit",
     "calculation": {
      "http://aquestive.com/role/CondensedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Royalty obligations, net",
        "label": "Unsecured Long-Term Debt, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of uncollateralized debt obligation (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "presentation": [
      "http://aquestive.com/role/RightofUseAssetsandLeaseObligationsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease expense",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r430",
      "r642"
     ]
    },
    "aqst_VestingConditionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionAxis",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition [Axis]",
        "label": "Vesting Condition [Axis]",
        "documentation": "Vesting Condition"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionDomain",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Condition [Domain]",
        "label": "Vesting Condition [Domain]",
        "documentation": "Market Conditions [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeFiveMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeFiveMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Five",
        "label": "Vesting Condition Range Five [Member]",
        "documentation": "Vesting Condition Range Five"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeFourMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Four",
        "label": "Vesting Condition Range Four [Member]",
        "documentation": "Vesting Condition Range Four"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeOneMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range One",
        "label": "Vesting Condition Range One [Member]",
        "documentation": "Vesting Condition Range One"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeSixMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeSixMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Six",
        "label": "Vesting Condition Range Six [Member]",
        "documentation": "Vesting Condition Range Six"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeThreeMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Three",
        "label": "Vesting Condition Range Three [Member]",
        "documentation": "Vesting Condition Range Three"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_VestingConditionRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "VestingConditionRangeTwoMember",
     "presentation": [
      "http://aquestive.com/role/ShareBasedCompensationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Market Condition Range Two",
        "label": "Vesting Condition Range Two [Member]",
        "documentation": "Vesting Condition Range Two"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r714"
     ]
    },
    "aqst_WarrantExercisesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "WarrantExercisesMember",
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofChangesinStockholdersDeficit"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant exercises",
        "label": "Warrant Exercises [Member]",
        "documentation": "Warrant exercises"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails",
      "http://aquestive.com/role/NetLossEarningsPerShareNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants on common shares outstanding",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r661",
      "r664",
      "r665",
      "r666",
      "r667"
     ]
    },
    "aqst_Warrants0.96ExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "Warrants0.96ExercisePriceMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, $0.96 Exercise Price",
        "label": "Warrants, $0.96 Exercise Price [Member]",
        "documentation": "Warrants, $0.96 Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_Warrants4.25ExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "Warrants4.25ExercisePriceMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, $4.25 Exercise Price",
        "label": "Warrants, $4.25 Exercise Price [Member]",
        "documentation": "Warrants, $4.25 Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "aqst_Warrants5.38ExercisePriceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "Warrants5.38ExercisePriceMember",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants, $5.38 Exercise Price",
        "label": "Warrants, $5.38 Exercise Price [Member]",
        "documentation": "Warrants, $5.38 Exercise Price"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsNoteDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and Rights Note Disclosure [Abstract]",
        "label": "Warrants and Rights Note Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsAndRightsOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsAndRightsOutstanding",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants and rights outstanding",
        "label": "Warrants and Rights Outstanding",
        "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price."
       }
      }
     },
     "auth_ref": [
      "r849",
      "r850",
      "r851"
     ]
    },
    "aqst_WarrantsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "WarrantsDisclosureTextBlock",
     "presentation": [
      "http://aquestive.com/role/Warrants"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrants Disclosure [Text Block]",
        "documentation": "The entire disclosure for warrants."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantsNotSettleableInCashFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantsNotSettleableInCashFairValueDisclosure",
     "crdr": "credit",
     "presentation": [
      "http://aquestive.com/role/WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of warrants",
        "label": "Warrants Not Settleable in Cash, Fair Value Disclosure",
        "documentation": "Fair value portion of warrants not settleable in cash classified as equity."
       }
      }
     },
     "auth_ref": [
      "r847",
      "r848",
      "r852"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted-average number of common shares - diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r177",
      "r186"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://aquestive.com/role/CondensedStatementsofOperationsandComprehensiveLossIncome",
      "http://aquestive.com/role/NetLossEarningsPerShareBasicandDilutedNetLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Basic (in shares)",
        "terseLabel": "Weighted-average number of common shares \u2013 basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r186"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r712"
     ]
    },
    "aqst_ZevraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://aquestive.com/20240930",
     "localname": "ZevraMember",
     "presentation": [
      "http://aquestive.com/role/RevenuesandTradeReceivablesNetNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Zevra",
        "label": "Zevra [Member]",
        "documentation": "Zevra"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2A"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Subparagraph": "(c)",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13",
   "SubTopic": "20",
   "Topic": "805",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-13"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-2"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "50",
   "Section": "40",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481303/470-50-40-4"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "63",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481620/480-10-55-63"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-4"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/235/tableOfContent"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/275/tableOfContent"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/360/tableOfContent"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/440/tableOfContent"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "38",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-38"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-3"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-11B"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479428/808-10-45-3"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-7"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483466/210-20-50-3"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-1"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/260/tableOfContent"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-26"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-3"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479483/340-40-50-3"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-4"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-3"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-4"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-3"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-4"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-10"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-12"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-15"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-9"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(l)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-2"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483399/855-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "940",
   "SubTopic": "820",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478119/940-820-50-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478451/942-360-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "440",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478522/954-440-50-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482395/460-10-55-27"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r757": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481174/470-10-25-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r759": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r760": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r761": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r762": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r763": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r766": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r767": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r768": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r769": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r770": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r773": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r774": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r775": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r776": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r777": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r778": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r779": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r780": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r781": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r782": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r783": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r784": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "40",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481628/310-20-40-7"
  },
  "r785": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r787": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r788": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r789": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r790": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r791": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r792": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r793": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r794": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r795": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r796": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r797": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r798": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r799": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/405-30/tableOfContent"
  },
  "r800": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r801": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r802": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r803": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r804": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r805": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r806": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r807": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r808": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r810": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r811": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r812": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r813": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r814": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r815": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r816": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r817": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r818": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r819": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r820": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r821": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r823": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r824": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r825": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r826": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r827": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r828": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r829": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r830": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "720",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483384/720-30-45-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-1A"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-2"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>113
<FILENAME>0001628280-24-045030-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-24-045030-xbrl.zip
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M+?#BA]:.^<<7#WEA;-6C6:.5:_%W2#R-Q6]($?$0+;2:$X,+$[V]RYM_O?5
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M\(&!_H!HO-YX8NNB6 &9H\(FE0^M*X> 2DQ \Q'0\N&2O:_?%IVD*\J3\F&
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M=8C*<?R9>'"?@:94'@OJ+I6K::$.)6)"=([&NOD*$77(%Q.BTUDB*M8^Z@!
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M\-<^MV;GES:^=SG$ET5=5MY0*7F=I<1^[B539#]=CPLFD/MS(49<Y.ER*+J
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M?HT,$T[ ]J(@K>\\V1@VQ/_[ ]CUC-'69(7ASXF=&W;G^^\4N=H&<6^D:>L
M;RT.OY%I(P-SO/AP@#CTWTGY.DDCCI%<0QS[_E]U]8A^6'A7T*BD0U0<<8>G
MK89)G25Z=(@U&02X.0QW#X+%Z;6A!TPXQ:D7*+)%9HK"HS?E5-^KQ^NBRK84
M-VD/^H9GS4@& T$S'W$J\C7<54^M)M;&@\V;VRPQ?7FG[3SCI(PG@F>33@@1
MS%UT>%4841[<.;"#.7<WLF.J%(AP%Q5,@5'4A(HD9J-E*3X8LZ#- [[97[G(
MA=> *U)0=A.C\@9D)PEX@N(@?V(=2&9G.==)EZD98CFGC!8:SS(B-Q=O?&&?
MMVC+41@U!OTL';O*.>55D5H<V2P+U>+=4,OW*=A0+Y@JVQGXK&CM?A)% )V!
M)@-P-E=\@^=SY+P/V3Y _@L*>/X9.I!K$XA.*MKN%$/&&?#RR%ZO6F9@$F%X
M)#:&'>()XAI!* P(;5(2;0,8_A?$__ZSA7YP3&#;M31A<2Y_7?J$+\\N))2;
M**XF?Z&4R*<X0-4,R[_^??O][NL-MRH2L/OX4'$1T,Z$I:*R;:&'5GO78UW"
MU\I,Q.X-J<SI65$:(<9DWG8$(0W!N7@SX5]HYJ8[Y;D!6JG^@AY.H.!1W.V]
M@#GQP/&]WRW3M-%K@!_M-Z#+>+MSC,]/<.2@-KGM_=2#N@5OP_[O125 %Z.0
MSV!KK7L<]#9:]M4'O1G^4KNMHUZ(Z_O;%OKR+Z10&W&!K[#G'"SZEOX*@1U,
M_OY31Q*US_[;8M:_N*[I[^H44)S]H&WM>\06]P4M?P%$[F4XLBV#HR>EF9[E
M,"Y#X '+)R5!T'1]GYMY+IJH21;'OVD:KXKZ>AR'9147:H*OV!F+'L2+6[@@
M.O3\?W!NM#TZ=CWN;Q)^!04N6C%4_A\P'25J:54#V6C"W* U:_4RKFME6^/_
M!SY[I\I IBZ )Y--Z#Z\.F7,_0M.B<>S>8:X&E6N\"LL\^?&_KI+HMQ8/,1*
M8U6B--:I54Y+F&>C>]][&'(W''$.Q<_<]<UM[_;RIO>-N[F]OGOXWAO>W-V^
M'?!RJ$G"G$* VXW")W\3P"DGMO[^D]@6/F__NR+&8-@;]K_W;X>#Y;' $XV7
MO/$".U&6<< ,/CPZ #E1 30_;C/B"&.4@G]Z(\6WSLW9WF^/_<'PYO<^-_RU
M_]"[[S\.;RX':-&XO6RE)M09ET$I;L!N8M36Y+X"&S@&Z7( -]-Y*!SXAQO<
ME,$-T3M,M'3#5]RY)CI?2T"L&?06OY'3C'YZH3W[E+85[,QU"O66VA;3UBG4
MA):NZ[G4*12EEJJV4[UJ]]_ECI;?H-ZOP[@G-$@9 40\*<@OCI:C Z* =R85
M:5%!T]HRTHO]W2 ZN2P+/%F,)$%24DQ3P)/<G4%?+FI<02,FAK@D1L8C2\<%
MNX52@90RS)2K&5MD%,5>B'CU<6W+Y/# *:5#1I7?R_4]2I*>CA4@Y9EPPD*G
M?1EZ'CFM1#3JXHP9:[1Q^\C9IE:<:E KIU6&P__5(GB)9@I< G]"@A,#_P#_
M#*UG8">E>*:9O\"5@?E_RS3%]:EY^*U4S>V+]8I/3EY[P"#;1J%C!0\8N M]
MLX'DVL&C)W\PFDBX36A84V#[/S?P;PZ80GQG\PF V066D)YCXO_T5^+1"RZ!
MY\T1.7X'=@@;>&-J"H*?&]9K<.&$TZ;I$@01OQ8I#R(+)&J$T95Q4Q8:74WC
M.SKR\-Z.=(<!.T;[#F91>N<@R48R!:FJ@B@%*(C8Z$HRW]$D2A0D)Y>Q+,LB
M.=].UD4WF*"@U$/1*>+LR(8^SSEP=QZIE(XDB8:@W-JR8SD!?_K!!2$KTI4[
M3-2'%4UO89!60:1&5^?;'26K?KPCIZ=80 YQLID,[;"X><N0W.AV>$43*9&A
M<P-<:_L-\2N:^/Z+-K'/A37V>T;+IXN3B?>D^+RG)H?Z7.56DSV>^X*4\R-4
M0T$..B](F56#'O^<R<VA#FT6N5$;W3:OM75*Y*9F;NN]!V? ,CGX.L,[Z/Z:
M!VN\P4.9_WJL48U)W(\HO/!#HGV;&'-.JS/M1E?D]>RA'G-E*12G/;;V!.*D
M87'JJ+1$1GD"ZJ).N0$>NCC_/P=;FW87LH*:L\<09]*13J.KMWE5$W+R4]+L
M%M/N_-99YO98ZTPRIS>ZBL#K[7899*YVCK,[0\.)#B#C7=!95&V#0;V97.6(
MJ/<V< +DVO07=$T?5RI"HROS':5#B5/#?.2S^LCYR9&(C# O:IGQ"0J=XQ*8
M65*2L>F.FR$N:T\6T^-M;#VPNCTV]@YI!L 5H+Y!X$-"W[OQ(XHD,7'3*H?4
MZ*J\+.;E%)?,[ZVX(.TQLKD*DHP%254U2@2I9L[LC1, Y\G"QW36;"S''-EC
MC>RUA4L7?;.>H;FB;10+;KD@8^L5FLV_H.<FZ(6"4TX[DBA]IL3_8'[L&4UL
M&C':;V-5#/-*&BT14<T\60+3<XCLS?S WHIKQSY/=K7Q<>LZQE$8F]+&X9TD
M,P^VB@*TSX/-0X T[+DJ<F:K2J'G6I+-LV0[NF_"AQU[K%K>?;K)5\<2'+0U
MF%;U.\BA$G1>5_-RJ0X^BEN$V\X4BBE4RGW/M JEH[54XQ61?GV*E]G%"&(R
MZB0)NKASYS*:B>F&&,=Y,\MC7WW.H57KB'ERL89%1[)%ZQ@?]P^:N#8BDA^7
MFT5:-;8,*Y=VV%D/9.?V?+4*<;Q?/L!>\?BX&@(YZ5[NS]<,$^\9I$:]S\W
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M=IY9#&)!/X6DA)VYF\C:1&4T%=,-1S8D,RV\T4D]AT;)JRL(DFC)3L(W HM
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MO >6V;0<\O,EF%D!^CNC4K=G&.$T1)$E- EI-MV]<Y'FT-9H%(0"A&Y#=UV
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MT!(UH??;8W\PO/F]SPU_[3_T[ON/PYO+ <_=W%ZV=IH,6M08R8&)*YN8W"
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MJN^=8DKS+>7+> ,3CTV1]K$1R)8 TB*!U R+3+BLM*1[1@,GK1D2.?@%'EN
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M'7P+PIBX]*,/(MVW4XH'=W9%IV0MA>W\D=@A2AEV%4*@2M 4:(K9(5RU/-
M/LN]BAN;P(NP);[P6R3__H%L=%?M!1ZPZ?7;*=O<[WEDTH\0'B]ES4%OIUR+
MR%U\E8.?./A PZ*H&>I1&)6F  #>M&>>&Y$.PO2C&T8QSBM49'N'I'H)CK%
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MF#LU* WSEZ'C24 5G#_[Y;\PN>]B,H]R;4Y>8-)$BVL6V;,[N2/4D]I27U%
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MG [@U%Y>KZS??1I:<1EC/^JF-5;3?V SLF/_X=Q!AUIC#7O%#N,'V']@GXU
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M5_N\["9S]*Y"*9WIV8 #// 7X5S$ZM/A2<W.-9?SI7 23WQ=7,SG00)+^1(
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M?V>Y/O;D%91>AC4:+Y6KE:GFXN-ETSV@,[PE%_X_]O$+9K07ZNQG6Q&0I+L
MD>''U+(IA 7@6N;)=<+]E'0G)V.#:+E'R7R9>>FMZWF6'P"%S.=)V,*COUT*
M7EP"-Q[&MNO'=W Z43!W:0NW;KRDOY<?,2X8KCWP;H3#AP*B;4[KXF.- GUR
M<#1N+*[Q!W\D+OS* M:PKP11*)S$M?U3&-2B"8@IWK%CNV4MW2@.0I2?DE[E
MYZI'890!+#(!N3Y;?BX1%ISI-9#Q#(X*5O;3#VY]=3^+!/MI\39L!Q9IS^_2
MM:^41QWQIF]<<<L+M"WX:AB+T+O#5;M1KGM<A;SESCPE_7IZSQ=J$?$Q(3,
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MPP0YK@/>#<058SH[I+ AOD'1;$OV@;J^AL?*)X#<4JXTFDG@Q&S4/LC@PJ4
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M7SB%0W&1U H9L\%L,&=C3_AF(*J?@O8WMU>Z<(0< I\"2+:?/E8^QK&NP,]
M=W&6@%CU@W"U=--%RI@3_Y=LD1YAPF%V9_A QD[3J#QXVG\D:";=@%S^O6CX
M;W.3TD-WX4X<=M?(2$_M*Q71SIBP*EQ$S4/Y7C%F5 A]57"P3%+D\@3]MO45
M\UIH"+:(FO3+KQ'Q5>+:5#S?)MGKGX5B 3_"BT%2X'=^$+.07MHC8=F=\GG8
M\5GH1C_!P4M\L(?,W<!>5WSIZB)UTW_4A&';^BX<)PU9?K)G3*<7WDT /ZGR
M@I")8<E7\E4UU>:& 75J7$%-)3GL='"68VL\+#$WLB2P]76TK0])* /-\CZW
MOTK2HU$2K5C7<60'5:@C$Y9X=-E<!K::1XZ5X@-8]$IWR5^X/FB /[%-_I<
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MJ0T9T](K=$POJ0SR7WDV&CM36X"L6:M:9F2]HB&+DBG/9G=GBC^ITNE4[:.
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M"Z(M)K*H>QLW>EI0?PQYB,7=E<:B,,@EK+HA4=AN]8N*W;LJ=ET:&:TIEBM
MSX^%X>B.3\[[K6%Y^#/CQXM?1D5$*XTO!G,N-^32",5%N@ZP9*9)Q>G),AT9
M1DQ!&16!4V 0L$.L:(G-["E"?2N0$?)-['%@?:92ECXPH7/%OL,59'\4DCA?
M*]L;EW8M-RJ&2D]#MF56/!C-$=N.QZ?94XDU)6,S/(8"%RMEI$R(-&B1$%<M
MYMRTZI6&<!#HQU9V?C9ED5FCJL<KD4,S>ML*RU74#(-(B)_<"*1T<(+JT:!*
M%6G/>#)RH]1XF56/K-'&GF0Q(@;(8K1;UL4"_Y>;E$6PDF\VE3\5Y4HFYU.Q
MI8KT2[8!VP/PK4\,V^U.P(HLS[]0D- \A9+J#+X2)9G6G=S1F9)Y^S&*$! 0
M6'\//&2<8^JHE!^WH*L=1V6A@X)]J8\F([V47+J\@Y_]:?L-T.,>:+Y7<R^8
MP>F!2:L3W5KR8^- G^\M8]MJX]6.HF#N4JB":/B3\/W@%]K<G<F;O]E1;">@
MX>]\)\1FR]0?DSLLH;T+(O@VX$$K5/=\)=LQ>Z 3*A/I15+(THY1K*B_NJG+
ME:P1*?<0:&2HI+ J*UN_J;S_0$EM1FVQ/JXH6U#NOBG94]A<$-;/IT]/SJ?5
MD&!EUYD AGN#"#9MZ@EZ3/4ZE>W""W:K.307Z4L=@#%K%@YB%7-'?SE+A"OZ
M&>B0XO^^_?BZOA#9[(/&L.E+'ECU)6A;W=%?AZ-N:SCNMS*#+G+PQ]SH,F,9
MHIB\D<6(&+C?M'!^I>M4/QV3!EK&Z\BE[&O:,H>4;&#GC$^1HBMH.?JW)>52
M:;O@M7Y"\?4E39!S$5WTZL^(^V7+<;M"CV<DQ_HXAUOJ[J:2:JWC:VZ7L"SF
MF97X4N6'M_G HF2^+.SYV*VRSZ 9DID;+5WK![@O,V6<IL[!T1AIB":2K5F
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M"L.%_M69)Q;QZ]YX;[Q)W;A&>XRT9T]BB&F!D_-/>(M6ER5L[XWU-;V+/Y*
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MH,4!^L>^0R>7/N=Q[+@WO!&\^M]LCUY^N10B/I;;-I6S$\!S\3SU/<*=4&P
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M_WMCARXU=>4'DK=.@B<H?5CQSEM: *CA5%6_E:K:1JLS2KPX'R%YQLSK7J_
MI'+!@$8+5T0\?SU2][_Y%.D0KT#_A43*S/^V ZL%.Q;O#LX.;XGD:H3#VY=9
MJ6^O8 5D_J#,#>FI<-)@6(?!+2E7&@C/H@#8!M8(#^0I.#FV<'W6Z&1AW=BN
MQV^.#?8HL%8++UVM5)1S5R5GP9HS]/V9&9D>+D\P9Z$9(B 4"P^L!-1<] C\
M!3PPC<GAI'6:9T_N"ORUTI/PR2\H0KLS<85"6*',3'HGW_D=7JE=!W ?M4G4
M/3GO#MK%X,]?\!QK+W"R^P52O\5V$1'Z%TEI9(3!7;O7R77N9DV33IMPTK:#
M/S*U:5JKHE7Z:>@BE9'U4,9'<^PX'2//D*9QQ S91KL$QV<=Y"2(5 )2WX;2
MSDK-.Y87:/VA'Y3QN1UQ([S J)0&?0!'UE)"B"6-@S<<Q4@X-T:4T,V;"I<Q
M7,.U&O#^-77Y\2FX]E LX9OXD%>?@B@ZM3[Z($-$&J;D8"=^/8U2%J*>TNR5
MH<\61RL+LN%AP<P-P>4L&[V%"R@))4[Z)^>#8;%:L'Y(<T-HM6PU]=)CDP%.
M3NH/BG6RV8"RR=3:9M@F,BJ915+TH-<>8^_W51"Y^)W7;'#<B#>JXSJE$HT?
M2A;MI#^Q9U'@)7'U3PZ@W)X8M]?)'9#QSV6H5K.RK\39#+3]SS-[ 8M];7NW
M]EV$.3]38(&TRIUA?ON5FUPL'B_#1F?MH/2A.W]-&AV_!6NR#V8M%D@7X*?_
MV")$#_*6:!ODV%MD1>IO9)^7W61U^/@>@>(]T6A.9*)AB08F&GAH_@%96ACQ
M@7,@'PT%6"IO6?_ 2>U2POZ/E"YK!2R.#"R9]K9S ;O58D8GY_V2NLZJC%Q]
M5==_'%6W(7^YG:K#XJ%^219SU]F[':BZ":FZ3G&Q6ZBZ/?#)ANO9BC2GL.7.
M+G+=&VYGF\5,.\ G):22XY-"BNYA6<9/RE/\;&/ ,[XC\5Y,/4X+2<;M\34'
MYAR4N-AHKN>S')P+B8"+/"^XC5[7\);V,0IHW!G7'04T&;9[H_[.!MSTUX\"
M>J*:L#A8[0GAQ\D?A\%090-<'EQ&\HR!GF5;/![ Y@; ]5K!^TV*(TT^7Q<?
M7-0._YNRA$4] =;S[F8>/).ZE_UQ-3#R\%XCT%]&JZE=4/Z[1'R!)_ZX%=Z-
M^$SV?EWC=8JHQ5:OI!+LJ%M0[94M1O=BB^=;,KD'MD 5\.,VJ,T-'+4L0<\V
M2N*QN&'<*(DGX0:,#M7FAR%'\7?5P:71#IOY84)!E'@I0D%Q^T99U&4/ N.N
MY8T?P6_BF^TZR!@?@B2\\)T?^L!K,\GHY'S8ZDP?W!+VL)0&O7?,*:&#Y1<N
M&UHDE)3.P@4>HE8>4%-ZE!Q55^'49J'QR?FTU2^IDMEQCZ9& VW7G<FE_O>.
MQIV],"6TR[9":WGF=U_!R(3S_M<<OGIQC?]5FX$FV$V@;&C1L39TV;?.J4(.
MNL49@@\J_>ZLJ_[>2B,]X^#W[@_HL.7.#L5.A<"I+5BF:-P.I]VG:'-0ZRIW
MU.R@4,CYD#K<_G.KP^UV=E2(^[<@<&Y=SP-/ZJ,?V_Z5"V?,%;2("?8"1%X7
MLN.C3J=0$ N?%0MSTV?*LMP6'$-\GRI<?GQ- ,#E?"F<Q!.880*6!':Z$85]
ME@, 1IWG"P#@##Z5;5!67M8H1JH>1167! O8+/R;NV!0BYO>EBUO"XN"X6M<
M)X  @04=)+6T<%[7P%,;O#/< V  Y'2[P[*Z#F)@W&E/QZ-=(08&TWJ/JOY\
MV"]_R;T6-7D(C.$HV]@=ZA3*@D:@;66Z@/SW+/SK>1D88\TV2]N /M?34#6Q
M5K^K#Z.?.8R7T*SY6Q+.EU19DPKU1QM5?VSN2^W]'X]WTIUNF+FZQI"Z3Y_W
M4:='_11+FBC?+PI_$,,&UK19;IBN8;H\T_4Z&T;3[ISI^L^(Z5Y"I^E47:]L
MK#%JL!5KF&5#C<YF9BGRP^#D?%A2%]',!CT&>NGMGEZ&AT0O+\&?V>"Z;Y'.
M?,F3FS;D''9N7HRPQW)_M"O,_J';] T9[J3-]\[)</R,R/ E6+G%"6);#0P[
M3AMFEUB5-9QCS"HR9Q+5YJ5)%2]M#U1IS.-#)*W["^5=D19V*FUU)@_!0#66
M]-;$\;&8Y"V99+6E+JP[]N)E!3$??#J'+6:>1H$59KQ0M\RS/T48E B3;@=]
MQ4FOVWNS6ZOOH7=YV.F&AH\;/GYD:Z'^K*91MTM%SN,=IRGVP<I;(!B?:3M*
MT_13#9'JS_#9T-S(?,G719ZTRD@'T\HEC8ZV&::3[;5%_95#WM(.VYIMVM$&
MC==)=]H_.?>#DI9.9??B^O,DQ)[83MI/?JNY0FF[LJW[<1JCB)Y@JE!]"AF<
MG)=(EIVWPJJ_,"S>+>EWDN\?]]&W_I' 77#O4]?'9?F"UTO=OVU+=HI6O<>Q
ML?(57#;WV<\/":!^L;9U9<.CL!UO]K<,'?5C7(WJOVM3S4OM1F8;;O)OL !L
M"OO5?^=&JLOG)A;90IF,4)D,.\5:-=4&&SE\98>R?7RP6&";^=D='9N#4I>Z
MX\INYNF\CYGL5[_C8_BH9Z85]\YJEC"XM8]A3#JUY!C4+>=1P-Q@'J<O,&GL
MMKUC>MMO)77]2 FO;/V3FH"F';\>@Q4EAU<\3:0FS5;(CW!V7[$\'(5P<%TU
MT.*^K9.U9ELCGPUI?@DBGRH)AH<V9>BS&AMPH415V>C$>Y=ZC)Y=J4=W1Z4>
M1'R;2SMZ):4=O9+2#J;E+X%_1B8%2$9^]KV*.WH/*NXP=@;KD<LIV=F+J.@(
MZ%Y\XUXXS%>C6*.ISFBJ,PX.XO%<ZQ&:ZHRF.J/0.36XHSF;8!\*]\;>96W&
M"PK+;MK\\41=US5,>LLY6' ()%5]UT15US?L42U&I\2]V3%@YAEE1AH.>Q$<
M5I'7V#F'X22@9\%A+P&/QB[L"\.=[;)72>IW?W:CN0"OT!=!8CCAM?F#&KGV
M^KMJ*-9@S0Z)G#8DCQ^!G*@/:MD\FJ92XY';;%5$H9XH9?^";+2''<WQ")?M
M==4#Y D5MNQ />WP"@_;?6H8MV'<G5D%#V#<,;;#VX$AL&?&/5X8V;L4D!0)
M(!#'^B.QPU@/E^JTY.@R_,9EX@<W2%>?W#GAFBZJ82U7/@V#KH59Z'4V:)/O
MXD;XB?@0!M<*-_ O-UZ^A3,-X![>_Y(# Y%NX?\[/^Q?M4EV<G(^*0T5X(F$
M.H),"R%TP#P($2$$9T=#LPLQ9@00<=F5Q+!4'HGLQ;T6RO'QRX=,E.0+#2/_
MNO@;7)L-OQ*.C):H_M*9 P RF>,AW *K1,(OP;7UIB?G1"#%_=>\RW6QG<\\
MLOS"]Q/;>W!XI]]!?Z/TSFQZ@QZ1?J5/25^4'M,7+^V8>NWAO#YY59*B"?65
MQWGAWS\'OM!HOPIN6(D0MX,H+Y_,\2@B1!/SU<7E6VLRZAP:'.0''%.T@/4A
MA5^*\,;%4>Z/O,:U*\(K<03#XX1UNQ3DZN!!BU]N1*V%4YXC&% L]Q RZWV&
MJX^7.":4F):&BV*CKIB^[ >Q^8.V=4%I_74@2Y54DW_JJB&QQ303OBYRY?31
MNNR?XZ0J 9#AI7386RE/;18#_>[)^2)(PG*@9OTM;"7#=KR%'FS!O1$;Y\SF
M9$1F;N<"5(W6>\S7GAW%:7-.E[_G^DA?\-\XDH2A>\H#7R$0-45S%A4$/L/5
MY.A;P'N.G%U+-)Y^DXO&#!A9]^!P9)<V3^W^P$,FI,;>J^! B-XB">DL08+8
MKA<A ' 9W,*%N)%Y$ZRI(R7^R\4[RPDFIO;V\)X#M@)-.)E!KCA6V8TBPD'.
M[171 !IUJ>;J#PY.<W%V@3T7*::E#L"!R-&C+W?MXMPJ<&HQ9%?$J/XF$<^7
M2P%_;Z.!H:^G+CRXU]E0^H%\'!EON/"=#T*4 >?[.!.QI..Y=8OU&[+Z@ 3;
MI?#@2*Y:UI7P16A[+;H?VT')&\4AY?K2<H7]8'1-ZZ\$BT^D[]WQ.''V0+;#
MR4I"D]0PZ/&D((6S?TV"!U:>(O/^DL5)2CG227]BS\##3>+JGQ0@27N2+KUN
M[H",?]: $$\UA'@9IBBL*W$V"X7]\XR&4;VVO5O[+D*?W13%((=S!Y\_L\J3
M62P>[618^CLH#XA07C-QP;=@3?;!K,5:AB@S_F.+*P*_@=0H, OZYSQ7RCXO
MN_X-0-C]X;Y[.\)]7\QI4$T$=BR>"<A/^"1,A/,I'7VR#A#>'Q0!X?U!$1 N
MGVJ]EW+S7D!P>O"]@>#;;+6BW7]_^"S!X>K0M;*2#AY\)!6%AHXWW?H;//AS
M2B0W>/ &#_Y"\.!*BF,E#XCQTG9H]X8"OJRLZHOJQK$A2_7^>N4%=T)\Y[2/
M802]O5\:M3]"@/A@^"PZ*C;-^AN>>WJXPNYYCKJ8@EI\#CSW$E#CWX7M@:N(
M,4 *^*U$& 7^_\_>ES:WC22)_A6$9ONM'4&Q2?"V)Q2A]C'K&=O26.[IV$\;
M(%&4T 8!#@[)G%__,K.J@,)%$#PA"B_>],HD4:C*RON$SY8>#A<-5EI@_,Q.
M$VWR@#<56]\1?,*$CX@F2Q?8D734JTEF;Y,H?D0>NR&"8*N.WLZJ2I/Z7=F,
M,3&(8DU#M?44#X[X&,S1/!:$GN/S+@;^MJV?G^^8\DK]:_HELX&NT;V'X;B/
MKO?>#:?!/+2E'U1-6<C0!RQ\!?_9DUI1 VV]P1H%:TJ&GFR/-5W$FD%-L.;8
M^N:Z -U!+_\3>NY Z<2DH$2_ ![):G3,BCJFA&>I%@&$=)73C*_1,I\_BI1H
MF44H4LU\[_<H);A;%T/E)>BAE,G4Z)2[E<IE N=K>&0?3/&]U=8TFF2=<&6C
MZJPJN#+(;Z#Y,O3'TQ5D&ZE$D:IR9VW%6V==T=NYQT+V#Z#SX1XEDF8-XZBH
M90VQOK.C[VR7[OTR3Z3F-^3<D//1E8']D?/HXFK8ZD_V97>?EIQW+=I6DC%[
MM:[>^4Y]\<V0(Y+E:'EY31J5GD1UR%&1&\XG$#^?NDZ($0-E2,4F%1.MW.[]
M@5(!MV*&Q]^"+6KF\D5MK4)J;+W!#S3E,8,F?6AIGR%"?N'Z 8!'K2VQ%@AD
M@(:E_%[<B;.^3MRA>LF,\WF4&(F181/OV33XY/B!%^);Y"Z_ 49088UYRSS,
M5#3N8__SI1[SAO'%5;?7SDKZ7P E',OUJ"#1YZ6/P8/EQ9T$J*PF?<IZ'G*R
MT2&I8'B!19JN4U0A+ N(BXJ$K326U!$>@\[F\$#<AOW^W7#@VE>:GAEYT.W5
MK53PL^O<7^+@"0W!=-(:U7H!YK1%DEBN9UK^+*3*P[4E\R<ABFXA47!JP(B[
M%+5I,C^/>N&M,PZD(/38$J""8@!@ ]>$H+)C_94J-I\>7%@#UO$TGQI0,&W.
ML 1^YEX"-#4_7&*M,JH^;+&,*T%ET?R4*KE3O5<P6<RS6( L"OY&I4G[; $.
M/1I.T!97QS<=KQ6=;(/%[E:+I?$?N))7\!76G;J:&P8V-<PAK<JEVF2LL49E
MX686N%,N(_77>QRX,M:?W<"5WIX*[Y"ZUQ76#?1L8=U SQ;6I:7#%F5U?-F<
ME^EE=6[)>ZD%*\B[NW4EK%6YMMXY*-?&@*"^3I6Y8V"O '$3$S\+-GV#H^J
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MK4<Z#W8!NLI7]U%XEENB]:C*'ZB(FEO4'($XBMV!%6B3R@+($+&6'%S,_Z'
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M1DG+J<($IHKR;RR:8)]IKU=595D8JTPRQ?8AU0,C;+$!$C4ZF8>\>A^C),!
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MI:#>_LHF6#$)JWCRDP5:NV'/0FX"3#$5\-&BY#_E.5#P73[MA5HITSN8>6D
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M-XX,3_:7B=!DP!W(]DG'Z)JQ%VN.6&\&<$SK1W@H\XB^O[/]4Y\TD(8 SIX
MMK1_UA# 8&<+J"& A@#J;@&M(8#ASC900P - =33!HK0?G,K:%2W_%BR@GZE
M&&.D\?.-T0A):\;_C6"RG-"@G:J3Y07(^WI[A-4JV5*6:/S[+Q>)!\7P^$[\
MB#'U701HX2/*J?B<T>-CEDX314<I$TGY[X,G=[,T[MGEU&/&CTMC#IM]8]A/
MQLI'H"MG6EC.90J&Z>,7'G(^/]@A.08!+;@>W?D;P#SF\<*COQJUV8OVX"'A
M_L7J=/7N2-=G^GQD]J>3OC$Q1FRF#\:#R;@W[>G_!X3WG0+I[EQ[AS3O!/Y?
M?S6N\FXRA>]12^8NR,?B;SN7>A)=%X9W#[<K$'V(U,&)]1+EP)ON."D<_@S]
MP)JO^$<6'-$)WESBC_:-Y9.-D%QI''STMR<!-08%&J'PT?6TX('!_W"0_,*E
M:>D,IZ5KT:1TSD1[G9:&8Y(UPS'QCUY+<^/,&2W9TSEPM:4L!:R<"[\^I><:
MT(2<*L ([]@L](#1,?_#SYD=PJX_>N[BG;M8A@$ATLT\+5^N%\#P@ZJ)/I/Q
MQ=6PU>MT6[V<E'@"2>5CKF_F>)IC8H/TUJ2KMX;]4?:8(OV<J)U<753TV<(6
MA$LVPYW:JY;VQ##/!K9_*?=/\&%BZ]H<]DXX-XL/@&L*3YGVX?:NK4F\A$/5
M!2W7M]T[Q7U-.IV]H^5D?;>WTQRSBVC9ZTU:W5XG<\R#<-0-M9;#E#AO)DR.
M1XU)>7X^TGA:%VD\:@_TO4KC@J:P<*^5^<'ZO._3\ -0"GL@ICJMWBB;=;L=
MVUO?!.XTQ^SA,?4Q'#/'W?\<I?$>T7)] X+3W%=__VBYON[]-,<<@-+1&;2&
M@ZPL;A\1*\]5*LWJ(I7V;B-&/15WT<,GZ\LV3T,2PXNK?FNH]UN348[=M!7E
MKR\#/,TQ1WC,_A#^IT_.0B#M!R/KY["8=,;[Q\CZ.2PFG4E-,/)<A9%9%V&4
M;R+A/57C 94$&7 +_#UHK8!_>-6,&I\11GVXN[W5#& @IL\QR'$##7_E68:=
MPH=LM"<__H-87>YVQPR@#1#M^#/1"66^N@'3NJ,V!V3VOW]-1,*RL?(D5WEO
M^3/;]4./W<R1?S#')WA]PU 8,]^Y?N!G&I_XWV'%WVP@]8A1=#N<GP&\F7D=
MB,_P?0R8RA(#85[(+JYHK4M:3%/?EPW@J?>;'[X0+\AYK1Y%4C<$P]WL@9FA
MG0("GA[H86WCEVL;X"!X;OS#]"K^;ROLV$?1G!S@9<"TGL.5\+-#L+,-_77?
M@9KQ[(:S B$P<^\=>-CD<N)R2K<^4T"C6?#_@=Q#QPA-*R"<P#/@[^Y $' 0
M(S>X63(>2/.)R^ [//8 OT1I(I)%/SFP-M-,$(V@>B2T$LWP0?+!53VERT]+
M*)P7LD;A7ZI2!&#:QM)G;^0?;TW+7]K&ZHWE$$CHH;?)Y7+:(M*=\:_C^&F[
MPV.H(LE7O%E\W8:O?LU^/NBWN\->[E>==C?W\Z*E)NW!2*^T4O'GO7&_=GL:
M]/+?<2Y[&JU=J21]_#DU<\K//(D.-=GD4#PAXT3'RJ^L_TZJTQ>N.GU U>FO
M4^_7JTA]TD!S*CQT]B9SZ[&?*VR^HB): 30O!]N5W,!-FUN4WS6L<:*+1M&]
ME[.6M2,X$V#U=N4(!P')27G%,T2A4\.K5X5YGD5#R"^&$\Z-61!ZW-/AA\NE
MO=I;/Z$T%IQ;>G7E\S_?W.NLLS:1K739RWAKN5M ],#*^ 0^_,0_6>1Q[<6^
M /WBJMO9>3!9U;NI:85V0ULOC[9ZG<ZA: O':6?#& UI-:3U4DBK>RC2ZF.)
MR<$;VC:TU=!6;6E+/Q1MX:R P> YT-:Q^Y.< BF^,9\9WNR!3$:3/3+;76*<
M:JLQ 6<X@B.7-GJ'HHWAQ56OFTV4; :WG /6] ^%-2,TLG?FJ W6U!)K!H?"
MFO'%U6@\;K#F++%F>"BLF:!EE,T1;>8\'>K>[Y@-']ZWM'OF,,^P25$SS(7E
M6'[@48>'748ZG3TEC/9#"9MD&L=DHG=P(%IWN"\SIP9>@@:I%*0:'XB]ZET<
M$;*S =!@32VQ9D]1MHJLB,I?A[V=97:#5'5$JNZ>PDL5D:J'\JW7VWG@YS/M
M)'P*M/CN!J#]%2:?,WZ3?E4=_,5Z]RN?_WRXQIY\"A5Y1A]YQF!OQF,MPFH[
M]*IL"._E$=ZAW#+ZX.)J--K7^.V&LFJ%8 UE;4!9>TH%J2C2>">'R<[#/!O"
M:PBO1@>O0GBG\:]BR+,U&CX+PA/&J=R$A'2?E^3NT1VRP?/%HTG5DVZ[>K.[
M9[.[E^ QN2ORE6"/EC>;%%0=:D)P\_R>GW\)D>!ON?T0=YJA=V9JV'F-"<R4
M:8U.$T :HZ[5Z>^KU*0& :2&1LZ61L:'*K?2)YB;NZ]2QH8(&B(X(!&<Q!O6
MZUQ<Z:W)N*&1AD:> 8T<JL"IA_,G<N;M-9D1![/SU;$M3>'2&@/B4,4$/1UP
M7F^*"<X3:PX5M>[U+J[ZPYTY98,UM<2:DP2&>I1D-)PTK.@\D6I/B?<5D0I+
MUEMZMRE[.AY:?%@L;7?%F'!U1^,6EC;LY16V4\_,KV[2PA7K9D\EZB5SE14:
M&>YMKG)]S/\&HQ2,VE/Y^N88M;])W0U&U1*C#F:-8L1JY]2@!FEJB30',T8G
M@#1U*9)["5Z[P]8SB4$5J52HXD2_LW;E[Q,TY\-+3E(%U>\<I IJISNM=S9Y
M0\D-)9^HK*K?/4!9U8LCU89:]P2=\R'8D^2G]/6#5&OM>JT-29\>=QN2?IYU
M8/W>0>K 3D'29/+_2L,6U4&PZA31T\QOI17?6&"L6[,$SN1/="V:B:I]^'=H
M!2OMFH;@9B:B;C[=]*OK/#(?,"FNAZ $('JQ?XV#FN$]!<-)^_V]#B?M'6-R
M;O%P4CX$%+!.([SQM:7G/EHFTRR'TQ'"W9BZ84"3B<4L4W*JC][Z.-@Z6U#"
M9P<I&56:(4 J9Y$F1ZEK2]B_:ZX?IGR&8TI'G?9D--S+J,NNWNY/JBUU^/F;
MM*GQ*09P$HH<7]SQ_8&L<?ELWC<@'IB'OTJ47O%DP]^14C@KTUY]N_O=?ZU=
M O)[C]9,>#-3*+_!,+L<.-5PMAIP:1Q/Z<YI7N7O>25H:\Y84O#WO$#Q!_U#
M3.Z\AIT9]XS^_IMG.('V'M0=[:-A>?39OPP[3'9J;29Z/H<)@_D'?F4Y( ?=
M$-8P_>),E.-,K'P.Z/ 2<I9^%XHISF=WY]I[-A.C?+ND!14/-GUA<5V*^?G9
M5I8E7J%\R_': V9[SW!FR6^K^">WQ@H_(A'-+8]/#LCP$#_T;T"%];X_&,X-
MKQF(3 HNW"I;H90?..GOG'1:GY2#IO#I7/PTM\PCJB@A-_T$U";U)Z$ZD=:$
M2A/J3*0N1;36B6EM>'&%EE=-2.TE)&K0O8"6VQ16K9%>I36WAZ,GNA__DW-+
MCIC*PHM::?5[9S1U:F=LK!T)5HY/G+GP2E';$857DMBVDF#CBZM!>["OK(*F
MF*0<Q?Y%ZL8+,[]>/1\)QN\GEF!9(36YN!IVLDI?QO/2F%:UEDXOP[0ZG71*
M$M(VTFG0(?NJ+M43+\&^^NAZ<V:]/ OK&0FHZ(K6R*A!]^*JW]M!1#4&5!U$
M5&- '8640B#PK>23?G'5;0_JTM_A)5A/J;!6E.*CR>R>70RK';)(GQ$E%D6\
M2GJ0U3;B->AAJ[_1[AV?*F%!8[ U!MN!8F'Z<XR%#?H75[UV[Z7::B?*$[RX
MPF1UR@4,7 UOKUPPYJ< ;F#6%4]U>,GRT?BW'QS!QW\G=E51-@Y0-@YZ._=+
MKX8"C:G8F(I'%8Y'(<(/?@#O!5Z[F4 <DD#,.F%J:1S* @;8*"NFQD/^:L>:
MHQI7QUPG)7*R&J6E_5>U&=LE9IKL52?R__-I(M+T>-4 =3]1OW_G^L%7-_A?
M!J^=N?<.'%:IE>,/I6FDLF@:75P-6\.<YA,(K8 :LH2.%[T_OR.+YC';$.I/
M*'T#OEK[D%]9Y&MP&EI%*D]3IBDO<X&0- ,^61B6@X5&3T(GU@RN%,M2(]CK
MVI(Q<FX=Z8JX._BCZXF/\'?=Q+T "L_>F*&W8H87WP2VJ%+"+)+>-/R5W]:P
MNFLCD-[SY"R$)A-GY'#VP^F? &C\PB@!%\Z5V9/!0__!*!3<'P=-/C">0*GQ
MF1/#8W)Q%3QXC%TB #)0@5.:(>'<(U\;</N!F2$H0EBNAN=UW$ ],Z *O=:)
M #CSK !6,S07J4@+@(P($)83PK<<>'B.=DIKAZV(GQ$0$BQ1\)R^WAYAK=G2
M]0D!WA"%6(\L+C'[)5EI*)AH)W[$F/JN'0;%CV0*(D[$6M'IDP"0\M^':,KA
M$NCU<NHQX\>E,8?-OC'L)V/EH]1110K(DQ0,T\<O/.1\?K!#KBL%^ZM1F[UH
M0#! P7^Q.EV].]+UF3X?F?WII&],C!&;Z8/Q8#+N37OZ_P'?IX)89)WOD/@=
MK-HRKO)N,H7ODD*[G4O](B:8ZT!^VKNH6,";SUQN8X(5E;S(2J3ON:2L=]BI
M5-9[]!K3R:0]'O0JEYC"%^-J]9]KJCD'W7V5F/;&@_UMJBDQK5)B^L7P?K
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M5<L=@F:YQ" Z-[L",.BE"Z?+ U$C?K.QSFS*S!YR-$2C]*2FZGI+K'<P$69
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M6?)OF&;O/T3>G#CW= U8/<S"9#]$5P6@0^G$,;B\P 1)WCR-K"IA?*@%.PZ
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M4LRV&F=(2?WO[I*PZF_,+N$9\5(FPQ +1[!HTQF)I4IY5!0=AHB!@%7D%2D
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M(3);KXP*2CIP)P]8E&MN= (A:(O\6QFY*%: Z)V('U.X'_@DV53\+1DE,K%
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ME.:E_:S%(7N;)RTVS:4?'%U'TURZ95"-;Z;FZ Y@LM]7@;7(>ZS\,AM:W!0
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M2^SV&V4)I[. R);C'7!!ZA<F!^W^1K/3*=,!Q;#3/O_G'AIM;1*:_^O+/RZ
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MGU.)'U('/F1N"[179!==^/'K0CLMHQY$/FL7:D54%IO^<AJ=E]MSX21L2@U
MM[J]/E-6 DHO$8I]HLZUF2?]J02V"P:;Y#0GP6A^+P1:\C%L1DQIF0&F,0=6
MSB[6]T%S$UO+5_V1-,%"P_JD!,OI5"Q3*>KE>I@DK 9]&8-VKN #-<PB_UX:
M7U4,3\9KN6$)A\EPCC,YHK&EMC]3 XI!2U(.,?$#-V1,T3;"B*IYBETZFANO
M9Y%063JY]5QJWTU65F4]/Y]]J<>:R*'*!*\0#%[J-2K\E$<FXXA%'NW$?]O*
ME-8<14V"WI:75$P;+26]Z@Z*-BE&] ?UH+$QED<96CR1D"Z^3HR)M")Q,EXG
M.>1LEM%=V,XT^1J4IX"0L)X8]P@KV!;8WW!!?)\F+,E)=&O/2MD0Q:78I?ER
M+L!C&;.MPB\IO@O^#@%,I:^3C#"++6>K9%LQO_EN6*X-3__5 -IO4M2=&$-7
M:>15E)K<H&C\G&N),B#A1>3>E/Y&N!PQLR:#4'2*>Q1>1D2QN:(R65$EJ,E!
M*0=<-T(I%!>@O5G(#]R<QI&(8%903)BW^KF>IN<AV>N7RJZN0^!C2&E!'=+B
M)?;RM_.\BSPWEQ+Z9YR0(+DJ74];LDKFL+&I5[+:%G#^!\H_S\*8C[4$L'$:
MIX_90DDV^4..6^1AJ;+9NT7CEL($WNQ33,3'?G*5:%OP9$+42<F+G;K4MU'6
M%M"T8.YX^D<6&BU/96A*Q)CC1'+8=!\S<].JKL0M>1OS/@M%O5@F690:NBIY
M;/"^F^"DLT'-;-^U7F\\XD%I[T83F()35<MR)3QUS[6<CR,0*4Z]N?V/BM?I
MPD7BQ-BE9D/_827G.:V&DDA!0P'.<*E8^XEPV7?K-L-ORF8X"39K59RP8!5Q
M)(,M2)595+A6QB5(W>0[#3O77)/'JJ%_3Z4@I90%CY5LQEM5!!RO+D5)S)9(
M)0X]P^ZJ<C!HDF;>JERLXVJ=DM.S0M=HOXPJ:S53L'DT-5U58(:QK*0R&H73
M<3P1^#BW>D**)0*'YK)CMH><SY*J?NJ<*4YW*8VS<A-H8HQNHH]*_0DPZH.5
M HDJ,0/0_3#L!242=#*Z GU5IC?<SCFH2Z@:N;'JZN^FQC#9*?(DX,HJP\_+
MC)F9Y+J1E,"#47,\R/TG[%'%I!F6S@D..X57RT%T",#"6!>@("'GZ<'K QF>
M%NYT7D"Y.?O11S71_S^VX,D5:B!$CI-3C HYJ%&TIKZ64DTGRA7)5X]A)N./
M2]Q@?6+E'#2$'\EASXE=SLGU0Y_D$9PRC=+5DLP-!G!.\I)<U<Q8?-,K%/WP
MMSC/EL#4T^E<V9_Y[W$;TJ?")Y"_,Y,S36A(3[">#2LY.;SU.U.SW@![J]>Z
MV%/_BD2-PGUE#*,N_])(XU6T:#17D;.!2AW/]V"8\A/,X:ZYA/AZ@[_H/@]=
M%Z'Q#:MNL<6KTLRI&_XTN@QA$0]UA-#LC)#,_>52TF+JIU0,DB3L$";"D>P:
M>-!J*6<J8^]TV#(+"N*XH!V^Y8;JZ@M4=FPC^8XZK>A$)MZ93M=5[@ZIA6DU
M"HZ"Q2]X*=)88#4N;O./S+M$%@*?ZO59.]4:UOX3["DOWI;-99+"UMCQB,DV
M2Y?S!E'CDL)7;L#8M.*5LCZ')GGEY^ 76#'W+$+56C7OTD.A$V$F+9J D<$L
M@W]Q)C()O)9UX0,]N7&0SZ>&9S8L90[+NIY'\+R+F0]2I98^UVETCD=&NQ_3
M(>'->; L9\BQF/!I-N]_AGJM.@ 5&H?2FG*GTS@3R >9L5*ETQ?D_M0+2-HW
M2#D4B:62?$]'EZ27+ JN) EC]3'EBG!31ME&B-1J;I"V,'"'<[EE\Z'BAET/
M+[54,J34TZGE<HD6C@.^HM'DNJHY,0G"?!6FG8IKN4>]>D0)KGE,UE4)&]AY
M!!2IXU/4JZ-F[Z)$)O)\^+$D\_$DU/,OU!Y4'4W(HQ&^.3[B!RM56IB'GX%6
MU+RD7!=_K6(M\EIO=PLF;ZR23X)B,OZ2*J>DA;DF^/+)S6]X35!FR4DA[6!)
MFSPU0;8<5(<R?;O+6)Q+'4(W*93_7G=W@/Z&6IJ]P;K%SCI9+*MC44OC!$7Z
M.U%UAJPFI<K#G^\)6-DRH@ 5P,M5X\BEJR&QY>@I/EBNWLUFKH\#[(V31N&;
M8J;LBA%K\VC#\R:3R<QD&C>93/78RU/.9&)UJY!6FG-@-8B62KIE*$OSBDD4
MQ\1_$_+CY:R:=2/YZS6VKJ8Q:>YMQ+Z/34SO%HF60F<=%B<AO7<^;4F@@R#,
MR &E\RM*;F>F'Z-3A6=$X8I34'+'M)%<[5[KFB<<X\'168J1L<X-YM8<VT;P
M3F%C(39*"MC7CB__"A*7C!F<E@R"$8<VYJHU9?*HDBI:(G?$"/D)&A;F-KBF
M6=Z H@-%YJQH;</H$DQ5TFP]<;;(TIU^=R\YC4ZNW++>FP?DU\N^6Z3(N*L8
M;IS\XLR(,+L_Y$V?@/HR\].$,I;!/@FB%;I&17A)M<]^:.XX5[E:E)JV 9+&
M#E107&W%-L!IQ:2X #;EO]D5!QH25G>KKOO4W&M.'OL%%5KGB>W&SH LL,&[
M;."!@; EQQJ^R>Y,!!DJ-YC&N*+-'D_U#VU_%M!H4))*L:!HD,QCU+%XY2=B
MHX4L>Q,O,C#'X[EX(K5L?4:]Z%U*B\\+@(!%3K4N._-_B)QLC>D*!9^L 0D.
M9Y]&P/]+,7%N!TX#-$(.9S7\?"T'0]L">6U&RWJG$&[ 49K=V^ZUCBYM(@ZQ
M1J?DD?5%.%U99[IB07H<\2U<PY*XW) \"_WTY68:-DFX2,$;")'G-JKM;R7+
MG*9O08X4]T,;JP34TZ#*/ U%!W\SRN+$/C54$2/'$V*$7X[*Q/(A1B !6V"5
M$F<EY0/[$)=D@N(L#S53GJ]SHN(FLB>]5*AR:C.W055+YG!Y&\D2^6C*K0&)
M24>S62+(VXUA9^X6Z)726I2KL4)2L5E92H\I% NI4N,*:YHZ]Y'[/PQX9@SG
M>L.C>0J"_BW3&'Y/PPO=/$" SBNX>D).BM6,@A/>,>8M*P"3>92!!(FFH'T0
MV.> 3Q&KW!]%\Q%YZO#6T6QF&337N, S?S&G&6 U*BU,:HV^ETHFEAN5S'U.
M%LH/ '9\@A--J7V\<A0BGO.E-B8:R7?$/B6GDCXE3U5(O5,$5)T,=70^LNHK
M^=NF:-Y)*=T7/L7UF-(X)]+6"0LT[!1KV&#CE$=)8W'4_9!VW,:HIZG9W0A,
M0Y_/5;U]S+A"KZ5^KRZS;6K0FJJZ%7)5:RJEJY\K+W^5M]&T\&VMZRO'7(47
M@*0^3C@)U'IO&KP^+EY_X#0*%FXW7$-M3'.R:2$_0)H3?NRQS!=&%MB[W[X0
ME6 MF/0+8P*VGTI]%2]U%F Z6M)@_W&Q7[ #*/^2#$R)?J4!%'4"[9SGG"&M
MX%.@HL'?H^*O6O%#EX:1(&.$4_)\LB>3N[]5#]&\K61:341!L=&9IB&<3J=F
M<3("]Q<P'U9=<'6N_7I03_/&MZ&[G*^"A6V]_=?%MW.G/<IC]3)(SR_P$:(
M8/,(W"R7L[!-+7_]=21G568I:5V_LPDTQV>Q+H <<.8JR7<_" 3W-!?N9:8R
M=PT63\8EIX"IG#&CP 1[&] V%/6E[ >@R'^0JD0VLF(KDNX2V5^O(B;*IFA>
MJV#4/B<ROZOTTA.Q.R[VB *?Q#7>Y\#:.,C-!4YM<F.BQYO545OGR+"*R]R5
MRV9D;Q1;MC.1"4":;9K&=<OZ0LL4'?;2$;TJE +P3[":@MY\[2>BD(EY,^.2
MC.0UWI*9H(Q#G)HK9!87YY5KI3W/ PK$I1L82KQQ U4Z$6EE!/W4_<&0S[NW
MJ71^;#<E"_3>*"^0VO6;O,?2)')C?OUW@=(&$ CJ/W;4!JB]*;CA.>%!(3P/
M!98,#NH+"0C^^,U*5DDJ%DD1JJ5.,JI)@7+>8D& 0LTUD,,\PL8MJ/O07+9)
MQH_)O N.7>C6+CDB;.2<\*F(M6<^RI%_&K(4W>);[E^1S/E?Y@0-33,VM[VR
M)>WE%"<C&NX/3:>Z6,1T&F/?'^HL5.YC)GYPNT$KD *72G,_O%.OX 03=DVK
MP!PU-8USXE4Y)!R.YK85[$WG5!-.$L'T,4E=OQ>%/KOD3*5!P47W$V>_=ZJ4
MDNHD&U4PE!O5YII&9HU>?HI,QRC8,5XG0N !TH<C"P6G6%P;AUSW:<AR%;!P
M@5GXR7<C\;@\E_0TB/IWP9U/3!Q*Q[DQ[^4&#[JL"ZURI.NT6<T1M*6-IA3V
M1'&Y;@S]TH ?]5:[0J,D9YN1')'OL7&#/:[!]8ZQHAKPE#+[E#9/6%<*_7:[
M^"DFI?7:35):/?9RZ&F5#1>Z)1?*,Y:0%>45%'13\EHCG?8DIP3(N6_<VK^G
MZ[AHXDYQ_ &EY-$(7E1R<62QB*BH!&<<))''I1NSF-O7JVD)R@%@E,)ZI)--
M9?-35]5WZ&%"5/2GGU]B1]28NDXN:> >:1ZJ)(2U/35CP2P0H3X)Y0J1$['Z
M/ZKL2&F]G(3^53Y487ZCS@>5F3"<XA%E*1:MDU(\ ;.>"GYDKH#3:?5?6)\C
MY>QRNL:_L9Z>,TG(D(1'^.?ZAS9U;^$B?JS@7+HKXG6ZPJ-04.HNL-]HWK\E
MB%RECK.9/DGSPB,UKU85X^1OSS=+$?@$>_AR'65A\WR%0/^367WX,?S"?NA9
M*_MVT8B 27W#0OSW</Y#=NVR528(B"F/TP_R9G<7NE<MCJRHGC-XR%8D8.UZ
MRDGTSEWBDQ@@Y[#Z04>Y3D#1O2:)D3?\ &L\4&;)EAMXHGS8]'*H'FE&&?R)
ML.DU_T*96^&_#613BLC:F"#=6(>]$&_SMD,LT]V\R)D8W"\T\2CA&3_*VBI\
MXUJ@%. [%.B5.N"TVLS:._@':@+<[3@?#(0%M[KZ5-ML9Z!8A&(YC^%_7Z(A
MCXX_?/!G.4 *E1=J5TVYR]2@AK4-K67-_#CAI0LK8Z*#=8DCIP)9*DA"H7@<
MW6,PI,I>]IUM/2/\8+<CYNKA&:A4?XJENWAI_2.;3M7AT#\7<"\;-U83=<Z<
ME]L.A1 ^Z[S<!1#Z_2JW5,_%S<D SS\-W"3A-CO4/&:2YKG.LDL-D\CS7M\&
MNB\(2AXC*T*508J)KA):))'50HH2OQA=;,QD5E_Z_VE$L>NK(?2\ 8DY[!&7
ML +,'J"\D%0=30X]HA\][P_L<6>0AQ&?@_P>]0?J./F.Z85\U&(E.-7B*J7"
M9#QKE\N\6^3,U H++^.7N1CYO4N-C/2/<$9VY/&ICU\M.>A\NIVTDGI![PD(
M;IZLP'Q*7N;XA)J_?3$F W;)ZF]7"^A/YESTTBR_3R[837,<A9(/S2W.^ZY\
MF%Y$S:_@'6H-[HNI"J_R1C4R/&&, ,\[=5$.4GGN'0B(3,A4-!IVDN%44WB!
MZN>7'\) M_J5=C^XRPBXXQ*K>?(2F7_^]^=/7_[QD2>#&#^@(BG4?=WE2CM/
M"FZ3:#;+'23 %K^"\/##Q'@A<$TJH%!.#574D ]\W>2\^>2NK Z/2FI3=%/'
MO=16%"%SL%.%DF@,C5I\?5XAO4:C!\55KTW2E2=%%#)+C!&'#O_(G)&'15&"
M*Z9T_3PI AIY%#:C_&%S1^[E)8XA2<U"DN?]XOIZX/5?_^(,VF^Z;>G"R@F@
MF@A/(UKU[QM.:9M8T@T"TX(6DBWQ CP?LNHD.QQY'&#*DKR=80F+N4ZIM38C
MR*T;%:4 32'5>1[/HELF8I>96>QB&T,F]2D5,<A&"UA9$J&9FX?5L-& $![K
M3DZ'-DP$_U\97$*>%*:O.XXVP$8BGIR]DY(FB&4(8<I9(+@E+W:O0W6OC?&7
M.+J2;>W0Q?I+J>VQGA<+N%A<+A+XWT4@QW-S\TMF4L9\GALPL(%0BWT*2</C
MN)\G2YQ1.5O3V7828#>^,B^31HL^'T SH\&OIW%SWN?3,N2XG>(Q@8_L(D,4
M%U7Z^/,1W2*LT2MV1Y<9S3&W@^8B8?T+U?['+B/PN2,Y+IEQF%ZQR!866)\T
MXM8P*]1\*;RW.%?,L)OS8;*F34;WILJ$WR*S94Z?9,[88"KA2;,$J+<7[ZS1
MH%TW3?^;ZKU*R1^4/X+ /[#&KWL[82\O[HA']J-,5,E)@F8[J_ZQ,N$EUYDX
M2U[FA1$-<*N:PM/(EXP5V,')=EF_;MBZD!SK9^98LM^R?5 /YTX&6H4'].BL
MI.K&3]I*\L,I#N_)Q3Q_L&\3OOK*A)U.6@A(8=M6;$("&(_S&=U4&\U+G4_@
M)]PFBEPTJMY%=<_$/IYBI7Q)WV*JQ89_9V3\S#+5+H^WL0 U0 2!&PKLP&?L
M4LE_'_,=6ZP*?YN+C=M@T^GF5ZM9 TKRJ'9HG JO$N_RMA)R>>0YG*/-X;5
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M+O-!B9\FU@0.=8W+7/D>W#9K H]_]Z+K4+UJX?X! .)3P.I!A@!'X$7 ]'8
MD3SY'TC2O,ID9:6K)5T,54F N!4N+*-?"F_0@#37E4O1];F>^_#(-6P;&(4(
M+]U+V)I>2N)YB> . ;2O[W1_X+H0Q+2HY7%A<&T"=YF(U^J/-YZ?+ -W]=H/
MB?CIH3?%-_27:P*77LA?O[GVO72.LK#5)GFHG)CRS?+K%GSU:OWS0:<U'(TJ
MOVJWG#T_[XYZ>SVQ:5.CEN-4?[/_GOK=_59ZC#W=%YP&K7Z[4\,];:>G&QSM
MM?"GCW<THJML@2UGJM3'Q[L<?8H\*3Z0WKVFG+;+RNG?)O&KGTC3I+^T@+5
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MEO6>\83KAGA]%WQ]Q;;K:]] ?GJ0#\&LX_0WH--S4Q?VG@K 0NI'(=-/Y(D
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M2=VE\V\,Z_T^]U$1 $;ERBANBN:7F&8I?SS)$GA_ JM,_F"AP1X.=SKW06G
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MR/BX!0DGZEDL6.WX)%BBC6](G6VT7B.-AY.]#;%,.\N/J[P@^H-LWI&MTXO
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M4Y)R.;U455J+;8J\X3 DB">(A/^,NG<#:: BE%;^"(9VRBK>8KL.^&JPWM,
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ME*\:-K$IJ\8X%Q3D8N,]^IK$-G,O:TE]0KU:4Z9%RTO:7N2GY:N'T!^KI]3
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MSED2@9_FW,99O^3\GLP!D'O/,N4=V7F;LUWUZ[F@*<#VW12@=G.HZWRHVX]
MI>?)-ZY26N^M8_R-VNQ<W&X[[H[A__6S0?CY?U!+ P04    " !6A619AC<;
M78$6   ' @$ $0   &%Q<W0M,C R-# Y,S N>'-D[5WK<^,VDO^>OX*GJ[K+
M5JW\D.V)9RZ>+5FV$]_9(Y_M2?;N2PHB(0DW%*$ H!_[UU\#)"A*? "D[!A9
M.E5)9!+=Z.X?'HU& _SQ;T^+T'O C!,:G?3V=_9Z'HY\&I!H=M+[>G_1/^[]
M[?-WW_WX+_W^WT]OK[PSZL<+' EOQ# 2./ >B9A[8HZ]7RG[1AZ0=Q,B,:5L
MT>]_5F0CNGQF9#87WF!O<*B+Z;?LT^3HP]'1_K[?/YH<'O4/#XZ/^Y.#XP_P
MGT.$_0D.CGW_K[-/@^E@;SKXL->?_C )^H?X!]R?H&#0/SXZ/)H<0<FCP9%B
M^L0_<7^.%\@#U2+^Z8F?].9"+#_M[CX^/NX\'NQ0-ML=[.WM[_[]^NI.%>VE
M94,2?5LK_31AH2Y_L"M?3Q#'NCCZG8NL./H]QER0![SCT\6NU'7OX\&>+BH9
MD1K6).("17[&.A"L+YZ7F.^7$\'[7?E>5K37W]OO#_8+I&;*07_OH'^PGQ<R
M6&F4E_!H-WG9\Y 0C$QB@2\ Y#,\17$()''T>XQ",B4X@!848ME&U@KD7@O$
M9EA\00O,E\C')@M^_L[S)*IDL:1,>%&!;HKX1,G)F5!D/2]I 5?41T(U;%F2
M:Y4*Y7=Q*+C\JR__VGGB06_7OM:8]V<(+1O5G*=):D^?-)&@KA65B5%*(O_J
M:[J^?-3?'T";:"W#JI,TDT'3;2E#:<>H L5$J?[FVXJ1];+&8J24C<0H[[66
M6&@""<)1DPHY]G=F]&'7IW$DV+--9R@CT7\TZ09KS ),FM2MB\L?K>O$?M"D
M3EU<_FA=)Q=+UJ32K+SZ55(MBB(J% ?Y)'VV7))H2I,'\$AVT4^ZG][BJ9XV
M"M-F.LGN?_SX<5>]A1E&$2/F,QKB^L*[2T:7F F">7[*50SF#$]/>G+B[>L)
MXK<EPSL@B2Y2J&!]L)&OH0;,8892^EZM%-(L9'\[Z7& (L2)B5S6/\#3IOH#
M"8G(/X7V(9HTU1Y(</BG5]Q'85/%@<2/PS:M7I+?PWN/!">]$8450\^3S[[>
M7E;X;ZK"I*1FI9FM6M_G/?7/OM=?K2SZGJ+Z<7>S[ :7F.-@''U6OS?[<TJ<
M%JDAW+"(-=UZ!RHE2Q]JR]7:,PIP!,2G*)1NV-T<8\$M#5Q*6F/QCQ^/!OM'
MTN)W8"^<F3SEXZ6,O(13YU&X00Q4FF-!0,@M(%GG8\1G8(F/]_T:X[]T$:_,
M3IQ.QS""*KDXBH(178"*<R@$ %U1SB\C0 DW0[$Q=R.V!Y78KNKRZ-1;U>9!
M==Y:?=[WLL:_>$F=74=]-$?1#',2W0GJ?YO3,,",GT&U/A'MT:[E:D3YT!+E
MM!:/1%Z^GG_WTIHZCRWB\XN0/C:<#\M9&%$[LD4-6'J*9Z?P62Q1]#P&[^R!
MX$<8E$X1)V#@FYQ:EC#9<#*B]4'ZC83[(>4QPPHNQ=?3C-7 J5A+T/+,.P3;
M7;Q8(/9,IW=D%A$85% DAKZ*M)!H=D-#&&:P7?>R9&4$[H=-X%+&$J4<:V_%
MV]/,.P3<+>'?I*?Q%?P])A")A"U.Y91&6(XW85%\5"=:X]0E#/ #CL"^8(-[
MA@)8+_N8/*!)B/D7;.=<&%@84?E80"5EJ(!1++T<S[]ZP+5#"%W#O,P("H<S
MAI,)V@J5$C(3$A_V-I'03+P5EPY9_H)$L!0%]2\C+IB*WO +1-@O*(SQ-4;2
M2/: V',SXK2_B5/&V\LQ]_[M7X\'^_O_X<E:/%6-EZ^G0TA>1C"B",ILYY=\
M>2,:@TTT<M0=LO%-$MY]AD'[_/>8+&4;LYU"JFB-MC_8M+WFI.:.C%?7YHQ;
MF9!"IU\Y'G*.A9R:KZ#GX_$D)+,DYF+I9YGY&#$Z+'I=P+5/IWW@ZR6,%5R*
MM9?CW2'$+D'R:$; P4D,8MMSRNB,B!P51RS-)<6C:QUF+.:8?:&1'S,9;DZ,
M8 5 .:41@L+27O'Q@%$_Y90BT2$08#7,8AR</RUE2,K._)LT1L,7EN8I!T^S
MZ)#!KV@TN\<RBVUB-]JL$1A-75AN2_*^I/<D@PX9^E?$&+)=*&2%C08NK)PU
M:8=,>X="3*<7L0 +I($#NU!?"9W)X#\4%LB2BPSJ)7QTY*)#Y@<W0>[4G2,6
MD6C&;S"[FR-F!T$5K1&&POH7..D=0\W- W:>XM<A-)2^I^!%J]U;F,[LMRPJ
M2(U8%%:_BE%?<?+RK#H$0[)K?8^>K,,-J_)&@Q>6O FUI\@[9.0151LG.++>
MW5FG,!JZL&Y=H^^0I>UVQ5YAH\URP^WPL#@CV&^X>=_K7UW*+JK?M+E7/UY@
M]R=E9,2O,(M8[ %YWR?<NP1;+K3< *,BE1&0DEDFX]%%PU=$J!N 4,_!"$AA
M-JJ)='<1((M0=9-1S9J;$;A"L-4Z_-U%&$OBV8T&NBIJ(TR%@&QY3+R+F)2&
MN!N@4D=OQ*40KZT*E'<1F8WH=P-,RBF-:!1"NIO1\RZBD(^*-X"@A,QH_T+$
M=SVDWD7KEP1R&X!036W"XM@R&-Q%3"HBNPUPJ>=@Q*99A+B+$)7'>YOTG#H&
M1H"LP\9=Q,;J^, 9%HB$MI'/!@R-V!5B _;'$KSOTUJZ!&=IMGH3^&H9&.$J
MR;\JS7KO)C:UX<LO<C]=8M$(K68LC?@5 P@6L5&8\71%[[@60$C?OARJ&PR-
MF!:B#7:89B[E.Z(; ( QT6S&<!(ZH],71]A0@1'Q0AS##O'U:N5T^MX&*C>;
MY"-XI2)$&^B]6#NPJ,38%HKGT*S:0O)"%DEB8,4-L?<FL8%6=L9]&(;T45XL
M,:7L% 4R6/)R;<*F%F.C:',,3OK>J_/U6>T>5 _^=Y#&A-Y;Q09>6?;!T >8
MB7B6MWS*Z V_Q:&\]C.SI&2@0IPH;.:QOV+]II;TL1"8LFM)N90)+5=R_:F2
MS$M%6[6RA)V6KI/-K'C(LDDCJ:8V0ER(;Y6<U.PD(M:G+)L U9BI$;]"^*O5
M"<Y.(IQ+1&F"80F9$:7Z))@.VKXBAR6;S\K>-P%I&_Y&-!MET*Q-A^4%WUO
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MEKKEPC='_M;KW9*<XUL:AA>4R6\"5>8P&JA>2RO;70/39=ZM;P%WU]E<W>D
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MP\V(QN0^-2!$P^%OO+Y]=^6I?<W((G?&T!KNHB-E2Y:79LQ(S54TJK4%? '
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MN[ Q.^-06M9ZD^0 F&-R(EMS9VBI-=::PY@!IOC"C.1@1<VUT%J (\.@GH]
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MMCLF>5_:I@UC#CPF>1<)M;V[X/IN*\Q%<^4AYHA5$Q8(J!T8EI/*(4KK!KG
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M'(\TM"'X ,D$=039'[6O^(MN^JQ;Q'E9C&^JM2<RA"**2\!U$;1Y*<%Q)H$
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M9MR$VD*G=F^NI0 Q!0;.YL2"2<&'UI47W[OC>!>):<:+@SF.Z;ON,TY'6,=
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MYU_HOAS-\.UTE/#;B[/S5V?\1'@FN:C9YJ584-XCN*PR1*:E#Y8'TSRI]T%
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MNLGP1@3>&_>#PLB9MY"YK0YSIR%4'Q>SAG[(1<HF^>-[YOH=11Q[8OHV=!W
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MQ&LI&H)1$L@VP>PL4ZEY<M!F:HZ53-90_X]W>R-1#SB=3!?TRC-5[SYB(XA
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M%-/<^ C3,/]],OY(]$WH-U9C#'_\\>T=<39[SU&!+JR.J(B%SF.CZ%I6"8U
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M,!DF"$C$^20\(C<IJ=9MD)XEZ,)0T4[X_0WWNRL[L[F@9'6TH#"@$B.8.B5
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M59_\&!?@D05 S:4WV0F7MS;.V7?Q%P.YHVCG*9K,R;RX/;O;,A>1654@11-
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MO0WHW:<#W1]CE1*S2CH%6:$#Q5V!*)V%HKTJ62?'??.A#D?E<(!([]D%&BZ
MSG.[_'R[+*VATT6AC8!8FZX$[FHKVU)/'<9%2";SYM[_L9@[HTUR!)0>?T/M
M ;$A);YWG"Y*U[:/2@0'B9SHZE<[\,X[,,X7:4K 6,[GTGG(V^M..LE..@!@
M9S5J>C7?\QZKQAADL52W2PHR%9P'7_MZVI24EZBYDN=S+3UA[W4[G60['0:S
M(23X=YD@^7Z\2EE4OHBL> ;+D(-R:,"1$B Y9K2FVY>I1_?2B8:+WE%\1MOC
M,.=FN#@X*SMLOU'7UJ(IT@?(00=0GDFZ394"KYR3CO:_:QZV&I@(7LP^&ZC\
M.T'PK RZ#J/*3;")>:QWKJ93214$'XT )G,PJI@4]=$'MAU]5/F@]]X0P#_
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M4F97BGN,+I)[I!(1& P16!LWYA0<"OHAQ^;8V4;4Y:"EJ?@WQA3WS!MZ$![
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M\O7]O__AU[N/,/W#__J/?_F7?_M_(/P_[[Y^!N\+NGGDZQI<EQS7G('O>?T
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M>KI]+FUG)MH?+%1JS<!Y. ^7AF/E! 0S8["57]($#=$N8;50R2LG@AMX24X
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M B_,D""10><97;)3URAU?#2-J!0GS>2RAI7FL%'5,6/2H44;48VP81*<S(S
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M;%)_N]W &Z$V#Y<9PVF"$@KCE,0081I C!"#E/D1"V).$U^_9F*<WL3ZWC,
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M)N9:'R'4@%<SE3D5:(99S</#AH?P?=V#;X^;28X@ZH/@_ERB!NVW.JRH#\O
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MBR'F,OJ, R_%G)L4P#@#S+P"YD[=HO;99H!-[^/H"@RS3UE/=0$:N@T0'W9
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MG]6?[=5A/3IQN= _BJ97S^UR7HJ7YK\[=S:*@SR,\@BGC'%,XI!A7A0I%E%
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MK=<1A'=+9:H_[]2_-F6ENF%&X'D']BN.?F#?,H*DY@0MEFM4-;QLQV/9>^P
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MT)F#L?WDF@>T:I@P'?BTCRPW"AD. %<<3N!:7""-#1G,;#?<H)H=9/BY0BV
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M7_1)N%"5?@4P?;;$V4[%_:,'T_I]X#H.VC$LA@>T9<*?)8 )[<DX6!*=U%[
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MX87<C-+?ETOY9SF?7R_D1[T#+1Y*[8S5?:96N\$1/3]*Y&%19 2G*C1GI##
M>5+D6 9!(=(BUT<G#K%(,/(CFZ,=!TWSL]45^@PU1T \[6S1>"C!#%''1YW
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MA(D 4U,%8XXID5!%1.S<E#>79&2;]NNBVK)BJFEVM=9",UNGJ]W]\BMB-6_
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MF#W5O;%_6;-J;1?&/J #^7:^IF;]!?U)/92+.H.+,_T+H>I)"TV759?Q"GM
M)5D8"QIS++G^#PD3H<U\P3!+5")(DJJ$%"U0VL.>#*:.EC5([VM"8R!D%^N_
M2&:8,6](7:$>,<\3$([)X7,2P=[ZTT\$.";>T<[\1S_H$,9_>%B_KRJ3Z7#]
MN+:.V.\]-79P_N&A4@]FK(8FN5RHY6;U:MC'<+[1.9DMXN_.X@)#[1=*"@NK
M'Q7*+8*^O]1TP?*C(NS%Q8]_PG&RI%H^5.SI:RFN*\56[3#=U0?-T_MO^HN]
M8/.;S6J]?-3?\6T!?ZZRE+&,XB)-,DRR),!4'UMP1%)]BI%)E">@!'<7)D96
MT!U+J.;IJAO=O$+F?:&.+[1ES+EI@M,KL-LEQP869@K&P10^G_("4'Q-J71A
M8=I9E1> =#"Q\I*U'$(M_Y]ZKEA[,A:<1!DC(0X"TWB!D 3G/.>8)U1F.0M)
M1*PJ=E\O/++YJ2D! @1]D2T"(XZ"P-2])N(2[>@+ XAL. KE%L48?D&P<,41
MQ@=#$_W/3Q>&.,+E7LCAV.]ARBM5.?NDH9K??M6.XN=-_07(A<H*&<2XR$*3
M&I<Q3)-<XE3(0H0T2!6QFNAR;/&1E;@FAVIZJ"%HIP1'<1C6ZDNE@VDV0#!K
M31B28,"!UX\U&Z[^8;?/'EUL$E49$J-3E\'/7'3<;9+YWRE3G%DNE(2GK5FL
M]=9'8U.>HSE#.]:<CLFGL0(=GKW Y/E(?8C0""W6(1A<>@(_3> MSN5GQ3UQ
M6C__G-L9OB[1.3D!?E9D,I)<>[]*ADKOH$1BE@<I5OKO*<MB&L#F+ ^3&]DZ
M-%.[/B\7N,VP;AJS *LSSR!F=[CVAP-,_1L(&L)[[7F]JCA,2D_GXC/$)CT!
MVPG^^JQK^913-YKU;;446FOKD[.9K62N7KX4'Q?ENF1S;5W4JFMW<;V0'\IJ
MM?Y2%*JZ,W,#5S.5JR1+:8ZC.#$]"/,<,W,H#K6#G9,\I6$(:5YS&3<CFPG-
M'GIJ^6N"2V7+H4F(+!L>D9D%MKI"?W;=8]A"HL(PJC^D.455S2JHE\R%[\CB
M[#XE\C##9$"_W0/]8P_TECWTN0']'WW0:QY1S22ZFQQT4+^?Z<!W"TS<?U6F
MZ@H)MOJJO^C%?/DG8JO54I3U'#$S&Q=I&X58,U:W4D+5C<XN5!)?8W1] 7RF
M<]&%1*9L=.0'CU=]D3PMZN:OWBP7=8SW'_J[V 5^[^KOH<DTORZTO;^>Z^^M
MX>G#LKJIE"S7G\S4:I5E)(LSA;4_FV$2%S'.\T)B(6D0)*1($YY!7%EG3D;>
MOG8\P/Q:=V3M7-Y)\()M.AU+C67KF#)72QU;5X@9QM"6,U0L*]3PACX-#54'
M.\L7X^/)CW;G8U(7^V*X7GO?ER_H/!JGJ@<>JN;/CXMM;ZD;]E2NV;PW4$ %
M(A0"YXP)3'B@3^.,ICC*)0M#%F8D!9DP>](CVZR;KR;'<&7JBI;;IFBL.:4:
MGV%>,E[.ZVI[X'QR +IV9FP<S&!VJ^,!_=!Q\:.!;M=/KN5DK*D[0 #\#>&Q
M)3SU3!X@($=&]$!7<)HCMVWB TAM>_78R(; S&6KR5V6T?9:UO-1^0O$A.FN
MFX30473'9'$=2+>WUI1CZ8X)\6HXW=&/>.[A;MI!OUN:=BXS*K.02KWW1HH&
M^@RA,LQYF&-&"=%'HCQ0&:@YH@7-T>^93[8K;^C[ZN+>0]%NH_6,#4Q++X#%
M7Q_W0T''[N/>H_A]]'$_A,"ZC_N11R^97;F=#&1NWXW)K@<2!"1G:4(Y9IFI
MO*."8EY$*<ZB(!69#%(2@PS" *V1#4$[MG$WNJJC[33,80@S:S_;!Q(PM=\;
MW-4BTE&^0C^U!2N^!SE8B.IUCN5Q2F\PQW)0Y.-S+(<?<55PK2]J92;"F*/^
M37,Y/"M8K-*($QSF,L.$Z-,V3U..9:3R5&5A0C+@:?L8F='5NB%J)F?!8X(G
MD+'5X$OEA9Z*6U%;@E?HQG<CM6&1O"GI42(3Z^>0H(>J.?CI"PI%#]K2]IHR
M__2R^TC;L[EN4],VF_VMZ5ZK/8)O3TKH'^^7YI]Z96+_4.9&0G_F61^V']3[
M;ZH2Y4K=5J50,U+(."0DQW',M*LO",4T%P&6A&9!7D12Q*!Q36\KSLA6IF%.
MOUZD6NY,&R#3/QBQ-5(+:?;3IEJT+O>4R_F<52OS3TWIITOEY]M]-^SLWU_G
MC0.=I%ZO]/T8QDXTQ%_0T9[J3?/T5L(KU'YQ3(SW?>^;8_YYKVCV"G6RHE98
MU$F+:G$]5]6^^6OS6<+[=L),7R_\YB_N:''RVW/EZ!D_/K&R:N;AZDV^C80T
M*6H?3)*'FIL8R8Q316(2<QRJ--?'8--^F&M7N5!!&(=*%BPC(%?9CN[8OO.6
MBR:GI>.CO9FZ0D7-"JYY 3K6EL!:>MK^X0*ZWGM([5AH,TVO4,-%$U'SZ([#
MY/;EGUM2G=9AAT%QX,$#'W<,L6_[I-?#M;O<(3-*8C4+%=->-LFPH%F$"2_T
M<3N,&,Y)H8BV(4JFH%3S(6)CWV*UI.MDD96AOLN.JZ<# 6/J0[!9!M,]@0&\
MZ^IPT$:AIKM+ZKP9A $>0[>0SU?P?(C4M%%S"Z$/PN4VS[BFYCT^ENMZ=>VN
MF'0:[9RHA2C5T4()(CC53@/#B4Q33%@2X3RD!19A&$K*"<\CT-P"&/FQ$UKZ
MY*%Y>" 8[?1_/'!@%J''1WWHV^-D_((4-QB\)=:!B$^<3><"S&$*G=,J;N;&
MS&O8K;K-XDI$'HA49)@RT\@WT6Z$_H<",YK&4<:IR&*0&W&<S,CFPQ#=TP;'
M]C G,+*S&9=+#K,-#D*##<"P3)X4_021215Z6-#7BGOFT^[^P')1NQEM0XY8
M92*.0KWE9TQO^9%(<$[U7U5" QH7&2UR8 K^*PJC[^J&7N/*PC?U?2SL]VUG
M">%;<R><QU;\9R7QN+ONKS_Y!GI4O&-[Y/$/PE,Z?U:LUE>356&9SME[9&1E
M:2E9YFN_%F=8/2Z0!*84+1%O*1\G&'=*S>RO,UE:YA'F^RF9QW[M4*]\IZ1Z
MK./?OPBU8%6YC+I6YT(4"2M2G I]5B1!E..<2XJS6-$\2**(9J%U(?)),B.K
MQHXNZ@BC"%"U>AJ>8;7Q)S1,BX[*Z]+=Z[3@@#I<+P"X%=C"7CRL^O6L6(-E
MK:>?GJY>]:P$>X6HYS]]0=Y)<\\?19',99+B3 BJ_=4PQ33/.,Z*7&FC0\(B
M /4JW2T]LH&I":$G0\E?O@4X]V&*/(11;O]'NXE_JUOQ\S?4E]P6UP.>-'_+
MA3*SP)]5]?)NH^Z7YL9ZL5)?BO>+8JG?87VU;5]Y!%AR9'5J.4$=*TANZI&/
M+3?UG+0=/U?@<B4(>.<=XY%P@RFG9\A@D]_@ +B-=P/0F6Z&&USXO4%M#H\[
M[K/=_9.2S3# VV;H1MW,_[/ZL_[5:D8E2\,BXK@(0HF)2@3F::'?!,N*D.:A
M8"R=:5;YTGH7MB(,48T^>;=X2UFS@S;U3/FG#9^7 JEF]&+=*<44];K/R;!#
MVG)G]XX><-??WB-KO-HID@T+5ZB;MJ'9:#[A\889)K<OI\&.Z+0.!0B( V<#
M]K3KU9!6F4K)IF1DEH2,%C+-L/XOPX2;V8Z\"+!(%0LXH6D0@<+.^\N/?A74
M$$-E30UZ_[,'A)V&NXL'T^2M9!^')7.XY#DF@+?+G;W%)[[4.2;8X67.T4_!
M^VF_7ZSU!O3^454/6E'_7BW_7'\U2:QL\3(C1<BXWIEP9A2+I$6!*>,$)S0N
ME$@4U_NV;6OM 3HC*U=#&76D44,;M<3M.VX/(36L=![EAVF?H^B@GMP6@CFU
MYQY:=[).W1;"]9MVVWS<;;>[EO^[6359%_?+:]D,[6/S6U9J$]#V#^EMN_OI
M@T&64):R#$<D##')I=9CK=<X)#1*:4(D9]EL47>,EO?V6^0E/%E]YVGSG3_@
M#.!^KYK$1-'XX2M;/QRV U_T<@05&GY&<%S/2B(\P)SIEY,I'A8JXD&2@M+J
M1W\K%W1NW[%FP@1LRQQZTMR9[D:BX>]J[TU=7918>]'+L7.FIH(<9OQ?H;WC
M"]VV:-]T:/?/6U>CY>_Z@,F3@W<1*Y.Z@SY >^T\>EG3U=6\4:8%W_RCMK[?
M_E_U,N.%DD$@*%94!GISRK3]XXKB,$\9"],B8]+JX':2PC3N94L4U521)@MU
M+%_C8NM27B"MDS-I+ZB#&WE"F L<R-<K3NPZGA#HT&D\]4'7J8T+I5>[7LAK
M^5@N2I/KMRZ?51OE;>_3541$%(@$"TYS,_B!X#R4D79"BIB)-&1I 1S3:$%U
M[%M1-9_7M<0/#3-U!CK;8P<Z?=$&2CM'P3M , W^>P^2?0:V5S;^<P)!,GL;
MGVA#<^)YB0 8#@<D0AYVO*H17Y7<S.LFW\_:&"VKE[;'Q[WI][$K1LED&(@H
M53@W\55"0WV:C'F$]58=J#2(9 A+OK<E/++AV!(W5PN6][I@["RO7T9 !'@!
MTW+05/IN@6FY0+_7?*!1RG>@PONZA;$E.^T]#!",@YL8Z/-NMN.36JV4^M2T
MMUV)JJQ3MFH2LSA.,F7:!N0!3S#A*L8Y*W*<1 ')9<P8Y5;)G!:T1K80#>4K
M5-.^0CWJK4( "W>&4+,S%)ZP@-F&"V  &P,+ 3WI_Q"E257>0N376F[S"#S;
MZ_-R\7>]>IOMW5\8.C3R_$HC:ZX9!_?WZ^M;U*7Z]WBPS^"R &18;?UC =/<
M(1A&& !I+ZI39I;%\I,E9-F+VL_# CSEI+ZW:OE9+:^?'^KFV6*]8?/YBXGR
M 1(TSRPS@>*:9NJ?]?]W/<'VVY&U[#0Q;6A.YCF,K-39%SQP7?:'#%2O;61V
M5>K!M:?4:!LA7ZFSU2,3M\K\P,KJ-S;?F$X_FZ:88M7U&?MM.=?+S,OURQU;
MJY_+_Y^[-VV.'$<2!?\*S'9LM\I,J.$!7O,^J?+H27N9*;U,5;7UUH<PG!)[
M0@PUR5"6^M<O0#+N"!( 04JU-E.=RA0)/T!W./PL\L?UXR+S,A+&J@:"Q1A*
MVSV#F/KRPI_XG%,<AYAHY7W,C_K4OOY-^\+G+? K\-B"GJFYI?EN:OH<WN0>
M&7HMQC>M5-2 AARP1\_5KG'ECB2@:+H"7P:V?[[>E-8[\=I]*,T1_VOTG+3>
M$&?])>TQ&.M$OJ9461Q5URY:N:XI+=><?=Z-^3IRCE(2!1&B*4P]X4/$,@]B
M1N5/* VHG[*8I&;'S@ADILZ$:<%OPBZ&*2VCN&SJ@IZ6=_9NZ0U>FT[P;52K
MX^L>;C,YJ^W9Y-R!;8'**SFU[9EVV=$]8DWS2W:C9.\>[_][]>-+\92_*RHF
M_V[J'^M?96I5I("#N_RQB9I+%,"7K[>?5-.V*I=,T&UZJ\&-X=NT.T:8Z95!
M'DS@'=.CU>H2/;#T;'=H/1+WK]":;]@9)Q^:'%]E0:T*:2!U@\JDQ9%YOKSG
MDIBJPJ$4PRQ.?!@*[B=AF&(2>296QUDH4]]+V^SE+5#+N6[G&:1G,(PFVTQB
MS2DV/MM[*7)T:)^',>MIW$OF\3';_["=6'[!Q5I@6J^EGKTM5VQ-ZYOZ@9==
M9I7P&?="CJ"'$P\BS\<P3:,09B%G%"7<$S0RD<]^<!,+JAID5^:\QN4+>&J!
M@Y(_\V+-KT!AFG8RP#D]P77'#S,)WH<+.L!7H $]01::'I6.I'H V*SBK4?X
ML9QKOF71]>MS3M6-]_J^Y(WG0DUB_[XN5L_YJKA]P.4CIGQ=YQ0OJT\%[;YD
MA#TF.$YARI$/$?81Q!1[D/HX]0+FB3C4JI&QQF#JS)(6)8 W.($?$BFPP0H<
MH76EJFE_,6BI9<7T?O4Q"RO--,J&B]<F7+3I4&;%3H/F95.SU:ZOV=T#!\N3
M#_41,][RN=KP^>F8SWG?UVK6 &T,:WI[HUDM/%_;M#%T'W14&[60A8-D6UV$
MO.#Y7&][71_)T$)3NTEVY7,2@9^>?][K8FW@(1EDAX:3Q"4G#/TD/4R8PD6B
M2ZF=EV1P]?D<);J$'OA*M%^:L.1<19W(<6#JFZJFKO*:?^?EL]0W;?L7U6[J
MOFA6:4)2"X)%G$8H@:%J_802HG*$60P)"R@-8B0\O<J_N1">6,.T4>D&-U6O
MOHM>\S9(-$'9\YC=T[M=OJ4],=1UMY_>79U/%=C%71L;LE2)M\T8*%4A"_90
MG+EVV@$?YZRO'H/NVZO!=L!\JSIM%W!M:[F_/_#E<M,#)Q D2I0F)R)+(*)Q
M '',4XCE[3T(HR0C<696R+V__-0>]+:XN8%HVQKH@!O]ZG$\C8;N<A/R+.JV
MSU$QHFC[8+F9*[;/D7):KGWV*<M:;9P7GU=5=5.H84IJ)LL=+Q_SHG44>$&0
MA$D00$&$E"I.*21!%L$DB+R4!YGZ?XO>/;U M;[#T<UY% I FC>T0P#4.PP,
M2[1[.>A'6<B]1$ >J@*T*%(-=KP$XM#C?L#\(.',J,I]-.OLU=1</-,S[IQQ
MPDR9-4SX20'^6?%B QO<:?#"O'Q=AT979>N]L.8M5]<A^Z1,7>LE6V-#M3HL
MGU9EL]KW6FJ==RK1IWQYMV)\$24T(X$(8!Q&2%XF@QBF88)AHN*#092@C!JV
MD>F%-X\Y<H"":M,DD0#-/:-!!"A,3*V4?C;JFBW.F&-EQXSBBX5YHT7M"'NG
M?_V9#2 M8D\M(KW7+*?,M7>=_-^<;32+NFI_Y?4B#C/BT8C!%'.5OA,@F$6,
MPPP%?I0&(J)!;#1N[B*HB45^#_#N>%?][BP2 WKXI7>RN^&"F6SO,V![IK]K
M&-#7D,-\2-T@;:ZFU5T&-._8ND&"3^;7#;]A'@JZ*]EU67XJV%U>+[7Z2IV^
M-;$,-C#THSE'% V';NR),1.ENQ(SU>_WR%/)\N><K?$2]--I%*,Y3Y)50.9H
MJ=FB+^=)V ^U7'C"[C#[K9"L4(DU:B!KEQS@(YP1FB2092*3IU@2P#25)BRA
MD4]]XF'!C9K GH$QL>AL(0(%TNRX.L<1O7-J))UF4G5(X@1):CW4.#J2SD&8
M]2SJ(?'X$.I[U'8:C;1*'S?-CQ;"\S&)&(%4V8^(^Q&44AC#6& BHEBU)C*K
M-SM8?NIHX0:87>^A(U;H29L]@6:"ID^;Q827<R0XF^1RL/C,$UO.$78ZF>7L
M4V;B5)7UHKG;\?()E_7+5_S8SO,-_"03# GHQTC>Q9C/H#S54LAB)$B4,IPA
MK53M2P"FOH'M@00*YM!$8#VN],N6"UH-[UFF9&H+V1 M?6(FW]T3,?FWG7A=
M7'86 1LB:B-B@\]9GEGY?9&+G.*B[BH;U3REU3*GJHYQFS8FSZHD"H,4$A]Q
MB!+&(49I"I,X)0PG(I8GF]%9I@5VZC-N_?BH*B56 NSA W8(@0U&AH>?'D\U
M#T7GG#(\+/LYXS@MSXYJ5^>K'M!YSUTC1IR<QV9OFX=.WN7URW7)<>/<]R/!
M"$H0C#&7MTR?^##SX@3B""7R-XF?^(%NC&1_X:G/9>7R5[ ,XQT'M \'-FPI
M,CQ]]8@Q"E*<P]PJ&G&PT&QAAW/H[\<7SO[>LE'MK@= UP?WFE2-?W.!$QPF
M@L8PQ)D'D> (IH)@F*2IAWP<("D@1GUJ+X*:6ERZ)LW+'0+_9=B8]C*7],Y$
M-[2;"=8>S+U&U1NX+GO2#A+GJB7M94#S=J0=)/BD(>WP&Q:E@Q^D-:W.Q[]C
MY=:NJ\Y3F! _X$'LPY@&D31]$9)&L"^@EV2<XC3!/M+*.^R!,76TOP,*-E -
M:M$N,*5?3AV1:B:@)U3:E-Y=(->@N&X\V7;E<_J;;%81UT]/;\W;A5?GJVKK
MQ_V@;FW@43MSX).ZK?.J5AG5*C@>!!DE4<*AM(8%1 3%,%6YESB+TC@1R!>^
MD4?X:/W),PBJ!_#4%BE433U"WL$W._Z/N:)WYH^@U4R/;  UC6U59T:Z7#?1
MSOT$@LU#5^#FB:N<%!4-I77^W!Q*[HR!"U0[L@".5Y_UV+] VO%9?^FQB8O.
M3KHA?I,XE+EJ;-B,KONMR.MJL QB(43@H2#ED*KR,Y30 *8\2B!!E!./R?M
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MMV3&^R-F;, #!=^F\8(&5PR2L-QRQWZ>,;Z_+YL!1O)K>>;%FH-[7JAZ<<Z
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MN@:(LA*J<^O-)DP]Q.P+4=]CEM>))S6:5"K)SVU@L!UZ]K(@24@PI1G,_#"
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MATD^Z;"I\8JM0&\=N6VSYC1%1!Z# H8(2<L]B@G,6)Q") 0A!"'B^V;SUH\
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MY.=!B!/+J0(-I W"#T K7Q<S'O4XS#T]*7;*$S.)5J#!3PKVSXHK'TZXTCL
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MD/A) B,2)"C*!(MBHRRG\V"FC]$UL,"] F:9A'C(%STI'T^MF6#OI2%N:6Y
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M-JEVJ*NZ6-6:9V\?&_JET!$'S"10EWAI4$MD0(.-HQKS 5JM2L@OK3E;A?@
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M?+D=XHMY%$"75E<!@$%X\_K^=<D_<?MKOVA^E[M]?CJ*TFM>YTY>G#J1$+^
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M383Z^K[DS7&Z;?+;';6+@(8T]C(,HU2UW$/4@RF+*9282W;)BVX48.W>Z8;
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M^$/!=M1#N9\PJURT"TO.EHO63])^+MK DQ/FHKU?\T4<H-CWO032, TA(EQ
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M?A!T',/:(4'DPVRQ#)/_/?ZZVA2=SD(X+B$(I%DH\JY""K0SHF/)Z\RCL>T
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M.A^F<+;3,P2;IHD'U8SI ] M[VDFH:;4OL6PP(^UVN7[\CLISLJND2\^BQJ
M+(F;>@^+0ZPIE*%:[YJL-5I<C1'T)$%#,'F:0*@=V_?'D%]C:(K+)@CZ=3P=
M+_'M^!OF-R2,Z=F8;/LUJU;K(3&%,0?P,M!<I,W@/3HH-F5GHT):(8TA]#1%
M0S!XFF"H(>.'H(ANS;1WLVFZVHZ5XY)E6^^ ,E6_:++4@@?,*$/*C$RWUG'Q
M1PD9@M'31O$<S>8!8&5-_P@3&6DF20B>W$-ELX"@30(6.)8D,BOEJ:3HPRWA
M?DJ%=18+WHN1 S!ZWXY#'$_&RS$NR/I:I>-]F4V(Z8MJB2TO;UCC>& JA00Y
M\0S*\P1>9P3N8@I6VYSY4]=P#P'(KK3U:PQW?A+5B8@&H'DVYG7?!_7:LJ)K
MC689-:U#7:^E95J,,LB</-<FMCYLV$Y-OR<,W4A_.\2.$<4 0/4BI5I[;_$A
M7-:X^'4H0EG+F5<!$M*J4SK7O+"B(?DL@\B6.]-:>SU.R6# =)2<[V]]QS-]
M&-"97]"H#W@T8EP)R90#HU?U$W3-'>,%F.?*6;+],30/$VXCIM_-KCL -6#]
M #!T-Q9Q/9_+FQNTD?S%R#)8:3@H%B,XKADHY3%SS;G$UE'$IRGJ-PC4$9H:
M"F$ D'HYFZY8\O?Q\LO+B\5R=H[S!W-"E$5)U.!<+?# Z)5G@5R/B#SI&()K
M?AZV"UW]QH<Z@E=S@?2=H+'!IT]A@N3'7"POYOAQ=ADFF[HXQYA20@N2N ;5
M40:GBZJ-FB)-BCFI[AE16Y(U=ARPWT!18_1TQND!J*BWLS"];_Q%10.)54^5
M3#RB"4&H5W1*=-JD8(Q]LDO102[<0S+ZC2YUI(".9?<0$//0TM-19):MA:"C
M R4*O4)70#)N=>".V=S:R#[0NFY^+ZIKO!S'[!ZCE"NE^0FGX]G\W6R)&V'V
M%].\CK;A72-O(Q#O1$PA6PV1!5H742KPI#LAJ\2Q1,FPI)VVJP,)&(RGUCYN
M=#*Y#$!5_3Y=U))J-.YL>O89Y^>O,)(3420O(@G@P=8=.AE:2J1O&=E]3";C
MLF]]%/LH(8-QX+H+3AXO@+X-[%5+*1IVXX3@ZN!I'3C#_.ML_F)E$BY>G-=W
M7N$<T^QL.OY/S!M+1R:52M'DL)94VY\:4ML<$;1GRDC:YV5R.ZFT5A0-QL'K
M2,?U(KD!*+TM(92-"?%HA#$^@>3"D 51 W/)*PA>1Z]L-M:>*)0UE,R"DRC#
MMH(9 -*>C*9L3,N78KCW$DBQ)U!92HA<"4#%A=4*A?-/78IO'N':$W6G\#&[
M0UT70AH ]E8)/!L,W)A)< E3T0DP"D_Z6I&^3LX!"\82UQS]]U2AIX.3I1ZE
M9C!>:8=ZK8TH!@"JC4F,HE+"V\#)*E6!=#$7Y+77IBRDI"-I8Y%"ZUM-&\/W
MTSJMK\2%O9@]@,RK6@!MO#Q?W>Z<YJIA:5=',C%I*I;L06,Q@)6Y5MIE%IP3
M"1S2QAXPFF!::Y\GR.FGV]J)-[@VPAB _GF"0\+8X(T7$&1@M#T+ =Z[ (9G
M^L$(3H9B8U@=F;77ODW;26'52!8#0-5&N<;U#?3$$B+S&:QP]8#3,6)+*)"$
MC!*UDTJW3AB^3T/?%4C:R/81370PHP< E!<YKU)?P^1#&.<WTY?AZYBVS)%0
MBFG/#0BL5;=<+D#:4T N.3!.O\S-J_)L(:7O=.%.8-."[0- ST=<AO$4\^LP
MG](.7,-L%^<7D[#$_ K+.(V7HY),P-J&6TA'VS$SG+AD/910HLRU645YJA[:
M(4!ZGJI^P_ =8:JQ, 8 KX>,&B$7/H>408A(ZM6)#)$<!IH&3X5)*XUK'5=Z
M2$6_8?2.X',DLP?@HCUG(XZ0<2_)OP2KA"3V! E1Y0Q,2\YD\3'IU@6UGJ.I
MI_:V?7G]Q\NE&<ZZ+_OX826"+[@<)S)C[M!_3 W(NX_MJB#D$\2?LCJDU0ZS
MP (NU-+RUCH(=0,KG+%$MC9'W5[?=U\=\BD=[A.W*A50M3F+2L+5N=?XA5;>
M:B.];U\/\SBOO[N=KC%"]G'X]Q## $RE#3^45N[[^8IU>>62?L#YJF7#J#;O
MD#Q%*)J4JPJ.@Y,2@50W4QB2X[GU]K<#67U#K T"MH<%FHAC6 A;=P!Y<;'\
M,IO7Q FR#D11M7006J]!F9+!1V(:BX(+'=&YV/X^PU9RAALQ:(.HH]@_1"2]
M62PN:!K2\NQL(:,2R<E0/A)[E"^ )/Q<; B6/=4NM F*UJ0,-S[0$D$'L'V(
MZ-GL1(2ZZ%1H+B$E6?/JR5E--*%8-+-*<J&:G^ >W?RIET!!2QP=*H!A5_"_
M,3X7LW*5QC6;+D(];CRGD;[0A^@/W\X6BS=3^FN\.ZL]';R]!VOH]ATWT4;.
MX/K1-Z3< +4$KG10#(04 10*!!]* I&"<O6V<0JMSZVVD')\K/P;3B_P5UJF
MC^5GO?Z>)A=U"=6$5?J7/X?OHZ"+$3[7?A@NUMQ[!L&K#%)G84)QGMV_PM<@
M>+XWF?U:\"V0\S"4WJVL!K"-WF2F7I6+O:VJ%*026F&&D%<ED4J!(!@'%K*F
M/4.K9#I+%;Y/3+^F?!?0:L/W 0#HY6RQ?%_^-IOE5507Y]_&"1>?R-P8.<.D
M<CJ +K6-#[>>K(N(]09_BMIX1R9"<RML&S7]:J=&XGY@@C7A_0!0])'$0034
M'@JO2.E.9JMJLE?,&@6>K$8F(#%66U;7;K2KGH',E1AT9$RWCBL\25"_ZJ@;
M++63P #@] DGD]K8&J?$J@E-Z44^'T_'E4W5^KV>%4-D18<(NB8*DCW.P67N
MP 8NK?&82VE=L&PWROH-/'0#L YD,@"D515<E>\UJT:%24F60("L>#V'H"_>
M: :,8;"6Y6Q5ZRNF]VGH-]S0W59W,)\'D)1PPY6U,5G=Z!%MQ%858@6ITD*N
M@@G@C+"@4RHJ":E2;.W4/D)&O[JF4]OZ0%X/ "[O9M/9W5E<M_.X9E!6KI18
M"THX7NJEK0(^!PTQBD@L\U[*UEGASQ+5K^+I DIMY3" _>K-E)Z%BVO#;G-^
M(\^0"YDM&7G1UJI]M8>(4J"U(U5+O!*V=9CI"7+Z==@:"_Y!HZ<V4CBB]<%9
M/8ENX[NMZF!=7AMP,=+6*R-1O7(59%+K%#&3I=?)H2NYM6*Z2T&_WEFWP#F"
MU\=BY7.;JAKWH'^GH-HZW+H8<=+,3+@$TA532] &" 8+6%+C*J7H_?TR+5L*
M9NPP6+_F3S=HZ831 \//=5^S-==JNP_+5 [6.1 6$Z@B36WAH&@QF!B$+2XG
MLQ=J'@S1KWUS JP<Q]0!F#=_"^/IHAK\N'@_??V]LNIBO/BR3AY<52 JQD0K
M%?%HE2?(HR3E27Z!EXF1;Y REM9&SK-$]5L!I=L=JZU$!@"Q6Z?R^EQP/+V@
M6=V>F?^"93;']><^A^^XH&G/ XEQ/ WSRS?DGJP*)=03Q=DJ)G:]_$91)UER
M;3C!Z\4-&20$92NW==)(_PO7^LRMP^GT6V*E:PM^&"@80*SB9HI7_/T%IUC&
M-(W@T87@P"KR8<@X];3"M0+&=#11\>1R-SD;#TCI5[]V$9=HP?,!Z%*R,#9B
M="$7LD,561A2U/6H(KA:-T:+9&N_'>8U-@;,'0+ZU5>=A*\.YN\ ],J=O+,;
MB_1]J5DV65BC%6)-7"0566@^D7$.Q6%R7D=K>.N3NR?(Z;?24Q? :<7[ <#H
M^A[T]86+V^T_>JE8%F!T/8[2&FNE=@<8B#]&<UUB:W6SC99^:SYU : F7!_
M#G5_'K^$Q3B-2G8Z"N. 1^M V>JM*,$@B)Q%UHSQU-JT>920?F/D;63\#'#V
M9_@ 4?-J/+E88AYY1WMLX PT>@LJUBJ?M:VQ%,B,T:ZDYL&'+:3T&R0_"7(.
M8?H L;-: *NHW*OQ(DUFBXOY1DZ%$M;G4@P4++09>QEH<DY!S!A-8BJHV+K_
MPEX$]EN%[A0[6SOY# !\?\?:B!WSBV\X#V?X[N(\UC+:#R[XK+6RTTFD0LR+
MW&8R!WD"%V,DR!3+2L9@FB>P[$7@L+;'AD"9G4IJ!T.2*(FS;D%YI=\?7C[C
M!E%$)J"DU:VVE"$FTO\L*%NO8:34O,CYGB0.:_<].3";2.['N3;X\DN8GN%B
M/-V\B7E=@NS.;(ZX+OCD(!U=$]Q]8NUKQ3QQJS4%G[,I'K*LB.6U$)8(M3V\
M"I'[F$SSGE0[$79\M9BK03[7'F(C])AL-H+626T>)H,&;VHOL6P+$ZYF4;>O
M$+-)0=\E.UICX6%9F(/Y/0!3[H;Z-4=J1&\V795*_CY>C#@:S3+CX)VIF1^1
M@ZL^4A*<A:0B1MXZ3?U)@@:"I0,DO0TT1[-] !BZ-X=7L_,PGHXT1K1210C!
M)&(/]^2D\PA%)<.QV.)3ZSKGCQ(R$,P<+^C['N;17!\ =#;*0_R&U>P;,<PB
M(OG;6M<\CYQK![FPJ@YAO<XJ)-=AW:DU$3U[A,<+=GL1C@.X/ "8;*F ?#49
MBT6Y;,@WU5+5AI<,/))G($4PEN=BM#A1^>D]X-.=W]8</NVX/P HW2]\?#6+
M(E@1B$BJ-Q-_ZL%E,%R %;1.C&6)A];EI!ZGI-],X_;@:<#O :#FTT5<C/,X
MS"_7&=(K7;K:PI%)&:,,D+BL-U%K\S]1^^XZQ$*J5++FAS5;B>F[EET[\[@)
MNX> FUORWX5S>KEJ.DDN)\GD>G%%1=YE4L!3/65(J>:T>F*6XHQ[)ITKK:N0
M/4]5ST9S&_'?!U5;6?3=>/;O84[T+U]_QWD:+_!:L2K&F/7,@N>UHY')](JT
M-V3D*%2@G]ENG;$??W[/P&@LPEE;?O8-B1?+SU_PMS#_1TW"HN%IO[V:!0I9
M'<H,6.IVRYFL_=/(T708,]?>&Q]W0L76(7K>>SH$1ANN]GI&MIK'AXLX&:>U
MA7=O(DI''5*1D(TD)Q"M@& =>8?9!ZQSI(GN!(_M8_1<);5#?#3BZQ"LE6L+
M[BU9[*N[!R->NS<0C(%[Z6HK=E)_02A@0@BG,=1**UU%@&^HZ+O";ONP[V$,
M'@!$WDS3O':G?H7K[V^F#X]5/LXFDU]G\S_"/(^$+<:@\I!8(!ZQNJI85N *
M)EI4:%ELC9\]21Q(?/A 1#R\\=&9> : OH>Y %$Z99-/$&V]K1"(8[3Y<M"6
M.1.U-DJU3BXZ+$^CRY*FW8G\OOXZBO\' ^@K[:FSFE,P7S;:YQYV%<)24J%5
M)K'0HC/:T<8?R!BPBH>86 JF=9K_@?V=NBQ@>CH@'2>!82%I71K_U44U_#ZL
M!UBMDW?XQ^I7BY',-GJC Q3T9%N:FI@>%<TR6JVYDAYCZURSW2CKO:S7:1'7
M5E*#2'O<,J]5]YC;:1D1A"S1 +$O@RJ6@Q/T(W?)6?0Y,=7Z>&,GPGJO!=8W
M_HZ0TP#LL1?YWR\6Z];JGV=;C@DW)EZ_UJ9QJS*-HX@B*ULRB%5+(TVJW]7T
M>I6<)A9DS53K+?<8>GN_'GXRJ)Y,JOT7"]II=WA]_G4RNT1<=^BZF*<O)( /
MDS!=C)*,,BHN:@J%I=EZ7=MR1?!6*9>SHN^==)C=G]3>KZWWK6F;RG( NO>I
M#67K+$<E2>E+"< -KXTGM(*("B&$E!R6R(II?EQ]"*&]7Y;O&ZX-Y3@ L.ZT
MI=0%&FF"JUY".%VLQ/T1B=N+\1*O&A>LN?,1T^QLNGK*BE$C$5Q&E3R0D>YI
M!2<&P3@#5D4O;&)8[A<#/(TQ<<2<>K_N/RR#XU3H&,!J>7('^XB+Y7R<ZLVH
M55I$Y?ZJZ@9)HN"X5FY<C%S1)7LM0!J2@?*>)LQB!BZ=%MS*8-OW+#B6Z-XO
M ?>M\CN2[P  O?,"_^7A K_#C=]I52^>7?0CD01&= E\]HZ$4[L).*&!?).8
MK'"%^-?7;M!FBKN=.; _PVH9,G@&L+:>5":K7[[_NBHU>)W9E$<Z)RXRR8#I
MI$&A(D^G\ "8C5%6"G*#6E_-V9_*W1#^YSA6ZU:$PP7IRCI[?()6,,VM+>"$
MH0DR\LL]2P&$RRE$H7)1K;MY[4WD;A#]\QS8=2; H2#T#NM6M0Y&4J"(G-,T
MBK6@+!E9WGH/+"6A,_.<=W!_^E%2=D/;G^>P[DAA#">X?+>^IHT8?%0<1# 9
M5 P!@JS]K93/C)7,@FT-J/WKE_(_Q9G;X8P?@D)ZD&LC360YQ@"RFJ.*I P^
M1 <NHBG),.Y3\]OXA^4Z_2F.P8X3P)$I*J^G;=KN/))H$YPBR[%PT 5K@5]2
MI]X*"=:9; )S66$GUO_^J4[\SW,>=;@(F@*I^RI&8?'EU\GLC\5=\H\I673S
MQ*[J$SU.<OMB1#<#W5;-0H$)HZ<MJ88:!,8:=$#(I&6$+T5QUV$-H@?T-"X]
ME*SG(7@%T=AZJAHUQ'JT*EW(FL5LDVA=RF&@I8>.D_PS%8?V8?,0[)JMESM)
MB6J3I"6M2C:]\D5 C(6!L-RCMDX:W]SE/^HJ]:DJ#>TEX9VO4N_#[B'@9H<K
M7#7N5?M."58SCKB40#NM!BF-2B)FSE/S).X?]BKU7N(_X"KU'K(8[KU9F4TR
MBBPSS@)9_#QX"/3'P IRE8*1#](*.KDWV^N%ZGT$N=N]V7VXVC<VGKC=:90U
MQA8-*48#JD0&Y AJ")FV<I9M=N(DMV9[O55]*#H:\74(&]/#*WSDP$6;K()Z
M<;CFFV1PEN82F$ L21DE.[-\W^YU:_94U6".,F&.8_  (/(.E]4%^#"??1N3
M2_G+Y>_D@[Z9WK2@?T%+ZMMX.=XHJ!RY,)A3@(">=&00CF98LU$5$]HI+XIH
M?7%V?RH'8B4?B(N'T>(NA30,&&[$P[4UY&1* 9HS<D&YMG5Q%J )\6PPJ=3\
M4MH!!Q%=@:=K:3]Y%+$/ZP> FSL9.#559IK&$[PSI<^S?;F9M-96L RE5I93
MB=/>H&T&3>^Q'$QFV#I%L8MY]-Q'_K0H[AT( U@,KY!&3N.UB*?YQ?ELOAS_
MY^K'47:9)\<8Y* Y**G(L9$B01"T%2$Q-S6OY?8$.?TJV/ZQ,NM&< / 8&V7
M71GX?EI["E?.?,;Y^7BZG@PO'KEF&D2IK:R4Y.!6N<(V2DQ%%NM:GQ,_25"_
M*G)P.&PGO.&DN#R>?SMBM8ZTXAZD"?66DH\0DI80Z^*R.C*KF]>V?)22?NL<
M# Z"#<0UB.('FSK\??F5UA!Q=GJVNHE,*KXV*II=$-='W-*\(O')8NUFA<5"
ML#F 1UL/[V5(LOE=\QUIZ[<$PN"@V8E(![!EKQ(8WQ%[B9=KWEXU91_EY)T*
MQ*-B?"';(YI:3"E K?3%C361\]9) %N)Z;?(P># V$9HQV[3'17NNV':U1V:
M&XYQG4(RV=4:.+SV[U:UY*T C%&H*+P7RC<&Y.[4]5O'8' ([4BL U"8#V?V
M(JU5/VT#JX5)_,?QMWJ\L!BIZ&1M1 #H#:U'KR0$[C48\N><*T+IYFW:]R)P
M:#4"VZ#D63"V$ME 5>B;Z3?B_FP^KE=R,3$R.R38%!DH4WLYB5QJ)6&GG7,F
M^=9G?D\2-+1B@B="W*$B&2C"/LSQ:QCG5U<479D?U\OIQ6*!9 I+9813W@%7
MQH-R-:DGBP1,1M2TPK)H7@3U,$J'5F[P1)AL+L2!@O5:VW\(E^M2V8JIVLH'
M$&,MIDB&C6?109 Q,OJ=9,WO&3]+U- J#IYX(SY$-$,U!N<71,<XQ/%D;4]?
MK:<;CF[\;I2Y=2RE +6['2B6.7CA:+$5$V)RS!"G3P'%/6@>6L'!TR&U*\$.
M$LC7N\)'),/E D?11Y9RC2<P6_M0D&T<HDL@E?9.J5*T[WXSOT?4T(H'G@B*
MQXAF$/'QW=,#R%;V/&1E01I>DRYK1@!7'#1/V0N.4;O^\LWZM1M/GRK4A= .
M5WXS6F%=PK&Z;(MML3$OE:/E!1EC[;&2%- "=Z3CD=N0.?.V=9;0_E0.)-/V
M;9=ID*V$-( ]F&S@ZVI2Z3\NQG.DN=+B6E[6RII+LC9J5OK7^I$1E\D5P6@)
MN]J40)0 4<0,Q5HGG.1"AM:A\-VI&V0"93.<S$XBM$%XTKNS<I1B\3ES!U8@
MF;O<6?#&%3#6H2/[Q,?FA?QWIVZ0N9!= ;(CH0UWF[XYBW^$D8&5H'UA4)S.
MQ$BI(6@7(:&5P@<TTG10U&9/*@?21J[3;;J5D(:P3<]G"3$O?B567O<8>%\^
MS,??B)&D]=.*FR.3O0D\<,@N)#*U-0-:M;2&+6>:G+ZBFW=NVHVR06[/S?!Q
M?WMN+ZS>;WX^,J5J9UQ5N'M?KCH&TSH.+B=3+&!DA=PP9! 4,8X,#JUE2L*Q
MW;KK[CSD('?:UMCJ4 J#56_KHE._3TF ;^B-::U?0]-]/&%SW;="F&A+X>3U
M"T]&C'("@L$ C$4A$WK#0^O\L5:T#S*N<UH5V;' !P;TQTN%&FN5L30AYEV@
M78&;U<4+6LA>%)^T]:ZYE_T<4?V>$_8(S>-%- 3,744+[F<0CX33VB=.A"L4
M- ]G(-;;/K'(E$/@F>FN CKW:>GW?._4"&LAD.'<=[F=SBN,R]??J\-_,5Y\
MJ6^NYQ5$3E9( RRS"$IH1VZ=]/3*\AREC(RW3@=[EJA^C_%Z0UP+$0TB3G@]
MI8\X6<%Y]CE\__MX^:46EZ39_3J;;[G8XY/UQ# -L1::4]D*<"$HLAA,(B;R
M;$/K[(=#:>VW\5=/&.U4H,/1FKMS=U2"-2(6 SH*VA:2YN"*D&"XX"%I-(BM
MU>?NU/7;F>O$&.U(: .(<]=IU?_KR=&W,%DOQ.N.,?47Y(?=?6/CD^O^!P]S
M1M+DHB[=U]_3ES ]PX^T@EZ7@B0$$8JRU7!&46IN2BV!%'( 8Z(K"FWFJC6D
M3SO#?EVFQO'U 8-C $OG 2ON,>!&\TCK6(PUNU2E6CB;QWK)(X+QD0<1F%6N
M=3;;KK3UZW\UAFLG AF (W_4,AP5)F.,68$.RI)S*5<6/NU[,J48/"VNYG;O
M403W>V34#89:ZM6]!'IDX7Q:H//E #"<0M!2V "1U>2!ZJIZK6K97B<QD/N:
MAF4V]'LT]0-@>!^!#J6+R,77KY/5;A4FU[7LWTS+;'Z^%NQ-57N1C;!DQ;A0
MTZ\$N0*1?%'0BA:F54(C:U[W=#?2^@U]-=[LNQ#' /;Z]1WZS^$[+FIS3W(\
M1P&5CMDBE"#)<26&@8^QWO/P/)44!>K6[>H?4M%W!?<.A/WPZL,QG!\$=NA9
MI'*OR?<V21=B!J:L!X68(&IA0&2/!FV,SK=.2+M'0L])X2=!S>$\;P:9MAV-
MSK^&Z>7[;[4U,/X1IOF7L!@O9N7#QM/OSF#7QD:[/+A%?Z.])]"HS='[^5F8
M7I5M>CF;+F:3<;ZNM+@Y^,WY7YC<]F"Z0:-3MD@G.60L@M#H"NV'J^X46'A1
MA0RGUJ>S30@_NCC4,434DEB3V>)BOLH;&9]-QV6<:D[\^LIO[=5*STMC7'PF
M8?]"X_Z#EKT.P:" PHVL>7@<? F*E+VWH9 OE9JGD9]ZCOWNVJ=?#P]J5PT9
M4X-4_Y\NSL_#_')6GISP(?I_QR<?OP$<,H5&.\##86Y@K+F*6B<)@?Q;4#K4
MQHDUB.,R&0DEV52:5U_<2LW1OO!NJ\$4&;)T#H2U'%31A8PA\O)]X-$7]#$W
M+V_^(^C%1BAYX!&W%\H@5=3'\>(?"S+K?I\FG"_#>+H\4",]_J#C%= .!#;2
M-ZN17MP;Z09,N:#)F1%Z9-TY=4S@O4;@&C.SJEC#=./E]R1!1\>09ZODX/E*
M'G6DVQWZ%MX"I5C!.R9&/GLP'D+MS<0E*]QK,AAL:SV["UT]GVHTP\F#,'!K
MF0Q3Y:R+7]1%_7D>,FZ4\*M1CD-TS]-/;*"$]B"YE39:#UD3J*^KNM=$KI<7
MB^7L'.<W>+/>RZ)0@@Z9@5))@$-A(#O%B@U:>=8ZH+DC:<>G!#PYS.V*T(*7
MQ(HF+\8A+3F+X'6-@=-F[S3GM!R;J^8=:>O[_+4]AA[F"70@I4'JK=_(EYV3
M4_OB;(YKI_807?7(4X[73\^1-JB8G.0RJI MB,P#*&E+[? H(=N4!"=6:=LZ
M@V<0,;F7LPF].ZN[^S=\4>\8GJT&>&R31REELH9#PN)IL11>*TXDR#XJJR-R
M9UJ'T_8@[\\0"=L'A0_MM&XD.4BU=\/$-U-BW<6*B[^&\?Q_A,D%_H:A3O=@
M;;C[PX]7D@=.I)'NO!GI%B0;Z=0AN>AX!&2AIE,SVANE+.!K!H<S5HK06B4^
M1<^QFNZQ9]^NB!*%PX@(J IM_\@L>*4*%"8B5X:^-+^<^21!_6JS9KBXKZ3:
M"6&0:FFS,/D!BN=!7?.C5,M68AHIC^OG7VX<H]QL9($YIHT%VLQJE0)IR'BW
M&1@K,9@D:=MIWUQC*SG'IUT\>/0&:'D1"E.$B(7\%!$8A)(R<"N4M4EQ+=HG
M[VRGI^\6#&TP\3 )HY$$!JDVKHN\A8WZ;@=&G;8]ZGAULA.1C53+UJIWM]$!
MQU01@H/GUA*8. <7T8!6FC-=%.>N^5W/YXAJ4$+B\0$> [WW1N68'!A-#H**
M&2%*9\!$81/Y"4JEUJE?^]#7KQIJBY]'ZDAT(Z=!*J>/X[,ORUGY?8'K%@ZT
M_M_6>U[OXV1\MGKT@4=SSS^VQ4'=GL0W4F"K038.?;W,VEH/B.3<JUH(PB/9
MN48Q+!(#1M'ZF/PN!<>JIK=([,/;TO2KA]^"G,GL8DH:-%.T P?:@1TR!L6J
M%%G4.HC6O7B?IJA?]7.$]._KFH:,'Z1V>4,/F)Z-X^1J@1YH]CSVF!8>U#/$
M-=(6?YO-\A_CR83VDOM#/F)')\9-4>1ZLR(3*.,07*D=Q60T,@>E9?.D[[T(
M/+KM]RZ#;1SAU+,:I!TU1*M!,5F7@*&-G2GAN$R6N]:%X?:CL%]=U!VV'G3\
M[DYN@U1=-VU3+^95$%>]OPY07H\_Z'CUM0.!O2@P9,$:63M_R7H;(W,)3LL,
MM7 &YR@X8ZT;9IU4@6WT.WL,^*D$Z9A(@$'+>LBCP*7J?[B<F4L^!]?:6'J:
MHA])0>V#G4?['+>1RR 5TE5/J:O&>P>IHON/.%X)/4E4JW#1NMU;S7];#1<F
MM\8WIEQT;62DK?!D?-<;R4+6-@G1IIQ-BKQYG&0[.<>JEGL-[JY'N--([#%L
M<U\"ZA! ^%@/?(V#:+,"H6G)I$(B$*U5[H&D]APX:H2D^ZKG%'(;I$YZ.YN>
M?<;Y>:U.>(A"NO/WQVNC[>0T4D7UP8]L6ZY(9FO"!6$D@_(UX:($#HPKIG+@
MAJ76.<N/4W*L KK[U(TPIPD$QZ1!ZEHYEW-/^S):B JY2,$B4ZV-FBVD]*M
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M+Z-X\G**?955C$+JJ). F+* >A9"B-$*4G+:NDQHDJVOH7=75G%5J/A]N3?
MY?KK1FYLCMI'H4$JJ4"ADN"SMR!#X9*CR.VOWN]&V6#+*NZ#DOLJK .A#*!6
M_#O\8V-&\]F47J9U+8G'YX>9]#Q'#4R)FI!-S/31U=OWR,A>]4[KUD=(^]+8
M;[7YCN#7J: & ,1GSK#NSTXD$8L7-<<MDBNC5 !?<H*H8BA)R!A+:V=R/PIW
M J'\P4#8H9 &:<8]73SQ\^K%(<;;3L_MNO;C8^2?.!\ARUBTE#6^H6NQ!U:3
MZ0."4!8S(FHC6[NK)ZH ^2E]P7Q13\U?TS)<7OY]G'&CY\@&%:^)Y?-IF%Q3
ML/CEDM1[OD@K5^E3[5Z1-B]SNB2\L):6$FI:5)(<,I]KJQ+M5(DB>)9:YX!U
M-ID?(VUB'Y0^*,8]"!P,8'\G-S^<G<WQ[*K W74:255"&^EH3M409P*TM?J+
MDK0YR9*!UR"#U5Q@\UX<.Q'6=R._[H':7CX# -WMZKN^6E%S*Q=O9V%:%]5-
MW^[;C7'#D=,*O4T9;#&A5L,FB\DR6_MYEXRTE1?9.G9X!+G]FINGU:3=RG)0
ML'U)@X]7B5^X^'4V?V22BY?K>[OW%FH.@=:DH]TA.P/*\0R!.PZ&S'MR [DA
M#Z S]!Y*=;]-TT\+XI-(=I!.U4;%P<,]J(</:5H*L4/?Z*GB=ZH4+J-+D"1)
M5''AP5O/0(:@&5>1*]G^B+RS@HBW8+\9Y'%(8RY2F>0A)%7[:X8$,:&&$!2+
M+.8L9>E,63U-6]]9 FVPLET--93,()7-EGJ$ARN>IQ_860'%#A72\V7PO.$Z
M>JV 65_['X@$SC$&Z D,"8N5MG7:=W]E%#=*/80HF#$>HO 1E,@%G#$1M%72
M>Z8YLR>K'CD0A=06*SN73#Q,)H-42#O4&CPBKKSSPT]2-+%#I76O>%Z40?FZ
M3T4ER,'+TD%D.4/.B=Y),870NI)T]Z43KZL^7/X6EA=S^GYO<_8A9BS90RKU
MA,]9"Q&E G)F!4KMZ5_KZ/D!9 ZJR.(^.-FER&)+$0U273U2W/ 8IVW;PSJI
MPMBA^MFS')417-9NGJ4D5N]=(@3& ^BB550N$RAMXX5ZTE)FM^[$K^/I>$FK
MXAL^&/;>R@B,-FPI$UB9%9 SDVE-6@2=+!D.,NO4O)7& 63^4$7/]D#9=H>P
M&PD.4K<]6OGP<.WVU.,Z*M,X& U7/!GV40K0O@8C,C((WF1@T6F5M"K)_M#5
M9F_7QT9YP%MI;!R0V6P8KJ;/5OT(%7A;,V!XJ6</T1;=^@!S5]I^)%VV#YZV
MZ[*&LAJD KM7-?%PU?7X@YJ7=>PRB/5D2;X0M"?3VT0G0(E2ZK6G"%XY4WQB
MV3?/%>RPN./#<]"GR@7>W[.]T-RK D$Q6E?("S@G,FCC@\6<<_"M+=%CZ!UR
MF<?=,?7\279'$ARDTMHLKGBXQGKD*6WK/G:HJ[94_[-6.99K?H*,&91F#H(5
M 9+C(<I<#+>MUV8WU1]OVO>MMUY"]0:<K[I5YO?3CUAWY/'TC#Y V_/\^L?5
M18OZ]ROQ?<;T93JNLKJ?BN05!JLSA) 2F0BILLM)\$$H&[E1(;2^B'"2B0VR
M,N4^V-S:S7$P<!A4BD_E^$9;UXU+D+EP)Q(9O29JTO1:TMRR U=<#"%@++[U
MJ=OS5/6;"-D!.AL+8E#0N@I*TS)[7Q[L;1O9<2R:'!.#VET1R( ACRAA))."
MB<RY95FT/D?8E\9^TQL[A5T'0AJDW?=(+<S#S;_M#^ND:.< KLH4%6L-Z C%
M. ^*D ?1Q0BF8+$J9H^\=6#I%*4[/\XNPV1Y>7MH_"*1-!X>I*$L6@D7P?'5
M6A.TLQ=R@#@SQ5KI?+'I.=#L,^"/<3-E'U#<*>C9!=L'J76VE,T\7/,\_<#.
MZGQVJ(&V5GE40F*(R0#*N*K'R$GXP1 _BI&\2#*Y6]>FZJK:Y\8UK'LC5/<B
MD<OQ:CRY6&*^?WY/^+=,UV3K6,_49*V8E G_Z'AM&6U\ZBXS=2]2!UHI=!\,
M/7%WKC.A#5)I/5ZD\PAKZ:GG=553M,L VG&5&U5M_AX\.7 V$"9S5N!%<."#
MUUD*DVQJG7K0;V71C5LG&V/707^=S1_4F7Q1NP6<K4M+O)BLGKZZ$?BXF%>D
M_[)*V;RW#(7/R3FOB<TIULXC9)Q436"TY](4X[/0W5U!.MU$?^@JIONLA2<N
M,PT45@.(QKR;3;^1PL3\D;[.QXE>?5K2/%;37FPQNX7,.F)*P%,]_I9)0R@1
M00O'<F ^J-R\R,X!=/8<#.P/^9T+=0# ?7Q=D@6V*EXP37@UV3_"//]^Q8YM
M,[=>^9H *V/-%*,E2D:@4)!%8LE)EIAJ'F!L1GW/H<<>U7L_ !@"]&\VML=Y
ML%KK[[^N[CALF;%1WH6<.*#/FG8II6IU<-JOI#8.Z8O-W=V_/I3J?N]?#\*2
M.8G !^ETUOF&Z>7[;[72#/X1IGEU\CHK'S:>_@J783PYL/3R'L]O49GYT.DT
M<E+?S\_"=/R?5];L=#&;C/-Z+4WS)@VKE.MZ]S],/M$[>!?51(=U.M:BNR[6
M'$4D0!L+MAXZ:N:0F=9)(4T(/UH%7\3%.(_#_/+]O%X#7%[^ALLOL_QFO='@
MNB/5:EW^<OGPP]<?6RW2D9'<Y8*UD6;M4"6,@"C1 .>(52^X:)M[H@WI[]?!
M/#V.'VCGOK P!%/D9CH;LWSQ?;P@=R+6FML:C&*)-AS:]'QP&FRMCNT*0ZY;
M9[5N):9?A/:'CZU /4980T#=+?GOPCF]_#P/9 JEU9XY.P_CZ<CXDE$5#[G4
MY'GA2FTIK&I'FA03EB)L\XL.SU(U%!P>)?[[H&HKBQ[1M3IY7J\YLO67\W&\
M6(GF;(ZKW>(W/(\X'VE3=,I% 2U$K(4-ZQ5_VB\T*YK9HKCESQJ;NPW5,UP:
M"W;6&9?[QLR+Y><O^%N8_P.7[PL-/YZ>7<U"H!6.2P2F7&V$I<G?(W,"LF#>
M(DLQ)+T35K8.T6^,LTN,M.%J[]@X7SEKSP/>.8LI*=K8\ZIGI1(0F" =S#%Z
MGXU$RW>#RHXC]ALX[!0Y7?"\;R"]'4_3;#+]0 OB_C2\*C)*6@HF59LPY0#!
MU,A],;+VZBHJ[@:=[6/T&WKK$BR-^#I$>-QV-5J%#:]GI;7DW@9@IG;99H@0
ME%/ )#*TA'B3\L%H>73(?NR8IM)]#C''L[IO /U.*G/^QWR\7.+TPT6<C-/]
M75<'IU)DD *2DX UP]MZ#R&@M<8&F=UNC>J?&VDGN.@?4=<TY?$ _/ :O:ZY
M$BO@K\\?KG?6S*Q.2=3\?TLLT@6\BA&$THPS;K@2K1,3MQ*S$Y[,#X:GMB+H
M$4N+^7+TL6;>K"(1W%AMD_(0M<_UE(Q#Y)K3''36GG.!<:>H(3UU S/TTRU>
M[@S8L_O4=V3P<.8/ 3'70/=&"4;;-Z;(05FEP+/B0 :F=/1%I++36?8NF.G3
MH#E"6/?%?0#G>A;X;^'[^/SB_(IP&4I.QA3@(I%A58('I^KD!0:;B6Z5=DI
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MX+BX#G9&%Z-2BOCC:C4&+L@)= 6$LK6LLX_Z?C;GEMCPKB/V>SC<##+=<7D
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M_C:>7;<.EEH%[K0%'VSMVQD]>$8\C8RFZS 8[7>KA;GWT#V'O[M$P>QD(AF
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MYB@9"5E?#-- X8(BNS&X&MGCVH#7-M5"$90NY( \/V4*';QZ3Q@Z5.B+YY3
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MQC#HO*@P^+',[@ O-]ERE<:UC4Q=>Q82E@FCBP6MMVE<9(&Y8@R@XQ%YH*/
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M6B-%<.+)1^#'EY@VMVD42+1AY]2@>$,&V)K4V^TM9,TX6L*U(>6FG+40=<G
M2V$:D7L?A@7+[__\:;.*1H%# T9.C87W^,<MZA5#6L4(R"I(4F\:P;' (,;$
M:M&9UG*88KCST=-F!8V"@./8-[7P+TAG?_/FS9^X3+,5?ES.TF5\B+&H@G"
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M :IVG=@ORH5M+BA9'8XI#*C$Z$@X)4 CG0[+>'*\]35Y@X!IBXU&1<WAC.X
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M?DVDU2_P=LZO22QKR1V@#(GLEAPAHD5(V6?C9#&:M\[7>Y2@:<'73.S#X'2
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M@.?[LE%RIC'V3@-F* ,T'8LHKQTP#%HBN$$0\<Q4'9(^]+22UW;B2,OTH5T
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MH(GFGU #M.<4&.@DC=\AY'*')U<S^1/UKW\I&S FG\_:$&R.!6XBJX]+3?#
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MIQO3?&]F_L.\<3?6_S'19G7C]U. FTE)K'QTUPU0-DJ/FOA)0LT!A-Y[I+S
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MZ+WG+S!'D!; @,+5$R?JV@_WCL(=<RG7L#0X_SFN%"8(U !G!<RP1SJ ]^C
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MWF]>ZC#RG]VNGZ<?T_7S=.SZ>?HI7#]/O0[T0G2@L?%$1"B42W]%D_[DRY=
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M?+08Q "?<W3A ]^'X&UT",'M@ML#^T)6'!^0$9)R1X1J:0PRA5?%HH??<)C
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M[G9_Q&<>1T/O'9D5X1UI2@,;>O<J&W@U.0*=4!.4CF+B]C->\:IWP6$X"A4
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MTQY>6G0QSUQJ4=A)A?!,U(X3=M36LPXH$CA BWZ17@J42<@CVB^'8@ILZ\;
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M_O/JXLT_\;\_7OWT]KO_#U!+ P04    " !6A619@*4!9/ '   1*@  #P
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M\H4P^@9,<UAQQ[[SIX?H"V+^H'9PHX/#_.?MX/A\4[7+I;/B+J+2=<BN:(Q
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MK:K(":ZL.FQ7^<@ER.9OO))YRE=!_P!02P,$%     @ 5H5D61E<M;,?"
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M[]\NZA(S?&:020)$ ##Y(8;XG+P%6^ 3I*HFNI@ 9<E*CMOC?M/R)91UH6>
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MUS[OA"4,_#&& ;)(]E(53N:&O"JI!IS)+7G-"P ] 0S^IO2:A('W"LO Y:P
M(Q3S*D!?<D#F&J"$. OF$9R R+Y<@C>92#+8(@"5G6L !JBU-,E  ,6J:2^[
M#I0.[6DQE9821A.P7V+=;83-#DO7(*[:2NI3*%C=#HS[;%?!W4H<S^98#/\R
M! Z_2P2*'%"UKE"1@!0*.QD>M9B6(SBF5.!7 6<6)GB "ZF4! 2 64 I8**
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M\99;7MSKW]7[_ZG[O\/?4$L#!!0    ( %:%9%GC?35/NP4  , 8   /
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M<W0M,C R-# Y,S N:'1M4$L! A0#%     @ 5H5D688W&UV!%@  !P(! !$
M             ( !4]8! &%Q<W0M,C R-# Y,S N>'-D4$L! A0#%     @
M5H5D6<9ANV8%'0  !1 ! !4              ( ! ^T! &%Q<W0M,C R-# Y
M,S!?8V%L+GAM;%!+ 0(4 Q0    ( %:%9%D^R 1NE(8  - '!@ 5
M      "  3L* @!A<7-T+3(P,C0P.3,P7V1E9BYX;6Q02P$"% ,4    " !6
MA619?^(AQ&8I 0!*DPL %0              @ $"D0( 87%S="TR,#(T,#DS
M,%]L86(N>&UL4$L! A0#%     @ 5H5D6<+MEL<[P@  1 4) !4
M     ( !F[H# &%Q<W0M,C R-# Y,S!?<')E+GAM;%!+ 0(4 Q0    ( %:%
M9%FO)0?QXTD  !HL 0 <              "  0E]! !A<75E<W1I=F5A;65N
M9&5D86YD<F5S=&$N:'1M4$L! A0#%     @ 5H5D68"E 63P!P  $2H   \
M             ( !)L<$ '$S,C R-&5X,S$Q+FAT;5!+ 0(4 Q0    ( %:%
M9%D97+6S'P@  .DJ   /              "  4//! !Q,S(P,C1E>#,Q,BYH
M=&U02P$"% ,4    " !6A619.G?$98\%  !^&   #P              @ &/
MUP0 <3,R,#(T97@S,C$N:'1M4$L! A0#%     @ 5H5D6>-]-4^[!0  P!@
M  \              ( !2]T$ '$S,C R-&5X,S(R+FAT;5!+!08     "P +
+ ,@"   SXP0    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>aqst-20240930_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:aqst="http://aquestive.com/20240930"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="aqst-20240930.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2024-11-01</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2024-03-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:WarrantExercisesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:PublicEquityOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AmendedEquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-03</startDate>
            <endDate>2024-04-03</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-23</startDate>
            <endDate>2024-04-23</endDate>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:AtTheMarketOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:EquityDistributionAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-12</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-12</startDate>
            <endDate>2022-04-12</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementCommitmentShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:LincolnParkAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-22</startDate>
            <endDate>2024-04-22</endDate>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:UnderwrittenPublicOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-03-22</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-22</startDate>
            <endDate>2024-04-22</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:CoDevelopmentAndResearchFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ManufacturedProductOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableDoubtfulAccountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:TradeAccountsReceivableSalesRelatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:TradeAccountsReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">aqst:OtherReceivablesAndAccruedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:HasicoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">aqst:ZevraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:CommercialExploitationAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-02</startDate>
            <endDate>2023-03-02</endDate>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:IndiviorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:ManufactureAndSupplyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:SupplementalAgreementWithIndiviorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-09-24</startDate>
            <endDate>2019-02-20</endDate>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">aqst:LicenseAndRoyaltyRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-01</endDate>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-01</endDate>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncUpfrontMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-01</endDate>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-04-01</startDate>
            <endDate>2016-04-01</endDate>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-03</instant>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:HaiscoPharmaceuticalGroupCoLtdUpfrontPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-17</instant>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:AtnahsPharmaUKLimitedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-26</startDate>
            <endDate>2022-09-26</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:LicenseSupplyAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:AtnahsPharmaUKLimitedAmendedAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-03-27</startDate>
            <endDate>2023-03-27</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">aqst:AssertioHoldingsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-10-26</startDate>
            <endDate>2022-10-26</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-06-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">aqst:SecuritiesPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-01</startDate>
            <endDate>2022-06-30</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:NewWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">aqst:ComputerNetworkEquipmentAndSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:PatentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MitsubishiTanabePharmaAmericaIncAndHaiscoForExarvanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <startDate>2019-07-15</startDate>
            <endDate>2019-07-15</endDate>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:OptionIndexedToIssuersEquityTypeAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-15</startDate>
            <endDate>2023-05-15</endDate>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-05-15</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-02-28</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-15</startDate>
            <endDate>2019-07-15</endDate>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-09-30</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:TwelvePointFiveSeniorSecuredNotesDueJune302025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:DebtCovenantRedemptionScenarioAxis">aqst:RedemptionScenario2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:ABLFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputDiscountRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">aqst:MeasurementInputProbabilityOfSuccessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-11-01</instant>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-11-01</startDate>
            <endDate>2023-11-01</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:SeniorSecuredNotes13.5DueNovember12028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">aqst:RoyaltyObligationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:InitialWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-15</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:FirstAdditionalWarrantOfferingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:PreFundedWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
        </entity>
        <period>
            <instant>2022-06-30</instant>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-14</startDate>
            <endDate>2023-06-14</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-08-02</startDate>
            <endDate>2023-08-02</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:CommonStockWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants0.96ExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-01</instant>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants0.96ExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-02</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:ExistingWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants4.25ExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">aqst:Warrants5.38ExercisePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:MarathonPangolinRoyaltyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-03</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">aqst:LicenseAgreementWithSunovionPharmaceuticalsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">aqst:MonetizationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:RoyaltyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">aqst:ManufacturingAndSupplyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">aqst:MarketBasedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-321">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-322">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-323">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-324">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-325">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-327">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-330">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-332">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="aqst:VestingConditionAxis">aqst:VestingConditionRangeSixMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-333">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-334">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-335">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-336">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-337">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-338">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:NeurelisIncVAquestiveTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-05</instant>
        </period>
    </context>
    <context id="c-339">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:NeurelisIncVAquestiveTherapeuticsIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-05-03</startDate>
            <endDate>2022-05-03</endDate>
        </period>
    </context>
    <context id="c-340">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-29</startDate>
            <endDate>2024-07-29</endDate>
        </period>
    </context>
    <context id="c-341">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-342">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">aqst:SuboxoneProduceLiabilityLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA-BC</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-10-15</instant>
        </period>
    </context>
    <context id="c-343">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-344">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-345">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:DanielBarberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <context id="c-346">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-347">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-348">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001398733</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">aqst:PeterBoydMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-09-30</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="product">
        <measure>aqst:product</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="lease">
        <measure>aqst:lease</measure>
    </unit>
    <unit id="payment">
        <measure>aqst:payment</measure>
    </unit>
    <unit id="noteholder">
        <measure>aqst:noteholder</measure>
    </unit>
    <unit id="transaction">
        <measure>aqst:transaction</measure>
    </unit>
    <unit id="quarterlyinstallment">
        <measure>aqst:quarterlyInstallment</measure>
    </unit>
    <unit id="cause">
        <measure>aqst:cause</measure>
    </unit>
    <unit id="plaintiff">
        <measure>aqst:plaintiff</measure>
    </unit>
    <unit id="lawsuit">
        <measure>aqst:lawsuit</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-25">0001398733</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-26">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-27">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-28">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag contextRef="c-1" id="f-29">false</dei:AmendmentFlag>
    <ecd:TrdArrDuration contextRef="c-346" id="f-1058">P364D</ecd:TrdArrDuration>
    <ecd:TrdArrDuration contextRef="c-343" id="f-1059">P382D</ecd:TrdArrDuration>
    <dei:DocumentType contextRef="c-1" id="f-1">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c-1" id="f-2">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-4">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-38599</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-6">Aquestive Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-8">30 Technology Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Warren</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">07059</dei:EntityAddressPostalZipCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-12">82-3827296</dei:EntityTaxIdentificationNumber>
    <dei:CityAreaCode contextRef="c-1" id="f-13">908</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">941-1900</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-15">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-16">AQST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-18">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-19">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-20">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-21">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-22">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany contextRef="c-1" id="f-23">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-2" decimals="0" id="f-24" unitRef="shares">91178193</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-30" unitRef="usd">77893000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-4" decimals="-3" id="f-31" unitRef="usd">23872000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <aqst:TradeAndOtherReceivablesNet contextRef="c-3" decimals="-3" id="f-32" unitRef="usd">9684000</aqst:TradeAndOtherReceivablesNet>
    <aqst:TradeAndOtherReceivablesNet contextRef="c-4" decimals="-3" id="f-33" unitRef="usd">8471000</aqst:TradeAndOtherReceivablesNet>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-3" id="f-34" unitRef="usd">7021000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-35" unitRef="usd">6769000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-3" decimals="-3" id="f-36" unitRef="usd">1972000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-4" decimals="-3" id="f-37" unitRef="usd">1854000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-3" decimals="-3" id="f-38" unitRef="usd">96570000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-4" decimals="-3" id="f-39" unitRef="usd">40966000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-40" unitRef="usd">3848000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-41" unitRef="usd">4179000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-3" decimals="-3" id="f-42" unitRef="usd">5310000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-4" decimals="-3" id="f-43" unitRef="usd">5557000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-44" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-45" unitRef="usd">1278000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-46" unitRef="usd">4230000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-47" unitRef="usd">5438000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-3" decimals="-3" id="f-48" unitRef="usd">109958000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-4" decimals="-3" id="f-49" unitRef="usd">57418000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-3" decimals="-3" id="f-50" unitRef="usd">7572000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-4" decimals="-3" id="f-51" unitRef="usd">8926000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-52" unitRef="usd">5025000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-53" unitRef="usd">6497000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-3" decimals="-3" id="f-54" unitRef="usd">482000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-4" decimals="-3" id="f-55" unitRef="usd">390000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-3" decimals="-3" id="f-56" unitRef="usd">1048000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-4" decimals="-3" id="f-57" unitRef="usd">1551000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent contextRef="c-3" decimals="-3" id="f-58" unitRef="usd">1000000</aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent>
    <aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent contextRef="c-4" decimals="-3" id="f-59" unitRef="usd">922000</aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent>
    <us-gaap:LoansPayableCurrent contextRef="c-3" decimals="-3" id="f-60" unitRef="usd">25000</us-gaap:LoansPayableCurrent>
    <us-gaap:LoansPayableCurrent contextRef="c-4" decimals="-3" id="f-61" unitRef="usd">22000</us-gaap:LoansPayableCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-62" unitRef="usd">15152000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-63" unitRef="usd">18308000</us-gaap:LiabilitiesCurrent>
    <aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-64" unitRef="usd">31253000</aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent>
    <aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-65" unitRef="usd">27508000</aqst:SeniorNotesNoncurrentAndFinanceLeaseLiabilityNoncurrent>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-3" decimals="-3" id="f-66" unitRef="usd">18835000</us-gaap:UnsecuredLongTermDebt>
    <us-gaap:UnsecuredLongTermDebt contextRef="c-4" decimals="-3" id="f-67" unitRef="usd">14761000</us-gaap:UnsecuredLongTermDebt>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent contextRef="c-3" decimals="-3" id="f-68" unitRef="usd">62730000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent>
    <aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent contextRef="c-4" decimals="-3" id="f-69" unitRef="usd">63568000</aqst:TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognizedNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-70" unitRef="usd">5109000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-71" unitRef="usd">5399000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-3" decimals="-3" id="f-72" unitRef="usd">20266000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-4" decimals="-3" id="f-73" unitRef="usd">32345000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-3" decimals="-3" id="f-74" unitRef="usd">2033000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-4" decimals="-3" id="f-75" unitRef="usd">2016000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-3" decimals="-3" id="f-76" unitRef="usd">155378000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-4" decimals="-3" id="f-77" unitRef="usd">163905000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-3" id="f-78" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-4" id="f-79" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="3"
      id="f-80"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-4"
      decimals="3"
      id="f-81"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-4" decimals="0" id="f-82" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-3" decimals="0" id="f-83" unitRef="shares">250000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-84" unitRef="shares">91178193</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="0" id="f-85" unitRef="shares">91178193</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="0" id="f-86" unitRef="shares">68533085</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="0" id="f-87" unitRef="shares">68533085</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-88" unitRef="usd">91000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-89" unitRef="usd">69000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital contextRef="c-3" decimals="-3" id="f-90" unitRef="usd">300648000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital contextRef="c-4" decimals="-3" id="f-91" unitRef="usd">212521000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-92" unitRef="usd">-346159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-4" decimals="-3" id="f-93" unitRef="usd">-319077000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-94" unitRef="usd">-45420000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-95" unitRef="usd">-106487000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-3" decimals="-3" id="f-96" unitRef="usd">109958000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-4" decimals="-3" id="f-97" unitRef="usd">57418000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-98" unitRef="usd">13542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-99" unitRef="usd">13002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-100" unitRef="usd">45694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-101" unitRef="usd">37377000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-5" decimals="-3" id="f-102" unitRef="usd">4437000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-6" decimals="-3" id="f-103" unitRef="usd">4798000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-3" id="f-104" unitRef="usd">13352000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-3" id="f-105" unitRef="usd">16152000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-5" decimals="-3" id="f-106" unitRef="usd">5269000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-6" decimals="-3" id="f-107" unitRef="usd">3196000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-108" unitRef="usd">15363000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-3" id="f-109" unitRef="usd">10216000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-5" decimals="-3" id="f-110" unitRef="usd">12126000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-6" decimals="-3" id="f-111" unitRef="usd">7385000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-112" unitRef="usd">34171000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-3" id="f-113" unitRef="usd">22200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:CostsAndExpenses contextRef="c-5" decimals="-3" id="f-114" unitRef="usd">21832000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-6" decimals="-3" id="f-115" unitRef="usd">15379000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-1" decimals="-3" id="f-116" unitRef="usd">62886000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses contextRef="c-7" decimals="-3" id="f-117" unitRef="usd">48568000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-5" decimals="-3" id="f-118" unitRef="usd">-8290000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-6" decimals="-3" id="f-119" unitRef="usd">-2377000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-120" unitRef="usd">-17192000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-3" id="f-121" unitRef="usd">-11191000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestExpenseNonoperating contextRef="c-5" decimals="-3" id="f-122" unitRef="usd">2780000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-6" decimals="-3" id="f-123" unitRef="usd">1256000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-3" id="f-124" unitRef="usd">8343000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-7" decimals="-3" id="f-125" unitRef="usd">4064000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:RoyaltyExpense contextRef="c-5" decimals="-3" id="f-126" unitRef="usd">1359000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="c-6" decimals="-3" id="f-127" unitRef="usd">0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="c-1" decimals="-3" id="f-128" unitRef="usd">4075000</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense contextRef="c-7" decimals="-3" id="f-129" unitRef="usd">0</us-gaap:RoyaltyExpense>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-5" decimals="-3" id="f-130" unitRef="usd">59000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">56000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-1" decimals="-3" id="f-132" unitRef="usd">175000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestExpenseSaleOfFutureRevenues contextRef="c-7" decimals="-3" id="f-133" unitRef="usd">163000</aqst:InterestExpenseSaleOfFutureRevenues>
    <aqst:InterestAndOtherIncomeNet contextRef="c-5" decimals="-3" id="f-134" unitRef="usd">979000</aqst:InterestAndOtherIncomeNet>
    <aqst:InterestAndOtherIncomeNet contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">1514000</aqst:InterestAndOtherIncomeNet>
    <aqst:InterestAndOtherIncomeNet contextRef="c-1" decimals="-3" id="f-136" unitRef="usd">2703000</aqst:InterestAndOtherIncomeNet>
    <aqst:InterestAndOtherIncomeNet contextRef="c-7" decimals="-3" id="f-137" unitRef="usd">16156000</aqst:InterestAndOtherIncomeNet>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-5" decimals="-3" id="f-138" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-6" decimals="-3" id="f-139" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-7" decimals="-3" id="f-141" unitRef="usd">-353000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-142" unitRef="usd">-11509000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-143" unitRef="usd">-2175000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-144" unitRef="usd">-27082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-145" unitRef="usd">385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-146" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-147" unitRef="usd">-140000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-148" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-149" unitRef="usd">144000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-150" unitRef="usd">-11509000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-151" unitRef="usd">-2035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">-27082000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-153" unitRef="usd">241000</us-gaap:NetIncomeLoss>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-5" decimals="-3" id="f-154" unitRef="usd">-11509000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-6" decimals="-3" id="f-155" unitRef="usd">-2035000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-156" unitRef="usd">-27082000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-3" id="f-157" unitRef="usd">241000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-158"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-159"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-160"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-161"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-162"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-163"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-164"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-165"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-166" unitRef="shares">91082081</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-167" unitRef="shares">64678761</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-168" unitRef="shares">85224263</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-169" unitRef="shares">59252768</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-170" unitRef="shares">91082081</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-171" unitRef="shares">64678761</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-172" unitRef="shares">85224263</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-173" unitRef="shares">61513736</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding contextRef="c-8" decimals="0" id="f-174" unitRef="shares">68533085</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-8" decimals="-3" id="f-175" unitRef="usd">69000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-3" id="f-176" unitRef="usd">212521000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-3" id="f-177" unitRef="usd">-319077000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-4" decimals="-3" id="f-178" unitRef="usd">-106487000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-11" decimals="0" id="f-179" unitRef="shares">4557220</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-180" unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-12" decimals="-3" id="f-181" unitRef="usd">12381000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-13" decimals="-3" id="f-182" unitRef="usd">12385000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-12" decimals="-3" id="f-183" unitRef="usd">410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-13" decimals="-3" id="f-184" unitRef="usd">410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-14" decimals="0" id="f-185" unitRef="shares">16666667</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-14" decimals="-3" id="f-186" unitRef="usd">17000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-15" decimals="-3" id="f-187" unitRef="usd">74983000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-16" decimals="-3" id="f-188" unitRef="usd">75000000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-15" decimals="-3" id="f-189" unitRef="usd">5187000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-16" decimals="-3" id="f-190" unitRef="usd">5187000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-17" decimals="-3" id="f-191" unitRef="usd">1580000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-18" decimals="-3" id="f-192" unitRef="usd">1580000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-19" decimals="0" id="f-193" unitRef="shares">490359</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-17" decimals="-3" id="f-194" unitRef="usd">-893000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-18" decimals="-3" id="f-195" unitRef="usd">-893000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-18" decimals="0" id="f-196" unitRef="shares">231400</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-18" decimals="-3" id="f-197" unitRef="usd">539000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-18" decimals="-3" id="f-198" unitRef="usd">539000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c-20" decimals="-3" id="f-199" unitRef="usd">-12828000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-3" id="f-200" unitRef="usd">-12828000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-21" decimals="0" id="f-201" unitRef="shares">90478731</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-202" unitRef="usd">90000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-203" unitRef="usd">295514000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-204" unitRef="usd">-331905000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-205" unitRef="usd">-36301000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-25" decimals="-3" id="f-206" unitRef="usd">158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-26" decimals="-3" id="f-207" unitRef="usd">158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-27" decimals="0" id="f-208" unitRef="shares">559801</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-27" decimals="-3" id="f-209" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-28" decimals="-3" id="f-210" unitRef="usd">2519000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-29" decimals="-3" id="f-211" unitRef="usd">2520000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-28" decimals="-3" id="f-212" unitRef="usd">359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-29" decimals="-3" id="f-213" unitRef="usd">359000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-30" decimals="0" id="f-214" unitRef="shares">17716</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-31" decimals="-3" id="f-215" unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-32" decimals="-3" id="f-216" unitRef="usd">46000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-31" decimals="-3" id="f-217" unitRef="usd">1523000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-32" decimals="-3" id="f-218" unitRef="usd">1523000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-30" decimals="0" id="f-219" unitRef="shares">3512</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-31" decimals="-3" id="f-220" unitRef="usd">-5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-32" decimals="-3" id="f-221" unitRef="usd">-5000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:NetIncomeLoss contextRef="c-33" decimals="-3" id="f-222" unitRef="usd">-2745000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-32" decimals="-3" id="f-223" unitRef="usd">-2745000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-34" decimals="0" id="f-224" unitRef="shares">91059760</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-225" unitRef="usd">91000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-226" unitRef="usd">299080000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-227" unitRef="usd">-334650000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-228" unitRef="usd">-35479000</us-gaap:StockholdersEquity>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-38" decimals="-3" id="f-229" unitRef="usd">1577000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-5" decimals="-3" id="f-230" unitRef="usd">1577000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-39" decimals="0" id="f-231" unitRef="shares">-7192</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-38" decimals="-3" id="f-232" unitRef="usd">-202000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-5" decimals="-3" id="f-233" unitRef="usd">-202000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-39" decimals="0" id="f-234" unitRef="shares">125625</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-38" decimals="-3" id="f-235" unitRef="usd">193000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-5" decimals="-3" id="f-236" unitRef="usd">193000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c-40" decimals="-3" id="f-237" unitRef="usd">-11509000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-238" unitRef="usd">-11509000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-41" decimals="0" id="f-239" unitRef="shares">91178193</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-3" id="f-240" unitRef="usd">91000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-3" id="f-241" unitRef="usd">300648000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-3" id="f-242" unitRef="usd">-346159000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-3" decimals="-3" id="f-243" unitRef="usd">-45420000</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding contextRef="c-44" decimals="0" id="f-244" unitRef="shares">54827734</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-3" id="f-245" unitRef="usd">55000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-246" unitRef="usd">192598000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-247" unitRef="usd">-311207000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-248" unitRef="usd">-118554000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-48" decimals="0" id="f-249" unitRef="shares">1078622</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-48" decimals="-3" id="f-250" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-49" decimals="-3" id="f-251" unitRef="usd">992000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-50" decimals="-3" id="f-252" unitRef="usd">993000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-49" decimals="-3" id="f-253" unitRef="usd">77000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-50" decimals="-3" id="f-254" unitRef="usd">77000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-51" decimals="-3" id="f-255" unitRef="usd">344000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-52" decimals="-3" id="f-256" unitRef="usd">344000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-53" decimals="0" id="f-257" unitRef="shares">16005</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-51" decimals="-3" id="f-258" unitRef="usd">-8000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-52" decimals="-3" id="f-259" unitRef="usd">-8000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:StockholdersEquityOther contextRef="c-51" decimals="-3" id="f-260" unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-52" decimals="-3" id="f-261" unitRef="usd">1000</us-gaap:StockholdersEquityOther>
    <us-gaap:NetIncomeLoss contextRef="c-54" decimals="-3" id="f-262" unitRef="usd">8068000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-52" decimals="-3" id="f-263" unitRef="usd">8068000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-55" decimals="0" id="f-264" unitRef="shares">55922361</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-55" decimals="-3" id="f-265" unitRef="usd">56000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-56" decimals="-3" id="f-266" unitRef="usd">193848000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-267" unitRef="usd">-303139000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-58" decimals="-3" id="f-268" unitRef="usd">-109235000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-59" decimals="0" id="f-269" unitRef="shares">3689452</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-59" decimals="-3" id="f-270" unitRef="usd">4000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-60" decimals="-3" id="f-271" unitRef="usd">3538000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-61" decimals="-3" id="f-272" unitRef="usd">3542000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-62" decimals="0" id="f-273" unitRef="shares">1981937</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-62" decimals="-3" id="f-274" unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-63" decimals="-3" id="f-275" unitRef="usd">4407000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-64" decimals="-3" id="f-276" unitRef="usd">4409000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-63" decimals="-3" id="f-277" unitRef="usd">235000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-64" decimals="-3" id="f-278" unitRef="usd">235000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-65" decimals="0" id="f-279" unitRef="shares">18699</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-66" decimals="-3" id="f-280" unitRef="usd">31000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-67" decimals="-3" id="f-281" unitRef="usd">31000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-66" decimals="-3" id="f-282" unitRef="usd">631000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-67" decimals="-3" id="f-283" unitRef="usd">631000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures contextRef="c-65" decimals="0" id="f-284" unitRef="shares">3510</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-66" decimals="-3" id="f-285" unitRef="usd">-3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition contextRef="c-67" decimals="-3" id="f-286" unitRef="usd">-3000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:StockholdersEquityOther contextRef="c-66" decimals="-3" id="f-287" unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:StockholdersEquityOther contextRef="c-67" decimals="-3" id="f-288" unitRef="usd">-1000</us-gaap:StockholdersEquityOther>
    <us-gaap:NetIncomeLoss contextRef="c-68" decimals="-3" id="f-289" unitRef="usd">-5792000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-67" decimals="-3" id="f-290" unitRef="usd">-5792000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-69" decimals="0" id="f-291" unitRef="shares">61615959</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-69" decimals="-3" id="f-292" unitRef="usd">62000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-70" decimals="-3" id="f-293" unitRef="usd">202218000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-71" decimals="-3" id="f-294" unitRef="usd">-308931000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-72" decimals="-3" id="f-295" unitRef="usd">-106651000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-73" decimals="0" id="f-296" unitRef="shares">5000000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-73" decimals="-3" id="f-297" unitRef="usd">5000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-74" decimals="-3" id="f-298" unitRef="usd">4795000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-75" decimals="-3" id="f-299" unitRef="usd">4800000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-76" decimals="0" id="f-300" unitRef="shares">124181</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-77" decimals="-3" id="f-301" unitRef="usd">264000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-78" decimals="-3" id="f-302" unitRef="usd">264000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-77" decimals="-3" id="f-303" unitRef="usd">80000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-78" decimals="-3" id="f-304" unitRef="usd">80000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-79" decimals="-3" id="f-305" unitRef="usd">774000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-6" decimals="-3" id="f-306" unitRef="usd">774000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-6" decimals="0" id="f-307" unitRef="shares">625</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-308" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-6" decimals="-3" id="f-309" unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:NetIncomeLoss contextRef="c-80" decimals="-3" id="f-310" unitRef="usd">-2035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-311" unitRef="usd">-2035000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding contextRef="c-81" decimals="0" id="f-312" unitRef="shares">66740765</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-81" decimals="-3" id="f-313" unitRef="usd">67000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-82" decimals="-3" id="f-314" unitRef="usd">207972000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-83" decimals="-3" id="f-315" unitRef="usd">-310966000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-84" decimals="-3" id="f-316" unitRef="usd">-102927000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-317" unitRef="usd">-27082000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-318" unitRef="usd">241000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-3" id="f-319" unitRef="usd">571000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-3" id="f-320" unitRef="usd">878000</us-gaap:DepreciationAndAmortization>
    <us-gaap:GainLossOnContractTermination contextRef="c-1" decimals="-3" id="f-321" unitRef="usd">300000</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination contextRef="c-7" decimals="-3" id="f-322" unitRef="usd">0</us-gaap:GainLossOnContractTermination>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-323" unitRef="usd">4696000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-3" id="f-324" unitRef="usd">1749000</us-gaap:ShareBasedCompensation>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-1" decimals="-3" id="f-325" unitRef="usd">8015000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-7" decimals="-3" id="f-326" unitRef="usd">174000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">-71000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-3" id="f-328" unitRef="usd">239000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-1" decimals="-3" id="f-329" unitRef="usd">1228000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="c-7" decimals="-3" id="f-330" unitRef="usd">3177000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-3" id="f-331" unitRef="usd">252000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-3" id="f-332" unitRef="usd">1299000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">-1083000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-3" id="f-334" unitRef="usd">-1217000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-335" unitRef="usd">146000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-7" decimals="-3" id="f-336" unitRef="usd">48000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-337" unitRef="usd">-2408000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-7" decimals="-3" id="f-338" unitRef="usd">-3469000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">-12582000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue contextRef="c-7" decimals="-3" id="f-340" unitRef="usd">2439000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-341" unitRef="usd">-29270000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-3" id="f-342" unitRef="usd">-1438000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-343" unitRef="usd">144000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-344" unitRef="usd">979000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">-144000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-3" id="f-346" unitRef="usd">-979000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-85" decimals="-3" id="f-347" unitRef="usd">11817000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-86" decimals="-3" id="f-348" unitRef="usd">5274000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-87" decimals="-3" id="f-349" unitRef="usd">71974000</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement contextRef="c-88" decimals="-3" id="f-350" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <aqst:ProceedsFromIssuanceAndExerciseOfWarrants contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">0</aqst:ProceedsFromIssuanceAndExerciseOfWarrants>
    <aqst:ProceedsFromIssuanceAndExerciseOfWarrants contextRef="c-7" decimals="-3" id="f-352" unitRef="usd">8342000</aqst:ProceedsFromIssuanceAndExerciseOfWarrants>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-1" decimals="-3" id="f-353" unitRef="usd">30000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans contextRef="c-7" decimals="-3" id="f-354" unitRef="usd">31000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-355" unitRef="usd">732000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-7" decimals="-3" id="f-356" unitRef="usd">0</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">18000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-7" decimals="-3" id="f-358" unitRef="usd">12548000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="c-1" decimals="-3" id="f-359" unitRef="usd">0</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="c-7" decimals="-3" id="f-360" unitRef="usd">1027000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-1" decimals="-3" id="f-361" unitRef="usd">1100000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation contextRef="c-7" decimals="-3" id="f-362" unitRef="usd">11000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">83435000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-3" id="f-364" unitRef="usd">61000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-365" unitRef="usd">54021000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-3" id="f-366" unitRef="usd">-2356000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-4" decimals="-3" id="f-367" unitRef="usd">23872000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-47" decimals="-3" id="f-368" unitRef="usd">27273000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-3" decimals="-3" id="f-369" unitRef="usd">77893000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-84" decimals="-3" id="f-370" unitRef="usd">24917000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-1" decimals="-3" id="f-371" unitRef="usd">305000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet contextRef="c-7" decimals="-3" id="f-372" unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-373" unitRef="usd">5566000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-3" id="f-374" unitRef="usd">2827000</us-gaap:InterestPaidNet>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-375">Company Overview and Basis of Presentation&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(A) Company Overview&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Aquestive Therapeutics, Inc. is a pharmaceutical company advancing medicines to bring meaningful improvement to patients&#x2019; lives through innovative science and delivery technologies. The Company is developing pharmaceutical products to deliver complex molecules through alternative administrations to invasive and inconvenient standard of care therapies. The Company has a proprietary commercial product, Libervant&#xae; (diazepam) Buccal Film for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;i.e.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, seizure clusters, acute repetitive seizures) that are distinct from a patient&#x2019;s usual seizure pattern in patients with epilepsy between two and five years of age, which was launched in April 2024. The Company is advancing a product pipeline for the treatment of severe allergic reactions, including anaphylaxis, under the trade name "Anaphylm&#x2122;", and its Adrenaverse epinephrine prodrug pipeline platform. The Company has five licensed commercialized products which are marketed by its licensees in the U.S. and around the world. The Company is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm&#xae;, and has proven drug development and commercialization capabilities. The Company&#x2019;s production facilities are located in Portage, Indiana, and its corporate headquarters and primary research laboratory facilities are based in Warren, New Jersey.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(B)&#160;Equity Transactions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Offering of Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company established its first ATM facility in September 2019, and since inception to September&#160;30, 2024, the Company has sold 19,857,518 shares of Common Stock which has generated net cash proceeds of approximately $60,558, net of commissions and other transactions costs of $3,085. On April 3, 2024, the Company filed a new shelf registration statement on Form S-3 to register the offer and sale of up to $250,000 worth of shares of Common Stock ("Registration Statement No. 333-278498" or the "2024 Registration Statement"), that was declared effective by the SEC on April 23, 2024. Included as part of the 2024 Registration Statement was a $100,000 ATM facility pursuant to the Amended Equity Distribution Agreement with Piper Sandler &amp;amp; Co. (successor to Piper Jaffray &amp;amp; Co.).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended September&#160;30, 2024, there were no shares of Common Stock sold under the ATM facility. For the nine months ended September 30, 2024, the Company sold 4,557,220 shares of Common Stock under the ATM facility which provided net proceeds of approximately $11,855 after deducting commissions and other transaction costs of $530. For the nine months ended September 30, 2023, the Company sold 3,184,740 shares under the ATM facility which provided net proceeds of approximately $5,274 after deducting commissions and other transaction costs of $392.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 12, 2022, the Company entered into the Lincoln Park Purchase Agreement, which provides that, upon the terms and subject to the conditions and limitations set forth in the Lincoln Park Purchase Agreement, the Company has the right, but not the obligation, to sell to Lincoln Park up to $40,000 worth of shares of Common Stock from time to time over the 36-month term of the Lincoln Park Purchase Agreement. The Lincoln Park Purchase Agreement contains an ownership limitation such that the Company will not issue, and Lincoln Park will not purchase, shares of Common Stock if it would result in Lincoln Park&#x2019;s beneficial ownership exceeding 9.99% of the Company&#x2019;s then outstanding Common Stock. Lincoln Park has covenanted under the Lincoln Park Purchase Agreement not to cause or engage in any manner whatsoever, any direct or indirect short selling or hedging of the Company&#x2019;s Common Stock. In 2022, the Company sold 1,600,000 shares, in addition to 236,491 commitment shares, which provided proceeds of approximately $1,987 in connection with the Lincoln Park Purchase Agreement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company did not sell shares in connection with the Lincoln Park Purchase Agreement in 2023 or for the nine months ended September 30, 2024. The Company has no current intent to use the Lincoln Park facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 22, 2024, the Company completed the Underwritten Public Offering of 16,666,667 shares of its common stock at the public offering price of $4.50 per share. In addition, pursuant to the partial exercise of the underwriters' option, on April 22, 2024, the Company sold an additional 559,801 shares of Common Stock. Net proceeds from the Underwritten Public Offering, including the exercise of underwriters' option were $72,868, after deducting underwriting discounts of $4,651. In addition to the underwriting discounts related to this offering, the Company incurred professional fees and other costs totaling $894 as of September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(C) Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and related notes for the fiscal year ended December&#160;31, 2023 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March&#160;5, 2024 (the &#x201c;2023 Annual Report on Form 10-K&#x201d;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2023 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2024, the Company dissolved its subsidiaries and no longer prepares its financial statements on a consolidated basis. The dissolution of the subsidiaries did not have a material impact on the Company&#x2019;s unaudited condensed financial statements as of September&#160;30, 2024 or the audited consolidated financial statements as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock>
    <aqst:RevenueFromContractWithCustomerNumberOfCommercializedProducts
      contextRef="c-1"
      decimals="INF"
      id="f-376"
      unitRef="product">5</aqst:RevenueFromContractWithCustomerNumberOfCommercializedProducts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-89" decimals="0" id="f-377" unitRef="shares">19857518</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-89" decimals="-3" id="f-378" unitRef="usd">60558000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-89" decimals="-3" id="f-379" unitRef="usd">3085000</us-gaap:PaymentsOfStockIssuanceCosts>
    <aqst:SaleOfStockAggregateOfferingPrice contextRef="c-90" decimals="-6" id="f-380" unitRef="usd">250000000</aqst:SaleOfStockAggregateOfferingPrice>
    <aqst:SaleOfStockAggregateOfferingPrice contextRef="c-91" decimals="-6" id="f-381" unitRef="usd">100000000</aqst:SaleOfStockAggregateOfferingPrice>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-92" decimals="0" id="f-382" unitRef="shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-85" decimals="0" id="f-383" unitRef="shares">4557220</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-85" decimals="-3" id="f-384" unitRef="usd">11855000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-85" decimals="-3" id="f-385" unitRef="usd">530000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-93" decimals="0" id="f-386" unitRef="shares">3184740</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-93" decimals="-3" id="f-387" unitRef="usd">5274000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-86" decimals="-3" id="f-388" unitRef="usd">392000</us-gaap:PaymentsOfStockIssuanceCosts>
    <aqst:RightToSellCommonStockValue contextRef="c-94" decimals="-3" id="f-389" unitRef="usd">40000</aqst:RightToSellCommonStockValue>
    <aqst:AgreementTerm contextRef="c-94" id="f-390">P36M</aqst:AgreementTerm>
    <aqst:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions contextRef="c-95" decimals="4" id="f-391" unitRef="number">0.0999</aqst:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipLimitationAfterAllTransactions>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-96" decimals="0" id="f-392" unitRef="shares">1600000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-97" decimals="0" id="f-393" unitRef="shares">236491</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-96" decimals="-3" id="f-394" unitRef="usd">1987000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-98" decimals="0" id="f-395" unitRef="shares">0</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-99" decimals="0" id="f-396" unitRef="shares">16666667</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-100"
      decimals="2"
      id="f-397"
      unitRef="usdPerShare">4.50</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-101" decimals="0" id="f-398" unitRef="shares">559801</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-101" decimals="-3" id="f-399" unitRef="usd">72868000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts contextRef="c-101" decimals="-3" id="f-400" unitRef="usd">4651000</aqst:SaleOfStockConsiderationReceivedOnTransactionUnderwritingDiscounts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-102" decimals="-3" id="f-401" unitRef="usd">894000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-402">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim unaudited condensed financial statements were prepared in conformity with U.S. GAAP and with Article 10 of Regulation S-X for interim financial reporting. In compliance with those rules, certain information and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;footnote disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. These condensed financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and related notes for the fiscal year ended December&#160;31, 2023 included in the Company&#x2019;s Annual Report on Form 10-K filed with the SEC on March&#160;5, 2024 (the &#x201c;2023 Annual Report on Form 10-K&#x201d;). As included herein, the Condensed Balance Sheet as of December&#160;31, 2023 is derived from the audited consolidated financial statements as of that date. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation of the results of interim periods have been included. The accompanying condensed financial statements reflect certain reclassifications from previously issued financial statements to conform to the current presentation. The Company has evaluated subsequent events for disclosure through the date of issuance of the accompanying unaudited condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Any reference in the Notes to applicable guidance refers to the authoritative U.S. GAAP as found in the ASC and ASU of FASB.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March 31, 2024, the Company dissolved its subsidiaries and no longer prepares its financial statements on a consolidated basis. The dissolution of the subsidiaries did not have a material impact on the Company&#x2019;s unaudited condensed financial statements as of September&#160;30, 2024 or the audited consolidated financial statements as of December&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-403">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company is no longer an &#x201c;emerging growth company,&#x201d; but remains a &#x201c;smaller reporting company&#x201d;. The Company complies with new or revised accounting standards by the relevant dates on which adoption of such standards is required for smaller reporting companies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Adopted as of September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#x2019;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#x2019;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#x2019;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s condensed financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This Accounting Standards Update was issued to clarify the guidance in Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for such equity securities. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASU 2023-0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which requires all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources and assess performance. Additionally, the standard requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. The guidance in this update is effective for fiscal years beginning after December 15, 2023, and interim periods after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This Accounting Standards Update was issued to enhance the transparency and decision usefulness of income tax &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It further requires disclosure on an annual basis of the following information about income taxes paid: 1. The amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes 2. The amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). Additionally, it requires the following information disclosure: 1. Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign 2. Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU eliminates certain current disclosure requirements. These disclosure requirements will be effective for the Company beginning January 1, 2025, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2023-09 on disclosures to its condensed financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-404">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the Company is no longer an &#x201c;emerging growth company,&#x201d; but remains a &#x201c;smaller reporting company&#x201d;. The Company complies with new or revised accounting standards by the relevant dates on which adoption of such standards is required for smaller reporting companies. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, new accounting pronouncements are issued by the FASB and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Adopted as of September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for Convertible Instruments and Contracts in an Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This Accounting Standards Update was issued to address the complexity in accounting for certain financial instruments with characteristics of liabilities and equity. Among other provisions, the amendments in this ASU significantly change the guidance on the issuer&#x2019;s accounting for convertible instruments and the guidance on the derivative scope exception for contracts in an entity&#x2019;s own equity such that fewer conversion features will require separate recognition, and fewer freestanding instruments, like warrants, will require liability treatment. More specifically, the ASU reduces the number of models that may be used to account for convertible instruments from five to three, amends diluted EPS calculations for convertible instruments, modifies the requirements for a contract that may be settled in an entity&#x2019;s own shares to be classified in equity and requires expanded disclosures intended to increase transparency. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s condensed financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the FASB issued ASU 2022-03, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement (Topic 820)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This Accounting Standards Update was issued to clarify the guidance in Topic 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, when measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security, and to introduce new disclosure requirements for such equity securities. The Company adopted the new guidance on January 1, 2024. The adoption of this guidance did not have a material impact on the Company&#x2019;s condensed financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recent Accounting Pronouncements Not Adopted as of September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;In November 2023, the FASB issued ASU 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;ASU 2023-0&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%"&gt;7&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;, which requires all public entities, including public entities with a single reportable segment, to provide in interim and annual periods one or more measures of segment profit or loss used by the chief operating decision maker to allocate resources and assess performance. Additionally, the standard requires disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures. The guidance in this update is effective for fiscal years beginning after December 15, 2023, and interim periods after December 15, 2024. The Company is currently evaluating the effects of this pronouncement on its related disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740)&#x2014;Improvements to Income Tax Disclosures. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This Accounting Standards Update was issued to enhance the transparency and decision usefulness of income tax &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;disclosures. The ASU requires that public business entities on an annual basis (1) disclose specific categories in the rate reconciliation and (2) provide additional information for reconciling items that meet a quantitative threshold (if the effect of those reconciling items is equal to or greater than 5 percent of the amount computed by multiplying pretax income (or loss) by the applicable statutory income tax rate). It further requires disclosure on an annual basis of the following information about income taxes paid: 1. The amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes 2. The amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in which income taxes paid (net of refunds received) is equal to or greater than 5 percent of total income taxes paid (net of refunds received). Additionally, it requires the following information disclosure: 1. Income (or loss) from continuing operations before income tax expense (or benefit) disaggregated between domestic and foreign 2. Income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU eliminates certain current disclosure requirements. These disclosure requirements will be effective for the Company beginning January 1, 2025, with early adoption of the amendments permitted. The Company is currently evaluating the impact from the adoption of ASU 2023-09 on disclosures to its condensed financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c-1" id="f-405">Risks and Uncertainties&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company assesses liquidity in terms of its ability to generate cash to fund its operating, investing and financing activities. The Company&#x2019;s cash requirements for the remainder of 2024 and beyond include expenses related to continuing development and clinical evaluation of its products, manufacture and supply costs, costs of regulatory filings, patent prosecution expenses and litigation expenses, expenses related to commercialization of its products, as well as costs to comply with the requirements of being a public company operating in a highly regulated industry. As of September&#160;30, 2024, the Company had $77,893 of cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has experienced a history of net losses. The Company&#x2019;s accumulated deficits totaled $346,159 as of September&#160;30, 2024. The net losses and accumulated deficits were partially offset by gross margins from sales of commercialized licensed and proprietary products, license fees, milestone and royalty payments from commercial licensees and co-development parties. The Company&#x2019;s funding requirements have been met by its cash and cash equivalents, as well as its equity and debt offerings, including the 13.5% Senior Secured Notes as further discussed in Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the ATM facility and other equity offerings, including the Underwritten Public Offering as discussed in Note 1, Part B &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Transactions.&lt;/span&gt;&lt;/div&gt;While the Company&#x2019;s ability to execute its business objectives and achieve profitability over the longer term cannot be assured, the Company&#x2019;s on-going business, existing cash and cash equivalents, expense management activities, including, but not limited to the ceasing of R&amp;amp;D activities, as well as access to the equity capital markets through its ATM facility and under the Lincoln Park Purchase Agreement, provide near term liquidity for the Company to fund its operating needs for at least the next twelve months as it continues to execute its business strategy.</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-3" decimals="-3" id="f-406" unitRef="usd">77893000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-3" decimals="-3" id="f-407" unitRef="usd">-346159000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-103" decimals="3" id="f-408" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-409">Revenues and Trade Receivables, Net&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#x2019;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;License and Royalty Revenu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e &#x2013; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.e&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Co-development and Research Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#x2019;s research and development projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of September&#160;30, 2024, and December&#160;31, 2023, such contract assets were $654 and $1,662, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#x2019;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September&#160;30, 2024 and December&#160;31, 2023, such contract liabilities were $21,314 and $33,896, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to obtain contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of September&#160;30, 2024 and December&#160;31, 2023, such costs to obtain contracts were $488 and $715, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Co-development and research fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides disaggregated net revenue by geographic area: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ex-United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and Hypera (manufacture and supply revenue) for revenue markets outside of the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2024, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), MTPA (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), Assertio (manufacture and supply revenue, license and royalty revenue and co-development and research fees), and a customer whose license and royalty revenue was previously recorded as deferred revenue and now recognized due to the termination of a contract. Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees), Haisco (license and royalty revenue that was previously recorded as deferred revenue and now recognized due to the termination of the contract), and Hypera (manufacture and supply revenue, license and royalty revenue) for revenue markets outside of the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), and Assertio (manufacture and supply revenue and license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-developm ent and research fees).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the nine months ended September&#160;30, 2023, United States revenues were derived primarily from Indivior (manufacture and supply revenue, and co-development and research fees), Assertio (manufacture and supply revenue, and license and royalty revenue), and Zevra (license and royalty revenue). Ex-United States revenues were derived primarily from Indivior (manufacture and supply revenue, license and royalty revenue and co-development and research fees) and Hypera (manufacture and supply revenue and license and royalty revenue) for revenue markets outside of the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sales-related allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the allowance for doubtful accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts at beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance expense (reduction)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sales-Related Allowances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues from sales of products are recorded net of prompt payment discounts, wholesaler service fees, returns allowances, rebates and co-pay support redemptions. These reserves are based on estimates of the amounts earned or to be claimed on the related sales. These amounts are treated as variable consideration, estimated and recognized as a reduction of the transaction price at the time of the sale. The Company includes these estimated amounts in the transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized for such transaction will not occur, or when the uncertainty associated with the variable consideration is resolved. The calculation of some of these items requires management to make estimates based on sales data, historical return data, contracts and other related information that may become known in the future. The adequacy of these provisions is reviewed on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provides a summary of activity with respect to sales-related allowances:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments / credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accruals for returns allowances and prompt pay discounts are reflected as a direct reduction of trade receivables and accruals for wholesaler service fees, co-pay support redemptions and other rebates as current liabilities. The accrued balances relative to these provisions included in Trade and other receivables, net and accrued expenses were $28 and $640, respectively, as of September 30, 2024, and $0 and $645, respectively, as of December 31, 2023. See Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accrued Expenses&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Concentration of Major Customers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customers are considered major customers when net revenue exceeds 10% of total revenue for the period or outstanding receivable balances exceed 10% of total receivables. For the nine months ended September 30, 2024, Indivior and Haisco, represented approximately 59% and 15%, and of total revenue, including the one-time recognition of deferred revenue for Haisco, respectively. As of September&#160;30, 2024, Indivior exceeded the 10% threshold for outstanding receivable balances and represented approximately 67% of total trade and other receivables. For the nine months ended September&#160;30, 2023, Indivior &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;represented approximately 79% of total revenue. As of December&#160;31, 2023,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Indivior and Zevra Therapeutics, Inc. represented 65% and 13% of total trade and other receivables, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-410">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues include (i) sales of manufactured products pursuant to contracts with commercialization licensees, (ii) license and royalty revenues, (iii) co-development and research fees generally in the form of milestone payments, and (iv) sales of its proprietary CNS product, Libervant, for patients between two to five years of age. The Company recognizes revenue to reflect the transfer of promised goods or services to customers in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services. To achieve this core principle, a five-step model is applied that includes (1) identifying the contract with a customer, (2) identifying the performance obligation in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations, and (5) recognizing when, or as, an entity satisfies a performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the current revenue recognition standard.&#160;A contract&#x2019;s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied.&#160;At contract inception, the Company assesses the goods promised in its contracts with customers and identifies a performance obligation for each promise to transfer to the customer a distinct good.&#160;When identifying performance obligations, the Company considers all goods or services promised in a contract regardless of whether explicitly stated in the contract or implied by customary business practice. The Company&#x2019;s performance obligations consist mainly of transferring goods and services identified in the contracts, purchase orders, invoices or statements of work.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; this revenue is derived from products manufactured exclusively for specific customers according to their strictly-defined specifications, subject only to specified quality control inspections. Accordingly, at the point in time when quality control requirements are satisfied, revenue net of related discounts is recorded.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;License and Royalty Revenu&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;e &#x2013; license revenues are determined based on an assessment of whether the license is distinct from any other performance obligations that may be included in the underlying licensing arrangement. If the customer is able to benefit from the license without provision of any other performance obligations by the Company and the license is thereby viewed as a distinct or functional license, the Company then determines whether the customer has acquired a right to use the license or a right to access the license. For functional licenses that do not require further development or other ongoing activities by the Company, the customer is viewed as acquiring the right to use the license as, and when, transferred and revenues are generally recorded at a point in time, subject to contingencies or constraints. For symbolic licenses providing substantial value only in conjunction with other performance obligations to be provided by the Company, revenues are generally recorded over the term of the license agreement. Such other obligations provided by the Company generally include manufactured products, additional development services or other deliverables that are contracted to be provided during the license term. Payments received in excess of amounts ratably or otherwise earned are deferred and recognized over the term of the license or as contingencies or other performance obligations are met.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Royalty revenue is estimated and recognized when sales under supply agreements with commercial licensees are recorded, absent any contractual constraints or collectability uncertainties. Royalties based on sales of licensed products have been recorded in this manner.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognition arising from milestone payments is dependent upon the facts and circumstances surrounding the milestone payments. Milestone payments based on a non-sales metric such as a development-based milestone (i&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.e&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;., an NDA filing or obtaining regulatory approval) represent variable consideration and are included in the transaction price subject to any constraints. If the milestone payments relate to future development, the timing of recognition depends upon historical experience and the significance a third party has on the outcome. For milestone payments to be received upon the achievement of a sales threshold, the revenue from the milestone payments is recognized at the later of when the actual sales occur or the performance obligation to which the sales relate to has been satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Co-development and Research Fees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; co-development and research fees are earned through performance of specific tasks, activities or completion of stages of development defined within a contractual development or feasibility study agreement with a customer. The nature of these performance obligations, broadly referred to as milestones or deliverables, are usually dependent on the scope and structure of the project as contracted, as well as the complexity of the product and the specific regulatory approval path necessary for that product. Accordingly, the duration of the Company&#x2019;s research and development projects may range from several months to approximately three years. Although each contractual arrangement is unique, common milestones included in these arrangements include those for the performance of efficacy and other tests, reports of findings, formulation of initial prototypes, production of stability clinical and/or scale-up batches, and stability testing of those batches. Additional milestones may be established and linked to clinical results of the product submission and/or approval of the product by the FDA and the commercial launch of the product.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - this net revenue is recognized when product is shipped and title passes to the customer, typically at time of delivery. At the time of sale, estimates for various revenue allowances are recorded based on historical trends and judgmental estimates. For sales of Libervant for patients between two to five years of age, returns allowances and prompt pay discounts are estimated based on contract terms and historical return rates, if available, and these estimates are recorded as a reduction of receivables. Similarly determined estimates are recorded relating to wholesaler service fees, co-pay support redemptions, and other rebates, and these estimates are reflected as a component of accrued liabilities. Once all related variable considerations are resolved and uncertainties as to collectable amounts are eliminated, estimates are adjusted to actual allowance amounts. Provisions for these estimated amounts are reviewed and adjusted on no less than a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms provide for invoicing in arrears. Accordingly, some, or all performance obligations may be completely satisfied before the customer may be invoiced under such agreements.&#160;In these situations, billing occurs after revenue recognition, which results in a contract asset supported by the estimated value of the completed portion of the performance obligation. These contract assets are reflected as a component of other receivables within Trade and other receivables within the Condensed Balance Sheets. As of September&#160;30, 2024, and December&#160;31, 2023, such contract assets were $654 and $1,662, respectively, consisting primarily of products and services provided under specific contracts to customers for which earnings processes have been met prior to shipment of goods or full delivery of completed services, as well as estimated receivables from contracts with third parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, customer contractual payment terms are structured to permit invoicing in advance of delivery of a good or service. In such instances, the customer&#x2019;s cash payment may be received before satisfaction of some, or any, performance obligations that are specified. In these situations, billing occurs in advance of revenue recognition, which results in contract liabilities. These contract liabilities are reflected as deferred revenue within the Condensed Balance Sheets. As remaining performance obligations are satisfied, an appropriate portion of the deferred revenue balance is credited to earnings. As of September&#160;30, 2024 and December&#160;31, 2023, such contract liabilities were $21,314 and $33,896, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Costs to obtain contracts&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - in certain situations, the Company may incur incremental costs of obtaining a contract with a customer. These costs, if expected to be recovered, are recognized as an asset and reflected as other assets within the Condensed Balance Sheets. The asset is amortized on a systematic basis that is consistent with the transfer to the customer of the goods or services to which the asset relates. As of September&#160;30, 2024 and December&#160;31, 2023, such costs to obtain contracts were $488 and $715, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <aqst:ResearchAndDevelopmentProjectDuration contextRef="c-104" id="f-411">P3Y</aqst:ResearchAndDevelopmentProjectDuration>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-3" decimals="-3" id="f-412" unitRef="usd">654000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet contextRef="c-4" decimals="-3" id="f-413" unitRef="usd">1662000</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability contextRef="c-3" decimals="-3" id="f-414" unitRef="usd">21314000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability contextRef="c-4" decimals="-3" id="f-415" unitRef="usd">33896000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:CapitalizedContractCostNet contextRef="c-3" decimals="-3" id="f-416" unitRef="usd">488000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:CapitalizedContractCostNet contextRef="c-4" decimals="-3" id="f-417" unitRef="usd">715000</us-gaap:CapitalizedContractCostNet>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock contextRef="c-1" id="f-418">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s revenues were comprised of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,409&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;License and royalty revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Co-development and research fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;492&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Proprietary product revenue, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-105" decimals="-3" id="f-419" unitRef="usd">10671000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-106" decimals="-3" id="f-420" unitRef="usd">11409000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-107" decimals="-3" id="f-421" unitRef="usd">29312000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-108" decimals="-3" id="f-422" unitRef="usd">32807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-109" decimals="-3" id="f-423" unitRef="usd">2162000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-110" decimals="-3" id="f-424" unitRef="usd">1103000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-111" decimals="-3" id="f-425" unitRef="usd">14514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-112" decimals="-3" id="f-426" unitRef="usd">3503000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-113" decimals="-3" id="f-427" unitRef="usd">492000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-114" decimals="-3" id="f-428" unitRef="usd">490000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-115" decimals="-3" id="f-429" unitRef="usd">1651000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-116" decimals="-3" id="f-430" unitRef="usd">1067000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-117" decimals="-3" id="f-431" unitRef="usd">217000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-118" decimals="-3" id="f-432" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-119" decimals="-3" id="f-433" unitRef="usd">217000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-120" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-435" unitRef="usd">13542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-436" unitRef="usd">13002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-437" unitRef="usd">45694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-438" unitRef="usd">37377000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-439">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides disaggregated net revenue by geographic area: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.016%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.578%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ex-United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,014&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,108&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,096&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,542&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-121" decimals="-3" id="f-440" unitRef="usd">10528000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-122" decimals="-3" id="f-441" unitRef="usd">9894000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-123" decimals="-3" id="f-442" unitRef="usd">30598000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-124" decimals="-3" id="f-443" unitRef="usd">25372000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-125" decimals="-3" id="f-444" unitRef="usd">3014000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-126" decimals="-3" id="f-445" unitRef="usd">3108000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-127" decimals="-3" id="f-446" unitRef="usd">15096000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-128" decimals="-3" id="f-447" unitRef="usd">12005000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-5" decimals="-3" id="f-448" unitRef="usd">13542000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-6" decimals="-3" id="f-449" unitRef="usd">13002000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-3" id="f-450" unitRef="usd">45694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-3" id="f-451" unitRef="usd">37377000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-452">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trade and other receivables, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade receivables&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract and other receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: sales-related allowances&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade and other receivables, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,684&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provides a summary of activity with respect to sales-related allowances:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.657%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.391%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.659%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments / credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(87)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="c-3" decimals="-3" id="f-453" unitRef="usd">7715000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-4" decimals="-3" id="f-454" unitRef="usd">5570000</us-gaap:AccountsReceivableGross>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-3" decimals="-3" id="f-455" unitRef="usd">1997000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:ContractWithCustomerAssetNetCurrent contextRef="c-4" decimals="-3" id="f-456" unitRef="usd">2915000</us-gaap:ContractWithCustomerAssetNetCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-129" decimals="-3" id="f-457" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-130" decimals="-3" id="f-458" unitRef="usd">14000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-131" decimals="-3" id="f-459" unitRef="usd">28000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-132" decimals="-3" id="f-460" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <aqst:TradeAndOtherReceivablesNet contextRef="c-3" decimals="-3" id="f-461" unitRef="usd">9684000</aqst:TradeAndOtherReceivablesNet>
    <aqst:TradeAndOtherReceivablesNet contextRef="c-4" decimals="-3" id="f-462" unitRef="usd">8471000</aqst:TradeAndOtherReceivablesNet>
    <us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock contextRef="c-1" id="f-463">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the changes in the allowance for doubtful accounts:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.536%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.533%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts at beginning of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance expense (reduction)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts at end of the period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCreditLossesForFinancingReceivablesCurrentTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-130" decimals="-3" id="f-464" unitRef="usd">14000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-133" decimals="-3" id="f-465" unitRef="usd">40000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-134" decimals="-3" id="f-466" unitRef="usd">14000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-135" decimals="-3" id="f-467" unitRef="usd">26000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-129" decimals="-3" id="f-468" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-130" decimals="-3" id="f-469" unitRef="usd">14000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-132" decimals="-3" id="f-470" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-136" decimals="-3" id="f-471" unitRef="usd">669000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-137" decimals="-3" id="f-472" unitRef="usd">45000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-138" decimals="-3" id="f-473" unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="c-137" decimals="-3" id="f-474" unitRef="usd">17000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="c-138" decimals="-3" id="f-475" unitRef="usd">87000</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <aqst:AccountsReceivableAllowanceForCreditLossReclassifications contextRef="c-137" decimals="-3" id="f-476" unitRef="usd">0</aqst:AccountsReceivableAllowanceForCreditLossReclassifications>
    <aqst:AccountsReceivableAllowanceForCreditLossReclassifications contextRef="c-138" decimals="-3" id="f-477" unitRef="usd">-582000</aqst:AccountsReceivableAllowanceForCreditLossReclassifications>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-131" decimals="-3" id="f-478" unitRef="usd">28000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-132" decimals="-3" id="f-479" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-139" decimals="-3" id="f-480" unitRef="usd">28000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-140" decimals="-3" id="f-481" unitRef="usd">640000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-141" decimals="-3" id="f-482" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-142" decimals="-3" id="f-483" unitRef="usd">645000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-143" decimals="2" id="f-484" unitRef="number">0.59</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-144" decimals="2" id="f-485" unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-145" decimals="2" id="f-486" unitRef="number">0.67</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-146" decimals="2" id="f-487" unitRef="number">0.79</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-147" decimals="2" id="f-488" unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-148" decimals="2" id="f-489" unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-490">Material Agreements&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Commercial Exploitation Agreement with Indivior&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2008, the Company entered into the Indivior License Agreement (with subsequent amendments) with Reckitt Benckiser Pharmaceuticals, Inc. which was later succeeded to in interest by Indivior.&#160;Pursuant to the Indivior License Agreement, the Company agreed to manufacture and supply Indivior&#x2019;s requirements for Suboxone&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a sublingual film formulation, both inside and outside the United States on an exclusive basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the terms of the Indivior License Agreement, the Company is required to manufacture Suboxone in accordance with current Good Manufacturing Practice standards and according to the specifications and processes set forth in the related quality agreements the Company entered into with Indivior. Additionally, the Company is required to obtain API&#160;for the manufacture of Suboxone directly from Indivior. The Indivior License Agreement specifies a minimum annual threshold quantity of Suboxone that the Company is obligated to fill and requires Indivior to provide the Company with a forecast of its requirements at various specified times throughout the year. The Indivior License Agreement provides for payment by Indivior of an agreed upon purchase price per unit until January 1, 2025 and, thereafter, that is subject to annual adjustments based on changes in an agreed upon price index. In addition to the purchase price for the Suboxone supplied, Indivior is required to make certain single digit percentage royalty payments tied to net sales value (as provided for in the Indivior License Agreement) outside of the U.S., subject to annual maximum amounts and limited to the life of the related patents. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Indivior License Agreement contains customary contractual termination provisions, including with respect to a filing for bankruptcy or corporate dissolution, an invalidation of the intellectual property surrounding Suboxone, and commission of a material breach of the Indivior License Agreement by either party. Additionally, Indivior may terminate the Indivior License Agreement if the FDA or other applicable regulatory authority declares the Company&#x2019;s manufacturing site to no longer be suitable for the manufacture of Suboxone or Suboxone is no longer suitable to be manufactured due to health or safety reasons. The initial term of the Indivior License Agreement was seven years from the commencement date. Thereafter, the Indivior License Agreement automatically renewed for successive one year periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of March 2, 2023, the Company and Indivior entered into the Indivior Agreement to the Indivior License Amendment. The Indivior Amendment was entered into for the primary purpose of amending the Agreement as follows: (i) extending the term of the Agreement until August 16, 2026 and thereafter providing for automatic renewal terms of successive one year periods unless Indivior delivers notice to the Company, at least twelve months prior to the expiration of the then current term, of Indivior&#x2019;s intent not to renew, subject to the earlier termination rights of the parties under the Agreement, and providing that the Agreement will not automatically renew for any renewal term beginning after the expiration of the last to expire of the product patents covered under the Indivior License Agreement; and (ii) agreeing to transfer pricing and payment terms for supplied product under the Indivior License Agreement. During the nine months ended September 30, 2023, in consideration of the agreements between the parties, the Company received a payment of $11,482 from Indivior, of which amount $5,482 represented: (a) payment of the portion of a 2022 price increase that had not been previously paid and (b) an estimated payment in 2023 for certain price increases. During the nine months ended September 30, 2023, the Company recognized $4,396, of which $1,682 was related to the 2022 price increases, in Manufacture and supply revenue and $6,000 in Interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income. As of December&#160;31, 2023, the $5,482 price increase had been fully recognized in Manufacture and supply revenue; there were no retroactive price adjustments included in Manufacture and supply revenue for the nine months ended September 30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Supplemental Agreement with Indivior&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 24, 2017, the Company entered into an agreement with Indivior, or the Indivior Supplemental Agreement. Pursuant to the Indivior Supplemental Agreement, the Company conveyed to Indivior all existing and future rights in the settlement of various ongoing patent enforcement legal actions and disputes related to the Suboxone product. The Company also conveyed to Indivior the right to sublicense manufacturing and marketing capabilities to enable an Indivior licensed generic buprenorphine product to be produced and sold by parties unrelated to Indivior or Aquestive. Under the Indivior Supplemental Agreement, the Company was entitled to receive certain payments from Indivior commencing on the date of the Indivior Supplemental Agreement through January 1, 2023. Once paid, all payments made under the Indivior Supplemental Agreement are non-refundable. Through February 20, 2019, the at-risk launch date of the competing generic products of Dr. Reddy&#x2019;s Labs and Alvogen, the Company received an aggregate of $40,750 from Indivior under the Indivior Supplemental Agreement. Further payments under the Indivior Supplemental Agreement were suspended until adjudication of related patent infringement litigation is finalized. No further payments are due to the Company under the Indivior Supplemental Agreement. See Note 19, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for details.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All payments made by Indivior to the Company pursuant to the Indivior Supplemental Agreement were in addition to, and not in place of, any amounts owed by Indivior to the Company pursuant to the Indivior License Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;License Agreement with Sunovion Pharmaceuticals, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 1, 2016, the Company entered into a license agreement with Cynapsus Therapeutics Inc. (which was later succeeded to in interest by Sunovion), referred to as the Sunovion License Agreement, pursuant to which Sunovion obtained an exclusive, worldwide license (with the right to sub-license) to certain intellectual property, including existing and future patents and patent applications, covering all oral films containing apomorphine for the treatment of off episodes in Parkinson&#x2019;s disease patients. Sunovion used this intellectual property to develop its apomorphine product KYNMOBI&#xae;, which was approved by the FDA on May 21, 2020. This approval triggered Sunovion&#x2019;s obligation to remit a payment of $4,000, due on the earlier of: (a) the first day of product availability at a pharmacy in the United States; or (b) within six months of FDA approval of the product. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;This amount was received as of September 30, 2020 and was included in License and royalty revenues for the twelve months ended December 31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 16, 2020, the Company entered into the First Amendment to the Sunovion License Agreement. The Amendment was entered into for the primary purpose of amending the Sunovion License Agreement as follows: (i) including the United Kingdom and any other country currently in the EU which later withdraws as a member country in the EU for purpose of determining the satisfaction of the condition triggering the obligation to pay the third milestone due under the Sunovion License Agreement, (ii) extending the date after which Sunovion has the right to terminate the Sunovion License Agreement for convenience from December 31, 2024 to March 31, 2028, (iii) modifying the effective inception date of the first minimum annual royalty due from Sunovion to the Company form January 1, 2020 to April 1, 2020, and (iv) modifying the termination provision to reflect the Company&#x2019;s waiver of the right to terminate the Sunovion License Agreement in the event that KYNMOBI was not commercialized by January 1, 2020. This Sunovion License Agreement will continue until terminated by Sunovion in accordance with the termination provisions of the Amendment to the Sunovion License Agreement. The Sunovion License Agreement continues (on a country-by-country basis) until the expiration of all applicable licensed patents unless earlier terminated under the termination provisions contained therein. Upon termination of the Sunovion License Agreement, all rights to intellectual property granted to Sunovion to develop and commercialize apomorphine-based products will revert to the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 23, 2020, the Company amended the Sunovion License Agreement to clarify the parties' agreement with respect to certain provisions in the Sunovion License Agreement, specifically the date after which Sunovion has the right to terminate the Sunovion License Agreement and the rights and obligations of the parties regarding the prosecution and maintenance of the Company&#x2019;s patents covered under the Sunovion License Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of the rights granted to Sunovion under the Sunovion License Agreement, the Company received aggregate payments totaling $22,000 to date. In addition to the upfront payment of $5,000, the Company has also earned an aggregate of $17,000 in connection with specified regulatory and development milestones in the United States and Europe (the &#x201c;Initial Milestone Payments&#x201d;), all of which have been received to date. With the Monetization Agreement (defined below) entered into on November 3, 2020 relating to KYNMOBI as described in the paragraph below, the Company is no longer entitled to receive any payments under the Sunovion License Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase and Sale Agreement with an affiliate of Marathon&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold to Marathon all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#x2019;s apomorphine product, KYNMOBI. In exchange for the sale of these rights, the Company received an upfront payment from Marathon of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through September&#160;30, 2024 under the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets; therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of Future Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details on the accounting for the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Agreement to Terminate CLA with Zevra Therapeutics, Inc. (formerly KemPharm)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2012, the Company entered into an agreement with Zevra to terminate a Collaboration and License Agreement entered into by the Company and Zevra in April 2011. Under this termination arrangement, the Company has the right to participate in any and all value that Zevra may derive from the commercialization or any other monetization of Zevra&#x2019;s KP-415 and KP-484 compounds or their derivatives. Among these monetization transactions are those related to any business combinations involving Zevra and collaborations, royalty arrangements, or other transactions from which Zevra may realize value from these compounds, including the product Azstarys&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing and Supply Agreement with Haisco for Exservan&#x2122; (Riluzole Oral Film) for ALS Treatment in China&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into the Haisco Agreement with Haisco, a Chinese limited company listed on the Shenzhen Stock Exchange, effective as of March 3, 2022, pursuant to which Aquestive granted Haisco an exclusive license to develop and commercialize Exservan&#x2122; (riluzole oral film) for the treatment of ALS in China. Under the terms of the Haisco Agreement, Aquestive was the exclusive sole manufacturer and supplier for Exservan in China. Under the Haisco Agreement, as amended, the Company received a $7,000 upfront cash payment in September 2022 and was entitled to receive regulatory milestone payments and double-digit royalties on net sales of Exservan in China and earn manufacturing revenue upon the sale of Exservan in China. In June 2024, the Haisco Agreement was terminated, and the Company will not receive any contingent &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;payments under the Haisco Agreement. The termination agreement released all parties from any existing or ongoing obligations. Commissions of $134 that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income. The Company recognized deferred revenue of $7,000 for the upfront payment received in September 2022 on the Company's condensed financial statements for the nine months ended September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compensatory Arrangements of Certain Officers&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 17, 2022, the Company announced that Keith J. Kendall, former President and Chief Executive Officer of the Company, was leaving the Company and the Company&#x2019;s Board of Directors, effective May 17, 2022. In connection with his departure, Mr. Kendall and the Company entered into a Separation Agreement, including a Consulting Agreement, dated as of May 17, 2022. Under the Separation Agreement, in addition to other severance benefits already received by Mr. Kendall in 2022, Mr. Kendall received a monthly severance payment for eighteen months following the Termination Date, or November 22, 2023. During the first quarter of 2023, net severance payments made to Mr. Kendall totaled approximately $274. By the end of December 31, 2023, all payments due to Mr. Kendall were made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing and Supply Agreement with Atnahs Pharma UK Limited &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into the Pharmanovia Agreement, effective as of September 26, 2022, pursuant to which the Company granted Pharmanovia an exclusive license to certain of the Company&#x2019;s intellectual property to develop and commercialize Libervant&#x2122; (diazepam) Buccal Film for the treatment of prolonged or acute, convulsive seizures in all ages in the Territory (as defined in the Pharmanovia Agreement) during the term of the Pharmanovia Agreement. Under the Pharmanovia Agreement, Pharmanovia will lead the regulatory and commercialization activities for Libervant in the Territory and the Company will serve as the exclusive sole manufacturer and supplier of Libervant in the Territory. Pursuant to the Pharmanovia Agreement, the Company received $3,500 upon agreement execution and, upon the occurrence of certain conditions set forth in the Pharmanovia Agreement, will receive additional milestone payments and profit shares, as well as manufacturing fees and royalty fees through the expiration of the Pharmanovia Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective March 27, 2023, the Company amended the Pharmanovia Agreement to expand the scope of territory for the license of Libervant to cover the rest of the world, excluding the U.S., Canada and China. Under the Pharmanovia Amendment, Pharmanovia will be responsible for seeking applicable regulatory approval in the expanded territories, which includes Latin America, Africa and Asia Pacific. Pursuant to the terms of the Pharmanovia Amendment, the Company received a non-refundable payment of $2,000 from Pharmanovia in connection with the execution of the Pharmanovia Amendment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing Agreement with Assertio Holdings, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective as of October 26, 2022, the Company entered into the Assertio Agreement to license Sympazan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (clobazam) oral film for the adjunctive treatment of seizures associated with Lennox&#x2010;Gastaut syndrome in patients aged two years of age and older. Under the terms of the Assertio Agreement, the Company granted to Assertio an exclusive, worldwide license of its intellectual property for Sympazan during the term of the Assertio License Agreement for an upfront payment of $9,000. In addition, Aquestive received a $6,000 milestone payment subsequent to Aquestive&#x2019;s receipt of a notice of allowance from the PTO of the Company&#x2019;s patent application U.S. Serial No. 16/561,573, and payment by the Company of the related allowance fee. The Company received the notice of allowance from the PTO and paid the related allowance fee on October 27, 2022. Further, under the Assertio Agreement, the Company will receive royalties from Assertio for the sale of the product through the expiration of the Assertio Agreement. The Company also entered into a long-term supply agreement with Assertio for Sympazan pursuant to which the Company is the exclusive sole worldwide manufacturer and supplier of the product and will receive manufacturing fees from Assertio for the product through the expiration of such supply agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Licensing Agreement with Mitsubishi Tanabe Pharma America, Inc.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2021, the Company announced that Aquestive granted an exclusive license to MTPA for the commercialization in the United States of Exservan. MTPA is a multinational pharmaceutical company with a focus on patients with ALS. The product was launched by MTPA in June 2021. Under the terms of the MTPA license agreement, Aquestive was the exclusive manufacturer and supplier of Exservan for MTPA in the United States. In June 2024, under the Second Amendment to the License and Supply Agreement, MTPA and the Company mutually agreed to terminate the agreement. As of June 30, 2024 and as part of the termination, the parties were released from any existing or ongoing obligations (except for the limited post-termination obligations). Upon termination, deferred revenue of $3,317 was recognized for milestone payments that had been received. Commissions of $57 that had been capitalized were expensed immediately in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <aqst:LicenseAgreementTerm contextRef="c-149" id="f-491">P7Y</aqst:LicenseAgreementTerm>
    <aqst:AutomaticRenewalPeriodOfAgreement contextRef="c-149" id="f-492">P1Y</aqst:AutomaticRenewalPeriodOfAgreement>
    <aqst:AutomaticRenewalPeriodOfAgreement contextRef="c-150" id="f-493">P1Y</aqst:AutomaticRenewalPeriodOfAgreement>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-151" decimals="-3" id="f-494" unitRef="usd">11482000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:DeferredIncome contextRef="c-152" decimals="-3" id="f-495" unitRef="usd">5482000</us-gaap:DeferredIncome>
    <us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer contextRef="c-153" decimals="-3" id="f-496" unitRef="usd">4396000</us-gaap:RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer>
    <us-gaap:DeferredIncomeRevenueRecognized contextRef="c-153" decimals="-3" id="f-497" unitRef="usd">1682000</us-gaap:DeferredIncomeRevenueRecognized>
    <aqst:InterestAndOtherIncomeNet contextRef="c-151" decimals="-3" id="f-498" unitRef="usd">6000000</aqst:InterestAndOtherIncomeNet>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-151" decimals="-3" id="f-499" unitRef="usd">5482000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:Revenues contextRef="c-154" decimals="-3" id="f-500" unitRef="usd">40750000</us-gaap:Revenues>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-155" decimals="-3" id="f-501" unitRef="usd">4000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:Revenues contextRef="c-156" decimals="-3" id="f-502" unitRef="usd">22000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-157" decimals="-3" id="f-503" unitRef="usd">5000000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-158" decimals="-3" id="f-504" unitRef="usd">17000000</us-gaap:Revenues>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-159" decimals="-3" id="f-505" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-160" decimals="-3" id="f-506" unitRef="usd">10000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-161" decimals="-3" id="f-507" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ContingentMonetizationAgreementMilestonePayment contextRef="c-159" decimals="-3" id="f-508" unitRef="usd">75000000</aqst:ContingentMonetizationAgreementMilestonePayment>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-162" decimals="-3" id="f-509" unitRef="usd">125000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss contextRef="c-163" decimals="-3" id="f-510" unitRef="usd">7000000</us-gaap:ContractWithCustomerReceivableAfterAllowanceForCreditLoss>
    <us-gaap:SalesCommissionsAndFees contextRef="c-164" decimals="-3" id="f-511" unitRef="usd">134000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:SalesCommissionsAndFees contextRef="c-165" decimals="-3" id="f-512" unitRef="usd">134000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-165" decimals="-3" id="f-513" unitRef="usd">7000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-164" decimals="-3" id="f-514" unitRef="usd">7000000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <aqst:SeveranceCostsMonthlyPaymentDuration contextRef="c-166" id="f-515">P18M</aqst:SeveranceCostsMonthlyPaymentDuration>
    <us-gaap:SeveranceCosts1 contextRef="c-167" decimals="-3" id="f-516" unitRef="usd">274000</us-gaap:SeveranceCosts1>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-168" decimals="-3" id="f-517" unitRef="usd">3500000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-169" decimals="-3" id="f-518" unitRef="usd">2000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:ProceedsFromCollaborators contextRef="c-170" decimals="-3" id="f-519" unitRef="usd">9000000</us-gaap:ProceedsFromCollaborators>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-170" decimals="-3" id="f-520" unitRef="usd">6000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized contextRef="c-171" decimals="-3" id="f-521" unitRef="usd">3317000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:SalesCommissionsAndFees contextRef="c-172" decimals="-3" id="f-522" unitRef="usd">57000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-523">Financial Instruments &#x2013; Fair Value Measurements&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain assets and liabilities are reported on a recurring basis at fair value. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs.&#160;Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 1 &#x2014; Observable quoted prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 2 &#x2014; Observable prices that are based on inputs not quoted on active markets but corroborated by market data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.5pt"&gt;Level 3 &#x2014; Unobservable inputs that are supported by little or no market activity, such as pricing models, discounted cash flow&#160;methodologies and similar techniques.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts reported in the balance sheets for trade and other receivables, prepaid and other current assets, accounts payable and accrued expenses, and deferred revenue approximate their fair values based on the short-term maturity of these assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted warrants to certain noteholders in connection with its debt repayment and debt refinancing during 2020 and 2019, respectively. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, Valuation of Privately-Held Company Equity Securities Issued as Compensation. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s 12.5% Senior Secured Notes contained a repurchase offer or put option which gave holders of the option the right, but not the obligation, to require the Company to redeem the 12.5% Notes up to a capped portion of milestone payments resulting from the Monetization Agreement. This put option was valued based on Level 3 inputs and its fair value was based primarily on an independent third-party appraisal consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants Accounting and Valuation Guide. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company issued pre-funded warrants to purchase up to 4,000,000 shares of Common Stock and Common Stock Warrants to purchase up to 8,850,000 shares of Common Stock in connection with its Securities Purchase Agreements with certain purchasers. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of the remaining warrants to purchase 5,000,000 of the shares of Common Stock. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock at $2.60 per share. Those warrants were valued based on Level 3 inputs and their&#160;fair value was based primarily on an independent third-party appraisal prepared as of the grant&#160;date consistent with generally accepted valuation methods of the Uniform Standards of Professional Appraisal Practice, the American Society of Appraisers and the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide. See Note 14&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Warrants&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further information on these warrants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, in connection with the issuance of the 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provided the Note Holders:&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#x2122; (epinephrine) Sublingual Film for a period of eight years from the first sale of Anaphylm on a global basis, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&#x2122; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Those Royalty Agreements were valued based on Level 3 inputs and their&#160;fair value was based primarily on internal management estimates developed based on third-party data and reflect management&#x2019;s judgements, the then current market conditions, and forecasts. The initial fair value measurement of the Royalty Right Agreements was determined based on &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further discussion.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-524" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-525" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants contextRef="c-174" decimals="0" id="f-526" unitRef="shares">4000000</aqst:SharesOfCommonStockEntitledToPurchasersByPreFundedWarrants>
    <aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants contextRef="c-174" decimals="0" id="f-527" unitRef="shares">8850000</aqst:SharesOfCommonStockToBePurchasedByCommonStockWarrants>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-175" decimals="0" id="f-528" unitRef="shares">5000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-175"
      decimals="2"
      id="f-529"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-176" decimals="0" id="f-530" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-176"
      decimals="2"
      id="f-531"
      unitRef="usdPerShare">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-532" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-178" decimals="3" id="f-533" unitRef="number">0.010</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-179" decimals="3" id="f-534" unitRef="number">0.020</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-180" id="f-535">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-178" decimals="3" id="f-536" unitRef="number">0.010</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-179" decimals="3" id="f-537" unitRef="number">0.020</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-180" id="f-538">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <us-gaap:InventoryDisclosureTextBlock contextRef="c-1" id="f-539">Inventories&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Inventory are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging material&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-540">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of Inventory are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw material&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Packaging material&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,731&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,050&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials contextRef="c-3" decimals="-3" id="f-541" unitRef="usd">3240000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials contextRef="c-4" decimals="-3" id="f-542" unitRef="usd">2118000</us-gaap:InventoryRawMaterials>
    <aqst:InventoryPackingMaterialGross contextRef="c-3" decimals="-3" id="f-543" unitRef="usd">2731000</aqst:InventoryPackingMaterialGross>
    <aqst:InventoryPackingMaterialGross contextRef="c-4" decimals="-3" id="f-544" unitRef="usd">3028000</aqst:InventoryPackingMaterialGross>
    <us-gaap:InventoryFinishedGoods contextRef="c-3" decimals="-3" id="f-545" unitRef="usd">1050000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryFinishedGoods contextRef="c-4" decimals="-3" id="f-546" unitRef="usd">1623000</us-gaap:InventoryFinishedGoods>
    <us-gaap:InventoryNet contextRef="c-3" decimals="-3" id="f-547" unitRef="usd">7021000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-4" decimals="-3" id="f-548" unitRef="usd">6769000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock contextRef="c-1" id="f-549">Property and Equipment, Net&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful&lt;br/&gt;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer, network equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total depreciation, amortization, and impairment related to property and equipment was $159 and $218 for the three months ended September 30, 2024 and 2023, respectively. For the respective nine month periods, these expenses totaled $493 and $760.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-550">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.371%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.647%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.534%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.558%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Useful&lt;br/&gt;Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-15 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,386&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer, network equipment and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3-7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,358)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,884)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,179&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt"&gt;Leasehold improvements are amortized over the shorter of the lease term or their estimated useful lives.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-181" id="f-551">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-182" id="f-552">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-183" decimals="-3" id="f-553" unitRef="usd">20317000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-184" decimals="-3" id="f-554" unitRef="usd">20248000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-185" id="f-555">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-186" id="f-556">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-187" decimals="-3" id="f-557" unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-188" decimals="-3" id="f-558" unitRef="usd">769000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-189" decimals="-3" id="f-559" unitRef="usd">21386000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-190" decimals="-3" id="f-560" unitRef="usd">21386000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-191" id="f-561">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-192" id="f-562">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-193" decimals="-3" id="f-563" unitRef="usd">2685000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-194" decimals="-3" id="f-564" unitRef="usd">2627000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-195" decimals="-3" id="f-565" unitRef="usd">2049000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-196" decimals="-3" id="f-566" unitRef="usd">2033000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-3" decimals="-3" id="f-567" unitRef="usd">47206000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-4" decimals="-3" id="f-568" unitRef="usd">47063000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-3" decimals="-3" id="f-569" unitRef="usd">43358000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-4" decimals="-3" id="f-570" unitRef="usd">42884000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-3" decimals="-3" id="f-571" unitRef="usd">3848000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-4" decimals="-3" id="f-572" unitRef="usd">4179000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-5" decimals="-3" id="f-573" unitRef="usd">159000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-6" decimals="-3" id="f-574" unitRef="usd">218000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-1" decimals="-3" id="f-575" unitRef="usd">493000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-3" id="f-576" unitRef="usd">760000</us-gaap:Depreciation>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-577">Right-of-Use Assets and Lease Obligations&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases all realty used at its production and warehouse facilities, corporate headquarters, commercialization operations center and research and laboratory facilities. None of these three leases include the characteristics specified in ASC 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which require classification as financing leases and, accordingly, these leases are accounted for as operating leases. These leases, as amended, provide remaining terms between 3.5 years and 9.0 years, including renewal options expected to be exercised to extend the lease periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the year ended December&#160;31, 2023, the Company recognized a lease supporting its manufacturing facilities as a finance lease. Commitments under finance leases are not significant, and are included in Property and equipment, net, and Notes payable, net on the Condensed Balance Sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not recognize a right-to use asset and lease liability for short-term leases, which have terms of 12 months or less on its Condensed Balance Sheets. For longer-term lease arrangements that are recognized on the Company&#x2019;s Condensed Balance Sheets, the right-of-use asset and lease liability is initially measured at the commencement date based upon the present value of the lease payments due under the lease. These payments represent the combination of the fixed lease and fixed non-lease components that are due under the arrangement. The costs associated with the Company&#x2019;s short-term leases, as well as variable costs relating to the Company&#x2019;s lease arrangements, are not material to the Company&#x2019;s financial results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The implicit interest rates of the Company&#x2019;s lease arrangements are generally not readily determinable and as such, the Company applies an incremental borrowing rate, which is established based upon the information available at the lease commencement date, to determine the present value of lease payments due under an arrangement. Measurement of the operating lease liability reflects a range of an estimated discount rate of 14.8% to 15.6% applied to minimum lease payments, including expected renewals, based on the incremental borrowing rate experienced in the Company&#x2019;s collateralized debt refinancing. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease costs are recorded in manufacture and supply, research and development and selling, general and administrative expenses in its Condensed Statements of Operations and Comprehensive (Loss) Income. For the three and nine months ended September&#160;30, 2024, total operating lease expenses totaled $457 and $1,345, respectively, including variable &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;lease expenses such as common area maintenance and operating costs of $123 and $349, respectively. For the three and nine months ended September&#160;30, 2023, total operating lease expenses totaled $438 and $1,308, respectively, including variable lease expenses such as common area maintenance and operating costs of $109 and $338, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <aqst:NumberOfOperatingLeases contextRef="c-3" decimals="INF" id="f-578" unitRef="lease">3</aqst:NumberOfOperatingLeases>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-197" id="f-579">P3Y6M</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-198" id="f-580">P9Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c-197" decimals="3" id="f-581" unitRef="number">0.148</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:LesseeOperatingLeaseDiscountRate contextRef="c-198" decimals="3" id="f-582" unitRef="number">0.156</us-gaap:LesseeOperatingLeaseDiscountRate>
    <us-gaap:OperatingLeaseCost contextRef="c-5" decimals="-3" id="f-583" unitRef="usd">457000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-584" unitRef="usd">1345000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-5" decimals="-3" id="f-585" unitRef="usd">123000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-586" unitRef="usd">349000</us-gaap:VariableLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-6" decimals="-3" id="f-587" unitRef="usd">438000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-3" id="f-588" unitRef="usd">1308000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-6" decimals="-3" id="f-589" unitRef="usd">109000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-7" decimals="-3" id="f-590" unitRef="usd">338000</us-gaap:VariableLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-591">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s payments due under its operating leases are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.263%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.537%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,284&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,318&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,346&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 and thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,769)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-592" unitRef="usd">317000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-3" decimals="-3" id="f-593" unitRef="usd">1284000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-3" decimals="-3" id="f-594" unitRef="usd">1318000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-3" decimals="-3" id="f-595" unitRef="usd">1346000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter contextRef="c-3" decimals="-3" id="f-596" unitRef="usd">5095000</aqst:LesseeOperatingLeaseLiabilityToBePaidYearFourAndThereafter>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-3" decimals="-3" id="f-597" unitRef="usd">9360000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-3" decimals="-3" id="f-598" unitRef="usd">3769000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-3" decimals="-3" id="f-599" unitRef="usd">5591000</us-gaap:OperatingLeaseLiability>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c-1" id="f-600">Intangible Assets, Net&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of identifiable intangible assets, all of which are finite lived:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased patent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense was $39 for the three months ended September&#160;30, 2023. There was no amortization expense incurred during the three months ended September 30, 2024. For the nine months ended September&#160;30, 2024 and 2023, these expenses totaled $78 and $117, respectively. In June 2024, in connection with a termination of an agreement, the Company recorded a gain on termination of the contract in the amount of $1,500, which was partially offset by an adjustment to the remaining balance of $1,200 of the intangible asset. The net gain of $300 was recorded within Other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024. See Note 5, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Material Agreements.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-601">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of identifiable intangible assets, all of which are finite lived:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased intangible&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchased patent&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;509&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,367&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,367)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,089)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-199" decimals="-3" id="f-602" unitRef="usd">3858000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-200" decimals="-3" id="f-603" unitRef="usd">3858000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-201" decimals="-3" id="f-604" unitRef="usd">509000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-202" decimals="-3" id="f-605" unitRef="usd">509000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-3" decimals="-3" id="f-606" unitRef="usd">4367000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-4" decimals="-3" id="f-607" unitRef="usd">4367000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-3" decimals="-3" id="f-608" unitRef="usd">4367000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-4" decimals="-3" id="f-609" unitRef="usd">3089000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-3" decimals="-3" id="f-610" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-4" decimals="-3" id="f-611" unitRef="usd">1278000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-6" decimals="-3" id="f-612" unitRef="usd">39000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-5" decimals="-3" id="f-613" unitRef="usd">0</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-614" unitRef="usd">78000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-3" id="f-615" unitRef="usd">117000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:GainLossOnDispositionOfIntangibleAssets contextRef="c-1" decimals="-3" id="f-616" unitRef="usd">1500000</us-gaap:GainLossOnDispositionOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsFinitelived contextRef="c-1" decimals="-3" id="f-617" unitRef="usd">1200000</us-gaap:ImpairmentOfIntangibleAssetsFinitelived>
    <us-gaap:GainLossOnContractTermination contextRef="c-5" decimals="-3" id="f-618" unitRef="usd">300000</us-gaap:GainLossOnContractTermination>
    <us-gaap:GainLossOnContractTermination contextRef="c-1" decimals="-3" id="f-619" unitRef="usd">300000</us-gaap:GainLossOnContractTermination>
    <us-gaap:OtherAssetsDisclosureTextBlock contextRef="c-1" id="f-620">Other Non-current Assets&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of other non-current assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the eight $1,000 annual minimum guaranteed royalty payments that are due to the Company. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfer and Servicing&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to determine whether the existing receivable was transferred to Marathon and concluded it was not transferred. As of September&#160;30, 2024 and December&#160;31, 2023, Royalty receivable consists of four and five, respectively, annual minimum payments due from Sunovion, the last of which is due in March 2028. The current portion of the royalty receivable is included in Trade and other receivables, net. See Note 15, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Sale of Future Revenue&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for further details on how this receivable relates to the Monetization Agreement transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-current portion of commissions capitalized under ASC 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;is recorded within Other non-current assets on the Condensed Balance Sheets. Commissions of $191 were expensed in Selling, general, and administrative expenses on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2024 due to the termination of the underlying contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:OtherAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock contextRef="c-1" id="f-621">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides the components of other non-current assets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total other non-current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,230&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock>
    <aqst:CumulativeRoyaltyReceivable contextRef="c-3" decimals="-3" id="f-622" unitRef="usd">3000000</aqst:CumulativeRoyaltyReceivable>
    <aqst:CumulativeRoyaltyReceivable contextRef="c-4" decimals="-3" id="f-623" unitRef="usd">4000000</aqst:CumulativeRoyaltyReceivable>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-3" decimals="-3" id="f-624" unitRef="usd">1230000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsMiscellaneousNoncurrent contextRef="c-4" decimals="-3" id="f-625" unitRef="usd">1438000</us-gaap:OtherAssetsMiscellaneousNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-3" decimals="-3" id="f-626" unitRef="usd">4230000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-4" decimals="-3" id="f-627" unitRef="usd">5438000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-203" decimals="-3" id="f-628" unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <aqst:NumberOfGuaranteedRoyaltyPayments
      contextRef="c-5"
      decimals="INF"
      id="f-629"
      unitRef="payment">8</aqst:NumberOfGuaranteedRoyaltyPayments>
    <aqst:MinimumAnnualRoyaltyReceivable contextRef="c-204" decimals="-3" id="f-630" unitRef="usd">1000000</aqst:MinimumAnnualRoyaltyReceivable>
    <aqst:NumberOfAnnualRoyaltyPaymentsReceivable
      contextRef="c-204"
      decimals="INF"
      id="f-631"
      unitRef="payment">4</aqst:NumberOfAnnualRoyaltyPaymentsReceivable>
    <aqst:NumberOfAnnualRoyaltyPaymentsReceivable
      contextRef="c-205"
      decimals="INF"
      id="f-632"
      unitRef="payment">5</aqst:NumberOfAnnualRoyaltyPaymentsReceivable>
    <us-gaap:SalesCommissionsAndFees contextRef="c-206" decimals="-3" id="f-633" unitRef="usd">191000</us-gaap:SalesCommissionsAndFees>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock contextRef="c-1" id="f-634">Accrued Expenses&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate and personal property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued distribution expenses and sales returns provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reduction in Accrued compensation is related to payments of accrued bonuses during the nine months ended September 30, 2024, partially offset by the current year accrual of bonuses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The decrease in Interest payable is mostly due to the timing of interest payments on the 13.5% Senior Notes. The third quarter 2024 interest payment on the 13.5% Senior Notes was made on September&#160;30, 2024. As of December&#160;31, 2023, interest payable on the 13.5% Senior Notes was due on January 2, 2024. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for discussion of 13.5% Notes and related interest payable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued distribution expenses and sales returns provision mostly represent estimated liabilities for wholesaler service fees, co-pay support redemptions and other rebates related to the proprietary product Libervant. and returns and other expenses related to the proprietary product Sympazan (prior to outlicensing to Assertio in October 2022).&lt;/span&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-635">&lt;div style="margin-bottom:6pt;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;br/&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Real estate and personal property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued distribution expenses and sales returns provision&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;640&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest payable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-636" unitRef="usd">3457000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-637" unitRef="usd">4202000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-3" decimals="-3" id="f-638" unitRef="usd">473000</us-gaap:TaxesPayableCurrent>
    <us-gaap:TaxesPayableCurrent contextRef="c-4" decimals="-3" id="f-639" unitRef="usd">337000</us-gaap:TaxesPayableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-140" decimals="-3" id="f-640" unitRef="usd">640000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-142" decimals="-3" id="f-641" unitRef="usd">645000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InterestPayableCurrent contextRef="c-3" decimals="-3" id="f-642" unitRef="usd">17000</us-gaap:InterestPayableCurrent>
    <us-gaap:InterestPayableCurrent contextRef="c-4" decimals="-3" id="f-643" unitRef="usd">1013000</us-gaap:InterestPayableCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-644" unitRef="usd">438000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-645" unitRef="usd">300000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-3" decimals="-3" id="f-646" unitRef="usd">5025000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-4" decimals="-3" id="f-647" unitRef="usd">6497000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-648" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-649" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-650" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-651" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-652">Long-Term Debt&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt; 12.5% Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 15, 2019, the Company completed a private placement of up to $100,000 aggregate principal of its 12.5% Notes which were due 2025 and issued Warrants to purchase 2,000,000 shares of Common Stock at $0.001 par value per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon closing of the Base Indenture, the Company issued $70,000 of the 12.5% Notes (the &#x201c;Initial Notes&#x201d;) along with the Warrants and rights of first offer (the &#x201c;First Offer Rights&#x201d;) to the noteholders participating in this transaction. Issuance of the Initial Notes and Warrants provided net proceeds of $66,082.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 3, 2020, the Company entered into the First Supplemental Indenture (the &#x201c;First Supplemental Indenture&#x201d; and, together with all other subsequent supplemental indentures and the Base Indenture, collectively, the &#x201c;Indenture&#x201d;) by and among the Company and U.S. Bank National Association, as Trustee (the &#x201c;Trustee&#x201d;) and Collateral Agent thereunder to the Base Indenture, by and between the Company and the Trustee. Under the Second Supplemental Indenture, the Company repaid $22,500 of its $70,000 outstanding 12.5% Notes from the upfront proceeds received under the Monetization Agreement. Further, the Company entered into an additional Purchase Agreement with its noteholders whereby the Company issued in aggregate $4,000 of additional 12.5% Notes (the &#x201c;Additional Notes&#x201d;) in lieu of paying a prepayment premium to two noteholders on the early repayment of the 12.5% Notes discussed above. The result of these two transactions reduced the net balance of the Company&#x2019;s 12.5% Notes outstanding in the aggregate to $51,500 at December 31, 2020. The $4,000 principal issuance would be repaid proportionally over the same maturities as the other 12.5% Notes. The Company also paid to one of its noteholders a $2,250 premium as result of the early retirement of debt. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounted for the $22,500 debt repayment as a debt modification of the 12.5% Notes. The fees paid to noteholders inclusive of (i) a $2,250 early premium prepayment and (ii) $4,000 issuance of Additional Notes in lieu of paying a prepayment penalty were recorded as additional debt discount, amortized over the remaining life of the 12.5% Notes using the effective interest method. Loan origination costs of $220 associated with the Additional Notes were expensed as incurred. Existing deferred discounts and loan origination fees on the 12.5% Notes are amortized as an adjustment of interest expense over the remaining term of modified debt using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The First Supplemental Indenture contained a provision whereby, as the Company receives any cash proceeds from the Monetization Agreement, each noteholder had the right to require the Company to redeem all or any part of such noteholder&#x2019;s outstanding 12.5% Notes at a repurchase price in cash equal to 112.5% of the principal amount, plus accrued and unpaid interest. This repurchase offer was capped at 30% of the cash proceeds received by the Company as the contingent milestones were attained, if any, up through June 30, 2025. The embedded put option was deemed to be a derivative under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 815, Derivatives and Hedging&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which required the recording of the embedded put option at fair value subject to remeasurement at each reporting period. Accordingly, a valuation study was performed by an independent third party appraiser and updated in June 30, 2023. Based on the valuation study, the put option was valued at $0. The put option fair value decreased by $45 and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;was recorded in interest income and other income, net on the Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September 30, 2023. There was no change in fair value during the three months ended September 30, 2023. In addition, as of the closing of this transaction, the Company issued to the holders of the 12.5% Notes warrants to purchase 143,000 shares of the Company&#x2019;s Common Stock. As of September&#160;30, 2024, the put option is no longer in place due to the refinancing of the 12.5% Notes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October 7, 2021, the Company entered into the Fourth Supplemental Indenture, pursuant to which the amortization schedule for the 12.5% Notes was amended to provide for the date of the first principal payment to be extended from September 30, 2021 to March 30, 2023. The Fourth Supplemental Indenture did not change the maturity date of the 12.5% Notes or the interest payment obligation due under the 12.5% Notes. In connection with the Fourth Supplemental Indenture, the Company entered into a Consent Fee Letter with the holders of the 12.5% Notes (the &#x201c;Consent Fee Letter&#x201d;), pursuant to which the Company agreed to pay the holders of the 12.5% Notes an additional cash payment ("Consent Fee") of $2,700 in the aggregate, payable in four quarterly payments beginning May 15, 2022. The last Consent Fee installment of $675 was made in February 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 12.5% Notes provided a stated fixed interest rate of 12.5%, payable quarterly in arrears, with the final quarterly principal repayment of the 12.5% Notes due at maturity on June 30, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company could have elected, at its option, to redeem the 12.5% Notes at any time at premiums that range from 101.56% of outstanding principal if prepayment occurs on or after the fifth anniversary of the issue date of the Initial Notes to 112.50% if payment occurs during the third year after the issuance of the 12.5% Notes. The Indenture also included change of control provisions under which the Company would have been required to redeem the 12.5% Notes at 101% of the remaining principal plus accrued interest at the election of the noteholders.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the nine months ended September 30 2023, the Company redeemed $5,647 of its outstanding 12.5% Notes. The Company also paid $353 in prepayment premium as result of the early retirement of debt which was reflected as a loss on extinguishment of debt on the Company's Condensed Statements of Operations and Comprehensive (Loss) Income for the nine months ended September&#160;30, 2023. The prepayments along with the scheduled principal payments of $6,878 during the nine months ended September 30, 2023 reduced the net balance of the 12.5% Notes outstanding in the aggregate to $38,975 as of September&#160;30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense arising from amortization of deferred debt issuance costs and debt discounts related to the 12.5% Notes for the three and nine months ended September&#160;30, 2023 was $3 and $11, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, the Company issued the 13.5% Notes, as described below, and used most of the proceeds from the issuance to repay the outstanding principal balance under the 12.5% Notes of $36,014, including accrued and unpaid interest and a redemption fee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"&gt;13.5% Senior Secured Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 1, 2023, the Company entered into an Indenture Agreement with certain institutional investors (the &#x201c;Note Holders&#x201d;) and issued $45,000 aggregate principal amount of its 13.5% Notes due 2028. The Company received net proceeds of approximately $4,326 from this transaction after the repayment of the 12.5% Notes and deduction of debt discount, and debt issuance costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The 13.5% Notes are senior secured obligations of the Company and mature on November 1, 2028. The 13.5% Notes bear interest at a fixed rate of 13.5% per year, payable quarterly commencing on December 30, 2023; the first interest payment was due and paid on January 2, 2024. On each payment date commencing on June 30, 2026, the Company will pay an installment of principal of the 13.5% Notes pursuant to a fixed amortization schedule, along with the applicable Exit Fee. The Exit Fee totals $2,000.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may, at its option, redeem the 13.5% Notes in full or in part:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;if such redemption occurs prior to November 1, 2025, at a redemption price equal to 100% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee, plus an Applicable Premium which is the greater of &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:-23.27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;i.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"&gt;1.0% of the principal redeemed; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:72pt;text-align:justify;text-indent:-26.04pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ii.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18pt"&gt;the amount, if any, by which the present value of the principal to be redeemed on November 1, 2025, plus all required interest due on such date, computed using a discount rate equal to the Treasury Rate, plus 100 basis points, exceeds the amount of principal to be redeemed; and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;if such redemption occurs after November 1, 2025, the redemption price is equal to 108.5% of the principal amount plus accrued and unpaid interest, plus the applicable Exit Fee. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company undergoes a change of control, the Note Holders may require the Company to repurchase for cash all or any portion of the 13.5% Notes at a change of control repurchase price equal at 108.5% plus the Exit Fee of the remaining principal, plus accrued interest at the election of the Note Holders. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Indenture permits the Company, upon the continuing satisfaction of certain conditions, including that the Company has at least $100,000 of net revenues for the most recently completed twelve calendar month period, to enter into an ABL facility not to exceed $10,000. The ABL Facility may be collateralized only by assets of the Company constituting inventory, accounts receivable, and the proceeds thereof. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the issuance of 13.5% Notes, the Company and the Note Holders entered into the Royalty Right Agreements dated as of November 1, 2023, which provides Note Holders:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;a tiered royalty between 1.0% and 2.0% of annual worldwide net sales of Anaphylm&#x2122; (epinephrine) Sublingual Film for a period of 8 years from the first sale of Anaphylm on a global basis, and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;a tiered royalty between 1.0% to 2.0% of annual worldwide net sales of Libervant&#x2122; (diazepam) Buccal Film until the earlier of (1) the first sale of Anaphylm and (2) eight years from the first sale of Libervant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Both the 13.5% Notes and Royalty Right Agreements, represent freestanding instruments which were issued in conjunction with each other. They are classified as debt within the scope of ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and are subsequently measured on an amortized cost basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The initial fair value measurement of the Royalty Right Agreements was determined based on significant unobservable inputs, including the discount rate, estimated probabilities of success, and the estimated amount of future sales of Anaphylm and Libervant. These inputs are derived using internal management estimates developed based on third-party data and reflect management&#x2019;s judgements, current market conditions, and forecasts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Royalty Right Agreements&#x2019; fair value is estimated by applying probability-weighted cash flows for future sales, which are then discounted to present value. Changes to fair value of the Royalty Rights Agreements can result from changes to one or a number of the aforementioned inputs. A significant change in unobservable inputs could result in a material increase or decrease to the effective interest rate of the Royalty Right Agreements liability. &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2024, there were no material changes to the significant unobservable inputs used to recognize the Royalty Right Agreements liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant unobservable inputs used in the initial fair value measurement of the Royalty Right Agreements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Methodology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (range, if applicable)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty Right Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighted&lt;br/&gt;income approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Years of Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since the Royalty Right Agreements were issued in connection with the 13.5% Notes, the Company allocated the proceeds to the two instruments based on their relative fair values. The Company allocated approximately $13,856 to the Royalty Right Agreements. The Company determined the allocated fair value by calculating the present value of estimated future royalties to be paid to Note Holders over the life of the arrangement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The excess of future estimated royalty payments of $56,926 over the $13,856 of allocated fair value is recognized as a discount related to the Royalty Right Agreements and is amortized as interest expense using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At inception, the allocated amounts of $13,856 when combined with the Exit Fee of $2,000, original issue discount of $1,125 and debt issuance costs of $3,517, resulted in a debt discount of $20,498. The debt discount is being amortized over the term of 13.5% Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense arising from the discounts related to the 13.5% Notes for the three and nine months ended September&#160;30, 2024 was $1,254 and $3,765, respectively. Amortization expense arising from the discounts related to the Royalty Right Agreements for the three and nine months ended September&#160;30, 2024 was $1,359 and $4,075, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized discounts totaled $13,900 and $17,665 for the 13.5% Notes and $38,091 and $42,165 for the Royalty obligations as of September&#160;30, 2024 and December&#160;31, 2023, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term notes and unamortized debt discount balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount, including Exit Fee&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The current portion of royalty obligations payable is not material as of September 30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments on the 13.5% Notes as of September&#160;30, 2024 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-653" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-208" decimals="-3" id="f-654" unitRef="usd">100000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-655" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-209" decimals="0" id="f-656" unitRef="shares">2000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-209"
      decimals="3"
      id="f-657"
      unitRef="usdPerShare">0.001</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-207" decimals="-3" id="f-658" unitRef="usd">70000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-659" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights contextRef="c-210" decimals="-3" id="f-660" unitRef="usd">66082000</aqst:NetProceedsFromIssuanceOfInitialNotesWarrantsAndFirstOfferRights>
    <us-gaap:RepaymentsOfDebt contextRef="c-211" decimals="-3" id="f-661" unitRef="usd">22500000</us-gaap:RepaymentsOfDebt>
    <us-gaap:LongTermDebt contextRef="c-212" decimals="-3" id="f-662" unitRef="usd">70000000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-663" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-213" decimals="-3" id="f-664" unitRef="usd">4000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-665" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:DebtInstrumentNumberOfNoteholders
      contextRef="c-211"
      decimals="INF"
      id="f-666"
      unitRef="noteholder">2</aqst:DebtInstrumentNumberOfNoteholders>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-667" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:DebtInstrumentNumberOfTransactions
      contextRef="c-214"
      decimals="INF"
      id="f-668"
      unitRef="transaction">2</aqst:DebtInstrumentNumberOfTransactions>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-669" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-214" decimals="-3" id="f-670" unitRef="usd">51500000</us-gaap:LongTermDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-213" decimals="-3" id="f-671" unitRef="usd">4000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-672" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:PremiumsPaidEarlyRetirementOfDebt contextRef="c-215" decimals="-3" id="f-673" unitRef="usd">2250000</aqst:PremiumsPaidEarlyRetirementOfDebt>
    <us-gaap:RepaymentsOfDebt contextRef="c-211" decimals="-3" id="f-674" unitRef="usd">22500000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-675" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:PremiumsPaidEarlyRetirementOfDebt contextRef="c-211" decimals="-3" id="f-676" unitRef="usd">2250000</aqst:PremiumsPaidEarlyRetirementOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt contextRef="c-211" decimals="-3" id="f-677" unitRef="usd">4000000</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-678" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsOfLoanCosts contextRef="c-213" decimals="-3" id="f-679" unitRef="usd">220000</us-gaap:PaymentsOfLoanCosts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-680" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-681" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-211" decimals="3" id="f-682" unitRef="number">1.125</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <aqst:DebtInstrumentCovenantMilestoneCapPercentageThreshold contextRef="c-216" decimals="2" id="f-683" unitRef="number">0.30</aqst:DebtInstrumentCovenantMilestoneCapPercentageThreshold>
    <us-gaap:DerivativeLiabilitiesNoncurrent contextRef="c-217" decimals="-3" id="f-684" unitRef="usd">0</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-218" decimals="-3" id="f-685" unitRef="usd">-45000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax contextRef="c-219" decimals="-3" id="f-686" unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-687" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod
      contextRef="c-220"
      decimals="-3"
      id="f-688"
      unitRef="shares">143000</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-689" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-690" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-691" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-692" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-693" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-694" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:PaymentsOfDebtExtinguishmentCosts contextRef="c-221" decimals="-3" id="f-695" unitRef="usd">2700000</us-gaap:PaymentsOfDebtExtinguishmentCosts>
    <aqst:DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments
      contextRef="c-222"
      decimals="INF"
      id="f-696"
      unitRef="quarterlyinstallment">4</aqst:DebtInstrumentAdditionalPaymentNumberOfQuarterlyInstallments>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-223" decimals="-3" id="f-697" unitRef="usd">675000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-698" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-699" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-700" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-701" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:ElectiveRedemptionPercentageOfDebt contextRef="c-224" decimals="4" id="f-702" unitRef="number">1.0156</aqst:ElectiveRedemptionPercentageOfDebt>
    <aqst:ElectiveRedemptionPercentageOfDebt contextRef="c-225" decimals="4" id="f-703" unitRef="number">1.1250</aqst:ElectiveRedemptionPercentageOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-704" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-705" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:RedemptionPercentageOfDebtUnderChangeOfControlProvisions contextRef="c-226" decimals="2" id="f-706" unitRef="number">1.01</aqst:RedemptionPercentageOfDebtUnderChangeOfControlProvisions>
    <us-gaap:RepaymentsOfDebt contextRef="c-227" decimals="-3" id="f-707" unitRef="usd">5647000</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-708" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt contextRef="c-227" decimals="-3" id="f-709" unitRef="usd">-353000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DebtInstrumentPeriodicPaymentPrincipal contextRef="c-228" decimals="-3" id="f-710" unitRef="usd">6878000</us-gaap:DebtInstrumentPeriodicPaymentPrincipal>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-711" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebt contextRef="c-229" decimals="-3" id="f-712" unitRef="usd">38975000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-713" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-230" decimals="-3" id="f-714" unitRef="usd">3000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts contextRef="c-231" decimals="-3" id="f-715" unitRef="usd">11000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-716" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-717" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-232" decimals="-3" id="f-718" unitRef="usd">36014000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-719" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-177" decimals="-3" id="f-720" unitRef="usd">45000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-721" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt contextRef="c-233" decimals="-3" id="f-722" unitRef="usd">4326000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-207" decimals="3" id="f-723" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-724" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-725" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-726" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-727" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFeeAmount contextRef="c-234" decimals="-3" id="f-728" unitRef="usd">2000000</us-gaap:DebtInstrumentFeeAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-729" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-235" decimals="2" id="f-730" unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed contextRef="c-235" decimals="2" id="f-731" unitRef="number">0.010</us-gaap:DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed>
    <aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate contextRef="c-235" decimals="2" id="f-732" unitRef="number">0.0100</aqst:DebtInstrumentRedemptionPriceBasisSpreadOnVariableRate>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-236" decimals="3" id="f-733" unitRef="number">1.085</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-734" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage contextRef="c-233" decimals="3" id="f-735" unitRef="number">1.085</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold contextRef="c-237" decimals="-3" id="f-736" unitRef="usd">100000</aqst:LineOfCreditFacilityAccordionFeatureNetRevenueThreshold>
    <aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit contextRef="c-238" decimals="-3" id="f-737" unitRef="usd">10000</aqst:LineOfCreditFacilityAccordionFeatureIncreaseLimit>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-738" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-178" decimals="3" id="f-739" unitRef="number">0.010</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-179" decimals="3" id="f-740" unitRef="number">0.020</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-180" id="f-741">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-178" decimals="3" id="f-742" unitRef="number">0.010</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentage contextRef="c-179" decimals="3" id="f-743" unitRef="number">0.020</aqst:DebtInstrumentCovenantTieredRoyaltyPercentage>
    <aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm contextRef="c-180" id="f-744">P8Y</aqst:DebtInstrumentCovenantTieredRoyaltyPercentageTerm>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-745" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-746">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant unobservable inputs used in the initial fair value measurement of the Royalty Right Agreements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:24.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.438%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.256%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.700%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.431%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Valuation Methodology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Significant Unobservable Input&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average (range, if applicable)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Discount Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty Right Agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability weighted&lt;br/&gt;income approach&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Probability of Success&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Projected Years of Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2033&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:LongTermDebtMeasurementInput contextRef="c-239" decimals="2" id="f-747" unitRef="number">0.15</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:LongTermDebtMeasurementInput contextRef="c-240" decimals="2" id="f-748" unitRef="number">0.75</us-gaap:LongTermDebtMeasurementInput>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-749" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtFairValue contextRef="c-241" decimals="-3" id="f-750" unitRef="usd">13856000</us-gaap:LongTermDebtFairValue>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-241" decimals="-3" id="f-751" unitRef="usd">56926000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-241" decimals="-3" id="f-752" unitRef="usd">13856000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:LongTermDebtFairValue contextRef="c-242" decimals="-3" id="f-753" unitRef="usd">13856000</us-gaap:LongTermDebtFairValue>
    <aqst:DebtInstrumentExitFee contextRef="c-243" decimals="-3" id="f-754" unitRef="usd">2000000</aqst:DebtInstrumentExitFee>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet contextRef="c-242" decimals="-3" id="f-755" unitRef="usd">1125000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumNet>
    <us-gaap:DeferredFinanceCostsNet contextRef="c-242" decimals="-3" id="f-756" unitRef="usd">3517000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet contextRef="c-242" decimals="-3" id="f-757" unitRef="usd">20498000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-758" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-759" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-244" decimals="-3" id="f-760" unitRef="usd">1254000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-245" decimals="-3" id="f-761" unitRef="usd">3765000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-246" decimals="-3" id="f-762" unitRef="usd">1359000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:AmortizationOfDebtDiscountPremium contextRef="c-247" decimals="-3" id="f-763" unitRef="usd">4075000</us-gaap:AmortizationOfDebtDiscountPremium>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-234" decimals="-3" id="f-764" unitRef="usd">13900000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-248" decimals="-3" id="f-765" unitRef="usd">17665000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-766" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-249" decimals="-3" id="f-767" unitRef="usd">38091000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-250" decimals="-3" id="f-768" unitRef="usd">42165000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock contextRef="c-1" id="f-769">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term notes and unamortized debt discount balances are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total outstanding notes&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount, including Exit Fee&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,900)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,665)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease, long-term&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Notes payable, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,508&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unamortized discount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,091)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(42,165)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalty obligations, net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-234" decimals="-3" id="f-770" unitRef="usd">45000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-248" decimals="-3" id="f-771" unitRef="usd">45000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-234" decimals="-3" id="f-772" unitRef="usd">13900000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-248" decimals="-3" id="f-773" unitRef="usd">17665000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-234" decimals="-3" id="f-774" unitRef="usd">31100000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent contextRef="c-248" decimals="-3" id="f-775" unitRef="usd">27335000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-234" decimals="-3" id="f-776" unitRef="usd">153000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-248" decimals="-3" id="f-777" unitRef="usd">173000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-234" decimals="-3" id="f-778" unitRef="usd">31253000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:LongTermDebtAndCapitalLeaseObligations contextRef="c-248" decimals="-3" id="f-779" unitRef="usd">27508000</us-gaap:LongTermDebtAndCapitalLeaseObligations>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-249" decimals="-3" id="f-780" unitRef="usd">56926000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount contextRef="c-250" decimals="-3" id="f-781" unitRef="usd">56926000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-249" decimals="-3" id="f-782" unitRef="usd">38091000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount contextRef="c-250" decimals="-3" id="f-783" unitRef="usd">42165000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:LongTermDebt contextRef="c-249" decimals="-3" id="f-784" unitRef="usd">18835000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt contextRef="c-250" decimals="-3" id="f-785" unitRef="usd">14761000</us-gaap:LongTermDebt>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock contextRef="c-1" id="f-786">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Scheduled principal payments on the 13.5% Notes as of September&#160;30, 2024 are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.303%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.497%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,535&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-177" decimals="3" id="f-787" unitRef="number">0.135</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear contextRef="c-3" decimals="-3" id="f-788" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths contextRef="c-3" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo contextRef="c-3" decimals="-3" id="f-790" unitRef="usd">9540000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree contextRef="c-3" decimals="-3" id="f-791" unitRef="usd">14535000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour contextRef="c-3" decimals="-3" id="f-792" unitRef="usd">20925000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour>
    <us-gaap:LongTermDebt contextRef="c-3" decimals="-3" id="f-793" unitRef="usd">45000000</us-gaap:LongTermDebt>
    <aqst:WarrantsDisclosureTextBlock contextRef="c-1" id="f-794">Warrants&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants Issued to 12.5% Senior Secured Noteholders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrants that were issued in conjunction with the Initial Notes (the &#x201c;Initial Warrants&#x201d;) and Additional Notes (the &#x201c;Additional Warrants&#x201d;) expire on June 30, 2025 and entitled the noteholders to purchase up to 2,143,000 shares of Common Stock and included specified registration rights. Management estimated the fair value of the Initial Warrants to be $6,800 and the Additional Warrants to be $735, each based on an assessment by an independent third-party appraiser. The fair value of the respective warrants was treated as a debt discount, amortizable over the term of the respective warrants, with the unamortized 12.5% Notes portion applied to reduce the aggregate principal amount of the 12.5% Notes. Additionally, since the Initial Warrants and Additional Warrants issued do not provide warrant redemption or put rights within the control of the holders that could require the Company to make a payment of cash or other assets to satisfy the obligations under the warrants, except in the case of a &#x201c;cash change in control&#x201d;, the fair value attributed to the warrants is presented in Additional Paid-in Capital in the Company&#x2019;s unaudited Condensed Balance Sheets. There were no warrants exercised as it relates to the Initial Warrants and the Additional Warrants during the nine months ended September&#160;30, 2024 and 2023, respectively. Warrants to purchase a total of 1,714,429 shares of Common Stock with exercise prices of $4.25 and $5.38 for 1,571,429 warrants and 143,000 warrants, respectively, remain outstanding as of September&#160;30, 2024 and December&#160;31, 2023. See Note 13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Long-Term Debt.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warrants Issued Under Securities Purchase Agreements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2022, the Company issued pre-funded warrants and Common Stock warrants to certain purchasers in connection with the Securities Purchase Agreements. The pre-funded warrants entitled purchasers to purchase up to 4,000,000 shares of Common Stock and were exercised in full during the year ended December 31, 2022. The Common Stock warrants expire on June 8, 2027 and entitled the purchasers to purchase up to 8,850,000 shares of Common Stock at an exercise price of $0.96 per share. Management estimated the fair value of the pre-funded warrants and Common Stock warrants to be $5,874 based on an assessment by an independent third-party appraiser. The fair value of the pre-funded and Common Stock warrants is treated as equity and presented in Additional Paid-in Capital in the Company&#x2019;s unaudited Condensed Balance Sheets. On June 14, 2023, 3,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements were exercised with proceeds of approximately $3,542.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2023, the Company entered into the Letter Agreement with the Exercising Holder of 5,000,000 of the remaining Common Stock Warrants. Pursuant to the Letter Agreement, the Exercising Holder and the Company agreed that the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Exercising Holder would exercise all of its Existing Warrants for shares of Common Stock underlying the Existing Warrants at $0.96 per share of Common Stock, the current exercise price of the Existing Warrants. Under the Letter Agreement, in consideration of the Exercising Holder exercising the Existing Warrants, the Company issued to the Exercising Holder New Warrants to purchase up to an aggregate of 2,750,000 shares of Common Stock. The New Warrants became exercisable after February 2, 2024, expire on February 2, 2029 and are issuable only for cash, subject to exception if the shares of Common Stock underlying the New Warrants are not registered in accordance with the terms of the Letter Agreement, in which case the New Warrants may also be exercised, in whole or in part, at such time by means of a "cashless exercise". The New Warrants have an exercise price of $2.60 per share. Management estimated the fair value of the warrants to be $4,671 based on an assessment by an independent third-party appraiser. The fair value of the New Warrants is treated as equity and is presented in Additional Paid-in Capital in the Company&#x2019;s Condensed Balance Sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 2, 2023, 5,000,000 of the Existing Warrants were exercised pursuant to the Securities Purchase Agreement with the Exercising Holder, with the Company receiving gross proceeds therefrom of $4,800. In total, 8,689,452 Common Stock warrants issued pursuant to the Securities Purchase Agreements with net proceeds of approximately $8,307 were exercised during the year ended December 31, 2023. The Company incurred $35 in relation to this transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no warrants issued or exercised as it relates to the Warrants Issued Under Securities Purchase Agreements during the nine months ended September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the warrants to purchase 2,750,000 shares of Common Stock described above, there remain outstanding warrants to purchase 160,548 shares of Common Stock at an exercise price of $0.96 and warrants to purchase 1,714,429 shares of Common Stock outstanding related to the original issuance of the 12.5% Notes prior to the debt refinancing described above in this Note 14, with exercise prices of $4.25 and $5.38 for 1,571,429 warrants and 143,000 warrants, respectively.&lt;/span&gt;&lt;/div&gt;</aqst:WarrantsDisclosureTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-795" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-251" decimals="0" id="f-796" unitRef="shares">2143000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure contextRef="c-252" decimals="-3" id="f-797" unitRef="usd">6800000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:WarrantsNotSettleableInCashFairValueDisclosure contextRef="c-253" decimals="-3" id="f-798" unitRef="usd">735000</us-gaap:WarrantsNotSettleableInCashFairValueDisclosure>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-799" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-800" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <aqst:ClassOfWarrantOrRightWarrantsExercised contextRef="c-7" decimals="0" id="f-801" unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <aqst:ClassOfWarrantOrRightWarrantsExercised contextRef="c-1" decimals="0" id="f-802" unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-254" decimals="0" id="f-803" unitRef="shares">1714429</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-254"
      decimals="2"
      id="f-804"
      unitRef="usdPerShare">4.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-255"
      decimals="2"
      id="f-805"
      unitRef="usdPerShare">5.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-254" decimals="0" id="f-806" unitRef="shares">1571429</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-255" decimals="0" id="f-807" unitRef="shares">143000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-256" decimals="0" id="f-808" unitRef="shares">4000000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-257" decimals="0" id="f-809" unitRef="shares">8850000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-258"
      decimals="2"
      id="f-810"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-259" decimals="-3" id="f-811" unitRef="usd">5874000</us-gaap:WarrantsAndRightsOutstanding>
    <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod contextRef="c-260" decimals="0" id="f-812" unitRef="shares">3689452</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-260" decimals="-3" id="f-813" unitRef="usd">3542000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-175" decimals="0" id="f-814" unitRef="shares">5000000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-175"
      decimals="2"
      id="f-815"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-176" decimals="0" id="f-816" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-176" decimals="0" id="f-817" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-176"
      decimals="2"
      id="f-818"
      unitRef="usdPerShare">2.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:WarrantsAndRightsOutstanding contextRef="c-176" decimals="-3" id="f-819" unitRef="usd">4671000</us-gaap:WarrantsAndRightsOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-261" decimals="0" id="f-820" unitRef="shares">5000000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-261" decimals="-3" id="f-821" unitRef="usd">4800000</us-gaap:ProceedsFromWarrantExercises>
    <aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod contextRef="c-262" decimals="0" id="f-822" unitRef="shares">8689452</aqst:ClassOfWarrantOrRightWarrantsIssuedDuringPeriod>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-263" decimals="-3" id="f-823" unitRef="usd">8307000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts contextRef="c-262" decimals="-3" id="f-824" unitRef="usd">35000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <aqst:ClassOfWarrantOrRightWarrantsExercised contextRef="c-7" decimals="0" id="f-825" unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <aqst:ClassOfWarrantOrRightWarrantsExercised contextRef="c-1" decimals="0" id="f-826" unitRef="shares">0</aqst:ClassOfWarrantOrRightWarrantsExercised>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-176" decimals="0" id="f-827" unitRef="shares">2750000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-264" decimals="0" id="f-828" unitRef="shares">160548</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-265"
      decimals="2"
      id="f-829"
      unitRef="usdPerShare">0.96</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights contextRef="c-266" decimals="0" id="f-830" unitRef="shares">1714429</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage contextRef="c-173" decimals="3" id="f-831" unitRef="number">0.125</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-267"
      decimals="2"
      id="f-832"
      unitRef="usdPerShare">4.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-268"
      decimals="2"
      id="f-833"
      unitRef="usdPerShare">5.38</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-267" decimals="0" id="f-834" unitRef="shares">1571429</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-268" decimals="0" id="f-835" unitRef="shares">143000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <aqst:SaleOfFutureRevenueTextBlock contextRef="c-1" id="f-836">Sale of Future Revenue&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 3, 2020, the Company entered into the Monetization Agreement with Marathon. Under the terms of the Monetization Agreement, the Company sold all of its contractual rights to receive royalties and milestone payments due under the Sunovion License Agreement related to Sunovion&#x2019;s apomorphine product, KYNMOBI, an apomorphine film therapy for the treatment of off episodes in Parkinson&#x2019;s disease patients, which received approval from the FDA on May 21, 2020. In exchange for the sale of these rights, the Company received an upfront payment of $40,000 and an additional payment of $10,000 through the achievement of the first milestone. The Company has received an aggregate amount of $50,000 through September&#160;30, 2024 under the Monetization Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Monetization Agreement, additional contingent payments of up to $75,000 may be due to the Company upon the achievement of worldwide royalty and other commercial targets within a specified timeframe, which could result in total potential proceeds of $125,000. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded the upfront proceeds of $40,000 and subsequent first milestone of $10,000, reduced by $2,909 of transaction costs, as a liability related to the sale of future revenue that will be amortized using the effective interest method over the life of the Monetization Agreement. As future contingent payments are received, they will increase the balance of the liability related to the sale of future revenue. Although the Company sold all of its rights to receive royalties and milestones, as a result of ongoing obligations related to the generation of these royalties, the Company will account for these royalties as revenue. Its ongoing obligations include the maintenance and defense of the intellectual property and to provide assistance to Marathon in executing a new license agreement for KYNMOBI in the event Sunovion terminates the Sunovion License Agreement in one or more jurisdictions of the licensed territory under the Sunovion License Agreement. The accounting liabilities, as adjusted over time, resulting from this transaction and any non-cash interest expenses associated with those liabilities do not and will not represent any obligation to pay or any potential future use of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the second quarter of 2020, under the Sunovion License Agreement, the Company recognized $8,000 of royalty revenue and corresponding royalty receivable, related to the $1,000 annual minimum guaranteed royalty that is due. In connection with the Monetization Agreement, the Company performed an assessment under ASC 860, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Transfer and Servicing &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to determine whether the existing receivable was transferred to Marathon and concluded that the receivable was not transferred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As royalties are remitted to Marathon from Sunovion, the collection of the royalty receivable and balance of the liability related to the sale of future revenue will be effectively repaid over the life of the agreement. In order to determine the amortization of the liability related to the sale of future revenue, the Company is required to estimate the total amount of future royalty and milestone payments to Marathon over the life of the Monetization Agreement and contingent milestone payments from Marathon to the Company. The sum of future royalty payments less the $50,000 in proceeds received and future contingent payments has been recorded as interest expense over the life of the Monetization Agreement. At execution, the estimate of this total interest expense resulted in an effective annual interest rate of approximately 24.9%. This estimate contained significant assumptions that impact both the amount recorded at execution and the interest expense that will be recognized over the life of the Monetization Agreement. The Company assesses the estimated royalty and milestone payments &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to Marathon from Sunovion and contingent milestone payments from Marathon to the Company. To the extent the amount or timing of such payments is materially different from the original estimates, an adjustment will be recorded prospectively to increase or decrease interest expense. There are a number of factors that could materially affect the amount and timing of royalty and milestone payments to Marathon from Sunovion and, correspondingly, the amount of interest expense recorded by the Company, most of which are not under the Company&#x2019;s control. Such factors include, but are not limited to, changing standards of care, the initiation of competing products, manufacturing or other delays, generic competition, intellectual property matters, adverse events that result in government health authority imposed restrictions on the use of products, significant changes in foreign exchange rates as the royalties remitted to Marathon are made in U.S. dollars (USD) while a portion of the underlying sales of KYNMOBI will be made in currencies other than USD, and other events or circumstances that are not currently foreseen. Changes to any of these factors could result in increases or decreases to both royalty revenue and interest expense related to the sale of future revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, Sunovion announced that it had voluntarily withdrawn KYNMOBI from the U.S. and Canadian markets. Therefore, the Company likely will not receive any of the additional contingent payments under the Monetization agreement. Further, the Company discontinued recording interest expense related to the sale of future revenue during the fourth quarter of 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the activity of the liability related to the sale of future revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties related to the sale of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:SaleOfFutureRevenueTextBlock>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-159" decimals="-3" id="f-837" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-160" decimals="-3" id="f-838" unitRef="usd">10000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-269" decimals="-3" id="f-839" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ContingentMonetizationAgreementMilestonePayment contextRef="c-159" decimals="-3" id="f-840" unitRef="usd">75000000</aqst:ContingentMonetizationAgreementMilestonePayment>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-162" decimals="-3" id="f-841" unitRef="usd">125000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-159" decimals="-3" id="f-842" unitRef="usd">40000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-160" decimals="-3" id="f-843" unitRef="usd">10000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:PaymentsOfFinancingCosts contextRef="c-270" decimals="-3" id="f-844" unitRef="usd">2909000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-203" decimals="-3" id="f-845" unitRef="usd">8000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <aqst:MinimumAnnualRoyaltyReceivable contextRef="c-271" decimals="-3" id="f-846" unitRef="usd">1000000</aqst:MinimumAnnualRoyaltyReceivable>
    <aqst:ProceedsFromSaleOfFutureRevenuesNet contextRef="c-269" decimals="-3" id="f-847" unitRef="usd">50000000</aqst:ProceedsFromSaleOfFutureRevenuesNet>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-272" decimals="3" id="f-848" unitRef="number">0.249</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <aqst:RoyaltyObligationActivityTableTextBlock contextRef="c-1" id="f-849">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the activity of the liability related to the sale of future revenue:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at beginning of the period&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Royalties related to the sale of future revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(935)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liability related to the sale of future revenue, net at end of the period (includes current portion of $1,000 and $922, respectively)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</aqst:RoyaltyObligationActivityTableTextBlock>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-4" decimals="-3" id="f-850" unitRef="usd">64490000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-47" decimals="-3" id="f-851" unitRef="usd">65259000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-273" decimals="-3" id="f-852" unitRef="usd">-935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-274" decimals="-3" id="f-853" unitRef="usd">-989000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-3" id="f-854" unitRef="usd">175000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-7" decimals="-3" id="f-855" unitRef="usd">220000</us-gaap:AmortizationOfFinancingCosts>
    <aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent contextRef="c-3" decimals="-3" id="f-856" unitRef="usd">1000000</aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent>
    <aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent contextRef="c-4" decimals="-3" id="f-857" unitRef="usd">922000</aqst:LiabilitiesSaleOfFutureRoyaltiesCurrent>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-3" decimals="-3" id="f-858" unitRef="usd">63730000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <aqst:LiabilitiesSaleOfFutureRoyalties contextRef="c-84" decimals="-3" id="f-859" unitRef="usd">64490000</aqst:LiabilitiesSaleOfFutureRoyalties>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-860">Net (Loss) Earnings Per Share&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net (loss) earnings per share is calculated by dividing net (loss) income by the weighted-average number of common shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the basic to diluted weighted average shares outstanding for the three and nine months ended September&#160;30, 2024 and 2023. Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#x2019;s equity compensation plans, warrants and ESPP. As a result of the Company&#x2019;s net loss incurred for the three months ended September&#160;30, 2024 and 2023, and for the nine months ended September&#160;30, 2024. all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended September&#160;30, 2024 and 2023 and the nine months ended September&#160;30, 2024 as reflected below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,082,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,678,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,252,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of stock options &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of warrants &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of Employee Stock Purchase Plan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,082,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,678,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,513,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Loss) Earnings per share attributable to common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Earnings per common share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Earnings per common share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,912,647 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,339,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 3,280,313 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 605,650. shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three and nine months ended September&#160;30, 2024 and the three months ended September&#160;30, 2023, the estimated effects of ESPP awards were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-861">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table reconciles the basic to diluted weighted average shares outstanding for the three and nine months ended September&#160;30, 2024 and 2023. Diluted EPS is adjusted by the effect of dilutive securities, including options and awards under the Company&#x2019;s equity compensation plans, warrants and ESPP. As a result of the Company&#x2019;s net loss incurred for the three months ended September&#160;30, 2024 and 2023, and for the nine months ended September&#160;30, 2024. all potentially dilutive instruments outstanding would have anti-dilutive effects on per-share calculations.&#160;Therefore, basic and diluted net loss per share are the same for the three months ended September&#160;30, 2024 and 2023 and the nine months ended September&#160;30, 2024 as reflected below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.383%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.556%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.529%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.563%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net (loss) income&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,509)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,035)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(27,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,082,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,678,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59,252,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of stock options &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of restricted stock units &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;654,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of warrants &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,547,751&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Effect of Employee Stock Purchase Plan &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares &#x2013; diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91,082,081&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64,678,761&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85,224,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,513,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;(Loss) Earnings per share attributable to common stockholders:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Earnings per common share &#x2013; basic&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(Loss) Earnings per common share &#x2013; diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.03)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.32)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,912,647 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding stock options to purchase 6,301,364 and 5,339,130&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 3,280,313 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding restricted stock units of 3,910,376 and 605,650. shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:8.03pt"&gt;For the three months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS. For the nine months ended September&#160;30, 2024 and 2023, outstanding warrants to purchase 4,624,977 and 4,464,429 shares of Common Stock, respectively, were anti-dilutive and excluded from the computation of diluted EPS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:7.52pt"&gt;For the three and nine months ended September&#160;30, 2024 and the three months ended September&#160;30, 2023, the estimated effects of ESPP awards were not material.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-3" id="f-862" unitRef="usd">-11509000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-6" decimals="-3" id="f-863" unitRef="usd">-2035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-864" unitRef="usd">-27082000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-3" id="f-865" unitRef="usd">241000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-5" decimals="0" id="f-866" unitRef="shares">91082081</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-6" decimals="0" id="f-867" unitRef="shares">64678761</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-868" unitRef="shares">85224263</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="0" id="f-869" unitRef="shares">59252768</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-275" decimals="0" id="f-870" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-276" decimals="0" id="f-871" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-277" decimals="0" id="f-872" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-278" decimals="0" id="f-873" unitRef="shares">57471</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-279" decimals="0" id="f-874" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-280" decimals="0" id="f-875" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-281" decimals="0" id="f-876" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-282" decimals="0" id="f-877" unitRef="shares">654682</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-5" decimals="0" id="f-878" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-6" decimals="0" id="f-879" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-1" decimals="0" id="f-880" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants contextRef="c-7" decimals="0" id="f-881" unitRef="shares">1547751</us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-283" decimals="0" id="f-882" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-284" decimals="0" id="f-883" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-285" decimals="0" id="f-884" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-286" decimals="0" id="f-885" unitRef="shares">1064</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-5" decimals="0" id="f-886" unitRef="shares">91082081</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-6" decimals="0" id="f-887" unitRef="shares">64678761</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-888" unitRef="shares">85224263</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="0" id="f-889" unitRef="shares">61513736</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-5"
      decimals="2"
      id="f-890"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-6"
      decimals="2"
      id="f-891"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-892"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-893"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-5"
      decimals="2"
      id="f-894"
      unitRef="usdPerShare">-0.13</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-6"
      decimals="2"
      id="f-895"
      unitRef="usdPerShare">-0.03</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-896"
      unitRef="usdPerShare">-0.32</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-897"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-287" decimals="0" id="f-898" unitRef="shares">6301364</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-288" decimals="0" id="f-899" unitRef="shares">5912647</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-289" decimals="0" id="f-900" unitRef="shares">6301364</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-290" decimals="0" id="f-901" unitRef="shares">5339130</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-291" decimals="0" id="f-902" unitRef="shares">3910376</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-292" decimals="0" id="f-903" unitRef="shares">3280313</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-293" decimals="0" id="f-904" unitRef="shares">3910376</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-294" decimals="0" id="f-905" unitRef="shares">605650</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-295" decimals="0" id="f-906" unitRef="shares">4624977</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-296" decimals="0" id="f-907" unitRef="shares">4464429</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-297" decimals="0" id="f-908" unitRef="shares">4624977</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-298" decimals="0" id="f-909" unitRef="shares">4464429</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c-1" id="f-910">Share-Based Compensation&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized share-based compensation in its unaudited Condensed Statements of Operations and Comprehensive (Loss) Income during 2024 and 2023 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation Equity Awards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about the Company&#x2019;s restricted stock unit and stock option activity during the nine month period ended September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Service-based:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2024, $6,677 of total unrecognized compensation expenses related to unvested service-based restricted stock units are expected to be recognized over a remaining weighted average period of 1.96 years. The service-based restricted stock units granted to employees are subject to a three-year graduated vesting schedule and are not subject to performance-based criteria other than continued employment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2024, $1,451 of unrecognized compensation expense related to unvested market condition vesting- based restricted stock units are expected to be recognized over a remaining weighted average period of 1.59 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The market conditions vesting-based restricted stock units vest based on a Performance Price measured as the 30-day average of the closing prices of the Company&#x2019;s common stock as reported on the NASDAQ Stock Market immediately prior to and including the last calendar day of the three-year performance period (which ends on the third anniversary of the grant date). To the extent the Performance Price is less than $1.75, the Vesting Percentage will be zero. To the extent the Performance Price is $1.75, the Vesting Percentage will be 50%. To the extent the Performance Price is $1.76 or greater, but less than $2.50, the Vesting Percentage will be a prorated amount between 50.01% and 99.99%, based on straight-line interpolation. To the extent the Performance Price is $2.50, the Vesting Percentage will be 100%. To the extent the Performance Price is $2.51 or greater, but less than $3.25, the Vesting Percentage will be a prorated amount between 100.01% and 149.99%, based on straight-line interpolation. To the extent the Performance Price is $3.25 or greater, the Vesting Percentage will be 150%. In no event will the Vesting Percentage exceed 150%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;2022 Inducement Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with NASDAQ Listing Rule 5635(c)(4), the Company adopted the 2022 Equity Inducement Plan approved by the Compensation Committee of the Board of Directors of the Company effective as of July 29, 2022. There were no awards outstanding under this Plan as of September&#160;30, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Stock Option Awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The weighted average grant date fair value of stock options granted during the nine months ended September&#160;30, 2024 was $3.98. During the nine months ended September&#160;30, 2024, stock options were granted with a weighted average exercise price of $4.83 and accordingly, given the Company&#x2019;s share price of $4.98 at September&#160;30, 2024, the intrinsic value provided by certain shares granted during this period was de minimis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of September&#160;30, 2024, $3,559 of unrecognized compensation expense related to non-vested stock options is expected to be recognized over a remaining weighted average period of 1.56 years.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock contextRef="c-1" id="f-911">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized share-based compensation in its unaudited Condensed Statements of Operations and Comprehensive (Loss) Income during 2024 and 2023 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:54.163%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.572%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.577%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Manufacture and supply&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;155&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,637&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation from:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,049&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;312&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,698&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,217&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Employee stock purchase plan (ESPP)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;774&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-299" decimals="-3" id="f-912" unitRef="usd">102000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-300" decimals="-3" id="f-913" unitRef="usd">59000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-301" decimals="-3" id="f-914" unitRef="usd">271000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-302" decimals="-3" id="f-915" unitRef="usd">155000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-303" decimals="-3" id="f-916" unitRef="usd">310000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-304" decimals="-3" id="f-917" unitRef="usd">105000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-305" decimals="-3" id="f-918" unitRef="usd">788000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-306" decimals="-3" id="f-919" unitRef="usd">277000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-307" decimals="-3" id="f-920" unitRef="usd">1165000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-308" decimals="-3" id="f-921" unitRef="usd">610000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-309" decimals="-3" id="f-922" unitRef="usd">3637000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-310" decimals="-3" id="f-923" unitRef="usd">1334000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-924" unitRef="usd">1577000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-925" unitRef="usd">774000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-926" unitRef="usd">4696000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-927" unitRef="usd">1766000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-279" decimals="-3" id="f-928" unitRef="usd">1049000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-280" decimals="-3" id="f-929" unitRef="usd">312000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-281" decimals="-3" id="f-930" unitRef="usd">2982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-282" decimals="-3" id="f-931" unitRef="usd">532000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-275" decimals="-3" id="f-932" unitRef="usd">528000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-276" decimals="-3" id="f-933" unitRef="usd">462000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-277" decimals="-3" id="f-934" unitRef="usd">1698000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-278" decimals="-3" id="f-935" unitRef="usd">1217000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-283" decimals="-3" id="f-936" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-284" decimals="-3" id="f-937" unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-285" decimals="-3" id="f-938" unitRef="usd">16000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-286" decimals="-3" id="f-939" unitRef="usd">17000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-5" decimals="-3" id="f-940" unitRef="usd">1577000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-6" decimals="-3" id="f-941" unitRef="usd">774000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-942" unitRef="usd">4696000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-3" id="f-943" unitRef="usd">1766000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock contextRef="c-1" id="f-944">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables provide information about the Company&#x2019;s restricted stock unit and stock option activity during the nine month period ended September&#160;30, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Service-based:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,430&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(607)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,539&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.33&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-311"
      decimals="-3"
      id="f-945"
      unitRef="shares">1948000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-311"
      decimals="2"
      id="f-946"
      unitRef="usdPerShare">0.97</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-281"
      decimals="-3"
      id="f-947"
      unitRef="shares">1430000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-281"
      decimals="2"
      id="f-948"
      unitRef="usdPerShare">5.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-281"
      decimals="-3"
      id="f-949"
      unitRef="shares">607000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-281"
      decimals="2"
      id="f-950"
      unitRef="usdPerShare">0.96</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-281"
      decimals="-3"
      id="f-951"
      unitRef="shares">43000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-281"
      decimals="2"
      id="f-952"
      unitRef="usdPerShare">1.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-312"
      decimals="-3"
      id="f-953"
      unitRef="shares">2728000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-312"
      decimals="2"
      id="f-954"
      unitRef="usdPerShare">3.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares
      contextRef="c-312"
      decimals="-3"
      id="f-955"
      unitRef="shares">2539000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue
      contextRef="c-312"
      decimals="2"
      id="f-956"
      unitRef="usdPerShare">3.33</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-312" decimals="-3" id="f-957" unitRef="usd">6677000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-281" id="f-958">P1Y11M15D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-279" id="f-959">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock contextRef="c-1" id="f-960">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:71.081%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.516%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.385%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.518%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Restricted Stock Unit Awards (RSUs) - Market conditions vesting-based:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted&lt;br/&gt;Average&lt;br/&gt;Grant Date Fair&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(150)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,182&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,089&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationPerformanceSharesAwardUnvestedActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-313"
      decimals="-3"
      id="f-961"
      unitRef="shares">1332000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-313"
      decimals="2"
      id="f-962"
      unitRef="usdPerShare">2.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-314"
      decimals="-3"
      id="f-963"
      unitRef="shares">150000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-314"
      decimals="2"
      id="f-964"
      unitRef="usdPerShare">2.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-314"
      decimals="-3"
      id="f-965"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-314"
      decimals="2"
      id="f-966"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-315"
      decimals="-3"
      id="f-967"
      unitRef="shares">1182000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-315"
      decimals="2"
      id="f-968"
      unitRef="usdPerShare">2.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares
      contextRef="c-315"
      decimals="-3"
      id="f-969"
      unitRef="shares">1089000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInShares>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue
      contextRef="c-315"
      decimals="2"
      id="f-970"
      unitRef="usdPerShare">2.40</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsEstimatedGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-315" decimals="-3" id="f-971" unitRef="usd">1451000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-314" id="f-972">P1Y7M2D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod contextRef="c-312" id="f-973">P30D</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAverageClosingPricesPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-316" id="f-974">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-317"
      decimals="2"
      id="f-975"
      unitRef="usdPerShare">1.75</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-318" decimals="2" id="f-976" unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-319"
      decimals="2"
      id="f-977"
      unitRef="usdPerShare">1.75</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-320" decimals="2" id="f-978" unitRef="number">0.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-321"
      decimals="2"
      id="f-979"
      unitRef="usdPerShare">1.76</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-322"
      decimals="2"
      id="f-980"
      unitRef="usdPerShare">2.50</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-323" decimals="4" id="f-981" unitRef="number">0.5001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-324" decimals="4" id="f-982" unitRef="number">0.9999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-325"
      decimals="2"
      id="f-983"
      unitRef="usdPerShare">2.50</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-326" decimals="2" id="f-984" unitRef="number">1</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-327"
      decimals="2"
      id="f-985"
      unitRef="usdPerShare">2.51</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-328"
      decimals="2"
      id="f-986"
      unitRef="usdPerShare">3.25</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-329" decimals="4" id="f-987" unitRef="number">1.0001</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-330" decimals="4" id="f-988" unitRef="number">1.4999</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare
      contextRef="c-331"
      decimals="2"
      id="f-989"
      unitRef="usdPerShare">3.25</aqst:ShareBasedCompensationArrangementByShareBasedPaymentMarketConditionPerformancePriceThresholdPerShare>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-332" decimals="2" id="f-990" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage contextRef="c-333" decimals="2" id="f-991" unitRef="number">1.50</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <aqst:InducementEquityCommonStockOptionsOutstandingShares contextRef="c-1" decimals="0" id="f-992" unitRef="shares">0</aqst:InducementEquityCommonStockOptionsOutstandingShares>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-993">&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.976%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.498%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"&gt;Stock Option Awards:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Number of&lt;br/&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,733&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(99)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,301&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected to vest as of September 30, 2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of September 30, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,688&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of stock options granted were estimated using the Black-Scholes pricing model based on the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.484%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.110%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:4.894%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.112%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Nine Months Ended&lt;br/&gt;September 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;104%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;107%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-334"
      decimals="-3"
      id="f-994"
      unitRef="shares">5733000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-334"
      decimals="2"
      id="f-995"
      unitRef="usdPerShare">5.58</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="c-277"
      decimals="-3"
      id="f-996"
      unitRef="shares">1024000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-277"
      decimals="2"
      id="f-997"
      unitRef="usdPerShare">4.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="c-277"
      decimals="-3"
      id="f-998"
      unitRef="shares">357000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-277"
      decimals="2"
      id="f-999"
      unitRef="usdPerShare">2.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod
      contextRef="c-277"
      decimals="-3"
      id="f-1000"
      unitRef="shares">99000</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriod>
    <aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="c-277"
      decimals="2"
      id="f-1001"
      unitRef="usdPerShare">3.84</aqst:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="c-335"
      decimals="-3"
      id="f-1002"
      unitRef="shares">6301000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-335"
      decimals="2"
      id="f-1003"
      unitRef="usdPerShare">5.68</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="c-335"
      decimals="-3"
      id="f-1004"
      unitRef="shares">6210000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="c-335"
      decimals="2"
      id="f-1005"
      unitRef="usdPerShare">5.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="c-335"
      decimals="-3"
      id="f-1006"
      unitRef="shares">4688000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="c-335"
      decimals="2"
      id="f-1007"
      unitRef="usdPerShare">6.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-277"
      decimals="3"
      id="f-1008"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
      contextRef="c-277"
      decimals="2"
      id="f-1009"
      unitRef="number">1.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
      contextRef="c-277"
      decimals="2"
      id="f-1010"
      unitRef="number">1.07</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-336" id="f-1011">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-337" id="f-1012">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-336"
      decimals="3"
      id="f-1013"
      unitRef="number">0.041</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-337"
      decimals="3"
      id="f-1014"
      unitRef="number">0.045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-277"
      decimals="4"
      id="f-1015"
      unitRef="usdPerShare">3.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="c-277"
      decimals="2"
      id="f-1016"
      unitRef="usdPerShare">4.83</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:SharePrice
      contextRef="c-4"
      decimals="2"
      id="f-1017"
      unitRef="usdPerShare">4.98</us-gaap:SharePrice>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions contextRef="c-335" decimals="-3" id="f-1018" unitRef="usd">3559000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-277" id="f-1019">P1Y6M21D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1020">Income Taxes&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has accounted for income taxes under the asset and liability method, which requires deferred tax assets and liabilities to be recognized for the estimated future tax consequences attributable to differences between financial statement carrying amounts and respective tax bases of existing assets and liabilities, as well as net operating loss carryforwards and research and development credits. Valuation allowances are provided if it is more likely than not that some portion or all of the deferred tax asset will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s tax provision for interim periods is determined using an estimate of its annual effective tax rate, adjusted for discrete items. For the three and nine months ended September&#160;30, 2024, the effective income tax rate was 0%, and the Company recorded no income tax expense from its pretax losses of $11,509 and $27,082, respectively. For the three and nine months ended September&#160;30, 2023, the effective income tax rate was 6.4% and 37.4%, respectively, and the Company recorded ($140) and $144 from its pretax (loss) income of ($2,175) and $385, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The primary factors impacting the effective tax rate for nine months ended September&#160;30, 2024 is the anticipated full year pre-tax book loss and a full valuation allowance against any associated net deferred tax assets.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-5" decimals="3" id="f-1021" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-1" decimals="3" id="f-1022" unitRef="number">0</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-5" decimals="-3" id="f-1023" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1024" unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-5" decimals="-3" id="f-1025" unitRef="usd">-11509000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1026" unitRef="usd">-27082000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-6" decimals="3" id="f-1027" unitRef="number">0.064</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations contextRef="c-7" decimals="3" id="f-1028" unitRef="number">0.374</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-6" decimals="-3" id="f-1029" unitRef="usd">-140000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-3" id="f-1030" unitRef="usd">144000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-6" decimals="-3" id="f-1031" unitRef="usd">-2175000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-3" id="f-1032" unitRef="usd">385000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c-1" id="f-1033">Contingencies&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company has been and may again become involved in legal proceedings arising in the course of its business, including product liability, intellectual property, securities, civil tort, and commercial litigation, and environmental or other regulatory matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Kentucky Litigation - Humana&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Humana Inc. v. Indivior Inc, Indivior Solutions Inc., Indivior PLC, Reckitt Benckiser Group plc, Reckitt Benckiser Healthcare (UK) Ltd., and Aquestive Therapeutics, Inc. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 20, 2021, Humana filed a complaint in state court in Kentucky, alleging conspiracy to violate the RICO Act, fraud under state law, unfair and deceptive trade practices under state law, insurance fraud, and unjust enrichment against the Company relating to Indivior&#x2019;s launch of Suboxone Sublingual Film in 2010. The Humana action was stayed pending related litigation, and the stay was lifted on October 30, 2023. On February 23, 2024, the Company filed a motion to dismiss the Complaint. Oral argument on the Company's motion to dismiss is currently set for December 9, 2024. No discovery schedule has been set in the action and there is no trial date set in this case. The Company is not able to determine or predict the ultimate outcome of the state court action in Kentucky by Humana or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;California Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Neurelis, Inc. v. Aquestive Therapeutics, Inc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 5, 2019, Neurelis Inc. filed a lawsuit against the Company in the Superior Court of California, County of San Diego alleging the following three causes of action: (1) Unfair Competition under California Business and Professional Code &#xa7; 17200 (&#x201c;UCL&#x201d;); (2) Defamation; and (3) Malicious Prosecution. Neurelis filed a First Amended Complaint on December 9, 2019, alleging the same three causes of action. The Company filed a Motion to Strike Neurelis&#x2019;s Complaint under California&#x2019;s anti-SLAPP (&#x201c;strategic lawsuit against public participation&#x201d;) statute on January 31, 2020, which Neurelis opposed. On August 6, 2020, the Court issued an order granting in part and denying in part the Company&#x2019;s anti-SLAPP motion. The parties cross-appealed the ruling to the California Court of Appeal. The appeals court held oral argument on the appeal on October 14, 2021, and issued its ruling on November 17, 2021. Under the ruling, the court struck the entirety of the malicious prosecution claim and struck portions of the UCL and defamation claims. On April 12, 2022, Neurelis filed a Second Amended Complaint in response to the Court of Appeal&#x2019;s decision. The Second Amended Complaint also added a cause of action for Trade Libel. On May 3, 2022, the Company filed a "demurrer" challenge to the sufficiency of the allegations of the Second Amended Complaint. Oral argument on the Company&#x2019;s motion for attorney fees related to the anti-SLAPP motion and on the Second Amended Complaint and demurer challenge was held on June 17, 2022. The Court entered an order granting the Company&#x2019;s motion for attorney fees, awarding $156 and ordering Neurelis to pay the fees within 60 days of June 17, 2022. The Court denied the Company&#x2019;s demurrer and the parties proceeded with discovery on the claims in the Second Amended Complaint. The plaintiff filed a motion to file a third amended complaint, which the Court granted on November 17, 2023. The Third Amended Complaint alleges additional facts but includes the same claims as the Second Amended Complaint. Trial in this matter is scheduled for March 7, 2025. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Neurelis FDA Lawsuit&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;Neurelis v. Califf, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"&gt;et al&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"&gt;.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, U.S. District court for the District of Columbia&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2024, Neurelis Inc. filed a complaint in the U.S. District Court for the District of Columbia against the U.S. Food and Drug Administration, the U.S. Department of Health and Human Services, and certain government officials. The complaint in this matter alleges that the defendants violated the Administrative Procedure Act by approving Aquestive&#x2019;s New Drug Application for Libervant&#x2122; for epilepsy patients aged between two and five years, and asks the Court to vacate that approval and enjoin the defendants from approving Libervant&#x2122; for this pediatric patient population until January 10, 2027, the scheduled date for the expiration of the orphan drug market exclusivity granted to the nasal spray product of Neurelis, Inc. by the FDA. Aquestive intervened in the litigation to defend the approval of Libervant&#x2122; for this pediatric patient population and on June 25, 2024, the Court entered a scheduling order governing further proceedings in the case. Pursuant to that order, Neurelis filed a motion for summary judgment on August 19, 2024; Aquestive and the federal defendants each filed their own cross-motions for summary judgment and opposed Neurelis&#x2019;s motion for summary judgment on September 18, 2024; Neurelis filed its combined reply brief in support of its motion for summary judgment and in opposition to the defendants&#x2019; cross-motions on October 9, 2024; and Aquestive and the federal defendants filed their closing briefs on October 30, 2024. No oral argument date has been set in this case. The Company is not able to determine or predict the ultimate outcome of this proceeding or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Suboxone Product Liability Litigation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;As of October 21, 2024, the Company was named as a defendant in over 560 product liability lawsuits, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#xae;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt; Sublingual Film, a prescription drug product for opioid use disorder, caused them dental injuries. On February 2, 2024, this litigation became a Multidistrict Litigation (&#x201c;MDL") consolidated in the United States District Court for the Northern District of Ohio. One case alleging the same allegations as contained in the MDL has been filed in a state court in the State of New Jersey. The parties to the MDL have agreed to a tolling of unfiled claimants in several states. Indivior has agreed to defend the Company in these litigation matters. No discovery schedule or trial date has been set in the MDL matter. The Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of October 15, 2024, the Company was named as a defendant in three proposed class action lawsuits filed in Canada, along with Indivior and several other named defendants, in which the individual plaintiffs in those cases allege that their use of Suboxone&#xae; products caused them dental injuries. Two of these cases have been filed in British Columbia, and the plaintiffs in those cases are seeking assignment of a case management judge. The anticipated next step in British Columbia will involve applications by the plaintiffs to determine which of the two cases will proceed towards a certification hearing and which will be stayed. The third case has been filed in Quebec, and is proceeding towards an authorization hearing (date to be set). The authorization and certification hearings are where the Courts will determine if the cases will proceed as class actions. No discovery schedule or trial dates have been set, as all the Canadian cases are pre-certification/pre-authorization. Given the early stages of these proceedings, the Company is not able to determine or predict the ultimate outcome of this litigation or provide a reasonable estimate or range of estimates of the possible outcome or loss, if any, in this matter.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-338"
      decimals="INF"
      id="f-1034"
      unitRef="cause">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-338"
      decimals="INF"
      id="f-1035"
      unitRef="cause">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LitigationSettlementAmountAwardedFromOtherParty contextRef="c-339" decimals="-3" id="f-1036" unitRef="usd">156000</us-gaap:LitigationSettlementAmountAwardedFromOtherParty>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="c-340"
      decimals="0"
      id="f-1037"
      unitRef="plaintiff">560</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-341"
      decimals="INF"
      id="f-1038"
      unitRef="lawsuit">3</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-342"
      decimals="INF"
      id="f-1039"
      unitRef="lawsuit">2</us-gaap:LossContingencyPendingClaimsNumber>
    <us-gaap:LossContingencyPendingClaimsNumber
      contextRef="c-342"
      decimals="INF"
      id="f-1040"
      unitRef="lawsuit">2</us-gaap:LossContingencyPendingClaimsNumber>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-5" id="f-1041">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-5" id="f-1042">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-5" id="f-1043">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-344" id="f-1045">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Chief Executive Officer Daniel Barber adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Barber Plan") on June 14, 2024. The Barber Plan commenced on September 13, 2024 and ends on September 30, 2025. The maximum number of shares to be sold under the Barber Plan is 650,055 shares and no shares have been sold as of the date of this Report; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Barber Plan.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndTitle contextRef="c-343" id="f-1044">Chief Executive Officer</ecd:TrdArrIndTitle>
    <ecd:TrdArrIndName contextRef="c-343" id="f-1046">Daniel Barber</ecd:TrdArrIndName>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-343" id="f-1047">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-343" id="f-1048">June 14, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrExpirationDate contextRef="c-343" id="f-1049">September 30, 2025</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-345"
      decimals="0"
      id="f-1050"
      unitRef="shares">650055</ecd:TrdArrSecuritiesAggAvailAmt>
    <ecd:MtrlTermsOfTrdArrTextBlock contextRef="c-347" id="f-1052">&lt;div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Vice President Peter Boyd adopted a written sales plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act (the "Boyd Plan") on September 11, 2024. The Boyd Plan commences on December 13, 2024 and ends on December 12, 2025. The maximum number of shares to be sold under the Boyd Plan is 35,000 shares; the actual number of shares sold will be dependent on the satisfaction of certain conditions set forth in the Boyd Plan.&lt;/span&gt;&lt;/div&gt;</ecd:MtrlTermsOfTrdArrTextBlock>
    <ecd:TrdArrIndTitle contextRef="c-346" id="f-1051">Senior Vice President</ecd:TrdArrIndTitle>
    <ecd:TrdArrIndName contextRef="c-346" id="f-1053">Peter Boyd</ecd:TrdArrIndName>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-346" id="f-1054">true</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:TrdArrAdoptionDate contextRef="c-346" id="f-1055">September 11, 2024</ecd:TrdArrAdoptionDate>
    <ecd:TrdArrExpirationDate contextRef="c-346" id="f-1056">December 12, 2025</ecd:TrdArrExpirationDate>
    <ecd:TrdArrSecuritiesAggAvailAmt
      contextRef="c-348"
      decimals="0"
      id="f-1057"
      unitRef="shares">35000</ecd:TrdArrSecuritiesAggAvailAmt>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
